Structure Search

List Search MOL Search Structure Search

 EN

English - EN Chinese - ZH

 Cart 0
Chemistry
Life Science
Catalysts Ligands
Materials Science
Catalysts Ligands
Achiral Nitrogen Ligands
Pyridine and Phenanthroline Ligands (162)
Other Achiral Nitrogen Ligands (53)
Achiral Oxygen Ligands
Achiral Oxygen Ligand (54)
Achiral Phosphine Ligands
Alkyl-phosphine Ligands (17)
Aryl-phosphine Ligands (86)
2-(Diphenylphosphaneyl)Benzaldehyde (5)[1,1'-Biphenyl]-2-Yldi-Tert-Butylphosphane (4)Triphenylphosphine Oxide (7)
Bis-phosphine Ligands (90)
Mono-phosphine Ligands (256)
Multi-phosphine Ligands (5)
Chiral Nitrogen Ligands
Chiral Bis-nitrogen Ligands (133)
Salen Ligands (7)
Other Chiral Nitrogen Ligands (69)
Chiral Oxazoline Ligands
BOX Ligands (510)
Chiral Mono Oxazoline Ligands (363)
Ferrocenyl-oxazoline Ligands (10)
PHOX Ligands (218)
SOX Ligands (34)
TOX Ligands (6)
Other Oxazoline Ligands (14)
Chiral Oxygen Ligands
BINOLs (46)
BIPHENs (2)
Chiral Diphenols (112)
Other Chiral Oxygen Ligands (24)
Chiral Phosphine Ligands
Atropisomeric Bisphosphine Ligands (137)
BIDIME and BIBOP Ligands (78)
BIDIME-BIBOP (7)
2,2',3,3'-Tetrahydro-4,4'-Bibenzo[D][1,3]Oxaphosphole (7)
Chiral Aminophosphine Ligands (50)
Chiral Ferrocenyl Phosphine Ligands (96)
Chiral Phosphoramidite Ligands (98)
Duphos and BPE Ligands (28)
PHOX Ligands (218)
Sadphos Ligands (110)
Other C-Chiral Ligands (76)
Other P-Chiral Ligands (10)
Main-Group Metals
Aluminum (11)
Tin (3)
Metalloids
Metalloid (5)
Organocatalysts
Chiral Hydrogen-Bonding Organocatalysts (79)
Chiral Phosphoric Acids (161)
4-Hydroxy-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepine 4-Oxide (20)
Cinchona Alkaloids (32)
MacMillan Imidazolidinone Organocatalysts (15)
NHTf (59)
Proline-Based Organocatalysts (51)
Other Organocatalysts (45)
Phase-Transfer Catalysts
Achiral Phase-Transfer Catalysts (61)
Chiral Phase-Transfer Catalysts (25)
Photoredox Catalysts
Organic-dye Photoredox Catalysts (86)
Photoredox Acridinium Catalysts (22)
Photoredox Carbazole Catalysts (10)
Photoredox Iridiums Catalysts (104)
Photoredox Rutheniums Catalysts (37)
Other Photoredox Catalysts (13)
Transition Metals
Cadmium (1)
Cobalt (92)
Copper (108)
Gold (70)
Iridium (60)
Iron (101)
Manganese (45)
Molybdenum (11)
Nickel (95)
Osmium (2)
Palladium (240)
Platinum (75)
Rhenium (6)
Rhodium (166)
Ruthenium (199)
Silver (33)
Tantalum (1)
Titanium (10)
Tungsten (6)
Vanadium (6)
Zinc (48)
Other Cheap Metals (6)
Chemistry
Asymmetric Synthesis
Chiral Building Blocks (18939)
Boronic Acids/Esters
1,3,2-Dioxaborinane (394)
Bcat (11)
Boronic Acids (13202)
MIDA Boronates (363)
Pinacol Boronates (16140)
Pinane Boronates (96)
Potassium Organotrifluoroborate Salts (1076)
Other Boronates (132)
Heterocyclic Building Blocks
Acridines (640)
1,2,3,4-Tetrahydroacridine (9)9,10-Diphenylacridin-10-Ium (6)Acridine (18)
Aliphatic Heterocycles (103)
(1R,5S)-3-Azabicyclo[3.1.0]Hexane (11)1,2-Dithiolane (6)1,4-Diazepan-2-One (5)1,4-Diazepan-5-One (9)1,4-Dioxane (17)1,4-Oxazepane (8)10,11-Dihydro-5H-Dibenzo[B,F]Azepine (9)11,12-Didehydro-5,6-Dihydrodibenz[B,F]Azocine (14)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Glycyl)-2,2-Dimethyloxazolidine-4-Carboxylic Acid (8)3H-Diazirine (11)4-Benzyl-1,4-Oxazepane (5)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)
Aromatic Heterocycles (30)
1,2,4,5-Tetrazine (7)3,4-Dihydronaphthalen-2(1H)-One (23)
Azetidines (2997)
1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Phenylsulfonyl)Azetidine (7)1-Benzhydrylazetidine (13)1-Benzylazetidine (6)1-Methylazetidine (6)1-Phenylazetidine (8)2,7-Diazaspiro[3.5]Nonane (7)2-Azaspiro[3.3]Heptane (11)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)3-Bromoazetidine (3)3-Methylazetidin-3-Ol (3)3-Methyleneazetidine (8)3-Phenylazetidine (5)4-(Azetidin-1-Yl)Piperidine (6)Azetidin-2-One (11)Azetidin-2-Ylmethanol (7)Azetidin-3-Amine (4)Azetidin-3-Ol (11)Azetidin-3-Yl Acetate (3)Azetidin-3-Ylmethanamine (3)Azetidine-2-Carboxylic Acid (6)Azetidine-3-Carboxylic Acid (5)Benzyl Azetidine-1-Carboxylate (9)Methyl Azetidine-2-Carboxylate (3)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)Tert-Butyl Azetidine-1-Carboxylate (64)
Benzimidazoles (4428)
Benzimidazole-Carboxylic Acid (43)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)1,2-Diphenyl-1H-Benzo[D]Imidazole (7)1-Benzyl-1H-Benzo[D]Imidazole (6)1-Ethyl-1H-Benzo[D]Imidazole (4)1-Methyl-1H-Benzo[D]Imidazole (47)1-Phenyl-1H-Benzo[D]Imidazole (4)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-2-Thiol (10)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-Benzyl-1H-Benzo[D]Imidazole (7)2-Bromo-1H-Benzo[D]Imidazole (4)2-Chloro-1H-Benzo[D]Imidazole (17)2-Methyl-1H-Benzo[D]Imidazole (20)4-Bromo-1H-Benzo[D]Imidazole (14)4-Methyl-1H-Benzo[D]Imidazole (7)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5-Bromo-1H-Benzo[D]Imidazole (13)5-Chloro-1H-Benzo[D]Imidazole (14)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methyl-1H-Benzo[D]Imidazole (10)6-Chloro-1H-Benzo[D]Imidazole (25)Methyl (1H-Benzo[D]Imidazol-2-Yl)Carbamate (5)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (5)
Benzisoxazoles (508)
3-Chlorobenzo[D]Isoxazole (7)3-Methylbenzo[D]Isoxazole (8)6-Bromobenzo[D]Isoxazole (5)Benzo[C]Isoxazole (5)Benzo[D]Isoxazol-3-Amine (8)
Benzodioxans (697)
(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)6-Bromo-2,3-Dihydrobenzo[B][1,4]Dioxine (6)
Benzofurans (3713)
Benzofuran-Carboxylic Acid (67)Dimethoxyisobenzofuran (4)Epoxyisobenzofuran (1)Fluorobenzofuran (19)Fluoroisobenzofuran (5)Methoxyisobenzofuran (4)Methylbenzofuran (25)1-(Benzofuran-2-Yl)Ethan-1-One (3)2,2-Dimethyl-2,3-Dihydrobenzofuran (7)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,3-Dihydrobenzofuran-7-Amine (5)2-(Benzofuran-3-Yl)Acetic Acid (3)2-Bromodibenzo[B,D]Furan (6)2-Ethylbenzofuran (3)2-Methylbenzofuran (5)3-Methylbenzofuran (4)4-Bromobenzofuran (3)4-Phenyldibenzo[B,D]Furan (8)5,7,8-Trimethylchromane (3)5-Bromo-2,3-Dihydrobenzofuran (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Methoxyisobenzofuran-1(3H)-One (5)6-Bromo-2,3-Dihydrobenzofuran (6)6-Fluoro-2,3-Dihydrobenzofuran (6)6-Methoxybenzofuran (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromobenzofuran (6)7-Fluoro-2,3-Dihydrobenzofuran (6)Benzofuran-2(3H)-One (7)Benzofuran-2-Carbaldehyde (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-2-Ylboronic Acid (8)Benzofuran-3(2H)-One (15)Benzofuran-3-Carboxylic Acid (6)Benzofuran-3-Yl(Phenyl)Methanone (11)Methyl Benzofuran-2-Carboxylate (6)
Benzothiazoles (2422)
Benzothiazole-Carboxylic Acid (27)Bromobenzothiazole (7)Dichlorobenzothiazole (10)Methoxybenzothiazole (4)Methylbenzothiazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-Bromobenzo[D]Thiazole (28)2-Chlorobenzo[D]Thiazole (21)2-Methylbenzo[D]Thiazole (26)4-Bromobenzo[D]Thiazole (9)4-Chlorobenzo[D]Thiazole (7)4-Fluorobenzo[D]Thiazole (6)4-Methylbenzo[D]Thiazole (10)5-Chlorobenzo[D]Thiazole (5)5-Nitrobenzo[D]Thiazole (3)6-Bromobenzo[D]Thiazole (7)6-Chlorobenzo[D]Thiazole (6)6-Fluorobenzo[D]Thiazole (5)6-Methoxybenzo[D]Thiazole (6)6-Methylbenzo[D]Thiazole (6)6-Nitrobenzo[D]Thiazole (3)7-Bromobenzo[D]Thiazole (8)7-Chlorobenzo[D]Thiazole (6)7-Fluorobenzo[D]Thiazole (9)Benzo[D]Thiazol-2-Amine (29)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzo[D]Thiazol-6-Ol (2)Benzo[D]Thiazole-2-Carbonitrile (11)Benzo[D]Thiazole-2-Thiol (11)Benzo[D]Thiazole-6-Carboxylic Acid (5)Methyl Benzo[D]Thiazole-6-Carboxylate (5)
Benzothiophenes (1116)
Benzothiophene-Carboxylic Acid (58)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-Methylbenzo[B]Thiophene (4)3-Bromobenzo[B]Thiophene (5)3-Chlorobenzo[B]Thiophene (6)3-Methylbenzo[B]Thiophene (4)4,5,6,7-Tetrahydrobenzo[B]Thiophene (21)5-Bromobenzo[B]Thiophene (3)5-Chlorobenzo[B]Thiophene (4)6-Bromobenzo[B]Thiophene (4)7-Bromobenzo[B]Thiophene (5)Benzo[B]Thiophen-2-Amine (5)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[B]Thiophene-3-Carbaldehyde (6)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Methyl Benzo[B]Thiophene-2-Carboxylate (27)
Benzoxazoles (2804)
Benzoxazole-Carboxylic Acid (25)2-Chlorobenzo[D]Oxazole (11)2-Methylbenzo[D]Oxazole (26)2-Phenylbenzo[D]Oxazole (22)3-Phenylbenzo[D]Oxazol-3-Ium (8)5-Bromobenzo[D]Oxazole (3)5-Chlorobenzo[D]Oxazole (5)5-Methylbenzo[D]Oxazole (3)6-Chlorobenzo[D]Oxazole (4)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Oxazole-2-Thiol (6)Methyl Benzo[D]Oxazole-2-Carboxylate (3)
Carbazole Series (482)
Carbazolyl-Phenyl-Boronic Acid/Ester (14)1-Methyl-9H-Carbazole (7)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2-Bromo-9H-Carbazole (4)3,9-Diphenyl-9H-Carbazole (7)3-(Tert-Butyl)-9H-Carbazole (3)3-Bromo-9-Phenyl-9H-Carbazole (16)3-Bromo-9H-Carbazole (4)3-Chloro-9H-Carbazole (3)3-Methyl-9H-Carbazole (3)7H-Benzo[C]Carbazole (5)9-([1,1'-Biphenyl]-4-Yl)-9H-Carbazole (9)9-(P-Tolyl)-9H-Carbazole (5)9-Benzyl-9H-Carbazole (7)9-Ethyl-9H-Carbazole (10)
Cinnolines (355)
Cinnoline (11)
Dioxolanes (1580)
(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)1,3-Dioxolan-2-One (11)2,2-Difluorobenzo[D][1,3]Dioxole (24)2,2-Dimethyl-1,3-Dioxolane (29)2,2-Dimethylbenzo[D][1,3]Dioxole (7)2-Phenyl-1,3-Dioxolane (18)4-Bromobenzo[D][1,3]Dioxole (6)4-Methyl-1,3-Dioxolane (5)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromobenzo[D][1,3]Dioxole (12)5-Chlorobenzo[D][1,3]Dioxole (5)5-Nitrobenzo[D][1,3]Dioxole (4)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)Benzo[D][1,3]Dioxol-5-Amine (3)
Dioxoles (13)
Epoxides (407)
Epoxy (7)Oxirane (64)7-Oxabicyclo[4.1.0]Heptane (7)Ethyl Oxirane-2-Carboxylate (4)Oxiran-2-Ylmethanol (3)
Furans (7000)
Aminodihydrofuran (7)Bromofuran (32)Chlorofuran (2)Chlorofuro (11)Cyanofuran (53)Dibromofuran (5)Dihydrofuran (31)Dihydrofuro (15)Dihydroxydihydrofuran (8)Dimethylfuran (10)Formylfuran (10)Hexahydrofuro (6)Hydroxydihydrofuran (31)Methyldihydrofuran (11)Methylfuran (58)Nitrofuran (10)2,3-Dihydrofuran-3-One (9)2-(Bromomethyl)Furan (3)2-(Chloromethyl)Furan (3)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-Bromofuran (21)2-Chlorofuran (3)2-Methylfuran (37)2-Nitrofuran (9)3-Bromofuran (13)4-Methylisobenzofuran-1(3H)-One (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Phenylfuran-2-Carbaldehyde (9)5-Phenylfuran-2-Carboxylic Acid (6)6-Chloro-2,3-Dihydrobenzofuran (3)6-Fluoroisobenzofuran-1(3H)-One (3)7-Chloro-2,3-Dihydrobenzofuran (3)Ethyl Furan-2-Carboxylate (6)Furan-2,5-Dione (8)Furan-2-Carbaldehyde (22)Furan-2-Carbonitrile (8)Furan-2-Carboxylic Acid (31)Furan-2-Ylmethanol (5)Furan-3-Carboxylic Acid (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Methyl Furan-2-Carboxylate (20)N-(Furan-2-Ylmethyl)Aniline (5)
Imidazoles (833)
Biimidazole (5)Bromoimidazo (102)Dibromoimidazo (8)Dichloroimidazo (9)Dihydroimidazo (25)Imidazol-Amine (1)Methoxyimidazo (13)Methylimidazo (121)Tetrahydroimidazo (40)1,1'-Diphenyl-4,4',5,5'-Tetrahydro-1H,1'H-2,2'-Biimidazole (11)1,2-Dimethyl-1H-Imidazole (6)1,3-Diphenyl-1H-Imidazol-3-Ium (14)1,3-Diphenyl-4,5-Dihydro-1H-Imidazol-3-Ium (5)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(Phenylsulfonyl)-1H-Imidazole (5)1-Benzyl-1H-Imidazole (19)1-Decyl-3-Methyl-1H-Imidazol-3-Ium (14)1-Ethyl-1H-Imidazole (3)1-Isopropyl-1H-Imidazole (5)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Trityl-1H-Imidazole (15)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Imidazol-2-Amine (6)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carbonitrile (2)1H-Imidazole-4-Carboxylic Acid (4)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-Bromo-1H-Imidazole (13)2-Bromoimidazo[1,2-A]Pyridine (5)2-Ethyl-1H-Imidazole (3)2-Methyl-1-Phenyl-1H-Imidazole (11)2-Methylimidazo[1,2-A]Pyridine (8)2-Phenyl-1H-Benzo[D]Imidazole (26)2-Phenyl-1H-Imidazole (26)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propyl-1H-Imidazole (5)3-Bromoimidazo[1,2-A]Pyrazine (6)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Iodoimidazo[1,2-A]Pyridine (10)3-Methylimidazo[1,2-A]Pyridine (3)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Methyl-1-Phenyl-1H-Imidazole (7)4-Methyl-1H-Imidazole (6)4-Phenyl-1H-Imidazole (8)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Benzyl-1H-Imidazole (1)5-Bromoimidazo[1,2-A]Pyridine (6)5-Chloro-1H-Imidazole (2)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Iodo-1H-Imidazole (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Phenyl-1H-Imidazole (6)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6-Bromoimidazo[1,2-A]Pyrazine (11)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloroimidazo[1,2-B]Pyridazine (30)7-Methylimidazo[1,2-A]Pyridine (3)8-Bromoimidazo[1,2-A]Pyrazine (7)8-Bromoimidazo[1,2-A]Pyridine (15)8-Chloroimidazo[1,2-A]Pyrazine (8)8-Chloroimidazo[1,2-A]Pyridine (7)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Methylimidazo[1,2-A]Pyridine (9)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Imidazo[1,2-A]Pyridin-8-Ol (3)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Imidazo[1,2-C]Pyrimidine (6)Imidazo[1,5-A]Pyrazine (9)Imidazo[2,1-B]Thiazole (14)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)
Imidazolidines (1145)
Methylimidazolidine (3)Oxoimidazolidine (8)Thioxoimidazolidin (9)(3Ar,6As)-Tetrahydro-1H-Thieno[3,4-D]Imidazol-2(3H)-One (18)1-Phenylimidazolidin-2-One (8)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylimidazolidine-2,4-Dione (4)Imidazolidin-2-One (16)Imidazolidine-2,4-Dione (17)
Imidazolines (695)
Indazoles (3081)
Indazol-Amide (3)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)1-Benzyl-1H-Indazole (7)1-Ethyl-1H-Indazole (7)1H-Indazol-3-Amine (23)1H-Indazol-3-Ol (10)1H-Indazol-4-Amine (12)1H-Indazol-4-Ol (4)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-6-Ol (6)1H-Indazol-7-Amine (6)1H-Indazole-3-Carbaldehyde (19)1H-Indazole-3-Carbonitrile (9)1H-Indazole-3-Carboxylic Acid (27)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)2,3-Dimethyl-2H-Indazole (4)2-Methyl-2H-Indazole (34)3-(Piperidin-4-Yl)-1H-Indazole (5)3-Chloro-1H-Indazole (13)4,5,6,7-Tetrahydro-1H-Indazole (12)4-Chloro-1H-Indazole (18)4-Fluoro-1H-Indazole (22)4-Methoxy-1H-Indazole (7)4-Methyl-1H-Indazole (12)4-Nitro-1H-Indazole (10)5-Bromo-1H-Indazole (14)5-Chloro-1H-Indazole (9)5-Methoxy-1H-Indazole (5)5-Nitro-1H-Indazole (5)6-(Trifluoromethyl)-1H-Indazole (6)6-Bromo-1H-Indazole (23)6-Chloro-1H-Indazole (14)6-Fluoro-1H-Indazole (15)6-Methoxy-1H-Indazole (14)6-Methyl-1H-Indazole (9)6-Nitro-1H-Indazole (9)7-Bromo-1H-Indazole (18)7-Chloro-1H-Indazole (7)7-Fluoro-1H-Indazole (12)7-Methoxy-1H-Indazole (5)7-Nitro-1H-Indazole (11)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Tert-Butyl 1H-Indazole-1-Carboxylate (29)
Indoles (7683)
Azaindole (44)Benzyloxyindole (1)Biindolinylidene (1)Bromo-Indole-Carboxylic Acid (28)Cyanoindole (5)Dihydroindolo (14)Fluoroindole (5)Formylindole (44)Hydroxyindole (7)Hydroxyisoindoline (2)Indolecarboxylic (2)Isoindole (26)Methoxyindole (9)Nitroindole (6)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1H-Indol-2-Yl)Boronic Acid (3)(1H-Indol-2-Yl)Methanol (8)(3As,7As)-Octahydro-1H-Indole (5)(9H-Fluoren-9-Yl)Methyl (2-(1H-Indol-3-Yl)Ethyl)Carbamate (12)1,2,3,4-Tetrahydrocyclopenta[B]Indole (5)1,2-Dimethyl-1H-Indole (4)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(Phenylsulfonyl)-1H-Indole (26)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)1-Benzyl-1H-Indole (10)1-Ethyl-1H-Indole (7)1-Methyl-1H-Indole (85)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Methyl-1H-Pyrrolo[2,3-B]Pyridine (14)1-Phenyl-1H-Indole (5)1H-Indol-3-Ol (5)1H-Indol-3-Yl Acetate (4)1H-Indol-4-Amine (10)1H-Indol-4-Ol (7)1H-Indol-5-Ol (4)1H-Indol-6-Amine (21)1H-Indol-6-Ol (6)1H-Indol-7-Amine (10)1H-Indole-2-Carbaldehyde (20)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-3-Carboxylic Acid (32)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carbonitrile (5)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carbonitrile (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carbonitrile (6)1H-Indole-7-Carboxylic Acid (7)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (12)2,3-Dimethyl-1H-Indole (9)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(4-Fluorophenyl)-1H-Indole (4)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Methyl-1H-Pyrrolo[2,3-B]Pyridine (12)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(Piperidin-4-Yl)-1H-Indole (8)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Methyl-1H-Indole (41)3H-Indole (8)4-Bromo-1H-Indole (25)4-Chloro-1H-Indole (21)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoroindoline-2,3-Dione (3)4-Methoxy-1H-Indole (11)4-Methyl-1H-Indole (23)4-Nitro-1H-Indole (6)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(Benzyloxy)-1H-Indole (8)5-Bromo-1-Methyl-1H-Indole (4)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoroindolin-2-One (4)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methyl-1H-Indole (33)5-Nitro-1H-Indole (6)6-(Trifluoromethyl)-1H-Indole (5)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Fluoro-1H-Indole (17)6-Methoxy-1H-Indole (12)6-Methyl-1H-Indole (29)6-Methyl-1H-Pyrrolo[2,3-B]Pyridine (8)6-Nitro-1H-Indole (8)7-Bromo-1H-Indole (28)7-Bromoindoline-2,3-Dione (3)7-Chloro-1H-Indole (29)7-Fluoro-1H-Indole (24)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)7-Methoxy-1H-Indole (8)7-Methyl-1H-Indole (34)7-Nitro-1H-Indole (11)9H-Pyrido[3,4-B]Indole (5)Benzo[Cd]Indol-2(1H)-One (5)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 2-(1H-Indol-3-Yl)Acetate (3)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)Tryptophan (21)
Indolines (4489)
Aminoindoline (10)Bromoindoline (17)Bromoisoindolin (5)Bromoisoindoline (6)Chloroindolin (4)Chloroisoindoline (3)Dibromoindoline (12)Dichloroindoline (16)Difluoroindoline (1)Dimethylindoline (21)Dioxoindoline (8)Dioxoisoindolin (72)Fluoroindolin (9)Fluoroindoline (9)Fluoroisoindoline (10)Hydroxyindolin (5)Indoline-Carboxylate (1)Isoindoline (20)Methoxyindoline (12)Methoxyisoindoline (9)Methylindoline (46)Methylisoindoline (18)Nitroindolin (6)Nitroindoline (11)Nitroisoindoline (8)Oxoindoline (32)Oxoisoindoline (16)Spiro-Indoline-Piperidine (34)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1-(Indolin-1-Yl)Ethan-1-One (9)1-Benzylindoline-2,3-Dione (5)1-Methylindolin-2-One (14)1-Methylindoline (3)1-Methylindoline-2,3-Dione (8)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-Methylindoline (7)2-Methylisoindolin-1-One (7)3,3-Dimethylindolin-2-One (5)3,3-Dimethylindoline (7)4-Bromoindoline (4)4-Chloroindoline-2,3-Dione (6)4-Methylindoline (3)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-Bromoindolin-2-One (5)5-Bromoindoline (8)5-Bromoisoindoline-1,3-Dione (3)5-Chloroindolin-2-One (3)5-Fluoroindoline (3)5-Methoxyindoline (4)5-Methylindolin-2-One (3)5-Methylindoline (3)6-Bromoindolin-2-One (8)6-Bromoindoline-2,3-Dione (4)6-Chloroindolin-2-One (5)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Fluoroindolin-2-One (5)6-Fluoroindoline-2,3-Dione (3)7-Bromoindoline (3)7-Fluoroindolin-2-One (3)7-Fluoroindoline-2,3-Dione (6)7-Methylindoline-2,3-Dione (7)Indoline-2-Carboxylic Acid (3)Methyl Indoline-6-Carboxylate (3)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Tert-Butyl Indoline-1-Carboxylate (24)
Isoquinolines (2729)
Bromoisoquinoline (69)Chloroisoquinoline (101)Dibromoisoquinoline (9)Dichloroisoquinoline (14)Dihydroisoquinoline (107)Fluoroisoquinoline (78)Methoxyisoquinoline (59)Methylisoquinoline (59)Nitroisoquinoline (23)1,3-Dichloroisoquinoline (14)1-Bromoisoquinoline (20)1-Chloroisoquinoline (20)1-Methylisoquinoline (9)1H-Benzo[De]Isoquinoline-1,3(2H)-Dione (14)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)3-Bromoisoquinoline (10)3-Chloroisoquinoline (20)3-Methylisoquinoline (8)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Chloroisoquinoline (11)4-Fluoroisoquinoline (6)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromoisoquinoline (17)5-Chloroisoquinoline (6)5-Methoxyisoquinoline (6)5-Nitroisoquinoline (7)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromoisoquinoline (9)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromoisoquinoline (6)7-Chloroisoquinoline (6)7-Fluoroisoquinoline (3)7-Methoxyisoquinoline (5)8-Bromoisoquinoline (17)8-Chloroisoquinoline (7)8-Fluoroisoquinolin-1(2H)-One (3)8-Fluoroisoquinoline (10)8-Methoxyisoquinoline (7)Isoquinolin-1-Amine (18)Isoquinolin-1-Ol (9)Isoquinolin-3-Amine (13)Isoquinolin-3-Ol (6)Isoquinolin-4-Amine (16)Isoquinolin-4-Ol (9)Isoquinolin-4-Ylboronic Acid (3)Isoquinolin-5-Amine (9)Isoquinolin-5-Ol (7)Isoquinolin-8-Amine (6)Isoquinoline-1-Carbonitrile (7)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-5-Sulfonyl Chloride (3)Isoquinoline-6-Carboxylic Acid (3)Methyl Isoquinoline-3-Carboxylate (3)Methyl Isoquinoline-4-Carboxylate (6)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)
Isothiazoles (343)
Methylisothiazole (5)Benzo[D]Isothiazol-3(2H)-One 1,1-Dioxide (10)Benzo[D]Isothiazole (12)Isothiazole (24)
Isoxazoles (3403)
Aminoisoxazole (7)Bromoisoxazole (5)Dihydroisoxazol (2)Dimethylisoxazole (17)Phenylisoxazole (28)(3-Phenylisoxazol-5-Yl)Methanol (7)3-Bromoisoxazole (7)3-Methyl-5-Phenylisoxazole (6)3-Methylisoxazole (30)3-Phenylisoxazol-5-Amine (8)5-(Thiophen-2-Yl)Isoxazole (5)5-Cyclopropylisoxazole (5)5-Methyl-3-Phenylisoxazole (4)5-Methylisoxazole (16)5-Phenylisoxazole-3-Carboxylic Acid (15)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Isoxazol-3-Amine (7)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Amine (15)Isoxazol-5-Ylmethanol (5)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl 5-Phenylisoxazole-3-Carboxylate (6)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)
Morpholines (4988)
Benzylmorpholine (25)Cyanomorpholine (6)Dimorpholine (3)Ethylmorpholine (9)Isopropylmorpholine (9)Methylmorpholine (68)Morpholinobenzaldehyde (11)Morpholinobenzo (13)Morpholinobenzoic (8)Morpholinoethanone (5)Morpholinoethoxy (1)Morpholinoethyl (5)Morpholinomethyl (16)Morpholinophenyl (14)Morpholinopropoxy (6)Morpholinopyrimidin (6)Morpholinosulfonyl (7)Oxomorpholine (6)(R)-3-Phenylmorpholine (7)(S)-3-Phenylmorpholine (10)2,2-Dimethylmorpholine (5)2,6-Dimethylmorpholine (5)2-(Methoxymethyl)Morpholine (4)2-(Morpholin-2-Yl)Acetic Acid (5)2-Ethylmorpholine (3)2-Isopropylmorpholine (4)2-Methylmorpholine (7)2-Phenylmorpholine (8)3-(4-Morpholinophenyl)Oxazolidin-2-One (4)3-(Methoxymethyl)Morpholine (4)3-Ethylmorpholine (4)3-Isopropylmorpholine (5)3-Methylmorpholine (13)3-Phenylmorpholine (8)4-(2-Fluorophenyl)Morpholine (8)4-(3-Phenoxypropyl)Morpholine (7)4-(O-Tolyl)Morpholine (6)4-(Pyrazin-2-Yl)Morpholine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-Benzylmorpholin-3-One (6)4-Morpholinoaniline (4)4-Morpholinobenzaldehyde (8)4-Morpholinobenzoic Acid (5)4-Phenylmorpholin-3-One (6)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)Benzyl Morpholine-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Morpholin-2-Ylmethanamine (8)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Morpholine-2-Carbonitrile (4)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Morpholino(Phenyl)Methanone (11)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl Morpholine-4-Carboxylate (23)
Naphthyridines (939)
1,5-Naphthyridine-3-Carboxylic Acid (6)1,6-Naphthyridine (22)1,7-Naphthyridine (23)2,7-Naphthyridine (5)3-Bromo-1,5-Naphthyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Chloro-1,5-Naphthyridine (6)5,6,7,8-Tetrahydro-1,6-Naphthyridine (22)5,6,7,8-Tetrahydro-1,7-Naphthyridine (6)
Oxadiazoles (3559)
1,2,4-Oxadiazole (19)1,2,5-Oxadiazole (12)1,3,4-Oxadiazole (25)2,5-Diphenyl-1,3,4-Oxadiazole (6)2-Phenyl-1,3,4-Oxadiazole (26)3-Phenyl-1,2,4-Oxadiazole (23)Benzo[C][1,2,5]Oxadiazole (17)
Oxazines (235)
2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromo-2H-Benzo[B][1,4]Oxazin-3(4H)-One (7)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-2H-Benzo[B][1,4]Oxazin-3(4H)-One (8)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)
Oxazoles (2026)
Bioxazole (12)2-Bromooxazole (7)2-Chlorooxazole (7)2-Methyloxazole (19)2-Phenyloxazole (16)3,4-Diphenylisoxazole (8)4,5-Diphenyloxazole (7)4-(Oxazol-5-Yl)Aniline (3)4-Methyloxazole (9)5-(4-Nitrophenyl)Oxazole (3)5-Methyloxazole (5)6-Bromobenzo[D]Oxazole (3)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Methyl Oxazole-4-Carboxylate (9)Oxazol-2-Amine (8)Oxazole-4-Carboxylic Acid (4)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)
Oxazolidines (1298)
Dimethyloxazolidin (6)Dioxooxazolidin (2)Oxazolidinone (5)Phenyloxazolidin (9)Propionyloxazolidin (5)(R)-4-Benzyloxazolidin-2-One (5)(S)-4-Benzyloxazolidin-2-One (11)3-(4-Morpholinophenyl)Oxazolidin-2-One (4)3-Phenyloxazolidin-2-One (4)4-Isopropyloxazolidine (6)Oxazolidine (21)Oxazolidine-2,5-Dione (9)
Oxazolines (1577)
(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,3-Bis(4,5-Dihydrooxazol-2-Yl)Benzene (8)2,2'-(1,3-Diphenylpropane-2,2-Diyl)Bis(4,5-Dihydrooxazole) (5)2,2'-(2-Phenylethane-1,1-Diyl)Bis(4,5-Dihydrooxazole) (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Phenyl-4,5-Dihydrooxazole (18)4,4',5,5'-Tetrahydro-2,2'-Bioxazole (10)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)Bis((3Ar,8As)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis((3As,8Ar)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis(4,5-Dihydrooxazol-2-Yl)Methane (22)
Oxetanes (772)
Methyloxetane (11)
Phthalazines (423)
Dihydrophthalazine (15)Phthalazine (16)
Piperazines (7427)
Isobutylpiperazine (6)Propylpiperazine (10)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(R)-2-Benzylpiperazine (5)1,4-Diphenylpiperazine (7)1-(2-Chlorophenyl)Piperazine (4)1-(2-Fluorophenyl)Piperazine (8)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-(Methylsulfonyl)Piperazine (5)1-(Phenylsulfonyl)Piperazine (17)1-(Piperidin-4-Yl)Piperazine (6)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-Benzhydryl-4-Benzylpiperazine (1)1-Benzhydrylpiperazine (9)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1-Benzyl-4-Methylpiperazine (10)1-Ethyl-4-Phenylpiperazine (4)1-Ethylpiperazine (5)1-Isopropylpiperazine (4)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methyl-4-Phenylpiperazine (22)1-Methylpiperazin-2-One (6)1-Methylpiperazine (21)10-(3-(Piperazin-1-Yl)Propyl)-10H-Phenothiazine (2)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperazin-1-Yl)Pyrazine (9)2-(Piperazin-1-Yl)Pyrimidine (11)2-Phenylpiperazine (17)3-(Piperazin-1-Yl)Aniline (3)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Piperazin-1-Yl)Pyridazine (7)3-Methylpiperazin-2-One (7)4-(Piperazin-1-Yl)Benzaldehyde (5)4-(Piperazin-1-Yl)Pyrimidine (13)Benzyl 2-Methylpiperazine-1-Carboxylate (7)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl 3-Methylpiperazine-1-Carboxylate (5)Phenyl(Piperazin-1-Yl)Methanone (20)Piperazine-2,5-Dione (9)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl 4-Benzylpiperazine-1-Carboxylate (13)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl Piperazine-1-Carboxylate (30)
Piperidines (21889)
Bipiperidine (12)Chloropiperidine (6)Dimethylpiperidine (46)Ethynylpiperidine (5)Fluoropiperidine (33)Formylpiperidine (9)Isopropylpiperidine (11)Piperidine-Carboxylate (3)Piperidineacetic (5)Piperidinecarboxylic (6)Piperidinyl-Phenyl-Boronic Acid/Ester (32)Propylpiperidine (8)(9H-Fluoren-9-Yl)Methyl Piperidine-1-Carboxylate (16)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(R)-2-Phenylpiperidine (10)(R)-3-Aminopiperidin-2-One (3)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)(S)-2-Phenylpiperidine (11)(S)-N-Phenylpiperidine-2-Carboxamide (1)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4'-Bipiperidine (8)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)Piperidine (23)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Piperidin-4-Yl)Piperazine (6)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-3-One (5)1-Benzylpiperidin-4-Amine (8)1-Benzylpiperidin-4-One (8)1-Isopropylpiperidine (5)1-Methyl-4-Phenylpiperidine (4)1-Methylpiperidin-2-One (3)1-Oxa-8-Azaspiro[4.5]Decane (5)1-Phenylpiperidin-2-One (8)2,2-Dimethylpiperidin-4-One (6)2,2-Dimethylpiperidine (21)2,7-Diazaspiro[3.5]Nonane (7)2,8-Diazaspiro[4.5]Decan-3-One (6)2,8-Diazaspiro[4.5]Decane (5)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-(Piperidin-4-Yl)Pyridine (5)2-Methylpiperidin-4-One (6)2-Methylpiperidine (14)2-Phenylpiperidine (14)3,3-Difluoropiperidin-4-One (3)3,3-Difluoropiperidine (29)3,3-Dimethylpiperidin-4-One (3)3,3-Dimethylpiperidine (5)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)-1H-Indazole (5)3-(Piperidin-4-Yl)-1H-Indole (8)3-(Piperidin-4-Yl)Pyridine (5)3-Fluoropiperidin-4-One (3)3-Fluoropiperidine (26)3-Methoxypiperidine (7)3-Methylpiperidin-4-One (3)3-Methylpiperidine (10)3-Phenylpiperidine (6)4,4-Difluoropiperidine (5)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-(Azetidin-1-Yl)Piperidine (6)4-(Piperidin-1-Yl)Pyrimidine (8)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Benzylpiperidine (18)4-Hydrazineylpiperidine (5)4-Hydroxypiperidin-2-One (3)4-Methyl-1-Phenylpiperidine (6)4-Methylenepiperidine (14)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenylpiperidin-4-Ol (10)5-Hydroxypiperidin-2-One (3)6-Azaspiro[2.5]Octane (10)6-Oxopiperidine-2-Carboxylic Acid (3)7-Azaspiro[3.5]Nonane (7)Azepane (25)Benzyl 3-Hydroxypiperidine-1-Carboxylate (7)Benzyl 4-Oxopiperidine-1-Carboxylate (12)Benzyl Piperidin-4-Ylcarbamate (7)Benzyl Piperidine-1-Carboxylate (50)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Ethyl Piperidine-1-Carboxylate (5)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)N-Benzylpiperidin-4-Amine (3)N-Methylpiperidin-3-Amine (5)N-Phenylpiperidine-2-Carboxamide (2)Phenyl(Piperidin-1-Yl)Methanone (21)Phenyl(Piperidin-4-Yl)Methanone (21)Piperidin-2-Ylmethanamine (6)Piperidin-2-Ylmethanol (11)Piperidin-3-Amine (17)Piperidin-3-Ol (27)Piperidin-3-One (13)Piperidin-3-Ylmethanamine (5)Piperidin-3-Ylmethanol (15)Piperidin-4-Amine (14)Piperidin-4-Ol (44)Piperidin-4-Ylmethanamine (7)Piperidin-4-Ylmethanol (11)Piperidine-2,4-Dione (5)Piperidine-2,6-Dione (13)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxamide (5)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (11)Quinuclidine (5)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Spiro[Indoline-3,4'-Piperidine] (5)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl (Piperidin-3-Ylmethyl)Carbamate (5)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Piperidin-3-Ylcarbamate (9)
Purines (2020)
(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (27)2-Chloro-7H-Purine (3)2-Chloro-9H-Purine (5)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)9H-Purin-6-Amine (3)
Pyrans (1095)
Chromene-Carboxylic Acid (1)Thioglucopyranoside (4)(S)-2-Phenylchroman-4-One (17)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)2,2-Dimethylchromane (5)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2H-Chromene (16)3,4-Dihydro-2H-Pyran (11)3,6-Dihydro-2H-Pyran (8)3-Acetyl-2H-Chromen-2-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-Hydroxy-2H-Chromen-2-One (10)4-Methyl-2H-Chromen-2-One (27)5-Fluorochroman-4-One (3)5-Fluorochromane (6)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)6-Bromochroman-4-One (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Fluorochroman-4-One (5)6-Fluorochromane (6)6-Methoxychromane (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromochroman-4-One (4)7-Bromochromane (7)7-Chlorochromane (5)7-Fluorochroman-4-One (5)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxychroman-4-One (3)8-Bromochroman-4-One (4)8-Bromochromane (6)8-Chlorochromane (5)8-Fluorochromane (5)8-Methylchroman-4-One (4)8-Methylchromane (10)Chroman-2-One (5)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Chroman-4-Ol (4)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Isochromane (11)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Tetrahydro-2H-Pyran-2-One (15)Tetrahydro-2H-Thiopyran (10)Tetrahydro-4H-Pyran-4-One (12)Thiochroman-4-One (10)
Pyrazines (3359)
Dibromopyrazine (7)Dichloropyrazine (21)Dihydropyrazine (6)Dimethylpyrazine (30)Ethoxypyrazine (5)Ethylpyrazine (7)Fluoropyrazine (6)Hydroxypyrazine (4)Iodopyrazine (17)Methoxypyrazine (36)Phenylpyrazin (5)Pyrazino (5)Pyrazino-Nitrile (50)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1-(Pyrazin-2-Yl)Ethan-1-One (5)1H-Pyrazolo[3,4-B]Pyrazine (5)2,3-Diphenylpyrazine (5)2,5-Dibromopyrazine (4)2,5-Dichloropyrazine (4)2,6-Dibromopyrazine (9)2,6-Dichloropyrazine (14)2-(Piperazin-1-Yl)Pyrazine (9)2-(Trifluoromethyl)Pyrazine (6)2-Bromo-3-Methoxypyrazine (5)2-Bromo-3-Methylpyrazine (5)2-Bromo-5-Chloropyrazine (6)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Methylpyrazine (5)2-Bromopyrazine (15)2-Chloro-3-Methylpyrazine (7)2-Chloro-6-Methylpyrazine (12)2-Chloropyrazine (24)2-Ethoxypyrazine (3)2-Ethylpyrazine (9)2-Fluoropyrazine (7)2-Iodopyrazine (25)2-Methoxypyrazine (45)2-Methylpyrazine (16)2-Phenylpyrazine (12)3-Chloropyrazin-2-Amine (6)3-Chloropyrazine-2-Carbonitrile (6)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4-(Pyrazin-2-Yl)Morpholine (5)5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine (11)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Bromopyrazin-2-Amine (13)5-Bromopyrazin-2-Ol (5)5-Chloropyrazin-2-Amine (9)5H-Pyrrolo[2,3-B]Pyrazine (14)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[4,3-A]Pyrazine (11)Ethyl Pyrazine-2-Carboxylate (10)Imidazo[1,5-A]Pyrazine (9)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl Pyrazine-2-Carboxylate (19)Pyrazin-2-Amine (22)Pyrazin-2-Ol (7)Pyrazin-2-Ylmethanamine (12)Pyrazine-2-Carbaldehyde (17)Pyrazine-2-Carbohydrazide (3)Pyrazine-2-Carbonitrile (15)Pyrazine-2-Carboxamide (10)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrazine (5)Pyrido[2,3-B]Pyrazine (12)Pyrido[3,4-B]Pyrazine (11)Tert-Butyl Pyrazin-2-Ylcarbamate (8)
Pyrazoles (16157)
Bipyrazole (5)Chloropyrazolo (33)Dichloropyrazolo (11)Dihydropyrazolo (28)Dimethylpyrazolo (6)Ethylpyrazole (7)Fluoropyrazolo (9)Hydroxypyrazolo (10)Methoxypyrazolo (16)Methyl-Pyrazole-Carboxylic Acid (147)Methyl-Pyrazolone (87)Methylpyrazolo (32)Pyrazolopyridine-Carboxylic Acid (48)Tetrahydropyrazolo (23)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)1,3-Dimethyl-1H-Pyrazole (28)1,3-Diphenyl-1H-Pyrazole (6)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1,5-Diphenyl-1H-Pyrazole (13)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Pyrazole (9)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Cyclopentyl-1H-Pyrazole (5)1-Cyclopropyl-1H-Pyrazole (9)1-Methyl-1H-Pyrazol-3-Amine (14)1-Methyl-3-Phenyl-1H-Pyrazole (21)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)1-Methyl-5-Phenyl-1H-Pyrazole (7)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)1-Trityl-1H-Pyrazole (5)1H-Pyrazol-4-Amine (6)1H-Pyrazol-4-Ol (3)1H-Pyrazol-5-Amine (19)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-4-Sulfonyl Chloride (8)1H-Pyrazole-5-Carboxamide (3)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrazolo[3,4-B]Pyrazine (5)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,4-Dihydro-3H-Pyrazol-3-One (10)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-Phenyl-2,4-Dihydro-3H-Pyrazol-3-One (23)3-(Tert-Butyl)-1-Phenyl-1H-Pyrazole (4)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Cyclopropyl-1H-Pyrazole (5)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Methyl-1-Phenyl-1H-Pyrazole (23)3-Phenyl-1H-Pyrazol-5-Amine (11)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyridine (6)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Iodo-1H-Pyrazole (9)4-Methyl-1-Phenyl-1H-Pyrazole (6)4-Methyl-1H-Pyrazole (11)4-Nitro-1H-Pyrazole (8)4-Phenyl-1H-Pyrazole (18)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)5-(Difluoromethyl)-1H-Pyrazole (6)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Cyclopropyl-1H-Pyrazole (6)5-Iodo-1H-Pyrazole (4)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)6,7-Dihydro-5H-Pyrazolo[5,1-B][1,3]Oxazine (13)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)7-Chloropyrazolo[1,5-A]Pyrimidine (8)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)Pyrazolo[1,5-A]Pyrazine (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)
Pyridazines (2753)
Aminopyridazine (12)Dihydropyridazine (26)Dimethylpyridazine (9)Hexahydropyridazines (10)Pyridazinecarboxylic (1)2-Methylpyridazin-3(2H)-One (7)3,6-Dichloropyridazine (20)3-(Piperazin-1-Yl)Pyridazine (7)3-(Trifluoromethyl)Pyridazine (3)3-Bromopyridazine (25)3-Chloro-4-Methylpyridazine (7)3-Chloropyridazine (44)3-Iodopyridazine (5)3-Methoxypyridazine (17)3-Methylpyridazine (6)3-Phenylpyridazine (8)4-Aminopyridazin-3(2H)-One (4)4-Bromopyridazin-3(2H)-One (3)4-Bromopyridazine (5)4-Chloropyridazin-3(2H)-One (4)4-Chloropyridazine (16)4-Methoxypyridazine (8)4-Methylpyridazine (3)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridazin-3-Amine (5)[1,2,4]Triazolo[4,3-B]Pyridazine (10)Ethyl Pyridazine-3-Carboxylate (6)Methyl Pyridazine-3-Carboxylate (7)Pyridazin-3-Amine (18)Pyridazin-3-Ol (3)Pyridazin-4-Amine (10)Pyridazine-3-Carboxylic Acid (7)
Pyridines (70617)
Acetylpyridin (5)Aminopicolinate (8)Benzyloxypyridine (36)Bipyridine (202)Bromopicolinate (19)Bromopicolinic (4)Bromopicolinic Acid (5)Bromopicolinonitrile (6)Bromopyrido (13)Butylpyridine (5)Chloroisonicotinic Acid (5)Chloronicotinaldehyde (23)Chloronicotinamide (11)Chloronicotinate (45)Chloronicotinic (41)Cyanopicolinate (7)Cyanopicolinic (6)Cyanopyridine (34)Cyclopropoxypyridine (6)Cyclopropylpyridine (30)Dibromopicolinate (4)Dibromopicolinic Acid (3)Dibromopyridine (36)Dichloropicolinate (9)Dichloropicolinonitrile (4)Dichloropyridine (120)Difluoropicolinic Acid (3)Difluoropyridine (58)Dihydropyrido (27)Diiodopyridine (13)Dimethoxypicolinic Acid (5)Dimethoxypyridine (33)Dimethylpyridine (143)Diphenylpyridine (6)Dipyridine (28)Ethoxypicolinic Acid (3)Ethoxypyridine (35)Ethylpyridine (36)Ethynylpicolinate (3)Fluoro-Pyridine--Boronate (79)Fluoropicolinaldehyde (8)Fluoropicolinamide (8)Fluoropicolinate (22)Fluoropyridine (288)Fluoropyrido (3)Formylpyridine (23)Hexahydropyrido (7)Hydrazinylpyridine (22)Hydroxymethylpyridine (26)Hydroxypicolinate (13)Hydroxypicolinic (9)Hydroxypicolinonitrile (7)Iodopicolinate (5)Iodopicolinic Acid (4)Iodopyridine (167)Isopropoxypyridine (20)Isopropylpyridine (32)Methoxyisonicotinaldehyde (10)Methoxynicotinaldehyde (18)Methoxypicolinaldehyde (13)Methoxypicolinamide (13)Methoxypicolinate (21)Methoxypicolinic (18)Methoxypicolinic Acid (16)Methoxypicolinimidamide (5)Methoxypicolinonitrile (13)Methoxypyridine (342)Methylisonicotinamide (8)Methylnicotinaldehyde (30)Methylnicotinamide (13)Methylpicolinaldehyde (16)Methylpicolinamide (15)Methylpicolinate (27)Methylpicolinic (23)Methylpicolinonitrile (28)Methylpyrido (13)Nitropyridine (393)Oxopyridin (2)Phenoxypyridin (1)Picolinate (42)Pyridinecarbonitrile (50)Pyridyl-Benzene-Boronic Acid/Ester (16)Pyridyl-Phenyl-Boronate (2)Pyridylmethyl (6)Terpyridine (32)Tetrachloropyridine (5)Tetrafluoropyridine (21)Tetrahydropyridine (49)Tetrahydropyrido (32)Tribromopyridine (9)Trichloropyridine (17)Trifluoropyridine (8)Trimethylpyridine (5)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3-Bromopyridin-2-Yl)Methanol (7)(3-Chloropyridin-2-Yl)Methanamine (6)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanol (10)(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(5-Chloropyridin-2-Yl)Methanamine (5)(6-Methylpyridin-2-Yl)Methanamine (6)(6-Methylpyridin-2-Yl)Methanol (5)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,1'-Diphenyl-[4,4'-Bipyridine]-1,1'-Diium (7)1,10-Phenanthrolin-4-Ol (3)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1,2,3,6-Tetrahydropyridine (22)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4-Di(Pyridin-4-Yl)Benzene (5)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-(Pyridin-4-Yl)Ethan-1-One (14)1-Benzyl-1,2,3,6-Tetrahydropyridine (9)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methylpyridin-1-Ium Iodide (5)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,2':6',2''-Terpyridine (15)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2,3'-Bipyridine (11)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (12)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dibromopyridine (21)2,3-Dichloropyridine (38)2,3-Difluoropyridine (13)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (5)2,3-Dihydro-[1,4]Dioxino[2,3-B]Pyridine (5)2,3-Dihydropyridin-2-One (5)2,3-Dimethoxypyridine (7)2,3-Dimethylpyridine (8)2,4,6-Trichloropyridine (5)2,4,6-Triphenylpyridine (7)2,4-Dibromopyridine (5)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloropyridine (50)2,4-Dimethylpyridine (5)2,5-Dibromopyridine (26)2,5-Dichloropyridine (32)2,5-Difluoropyridine (8)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Iodopyridine (4)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloronicotinonitrile (8)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2,6-Difluoropyridine (29)2,6-Dimethoxypyridine (11)2,6-Dimethylpyridin-4-Ol (4)2,6-Dimethylpyridine (26)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(2-Chlorophenyl)Pyridine (3)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-Fluorophenyl)Pyridine (11)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzyloxy)Pyridine (18)2-(Bromomethyl)Pyridine (27)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Difluoromethyl)Pyridine (21)2-(Methylsulfonyl)Pyridine (11)2-(Methylthio)Pyridine (5)2-(P-Tolyl)Pyridine (6)2-(Phenoxymethyl)Pyridine (5)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-4-Yl)Pyridine (5)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)Pyridine (6)2-Aminonicotinonitrile (6)2-Benzylpyridine (12)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Iodopyridine (6)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitropyridine (5)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Methylpyridine (6)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodopyridine (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Phenylpyridine (4)2-Bromonicotinic Acid (5)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Fluoropyridine (20)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Iodopyridine (19)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methylpyridine (31)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Iodopyridine (18)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodopyridine (9)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylpyridine (49)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Ethoxypyridine (20)2-Ethylpyridine (9)2-Ethynylpyridine (31)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Fluoro-3-Iodopyridine (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methoxypyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoropyridine (15)2-Hydrazineylpyridine (32)2-Iodo-6-Methylpyridine (5)2-Iodopyridine (27)2-Isopropoxypyridine (16)2-Isopropylpyridine (14)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Methoxy-5-Methylpyridine (5)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Methylpyridine (14)2-Methoxyisonicotinic Acid (13)2-Methoxypyridin-3-Amine (6)2-Methoxypyridine (436)2-Methyl-1,10-Phenanthroline (3)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-Nitropyridine (9)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)2-Methylimidazo[1,2-A]Pyridine (8)2-Methylpyridin-3-Ol (8)2-Methylpyridin-4-Amine (7)2-Methylpyridine 1-Oxide (9)2-Nitropyridine (40)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propoxypyridine (9)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,3'-Bipyridine (7)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)3,5-Dibromopyridine (12)3,5-Dichloropyridine (16)3,5-Difluoropyridine (12)3,5-Dimethoxypyridine (4)3,5-Dimethylpyridine (8)3,5-Diphenylpyridine (5)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-(Benzyloxy)Pyridine (19)3-(Bromomethyl)Pyridine (18)3-(Chloromethyl)Pyridine (22)3-(Cyclopropylmethyl)Pyridine (6)3-(Difluoromethyl)Pyridine (5)3-(Methylsulfonyl)Pyridine (5)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)Pyridine (5)3-(Pyrrolidin-2-Yl)Pyridine (6)3-(Tert-Butyl)Pyridine (5)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (52)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Methylpyridine (13)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylpyridine (4)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Cyclopropylpyridine (28)3-Ethoxypyridine (12)3-Ethylpyridine (11)3-Ethynylpyridine (22)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-2-Methylpyridine (15)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Fluoropicolinic Acid (6)3-Fluoropicolinonitrile (5)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Hydrazineylpyridine (8)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Methoxypyridin-2-Amine (5)3-Methoxypyridine (52)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Methyl-2-Phenylpyridine (3)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)3-Methyl-5-Nitropyridine (4)3-Methylimidazo[1,2-A]Pyridine (3)3-Methylpicolinic Acid (13)3-Methylpyridin-2-Amine (7)3-Methylpyridine (50)3-Methylpyridine 1-Oxide (7)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Phenoxypyridine (12)4'-Phenyl-2,2':6',2''-Terpyridine (13)4,4'-Bipyridine (10)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,7-Diphenyl-1,10-Phenanthroline (4)4-(2,4-Diphenyl-1H-Imidazol-5-Yl)Pyridine (5)4-(Benzyloxy)Pyridine (8)4-(Bromomethyl)Pyridine (8)4-(Pyridin-2-Yl)Morpholine (21)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-(Tert-Butyl)Pyridine (5)4-(Trifluoromethyl)Nicotinic Acid (3)4-(Trifluoromethyl)Pyridine (14)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-Methylpyridine (5)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Bromopyridine (31)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-3-Methylpyridine (7)4-Chloronicotinic Acid (4)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Cyclopropylpyridine (7)4-Ethoxypyridine (7)4-Ethynylpyridine (10)4-Iodopyridine (17)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Methoxypyridine (136)4-Methyl-2,2'-Bipyridine (8)4-Methyl-2-Phenylpyridine (3)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)4-Methyl-3-Nitropyridine (8)4-Methylnicotinic Acid (5)4-Methylpyridine (24)4-Nitropyridine (11)4-Phenoxypyridine (7)4-Phenyl-1,2,3,6-Tetrahydropyridine (7)4-Phenyl-1,4-Dihydropyridine (10)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5,6-Dichloropyridin-2-Amine (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Iodopyridine (5)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Fluoro-2-Methoxypyridine (15)5-Fluoro-2-Methylpyridine (8)5-Fluoropicolinonitrile (5)5-Fluoropyridin-2-Amine (15)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5-Methoxypyridin-3-Amine (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)5-Phenylpicolinic Acid (4)6,7-Dihydro-5H-Cyclopenta[B]Pyridine (18)6,7-Dihydro-5H-Cyclopenta[C]Pyridine (7)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromonicotinaldehyde (11)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chloro-5-Iodopyridin-2-Amine (3)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxynicotinaldehyde (4)6-Methoxypicolinic Acid (9)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylnicotinic Acid (6)6-Methylnicotinonitrile (7)6-Methylpicolinic Acid (12)6-Methylpicolinonitrile (10)6-Methylpyridin-2-Amine (46)6-Methylpyridin-2-Ol (23)6-Methylpyridin-3-Amine (5)6-Methylpyridin-3-Ol (7)6-Phenoxypyridin-3-Amine (5)6-Phenylnicotinic Acid (8)6-Phenylpicolinic Acid (3)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methylimidazo[1,2-A]Pyridine (3)9H-Pyrido[3,4-B]Indole (5)Bis(Pyridin-2-Ylmethyl)Amine (6)Dimethyl Pyridine-2,6-Dicarboxylate (7)Dimethyl(Pyridin-2-Yl)Phosphine Oxide (8)Dimethyl(Pyridin-3-Yl)Phosphine Oxide (7)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Methylnicotinate (6)Ethyl 4,6-Dichloronicotinate (4)Ethyl 6-Chloropicolinate (7)Ethyl Isonicotinate (12)Ethyl Nicotinate (25)Ethyl Picolinate (41)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Imidazo[1,2-A]Pyridin-2-Ylmethanol (4)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinaldehyde (68)Isonicotinamide (12)Isonicotinic Acid (23)Isonicotinohydrazide (6)Isonicotinonitrile (16)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Bromopicolinate (9)Methyl 3-Chloropicolinate (9)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)Methyl 5-Hydroxypicolinate (5)Methyl 6-Bromonicotinate (6)Methyl 6-Chloropicolinate (11)Methyl 6-Fluoronicotinate (4)Methyl 6-Methoxynicotinate (4)Methyl Isonicotinate (16)Methyl Nicotinate (52)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N-(Pyridin-2-Yl)Benzamide (9)N-Benzylpyridin-2-Amine (9)N-Methylpicolinamide (10)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpicolinamide (8)N-Phenylpyridin-2-Amine (9)Nicotinaldehyde (153)Nicotinamide (64)Nicotinic Acid (53)Nicotinonitrile (82)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)Phenyl(Pyridin-2-Yl)Methanone (10)Phenyl(Pyridin-3-Yl)Methanone (9)Picolinaldehyde (98)Picolinamide (26)Picolinic Acid (22)Picolinimidamide (11)Picolinohydrazide (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyridin-2-Amine (29)Pyridin-2-Ol (170)Pyridin-2-Ylboronic Acid (9)Pyridin-2-Ylmethanamine (38)Pyridin-2-Ylmethanol (65)Pyridin-3-Amine (21)Pyridin-3-Ol (13)Pyridin-3-Ylboronic Acid (49)Pyridin-3-Ylmethanamine (29)Pyridin-3-Ylmethanol (39)Pyridin-4-Amine (22)Pyridin-4-Ol (16)Pyridin-4-Ylboronic Acid (21)Pyridin-4-Ylmethanamine (12)Pyridin-4-Ylmethanol (16)Pyridine 1-Oxide (33)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyridine-2,6-Dicarboxylic Acid (9)Pyridine-2,6-Diol (6)Pyridine-2-Sulfonamide (6)Pyridine-2-Sulfonyl Chloride (9)Pyridine-2-Thiol (8)Pyridine-3-Sulfonic Acid (6)Pyridine-3-Sulfonyl Chloride (25)Pyrido[2,3-B]Pyrazine (12)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-B]Pyrazine (11)Pyrido[3,4-D]Pyrimidine (10)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl Pyridin-2-Ylcarbamate (37)Tert-Butyl Pyridin-3-Ylcarbamate (16)Tert-Butyl Pyridin-4-Ylcarbamate (6)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[3,2-B]Pyridine (18)Thieno[3,2-C]Pyridine (13)
Pyrimidines (14557)
Bipyrimidine (4)Dibromopyrimidine (15)Methoxypyrimidine (107)Pyrimidinone (3)Tetraoxatetradecan (10)Trichloropyrimidine (11)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)1,4,5,6-Tetrahydropyrimidine (4)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (9)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (30)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (46)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyrimidine (14)2,4,6-Triphenylpyrimidine (9)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichloropyrimidin-5-Amine (6)2,4-Dimethoxypyrimidine (13)2,4-Dimethylpyrimidine (7)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(Chloromethyl)Pyrimidine (5)2-(Methylsulfonyl)Pyrimidine (25)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Piperazin-1-Yl)Pyrimidine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Propylthio)Pyrimidine (5)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Trifluoromethyl)Pyrimidine (27)2-Aminopyrimidin-4(3H)-One (11)2-Bromopyrimidine (22)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloropyrimidin-4-Amine (22)2-Cyclopropylpyrimidine (10)2-Ethoxypyrimidine (7)2-Ethylpyrimidine (6)2-Fluoropyrimidine (9)2-Hydrazineylpyrimidine (6)2-Iodopyrimidine (8)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methylpyrimidin-4-Amine (22)2-Methylpyrimidin-4-Ol (11)2-Phenoxypyrimidine (8)2-Phenylpyrimidin-5-Amine (5)3-Methylpyrimidin-4(3H)-One (6)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyrimidin-2-Amine (9)4,6-Dichloropyrimidine (14)4,6-Diphenylpyrimidine (7)4-(Dimethoxymethyl)Pyrimidine (5)4-(Piperazin-1-Yl)Pyrimidine (13)4-(Piperidin-1-Yl)Pyrimidine (8)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-(Pyrimidin-4-Yl)Morpholine (13)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (19)4-Bromopyrimidine (24)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Chloro-5-Iodopyrimidine (6)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-6-Methoxypyrimidine (5)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Chloropyrimidine-5-Carbonitrile (6)4-Ethoxypyrimidine (6)4-Fluoropyrimidine (8)4-Iodopyrimidine (9)4-Methoxy-2-Methylpyrimidine (8)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Methyl-2-(Methylthio)Pyrimidine (7)4-Methylpyrimidin-2-Amine (9)4-Methylpyrimidine (22)4-Phenoxypyrimidine (5)4-Phenylpyrimidin-2-Amine (15)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(Benzyloxy)Pyrimidine (5)5-Benzylpyrimidine (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Bromo-2-(Methylthio)Pyrimidine (6)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Methylpyrimidine (5)5-Bromo-4-Chloropyrimidine (4)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine (8)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Ethylpyrimidine (5)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (2)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine (11)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyrimidine (5)5-Methylpyrimidine (3)5-Phenylpyrimidine (16)5H-Pyrrolo[3,2-D]Pyrimidine (16)6,7-Dihydro-5H-Cyclopenta[D]Pyrimidine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)6-Chloropyrimidin-4-Amine (8)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)[1,2,4]Triazolo[1,5-A]Pyrimidine (14)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Imidazo[1,2-C]Pyrimidine (6)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)N,N-Dimethylpyrimidin-2-Amine (10)N-(9-((2R,5S)-5-((Trityloxy)Methyl)Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)N-Benzyl-9H-Purin-6-Amine (6)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-D]Pyrimidine (10)Pyrimidin-2-Ol (21)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-2-Ylmethanol (5)Pyrimidin-4-Amine (29)Pyrimidin-4-Ol (25)Pyrimidin-5-Amine (6)Pyrimidin-5-Ol (5)Pyrimidin-5-Ylboronic Acid (9)Pyrimidine-2,4-Diamine (14)Pyrimidine-2-Carbonitrile (14)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-2-Thiol (6)Pyrimidine-4,6(1H,5H)-Dione (3)Pyrimidine-4-Carbonitrile (9)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carbaldehyde (38)Pyrimidine-5-Carbonitrile (6)Pyrimidine-5-Carboxylic Acid (7)Tetrahydropyrimidin-2(1H)-One (6)Thiazolo[5,4-D]Pyrimidine (5)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-D]Pyrimidine (24)
Pyrroles (4953)
Bromopyrrolo (8)Chloropyrrolo (10)Dihydropyrrolo (15)Octahydropyrrolo (6)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(Phenylsulfonyl)-1H-Pyrrole (24)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-Benzylpyrrolidin-2-One (18)1-Methyl-1H-Pyrrole (43)1H-Pyrrol-1-Amine (7)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrole-3-Carbonitrile (9)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (5)2-Bromo-1H-Pyrrole (11)2-Methyl-1H-Pyrrole (49)2-Nitro-1H-Pyrrole (5)2-Phenyl-1H-Pyrrole (24)3,6-Di(Thiophen-2-Yl)-2,5-Dihydropyrrolo[3,4-C]Pyrrole-1,4-Dione (17)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Phenyl-1H-Pyrrole (5)3-Phenylpyrrolidine (26)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4H-Thieno[3,2-B]Pyrrole (6)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5H-Pyrrolo[2,3-B]Pyrazine (14)5H-Pyrrolo[3,2-D]Pyrimidine (16)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Pyrrolo[2,1-F][1,2,4]Triazine (14)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)
Pyrrolidines (14879)
Acetylpyrrolidine (9)Benzylpyrrolidine (33)Bipyrrolidine (9)Bromopyrrolidine (7)Carbamoylpyrrolidine (5)Difluoropyrrolidine (16)Dimethylpyrrolidine (31)Dioxopyrrolidin (131)Ethylpyrrolidine (9)Fluoropyrrolidine (26)Formylpyrrolidine (10)Mercaptopyrrolidine (4)Methoxypyrrolidine (19)Methylenepyrrolidine (2)Methylpyrrolidine (129)Phenoxypyrrolidine (3)Pyrrolidine-Benzene-Boronic Acid/Ester (20)(3Ar,6As)-Octahydrocyclopenta[C]Pyrrole (5)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylpyrrolidine (8)(S)-3-Phenylpyrrolidine (14)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)(S)-N-(4-(Thiazol-5-Yl)Benzyl)Pyrrolidine-2-Carboxamide (7)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Phenylsulfonyl)Pyrrolidine (15)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzylpyrrolidin-2-One (18)1-Benzylpyrrolidine (26)1-Methylpyrrolidin-2-One (13)1-Phenylpyrrolidin-2-One (18)2,2-Dimethylpyrrolidine (4)2,5-Dioxopyrrolidin-1-Yl ((Benzyloxy)Carbonyl)Glycinate (8)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2,8-Diazaspiro[4.5]Decan-3-One (6)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(2-Chlorophenyl)Pyrrolidine (17)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Pyrrolidine (5)2-(Methoxymethyl)Pyrrolidine (6)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-1-Yl)Pyridine (11)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Azabicyclo[2.2.1]Heptane (6)2-Methyl-1-Phenyl-1H-Pyrrole (8)2-Methylpyrrolidine (21)3,3-Difluoropyrrolidine (29)3-(Pyrrolidin-2-Yl)Pyridine (6)3-Aminopyrrolidin-2-One (5)3-Bromopyrrolidine (6)3-Hydroxypyrrolidin-2-One (4)3-Phenoxypyrrolidine (5)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenylpyrrolidine (26)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Hydroxypyrrolidin-2-One (7)4-Phenylpyrrolidin-2-One (7)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Azaspiro[2.4]Heptane (13)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Azaspiro[3.4]Octane (4)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Hydroxypyrrolidine-1-Carboxylate (5)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Hexahydro-1H-Pyrrolizine (12)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl Prolinate (43)Methyl Pyrrolidine-3-Carboxylate (9)N,N-Dimethylpyrrolidin-3-Amine (7)N-Methylpyrrolidin-3-Amine (6)Octahydrocyclopenta[C]Pyrrole (6)Phenyl(Pyrrolidin-1-Yl)Methanone (12)Proline (13)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ol (59)Pyrrolidin-3-Ylmethanamine (6)Pyrrolidin-3-Ylmethanol (13)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-2-Carboxamide (12)Pyrrolidine-3-Carbonitrile (6)Pyrrolidine-3-Carboxylic Acid (14)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Hydroxypyrrolidine-1-Carboxylate (20)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl Pyrrolidin-3-Ylcarbamate (12)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Pyrrolines (1763)
1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1-Phenyl-1H-Pyrrole-2,5-Dione (12)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,5-Dihydro-1H-Pyrrol-2-One (5)2,5-Dihydro-1H-Pyrrole (13)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)3,4-Dihydro-2H-Pyrrole (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)
Quinazolines (3143)
Dichloroquinazoline (14)Iodoquinazoline (10)Methylquinazoline (46)Nitroquinazoline (20)Trichloroquinazoline (5)2,4-Dichloroquinazoline (19)2-(Trifluoromethyl)Quinazoline (4)2-Bromoquinazoline (4)2-Chloroquinazolin-4(3H)-One (4)2-Cyclopropylquinazoline (5)2-Mercaptoquinazolin-4(3H)-One (3)2-Methylquinazoline (20)4-Chloroquinazoline (39)4-Methylquinazoline (4)5,6,7,8-Tetrahydroquinazoline (8)5-Chloroquinazoline (4)6-Bromoquinazoline (7)7-Bromoquinazolin-4(3H)-One (4)7-Fluoroquinazolin-4(3H)-One (4)7-Methoxy-N-Phenylquinazolin-4-Amine (12)8-Bromoquinazoline (8)8-Chloroquinazoline (5)8-Fluoroquinazoline (4)8-Methoxyquinazoline (3)8-Methylquinazoline (3)Ethyl Quinazoline-2-Carboxylate (4)N-(3-Chlorophenyl)Quinazolin-4-Amine (9)Quinazolin-2-Amine (13)Quinazolin-2-Ol (7)Quinazolin-4-Amine (8)Quinazolin-4-Ol (10)
Quinolines (11910)
Iodoquinoline (32)1,2-Dihydroquinoline (5)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)2,2'-Biquinoline (3)2,3,6,7-Tetrahydro-1H,5H-Pyrido[3,2,1-Ij]Quinoline (7)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Hydroxyquinolin-4(1H)-One (3)2-Phenylquinoline (18)3,4-Dihydroisoquinoline (11)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Phenoxyquinoline (5)4-Phenylquinoline (9)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)7,8-Dihydroquinolin-5(6H)-One (5)7-(Benzyloxy)Quinoline (6)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)N-Phenylquinolin-4-Amine (11)
Quinoxalines (1411)
Dichloroquinoxaline (8)Dihydroquinoxalin (7)1,2,3,4-Tetrahydroquinoxaline (6)2-Chloroquinoxaline (39)2-Methylquinoxaline (5)2-Phenylquinoxaline (5)3,4-Dihydroquinoxalin-2(1H)-One (7)5-Bromoquinoxaline (6)6-Bromoquinoxaline (9)6-Chloroquinoxaline (3)6-Methoxyquinoxaline (6)Quinoxalin-2-Amine (3)Quinoxalin-2-Ol (4)
Quinuclidines (202)
Spiroes (4763)
Aminospiro (4)Azaspiro (246)Bromospiro (11)Diazaspiro (182)Dihydrospiro (18)Dioxaspiro (39)Fluorospiro (4)Oxospiro (22)Triazaspiro (13)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4-Dioxaspiro[4.5]Decane (17)2,8-Diazaspiro[4.5]Decane (5)2-Oxa-8-Azaspiro[4.5]Decane (5)3-Phenyloxetane (11)6-Azaspiro[3.4]Octane (4)7-Azaspiro[3.5]Nonane (7)9,9'-Spirobi[Fluorene] (19)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidine] (5)
Tetrahydrofurans (2265)
Hydroxytetrahydrofuran (16)Iodotetrahydrofuran (3)Methoxytetrahydrofuran (11)Oxotetrahydrofuran (26)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(3Ar,6Ar)-Hexahydrofuro[3,2-B]Furan (5)(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-2-Yl)Methanol (6)(Tetrahydrofuran-3-Yl)Methanamine (3)1,3-Dihydrobenzo[C][1,2]Oxaborole (20)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (9)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (30)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (46)1-Oxa-8-Azaspiro[4.5]Decane (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (27)2-Oxa-8-Azaspiro[4.5]Decane (5)2-Oxabicyclo[2.1.1]Hexane (6)3-Aminodihydrofuran-2(3H)-One (4)3-Iodotetrahydrofuran (3)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (19)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Hydroxydihydrofuran-2(3H)-One (14)5-(Hydroxymethyl)Dihydrofuran-2(3H)-One (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (2)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)Dihydrofuran-3(2H)-One (7)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Amine (6)Tetrahydrofuran-3-Carboxylic Acid (4)Tetrahydrofuran-3-Ol (7)
Tetrahydroisoquinolines (1291)
Tetrahydroisoquinoline-Carboxylic Acid (48)(9H-Fluoren-9-Yl)Methyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (7)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,4-Dihydroisoquinolin-3(2H)-One (5)1-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)2-Methyl-1,2,3,4-Tetrahydroisoquinoline (13)4,4-Dimethyl-1,2,3,4-Tetrahydroisoquinoline (3)5,6,7,8-Tetrahydroisoquinoline (5)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)Isoquinoline-1,3(2H,4H)-Dione (7)
Tetrahydropyrans (3359)
Chroman-Amine (1)Difluorochroman (16)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)4-Phenoxytetrahydro-2H-Pyran (5)9-Bromoanthracene (5)
Tetrahydroquinolines (1464)
Tetrahydroquinoline-Carboxylic Acid (18)1-Ethyl-1,2,3,4-Tetrahydroquinoline (6)1-Methyl-1,2,3,4-Tetrahydroquinoline (6)2,3-Dihydroquinolin-4(1H)-One (19)2-Methyl-1,2,3,4-Tetrahydroquinoline (3)4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline (3)4-Methyl-1,2,3,4-Tetrahydroquinoline (2)5,6,7,8-Tetrahydroquinoline (17)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)Tert-Butyl 3,4-Dihydroquinoline-1(2H)-Carboxylate (11)
Tetrazoles (82)
1-Phenyl-1H-Tetrazole (6)5-Phenyl-1H-Tetrazole (23)5-Phenyl-2H-Tetrazole (9)
Thiadiazoles (2122)
1,2,3-Thiadiazole (8)1,2,4-Thiadiazole (15)1,2,5-Thiadiazole (6)1,3,4-Thiadiazol-2-Amine (9)2-Bromo-1,3,4-Thiadiazole (11)2-Methyl-1,3,4-Thiadiazole (12)2-Phenyl-1,3,4-Thiadiazole (19)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-Bromobenzo[C][1,2,5]Thiadiazole (14)Benzo[D][1,2,3]Thiadiazole (7)
Thiazines (62)
Thiazoles (6687)
Acetylthiazole (7)Bromothiazolo (9)Chlorothiazole (32)Chlorothiazolo (18)Cyanothiazole (7)Cyclopropylthiazole (11)Dibromothiazole (7)Dichlorothiazole (8)Dihydrothiazole (16)Dihydrothiazolo (14)Dimethylthiazole (22)Ethylthiazole (8)Formylthiazole (7)Methylthiazole (109)Nitrothiazol (8)Tetrahydrothiazolo (8)1-(Thiazol-2-Yl)Ethan-1-One (9)2,4-Dibromothiazole (5)2,4-Dichlorothiazole (4)2,4-Dimethylthiazole (7)2,5-Dibromothiazole (5)2,5-Dimethylthiazole (4)2-(Chloromethyl)Thiazole (5)2-(Methylthio)Thiazole (5)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethyl)Thiazole (11)2-Bromo-4-Methylthiazole (7)2-Bromo-5-Methylthiazole (7)2-Chloro-4-Methylthiazole (5)2-Chloro-5-Methylthiazole (5)2-Chlorothiazole (32)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)2-Isopropylthiazole (11)2-Methyl-4-Phenylthiazole (6)2-Phenoxythiazole (5)2-Phenylbenzo[D]Thiazole (16)2-Phenylthiazole-4-Carbaldehyde (9)4,5,6,7-Tetrahydrobenzo[D]Thiazole (14)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5-Dihydrothiazole (8)4-(4-Fluorophenyl)Thiazole (9)4-(Trifluoromethyl)Thiazole (7)4-Bromothiazole (10)4-Cyclopropylthiazole (6)4-Methyl-2-Phenylthiazole (6)4-Methylthiazol-2-Amine (7)4-Methylthiazole (5)4-Phenylthiazol-2-Amine (37)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)5-Bromothiazol-2-Amine (6)5-Bromothiazole (8)5-Methyl-4-Phenylthiazole (5)5-Methylthiazol-2-Amine (6)5-Phenylthiazole (20)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Phenylthiazole-4-Carboxylate (12)Ethyl 2-Phenylthiazole-5-Carboxylate (9)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)N-(Thiazol-2-Yl)Acetamide (9)N-(Thiazol-2-Yl)Benzamide (9)N-Phenylthiazol-2-Amine (9)Tert-Butyl Thiazol-2-Ylcarbamate (22)Thiazol-2-Ylmethanamine (5)Thiazol-2-Ylmethanol (9)Thiazol-5-Amine (6)Thiazole-2-Carbaldehyde (9)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carbaldehyde (19)Thiazole-5-Carbonitrile (7)Thiazole-5-Carboxylic Acid (10)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thiazolo[5,4-D]Pyrimidine (5)
Thiazolidines (1260)
Thioxothiazolidin (23)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)1,2,3-Oxathiazolidine 2,2-Dioxide (14)2-Thioxothiazolidin-4-One (6)Thiazolidine (16)
Thiomorpholines (454)
Thiomorpholine (10)Thiomorpholine 1,1-Dioxide (6)
Thiophenes (960)
Acetylthiophene (5)Aminothiophene (23)Bromothieno (29)Chlorothieno (41)Chlorothiophene (61)Cyanothiophene (5)Dibromothieno (5)Dibromothiophene (17)Dichlorothieno (10)Dichlorothiophene (13)Dihydrothieno (24)Dihydrothiophene (1)Dihydroxythiophene (7)Dimethylthieno (10)Dimethylthiophene (21)Dithiophene (40)Fluorothiophene (18)Formylthiophene (16)Hydroxythiophene (7)Iodothieno (6)Iodothiophene (13)Methylthieno (27)Nitrothiophene (27)Terthiophene (10)Tetrahydrothieno (17)Thiophenecarboxaldehyde (10)Thiphen-Amine-Hydrochloride (58)Trithiophene (5)(9H-Fluoren-9-Yl)Methyl (2-(Thiophen-2-Yl)Ethyl)Carbamate (5)1-(Thiophen-2-Yl)Ethan-1-One (17)2,2'-Bithiophene (25)2,2':5',2''-Terthiophene (9)2,3-Dihydrothieno[3,4-B][1,4]Dioxine (9)2,5-Dibromothiophene (18)2,5-Diphenylthiophene (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethyl)Thiophene (11)2-Chlorothiophene (20)2-Ethynylthiophene (8)2-Iodothiophene (14)2-Methoxythiophene (7)2-Nitrothiophene (20)3-Bromothiophene (6)3-Chlorothiophene (17)3-Fluorothiophene (6)3-Methoxythiophene (9)3-Methylthiophene (14)3-Nitrothiophene (6)3-Phenylthiophene (13)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,7-Di(Thiophen-2-Yl)Benzo[C][1,2,5]Thiadiazole (9)4,8-Di(Thiophen-2-Yl)Benzo[1,2-B:4,5-B']Dithiophene (8)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-Cyclopenta[2,1-B:3,4-B']Dithiophene (9)4H-Thieno[3,2-B]Pyrrole (6)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5,6-Dihydro-4H-Cyclopenta[B]Thiophene (7)5-(Thiophen-2-Yl)Isoxazole (5)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Phenylthiophen-2-Amine (5)Benzo[1,2-B:4,5-B']Dithiophene (7)Dibenzo[B,D]Thiophene (22)Dihydrothiophen-3(2H)-One (4)Dithieno[3,2-B:2',3'-D]Thiophene (5)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Methyl Thiophene-3-Carboxylate (34)N,N-Diphenyl-4-(Thiophen-2-Yl)Aniline (5)Phenyl(Thiophen-2-Yl)Methanone (6)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-B]Pyridine (18)Thieno[3,2-B]Thiophene (19)Thieno[3,2-C]Pyridine (13)Thieno[3,2-D]Pyrimidine (24)Thieno[3,4-B]Thiophene (5)Thiophen-2-Ylboronic Acid (20)Thiophen-2-Ylmethanol (11)Thiophen-3-Amine (18)Thiophen-3-Ol (6)Thiophene-2-Carbaldehyde (43)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbaldehyde (17)Thiophene-3-Carbonitrile (13)Thiophene-3-Carboxamide (5)Thiophene-3-Carboxylic Acid (8)
Triazines (1387)
1,2,4-Triazine (9)1,3,5-Triazin-2-Amine (3)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4,6-Triphenyl-1,3,5-Triazine (24)2,4-Diphenyl-1,3,5-Triazine (6)2-Chloro-1,3,5-Triazine (10)2-Methoxy-1,3,5-Triazine (10)2-Phenyl-1,3,5-Triazine (6)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)Pyrrolo[2,1-F][1,2,4]Triazine (14)
Triazoles (7749)
(5As,10Br)-2-Phenyl-2,5A,6,10B-Tetrahydro-4H-Indeno[2,1-B][1,2,4]Triazolo[4,3-D][1,4]Oxazin-11-Ium (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-Benzyl-1H-1,2,3-Triazole (8)1-Benzyl-1H-1,2,4-Triazole (6)1-Methyl-1H-1,2,3-Triazole (9)1-Methyl-1H-1,2,4-Triazole (17)1-Methyl-1H-Benzo[D][1,2,3]Triazole (10)1-Phenethyl-1H-1,2,4-Triazole (6)1-Phenyl-1H-1,2,3-Triazole (7)1-Phenyl-1H-1,2,4-Triazole (20)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenyl-2H-Benzo[D][1,2,3]Triazole (8)2H-1,2,3-Triazole (7)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-Phenyl-4H-1,2,4-Triazole (6)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-1,2,4-Triazole (13)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)
Other Aliphatic Heterocycles (6209)
1,3-Dioxane (20)1,4-Diazepane (12)3-Azabicyclo[3.1.0]Hexane (14)
Other Aromatic Heterocycles (37751)
Indolizine (15)Phenazine (8)
NHCs
Achiral NHCs Catalysts (35)
Achiral NHCs Ligands (110)
Chiral NHCs Catalysts (138)
Chiral NHCs Ligands (84)
Organic Building Blocks
Acyl Chlorides (3025)
2-Chlorobenzoyl Chloride (13)2-Phenoxyacetyl Chloride (3)2-Phenylacetyl Chloride (9)
Alcohols (45771)
Amino-Propanol (6)Cyclopropylethanol (6)Diethanol (23)Diethanol (23)Dihydroxybenzylidene (4)Dihydroxynaphthalene (7)Dihydroxypropanoate (7)Dihydroxyterephthalic Acid (3)Hydroxyacetamide (1)Hydroxyacetimidamide (3)Hydroxyadamantan (4)Hydroxyadamantan (4)Hydroxyazetidine (7)Hydroxybenzyl (18)Hydroxybenzylidene (5)Hydroxybicyclo (7)Hydroxybutan (4)Hydroxybutan (4)Hydroxybutanoate (36)Hydroxybutanoic (33)Hydroxycarbamimidoyl (2)Hydroxycinnamic Acid (2)Hydroxycyclobutyl (3)Hydroxycyclohexyl (7)Hydroxycyclopentyl (1)Hydroxydiphenylmethyl (2)Hydroxyethoxy (22)Hydroxyethoxy (22)Hydroxyhexanoate (8)Hydroxyhexanoic (6)Hydroxyimino (11)Hydroxyisonicotinaldehyde (7)Hydroxyisonicotinate (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic Acid (4)Hydroxymethyl-Phenyl-Boronic-Acid (31)Hydroxynaphthalene (29)Hydroxynicotinaldehyde (7)Hydroxynicotinate (13)Hydroxynicotinonitrile (6)Hydroxyoctadec (1)Hydroxyoctadec (1)Hydroxyoctadecanoic (7)Hydroxypentanoate (6)Hydroxypropanoic (35)Pentahydroxyhexanal (9)Phenyl-Methanol (3)Propanediol (9)Propanediol (9)Tetrahydroxy (25)Tetrahydroxy (25)Tetrahydroxyhexanal (9)Tetrahydroxypentanal (5)Trihydroxy (246)Trihydroxy (246)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenylcyclopropyl)Methanol (3)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)(1H-Indol-2-Yl)Methanol (8)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromophenyl)Methanol (39)(2-Chlorophenyl)Methanol (39)(2-Fluorophenyl)Methanol (60)(2-Iodophenyl)Methanol (12)(2-Nitrophenyl)Methanol (29)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Methanol (21)(3-Chlorophenyl)Methanol (38)(3-Fluorophenyl)Methanol (58)(3-Iodophenyl)Methanol (13)(3-Methylpyridin-2-Yl)Methanol (10)(3-Nitrophenyl)Methanol (31)(3-Phenoxyphenyl)Methanol (3)(3-Phenylisoxazol-5-Yl)Methanol (7)(4-Fluorophenyl)Methanol (29)(4-Nitrophenyl)Methanol (17)(6-Methylpyridin-2-Yl)Methanol (5)(Tetrahydrofuran-2-Yl)Methanol (6)1,2-Diphenylethan-1-Ol (8)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenylethan-1-Ol (102)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Amino-2-Phenylethan-1-Ol (196)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxyethyl Benzoate (3)2-Phenoxyethan-1-Ol (14)2-Phenylethan-1-Ol (77)2-Phenylpropan-2-Ol (21)3-Phenylpropan-1-Ol (24)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Phenylpiperidin-4-Ol (10)Azetidin-2-Ylmethanol (7)Azetidin-3-Ol (11)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Cyclobutanol (46)Cyclobutylmethanol (15)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanol (51)Diphenylmethanol (20)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Ylmethanol (5)M-Tolylmethanol (34)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Naphthalen-1-Ylmethanol (8)O-Tolylmethanol (35)Oxiran-2-Ylmethanol (3)Piperidin-2-Ylmethanol (11)Piperidin-3-Ol (27)Piperidin-3-Ylmethanol (15)Piperidin-4-Ylmethanol (11)Pyridin-2-Ylmethanol (65)Pyridin-3-Ylmethanol (39)Pyridin-4-Ylmethanol (16)Pyrimidin-2-Ylmethanol (5)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ylmethanol (13)Quinazolin-2-Ol (7)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Thiazol-2-Ylmethanol (9)Thiophen-2-Ylmethanol (11)Triphenylmethanol (13)
Aldehydes (18914)
Aminonicotinaldehyde (5)Aminonicotinaldehyde (5)Carboxyaldehyde (1094)Dicarbaldehyde (37)Dicarbaldehyde (37)Formylisonicotinate (7)Tetracarbaldehyde (8)Tetracarbaldehyde (8)Tricarbaldehyde (10)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Naphthaldehyde (23)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Indazole-3-Carbaldehyde (19)1H-Indole-2-Carbaldehyde (20)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3-Dichlorobenzaldehyde (7)2,3-Difluorobenzaldehyde (18)2,4-Dichlorobenzaldehyde (8)2,4-Difluorobenzaldehyde (19)2,6-Dibromobenzaldehyde (4)2,6-Difluorobenzaldehyde (25)2-(Benzyloxy)Benzaldehyde (13)2-(Phenylethynyl)Benzaldehyde (9)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethyl)Benzaldehyde (27)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-6-Fluorobenzaldehyde (15)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-4-Fluorobenzaldehyde (10)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluorobenzaldehyde (175)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodobenzaldehyde (17)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Naphthaldehyde (12)2-Nitrobenzaldehyde (53)2-Oxo-2-Phenylacetaldehyde (12)2-Phenylacetaldehyde (20)3-(Benzyloxy)Benzaldehyde (13)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethyl)Benzaldehyde (31)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Methoxybenzaldehyde (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-4-Methoxybenzaldehyde (7)3-Chlorobenzaldehyde (106)3-Fluorobenzaldehyde (137)3-Iodobenzaldehyde (28)3-Methoxy-2-Nitrobenzaldehyde (3)3-Nitrobenzaldehyde (49)3-Phenoxybenzaldehyde (7)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-(Benzyloxy)Benzaldehyde (23)4-(Piperazin-1-Yl)Benzaldehyde (5)4-Fluorobenzaldehyde (78)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Morpholinobenzaldehyde (8)4-Nitrobenzaldehyde (18)4-Phenoxybenzaldehyde (12)5-Phenylfuran-2-Carbaldehyde (9)6-Methoxynicotinaldehyde (4)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-4-Carbaldehyde (31)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-3-Carbaldehyde (6)Benzo[D][1,3]Dioxole-5-Carbaldehyde (6)Benzofuran-2-Carbaldehyde (5)Furan-2-Carbaldehyde (22)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Isonicotinaldehyde (68)Methyl 3-Formylbenzoate (23)Nicotinaldehyde (153)Picolinaldehyde (98)Pyrazine-2-Carbaldehyde (17)Pyrimidine-5-Carbaldehyde (38)Thiazole-2-Carbaldehyde (9)Thiazole-5-Carbaldehyde (19)Thiophene-2-Carbaldehyde (43)Thiophene-3-Carbaldehyde (17)
Aliphatic Chain Hydrocarbons (12579)
Acetylthio (7)Acetylthio (7)Azanonadecan (7)Azanylylidene (1)Azapentadecan (10)Azapentadecan (10)Azatridecan (4)Butyloctyl (4)Butyloctyl (4)Carbonylbis (2)Carbonylbis (2)Diazirine (13)Diazirine (13)Didodecyl (7)Didodecyl (7)Diethyl (73)Diethyl (73)Dihydroxypropan (6)Diisobutyl (2)Diisopropyl (27)Diisopropyl (27)Dimethoxy (306)Dimethyladamantane (14)Dimethyladamantane (14)Dimethylalkanes (7)Dinonyl (1)Dinonyl (1)Dioctyl (1)Dioxide (451)Dioxide (451)Ethoxy (711)Ethoxyethoxy (5)Ethoxyethoxy (5)Ethoxyethyl (16)Ethoxyethyl (16)Ethoxymethyl (11)Ethoxymethylene (1)Ethoxymethylene (1)Isopropylidenebis (2)Isopropylsulfonyl (10)Isopropylsulfonyl (10)Methoxybut (2)Methoxybut (2)Methoxyethoxy (67)Methoxyethoxy (67)Methoxyethyl (69)Methoxyisonicotinic (11)Methoxyisonicotinic (11)Methoxymethoxy (23)Methoxymethoxy (23)Methoxymethyl (117)Methoxynicotinic (26)Methoxynicotinic (26)Methoxynicotinic Acid (20)Methoxypropan (24)Methoxypropan (24)Methoxypropoxy (8)Methoxypropoxy (8)Methoxypropyl (10)Methoxytetrahydro (14)Methoxytetrahydro (14)Methyladamantan (4)Methylisonicotinic (13)Oxoethoxy (1)Oxopropane (10)Oxopropyl (32)Oxopropyl (32)Pentyloxy (7)Tetramethoxy (6)Trimethoxy (15)Trimethoxy (15)Yldisulfanyl (7)
Aliphatic Cyclic Hydrocarbons (11046)
Aminobicyclo (24)Aminocyclobutanol (5)Aminocyclobutyl (5)Aminocyclohexane (55)Aminocyclohexanol (21)Aminocyclopentanol (17)Aminocyclopentyl (6)Aminocyclopropyl (4)Azabicyclo (292)Azabicyclo (292)Azatricyclo (5)Azatricyclo (5)Azetidine (185)Azetidine (185)Benzylazetidin (9)Bicyclo (61)Bicyclohexyl (6)Bromobicyclo (9)Butylcyclohexyl (9)Butylsulfonyl (6)Chlorocyclopropyl (2)Cyanoazetidine (5)Cyanocyclopropyl (4)Cyclobutanecarbonitrile (2)Cyclobutylacetic (4)Cyclobutylmethyl (4)Cyclobutylmethyl (4)Cyclodextrin (1)Cyclodextrin (1)Cyclohexa (176)Cyclohexa (176)Cyclohexane (127)Cyclohexane (127)Cyclohexanecarboxylic (19)Cyclohexanediamine (8)Cyclohexanone (92)Cyclohexylacetic (2)Cyclohexylamino (9)Cyclohexylbutanoic (4)Cyclohexylcarbamoyl (5)Cyclohexylethanamine (12)Cyclohexylmethoxy (4)Cyclohexylmethoxy (4)Cyclohexylmethyl (7)Cyclohexylmethyl (7)Cyclohexyloxy (10)Cyclohexylpropan (94)Cyclohexylpropanoic (9)Cyclopentadienyl (2)Cyclopentane (169)Cyclopentane (169)Cyclopentanecarboxylic (7)Cyclopentyl (56)Cyclopentyl (56)Cyclopentylacetic (3)Cyclopentylamino (1)Cyclopentylmethyl (4)Cyclopentyloxy (16)Cyclopentyloxy (16)Cyclopentylpropanoic (1)Cyclopropanamine (32)Cyclopropanamine (32)Cyclopropanecarbonitrile (14)Cyclopropanecarbonyl (6)Cyclopropanecarbonyl (6)Cyclopropanecarboxamide (14)Cyclopropanol (4)Cyclopropoxyphenyl (7)Cyclopropyl (355)Cyclopropyl (355)Cyclopropylacetate (6)Cyclopropylacetic (3)Cyclopropylamino (24)Cyclopropylcarbamoyl (5)Cyclopropylethan (5)Cyclopropylethan (5)Cyclopropylethynyl (1)Cyclopropylmethoxy (32)Cyclopropylmethoxy (32)Cyclopropylmethyl (22)Cyclopropylmethyl (22)Cyclopropylpropanoic (5)Cyclopropylsulfonyl (6)Cyclopropylsulfonyl (6)Diazabicyclo (77)Diazabicyclo (77)Dicyclohexyl (6)Dicyclohexyl (6)Dicyclohexylphosphino (18)Dicyclohexylphosphino (18)Difluorocyclobutyl (6)Difluorocyclohexyl (7)Dihydroinden (8)Dihydroindeno (5)Dihydroindeno (5)Dihydropteridin (6)Dimethylbicyclo (5)Dimethylbicyclo (5)Dimethylcyclohex (5)Dimethylcyclohexane (16)Dimethylcyclohexanone (7)Dioxathiolane (1)Dioxathiolane (1)Dioxol (175)Dithiolan (1)Dithiolan (1)Ethylcyclohexyl (4)Ethylcyclohexyl (4)Ethylsulfonyl (42)Fluoroazetidine (1)Fluorobicyclo (4)Hexahydrocyclohepta (6)Hexahydrocyclohepta (6)Hexahydrocyclopenta (4)Hydroxycyclobutanecarboxylic (4)Hydroxycyclohexanecarboxylic (6)Methanesulfonyl (314)Methanesulfonyl (314)Methoxycyclohexanamine (6)Methylazetidine (30)Methylbicyclo (6)Methylbicyclo (6)Methylcyclobutanamine (5)Methylcyclobutanecarboxylic (5)Methylcyclohexanamine (12)Methylcyclohexane (8)Methylcyclohexane (8)Methylcyclohexanecarboxylic (5)Methylcyclohexanecarboxylic Acid (4)Methylcyclohexanol (21)Methylcyclohexanone (5)Methylcyclohexyl (33)Methylcyclopentane (2)Methylcyclopropanamine (4)Methylcyclopropanamine (4)Methylcyclopropane (16)Methylsulfinyl (24)Methylsulfonimidoyl (6)Methylsulfonimidoyl (6)Methylsulphonyl (10)Octahydrocyclopenta (14)Oxabicyclo (40)Oxabicyclo (40)Oxazepane (13)Oxetanes (228)Oxoazetidine (8)Oxoazetidine (8)Oxobicyclo (11)Oxobicyclo (11)Oxocyclobutyl (2)Oxocyclohex (3)Oxocyclohexane (4)Oxocyclohexane (4)Oxocyclohexanecarboxylic (6)Oxocyclohexyl (3)Oxocyclohexyl (3)Oxocyclopentane (2)Oxocyclopentyl (5)Pentamethylcyclopentadienyl (11)Pentylcyclohexyl (10)Pentylcyclohexyl (10)Phenylcyclopropanamine (8)Propylcyclohexyl (15)Propylcyclohexyl (15)Tetraazacyclododecane (13)Tetraazacyclododecane (13)Tetraazacyclotetradecane (7)Tetraazacyclotetradecane (7)Tetramethylcyclohexane (4)Tetraoxatridecan (3)Tetraoxatridecan (3)Thiazepine (2)Tricyclohexylphosphine (9)Trimethylbicyclo (21)Trimethylcyclohex (20)Trimethylcyclohexane (1)Trimethylcyclohexane (1)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1-Phenylcyclopropyl)Methanol (3)(3Ar,E)-4-((Z)-2-(2-Methylenecyclohexylidene)Ethylidene)Octahydro-1H-Indene (7)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Pentylcyclohexyl)Benzene (5)(4-Propylcyclohexyl)Benzene (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Cyclopropylmethoxy)Benzene (18)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,1-Difluorocyclopentane (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-3-Cyclopropylbenzene (6)1-Chloro-2-Cyclopropylbenzene (7)1-Cyclohexyl-2-Fluorobenzene (4)1-Cyclopropyl-3-Methylbenzene (3)1-Methylcyclohex-1-Ene (26)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropan-1-Amine (26)1-Phenylcyclopropane-1-Carbonitrile (19)1-Phenylcyclopropane-1-Carboxylic Acid (23)2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-2-Phenylacetic Acid (5)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Cyclohexylacetic Acid (14)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Cyclopropylpyrimidine (10)2-Iodo-9H-Fluorene (8)2-Methylcyclohexan-1-One (3)2-Phenylcyclopropan-1-Amine (19)3,3-Dimethylcyclohexan-1-One (4)3-Cyclopropylpyridine (28)3-Methylcyclohexan-1-One (9)4-Cyclohexylbenzoic Acid (6)4-Cyclohexylbenzonitrile (10)4-Cyclohexylphenol (7)5-Azaspiro[2.4]Heptane (13)6-Azaspiro[2.5]Octane (10)9,9-Dimethyl-9H-Fluorene (16)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Bicyclo[2.2.1]Hept-2-Ene (18)Bicyclo[2.2.1]Heptane (15)Bromocyclohexane (7)Cyclobutanamine (90)Cyclobutanecarboxylic Acid (23)Cyclobutanol (46)Cyclobutylmethanol (15)Cycloheptane (12)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanamine (59)Cyclohexanecarboxylic Acid (83)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanamine (5)Cyclopentanecarboxylic Acid (26)Cyclopentanol (51)Cyclopropoxybenzene (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Isopropylcyclohexane (19)Methoxycyclohexane (7)Methyl 1-Phenylcyclopropane-1-Carboxylate (10)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)N-Methylcyclohexanamine (7)Naphthalene-1,4-Dione (23)Spiro[3.3]Heptane (11)Tert-Butyl (1-Phenylcyclopropyl)Carbamate (6)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclobutylcarbamate (17)Tert-Butyl Cyclohexylcarbamate (9)Tert-Butyl Cyclopentylcarbamate (28)
Alkenyls (16078)
Acrylaldehyde (11)Acryloyl (9)Acryloyl (9)Annulene (2)Cyclohexene (88)Cyclooctene (9)Cyclopentene (3)Diacrylamide (6)Diallyl (5)Diazene (21)Divinyl (1)Divinyl (1)Enamide (6)Enamide (6)Enecarbaldehyde (2)Enoyl (9)Methacrylamide (3)Methacrylamide (3)Methoxycinnamaldehyde (3)Nitroethylene (37)Tetrahydrocyclopenta (19)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Nitrovinyl)Benzene (28)(Allyloxy)Benzene (19)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1,2-Diphenylethene (5)1,3,3-Trimethylcyclohex-1-Ene (12)1-Bromo-4-Styrylbenzene (5)1-Methylcyclohex-1-Ene (26)2-Benzalacetophenone (36)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methyleneazetidine (8)3-Phenylacrylaldehyde (29)3-Styrylphenol (11)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Prop-1-En-2-Yl)Cyclohex-1-Ene (5)5H-Dibenzo[B,F]Azepine (4)Allyl Benzoate (5)Cyclohex-1-En-1-Yl Trifluoromethanesulfonate (3)Cyclohex-1-En-1-Ylboronic Acid (4)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohexa-1,3-Diene (5)Cyclopent-2-En-1-Amine (4)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Methyl Cinnamate (36)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methylenecyclobutane (8)Methylenecyclohexane (8)N-Phenylacrylamide (7)Styrene (81)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Vinylcyclopropane (8)
Alkyls (195)
Isopropyl-Phenyl-Boronic Acid/Ester (26)Methylpentan (11)
Alkynyls (2698)
(Bromoethynyl)Benzene (5)(Prop-2-Yn-1-Yloxy)Benzene (13)1,3,5-Tris(Phenylethynyl)Benzene (6)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-Ethynyl-2-Fluorobenzene (10)1-Methyl-4-(Phenylethynyl)Benzene (7)2-(Phenylethynyl)Benzaldehyde (9)2-Ethynylpyridine (31)2-Ethynylthiophene (8)3-Ethynylpyridine (22)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-(Phenylethynyl)Phenol (7)4-Ethynylpyridine (10)9,10-Bis(Phenylethynyl)Anthracene (5)Ethynylbenzene (145)Trimethyl(Phenylethynyl)Silane (23)
Amides (90371)
Acetamide (651)Acetamide (651)Acetamido (156)Carboxamide (929)Carboxamide (929)Diacetamide (3)Dicarboxamide (19)Diethylacetamide (4)Diethylacetamide (4)Dimethylacetamide (9)Dimethylnicotinamide (7)Dimethylnicotinamide (7)Formamidophenylboronic Acid/Ester (11)Isobutyramide (7)Oxobutanamide (10)Oxobutanamide (10)Pentanamide (18)Pentanamide (18)Propanamide (2)Propanamido (5)Propanamido (5)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)(S)-N-Phenylpiperidine-2-Carboxamide (1)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-Methylindoline-2,3-Dione (8)1-Phenylurea (11)1H-Pyrazole-5-Carboxamide (3)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Trifluoromethyl)Benzamide (6)2-Amino-3-Phenylpropanamide (8)2-Amino-N-Phenylbenzamide (21)2-Aminobenzamide (30)2-Bromo-N-Phenylacetamide (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylbenzamide (4)2-Chlorobenzamide (16)2-Fluoro-N-Methylbenzamide (12)2-Fluorobenzamide (32)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Iodobenzamide (4)2-Methoxybenzamide (9)3-Benzamidopropanoic Acid (3)3-Bromo-4-Fluorobenzamide (3)3-Fluorobenzamide (26)3-Nitrobenzamide (17)3-Oxo-N-Phenylbutanamide (10)4-Amino-N-Phenylbenzamide (7)4-Benzamidobenzoic Acid (3)4-Fluorobenzamide (19)4-Oxo-4-(Phenylamino)Butanoic Acid (7)Benzoylglycine (15)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Phenylcarbamate (15)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Isonicotinamide (12)N,N-Diethylbenzamide (17)N,N-Dimethylbenzamide (34)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)N-(2-Chlorophenyl)Acetamide (16)N-(2-Iodophenyl)Acetamide (8)N-(2-Nitrophenyl)Acetamide (11)N-(3-Fluorophenyl)Acetamide (14)N-(4-Aminophenyl)Benzamide (2)N-(4-Chlorophenyl)Acetamide (9)N-(4-Chlorophenyl)Benzamide (6)N-(4-Fluorophenyl)Benzamide (3)N-(4-Phenoxyphenyl)Acetamide (4)N-(O-Tolyl)Benzamide (9)N-(P-Tolyl)Benzamide (6)N-(Thiazol-2-Yl)Acetamide (9)N-Isopropylbenzamide (16)N-Methoxy-N-Methylbenzamide (24)N-Methylbenzamide (58)N-Methylpicolinamide (10)N-Phenylacrylamide (7)N-Phenylpivalamide (11)Nicotinamide (64)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Picolinamide (26)Piperidine-3-Carboxamide (5)Pyrazine-2-Carboxamide (10)Pyrrolidine-2-Carboxamide (12)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Thiophene-3-Carboxamide (5)
Amidines (1564)
Carbamimidoyl (16)Benzimidamide (50)N'-Hydroxybenzimidamide (13)Picolinimidamide (11)
Amines (139951)
Amino-Carboxylate (2)Amino-Propanol (6)Aminoacetamido (4)Aminoacetyl (2)Aminoadamantan (5)Aminoadamantan (5)Aminoazepane (10)Aminobutane (23)Aminobutane (23)Aminobutyl (15)Aminobutyl (15)Aminoethoxy (18)Aminoethoxy (18)Aminoethyl (157)Aminoethyl (157)Aminohexan (6)Aminohexyl (3)Aminohexyl (3)Aminoisonicotinic Acid (12)Aminomethyl (403)Aminomethyl (403)Aminooxy (6)Aminopentyl (10)Aminopentyl (10)Aminopropanamido (1)Aminopropane (20)Aminopropane (20)Aminopropoxy (2)Aminopropoxy (2)Aminotetrahydro (12)Aminotetrahydro (12)Benzylazetidine (4)Bromobenzylamine (6)Bromobenzylcarbamate (28)Butoxycarbonylamino (8)Butylcarbamoyl (5)Carbamothioyl (2)Carbamoyl (114)Chlorobenzylamine (4)Chroman-Amine (1)Diamino (90)Diamino (90)Diaminopteridin (3)Diaminopteridin (3)Dibutylamino (6)Dibutylamino (6)Dichlorobenzylamine (5)Diethylamino (91)Diethylamino (91)Diisopropylamino (1)Dimethyl-Ethylamine (2)Dimethylamino (490)Dimethylamino (490)Dimethylcarbamoyl (14)Dimethylmethanamine (16)Dipropylamino (1)Dipropylamino (1)Ethylamino (37)Ethylamino (37)Fluindamine (32)Hydroxyamino (3)Hydroxyamino (3)Imidazol-Amine (1)Methoxyethanamine (1)Methoxyethanamine (1)Methoxyimino (2)Methylamino (241)Methylamino (241)Methylcarbamoyl (19)Methylcarbamoyl (19)Propanediamine (6)Propylamino (5)Propylamino (5)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)Silanamine (3)Triamine (25)Triamine (25)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)Methanamine (12)(2-Chlorophenyl)Methanamine (28)(2-Fluorophenyl)Methanamine (49)(3-Chlorophenyl)Methanamine (19)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Fluorophenyl)Methanamine (27)(6-Methylpyridin-2-Yl)Methanamine (6)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-3-Yl)Methanamine (3)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2-Diphenylethan-1-Amine (15)1,3,4-Thiadiazol-2-Amine (9)1,3,5-Triazin-2-Amine (3)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-Aminoanthracene-9,10-Dione (8)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-4-Amine (8)1-Methyl-1H-Pyrazol-3-Amine (14)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclopropan-1-Amine (26)1-Phenylethan-1-Amine (436)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Imidazol-2-Amine (6)1H-Indazol-3-Amine (23)1H-Indazol-4-Amine (12)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-7-Amine (6)1H-Indol-4-Amine (10)1H-Indol-6-Amine (21)1H-Indol-7-Amine (10)1H-Pyrazol-4-Amine (6)1H-Pyrazol-5-Amine (19)1H-Pyrrol-1-Amine (7)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,3-Dichloroaniline (18)2,3-Difluoroaniline (34)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,4-Dibromoaniline (18)2,4-Dichloropyrimidin-5-Amine (6)2,4-Difluoroaniline (44)2,5-Difluoroaniline (34)2,6-Dibromoaniline (17)2,6-Dichloroaniline (27)2,6-Difluoroaniline (23)2,6-Diiodoaniline (8)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(Diethylamino)Ethyl Benzoate (3)2-(Methylsulfonyl)Aniline (3)2-(Phenylamino)Benzoic Acid (11)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethyl)Aniline (58)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-Phenylethan-1-Ol (196)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-Chlorophenol (4)2-Amino-3-Fluorobenzoic Acid (11)2-Amino-6-Bromophenol (3)2-Amino-6-Chlorobenzoic Acid (5)2-Amino-6-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Aminobenzamide (30)2-Aminobenzenesulfonic Acid (9)2-Aminophenol (107)2-Aminopyrimidin-4(3H)-One (11)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Methylaniline (6)2-Bromo-4-Methylaniline (14)2-Bromo-6-Methylaniline (11)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Chloro-3-Methylaniline (4)2-Chloro-4-Methylaniline (7)2-Chloro-6-Methylaniline (11)2-Chloro-N-Methylaniline (4)2-Chloro-N-Phenylaniline (7)2-Chloroaniline (214)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,4-Diamine (6)2-Chloropyrimidin-4-Amine (22)2-Fluoro-6-Iodoaniline (7)2-Fluoro-N-Phenylaniline (4)2-Fluoroaniline (262)2-Iodo-4-Methylaniline (5)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Methoxypyridin-3-Amine (6)2-Methyl-6-Nitroaniline (10)2-Methyl-N-Phenylaniline (6)2-Methylpyridin-4-Amine (7)2-Methylpyrimidin-4-Amine (22)2-Nitro-N-Phenylaniline (3)2-Phenoxyaniline (4)2-Phenylcyclopropan-1-Amine (19)2-Phenylpyrimidin-5-Amine (5)3,4-Dibromoaniline (4)3,4-Dichloroaniline (21)3,4-Difluoroaniline (44)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(Benzyloxy)Aniline (12)3-(Methylsulfonyl)Aniline (7)3-(Piperazin-1-Yl)Aniline (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethyl)Aniline (102)3-Aminobenzenesulfonic Acid (6)3-Aminodihydrofuran-2(3H)-One (4)3-Bromo-2-Fluoroaniline (15)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methylaniline (14)3-Bromoaniline (187)3-Bromobenzene-1,2-Diamine (11)3-Chloro-2-Iodoaniline (3)3-Chloro-2-Methylaniline (11)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Iodoaniline (3)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methylaniline (12)3-Chlorobenzene-1,2-Diamine (6)3-Chloropyrazin-2-Amine (6)3-Fluoro-2-Methylaniline (9)3-Fluoroaniline (289)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Methoxypyridin-2-Amine (5)3-Methyl-N-Phenylaniline (4)3-Methylpyridin-2-Amine (7)3-Nitroaniline (98)3-Phenoxyaniline (2)3-Phenyl-1H-Pyrazol-5-Amine (11)3-Phenylisoxazol-5-Amine (8)4,6-Dichloropyrimidin-2-Amine (9)4-(Benzyloxy)Aniline (8)4-(Oxazol-5-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Trifluoromethoxy)Aniline (26)4-Amino-2-Chlorobenzonitrile (8)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorobenzoic Acid (6)4-Amino-3-Chlorophenol (5)4-Amino-N-Phenylbenzenesulfonamide (3)4-Aminopyridazin-3(2H)-One (4)4-Benzylaniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Iodoaniline (3)4-Chloro-3-Methylaniline (11)4-Chloro-N-Phenylaniline (6)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Fluoro-N-Phenylaniline (4)4-Fluoroaniline (225)4-Iodo-N,N-Diphenylaniline (3)4-Methoxy-N-Phenylaniline (5)4-Methyl-3-Nitroaniline (8)4-Methylpyrimidin-2-Amine (9)4-Methylthiazol-2-Amine (7)4-Morpholinoaniline (4)4-Nitroaniline (65)4-Phenoxyaniline (6)4-Phenylpyrimidin-2-Amine (15)4-Phenylthiazol-2-Amine (37)5-Bromopyrazin-2-Amine (13)5-Bromothiazol-2-Amine (6)5-Chloropyrazin-2-Amine (9)5-Methoxypyridin-3-Amine (4)5-Methyl-2-Nitroaniline (6)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Methylthiazol-2-Amine (6)5-Phenylthiophen-2-Amine (5)5H-Dibenzo[B,F]Azepine (4)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)6-Chloropyridazin-3-Amine (5)6-Chloropyrimidin-4-Amine (8)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylpyridin-2-Amine (46)6-Methylpyridin-3-Amine (5)6-Phenoxypyridin-3-Amine (5)7-Methoxy-N-Phenylquinazolin-4-Amine (12)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)9H-Purin-6-Amine (3)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-3-Amine (11)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Azetidin-3-Amine (4)Azetidin-3-Ylmethanamine (3)Aziridine (9)Benzo[B]Thiophen-2-Amine (5)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Thiazol-2-Amine (29)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Bis(Pyridin-2-Ylmethyl)Amine (6)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Cyclobutanamine (90)Cyclohexanamine (59)Cyclopent-2-En-1-Amine (4)Cyclopentanamine (5)Cyclopropyl(Phenyl)Methanamine (22)Diphenylmethanamine (26)Ethyl 2-Aminobenzoate (23)Ethyl 3-Aminobenzoate (19)Ethyl 4-Aminobenzoate (23)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Isoquinolin-1-Amine (18)Isoquinolin-3-Amine (13)Isoquinolin-4-Amine (16)Isoquinolin-5-Amine (9)Isoquinolin-8-Amine (6)Isoxazol-5-Amine (15)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 4-Aminobenzoate (71)Methyl L-Phenylalaninate (20)Morpholin-2-Ylmethanamine (8)N,N-Diethylaniline (17)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N,N-Dimethylaniline (117)N,N-Dimethylnaphthalen-1-Amine (4)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N,N-Dimethylpyrimidin-2-Amine (10)N,N-Dimethylpyrrolidin-3-Amine (7)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-(4-Aminophenyl)Benzamide (2)N-(Furan-2-Ylmethyl)Aniline (5)N-(Prop-2-Yn-1-Yl)-2,3-Dihydro-1H-Inden-1-Amine (3)N-Benzyl-1-Phenylethan-1-Amine (7)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylpiperidin-4-Amine (3)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-1,2-Diphenylethan-1-Amine (7)N-Methyl-1-Phenylmethanamine (65)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)N-Methylaniline (140)N-Methylcyclohexanamine (7)N-Methylpiperidin-3-Amine (5)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Methylpyrrolidin-3-Amine (6)N-Phenyl-3-(Trifluoromethyl)Aniline (3)N-Phenyl-4-(Trifluoromethyl)Aniline (3)N-Phenylnaphthalen-1-Amine (5)N-Phenylpyridin-2-Amine (9)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N1,N1-Diphenylbenzene-1,4-Diamine (2)N1-Phenylbenzene-1,4-Diamine (3)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Naphthalen-2-Amine (12)O-Benzylhydroxylamine (16)Oxazol-2-Amine (8)Phenylmethanamine (315)Piperidin-2-Ylmethanamine (6)Piperidin-3-Amine (17)Piperidin-3-Ylmethanamine (5)Piperidin-4-Amine (14)Piperidin-4-Ylmethanamine (7)Pyrazin-2-Amine (22)Pyrazin-2-Ylmethanamine (12)Pyridazin-3-Amine (18)Pyridazin-4-Amine (10)Pyridin-2-Amine (29)Pyridin-2-Ylmethanamine (38)Pyridin-3-Amine (21)Pyridin-3-Ylmethanamine (29)Pyridin-4-Amine (22)Pyridin-4-Ylmethanamine (12)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-4-Amine (29)Pyrimidin-5-Amine (6)Pyrimidine-2,4-Diamine (14)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-3-Ylmethanamine (6)Quinazolin-2-Amine (13)Quinazolin-4-Amine (8)Quinoxalin-2-Amine (3)Tetrahydrofuran-3-Amine (6)Thiazol-2-Ylmethanamine (5)Thiazol-5-Amine (6)Thiophen-3-Amine (18)Tri([1,1'-Biphenyl]-4-Yl)Amine (9)
Anhydrides (659)
Dianhydride (3)1H,3H-Benzo[De]Isochromene-1,3-Dione (8)Furan-2,5-Dione (8)
Aryls (187653)
Acetylbenzonitrile (3)Aminobenzyl (7)Benzylamine (21)Benzylamino (47)Benzylhydroxylamine (25)Benzylidene (16)Benzylidene (16)Benzyloxy (1061)Benzylthio (16)Benzylthio (16)Cyanobenzyl (12)Dibenzyl (15)Dibenzylamino (7)Dichlorobenzylidene (8)Difluorobenzyl (17)Dimethoxybenzyl (20)Dimethoxybenzyl (20)Dimethylbenzonitrile (25)Dimethylbenzyl (6)Dimethylbenzyl (6)Dimethylbenzylamine (6)Ethoxybenzyl (8)Ethoxybenzyl (8)Fluorobenzyl (132)Fluorobenzylidene (2)Formylbenzonitrile (35)Iodobenzyl (9)Isopropylbenzonitrile (4)Methoxybenzyl (176)Methoxybenzylamine (7)Methoxybenzylidene (6)Methylbenzonitrile (104)Methylbenzyl (73)Methylbenzyl (73)Methylbenzylamine (8)Methylbenzylidene (1)Methylbenzylidene (1)Nitrobenzyl (33)Nitrobenzylidene (2)Phenoxybenzonitrile (5)Trifluorobenzyl (2)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(8S,9S,14R)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-Tetradecahydro-3H-Cyclopenta[A]Phenanthren-3-One (1)(9H-Fluoren-9-Yl)Methyl (2-(Tritylthio)Ethyl)Carbamate (10)(9H-Fluoren-9-Yl)Methyl Cyclohexylcarbamate (8)(Benzylsulfonyl)Benzene (11)(Cyclopentyloxy)Benzene (12)1,1-Dimethylcyclopropane (5)1,3,4,5-Tetrahydro-2H-Benzo[B]Azepin-2-One (15)1,3-Diphenylurea (24)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-Benzyl-4-Chlorobenzene (6)1-Benzyl-4-Fluorobenzene (2)1-Bromonaphthalene (4)1-Chloronaphthalene (24)1-Fluoronaphthalene (23)1-Methoxynaphthalene (17)1-Methyl-4-(Phenylethynyl)Benzene (7)1-Methylnaphthalene (10)1-Naphthaldehyde (23)1-Naphthoic Acid (23)1-Nitronaphthalene (3)10H-Phenothiazine (20)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,5-Diphenylthiophene (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-Benzylaniline (5)2-Bromo-1,1'-Biphenyl (12)2-Bromonaphthalene (4)2-Chloro-1,1'-Biphenyl (8)2-Chloronaphthalene (6)2-Ethoxynaphthalene (4)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Iodonaphthalene (5)2-Methoxy-1,1'-Biphenyl (7)2-Methoxynaphthalene (22)2-Methoxytetrahydro-2H-Pyran (9)2-Methyl-1,1'-Biphenyl (26)2-Methylnaphthalene (13)2-Naphthaldehyde (12)2-Naphthoic Acid (14)2-Naphthonitrile (15)2-Nitronaphthalene (4)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)2-Phenylnaphthalene (12)3,3'-Diphenyl-5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (13)3,3-Diphenyl-3H-Benzo[C][1,2]Oxathiole 1,1-Dioxide (19)3-Bromo-1,1'-Biphenyl (12)3-Chloro-1,1'-Biphenyl (12)3-Fluoro-1,1'-Biphenyl (16)3-Methyl-1,1'-Biphenyl (10)3-Methyl-1,1':4',1''-Terphenyl (3)3-Phenethylphenol (5)3-Phenyl-1,2,4,5-Tetrazine (9)3-Styrylphenol (11)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Phenylsulfonyl)Morpholine (14)4-(Tert-Butyl)-1,1'-Biphenyl (5)4-Cyclohexylphenol (7)4-Iodo-1,1'-Biphenyl (9)4-Methoxy-1,1'-Biphenyl (4)9H-Xanthene (7)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-2-Ol (16)[1,1'-Biphenyl]-3-Amine (11)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-3-Carboxylic Acid (39)[1,1'-Biphenyl]-3-Ol (9)[1,1'-Biphenyl]-4-Carbaldehyde (31)[1,1'-Biphenyl]-4-Carbonitrile (27)[1,1'-Biphenyl]-4-Ol (28)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzyltriphenylphosphonium (14)Cyclopentylbenzene (28)Cyclopropanecarboxylic Acid (11)Cyclopropyl(Phenyl)Methanamine (22)Cyclopropyl(Phenyl)Methanone (13)Diphenyl Phosphonate (11)Diphenylphosphane (25)Diphenylphosphine Oxide (27)Ethane-1,1-Diyldibenzene (3)Ethene-1,1,2-Triyltribenzene (13)Ethyl Cyclopropanecarboxylate (8)Methyl 1-Naphthoate (7)Methyl 2-Naphthoate (11)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Cyclopropanecarboxylate (8)N,1-Diphenylmethanimine (15)N,N-Dimethylnaphthalen-1-Amine (4)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-2-Phenylacetamide (5)N-Benzylbenzamide (21)N-Benzylbenzenesulfonamide (17)N-Cyclopropylbenzamide (14)N-Cyclopropylbenzenesulfonamide (10)N-Phenethylbenzamide (9)N-Phenyl-2-Naphthamide (11)Naphthalen-1-Ol (28)Naphthalen-1-Ylboronic Acid (4)Naphthalen-1-Ylmethanol (8)Naphthalen-2-Amine (12)Naphthalen-2-Ol (25)Naphthalen-2-Ylboronic Acid (8)Naphthalene-1,4-Diol (3)Naphthalene-2-Sulfonic Acid (4)Propane-2,2-Diyldibenzene (17)Tert-Butyl Cyclopropylcarbamate (7)Tetrahydro-2H-Pyran-2-Ol (12)Tetrahydro-2H-Pyran-2-Yl Acetate (12)Tetraphenylmethane (16)Triphenylene (12)Vinylcyclopropane (8)
Azides (42)
Azoes (112)
(E)-1-(Naphthalen-1-Yl)-2-Phenyldiazene (7)1,2-Diphenyldiazene (7)3-(Phenyldiazenyl)Benzoic Acid (7)
Benzene Compounds (19035)
Acetamidophenoxy (1)Acetamidophenyl (5)Acetylbenzoate (7)Acetylphenyl (13)Acetylphenyl (13)Acetylphenylboronic (3)Aminobenzoyl (4)Aminobiphenyl (4)Aminonaphthalene (14)Aminophenoxy (19)Aminophenyl (239)Anisole (4)Anthracenes (142)Benzaldehyde (1601)Benzamidophenyl (1)Benzenedimethanol (4)Benzenethiol (8)Benzhydrylazetidine (10)Benzhydrylazetidine (10)Benzhydryloxy (4)Benzhydryloxy (4)Benziodoxol (2)Benzodioxole (5)Benzoquinone (6)Benzoquinone (6)Benzoylbenzoate (4)Benzoylphenyl (4)Binaphthalene (123)Binaphthalene (123)Biphenyl (1393)Boronophenyl (1)Boronophenyl (1)Bromobenzo (104)Bromobenzoyl (6)Bromodibenzo (9)Bromophenoxy (34)Bromophenyl (989)Butoxyphenyl (8)Butylaniline (7)Butylbenzene (16)Butyldiphenylsilyl (7)Butylphenol (20)Butylphenyl (32)Butylphenyl (32)Carbamoylphenoxy (12)Carbamoylphenyl (8)Carboxyphenyl (17)Carboxyphenyl (17)Chlorobenzenesulfonyl (23)Chlorobenzoyl (9)Chlorodibenzo (18)Chloronaphthalene (36)Chlorophenethyl (7)Chlorophenoxy (44)Chlorophenylacetate (4)Chlorophenylacetate Acid (9)Chlorophenylboronic (5)Cyclopropylaniline (6)Cyclopropylbenzoate (5)Cyclopropylnaphthalen (10)Cyclopropylnaphthalen (10)Cyclopropylphenyl (12)Cyclopropylphenyl (12)Diaminobenzene (7)Dibenzaldehyde (19)Dibenzene (7)Dibenzimidamide (5)Dibenzo (108)Dibenzo (108)Dibenzoate (9)Dibenzonitrile (11)Dibromobenzene (45)Dibromobenzo (14)Dibromodibenzo (8)Dibromonaphthalene (15)Dibromophenanthrene (3)Dibromophenoxy (2)Dibromophenylboronic (3)Dichlorobenzene (38)Dichlorobenzoyl (4)Dichlorophenoxy (16)Dichlorophenyl (345)Dichlorophenylboronic (5)Didehydrodibenz (2)Didehydrodibenz (2)Diethoxyphenyl (10)Diethylaniline (6)Diethylbenzamide (7)Diethylbenzene (6)Diethylbenzene (6)Difluorobenzene (57)Difluorobenzo (12)Difluorobenzoyl (9)Difluorophenoxy (9)Difluorophenyl (403)Difluorophenylboronic (11)Dihydroanthracene (1)Dihydroanthracene (1)Dihydrobenzo (189)Dihydrobenzo (189)Dihydrodibenzo (7)Dihydronaphthalene (104)Dihydronaphthalene (104)Diiodobenzene (12)Diisopropylaniline (5)Diisopropylbenzamide (8)Diisopropylphenyl (40)Diisopropylphenyl (40)Dimesityl (12)Dimesityl (12)Dimethoxyacetophenone (5)Dimethoxyaniline (20)Dimethoxybenzaldehyde (40)Dimethoxybenzamide (6)Dimethoxybenzene (47)Dimethoxybenzo (4)Dimethoxybenzo (4)Dimethoxybenzoate (20)Dimethoxybenzohydrazide (3)Dimethoxybenzonitrile (11)Dimethoxybenzoyl (4)Dimethoxybiphenyl (3)Dimethoxybiphenyl (3)Dimethoxynaphthalene (10)Dimethoxynaphthalene (10)Dimethoxyphenol (22)Dimethoxyphenyl (257)Dimethoxyphenylboronic (17)Dimethoxyphenylboronic (17)Dimethoxystyryl (4)Dimethylaminophenyl (4)Dimethylanthracene (4)Dimethylbenzaldehyde (27)Dimethylbenzamide (37)Dimethylbenzene (334)Dimethylbenzene (334)Dimethylbenzenesulfonamide (16)Dimethylbenzo (21)Dimethylbenzo (21)Dimethylbenzoate (27)Dimethylbenzoyl (3)Dimethylbenzoyl (3)Dimethylnaphthalene (6)Dimethylphenol (36)Dimethylphenoxy (13)Dimethylphenoxy (13)Dimethylphenylboronic (6)Dimethylphenylboronic (6)Dimethylphenylhydrazine (3)Dimethylphenylisothiocyanate (4)Dinaphtho (5)Dinitrobenzene (20)Diphenol (32)Diphenylamino (27)Diphenylaniline (9)Diphenylethane (19)Diphenylethanone (5)Diphenylethene (6)Diphenylethyl (7)Diphenylethyl (7)Diphenylmethyl (8)Diphenylmethyl (8)Diphenylmethylene (6)Diphenylphosphine (204)Diphenylphosphine (204)Diphenylpropane (22)Diphenylsilane (2)Diphenylurea (4)Diphenylurea (4)Ethoxyaniline (10)Ethoxybenzaldehyde (9)Ethoxybenzoate (12)Ethoxybenzonitrile (6)Ethoxyphenoxy (7)Ethoxyphenoxy (7)Ethoxyphenyl (46)Ethoxyphenyl (46)Ethoxyphenylboronic (7)Ethylaniline (8)Ethylaniline (8)Ethylbenzenesulfonamide (338)Ethylbenzo (7)Ethylbenzo (7)Ethylbenzoate (9)Ethylphenol (12)Ethylphenyl (39)Ethylphenyl (39)Ethynylaniline (7)Ethynylbenzaldehyde (17)Ethynylphenyl (35)Fluorobenzeneboronic (24)Fluoronaphthalene (34)Fluorophenoxy (46)Formylbenzoate (39)Formylphenoxy (4)Formylphenoxy (4)Formylphenyl (43)Formylphenyl (43)Formylphenylboronic (9)Formylphenylboronic (9)Hexahydrobenzo (3)Hexahydrobenzo (3)Hexylphenyl (3)Hexylphenyl (3)Homophenylalanine (18)Hydroxybenzenesulfonate (5)Hydroxybenzimidamide (11)Hydroxyisophthalaldehyde (6)Hydroxyphenethyl (2)Hydroxyphenethyl (2)Hydroxyphenyl (461)Hydroxyphenyl (461)Iodobenzo (15)Iodobenzoic (54)Iodobenzoyl (7)Iodobiphenyl (24)Iododibenzo (7)Iodonaphthalene (9)Iodophenoxy (6)Isobutoxyphenyl (15)Isobutoxyphenyl (15)Isobutylbenzene (5)Isobutylbenzene (5)Isobutylphenyl (9)Isophthalate (8)Isophthalonitrile (4)Isopropoxyaniline (10)Isopropoxyaniline (10)Isopropoxybenzaldehyde (7)Isopropoxybenzoate (7)Isopropoxyphenyl (41)Isopropoxyphenyl (41)Isopropylaniline (18)Isopropylbenzaldehyde (6)Isopropylbenzamide (9)Isopropylbenzenesulfonamide (19)Isopropylbenzoate (8)Isopropylphenyl (58)Mercaptobenzo (21)Methanobenzo (15)Methanobenzo (15)Methoxyacetophenone (12)Methoxyaniline (74)Methoxybenzaldehyde (104)Methoxybenzene (1749)Methoxybenzene (1749)Methoxybenzenesulfonamide (6)Methoxybenzenesulfonic (3)Methoxybenzenesulfonyl (13)Methoxybenzenesulfonyl (13)Methoxybenzimidamide (5)Methoxybenzo (52)Methoxybenzo (52)Methoxybenzoate (116)Methoxybenzonitrile (67)Methoxybenzoyl (12)Methoxybenzoyl (12)Methoxycarbonylphenylboronic (5)Methoxynaphthalene (56)Methoxynaphthalene (56)Methoxyphenethyl (1)Methoxyphenethyl (1)Methoxyphenol (72)Methoxyphenoxy (41)Methoxyphenoxy (41)Methoxyphenylacetate (4)Methoxyphenylboronic (24)Methoxyphenylboronic (24)Methoxyphenylhydrazine (4)Methoxystyryl (13)Methylacetophenone (6)Methylaniline (183)Methylanisole (3)Methylanthracene (5)Methylbenzaldehyde (101)Methylbenzamide (90)Methylbenzamido (3)Methylbenzenesulfinamide (4)Methylbenzenesulfonamide (81)Methylbenzenesulfonic (9)Methylbenzenesulfonyl (4)Methylbenzenesulfonyl (4)Methylbenzimidamide (6)Methylbenzoate (193)Methylbenzohydrazide (7)Methylbenzothioamide (6)Methylbenzothioamide (6)Methylbenzotrifluoride (5)Methylbenzoyl (24)Methylbenzoyl (24)Methylnaphthalene (34)Methylnaphthalene (34)Methylphenol (107)Methylphenoxy (18)Methylphenoxy (18)Methylphenyl (529)Methylphenylacetonitrile (45)Methylphenylboronic (24)Methylphenylhydrazine (10)Methylpropiophenone (5)Methylpropiophenone (5)Naphthaldehyde (28)Naphthalene (465)Naphthalene (465)Naphthaleneboronic (15)Naphthalenesulfonic (7)Naphthamide (15)Naphthonitrile (18)Nitrobenzenesulfonyl (8)Nitrobenzo (54)Nitrobenzoyl (13)Nitronaphthalene (24)Nitrophenoxy (43)Nitrophenyl (727)Nitrophenylboronic (14)Nitrotoluene (27)Octylbenzene (11)Octylbenzene (11)Paracyclophane (2)Paracyclophane (2)Pentafluorobenzene (13)Pentylbenzene (5)Pentylbenzene (5)Pentylbenzoate (2)Pentylphenol (4)Pentylphenyl (5)Pentylphenyl (5)Perfluorophenoxy (5)Perfluorophenyl (31)Phenoxyacetate (5)Phenoxyaniline (8)Phenoxybenzaldehyde (5)Phenoxybenzoate (5)Phenoxyethyl (6)Phenoxyethyl (6)Phenoxymethyl (7)Phenoxymethyl (7)Phenoxyphenyl (61)Phenoxyphenyl (61)Phenoxypropan (4)Phenylacetamide (34)Phenylacetonitrile (8)Phenylacetyl (2)Phenylacetyl (2)Phenylacrylamide (3)Phenylalaninol (4)Phenylamino (31)Phenylaniline (19)Phenylanthracene (16)Phenylbenzamide (23)Phenylbenzenesulfonamide (3)Phenylbutanoate (12)Phenylbutoxy (2)Phenylbutoxy (2)Phenylcarbamoyl (4)Phenylcyclohexanone (6)Phenylcyclopropanecarboxylic (6)Phenylcyclopropyl (7)Phenylcyclopropyl (7)Phenyldiazenyl (4)Phenylene (169)Phenylene (169)Phenylenediamine (13)Phenylenedimethanamine (5)Phenylethanamine (12)Phenylethane (14)Phenylethane (14)Phenylethanol (10)Phenylethanone (20)Phenylethoxy (2)Phenylethyl (70)Phenylethyl (70)Phenylethylisocyanate (2)Phenylhex (3)Phenylimino (1)Phenylisocyanate (9)Phenylisoserine (4)Phenylmethanesulfonyl (2)Phenylmethanesulfonyl (2)Phenylmethanone (2)Phenylmethoxy (4)Phenylmethoxy (4)Phenylmethyl (8)Phenylmethyl (8)Phenylnaphthalene (6)Phenylpentan (11)Phenylpentan (11)Phenylpropanamide (15)Phenylpropyl (20)Phenylpyrazolo (8)Phenylsulfinyl (3)Phenylsulfinyl (3)Phenylsulfonyl (88)Phenylsulfonyl (88)Phenylthio (24)Phenylthio (24)Phenylthiophene (23)Phenylthiophene (23)Phenylthiourea (6)Phenylurea (3)Phenylurea (3)Phenylvinyl (9)Phthalate (23)Phthalimide (12)Phthalonitrile (9)Propoxybenzaldehyde (4)Propoxyphenyl (29)Propoxyphenyl (29)Propoxyphenylboronic (79)Propylphenyl (26)Propylphenyl (26)Pyrenes (52)Quaternaphthalene (6)Quaterphenyl (15)Quaterphenyl (15)Styryl (12)Sulfamoylphenyl (3)Sulfophenyl (4)Sulfophenyl (4)Terephthalaldehyde (11)Terephthalate (13)Terphenyl (239)Terphenyl (239)Tetraaniline (6)Tetrabenzaldehyde (7)Tetrafluorobenzene (17)Tetrahydrobenzo (70)Tetrahydrobenzo (70)Tetrahydronaphthalene (149)Tetrahydronaphthalene (149)Tetralone (12)Tetramethylbenzene (9)Tetramethylbenzene (9)Tetramethylbiphenyl (57)Tetramethylbiphenyl (57)Tetraphenyl (11)Tetraphenyl (11)Toluenesulfonyl (68)Tolyl (418)Tolyl (418)Tolylamino (3)Tolylazanediyl (4)Tolylazanediyl (4)Tolylethynyl (3)Tolyloxy (19)Tolyloxy (19)Tolylphosphine (8)Tolylphosphine (8)Tolylthio (3)Tolylthio (3)Trianiline (7)Tribenzaldehyde (5)Tribromobenzene (7)Trichlorobenzene (20)Trichlorophenoxy (3)Trichlorophenylboronic (6)Triethylbenzene (5)Trifluorophenyl (56)Trifluorophenylboronic (154)Triiodobenzene (5)Triisopropylbenzene (9)Triisopropylphenyl (6)Triisopropylphenyl (6)Trimethoxybenzene (43)Trimethoxystyryl (5)Trimethylaniline (18)Trimethylbenzene (28)Trimethylphenol (6)Trimethylphenyl (20)Trimethylphenyl (20)Trimethylpropiophenone (4)Triphenylphosphoranylidene (9)Triphenylphosphoranylidene (9)Triphenylvinyl (11)Trityl (19)Trityl (19)Tritylamino (2)Trityloxy (2)Tritylthio (3)Tritylthio (3)(((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Fluorophenyl)Propanoic Acid (3)(10Ar)-1,2,3,4,4A,9,10,10A-Octahydrophenanthrene (3)(1E,1'E)-N,N'-(Ethane-1,2-Diyl)Bis(1-Phenylmethanimine) (5)(1R,4R)-4-Phenyl-1,1'-Bi(Cyclohexane) (24)(9H-Fluoren-9-Yl)Methyl Benzylcarbamate (22)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(Cyclopentylmethyl)Benzene (5)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylmorpholine (7)(R)-4-Benzyloxazolidin-2-One (5)(R)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)(S)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)1,1':2',1''-Terphenyl (4)1,1':3',1''-Terphenyl (28)1,1':4',1'':4'',1'''-Quaterphenyl (7)1,1,2,2-Tetra([1,1'-Biphenyl]-4-Yl)Ethene (10)1,1-Dimethyl-1,2,3,4-Tetrahydronaphthalene (10)1,2,3,4-Tetrahydronaphthalen-1-Amine (36)1,2,3,4-Tetrahydronaphthalen-1-Ol (5)1,2,3,4-Tetrahydronaphthalene-1-Carboxylic Acid (3)1,2,3,5,6,7-Hexahydro-S-Indacene (23)1,2,4-Trimethylbenzene (41)1,2-Dihydroacenaphthylene (6)1,2-Dinitrobenzene (6)1,3,5-Tris(Phenylethynyl)Benzene (6)1,3,6,8-Tetraphenylpyrene (10)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dihydro-2H-Inden-2-One (6)1,3-Diphenoxypropane (6)1,3-Diphenyl-1H-Pyrazole (6)1,3-Diphenylpropane (7)1,3-Diphenylpropane-1,3-Dione (4)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-Benzylazetidine (6)1-Bromopyrene (4)1-Cyclohexyl-4-(Phenylethynyl)Benzene (10)1-Cyclopropylnaphthalene (6)1-Phenyl-1H-Tetrazole (6)1-Phenylnaphthalene (12)1-Trityl-1H-Pyrazole (5)1H-Indene (19)1H-Indene-1,3(2H)-Dione (5)2,2 ', 3,3' - Tetrahydro-1,1 '- Spiro [Indene] (5)2,3,4,5-Tetrahydro-1H-Benzo[C]Azepine (7)2,3-Dihydro-1H-Inden-1-Amine (52)2,3-Dihydro-1H-Inden-1-Ol (13)2,3-Dihydro-1H-Inden-4-Amine (6)2,3-Dihydro-1H-Inden-4-Ol (6)2,3-Dihydro-1H-Indene-1-Carboxylic Acid (5)2,3-Dihydro-1H-Indene-4-Carbonitrile (4)2,4-Diphenyl-1,3,5-Triazine (6)2,5-Diphenyl-1,3,4-Oxadiazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(2-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (24)2-(2-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (21)2-(2-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (29)2-(3-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (14)2-(3-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (19)2-(3-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (30)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (17)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (20)2-(4-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (15)2-(4-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Methyl-2,3-Dihydro-1H-Inden-1-One (9)2-Phenyl-1,3,5-Triazine (6)2-Phenyl-1,3-Dioxane (7)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenylisoindoline-1,3-Dione (7)2H-Benzo[B][1,4]Thiazin-3(4H)-One (6)3,3-Dimethyl-2,3-Dihydro-1H-Inden-1-One (5)3,4-Dihydro-2H-Benzo[B][1,4]Dioxepine (7)3,5,6,7-Tetrahydro-S-Indacen-1(2H)-One (5)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Chlorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-(Trifluoromethyl)Phenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Fluorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Methoxyphenyl)Propanoic Acid (4)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(O-Tolyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(P-Tolyl)Propanoic Acid (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (19)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoic Acid (12)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (13)3-Methyl-2,3-Dihydro-1H-Inden-1-One (4)3-Phenyl-1H-Pyrrole (5)3-Phenylazetidine (5)3-Phenyloxazolidin-2-One (4)3-Phenylpiperidine (6)4',5'-Diphenyl-1,1':2',1''-Terphenyl (7)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(3-Nitrophenyl)-1,3,2-Dioxaborolane (24)4,4,5,5-Tetramethyl-2-(M-Tolyl)-1,3,2-Dioxaborolane (21)4,4,5,5-Tetramethyl-2-(O-Tolyl)-1,3,2-Dioxaborolane (24)4,5-Diphenyloxazole (7)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-Bromo-2,3-Dihydro-1H-Inden-1-One (5)4-Bromo-2,3-Dihydro-1H-Indene (10)4-Chloro-2,3-Dihydro-1H-Inden-1-One (8)4-Chloro-2,3-Dihydro-1H-Indene (5)4-Cyclohexyl-1,1'-Biphenyl (18)4-Fluoro-2,3-Dihydro-1H-Inden-1-One (6)4-Fluoro-2,3-Dihydro-1H-Indene (14)4-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)4-Methyl-2,3-Dihydro-1H-Inden-1-One (8)4-Methyl-2,3-Dihydro-1H-Indene (3)4-Phenyl-1,1'-Bi(Cyclohexane) (8)4-Phenyl-4H-1,2,4-Triazole (6)5''-([1,1'-Biphenyl]-4-Yl)-1,1':4',1'':3'',1''':4''',1''''-Quinquephenyl (5)5',5''-Diphenyl-1,1':3',1'':3'',1'''-Quaterphenyl (8)5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (6)5,6,7,8-Tetrahydronaphthalen-2-Ol (5)5-Bromo-1,2,3,4-Tetrahydronaphthalene (6)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Methoxy-1,2,3,4-Tetrahydronaphthalene (3)5-Methoxy-2,3-Dihydro-1H-Indene (2)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Phenyl-1H-Imidazole (6)5-Phenylcyclohexane-1,3-Dione (6)6,7,8,9-Tetrahydro-5H-Benzo[7]Annulen-5-One (6)6-Bromo-1,2,3,4-Tetrahydronaphthalene (9)6-Bromo-2,3-Dihydro-1H-Inden-1-One (8)6-Bromo-3,4-Dihydronaphthalen-1(2H)-One (3)6-Chloro-1,2,3,4-Tetrahydronaphthalene (3)6-Chloro-2,3-Dihydro-1H-Inden-1-One (5)6-Fluoro-1,2,3,4-Tetrahydronaphthalene (6)6-Fluoro-2,3-Dihydro-1H-Inden-1-One (4)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methyl-1,2,3,4-Tetrahydronaphthalene (5)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)6-Methyl-3,4-Dihydronaphthalen-1(2H)-One (2)7-Bromo-2,3-Dihydro-1H-Inden-1-One (13)7-Chloro-2,3-Dihydro-1H-Inden-1-One (9)7-Fluoro-2,3-Dihydro-1H-Inden-1-One (8)7-Hydroxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methyl-2,3-Dihydro-1H-Inden-1-One (7)9,10-Bis(Phenylethynyl)Anthracene (5)9,10-Diphenylanthracene (16)9-Methylanthracene (4)9-Phenylxanthylium (7)9H-Fluoren-9-One (17)[1,1'-Binaphthalen]-2-Amine (3)[1,1':4',1''-Terphenyl]-4,4''-Dicarbaldehyde (9)Benzenesulfinic Acid (6)Benzil (17)Benzo-18-Crown-6 (7)Benzo[Lmn][3,8]Phenanthroline-1,3,6,8(2H,7H)-Tetraone (10)Benzyl ((Benzyloxy)Carbonyl)Glycinate (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Phenylpropanoate (8)Benzyl Piperidin-4-Ylcarbamate (7)Bicyclo[4.2.0]Octa-1,3,5-Triene (13)Cumene (181)Dibenzyl Phosphonate (6)Diphenylmethanimine (9)Ethane-1,1,2-Triyltribenzene (5)Ethylbenzene (198)Mesitylene (71)Methyl 2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (14)Methyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (11)N,2-Diphenylacetamide (7)N,N,N-Trimethyl-1-Phenylmethanaminium (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylcyclopropanamine (6)N-Phenylcinnamamide (16)N1,N1,N4,N4-Tetraphenylbenzene-1,4-Diamine (6)N4,N4,N4',N4'-Tetraphenyl-[1,1'-Biphenyl]-4,4'-Diamine (7)Phenanthrene (23)Phenanthrene-9,10-Dione (8)Phenethyldiphenylphosphane (6)Phenothiazin-5-Ium (6)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl 4-Cyclohexylbenzoate (8)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butylbenzene (251)Triphenyl Phosphate (6)
Benzyl Bromides (1065)
1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Bromomethyl)-3-Methoxybenzene (19)1-Bromo-2-(Bromomethyl)Benzene (34)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-(Bromomethyl)Benzonitrile (15)Methyl 2-(Bromomethyl)Benzoate (33)
Benzyl Chlorides (646)
Dichlorobenzyl (39)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)
Bromides (52859)
Bromoacetyl (14)Bromoaniline (2)Bromoanthracene (5)Bromoanthracene (5)Bromobenzaldehyde (15)Bromobenzamide (7)Bromobenzimidamide (6)Bromobenzyl (36)Bromobut (2)Bromobut (2)Bromobutoxy (4)Bromobutoxy (4)Bromobutyl (6)Bromobutyl (6)Bromochroman (26)Bromochroman (26)Bromocyclopropanecarboxylate (1)Bromoethoxy (22)Bromoethoxy (22)Bromoethyl (86)Bromoethyl (86)Bromoethynyl (6)Bromohexyl (11)Bromohexyl (11)Bromomethyl (760)Bromonicotinaldehyde (5)Bromonicotinamide (5)Bromooctyl (3)Bromopentyl (8)Bromopentyl (8)Bromopropane (10)Bromopropane (10)Bromopropoxy (6)Bromopropoxy (6)Bromopropyl (25)Bromopropyl (25)Bromothiochroman (4)Bromothiochroman (4)Bromovinyl (2)Dibromo (698)Dibromo (698)Dibromoanthracene (3)Dibromoanthracene (3)Dibromobenzaldehyde (8)Dibromobenzonitrile (8)Dibromomethyl (6)Dibromomethyl (6)Dibromopropoxy (1)Dibromopropoxy (1)Tetrabromo (10)Tetrabromo (10)Tribromo (9)Tribromo (9)(1-Bromoethyl)Benzene (11)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromoethyl)Benzene (33)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Bromophenyl)Boronic Acid (39)(2-Bromophenyl)Hydrazine (8)(2-Bromophenyl)Methanamine (12)(2-Bromophenyl)Methanol (39)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Bromopropyl)Benzene (10)(3-Bromopyridin-2-Yl)Methanol (7)(4-Bromophenyl)(Phenyl)Methanone (9)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(Bromoethynyl)Benzene (5)(Dibromomethyl)Benzene (6)1,2,3-Tribromobenzene (5)1,2,4-Tribromobenzene (13)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-3-Methylbenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dibromobenzene (64)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2,4-Dimethylbenzene (3)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dibromo-2-Iodobenzene (4)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dibromo-2-Methylbenzene (14)1,3-Dibromo-2-Nitrobenzene (4)1,4-Dibromo-2-Iodobenzene (3)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Bromophenyl)Ethan-1-One (27)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-4-Bromobenzene (8)1-(Bromomethyl)-2-Iodobenzene (9)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-2-Methylbenzene (14)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Bromomethyl)-3-Methylbenzene (11)1-Benzyl-3-Bromobenzene (7)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2,3-Dimethylbenzene (23)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-(Bromomethyl)Benzene (34)1-Bromo-2-(Difluoromethyl)Benzene (5)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-2-(Tert-Butyl)Benzene (7)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Ethylbenzene (13)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-2-Iodobenzene (65)1-Bromo-2-Isopropylbenzene (10)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-3-Cyclopropylbenzene (6)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-3-Iodobenzene (70)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Bromo-4-Iodobenzene (67)1-Bromo-4-Phenoxybenzene (8)1-Bromo-4-Styrylbenzene (5)1-Bromobicyclo[1.1.1]Pentane (3)1-Bromoisoquinoline (20)1-Bromonaphthalene (4)2,3-Dibromopyridine (21)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dibromoaniline (18)2,4-Dibromophenol (16)2,4-Dibromopyridine (5)2,4-Dibromothiazole (5)2,5-Dibromopyrazine (4)2,5-Dibromopyridine (26)2,5-Dibromothiazole (5)2,5-Dibromothiophene (18)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromoaniline (17)2,6-Dibromobenzaldehyde (4)2,6-Dibromobenzonitrile (4)2,6-Dibromophenol (21)2,6-Dibromopyrazine (9)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Bromophenyl)Acetonitrile (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(Bromomethyl)Furan (3)2-(Bromomethyl)Pyridine (27)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Bromophenol (3)2-Amino-6-Bromophenol (3)2-Bromo-1,1'-Biphenyl (12)2-Bromo-1,3,4-Thiadiazole (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3,4-Trimethylbenzene (4)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,3-Dimethylbenzene (35)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1,4-Dimethylbenzene (22)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-1H-Benzo[D]Imidazole (4)2-Bromo-1H-Imidazole (13)2-Bromo-1H-Pyrrole (11)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylaniline (6)2-Bromo-3-Methylphenol (4)2-Bromo-3-Methylpyrazine (5)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-3-Nitropyridine (5)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-4-Methylaniline (14)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-4-Methylpyridine (6)2-Bromo-4-Methylthiazole (7)2-Bromo-4-Nitroaniline (12)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyrazine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Methylthiazole (7)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorobenzaldehyde (15)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Fluorobenzonitrile (7)2-Bromo-6-Fluorophenol (9)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylaniline (11)2-Bromo-6-Methylbenzoic Acid (5)2-Bromo-6-Methylphenol (7)2-Bromo-6-Methylpyrazine (5)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Bromo-6-Phenylpyridine (4)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Bromo-N-Phenylacetamide (5)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Bromobenzenesulfonyl Chloride (8)2-Bromobenzo[D]Thiazole (28)2-Bromodibenzo[B,D]Furan (6)2-Bromofuran (21)2-Bromoimidazo[1,2-A]Pyridine (5)2-Bromonaphthalene (4)2-Bromonicotinic Acid (5)2-Bromooxazole (7)2-Bromopyrazine (15)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Bromopyrimidine (22)2-Bromoquinazoline (4)3,4-Dibromoaniline (4)3,4-Dibromophenol (3)3,5-Dibromopyridine (12)3-(Bromomethyl)Pyridine (18)3-Bromo-1,1'-Biphenyl (12)3-Bromo-1,5-Naphthyridine (8)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoroaniline (15)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Fluorophenol (5)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Fluorobenzamide (3)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Fluorophenol (11)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methoxybenzaldehyde (9)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylaniline (14)3-Bromo-4-Methylbenzoic Acid (9)3-Bromo-4-Methylpyridine (13)3-Bromo-5'-Phenyl-1,1':3',1''-Terphenyl (4)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromoaniline (187)3-Bromoazetidine (3)3-Bromobenzene-1,2-Diamine (11)3-Bromobenzene-1,2-Diol (8)3-Bromobenzo[B]Thiophene (5)3-Bromobenzoic Acid (159)3-Bromobenzonitrile (110)3-Bromofuran (13)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Bromoisoquinoline (10)3-Bromoisoxazole (7)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Bromopyridazine (25)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Bromopyrrolidine (6)3-Bromothiophene (6)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Bromomethyl)Pyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Benzo[D]Imidazole (14)4-Bromo-1H-Indole (25)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Iodoaniline (8)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-(Trifluoromethyl)Aniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Methylpyridine (5)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Bromobenzo[C][1,2,5]Thiadiazole (14)4-Bromobenzo[D][1,3]Dioxole (6)4-Bromobenzo[D]Thiazole (9)4-Bromobenzofuran (3)4-Bromoindoline (4)4-Bromoisoindolin-1-One (3)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Bromopyridazine (5)4-Bromopyridine (31)4-Bromopyrimidine (24)4-Bromothiazole (10)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Bromo-1-Methyl-1H-Indole (4)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Bromo-1H-Benzo[D]Imidazole (13)5-Bromo-1H-Indazole (14)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Bromo-2,3-Dihydrobenzofuran (6)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Methylpyrimidine (5)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromobenzo[B]Thiophene (3)5-Bromobenzo[D][1,3]Dioxole (12)5-Bromobenzo[D]Oxazole (3)5-Bromoimidazo[1,2-A]Pyridine (6)5-Bromoindoline (8)5-Bromoisoindolin-1-One (8)5-Bromoisoquinoline (17)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyrazin-2-Ol (5)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Bromoquinoxaline (6)5-Bromothiazole (8)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indazole (23)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)6-Bromobenzo[B]Thiophene (4)6-Bromobenzo[D]Oxazole (3)6-Bromobenzo[D]Thiazole (7)6-Bromochroman-4-One (6)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Bromoindoline-2,3-Dione (4)6-Bromoisoindolin-1-One (4)6-Bromoisoquinoline (9)6-Bromonicotinaldehyde (11)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Bromoquinazoline (7)6-Bromoquinoxaline (9)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Bromo-1H-Indazole (18)7-Bromo-1H-Indole (28)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromobenzo[B]Thiophene (5)7-Bromobenzo[D]Thiazole (8)7-Bromobenzofuran (6)7-Bromochromane (7)7-Bromoindoline (3)7-Bromoisoquinoline (6)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)8-Bromochromane (6)8-Bromoimidazo[1,2-A]Pyridine (15)8-Bromoisoquinoline (17)8-Bromoquinazoline (8)9-Bromoanthracene (5)Bromocyclohexane (7)Ethyl 2-Bromo-2-Phenylacetate (6)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopicolinate (9)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 6-Bromonicotinate (6)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)
Carbamates (7957)
Carboxylic Acid Salts (668)
Carboxylic Acids (58191)
Aceticacid (1249)Acetylbenzoic Acid (3)Acrylic (95)Aminobenzoic (7)Aminobutanoic (8)Aminoheptanoic (6)Aminohexanoic (10)Aminonicotinic Acid (4)Aminopentanoic (8)Aminophenylacetic Acid (22)Aminopropanoic (11)Aminoundecanoic Acid (4)Benzenedicarboxylic (6)Benzenedicarboxylic Acid (6)Benzylpropanoic Acid (75)Benzylsuccinic Acid (6)Boronobenzoic (4)Bromobutanoic (5)Bromododecanoate (3)Bromoisonicotinic Acid (4)Bromonicotinic (8)Bromonicotinic Acid (9)Bromophenylacetic Acid (15)Bromovalerate (4)Butanoic (124)Chlorobenzoic (35)Chloromandelic Acid (3)Chromene-Carboxylic Acid (1)Cyanonicotinic (5)Cyanonicotinic Acid (3)Diacetic (19)Diacetic (19)Diaminobenzoic (7)Diaminobutanoic (5)Diaminohexanoic (4)Dibenzoic (40)Dibromobenzoic (10)Dibromobenzoic Acid (10)Dibromonicotinic Acid (7)Dicarboxylic (183)Dicarboxylic (183)Dichlorobenzoic (21)Dichlorobenzoic Acid (22)Dichloroisonicotinic (6)Dichloroisonicotinic Acid (6)Dichlorophenylacetic Acid (4)Dienoate (14)Dienoic (10)Difluorobenzoic (54)Difluorobutanoic (3)Difluoroisonicotinic Acid (7)Difluorophenylacetic (7)Difluorophenylacetic Acid (7)Diiodobenzoic (5)Diisophthalic (17)Diisophthalic Acid (9)Diisopropylbenzoic Acid (4)Dimethoxybenzoic (33)Dimethoxyphenylacetic Acid (3)Dimethylbenzoic (32)Dimethylbutanoic (13)Dimethylbutanoic (13)Dimethylpropanoic (5)Diphenylpropanoic (8)Diyldimethanol (17)Enedioic (8)Enoic (127)Ethoxybenzoic (9)Ethylbenzoic (11)Ethylbenzoic Acid (12)Ethynylbenzoic (6)Ethynylbenzoic Acid (5)Fluoroisophthalic Acid (4)Fluorophenylacetic (10)Fluorophenylacetic Acid (11)Fluorophthalic (5)Fluorophthalic Acid (3)Fluoropicolinic (12)Formylbenzoic (22)Formylbenzoic Acid (19)Guanidinopentanoic (8)Heptanoic (6)Heptanoic (6)Hexacarboxylic Acid (5)Hexanoic (25)Hexanoic (25)Hydrazinylbenzoic (6)Hydrazinylbenzoic Acid (5)Hydroxynicotinic (15)Indolecarboxylic (2)Isophthalic (29)Isophthalic Acid (15)Isopropoxybenzoic (8)Isopropoxybenzoic Acid (7)Isopropylbenzoic (13)Isopropylnicotinic Acid (4)Malonate (39)Mercaptobenzoic (6)Mercaptobenzoic Acid (4)Mercaptopropanoic (11)Methoxybenzoic (142)Methoxybutanoic (4)Methoxybutanoic (4)Methoxyisophthalic Acid (5)Methoxyphenylacetic (10)Methoxyphenylacetic Acid (11)Methoxypropanoic (7)Methoxypropanoic (7)Methylbenzoic (175)Methylbutanoic (32)Methylbutanoic (32)Methylcinnamic Acid (9)Methylhexanoic (8)Methylhexanoic (8)Methylisophthalic Acid (17)Methylnicotinic (46)Methyloctanoic (6)Methylpentanoic (108)Methylpentanoic (108)Methylpropanoic (57)Naphthoic (64)Nitrobenzoic (161)Nitroisonicotinic Acid (5)Nitroisophthalic Acid (3)Nitronicotinic (10)Nitropicolinic (11)Octanoic (6)Octanoic (6)Oxoacetic (22)Oxobutanoic (57)Oxobutanoic (57)Oxodecanoic (5)Oxodecanoic (5)Oxododecanoic (9)Oxododecanoic (9)Oxoheptanoic (5)Oxoheptanoic (5)Oxoheptanoic Acid (4)Oxohexadecanoic (13)Oxohexadecanoic (13)Oxohexanoic (10)Oxohexanoic (10)Oxooctadecanoic (7)Oxooctadecanoic (7)Oxopentanoic (37)Oxopentanoic (37)Oxopropanoic (8)Pentanedioic (18)Pentanedioic (18)Pentanoic (27)Phenoxybenzoic (5)Phenylacetic (35)Phenylbutanoic (47)Phenylpentanoic (11)Phenylpropanoic (45)Propanoic (1167)Propenoic (6)Pyridazinecarboxylic (1)Succinic (13)Sulfamoylbenzoic (15)Sulfobenzoic (5)Terephthalic (7)Tetraacetic (5)Tetrabenzoic (13)Tetrabenzoic Acid (14)Tetracarboxylic (13)Tribenzoic (15)Tribenzoic Acid (14)Tricarboxylic (18)Trichlorobenzoic (5)Trichlorobenzoic Acid (4)Trifluorobenzoic (12)Trifluorobenzoic Acid (11)Trifluorobutanoic (3)Trifluoromethylbenzoic (5)Trifluoromethylbenzoic Acid (4)Trifluoropentanoic (4)Trifluorophenylacetic Acid (16)Trifluoropropanoic (4)Triiodobenzoic (4)Trimethylbenzoic Acid (4)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,5-Naphthyridine-3-Carboxylic Acid (6)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Naphthoic Acid (23)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropane-1-Carboxylic Acid (23)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carboxylic Acid (4)1H-Indazole-3-Carboxylic Acid (27)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)1H-Indole-3-Carboxylic Acid (32)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carboxylic Acid (7)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,3-Difluorobenzoic Acid (35)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)2,4-Difluorobenzoic Acid (29)2,5-Dichlorobenzoic Acid (13)2,5-Difluorobenzoic Acid (32)2,6-Dichlorobenzoic Acid (13)2,6-Difluorobenzoic Acid (33)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(2-Methoxyphenyl)Acetic Acid (16)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Hydroxyphenyl)Acetic Acid (7)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-Chlorophenoxy)Acetic Acid (3)2-(4-Fluorophenyl)Acetic Acid (30)2-(4-Methoxyphenyl)Acetic Acid (19)2-(4-Nitrophenyl)Acetic Acid (9)2-(Benzofuran-3-Yl)Acetic Acid (3)2-(M-Tolyl)Acetic Acid (16)2-(Morpholin-2-Yl)Acetic Acid (5)2-(O-Tolyl)Acetic Acid (17)2-(P-Tolyl)Acetic Acid (9)2-(Phenylamino)Benzoic Acid (11)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethyl)Benzoic Acid (33)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (16)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-6-Chlorobenzoic Acid (5)2-Benzoylbenzoic Acid (10)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Methylbenzoic Acid (5)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-6-Fluorobenzoic Acid (8)2-Chlorobenzoic Acid (130)2-Cyclohexylacetic Acid (14)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluorobenzoic Acid (220)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Iodobenzoic Acid (47)2-Methoxyisonicotinic Acid (13)2-Methyl-2-Phenylpropanoic Acid (20)2-Methyl-3-Nitrobenzoic Acid (7)2-Naphthoic Acid (14)2-Nitrobenzoic Acid (65)2-Oxo-2-Phenylacetic Acid (17)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2-Phenoxypropanoic Acid (13)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-(3-Chlorophenyl)Propanoic Acid (11)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Benzoic Acid (5)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Methylsulfonyl)Benzoic Acid (6)3-(Phenyldiazenyl)Benzoic Acid (7)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethyl)Benzoic Acid (52)3-Benzamidopropanoic Acid (3)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylbenzoic Acid (9)3-Bromobenzoic Acid (159)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Methoxybenzoic Acid (5)3-Chlorobenzoic Acid (144)3-Fluoro-4-Methoxybenzoic Acid (6)3-Fluorobenzoic Acid (206)3-Fluoropicolinic Acid (6)3-Iodobenzoic Acid (55)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methylpicolinic Acid (13)3-Nitrobenzoic Acid (109)3-Phenoxybenzoic Acid (6)3-Phenoxypropanoic Acid (14)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(Benzyloxy)Benzoic Acid (5)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Trifluoromethyl)Nicotinic Acid (3)4-Amino-3-Chlorobenzoic Acid (6)4-Benzamidobenzoic Acid (3)4-Cyclohexylbenzoic Acid (6)4-Fluoro-3-Iodobenzoic Acid (5)4-Fluorobenzoic Acid (114)4-Methylnicotinic Acid (5)4-Morpholinobenzoic Acid (5)4-Nitrobenzoic Acid (35)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Oxo-4-(Phenylamino)Butanoic Acid (7)4-Oxo-4-Phenylbutanoic Acid (16)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenoxybenzoic Acid (4)4-Phenylbutanoic Acid (19)5'-(4-Carboxyphenyl)-[1,1':3',1''-Terphenyl]-4,4''-Dicarboxylic Acid (7)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)5-Phenylfuran-2-Carboxylic Acid (6)5-Phenylisoxazole-3-Carboxylic Acid (15)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)6-Methoxypicolinic Acid (9)6-Methylnicotinic Acid (6)6-Methylpicolinic Acid (12)6-Oxopiperidine-2-Carboxylic Acid (3)6-Phenylpicolinic Acid (3)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-3-Carboxylic Acid (39)Azetidine-2-Carboxylic Acid (6)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[D]Thiazole-6-Carboxylic Acid (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-3-Carboxylic Acid (6)Benzoic Acid (3519)Benzoylglycine (15)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Cyclobutanecarboxylic Acid (23)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanecarboxylic Acid (83)Cyclopentanecarboxylic Acid (26)Cyclopropanecarboxylic Acid (11)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Furan-2-Carboxylic Acid (31)Furan-3-Carboxylic Acid (11)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Indoline-2-Carboxylic Acid (3)Isonicotinic Acid (23)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-6-Carboxylic Acid (3)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl Benzofuran-2-Carboxylate (6)Methyl Isoquinoline-3-Carboxylate (3)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Nicotinic Acid (53)Oxazole-4-Carboxylic Acid (4)Picolinic Acid (22)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (11)Proline (13)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Pyridazine-3-Carboxylic Acid (7)Pyridine-2,6-Dicarboxylic Acid (9)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carboxylic Acid (7)Pyrrolidine-3-Carboxylic Acid (14)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Carboxylic Acid (4)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carboxylic Acid (10)Thiophene-3-Carboxylic Acid (8)Tryptophan (21)
Chlorides (77875)
Chloroacetamide (17)Chloroacetyl (12)Chloroaniline (18)Chlorobenzaldehyde (18)Chlorobenzamide (12)Chlorobutyl (6)Chlorobutyl (6)Chlorocarbonyl (7)Chloroethoxy (10)Chloroethoxy (10)Chloroethyl (89)Chloromethyl (479)Chloropicolinaldehyde (8)Chloropicolinamide (5)Chloropropane (18)Chloropropane (18)Chloropropoxy (2)Chloropropoxy (2)Chloropropyl (23)Dichloride (28)Dichloroaniline (9)Dichloroanthracene (3)Dichlorobenzaldehyde (13)Dichlorobenzamide (8)Dichloroisonicotinaldehyde (4)Dichloromethyl (3)Dichloromethyl (3)Dichloronicotinaldehyde (6)Dichloronicotinic (6)Dichloronicotinic (6)Dichloronicotinic Acid (5)Dichloropalladium (4)Dichloropalladium (4)Tetrachloro (2)Tetrachloro (2)Trichloro (36)Trichloro (36)Trichloroacetimidate (5)Trichloroaniline (6)Trichlorobenzaldehyde (4)Trichloromethyl (11)Trichloromethyl (11)(2,3-Dichlorophenyl)Boronic Acid (11)(2,6-Dichlorophenyl)Boronic Acid (6)(2-Chloroethoxy)Benzene (5)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Chlorophenyl)Hydrazine (16)(2-Chlorophenyl)Methanamine (28)(2-Chlorophenyl)Methanol (39)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3,4-Dichlorophenyl)Boronic Acid (10)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Chlorophenyl)Boronic Acid (121)(3-Chlorophenyl)Hydrazine (12)(3-Chlorophenyl)Methanamine (19)(3-Chlorophenyl)Methanol (38)(3-Chloropyridin-2-Yl)Methanamine (6)(4-Chlorophenyl)(Phenyl)Methanone (10)(5-Chloropyridin-2-Yl)Methanamine (5)(Chloromethanetriyl)Tribenzene (7)(Chloromethylene)Dibenzene (5)1,2,3,4-Tetrachlorobenzene (8)1,2,4-Trichlorobenzene (26)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-3-Methylbenzene (8)1,2-Dichloro-4-Fluorobenzene (15)1,2-Dichloro-4-Methoxybenzene (11)1,2-Dichloro-4-Nitrobenzene (16)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dichloro-2-Fluorobenzene (23)1,3-Dichloro-2-Iodobenzene (5)1,3-Dichloro-2-Methoxybenzene (9)1,3-Dichloro-2-Nitrobenzene (5)1,3-Dichloroisoquinoline (14)1,4-Dichloro-2-Fluorobenzene (11)1,4-Dichloro-2-Methoxybenzene (8)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Chlorophenyl)Piperazine (4)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Chloromethyl)-2-Methylbenzene (7)1-Benzyl-2-Chlorobenzene (9)1-Benzyl-3-Chlorobenzene (3)1-Benzyl-4-Chlorobenzene (6)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-(Chloromethyl)Benzene (12)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-2-Cyclopropylbenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Iodobenzene (65)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3,5-Dimethylbenzene (8)1-Chloro-3-(Chloromethyl)Benzene (7)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Nitrobenzene (161)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Chloro-4-Iodobenzene (49)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Chloroanthracene-9,10-Dione (6)1-Chloroisoquinoline (20)1-Chloronaphthalene (24)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dichloroaniline (18)2,3-Dichlorobenzaldehyde (7)2,3-Dichlorophenol (9)2,3-Dichloropyridine (38)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyridine (5)2,4,6-Trichloropyrimidine (14)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dichloro-1-Fluorobenzene (27)2,4-Dichloro-1-Methoxybenzene (18)2,4-Dichloro-1-Nitrobenzene (19)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichlorobenzaldehyde (8)2,4-Dichlorobenzonitrile (4)2,4-Dichloropyridine (50)2,4-Dichloroquinazoline (19)2,4-Dichlorothiazole (4)2,5-Dichlorophenol (7)2,5-Dichloropyrazine (4)2,5-Dichloropyridine (32)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloroaniline (27)2,6-Dichlorobenzoic Acid (13)2,6-Dichlorobenzonitrile (8)2,6-Dichloronicotinonitrile (8)2,6-Dichlorophenol (16)2,6-Dichloropyrazine (14)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(2-Chlorophenyl)Pyridine (3)2-(2-Chlorophenyl)Pyrrolidine (17)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Chlorophenyl)Acetonitrile (16)2-(4-Chlorophenoxy)Acetic Acid (3)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Furan (3)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Chloromethyl)Pyrimidine (5)2-(Chloromethyl)Thiazole (5)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Chloro-1,1'-Biphenyl (8)2-Chloro-1,3,5-Triazine (10)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-1-Phenylethan-1-One (20)2-Chloro-1H-Benzo[D]Imidazole (17)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylaniline (4)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-3-Methylpyrazine (7)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Methylaniline (7)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-4-Methylpyridine (31)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Methylthiazole (5)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Methoxyaniline (8)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Methylthiazole (5)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorophenol (5)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodophenol (3)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylaniline (11)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylphenol (5)2-Chloro-6-Methylpyrazine (12)2-Chloro-6-Methylpyridine (49)2-Chloro-6-Nitroaniline (11)2-Chloro-7H-Purine (3)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloro-9H-Purine (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylaniline (7)2-Chloroaniline (214)2-Chlorobenzamide (16)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,3-Diol (4)2-Chlorobenzene-1,4-Diamine (6)2-Chlorobenzenesulfonyl Chloride (24)2-Chlorobenzenethiol (7)2-Chlorobenzo[D]Oxazole (11)2-Chlorobenzo[D]Thiazole (21)2-Chlorobenzoic Acid (130)2-Chlorobenzonitrile (99)2-Chlorobenzoyl Chloride (13)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chlorofuran (3)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronaphthalene (6)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chlorooxazole (7)2-Chlorophenol (163)2-Chloropyrazine (24)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Chloroquinoxaline (39)2-Chlorothiazole (32)2-Chlorothiophene (20)3,4-Dichloroaniline (21)3,5-Dichloropyridine (16)3,6-Dichloropyridazine (20)3-(3-Chlorophenyl)Propanoic Acid (11)3-(Chloromethyl)Pyridine (22)3-Chloro-1,1'-Biphenyl (12)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Chloro-1-Phenylpropan-1-One (10)3-Chloro-1H-Indazole (13)3-Chloro-2-Fluoroaniline (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Fluorobenzonitrile (7)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylaniline (11)3-Chloro-2-Methylpyridine (4)3-Chloro-2-Nitroaniline (5)3-Chloro-4-(Trifluoromethyl)Aniline (5)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chloro-4-Methylaniline (12)3-Chloro-4-Methylpyridazine (7)3-Chloro-4-Nitroaniline (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloro-9H-Carbazole (3)3-Chlorobenzaldehyde (106)3-Chlorobenzene-1,2-Diamine (6)3-Chlorobenzene-1,2-Diol (6)3-Chlorobenzenesulfonyl Chloride (21)3-Chlorobenzo[B]Thiophene (6)3-Chlorobenzoic Acid (144)3-Chlorobenzonitrile (100)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloroisoquinoline (20)3-Chlorophenol (112)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridazine (44)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Chlorothiophene (17)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,6-Dichloropyrimidine (14)4-Chloro-1,5-Naphthyridine (6)4-Chloro-1-Phenylbutan-1-One (8)4-Chloro-1H-Indazole (18)4-Chloro-1H-Indole (21)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Methylaniline (11)4-Chloro-3-Methylpyridine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-N-Phenylaniline (6)4-Chlorobenzene-1,3-Diol (6)4-Chlorobenzenesulfonic Acid (4)4-Chlorobenzenesulfonyl Chloride (12)4-Chlorobenzo[D]Thiazole (7)4-Chloroindoline-2,3-Dione (6)4-Chloroisoquinoline (11)4-Chloronicotinic Acid (4)4-Chloropyridazine (16)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Chloroquinazoline (39)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5,6-Dichloropyridin-2-Amine (4)5-Bromo-4-Chloropyrimidine (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Chloro-1H-Imidazole (2)5-Chloro-1H-Indazole (9)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chlorobenzo[B]Thiophene (4)5-Chlorobenzo[D]Oxazole (5)5-Chlorobenzo[D]Thiazole (5)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloroindolin-2-One (3)5-Chloroisoquinoline (6)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Chloropyrimidine (8)5-Chloroquinazoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Chloro-1H-Benzo[D]Imidazole (25)6-Chloro-1H-Indazole (14)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-2,3-Dihydrobenzofuran (3)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chlorobenzo[D]Oxazole (4)6-Chlorobenzo[D]Thiazole (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Chloroquinoxaline (3)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Chloro-1H-Indazole (7)7-Chloro-1H-Indole (29)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Chloro-2,3-Dihydrobenzofuran (3)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Chlorobenzo[D]Thiazole (6)7-Chlorochromane (5)7-Chloroisoquinoline (6)7-Chloropyrazolo[1,5-A]Pyrimidine (8)8-Chlorochromane (5)8-Chloroimidazo[1,2-A]Pyridine (7)8-Chloroisoquinoline (7)8-Chloroquinazoline (5)Ethyl 4,6-Dichloronicotinate (4)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloropicolinate (7)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 2,6-Dichlorobenzoate (7)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Chlorobenzoate (88)Methyl 3-Chloropicolinate (9)Methyl 6-Chloropicolinate (11)N-(2-Chlorophenyl)Acetamide (16)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(3-Chlorophenyl)Quinazolin-4-Amine (9)N-(4-Chlorophenyl)Acetamide (9)Phenyl Carbonochloridate (5)Pyridine-2-Sulfonyl Chloride (9)Pyridine-3-Sulfonyl Chloride (25)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)
Diazoes (3)
Difluoromethyls (32566)
(Difluoromethyl)Benzene (63)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-(Difluoromethyl)-2-Fluorobenzene (13)1-Bromo-2-(Difluoromethyl)Benzene (5)2-(Difluoromethoxy)Phenol (5)2-(Difluoromethyl)Pyridine (21)3-(Difluoromethyl)Pyridine (5)4-(Difluoromethoxy)Aniline (6)5-(Difluoromethyl)-1H-Pyrazole (6)
Esters (51168)
Acetoxymethyl (85)Acetoxyphenyl (1)Acetyloxy (53)Acrylate (118)Acryloyloxy (3)Adipate (17)Adipate (17)Amino-Carboxylate (2)Aminobenzoate (18)Aminobenzylcarbamate (8)Aminobutanoate (14)Aminocyclobutanecarboxylic Acid (4)Aminocyclohexanecarboxylic (16)Aminocyclohexanecarboxylic Acid (10)Aminocyclopentanecarboxylic (13)Aminoheptanoate (9)Aminohexanoate (6)Aminoisonicotinate (4)Aminoisophthalate (5)Aminonicotinate (7)Aminopentanedioate (15)Aminopentanoate (7)Aminopropanoate (16)Benzoyloxy (14)Benzylcarbamate (8)Bromobenzoate (26)Bromobutanoate (9)Bromocyclopropanecarboxylate (1)Bromodecanoate (20)Bromoisonicotinate (8)Bromoisophthalate (3)Bromonicotinate (13)Bromopropanoate (9)Bromoundecanoate (3)Butoxycarbonyl (1675)Butoxycarbonyl (1675)Carbamate (1539)Chlorobenzoate (49)Chloroformate (4)Chloropicolinate (30)Chloropropanoate (5)Cyanoacrylate (6)Decanedioate (9)Decanedioate (9)Decanoate (7)Decanoate (7)Diacetate (56)Diacetoxy (1)Diacrylate (15)Diaminobenzoate (7)Dibromobenzoate (4)Dicarbamate (14)Dichlorobenzoate (24)Dichloroisonicotinate (9)Dimethacrylate (1)Dimethylbutanoate (14)Dimethylcarbamate (3)Dimethylnicotinate (10)Dimethylnicotinate (10)Dipropanoate (6)Dipropanoate (6)Diyldicarbamate (5)Dodecanoate (11)Enecarboxylate (9)Enoate (116)Ethoxycarbonyl (70)Ethylbutanoate (6)Ethynylbenzoate (7)Ethynylbenzylcarbamate (3)Glutarate (3)Glutarate (3)Hexanoate (14)Hexanoate (14)Indoline-Carboxylate (1)Iodoacrylate (6)Iodobutanoate (4)Iodopropanoate (1)Isobutyrate (18)Isobutyrate (18)Methacrylate (87)Methacryloyloxy (7)Methoxycarbonyl (169)Methoxycarbonyl (169)Methoxyisonicotinate (11)Methoxyisonicotinate (11)Methoxynicotinate (24)Methoxynicotinate (24)Methoxypropanoate (5)Methoxypropanoate (5)Methylacrylate (13)Methylbutanoate (38)Methylmalonate (6)Methylnicotinate (57)Methylpentanoate (17)Methylpropanoate (47)Nitropicolinate (13)Nonanedioate (4)Nonanedioate (4)Oxoacetate (21)Oxoacetate (21)Oxobutanoate (56)Oxobutanoate (56)Oxoheptanoate (8)Oxoheptanoate (8)Oxohexanoate (14)Oxohexanoate (14)Oxopentanoate (31)Oxopropanoate (39)Oxopropanoate (39)Pentanoate (13)Pentanoate (13)Phenylacrylate (5)Phenylpropanoate (42)Propanoate (296)Propylpentanoate (5)Propylpentanoate (5)Succinate (23)Succinate (23)Sulfamoylbenzoate (6)Tetraacetate (7)Tetraacetate (7)Tetradecanoate (10)Tetradecanoate (10)Thiophenecarboxylate (2)Tosylcarbamate (4)Tosyloxy (12)Triacetate (12)Triacetate (12)Vinylbenzoate (3)Vinylcyclopropanecarboxylic Acid (3)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1H-Indol-3-Yl Acetate (4)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Diethylamino)Ethyl Benzoate (3)2-Ethylhexyl Benzoate (13)2-Hydroxyethyl Benzoate (3)2-Phenoxyacetyl Chloride (3)4-Cyanophenyl Benzoate (11)Allyl Benzoate (5)Azetidin-3-Yl Acetate (3)Benzoic Anhydride (6)Benzyl Acetate (11)Benzyl Benzoate (12)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Morpholine-4-Carboxylate (5)Benzyl Phenylcarbamate (15)Benzyl Piperidine-1-Carboxylate (50)Butyl Benzoate (10)Dimethyl Isophthalate (32)Dimethyl Phthalate (14)Dimethyl Pyridine-2,6-Dicarboxylate (7)Ethane-1,2-Diyl Dibenzoate (11)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Aminobenzoate (23)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Bromo-2-Phenylacetate (6)Ethyl 2-Fluorobenzoate (37)Ethyl 2-Hydroxybenzoate (18)Ethyl 2-Iodobenzoate (4)Ethyl 2-Methylbenzoate (26)Ethyl 2-Methylnicotinate (6)Ethyl 2-Nitrobenzoate (9)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Ethyl 2-Phenoxyacetate (10)Ethyl 2-Phenylacetate (60)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Ethyl 3-Aminobenzoate (19)Ethyl 3-Fluorobenzoate (34)Ethyl 3-Hydroxybenzoate (12)Ethyl 3-Iodobenzoate (11)Ethyl 3-Nitrobenzoate (22)Ethyl 3-Oxo-3-Phenylpropanoate (41)Ethyl 3-Phenylpropanoate (17)Ethyl 4-Aminobenzoate (23)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Ethyl Cinnamate (26)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Ethyl Cyclopropanecarboxylate (8)Ethyl Furan-2-Carboxylate (6)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Ethyl Isonicotinate (12)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Ethyl Nicotinate (25)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Ethyl Oxirane-2-Carboxylate (4)Ethyl Picolinate (41)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Ethyl Pyrazine-2-Carboxylate (10)Ethyl Pyridazine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Ethyl Quinazoline-2-Carboxylate (4)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Hexyl Benzoate (5)Isobutyl Benzoate (10)Isopropyl Benzoate (10)Methyl 1-Naphthoate (7)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Methyl 2,6-Dichlorobenzoate (7)Methyl 2,6-Difluorobenzoate (17)Methyl 2-(1H-Indol-3-Yl)Acetate (3)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-(Bromomethyl)Benzoate (33)Methyl 2-(Chlorosulfonyl)Benzoate (7)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Cyanobenzoate (22)Methyl 2-Fluorobenzoate (132)Methyl 2-Hydroxybenzoate (74)Methyl 2-Iodobenzoate (28)Methyl 2-Methoxybenzoate (70)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Methyl 2-Methylbenzoate (101)Methyl 2-Naphthoate (11)Methyl 2-Nitrobenzoate (54)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 2-Phenylacetate (114)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-(Trifluoromethyl)Benzoate (22)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 3-Chlorobenzoate (88)Methyl 3-Cyanobenzoate (29)Methyl 3-Fluorobenzoate (136)Methyl 3-Formylbenzoate (23)Methyl 3-Hydroxybenzoate (58)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 3-Methoxybenzoate (70)Methyl 3-Methylbenzoate (75)Methyl 3-Nitrobenzoate (109)Methyl 3-Oxo-3-Phenylpropanoate (16)Methyl 3-Phenylpropanoate (28)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 4-Amino-3-Iodobenzoate (7)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Aminobenzoate (71)Methyl 4-Fluorobenzoate (75)Methyl 4-Nitrobenzoate (29)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl 4-Phenoxybenzoate (3)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 5-Hydroxypicolinate (5)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl 5-Phenylisoxazole-3-Carboxylate (6)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl 6-Methoxynicotinate (4)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Azetidine-2-Carboxylate (3)Methyl Benzo[B]Thiophene-2-Carboxylate (27)Methyl Benzo[D]Oxazole-2-Carboxylate (3)Methyl Benzo[D]Thiazole-6-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cinnamate (36)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)Methyl Cyclopropanecarboxylate (8)Methyl Furan-2-Carboxylate (20)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Methyl Indoline-6-Carboxylate (3)Methyl Isonicotinate (16)Methyl Isoquinoline-4-Carboxylate (6)Methyl L-Phenylalaninate (20)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Methyl Nicotinate (52)Methyl Oxazole-4-Carboxylate (9)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)Methyl Prolinate (43)Methyl Pyrazine-2-Carboxylate (19)Methyl Pyridazine-3-Carboxylate (7)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)Methyl Pyrrolidine-3-Carboxylate (9)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)Methyl Thiophene-3-Carboxylate (34)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Propyl Benzoate (11)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (5)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)Tert-Butyl 1H-Indazole-1-Carboxylate (29)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Azetidine-1-Carboxylate (64)Tert-Butyl Benzoate (66)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclopentylcarbamate (28)Tert-Butyl Isoindoline-2-Carboxylate (13)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl Morpholine-4-Carboxylate (23)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl Piperazine-1-Carboxylate (30)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Ethers (82526)
Butoxy-Phenyl-Boronic Acid/Ester (76)Diethoxy (14)Diethoxy (14)Diethoxyethyl (9)Diethoxyethyl (9)Diethoxymethyl (8)Diethoxymethyl (8)Dimethoxyethyl (8)Dimethoxypropane (11)Dimethoxypropane (11)Dioxane (153)Dioxepine (7)Dioxepine (7)Disulfide (38)Methoxyphenylboronic-Acid (32)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Benzyloxy)Phenyl)Boronic Acid (23)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloroethoxy)Benzene (5)(2-Methoxyethoxy)Benzene (32)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Phenoxyphenyl)Methanol (3)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-Methoxyphenyl)(Phenyl)Methanone (7)(9H-Fluoren-9-Yl)Methyl (2-(Benzyloxy)Ethyl)Carbamate (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Allyloxy)Benzene (19)(Ethoxymethyl)Benzene (7)(Hexyloxy)Benzene (7)(Methoxymethyl)Benzene (30)(Prop-2-Yn-1-Yloxy)Benzene (13)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)1,2-Bis(Benzyloxy)Benzene (11)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-4-Methoxybenzene (11)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-4-Methoxybenzene (19)1,2-Dimethoxybenzene (223)1,2-Diphenoxyethane (11)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dichloro-2-Methoxybenzene (9)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Dimethoxybenzene (235)1,3-Diphenoxybenzene (8)1,4-Dichloro-2-Methoxybenzene (8)1,4-Dimethoxybenzene (66)1-(2-Methoxyphenyl)Ethan-1-One (33)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-2-Methoxybenzene (19)1-(Benzyloxy)-2-Methylbenzene (12)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Benzyloxy)-3-Methylbenzene (8)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Benzyloxy)-4-Bromobenzene (8)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-3-Methoxybenzene (19)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-Benzyl-4-Methoxybenzene (8)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-Phenoxybenzene (8)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Phenoxybenzene (8)1-Iodo-2-Methoxybenzene (50)1-Iodo-3-Methoxybenzene (48)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-(Phenoxymethyl)Benzene (3)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methoxy-4-Nitrobenzene (90)1-Methoxynaphthalene (17)1-Methyl-3-Phenoxybenzene (9)1-Nitro-2-Phenoxybenzene (4)1-Nitro-4-Phenoxybenzene (5)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)2,3,5,6,8,9,11,12-Octahydrobenzo[B][1,4,7,10,13]Pentaoxacyclopentadecine (8)2,3-Dimethoxypyridine (7)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dichloro-1-Methoxybenzene (18)2,4-Difluoro-1-Methoxybenzene (25)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethoxypyrimidine (13)2,6-Dimethoxypyridine (11)2-(2-Methoxyphenyl)Acetic Acid (16)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(4-Methoxyphenyl)Acetic Acid (19)2-(Benzyloxy)Benzaldehyde (13)2-(Benzyloxy)Naphthalene (5)2-(Benzyloxy)Phenol (5)2-(Methoxymethyl)Morpholine (4)2-(Methoxymethyl)Pyrrolidine (6)2-(Phenoxymethyl)Oxirane (13)2-(Phenoxymethyl)Pyridine (5)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-3-Methoxypyrazine (5)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-5-Methoxyaniline (8)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Ethoxynaphthalene (4)2-Ethoxypyridine (20)2-Ethoxypyrimidine (7)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-6-Methoxypyridine (6)2-Isopropoxypyridine (16)2-Methoxy-1,1'-Biphenyl (7)2-Methoxy-1,3,5-Triazine (10)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-Methylpyridine (5)2-Methoxy-6-Methylpyridine (14)2-Methoxy-6-Nitrophenol (5)2-Methoxybenzamide (9)2-Methoxybenzenesulfonyl Chloride (15)2-Methoxynaphthalene (22)2-Methoxyphenol (197)2-Methoxypyrazine (45)2-Methoxypyridine (436)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methoxythiophene (7)2-Methyl-N-Phenylaniline (6)2-Phenoxyacetonitrile (11)2-Phenoxyaniline (4)2-Phenoxybenzonitrile (5)2-Phenoxyethan-1-Ol (14)2-Phenoxypropanoic Acid (13)2-Phenoxypyrimidine (8)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxythiazole (5)2-Propoxypyridine (9)3,5-Dimethoxypyridine (4)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Aniline (12)3-(Benzyloxy)Benzaldehyde (13)3-(Benzyloxy)Benzoic Acid (5)3-(Benzyloxy)Phenol (5)3-(Methoxymethyl)Morpholine (4)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methoxybenzaldehyde (7)3-Chloro-4-Methoxybenzoic Acid (5)3-Ethoxypyridine (12)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-4-Methoxybenzoic Acid (6)3-Methoxypiperidine (7)3-Methoxypyridazine (17)3-Methoxypyridine (52)3-Methoxythiophene (9)3-Phenoxyaniline (2)3-Phenoxybenzaldehyde (7)3-Phenoxybenzoic Acid (6)3-Phenoxybenzonitrile (5)3-Phenoxypropanoic Acid (14)3-Phenoxypyrrolidine (5)4-(3-Phenoxypropyl)Morpholine (7)4-(Benzyloxy)Aniline (8)4-(Benzyloxy)Benzaldehyde (23)4-(Benzyloxy)Benzoic Acid (5)4-(Benzyloxy)Phenol (2)4-(Difluoromethoxy)Aniline (6)4-(Dimethoxymethyl)Pyrimidine (5)4-(Phenylethynyl)Phenol (7)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-6-Methoxypyrimidine (5)4-Ethoxypyridine (7)4-Ethoxypyrimidine (6)4-Methoxy-1,1'-Biphenyl (4)4-Methoxy-1H-Indazole (7)4-Methoxy-1H-Indole (11)4-Methoxy-2-Methylpyrimidine (8)4-Methoxy-N-Phenylaniline (5)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methoxypyridazine (8)4-Methoxypyridine (136)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Phenoxyaniline (6)4-Phenoxybenzaldehyde (12)4-Phenoxybenzoic Acid (4)4-Phenoxypyridine (7)4-Phenoxypyrimidine (5)4-Phenoxyquinoline (5)4-Phenoxytetrahydro-2H-Pyran (5)5-(Benzyloxy)Pyrimidine (5)5-Fluoro-2-Methoxypyridine (15)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methoxy-1H-Indazole (5)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methoxy-2-Nitroaniline (7)5-Methoxyindoline (4)5-Methoxyisobenzofuran-1(3H)-One (5)5-Methoxyisoquinoline (6)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1H-Indazole (14)6-Methoxy-1H-Indole (12)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)6-Methoxybenzo[D]Thiazole (6)6-Methoxybenzofuran (4)6-Methoxychromane (5)6-Methoxyisoindolin-1-One (3)6-Methoxyquinoxaline (6)7-(Benzyloxy)Quinoline (6)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Methoxy-1H-Indazole (5)7-Methoxy-1H-Indole (8)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)7-Methoxyisoquinoline (5)8-Methoxyisoquinoline (7)8-Methoxyquinazoline (3)Butoxybenzene (51)Ethoxybenzene (285)Ethyl 2-Phenoxyacetate (10)Isobutoxybenzene (22)Isopropoxybenzene (85)Methoxycyclohexane (7)Methyl 2-Methoxybenzoate (70)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-Methoxybenzoate (70)Methyl 4-Phenoxybenzoate (3)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(4-Phenoxyphenyl)Acetamide (4)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)Phenethoxybenzene (23)Propoxybenzene (63)Tert-Butoxybenzene (19)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)
Fluorinated Building Blocks (99063)
Dichlorofluorobenzene (23)Difluoro (901)Difluoroaniline (37)Difluorobenzaldehyde (33)Difluorobenzamide (6)Difluorobenzenesulfonamide (5)Difluorobenzoate (59)Difluoroethyl (27)Difluoroethyl (27)Difluoromethoxy (200)Difluoromethoxy (200)Difluoropropan (7)Difluoropropan (7)Fluindamine (32)Fluoroacetanilide (5)Fluoroacetophenone (8)Fluoroaniline (65)Fluoroanisole (9)Fluorobenzaldehyde (69)Fluorobenzamide (28)Fluorobenzenesulfonamide (7)Fluorobenzenethiol (6)Fluorobenzylamine (10)Fluorobromobenzene (3)Fluorocinnamic (10)Fluorocinnamic (10)Fluorocinnamic Acid (9)Fluorocyclopropanecarboxylic (9)Fluoroethoxy (4)Fluoroethyl (8)Fluoroethyl (8)Fluoroindan (3)Fluoroindan (3)Fluoroisonicotinaldehyde (7)Fluoroisonicotinate (8)Fluoroisonicotinic (13)Fluoroisonicotinic Acid (13)Fluoromethyl (15)Fluoromethyl (15)Fluoronicotinaldehyde (20)Fluoronicotinamide (3)Fluoronicotinic (19)Fluoronicotinic (19)Fluoronicotinic Acid (14)Fluorophenylisocyanate (3)Fluoropropan (15)Fluoropropan (15)Fluorostyryl (7)Fluorosulfonyl (12)Fluorosulfonyl (12)Hexafluoro (9)Hexafluoro (9)Hexafluoropropan (4)Hexafluoropropan (4)Nonafluoro (2)Nonafluoro (2)Octafluoro (2)Octafluoro (2)Pentafluoro (4)Pentafluorobenzoate (4)Tetrafluoro (12)Tetrafluoro (12)Tetrafluoroaniline (7)Tetrafluoroethoxy (3)Tetrafluoroethoxy (3)Trifluoro (271)Trifluoro (271)Trifluoroacetamide (8)Trifluoroacetyl (13)Trifluoroaniline (11)Trifluorobenzaldehyde (9)Trifluorobenzoate (14)Trifluorobut (36)Trifluorobut (36)Trifluoroethan (2)Trifluoroethan (2)Trifluoroethanamine (23)Trifluoroethanol (6)Trifluoroethoxy (60)Trifluoroethoxy (60)Trifluoroethyl (63)Trifluoromethanesulfonamide (4)Trifluoromethanesulfonyl (22)Trifluoromethoxy (480)Trifluoromethoxy (480)Trifluoromethylthio (5)Trifluoromethylthio (5)Trifluoropropane (36)Trifluoropropanoate (5)Trifluoropropyl (9)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Difluorophenyl)Boronic Acid (28)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Fluorophenyl)Boronic Acid (229)(2-Fluorophenyl)Hydrazine (22)(2-Fluorophenyl)Methanamine (49)(2-Fluorophenyl)Methanol (60)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Fluorophenyl)Boronic Acid (169)(3-Fluorophenyl)Methanol (58)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Fluorophenyl)Boronic Acid (93)(4-Fluorophenyl)Methanamine (27)(4-Fluorophenyl)Methanol (29)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,2,3,4,5-Pentafluorobenzene (51)1,2,3,4-Tetrafluorobenzene (73)1,2,3-Trifluorobenzene (156)1,2,4-Trifluorobenzene (210)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-4-Fluorobenzene (15)1,2-Difluoro-3-Iodobenzene (13)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-3-Methylbenzene (23)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Methoxybenzene (19)1,2-Difluoro-4-Nitrobenzene (43)1,2-Difluorobenzene (658)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dichloro-2-Fluorobenzene (23)1,3-Difluoro-2-Iodobenzene (12)1,3-Difluoro-2-Methylbenzene (18)1,3-Difluoro-2-Nitrobenzene (16)1,4-Dichloro-2-Fluorobenzene (11)1,4-Difluoro-2-Iodobenzene (8)1,4-Difluoro-2-Nitrobenzene (28)1,4-Difluorobenzene (361)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Fluorophenyl)Piperazine (8)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-Fluorophenyl)Ethan-1-One (63)1-(4-Fluorophenyl)Ethan-1-One (36)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)1-Benzyl-4-Fluorobenzene (2)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Cyclohexyl-2-Fluorobenzene (4)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethynyl-2-Fluorobenzene (10)1-Fluoro-2,3-Dimethylbenzene (8)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Methylbenzene (255)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3,5-Dimethylbenzene (12)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Methylbenzene (255)1-Fluoro-3-Nitrobenzene (216)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-Iodobenzene (65)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Methylbenzene (140)1-Fluoro-4-Phenoxybenzene (8)1-Fluorobicyclo[1.1.1]Pentane (4)1-Fluoronaphthalene (23)2'-Fluoro-1,1':4',1''-Terphenyl (6)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,3-Difluoroaniline (34)2,3-Difluorobenzaldehyde (18)2,3-Difluorobenzoic Acid (35)2,3-Difluorobenzonitrile (29)2,3-Difluorophenol (36)2,3-Difluoropyridine (13)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dichloro-1-Fluorobenzene (27)2,4-Difluoro-1-Iodobenzene (14)2,4-Difluoro-1-Methoxybenzene (25)2,4-Difluoro-1-Nitrobenzene (46)2,4-Difluoroaniline (44)2,4-Difluorobenzaldehyde (19)2,4-Difluorobenzoic Acid (29)2,4-Difluorobenzonitrile (21)2,4-Difluorophenol (21)2,5-Difluoroaniline (34)2,5-Difluorobenzoic Acid (32)2,5-Difluoropyridine (8)2,6-Difluoroaniline (23)2,6-Difluorobenzaldehyde (25)2,6-Difluorobenzoic Acid (33)2,6-Difluorobenzonitrile (28)2,6-Difluorophenol (24)2,6-Difluoropyridine (29)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Fluorophenyl)Acetonitrile (30)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Fluorophenyl)Pyrrolidine (5)2-(4-Fluorophenyl)-1H-Indole (4)2-(4-Fluorophenyl)Acetic Acid (30)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (16)2-Amino-3-Fluorobenzoic Acid (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorophenol (9)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-3-Fluoropyridine (20)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluorobenzaldehyde (10)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-4-Fluorophenol (9)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorobenzoic Acid (8)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-6-Fluorophenol (5)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1,3-Dimethylbenzene (14)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoro-N-Methylbenzamide (12)2-Fluoro-N-Phenylaniline (4)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluoroaniline (262)2-Fluorobenzaldehyde (175)2-Fluorobenzamide (32)2-Fluorobenzenesulfonamide (12)2-Fluorobenzenesulfonyl Chloride (31)2-Fluorobenzoic Acid (220)2-Fluoropyridine (15)2-Fluoropyrimidine (9)3,3-Difluoropiperidine (29)3,3-Difluoropyrrolidine (29)3,4-Difluoroaniline (44)3,4-Difluorophenol (19)3,5-Difluoropyridine (12)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-Chloro-2-Fluoroaniline (9)3-Fluoro-1,1'-Biphenyl (16)3-Fluoro-2-Iodoaniline (8)3-Fluoro-2-Methylaniline (9)3-Fluoro-2-Methylpyridine (15)3-Fluoro-4-Nitroaniline (7)3-Fluoroaniline (289)3-Fluorobenzaldehyde (137)3-Fluorobenzamide (26)3-Fluorobenzenesulfonyl Chloride (22)3-Fluorobenzoic Acid (206)3-Fluorophenol (180)3-Fluoropiperidine (26)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Fluorothiophene (6)4,4-Difluoropiperidine (5)4-(2-Fluorophenyl)Morpholine (8)4-(4-Fluorophenyl)Thiazole (9)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-1H-Indazole (22)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-2-Nitroaniline (14)4-Fluoroaniline (225)4-Fluorobenzaldehyde (78)4-Fluorobenzamide (19)4-Fluorobenzenesulfonyl Chloride (26)4-Fluorobenzo[D]Thiazole (6)4-Fluorobenzoic Acid (114)4-Fluorobenzonitrile (89)4-Fluoroisoquinoline (6)4-Fluorophenol (111)4-Fluoropyrimidine (8)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Fluoro-2-Methylpyridine (8)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochromane (6)5-Fluoroindoline (3)5-Fluoroisoindolin-1-One (3)5-Fluoropyridin-2-Amine (15)5-Fluoropyrimidine (11)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1H-Indazole (15)6-Fluoro-1H-Indole (17)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluorobenzo[D]Thiazole (5)6-Fluorochromane (6)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1H-Indazole (12)7-Fluoro-1H-Indole (24)7-Fluorobenzo[D]Thiazole (9)7-Fluoroindoline-2,3-Dione (6)7-Fluoroisoquinoline (3)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluorochromane (5)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Fluoroisoquinoline (10)8-Fluoroquinazoline (4)Benzenesulfonyl Fluoride (51)Ethyl 2-Fluorobenzoate (37)Ethyl 3-Fluorobenzoate (34)Fluorobenzene (9967)Methyl 2,6-Difluorobenzoate (17)Methyl 2-Fluorobenzoate (132)Methyl 3-Fluorobenzoate (136)Methyl 4-Fluorobenzoate (75)Methyl 6-Fluoronicotinate (4)N-(3-Fluorophenyl)Acetamide (14)N-(4-Fluorophenyl)Benzamide (3)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl Trifluoromethanesulfonate (27)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Trifluoro(Phenyl)Borate (80)
Guanidines (776)
Biguanide (2)Biguanide (2)
Hydrazides (3103)
Acetohydrazide (17)Acetohydrazide (17)Chlorobenzhydrazide (3)Dihydrazide (5)Dihydrazide (5)Fluorobenzohydrazide (6)Pyrazine-2-Carbohydrazide (3)
Hydrazines (6277)
Dichlorophenylhydrazine (3)Hydrazinecarbothioamide (2)Hydrazinecarboxamide (1)Hydrazinylbenzoate (6)(2-Bromophenyl)Hydrazine (8)(2-Chlorophenyl)Hydrazine (16)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)Hydrazine (22)(3-Chlorophenyl)Hydrazine (12)2-Hydrazineylpyridine (32)2-Hydrazineylpyrimidine (6)3-Hydrazineylpyridine (8)4-Hydrazineylpiperidine (5)Isonicotinohydrazide (6)Phenylhydrazine (153)Picolinohydrazide (5)
Hydrazones (2042)
1-Benzylidene-2-Phenylhydrazine (4)
Hydroxylamines (623)
N-Hydroxybenzamide (8)
Iodides (14083)
Diiodo (19)Diiodobenzoate (5)Iodoaniline (60)Iodoanisole (5)Iodobenzaldehyde (38)Iodobenzamide (6)Iodobutane (1)Iodobutane (1)Iodoethoxy (6)Iodoethoxy (6)Iodoethyl (5)Iodoethyl (5)Iodomethyl (26)Iodomethyl (26)Iodonicotinaldehyde (6)Iodonicotinic (14)Iodonicotinic (14)Iodopropyl (4)Iodopropyl (4)(2-Iodophenyl)(Phenyl)Methanone (4)(2-Iodophenyl)Methanol (12)(3-Iodophenyl)Boronic Acid (5)(3-Iodophenyl)Methanol (13)1,2-Benziodoxol-3-(1H)-One (6)1,2-Difluoro-3-Iodobenzene (13)1,2-Diiodobenzene (10)1,3-Dibromo-2-Iodobenzene (4)1,3-Dichloro-2-Iodobenzene (5)1,3-Difluoro-2-Iodobenzene (12)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Diiodobenzene (59)1,4-Dibromo-2-Iodobenzene (3)1,4-Difluoro-2-Iodobenzene (8)1-(2-Iodophenyl)Ethan-1-One (4)1-(3-Iodophenyl)Ethan-1-One (7)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Iodobenzene (9)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Bromo-2-Iodobenzene (65)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Iodobenzene (70)1-Bromo-4-Iodobenzene (67)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Iodobenzene (65)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-4-Iodobenzene (49)1-Ethyl-2-Iodobenzene (6)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-4-Iodobenzene (65)1-Iodo-2,3-Dimethylbenzene (8)1-Iodo-2,4-Dimethylbenzene (9)1-Iodo-2-(Trifluoromethoxy)Benzene (6)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-2-Isopropylbenzene (4)1-Iodo-2-Methoxybenzene (50)1-Iodo-2-Methylbenzene (91)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-(Trifluoromethoxy)Benzene (6)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Iodo-3-Methoxybenzene (48)1-Iodo-3-Methylbenzene (60)1-Iodo-3-Nitrobenzene (45)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)2,4-Difluoro-1-Iodobenzene (14)2,6-Dichloro-4-Iodopyridine (4)2,6-Diiodoaniline (8)2,6-Diiodophenol (16)2-Bromo-3-Iodopyridine (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Iodopyridine (5)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-4-Iodopyridine (19)2-Chloro-5-Iodopyridine (18)2-Chloro-6-Iodophenol (3)2-Chloro-6-Iodopyridine (9)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Iodopyridine (8)2-Fluoro-6-Iodoaniline (7)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodo-1,3-Dimethylbenzene (15)2-Iodo-1,4-Dimethylbenzene (5)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-4-Methylaniline (5)2-Iodo-6-Methylpyridine (5)2-Iodo-6-Nitroaniline (3)2-Iodo-9H-Fluorene (8)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Iodobenzaldehyde (17)2-Iodobenzamide (4)2-Iodobenzene-1,3-Diol (3)2-Iodobenzoic Acid (47)2-Iodobenzonitrile (26)2-Iodonaphthalene (5)2-Iodophenol (63)2-Iodopyrazine (25)2-Iodopyridine (27)2-Iodopyrimidine (8)2-Iodothiophene (14)3-Chloro-2-Iodoaniline (3)3-Chloro-4-Iodoaniline (3)3-Fluoro-2-Iodoaniline (8)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Iodobenzaldehyde (28)3-Iodobenzoic Acid (55)3-Iodobenzonitrile (27)3-Iodoimidazo[1,2-A]Pyridine (10)3-Iodophenol (21)3-Iodopyridazine (5)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Iodotetrahydrofuran (3)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Iodoaniline (8)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Iodoaniline (3)4-Chloro-5-Iodopyrimidine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-3-Iodobenzoic Acid (5)4-Iodo-1,1'-Biphenyl (9)4-Iodo-1H-Pyrazole (9)4-Iodo-N,N-Diphenylaniline (3)4-Iodopyridine (17)4-Iodopyrimidine (9)5-Bromo-2-Iodopyridine (5)5-Iodo-1H-Imidazole (4)5-Iodo-1H-Pyrazole (4)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Iodopyrimidine (5)6-Chloro-5-Iodopyridin-2-Amine (3)Ethyl 2-Iodobenzoate (4)Ethyl 3-Iodobenzoate (11)Methyl 2-Iodobenzoate (28)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 4-Amino-3-Iodobenzoate (7)N-(2-Iodophenyl)Acetamide (8)Phenyl(O-Tolyl)Iodonium (14)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)
Isocyanates and Isothiocyanates (237)
Isocyanate (4)Isocyanate (4)(Isothiocyanatomethyl)Benzene (6)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)Isocyanatobenzene (47)Isothiocyanatobenzene (39)
Isocyanides (69)
Isocyanato (7)Isocyanide (1)Isothiocyanato (5)Isothiocyanato (5)
Ketones (40074)
Acetylacetonate (26)Bromoethanone (4)Butanedione (6)Butanedione (6)Butanone (10)Butanone (10)Carbonyl-Phenyl-Boronic Acid/Ester (184)Chloroethanone (2)Dicarbonyl (2)Dicarbonyl (2)Dichloroacetophenone (5)Dienone (2)Diethanone (5)Diethanone (5)Dione (1793)Dioxobutanoate (2)Enone (21)Ethanone (1026)Heptanedionato (7)Heptanedionato (7)Hydroxyethanone (3)Methyl-Pyrazolone (87)Oxoacetaldehyde (4)Oxoazepane (3)Oxoazepane (3)Oxochroman (5)Oxotetrahydro (11)Pyrimidinone (3)Tetraone (48)Tetraone (48)Trifluoroacetophenone (9)Trifluoroethanone (15)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Hydroxyphenyl)(Phenyl)Methanone (24)(2-Iodophenyl)(Phenyl)Methanone (4)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)(Phenyl)Methanone (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Bromophenyl)(Phenyl)Methanone (9)(4-Chlorophenyl)(Phenyl)Methanone (10)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Hydroxyphenyl)(Phenyl)Methanone (3)(4-Methoxyphenyl)(Phenyl)Methanone (7)(4-Nitrophenyl)(Phenyl)Methanone (3)(R)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-8-One (8)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1,3-Diphenylpropan-1-One (9)1,4-Diazepan-5-One (9)1,4-Dihydroisoquinolin-3(2H)-One (5)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-One (27)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-(2-Hydroxyphenyl)Ethan-1-One (73)1-(2-Iodophenyl)Ethan-1-One (4)1-(2-Methoxyphenyl)Ethan-1-One (33)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Fluorophenyl)Ethan-1-One (63)1-(3-Hydroxyphenyl)Ethan-1-One (19)1-(3-Iodophenyl)Ethan-1-One (7)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Fluorophenyl)Ethan-1-One (36)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Benzofuran-2-Yl)Ethan-1-One (3)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(M-Tolyl)Ethan-1-One (37)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-(O-Tolyl)Ethan-1-One (26)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Pyrazin-2-Yl)Ethan-1-One (5)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-4-Yl)Ethan-1-One (14)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-(Thiazol-2-Yl)Ethan-1-One (9)1-(Thiophen-2-Yl)Ethan-1-One (17)1-Aminoanthracene-9,10-Dione (8)1-Benzylindoline-2,3-Dione (5)1-Benzylpiperidin-3-One (5)1-Chloroanthracene-9,10-Dione (6)1-Hydroxyanthracene-9,10-Dione (11)1-Methylpiperazin-2-One (6)1-Methylpyrrolidin-2-One (13)1-Phenylbutan-1-One (13)1-Phenylpentan-1-One (12)1-Phenylpiperidin-2-One (8)1-Phenylpropan-2-One (36)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2,2-Dimethyl-1-Phenylpropan-1-One (8)2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2,3-Dihydrofuran-3-One (9)2,3-Dihydropyridin-2-One (5)2,5-Dichlorobenzoic Acid (13)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Benzalacetophenone (36)2-Benzoylbenzoic Acid (10)2-Chloro-1-Phenylethan-1-One (20)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chloroquinazolin-4(3H)-One (4)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Hydroxyquinolin-4(1H)-One (3)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methyl-1-Phenylpropan-1-One (20)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)2-Methylcyclohexan-1-One (3)2-Methylisoindolin-1-One (7)2-Methylisoindoline-1,3-Dione (5)2-Methylpyridazin-3(2H)-One (7)2-Oxo-2-Phenylacetaldehyde (12)2-Oxo-2-Phenylacetic Acid (17)3,3-Difluoropiperidin-4-One (3)3,3-Dimethylcyclohexan-1-One (4)3,3-Dimethylpiperidin-4-One (3)3,4-Dihydroquinoxalin-2(1H)-One (7)3-Acetyl-2H-Chromen-2-One (3)3-Aminopyrrolidin-2-One (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)3-Chloro-1-Phenylpropan-1-One (10)3-Fluoropiperidin-4-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)3-Hydroxypyrrolidin-2-One (4)3-Methylcyclohexan-1-One (9)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methylpiperazin-2-One (7)3-Methylpyrimidin-4(3H)-One (6)3-Oxo-3-Phenylpropanenitrile (21)3-Oxo-N-Phenylbutanamide (10)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylacrylaldehyde (29)3-Phenylimidazolidine-2,4-Dione (4)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-Benzylmorpholin-3-One (6)4-Bromoisoindolin-1-One (3)4-Bromopyridazin-3(2H)-One (3)4-Chloro-1-Phenylbutan-1-One (8)4-Chloropyridazin-3(2H)-One (4)4-Fluoroindoline-2,3-Dione (3)4-Hydroxy-2H-Chromen-2-One (10)4-Hydroxydihydrofuran-2(3H)-One (14)4-Hydroxypiperidin-2-One (3)4-Hydroxypyrrolidin-2-One (7)4-Methyl-2H-Chromen-2-One (27)4-Methylisobenzofuran-1(3H)-One (3)4-Oxo-4-Phenylbutanoic Acid (16)4-Phenylbutan-2-One (14)4-Phenylcyclohexan-1-One (11)4-Phenylmorpholin-3-One (6)4-Phenylpyrrolidin-2-One (7)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Bromoisoindolin-1-One (8)5-Bromoisoindoline-1,3-Dione (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloroisoindoline-1,3-Dione (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochroman-4-One (3)5-Fluoroindolin-2-One (4)5-Fluoroisoindolin-1-One (3)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Hydroxypiperidin-2-One (3)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Methylindolin-2-One (3)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Bromoisoindolin-1-One (4)6-Fluorochroman-4-One (5)6-Fluoroindoline-2,3-Dione (3)6-Fluoroisobenzofuran-1(3H)-One (3)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methoxyisoindolin-1-One (3)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)7,8-Dihydroquinolin-5(6H)-One (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromochroman-4-One (4)7-Bromoindoline-2,3-Dione (3)7-Bromoquinazolin-4(3H)-One (4)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Fluorochroman-4-One (5)7-Fluoroindolin-2-One (3)7-Fluoroquinazolin-4(3H)-One (4)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methoxychroman-4-One (3)7-Methylindoline-2,3-Dione (7)8-Bromochroman-4-One (4)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluoroisoquinolin-1(2H)-One (3)8-Methylchroman-4-One (4)Acetophenone (1120)Azepan-2-One (18)Benzo[Cd]Indol-2(1H)-One (5)Benzofuran-2(3H)-One (7)Chroman-2-One (5)Cyclobutanone (24)Cyclohex-2-En-1-One (27)Cyclohexane-1,3-Dione (12)Cyclopent-2-En-1-One (21)Cyclopentane-1,3-Dione (6)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Dihydrofuran-2,5-Dione (12)Dihydrofuran-3(2H)-One (7)Dihydrothiophen-3(2H)-One (4)Ethene-1,1-Diyldibenzene (10)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 3-Oxo-3-Phenylpropanoate (41)Furan-2(5H)-One (26)Isoquinolin-1-Ol (9)Methyl 3-Oxo-3-Phenylpropanoate (16)Morpholin-3-One (11)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(M-Tolyl)Methanone (3)Phenyl(P-Tolyl)Methanone (4)Phenyl(Pyridin-3-Yl)Methanone (9)Phenyl(Thiophen-2-Yl)Methanone (6)Piperidine-2,4-Dione (5)Propiophenone (59)Pyrimidine-4,6(1H,5H)-Dione (3)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tetrahydropyrimidin-2(1H)-One (6)
Mercaptos (11)
Mercaptopropanoate (10)
Nitrates and Nitrites (1)
Nitriles (28529)
Acetonitrile (255)Acrylonitrile (8)Aminobutanenitrile (5)Aminocyclohexanecarbonitrile (6)Bromobenzonitrile (15)Bromonicotinonitrile (9)Bromophenylacetonitrile (2)Butanenitrile (2)Butanenitrile (2)Chlorobenzonitrile (27)Chloroisonicotinonitrile (4)Chloronicotinonitrile (40)Cyanide (434)Cyanide (434)Cyanoacetamide (4)Cyanoacetate (14)Cyanobenzaldehyde (4)Cyanobenzoate (27)Cyanobenzoic (20)Cyanoethyl (15)Cyanoethyl (15)Cyanoisonicotinate (4)Cyanomethyl (42)Cyanomethyl (42)Cyanonicotinate (8)Cyanophenoxy (8)Cyanophenyl (64)Cyanophenylboronic (5)Cyanopropan (4)Cyanopropan (4)Diacetonitrile (1)Diaminobenzonitrile (8)Dibromoisonicotinonitrile (3)Dicarbonitrile (45)Dicarbonitrile (45)Dichlorobenzonitrile (12)Dichloroisonicotinonitrile (4)Difluorobenzonitrile (41)Fluorobenzonitrile (85)Fluoroisonicotinonitrile (5)Fluoronicotinonitrile (14)Fluorophenylacetonitrile (8)Fluoropicolinonitrile (13)Formylnicotinonitrile (5)Formylnicotinonitrile (5)Hydrazinylbenzonitrile (6)Iodobenzonitrile (44)Iodonicotinonitrile (8)Malononitrile (43)Malononitrile (43)Methoxyisonicotinonitrile (7)Methoxyisonicotinonitrile (7)Methoxynicotinonitrile (18)Methoxynicotinonitrile (18)Methylnicotinonitrile (57)Methylnicotinonitrile (57)Methylpropanenitrile (9)Methylpropanenitrile (9)Nitropicolinonitrile (10)Oxopropanenitrile (8)Phenylacrylonitrile (21)Propanenitrile (41)Propanenitrile (41)Pyrazino-Nitrile (50)Tetrafluorobenzonitrile (5)Thiocyanatoaniline (3)Tricarbonitrile (5)Tricarbonitrile (5)Trifluorobenzonitrile (7)Trifluoromethylbenzonitrile (5)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclopropane-1-Carbonitrile (19)1H-Imidazole-4-Carbonitrile (2)1H-Indazole-3-Carbonitrile (9)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-5-Carbonitrile (5)1H-Indole-6-Carbonitrile (4)1H-Indole-7-Carbonitrile (6)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-3-Carbonitrile (9)2,3-Difluorobenzonitrile (29)2,4-Dichlorobenzonitrile (4)2,4-Difluorobenzonitrile (21)2,6-Dibromobenzonitrile (4)2,6-Dichlorobenzonitrile (8)2,6-Difluorobenzonitrile (28)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(2-Bromophenyl)Acetonitrile (10)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Fluorophenyl)Acetonitrile (30)2-(3-Chlorophenyl)Acetonitrile (16)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(Bromomethyl)Benzonitrile (15)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethyl)Benzonitrile (35)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorobenzonitrile (3)2-Aminonicotinonitrile (6)2-Bromo-6-Fluorobenzonitrile (7)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-N-Methylaniline (4)2-Chlorobenzonitrile (99)2-Hydroxybenzonitrile (45)2-Iodobenzonitrile (26)2-Naphthonitrile (15)2-Nitrobenzonitrile (37)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Phenoxyacetonitrile (11)2-Phenoxybenzonitrile (5)2-Phenylacetonitrile (172)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethyl)Benzonitrile (47)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromobenzonitrile (110)3-Chloro-2-Fluorobenzonitrile (7)3-Chlorobenzonitrile (100)3-Chloropyrazine-2-Carbonitrile (6)3-Fluoropicolinonitrile (5)3-Hydroxybenzonitrile (40)3-Iodobenzonitrile (27)3-Nitrobenzonitrile (59)3-Oxo-3-Phenylpropanenitrile (21)3-Phenoxybenzonitrile (5)4-Amino-2-Chlorobenzonitrile (8)4-Chloropyrimidine-5-Carbonitrile (6)4-Cyanophenyl Benzoate (11)4-Cyclohexylbenzonitrile (10)4-Fluorobenzonitrile (89)4-Nitrobenzonitrile (25)5-Fluoropicolinonitrile (5)6-Methylnicotinonitrile (7)6-Methylpicolinonitrile (10)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-4-Carbonitrile (27)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[D]Thiazole-2-Carbonitrile (11)Benzonitrile (1312)Furan-2-Carbonitrile (8)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinonitrile (16)Isoquinoline-1-Carbonitrile (7)Methyl 2-Cyanobenzoate (22)Methyl 3-Cyanobenzoate (29)Morpholine-2-Carbonitrile (4)Nicotinonitrile (82)Pyrazine-2-Carbonitrile (15)Pyrimidine-2-Carbonitrile (14)Pyrimidine-4-Carbonitrile (9)Pyrimidine-5-Carbonitrile (6)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-3-Carbonitrile (6)Thiazole-5-Carbonitrile (7)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbonitrile (13)
Nitroes (23714)
Difluoronitrobenzene (9)Dinitro (7)Dinitroaniline (5)Nitroacetophenone (7)Nitroaniline (211)Nitrobenzaldehyde (100)Nitrobenzamide (35)Nitrobenzenesulfonamide (26)Nitrobenzonitrile (106)Nitrobenzotrifluoride (16)Nitroisophthalate (4)(2-Nitrophenyl)Boronic Acid (13)(2-Nitrophenyl)Methanol (29)(2-Nitrovinyl)Benzene (28)(3-Nitrophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)Boronic Acid (32)(3-Nitrophenyl)Methanol (31)(4-Nitrophenyl)(Phenyl)Methanone (3)(4-Nitrophenyl)Methanol (17)1,2-Dichloro-4-Nitrobenzene (16)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Nitrobenzene (43)1,2-Dimethyl-3-Nitrobenzene (6)1,2-Dinitrobenzene (6)1,3-Dibromo-2-Nitrobenzene (4)1,3-Dichloro-2-Nitrobenzene (5)1,3-Difluoro-2-Nitrobenzene (16)1,3-Dimethyl-2-Nitrobenzene (9)1,3-Dinitrobenzene (31)1,4-Difluoro-2-Nitrobenzene (28)1,4-Dimethyl-2-Nitrobenzene (10)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Tert-Butyl)-2-Nitrobenzene (4)1-(Tert-Butyl)-3-Nitrobenzene (7)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Nitrobenzene (161)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-3-Nitrobenzene (216)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-Nitrobenzene (45)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-Nitrobenzene (90)1-Methyl-2-Nitrobenzene (176)1-Methyl-3-Nitrobenzene (147)1-Methyl-4-Nitrobenzene (82)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-2-Phenoxybenzene (4)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Nitro-4-Phenoxybenzene (5)1-Nitronaphthalene (3)2,4-Dichloro-1-Nitrobenzene (19)2,4-Difluoro-1-Nitrobenzene (46)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethyl-1-Nitrobenzene (15)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(4-Nitrophenyl)Acetic Acid (9)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Nitroaniline (12)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Nitrophenol (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-6-Nitroaniline (11)2-Chloro-6-Nitrophenol (7)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-6-Nitroaniline (3)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Nitrophenol (5)2-Methyl-3-Nitrobenzoic Acid (7)2-Methyl-3-Nitropyridine (9)2-Methyl-6-Nitroaniline (10)2-Nitro-1H-Pyrrole (5)2-Nitro-N-Phenylaniline (3)2-Nitrobenzaldehyde (53)2-Nitrobenzoic Acid (65)2-Nitrobenzonitrile (37)2-Nitrofuran (9)2-Nitronaphthalene (4)2-Nitropyridine (40)2-Nitrothiophene (20)3-Chloro-2-Nitroaniline (5)3-Chloro-4-Nitroaniline (5)3-Fluoro-4-Nitroaniline (7)3-Methoxy-2-Nitrobenzaldehyde (3)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methyl-5-Nitropyridine (4)3-Nitroaniline (98)3-Nitrobenzaldehyde (49)3-Nitrobenzamide (17)3-Nitrobenzene-1,2-Diol (6)3-Nitrobenzenesulfonamide (8)3-Nitrobenzoic Acid (109)3-Nitrobenzonitrile (59)3-Nitrophenol (72)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Nitrothiophene (6)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-2-Nitroaniline (14)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Methyl-3-Nitroaniline (8)4-Methyl-3-Nitropyridine (8)4-Nitro-1H-Indazole (10)4-Nitro-1H-Indole (6)4-Nitro-1H-Pyrazole (8)4-Nitroaniline (65)4-Nitrobenzaldehyde (18)4-Nitrobenzene-1,3-Diol (5)4-Nitrobenzoic Acid (35)4-Nitrobenzonitrile (25)4-Nitrophenol (67)4-Nitropyridine (11)5-(4-Nitrophenyl)Oxazole (3)5-Methoxy-2-Nitroaniline (7)5-Methyl-2-Nitroaniline (6)5-Nitro-1H-Indazole (5)5-Nitro-1H-Indole (6)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Nitrobenzo[D][1,3]Dioxole (4)5-Nitrobenzo[D]Thiazole (3)5-Nitroisoquinoline (7)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1H-Indazole (9)6-Nitro-1H-Indole (8)6-Nitrobenzo[D]Thiazole (3)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Nitro-1H-Indazole (11)7-Nitro-1H-Indole (11)Ethyl 2-Nitrobenzoate (9)Ethyl 3-Nitrobenzoate (22)Ethyl Cinnamate (26)Methyl 2-Nitrobenzoate (54)Methyl 3-Nitrobenzoate (109)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Nitrobenzoate (29)N-(2-Nitrophenyl)Acetamide (11)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)Nitrobenzene (2309)
Oximes (561)
Phenols (1786)
Aminophenol (9)Bromophenol (13)Chlorophenol (28)Dibromophenol (9)Dichlorophenol (17)Difluorophenol (36)Dihydroxybenzaldehyde (16)Dihydroxybenzamide (6)Dihydroxybenzoate (15)Dihydroxybenzoic (17)Dihydroxybenzonitrile (6)Dihydroxyphenyl (98)Dihydroxystyryl (4)Diiodophenol (7)Fluorophenol (73)Hydroxyacetophenone (16)Hydroxybenzaldehyde (88)Hydroxybenzamide (24)Hydroxybenzenesulfonic (4)Hydroxybenzenesulfonic Acid (3)Hydroxybenzoate (113)Hydroxybenzohydrazide (4)Hydroxybenzoic (89)Hydroxybenzonitrile (60)Hydroxybenzoyl (1)Hydroxyphenoxy (7)Hydroxyphenylacetic (7)Hydroxyphenylacetic Acid (7)Hydroxyphenylboronic (8)Hydroxypropiophenone (3)Iodophenol (41)Nitrophenol (134)Tetrafluorophenol (9)Trifluorophenol (5)Trihydroxybenzaldehyde (5)Trihydroxybenzoate (12)Trihydroxybenzoic (5)Trihydroxybenzoic Acid (4)Trihydroxyphenyl (10)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1-(2-Hydroxyphenyl)Ethan-1-One (73)1-(3-Hydroxyphenyl)Ethan-1-One (19)1-Hydroxyanthracene-9,10-Dione (11)2,3-Dichlorophenol (9)2,3-Difluorophenol (36)2,4-Dibromophenol (16)2,4-Difluorophenol (21)2,5-Dichlorophenol (7)2,6-Dibromophenol (21)2,6-Dichlorophenol (16)2,6-Difluorophenol (24)2,6-Diiodophenol (16)2,6-Dimethylphenol (19)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(3-Hydroxyphenyl)Acetic Acid (7)2-(Benzyloxy)Phenol (5)2-(Difluoromethoxy)Phenol (5)2-(Tert-Butyl)Phenol (56)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethyl)Phenol (23)2-Amino-3-Bromophenol (3)2-Amino-3-Chlorophenol (4)2-Aminophenol (107)2-Benzylphenol (8)2-Bromo-3-Methylphenol (4)2-Bromo-6-Methylphenol (7)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Chloro-4-Fluorophenol (9)2-Chloro-4-Nitrophenol (5)2-Chloro-6-Methylphenol (5)2-Chloro-6-Nitrophenol (7)2-Chlorobenzene-1,3-Diol (4)2-Chlorophenol (163)2-Ethylphenol (10)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Hydroxybenzonitrile (45)2-Iodobenzene-1,3-Diol (3)2-Iodophenol (63)2-Isopropylphenol (28)2-Methoxyphenol (197)3,4-Dibromophenol (3)3,4-Difluorophenol (19)3-(Benzyloxy)Phenol (5)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)Phenol (43)3-Bromo-2-Fluorophenol (5)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluorophenol (11)3-Bromobenzene-1,2-Diol (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chlorobenzene-1,2-Diol (6)3-Chlorophenol (112)3-Fluorophenol (180)3-Hydroxybenzonitrile (40)3-Iodophenol (21)3-Nitrobenzene-1,2-Diol (6)3-Nitrophenol (72)4-(Benzyloxy)Phenol (2)4-(Trifluoromethyl)Phenol (18)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorophenol (5)4-Benzylphenol (14)4-Chlorobenzene-1,3-Diol (6)4-Fluorophenol (111)4-Hydroxybenzenesulfonic Acid (5)4-Nitrobenzene-1,3-Diol (5)4-Nitrophenol (67)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)Ethyl 2-Hydroxybenzoate (18)Ethyl 3-Hydroxybenzoate (12)M-Cresol (147)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-Hydroxybenzoate (74)Methyl 3-Hydroxybenzoate (58)O-Cresol (164)P-Cresol (71)Pyrocatechol (131)Resorcinol (146)
Phosphoruses (827)
Diethoxyphosphoryl (5)Diisopropylphosphoramidite (4)Dimethoxyphosphoryl (4)Dimethoxyphosphoryl (4)Dimethylphosphine (28)Dioxaphosphepine (146)Diphosphonic (9)Phosphorothioate (1)1,1,1-Trifluoro-N-(4-Oxido-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepin-4-Yl)Methanesulfonamide (16)Diethyl Benzylphosphonate (17)Dimethyl(Phenyl)Phosphine Oxide (20)Ethyltriphenylphosphonium (2)Methyltriphenylphosphonium (3)Phenyl Phosphate (3)Phenylphosphonic Acid (6)
Polycyclic Aromatic Hydrocarbons (6)
Protective Groups (23)
Saturated Aliphatic Fused Rings (2)
(8Ar,12Br,14Br)-1,2,3,4,4A,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-Icosahydropicene (2)
Silicon Compounds (450)
Butyldimethylsilyl (94)Butyldimethylsilyl (94)Butyldimethylsilyloxy (8)Dimethylsilane (16)Dimethylsilane (16)Dimethylsilyl (4)Tetramethyldisiloxane (3)Tetramethyldisiloxane (3)Triethoxysilyl (13)Triethoxysilyl (13)Triisopropylsilyl (22)Triisopropylsilyl (22)Trimethoxysilane (19)Trimethoxysilane (19)Trimethylsilane (155)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)Tert-Butyldimethyl(Phenoxy)Silane (17)Tetraphenylsilane (7)Trimethoxy(Phenyl)Silane (6)Trimethyl(Phenyl)Silane (22)Trimethyl(Phenylethynyl)Silane (23)
Sulfamides (10218)
Dimethylsulfamoyl (5)Dimethylsulfamoyl (5)Methanesulfonamide (54)Methanesulfonamide (54)Methylmethanesulfonamide (3)Methylmethanesulfonamide (3)Methylsulfonamido (4)Methylsulfonamido (4)Sulfinamide (55)Sulfinamide (55)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluorobenzenesulfonamide (12)2-Methylbenzenesulfonamide (8)3-Nitrobenzenesulfonamide (8)4-Amino-N-Phenylbenzenesulfonamide (3)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Chloro-N-Phenylbenzenesulfonamide (4)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methyl-N-Phenylbenzenesulfonamide (13)N,N-Diethylbenzenesulfonamide (8)N,N-Dimethylbenzenesulfonamide (23)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(O-Tolyl)Benzenesulfonamide (4)N-(Tert-Butyl)Benzenesulfonamide (14)N-Ethylbenzenesulfonamide (8)N-Isopropylbenzenesulfonamide (8)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylbenzenesulfonamide (15)N-Phenylbenzenesulfonamide (81)N-Phenylmethanesulfonamide (37)Phenylmethanesulfonamide (13)Pyridine-2-Sulfonamide (6)
Sulfides (10123)
Methylthio (432)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)1,2-Diphenyldisulfane (19)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-(Methylthio)Pyridine (5)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Methylthio)Thiazole (5)2-(Propylthio)Pyrimidine (5)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Methyl-2-(Methylthio)Pyrimidine (7)5-Bromo-2-(Methylthio)Pyrimidine (6)Benzyl(Phenyl)Sulfane (5)Ethyl(Phenyl)Sulfane (8)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl(Trifluoromethyl)Sulfane (23)
Sulfonates (1160)
4-Methylbenzenesulfonate (9)
Sulfones (3927)
(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(Ethylsulfonyl)Benzene (8)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Methylsulfonyl)Piperazine (5)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-(Phenylsulfonyl)-1H-Imidazole (5)1-(Phenylsulfonyl)Azetidine (7)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Methyl-3-(Methylsulfonyl)Benzene (5)2-(Methylsulfonyl)Aniline (3)2-(Methylsulfonyl)Pyridine (11)2-(Methylsulfonyl)Pyrimidine (25)3-(Methylsulfonyl)Aniline (7)3-(Methylsulfonyl)Benzoic Acid (6)3-(Methylsulfonyl)Pyridine (5)Benzenesulfonyl Fluoride (51)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)Tetrahydrothiophene 1,1-Dioxide (13)
Sulfonic Acids (1261)
Aminobenzenesulfonic (4)Bromobenzenesulfonic Acid (4)Disulfonic (9)Disulfonic (9)Ethanesulfonic (3)Methanesulfonic (2)Methanesulfonic (2)Methylbenzenesulfonate (144)Propanesulfonic Acid (2)Trifluoromethanesulfonic (4)2-Aminobenzenesulfonic Acid (9)2-Methylbenzenesulfonic Acid (8)3-Aminobenzenesulfonic Acid (6)4-Chlorobenzenesulfonic Acid (4)4-Hydroxybenzenesulfonic Acid (5)Naphthalene-2-Sulfonic Acid (4)Pyridine-3-Sulfonic Acid (6)
Sulfonyl Chlorides (4029)
Fluorobenzenesulfonyl (12)1H-Pyrazole-4-Sulfonyl Chloride (8)2-Bromobenzenesulfonyl Chloride (8)2-Chlorobenzenesulfonyl Chloride (24)2-Fluorobenzenesulfonyl Chloride (31)2-Methoxybenzenesulfonyl Chloride (15)2-Methylbenzenesulfonyl Chloride (22)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-Chlorobenzenesulfonyl Chloride (21)3-Fluorobenzenesulfonyl Chloride (22)4-Chlorobenzenesulfonyl Chloride (12)4-Fluorobenzenesulfonyl Chloride (26)Isoquinoline-5-Sulfonyl Chloride (3)Methyl 2-(Chlorosulfonyl)Benzoate (7)Phenylmethanesulfonyl Chloride (20)
Sulfonyl Hydrazides (25)
Benzenesulfonohydrazide (12)
Sulfoxides (333)
(Methylsulfinyl)Benzene (7)
Thioesters (625)
Thiols (468)
Dithiole (9)Dithiole (9)Ethanethioate (9)Ethanethioate (9)Methanethiol (6)1H-Benzo[D]Imidazole-2-Thiol (10)2-Chlorobenzenethiol (7)2-Mercaptoquinazolin-4(3H)-One (3)Benzo[D]Oxazole-2-Thiol (6)Benzo[D]Thiazole-2-Thiol (11)Phenylmethanethiol (16)Pyridine-2-Thiol (8)Pyrimidine-2-Thiol (6)
Thiophenols (3045)
Thioureas (1128)
Carbamimidothioate (4)1,3-Diphenylthiourea (8)1-Phenylthiourea (33)
Trifluoromethyls (28951)
Trifluoromethyl-Picolinamide (7)Trifluoromethylaniline (3)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-(Trifluoromethyl)Phenyl)Methanol (21)(4-(Trifluoromethyl)Phenyl)Boronic Acid (22)(Perfluoropropane-2,2-Diyl)Dibenzene (7)(Trifluoromethyl)Benzene (1336)1,3-Bis(Trifluoromethyl)Benzene (70)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-(Trifluoromethyl)Benzene (126)1-Fluoro-3-(Trifluoromethyl)Benzene (98)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-(Trifluoromethyl)Benzene (53)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methyl-2-(Trifluoromethoxy)Benzene (5)1-Methyl-2-(Trifluoromethyl)Benzene (43)1-Methyl-3-(Trifluoromethyl)Benzene (22)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-(Trifluoromethyl)Aniline (58)2-(Trifluoromethyl)Benzaldehyde (27)2-(Trifluoromethyl)Benzamide (6)2-(Trifluoromethyl)Benzoic Acid (33)2-(Trifluoromethyl)Benzonitrile (35)2-(Trifluoromethyl)Phenol (23)2-(Trifluoromethyl)Pyrazine (6)2-(Trifluoromethyl)Pyridine (6)2-(Trifluoromethyl)Pyrimidine (27)2-(Trifluoromethyl)Quinazoline (4)2-(Trifluoromethyl)Thiazole (11)2-(Trifluoromethyl)Thiophene (11)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Aniline (102)3-(Trifluoromethyl)Benzaldehyde (31)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-(Trifluoromethyl)Benzoic Acid (52)3-(Trifluoromethyl)Benzonitrile (47)3-(Trifluoromethyl)Phenol (43)3-(Trifluoromethyl)Pyridazine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (52)3-Chloro-4-(Trifluoromethyl)Aniline (5)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4-(Trifluoromethoxy)Aniline (26)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-(Trifluoromethyl)Phenol (18)4-(Trifluoromethyl)Pyridine (14)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-(Trifluoromethyl)Thiazole (7)4-Bromo-3-(Trifluoromethyl)Aniline (7)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)6-(Trifluoromethyl)-1H-Indazole (6)6-(Trifluoromethyl)-1H-Indole (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 3-(Trifluoromethyl)Benzoate (22)N-Phenyl-4-(Trifluoromethyl)Aniline (3)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(Trifluoromethyl)Sulfane (23)
Ureas (1841)
Other Function Groups (5)
Organometallic Reagents
Organoborons (34729)
Fluorene-Phenyl-Boronic Acid/Ester (4)Hydroxymethyl-Phenyl-Boronic-Acid (31)Methoxyphenylboronic-Acid (32)Phenyl-Naphthalene-Boronic Acid/Ester (9)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)(1H-Indol-2-Yl)Boronic Acid (3)(2,3-Dichlorophenyl)Boronic Acid (11)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Dichlorophenyl)Boronic Acid (6)(2,6-Difluorophenyl)Boronic Acid (28)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-Bromophenyl)Boronic Acid (39)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(2-Fluorophenyl)Boronic Acid (229)(2-Nitrophenyl)Boronic Acid (13)(3,4-Dichlorophenyl)Boronic Acid (10)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)Boronic Acid (121)(3-Fluorophenyl)Boronic Acid (169)(3-Iodophenyl)Boronic Acid (5)(3-Nitrophenyl)Boronic Acid (32)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(4-(Trifluoromethyl)Phenyl)Boronic Acid (22)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Fluorophenyl)Boronic Acid (93)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(E)-4,4,5,5-Tetramethyl-2-Styryl-1,3,2-Dioxaborolane (16)1,3,2-Dioxaborinane (6)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Cyclopropylphenyl)-1,3,2-Dioxaborolane (5)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(4-Cyclopropylphenyl)-1,3,2-Dioxaborolane (8)2-(4-Fluorophenyl)-1,3,2-Dioxaborinane (5)2-([1,1'-Biphenyl]-4-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Cyclohex-1-En-1-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-(M-Tolyl)-1,3,2-Dioxaborinane (4)2-Benzyl-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (12)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(Naphthalen-1-Yl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(Naphthalen-2-Yl)-1,3,2-Dioxaborolane (12)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzofuran-2-Ylboronic Acid (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Cyclohex-1-En-1-Ylboronic Acid (4)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Isoquinolin-4-Ylboronic Acid (3)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)Naphthalen-1-Ylboronic Acid (4)Naphthalen-2-Ylboronic Acid (8)Phenylboronic Acid (1286)Pyridin-2-Ylboronic Acid (9)Pyridin-3-Ylboronic Acid (49)Pyridin-4-Ylboronic Acid (21)Pyrimidin-5-Ylboronic Acid (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)Tetraphenylborate (8)Thiophen-2-Ylboronic Acid (20)
Organosilicons (73)
Organotins (5)
Other Organometallic Reagents (1)
Specialty Synthesis
Ionic Liquids (738)
Synthetic Reagents
C-C Bond Formation (62)
Condensation Agents (74)
Fluorination Reagents (20)
Halogenation Reagents (20)
Inorganic Salts (25506)
Phase Transfer Catalysts (29)
Other Synthetic Reagents (106)
Materials Science
Electronic Materials
Contact Printing & Self-Assembly Materials (77)
Liquid Crystal (LC) Materials (413)
Molecular Conductors (80)
Organic Field-Effect Transistors (OFETs) (86)
Organic Light-Emitting Diode (OLED) Materials (22)
4-(Diphenylamino)Benzaldehyde (8)4-Bromo-N,N-Bis(4-Methoxyphenyl)Aniline (3)4-Methoxy-N,N-Diphenylaniline (5)4-Methyl-N,N-Diphenylaniline (6)
Photoresist Materials (249)
Silane Coupling Agents (176)
Energy and Battery Materials
Battery Additives (75)
Battery Electrolytes Materials (16)
Battery Solvent Materials (24)
Electrode Active Materials (4)
Ionic Liquids (738)
Organic Redox Flow Battery Materials (26)
Solution & Vapor Deposition Precursors (31)
Material Building Blocks
Alkyl Chain Building Blocks (93)
Ligands for Functional Metal Complexes (198)
Liquid Crystal (LC) Building Blocks (558)
Phthalocyanine Building Blocks (71)
Small Molecule Semiconductor Building Blocks (1878)
Organic Frameworks and Supramolecular Materials
Covalent Organic Framework (COF) Linkers (1087)
Metal Organic Framework (MOF) Linkers (1693)
Metal Organic Frameworks (MOFs) (85)
Organic Framework Building Blocks (218)
Supramolecular Host Materials  (185)
Polymer Additives
Antioxidants (81)
Crosslinking Agents (75)
Flame Retardants (35)
Light Stabilizers (67)
Plasticizers (84)
Polymerization Catalysts (156)
Polymerization Initiators (141)
Polymerization Reagents (170)
Surfactants (340)
Other Additives (34)
Polymer Reagents
Dendrimer Materials (59)
Ion Exchange Resins (7)
Monomers (3050)
Photopolymer Monomers (180)
Polybenzoxazole and Polyimide Raw Materials (240)
Polymer Semiconductor Monomers (269)
Polymers (375)
Quantum Dots and Micro/Nano Materials
Nanocarbon Materials (45)
Quantum Dots (QD) Capping Agents (178)
Quantum Dots (QD) Synthetic Reagents (13)
Solar Cells and Photonic Materials
Donor Intermediates & Acceptor Intermediates (1029)
Dye-Sensitized Solar Cell (DSSC) Materials (130)
Dyes and Pigments (392)
Organic Non-Linear Optical (NLO) Materials (39)
Organic Phto-Voltaics (OPV) Materials (185)
Perovskite Solar Cell (PSC) Materials (278)
Visible Light Photoredox Catalysts (29)
Other Functional Materials
Aggregation-Induced Emission Materials (169)
Inorganic Compounds and Ceramic Materials (33)
Magnetic Materials (50)
Life Science
Inhibitors/Agonists
ADC (371)
ADC Linker (371)
Angiogenesis (1714)
ALK (86)Bcr-Abl (105)BTK (149)EGFR (403)FAK (56)FGFR (136)FLT3 (134)HER2 (31)HIF (112)JAK (245)PDGFR (127)Src (110)Syk (40)VDA (1)VEGFR (271)
Anti-Infection (4763)
3CLpro (41)Antibacterial (2101)Antifungal (525)Antiparasitic (648)Antiprotozoal (2)Antiviral (48)Arenavirus (5)BVDV (3)CMV (30)Dengue Virus (36)EBV (14)Enterovirus (33)FCoV (3)Filovirus (14)Flavivirus (64)GraR (1)HBV (151)HCV (222)HHV (1)HIV (447)HIV Integrase (39)HIV Protease (68)HPV (10)HRV (3)HSV (75)Influenza Virus (251)LpxC (2)M2 proton channel (2)MERS-CoV (1)Neuraminidase (4)NNRTI (12)NRTI (22)Orthopoxvirus (28)Penicillin-Binding Protein (7)PLP (13)Prion (1)Protein Synthesis (4)Reverse Transcriptase (99)RSV (43)SAMHD1 (1)SARS-CoV (298)SQLE (5)TMV (12)Viral MTase (3)Virus Protease (62)VSV (1)β-lactamase (51)
Antibody-Drug Conjugate/ADC Related (647)
ADC Linker (371)ADC Toxins (123)Payload-Linker Conjugate (165)
Apoptosis (2443)
Apoptosis (2143)Apoptosis Inducer (1407)Bcl-2 (195)Bcl-6 (6)BRK (3)c-Myc (47)c-RET (64)C/EBP (2)Caspase (170)DAPK (12)Ferroptosis (109)FKBP (15)GDNF Receptor (1)IAP (48)IDO (70)MDM2 (143)MRCK (2)Necroptosis (33)p32 (1)p53 (41)PERK (35)PKD (10)Pyroptosis (13)RIP Kinase (84)Survivin (12)Thymidylate Synthase (24)TNF (22)TNF Receptor (117)TNF-alpha (30)
Autophagy (745)
ATG4B (4)ATTECs (3)AUTACs (7)Autophagy (730)Beclin1 (1)FKBP (15)LC3 (1)LRRK2 (32)Lysosome (1)mitoNEET (1)Mitophagy (3)PPT (1)SPHK (27)TFEB (1)ULK (17)
Cell Cycle (4595)
Antifolate (31)APC (6)Aurora Kinase (87)BUB (3)Casein Kinase (101)CDK (475)Chk (46)CRISPR/Cas9 (7)CRM1 (17)DHFR (55)DNA polymerase θ (2)DNA/RNA Synthesis (620)DOCK (3)DYRK (60)E2F (2)eIF (43)Endonuclease (3)FOXM1 (3)G-quadruplex (6)Haspin Kinase (8)HDAC (336)HGF (1)HSF (4)HSP (161)IRE1 (27)Kinesin (35)Lats kinase (1)LIMK (17)Mad2 (1)Microtubule/Tubulin (305)MKLP (1)Mps1 (21)MTH2 (1)Nucleoside Antimetabolite/Analog (1441)p21 (1)PAK (30)PDI (1)PKMYT1 (2)PLK (50)PPAR (193)PTEN (5)RAD51 (18)Rho (14)RNA polymerase 2 (1)RNA polymerase 1 (2)ROCK (90)Separase (1)Sirtuin (129)SRPK (51)STK33 (2)TACC (3)Telomerase (21)TOPK (1)Topoisomerase (271)Wee1 (16)YB-1 (5)
Cytoskeleton (728)
Actin (1)Arp2/3 Complex (6)CYTH (1)Cytoplasmic dynein (1)Dynamin (14)FAK (56)Filamin-A (1)Gap Junction (11)Integrin (134)Kinesin (35)MARK (1)Microtubule/Tubulin (305)MLCK (5)Mps1 (21)Myosin (25)PAK (30)ROCK (90)Spastin (1)
DNA Damage (3023)
ADAR (1)AP endonuclease (1)ATAD5 (1)ATM/ATR (67)Aurora Kinase (87)Casein Kinase (101)ClpP (5)CRISPR/Cas9 (7)DNA Alkylator/Crosslinker (75)DNA-PK (39)DNA/RNA Synthesis (620)HDR (1)HSP (161)MRE11 (1)MTH1 (8)Nucleoside Antimetabolite/Analog (1441)OGG (3)p97 (15)PARP (175)RAD51 (18)RAD52 (3)Telomerase (21)Topoisomerase (271)WRN (5)YB-1 (5)
Endocrinology/Hormones (826)
5 Alpha Reductase (2)ACE (76)Adrenergic Receptor (184)Androgen Receptor (96)Aromatase (8)ERR (218)GHSR (21)Glucocorticoid Receptor (44)GNRH Receptor (19)Mineralocorticoid Receptor (12)Opioid Receptor (54)Progesterone Receptor (9)PTHR (1)Renin (18)Sepiapterin reductase (2)SSTR (28)Taste receptor (3)Thyroid Hormone Receptor (7)TPO (4)TRHR (1)TSH Receptor (17)TTR (7)
Endoplasmic Reticulum Stress (567)
Antioxidant (33)IRE1 (27)JNK (79)PDI (1)PERK (35)ROS (398)
Epigenetics (2366)
AMPK (105)Aurora Kinase (87)DNA Methyltransferase (43)Epigenetic Reader Domain (396)FTO (15)HDAC (336)HIF (112)Histone Acetyltransferase (95)Histone Demethylase (147)Histone Methyltransferase (294)JAK (245)MBD-containing protein (1)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (157)SF3B1 (3)Sirtuin (129)TET (8)
Ferroptosis Signaling Pathway (78)
ABC Transporter (2)ACC (22)GPx (25)SCD (18)SLC (6)VDAC (6)
GPCR/G Protein (3483)
5-HT Receptor (402)Adenosine Receptor (169)Adenylyl Cyclase (1)Adiponectin Receptor (2)Adrenergic Receptor (184)Amylin receptor (1)Angiotensin Receptor (72)Apelin Receptor (22)Bombesin Receptor (7)Bradykinin Receptor (17)cAMP (34)Cannabinoid Receptor (65)CaSR (23)CCR (89)CGRP Receptor (14)Chemerin Receptor (2)Cholecystokinin Receptor (32)CRF Receptor (19)CXCR (112)Dopamine Receptor (170)Endothelin Receptor (47)Epac (9)G protein (2)GHSR (21)GLP Receptor (25)Glucagon Receptor (50)GNRH Receptor (19)GPCR (203)GPCR19 (2)GPR109A (1)GPR119 (2)GPR139 (3)GPR24 (1)GPR35 (1)GPR40 (7)GPR52 (4)GPR6 (3)GPR68 (2)GPR84 (1)GPR88 (10)Guanylate Cyclase (31)HCAR (2)Histamine Receptor (239)ICMT (61)Kisspeptin Receptor (2)LHCGR (39)LPA Receptor (11)LPL Receptor (118)Melanocortin Receptor (31)mGluR (226)Motilin Receptor (1)MRGPR (13)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NMUR (2)NPFF receptor (3)Opioid Receptor (54)OXTR (10)P2Y Receptor (77)PACAP Receptor (3)PAFR (38)PAR (55)Prostaglandin Receptor (217)Ras (275)RGS (6)RXFP Receptor (14)Sigma Receptor (53)SOS (7)SRPK (51)SSTR (28)SUCNR1 (4)TAAR (8)TSH Receptor (17)Urotensin Receptor (7)Vasopressin Receptor (23)β-arrestin (17)
Hedgehog (Hh) (832)
BMI-1 (3)c-Myc (47)Casein Kinase (101)CDK (475)Cytoplasmic dynein (1)Gli (6)GSK-3 (126)PKA (59)Smo (36)ULK (17)
Hippo (80)
Lats kinase (1)MAP4K (47)MST (2)TEAD (10)YAP (28)
Immunology/Inflammation (2700)
AIM2 (5)AP-1 (14)Arginase (15)Calcineurin (8)CCR (89)CD19 (1)CD20 (2)CD22 (2)CD28 (2)CD28-B7 (1)CD3 (3)CD38 (10)CD47 (6)CD6 (1)CD73 (26)CD80 (1)cGAS (8)Complement System (45)COX (344)CRTH2 (9)CTLA-4 (2)CXCR (112)CYPA (1)FAP (17)FKBP (15)FLAP (17)FPR (17)Galectin (3)Glucocorticoid Receptor (44)Glycoprotein VI (3)GM-CSF (2)Histamine Receptor (239)HMGB (1)IFNAR (24)IL (172)IL Receptor (9)Immunology & Inflammation Related (75)IRAK (71)IRF3 (1)LAG-3 (1)LanC-like protein (1)Legumain (1)LTA4H (3)LTR (71)MALT1 (24)MIF (18)MyD88 (6)NADPH Oxidase (32)NFAT (11)NLR (73)NO Synthesis (6)NOS (186)NOT (1)Nrf2 (99)PD-1/PD-L1 (80)PG Synthase (30)PSMA (13)Pyroptosis (13)ROS (398)Ros1 (18)S100A9 (1)Scavenger receptor (1)SIK (15)SOD (4)SPHK (27)STING (98)TENT (1)Thrombopoietin Receptor (11)Tim3 (4)TLR (163)TSPO (2)VISTA (1)XBP1 (1)
JAK-STAT-Signaling (837)
EGFR (403)JAK (245)Pim (58)STAT (160)
MAPK/ERK Pathway (712)
AP-1 (14)ERK (166)HPK1 (2)JNK (79)KLF (5)MAP3K (24)MAP3K12 (1)MAP4K (47)MAP4K4 (5)MAP4K6 (1)MEK (99)MK2 (11)MLK (14)MNK (11)p38 MAPK (163)Raf (106)RSK (33)TAOK (1)
Membrane Transporter/Ion Channel (1711)
ABC Transporter (2)AKK1 (3)ANT (1)AQP (5)AQP3 (1)ARF (2)ATP synthase (19)ATPase (41)BCRP (23)Calcium Channel (269)CFTR (61)Chloride Channel (30)CRAC Channel (14)CRM1 (17)EAAT (3)Efflux pump (1)ENT (2)Ferroportin (2)GABA Receptor (188)GLUT (32)Glutamate transporter (21)Glycine transporter (23)HCN Channel (2)IBAT (10)ITPKA (2)MAT (24)MCT (17)Na+/Ca2+ Exchanger (15)Na+/K+ ATPase (16)Na/HCO3 cotransporter (1)NKCC (1)Oct (11)OCTN (1)Organic Anion Transporter (1)P-gp (53)P2X Receptor (79)Piezo (4)Potassium Channel (287)Proton Pump (54)SEO1 (1)SGLT (44)SLC (6)Sodium Channel (195)SV2 (2)TRP Channel (182)URAT1 (18)Urea Transporter (2)VDAC (6)VRAC (1)
Metabolic Enzyme (3492)
15-PGDH (2)2OG Oxygenase (1)3-PGDH (2)3MST (1)6PGD (2)ACAT (38)ACC (22)ACMSD (2)Aconitate hydratase (1)ACS (3)Adenosine Deaminase (12)Adenosylhomocysteinase (8)ADP-ribosyltransferase (1)AhR (49)AKR (15)ALDH (30)Aldose Reductase (54)Aminopeptidase (28)Antifolate (31)AO (1)ApoE (1)Arginase (15)Asparagine synthetase (1)ATF/CREB proteins (2)ATP Citrate Lyase (6)ATP synthase (19)BDK (1)Beta-glucuronidase (3)Carbonic Anhydrase (121)Carboxylesterase (23)Carboxypeptidase (7)Cardiolipin Peroxidase (1)Cathepsin (98)Ceramidase (4)CETP (15)Cholesterol Transporter (1)CPA (5)CPSI (2)Creatine kinase (1)Cryptochrome (5)CSE (2)CYP51 (1)D-amino acid oxidase (3)D6D (1)DAPA synthase (1)Decarboxylase (8)Dehydrogenase (156)DGAT (62)DGK (20)Dopamine β-hydroxylase (8)E-NTPDase (1)Elastase (32)Enolase (7)Enteropeptidase (5)ERAP (3)FABP (8)Factor Xa (45)Farnesyl Transferase (4)FAS (35)FBPase (4)Ferroptosis (109)FOXO (3)FPR (17)FTO (15)Fumarate hydratase (2)FVII (2)FXR (71)G0/G1 switch protein 2 (2)Galactosidases (5)GCN (1)GCS (3)GGTase (6)Glucokinase (26)Glucosidase (131)GLUT (32)Glutaminase C (2)Glutathione Reductase (1)Glyoxalase (14)GOAT (1)GPx (25)GSNOR (3)GST (16)Hexokinase (8)HMGCR (45)HPSE (2)Hydrolase (12)Hydroxylase (24)IDH (37)IDO (70)Ketohexokinase (5)LDL (11)LDLR (1)Lipase (93)Lipoxygenase (109)LOX (4)LRH-1 (4)LXR (27)MAGL (2)MASTL (1)MDH (3)MetAP (10)MGAT (7)Mineralocorticoid Receptor (12)Mitochondrial Electron Transport Chain (3)Mitochondrial Metabolism (98)MPC (3)NAMPT (33)Neprilysin (20)NNMT (8)NPP (2)NPR (15)NQO (2)OGT (2)OPA1 (1)P448 (1)P450 (261)PAI-1 (25)PARG (12)PDE (366)PDHK (12)PEPCK (2)PGAM1 (1)PGC-1α (4)PHGDH (5)Phospholipase (108)Phosphorylase (10)PI5P4K (11)PKM1 (2)PKM2 (6)Procollagen C Proteinase (1)Proprotein convertases (5)Pyruvate Kinase (28)QR (2)RAR/RXR (86)RBP (3)REV-ERB (4)ROR (67)SCD (18)sEH (33)SGK (15)SHMT (7)Sialyltransferase (1)Sphingosine acyltransferase (2)SQOR (2)Srx (1)Steroid Sulfatase (8)TDO (3)TGH (1)Thioredoxin (12)Thrombin (43)Thymidylate Synthase (24)Transferase (80)Transketolase (7)TrxR (11)Trypanothione reductase (1)UGT (3)VD/VDR (47)Xanthine Oxidase (49)αKGD (2)
Neuronal Signaling (3852)
5-HT Receptor (402)AAK1 (17)AChE (43)AChR (348)Adenosine Kinase (5)Adrenergic Receptor (184)AMPAR (54)Amylin receptor (1)Amyloid-β (172)Calcium Channel (269)CaMK (54)Cannabinoid Receptor (65)CGRP Receptor (14)Cholecystokinin Receptor (32)Cholinesterase (235)CHT (1)COMT (16)DAT (21)Dopamine Receptor (170)Endorphin (1)Enkephalinase (3)FAAH (45)GABA Receptor (188)Glucosylceramide Synthase (13)GluR (208)GPR119 (2)GPR139 (3)GPR24 (1)Histamine Receptor (239)Huntingtin (3)Imidazoline Receptor (14)Kainate receptor (5)MAO (195)Melanocortin Receptor (31)mGluR (226)MT Receptor (12)NET (3)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NGF (3)NK Receptor (57)NMDA (1)NMDAR (50)Notch (26)Nurr1 (7)OLIG2 (1)Opioid Receptor (54)OX Receptor (50)P2X Receptor (79)Proprotein convertases (5)QC (3)RAGE (3)REST (1)Ryanodine Receptor-1 (1)S100β (1)Secretase (112)SERT (27)Sigma Receptor (53)SMS (4)SSRIs (5)Substance P (2)TAAR (8)Tau Protein (28)TLX (1)Trk Receptor (80)TRP Channel (182)TTR (7)α-synuclein (1)
NF-κB Signaling Pathway (540)
IKK (74)MALT1 (24)NF-κB (419)Nrf2 (99)Pirin (3)RANKL (1)RANKL/RANK (3)RIP Kinase (84)TAK1 (3)
Notch Signaling Pathway (763)
ERK (166)Gli (6)MRCK (2)Notch (26)p53 (41)ROCK (90)TGF-beta/Smad (381)β-catenin (71)
PI3K/AKT/mTOR (1044)
Akt (207)AMPK (105)ATM/ATR (67)DNA-PK (39)FOXO (3)GSK-3 (126)MELK (9)mTOR (187)PDK (22)PDK-1 (3)PI3K (340)PI4K (28)PIKfyve (9)PIN1 (10)PTEN (5)RSK (33)
PPAR Signaling Pathway (2131)
ACS (3)Akt (207)AMPK (105)AQP (5)Bcl-6 (6)FABP (8)FATP (3)IL (172)LXR (27)MMP (179)NF-κB (419)NLR (73)OxPhos (4)PDK-1 (3)PEPCK (2)PPAR (193)RAR/RXR (86)RGS (6)ROS (398)SCD (18)SGK (15)Sirtuin (129)STAT (160)TNF-alpha (30)
Protease (697)
ADAMTS (5)Aspartic Protease (2)Cysteine Protease (24)Dipeptidase 1 (2)DP-IV (2)DPP1 (2)DPP2 (2)DPP4 (72)Glutaminase (25)MMP (179)NEP (4)PE (2)Proteasome (122)Ser/Thr Protease (164)SPP (1)Tyrosinase (100)
Protein Tyrosine Kinase/RTK (2741)
Ack1 (5)ALK (86)Bcr-Abl (105)BMX Kinase (3)BRK (3)BTK (149)c-FMS (60)c-Kit (87)c-Met/HGFR (131)c-RET (64)DDR1/DDR2 Receptor (22)DYRK (60)EGFR (403)Ephrin Receptor (16)ErbB (6)FAK (56)FGF (2)FGFR (136)FLT3 (134)GAK (624)HER2 (31)IGF-1R (28)Insulin Receptor (26)ITK (18)JAK (245)MRCK (2)PDGFR (127)PTK (7)Pyk2 (4)Ros1 (18)SHP2 (48)Src (110)Syk (40)TAM Receptor (50)Tie-2 (16)Trk Receptor (80)VEGFR (271)
Pyroptosis (993)
Caspase (170)Cathepsin (98)IL (172)MyD88 (6)NF-κB (419)TLR (163)
Stem Cells (1527)
BMI-1 (3)Casein Kinase (101)CREB (5)ERK (166)Frizzled (2)Gli (6)GSK-3 (126)Hedgehog (32)JAK (245)LIN28 (4)MST (2)Notch (26)Notum (2)PKA (59)PORCN (10)ROCK (90)sFRP-1 (1)Smo (36)SOD1 (2)STAT (160)TGF-beta/Smad (381)Wnt (104)YAP (28)β-catenin (71)
TGF-beta/Smad (458)
Bcr-Abl (105)PKC (157)ROCK (90)TGF-beta/Smad (381)
Toll-Like Receptor (TLR) (549)
CREB (5)IKK (74)IRAK (71)IRF3 (1)JNK (79)MyD88 (6)p38 MAPK (163)TAK1 (3)TLR (163)
Ubiquitin (370)
DUB (83)E1/E2/E3 Enzyme (142)FBXO (2)NAE (8)p97 (15)Proteasome (122)SUMO (4)
Vitamin D Related/Nuclear Receptor (587)
Androgen Receptor (96)Glucocorticoid Receptor (44)LXR (27)Mineralocorticoid Receptor (12)PPAR (193)Progesterone Receptor (9)RAR/RXR (86)REV-ERB (4)ROR (67)Thyroid Hormone Receptor (7)VD/VDR (47)
Wnt Signaling Pathway (2371)
AP-1 (14)APC (6)ATF/CREB proteins (2)c-Myc (47)Calcineurin (8)CaMK (54)Casein Kinase (101)CDK (475)CREB (5)Frizzled (2)GSK-3 (126)JNK (79)MMP (179)NF-κB (419)NFAT (11)p300/CBP/PROTAC (2)PDE (366)Phospholipase (108)PKC (157)PKG (10)Rho (14)ROCK (90)ROR (67)Wnt (104)β-catenin (71)
Other Inhibitors/Agonists (3218)
20-HETE (2)AIMP2-DX2 (2)Amino Acids and Amino Acid Derivatives (126)Aminoacyl-tRNA Synthetase (18)Anesthetic (3)Anti-inflammation (30)Anti-Thyroid Agent (1)Anti-tumor (7)Anti-ulcer (1)Antioxidant (33)Antispasmodic Agent (3)ASGPR (11)Bcat (11)c-RET (64)Cancer Stem Cells (2)CAR (5)Cardiac transcription factor (2)CBFβ-SMMHC (1)CD20 (2)CD52 (1)CD73 (26)CerK (1)Chelating Agent (15)Choleretic (1)Choline Kinase (3)CNT (1)CRTH2 (9)CSE (2)DCLK (1)DcpS (1)Decarboxylase (8)Dehydrogenase (156)Diabetes (2)Diuretic (1)Drug Metabolite (286)DUE-B (1)E2F (2)ECE (2)Endogenous Metabolite (1247)ERO1 (2)FAP (17)FATP (3)Fer/FerT (1)FPP synthase (1)Fucosyltransferase (4)Fungicide (60)G protein (2)Galectin (3)Galectin-3 (12)GBF1 (1)GCase (4)Glucocorticoid Receptor (44)GRK (21)Herbicide (17)HIPK2 (3)Histidine kinase (1)HNF4α (1)HPPD (3)HRGP (1)Hydroxylase (24)IgE (2)IMP1 (1)Importin β (1)Insecticide (27)ITPKA (2)LAT1 (3)LDL (11)Lipase (93)Lipocalin-2 (1)LYTACs (8)MALAT1 (1)MITF (1)MLKL (4)Molecular Glues (41)MPO (5)MTTP (8)Muscle Relaxant (1)MYOF (1)NAADP (1)Neuroprotection/neurogenic Agent (4)NMD (1)NT (2)Nur77 (8)O-GlcNAcase (9)O-glycosylation (1)OSBP (1)OSBPL (1)OSC (2)Osteoclasts/Bone/Osteogenesis (15)OxPhos (4)PAM complex (1)PANK (2)PAX2 (1)PBR (4)PCA1 (1)PCSK9 (7)PDX1 (1)PEPT (1)PFKFB3 (7)Phosphatase (248)Phosphorylase (10)Photosensitizer (6)PIN1 (10)PKG (10)Platelet (5)PME-1 (2)PMO/MNA (4)PNP (1)PREP (20)Protein Synthesis (4)PXR (3)Quorum Sensing (57)RasGAP (2)Rev-ErbA (3)RUNX (7)SAP (1)SMARC (6)SQS (4)SREBP (5)SRPK (51)Sweetener (3)Tgase (2)Thioredoxin (12)TIR1 (1)TNIK (8)TNK (4)TNNI3K (1)UGT1A1 (1)Urease (5)vanin (4)VDA (1)Vitamin (61)VPS (3)XOR (1)α-amylase (15)Others (2611)
Inhibitory Monoclonal Antibody
Human Inhibitory Monoclonal Antibody (62)
Amyloid-β/monoclonal antibody (2)CA Ⅸ/monoclonal antibody (1)CCR/monoclonal antibody (1)CD19/monoclonal antibody (1)CD20/monoclonal antibody (2)CD22/monoclonal antibody (1)CD25/monoclonal antibody (1)CD3/monoclonal antibody (1)CD38/monoclonal antibody (1)CD4/monoclonal antibody (1)CD40/monoclonal antibody (1)CD47/monoclonal antibody (1)CD52/monoclonal antibody (1)CD6/monoclonal antibody (1)CD62p/monoclonal antibody (1)CD73/monoclonal antibody (1)CGRP Receptor/monoclonal antibody (2)Complement System/monoclonal antibody (1)CTLA-4/monoclonal antibody (1)EGFR/monoclonal antibody (2)HER2/monoclonal antibody (2)IFNAR/monoclonal antibody (1)IgE/monoclonal antibody (2)IGF-1R/monoclonal antibody (1)IL-13/monoclonal antibody (1)IL-17a/monoclonal antibody (1)IL-1β/monoclonal antibody (1)IL-23/monoclonal antibody (2)IL-4Ra/monoclonal antibody (1)IL-5/monoclonal antibody (1)IL-5Rα/monoclonal antibody (1)IL-6/monoclonal antibody (3)Integrin/monoclonal antibody (1)KIR/monoclonal antibody (1)LAG-3/monoclonal antibody (1)PCSK9/monoclonal antibody (2)PD-1/PD-L1/monoclonal antibody (4)RANKL /monoclonal antibody (1)Sclerostin/monoclonal antibody (1)SLAMF7/monoclonal antibody (1)TIGIT/monoclonal antibody (1)Tim3/monoclonal antibody (1)TNF Receptor/monoclonal antibody (3)TNF-alpha/monoclonal antibody (2)TROP2/monoclonal antibody (1)VEGFR/monoclonal antibody (1)
Animal Modeling Reagents
Circulatory System Disease Models (11)
Cardiomyopathy Model (1)Heart Disease Correlation Model (2)Heart Failure Model (1)Hyperlipidemia Model (1)Hypertension Model (3)Thrombolysis Model (2)Vascular Inflammation Model (1)
Digestive System Disease Models (17)
Gallstone Model (1)Gastrointestinal Disease Model (8)Liver Disease Model (5)Pancreatic Disease Model (3)
Endocrine System Disease Models (12)
Aging Model (1)Diabetes Model (4)Hyperuricemia Model (8)
Immune and Inflammatory Disease Models (29)
Arthritis Model (1)Cystitis Model (1)Dermatitis Model (1)Ear Edema Model (1)Encephalomyelitis Model (2)Foot Edema Model (2)Gastrointestinal Inflammation and Ulcer Model (8)Gouty Arthritis Model (1)Liver Inflammation Model (2)Myocarditis Model (2)Nephritis Model (1)Pancreatitis Model (5)Psoriasis Model (3)Systemic Lupus Erythematosus Model (2)
Nervous System Disease Models (10)
Alzheimers Disease Model (3)Epilepsy Model (3)Neuropathic Pain Model (1)Parkinsons Disease Model (3)Schizophrenia Model (1)
Otorhinolaryngological Disease Models (4)
Cataract Model (1)Gingival Hyperplasia Model (2)Optic Neuropathy Model (1)Other Otorhinolaryngological Disease Model (1)
Skin Disease Models (1)
Atopic Dermatitis Model (1)
Tumor Models (9)
Breast Tumor Model (2)Colon Tumor Model (1)Esophageal Tumor Model (1)Kidney Tumor Model (1)Liver Tumor Model (1)Lung Tumor Model (2)Skin Tumor Model (2)Uterine Fibroid Model (1)
Urinary System Disease Models (19)
Aging Model (1)Chronic Kidney Disease Model (2)Diabetes Model (4)Hyperuricemia Model (8)Kidney Stone Model (1)Nephrotoxicity Model (1)Renal Injury Model (5)Other Urinary System Disease Model (3)
Antibiotic and Antivirus
Function (133)
Anti-bacterial Antibiotic (2)Anti-fungal Antibiotic (7)Antivirus (62)Cell Culture Antibiotic (2)Insect Repellent (42)Plant Tissue Culture Antibiotic (2)Preservative and Disinfectant (20)
Structure (8762)
Amino Acid Derivative (3)Aminoglycoside (9)Ansamycin (2)Cephalosporin (7)Chloramphenicol (1)Imidazole (6042)Macrolide (8)Nucleoside (5)Penicillin (3)Pyridine / Pyrimidine (6)Quinolone (19)Sulfonamide (17)Tetracycline (6)β-Lactam (4)Other Antibiotics (35)Others (2611)
Biochemical Reagents
Amino Acids (799)
Amino Acid Amide (17)Biologically Modified Amino Acid (29)C-protective Amino Acid (194)N-protective Amino Acid (438)Non-protein Amino Acid (115)Protein Amino Acid (55)Side Chain Protected Amino Acid (25)
Biological Buffers (2643)
Good's Buffer (19)Other Buffers (13)Others (2611)
Cross-Linking Agents (33)
Amino-amino Crosslinker (7)Amino-sulfhydryl Crosslinker (15)Photoreactive Crosslinker (3)Sulfhydryl-carbonyl Crosslinker (1)Sulfhydryl-sulfhydryl Crosslinker (4)Other Reactive Crosslinkers (3)
Denaturants (2)
Surface Active Agent (2)
Detergents (18)
Amphoteric Surfactant (4)Anionic Surfactant (3)Cationic Surfactant (2)Nonionic Surfactant (6)Sulfonated Betaine (3)
Lipids (219)
Aliphatic Acyl (210)Glycerol Lipid (7)Sphingolipid (2)
Polypeptides (39)
Dipeptide and Tripeptide (36)Oligopeptide (3)
Steroids (2675)
Bile Acid (49)Cholestane (3)Estrogen (1)Plant Sterol (10)Steroidal Glycoside (3)Other Steroids (2)Others (2611)
Sugar and Derivatives (151)
Sugar (137)Sugar Alcohol (15)
Sweeteners (For Research Experiments) (18)
Artificial sweetener (6)Natural sweetener (12)
Cancer
Cancer Stem Cells (2475)
Cathepsin (98)CXCR (112)Hedgehog (32)IL (172)IL Receptor (9)Integrin (134)MIF (18)MMP (179)NF-κB (419)NOS (186)Notch (26)PDGFR (127)PPAR (193)STAT (160)TGF-beta/Smad (381)VEGFR (271)Wnt (104)YAP (28)
Tumor Development and Microenvironment Evolution (1825)
ALK (86)AP-1 (14)CAR (5)CCR (89)Complement System (45)COX (344)DDR1/DDR2 Receptor (22)ErbB (6)GABA Receptor (188)GSK-3 (126)IFNAR (24)IRAK (71)JAK (245)LAG-3 (1)NLR (73)Nrf2 (99)PD-1/PD-L1 (80)STING (98)Syk (40)TLR (163)TNF-alpha (30)TNK (4)
Tumor Epigenetics and Gene Regulation (2861)
Aminoacyl-tRNA Synthetase (18)ATM/ATR (67)DNA Methyltransferase (43)DNA/RNA Synthesis (620)Epigenetic Reader Domain (396)HDAC (336)HIF (112)Histone Acetyltransferase (95)Histone Demethylase (147)Histone Methyltransferase (294)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (157)RNA polymerase 1 (2)Sirtuin (129)TET (8)Topoisomerase (271)
Tumor Growth, Proliferation and Apoptosis (2213)
Akt (207)Aurora Kinase (87)Bcl-2 (195)c-Met/HGFR (131)c-Myc (47)EGFR (403)ERK (166)HER2 (31)MEK (99)MLKL (4)mTOR (187)p53 (41)PI3K (340)PTEN (5)Raf (106)Ras (275)ROR (67)Telomerase (21)
Tumor Metabolism (1274)
ACC (22)ALDH (30)AMPK (105)Arginase (15)ATP Citrate Lyase (6)Dehydrogenase (156)FBPase (4)FTO (15)GLUT (32)Glutaminase (25)Hexokinase (8)IDH (37)IDO (70)MCT (17)MDH (3)NADPH Oxidase (32)OGT (2)P450 (261)PDHK (12)PHGDH (5)PKM2 (6)ROS (398)SHMT (7)SLC (6)SOD (4)SREBP (5)
Cell Biology
Cell Analysis (2)
Cell Proliferation and Cytotoxicity (2)
Cell Apoptosis/Death Detection (1419)
Apoptosis Inducer (1407)Apoptosis Inhibitor (2)Iron death Inhibitor (10)
Cell Culture (292)
Additive and Auxiliary Reagent (130)Cell Assay Reagents (9)Cell Staining (3)Organoid Culture Additive (90)Stem Cell Induction (83)
Enzymology
Enzyme Inhibitors (206)
Acetaldehyde Dehydrogenase Inhibitor (1)Acyltransferase Inhibitor (4)Alkaline Phosphatase Inhibitor (2)Angiotensin Converting Enzyme Inhibitor (4)ATP Enzyme Inhibitor (7)Calcineurin Inhibitor (1)Carbonic Acid Dehydratase Inhibitor (2)Caspase Inhibitor (2)Cyclooxygenase (COX) Inhibitor (47)DNA Topoisomerase II Inhibitor (11)Hypoxia Inducible Factor (HIF) Inhibitor (3)Inosine Monophosphate (IMP) Dehydrogenase Inhibitor (10)Leukotriene A4 Hydrolase Inhibitor (3)Lipoxygenase Inhibitor (11)Monoamine Oxidase Inhibitor (4)NADH Peroxidase Inhibitor (2)Pancreatic Lipase Inhibitor (2)Phosphodiesterase Inhibitor (20)Protease Inhibitor (20)Reverse Transcriptase Inhibitor (16)Starch Glucosidase Inhibitor (3)Thromboxane Synthase Inhibitor (2)Topoisomerase I Inhibitor (8)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)
Enzyme Preparation (63)
Cyclooxygenase (COX) (46)E3 Ubiquitin Ligase (2)Hydrolase (12)Nitric Oxide Metabolism (3)
Enzyme Substrates (4)
Peroxidase Substrate (2)β-Glucuronidase Substrate (2)
Fluorescent Probe / Staining
Cell Biology Fluorescent Dyes (61)
Apoptosis Dyes (6)BODIPY (21)Cytoplasm Dyes (5)Cytotoxicity Analysis Dyes (12)Endocytosis and pinocytosis Dyes (5)Endoplasmic Reticulum Dyes (2)Exosome Dyes (4)Lipid Droplet Dyes (3)Lysosome Dyes (4)Membrane Dyes (4)Mitochondrial Dyes (5)NOS Dyes (6)Nucleic Acid Dyes (1)Nucleus Dyes (10)PH Indicators (18)ROS Dyes (27)
Fluorescence Labeling Reagents (2848)
Anthocyanine (1)Boron Dipyrrole Methylene  (2)Coumarin (8)Danacyl (2)Fluoressin (7)Nitrobenzoxadiazole (NBD) (2)Pyrene (6)Other Fluorescence Labeling Reagents (213)Others (2611)
Fluorescent Dyes (2797)
Acridine Dye (8)Blood Dyes (2)Cancer Analysis Dyes (8)Coumarine Dye (57)Cyanine Dye (25)Neuroscience Analysis Dyes (33)Protein (3)Other Fluorescent Dyes (7)Others (2611)
Molecular Biology
Extraction and Analysis Of Nucleic Acid (5)
Hybridization Reagent (3)Probe (2)
Gene Cloning (21)
Buffer (21)
Nucleic Acid Electrophoresis (5)
Electrophoretic Buffer (3)Gelatin (2)
Natural Products
Acanthaceae (20)
Adhatoda (4)Andrographis (9)Justicia (4)Phlogacanthus (2)Strobilanthes (1)
Aceraceae (2)
Acer (2)
Adiantaceae (2)
Adiantum (2)
Alariaceae (76)
Acanthopanax (5)Aralia (8)Diplopanax (3)Eleutherococcus (3)Hedera (3)Oplopanax (1)Panax (53)
Alismataceae (2)
Alisma (2)
Amaranthaceae (5)
Achyranthes (3)Celosia (1)Cyathula (1)
Amaryllidaceae (23)
Agave (4)Allium (5)Curculigo (10)Lycoris (3)Narcissus (1)
Anacardiaceae (15)
Lannea (1)lodes (1)Mangifera (6)Rhus (4)Toxicodendron (3)
Annonaceae (19)
Annona (2)Fissistigma (6)Goniothalamus (4)Guatteria (1)Miliusa (1)Orophea (2)Polyalthia (2)Uvaria (1)
Apocynaceae (45)
Alstonia (3)Apocynum (1)Aspidosperma (1)Catharanthus (5)Cerbera (5)Kopsia (1)Nerium (10)Plumeria (2)Rauvolfia (9)Thevetia (3)Trachelospermum (4)Voacanga (1)
Aquifoliaceae (3)
Ilex (3)
Araceae (14)
Acorus (10)Eminium (2)Pinellia (2)
Aristolochiaceae (15)
Aristolochia (11)Asarum (3)Holostylis (1)
Asclepiadaceae (19)
Cryptolepis (3)Cynanchum (7)Marsdenia (5)Periploca (4)
Asparagaceae (11)
Eucomis (2)Muscari (1)Scilla (8)
Asteraceae (228)
Achillea (3)Ageratum (1)Ambrosia (2)Arctium (2)Arnica (1)Artemisia (25)Aster (2)Atractylodes (9)Aucklandia (5)Bellis (1)Blumea (4)Cacalia (1)Carpesium (1)Carthamus (7)Centaurea (5)Centipeda (4)Chrysactinia (4)Chrysanthemum (6)Cichorium (2)Cirsium (2)Conyza (1)Coreopsis (1)Cosmos (1)Crepis (3)Cynara (1)Dahlia (2)Dittrichia (1)Doronicum (1)Echinacea (2)Eclipta (6)Elephantopus (1)Erigeron (3)Eupatorium (20)Gnaphalium (1)Gynura (2)Helianthus (4)Heterotheca (1)Inula (8)Kalimeris (1)Laggera (13)Laurentia (1)Ligularia (4)Matricaria (2)Petasites (2)Pulicaria (4)Saussurea (3)Scorzonera (2)Senecio (9)Siegesbeckia (2)Silybum (5)Smallanthus (1)Stevia (10)Tagetes (4)Telekia (1)Tessaria (1)Tussilago (2)Verbesina (1)Vernonia (5)Wedelia (2)Xanthium (6)Zinnia (1)
Athyriaceae (1)
Cystopteris (1)
Balsaminaceae (5)
Impatiens (5)
Berberidaceae (37)
Berberis (3)Bongardia (1)Caulophyllum (2)Dysosma (3)Epimedium (26)Sinopodophyllum (2)
Betulaceae (11)
Alnus (6)Betula (1)Carpinus (1)Corylus (3)
Bignoniaceae (16)
Catalpa (8)Crescentia (2)Incarvillea (1)Kigelia (1)Macfadyena (1)Markhamia (1)Oroxylum (2)
Blechnaceae (1)
Woodwardia (1)
Boraginaceae (18)
Arnebia (2)Echium (1)Ehretia (1)Lithospermum (13)Tournefortia (1)
Burseraceae (11)
Boswellia (3)Canarium (5)Commiphora (3)
Buxaceae (3)
Buxus (3)
By Structure (5433)
Alkaloids (149)Coumarins (21)Lignans (36)Phenols (1786)Phenylpropanane (54)Quinones (35)Natural Products-Other Structure (3377)
Calophyllaceae (8)
Pseudostellaria (2)Stellaria (1)Vaccaria (5)
Campanulaceae (14)
Codonopsis (1)Lobelia (2)Platycodon (10)Sphenoclea (1)
Cannabaceae (11)
Cannabis (3)Humulus (8)
Caprifoliaceae (23)
Lonicera (20)Sambucus (1)Viburnum (2)
Celastraceae (16)
Celastrus (3)Euonymus (2)Maytenus (1)Tripterygium (10)
Cephalotaxaceae (10)
Cephalotaxus (10)
Chenopodiaceae (3)
Kochia (1)Spinacia (1)Suaeda (1)
Chloranthaceae (11)
Chloranthus (10)Sarcandra (1)
Clusiaceae (94)
Alliaria (1)Brassica (6)Calophyllum (6)Cratoxylum (2)Descurainia (1)Eruca (1)Garcinia (47)Hypericum (15)Isatis (2)Lepidium (4)Mammea (1)Mesua (1)Raphanus (3)Sinapis (3)Symphonia (1)
Combretaceae (6)
Calycopteris (1)Combretum (2)Terminalia (3)
Convolvulaceae (2)
Erycibe (1)Ipomoea (1)
Coriariaceae (2)
Coriaria (2)
Cornaceae (2)
Cornus (2)
Crassulaceae (12)
Rhodiola (7)Sedum (5)
Cucurbitaceae (44)
Bolbostemma (1)Bryonia (1)Cucumis (1)Cucurbita (1)Echinocystis (1)Gynostemma (4)Hemsleya (2)Herpetospermum (1)Lagenaria (3)Luffa (1)Momordica (9)Siraitia (17)Trichosanthes (2)
Cupressaceae (11)
Chamaecyparis (2)Juniperus (5)Platycladus (4)
Cyperaceae (5)
Carex (2)Cyperus (3)
Daphniphyllaceae (36)
Aquilaria (10)daphne (3)Daphniphyllum (1)Edgeworthia (1)Excoecaria (1)Pieris (2)Stellera (10)Wikstroemia (8)
Dennstaedtiaceae (1)
Dennstaedtia (1)
Dicksoniaceae (4)
Cibotium (4)
Dioscoreaceae (11)
Dioscorea (11)
Dipsacaceae (2)
Dipsacus (2)
Dryopteridaceae (4)
Dryopteris (4)
Elaeagnaceae (7)
Elaeagnus (2)Hippophae (5)
Equisetaceae (3)
Equisetum (3)
Erythroxylaceae (1)
Erythroxylum (1)
Eucommiaceae (12)
Eucommia (12)
Euphorbiaceae (46)
Breynia (1)Croton (7)Endospermum (1)Euphorbia (10)Excoecaria (1)Flueggea (1)Hevea (3)Jatropha (5)Macaranga (1)Mallotus (1)Phyllanthus (11)Suregada (2)Trigonostemon (2)
Fabaceae (348)
Abrus (1)Acacia (9)Adenanthera (1)Albizia (1)Ammothamnus (1)Antheroporum (1)Astragalus (23)Butea (1)Caesalpinia (18)Cajanus (3)Campylotropis (1)Cassia (26)Cicer (1)Crotalaria (5)Cytisus (3)Dalbergia (10)Derris (13)Desmodium (3)Erythrina (13)Flemingia (3)Genista (1)Glycine (22)Glycyrrhiza (41)Griffonia (1)Hedysarum (1)Lespedeza (5)Leucaena (3)Lotus (5)Lupinus (8)Maackia (4)Medicago (1)Millettia (6)Mimosa (1)Mucuna (2)Ononis (2)Parochetus (2)Phyllodium (1)Pisum (1)Pongamia (1)Prosopis (2)Psoralea (18)Pterocarpus (1)Pterolobium (1)Pueraria (25)Robinia (2)Saraca (1)Senna (1)Sophora (36)Spartium (1)Spatholobus (2)Styphnolobium (1)Trifolium (6)Trigonella (2)Vicia (2)Wisteria (2)
Fagaceae (2)
Castanea (1)Lithocarpus (1)
Gentianaceae (28)
Anthocleista (1)Canscora (1)Gentiana (16)Gentianella (1)Halenia (1)Swertia (8)
Geraniaceae (3)
Geranium (2)Pelargonium (1)
Gesneriaceae (1)
Lysionotus (1)
Ginkgoaceae (9)
Ginkgo (9)
Gnetaceae (4)
Gnetum (4)
Hamamelidaceae (2)
Hamamelis (1)Loropetalum (1)
Hernandiaceae (129)
Ammi (2)Angelica (32)Bupleurum (13)Centella (4)Cnidium (9)Cuminum (1)Ferula (3)Heracleum (13)Hernandia (2)Ledebouriella (1)Ligusticopsis (1)Ligusticum (9)Notopterygium (7)Oenanthe (1)Petroselinum (2)Peucedanum (20)Pimpinella (1)Saposhnikovia (7)Seseli (1)
Hippocastanaceae (5)
Aesculus (5)
Illiciaceae (7)
Illicium (7)
Iridaceae (19)
Belamcanda (8)Crocus (6)Eleutherine (3)Iris (2)
Juglandaceae (6)
Diospyros (2)Engelhardtia (1)Juglans (1)Sesamum (2)
Juncaceae (5)
Juncus (5)
Lamiaceae (140)
Ajuga (2)Ballota (1)Clinopodium (3)Coleus (2)Dracocephalum (3)Elsholtzia (1)Isodon (5)Lamiophlomis (1)Leonurus (9)Marrubium (2)Mentha (4)Mosla (2)Perilla (4)Phlomis (1)Plectranthus (1)Pogostemon (1)Rosmarinus (5)Salvia (45)Scutellaria (40)Stachys (2)Tectona (1)Thymus (5)
Lauraceae (22)
Cinnamomum (7)Cryptocarya (3)Endlicheria (1)Laurus (1)Lindera (4)Litsea (1)Nectandra (2)Ocotea (3)
Lepidoziaceae (1)
Lepidozia (1)
Lichenes (1)
Usnea (1)
Liliaceae (78)
Aloe (4)Anemarrhena (9)Asparagus (1)Dracaena (11)Fritillaria (3)Hosta (1)Lilium (3)Liriope (3)Ophiopogon (28)Paris (8)Polygonatum (3)Smilax (1)Trillium (1)Tupistra (1)Veratrum (1)
Linaceae (2)
Linum (2)
Loganiaceae (5)
Buddleja (2)Gelsemium (1)Strychnos (2)
Loranthaceae (1)
Taxillus (1)
Lycopodiaceae (3)
Lycopodium (3)
Lygodiaceae (1)
Lygodium (1)
Lythraceae (11)
Lawsonia (4)Punica (7)
Magnoliaceae (24)
Liriodendron (4)Magnolia (19)Michelia (1)
Malvaceae (5)
Abelmoschus (1)Gossypium (1)Guazuma (2)Hibiscus (1)
Meliaceae (24)
Aglaia (12)Amoora (2)Aphanamixis (3)Melia (4)Walsura (3)
Menispermaceae (13)
Cocculus (2)Diploclisia (1)Menispermum (1)Stephania (5)Tinospora (3)Triclisia (1)
Moraceae (69)
Artocarpus (2)Broussonetia (13)Cudrania (16)Morus (37)Trilepisium (1)
Moringaceae (7)
Moringa (7)
Musaceae (13)
Musa (10)Musella (3)
Myricaceae (6)
Morella (6)
Myristicaceae (7)
Myristica (7)
Myrsinaceae (1)
Ardisia (1)
Myrtaceae (27)
allspice (1)Eucalyptus (16)Psidium (6)Rhodomyrtus (1)Syzygium (3)
Nartheciaceae (4)
Narthecium (1)Philydrum (1)Xanthorrhoea (2)
Nelumbonaceae (3)
Nelumbo (3)
Nyctaginaceae (33)
Atropa (1)Boerhavia (3)Capsicum (5)Datura (7)Lycium (3)Mirabilis (1)Nicotiana (2)Physalis (4)Solanum (6)Withania (1)
Nyssaceae (52)
Camptotheca (6)Gaultheria (1)Pyrola (2)Rhododendron (5)Vaccinium (38)
Oleaceae (37)
Abeliophyllum (1)Forsythia (12)Fraxinus (4)Jasminum (6)Ligustrum (11)Olax (1)Osmanthus (1)Syringa (1)
Orchidaceae (28)
Anoectochilus (1)Bletilla (2)Cremastra (2)Dendrobium (7)Gastrodia (3)Gymnadenia (8)Pholidota (3)Vanda (1)Vanilla (1)
Orobanchaceae (10)
Cistanche (10)
Paeoniaceae (6)
Paeonia (6)
Palmae (6)
Areca (4)Euterpe (1)Trachycarpus (1)
Pandanaceae (3)
Pandanus (3)
Papaveraceae (26)
Chelidonium (10)Corydalis (8)Glaucium (1)Hylomecon (1)Hypecoum (1)Macleaya (2)Papaver (1)Sanguinaria (2)
Parmeliaceae (4)
Parmelia (4)
Passifloraceae (2)
Passiflora (2)
Pentaphylacaceae (1)
Adinandra (1)
Phyllanthaceae (4)
Securinega (3)Uapaca (1)
Phytolaccaceae (6)
Microtea (1)Phytolacca (5)
Pinaceae (35)
Abies (2)Cedrus (4)Larix (1)Pinus (18)Pseudolarix (9)Tsuga (1)
Piperaceae (28)
Piper (28)
Pittosporaceae (1)
Pittosporum (1)
Plantaginaceae (2)
Picrorhiza (1)Plantago (1)
Plumbaginaceae (2)
Limoniastrum (1)Plumbago (1)
Poaceae (14)
Avena (2)Coix (1)Hordeum (2)Leptochloa (1)Oryza (1)Phyllostachys (1)Poa (2)Saccharum (1)Secale (2)Zea (1)
Podocarpaceae (8)
Podocarpus (8)
Polygalaceae (32)
Polygala (31)Securidaca (1)
Polygonaceae (40)
Atraphaxis (2)Fallopia (3)Polygonum (9)Rheum (22)Rumex (4)
Polypodiaceae (2)
Phymatopteris (2)
Pontederiaceae (1)
Monochoria (1)
Portulacaceae (1)
Talinum (1)
Primulaceae (4)
Lysimachia (3)Primula (1)
Proteaceae (4)
Grevillea (1)Helicia (3)
Ranunculaceae (45)
Aconitum (2)Anemone (6)Cimicifuga (9)Clematis (3)Coptis (7)Delphinium (2)Hydrastis (2)Pulsatilla (10)Semiaquilegia (1)Thalictrum (3)
Resedaceae (1)
Reseda (1)
Rhamnaceae (16)
Hovenia (1)Rhamnus (11)Ziziphus (4)
Rhizophoraceae (3)
Cassipourea (1)Kandelia (2)
Rosaceae (31)
Agrimonia (4)Crataegus (4)Exochorda (5)Filipendula (2)Malus (1)Photinia (1)Potentilla (1)Pourthiaea (1)Prunus (3)Rosa (3)Rubus (3)Sanguisorba (1)Sorbus (1)Spiraea (1)
Rubiaceae (69)
Borreria (1)Cinchona (2)Coffea (3)Emmenopterys (1)Galium (5)Gardenia (11)Hedyotis (8)Knoxia (2)Mitragyna (1)Morinda (4)Mussaenda (1)Nauclea (2)Paederia (5)Pausinystalia (2)Pentas (1)Rubia (14)Uncaria (6)
Rutaceae (162)
Aegle (1)Boenninghausenia (2)Cedrelopsis (1)Citrus (38)Clausena (7)Dictamnus (8)Euodia (1)Evodia (13)Flindersia (1)Fortunella (1)Glycosmis (3)Haplophyllum (3)Melicope (1)Micromelum (11)Murraya (21)Phebalium (2)Phellodendron (8)Ptaeroxylon (1)Ruta (3)Skimmia (1)Tetradium (1)Toddalia (14)Zanthoxylum (20)
Salicaceae (2)
Populus (2)
Santalaceae (3)
Thesium (3)
Sapindaceae (10)
Dodonaea (10)
Saururaceae (6)
Houttuynia (1)Saururus (5)
Saxifragaceae (11)
Astilbe (1)Bergenia (1)Dichroa (3)Hydrangea (5)Penthorum (1)
Schisandraceae (18)
Kadsura (5)Schisandra (13)
Scrophulariaceae (33)
Bacopa (6)Euphrasia (1)Limnophila (1)Linaria (2)Melampyrum (1)Paulownia (1)Pedicularis (2)Picria (3)Rehmannia (12)Scrophularia (4)
Selaginellaceae (3)
Selaginella (3)
Simaroubaceae (32)
Ailanthus (8)Brucea (8)Eurycoma (1)Picrasma (14)Quassia (1)
Sinopteridaceae (17)
Onychium (4)Pteridium (3)Pteris (10)
Stemonaceae (1)
Stemona (1)
Sterculiaceae (4)
Casearia (1)Gynocardia (2)Hydnocarpus (1)
Styracaceae (3)
Styrax (3)
Tamaricaceae (1)
Tamarix (1)
Taxaceae (8)
Taxus (7)Torreya (1)
Taxodiaceae (5)
Cryptomeria (2)Sequoia (3)
Theaceae (9)
Camellia (9)
Tiliaceae (2)
Microcos (1)Tilia (1)
Toricelliaceae (3)
Toricellia (3)
Tropaeolaceae (1)
Tropaeolum (1)
Typhaceae (4)
Typha (4)
Ulmaceae (1)
Ulmus (1)
Valerianaceae (19)
Nardostachys (4)Patrinia (5)Valeriana (10)
Verbenaceae (39)
Callicarpa (10)Clerodendrum (7)Duranta (1)Gmelina (1)Lippia (1)Stachytarpheta (1)Verbena (2)Vitex (16)
Violaceae (7)
Viola (7)
Viscaceae (2)
Viscum (2)
Vitaceae (18)
Ampelopsis (4)Turpinia (2)Vitis (12)
Winteraceae (4)
Drimys (4)
Zingiberaceae (79)
Aframomum (1)Alpinia (25)Amomum (1)Boesenbergia (2)Curcuma (33)Kaempferia (1)Zingiber (16)
Zygophyllaceae (6)
Peganum (4)Tribulus (2)
Pharmaceutical Research
Animal Modeling Agents (46)
Cardio-cerebrovascular Disease Model (2)Diabete Model (1)Inflammation Model (21)Lifestyle-related Disease Model (10)Nervous System Model (5)Pain and Pruritus Model (8)Tumor Model (6)Other Modeling Agents (6)
Classical Positive Drugs (61)
Cardiovascular System (20)Diabete (30)Digestive System (11)
Drug Analysis (663)
Drug Standard (208)Plant Standard (457)
Drug Delivery (560)
Cationic Lipids (119)Cholesterol (10)Fluorescent Lipids (1)Pegylated Lipids (11)Phospholipids (175)
Pharmacy Related (27)
Biomaterial (2)Classical Raw Material Drug (2)Cosolvents (12)Medicinal Excipient (14)
Small Molecule Positive Drugs (2843)
Anti-allergy (5)Anti-inflammation (30)Anti-osteoporosis (2)Anti-rheumatoid Arthritis (6)Anti-tumor (7)Antivirus (62)Depressurization (18)Diabete (30)Neurotransmitter (32)Reduce Blood Lipid (6)Other Compounds (66)Others (2611)
PROTACS
E3 Ligand-Linker Conjugate (166)
CRBN Ligand-Linkers (117)VHL Ligand-Linkers (49)
E3 Ligands (72)
CRBN Inactive Ligand (4)CRBN Ligand (56)IAP Ligand (2)MDM2 Ligand (2)VHL Ligand (8)
Molecular Glue (31)
Bcl-6/PROTAC (3)Casein Kinase 1α/PROTAC (2)Cyclin K/PROTAC (5)GSPT1/PROTAC (5)IKZF1/3/PROTAC (7)mHTT/PROTAC (2)PDE6D/PROTAC (2)RBM39/PROTAC (4)β-catenin/PROTAC (1)
Warhead (1)
Bcr-Abl/Warhead Ligand (1)
Vesicle
Exosome (2591)
ApoE (1)ARF (2)Calcium Channel (269)Ceramidase (4)FGF (2)HBV (151)HIV (447)HSP (161)HSV (75)Integrin (134)LPL Receptor (118)MicroRNA (16)mTOR (187)Neurotransmitter (32)p53 (41)PD-1/PD-L1 (80)Phospholipase (108)Ras (275)STAT (160)TGF-beta/Smad (381)
Parkinson'S Disease and Alzheimer'S Disease (5789)
Akt (207)AMPAR (54)Apoptosis (2143)Caspase (170)CDK (475)CREB (5)Dopamine Receptor (170)Dopamine β-hydroxylase (8)ERK (166)Glucagon Receptor (50)GPCR (203)GSK-3 (126)IL (172)JAK (245)JNK (79)LRRK2 (32)MyD88 (6)NF-κB (419)Notch (26)p53 (41)PI3K (340)PKA (59)PTEN (5)RAGE (3)Ras (275)Rho (14)ROCK (90)ROS (398)Secretase (112)STAT (160)STING (98)Tau Protein (28)TLR (163)TNF (22)Tyrosinase (100)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)Wnt (104)α-synuclein (1)β-catenin (71)
Zoology and Botany
Pesticide Composition (103)
Fungicide (60)Herbicide (17)Insecticide (27)
Home Cart Sign in  
/
Inhibitors/Agonists
/
Apoptosis
/
Apoptosis Inducer
/
Cisplatin
/
Inhibitors/Agonists
/
Apoptosis
Other Inhibitors/Agonists DNA Damage
/
Apoptosis Inducer
Anti-tumor DNA Alkylator/Crosslinker
/
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 15663-27-1 Chemical Structure| 15663-27-1

Structure of Cisplatin
CAS No.: 15663-27-1

Chemical Structure| 15663-27-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cisplatin (CDDP) is an antitumor chemotherapeutic agent that induces DNA damage in cancer cells through DNA cross-linking. Cisplatin can activate ferroptosis and induce autophagy.

Synonyms: cis-Platinum; CDDP; CACP

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

Quality Control of Cisplatin Purity: 99% SDS Specification
COA

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 NMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 CNMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 HPLC

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 LC-MS

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations      Show More

Marlhoux, Léna ; Arnaud, Alexandre ; Hervieu, Céline ; Makulyte, Gabriela ; Martinasso, Charlotte ; Mularoni, Angélique , et al.

DOI: PubMed ID:

Abstract: Casein kinase 2 (CK2) has emerged as a promising therapeutic target across a broad spectrum of malignancies, including pediatric and orphan cancers. The identification of a ligandable allosteric αD pocket on the CK2α subunit has enabled the development of bivalent inhibitors, which bind simultaneously to both the adenosine triphosphate (ATP) site and the allosteric pocket. Here, we report the discovery and pharmacological characterization of KDX1381, a structure-guided bivalent CK2α inhibitor with low-nanomolar potency and high selectivity, confirmed by cocrystal structures. In mice, KDX1381 suppressed CK2-driven tumor growth as a monotherapy and enhanced therapeutic efficacy when combined with vascular endothelial growth factor receptor (VEGFR) inhibitors or DNA-damaging agents in hepatocellular carcinoma and glioma models. These findings support bivalent CK2α inhibition as a differentiated therapeutic strategy with broad applicability in CK2-dependent cancers.

Purchased from AmBeed: ; ; ; ; ; ; ; ; ; ;

Marta Stolarek ; Kamil Kaminski ; Marta Kaczor-Kamińska ; Magdalena Obłoza ; Piotr Bonarek ; Anna Czaja , et al.

DOI: PubMed ID:

Abstract: A photoactive analogue of was synthesized with two arylazopyrazole ligands, able to undergo trans−cis/cis−trans photoisomerizations. The cis photoisomer showed a dark half-life of 9 days. The cytotoxicities of both photoisomers of the complex were determined in several cancer and normal cell lines and compared to that of . The trans photoisomer of the complex was much more cytotoxic than both the cis photoisomer and , and was more toxic for cancer (4T1) than for normal (NMuMG) murine breast cells. 4T1 cell death occurred through necrosis. Photoisomerization of the trans and cis photoisomers internalized by the 4T1 cells increased and decreased their viability, respectively. The cellular uptake of the trans photoisomer was stronger than that of both the cis photoisomer and . Both photoisomers interacted with DNA faster than . The trans photoisomer was bound stronger by bovine serum albumin and induced a greater decrease in cellular levels than the cis photoisomer.

Purchased from AmBeed: ;

Behymer, Matthew M. ; Mo, Huaping ; Fujii, Naoaki ; Suresh, Vallabh ; Chan, Adriano ; Lee, Jangweon , et al.

DOI: PubMed ID:

Abstract: The development of rapidly acting cyanide countermeasures using i.m. injection (IM) represents an unmet medical need to mitigate toxicant exposures in mass casualty settings. Previous work established that cisplatin and other platinum(II) or platinum(IV)-based agents effectively mitigate cyanide toxicity in zebrafish. Cyanide′s in vivo reaction with platinum-containing materials was proposed to reduce the risk of acute toxicities. However, cyanide antidote activity depended on a formulation of platinum-chloride salts with DMSO (DMSO) followed by dilution in phosphate-buffered saline (PBS). A working hypothesis to explain the DMSO requirement is that the formation of platinum-sulfoxide complexes activates the cyanide scavenging properties of platinum. Preparations of isolated NaPtCl5-DMSO and Na (NH3)2PtCl-DMSO complexes in the absence of excess DMSO provided agents with enhanced reactivity toward cyanide in vitro and fully recapitulated in vivo cyanide rescue in zebrafish and mouse models. The enhancement of the cyanide scavenging effects of the DMSO ligand could be attributed to the activation of platinum(IV) and (II) with a sulfur ligand. Unfortunately, the efficacy of DMSO complexes was not robust when administered IM. Alternative Pt(II) materials containing sulfide and amine ligands in bidentate complexes show enhanced reactivity toward cyanide addition The cyanide addition products yielded tetracyanoplatinate(II), translating to a stoichiometry of 1:4 Pt to each cyanide scavenger. These new agents demonstrate a robust and enhanced potency over the DMSO-containing complexes using IM administration in mouse and rabbit models of cyanide toxicity. Using the zebrafish model with these Pt(II) complexes, no acute cardiotoxicity was detected, and dose levels required to reach lethality exceeded 100 times the ED. Data are presented to support a general chem. design approach that can expand a new lead candidate series for developing next-generation cyanide countermeasures.

Purchased from AmBeed: ; ; ; ; ; ;

Alternative Products

Product Details of Cisplatin

CAS No. :15663-27-1
Formula : Cl2H6N2Pt
M.W : 300.05
SMILES Code : Cl[Pt]Cl.N.N
Synonyms :
cis-Platinum; CDDP; CACP
MDL No. :MFCD00011623
InChI Key :DQLATGHUWYMOKM-UHFFFAOYSA-L
Pubchem ID :2767

Safety of Cisplatin

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H300-H316-H319-H360-H362-H370-H372-H340-H350
Precautionary Statements:P501-P263-P260-P270-P202-P201-P264-P280-P337+P313-P305+P351+P338-P308+P311-P332+P313-P301+P310+P330-P405
Class:6.1
UN#:3288
Packing Group:Ⅱ

Related Pathways of Cisplatin

DNA

Isoform Comparison

Biological Activity

Description
Cisplatin (CDDP) is an antineoplastic chemotherapy agent, primarily by forming cross-links with DNA and thus inflicting DNA damage within cancer cells. Cisplatin triggers ferroptosis and induce autophagy, contributing to its effectiveness against various cancer types[1].[2].[3].
Target

  • DNA synthesis

In Vitro:

Cell Line
Concentration Treated Time Description References
N-DNA 3.3 mM 1 h To investigate the effect of Cisplatin on N-DNA, it was found that Cisplatin could effectively fix the N-DNA structure even under 180 mM NaCl conditions. PMC8643659
N-DNA 0.1 mM To investigate the effect of low concentration Cisplatin on N-DNA, it was found that even low concentration Cisplatin could partially fix the N-DNA structure. PMC8643659
SKOV3 3.3 µM 24 h Generate cisplatin-resistant cell lines and validate cisplatin resistance PMC9356138
OVCAR5 3.3 µM 24 h Generate cisplatin-resistant cell lines and validate cisplatin resistance PMC9356138
COV362 3.3 µM 24 h Generate cisplatin-resistant cell lines and validate cisplatin resistance PMC9356138
T24 0-100 μM 3 days To evaluate the cytotoxicity of cisplatin in bladder cancer cell lines, T24 cells exhibited the lowest sensitivity to cisplatin. PMC8819945
T24 0.25 μM 7 or 14 days Genome-wide CRISPR screening identified HNRNPU as the top candidate gene related to cisplatin resistance. PMC8819945
Murine proximal tubular epithelial cells (TKPTs) 20 μM 24 hours To investigate the effect of UNC0379 on cisplatin-induced apoptosis, results showed that UNC0379 reduced the number of TUNEL-positive cells, restored PTEN expression, and decreased cleaved caspase 3 levels. PMC11958763
HSC4 5 μM 9 days Generate cisplatin-tolerant persister cells (DTP cells) and observe high expression of FSP1 and lipid metabolism-related targets PMC10817390
HSC3 5 μM 9 days Generate cisplatin-tolerant persister cells (DTP cells) and observe high expression of FSP1 and lipid metabolism-related targets PMC10817390

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Patient-derived xenograft model (PDX) Intraperitoneal injection 10 mg/kg Weekly for 3 weeks Validate the effect of FAO inhibitor combined with platinum drugs on cisplatin-resistant tumors PMC9356138
BALB/c nu/nu female mice Tumor xenograft model Tail injection 2 mg/kg Every other day for 4 weeks To validate the effect of HNRNPU knockout on cisplatin sensitivity in vivo, results showed that HNRNPU knockout significantly enhanced cisplatin sensitivity. PMC8819945
BALB/c nu/nu mice Subcutaneous xenograft model Intraperitoneal injection 5 mg/kg Once per week for 2-3 weeks SQLE depletion significantly inhibited tumor growth, and the combination with cisplatin exhibited a more robust inhibitory effect than cisplatin alone PMC10520660

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02128282 Cholangiocarcinoma Phase 1 Phase 2 Recruiting November 2021 United States, Arizona ... More >> Mayo Clinic Recruiting Scottsdale, Arizona, United States, 85259-5499 Contact: Mayo Clinic Clinical Trials Office    855-776-0015       Principal Investigator: Mitesh Borad, M.D.          United States, Colorado University of Colorado- Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Amy Szilard    720-848-0702    Amy.Szilard@ucdenver.edu    Principal Investigator: Sarah (Lindsey) Davis, MD          United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States, 32224 Contact: Mayo Clinic Clinical Trials Office    855-776-0015       Principal Investigator: Kabir Mody, MD          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Mayo Clinic Clinical Trials Office    855-776-0015       Principal Investigator: Joleen Hubbard, MD          United States, Texas Texas Oncology - Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States, 75246 Contact: Tammy Carmical, RN    214-370-1937    tammy.carmical@usoncology.com    Principal Investigator: Carlos Becerra, M.D.          Texas Oncology-Tyler Recruiting Tyler, Texas, United States, 75702 Contact: Karen Poe, RN    903-579-9869    karen.poe@usoncology.com    Principal Investigator: Donald A Richards, M.D.          Korea, Republic of Asan Medical Center Recruiting Seoul, Songpa-gu, Korea, Republic of, 138-736 Contact: Heung-Moon Chang, MD    82-3010-3219 ext 3210    changhm@amc.seoul.kr    Contact: Seok kyung Jeong    82-2-3010-5634    jsk0213@amc.seoul.kr    Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Eunyou Lee    82-2-3410-0955    ley0709@samsung.com    Principal Investigator: Joon Oh Park, MD          Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Myoungsun Choi    82-2-2072-7612    iamyou3@hanmail.net    Principal Investigator: Do-Youn Oh, MD          Severance Hospital, Yonsei University Health System Recruiting Seoul, Korea, Republic of Contact: So Young Hwang    82-2-2228-8180    syhwang@yuhs.ac    Principal Investigator: Sun Young Rha, MD          Taiwan China Medical University Hospital Recruiting Taichung City, Taiwan Contact: Pei-Chen Hsu    +886-4-2205-2121    peggyshiu0807@gmail.com    Principal Investigator: Li-Yuan Bai, M.D. Less <<
NCT00915382 Advanced Gastric Cancer Phase 3 Completed - Korea, Republic of ... More >> Department of Oncology, Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT03427359 Nasopharyngeal Carcinoma Phase 2 Completed - -
NCT02639091 Medical Oncology Phase 1 Active, not recruiting June 28, 2019 United States, Illinois ... More >> Chicago, Illinois, United States, 60637 United States, Maryland Bethesda, Maryland, United States, 20892 United States, Michigan Detroit, Michigan, United States, 48202 United States, South Carolina Charleston, South Carolina, United States, 29425 Italy Milano, Lombardia, Italy, 20089 Milano, Lombardia, Italy, 20133 Less <<
NCT00522795 Esophageal Cancer Phase 2 Completed - United States, Rhode Island ... More >> Lifespan Hospitals Providence, Rhode Island, United States, 02903 Less <<
NCT02897375 Solid Neoplasm ... More >> Stage III Pancreatic Cancer Stage IIIA Breast Cancer Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Breast Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Stage IV Non-Small Cell Lung Cancer Stage IVA Pancreatic Cancer Stage IVB Pancreatic Cancer Sarcoma Colorectal Cancer Head and Neck Cancer Cancer of Unknown Primary Bladder Cancer Ovarian Cancer Less << Phase 1 Recruiting December 2021 United States, Georgia ... More >> Emory University/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Nakita Brown    404-616-9850    nlbrown@emory.edu    Contact: Monique Williams    404-778-4383    monique.guyinn@emory.edu Less <<
NCT01417390 Nasopharyngeal Carcinoma Phase 2 Unknown December 2015 China, Guangdong ... More >> Wei-wei Hong Recruiting Foshan, Guangdong, China, 528000 Contact: Wei wei Hong, M.D.          Sub-Investigator: Tao Xu, M.D. Less <<
NCT01918306 - Terminated(company stopped pro... More >>duction of study drug due to excessive toxicities, lack of efficacy) Less << - -
NCT02585973 Carcinoma, Squamous Cell of He... More >>ad and Neck Less << Phase 1 Recruiting November 2021 United States, North Carolina ... More >> UNC Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Dan Goldin    919-966-4432    dan_goldin@med.unc.edu    Contact: Chris Hilliard    919-966-4432    Chris_Hilliard@med.unc.edu Less <<
NCT01918306 Estrogen Receptor Negative Bre... More >>ast Cancer Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Triple Negative Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Triple-negative Breast Cancer Less << Phase 1 Phase 2 Terminated(company stopped pro... More >>duction of study drug due to excessive toxicities, lack of efficacy) Less << - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States United States, California University of California, San Francisco San Francisco, California, United States United States, District of Columbia Georgetown University Washington, D.C., District of Columbia, United States United States, Georgia Emory University Atlanta, Georgia, United States United States, Illinois University of Chicago Chicago, Illinois, United States United States, Indiana Indiana University Indianapolis, Indiana, United States United States, Maryland John Hopkins University Baltimore, Maryland, United States United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States United States, Michigan University of Michigan Ann Arbor, Michigan, United States United States, Minnesota Mayo Clinic Rochester, Minnesota, United States United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States United States, North Carolina University of North Carolina Charlotte, North Carolina, United States United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas Baylor Breast Center Houston, Texas, United States United States, Washington University of Washington Seattle, Washington, United States Less <<
NCT03168594 Neuroendocrine Carcinoma Phase 2 Recruiting May 1, 2020 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Shen Lin, Professor    010-88196561    Linshenpku@163.com    Principal Investigator: Shen Lin, professor Less <<
NCT03649048 Locally Advanced Head and Neck... More >> Squamous Cell Carcinoma Less << Not Applicable Not yet recruiting February 2025 -
NCT01426646 Gastric Cancer Phase 2 Unknown September 2016 Korea, Republic of ... More >> Donga university hospital Recruiting Busan, Korea, Republic of, 602-715 Contact: Hyuk-Chan Kwon, Professor          Principal Investigator: Hyuk-Chan Kwon, Professor          Ulsan University Hospital Recruiting Ulsan, Korea, Republic of, 682-714 Contact: Jin Ho Baek, Professor          Principal Investigator: Jin-Ho Baek, Professor Less <<
NCT02407912 Pleural Effusion, Malignant Not Applicable Recruiting March 2020 China, Guangdong ... More >> Department of medical oncology Recruiting Shantou, Guangdong, China, 515031 Contact: Hongbiao Wang, Master    8613592882093    wanghongbiao123@qq.com Less <<
NCT00858663 Head and Neck Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01345357 Solid Tumors or Mantle Cell Ly... More >>mphoma Less << Phase 1 Completed - Belgium ... More >> Teva Investigational Site 3 Bruxelles, Belgium France Teva Investigational Site 1 Nantes, France Teva Investigational Site 2 Villejuif, France Less <<
NCT01009346 Head and Neck Cancer Phase 1 Phase 2 Terminated(Toxicity) - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21231 Less <<
NCT00998036 Triple Negative Breast Cancer Phase 1 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01574092 Pediatric High Risk Gliomas Phase 2 Completed - Spain ... More >> Hospital Sant Joan De Déu Esplugues de Llobregat, Barcelona, Spain, 08950 Less <<
NCT00522795 - Completed - -
NCT00148694 Breast Cancer PHASE2 COMPLETED 2025-05-10 Beth Israel Deaconess Medical ... More >>Center, Boston, Massachusetts, 02115, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, United States|Massachusetts General Hospital, Boston, Massachusetts, 02115, United States Less <<
NCT01073839 Cholangiocellular Carcinoma Phase 1 Phase 2 Completed - Switzerland ... More >> Zurich, Switzerland Less <<
NCT00922896 Metastatic Pancreatic Cancer Phase 2 Completed - Korea, Republic of ... More >> Dong-A University Hospital Busan, Korea, Republic of, 602-715 Gyeongsang Unversity Hospital JinJU, Korea, Republic of Chung-Ang University Hospital Seoul, Korea, Republic of, 156-755 Less <<
NCT03557112 Nasopharyngeal Carcinoma Phase 2 Recruiting December 1, 2021 China, Guizhou ... More >> Cancer Hospital of Guizhou Medical University Recruiting Guiyang, Guizhou, China, 550000 Contact: Feng Jin, Bachelor    86-13985124806    jinf8865@yahoo.com.cn    Contact: Weili Wu, Master    86-13885124077    wwlmhy@163.com    Sub-Investigator: Weili Wu, master          Sub-Investigator: Yuanyuan Li, master          Sub-Investigator: Jinhua Long, master          Sub-Investigator: Xiuyun Gong, bachelor          Sub-Investigator: Xiaoxiao Chen, bachelor          Sub-Investigator: Yu Chen, master Less <<
NCT02632305 Unresectable Biliary Tract Can... More >>cer Less << Phase 2 Recruiting June 2020 Canada, Alberta ... More >> Cross Cancer Institute Recruiting Edmonton, Alberta, Canada Contact: Jennifer Spratlin, MD FRCPC       Jennifer.Spratlin@albertahealthservices.ca Less <<
NCT01579929 Lung Cancer Phase 1 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Sleepy Hollow, New York, United States Less <<
NCT03371550 Locally Advanced Non-small Cel... More >>l Lung Cancer Less << Phase 2 Completed - -
NCT03012477 Triple-negative Metastatic Bre... More >>ast Cancer Less << Phase 2 Recruiting December 2024 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Steven Isakoff, MD, PhD          Contact    617-726-4920    sisakoff@partners.org    Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Sara Tolaney, MD, MPH    617-632-3800    stolaney@partners.org    Principal Investigator: Sara Tolaney, MD, MPH Less <<
NCT01661114 Pancreatic Cancer ... More >> Biliary Cancer Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT01661114 - Completed - -
NCT03660449 Esophageal Squamous Cell Carci... More >>noma Less << Phase 2 Recruiting August 2023 China, Guangdong ... More >> Hui Liu Recruiting Guangzhou, Guangdong, China, 510000 Contact: Hui Liu, professor    +86-020-87343031    liuhui@sysucc.org.cn Less <<
NCT02967887 Hepatocellular Carcinoma Non-R... More >>esectable Less << Phase 2 Recruiting December 2018 Korea, Republic of ... More >> Korea University Ansan Hospital Not yet recruiting Ansan, Korea, Republic of Contact: Yim, MD., PhD.          Sooncheonhyang University Hospital Bucheon Not yet recruiting Bucheon, Korea, Republic of Contact: Kim, MD., PhD.          The Catholic University of Korea Bucheon ST. Mary's Hospital Not yet recruiting Bucheon, Korea, Republic of Contact: Lee, MD., PhD.          Keimyung University Dongsan Medical Center Not yet recruiting Daegu, Korea, Republic of Contact: Chung, MD., PhD.          The Catholic University of Korea Daejeon ST. Mary's Hospital Not yet recruiting Daejeon, Korea, Republic of Contact: Song, MD., PhD.          Chonnam National University Hwasun Hospital Not yet recruiting Hwasun, Korea, Republic of Contact: Cho, MD., PhD.          Korea University Anam Hospital Not yet recruiting Seoul, Korea, Republic of Contact: Seo, MD., PhD.          Seoul National University Hospital Not yet recruiting Seoul, Korea, Republic of Contact: Yoon, MD., PhD.          Sooncheonhyang University Hospital Seoul Recruiting Seoul, Korea, Republic of Contact: Jang, MD., PhD.          The Catholic University of korea, Seoul ST. Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Si Hyun Bae, MD., PhD.          Ajou University Hospital Recruiting Suwon, Korea, Republic of Contact: Wang, MD., PhD.          Contact: Cheong, MD., PhD.          The Catholic University of Korea ST. Vincent's Hospital Not yet recruiting Suwon, Korea, Republic of Contact: Song, MD., PhD. Less <<
NCT01275183 Head and Neck Cancer Early Phase 1 Completed - United States, New Mexico ... More >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 Less <<
NCT03296306 Bladder Cancer ... More >> Ureter Cancer Urethral Cancer Transitional Cell Carcinoma Less << Phase 3 Recruiting February 2022 Korea, Republic of ... More >> Kwonoh Park Recruiting Yangsan, Gyeongsangnam-do, Korea, Republic of, 50612 Contact: Kwonoh Park, MD, PhD    1033783529    parkkoh@daum.net    Hallym University Medical Center, Hallym University College of Medicine Recruiting Anyang, Korea, Republic of Contact: Ho Young Kim       ksfam@daum.net    Fatima Hospital Recruiting Daegu, Korea, Republic of Contact: Jung Lim Lee       junglim3@gmail.com    Keimyeong University Dongsan Medical Center Recruiting Daegu, Korea, Republic of Contact: Jin Young Kim, MD       takgu@dsmc.or.kr    Chungnam University Hospital Recruiting Daejeon, Korea, Republic of Contact: Hyo Jin Lee, MD, PhD.       cymed@cnu.ac.kr    National Health Insurance Service Ilsan Hospital Recruiting Goyang, Korea, Republic of Contact: Soo Jung Hong       suzzy901@nhimc.or.kr    Gil Medical Center Recruiting Incheon, Korea, Republic of Contact: Inkeun Park, MD, PhD       ingni79@hanmail.net    Inje University Haeundae Paik Hospital Recruiting Pusan, Korea, Republic of Contact: Il-Hwan Kim       onelement@daum.net    Kosin University Hospital Recruiting Pusan, Korea, Republic of Contact: Sung-Hoon Shin       ssh1533@daum.net    Pusan National University Hospital, Pusan National University School of Medicine Recruiting Pusan, Korea, Republic of Contact: Hyo Jung Kim       leonkim80@naver.com    Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Jae-Lyun Lee, MD, PhD       jaelyun@amc.seoul.kr    Chung Ang University Hospital Recruiting Seoul, Korea, Republic of Contact: Hee Joon Kim          Inje University Sanggye Paik Hospital Recruiting Seoul, Korea, Republic of Contact: Byeong Seok Sohn       imbs@paik.ac.kr    Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine Recruiting Seoul, Korea, Republic of Contact: Yun-Gyoo Lee       gosciny@gmail.com    Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Contact: Yoon Ji Choi       yoonji23@hanmail.net    Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine Recruiting Seoul, Korea, Republic of Contact: Bhum Suk Keam          Contact       bhumsuk@snu.ac.kr    VHS medical center Recruiting Seoul, Korea, Republic of Contact: Bong-Seog Kim          Yonsei Cancer Center Recruiting Seoul, Korea, Republic of Contact: Sang Joon Shin       ssj338@yuhs.ac    St. Vincent's Hospital, The Catholic University of Korea Recruiting Suwon, Korea, Republic of Contact: Byoung Yong Shim       shimby@catholic.ac.kr Less <<
NCT01587820 Head and Neck Cancer Early Phase 1 Terminated(lack of enrollment) - United States, Illinois ... More >> Southern Illinois University School of Medicine Springfield, Illinois, United States, 62701 Simmons Cancer Institute at SIU School of Medicine Springfield, Illinois, United States, 62702 Less <<
NCT00580333 Breast Cancer Phase 2 Active, not recruiting June 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02291211 Stage IV Gastric Cancer Phase 2 Unknown December 2016 China, Shaanxi ... More >> IEC of Insititution for National Drug Clinical Trials,Tangdu Hospital,Fourth Military Medical University Recruiting Xi'an, Shaanxi, China, 029 Contact: Lina Liu    029-84777631    tangduec@126.com Less <<
NCT03068936 Nasopharyngeal Carcinoma Phase 3 Not yet recruiting September 2021 -
NCT02546934 Breast Cancer Phase 2 Recruiting December 2019 China ... More >> Fudan University Cancer Hospital Recruiting Shanghai, China, 200032 Contact: Xichun Hu, MD,PhD    64175590 ext 5006    huxicun@gmail.com    Contact: Zhonghua Wang, MD    64175590 ext 5000    zhonghuawang95@hotmail.com Less <<
NCT01554410 Cervical Carcinoma Phase 1 Unknown August 2015 United States, California ... More >> Moores UC San Diego Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Norma Hernandez    858-822-5036    nohernandez@ucsd.edu    Principal Investigator: Loren Mell, MD          Sub-Investigator: Arno Mundt, MD          Sub-Investigator: Catheryn Yashar, MD          Sub-Investigator: Steven Plaxe, MD          Sub-Investigator: Michael McHale, MD          Sub-Investigator: Cheryl Saenz, MD Less <<
NCT00580333 - Active, not recruiting - -
NCT02202772 Urothelial Carcinoma of the Ur... More >>inary Bladder Less << Phase 1 Active, not recruiting December 1, 2020 United States, New York ... More >> Columbia University Medical Center- HIP New York, New York, United States, 10032 Less <<
NCT01312311 Nasopharyngeal Cancer Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Myung-Ju Ahn, Pf    822-3410-3459    silkahn@skku.edu Less <<
NCT01743365 Gastric Cancer ... More >> Gastroesophageal Junction Cancer Less << Phase 2 Active, not recruiting June 2019 Greece ... More >> 2nd Dept of Internal Medicine, Agios Savvas Cancer Hospital Athens, Greece, 11522 Dept of Medical Oncology, 251 Air Force Hospital Athens, Greece, 11525 2nd Dept of Internal Medicine, General Hospital of Athens "Hippokratio" Athens, Greece, 11527 Oncology Section, Dept of Clinical Therapeutics, General Hospital of Athens "Alexandra" Athens, Greece, 11528 Division of Oncology, 2nd Dept of Internal Medicine, University Hospital "Attikon" Athens, Greece, 12462 2nd Dept of Medical Oncology, Agii Anargiri Cancer Hospital Athens, Greece, 14564 3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital Athens, Greece, 14564 3rd Dept of Medical Oncology, Hygeia Hospital Athens, Greece, 15123 1st Dept of Medical Oncology, Metropolitan Hospital Athens, Greece, 18547 2nd Dept of Medical Oncology, Metropolitan Hospital Athens, Greece, 18547 Dept of Medical Oncology, University Hospital of Heraklion Heraklion, Greece, 71110 Dept of Medical Oncology, Ioannina University Hospital Ioannina, Greece, 45110 Division of Oncology, Dept of Internal Medicine, University Hospital of Patras Patras, Greece, 26504 Dept of Medical Oncology, Papageorgiou General Hospital Thessaloniki, Greece, 56429 Dept of Medical Oncology, Thermi Clinic S.A Thessaloniki, Greece, 57001 Less <<
NCT02143388 Local Advanced High Risk Nasop... More >>haryngeal Carcinoma Less << Phase 2 Phase 3 Recruiting December 2018 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China Contact: Zhao chong, M.D    +86-13902206160    zhaochong@sysucc.org.cn Less <<
NCT01009346 - Terminated(Toxicity) - -
NCT03311789 Biliary Tract Cancer Phase 1 Phase 2 Recruiting October 2019 China ... More >> Department of Biotherapeutic, Chinese PLA General Hospital Recruiting Beijing, China Contact: Weidong Han, Ph.D    +86-10-66937463    hanwdrsw@sina.com    Contact: Kaichao Feng, MD    +86-10-55499341    timothyfkc@126.com Less <<
NCT01372904 Cisplatin Ototoxicity Phase 4 Completed - Israel ... More >> Clalit Health Services Haifa, Israel Less <<
NCT01182168 Bladder Cancer ... More >> Renal Pelvis Cancer Ureter Cancer Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00353015 Gastrointestinal Cancer ... More >> Carcinoma, Neuroendocrine Less << Phase 2 Completed - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03601975 Nasopharyngeal Carcinoma Phase 3 Recruiting July 30, 2021 China, Tianjin ... More >> 20th Floor, Block C, Lake Road, Hexi District, Tianjin Medical University Cancer Institute and Hospital . Recruiting Tianjin, Tianjin, China, 300600 Contact: Ming Gao, doctor       yunspider@126.com Less <<
NCT02481518 Acute Kidney Injury Phase 4 Recruiting July 2019 Thailand ... More >> Faculty of medicine, Ramathibodi Hospital, Mahidol University Recruiting Bangkok, Thailand, 10400 Contact: Arkom Nongnuch, MD.    +6622011400    oatega@yahoo.com Less <<
NCT00257816 Cervical Cancer Phase 2 Completed - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT01320254 Cholangiocarcinomas Phase 2 Completed - Germany ... More >> Esslingen Hospital Esslingen, Baden-Wuerttemberg, Germany, 73730 University Hospital Freiburg Freiburg, Baden-Wuerttemberg, Germany, 79106 National Centre for Tumor Diseases (NCT) Heidelberg, Baden-Wuerttemberg, Germany, 69120 University Hospital Mannheim Mannheim, Baden-Wuerttemberg, Germany, 68167 Kreiskliniken Reutlingen GmbH Reutlingen, Baden-Wuerttemberg, Germany, 72764 University Hospital Tuebingen Tuebingen, Baden-Wuerttemberg, Germany, 72076 Klinikum rechts der Isar der TU München München, Bavaria, Germany, 81675 University Hospital Regensburg Regensburg, Bavaria, Germany, 93042 Charité Berlin Berlin, Berlin-City, Germany, 13353 University Hospital Hamburg-Eppendorf Hamburg, Free City of Hamburg, Germany, 20246 University Hospital Marburg Marburg, Hesse, Germany, 35043 Medical School Hannover Hannover, Lower Saxony, Germany, 30625 University Hospital Essen Essen, Northrhine-Westfalia, Germany, 45122 University Hospital Köln Köln, Northrhine-Westfalia, Germany, 50924 University Hospital Mainz Mainz, Rhineland-Palatinate, Germany, 55131 Magdeburg Hospital Magdeburg, Saxony-Anhalt, Germany, 39130 Less <<
NCT02838745 Mesothelioma Phase 1 Recruiting August 2018 United States, Texas ... More >> Baylor St Lukes Recruiting Houston, Texas, United States, 77030 Contact: Michelle G Almarez, BBA    713-798-3680    Michelle.Almarez@bcm.edu    Contact: Bryan Burt, MD    713-798-8266    Bryan.Burt@bcm.edu    Principal Investigator: Bryan Burt, MD Less <<
NCT02512692 Intrahepatic Cholangiocarcinom... More >>a Less << Not Applicable Recruiting August 2021 United States, South Carolina ... More >> Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Sarah Annand    843-792-9321    hcc-clinical-trials@musc.edu Less <<
NCT01261728 Urothelial Carcinoma Phase 2 Recruiting December 2019 United States, Connecticut ... More >> Hartford Hospital Recruiting Hartford, Connecticut, United States Contact: Robert Siegel, MD          Principal Investigator: Robert Siegel, MD          United States, Florida Baptist Alliance MCI Recruiting Miami, Florida, United States, 33143 Contact: Antonio Muina, MD    786-596-2000       United States, New Jersey Memorial Sloan Kettering at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Jonathan Coleman, MD    646-422-4432       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Jonathan Coleman, MD    646-422-4432       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Jonathan Coleman, MD    646-422-4432       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Jonathan Coleman, MD    646-422-4432       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Jonathan Coleman, MD    646-422-4432       Contact: Dean Bajornin, MD    646-422-4333       Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Jonathan Coleman, MD    646-422-4432       United States, Pennsylvania Lehigh Valley Health Network Recruiting Allentown, Pennsylvania, United States, 18103 Contact: Jonathan Coleman, MD    646-422-4432 Less <<
NCT01650090 Pulmonary Relapse of Osteosarc... More >>oma Less << Phase 2 Active, not recruiting December 2018 United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Louisiana Ochsner Clinic Foundation New Orleans, Louisiana, United States, 70121 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York The Children's Hospital at Montefiore Bronx, New York, United States, 10467 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas UT Southwestern Medical Center Dallas, Texas, United States, 75390 Baylor College of Medicine/Texas Children's Hospital Houston, Texas, United States, 77030 United States, Utah Primary Children's Medical Center Salt Lake City, Utah, United States, 84113 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT02128906 Squamous Cell Carcinoma Phase 2 Recruiting December 2020 United States, Pennsylvania ... More >> University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Karen Holeva, RN    412-623-1275    holevakd@upmc.edu Less <<
NCT01285674 Cisplatin Oto... More >>toxicity Intratympanic Steroids Less << Not Applicable Unknown January 2012 Israel ... More >> Ziv Medical Center Recruiting Safed, Israel, 13100 Contact: Peter Gilbey, MD    972-50-8434014    peter.g@ziv.health.gov.il    Principal Investigator: Peter Gilbey, MD          Sub-Investigator: Khalil Khalil, MD          Sub-Investigator: Jamal Zidan, MD Less <<
NCT01444547 Esophageal Cancer Phase 2 Unknown December 2015 China ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, China, 100021 Contact: Yi Zhou, M.D    8610-87788800    mondaycm@yahoo.com.cn    Contact: Xiao Lv, M.D    8610-87788800    xiaoxiao81473@126.com    Principal Investigator: Jing Huang, M.D.,Ph.D Less <<
NCT03079427 Cholangiocarcinoma ... More >> Biliary Tract Cancer Adjuvant Chemotherapy Capecitabine Gemcitabine Cisplatin Less << Phase 2 Recruiting April 2022 Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 05505 Contact: Changhoon Yoo, MD    +82-2-3010-1727    yooc@amc.seoul.kr Less <<
NCT01801644 Bladder Cancer Not Applicable Completed - Austria ... More >> Barmherzige Brüder Vienna Vienna, Austria, 1020 Less <<
NCT03193853 Triple Negative Breast Cancer Phase 2 Recruiting June 9, 2022 United States, Texas ... More >> Baylor University Medical Center Recruiting Dallas, Texas, United States, 75246 Contact: Amy Solis    214-820-8685    amy.solis@bswhealth.org    Contact: Silviya Meletath, MD    214-820-4987    silviya.meletath@bswhealth.org    Principal Investigator: Joyce O'Shaughnessy, MD Less <<
NCT01444521 Gastric Cancer Phase 2 Completed - China ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, China, 100021 Less <<
NCT02351765 Biliary Tract Cancer ... More >> Gallbladder Cancer Cholangiocarcinoma Ampullary Cancer Less << Phase 1 Active, not recruiting February 2019 United Kingdom ... More >> Beatson Oncology Centre Glasgow, United Kingdom Clatterbridge Cancer Centre Liverpool, United Kingdom Imperial College London London, United Kingdom University College London London, United Kingdom The Christie NHS Foundation Trust Manchester, United Kingdom Less <<
NCT00968435 Head and Neck Cancer Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States, 07939 United States, New York Memorial Sloan Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT03275857 Prostate Cancer EARLY_PHASE1 COMPLETED 2023-07-31 Wilmot Cancer Institute, Roche... More >>ster, New York, 14642, United States Less <<
NCT01096745 Metastatic Biliary Tract Cance... More >>r Locally Advanced Biliary Tract Cancer Less << Phase 2 Terminated(Planning for random... More >>ized phase III trial for this issue.) Less << September 2013 Korea, Republic of ... More >> Gyeongsang University Hospital Jinju, Gyeongsang Namdo, Korea, Republic of, 660-702 Less <<
NCT01872962 Nasopharyngeal Carcinoma Phase 3 Active, not recruiting November 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT02254681 Intrahepatic Cholangiocarcinom... More >>a Less << Phase 2 Terminated(lack of funding) - United States, Minnesota ... More >> Virginia Piper Cancer Institute Minneapolis, Minnesota, United States, 55407 Less <<
NCT01336842 Solid Tumors ... More >>Non-Small Cell Lung Cancer (NSCLC) Less << Phase 1 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 Less <<
NCT00808145 Hepatocellular Carcinoma Phase 2 Withdrawn(Lack of enrollment, ... More >>many screen failures and non eligible study participants) Less << - United States, Massachusetts ... More >> Lahey Clinic Burlington, Massachusetts, United States, 01805 Less <<
NCT02254681 - Terminated(lack of funding) - -
NCT01982448 Triple Negative Breast Cancer Phase 2 Active, not recruiting June 2021 United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, Indiana Indiana University- Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 South Shore Hospital Weymouth, Massachusetts, United States, 02190 United States, New Jersey Memorial Sloan Kettering Cancer Center-Basking Ridge Basking Ridge, New Jersey, United States, 07920 Memorial Sloan Kettering Cancer Center-Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Cancer Center-Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center-West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center-Rockville Centre Rockville Centre, New York, United States, 11570 Memorial Sloan Kettering Cancer Center-Sleepy Hollow Sleepy Hollow, New York, United States, 10591 United States, North Carolina University of North Carolina- Lineberger Cancer Center Chapel Hill, North Carolina, United States, 27599 Duke University Durham, North Carolina, United States, 27710 United States, Pennsylvania Universtiy of Pittsburgh- Magee-Womens Hospital Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Seattle Cancer Alliance at EvergreenHealth Kirkland, Washington, United States, 98034 University of Washignton Seattle, Washington, United States, 98195 Less <<
NCT02207660 - Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT01869023 Advanced Malignant Pleural Mes... More >>othelioma Less << Phase 2 Active, not recruiting December 2017 Mexico ... More >> Instituto Nacional de Cancerología Mexico City, Mexico Less <<
NCT00935961 HEAD & NECK Cancer Phase 1 Completed - United States, New Jersey ... More >> Memorial Sloan-Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States, 07939 United States, New York Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT01854203 Nasopharyngeal Carcinoma Phase 2 Phase 3 Unknown December 2016 China, Guangdong ... More >> Cancer Center,Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Jian-jun Li, MD    +862087343381    lijj@sysucc.org.cn    China State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University Not yet recruiting Guangzhou, China, 510060 Principal Investigator: Jian-jun Li, M.D.          Sub-Investigator: Li-zhi Liu, M.D. Less <<
NCT01387399 Ovarian Cancer Phase 1 Unknown July 2013 Germany ... More >> University Hospital Bonn, Germany, 53127 Less <<
NCT02392637 Biliary Tract Cancer Phase 2 Active, not recruiting April 2019 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55902 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02182778 Biliary Tract Cancer Phase 3 Active, not recruiting May 2019 Japan ... More >> Kyoto University Hospital Kyoto, Japan, 606-8507 Less <<
NCT01670500 Breast Cancer Phase 2 Recruiting October 2021 United States, Colorado ... More >> University of Colorado Cancer Center Recruiting Aurora, Colorado, United States, 80045 Contact: Virginia Borges, MD    303-724-0186    virginia.borges@ucdenver.edu    United States, Connecticut Smilow Cancer Hospital Care Center at Derby Recruiting Derby, Connecticut, United States, 06418 Contact: Erin Hofstatter, MD       erin.hofstatter@yale.edu    Smilow Cancer Hospital Care Center at Guilford Recruiting Guilford, Connecticut, United States, 06437 Contact: Erin Hofstatter, MD       erin.hofstatter@yale.edu    St. Francis Hospital and Medical Center Recruiting Hartford, Connecticut, United States, 06105 Contact: Erin Hofstatter, MD       erin.hofstatter@yale.edu    Yale School of Medicine Recruiting New Haven, Connecticut, United States, 06520 Contact: Erin Hofstatter, MD    203-737-1600    erin.hofstatter@yale.edu    United States, District of Columbia Georgetown University Medical Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Claudine Isaacs, MD       isaacsc@georgetown.edu    Sibley Memorial Hospital Recruiting Washington, District of Columbia, United States, 20016-2698 Contact: Antonio Wolff, MD       awolff@jhmi.edu    United States, Maryland Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Antonio Wolff, MD       awolff@jhmi.edu    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Steven Isakoff, MD, PhD    617-726-4920    sisakoff@partners.org    Principal Investigator: Steven Isakoff, MD, PhD          Dana-Farber Cancer Institute at Faulkner Hospital Withdrawn Boston, Massachusetts, United States, 02130 Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Nadine Tung, MD    617-667-7081    ntung@bidmc.harvard.edu    Principal Investigator: Nadine Tung, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Judy Garber, MD, MPH    617-632-2282    jegarber@partners.org    Principal Investigator: Judy Garber, MD, MPH          United States, New Hampshire New Hampshire Oncology-Hematology Withdrawn Hooksett, New Hampshire, United States, 03106 United States, New Jersey Rutgers Cancer Institute of New Jersey Active, not recruiting New Brunswick, New Jersey, United States, 08901 United States, New York Memorial Sloan-Kettering Cancer Center Withdrawn New York, New York, United States, 10065 United States, North Carolina Duke University Recruiting Durham, North Carolina, United States, 27708 Contact: P. Kelly Marcom       kelly.marcom@dm.duke.edu    United States, Rhode Island Women and Infants Hospital Recruiting Providence, Rhode Island, United States, 02905 Contact: Robert Legare, MD    401-453-7540    rlegare@wihri.org    United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Banu Arun, MD    713-792-2817    barun@mdanderson.org    MD Anderson in Katy Withdrawn Houston, Texas, United States, 77094 MD Anderson in the Bay Area Withdrawn Nassau Bay, Texas, United States, 77058 MD Anderson - Sugar Land Withdrawn Sugar Land, Texas, United States, 77478 MD Anderson - The Woodlands Withdrawn The Woodlands, Texas, United States, 77384 Less <<
NCT01114958 Lung Neoplasms ... More >> Neoplasm Metastasis Less << Phase 1 Unknown - United States, California ... More >> University of California, San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Yuri Matusov    858-246-0357    matusov@ucsd.edu    Principal Investigator: William Read, M.D. Less <<
NCT01165385 Solid Tumors ... More >>Metastatic Cancer Less << Phase 1 Completed - France ... More >> Centre François BACLESSE Caen, France, 14076 Centre Georges François LECLERC Dijon, France, 21079 Centre Léon Berard Lyon, France, 69373 CEDEX 08 Centre René Gauducheau Nantes Saint Herblain, France, 44805 Institut Curie Paris, France, 75248 Less <<
NCT02723864 Neoplasms Phase 1 Recruiting December 31, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937       United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030-4096 Less <<
NCT00995761 Non-small Cell Lung Cancer Phase 2 Completed - Korea, Republic of ... More >> Gyeongsang National University Hospital Jinju, Gyeongsang-Nam-Do, Korea, Republic of, 660-702 Less <<
NCT01149798 Metastatic Breast Cancer Phase 2 Completed - China ... More >> Fudan University Cancer Hospital Shanghai, China, 200032 Less <<
NCT03644589 Estrogen Receptor Negative ... More >> HER2/Neu Negative Metastatic Breast Cancer Progesterone Receptor Negative Recurrent Breast Carcinoma Triple Negative Breast Cancer Less << Phase 2 Not yet recruiting October 30, 2022 United States, Washington ... More >> Seattle Cancer Care Alliance, Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Jennifer Specht, MD Less <<
NCT03558087 Bladder Cancer Phase 2 Recruiting June 2022 United States, New York ... More >> Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center Recruiting New York, New York, United States, 10029 Contact: Matthew Galsky, M.D.    212-241-8214    matthew.galsky@mssm.edu Less <<
NCT00995761 - Completed - -
NCT03639467 Recurrent Nasopharyngeal Carci... More >>noma Metastatic Nasopharyngeal Carcinoma Less << Phase 1 Phase 2 Recruiting August 15, 2023 China, Beijing ... More >> National Cancer Center/Cancer Hospitial,Chinese Academy of Medical Sciences and Peking Union Medical College Recruiting Beijing, Beijing, China, 100021 Contact: Yuankai Shi, MD    +86-10-87788293    syuankaipumc@126.com Less <<
NCT02030574 - Terminated(The study is being ... More >>closed to accrual secondary to low accrual and an interest in opening up a different trial.) Less << - -
NCT00916500 CERVICAL NEOPLASMS Phase 2 Completed - Korea, Republic of ... More >> Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences Seoul, Korea, Republic of, 139-706 Less <<
NCT00901537 Non-small Cell Lung Cancer ... More >> Squamous Cell Carcinoma of the Head and Neck Less << Phase 1 Terminated(Sponsor terminated ... More >>due to no enrollments within last 4 months.) Less << - United States, California ... More >> Loma Linda University Cancer Center Loma Linda, California, United States, 92354 Less <<
NCT02475772 Ovarian Cancer Phase 1 Completed - Germany ... More >> Ruhr University Bochum, Germany, Marienhospital Herne Herne, North-Rhine Westphalia, Germany, 44625 Less <<
NCT01928680 Metastatic Breast Cancer Phase 2 Unknown March 2016 China, Beijing ... More >> Cancer Hospital, ChineseAMS Beijing, Beijing, China, 100021 Less <<
NCT02030574 Invasive Bladder Cancer ... More >> Bladder Cancer Less << Phase 2 Terminated(The study is being ... More >>closed to accrual secondary to low accrual and an interest in opening up a different trial.) Less << - United States, Rhode Island ... More >> Rhode Island Hospital (including Newport Hospital and East Greenwich) Providence, Rhode Island, United States, 02903 The Miriam Hospital Providence, Rhode Island, United States, 02906 Less <<
NCT01674842 Breast Cancer Phase 1 Active, not recruiting October 2023 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Dana-Farber at Milford Milford, Massachusetts, United States, 01757 Dana Farber at South Shore Hospital Weymouth, Massachusetts, United States, 02190 Less <<
NCT03330249 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Active, not recruiting December 2020 France ... More >> Centre Paul Strauss Strasbourg, France, 67065 Less <<
NCT01928680 - Unknown - -
NCT02250872 Cancer Cispla... More >>tin Adverse Reaction Less << Phase 2 Phase 3 Unknown June 2018 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Contact: Hyunjin Cho    82 31 787 7030       Principal Investigator: Ki Young Na, MD PhD Less <<
NCT01561586 Cervical Cancer Phase 3 Recruiting March 2023 China ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China Contact: Gui Hao Ke          Korea, Republic of Dongnam Inst.of Radiological/Medical Science Recruiting Busan, Korea, Republic of Contact: Sang-IL Park          Soon Chun Hyang University Hospital Recruiting Cheonan, Korea, Republic of Contact: Seob Jeon          Dongsan Medical Center Recruiting Daegu, Korea, Republic of Contact: Chi-Heum Cho          Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Joo-Hyun Nam          Ewha Womans University Mokdong Hospital Recruiting Seoul, Korea, Republic of Contact: Seung Cheol Kim          Gachon University Gil Hospital Recruiting Seoul, Korea, Republic of Contact: Gwang Beom Lee          Gangnam Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Jae-Hoon Kim          Korea Cancer Center Hospital, Korea Institute of Radiological & Medical Sciences Recruiting Seoul, Korea, Republic of Contact: SANG YOUNG RYU, M.D.    82-2-970-1227    ryu@kcch.re.kr    Principal Investigator: SANG YOUNG RYU, M.D.          Korea University Guro Hospital Recruiting Seoul, Korea, Republic of Contact: Jin Hwa Hong          Kyungpook National University Hospital Recruiting Seoul, Korea, Republic of Contact: Sun-joo Lee          Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Hak Jae Kim          Severance Hospital/Sinchon Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Young Tae Kim          Thailand Faculty of Medicine, Ramathibodi Hospital, Mahidol University Recruiting Bankok, Thailand Contact: SARIKAPAN WILAILAK, M.D.    66-2-2011451    raswl@mahidol.ac.th    Principal Investigator: SARIKAPAN WILAILAK, M.D.          Vietnam Ho Chi Minh City Oncology Hospital Recruiting Ho Chi Minh, Vietnam Contact: Thinh Dang huy Quoc Less <<
NCT02277184 Carcinoma, Squamous Cell of He... More >>ad and Neck Less << Phase 1 Terminated(the investigator le... More >>ft the institution) Less << - United States, Pennsylvania ... More >> UPMC Presbyterian Pittsburgh, Pennsylvania, United States, 15213 Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 UPMC Shadyside Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02994069 Carcinoma, Squamous Cell ... More >> Head and Neck Cancer Less << Phase 2 Recruiting October 31, 2028 United States, Kentucky ... More >> University of Kentucky Recruiting Lexington, Kentucky, United States, 40536 Contact: Susanne Arnold, MD    859-323-8043    susanne.arnold@uky.edu Less <<
NCT01980667 Advanced Solid Tumors Phase 1 Completed - Switzerland ... More >> Bellinzona, Switzerland United Kingdom London, United Kingdom Newcastle, United Kingdom Less <<
NCT01644994 Malignant Pleural Mesothelioma Phase 1 Phase 2 Recruiting August 2020 Switzerland ... More >> University Hospital Zurich, Division of Thoracic Surgery Recruiting Zurich, ZH, Switzerland, 8091 Contact: Isabelle Opitz, Prof MD    +41 44 255 11 11    isabelle.schmitt-opitz@usz.ch Less <<
NCT03639168 Adenoid Cystic Carcinomas ... More >> Chidamide Cisplatin Less << Phase 2 Recruiting June 1, 2020 China, Shanghai ... More >> Kai Xue Recruiting Shanghai, Shanghai, China, 200032 Contact: Kai Xue, MD    13818659448    xuekaishanghai@126.com Less <<
NCT01611727 BRCA1 Mutation|Metastatic Brea... More >>st Cancer Less << PHASE2 COMPLETED 2025-04-09 Pomenarian Medical University,... More >> Szczecin, Poland Less <<
NCT00826644 Carcinoma, Small Cell Phase 3 Unknown December 2012 Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Recruiting Hwasun-gun, Jeonnam, Korea, Republic of Contact: In-Jae Oh, M.D.,Ph.D.    82-61-379-7617    droij@chonnam.ac.kr Less <<
NCT01281696 Breast Neoplasms ... More >> Leptomeningeal Metastasis Brain Metastases Less << Phase 2 Completed - Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei City, Taiwan, 100 Less <<
NCT00895245 - Terminated(Study stopped due t... More >>o lack of efficacy in first 6 patients) Less << - -
NCT02639767 Malignant Pleural Mesothelioma Phase 1 Withdrawn(Lack of accrual) - United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Memorial Sloan Kettering West Harrison West Harrison, New York, United States, 10604 Less <<
NCT01893801 Stage IV Pancreatic Cancer Phase 1 Phase 2 Unknown August 2014 United States, Arizona ... More >> Scottsdale Health Care Recruiting Scottsdale, Arizona, United States, 85260 Contact: Joyce Schaffer, MSN RN AOCNS    480-323-1339    joschaffer@shc.org    Principal Investigator: Gayle S Jameson, MSN ACNP-BC          Sub-Investigator: Ramesh K Ramanathan, MD          Sub-Investigator: Daniel D Von Hoff, MD FACP          Sub-Investigator: Katy B Schroeder, RN BSN OCN          United States, New Jersey Rutgers - Cancer Institute of New Jersey (CINJ) Recruiting New Brunswick, New Jersey, United States, 08901 Contact: Anjali Krishnan, RN    732-235-8996    warrieac@cinj.rutgers.edu    Contact: Tatianna Zelinskaya    732-235-9837    zelinska@cinj.rutgers.edu    Principal Investigator: Elizabeth Popllin, MD          United States, Pennsylvania Vita Medical Associates, PC Recruiting Bethlehem, Pennsylvania, United States, 18015 Contact: Colleen Saitta, NP    610-866-0113    nurses@vitahemonc.org    Contact: Gulyun Zhou, NP    610-866-0113    nurses@vitahemonc.org    Principal Investigator: Anna A Niewiarowska, MD Less <<
NCT00895245 Nausea and Vomiting ... More >> Stage III Squamous Cell Carcinoma of the Hypopharynx Stage III Squamous Cell Carcinoma of the Larynx Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Stage III Squamous Cell Carcinoma of the Nasopharynx Stage III Squamous Cell Carcinoma of the Oropharynx Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Larynx Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IV Squamous Cell Carcinoma of the Oropharynx Less << Phase 2 Terminated(Study stopped due t... More >>o lack of efficacy in first 6 patients) Less << - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00322920 Cervix Cancer Phase 1 Terminated(Low accrual) - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 Less <<
NCT03081039 Intrahepatic Cholangiocarcinom... More >>a Less << Phase 3 Withdrawn(Competing study) December 31, 2022 United States, Kentucky ... More >> University of Louisville Louisville, Kentucky, United States, 40202 Less <<
NCT02610556 Nasopharyngeal Carcinoma Phase 2 Recruiting January 2022 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Fang-Yun Xie, M.D.    +86-020-87342618    xiefy@sysucc.org.cn    Contact: Pu-Yun OuYang, M.D.    +86-020-87342618    ouyangpy@sysucc.org.cn Less <<
NCT00847015 Bladder Cancer ... More >> Urinary Bladder Less << Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center@Phelps Sleepy Hollow, New York, United States Less <<
NCT00969761 Neoplasms Phase 1 Completed - Belgium ... More >> 1230.6.3201 Boehringer Ingelheim Investigational Site Bruxelles, Belgium 1230.6.3202 Boehringer Ingelheim Investigational Site Leuven, Belgium Less <<
NCT00847015 - Completed - -
NCT00702299 - Completed - -
NCT00174837 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 3 Completed - -
NCT02094625 Neuroectodermal Tumors, Primit... More >>ive Liver Neoplasms Osteosarcoma Other Childhood Cancers Using Cisplatin-based Regimens Less << Phase 1 Recruiting October 2020 United States, California ... More >> Childrens Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Principal Investigator: Etan Orgel, MD MS          Sub-Investigator: David R Freyer, DO MS Less <<
NCT02734537 Head and Neck Squamous Cell Ca... More >>rcinoma Hypopharyngeal Squamous Cell Carcinoma Laryngeal Squamous Cell Carcinoma Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant Lip and Oral Cavity Squamous Cell Carcinoma p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma Stage III Hypopharyngeal Carcinoma AJCC v8 Stage III Laryngeal Cancer AJCC v8 Stage III Lip and Oral Cavity Cancer AJCC v8 Stage III Oral Cavity Verrucous Carcinoma Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Stage IVA Hypopharyngeal Carcinoma AJCC v8 Stage IVA Laryngeal Cancer AJCC v8 Stage IVA Lip and Oral Cavity Cancer AJCC v8 Stage IVA Oral Cavity Verrucous Carcinoma Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 Less << Phase 2 Recruiting May 1, 2027 -
NCT02422498 Locally Recurrent/Metastatic T... More >>riple Negative Breast Cancer Less << Phase 2 Recruiting April 2019 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Simon Powell, MD, PhD    212-639-3639       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Simon Powell, MD, PhD    212-639-3639       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Simon Powell, MD, PhD    212-639-3639       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Simon Powell, PhD    212-639-3639       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Simon Powell, MD, PhD    212-639-3639       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Simon Powell, MD, PhD    212-639-3639       Contact: George Plitas, MD, PhD    646-888-4587       Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Simon Powell, MD, PhD    212-639-3639 Less <<
NCT01287624 Breast Cancer Phase 3 Completed - China, Shanghai ... More >> Fudan University Cancer Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT00702299 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 1 Completed - United States, Arizona ... More >> Arizona Oncology - Scottsdale Scottsdale, Arizona, United States, 85258 Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724-5024 Less <<
NCT02308072 Head and Neck Cancer Phase 1 Recruiting June 2022 United Kingdom ... More >> Guy's and St Thomas' NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Maria Teresa Guerrero-Urbano          University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Martin Forster          Velindre Cancer Centre Recruiting Wales, United Kingdom, CF14 2TL Principal Investigator: Mererid Evans Less <<
NCT00770874 Cervical Cancer Phase 3 Completed - Japan ... More >> Yanagawa Hospital Chikushimachi, Yanagawa, Fukuoka, Japan, 832-0077 Cancer Institute Hospital Ariake, Koto-ku, Tokyo, Japan, 135-8550 Korea, Republic of Konkuk University Medical Center Hwayang-dong, Gwangjin-gu, Seoul, Korea, Republic of, 143-729 Taiwan Chang Gung Medical Foundation- Linkou Fu-Hsing St. Kuei Shan Hsiang, TaoYuan Hsien, Taiwan, 33305 Less <<
NCT01355302 - Terminated(Sites not recruitin... More >>g) Less << - -
NCT01854255 Gastric Cancer Phase 2 Completed - Germany ... More >> Ruhr University of Bochum Herne, North Rhine Westphalia, Germany, 44625 Less <<
NCT02882308 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Recruiting May 2019 Greece ... More >> Euromedica General Clinic of Thessaloniki Recruiting Thessaloníki, Thessaloniki, Greece, 54645 Contact: George Fountzilas, Prof.Emeritus    00302310683136    fountzil@auth.gr    University Hospital "Attikon", 2nd Department of Internal Medicine, Division of Oncology Recruiting Athens, Greece, 12462 Contact: Diamanto Psyrri, MD,Ass.Prof    0030 2105831256    dp237@email.med.yale.edu Less <<
NCT01689194 Locally Advanced Head and Neck... More >> Squamous Cell Carcinoma Less << Phase 2 Unknown December 2017 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT02016274 Esophageal Squamous Cell Cance... More >>r Less << Phase 2 Unknown July 2016 China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Lin Shen, MD    86-10-88196561    lin100@medmail.com.cn    Contact: Zhihao Lu, MD    86-10-88196561    pppeirain@126.com    Principal Investigator: Lin Shen, MD Less <<
NCT02631590 Biliary Carcinoma ... More >> Gall Bladder Carcinoma Cholangiocarcinoma Gastrointestinal Tumor Less << Phase 2 Recruiting December 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Maria Martinez Jimenez    813-745-1946    maria.martinez@moffitt.org    Contact: Richard D. Kim    813-745-1277    richard.kim@moffitt.org    Principal Investigator: Richard D. Kim, M.D.          Sub-Investigator: Rutika Mehta, M.D.          Sub-Investigator: Dae Won Kim, M.D. Less <<
NCT02429726 Malignant Pleural Effusion Phase 2 Unknown June 2017 China, Shanxi ... More >> The First Affiliated Hospital of Xi'an Jiao Tong University Not yet recruiting Xian, Shanxi, China, 710061 Contact: wei wang, MD    86-13923853040    wei.wang@163.com    Contact: shuanying yang, MD    86-18149098803    yangshuanying66@163.com Less <<
NCT00531687 Testicular Cancer Phase 2 Terminated(slow accrual) - Denmark ... More >> Department of Oncology 5073, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT00198172 Germ Cell Tumor Phase 2 Terminated(Accrual Goal Met) - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00463788 - Completed - -
NCT02485548 Head and Neck Squamous Cell Ca... More >>ncer Less << Phase 3 Unknown June 2018 China, Jiangsu ... More >> Jiangsu Cancer Hospital Recruiting Nanjing, Jiangsu, China, 210009 Contact: Xuesong Jiang, M.D.       13851700790@126.com    Sub-Investigator: Xuesong Jiang, M.D. Less <<
NCT00463788 Breast Neoplasm Phase 2 Completed - -
NCT02990468 Head and Neck Cancer Phase 1 Phase 2 Recruiting February 2020 United States, Nebraska ... More >> University of Nebraska Medical Center Not yet recruiting Omaha, Nebraska, United States, 68198 Contact: Amy Filler-Katz    402-552-2790    afillerkatz@unmc.edu    Principal Investigator: Weining Zhen, MD          United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Joan Cahill, RN    919-668-5211    joan.cahill@duke.edu Less <<
NCT00960349 Gastric Cancer Phase 1 Completed - Japan ... More >> Research Site Nagoya, Aichi, Japan Research Site Osakasayama, Osaka, Japan Research Site Sunto-gun, Shizuoka, Japan Research Site Chuo, Tokyo, Japan Less <<
NCT01126749 Bladder Cancer Phase 1 Phase 2 Completed - -
NCT00845884 Advanced Gastric Cancer Phase 1 Phase 2 Unknown December 2012 Israel ... More >> Davidoff Cancer Center, Rabin Medical Center Not yet recruiting Petach Tikva, Israel, 49100 Contact: Baruch Brenner, MD    972-3-9378005    brennerb@clalit.org.il    Principal Investigator: Baruch Brenner, MD Less <<
NCT01951469 Non-small Cell Lung Cancer ... More >> Brain Metastases EGFR Mutation Less << Phase 2 Recruiting June 2019 China, Guangdong ... More >> Sun Yat-sen University of Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: li-kun Chen, doctor    13798019964    chenlk@sysucc.org.cn    Principal Investigator: li-kun Chen, doctor Less <<
NCT00251407 Solid Tumor Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02562599 Nasopharyngeal Carcinoma Phase 2 Unknown August 2018 China, Hubei ... More >> Hubei Cancer hospital Recruiting Wu Han, Hubei, China, 430079 Contact: Han Guang, PH.D          Principal Investigator: Hu Desheng, M.D Less <<
NCT01282333 Advanced Adult Primary Liver C... More >>ancer Localized Unresectable Adult Primary Liver Cancer Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Stage III Bladder Cancer Stage III Pancreatic Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Bladder Cancer Stage IV Non-small Cell Lung Cancer Stage IV Pancreatic Cancer Transitional Cell Carcinoma of the Bladder Unresectable Extrahepatic Bile Duct Cancer Unresectable Gallbladder Cancer Less << Phase 1 Terminated - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00169221 Head and Neck Cancer Phase 2 Terminated(Toxicity in an inde... More >>pendent study IMEX. The trial was subsequently terminated (54 pts instead of 140) despite safety analyses showing no excess of toxicity) Less << - France ... More >> Centre Antoine Lacassagne Nice, France, 06189 Less <<
NCT00571298 Malignant Pleural Mesothelioma Phase 1 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00386815 Malignant Pleural Mesothelioma Phase 2 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 464-8681 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 811-1395 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 060-8648 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 663-8501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 702-8055 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 589-8511 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 104-0045 Less <<
NCT01614938 Nasopharyngeal Carcinoma Phase 2 Unknown August 2014 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Shanghai, Shanghai, China, 200032 Less <<
NCT02537561 Solid Tumors ... More >>Carcinoma, Non-Small Cell Lung Non-Small Cell Lung Cancer Non-Small-Cell Lung Carcinoma Nonsmall Cell Lung Cancer Less << Phase 1 Withdrawn(The pharmaceutical c... More >>ompany did not want to follow through with support for the study.) Less << December 2018 -
NCT02643407 Non-Small Cell Lung Cancer Phase 3 Unknown December 2017 China, Guangdong ... More >> Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences Recruiting Guangzhou, Guangdong, China, 510080 Contact: Haiyan Tu, MD    +86 20 83827812 ext 50810    thoraciconcology88@163.com    Contact: Yi-Long Wu, MD    +86 20 83827812 ext 51221    syylwu@live.cn    Principal Investigator: Yi-Long Wu, MD          Sub-Investigator: Haiyan Tu, MD Less <<
NCT01240590 Solid Tumor A... More >>naplastic Thyroid Cancer Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01126008 Head and Neck Cancer Phase 2 Unknown December 2016 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00982436 Head and Neck Neoplasms Phase 1 Phase 2 Unknown December 2012 United States, Vermont ... More >> Mountainview Medical Center Recruiting Berlin, Vermont, United States, 05602 Contact: John Valentine, MD    802-225-5400    john.valentine@cvmc.org    Principal Investigator: John Valentine, MD          Sub-Investigator: David Ospina, MD          Sub-Investigator: Daniel Fram, MD          Fletcher Allen Health Care Recruiting Burlington, Vermont, United States, 05401 Contact: Steven Grunberg, MD    802-847-8400    Steven.Grunberg@vtmednet.org    Contact: Madhuri V Vithala, MD    802-847-8400    Madhuri.Vithala@vtmednet.org    Principal Investigator: Steven M Grunberg, MD          Sub-Investigator: Madhuri V Vithala, MD          Sub-Investigator: Havaleh Gagne, MD          Sub-Investigator: William Brundage, MD          Vermont Center for Cancer Medicine Recruiting Colchester, Vermont, United States, 05446 Contact: Christian Thomas, MD    802-655-3400    Christian.Thomas@vtmednet.org    Sub-Investigator: Paul Unger, MD          Sub-Investigator: Dennis Sanders, MD          Sub-Investigator: Johannes Nunnink, MD          Sub-Investigator: Christian Thomas, MD Less <<
NCT03579771 Resectable Cholangiocarcinoma ... More >> Stage IB Intrahepatic Cholangiocarcinoma AJCC v8 Stage II Intrahepatic Cholangiocarcinoma AJCC v8 Stage III Intrahepatic Cholangiocarcinoma AJCC v8 Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 Less << Phase 2 Recruiting September 30, 2024 United States, Arizona ... More >> Mayo Clinic in Arizona Not yet recruiting Scottsdale, Arizona, United States, 85259 Contact: Shishir Maithel, MD       smaithe@emory.edu    Principal Investigator: Mitesh Borad, MD          United States, Florida Mayo Clinic in Florida Not yet recruiting Jacksonville, Florida, United States, 32224 Contact: Shishir Maithel       smaithe@emory.edu    Principal Investigator: Kabir Mody, MD          Principal Investigator: Kristopher Croome, MD          United States, Georgia Emory University Hospital Midtown Recruiting Atlanta, Georgia, United States, 30308 Contact: Shabnam Montazeri    404-686-0242    shabnam.montazeri@emory.edu    Principal Investigator: Shishir Maithel, MD          Emory University Hospital/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Tyra Gaines    404-712-3308    tgaine3@emory.edu    Principal Investigator: Shishir Maithel, MD          Emory Saint Joseph's Hospital Recruiting Atlanta, Georgia, United States, 30342 Contact: Alicia Escobar    678-843-7029    alicia.m.escobar@emory.edu    Principal Investigator: Shishir Maithel, MD          United States, Minnesota Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Shishir Maithel, MD       smaithe@emory.edu    Principal Investigator: Amit Mahipal, MD          Principal Investigator: Rory Smoot, MD          United States, Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Shishir Maithel, MD       smaithe@emory.edu    Principal Investigator: Milind Javle, MD          Principal Investigator: J. Nicolas Vauthey, MD          United States, Washington Virginia Mason Medical Center Not yet recruiting Seattle, Washington, United States, 98101 Contact: Shishir Maithel, MD       smaithe@emory.edu    Principal Investigator: Flavio G. Rocha, MD          Principal Investigator: Bruce Lim, MD Less <<
NCT02567422 Head and Neck Squamous Cell Ca... More >>rcinoma Human Papillomavirus Negative Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7 Less << Phase 1 Recruiting - United States, California ... More >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Site Public Contact    800-826-4673    becomingapatient@coh.org    Principal Investigator: Erminia Massarelli          University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact    916-734-3089       Principal Investigator: Jonathan W. Riess          United States, Connecticut Smilow Cancer Center/Yale-New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu    Principal Investigator: Barbara A. Burtness          Yale University Recruiting New Haven, Connecticut, United States, 06520 Contact: Site Public Contact    203-785-5702    canceranswers@yale.edu    Principal Investigator: Barbara A. Burtness          United States, Georgia Emory University Hospital Midtown Recruiting Atlanta, Georgia, United States, 30308 Contact: Site Public Contact    888-946-7447       Principal Investigator: Conor E. Steuer          Emory University Hospital/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Site Public Contact    404-778-1868       Principal Investigator: Conor E. Steuer          United States, Kentucky University of Kentucky/Markey Cancer Center Recruiting Lexington, Kentucky, United States, 40536 Contact: Site Public Contact    859-257-3379       Principal Investigator: Susanne M. Arnold          United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Suspended Baltimore, Maryland, United States, 21287 United States, Ohio Case Western Reserve University Suspended Cleveland, Ohio, United States, 44106 Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Site Public Contact    800-293-5066    Jamesline@osumc.edu    Principal Investigator: Darrion L. Mitchell          United States, Virginia University of Virginia Cancer Center Recruiting Charlottesville, Virginia, United States, 22908 Contact: Site Public Contact    434-243-6303    PAS9E@virginia.edu    Principal Investigator: Varinder Kaur          United States, Wisconsin University of Wisconsin Hospital and Clinics Recruiting Madison, Wisconsin, United States, 53792 Contact: Site Public Contact    800-622-8922       Principal Investigator: Justine Yang-Bruce Less <<
NCT03387943 Poorly Differentiated Thyroid ... More >>Carcinoma Less << Phase 2 Recruiting December 31, 2019 China ... More >> Zhejiang Cancer Hospital Recruiting Zhejiang, China Contact: haiyan yang, doctor Less <<
NCT01355302 Advanced or Metastatic Solid T... More >>umors Previously Untreated Gastric Cancer Less << Phase 1 Phase 2 Terminated(Sites not recruitin... More >>g) Less << - United States, Arizona ... More >> Arizona Oncology Associates, PC - CASA Tucson, Arizona, United States, 85715 United States, Florida Boca Raton Clinical Research Associates, Inc Plantation, Florida, United States, 33324 United States, Illinois Robert H. Lurie Comprenhensive Cancer Center of Northwestern University Chicago, Illinois, United States, 60611 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48084 Henry Ford Medical Center Detroit, Michigan, United States, 48202 United States, North Carolina University of North Carolina at Chapel Hill Chapell Hill, North Carolina, United States, 27599 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Mercy Cancer Centerr at St. Anne Toledo, Ohio, United States, 43623 Russian Federation Chelyabinsk Regional Oncology Dispensary Chelyabinsk, Russian Federation, 454087 GOU VPO St-Petersburg SMA n/a Mechnikov Fed. Agen. of Healthcare and Social Developm. St Petersburg, Russian Federation, 195067 FSI "SRC of Oncology n. a. N.N.Petrov of Rosmedtekhnologiy" St Petersburg, Russian Federation, 197758 Ukraine SI Dnipropetrovsk Medical Academy of MOHU ch of Oncology and Medical Radiology Dnipropetrovsk, Ukraine, 49102 Municipal Clinical Medical and Prophylactic Institution Donetsk Regional Antitumor Centre Donetsk, Ukraine, 83092 Kyiv City Clinical Oncological Center Kyiv, Ukraine, 3115 Lviv State Oncol. Reg. Treatment and Diagnostic Center Lviv, Ukraine, 79031 United Kingdom Barts and the London NHS Trust London, Greater London, United Kingdom, EC1A 7BE Sarah Cannon Research UK London, Greater London, United Kingdom, W1G 6AD The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom, M20 4BX Less <<
NCT01356303 Non-small Cell Lung Cancer Met... More >>astatic Less << Phase 2 Suspended(Difficulty in enroll... More >>ing patients) Less << August 2016 Saudi Arabia ... More >> King Abdul Aziz Medical City for National Guard Health Affairs Riyadh, Saudi Arabia, 11426 Less <<
NCT02611037 Malignant Pleural Mesothelioma... More >> Mesothelioma Less << Phase 2 Recruiting December 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 22612 Contact: Malesa Pereira    813-745-4090    malesa.pereira@moffitt.org    Contact: Bela Kis    813-745-8425    bela.kis@moffitt.org    Principal Investigator: Bela Kis, M.D., Ph.D.          Sub-Investigator: Scott Antonia, M.D.          Sub-Investigator: Ghassan El-Haddad, M.D.          Sub-Investigator: Jacques-Pierre Fontaine, M.D.          Sub-Investigator: Lary Robinson, M.D.          Sub-Investigator: Tawee Tanvetyanon, M.D.          Sub-Investigator: Benjamin Creelan, M.D.          Sub-Investigator: Junsung Choi, M.D.          Sub-Investigator: Daniel Jeong, M.D.          Sub-Investigator: Brian Morse, M.D. Less <<
NCT00984035 - Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01855451 HPV Positive Oropharyngeal Squ... More >>amous Cell Carcinoma Less << Phase 3 Active, not recruiting June 2022 Australia, Australian Capital ... More >>Territory Canberra Hospital Canberra, Australian Capital Territory, Australia Australia, New South Wales Chris O'Brien Lifehouse Camperdown, New South Wales, Australia, 2050 Liverpool Hospital Liverpool, New South Wales, Australia, 2170 St George Hospital St George, New South Wales, Australia, 2217 Riverina Cancer Care Centre Wagga Wagga, New South Wales, Australia Calvary Mater Newcastle Waratah, New South Wales, Australia Westmead Hospital Westmead, New South Wales, Australia, 2145 Australia, Queensland Royal Brisbane and Womens Hospital Herston, Queensland, Australia, 4006 Townsville Hospital Townsville, Queensland, Australia, 4810 Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Australia, South Australia Flinders Medical Centre Bedford Park, South Australia, Australia, 5042 Australia, Victoria Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 Austin Hospital Melbourne N., Victoria, Australia, 3084 Australia, Western Australia Sir Charles Gairdner Nedlands, Western Australia, Australia, 6009 New Zealand Auckland City Hospital Auckland, New Zealand, 1344 Palmerston North Hospital Palmerston, New Zealand, 4442 Less <<
NCT01240590 - Completed - -
NCT01091454 - Completed - -
NCT03345784 Endometrioid Adenocarcinoma ... More >> Recurrent Cervical Carcinoma Stage I Uterine Corpus Cancer AJCC v7 Stage I Vaginal Cancer AJCC v6 and v7 Stage IA Uterine Corpus Cancer AJCC v7 Stage IB Cervical Cancer AJCC v6 and v7 Stage IB Uterine Corpus Cancer AJCC v7 Stage IB2 Cervical Cancer AJCC v6 and v7 Stage II Cervical Cancer AJCC v7 Stage II Uterine Corpus Cancer AJCC v7 Stage II Vaginal Cancer AJCC v6 and v7 Stage IIA Cervical Cancer AJCC v7 Stage IIB Cervical Cancer AJCC v6 and v7 Stage III Cervical Cancer AJCC v6 and v7 Stage III Uterine Corpus Cancer AJCC v7 Stage III Vaginal Cancer AJCC v6 and v7 Stage IIIA Cervical Cancer AJCC v6 and v7 Stage IIIA Uterine Corpus Cancer AJCC v7 Stage IIIB Cervical Cancer AJCC v6 and v7 Stage IIIB Uterine Corpus Cancer AJCC v7 Stage IIIC Uterine Corpus Cancer AJCC v7 Less << Phase 1 Recruiting October 18, 2020 United States, California ... More >> University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact    916-734-3089       Principal Investigator: Vanessa A. Kennedy          United States, Colorado University of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Site Public Contact    720-848-0650       Principal Investigator: Bradley R. Corr          United States, Kentucky University of Kentucky/Markey Cancer Center Recruiting Lexington, Kentucky, United States, 40536 Contact: Site Public Contact    859-257-3379       Principal Investigator: Rachel W. Miller          United States, New Jersey Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Site Public Contact    732-235-8675       Principal Investigator: Eugenia Girda          Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Site Public Contact    732-235-8675       Principal Investigator: Eugenia Girda          United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Site Public Contact    888-275-3853       Principal Investigator: James L. Abbruzzese          Canada, Ontario University Health Network-Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Site Public Contact    416-946-4501    clinical.trials@uhn.on.ca    Principal Investigator: Stephanie Lheureux Less <<
NCT02695459 Neuroendocrine Carcinomas Phase 2 Recruiting January 2019 Netherlands ... More >> NKI-AVL Recruiting Amsterdam, Netherlands, 1066CX Contact: M. Tesselaar, MD          UMCG Recruiting Groningen, Netherlands Contact: A.M.E. Walenkamp, MD          Erasmus Medisch Centrum Recruiting Rotterdam, Netherlands Contact: F. Eskens, MD Less <<
NCT01091454 Triple-negative Breast Cancer Phase 2 Completed - -
NCT01977235 Small Cell Lung Carcinoma Phase 2 Unknown September 2017 China, Chongqing ... More >> Chongqing Cancer Hospital Recruiting Chongqing, Chongqing, China Contact: Qiying Li, M.D.    13637808684       Principal Investigator: Qiying Li, M.D.          Principal Investigator: Dairong Li          Xinan Hospital, Third Military Medical University Recruiting Chongqing, Chongqing, China Contact: Wei Xiong, M.D.    +86-13512345225       Principal Investigator: Wei Xiong          Xinqiao Hospital, Third Military Medical University Recruiting Chongqing, Chongqing, China Contact: Bo Zhu, M.D.    +86-15923366951       Principal Investigator: Bo Zhu, M.D. Less <<
NCT02199418 Tubular Breast Cancer ... More >> Mucinous Breast Cancer Invasive Ductal Breast Cancer Inflammatory Breast Cancer Less << Phase 2 Completed - China, Shanghai ... More >> Fudan University Shanghai Cancer Center Shanghai, Shanghai, China, 200032 Shanghai Jiaotong University School of Medicine, Renji Hospital Shanghai, Shanghai, China, 200127 Less <<
NCT02906800 Head and Neck Cancer Phase 1 Phase 2 Recruiting May 2019 France ... More >> Hopital Europeen Georges Pompidou Recruiting Paris, Île-de-France, France, 75015 Contact: Stephane Hans, MD       stephane.hans@aphp.fr    Principal Investigator: Stephane Hans, MD Less <<
NCT03768414 Stage III Distal Bile Duct Can... More >>cer AJCC v8 Stage III Gallbladder Cancer AJCC v8 Stage III Intrahepatic Cholangiocarcinoma AJCC v8 Stage IIIA Distal Bile Duct Cancer AJCC v8 Stage IIIA Gallbladder Cancer AJCC v8 Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8 Stage IIIB Distal Bile Duct Cancer AJCC v8 Stage IIIB Gallbladder Cancer AJCC v8 Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8 Stage IV Distal Bile Duct Cancer AJCC v8 Stage IV Gallbladder Cancer AJCC v8 Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 Stage IVA Gallbladder Cancer AJCC v8 Stage IVB Gallbladder Cancer AJCC v8 Unresectable Extrahepatic Bile Duct Carcinoma Unresectable Gallbladder Carcinoma Unresectable Intrahepatic Cholangiocarcinoma Less << Phase 3 Recruiting January 1, 2024 United States, Arizona ... More >> University of Arizona Recruiting Tucson, Arizona, United States, 85724 Contact: Rachna Shroff    520-626-2430    rshroff@email.arizona.edu Less <<
NCT02992340 Biliary Tract Cancer Phase 1 Phase 2 Recruiting December 2020 Korea, Republic of ... More >> Recruiting Seoul, Korea, Republic of Singapore Recruiting Singapore, Singapore Taiwan Recruiting Taipei, Taiwan Less <<
NCT01093092 Adult Solid Neoplasm Phase 1 Terminated(Study transferring ... More >>to INOVA Health) Less << - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Virginia Emily Couric Clinical Cancer Center Charlottesville, Virginia, United States, 22903 Less <<
NCT01206426 - Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01874171 Oropharyngeal Squamous Cell Ca... More >>rcinoma Less << Phase 3 Active, not recruiting February 2019 Ireland ... More >> St Luke's Hospital Dublin, Ireland, 6 Beaumont Hospital Dublin, Ireland Netherlands VU University Medical Center Amsterdam, Netherlands United Kingdom Aberdeen Royal Infirmary Aberdeen, United Kingdom Royal United Hospital Bath, United Kingdom, BA1 3NG Clatterbridge Cancer Centre Bebington, United Kingdom, CH63 4JY Bradford Royal Infirmary Bradford, United Kingdom Bristol Haematology & Oncology Centre Bristol, United Kingdom, BS2 8ED Velindre Hospital Cardiff, United Kingdom, CF14 2TL Cheltenham General Hospital Cheltenham, United Kingdom, GL53 7AN Colchester General Hospital Colchester, United Kingdom Castle Hill Hospital Cottingham, United Kingdom University Hospitals Coventry & Warwickshire Coventry, United Kingdom, CV2 2DX Royal Derby Hospital Derby, United Kingdom Queen Elizabeth Hospital Birmingham Edgbaston, United Kingdom, B15 2TH Western General Hospital Edinburgh, United Kingdom, EH4 2XU Royal Devon & Exeter Hospital Exeter, United Kingdom, EX2 5DW Royal Surrey County Hospital Guildford, United Kingdom, GU2 7XX St James's Institute of Oncology Leeds, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, United Kingdom, LE1 5WW University College Hospital London, United Kingdom, NW1 2PG Royal Marsden Hospital London, United Kingdom, SW3 6JJ James Cook University Hospital Middlesbrough, United Kingdom, TS4 3BW New Cross Hospital New Cross, United Kingdom Northampton General Hospital Northampton, United Kingdom Norfolk & Norwich University Hospital Norwich, United Kingdom Nottingham University Hopsital Nottingham, United Kingdom, NG5 1PB Glan Clwyd Hospital Rhyl, United Kingdom Weston Park Hospital Sheffield, United Kingdom, S10 2SJ Royal Shrewsbury Hospital Shrewsbury, United Kingdom Royal Marsden Hospital Sutton, United Kingdom Singleton Hospital Swansea, United Kingdom, SA2 8QA Musgrove Park Hospital Taunton, United Kingdom Less <<
NCT01900158 Cholangiocarcinoma Phase 1 Phase 2 Recruiting - Germany ... More >> National Center for Tumor Diseases Active, not recruiting Heidelberg, Baden-Württemberg, Germany, D-69120 Klinikum rechts der Isar Recruiting Munich, Bayern, Germany, 81675 Contact: Hana Alguel, PhD       hana.alguel@mri.tum.de    Klinikum der Ludwig-Maximilians-Universität Recruiting München, Bayern, Germany, 81377 Contact: Prof. Dr. Jörg Schirra, MD    +49 89 4400 73031    Joerg.schirra@med.uni-muenchen.de    Klinikum der Johann Wolfgang Goethe-Universität Recruiting Frankfurt am Main, Hessen, Germany, 60590 Contact: Prof. Dr. Jörg Trojan, MD    +49 69 6301 87686    trojan@em.uni-frankfurt.de    Universitätsklinikum Essen Recruiting Essen, Nordrhein-Westfalen, Germany, 45122 Contact: Dr.med. Stefan Kasper, MD    +49 201 723 1631    stefan.kasper@uk-essen.de    Contact: Dr.med. Alexander Dechêne, MD    +49 49 201 723 2390    alexander.dechene@uk-essen.de    Klinikum Ludwigshafen Active, not recruiting Ludwigshafen, Rheinland-Pfalz, Germany, D-67063 Universitätsklinikum Leipzig Recruiting Leipzig, Sachsen, Germany, 04103 Contact: Prof. Dr. Albrecht Hoffmeister, MD    + 49341 9712251    Albrecht.Hoffmeister@medizin.uni-leipzig.de    Klinikum Augsburg Not yet recruiting Augsburg, Germany, 86156 Contact: Helmut Messmann, MD    0049 821 400-2351    helmut.messmann@klinikum-augsburg.de    Charité, Campus Mitte Recruiting Berlin, Germany, D-10117 Contact: Dr. med. Christian Jürgensen, MD    0049 30 450 514 134    Christian.Juergensen@charite.de    Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden Active, not recruiting Dresden, Germany, 01307 Lithuania Hospital of Lithuanian University of Health Sciences (LUHS) Not yet recruiting Kaunas, Lithuania, LT-50009 Contact: Limas Kupcinskas, MD    0037068640575    l.kupcinskas@gmail.com    National Cancer institute Not yet recruiting Vilnius, Lithuania, LT-08660 Contact: Mantas Trakymas, MD    0037061534951    trakymas@gmail.com    Vilnius University hospital Santariskiu Klinikos Not yet recruiting Vilnius, Lithuania, LT-08661 Contact: Juozas Stanaitis, MD    0037068661534    juozas.stanaitis@santa.lt    Norway Oslo Universtiy Hospital Active, not recruiting Oslo, Norway, 0310 United Kingdom University Hospital Aintree Recruiting Aintree, Liverpool, United Kingdom, L9 7AL Contact: Dr Richard Sturgess, MD    0044 (0) 151 529 8157    RICHARD.STURGESS@aintree.nhs.uk    Contact: Dr Dan Palmer, MD    0044 (0)151 706 4177    Daniel.Palmer@liverpool.ac.uk    Hammersmith Hospital Not yet recruiting London, United Kingdom, W12OHS Contact: Christopher Wadsworth          Contact       Christopher.Wadsworth@imperial.nhs.uk Less <<
NCT00798655 Cancer of Head ... More >> Cancer of Head and Neck Cancer of Neck Cancer of the Head Cancer of the Head and Neck Cancer of the Neck Head and Neck Cancer Head Cancer Head Neoplasms Head, Neck Neoplasms Neck Cancer Neck Neoplasms Neoplasms, Head Neoplasms, Head and Neck Neoplasms, Neck Neoplasms, Upper Aerodigestive Tract UADT Neoplasms Upper Aerodigestive Tract Neoplasms Less << Phase 2 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02347917 Malignant Pleural Mesothelioma... More >> Non-Small Cell Lung Cancer Less << Phase 1 Phase 2 Completed - Japan ... More >> National Cancer Center Hospital East Chiba, Japan National Cancer Center Hospital Tokyo, Japan Less <<
NCT00798655 - Completed - -
NCT01410214 Non-small Cell Lung Cancer Sta... More >>ge IIIA Less << Phase 2 Unknown July 2017 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Chao Lv          Principal Investigator: Yue Yang          Chinese PLA General Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Tao Wang          Principal Investigator: Xiangyang Chu          China, Guangdong Sun Yat-Sen University Cancer Center Not yet recruiting Guangzhou, Guangdong, China, 510000 Contact: Lanjun Zhang          Principal Investigator: Lanjun Zhang          China, Hebei Hebei Medical University Fourth Hospital Recruiting Shijiazhuang, Hebei, China, 050000 Contact: Xinbo Liu          Principal Investigator: Junfeng Liu          China, Heilongjiang Harbin Medical University Cancer Hospital Recruiting Harbin, Heilongjiang, China, 150000 Contact: Changfa Qu          Principal Investigator: Shidong Xu          China, Jiangsu The First Affiurted Hospital of Soochow University Not yet recruiting Suzhou, Jiangsu, China, 215000 Contact: Haitao Ma          Principal Investigator: Haitao Ma          China, Shandong Qingdao University Medical College Not yet recruiting Qingdao, Shandong, China, 266000 Contact: Yongjie Wang          Principal Investigator: Yi Shen          China, Shanghai Fudan University Shanghai Cancer Center Not yet recruiting Shanghai, Shanghai, China, 200000 Contact: Yihua Sun          Principal Investigator: Haiquan Chen          China, Sichuang The Second People's Hospital of Sichuan Recruiting Chengdu, Sichuang, China, 610000 Contact: Qiang Li          Principal Investigator: Qiang Li          China, Tianji Tianjin Medical University Cancer Institute and Hospital Recruiting Tianji, Tianji, China, 300000 Contact: Xuefeng Kan          Principal Investigator: Changli Wang          China, Zhejiang Zhejiang Cancer Hospital Not yet recruiting Hangzhou, Zhejiang, China, 310000 Contact: Xinming Zhou          Principal Investigator: Weimin Mao Less <<
NCT00165503 - Terminated(lack of acurral) - -
NCT00703638 Breast Cancer ... More >> Colorectal Cancer Head and Neck Cancer Lung Cancer Mesothelioma Pancreatic Cancer Prostate Cancer Sarcoma Less << Phase 1 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01810367 Non Small Cell Lung Cancer Phase 2 Completed - China, Shanghai ... More >> Cancer hospital Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT02778191 - Completed - Netherlands ... More >> VUmc Amsterdam, Netherlands University Medical Center Groningen Groningen, Netherlands, 9713 GZ Less <<
NCT00165503 Pleural Mesothelioma ... More >> Malignant Pleural Mesothelioma Less << Phase 2 Terminated(lack of acurral) - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00254384 Lung Cancer Not Applicable Active, not recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02216617 HNSCC Phase 1 Completed - France ... More >> ICM Val d'Aurelle, Montpellier Montpellier, France, 34298 Less <<
NCT01846390 Peripheral T-Cell Lymphoma ... More >> Diffuse Large B-Cell Lymphoma Less << Phase 1 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, New Brunswick Regional Health Authority B, Zone 2 Saint John, New Brunswick, Canada, E2L 4L2 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01747707 Gastric Cancer ... More >> Gastroesophageal Junction Cancer Less << Phase 2 Unknown May 2014 China ... More >> Cancer Hospital & Institute, Chinese Academy of Medical Sciences Recruiting Beijing, China, 10021 Contact: Yongkun Sun, M.D    8610-87788145    hsunyk@tom.com Less <<
NCT02397928 Malignant Pleural Mesothelioma Phase 2 Completed - Belgium ... More >> Antwerp University Hospital, Thoracic Oncology Antwerp, Belgium France Goustave Roussy - Cancer Campus Grand Paris Villejuif, France Germany Universitätsklinikum Halle (Saale) Halle, Germany Italy A.S.O. "SS Antonio e Biagio e Cesare Arrigo" Alessandria, Italy Cliniche Humanitas Gavazzeni Bergamo, Italy Ospedale Villa Scassi Genoa, Italy Ospedaliera di Perugia Perugia, Italy Ospedaliero Universitaria Pisana Pisa, Italy Netherlands Erasmus Mc Rotterdam, Netherlands Poland Medical University Gdansk Gdansk, Poland Katedra i Klinika Onkologii Uniwersytetu Medycznegi im. Karola Marcinkowskiego w Poznaniu Poznań, Poland Klinika Nowotworów Pluca I Klatki Piersiowej Warsaw, Poland Spain Vall d' Hebron Institute of Oncology (VHIO) Hospital Vall d'Hebron Barcelona, Spain Less <<
NCT02648425 Solid Tumor Phase 1 Completed - Hong Kong ... More >> Queen Mary Hospital Hong Kong, Hong Kong Taiwan National Taiwan University Hospital Taipei, Taiwan, 100 Taipei Veterans General Hospital Taipei, Taiwan, 112 Less <<
NCT02452970 Cholangiocarcinoma Phase 2 Active, not recruiting December 2018 United States, Maryland ... More >> Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 Less <<
NCT02301208 Nasopharyngeal Carcinoma Phase 3 Unknown - -
NCT03051373 Carcinoma, Transitional Cell Phase 2 Not yet recruiting December 31, 2020 China ... More >> Chinese PLA General Hospital Not yet recruiting Beijing, China, 100022 Contact: Bo Yang       shybomb@126.com Less <<
NCT00548821 Locally Advanced Cervical Canc... More >>er Less << PHASE3 UNKNOWN - National University Hospital, ... More >>Singapore, 119074, Singapore Less <<
NCT01593306 Carcinoma Cervix Phase 3 Unknown February 2013 India ... More >> Indira Gandhi Medical College Recruiting Shimla, Himachal Pradesh, India, 171001 Contact: Pragyat Thakur, MBBS    919418029244    pragyat28rpgmc@gmail.com    Principal Investigator: Pragyat Thakur, MBBS Less <<
NCT02969473 Esophageal Neoplasm ... More >> Chemoradiation Less << Phase 2 Unknown May 2017 China, Guangdong ... More >> SYSU Cancer Center Guangzhou, Guangdong, China, 510000 Less <<
NCT01412294 Gastric Cancer Phase 2 Active, not recruiting December 2017 Japan ... More >> Epidemiological and Clinical Research Information Network Kyoto, Japan, 606-8392 Less <<
NCT02492360 - Withdrawn(Lack of funding) December 2019 United States, Indiana ... More >> IU Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00551512 Cancer Solid ... More >>Tumors Less << Phase 1 Completed - United States, Arizona ... More >> Scottsdale Clinical Research Institute Scottsdale, Arizona, United States, 85258 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Less <<
NCT01284413 Biliary Tract Cancer Phase 1 Phase 2 Completed - Japan ... More >> Kyoto University Hospital Kyoto, Japan, 606-8507 Less <<
NCT00390416 Stomach Neoplasms ... More >> Esophageal Neoplasms Less << Phase 2 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York, New York, United States, 10021 Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Sleepy Hollow, New York, United States Less <<
NCT00645593 Bladder Cancer Phase 2 Completed - United States, California ... More >> City of Hope Cancer Center Duarte, California, United States, 91010 Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine, University of Southern California Los Angeles, California, United States, 90033 Stanford University Stanford, California, United States, 94305 United States, Illinois Robert H. Lurie Comprehensive Cancer Center, Center of Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Boston Medical Center Boston, Massachusetts, United States, 02118 Lahey Clinic Burlington, Massachusetts, United States, 01805 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-3721 United States, Utah University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 United States, Washington University of Washington Seattle, Washington, United States, 98109 Less <<
NCT00390416 - Completed - -
NCT03093922 Urothelial Carcinoma ... More >> Locally Advanced Unresectable Less << Phase 2 Suspended(Safety Related) March 2019 United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 United States, New Jersey Memoral Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00645593 - Completed - -
NCT01301248 Head and Neck Neoplasms ... More >> AJCC Stage III/IV Less << Phase 2 Unknown June 2011 Greece ... More >> Theagenio Cancer Hospital Thessaloniki, Greece, 54007 Less <<
NCT00423865 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01021150 Neoplasms, Malignant Phase 1 Completed - Japan ... More >> Sanofi-Aventis Administrative Office Tokyo, Japan Less <<
NCT01097252 Cervical Cancers Phase 3 Completed - Korea, Republic of ... More >> Korea Institute of Radiological & Medical Sciences Seoul, Korea, Republic of, 139-706 Less <<
NCT03201861 Tubular Breast Cancer ... More >> Mucinous Breast Cancer Invasive Duct Carcinoma of Breast Less << Phase 3 Recruiting December 31, 2021 China, Shanghai ... More >> Renji Hospital, School of Medicine, Shanghai Jiaotong University Recruiting Shanghai, Shanghai, China, 200127 Contact: Yueyao Du, M.D.    86-21-68385569    jessicayy8629@126.com    Contact: Jie Zhang, M.D.    86-21-68385516    doudou090227@163.com Less <<
NCT01641575 Solid Tumor N... More >>on-small-cell Lung Cancer Lung Cancer Less << Phase 1 Terminated(Registrational stud... More >>y did not meet endpoint so entire program (including CO-101-011) was terminated.) Less << - United States, Florida ... More >> Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 United Kingdom The Beatson West Glasgow, Scotland, United Kingdom, G12 0YN University College London Cancer Institute London, United Kingdom, W1T 4TJ Less <<
NCT00324012 Adrenocortical Carcinoma Phase 2 Completed - Denmark ... More >> Department of Oncology 5073, Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT01524991 Urothelial Carcinoma Phase 2 Active, not recruiting December 2018 United States, California ... More >> City of Hope: Duarte Duarte, California, United States, 91010 United States, Indiana IU Health Goshen Hospital Goshen, Indiana, United States, 46527 Indiana University Melvin & Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 IU Health Central Indiana Cancer Centers Indianapolis, Indiana, United States, 46219 United States, Nebraska Nebraska Cancer Specialists Omaha, Nebraska, United States, 68114 United States, New York Tisch Cancer Institute at Mount Sinai Medical Center New York, New York, United States, 10029 United States, Texas Texas Oncology, PA Dallas, Texas, United States, 75246 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 Less <<
NCT02620839 Solid Tumors Phase 1 Recruiting March 2020 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94143-1711 Contact: Pamela N. Munster, MD    877-827-3222    cancertrials@ucsf.edu Less <<
NCT00123825 Gallbladder Cancer ... More >> Biliary Tract Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00919061 - Completed - -
NCT00919061 Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00165464 Esophageal Cancer ... More >> Gastric Cancer GE Junction Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Faulkner Hospital Boston, Massachusetts, United States, 02130 Less <<
NCT00047047 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02151084 Biliary Tract Carcinoma ... More >> Gallbladder Carcinoma Less << Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01616875 Infiltrating Bladder Urothelia... More >>l Carcinoma Less << Phase 2 Recruiting January 2018 United Kingdom ... More >> Bristol Haematology + Oncology Centre, Horfield Road Recruiting Bristol, United Kingdom, BS2 8ED Contact: Sylvia Pearson    0117 3424263    sylvia.pearson@uhbristol.nhs.uk    Contact: Seonaid Wright    0117 342 2069    seonaid.wright@uhbristol.nhs.uk    Principal Investigator: Amit K Bahl          Sub-Investigator: Susan Masson Less <<
NCT01445405 Carcinoma, Squamous ... More >> Head and Neck Cancer Oral Cancer Laryngeal Cancer Pharyngeal Cancer Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00165191 Adenocarcinoma of Stomach ... More >> Adenocarcinoma of GE Junction Adenocarcinoma of Esophagus Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01483300 Breast Cancer Phase 2 Unknown November 2014 China, Heilongjiang ... More >> Cancer Hospital of Harbin Medical University Recruiting Harbin, Heilongjiang, China, 150081 Contact: Qingyuan Zhang, MD    86-451-86298276    zhma19650210@163.com    Contact: Xinmei Kang, MD    86-451-86298683    kxm791107@163.com    Principal Investigator: Qingyuan Zhang, MD          Sub-Investigator: Xinmei Kang, MD Less <<
NCT00077545 Adenocarcinoma of the Esophagu... More >>s Recurrent Esophageal Cancer Stage IV Esophageal Cancer Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT03502148 Oral Squamous Cell Carcinoma Phase 1 Phase 2 Recruiting April 30, 2020 United States, Ohio ... More >> University of Cincinnati Cancer Institute Recruiting Cincinnati, Ohio, United States, 45267 Contact: Lisa Schmid, BSN    513-584-0502    wallslm@ucmail.uc.edu    Principal Investigator: Alice Tang, MD          United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Vlad Sandulache, MD    713-798-7218    vlad.sandulache@BCM.edu    Ben Taub Hospital Recruiting Houston, Texas, United States, 77030 Contact: Vlad Sandulache, MD    713-798-7218    vlad.sandulache@bcm.edu    Harris health System - Smith Clinic Recruiting Houston, Texas, United States, 77054 Contact: Vlad Sandulache, MD    713-798-7218    vlad.sandulache@bcm.edu    The University of Texas Health Science Center School of Dentistry Recruiting Houston, Texas, United States, 77054 Contact: Simon Young, DDS, MD, PhD    713-486-2568    Simon.Young@uth.tmc.edu Less <<
NCT00915850 Esophageal Cancer Phase 1 Phase 2 Unknown August 2015 Japan ... More >> Wakayama Medical University Recruiting Wakayama, Japan, 641-8510 Contact: Makoto Iwahashi, MD    81-73-441-0613    makato@wakayama-med.ac.jp Less <<
NCT02460887 Nasopharyngeal Carcinoma Phase 2 Recruiting June 2021 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Peiyu Huang, Dr    +86-20-87343380    huangpy@sysucc.org.cn    Contact: Donghua Luo, Dr    +86-20-87343379    luodh@sysucc.org.cn Less <<
NCT01196416 - Completed - -
NCT01368848 NSCLC Phase 2 Completed - Austria ... More >> Univ.-Klinik für Innere Medizin V Innsbruck, Abteilung für Hämatologie und Onkologie Innsbruck, Tirol, Austria, 6020 Landeskrankenhaus Feldkirch Feldkirch, Vorarlberg, Austria, 6806 Universitaetsklinik der PMU Salzburg, UK f. Innere Medizin III Salzburg, Austria, 5020 Less <<
NCT00104910 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Small Cell Carcinoma Cervical Squamous Cell Carcinoma Stage IB Cervical Cancer Stage IIA Cervical Cancer Stage IIB Cervical Cancer Stage III Cervical Cancer Stage IVA Cervical Cancer Less << Phase 1 Completed - United States, Georgia ... More >> Georgia Regents University Medical Center Augusta, Georgia, United States, 30912 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Indiana Indiana University/Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Maryland Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, New Jersey Cooper Hospital University Medical Center Camden, New Jersey, United States, 08103 United States, Ohio MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Riverside Methodist Hospital Columbus, Ohio, United States, 43214 Lake University Ireland Cancer Center Mentor, Ohio, United States, 44060 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 United States, Rhode Island Women and Infants Hospital Providence, Rhode Island, United States, 02905 United States, Texas Parkland Memorial Hospital Dallas, Texas, United States, 75235 University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01596868 Nasopharyngeal Squamous Cell C... More >>arcinoma Toxicity Due to Radiotherapy Less << Phase 2 Completed - China, Shanxi ... More >> Department of Radiation Oncology, Xijing Hospital, Fourth Military Xi'an, Shanxi, China, 710032 Less <<
NCT01196416 Recurrent Melanoma ... More >> Stage IV Skin Melanoma Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00096174 - Unknown - -
NCT02608073 Nasopharyngeal Cancer Phase 2 Completed - Hong Kong ... More >> Hong Kong, Hong Kong, 852 Hong Kong, Hong Kong Indonesia Jogjakarta, Indonesia, 55284 Malaysia Kuala Lumpur, Malaysia, 50603 Taiwan Kueishan, Taiwan, 333 Taipei, Taiwan, 00112 Taipei, Taiwan, 106 Thailand Bangkok, Thailand, 10330 Bangkok, Thailand, 10400 Less <<
NCT00096174 Head and Neck Cancer Phase 2 Unknown July 2016 -
NCT01086254 Non-small Cell Lung Cancer Sta... More >>ge IV Less << Phase 2 Completed - France ... More >> Sanofi-Aventis Investigational Site Number 250002 Caen Cedex, France, 14033 Sanofi-Aventis Investigational Site Number 250003 Marseille Cedex 09, France, 13009 Sanofi-Aventis Investigational Site Number 250004 Toulouse, France, 31059 Sanofi-Aventis Investigational Site Number 250001 Villejuif, France, 94805 Germany Sanofi-Aventis Investigational Site Number 276003 Essen, Germany, 45122 Sanofi-Aventis Investigational Site Number 276002 Gauting, Germany, 82131 Sanofi-Aventis Investigational Site Number 276001 Großhansdorf, Germany, 22927 Italy Sanofi-Aventis Investigational Site Number 380003 Livorno, Italy, 57123 Sanofi-Aventis Investigational Site Number 380001 Orbassano, Italy, 10043 Sanofi-Aventis Investigational Site Number 380002 Rozzano, Italy, 20089 Spain Sanofi-Aventis Investigational Site Number 724001 Badalona, Spain, 08916 Sanofi-Aventis Investigational Site Number 724002 Barcelona, Spain, 08035 United Kingdom Sanofi-Aventis Investigational Site Number 826001 Newcastle Upon Tyne, United Kingdom, NE7 7DN Sanofi-Aventis Investigational Site Number 826002 Wolverhampton, United Kingdom, WV10 0QP Less <<
NCT02611700 Esophageal Squamous Cell Carci... More >>nomas Less << Phase 3 Recruiting June 2019 -
NCT01396681 Pancreatic Cancer Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT00251550 Malignant Pleural Mesotherioma Phase 1 Phase 2 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Aichi, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ehime, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Fukuoka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Hokkaido, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Okayama, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Osaka, Japan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tokyo, Japan Less <<
NCT00702481 Head and Neck Cancer Phase 2 Active, not recruiting March 2019 Singapore ... More >> National Cancer Center Singapore Singapore, Singapore, 169610 Less <<
NCT01109524 Lung Neoplasms ... More >> Carcinoma Cancer of the Lung Non-Small-Cell Lung Carcinoma Less << Phase 2 Completed - United States, Arizona ... More >> Donald W. Hill M.D., P.C. Casa Grande, Arizona, United States, 85122 United States, California Beverly Hills Cancer Center Beverly Hills, California, United States, 90211 Cancer Care Institute Los Angeles, California, United States, 90036 Northern California Hematology & Oncology Oakland, California, United States, 94609 Sharp Clinical Oncology Research San Diego, California, United States, 92123 United States, Florida Broward Oncology Associates, P.A. Ft. Lauderdale, Florida, United States, 33308 Elite Research Institute Miami, Florida, United States, 33125 United States, Illinois Edward H. Kaplan, MD & Associates Skokie, Illinois, United States, 60076 United States, Minnesota Fairview Southdale Medical Oncology Clinic Edina, Minnesota, United States, 55435 United States, North Dakota Mid Dakota Clinic, Pc Bismarck, North Dakota, United States, 58501 United States, Pennsylvania Temple University Hospital Philadelphia, Pennsylvania, United States, 19140 United States, Texas University Medical Center Lubbock, Texas, United States, 79415 United States, Washington Columbia Basin Hematology and Oncology Kennewick, Washington, United States, 99336 Canada, New Brunswick The Moncton Hospital Moncton, New Brunswick, Canada, E1C 6Z8 Canada, Newfoundland and Labrador Local Institution Grand Falls-Windsor, Newfoundland and Labrador, Canada, A2A 2E2 Canada, Ontario The Credit Valley Hospital Mississauga, Ontario, Canada, L5M 2N1 Sudbury Regional Hospital Sudbury, Ontario, Canada, P3E 5J1 Thunder Bay Regional Health Sciences Centre (Regional Cancer Care) Thunder Bay, Ontario, Canada, P7B 6V4 Toronto East General Hospital Toronto, Ontario, Canada, M4C 3E7 Canada, Quebec Centre de sante et de services sociaux de Rimouski-Neigette Rimouski, Quebec, Canada, G5L 5T1 Puerto Rico Ponce School of Medicine (Caimed Center) Ponce, Puerto Rico, 00716 Fundacion de Investigacion de Diego San Juan, Puerto Rico, 00927 Less <<
NCT00139269 Advanced Squamous Cell Carcino... More >>ma Squamous Cell Carcinoma of Head and Neck SSCHN Less << Phase 1 Phase 2 Completed - -
NCT00661778 Non-small Cell Lung Cancer Phase 2 Completed - Spain ... More >> Cádiz, Cadiz, Spain, 11009 San Sebastian, Guipuzcoa, Spain, 20080 Palma de Mallorca, Islas Baleares, Spain, 07198 Alcala de Henares, Madrid, Spain, 28805 Sagunto, Valencia, Spain, 46520 Castellon, Spain, 12002 Madrid, Spain, 28036 Madrid, Spain, 28935 Malaga, Spain, 29010 Palencia, Spain, 34005 Valencia, Spain, 46017 Valladolid, Spain, 47005 Valladolid, Spain, 47010 Zamora, Spain, 49021 Less <<
NCT02316327 Non-Small Cell Lung Cancer (NS... More >>CLC) Less << Phase 4 Completed - Spain ... More >> Hospital Clinic Barcelona, Spain, 08036 Less <<
NCT00661778 - Completed - -
NCT00185835 Head and Neck Cancer ... More >> Carcinoma, Squamous Cell Less << Phase 1 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00254904 Carcinoma, Non-Small-Cell Lung Phase 3 Terminated(See Termination Rea... More >>son in Detailed Description) Less << - -
NCT01029873 Metastatic Melanoma Phase 1 Phase 2 Completed - United States, California ... More >> The Angeles Clinic and Research Institute Los Angeles, California, United States, 90025 United States, Florida MD Anderson Cancer Center Orlando Orlando, Florida, United States, 32806 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, North Carolina Carolinas Medical Center-Brumenthal Cancer Center Charlotte, North Carolina, United States, 28204 United States, Pennsylvania St. Luke's Hospital and Health Network Bethlehem, Pennsylvania, United States, 18015 United States, Washington University of Washington, Seattle Cancer Care Center Seattle, Washington, United States, 98109 Less <<
NCT01109524 - Completed - -
NCT01830556 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Unknown November 2015 Denmark ... More >> Lena Specht Recruiting Copenhagen, Denmark, 2100 Contact: Lena Specht, MD DMSc Professor       lena.specht@rh.regionh.dk    Principal Investigator: Lena Specht, MD DMSc Professor          Sweden Hedda Haugen Recruiting Göteborg, Sweden, 413 45 Contact: Hedda Haugen, MD       hedda.haugen@vgregion.se    Principal Investigator: Hedda Haugen, MD          Karolinska Universityhospital Recruiting Stockholm, Sweden, 17176 Contact: Teresa herlestam-calero-moreno, MD       maria.herlestam-calero-moreno@karolinska.se    Principal Investigator: Teresa maria.herlestam-calero-moreno, MD          Karin Söderström Recruiting Umeå, Sweden, 90189 Contact: Karin Söderström, D       karin.soderstrom@onkologi.umu.se    Principal Investigator: Karin Söderström, MD          Akademiska Universityhospital Not yet recruiting Uppsala, Sweden, 751 85 Contact: Silvia Johansson, MD       silvia.johansson@onkologi.uu.se    Principal Investigator: Silvia Johansson, MD Less <<
NCT00388960 Small Cell Lung Cancer Phase 2 Completed - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerpen, Belgium, 2020 Universitair Ziekenhuis Antwerpen Edegem, Belgium, 2650 Universiteit Gent Gent, Belgium, 9000 U.Z. Gasthuisberg Leuven, Belgium, 3000 Domaine Universitaire du Sart-Tilman Liege, Belgium, 1BE Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 Clinique Sainte Elisabeth Namur, Belgium, 5000 Italy Instituto Nazionale per la Ricerca sul Cancro Genova, Italy, 16132 Universita Degli Studi Di Udine Udine, Italy, 33100 Netherlands Academisch Medisch Centrum Amsterdam, Netherlands, 1105 AZ The Netherlands Cancer Institute Antoni Van Leeuwenhoekziekenhuis Amsterdam, Netherlands Medisch Spectrum Twente - Dept of Pulmonary Diseases Enschede, Netherlands, 7500 KA Leiden University Medical Centre Leiden, Netherlands, 2300RC Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 Isala Kliniek Zwolle, Netherlands, 8001 Poland Medical University of Gdansk - Dept Radiotherapy Gdansk, Poland, 80211 United Kingdom Clatterbridge Centre for Oncology NHS Trust Bebington, Merseyside, United Kingdom, CH684JY University of Dundee - Ninewells Hospital Dundee, Scotland, United Kingdom, D01 9SY Belfast City Hospital Belfast, United Kingdom, BT9 7AB Western General Hospital Edinburgh, United Kingdom, EH4 2XU Princess Royal Hospital Hull, United Kingdom, HU8 9HE Royal Marsden Hospital, London London, United Kingdom, SM2 5PT Christie Hospital Manchester, United Kingdom, M20 4BX Sir Bobby Robson Cancer Trials Research Centre Newcastle-Upon-Tyne, United Kingdom, NE4 6BE Royal Marsden Hospital Lung Unit Sutton, United Kingdom, (Surrey) SM2 5PT Less <<
NCT00623064 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Less << Phase 1 Completed - Denmark ... More >> Rigshospitalet - Copenhagen University Hospital Copenhagen, Denmark, 2100 Less <<
NCT02633176 Nasopharyngeal Carcinoma Phase 3 Recruiting - China, Fujian ... More >> Fujian Provincial Cancer Hospital Recruiting Fuzhou, Fujian, China, 350014 Contact: Cheng Huang, MD       cheng671@sina.com    Principal Investigator: Cheng Huang, MD          China, Guangdong Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhao Wang, MD    +86-20-87343694    wangzhao@sysucc.org.cn    Sub-Investigator: He Huang, MD          The First Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Mengping Zhang, MD    +86-20-87755766-8576    zhangmp1989@163.com    Principal Investigator: Sheng Ye, MD          China, Guangxi Guangxi Cancer Hospital Recruiting Nanning, Guangxi, China, 530021 Contact: Chaoyong Liang, MD       lmlm1995@qq.com    Principal Investigator: Xiaohua Hu, MD          China, Hubei Union Hospital,Tongji Medical College of Huazhong University of Science ＆ Technology Recruiting Wuhan, Hubei, China, 430022 Contact: Gang Wu, MD       xhzlwg@163.com    Principal Investigator: Gang Wu, MD          Tongji Hospital,Tongji Medical College of Huazhong University of Science ＆ Technology Recruiting Wuhan, Hubei, China, 430030 Contact: Shiying Yu, MD       syyu@tjh.tjmu.edu.cn    Principal Investigator: Shiying Yu, MD          China, Jiangsu Jiangsu Cancer Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Jifeng Feng, MD       fjif@vip.sina.com    Principal Investigator: Jifeng Feng, MD          China, Shanghai Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Xichun Hu, MD       xchu2009@hotmail.com    Principal Investigator: Xichun Hu, MD          China, Sichuan Sichuan Cancer Hospital Recruiting Chengdu, Sichuan, China, 610047 Contact: Jinyi Lang, MD       langjy610@163.com    Principal Investigator: Jinyi Lang, MD          China, Zhejiang Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Yuan Zhu, MD       zhuyuan63@hotmail.com    Principal Investigator: Yuan Zhu, MD Less <<
NCT00639769 Head and Neck Cancer Phase 2 Completed - United States, Georgia ... More >> Central Georgia Hematology Oncology Associates, P.C. Macon, Georgia, United States United States, Tennessee Erlanger Health System Chattanooga, Tennessee, United States Jackson-Madison County Hospital Jackson, Tennessee, United States East Tennessee State University Johnson City, Tennessee, United States Center for Biomedical Research Knoxville, Tennessee, United States Meharry Medical College Nashville, Tennessee, United States VA Tennessee Valley Healthcare Center Nashville, Tennessee, United States Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States Less <<
NCT01281852 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Recurrent Cervical Carcinoma Stage IVB Cervical Cancer Less << Phase 1 Completed - -
NCT00639769 - Completed - -
NCT00821327 - Completed - -
NCT01342172 Urinary Bladder Neoplasms Phase 1 Phase 2 Terminated(low accrual) - United States, Maryland ... More >> National Cancer Institute Bethesda, Maryland, United States, 20892 United States, New York Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT00371553 Relapsed or Cisplatin-Refracto... More >>ry Germ Cell Cancer Less << Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T4N 4N2 Canada, British Columbia BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba Cancer Care Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Science Center Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G2M9 Less <<
NCT01917617 Biliary Tract Cancer Phase 2 Active, not recruiting March 2018 Japan ... More >> Osaka University, Graduate School of Medicine Osaka, Japan, 565-0871 Less <<
NCT01342172 - Terminated(low accrual) - -
NCT01611662 Distal Urethral Cancer ... More >> Proximal Urethral Cancer Squamous Cell Carcinoma of the Bladder Stage II Bladder Cancer Stage III Bladder Cancer Urethral Cancer Associated With Invasive Bladder Cancer Less << Phase 2 Terminated(Extreme Toxicity) December 2018 United States, Pennsylvania ... More >> Thomas Jefferson University, Kimmel Cancer Center Philadelphia, Pennsylvania, United States, 19107 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT01611662 - Terminated(Extreme Toxicity) - -
NCT01821248 Biliary Tract Cancer Phase 2 Recruiting February 2019 Japan ... More >> Kyoto University Hospital Recruiting Kyoto, Japan, 606-8507 Contact: Satoru Seo    +81-75-751-4323    rutosa@kuhp.kyoto-u.ac.jp Less <<
NCT00349492 Small Cell Lung Cancer Phase 3 Completed - Korea, Republic of ... More >> Soonchunhyang University Bucheon Hospital Bucheon-si, Korea, Republic of, 420-767 Yeungnam University Hospital Daegu, Korea, Republic of, 705-717 Daegu Catholic University Hospital Daegu, Korea, Republic of, 705-718 Gyeongsang National University Hospital Jinju, Korea, Republic of, 660-702 Seoul National University Bundang Hospital Seongnam-Si, Korea, Republic of, 463-707 Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Kangbuk Samsung Hospital Seoul, Korea, Republic of, 110-746 Yonsei Cancer Center Seoul, Korea, Republic of, 120-752 Seoul Veterans Hospital Seoul, Korea, Republic of, 134-791 Kangnam St.Mary's Hospital Seoul, Korea, Republic of, 137-040 Asan Medical Center Seoul, Korea, Republic of, 138-736 Chung-Ang University Medical Center Seoul, Korea, Republic of, 151-756 Seoul Municipal Boramae Hospital Seoul, Korea, Republic of, 156-707 St.Vincent Hospital Suwon, Korea, Republic of, 422-723 Less <<
NCT00537511 Carcinoma, Small Cell Phase 1 Phase 2 Terminated(This study was term... More >>inated for administrative reasons.) Less << - United States, Ohio ... More >> Ireland Cancer Center, Case Western Reserve University, Division of Hematology/Oncology Cleveland, Ohio, United States, 44106 United States, Pennsylvania Pennsylvania State University Hershey, Pennsylvania, United States, 17033 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Canada, Ontario Juranvinski Cancer Center - Medical Oncology Hamilton, Ontario, Canada, L8V 5C2 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Mc Gill University - Department of Oncology - Clinical Research Program Montreal, Quebec, Canada, H2W 1S6 Less <<
NCT00982111 Non Small Cell Lung Cancer Phase 3 Suspended December 31, 2018 -
NCT00537511 - Terminated(This study was term... More >>inated for administrative reasons.) Less << - -
NCT02061631 Squamous Cell Carcinoma of Hea... More >>d and Neck Less << Phase 2 Completed - Pakistan ... More >> Pakistan, Pakistan Less <<
NCT01702714 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 1 Withdrawn(Project Team decisio... More >>n) Less << February 2016 -
NCT00982111 - Suspended - -
NCT00002913 Brenner Tumor ... More >> Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mixed Epithelial Carcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma Ovarian Undifferentiated Adenocarcinoma Stage III Ovarian Epithelial Cancer Stage IV Ovarian Epithelial Cancer Less << Phase 1 Completed - United States, Arizona ... More >> Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States, 85012 Less <<
NCT00942825 Metastatic Non-squamous Non Sm... More >>all Cell Lung Cancer Less << Phase 2 Completed - United States, Nevada ... More >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, Pennsylvania Penn State Cancer Institute Hershey, Pennsylvania, United States, 17033 United States, Texas Mary Crowley Cancer Research Centers Dallas, Texas, United States, 75246 Less <<
NCT01301612 Carcinoma Ade... More >>nocarcinoma Uterine Cervix Adenosquamous Carcinoma Less << Phase 2 Withdrawn(Regulatory requireme... More >>nt. A phase III study is being designed.) Less << - Brazil ... More >> Centro de Pesquisa Clínica da Liga Norte Riograndense contra o Câncer Natal, Rio Grande do Norte, Brazil, 59075740 Hospital de Caridade de Ijui - ONCOSITE Centro de Pesquisa Clínica em Oncologia Ijui, Rio Grande do Sul, Brazil, 98700000 Hospital Santa Rita - Núcleo de Novos Tratamentos em Câncer Porto Alegre, Rio Grande do Sul, Brazil, 90020-160 Caism - Unicamp Campinas, São Paulo, Brazil, 13083970 Centro de Pesquisas Clínicas da Fundação Amaral Carvalho Jau, São Paulo, Brazil, 17210000 ICESP São Paulo, Brazil, 01246000 Hospital Santa Marcelina São Paulo, Brazil, 08270070 Less <<
NCT00139243 Squamous Cell Carcinoma ... More >> Carcinoma of Head and/or Neck Less << Phase 1 Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00942825 - Completed - -
NCT03044587 Adenocarcinoma Metastatic ... More >> Biliary Tract Cancer Adenocarcinoma of the Biliary Tract Adenocarinoma Locally Advanced Non-Resectable Hepatocellular Carcinoma Intrahepatic Bile Duct Carcinoma Extrahepatic Bile Duct Carcinoma Less << Phase 2 Recruiting January 2024 Germany ... More >> Universitätsklinikum Ulm Recruiting Ulm, Germany, 89081 Contact: Thomas J. Ettrich, Dr.       thomas.ettrich@uniklinik-ulm.de Less <<
NCT03588533 HER-2 Positive Gastric Cancer ... More >> Metastatic Cancer Less << Phase 2 Recruiting August 31, 2021 Korea, Republic of ... More >> Dong-A University Hospital Recruiting Busan, Korea, Republic of, 49201 Contact: Sung Yong Oh, MD    +82512402808    drosy@dau.ac.kr    Contact: Enhee Choi, RN    +82512405044    dongahicrc8@naver.com Less <<
NCT00747799 Nasopharyngeal Neoplasms Phase 2 Completed - China, Guangdong ... More >> Cancer Center of Sun-Yat Sen University Guangzhou, Guangdong, China, 510000 Less <<
NCT01407822 Non-small Cell Lung Cancer Phase 2 Phase 3 Active, not recruiting December 2022 China, Guangdong ... More >> Guangdong General Hospital Guangzhou, Guangdong, China, 510080 Less <<
NCT01360827 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 1 Terminated(Study terminated du... More >>e to potential safety concerns in combination with platinum-based therapies) Less << - France ... More >> Clinical Research Unit and Pharmacology Lab EA 3035 Institut Claudius Regaud Toulouse, France Less <<
NCT00515411 Gastroesophageal Junction Aden... More >>ocarcinoma Gastric Cancer Less << Phase 2 Completed - United States, California ... More >> City of Hope Cancer Center Duarte, California, United States, 91010 United States, Florida Memorial Cancer Institute Pembroke Pines, Florida, United States, 33025 United States, Georgia Piedmont Hospital Research Institute Atlanta, Georgia, United States, 30309 United States, Nebraska Nebraska Cancer Specialists, Methodist Estabrook Cancer Center Omaha, Nebraska, United States, 68114 United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Queens Cancer Center of Queens Hospital Jamaica, New York, United States, 11432 Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Weill Medical College of Cornell University New York, New York, United States, 10021 Memorial Sloan Kettering Cancer Center 1275 York Avenue New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center@Phelps Memorial Hospital Sleepy Hollow, New York, United States United States, Ohio University Hospital of Cleveland Cleveland, Ohio, United States, 44106 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00821327 Urothelial Cancer Phase 2 Completed - -
NCT01788566 Non-small Cell Lung Cancer Phase 2 Completed - United States, Alabama ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States, 35294 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Deerfield Beach, Florida, United States, 33442 United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Farmington Hills, Michigan, United States, 48334 Canada, Alberta For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamilton, Ontario, Canada, L8V 5C2 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, Ontario, Canada, N6A 4L6 Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montreal, Quebec, Canada, H3A 1A1 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75970 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Durango, Mexico, 34000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guadalajara, Mexico, 44200 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Breda, Netherlands, 4818 CK For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Eindhoven, Netherlands, 5623 EJ Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Majadahonda, Spain, 28222 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41014 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 404 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 112 Less <<
NCT01788566 - Completed - -
NCT00826891 Cervical Cancer Phase 2 Unknown January 2010 -
NCT00527761 Metastatic Melanoma Phase 1 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03101566 Biliary Tract Neoplasms Phase 2 Recruiting November 1, 2020 United States, Georgia ... More >> Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Walid Shaib, MD    404-778-1900       Principal Investigator: Walid Shaib, MD          United States, Illinois Northwestern University Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Al B. Benson, III, MD    312-695-0990       Principal Investigator: Al B. Benson, III, MD          United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Vaibhav Sahai, MBBS, MS    734-936-4991       Principal Investigator: Vaibhav Sahai, MBBS, MS          United States, Pennsylvania University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Peter O'Dwyer, MD    215-360-0716       Principal Investigator: Peter O'Dwyer, MD          United States, Texas University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 Contact: Muhammad Beg, MD    214-645-4673       Principal Investigator: Muhammad Beg, MD          United States, Washington University of Washington Recruiting Seattle, Washington, United States, 98109 Contact: David Zhen, MD    206-606-1743       Principal Investigator: David Zehn, MD          United States, Wisconsin University of Wisconsin Recruiting Madison, Wisconsin, United States, 53705 Contact: Dustin Deming, MD    608-265-1700       Principal Investigator: Dustin Deming, MD Less <<
NCT00281125 Non-Small Cell Lung Cancer and... More >> Pleural Mesothelioma Less << Phase 1 Phase 2 Terminated(Suspended due to da... More >>ta issues revealed at DSMB meeting. Planned amendment but was never submitted. Study was then closed.) Less << - United States, Nevada ... More >> Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 Less <<
NCT00575952 Endometrial Adenosquamous Carc... More >>inoma Endometrial Clear Cell Adenocarcinoma Endometrial Mixed Adenocarcinoma Endometrial Serous Adenocarcinoma Endometrial Squamous Cell Carcinoma Endometrial Undifferentiated Carcinoma Recurrent Uterine Corpus Carcinoma Stage IIIA Uterine Corpus Cancer Stage IIIC Uterine Corpus Cancer Stage IVA Uterine Corpus Cancer Stage IVB Uterine Corpus Cancer Less << Phase 1 Completed - United States, Connecticut ... More >> Hartford Hospital Hartford, Connecticut, United States, 06102 The Hospital of Central Connecticut New Britain, Connecticut, United States, 06050 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Cooper Hospital University Medical Center Camden, New Jersey, United States, 08103 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 United States, Rhode Island Women and Infants Hospital Providence, Rhode Island, United States, 02905 Less <<
NCT00966914 Non-small Cell Lung Cancer Phase 3 Completed - -
NCT00608205 Head and Neck Cancer Phase 3 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00707473 Locally Advanced Nasal Cavity ... More >>and Paranasal Sinus Squamous Cell Carcinoma Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma Sinonasal Undifferentiated Carcinoma Stage II Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8 Less << Phase 2 Recruiting June 30, 2019 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Ehab Y. Hanna    713-745-2672       Principal Investigator: Ehab Y. Hanna Less <<
NCT01888302 Hepatic Complication Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00400205 Squamous Cell Carcinoma ... More >> Oral Cancer Less << Phase 2 Terminated(Safety reasons) - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00400205 - Terminated(Safety reasons) - -
NCT00195078 Head and Neck Cancer Phase 1 Phase 2 Terminated - United States, New York ... More >> Weill Medical College of Cornell University New York, New York, United States, 10021 Less <<
NCT00002998 Breast Cancer Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 10309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinical and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Canada, Saskatchewan Saskatchewan Cancer Agency Regina, Saskatchewan, Canada, S4S 6X3 Less <<
NCT00608205 - Completed - -
NCT01187212 Malignant Neoplasm of Stomach ... More >> Effects of Chemotherapy Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Songpa-gu, Seoul, Korea, Republic of, 138-736 Less <<
NCT01595061 Stage IIIA Vulvar Cancer AJCC ... More >>v7 Stage IIIB Vulvar Cancer AJCC v7 Stage IIIC Vulvar Cancer AJCC v7 Stage IVA Vulvar Cancer AJCC v7 Vulvar Squamous Cell Carcinoma Less << Phase 2 Recruiting - -
NCT02270814 Head and Neck Cancer ... More >> Head and Neck Squamous Cell Carcinoma Cancer of the Head and Neck Less << Phase 2 Recruiting May 31, 2021 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Omar Atiq, M.D.    870-535-2800    otatiq@uams.edu    Principal Investigator: Omar Atiq, M.D.          Sub-Investigator: Laura Hutchins, M.D.          Sub-Investigator: Konstantinos Arnaoutakis, M.D.          Sub-Investigator: Issam Makhoul, M.D.          Sub-Investigator: Rangaswamy Govindarajan, M.D.          Sub-Investigator: Fade Mahmoud, M.D.          Sub-Investigator: Peter Emanuel, M.D.          Sub-Investigator: Natasa Milojkovic, M.D.          Sub-Investigator: Pooja Motwani, M.D.          Sub-Investigator: Liudmila Schafer, M.D.          United States, Mississippi University of Mississippi Medical Center Recruiting Jackson, Mississippi, United States, 39216 Contact: Robert Hamilton, M.D.    601-984-5590       Principal Investigator: Robert Hamilton, M.D.          Sub-Investigator: James T Thigpen, M.D.          Sub-Investigator: Barbara Craft, M.D.          Sub-Investigator: Louis Puneky, M.D.          Sub-Investigator: Jennifer Eubanks, M.D.          Sub-Investigator: Natale Sheehan, M.D.          Sub-Investigator: John C Henegan, M.D.          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Douglas R Adkins, M.D.    314-362-5654    dadkins@wustl.edu    Principal Investigator: Douglas Adkins, M.D.          Sub-Investigator: Tanya Wildes, M.D.          Sub-Investigator: Peter Oppelt, M.D.          United States, North Dakota Sanford Roger Maris Cancer Center Recruiting Fargo, North Dakota, United States, 58122 Contact: Mark Gitau, M.D.    701-234-6161       Principal Investigator: Mark Gitau, M.D.          Sub-Investigator: Anu Gaba, M.D.          Sub-Investigator: Louis Geeraerts, M.D.          Sub-Investigator: Mahendra Gupta, M.D.          Sub-Investigator: Gerald Gross, M.D.          Sub-Investigator: Susan Hofland, NP          Sub-Investigator: Amit Panwalkar, M.D.          Sub-Investigator: Carrie Pfaff, NP          Sub-Investigator: John Roll, CNS          Sub-Investigator: Howard Russell, M.D.          Sub-Investigator: Denise Snow, M.D.          Sub-Investigator: Preston Steen, M.D.          Sub-Investigator: Shelby Terstriep, M.D.          Sub-Investigator: Matthew Tinguely, M.D.          Sub-Investigator: Radhakrishna Vegunta, M.D.          Sub-Investigator: Lorelei Wolf, NP          United States, South Dakota Sanford Cancer Center Oncology Clinic and Pharmacy Recruiting Sioux Falls, South Dakota, United States, 57104 Contact: Steven Powell, M.D.    605-328-8000       Principal Investigator: Steven Powell, M.D.          Sub-Investigator: Jonathan Bleecker, M.D.          Sub-Investigator: Keely Hack, M.D.          Sub-Investigator: Michael Keppen, M.D.          Sub-Investigator: James Kuzman, M.D.          Sub-Investigator: Miroslaw Mazurczak, M.D.          Sub-Investigator: Amy Sanford, M.D.          Sub-Investigator: Christopher Sumey, M.D.          Sub-Investigator: Heather Casper-McLay, CNP          Sub-Investigator: Avigayil East, CNP          Sub-Investigator: Matthew Graham, CNP          Sub-Investigator: Susan Halbritter, CNP          Sub-Investigator: Kimberly Hamer, CNP          Sub-Investigator: Shauna Jacobs, CNP          Sub-Investigator: Jacqueline Kelley, CNP Less <<
NCT01645748 Head and Neck Cancer Phase 2 Completed - Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Gwangju, Jeollanamdo, Korea, Republic of, 519-809 Less <<
NCT02735928 Ovarian Epithelial Cancer Recu... More >>rrent Platinum-resistant Less << Phase 1 Phase 2 Recruiting October 2018 Italy ... More >> Catholic University of Sacred Heart Recruiting Rome, Italy, 00168 Contact: Giovanni Scambia, Professor    +39 0630156279    clinicaltrials@rm.unicatt.it    Contact: Federica Nardelli, MD    +39-06-30156279    nardelli.fede@gmail.com Less <<
NCT00832637 Hepatocellular Carcinoma ... More >> Cholangiocellular Carcinoma Cholangiocarcinoma of the Extrahepatic Bile Duct Bile Duct Cancer Periampullary Adenocarcinoma Gallbladder Cancer Extrahepatic Bile Duct Cancer Less << Phase 2 Terminated(Low accrual) - United States, California ... More >> California Pacific Medical Center San Francisco, California, United States, 94115 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 Less <<
NCT00253370 Adenocarcinoma of the Gastroes... More >>ophageal Junction Metastatic Gastric Cancer Advanced Unresectable Gastric Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT01034189 Esophageal Cancer Phase 2 Unknown June 2012 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 10002 Contact: Chih-Hung Hsu, M.D., Ph.D.    886-2-23123456 ext 67680    chihhunghsu@ntu.edu.tw    Principal Investigator: Chih-Hung Hsu, M.D., Ph.D. Less <<
NCT01282151 Carcinoma, Non Small Cell Lung Phase 3 Terminated(Difficulty in recru... More >>itment due to approval of maintenance pemetrexed treatment) Less << - Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun, Jeonnam, Korea, Republic of, 519-709 Kyungpook National University Medical Center Daegu, Kyungpook, Korea, Republic of Hallym University Medical Center Anyang, Korea, Republic of Dankook University Hospital Cheonan, Korea, Republic of, 330-715 Keimyung University Dongsan Center Daegu, Korea, Republic of, 700-712 Yeungnam Univeristy Hospital Daegu, Korea, Republic of Chosun University Hospital Gwangju, Korea, Republic of Wonkwang University Hospital Iksan, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of Pusan National University Hospital Pusan, Korea, Republic of, 602-739 Kosin University Gospel Hospital Pusan, Korea, Republic of Konkuk university medical center Seoul, Korea, Republic of, 143-729 Korea Cancer Center Hospital Seoul, Korea, Republic of Korea University Medical Center Seoul, Korea, Republic of Wonju Christian Hospital Wonju, Korea, Republic of Less <<
NCT00253370 - Completed - -
NCT02560038 - Terminated(slow enrollment; re... More >>source re-allocation) Less << - -
NCT00265941 Head and Neck Cancer Phase 3 Active, not recruiting - -
NCT00030576 Head and Neck Cancer Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Queen's University Kingston, Ontario, Canada, K7L 3N6 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Regional Cancer Centre Ottawa, Ontario, Canada, K1H 1C4 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Centre Hospitalier de l'Universite de Montreal Montreal, Quebec, Canada, H2L-4M1 Less <<
NCT02560038 Urinary Bladder Neoplasms Phase 2 Terminated(slow enrollment; re... More >>source re-allocation) Less << - United States, Texas ... More >> UTHealth Memorial Hermann Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00265941 - Active, not recruiting - -
NCT01411098 Recurrent Non-small Cell Lung ... More >>Cancer Stage IIB Non-small Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Less << Phase 1 Terminated(Low accrual) - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01104259 Estrogen Receptor-negative Bre... More >>ast Cancer HER2-negative Breast Cancer Hereditary Breast/Ovarian Cancer - BRCA1 Hereditary Breast/Ovarian Cancer - BRCA2 Male Breast Cancer Progesterone Receptor-negative Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Triple-negative Breast Cancer Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT03673072 Incidental Gallbladder Carcino... More >>ma Biliary Tract Cancer Less << Phase 3 Not yet recruiting November 2024 -
NCT01437449 Head and Neck Cancer Phase 2 Active, not recruiting January 2021 United States, California ... More >> University of California Davis Medical Center Davis, California, United States, 95616 Stanford University, School of Medicine Stanford, California, United States, 95305 Less <<
NCT00320983 Cervical Cancer Phase 1 Completed - United States, New Mexico ... More >> University of New Mexico Albuquerque, New Mexico, United States, 87131 Less <<
NCT00832637 - Terminated(Low accrual) - -
NCT03095079 Melanoma Phase 2 Recruiting October 2018 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100000 Contact: Chuanliang Cui, MD    +86 13691489319 Less <<
NCT03649321 Cancer of Pancreas Phase 1 Phase 2 Not yet recruiting May 2022 -
NCT00818090 Thymoma Thymi... More >>c Carcinoma Less << Phase 2 Terminated(marginal statistica... More >>l significance) Less << - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT03717155 Squamous Non-Small Cell Lung C... More >>ancer Less << Phase 2 Recruiting January 25, 2021 Hungary ... More >> Tudogyogyintezet Torokbalint - Onkopulmonologiai es Jarobeteg centrum Recruiting Torokbalint, Hungary, 2045 Spain Hospital Universitario Virgen Macarena - Servicio de Oncologia Recruiting Sevilla, Spain, 41009 Contact    +49 6151 72 5200    service@merckgroup.com Less <<
NCT00234494 Bladder Cancer Phase 2 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Quality Cancer Center (MCGOP) Indianapolis, Indiana, United States, 46202 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 AP&S Clinic Terre Haute, Indiana, United States, 47804 United States, Missouri Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, Ohio Oncology Hematology Care, Inc. Cincinnati, Ohio, United States, 45242 Less <<
NCT00234494 - Completed - -
NCT01326871 Transitional Cell Carcinoma of... More >> Bladder Urethra Cancer Ureter Cancer Malignant Tumor of Renal Pelvis Less << Phase 1 Phase 2 Unknown October 2017 United States, Arizona ... More >> The University of Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, Florida UF Health Center at Orlando Health Orlando, Florida, United States, 32806 Martin Health System Stuart, Florida, United States, 34994 H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois Robert Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States, 60611 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Kansas University of Kansas Cancer Center Fairway, Kansas, United States, 66205 United States, Michigan Karmanos Cancer Center Detroit, Michigan, United States, 48201 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28203 United States, Oklahoma University of Oklahoma Health Science Center Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania St. Luke's Hospital and Health Network Easton, Pennsylvania, United States, 18045 Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 UPMC Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01971489 Adult Solid Neoplasm ... More >> Recurrent Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Less << Phase 1 Withdrawn - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT00874328 Advanced Non-Small Cell Lung C... More >>ancer Less << Phase 1 Phase 2 Unknown December 2012 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Dae Ho Lee, M.D.    +82-2-3010-3214    leedaeho@amc.seoul.kr Less <<
NCT00049166 Stage II Squamous Cell Carcino... More >>ma of the Lip and Oral Cavity Stage II Squamous Cell Carcinoma of the Oropharynx Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Stage III Squamous Cell Carcinoma of the Oropharynx Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IV Squamous Cell Carcinoma of the Oropharynx Less << Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT01459614 Pancreatic Cancer Phase 2 Active, not recruiting November 2019 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21205 Less <<
NCT01095302 Neoplasms, Malignant Phase 1 Completed - Japan ... More >> Investigational Site Number 392003 Akashi-Shi, Japan Investigational Site Number 392001 Koto-Ku, Japan Investigational Site Number 392002 Nagoya-Shi, Japan Less <<
NCT00493025 - Terminated(Closed due to early... More >> stopping rule-Low accrual) Less << - -
NCT01045538 Gastric Cancer ... More >> Histone Deacetylase Inhibitor Less << Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00794417 Advanced Carcinoma ... More >> Non-small Cell Lung Cancer Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Arizona Cancer Institute, LLC Tucson, Arizona, United States, 85715 United States, Arkansas University of Arkansas for Medical Science Little Rock, Arkansas, United States, 72205 United States, California Stanford University Medical Center Stanford, California, United States, 94305 United States, Florida Palm Beach Institute of Hematology and Oncology Boynton Beach, Florida, United States, 33435 United States, Illinois Edward Hines Jr. VA Medical Center Hines, Illinois, United States, 60141 United States, Kentucky Kentucky Cancer Clinic Hazard, Kentucky, United States, 41701 United States, Maryland Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231-1000 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New Mexico UNM Cancer Clinic Albuquerque, New Mexico, United States, 87131 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, North Carolina Presbyterian Hospital Center for Cancer Research Charlotte, North Carolina, United States, 28204 United States, Pennsylvania Erie Regional Cancer Center Erie, Pennsylvania, United States, 16505 United States, West Virginia Schiffler Cancer Center - Medical Oncology Division Wheeling, West Virginia, United States, 26003 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00493025 Esophageal Cancer Phase 2 Terminated(Closed due to early... More >> stopping rule-Low accrual) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00191763 Carcinoma, Non-Small-Cell-Lung... More >> Cancer Less << Phase 2 Completed - Turkey ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician. Istanbul, Turkey Less <<
NCT00144989 Small-Cell-Lung Cancer Phase 3 Completed - Japan ... More >> Aichi Cancer Center Hospital Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi, Japan, 464-8681 Aichi Cancer Center,Aichi Hospital Okazaki,Kake-machi,Kuriyado,18, Aichi, Japan, 444-0011 National Cancer Center Hospital East Kashiwa-shi,Kashiwanoha,6-5-1, Chiba, Japan, 277-8577 National Hospital Organization Shikoku Cancer Center Matsuyama,Horinouchi,13, Ehime, Japan, 790-0007 Kyushu University Hospital Higashi-ku,Maidashi,3-1-1, Fukuoka, Japan, 812-8582 Gifu Municipal Hospital Gifu,Kashima-cho,7-1, Gifu, Japan, 500-8323 Gunma Prefectural Cancer Center Ota,Takabayashi-nishi-cho,617-1, Gunma, Japan, 373-8550 National Nishigunma Hospital Shibukawa,Kanai,2854, Gunma, Japan, 377-8511 National Hospital Organization, Dohoku National Hospital Asahikawa,Hanasaki,7-4048, Hokkaido, Japan, 070-8644 National Hospital Organization Hokkaido Cancer Center Sapporo,Shiroishi-ku,Kikusui,4-2-3-54, Hokkaido, Japan, 003-0804 Hyogo Medical Center for Adults Akashi,Kitaouji-cho,13-70, Hyogo, Japan, 673-8558 Kobe City General Hospital Kobe,Chuo-ku,Minatojimanakamachi,4-6, Hyogo, Japan, 650-0046 Hyogo College of Medicine Nishinomiya,Mukogawa-cho,1-1, Hyogo, Japan, 663-8501 Ibaraki Kenritsu Chuo Hospital & Cancer Center Nishi-ibarakigun,Tomobemachi,Koibuchi,6528, Ibaraki, Japan, 309-1793 Kanagawa Cancer Center Yokohama,Asahi-ku,Nakao,1-1-2, Kanagawa, Japan, 241-0815 Yokohama Mucipical Citizen's Hospital Yokohama,Hodogaya-ku,Okazawa-cho,56, Kanagawa, Japan, 240-8555 Kumamoto Regional Medical Center Hospital Kumamoto,Honjo,5-16-10, Kumamoto, Japan, 860-0811 Tohoku University Hospital Sendai,Aoba-ku,Seiryo-machi,1-1, Miyagi, Japan, 980-0874 Niigata Cancer Center Hospital Niigata,Kawagishi-cho,2-15-3, Niigata, Japan, 951-8566 Okayama University Hospital Okayama,Shikata-cho,2-5-1, Okayama, Japan, 700-8558 Osaka Prefectural Medical Center for Respiratory and Allergic Disease Habikino,Habikino,3-7-1, Osaka, Japan, 583-8588 Rinku General Medical Center Izumisano,rinku-ohrai-kita,2-23, Osaka, Japan, 598-0048 Graduate School of Medicine, Osaka City University Osaka,Abeno-ku,Asahi-machi,1-5-7, Osaka, Japan, 545-0051 Osaka Medical Center for Cancer and Cardiovascular Diseases Osaka,Higashinari-ku,Nakamichi,1-3-3, Osaka, Japan, 537-8511 Osaka City General Hospital Osaka,Miyakojima-ku,Miyakojimahondori,2-13-22, Osaka, Japan, 534-0021 Osaka General Medical Center Osaka,Sumiyoshi-ku,Bandai-higashi,3-1-56, Osaka, Japan, 558-8558 Kinki University School of Medicine Osaka-Sayama,Ohno-higashi,377-2, Osaka, Japan, 589-8511 National Hospital Organization Kinki-Chuo Chest Medical Center Sakai,Nagasone,1180, Osaka, Japan, 591-8555 National Hospital Organization Toneyama National Hospital Toyonaka,Toneyama,5-1-1, Osaka, Japan, 560-8552 Saitama Cancer Center Kita-adachi,Ina,Komuro,818, Saitama, Japan, 362-0806 Sizuoka Cancer Center Sunto-gun,Nagaizumi-cho,Shimonagakubo,1007, Shizuoka, Japan, 411-8777 Tochigi Cancer Center Utsunomiya,Yohnan,4-9-13, Tochigi, Japan, 320-0834 National Cancer Center Hospital Chuo-ku,Tsukiji,5-1-1, Tokyo, Japan, 104-0045 Cancer Institute Hospital Koto-ku,Ariake,3-10-6, Tokyo, Japan, 135-8550 Toranomon Hospital Minato-ku,Toranomon,2-2-2, Tokyo, Japan, 105-8470 International Medical Center of Japan Shinjuku-ku,Toyama,1-21-1, Tokyo, Japan, 162-8655 Yamagata Prefectural Central Hospital Yamagata,Aoyagi,1800, Yamagata, Japan, 990-2292 Less <<
NCT02429466 Germ Cell Tumor ... More >> Testis Cancer Testicular Cancer Less << Phase 1 Suspended December 31, 2019 United States, Indiana ... More >> Indiana University Hospital Indianapolis, Indiana, United States, 46202 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00477607 Ototoxicity U... More >>nspecified Adult Solid Tumor Less << Phase 2 Phase 3 Completed - United States, Oregon ... More >> VA Medical Center, Portland Portland, Oregon, United States, 97201 Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT00165516 Pleural Mesothelioma ... More >> Malignant Pleural Mesothelioma Less << Phase 2 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00477607 - Completed - -
NCT03225157 - Recruiting March 1, 2022 United States, Maryland ... More >> Suburban Hospital Recruiting Bethesda, Maryland, United States, 20814 National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01460537 Neoplasms Phase 1 Completed - United States, Florida ... More >> Tampa, Florida, United States, 33612 United States, Minnesota Rochester, Minnesota, United States, 55905 United States, North Carolina Chapel Hill, North Carolina, United States, 27599-7305 Less <<
NCT00621361 Lung Cancer Phase 1 Completed - United States, California ... More >> Research Site Sacramento, California, United States United States, Colorado Research Site Denver, Colorado, United States United States, Kansas Research Site Kansas City, Kansas, United States United States, Texas Research Site Houston, Texas, United States Less <<
NCT00882583 Head and Neck Cancer Phase 1 Phase 2 Terminated(Low accrual) - United States, Maryland ... More >> Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00882583 - Terminated(Low accrual) - -
NCT03609216 Infiltrating Bladder Urothelia... More >>l Carcinoma Stage II Bladder Urothelial Carcinoma Stage III Bladder Urothelial Carcinoma Less << Phase 2 Recruiting February 2029 -
NCT01326559 Nasopharyngeal Carcinoma Phase 2 Completed - China ... More >> Department of Clinical Oncology, Queen Mary Hospital(QMH), Hong Kong Hong Kong, China Department of Clinical Oncology, Queen Mary Hospital Hong Kong, China Department of Clinical Oncology, Tuen Mun Hospital (TMH), Hong Kong Hong Kong, China Department of Oncology, Princess Margaret Hospital Hong Kong, China Less <<
NCT03092986 Carcinoma, Non-Small-Cell Lung Phase 3 Not yet recruiting April 2018 -
NCT02466971 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Stage IB2 Cervical Cancer AJCC v6 and v7 Stage II Cervical Cancer AJCC v7 Stage II Vaginal Cancer AJCC v6 and v7 Stage IIA Cervical Cancer AJCC v7 Stage IIB Cervical Cancer AJCC v6 and v7 Stage III Vaginal Cancer AJCC v6 and v7 Stage IIIB Cervical Cancer AJCC v6 and v7 Stage IVA Cervical Cancer AJCC v6 and v7 Stage IVA Vaginal Cancer AJCC v6 and v7 Vaginal Adenocarcinoma Vaginal Adenosquamous Carcinoma Vaginal Squamous Cell Carcinoma, Not Otherwise Specified Less << Phase 2 Recruiting September 30, 2018 -
NCT00077883 Non-small Cell Lung Cancer Phase 1 Phase 2 Completed - United States, Maryland ... More >> Univ. of MD, Greenbaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Tennessee The Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 United States, Texas Univ. of TX, MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01128387 - Terminated(slow accrual) - -
NCT00084812 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01128387 Cancer Phase 1 Phase 2 Terminated(slow accrual) - United States, Wisconsin ... More >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00072033 Esophageal Cancer Phase 2 Completed - Switzerland ... More >> Kantonspital Aarau Aarau, Switzerland, CH-5001 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Inselspital Bern Bern, Switzerland, CH-3010 Spitaeler Chur AG Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Ospedale Civico Lugano, Switzerland, CH-6900 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 City Hospital Triemli Zurich, Switzerland, 8063 Less <<
NCT00909402 Stomach Neoplasms ... More >> Esophageal Neoplasms Less << Phase 1 Completed - United States, California ... More >> City Of Hope National Medical Center Duarte, California, United States, 91010-3012 Usc/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Texas The University Of Texas Md Anderson Cancer Center Houston, Texas, United States, 77030-4009 Canada, Ontario Local Institution Toronto, Ontario, Canada, M5G 2M9 France Local Institution Villejuif, France, 94805 Netherlands Local Institution Amsterdam, Netherlands, 1105 AZ Less <<
NCT01480986 Progression Free Survival of t... More >>he Treatment Less << Phase 2 Completed - China, Beijing ... More >> Beijing Tumor Hospital Beijing, Beijing, China Less <<
NCT02225405 Stage IB Non-Small Cell Lung C... More >>arcinoma AJCC v7 Stage II Non-Small Cell Lung Cancer AJCC v7 Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Less << Phase 1 Active, not recruiting April 30, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00216125 Non-Small Cell Lung Cancer Phase 3 Completed - United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Elkhart Clinic Elkhart, Indiana, United States, 46515 Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Center for Cancer Care at Goshen Health System Goshen, Indiana, United States, 46527 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Quality Cancer Center (MCGOP) Indianapolis, Indiana, United States, 46202 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Center for Cancer Care, Inc., P.C. New Albany, Indiana, United States, 47150 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 AP&S Clinic Terre Haute, Indiana, United States, 47804 United States, Missouri Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Texas US Oncology Houston, Texas, United States, 77060 Less <<
NCT00006105 Bladder Cancer ... More >> Drug/Agent Toxicity by Tissue/Organ Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT00813696 Pancreatic Cancer Phase 3 Unknown September 2009 Italy ... More >> Ospedal Miulli Acquaviva delle Fonti, Italy Ospedale Regionale Torrette Ancona, Italy Presidio Osp. Alto Garda e Ledro ARco, Italy Centro Riferimento Oncologico Aviano, Italy Istituto Oncologico Giovanni Paolo II Bari, Italy Azienda Ospedaliera G. Rummo Benevento, Italy Ospedale Fatebenefratelli Benevento, Italy Ospedale Riuniti Bergamo, Italy Ospedale degli Infermi Biella, Italy Ospedale Regionale Bolzano, Italy Policlinico Universitario Cagliari, Italy Ospedale A. Cardarelli Campobasso, Italy Ospedale Ramazzini Carpi, Italy Centro Catanese di Oncologia Catania, Italy Università di Chieti "D'Annunzio" Chieti, Italy Ospedale Valduce Como, Italy Ospedale Santa Croce Fano, Italy Azienda Ospedaliera Universitaria Ferrara, Italy Azienda Ospedale Careggi Firenze, Italy Azienda Ospedaliera Vito Fazzi Lecce, Italy Ospedale Umberto I Lugo, Italy Pres. Osp. di Manerbio Manerbio, Italy Ospedale L. Sacco Milano, Italy Ospedale San Paolo Milano, Italy Ospedale G. Moscati Monteforte Irpino, Italy Ospedale San Gerardo Monza, Italy Istituto Nazionale Tumori Napoli, Italy Ospedale Cardarelli Napoli, Italy Ospedale Civile Olbia, Italy Casa di Cura La Maddalena Palermo, Italy Policlinico Giaccone Palermo, Italy Ospedale San Salvatore-Muraglia Pesaro, Italy Ospedale Guglielmo da Saliceto Piacenza, Italy Ospedale San Carlo Potenza, Italy Azienda Policlinico S. Andrea Roma, Italy Ospedale Fatebenefratelli Roma, Italy Ospedale San Raffaele Roma, Italy Policlinico Militare Celio Roma, Italy Polo Oncologico Istituto Regina Elena Roma, Italy Ospedale Civile Rovereto, Italy Ospedale Civile Rovigo, Italy Centro Oncologico S. Vito al Tagliamento, Italy Ospedale Santa Chiara Trento, Italy Azienda Ospedaliera Treviglio-Caravaggio Treviglio, Italy Ospedale San Bortolo Vicenza, Italy Less <<
NCT00084435 Head and Neck Cancer Phase 2 Withdrawn(Poor accrual and sus... More >>pension of head and neck committee) Less << - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 United States, Illinois Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States, 62526 Regional Cancer Center at Memorial Medical Center Springfield, Illinois, United States, 62781-0001 United States, Kansas Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City, Kansas, United States, 66160-7357 United States, Louisiana Feist-Weiller Cancer Center at Louisiana State University Health Sciences Shreveport, Louisiana, United States, 71130-3932 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0942 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 United States, Missouri Saint Louis University Cancer Center Saint Louis, Missouri, United States, 63110 United States, North Carolina Rutherford Hospital Rutherfordton, North Carolina, United States, 28139 United States, Ohio Adena Regional Medical Center Chillicothe, Ohio, United States, 45601 Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Riverside Methodist Hospital Cancer Care Columbus, Ohio, United States, 43214-3998 CCOP - Columbus Columbus, Ohio, United States, 43215 Grant Riverside Cancer Services Columbus, Ohio, United States, 43215 Mount Carmel Health - West Hospital Columbus, Ohio, United States, 43222 Doctors Hospital at Ohio Health Columbus, Ohio, United States, 43228 Grady Memorial Hospital Delaware, Ohio, United States, 43015 Community Oncology Group at Cleveland Clinic Cancer Center Independence, Ohio, United States, 44131 Fairfield Medical Center Lancaster, Ohio, United States, 43130 Strecker Cancer Center at Marietta Memorial Hospital Marietta, Ohio, United States, 45750 Licking Memorial Cancer Care Program at Licking Memorial Hospital Newark, Ohio, United States, 43055 Mercy Medical Center Springfield, Ohio, United States, 45504 Community Hospital of Springfield and Clark County Springfield, Ohio, United States, 45505 Mount Carmel Cancer Services at Mount Carmel St. Ann's Hospital Westerville, Ohio, United States, 43081 Cleveland Clinic - Wooster Wooster, Ohio, United States, 44691 Genesis - Good Samaritan Hospital Zanesville, Ohio, United States, 43701 United States, South Carolina AnMed Health Cancer Center Anderson, South Carolina, United States, 29621 CCOP - Upstate Carolina Spartanburg, South Carolina, United States, 29303 Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 Less <<
NCT00658580 Small Cell Lung Carcinoma, Ext... More >>ensive Disease Less << Phase 3 Completed - Belgium ... More >> Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet Brussels, Belgium, 1000 France Department of Pneumology CHRU Lille Lille, France Greece Hellenic Cancer Institute - St Savas Oncology Hospital Athens, Greece Spain Medical Oncology Hospital de Sagunto Valencia, Spain Less <<
NCT00490399 Biliary Tract Carcinoma Phase 2 Completed - Korea, Republic of ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of Less <<
NCT01998347 Esophageal Cancer Phase 3 Withdrawn(slow enrollment) - China, Guangdong ... More >> Department of medical oncology,Cancer hospital of Shantou University Medical colledge Shantou, Guangdong, China, 515031 Less <<
NCT01064648 Epithelioid Mesothelioma ... More >> Pleural Malignant Mesothelioma Recurrent Malignant Mesothelioma Sarcomatoid Mesothelioma Less << Phase 1 Phase 2 Active, not recruiting - -
NCT00678132 Neoplasms Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00930930 - Completed - -
NCT00930930 Breast Cancer Phase 2 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35249 United States, Mississippi University of Mississippi Medical Center Research Institute Jackson, Mississippi, United States, 39213 United States, Pennsylvania Hershey Medical Center Hershey, Pennsylvania, United States, 17033 United States, Tennessee Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 MBCCOP - Meharry Medical College - Nashville Nashville, Tennessee, United States, 37208 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 United States, Texas The Methodist Hospital Research Institute Houston, Texas, United States, 77030 United States, Virginia University of Virginia Health Sciences Center Charlottesville, Virginia, United States, 22098 Less <<
NCT00410826 Stage III Squamous Cell Carcin... More >>oma of the Hypopharynx Stage III Squamous Cell Carcinoma of the Larynx Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Stage III Squamous Cell Carcinoma of the Nasopharynx Stage III Squamous Cell Carcinoma of the Oropharynx Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Larynx Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IV Squamous Cell Carcinoma of the Oropharynx Less << Phase 2 Completed - United States, Alaska ... More >> Alaska Oncology and Hematology LLC Anchorage, Alaska, United States, 99508 United States, Florida University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States, 33136 United States, New Mexico University of New Mexico Health Science CCOP Albuquerque, New Mexico, United States, 87131 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 New Hanover Radiation Oncology Center Wilmington, North Carolina, United States, 28401 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee University of Tennessee Cancer Institute-Boston Cancer Group PLC Memphis, Tennessee, United States, 38104 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Multicare Health System Tacoma, Washington, United States, 98415 Less <<
NCT02357147 Mesothelioma, Malignant Phase 2 Active, not recruiting November 30, 2018 -
NCT00270569 Breast Neoplasms Phase 2 Unknown - Taiwan ... More >> Far Eastern Memorial Hospital Recruiting Taipei, Ban-Ciao, Taiwan, 220 Contact: Kun Huei Yeh, Ph.D.    886-2-89667000 ext 1611    khyeh@mail.femh.org.tw Less <<
NCT00270582 Carcinoma, Non-Small-Cell Lung Phase 2 Unknown - Taiwan ... More >> Chi-Huang Hsiao Recruiting Taipei, Ban-Ciao, Taiwan, 220 Contact: CHI HUANG HSIAO, M.D.    886-2-89667000 ext 2102    onchsiao@ms28.hinet.net Less <<
NCT00410826 - Completed - -
NCT01656551 Non-small Cell Lung Cancer Met... More >>astatic Non-small Cell Lung Cancer Stage IIIB Less << Phase 3 Active, not recruiting September 2018 -
NCT00680758 Breast Cancer Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Sarah Cannon Cancer Center at Centennial Medical Center Nashville, Tennessee, United States, 37203 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT02281006 DDP Head and ... More >>Neck Cancer Adverse Effect Less << Phase 2 Terminated(poor accrual) - Canada ... More >> CHU de Quebec Quebec, Canada, G1R 2J6 Less <<
NCT01386632 - Active, not recruiting - -
NCT01386632 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Active, not recruiting January 2019 United States, North Dakota ... More >> Sanford Roger Maris Cancer Center Fargo, North Dakota, United States, 58122 United States, South Dakota Sanford Hematology and Oncology Sioux Falls, South Dakota, United States, 57104 Less <<
NCT01771289 Non-small Cell Lung Cancer Phase 2 Unknown - China, Beijing ... More >> Peking university people's hospital Recruiting Beijing, Beijing, China, 100000 Contact: Fan Yang    +8688326657    dr.yangf@gmail.com Less <<
NCT01083537 Ovarian Cancer ... More >> Peritoneal Cancer Fallopian Tube Cancer Bowel Obstruction Less << Phase 1 Phase 2 Terminated(Slow accrual) - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02341989 Testicular Neoplasms ... More >> Seminoma Less << Phase 3 Recruiting December 2020 Norway ... More >> Institutt for kreftforskning og molekylær medisin, St Olavs Hospital Recruiting Trondheim, Norway Contact: Torgrim Tandstad, md phd       torgrim.tandstad@ntnu.no Less <<
NCT01375972 Metastatic Biliary Cancer Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138736 Less <<
NCT00083161 Lung Cancer Phase 2 Completed - United States, Wisconsin ... More >> Gundersen Lutheran Center for Cancer and Blood La Crosse, Wisconsin, United States, 54601 Less <<
NCT00215995 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Puerto Rico Ponce School of Medicine Ponce, Puerto Rico, 00732 University of Puetro Rico Cancer Center San Juan, Puerto Rico, 00936-5067 Less <<
NCT01194869 Breast Cancer Phase 2 Terminated(Slow accrual, avail... More >>ability of other clinical options) Less << - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00176813 Pancreatic Cancer Phase 2 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT01194869 - Terminated(Slow accrual, avail... More >>ability of other clinical options) Less << - -
NCT01088620 Carcinoma, Non-Small-Cell Lung Phase 2 Suspended(the DSMB stopped the... More >> trial due to unacceptable side effects in the experimental arm which has not yet been verified) Less << January 2014 Germany ... More >> Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gesundheitszentrum St. Marien GmbH Amberg, Germany, 92224 Universitätsklinikum Charité - Campus Mitte Berlin, Germany, 10117 Charité Campus Benjamin Franklin Medizinische Klinik m. S. Hämatologie und Onkologie Berlin, Germany, 12200 HELIOS Klinikum Emil von Behring - Lungenklinik Heckeshorn Berlin, Germany, 14165 Augusta-Kranken-Anstalt gGmbH Bochum, Germany, 44791 Johanniter-Krankenhaus Bonn Bonn, Germany, 53113 Carl-Thiem-Klinikum Cottbus gGmbH Cottbus, Germany, 03048 Medizinische Fakultät Carl Gustav Carus der Technischen Universität Dresden Medizinische Klinik 1 Dresden, Germany, 01307 Katholisches Klinikum Duisburg/St. Johannes-Hospital Duisburg, Germany, 47166 Klinikum Frankfurt (Oder) GmbH Frankfurt (Oder), Germany, 15236 Krankenhaus Großhansdorf GmbH Onkologischer Schwerpunkt Großhansdorf, Germany, 22927 Krankenhaus - Martha-Maria Halle-Dölau GmbH Halle/Saale, Germany, 06120 Universitätsklinikum Halle (Saale), Klinik und Poliklinik für Innere Medizin I Halle/Saale, Germany, 06120 Universitätsklinikum Jena, Klinik für Innere Medizin I Jena, Germany, 07740 Onkologische Schwerpunktpraxis Dr. Stauch Kronach, Germany, 96317 Kliniken der Stadt Köln, Krankenhaus Merheim Köln, Germany, 51109 UK-SH, Campus Lübeck, Med. Klinik III Lübeck, Germany, 23538 LMU-Klinikum der Universität München, Medizinische Klinik München-Innenstadt München, Germany, 80336 Oncologianova GmbH Recklinghausen, Germany, 45657 Uniklinikum Ulm, Klinik für Innere Medizin II, Pneumologie Ulm, Germany, 89081 Less <<
NCT02964689 Advanced Non-small Cell Lung C... More >>ancer KRAS Gene Mutation Lung Cancer Less << Phase 1 Recruiting September 2020 Switzerland ... More >> Universitaetsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Sacha Rothschild, MD    +41 (0)61 265 25 25    sacha.rothschild@usb.ch    Principal Investigator: Sacha Rothschild, MD          IOSI Ospedale Regionale di Bellinzona e Valli Recruiting Bellinzona, Switzerland, 6500 Contact: Patrizia Froesch, MD    +41 (0)91 811 48 40    patrizia.froesch@eoc.ch    Principal Investigator: Patrizia Froesch, MD          Kantonsspital Graubuenden Recruiting Chur, Switzerland, CH-7000 Contact: Michael Mark, MD    +41 (0)81 256 61 11    michael.mark@ksgr.ch    Principal Investigator: Michael Mark, MD          Kantonsspital St. Gallen Recruiting St. Gallen, Switzerland, 9007 Contact: Martin Früh, MD    +41 (0)71 494 11 11    martin.frueh@kssg.ch    Principal Investigator: Martin Früh, MD Less <<
NCT02624128 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Recruiting October 2019 Italy ... More >> Istituto Nazionale Tumori Fondazione G. Pascale Recruiting Napoli, Italy Less <<
NCT02325401 Head and Neck Cancer Phase 1 Active, not recruiting March 2021 United States, Ohio ... More >> University of Cincinnati Cancer Institute Cincinnati, Ohio, United States, 45267 Less <<
NCT00889733 Epithelial Ovarian Cancer Phase 1 Phase 2 Terminated(Poor recruitment) - Canada, Ontario ... More >> University Health Network - Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00678977 Lung Cancer, Non-Small Cell Phase 1 Completed - Germany ... More >> GSK Investigational Site Essen, Nordrhein-Westfalen, Germany, 45122 United Kingdom GSK Investigational Site Newcastle Upon Tyne, Northumberland, United Kingdom, NE4 6BE Less <<
NCT00492778 Endometrial Adenocarcinoma ... More >> Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation Endometrial Serous Adenocarcinoma Recurrent Uterine Corpus Carcinoma Less << Phase 2 Recruiting - -
NCT03382600 Gastric Cancer Phase 2 Recruiting August 17, 2020 Japan ... More >> National Cancer Center Hospital East ( Site 0001) Recruiting Kashiwa, Chiba, Japan, 277-8577 Contact: Study Coordinator    +81471331111       National Hospital Organization Shikoku Cancer Center ( Site 0024) Recruiting Matsuyama, Ehime, Japan, 791-0280 Contact: Study Coordinator    +81899991111       Gunma Prefectural Cancer Center ( Site 0005) Recruiting Ohta, Gunma, Japan, 373-8550 Contact: Study Coordinator    +81276380771       Hokkaido University Hospital ( Site 0006) Recruiting Sapporo, Hokkaido, Japan, 060-8648 Contact: Study Coordinator    +81117161161       Hyogo Cancer Center ( Site 0016) Recruiting Akashi, Hyogo, Japan, 673-8558 Contact: Study Coordinator    +81789291151       Kobe City Medical Center General Hospital ( Site 0015) Recruiting Kobe, Hyogo, Japan, 650-0047 Contact: Study Coordinator    +81783024321       Ibaraki Prefectural Central Hospital ( Site 0018) Recruiting Kasama, Ibaraki, Japan, 309-1793 Contact: Study Coordinator    +81296771121       Kitasato University Hospital ( Site 0019) Recruiting Sagamihara, Kanagawa, Japan, 252-0375 Contact: Study Coordinator    +81427788111       Kanagawa Cancer Center ( Site 0003) Recruiting Yokohama, Kanagawa, Japan, 241-8515 Contact: Study Coordinator    +81455202222       Tohoku University Hospital ( Site 0023) Recruiting Sendai, Miyagi, Japan, 980-8574 Contact: Study Coordinator    +81227177000       Kindai University Hospital ( Site 0013) Recruiting Osakasayama, Osaka, Japan, 589-8511 Contact: Study Coordinator    +81723660221       Osaka University Hospital ( Site 0010) Recruiting Suita, Osaka, Japan, 565-0871 Contact: Study Coordinator    +81668795111       Saitama Cancer Center ( Site 0004) Recruiting Kitaadachi-gun, Saitama, Japan, 362-0806 Contact: Study Coordinator    +81487221111       Shizuoka Cancer Center Hospital and Research Institute ( Site 0020) Recruiting Sunto-gun, Shizuoka, Japan, 411-8777 Contact: Study Coordinator    +81559895222       Jichi Medical University Hospital ( Site 0009) Recruiting Shimotsuke, Tochigi, Japan, 329-0498 Contact: Study Coordinator    +81285442111       Chiba Cancer Center ( Site 0012) Recruiting Chiba, Japan, 260-8717 Contact: Study Coordinator    +81432645431       National Hospital Organization Kyushu Cancer Center ( Site 0017) Recruiting Fukuoka, Japan, 811-1395 Contact: Study Coordinator    +81925413231       Kyushu University Hospital ( Site 0014) Recruiting Fukuoka, Japan, 812-8582 Contact: Study Coordinator    +81926411151       Gifu University Hospital ( Site 0021) Recruiting Gifu, Japan, 501-1194 Contact: Study Coordinator    +81582306000       Kochi Health Sciences Center ( Site 0022) Recruiting Kochi, Japan, 781-8555 Contact: Study Coordinator    +81888373000       Kumamoto University Hospital ( Site 0002) Recruiting Kumamoto, Japan, 860-8556 Contact: Study Coordinator    +81963442111       Osaka International Cancer Institute ( Site 0011) Recruiting Osaka, Japan, 541-8567 Contact: Study Coordinator    +81669451181       National Cancer Center Hospital ( Site 0025) Recruiting Tokyo, Japan, 104-0045 Contact: Study Coordinator    +81335422511       Tokyo Metropolitan Komagome Hospital ( Site 0008) Recruiting Tokyo, Japan, 113-8677 Contact: Study Coordinator    +81338232101       The Cancer Institute Hospital of JFCR ( Site 0007) Recruiting Tokyo, Japan, 135-8550 Contact: Study Coordinator    +81335200111 Less <<
NCT02439489 Solid Tumors Phase 1 Completed - Italy ... More >> Ospedale San Raffaele Milano, MI, Italy, 20100 Less <<
NCT02314117 - Active, not recruiting - -
NCT00082706 Bladder Cancer ... More >> Urethral Cancer Urachal Cancer Less << Phase 2 Active, not recruiting April 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT01295502 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Stage IB Cervical Cancer Stage IIA Cervical Cancer Stage IIB Cervical Cancer Stage IIIA Cervical Cancer Stage IIIB Cervical Cancer Stage IVA Cervical Cancer Less << Phase 1 Active, not recruiting - United States, California ... More >> UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 United States, Connecticut Hartford Hospital Hartford, Connecticut, United States, 06102 The Hospital of Central Connecticut New Britain, Connecticut, United States, 06050 United States, Georgia Augusta University Medical Center Augusta, Georgia, United States, 30912 United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 United States, Ohio Summa Akron City Hospital/Cooper Cancer Center Akron, Ohio, United States, 44304 Case Western Reserve University Cleveland, Ohio, United States, 44106 MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Riverside Methodist Hospital Columbus, Ohio, United States, 43214 Hillcrest Hospital Cancer Center Mayfield Heights, Ohio, United States, 44124 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 United States, Rhode Island Women and Infants Hospital Providence, Rhode Island, United States, 02905 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT02314117 Metastatic Gastric Adenocarcin... More >>oma Gastroesophageal Junction Adenocarcinoma Less << Phase 3 Active, not recruiting January 31, 2019 -
NCT00137852 Esophageal Cancer Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01471470 Advanced Gastric Cancer Phase 2 Active, not recruiting December 2019 Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT03126708 Esophageal Cancer, Squamous Ce... More >>ll Cetuximab Effect Chemotherapy Effect Less << Phase 2 Recruiting April 2020 China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Lin Shen, MD    +86-10-88196561    lin100@medmail.com.cn Less <<
NCT00957411 Cervical Cancer Phase 2 Completed - France ... More >> Institut Curie Hopital Paris, France, 75248 Less <<
NCT01873326 Germ Cell Tumors Phase 2 Active, not recruiting June 2019 United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033 Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Illinois University of Chicago Chicago, Illinois, United States United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27514 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00660504 - Completed - -
NCT00497315 Non-Small Cell Lung Cancer Phase 2 Completed - Belgium ... More >> ZNA Middelheim Antwerpen, Antwerp, Belgium, 2020 University Hospital Antwerp Edegem, Antwerp, Belgium, 2650 St Augustinus Ziekenhuis Wilrijk, Antwerp, Belgium, 2610 Less <<
NCT00887822 Gastric Cancer Phase 3 Completed - China ... More >> Beijing, China, 100021 Beijing, China, 100071 Beijing, China, 100142 Beijing, China, 100853 ChongQing, China, 400042 Guangzhou, China, 510060 Hangzhou, China, 310016 Nanjing, China, 210036 Nanjing, China Shanghai, China, 200032 Shanghai, China, 200080 Shantou, China, 515041 Shenyang, China, 110001 Wuhan, China, 430030 Less <<
NCT01633645 Non Small Cell Lung Cancer ... More >> Metastatic Less << Phase 2 Completed - Greece ... More >> Air Forces Military Hospital of Athens Athens, Greece Athens, Greece METAXA Hospital, B' Pathology Department Athens, Greece SOTIRIA Hospital, Medical Oncology Department Athens, Greece University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece Heraklion, Greece "Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology Thessaloniki, Greece Less <<
NCT00660504 Lung Cancer Phase 3 Completed - China, Fujian ... More >> Fuzhou, Fujian, China China, Gansu Lanzhou, Gansu, China China, Guangdong Guangzhou, Guangdong, China China, Hunan Changsha, Hunan, China China, Jiangsu Nanjing, Jiangsu, China China, Jiangxi Nanchang, Jiangxi, China China, Jilin Changchun, Jilin, China China, Liaoning Dalian/Shenyang, Liaoning, China Shenyang, Liaoning, China China, Shanxi Xian, Shanxi, China China, Sichuan Chengdu, Sichuan, China China, Zhejiang Hangzhou, Zhejiang, China China Beijing, China Shanghai, China Tianjin, China Less <<
NCT01105390 Advanced Malignant Mesotheliom... More >>a Epithelial Mesothelioma Recurrent Malignant Mesothelioma Sarcomatous Mesothelioma Less << Phase 2 Withdrawn(withdrawn) - -
NCT00812266 Extensive Disease ... More >> First-Line Small Cell Lung Cancer Less << Phase 3 Terminated(Slow accrual) - Denmark ... More >> Dept. Oncology, Rigshospitalet Copenhagen, Denmark Less <<
NCT00281970 Lung Cancer Phase 2 Unknown - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6307 Less <<
NCT01969877 Locally Advanced Head and Neck... More >> Cancer Less << Phase 3 Active, not recruiting November 2024 Sweden ... More >> Gävle Hospital Gävle, Sweden Sahlgrenska University Hospital Göteborg, Sweden County Hospital Ryhov Jönköping, Sweden Central Hospital Karlstad, Sweden University Hospital Linköping Linköping, Sweden Karolinska Universityhospital Stockholm, Sweden Norrland University Hospital Umeå, Sweden Västmanlands Hospital Västerås Västerås, Sweden University Hospital Örebro Örebro, Sweden Less <<
NCT00674167 Gastric Cancer Phase 2 Unknown December 2017 Singapore ... More >> National University Hospital Singapore, Singapore Less <<
NCT01591135 Esophageal Squamous Cell Carci... More >>noma Less << Phase 3 Completed - China, Shanghai ... More >> Fudan University Cancer Center Shanghai, Shanghai, China Less <<
NCT03697239 Metastatic Pancreatic Cancer Phase 1 Phase 2 Not yet recruiting October 2022 -
NCT00003928 Kidney Cancer Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT02409355 Non-Small Cell Lung Cancer Phase 3 Terminated(The study was close... More >>d due to low patient enrollment and the Sponsor's decision to include patients with squamous NSCLC into the GO29431 study, NCT02409342.) Less << - -
NCT01973101 Patients Diagnosed With Advanc... More >>ed Carcinoma of Uterine Cervix t Less << Phase 2 Unknown April 2017 Brazil ... More >> ICESP Recruiting São Paulo, SP, Brazil Contact: Maria Del Pilar Estevez Diz, MD    55 11 3893-2000    pesquisa.clinica@icesp.org.br Less <<
NCT03435302 Melanoma Phase 3 Recruiting February 2019 China ... More >> Beijing Cancer Hospital Recruiting Beijing, China, 100142 Contact: Bin Lian, MD    +86(10)88196951    lianbin0214@126.com    Contact: Lu Si, MD    +86(10)88196951    silu.net@hotmail.com    Sub-Investigator: Bin Lian, MD Less <<
NCT00744900 Lung Cancer Phase 2 Completed - France ... More >> Centre Hôspitalier du Pays d'Aix, Service des Maladies Respiratoires Aix En Provence, France, 13616 CHU d'Angers, Service de Pneumologie Angers, France, 49033 Médecine 4, C.H.G. de la Fontonne Antibes Antibes, France, 06606 CHU brest, institut de cancérologie et d'hématologie Brest, France, 29200 Centre François Baclesse Caen, France, 14000 Centre Hospitalier René Dubos - Pontoise, Service d'Oncologie - Hématologie Clinique Cergy Pontoise, France, 95303 Centre Hospitalier, Service de Pneumologie Charleville, France, 08 000 CHI, Service de Pneumologie Creteil, France, 94010 Pneumologie, Centre hôspitalier, DRAGUIGNAN Draguignan, France, 83300 CH GAP GAP, France, 05000 Centre Hospitalier Départemental, Service de Pneumologie, La Roche Sur Yon, France, 85000 Hôpital A. Mignot, Service de Pneumologie Le Chesnay, France, 78157 Hopital de la Croix Rousse Lyon, France, 69317 Centre Hôspitalier, Service de Pneumo-Neuro Mantes La Jolie, France, 78200 Hôpital Sainte Margueritte Marseilles, France, 13274 Serv. de Pneumo-Allergo, CH de Martigues Martigues, France, 13695 Serv. de Pneumo - Hôpital St Antoine Paris, France, 75571 Service Pneumologie, Pavillon 1A, CH de Lyon-Sud Pierre-benite, France, 69495 Hôpital Pontchailloux, Service de Pneumologie. Rennes, France, 35033 CHG, Service de Pneumologie Roanne, France, 42300 Luc THIBERVILLE Rouen, France, 76031 CHU de ROUEN, Hôpital Bois Guillaume, Serv. de Pneumo. Rouen, France, 76233 Institut de Cancérologie de la Loire Saint-Priest en Jarez Cedex, France, 42271 CHU, Service du Pr. Carles Toulouse, France, 31059 Pneumologie, Centre Hospitalier VILLEFRANCHE sur SAONE, France, 69655 Less <<
NCT02409355 - Terminated(The study was close... More >>d due to low patient enrollment and the Sponsor's decision to include patients with squamous NSCLC into the GO29431 study, NCT02409342.) Less << - -
NCT00374868 Urologic Neoplasms Phase 1 Phase 2 Completed - Spain ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain, 08208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santander, Spain, 39008 Less <<
NCT00374868 - Completed - -
NCT00415168 - Completed - -
NCT01528618 Nasopharyngeal Neoplasms Phase 3 Unknown June 2017 China, Guangdong ... More >> Department of Medical Oncology,Cancer Center of Sun Yat-Sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT00887822 - Completed - -
NCT00980603 Gastric Cancer Phase 2 Unknown May 2011 Korea, Republic of ... More >> Chungbuk National University Hospital Recruiting Chonju, Korea, Republic of, 361-711 Contact: Hye-Suk Han, M.D.       sook3529@hanmail.net    Sub-Investigator: Hye-Suk Han, M.D.          Research Institute and Hospital, National Cancer Center Korea Recruiting Goyang, Korea, Republic of, 410-769 Contact: Sook Ryun Park, M.D.    82-31-920-1609 ext 1609    sukryun73@hanmail.net    Contact: Young Lan Park, RN    82-31-920-0422 ext 0422    lan0729@hanmail.net    Principal Investigator: Sook Ryun Park, M.D.          Sub-Investigator: Noe Kyeong Kim, M.D., Ph.D.          Sub-Investigator: Youngiee Park, M.D., Ph.D.          Sub-Investigator: Byung-Ho Nam, Ph.D.          Gachon University Gil Hospital Not yet recruiting Inchon, Korea, Republic of, 405-760 Contact: Dong Bok Shin, M.D., Ph.D.       dbs@gilhospital.com    Principal Investigator: Dong Bok Shin, M.D., Ph.D.          Sub-Investigator: Sun Jin Sym, M.D.          Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of, 463-707 Contact: Keun-Wook Lee, M.D., Ph.D.       hmodoctor@hanmail.net    Principal Investigator: Keun-Wook Lee, M.D., Ph.D. Less <<
NCT02709720 Lung Cancer Phase 2 Active, not recruiting April 15, 2021 Spain ... More >> Hospital General Universitario de Elche Elche, Alicante, Spain, 03203 ICO-Badalona Badalona, Barcelona, Spain, 08916 Hospital Provincial de Castellón Castelló de la Plana, Castelló, Spain, 12002 H. Son Espases Palma de Mallorca, Mallorca, Spain, 07014 Hospital Lluís Alcanyís Xàtiva, Valencia, Spain, 46800 Hospital de Basurto Bilbao, Vizcaya, Spain, 48013 H.G.U. Alicante Alicante, Spain, 03010 Hospital de La Santa Creu I Sant Pau Barcelona, Spain, 08041 Hospital de Jaén Jaén, Spain, 23007 Hospital Universitario Lucus Augusti Lugo, Spain, 27003 H. de la Princesa Madrid, Spain, 28006 H.U. Puerta de Hierro Madrid, Spain, 28035 Hospital Fundación Jiménez Díaz Madrid, Spain, 28040 H. Clínico San Carlos Madrid, Spain H. Son Llàtzer Palma de Mallorca, Spain, 07198 H. de Donostia San Sebastian, Spain, 20014 Hospital Virgen de La Macrena Sevilla, Spain, 41009 Hospital Clínico Lozano Blesa Zaragoza, Spain, 50009 Less <<
NCT00423930 Head and Neck Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00869752 Lung Cancer Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Ottawa Health Research Institute - General Division Ottawa, Ontario, Canada, K1H 8L6 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00772681 Head and Neck Neoplasms Phase 4 Completed - Turkey ... More >> Sanofi-Aventis Administrative Office Istanbul, Turkey Less <<
NCT00423930 - Completed - -
NCT02240017 Advanced Urothelial Cancer ... More >> Metastatic Urothelial Cancer Less << Phase 2 Phase 3 Recruiting September 2023 France ... More >> INSTITUT DE CANCEROLOGIE DE L'OUEST - Site Paul Papin Recruiting Angers, France, 49933 Contact: Sophie ABADIE-LACOURTOISIE, MD    33241352734    sophie.abadie-lacourtoisie@ico.unicancer.fr    Principal Investigator: Sophie ABADIE-LACOURTOISIE, MD          Chru Besancon - Hopital Jean Minjoz Recruiting Besançon, France, 25030 Contact: Tristan MAURINA, MD    33381668166    tmaurina@chu-besancon.fr    Principal Investigator: Tristan MAURINA, MD          Institut Bergonie Recruiting Bordeaux, France, 33076 Contact: Guilhem ROUBAUD, MD    33556333341    g.roubaud@bordeaux.unicancer.fr    Principal Investigator: Guilhem ROUBAUD, MD          Centre Francois Baclesse Recruiting Caen, France, 14076 Contact: Florence JOLY, PhD    02 31 45 50 02    f.joly@baclesse.fr    Principal Investigator: Emmanuel SEVIN, PhD          Centre Georges Francois Leclerc Recruiting Dijon, France, 21079 Contact: Sylvain LADOIRE, MD    33380737506    sladoire@cgfl.fr    Principal Investigator: Sylvain LADOIRE, MD          CH VERSAILLES - Hôpital André Mignot Recruiting Le Chesnay, France, 78157 Contact: Christine ABRAHAM, MD    33139638909    cabraham@ch-versailles.fr    Principal Investigator: Christine ABRAHAM, MD          CHU LIMOGES - Hôpital Dupuytren Recruiting Limoges, France, 87042 Contact: Sabrina FALKOWSKI, MD    33555056100    sabrina.falkowski@chu-limoges.fr    Principal Investigator: Sabrina FALKOWSKI, MD          Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Aude FLECHON, MD    33478782828    flechon@lyon.unicancer.fr    Principal Investigator: Aude FLECHON, MD          Institut Paoli Calmettes Recruiting Marseille, France, 13273 Contact: Gwénaëlle GRAVIS-MESCAM    04 91 22 37 40    gravisg@ipc.unicancer.fr    Ch Mont de Marsan Recruiting Mont de Marsan, France, 40024 Contact: Jérôme DAUBA, MD    05 58 05 10 10    jerome.dauba@ch-mt-marsan.fr    Principal Investigator: Jérôme DAUBA, MD          Institut Regional Du Cancer Montpellier Recruiting Montpellier, France, 34298 Contact: Diego TOSI, MD    33467612304    diego.tosi@icm.unicancer.fr    Principal Investigator: Diego TOSI, MD          Ap-Hp-Hopital Saint-Louis Recruiting Paris, France, 75010 Contact: Hélène GAUTHIER, MD    01 42 49 42 47    helene.gauthier@aphp.frphp.fr    Principal Investigator: Hélène GAUTHIER, MD          INSTITUT DE CANCEROLOGIE DE L'OUEST - Site René Gauducheau Recruiting Saint-Herblain, France, 44805 Contact: Frédéric ROLLAND, MD    33240679976    frederic.rolland@ico.unicancer.fr    Principal Investigator: Frédéric ROLLAND, MD          Institut de Cancerologie Lucien Neuwirth Recruiting Saint-Priest en Jarez, France, 42271 Contact: Aline GUILLOT, MD    33477917032    aline.guillot@icloire.fr    Principal Investigator: Aline GUILLOT, MD          CHU de STRASBOURG Recruiting Strasbourg, France, 67091 Contact: Philippe BARTHELEMY    03 88 11 67 28    philippe.barthelemy@chru-strasbourg.fr    Institut Claudius Regaud Recruiting Toulouse, France, 31052 Contact: Loïc MOUREY, PhD    33561424548    mourey.loic@claudiusregaud.fr    Principal Investigator: Loïc MOUREY, MD          Chru Tours Recruiting Tours, France, 37044 Contact: Claude LINASSIER, MD    33247479919    claude.linassier@univ-tours.fr    Principal Investigator: Claude LINASSIER, MD          Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Yohann LORIOT, MD    33142114211    yohann.loriot@igr.fr    Principal Investigator: Yohann LORIOT, MD Less <<
NCT00201760 Breast Cancer Phase 2 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00415168 Gastric Cancer Phase 2 Completed - Russian Federation ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barnaul, Russian Federation, 656049 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ivanovo, Russian Federation, 153040 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kazan, Russian Federation, 420029 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 117997 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 197758 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stavropol, Russian Federation, 355001 Less <<
NCT00201760 - Completed - -
NCT00833261 Head and Neck Cancer Phase 2 Completed - United States, Ohio ... More >> University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 United States, Texas Baylor Research Institute Dallas, Texas, United States, 75204 University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00885534 Melanoma Skin... More >> Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02478502 Testicular Cancer Phase 2 Recruiting June 2019 Denmark ... More >> Rigshospitalet Recruiting Copenhagen, Denmark Contact: Gedske Daugaard, MD, PhD    35453545 ext +45    gedske.daugaard@rh.regionh.dk    Principal Investigator: Gedske Daugaard, MD, PhD          Germany University Clinic Hamburg Eppendorf Withdrawn Hamburg, Germany, 20246 Italy Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T) Active, not recruiting Meldola, Italy, 47014 Norway Oslo University Hospital Recruiting Oslo, Norway, N-0424 Contact: Helene Negaard, MD, PhD       UXHEGA@ous-hf.no    Contact: Marit Husby, MD    23026600 ext +47    UXHUMC@ous-hf.no    Principal Investigator: Helene Negaard, MD, PhD          Sweden University Hospital of Uppsala, Department of Oncology Active, not recruiting Uppsala, Sweden, 75185 Less <<
NCT00859339 Transitional Cell Carcinoma of... More >> the Bladder Less << Phase 2 Terminated(Patient Toxicities) - United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 United States, Indiana Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United Kingdom St. Bartholomew's Hospital (Barts) London, United Kingdom, EC1A 7BE Less <<
NCT01269255 Gastric Cancer Phase 1 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT00859339 - Terminated(Patient Toxicities) - -
NCT01161498 Squamous Cell Carcinoma ... More >> Head and Neck Cancer Less << Phase 3 Terminated(The changing aetiol... More >>ogy of squamous cell carcinoma of the head and neck (SCCHN).) Less << - United States, Indiana ... More >> Investigative Clinical Research of Indiana Indianapolis, Indiana, United States, 46260 United States, Kentucky James Graham Brown Cancer Center, University of Louisville Louisville, Kentucky, United States, 40202 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, South Carolina Medical Univesity of South Carolina Charleston, South Carolina, United States, 29425 United States, Virginia VCU Massey Cancer Center Richmond, Virginia, United States, 23298 United Kingdom The Royal Marsden Hospital London, United Kingdom, SE1 7EH Less <<
NCT00885534 - Completed - -
NCT00510107 Stomach Neoplasm ... More >> Stage IV Recurrent Less << Phase 2 Unknown July 2009 Korea, Republic of ... More >> Gachon University Gil Medical Center Recruiting Incheon, Korea, Republic of, 405 760 Less <<
NCT01161498 - Terminated(The changing aetiol... More >>ogy of squamous cell carcinoma of the head and neck (SCCHN).) Less << - -
NCT01041833 Non Small Cell Lung Cancer Phase 3 Unknown September 2013 Mexico ... More >> Department of Medical Oncology, Instituto Nacional de Cancerología Not yet recruiting Mexico, Mexico, 14080 Contact: Oscar Arrieta, M.D.    (+52) (55) 5628-0400 ext 832    ogar@servidor.unam.mx    Contact: Oscar Arrieta    (+52) (55) 5628-0400 ext 832    ogar@servidor.unam.mx Less <<
NCT02016417 Nasopharyngeal Carcinoma Phase 2 Not yet recruiting December 2020 -
NCT01836341 Non-small Cell Lung Cancer Phase 1 Withdrawn April 2015 -
NCT03117335 Advanced Non-small Cell Lung C... More >>ancer Less << Phase 3 Completed - -
NCT02370849 Stomach Neoplasms Phase 2 Completed - China ... More >> Cancer Hospital, Chinese Academy of Medical Sciences Beijing, China, 100021 Less <<
NCT02573493 Squamous Cell Carcinoma of the... More >> Head and Neck Carcinoma, Squamous Cell of the Head and Neck Cancer of Head and Neck Cancer of the Head and Neck Head and Neck Cancer Neoplasms, Head and Neck Less << Phase 2 Recruiting October 31, 2029 United States, Kansas ... More >> The University of Kansas Cancer Center and Medical Pavilion Recruiting Westwood, Kansas, United States, 66205 Contact: Prakash Neupane, M.D.    913-588-1227    pneupane@kumc.edu    Principal Investigator: Prakash Neupane, M.D.          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Douglas Adkins, M.D.    314-747-8475    dadkins@wustl.edu    Principal Investigator: Douglas Adkins, M.D.          Sub-Investigator: Mackenzie Daly, M.D.          Sub-Investigator: Hiram Gay, M.D.          Sub-Investigator: Ryan Jackson, M.D.          Sub-Investigator: Jose Zevallos, M.D.          Sub-Investigator: Randall Paniello, M.D.          Sub-Investigator: Jason Rich, M.D.          Sub-Investigator: Wade Thorstad, M.D. Less <<
NCT01396668 Pancreatic Cancer Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Bundang Hospital Seongnam, Korea, Republic of Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT03050437 Carcinoma, Non-Small-Cell Lung Phase 2 Recruiting March 2017 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Myung-Ju Ahn, Ph.D.    822-3410-1795    silkahn@skku.edu Less <<
NCT02608684 Ovarian Cancer Phase 2 Recruiting January 2020 United States, California ... More >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Christine Walsh, MD    310-423-3599    Christine.Walsh@cshs.org    Contact: Jaime Richardson    310-423-2133    cancer.trial.info@cshs.org    Principal Investigator: Christine Walsh, MD Less <<
NCT00232206 Non-small-Cell Lung Carcinoma Phase 2 Terminated(study terminated du... More >>e to slow accrual) Less << - United States, Oregon ... More >> Providence Portland Medical Center Portland, Oregon, United States, 97213 Less <<
NCT00394433 - Completed - -
NCT00192101 Metastatic Breast Cancer Phase 2 Completed - Saudi Arabia ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Jeddah, Saudi Arabia Less <<
NCT00183807 Esophageal Cancer Phase 2 Terminated(Insufficient Accrua... More >>l) Less << - United States, California ... More >> U.S.C. / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00865982 Gastric Cancer ... More >> Esophageal Cancer Less << Phase 2 Unknown September 2015 Germany ... More >> HELIOS-Klinik Bad Saarow Bad Saarow, Germany Klinik für Hämatologie, Onkologie und Tumorimmunologie, Charite Campus Buch Berlin, Germany Medizinische Klinik mit Schwerpunkt Gastroenterologie, Infektiologie und Rheumatologie, Charite Campus Benjamin-Franklin Berlin, Germany Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie, Charite Campus Virchow Klinikum Berlin, Germany Klinik für Innere Medizin Abteilung Hämatologie/Onkologie, Städtisches Klinikum Dessau Dessau, Germany Universitätsklinik und Poliklinik für Innere Medizin IV, Martin Luther Universität Halle-Wittenberg Halle (Saale), Germany II. Medizinische Klinik und Poliklinik, Universitätsklinikum Schleswig-Holstein Campus Kiel Kiel, Germany Internistische Onkologie/ Hämatologie, Städtisches Krankenhaus St. Georg Leipzig, Germany 3. Medizinische Klinik, Onkologisches Zentrum, Universitätsklinikum Mannheim Mannheim, Germany Less <<
NCT00238407 Esophageal Cancer Phase 2 Completed - Switzerland ... More >> Hirslanden Klinik Aarau Aarau, Switzerland, CH-5001 Saint Claraspital AG Basel, Switzerland, CH-4016 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Kantonsspital Liestal, Switzerland, CH-4410 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 City Hospital Triemli Zurich, Switzerland, CH-8063 Less <<
NCT00678535 Gastric Cancer Phase 3 Completed - -
NCT00291850 Non-Small Cell Lung Cancer Phase 2 Terminated(no patient recruitm... More >>ent) Less << - Austria ... More >> AKH, Universitätsklinik für Innere Medizin 1 Vienna, Austria, 1090 Hungary Somogy Country Pulmo and Cardio Hospital, Mosdos, Hungary Markusovszky Hospital Szombathely, Hungary Poland M. Sklodowska-Curie Memorial Dep. Of Lung and Thoracic Tumours, Warszawa, Poland, 02-781 Klinika Chirurgii Instytutu Gruzlicy i Chorob Pluc Warszawa, Poland Less <<
NCT00590031 - Completed - -
NCT01076400 Cervical Cancer Phase 1 Phase 2 Terminated(The sponsor permane... More >>ntly suspended new enrollment into the trial and discontinued the study; which was not related to any concerns over product safety.) Less << - -
NCT01353482 Malignant Pleural Mesothelioma Phase 1 Phase 2 Withdrawn(UCL CTC were informe... More >>d by Merck Sharp & Dohme on 22.08.11 that support for the trial had been withdrawn in light of results from another trial with trial drug.) Less << - -
NCT00678535 - Completed - -
NCT00394433 Esophageal Cancer ... More >> Stomach Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00081276 Primary Peritoneal Cavity Canc... More >>er Recurrent Ovarian Epithelial Cancer Stage III Ovarian Epithelial Cancer Stage IV Ovarian Epithelial Cancer Less << Phase 2 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00590031 Esophageal Carcinoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01076400 - Terminated(The sponsor permane... More >>ntly suspended new enrollment into the trial and discontinued the study; which was not related to any concerns over product safety.) Less << - -
NCT00851877 - Completed - -
NCT02375880 Carcinoma of Intrahepatic and ... More >>Extra-hepatic Biliary System Carcinoma of Gallbladder Bile Duct Cancer Cholangiocarcinoma Less << Phase 1 Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio University Hospitals, Case Medical Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Texas University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00731380 Head and Neck Cancer Phase 1 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 3M9 Less <<
NCT03583710 ENSAT Stage I Adrenal Cortex C... More >>arcinoma ENSAT Stage II Adrenal Cortex Carcinoma ENSAT Stage III Adrenal Cortex Carcinoma Less << Phase 3 Recruiting January 22, 2025 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Mouhammed A. Habra    713-792-2841    mahabra@mdanderson.org    Principal Investigator: Mouhammed A. Habra Less <<
NCT00949949 Cholangiocarcinoma of the Gall... More >>bladder Localized Gallbladder Cancer Unresectable Gallbladder Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00895648 Mesothelioma ... More >>Pleural Mesothelioma Less << Phase 2 Terminated(low accrual due to ... More >>competing study for same group of patients) Less << - Canada, Ontario ... More >> University Health Network Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00851877 Head and Neck Cancer Phase 1 Phase 2 Completed - United States, Texas ... More >> Baylor Research Institute Dallas, Texas, United States, 75204 University of Texas Southwestern Medical Center Dallas, Texas, United States, 75239 Less <<
NCT01938573 Recurrent Bladder Carcinoma ... More >> Stage II Bladder Cancer Stage III Bladder Cancer Stage IV Bladder Cancer Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01388790 Gastric Cancer Phase 2 Completed - Germany ... More >> Please contact the Merck KGaA Communication Center located in Darmstadt, Germany Less <<
NCT00216125 - Completed - -
NCT02913066 Esophageal Squamous Cell Carci... More >>noma Less << Phase 2 Recruiting March 2019 China, Sichaung ... More >> Xiaobo du Recruiting Mianyang, Sichaung, China, 621000 Contact: Xaiobo Du, MD    +86 08162230478    duxiaobo2005@126.com Less <<
NCT02001519 Breast Cancer Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT02856568 Non-Resectable Cholangiocarcin... More >>oma Recurrent Cholangiocarcinoma Stage III Extrahepatic Bile Duct Cancer Stage III Intrahepatic Cholangiocarcinoma Stage IIIA Hilar Cholangiocarcinoma Stage IIIB Hilar Cholangiocarcinoma Stage IVA Extrahepatic Bile Duct Cancer Stage IVA Hilar Cholangiocarcinoma Stage IVA Intrahepatic Cholangiocarcinoma Stage IVB Extrahepatic Bile Duct Cancer Stage IVB Hilar Cholangiocarcinoma Stage IVB Intrahepatic Cholangiocarcinoma Unresectable Extrahepatic Bile Duct Carcinoma Less << Phase 1 Withdrawn(Site dropped study) October 2021 United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01938573 - Completed - -
NCT01384799 Head and Neck Cancer Phase 1 Completed - United States, California ... More >> Stanford Cancer Center Stanford, California, United States, 94305 United States, Colorado University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Louisiana Overton Brooks VA Medical Center Shreveport, Louisiana, United States, 71101 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02115 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 01911 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 Less <<
NCT01388790 - Completed - -
NCT01825603 Ampulla of Vater Adenocarcinom... More >>a Gallbladder Adenocarcinoma Metastatic Pancreatic Adenocarcinoma Pancreatic Adenocarcinoma Stage III Ampulla of Vater Cancer Stage III Intrahepatic Cholangiocarcinoma Stage III Pancreatic Cancer Stage IIIA Gallbladder Cancer Stage IIIA Hilar Cholangiocarcinoma Stage IIIB Gallbladder Cancer Stage IIIB Hilar Cholangiocarcinoma Stage IV Ampulla of Vater Cancer Stage IVA Gallbladder Cancer Stage IVA Hilar Cholangiocarcinoma Stage IVA Intrahepatic Cholangiocarcinoma Stage IVA Pancreatic Cancer Stage IVB Gallbladder Cancer Stage IVB Hilar Cholangiocarcinoma Stage IVB Intrahepatic Cholangiocarcinoma Stage IVB Pancreatic Cancer Less << Phase 1 Completed - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT03366766 Non-Squamous Non-Small Cell Lu... More >>ng Carcinoma Stage I Non-Small Cell Lung Cancer Stage IA Non-Small Cell Lung Carcinoma Stage IB Non-Small Cell Lung Carcinoma Stage II Non-Small Cell Lung Cancer Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Less << Phase 2 Recruiting July 2022 United States, Pennsylvania ... More >> Abington Hospital - Jefferson Health Not yet recruiting Abington, Pennsylvania, United States, 19001 Contact: Mark Sundemeyer, MD    215-481-2400       Principal Investigator: Mark Sundemeyer, MD          Sidney Kimmel Cancer Center at Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Ralph Zinner, MD    215-503-5098    ralph.zinner@jefferson.edu    Lankenau Institute for Medical Research Not yet recruiting Wynnewood, Pennsylvania, United States, 19096 Contact: Paul Gilman, MD    484-476-4837       Principal Investigator: Paul Gilman, MD Less <<
NCT02768558 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting October 2024 United States, California ... More >> UC San Diego Moores Cancer Center La Jolla, California, United States, 92093 Stanford University Stanford, California, United States, 94305 United States, Florida University of Florida Gainesville, Florida, United States, 32610 Mount Sinai Cancer Research Center Miami Beach, Florida, United States, 33140 United States, Georgia Nancy N. & J.C. Lewis Cancer & Research Pavilion at St. Joseph's/Candler Hospital Savannah, Georgia, United States, 31405 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 United States, Maryland Mercy Medical Cancer Center Baltimore, Maryland, United States, 21202 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 University of Rochester Rochester, New York, United States, 14642 United States, Ohio Metro Health Medical Center Cleveland, Ohio, United States, 44109 United States, Pennsylvania Reading Hospital/McGlinn Cancer Institute West Reading, Pennsylvania, United States, 19611 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 United States, Virginia Inova Fairfax Hospital Falls Church, Virginia, United States, 22042 United States, Washington Virginia Mason Seattle, Washington, United States, 98101 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT02535312 Advanced Malignant Solid Neopl... More >>asm Advanced Peritoneal Malignant Mesothelioma Advanced Pleural Malignant Mesothelioma Recurrent Peritoneal Malignant Mesothelioma Recurrent Pleural Malignant Mesothelioma Stage III Non-Small Cell Lung Cancer AJCC v7 Stage III Ovarian Cancer AJCC v6 and v7 Stage III Pleural Malignant Mesothelioma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Ovarian Cancer AJCC v6 and v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IIIB Ovarian Cancer AJCC v6 and v7 Stage IIIC Ovarian Cancer AJCC v6 and v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Stage IV Ovarian Cancer AJCC v6 and v7 Stage IV Pleural Malignant Mesothelioma AJCC v7 Thymoma Unresectable Solid Neoplasm Less << Phase 1 Phase 2 Recruiting - United States, California ... More >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Site Public Contact    800-826-4673    becomingapatient@coh.org    Principal Investigator: Marianna Koczywas          Los Angeles County-USC Medical Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact    323-865-0451       Principal Investigator: Anthony El-Khoueiry          USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact    323-865-0451       Principal Investigator: Anthony El-Khoueiry          Keck Medical Center of USC Pasadena Recruiting Pasadena, California, United States, 91105 Contact: Site Public Contact    323-865-0451       Principal Investigator: Anthony El-Khoueiry          University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact    916-734-3089       Principal Investigator: Karen L. Kelly          United States, Colorado University of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Site Public Contact    720-848-0650       Principal Investigator: Stephen Leong          United States, Maryland University of Maryland/Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact    800-888-8823       Principal Investigator: Edward A. Sausville          United States, Michigan University of Michigan Comprehensive Cancer Center Suspended Ann Arbor, Michigan, United States, 48109 United States, Minnesota Mayo Clinic Active, not recruiting Rochester, Minnesota, United States, 55905 United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Site Public Contact    800-293-5066    Jamesline@osumc.edu    Principal Investigator: Gregory A. Otterson          United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Site Public Contact    412-647-8073       Principal Investigator: Liza C. Villaruz          United States, Tennessee Vanderbilt University/Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Site Public Contact    800-811-8480       Principal Investigator: Leora Horn          United States, Wisconsin University of Wisconsin Hospital and Clinics Active, not recruiting Madison, Wisconsin, United States, 53792 Less <<
NCT00118131 - Terminated(Slow accrual) - -
NCT00118131 Lung Cancer Phase 2 Terminated(Slow accrual) - United States, New Jersey ... More >> Central Jersey Oncology Center, PA - East Brunswick East Brunswick, New Jersey, United States, 08816 JFK Medical Center in Edison Edison, New Jersey, United States, 08818 CentraState Medical Center Freehold, New Jersey, United States, 07728 Cancer Institute of New Jersey at Hamilton Hamilton, New Jersey, United States, 08690 Monmouth Medical Center Long Branch, New Jersey, United States, 07740 Mountainside Hospital Cancer Center Montclair, New Jersey, United States, 07042 Jersey Shore University Medical Center Neptune, New Jersey, United States, 07754 Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 Saint Peter's University Hospital New Brunswick, New Jersey, United States, 08903 UMDNJ - University Hospital Newark, New Jersey, United States, 07103 Raritan Bay Medical Center Perth Amboy, New Jersey, United States, 08861 Somerset Medical Center Somerville, New Jersey, United States, 08876 Overlook Hospital Summit, New Jersey, United States, 07901 Less <<
NCT02034968 Stage IV Esophageal Squamous C... More >>ell Carcinoma Less << Phase 2 Withdrawn(No recruitment) January 2017 China, Zhejiang ... More >> The first affiliated hospital, Zhejiang University Hangzhou, Zhejiang, China, 310003 Less <<
NCT01005329 Endometrial Adenocarcinoma ... More >> Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Serous Adenocarcinoma Stage IA Uterine Corpus Cancer AJCC v7 Stage IB Uterine Corpus Cancer AJCC v7 Stage II Uterine Corpus Cancer AJCC v7 Stage IIIA Uterine Corpus Cancer AJCC v7 Stage IIIB Uterine Corpus Cancer AJCC v7 Stage IIIC Uterine Corpus Cancer AJCC v7 Stage IVA Uterine Corpus Cancer AJCC v7 Stage IVB Uterine Corpus Cancer AJCC v7 Less << Phase 2 Completed - -
NCT02075112 Cancer of Head and Neck Phase 1 Active, not recruiting July 2022 United States, Georgia ... More >> Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00154739 Non-Small Cell Lung Cancer Phase 2 Completed - Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei, Taiwan, 112 Less <<
NCT01262482 Advanced or Metastatic Gastric... More >> or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment) Less << Phase 2 Completed - Spain ... More >> Hospital Clinic de Barcelona Barcelona, Spain Hospital Sant Pau Barcelona, Spain H. Josep Trueta Girona, Spain Centro Oncológico M.D. Anderson Spain Madrid, Spain Hospital de Fuenlabrada Madrid, Spain Hospital La Paz Madrid, Spain Hospital Althaia Manresa, Spain Clínica Universitaria de Navarra Pamplona, Spain Hospital Parc Taulí Sabadell, Spain Hospital General de Valencia Valencia, Spain Less <<
NCT01663285 Urothelial Cancer ... More >> Bladder Cancer Less << Phase 2 Terminated(Low study participa... More >>nt enrollment.) Less << - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 United States, New York University of Rochester Rochester, New York, United States, 14642 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 Less <<
NCT00287911 Cervical Cancer Phase 1 Completed - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00101907 Lung Cancer P... More >>ancreatic Cancer Esophageal Cancer Less << Phase 1 Terminated(Study terminated pe... More >>r recommendation of Data Review Team) Less << - -
NCT00057850 Head and Neck Cancer Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00101907 - Terminated(Study terminated pe... More >>r recommendation of Data Review Team) Less << - -
NCT01277744 Advanced Cancers ... More >> Sarcoma Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00816634 First Line Chemotherapy ... More >> Capecitabine Plus Cisplatin Versus Capecitabine Plus Paclitaxel Advanced or Recurrent Esophageal Squamous Cell Carcinoma Less << Phase 2 Recruiting December 2018 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Young-Hyuck Im, MD, PhD    82-2-3410-3445    imyh00@skku.edu    Principal Investigator: Young-Hyuck Im, MD, PhD          Sub-Investigator: Yeon-Hee Park, MD, PhD Less <<
NCT00842244 Stomach Neoplasms ... More >> Advanced Gastric Cancer Less << Phase 1 Completed - Japan ... More >> Pfizer Investigational Site Kashiwa, Chiba, Japan Pfizer Investigational Site Yufu-city, Oita, Japan Korea, Republic of Pfizer Investigational Site Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Pfizer Investigational Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Less <<
NCT02560298 Anal Basaloid Carcinoma ... More >> Anal Canal Cloacogenic Carcinoma Anal Squamous Cell Carcinoma Metastatic Anal Canal Carcinoma Recurrent Anal Canal Carcinoma Stage IIIB Anal Canal Cancer Stage IV Anal Canal Cancer Less << Phase 2 Active, not recruiting August 2023 United States, Pennsylvania ... More >> ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00156884 Hormone Refractory Prostate Ca... More >>ncer Bone Metastases Less << Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada Less <<
NCT00842244 - Completed - -
NCT02919462 Carcinoma, Non-Small-Cell Lung... More >> Secondary Advanced Stage IIIB High Thymidylate Synthase Expression Less << Phase 2 Terminated(low recruitement ra... More >>te) Less << - Italy ... More >> Ircc Irst Meldola, FC, Italy, 47014 U.O. Oncologia Medica Faenza, RA, Italy, 48018 Claudio Dazzi Ravenna, RA, Italy, 48121 Ospedale di Piacenza, ASL Piacenza Piacenza, Italy U.O. Oncologia Ospedale degli Infermi Rimini, Italy Less <<
NCT00079040 Extensive Stage Small Cell Lun... More >>g Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00757172 - Completed - -
NCT01663285 - Terminated(Low study participa... More >>nt enrollment.) Less << - -
NCT00924209 NSCLC Stage I... More >>IIA (N2) Less << Phase 2 Terminated(Study was terminate... More >>d due to poor accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Croatia University Hospital for Lung Diseases Zagreb, Croatia Less <<
NCT00924209 - Terminated(Study was terminate... More >>d due to poor accrual.) Less << - -
NCT00757172 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Cancer Less << Phase 2 Completed - United States, Georgia ... More >> Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah, Georgia, United States, 31403-3089 United States, Illinois Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Evanston Hospital Evanston, Illinois, United States, 60201-1781 Simmons Cooper Cancer Institute Springfield, Illinois, United States, 62794-9677 United States, Kentucky Central Baptist Hospital Lexington, Kentucky, United States, 40503-9985 United States, Michigan William Beaumont Hospital - Royal Oak Campus Royal Oak, Michigan, United States, 48073 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New Hampshire Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756-0002 United States, North Carolina Blumenthal Cancer Center at Carolinas Medical Center Charlotte, North Carolina, United States, 28232-2861 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Good Samaritan Hospital Dayton, Ohio, United States, 45406 Wayne Hospital Greenville, Ohio, United States, 45331 Charles F. Kettering Memorial Hospital Kettering, Ohio, United States, 45429 United States, Oregon Providence Cancer Center at Providence Portland Medical Center Portland, Oregon, United States, 97213-2967 Legacy Emanuel Hospital and Health Center and Children's Hospital Portland, Oregon, United States, 97227 United States, Pennsylvania Geisinger Cancer Institute at Geisinger Health Danville, Pennsylvania, United States, 17822-0001 Allegheny Cancer Center at Allegheny General Hospital Pittsburgh, Pennsylvania, United States, 15212 UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT00397904 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02360501 Nasopharyngeal Neoplasms Phase 2 Completed - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT01405586 Non-small Cell Lung Cancer Met... More >>astatic Non-small Cell Lung Cancer Stage IIIB Less << Phase 3 Active, not recruiting September 2018 -
NCT03691090 Advanced Esophageal Cancer Phase 3 Not yet recruiting October 2021 China, Guangdong ... More >> Cancer Center of Sun-Yat Sen University (CCSYSU) Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Ruihua Xu Less <<
NCT02017600 Localized Squamous Cell Carcin... More >>oma of the Esophagus Less << Phase 2 Terminated March 2017 Taiwan ... More >> Taipei Veterans General Hospital Taipei, Taiwan, 112 Less <<
NCT00397904 - Completed - -
NCT00055757 Stage IIIB Non-small Cell Lung... More >> Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03623737 Esophageal Squamous Cell Carci... More >>noma Chemoradiation Less << Phase 2 Phase 3 Recruiting March 1, 2022 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Ta-Chen Huang, MD    +886-2-2312-3456    e360215@gmail.com Less <<
NCT00335998 Recurrent Cervical Cancer ... More >> Recurrent Ovarian Epithelial Cancer Recurrent Vaginal Cancer Recurrent Vulvar Cancer Stage III Vaginal Cancer Stage IIIA Cervical Cancer Stage IIIA Ovarian Epithelial Cancer Stage IIIA Vulvar Cancer Stage IIIB Cervical Cancer Stage IIIB Ovarian Epithelial Cancer Stage IIIB Vulvar Cancer Stage IIIC Ovarian Epithelial Cancer Stage IIIC Vulvar Cancer Stage IV Ovarian Epithelial Cancer Stage IVA Cervical Cancer Stage IVA Vaginal Cancer Stage IVB Cervical Cancer Stage IVB Vaginal Cancer Less << Phase 1 Completed - United States, Ohio ... More >> Case Western Reserve University Cleveland, Ohio, United States, 44106 Less <<
NCT02142010 Breast Cancer Not Applicable Unknown - China ... More >> Shanghai Jiaotong University School of Medicine, Renji Hospital Recruiting Shanghai, China Contact: Jinsong Lu, MD       lujjss@126.com    Principal Investigator: Jinsong Lu, Phd Less <<
NCT01116219 Lung Cancer Phase 2 Completed - Switzerland ... More >> Kantonsspital Aarau Aarau, Switzerland, CH-5001 Kantonsspital Baden Baden, Switzerland, 5404 Saint Claraspital AG Basel, Switzerland, CH-4016 Clinical Cancer Research Center at University Hospital Basel Basel, Switzerland, CH-4031 Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland, CH-6500 Inselspital Bern Bern, Switzerland, CH-3010 Spitalzentrum Biel Biel, Switzerland, CH-2501 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Kantonsspital Freiburg Freiburg, Switzerland, 1700 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Pluridisciplinaire d' Oncologie Lausanne, Switzerland, 1011 Kantonsspital Liestal Liestal, Switzerland, CH-4410 Kantonsspital Luzern Luzerne, Switzerland, CH-6000 Kantonsspital Olten Olten, Switzerland, 4600 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 Spital Uster Uster, Switzerland, 8610 Kantonsspital Winterthur Winterthur, Switzerland, CH-8401 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8044 City Hospital Triemli Zurich, Switzerland, CH-8063 Onkozentrum Hirslanden Zürich, Switzerland, 8008 Less <<
NCT00069875 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - United States, Alabama ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Birmingham, Alabama, United States United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Boston, Massachusetts, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Manhasset, New York, United States United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Durham, North Carolina, United States United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Cleveland, Ohio, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Houston, Texas, United States Canada, Ontario For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ottawa, Ontario, Canada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Toronto, Ontario, Canada Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Montreal, Quebec, Canada Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Gauting, Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Hamburg, Germany Israel For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Haifa, Israel For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Kfar Saba, Israel Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Amsterdam, Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Rotterdam, Netherlands Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Oviedo, Asturias, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Badalona, Barcelona, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Pamplona, Navarra, Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Madrid, Spain Less <<
NCT01517009 Gastric Cancer Phase 2 Completed - Netherlands ... More >> VieCuri Hospital Venlo, Limburg, Netherlands, 5912 BL Elkerliek Hospital Helmond, Noord Brabant, Netherlands, 5700 AB Jeroen Bosch Hospital Den Bosch, Noord-Brabant, Netherlands, 5200 ME Catharina Hospital Eindhoven, Noord-Brabant, Netherlands, 5602 ZA Maxima Medical Centre Veldhoven, Noord-Brabant, Netherlands, 5500 MB Less <<
NCT00079040 - Completed - -
NCT02348450 Small Cell Lung Cancer Phase 4 Unknown December 2018 China, Anhui ... More >> The First Affiliated Hospital of AnHui Medical University Recruiting Hefei, Anhui, China Contact: yueyin pan    86-13805695536    yueyinpan@gmail.com    Contact: wei huang    86-13505514938    huangweibsh@163.com    China, Fujian FuJian Provincial Tumor Hospital Not yet recruiting Fuzhou, Fujian, China Contact: cheng huang    13905010379    cheng671@sina.com    China, Guangdong Guangdong General Hospital Active, not recruiting Guangzhou, Guangdong, China China, Guangxi Cancer Hospital Affiliated To GuangXi Medical University Recruiting Nanning, Guangxi, China Contact: xiangqun song    86-13877104657    xiangquns@163.com    Contact: shaozhang zhou    86-18677115144    zhoushaozhang@qq.com    China, Hebei Fourth hospital of hebei medical university Recruiting Shijiazhuang, Hebei, China Contact: cuimin ding    86-13933083069    wjwdcm@sina.com    Contact: ruijuan li    86-18231196950    lrj0310@sina.com    China, Heilongjiang The First Affiliated Hospital of HaErBin Medical University Recruiting Haerbin, Heilongjiang, China Contact: gongyan chen          Contact: xuan hong    13946066560    hongxuan_1218@sina.com    China, Henan HeNan Provincial Tumor Hospital Recruiting Zhengzhou, Henan, China Contact: zhiyong Ma          Contact: xiangtao Yan    18638628118    skyliuyun@126.com    China, Hubei WuHan Tongji Hospital Recruiting WuHan, Hubei, China Contact: yuan chen          Contact: qian chu       qianchu@tjh.tjmu.edu.cn    China, Hunan HuNan Provincial Tumor Hospital Recruiting Changsha, Hunan, China Contact: jianhua chen          Contact: yongzhong luo    13607443876    65523714@qq.com    China, Jiangsu JiangSu Provincial Tumor Hospital Recruiting Nanjing, Jiangsu, China Contact: meiqi shi    13809029766    shimeiqi1963@163.com    China, Jiangxi The First Affiliated Hospital of NanChang University Active, not recruiting Nanchang, Jiangxi, China China, Liaoning LiaoNing Provincial Tumor Hospital Active, not recruiting Shenyang, Liaoning, China China, Shandong ShanDong Provincial Tumor Hospital Recruiting Jinan, Shandong, China Contact: qisen guo          Contact: yan guan    15865298279    qhgy219@163.com    Linyi cancer hospital Recruiting Linyi, Shandong, China Contact: jianhua shi    86-15963998868    shijianhualy@126.com    Contact: shuoxin liu    86-15969916696    lyzlyygcp@163.com    China, Shanghai Changhai Hospital of Shanghai Recruiting Shanghai, Shanghai, China Contact: chong bai          Contact: huijie zhang    18621775835    15236196601@163.com    East Hospital Affiliated To Tongji University Active, not recruiting Shanghai, Shanghai, China Shanghai Chest hospital of Shanghai Jiaotong University Recruiting Shanghai, Shanghai, China Contact: Shun Lu, MD    86 13601813062    shun_lu@hotmail.com    Contact: Zhiwei Chen    86 13916251926    drchenzhiwei@163.com    China, Zhejiang Hangzhou First People's Hospital Active, not recruiting Hangzhou, Zhejiang, China The second affiliated hospital of zhejiang university school of medicine Recruiting Hangzhou, Zhejiang, China Contact: kai wang    86-13957158572    doctorhuxi@163.com    Contact: liren ding    86-13906535702    lirending@zju.edu.cn    ZheJiang Provincial Tumor Hospital Active, not recruiting Hangzhou, Zhejiang, China Less <<
NCT00004919 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> COG Phase I Consortium Arcadia, California, United States, 91006-3776 Less <<
NCT00846443 Local Advanced Non-Small Cell ... More >>Lung Cancer Less << Phase 1 Unknown - China, Shanghai ... More >> Department of Radiation Oncolory, Cancer Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Liang Xiahou, MB    862164175590 ext 1404    xiahouliang@hotmail.com    Principal Investigator: Xiaolong Fu, MD Less <<
NCT00970996 Melanoma Phase 1 Completed - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00526643 Non-Small Cell Lung Cancer Phase 3 Terminated(scarce enrolment an... More >>d presentation of positive results of similar study in June 2012.) Less << - Italy ... More >> Azienda Ospedaliera S. Giuseppe Moscati, U.O. di Oncologia Medica Monteforte Irpino, AV, Italy, 83024 Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica Acquaviva delle Fonti, BA, Italy, 70021 Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale Bari, BA, Italy, 70126 Istituto Scientifico S. Raffaele Milano, MI, Italy, 20132 Azienda Ospedaliera C. Poma Mantova, MN, Italy, 46100 Istituto Oncologico Veneto Padova, PD, Italy Ospedale E. Morelli Sondalo, SO, Italy, 23039 Ospedale Senatore Antonio Perrino Brindisi, Italy A.O. Ospedale Mater Domini, Oncoematologia Università Magna Grecia Catanzaro, Italy Ospedale F. Veneziale Isernia, Italy A.O. Vito Fazzi Lecce, Italy Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B Napoli, Italy, 80131 Ospedale Regional, Unità Operative di Oncologia Parma, Italy Ospedale San Camillo - Forlanini Rome, Italy Ospedale S. Felice a Cancello San Felice a Cancello, Italy Less <<
NCT01005329 - Completed - -
NCT00573690 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT01490437 Urothelial Carcinoma Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00357149 Head and Neck Neoplasms Phase 2 Completed - Italy ... More >> Sanofi-Aventis Milan, Italy Less <<
NCT02550327 Pancreatic Adenocarcinoma Early Phase 1 Recruiting September 2018 United States, Texas ... More >> Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States, 75246 Contact: Brooke Murphy    214-818-8472    cancer.trials@bswhealth.org    Principal Investigator: Carlos Becerra, MD          Sub-Investigator: David McCollum, MD          Sub-Investigator: Scott Paulson, MD          Sub-Investigator: Scott Celinski, MD Less <<
NCT00210041 Genital Neoplasms, Male Phase 2 Completed - France ... More >> Centre Paul Papin Angers, France Institut Bergonie Bordeaux, France Centre François Baclesse Caen, France CHU Grenoble Grenoble, France Centre Léon Bérard Lyon, France Institut Paoli Calmette Marseille, France Institut Val d'aurelle Montpellier, France Institut Curie Paris, France Centre Eugène Marquis Rennes, France Centre Médico-Chirurgical Foch Suresnes, France Institut Claudius Regaud Toulouse, France Less <<
NCT00084734 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00823186 Cervical Cancer Phase 1 Unknown January 2013 Taiwan ... More >> Chang Gung Memorial Hospital Tao Yuan, Lin kou, Taiwan, 333 Chang Gung Memory Hpspital Chia Yi, Taiwan Taipei Chang Gung Memory Hospital Taipei, Taiwan Less <<
NCT00083122 - Completed - -
NCT01939418 Metastatic Breast Cancer Phase 1 Phase 2 Terminated(slow recruitment) - Korea, Republic of ... More >> National cancer center Goyangsi, Gyeonggido, Korea, Republic of, 410-769 Less <<
NCT02119650 NSCLC (Non-small Cell Lung Car... More >>cinoma) Less << Phase 2 Terminated(The study was termi... More >>nated as other related studies of ruxolitinib did not provide sufficient efficacy to warrant continuation.) Less << - -
NCT02119650 - Terminated(The study was termi... More >>nated as other related studies of ruxolitinib did not provide sufficient efficacy to warrant continuation.) Less << - -
NCT00083122 Recurrent Ovarian Epithelial C... More >>ancer Recurrent Primary Peritoneal Cavity Cancer Stage IIIA Ovarian Epithelial Cancer Stage IIIA Primary Peritoneal Cavity Cancer Stage IIIB Ovarian Epithelial Cancer Stage IIIB Primary Peritoneal Cavity Cancer Stage IIIC Ovarian Epithelial Cancer Stage IIIC Primary Peritoneal Cavity Cancer Stage IV Ovarian Epithelial Cancer Stage IV Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00680940 Non Small Cell Lung Cancer Phase 2 Completed - India ... More >> Gujarat Cancer & Research Institute, New Civil Hospital Campus Asarwa, Ahmedabad, India, 380013 Regional Cancer Center, Indira Gandhi Medical College Shimla, Himachal Pradesh, India, 171001 MNJ Institute of Oncology, Regional Cancer Centre Red Hills, Hyderabad, India, 500004 Malabar Institute of Medical Science (MIMS) Calicut, Kerala, India, 673016 B.P. Poddar Hospital and Medical Research Ltd. New Alipore, Kolkata, India, 700053 Choithram Hospital and Research Centre Indore, Madhya Pradesh, India, 452014 Regional Cancer Centre, Indira Gandhi Institute of Medical Science Sheikhpura, Patna, India, 800014 Patel Hospital Pvt. Ltd Jalandhar, Punjab, India, 144001 Acharya Tulsi Regional Cancer Treatment & Research Institute Bikaner, Rajasthan, India, 334003 V.N. Cancer Center, GKNM Hospital Coimbatore, TamilNadu, India, 641037 Netaji Subash Chandra Bose Cancer Research Institute Kolkata, West Bangal, India, 700016 Bankura Sammilani Medical College Gobindnagar, West Bengal, India, 722101 Institute of Post Graduate Medical education & Research Kolkata, West Bengal, India, 700020 Chittaranjan National Cancer Institute Kolkata, West Bengal, India, 700026 Less <<
NCT00143455 Small Cell Lung Carcinoma Phase 3 Completed - -
NCT00369122 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Stage IB Cervical Cancer AJCC v6 and v7 Stage IIA Cervical Cancer AJCC v7 Stage IIB Cervical Cancer AJCC v6 and v7 Stage III Cervical Cancer AJCC v6 and v7 Less << Phase 2 Completed - -
NCT01286766 Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-750 Less <<
NCT02241876 Head and Neck Neoplasms Phase 4 Unknown - Brazil ... More >> State University of Campinas - UNICAMP, Hospital das Clinicas Not yet recruiting Campinas, São Paulo, Brazil, 13083-888 Contact: Patricial Moriel    55 (19) 35218884    morielpa@fcm.unicamp.br    Contact: Marília B Visacri    55 (19) 35218884    mariberlofa@gmail.com    Principal Investigator: Marilia B Visacri Less <<
NCT02807181 Intrahepatic Cholangiocarcinom... More >>a Less << Phase 2 Phase 3 Recruiting June 2021 -
NCT01536223 Chemoradiation ... More >> Nasopharyngeal Carcinoma Less << Phase 3 Unknown February 2015 China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Xiaozhong Chen, MD    86-571-88122098    cxzfyun@sina.com    Contact: Weifeng Qin, MD    86-571-88122091    qinweifeng@yahoo.com.cn    Principal Investigator: Xiaozhong Chen, MD Less <<
NCT00143455 - Completed - -
NCT00369122 - Completed - -
NCT03535727 Adenocarcinoma ... More >> Pancreatic Neoplasms Neoplasm, Glandular Neoplasms Neoplasms Pancreatic Digestive System Neoplasm Endocrine Gland Neoplasms Digestive System Disease Pancreatic Diseases Endocrine System Diseases Less << Phase 1 Phase 2 Recruiting June 2021 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Susan Sartorius-Mergenthaler, RN    410-614-3644    Sartosu@jhmi.edu    Contact: Jane Zorzi, RN    410-614-5818    Jzorzi1@jhmi.edu Less <<
NCT02409342 Non-Squamous Non-Small Cell Lu... More >>ng Cancer, Squamous Non-Small Cell Lung Cancer Less << Phase 3 Active, not recruiting April 23, 2020 -
NCT02535325 Non-Squamous Non-Small Cell Lu... More >>ng Carcinoma Stage III Large Cell Lung Carcinoma AJCC v7 Stage III Lung Adenocarcinoma AJCC v7 Stage III Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Large Cell Lung Carcinoma AJCC v7 Stage IIIA Lung Adenocarcinoma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Large Cell Lung Carcinoma AJCC v7 Stage IIIB Lung Adenocarcinoma AJCC v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IV Large Cell Lung Carcinoma AJCC v7 Stage IV Lung Adenocarcinoma AJCC v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Less << Phase 1 Recruiting - United States, Ohio ... More >> Case Western Reserve University Recruiting Cleveland, Ohio, United States, 44106 Contact: Tithi Biswas    800-641-2422       Principal Investigator: Tithi Biswas Less <<
NCT03069820 Liver Injury, Drug-Induced Phase 4 Recruiting January 1, 2018 China, Jiangxi ... More >> The Second Afiliated Hospital of Nanchang University Recruiting Nanchang, Jiangxi, China, 330006 Contact: Anwen Liu, MD    13767120022    awliu666@163.com Less <<
NCT03410615 Oropharyngeal Squamous Cell Ca... More >>rcinoma Less << Phase 2 Recruiting July 2024 Canada, Alberta ... More >> Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Neil Sun Chua    780 432-8340       Canada, Manitoba CancerCare Manitoba Recruiting Winnipeg, Manitoba, Canada, R3E 0V9 Contact: Andrew Maksymiuk    204 787-2021       Canada, Nova Scotia QEII Health Sciences Centre Recruiting Halifax, Nova Scotia, Canada, B3H 1V7 Contact: Stephanie Snow    902 473-3739       Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: Brandon M. Meyers    905 387-9495 ext 64604       Kingston Health Sciences Centre Recruiting Kingston, Ontario, Canada, K7L 2V7 Contact: Richard W. Gregg    613 549-6666 ext 4509       London Regional Cancer Program Recruiting London, Ontario, Canada, N6A 5W9 Contact: Eric W. Winquist    519 685-8261       Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: John Hilton    613 737-7700 ext 70179       Health Sciences North Recruiting Sudbury, Ontario, Canada, P3E 5J1 Contact: Lacey Pitre    705 522-6237       University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Anna Spreafico    416 946-4501 ext 4012       Canada, Quebec The Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Khalil Sultanem    514 340-8288       CHUQ-Pavillon Hotel-Dieu de Quebec Not yet recruiting Quebec City, Quebec, Canada, G1R 2J6 Contact: Andre Fortin    418 691-5264       Canada, Saskatchewan Allan Blair Cancer Centre Recruiting Regina, Saskatchewan, Canada, S4T 7T1 Contact: Osama Souied    306 766-2691 Less <<
NCT00530634 Lung Cancer Phase 2 Terminated(Poor accrual) - -
NCT01565772 Non-Small Cell Lung Cancer Phase 1 Terminated(Slow accrual) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Less <<
NCT00907504 Carcinoma, Non-Small-Cell Lung Phase 3 Withdrawn May 2014 -
NCT00530634 - Terminated(Poor accrual) - -
NCT00521521 Head and Neck Neoplasms Phase 2 Completed - France ... More >> Sanofi-Aventis Paris, France Less <<
NCT02185352 Breast Cancer ... More >> Brain Metastases Less << Phase 2 Recruiting July 2019 Taiwan ... More >> Kaohsiung Chang Gung Memorial Hospital Recruiting Kaohsiung, Taiwan Contact: Kun-Ming Rau, MD    +886-7-7317123 ext 8303    kmrau58@adm.cgmh.org.tw    Principal Investigator: Kun-Ming Rau, MD          Shuang Ho Hospital Recruiting New Taipei City, Taiwan Contact: Tsu-Yi Chao, MD    +886-2-22490088 ext 8402    10575@shh.org.tw    Principal Investigator: Tsu-Yi Chao, MD          China Medical University Hospital Recruiting Taichung, Taiwan Contact: Chang-Fang Chiu, MD    +886-4-22052121 ext 1921    d5686@mail.cmuh.org.tw    Principal Investigator: Chang-Fang Chiu, MD          National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Yen-Shen Lu, MD, PhD    +886-2-23123456 ext 71673    yslu@ntu.edu.tw    Principal Investigator: Yen-Shen Lu, MD, PhD          Tri-Service General Hospital Recruiting Taipei, Taiwan, 114 Contact: Jyh-Cherng Yu, MD    +886-2-89723311 ext 16020    doc20106@ndmctsgh.edu.tw    Contact: Ming-Shen Dai, MD, PhD    +886-2-89723311 ext 12623    dms1201@gmail.com    Principal Investigator: Jyh-Cherng Yu, MD          Mackay Memorial Hospital Active, not recruiting Taipei, Taiwan Taipei Veterans General Hospital Recruiting Taipei, Taiwan Contact: Ling-Ming Tseng, MD    +886-2-28757535 ext 134    lmtseng@vghtpe.gov.tw    Contact: Ta-Chung Chao, MD       tcchao@vghtpe.gov.tw    Principal Investigator: Ling-Ming Tseng, MD          Chang Gung Memorial Hospital-LinKou Recruiting Taoyuan, Taiwan Contact: Shin-Cheh Chen, MD    +886-2-27135211 ext 3141    chensc@adm.cgmh.org.tw    Principal Investigator: Shin-Cheh Chen, MD Less <<
NCT02495493 Gastric Adenocarcinoma Phase 2 Active, not recruiting June 2019 Korea, Republic of ... More >> Severance Hospital, Yonsei University Health System, Yonsei Cancer Center Seoul, Korea, Republic of, 120-752 Less <<
NCT00942331 Bladder Urothelial Carcinoma ... More >> Distal Urethral Carcinoma Infiltrating Bladder Urothelial Carcinoma Associated With Urethral Carcinoma Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Proximal Urethral Carcinoma Recurrent Bladder Carcinoma Recurrent Prostate Carcinoma Recurrent Urethral Carcinoma Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter Regional Urothelial Carcinoma of the Renal Pelvis and Ureter Stage IV Bladder Cancer AJCC v7 Stage IV Prostate Cancer AJCC v7 Stage IV Urethral Cancer AJCC v7 Ureter Carcinoma Less << Phase 3 Active, not recruiting - -
NCT01283217 Gastric Adenocarcinoma Phase 3 Unknown March 2016 Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Sun-Young Rha, MD, Ph.D    82-2-2228-8050    rha7655@yuhs.ac Less <<
NCT02743923 Carcinoma, Non-Small Cell Lung Phase 3 Recruiting April 2020 Netherlands ... More >> VUmc Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081HV Contact: Idris Bahce, MD       i.bahce@vumc.nl    Principal Investigator: Idris Bahce, MD          Medical spectrum Twente Recruiting Enschede, Overijssel, Netherlands, 7500 KA Contact: Hugo Schouwink, MD       J.Schouwink@mst.nl    Principal Investigator: Hugo Schouwink, MD          Meander Medical Center Recruiting Amersfoort, Utrecht, Netherlands, 3818 ES Contact: Joop van den Brand, MD       JJG.vanden.Brand@meandermc.nl    Principal Investigator: Joop van den Brand, MD          ZGT Recruiting Almelo, Netherlands, 7609 PP Contact: Jeske Staal, MD       j.staal@zgt.nl    Principal Investigator: Jeske Staal, MD          Antoni van Leeuwenhoek Recruiting Amsterdam, Netherlands, 1066CX Contact: Egbert Smit       e.smit@nki.nl    Principal Investigator: Egbert Smit, MD          OLVG Not yet recruiting Amsterdam, Netherlands, 1090 HM Contact: A Moons, MD       A.Moons-Pasic@olvg.nl    Principal Investigator: A Moons, MD          Gelre Ziekenhuis Recruiting Apeldoorn, Netherlands Contact: Niels Pronk, MD       n.pronk@gelre.nl    Principal Investigator: Niels Pronk, MD          Amphia Hospital Recruiting Breda, Netherlands Contact: Nicolaas van Walree, MD       nwalree@amphia.nl    Principal Investigator: Nicolaas van Walree, MD          Jeroen Bosch Hospital Recruiting Den Bosch, Netherlands Contact: Bonne Biesma, MD       b.biesma@jbz.nl    Principal Investigator: Bonne Biesma, MD          Haga Recruiting Den Haag, Netherlands, 2545 CH Contact: Pepijn Brocken, MD       p.brocken@hagaziekenhuis.nl    Principal Investigator: Pepijn Brocken, MD          Deventer Ziekenhuis Recruiting Deventer, Netherlands Contact: Suzy Samii, MD       s.samii@dz.nl    Principal Investigator: Suzy Samii, MD          Albert Schweitzer ziekenhuis Recruiting Dordrecht, Netherlands Contact: Eric van Thiel, MD       EricvanThiel@asz.nl    Principal Investigator: Eric van Thiel, MD          Ziekenhuis Gelderse Vallei Recruiting Ede, Netherlands Contact: Wouter de Jong, MD       jongw@zgv.nl    Principal Investigator: Wouter de Jong, MD          Maxima Medisch Centrum Recruiting Eindhoven, Netherlands, 5631 BM Contact: Arjen van Henten, MD       a.vanhenten@mmc.nl    Principal Investigator: Arjen van Henten, MD          Groene Hart Recruiting Gouda, Netherlands Contact: ten Heuvel, MD       alexandra.ten.heuvel@ghz.nl    Principal Investigator: ten Heuvel, MD          UMCG Recruiting Groningen, Netherlands, 9713 GZ Contact: Harry Groen, MD       h.j.m.groen@umcg.nl    Principal Investigator: Harry Groen, MD          Martini Ziekenhuis Recruiting Groningen, Netherlands Contact: John van Putten, MD       jwg.van.putten@mzh.nl    Principal Investigator: John van Putten, MD          Tergooi ziekenhuizen Recruiting Hilversum, Netherlands Contact: Jan Maarten van Haarst, MD       jvanhaarst@tergooi.nl    Principal Investigator: Jan Maarten van Haarst, MD          Spaarne Gasthuis Recruiting Hoofddorp, Netherlands, 2130 AT Contact: Frans Krouwels, MD       fkrouwels@spaarnegasthuis.nl    Principal Investigator: Frans Krouwels, MD          Medisch Centrum Leeuwarden Recruiting Leeuwarden, Netherlands Contact: Venmans, MD          Principal Investigator: Venmans, MD          Maastricht University Medical Center Recruiting Maastricht, Netherlands Contact: Anne-Marie Dingemans, MD       a.dingemans@mumc.nl    Principal Investigator: Anne-Marie Dingemans, MD          Maasstad ziekenhuis Recruiting Rotterdam, Netherlands, 3007 AC Contact: Susan van 't Westeinde, MD       westeindes@maasstadziekenhuis.nl    Contact: , MD          Principal Investigator: Susan van 't Westeinde, MD          St. Fransicus Gasthuis Recruiting Rotterdam, Netherlands, 3045 PM Contact: Wessel Hanselaar, MD       w.hanselaar@franciscus.nl    Principal Investigator: Wessel Hanselaar, MD          Medical Center Haaglanden Recruiting the Hague, Netherlands Contact: Klaar Maas, MD       k.maas@mchaaglanden.nl    Principal Investigator: Klaar Maas, MD          Diakonessenhuis Utrecht Recruiting Utrecht, Netherlands, 3582 KE Contact: Leontine van Elden, MD       lvelden@diakhuis.nl    Principal Investigator: Leontine van Elden, MD          St. Antonius ziekenhuis Recruiting Utrecht, Netherlands Contact: Franz Schramel, MD       f.schramel@antoniusziekenhuis.nl    Principal Investigator: Franz Schramel, MD          VieCuri Medisch Centrum voor Noord-Limburg Recruiting Venlo, Netherlands Contact: Vivian van Kampen, MD       vvankampen@viecuri.nl    Principal Investigator: Vivian van Kampen, MD          Isala Klinieken Recruiting Zwolle, Netherlands, 8000 GK Contact: Jos Stigt       j.a.stigt@isala.nl    Principal Investigator: Jos Stigt, MD Less <<
NCT02997332 Head and Neck Cancers Phase 1 Recruiting December 2019 France ... More >> Gustave Roussy Recruiting Villejuif, Val de Marne, France, 94805 Contact: Caroline EVEN, MD    0142116537 ext +33    caroline.even@gustaveroussy.fr    Contact: Matthieu TEXIER    0142116309 ext +33    matthieu.texier@gustaveroussy.fr Less <<
NCT03046862 Biliary Tract Neoplasms Phase 2 Recruiting May 2020 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Do-Youn Oh, MD, PhD    82-2-2072-0701    ohdoyoun@snu.ac.kr Less <<
NCT00424853 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - Italy ... More >> Sanofi-Aventis Administrative Office Milan, Italy Less <<
NCT01704690 Esophageal Cancer Phase 2 Phase 3 Terminated(The enrollment of t... More >>he study is much slower than expected.) Less << - China ... More >> Beijing Cancer Hospital, Peking University Cancer Hospital Beijing, China, 100142 Less <<
NCT00668499 Mesothelioma Phase 1 Phase 2 Withdrawn(Sponsor withdrew sup... More >>port) Less << April 2011 United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT00629226 Head and Neck Cancer Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 United States, Pennsylvania UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00925743 Solid Cancer Phase 1 Completed - United States, California ... More >> Investigational Site Number 840008 Los Angeles, California, United States, 90048 Investigational Site Number 840003 San Diego, California, United States, 92123 United States, Illinois Investigational Site Number 840010 Decatur, Illinois, United States, 62526 United States, Maryland Investigational Site Number 840002 Baltimore, Maryland, United States, 21201 United States, Missouri Investigational Site Number 840006 St Louis, Missouri, United States, 63110 United States, Ohio Investigational Site Number 840007 Cincinnati, Ohio, United States, 45267-0542 United States, Texas Investigational Site Number 840005 San Antonio, Texas, United States, 78229 Less <<
NCT00832117 - Completed - -
NCT02607592 Carcinoma，Non-Small-Cell Lung Phase 3 Recruiting August 2020 China, Guangdong ... More >> Sun Yat-sen University of cancer center Recruiting Guangzhou, Guangdong, China, 510000 Contact: li-kun chen, doctor    13798019964 Less <<
NCT01642251 Extensive Stage Small Cell Lun... More >>g Carcinoma Large Cell Lung Carcinoma Neuroendocrine Carcinoma Small Cell Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7 Less << Phase 1 Phase 2 Active, not recruiting - -
NCT02137343 Gastric Cancer Phase 3 Terminated(All Amgen sponsored... More >> AMG102 clinical studies were terminated following a pre-planned Data Monitoring Committee safety review of study 20070622.) Less << - Japan ... More >> Research Site Nagoya-shi, Aichi, Japan, 464-8681 Research Site Chiba-shi, Chiba, Japan, 260-8717 Research Site Kashiwa-shi, Chiba, Japan, 277-8577 Research Site Matsuyama-shi, Ehime, Japan, 791-0280 Research Site Fukuoka-shi, Fukuoka, Japan, 811-1395 Research Site Sapporo-shi, Hokkaido, Japan, 060-8648 Research Site Akashi-shi, Hyogo, Japan, 673-8558 Research Site Kawasaki-shi, Kanagawa, Japan, 216-8511 Research Site Osaka-shi, Osaka, Japan, 537-8511 Research Site Osaka-shi, Osaka, Japan, 540-0006 Research Site Osakasayama-shi, Osaka, Japan, 589-8511 Research Site Suita-shi, Osaka, Japan, 565-0871 Research Site Takatsuki-shi, Osaka, Japan, 569-8686 Research Site Kitaadachi-gun, Saitama, Japan, 362-0806 Research Site Suntou-gun, Shizuoka, Japan, 411-8777 Research Site Utsunomiya-shi, Tochigi, Japan, 320-0834 Research Site Bunkyo-ku, Tokyo, Japan, 113-8677 Korea, Republic of Research Site Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Research Site Hwasun, Korea, Republic of, 519-763 Research Site Seoul, Korea, Republic of, 110-744 Research Site Seoul, Korea, Republic of, 120-752 Research Site Seoul, Korea, Republic of, 135-710 Research Site Seoul, Korea, Republic of, 136-705 Research Site Seoul, Korea, Republic of, 137-701 Research Site Seoul, Korea, Republic of, 138-736 Less <<
NCT00832117 Non Small Cell Lung Cancer Phase 1 Completed - United States, District of Col... More >>umbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, New Jersey The Cancer Institute Of New Jersey New Brunswick, New Jersey, United States, 08901 United States, Pennsylvania Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Italy Local Institution Lucca, Italy, 55100 Local Institution Meldola (Fc), Italy, 47014 Local Institution Rimini, Italy, 47900 Local Institution Viterbo, Italy, 01100 Less <<
NCT00428194 Cervical Cancer Phase 1 Withdrawn(Withdrawn due to lac... More >>k of accrual) Less << - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00436293 Nasopharyngeal Neoplasms Phase 2 Completed - Hong Kong ... More >> Sanofi-Aventis Hong Kong, Hong Kong Less <<
NCT00941070 - Completed - -
NCT01281800 Mesothelioma Phase 2 Unknown - Slovenia ... More >> Institute of Oncology Ljubljana Recruiting Ljubljana, Slovenia, 1000 Contact: Viljem Kovac, MD    +386 1 5879 504    vkovac@onko-i.si    Sub-Investigator: Matjaz Zwitter, MD, PhD          Principal Investigator: Viljem Kovac, MD Less <<
NCT01998529 Lung Cancer Phase 1 Recruiting August 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00118235 Extensive Stage Small Cell Lun... More >>g Cancer Less << Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT01911598 Head and Neck Cancer Phase 1 Completed - United States, Colorado ... More >> University of Colorado Cancer Center Department of Hematology Aurora, Colorado, United States, 80045 United States, Illinois University of Chicago; Hematology/Oncology Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital;Hematology/ Oncology Boston, Massachusetts, United States, 02114 Belgium Cliniques Universitaires St-Luc Bruxelles, Belgium, 1200 UZ Antwerpen Edegem, Belgium, 2650 UZ Leuven Gasthuisberg Leuven, Belgium, 3000 Less <<
NCT00941070 Recurrent Cervical Cancer ... More >> Recurrent Vaginal Cancer Stage IB Cervical Cancer Stage II Vaginal Cancer Stage IIA Cervical Cancer Stage IIB Cervical Cancer Stage III Cervical Cancer Stage III Vaginal Cancer Stage IVA Cervical Cancer Stage IVA Vaginal Cancer Stage IVB Cervical Cancer Stage IVB Vaginal Cancer Therapy-related Toxicity Less << Phase 2 Completed - United States, Ohio ... More >> Case Western Reserve University Cleveland, Ohio, United States, 44106 Less <<
NCT02484677 Patients With Head and Neck Ca... More >>ncer (ORL) Less << Phase 4 Unknown - France ... More >> Assistance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13354 Contact: Urielle DESALBRES, Director          Principal Investigator: Sebastien SALAS, Professor Less <<
NCT00735904 - Completed - -
NCT03113188 Advanced Solid Tumors Phase 1 Recruiting March 2019 United States, Arizona ... More >> HonorHealth Recruiting Scottsdale, Arizona, United States, 85258 Contact: Joyce Schaffer, RN    480-323-1339    clinicaltrials@honorhealth.com    Contact    877-273-3713       United States, Louisiana Ochsner Clinic Foundation Recruiting New Orleans, Louisiana, United States, 70121 Contact: Marc R. Matrana, MD,MSc,FACP    504-703-2654    MaMatrana@ochsner.org    United States, Massachusetts Dana Faber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Solida Pruitt-Thompson, Sr. RC    617-632-6718    SOLIDA_THOMPSON@dfci.harvard.edu Less <<
NCT00483223 Breast Cancer Phase 2 Completed - United States, Alabama ... More >> University of Alabama-Birmingham Birmingham, Alabama, United States United States, California UCSF San Francisco, California, United States United States, District of Columbia Georgetown - Lombardi Cancer Center Washington, D.C., District of Columbia, United States United States, Maryland Johns Hopkins University Medical Center Baltimore, Maryland, United States United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 North Shore Medical Center Peabody, Massachusetts, United States, 01960 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States Less <<
NCT00173888 Non-small Cell Lung Cancer Phase 2 Completed - Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei, Taiwan Less <<
NCT00483223 - Completed - -
NCT02024841 Gastric Cancer ... More >> Peritoneal Carcinomatosis Less << Phase 1 Completed - China, Hong Kong ... More >> The University of Hong Kong Hong Kong, Hong Kong, China Less <<
NCT01474642 Advanced or Recurrent Esophage... More >>al Squamous Cell Carcinoma Less << Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT00735904 Carcinoma, Non-Small-Cell Lung... More >> (NSCLC) Less << Phase 2 Completed - Poland ... More >> Pfizer Investigational Site Torun, Poland, 87-100 Pfizer Investigational Site Wodzislaw Sl., Poland, 44-300 Romania Pfizer Investigational Site Cluj-Napoca, Cluj, Romania, 400015 Pfizer Investigational Site Bucuresti, Romania, 022328 Pfizer Investigational Site Oradea, Romania, 410032 South Africa Pfizer Investigational Site Parktown, South Africa, 2193 Ukraine Pfizer Investigational Site Dnipropetrovsk, Ukraine, 49102 Pfizer Investigational Site Donetsk, Ukraine, 83092 Pfizer Investigational Site Kyiv, Ukraine, 04107 Pfizer Investigational Site Lviv, Ukraine, 79031 Less <<
NCT01491139 Carcinoma, Squamous Cell Phase 1 Withdrawn(Study stopped due to... More >> issues surrounding development and formulation of olaparib) Less << - -
NCT00148798 Non Small Cell Lung Cancer (NS... More >>CLC) Less << Phase 3 Completed - -
NCT00148798 - Completed - -
NCT03410030 Pancreatic Cancer ... More >> Pancreas Cancer Pancreatic Adenocarcinoma Resectable Pancreatic Ductal Adenocarcinoma Pancreas Metastases Less << Phase 1 Phase 2 Recruiting December 15, 2019 United States, Arizona ... More >> HonorHealth Research Institute Recruiting Scottsdale, Arizona, United States, 85258 Contact: Joyce Schaffer, MSN, AOCNS    480-323-1339 ext option #2    Joyce.Schaffer@HonorHealth.com    Principal Investigator: Gayle S Jameson, RN, MSN, ACNP-BC, AOCN          United States, California University of California San Diego Moores Cancer Center Not yet recruiting San Diego, California, United States, 92093 Contact: Julie Lewis    858-822-4907    jml111@ucsd.edu    Principal Investigator: Hitendra Patel, MD          United States, Georgia Piedmont Cancer Institute, PC Not yet recruiting Atlanta, Georgia, United States, 30318 Contact: Derrick Carter    678-298-3238    dcarter@piedmontcancerinstitute.com    Principal Investigator: Vasileios Assikis, MD          Piedmont Cancer Institute, PC Not yet recruiting Fayetteville, Georgia, United States, 30214 Contact: Derrick Carter    678-298-3238    dcarter@piedmontcancerinstitute.com    Principal Investigator: Vasileios Assikis, MD          Piedmont Cancer Institute, PC Not yet recruiting Newnan, Georgia, United States, 30265 Contact: Derrick Carter    678-298-3238    dcarter@piedmontcancerinstitute.com    Principal Investigator: Vasileios Assikis, MD Less <<
NCT01194453 Non-small Cell Lung Cancer ... More >> Efficacy Less << Phase 2 Completed - China, Guangdong ... More >> Cancer Center of Sun Yat-Sen University (CCSU) Guangzhou, Guangdong, China Less <<
NCT01194453 - Completed - -
NCT02365766 Urothelial Carcinoma ... More >> Bladder Cancer Less << Phase 1 Phase 2 Recruiting December 2018 United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Costantine Albany, M.D.    317-278-1711    calbany@iu.edu    Contact: Marietta Moore    317-274-7477    marlmoor@iupui.edu    IU Health Central Indiana Cancer Center Recruiting Indianapolis, Indiana, United States, 46219 Contact: Deborah McCullough    317-948-1921    dmccullough2@iuhealth.org    Principal Investigator: Andrew Greenspan, MD          Community Regional Cancer Care Recruiting Indianapolis, Indiana, United States, 46256 Contact: Kelly Verel    317-497-2836    KVerel@ecommunity.com    Principal Investigator: Radhika Walling, MD          St. Vincent Hospital Recruiting Indianapolis, Indiana, United States, 46260 Contact: Deborah Estes    317-338-6594    deborah.estes@ascension.org    Principal Investigator: Niraj Gupta, MD          United States, Missouri Washington University: Siteman Cancer Center Recruiting Saint Louis, Missouri, United States, 63110 Contact: Joel Picus, M.D.    314-362-5740    jpicus@dom.wustl.edu    Contact: Amber Smith, R.N.    314-508-7249    asmith1@wustl.edu    United States, New Mexico University of New Mexico Cancer Center Recruiting Albuquerque, New Mexico, United States, 87106 Contact: Mollie Geske    505-925-0377    mgeske@nmcca.org    Principal Investigator: Richard Lauer, MD          United States, Ohio University Hospitals Seidman Cancer Center Recruiting Cleveland, Ohio, United States, 44106 Contact: Christopher Hoimes, D.O.    216-844-3951    cjh122@case.edu    Contact: Cheryl Eitman    216-844-5393    cheryl.eitman2@uhhospitals.org    United States, Pennsylvania Thomas Jefferson University: Kimmel Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Jean Hoffman-Censits, M.D.    215-955-8874    jean.hoffman-censits@jefferson.edu    Contact: Monica Byrnes    215.503.0552    monica.byrnes@jefferson.edu    United States, Virginia Virginia Oncology Associates Recruiting Norfolk, Virginia, United States, 23502 Contact: Mark Fleming, M.D.    757-213-5813    mark.fleming@usoncology.com    Contact: Wendi Gobhart    757.213.5813    wendi.gobhart@usoncology.com Less <<
NCT00006942 Fallopian Tube Cancer ... More >> Primary Peritoneal Cavity Cancer Recurrent Ovarian Epithelial Cancer Stage III Ovarian Epithelial Cancer Stage IV Ovarian Epithelial Cancer Less << Phase 2 Completed - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Less <<
NCT01000480 Non Small Cell Lung Cancer Phase 2 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Le Mans, France, 72000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lyon, France, 69373 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montpellier, France, 34070 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75015 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toulouse, France, 31300 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 14165 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hemer, Germany, 58675 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Köln, Germany, 51109 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lübeck, Germany, 23538 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nürnberg, Germany, 90419 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Avellino, Italy, 50019 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Firenze, Italy, 50139 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20132 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Monza, Italy, 20900 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Perugia, Italy, 06156 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain, 08208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41013 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 Less <<
NCT00799240 Non Small Cell Lung Cancer Phase 2 Completed - United States, Kansas ... More >> Hutchinson Clinic, PA Hutchinson, Kansas, United States, 67502 Kansas University Cancer Center Kansas City, Kansas, United States, 66160 Stormont Vail Healthcare Topeka, Kansas, United States, 66606 United States, Missouri VA Medical Center Kansas City, Missouri, United States, 64128 Less <<
NCT00318890 Cancer of Head and Neck ... More >> Head Cancer Head and Neck Cancer Neck Cancer Neck Neoplasms Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT00603408 - Terminated(Study was discontin... More >>ued due to lack of accrual.) Less << - -
NCT00603408 Breast Cancer Phase 2 Terminated(Study was discontin... More >>ued due to lack of accrual.) Less << - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00814086 Chemotherapeutic Agent Toxicit... More >>y Endometrial Adenocarcinoma Fallopian Tube Carcinoma Gastrointestinal Complication Malignant Ovarian Mixed Epithelial Tumor Neurotoxicity Syndrome Ovarian Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma Primary Peritoneal Carcinoma Stage II Ovarian Cancer Stage III Ovarian Cancer Stage IV Ovarian Cancer Undifferentiated Ovarian Carcinoma Less << Phase 1 Completed - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, New Jersey Cooper Hospital University Medical Center Camden, New Jersey, United States, 08103 United States, Ohio Riverside Methodist Hospital Columbus, Ohio, United States, 43214 United States, Oklahoma Tulsa Cancer Institute Tulsa, Oklahoma, United States, 74146 United States, Rhode Island Women and Infants Hospital Providence, Rhode Island, United States, 02905 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00301808 Lung Cancer Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Veterans Affairs Medical Center - Detroit Detroit, Michigan, United States, 48201 Less <<
NCT00565370 Advanced Gastric Cancer Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00301808 - Completed - -
NCT02657434 Non-Small Cell Lung Cancer Phase 3 Recruiting November 30, 2019 -
NCT00496275 Non Small Cell Lung Cancer Phase 1 Completed - -
NCT02035527 Metastatic Squamous Neck Cance... More >>r With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IVA Salivary Gland Cancer Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Oral Cavity Squamous Cell Carcinoma Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Salivary Gland Cancer Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Salivary Gland Cancer Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Verrucous Carcinoma of the Oral Cavity Tongue Cancer Untreated Metastatic Squamous Neck Cancer With Occult Primary Less << Phase 1 Completed - United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00998166 Non-Small Cell Lung Cancer Phase 2 Terminated(Poor enrollment) - United States, New York ... More >> North Shore University Hospital Lake Success, New York, United States, 11042 Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT02567409 Metastatic Urothelial Carcinom... More >>a of the Renal Pelvis and Ureter Stage IV Bladder Urothelial Carcinoma AJCC v7 Less << Phase 2 Recruiting - -
NCT00565370 - Completed - -
NCT01450696 Gastric Cancer Phase 3 Terminated(futility following ... More >>planned interim analysis) Less << - -
NCT01000480 - Completed - -
NCT01450696 - Terminated(futility following ... More >>planned interim analysis) Less << - -
NCT02508246 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 1 Active, not recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01369641 Cancer Not Applicable Terminated(Poor accrual) - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01369641 - Terminated(Poor accrual) - -
NCT00012194 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Terminated - United States, New Hampshire ... More >> Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT01824459 Gastric Cancer Phase 3 Recruiting September 1, 2018 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ruihua Xu, phD    86-20-87342479    xurh@sysucc.org.cn Less <<
NCT00565448 Nasopharyngeal Neoplasms ... More >> Carcinoma Less << Phase 2 Completed - -
NCT00565448 - Completed - -
NCT01379807 Gastric Adenocarcinoma ... More >> Gastroesophageal Junction Adenocarcinoma Less << Phase 2 Unknown December 2015 Spain ... More >> Hospital Arquitecto Mercide Ferrol, La Coruña, Spain, 15405 Complejo Hospitalario Universitario de Santiago (CHUS) Santiago de Compostela, La Coruña, Spain, 15706 Complejo Hospitalario Universitario de Vigo (Xeral Cies) Vigo, Pontevedra, Spain, 36204 Policlínica de Vigo S.A. Vigo, Pontevedra, Spain, 36211 Complejo Hospitalario Universitario de A Coruña La Coruña, Spain, 15006 Centro Oncológico de Galícia La Coruña, Spain, 15009 Hospital Universitario Lucus Augusti Lugo, Spain, 27003 Complejo Hospitalario Ourense Ourense, Spain, 32005 Hospital de Pontevedra Pontevedra, Spain, 36002 Less <<
NCT00320515 Neoplasm, Gastric Phase 1 Phase 2 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buenos Aires, Argentina, 1264 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tucumain, Argentina, 4000 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 136-705 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ciudad Obregon, Mexico, 85100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guadalajara, Mexico, 44280 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan, 704 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 112 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Less <<
NCT01031446 - Completed - -
NCT03574818 Squamous Cell Lung Cancer Phase 2 Recruiting February 26, 2022 United States, New York ... More >> Montefiore Medical Center Recruiting Bronx, New York, United States, 10461 Contact: Mariano Bazan, BS    718-862-8840 ext 436    mbazan@montefiore.org    Contact: Anna L Araiza, MPH    718-3796866    aaraiza@montefiore.org Less <<
NCT00242749 Cancer of Head and Neck Phase 2 Completed - Spain ... More >> Research Site Badalona, Spain Research Site Murcia, Spain Research Site Málaga, Spain Research Site Santander, Spain Less <<
NCT01096199 Cancer Phase 1 Terminated - Singapore ... More >> National University Hospital Singapore, Singapore, 119074 Less <<
NCT00320515 - Completed - -
NCT02121990 Ovarian Cancer ... More >> Primary Peritoneal Cancer Fallopian Tube Cancer Less << Phase 1 Active, not recruiting April 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Less <<
NCT01031446 Breast Cancer Phase 1 Phase 2 Completed - United States, Tennessee ... More >> Erlanger Cancer Center at Erlanger Hospital - Baroness Chattanooga, Tennessee, United States, 37403 West Tennessee Cancer Center at Jackson-Madison County General Hospital Jackson, Tennessee, United States, 38301 Baptist Regional Cancer Center at Baptist Riverside Knoxville, Tennessee, United States, 37901 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00475657 Small Cell Lung Cancer Phase 2 Terminated(Terminated due to l... More >>ack of efficacy) Less << - Spain ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ferrol, Spain, 15405 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lugo, Spain, 27004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ourense, Spain, 15009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santiago de Compostela, Spain, 15706 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vigo, Spain, 36211 Less <<
NCT01073683 Larynx Cancer Phase 2 Unknown December 2014 Israel ... More >> Rabin MC Not yet recruiting Petach Tikva, Israel, 49100 Contact: Aron Popovtzer, MD    039378004    aronp@clalit.org.il    Contact: Salomon Stemmer, MD    039378023    sstemmer@clalit.org.il    Principal Investigator: Aron Popovtzer, MD Less <<
NCT00759226 Esophageal Cancer Phase 2 Completed - Germany ... More >> Charite Universitätsmedizin Berlin Berlin, Germany, 13353 Less <<
NCT01015664 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 1 Phase 2 Terminated - United States, Tennessee ... More >> Boston Baskin Caner Foundation Memphis, Tennessee, United States, 38138 Less <<
NCT00116896 Advanced Solid Tumors Phase 1 Completed - United States, Tennessee ... More >> Vanderbilt Universtiy Medical Center Nashville, Tennessee, United States, 37232-6307 United States, Texas Institute for Drug DevelopmentCancer Therapy & Research Center San Antonio, Texas, United States, 78229 Less <<
NCT00072332 Esophageal Cancer ... More >> Gastric Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01374789 Urinary Bladder Cancer Phase 2 Terminated(The study was termi... More >>nated due to insufficient recruitment.) Less << - Germany ... More >> Bundeswehrkrankenhaus Berlin Berlin, Germany, 10115 Krankenhaus am Urban Berlin, Germany, 10967 St.-Josefs-Hospitals Dortmund Dortmund, Germany, 44263 Universitätsklinikum Dresden Dresden, Germany, 01307 Universitätsklinikum Düsseldorf Düsseldorf, Germany, 40225 Universitätsklinikum Erlangen Erlangen, Germany, 91054 Klinikum Fulda Fulda, Germany, 36043 Universitätsklinikum Hamburg Eppendorf Hamburg, Germany, 20246 Medizinische Hochschule Hannover, Urologie Hannover, Germany, 30625 Universitätskllinikum Heidelberg Heidelberg, Germany, 69121 Klinikum Kassel Kassel, Germany, 34215 Heilig-Geist-Krankenhaus Köln, Germany, 50737 Klinikum Ludwigshafen Ludwigshafen, Germany, 67063 Universitätsklinikum Mainz Mainz, Germany, 55131 Uroloische Praxis Markkleeberg, Germany, 04416 Universitätsklinikum Münster Münster, Germany, 48149 Johanniter Krankenhaus Stendal, Germany, 39576 Universitätsklinikum Ulm, Urologische Klinik Ulm, Germany, 89075 Klinikum Weiden Weiden, Germany, 92637 Gemeinschaftspraxis für Urologie DGU Wuppertal, Germany, 742103 Less <<
NCT00415324 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 City of Hope Duarte, California, United States, 91010 University of Southern California/Norris Cancer Center Los Angeles, California, United States, 90033 University of California at Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT01487915 Advanced Urothelial Carcinoma Phase 2 Unknown - Korea, Republic of ... More >> Keimyeong University Dongsan Medical Center Recruiting Daegu, Korea, Republic of, 700-712 Contact: Hong Seok Song, MD, PhD.          Contact: Jin Young Kim, MD          Chungnam University Hospital Recruiting Daejeon, Korea, Republic of, 301-721 Contact: Hyo Jin Lee, MD, PhD.          Korea University Anam Hospital Recruiting Seoul, Korea, Republic of, 136-705 Contact: Kyeong Hwa Park, MD, PhD          Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Jeong-Mi Ko, MSc       crnonc8@amc.seoul.kr    Principal Investigator: Jae-Lyun Lee, MD, PhD.          Sub-Investigator: Jin-Hee Ahn, MD, PhD.          Sub-Investigator: Hanjong Ahn, MD, PhD.          Sub-Investigator: Jun Hyuk Hong, MD, PhD.          Sub-Investigator: Cheryn Song, MD, PhD.          Sub-Investigator: Cheong Soo Kim, MD, PhD.          Chung Ang University Hospital Not yet recruiting Seoul, Korea, Republic of, 156-755 Contact: Hee Joon Kim, MD Less <<
NCT00595972 Gastric Cancer Phase 2 Completed - China, Shanghai ... More >> Fudan University Cancer Hospital ShangHai, Shanghai, China, 200032 Less <<
NCT00449033 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - -
NCT03707509 Nasopharyngeal Carcinoma Phase 3 Not yet recruiting November 1, 2021 -
NCT00449033 - Completed - -
NCT02414685 Germ Cell Tumor Phase 2 Recruiting December 2019 Slovakia ... More >> National Cancer Institute Recruiting Bratislava, Slovakia, 83310 Contact: Michal Mego, Assoc. Prof    +421259378 ext 366    michal.mego@nou.sk    Contact: Jozef Mardiak, Prof    +421259378 ext 108    jozef.mardiak@nou.sk    Principal Investigator: Jozef Mardiak, Prof          Principal Investigator: Michal Mego, Assoc. Prof Less <<
NCT03732677 Muscle Invasive Bladder Cancer Phase 3 Recruiting December 18, 2025 -
NCT01139775 Non Small Cell Lung Cancer Phase 1 Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Baden-Wurttemberg, Germany, 68167 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Munster, Nordhein-Westfalen, Germany, 48149 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Sachsen, Germany, 01640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 14165 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60596 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69126 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg, Germany, 66421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Immenhausen, Germany, 34376 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lübeck, Germany, 23538 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, D-55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rheine, Germany, 48431 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ulm, Germany, 89081 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oviedo, Asturias, Spain, 33006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mataro, Barcelona, Spain, 08304 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pozuelo de Alarcon, Madrid, Spain, 28223 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08908 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Girona, Spain, 17007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28050 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sevilla, Spain, 41013 Less <<
NCT00458913 Malignant Mesothelioma Phase 2 Completed - United Kingdom ... More >> Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Less <<
NCT01139775 - Completed - -
NCT00192036 Non Small Cell Lung Cancer Phase 2 Completed - Belgium ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aalst, Belgium, 9300 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Charleroi, Belgium, 6000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gilly, Belgium, 6060 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Haine-St.- Paul, Belgium, 7100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Herentals, Belgium, 2200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mechelen, Belgium, 2800 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ottignies, Belgium, 1340 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Turnhout, Belgium, 2300 Less <<
NCT00192036 - Completed - -
NCT00475657 - Terminated(Terminated due to l... More >>ack of efficacy) Less << - -
NCT00323830 Gastric Cancer ... More >> Surgery Less << Phase 3 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT03382561 Extensive Stage Lung Small Cel... More >>l Carcinoma Recurrent Small Cell Lung Carcinoma Less << Phase 2 Active, not recruiting June 2, 2020 -
NCT02201355 Squamous Cell Carcinoma of the... More >> Head and Neck T1/2N0-2 Less << Phase 1 Active, not recruiting February 2021 United States, Texas ... More >> University of Texas at Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00448643 Endometrial Cancer Phase 1 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT02677727 - Active, not recruiting July 26, 2019 United States, Indiana ... More >> Indiana University Health Hospital Indianapolis, Indiana, United States, 46202 Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Minnesota Mayo Clinic Department of Medical Oncology Rochester, Minnesota, United States, 55905 Less <<
NCT02639650 Gestational Trophoblastic Neop... More >>lasms Less << Phase 3 Recruiting March 2021 China, Zhejiang ... More >> Weiguo Lv Recruiting Hangzhou, Zhejiang, China Contact: Weiguo Lv, Doctor Less <<
NCT02395705 Esophageal Neoplasm Phase 3 Recruiting July 2022 China, Beijing ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100029 Contact: Yousheng Mao, MD.       maoysherx@qq.com    Principal Investigator: Yousheng Mao, MD.          Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Keneng Chen, MD.       chenkeneng@bjmu.edu.cn    Principal Investigator: Keneng Chen, MD.          China, Fujian Fujian Medical University Union Hospital Recruiting FuZhou, Fujian, China Contact: Chun Chen, MD       chenchun0209@163.com    Principal Investigator: Chun Chen, MD          China, Guangdong Sun Yat-sen Uniersity Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Peng Lin, MD & PhD       linpeng@sysucc.org.cn    Principal Investigator: Peng Lin, MD & PhD          China, Henan Anyang cancer hospital Recruiting Anyang, Henan, China Contact: Xiaobing Li, MD          Principal Investigator: Xiaobing Li, MD          Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Recruiting ZhengZhou, Henan, China, 450008 Contact: Yin Li, M.D.& Ph.D.    8613903838752    liyin825@aliyun.com    Contact: Yan Zheng, M.D.& Ph.D.    8615713660065    sunnyzheng1@126.com    Principal Investigator: Yin Li, M.D.& Ph.D          China, Hunan Hunan Province Tumor Hospital Recruiting Changsha, Hunan, China, 410013 Contact: Gaoming Xiao, MD.       xiaogaoming617@163.com    Principal Investigator: Gaoming Xiao          China, Shanghai Fudan Universitay Shanghai Cancer Center Recruiting Shanghai, Shanghai, China Contact: Jiaqing Xiang, MD       j.q.xiang@hotmail.com    Principal Investigator: Jiaqing Xiang, MD          China, Tianjin Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Zhentao Yu, MD.       yuzhtao@hotmail.com    Principal Investigator: Zhentao Yu, MD. Less <<
NCT02723838 Muscle-invasive Transitional C... More >>ell Carcinoma of the Bladder Less << Phase 1 Withdrawn(Company has repriori... More >>tized clinical plans to focus on later-stage studies.) Less << February 28, 2018 -
NCT02985203 Lung Neoplasm Malignant Phase 2 Recruiting November 2018 China, Guangdong ... More >> Guangdong General Hospital Recruiting Guangzhou, Guangdong, China, 510080 Contact: ZHEN WANG, Dr    +8683827812 ext 50811    hunterol@163.com Less <<
NCT03143153 Various Advanced Cancer Phase 3 Recruiting December 30, 2021 -
NCT00772863 Ovarian Neoplasms Phase 2 Completed - Turkey ... More >> Sanofi aventis administrative office Istanbul, Turkey Less <<
NCT00743964 Advanced Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135 710 Less <<
NCT00006389 Stage III Gastric Cancer ... More >> Stage IV Gastric Cancer Less << Phase 2 Completed - United States, California ... More >> University of Southern California Los Angeles, California, United States, 90033-0804 Less <<
NCT02544243 Metastatic Breast Cancer Phase 2 Unknown - -
NCT01089088 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 2 Completed - United Kingdom ... More >> Bristol Haematology and Oncology Centre Bristol, Avon, United Kingdom, BS2 8ED Castle Hill Hospital Cottingham, East Yorkshire, United Kingdom, HU16 5JQ Royal Bournemouth Hospital Bournemouth, England, United Kingdom, BH7 7DW Churchill Hospital Oxford, Oxfordshire, United Kingdom, OX3 7LJ Royal Shrewsbury Hospital Shrewsbury, Shropshire, United Kingdom, SY3 8XQ The Royal Marsden Hospitals (Surrey) Sutton, Surrey, United Kingdom, Surrey St James's University Hospital Leeds, Yorkshire, United Kingdom, LS9 7TF Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ Velindre Hospital Cardiff, United Kingdom, CF14 2TL Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN St Bartholomew's Hospital London, United Kingdom, EC1A 7BE Hammersmith Hospital London, United Kingdom, W12 0HS St Mary's Hospital (Paddington) London, United Kingdom, W2 1NY Charing Cross Hospital London, United Kingdom, W6 8RF Christie Hospital Manchester, United Kingdom, M20 4BX Southampton General Hospital Southampton, United Kingdom, SO16 6YD Less <<
NCT01401192 Non-small Cell Lung Cancer Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Myung-Ju Ahn, M.D., Ph.D.          Sub-Investigator: Jong-Mu Sun, M.D., Ph.D. Less <<
NCT01312324 Locally Advanced Stage III or ... More >>IV Thymic Cancer Less << Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00510250 Cancer of the Cervix Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00012012 Cervical Cancer ... More >> Radiation Toxicity Less << Phase 1 Phase 2 Completed - United States, Florida ... More >> Integrated Community Oncology Network Jacksonville Beach, Florida, United States, 32250 Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States, 32207 Florida Oncology Associates at Southside Cancer Center Jacksonville, Florida, United States, 32207 Baptist Medical Center South Jascksonville, Florida, United States, 32258 Florida Oncology Associates Orange Park, Florida, United States, 32073 Florida Cancer Center - Palatka Palatka, Florida, United States, 32177 Flagler Cancer Center Saint Augustine, Florida, United States, 32086 United States, Michigan Borgess Medical Center Kalamazooaa, Michigan, United States, 49001 West Michigan Cancer Center Kalamazoo, Michigan, United States, 49007-3731 Bronson Methodist Hospital Kalamazoo, Michigan, United States, 49007 United States, Nevada University Medical Center of Southern Nevada Las Vegas, Nevada, United States, 89102 CCOP - Nevada Cancer Research Foundation Las Vegas, Nevada, United States, 89106 United States, New Jersey Fox Chase Virtua Health Cancer Program at Virtua Memorial Hospital Marlton Marlton, New Jersey, United States, 08053 Franklin & Edith Scarpa Regional Cancer Center at South Jersey Healthcare Vineland, New Jersey, United States, 08360 United States, Ohio Akron City Hospital Akron, Ohio, United States, 44309-2090 Cancer Treatment Center Wooster, Ohio, United States, 44691 United States, Pennsylvania Mercy Cancer Institute at Mercy Hospital Pittsburgh, Pennsylvania, United States, 15219 Less <<
NCT00002583 Lung Cancer Phase 3 Completed - -
NCT00006389 - Completed - -
NCT01630174 - Unknown - China, Shandong ... More >> Shandong Cancer hospital and institute Recruiting Jinan, Shandong, China, 250017 Principal Investigator: Baosheng Li, Ph.D.          Sub-Investigator: Zhongtang Wang, M.D. Less <<
NCT00012012 - Completed - -
NCT00911820 Esophageal Cancer ... More >> Gastric Cancer Stomach Cancer Less << Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02214 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas Texas Oncology Research Dallas, Texas, United States, 75251 Less <<
NCT01593475 Pancreatic Carcinoma Non-resec... More >>table Less << Phase 2 Completed - Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Less <<
NCT00869310 Emesis Phase 3 Terminated(we terminated the s... More >>tudy before enrolling 303/560 due to a slow accrual) Less << - Italy ... More >> Fausto Roila Terni, Italy, 05100 Less <<
NCT00084604 Adenocarcinoma of the Gastroes... More >>ophageal Junction Diffuse Adenocarcinoma of the Stomach Intestinal Adenocarcinoma of the Stomach Mixed Adenocarcinoma of the Stomach Recurrent Gastric Cancer Stage IIIA Gastric Cancer Stage IIIB Gastric Cancer Stage IIIC Gastric Cancer Stage IV Gastric Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00147160 Glioma Phase 2 Completed - France ... More >> Institut Gustave-Roussy Villejuif, France, 94805 United Kingdom Bristol Royal Hospital for Children Bristol, United Kingdom, BS2 8BJ Less <<
NCT00601510 Gastric Cancer Phase 1 Completed - Germany ... More >> Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Less <<
NCT00911820 - Active, not recruiting - -
NCT01017874 - Completed - -
NCT01285557 Metastatic Diffuse Gastric Can... More >>cer Including Carcinoma of the Gastro-esophageal Junction Less << Phase 3 Unknown May 2017 -
NCT01017874 Non Small Cell Lung Cancer Phase 3 Completed - Hong Kong ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kowloon, Hong Kong Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Incheon, Korea, Republic of, 405-760 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 110-744 Singapore For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Singapore, Singapore, 258499 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kuei Shan Hsiang, Taiwan, 33305 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liouying/Tainan, Taiwan, 736 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Puzih City, Taiwan, 613 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taichung, Taiwan, 407 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 Thailand For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangkok, Thailand, 10700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiang Mai, Thailand, 50200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hat Yai, Thailand, 90110 Less <<
NCT02641093 Head and Neck Cancer Phase 2 Recruiting July 2021 United States, Michigan ... More >> University of Michigan Recruiting Ann Arbor, Michigan, United States Contact: Frank Worden, MD          Principal Investigator: Frank Worden, MD          United States, Ohio University of Cincinnati Medical Center Recruiting Cincinnati, Ohio, United States, 45219 Contact: UC Cancer Institute Clinical Trials Office    513-584-7698    cancer@uchealth.com    Principal Investigator: Trisha Wise-Draper, MD, PhD          Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Katrina Banyas, BS    614-685-2127    Katrina.Banyas@osumc.edu    Principal Investigator: Matthew Old, MD          United States, South Carolina Medical University of South Carolina Recruiting Charleston, South Carolina, United States Contact: Brittanie Weinerman    843-792-6349    weinerma@musc.edu    Principal Investigator: Paul O'Brien, MD Less <<
NCT03656536 Unresectable Cholangiocarcinom... More >>a Metastatic Cholangiocarcinoma Less << Phase 3 Not yet recruiting March 2023 -
NCT03116971 Small Cell Lung Cancer Phase 1 Phase 2 Terminated(The study has been ... More >>terminated because of low recruitment rate of subjects and also due to change in focus of the study.) Less << - -
NCT00482014 Non-Small-Cell Lung Cancer Phase 1 Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States, 90095 United States, Kansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wichita, Kansas, United States, 67214 United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Louis, Missouri, United States, 63110 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States, 89135 United States, North Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Burlington, North Carolina, United States, 27216 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States, 38120 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Corpus Christi, Texas, United States, 78405 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75390 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Temple, Texas, United States, 76508 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Delhi, India, 110085 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trivandrum, India, 695 011 Less <<
NCT00442455 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 3 Completed - Spain ... More >> Hospital de Navarra Pamplona, Navarra, Spain, 31008 Hospital Clínico San Carlos Madrid, Spain, 28003 Hospital General Universitario Gregorio Marañón Madrid, Spain, 28007 Hospital Universitario Clínica Puerta de Hierro Madrid, Spain, 28035 Hospital Regional Universitario Carlos Haya Málaga, Spain, 29010 Less <<
NCT01275612 Solid Tumors ... More >>Acute Kidney Injury Less << Phase 1 Withdrawn(Patients evaluated s... More >>o far could not be enrolled because they did not meet the primary criterion of acute renal failure provided by the study protocol) Less << - Italy ... More >> Unit of Oncology - Ospedali Riuniti of Bergamo Bergamo, BG, Italy, 24128 Less <<
NCT01266512 Lung Neoplasms Phase 2 Completed - Hong Kong ... More >> Sanofi-Aventis Administrative Office Hong Kong, Hong Kong Less <<
NCT00675194 Gastric Cancer Phase 2 Completed - Germany ... More >> Johannes Gutenberg Universität , I. Medizinische Klinik und Polokilinik Mainz, Germany, 55101 Less <<
NCT01143974 Locally Advanced Malignant Neo... More >>plasm Less << Phase 4 Completed - China ... More >> Cancer Institute & Hospital. Chinese Academy of Medical Sciences Beijing, China, 100021 Less <<
NCT00482014 - Completed - -
NCT01953952 Stage III Squamous Cell Carcin... More >>oma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Oropharynx Tongue Cancer Less << Phase 2 Withdrawn(Slow accrual) - United States, California ... More >> Stanford University Hospitals and Clinics Stanford, California, United States, 94305 Less <<
NCT00003299 Lung Cancer Phase 3 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT03268499 Hepatocellular Carcinoma Phase 2 Recruiting September 2020 Hong Kong ... More >> Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Carmen Wong    (852)3505 3210    carmenwongsp@cuhk.edu.hk    Contact: Pui Man Chong    (852)3505 3211    siuman@cuhk.edu.hk Less <<
NCT02421640 Nasopharyngeal Carcinoma Phase 2 Recruiting March 2020 China, Guangdong ... More >> Haiqiang Mai Recruiting Guangzhou, Guangdong, China, 510060 Contact: Qiuyan Chen, MD,PhD    86-20-87343380    chenqy@sysucc.org.cn Less <<
NCT00553696 - Completed - -
NCT00158678 Oral Cancer O... More >>ropharynx Cancer Hypopharynx Cancer Less << Phase 3 Active, not recruiting December 2018 France ... More >> Centre Alexis Vautrin Vandoeuvre les Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT00237575 Bladder Cancer Phase 3 Terminated - United States, Kentucky ... More >> University of Louisville Louisville, Kentucky, United States, 40202 United States, Nebraska University of Nebraska Omaha, Nebraska, United States, 68198-7680 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 New York Medical College Hawthorne, New York, United States, 10532 Less <<
NCT00553696 Stomach Neoplasms Phase 1 Completed - Japan ... More >> Aichi cancer center central hospital / Medical Oncology Nagoya, Aichi, Japan, 464-8681 Saku Central Hospital, GI Devision Saku, Nagano, Japan Shizuoka Cancer Center Suntougun, Shizuoka, Japan, 411-8777 Less <<
NCT03576417 Squamous Cell Carcinoma of Hea... More >>d and Neck Less << Phase 3 Recruiting December 2023 France ... More >> Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Joël GUIGAY, MD    04 92 03 15 01 ext +33    Joel.Guigay@nice.unicancer.fr Less <<
NCT00003377 Cervical Cancer Phase 1 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242 United States, New Jersey Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees Camden, New Jersey, United States, 08103 United States, North Carolina Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157 United States, Ohio MetroHealth's Cancer Care Center at MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Cleveland Clinic Cancer Center at Fairview Hospital Cleveland, Ohio, United States, 44111 Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States, 43210 Riverside Methodist Hospital Cancer Care Columbus, Ohio, United States, 43214 United States, Oklahoma Oklahoma University Medical Center Oklahoma City, Oklahoma, United States, 73104 Cancer Care Associates - Midtown Tulsa Tulsa, Oklahoma, United States, 74104 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00003377 - Completed - -
NCT00548418 Cervical Cancer Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, North Carolina Duke Cancer Institute Durham, North Carolina, United States United States, Ohio The Ohio State University College of Medicine Columbus, Ohio, United States Less <<
NCT00548418 - Completed - -
NCT01116791 Peritoneal Carcinomatosis ... More >> Gastrointestinal Cancer Less << Phase 2 Terminated(Insufficient enroll... More >>ment in Pancreatic & Biliary arm) Less << - Belgium ... More >> University Hospitals Leuven Leuven, Belgium, 3000 Less <<
NCT00136955 Uterine Cervical Neoplasms Phase 2 Completed - Taiwan ... More >> Pfizer Investigational Site Kaoshiung, Taiwan, 813 Pfizer Investigational Site Kwei-Shan County, TaoYuan,, Taiwan Pfizer Investigational Site Taichung, Taiwan Pfizer Investigational Site Taipei, Taiwan, 112 Pfizer Investigational Site Taipei, Taiwan Less <<
NCT02949791 Pseudomyxoma Peritonei ... More >> Colorectal Cancer Less << Phase 2 Completed - Italy ... More >> Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Milano, MI, Italy, 20133 Less <<
NCT02465736 Esophageal Squamous Cell Carci... More >>noma Esophageal Cancer Oesophageal Cancer Less << Phase 3 Recruiting July 2023 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Hong Yang, MD, PhD    +86+13560405144    yanghong@sysucc.org.cn Less <<
NCT01728480 Mucositis Rec... More >>urrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Stage III Squamous Cell Carcinoma of the Hypopharynx Stage III Squamous Cell Carcinoma of the Larynx Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Stage III Squamous Cell Carcinoma of the Nasopharynx Stage III Squamous Cell Carcinoma of the Oropharynx Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage III Verrucous Carcinoma of the Larynx Stage III Verrucous Carcinoma of the Oral Cavity Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Stage IVC Squamous Cell Carcinoma of the Larynx Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVC Squamous Cell Carcinoma of the Oropharynx Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IVC Verrucous Carcinoma of the Larynx Stage IVC Verrucous Carcinoma of the Oral Cavity Tongue Cancer Less << Phase 1 Withdrawn(Financial Sponsor re... More >>quested termination) Less << - -
NCT02501954 Endometrial Clear Cell Adenoca... More >>rcinoma Endometrial Serous Adenocarcinoma Stage IIIA Uterine Corpus Cancer Stage IIIB Uterine Corpus Cancer Stage IIIC Uterine Corpus Cancer Stage IVA Uterine Corpus Cancer Less << Phase 3 Recruiting March 2023 United States, New York ... More >> Women's Cancer Care Associates, LLC Recruiting Albany, New York, United States, 12208 Contact: Joyce N Barlin, MD    518-458-1390    jbarlin@womenscancercareassociates.com    Contact: Kimberly A Fredericks, BS, CCRP    518-458-1390    kfredericks@womenscancercareassociates.com    United States, Ohio The Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Amanda Dunson    614-688-8849       Principal Investigator: Ritu Salani, MD          Canada, Quebec CHUM Hopital Notre-Dame Recruiting Montréal, Quebec, Canada, H2L4M1 Contact: Nathalie Grenier    514-890-8000 ext 25165       Principal Investigator: Beatrice Cormier, MD Less <<
NCT02563054 Gastric Cancer Phase 3 Completed - -
NCT01742767 NSCLC Phase 2 Unknown April 2015 Germany ... More >> University hospital essen Recruiting Essen, Northrhine westphalia, Germany, 45122 Contact: Diana Cortes-Incio    02017232011    diana.cortez-incio@uk-essen.de Less <<
NCT00354679 Esophageal Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00354679 - Completed - -
NCT02363829 Uterine Cervix Cancer Phase 1 Recruiting February 2020 United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Principal Investigator: Fiona Simpkins, MD Less <<
NCT00349089 Non-small Cell Lung Cancer Phase 2 Unknown December 2013 Belgium ... More >> Ziekenhuis Oost Limburg Genk, Belgium, 3600 Department of Pulmonology (Respiratory Tumor Unit), University Hospital Gasthuisberg, Catholic University Leuven, Belgium. Leuven, Belgium, 3000 Germany Helios-Klinikum Emil von Behring Berlin, Germany, 14109 Klinikum Bremen-Ost Bremen, Germany, 28325 Westdeutsches Tumorzentrum Essen, Germany, 45122 Department of Hematology and Oncology, University of Goettingen Goettingen, Germany, 37075 Lungenzentrum Großhansdorf Großhansdorf, Germany, 22927 Clinic for thoracic diseases at the University of Heidelberg Heidelberg, Germany, 69120 Lungenklinik Hemer Hemer, Germany, 58675 Klinik Löwenstein Loewenstein, Germany, 74245 University of München Muenchen, Germany Oldenburg Hospital Oldenburg, Germany Dr. Horst Schmidt Klinik Wiesbaden, Germany, 65199 Luxembourg Centre Hospitalier du Luxembourg Luxembourg, Luxembourg, L-1210 Less <<
NCT00136955 - Completed - -
NCT00881114 Head and Neck Cancer Phase 2 Withdrawn(Investigator decided... More >> it was not feasible to conduct this study) Less << June 2013 -
NCT00842491 Advanced Gastric Cancer Phase 2 Completed - China, Beijing ... More >> Department of GI Oncology, Peking University, School of Oncology Beijing, Beijing, China, 100142 Less <<
NCT00004083 Ovarian Cancer Phase 2 Completed - United States, New York ... More >> Kaplan Cancer Center New York, New York, United States, 10016 Less <<
NCT02223611 Non-small Cell Lung Cancer Sta... More >>ge Ⅱ Non-small Cell Lung Cancer Stage ⅢA Less << Phase 2 Unknown December 2018 China, Hebei ... More >> Jun Feng Liu Not yet recruiting Shijiazhuang, Hebei, China, 050011 Contact: Xin-Bo Liu, MD    +86-311-86095353    lxbbbsj@163.com    Principal Investigator: Jun Feng Liu, MD, PhD Less <<
NCT02891447 Gastric Adenocarcinoma ... More >> Gastroesophageal Junction Adenocarcinoma Peritoneal Carcinomatosis Less << Phase 2 Recruiting September 1, 2021 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Brian D. Badgwell    713-792-6940       Principal Investigator: Brian D. Badgwell Less <<
NCT00295503 - Completed - -
NCT01669707 Non-small Cell Lung Cancer Phase 2 Recruiting September 2020 China ... More >> The Beijing Chest Hospital Recruiting Beijing, China Contact: Liyan Xu, MD       xuliyan2009@yahoo.cn    Principal Investigator: Liyan Xu, MD Less <<
NCT01346540 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - Italy ... More >> 1199.82.39004 Boehringer Ingelheim Investigational Site Milano, Italy Netherlands 1199.82.3102 Boehringer Ingelheim Investigational Site Maastricht, Netherlands Spain 1199.82.3401 Boehringer Ingelheim Investigational Site Barcelona, Spain 1199.82.3406 Boehringer Ingelheim Investigational Site Madrid, Spain 1199.82.3410 Boehringer Ingelheim Investigational Site Málaga, Spain United Kingdom 1199.82.4401 Boehringer Ingelheim Investigational Site London, United Kingdom 1199.82.4402 Boehringer Ingelheim Investigational Site Manchester, United Kingdom Less <<
NCT02703961 Cervical Cancer Phase 3 Recruiting February 2021 China, Shaanxi ... More >> Xijing hospital, the Fourth Military Medical University Recruiting Xi` An, Shaanxi, China, 710032 Contact: Mei Shi, professor    0086-029-84775432    mshi82@fmmu.edu.cn    Contact: ying zhang, doctor    0086-029-84775432    zhangying@fmmu.edu.cn    China, Shanxi Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University Recruiting Xi'an, Shanxi, China, 710032 Contact: Mei Shi, MM    +86-029-84775425    mshi82@fmmu.edu.cn    Principal Investigator: Mei Shi, MM          Department of Radiation Oncology, Xijing Hospital, Fourth Military Recruiting Xi'an, Shanxi, China, 710032 Contact: Mei Shi, MD    86-29-84775425    Shimei82@gmail.com Less <<
NCT00296322 - Completed - -
NCT00296322 Stomach Cancer Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00295503 Mesothelioma Phase 2 Completed - United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390-8852 Less <<
NCT00707161 Cancer Melano... More >>ma Less << Phase 2 Terminated(discontinued due to... More >> low enrollment) Less << - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 Less <<
NCT00619359 Chemotherapy-Induced Nausea an... More >>d Vomiting (CINV) Less << Phase 3 Completed - -
NCT00619359 - Completed - -
NCT00248482 Lung Cancer Phase 2 Completed - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0942 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00707161 - Terminated(discontinued due to... More >> low enrollment) Less << - -
NCT02051868 Squamous Cell Carcinoma of the... More >> Anus Less << Phase 2 Unknown February 2018 United States, Massachusetts ... More >> Laura Gagnon Not yet recruiting Boston, Massachusetts, United States, MA 02215 Contact: Laura Gagnon    617-632-3610    gagnon.laura@jimmy.harvard.edu    Australia, New South Wales Margot Gorzeman Not yet recruiting Sydney, New South Wales, Australia, NSW 1450 Contact: Margot Gorzeman    +61 295625359    interAACT@ctc.usyd.edu.au    United Kingdom Royal Marsden NHS Foundation Trust, London & Sutton Recruiting Sutton, United Kingdom, SM2 5PT Contact: Annette Bryant, BSc (Hons)    +44 (0) 0208 661 3637 ext 3637    annette.bryant@rmh.nhs.uk    Principal Investigator: Sheela Rao, MD.FRCP Less <<
NCT02595424 Gastric Neuroendocrine Carcino... More >>ma Intestinal Neuroendocrine Carcinoma Pancreatic Neuroendocrine Carcinoma Less << Phase 2 Recruiting January 1, 2029 -
NCT00627835 Locally Advanced Squamous Cell... More >> Carcinomas of the Head and Neck (SCCHN) Less << Phase 1 Withdrawn(Site decided not to ... More >>open this study) Less << - Canada, British Columbia ... More >> BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Less <<
NCT00981058 - Active, not recruiting - -
NCT00346801 Lung Cancer Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00981058 Non Small Cell Lung Cancer Phase 3 Active, not recruiting December 31, 2018 -
NCT03473574 Cholangiocarcinoma ... More >> Gall Bladder Carcinoma Cholangiocarcinoma Non-resectable Gallbladder Carcinoma Non-Resectable Less << Phase 2 Recruiting July 2021 Germany ... More >> Medizinische Hochschule Hannover, Klinik für Gastroenterologie, Hepatologie & Endokrinologie Recruiting Hannover, Germany, 30625 Contact: Arndt Vogel, Prof.Dr.       Vogel.Arndt@mh-hannover.de Less <<
NCT00262821 - Terminated(Study drug no longe... More >>r available resulting in lack of study drug for participants.) Less << - -
NCT03067181 Adult Germ Cell Tumor ... More >> Childhood Extracranial Germ Cell Tumor Childhood Germ Cell Tumor Extragonadal Embryonal Carcinoma Grade 2 Immature Ovarian Teratoma Grade 3 Immature Ovarian Teratoma Malignant Germ Cell Tumor Stage I Ovarian Choriocarcinoma Stage I Ovarian Embryonal Carcinoma Stage I Ovarian Teratoma Stage I Ovarian Yolk Sac Tumor Stage I Testicular Choriocarcinoma AJCC v6 and v7 Stage I Testicular Embryonal Carcinoma AJCC v6 and v7 Stage I Testicular Yolk Sac Tumor AJCC v6 and v7 Stage II Ovarian Choriocarcinoma Stage II Ovarian Embryonal Carcinoma Stage II Ovarian Yolk Sac Tumor Stage II Testicular Choriocarcinoma AJCC v6 and v7 Stage II Testicular Embryonal Carcinoma AJCC v6 and v7 Stage II Testicular Yolk Sac Tumor AJCC v6 and v7 Stage III Ovarian Choriocarcinoma Stage III Ovarian Embryonal Carcinoma Stage III Ovarian Yolk Sac Tumor Stage III Testicular Choriocarcinoma AJCC v6 and v7 Stage III Testicular Embryonal Carcinoma AJCC v6 and v7 Stage III Testicular Yolk Sac Tumor AJCC v6 and v7 Stage IV Ovarian Choriocarcinoma Stage IV Ovarian Embryonal Carcinoma Stage IV Ovarian Yolk Sac Tumor Testicular Mixed Choriocarcinoma and Embryonal Carcinoma Testicular Mixed Choriocarcinoma and Teratoma Testicular Mixed Choriocarcinoma and Yolk Sac Tumor Less << Phase 3 Recruiting June 30, 2027 -
NCT00160875 Esophageal Cancer Phase 2 Phase 3 Completed - Canada, Ontario ... More >> University Health Network Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02537223 Squamous Cell Carcinoma of Hea... More >>d and Neck Locoregionally Advanced Less << Phase 1 Recruiting March 2020 Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M3G 2M9 Contact: Aaron Hansen, M.D.    416-946-4501 ext 5606       Principal Investigator: Aaron Hansen, M.D. Less <<
NCT02170090 Cholangiocarcinoma ... More >> Gall Bladder Carcinoma Less << Phase 3 Recruiting April 2022 -
NCT01346540 - Completed - -
NCT01752023 - Terminated(Low Accrual) - -
NCT02196168 - Terminated(Inadequate accrual ... More >>rate) Less << - -
NCT00262821 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Cell Carcinoma Cervical Squamous Cell Carcinoma Stage IB Cervical Cancer Stage IIA Cervical Cancer Stage IIB Cervical Cancer Stage III Cervical Cancer Stage IVA Cervical Cancer Less << Phase 3 Terminated(Study drug no longe... More >>r available resulting in lack of study drug for participants.) Less << - -
NCT01088347 Advanced Cervical Cancer Phase 1 Phase 2 Completed - Netherlands ... More >> University Medical Center Groningen Groningen, Netherlands, 9700 RB Less <<
NCT00006036 Head and Neck Cancer ... More >> Lung Cancer Ovarian Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - Canada, British Columbia ... More >> British Columbia Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT01752023 Non-small Cell Lung Cancer Met... More >>astatic Less << Phase 2 Terminated(Low Accrual) - United States, Maryland ... More >> Bayview Medical Center at Johns Hopkins Baltimore, Maryland, United States, 21224 Johns Hopkins University, SKCCC Baltimore, Maryland, United States, 21287 Less <<
NCT00966706 Pancreatic Cancer Phase 2 Completed - Italy ... More >> San Raffaele Scientific Institute Milan, Italy, 20132 Less <<
NCT02196168 Recurrent Hypopharyngeal Squam... More >>ous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Laryngeal Verrucous Carcinoma Recurrent Lip and Oral Cavity Squamous Cell Carcinoma Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Recurrent Oral Cavity Verrucous Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary Stage IV Hypopharyngeal Squamous Cell Carcinoma Stage IVA Laryngeal Squamous Cell Carcinoma Stage IVA Laryngeal Verrucous Carcinoma Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage IVA Oral Cavity Verrucous Carcinoma Stage IVA Oropharyngeal Squamous Cell Carcinoma Stage IVB Laryngeal Squamous Cell Carcinoma Stage IVB Laryngeal Verrucous Carcinoma Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage IVB Oral Cavity Verrucous Carcinoma Stage IVB Oropharyngeal Squamous Cell Carcinoma Stage IVC Laryngeal Squamous Cell Carcinoma Stage IVC Laryngeal Verrucous Carcinoma Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Stage IVC Oral Cavity Verrucous Carcinoma Stage IVC Oropharyngeal Squamous Cell Carcinoma Tongue Carcinoma Less << Phase 2 Terminated(Inadequate accrual ... More >>rate) Less << - Canada, Ontario ... More >> Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00087698 Pleural Neoplasms Phase 2 Completed - United States, California ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States United States, Massachusetts For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Boston, Massachusetts, United States United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Detroit, Michigan, United States United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. New York, New York, United States United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States Less <<
NCT00546130 Small Cell Lung Cancer Phase 2 Unknown September 2011 Japan ... More >> Toho University Sakura Medical Center Recruiting Sakura, Chiba, Japan, 285-8741 Contact: Ryoji Kato, MD    +81-43-462-8811    ryochan@sakura.med.toho-u.ac.jp    Principal Investigator: Ryoji Kato, MD          Hokkaido University Hospital Recruiting Sapporo, Hokkaido, Japan, 060-8648 Contact: Satoshi Oizumi, MD    +81-11-716-1161    soizumi@med.hokudai.ac.jp    Principal Investigator: Satoshi Oizumi, MD          Kanazawa University Hospital Recruiting Kanazawa, Ishikawa, Japan, 920-8641 Contact: Kazuo Kasahara, MD    +81-076-265-2000    kasa1237@med3.m.kanazawa-u.ac.jp    Principal Investigator: Kazuo Kasahara, MD          Kanazawa Medical University Hospital Recruiting Uchinada, Ishikawa, Japan, 920-0293 Contact: Hirohisa Toga, MD    +81-76-286-3511    toga-h@kanazawa-med.ac.jp    Principal Investigator: Hirohisa Toga, MD          Kinkidaigakuigakubu Nara Hospital Recruiting Ikoma, Nara, Japan, 630-0293 Contact: Toshio Shimizu, MD    +81-743-77-0880    tshimizu@nara.med.kindai.ac.jp    Principal Investigator: Toshio Shimizu, MD          Kurashiki Central Hospital Recruiting Kurashiki, Okayama, Japan, 710-8602 Contact: Hiroshige Yoshioka, MD    +81-86-422-0210    hirotin@kchnet.or.jp    Principal Investigator: Hirishige Yoshioka, MD          Osaka Prefectural Medical Center for Respiratory and Allergic Diseases Recruiting Habikino, Osaka, Japan, 583-8588 Contact: Tomonori Hirasima, MD    +81-957-2121    hirashima@opho.jp    Principal Investigator: Tomonori Hirasima, MD          Kinkidaigakuigakubu Sakai Hospital Not yet recruiting Sakai, Osaka, Japan, 590-0132 Contact: Minoru Takada, MD    +81-72-299-1120    m-takada@sakai.med.kindai.ac.jp    Principal Investigator: Minoru Takada, MD          NHO Kinki-chuo Chest Medical Center Recruiting Sakai, Osaka, Japan, 591-8555 Contact: Akihito Kubo, MD    +81-72-252-3021    a-kubo@kch.hosp.go.jp    Principal Investigator: Akihito Kubo, MD          Osaka Medikal College Hospital Recruiting Takatsuki, Osaka, Japan, 569-8686 Contact: Takayasu Kurata, MD    +81-72-683-1221    ctc002@poh.osaka-med.ac.jp    Principal Investigator: Takayasu Kurata, MD          Hiroshima City Hospital Not yet recruiting Hiroshima, Japan, 730-8518 Contact: Yasuo Iwamoto, MD    +81-82-221-2291    y-iwamoto@do.enjoy.ne.jp    Principal Investigator: Yasuo Iwamoto, MD          Osaka City General Hospital Recruiting Osaka, Japan, 534-0021 Contact: Koji Takeda, MD    +81-6-6929-1221    kkk-take@ga2.so-net.ne.jp    Principal Investigator: Koji Takeda, MD          Tokyo Medical University Hospital Recruiting Tokyo, Japan, 160-0023 Contact: Masahiro Tsuboi, MD    +81-3-3342-6111    mtsuboi@za2.so-net.ne.jp    Principal Investigator: Masahiro Tsuboi, MD          Toyama University Hospital Recruiting Toyama, Japan, 930-0194 Contact: Tatsuhiko Kashii, MD, PhD    +81-76-434-7808    tkashii@med.u-toyama.ac.jp    Principal Investigator: Tatsuhiko Kashii, MD, PhD          Toyama Red Cross Hospital Recruiting Toyama, Japan, 930-0859 Contact: Keiichi Iwase, MD    +81-76-433-2222    iwasa@toyama-med.jrc.or.jp    Principal Investigator: Keiichi Iwase, MD Less <<
NCT00535509 Breast Cancer Not Applicable Completed - -
NCT00006482 Cervical Cancer Phase 2 Terminated - -
NCT00087698 - Completed - -
NCT00967928 Cervical Cancer Phase 1 Withdrawn(Lack of enrollment) December 2010 -
NCT00132639 Pulmonary Neoplasms Phase 2 Completed - Japan ... More >> National Cancer Center Chuo-ku,Tsukiji,5-1-1, Tokyo, Japan, 104-0045 Less <<
NCT00803062 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma Recurrent Cervical Carcinoma Stage IVB Cervical Cancer Less << Phase 3 Completed - -
NCT03451331 Metastatic Urothelial Cancer Phase 2 Recruiting December 1, 2020 United States, New York ... More >> Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center Recruiting New York, New York, United States, 10029 Contact: Matthew Galsky, M.D.    212-241-8214    matthew.galsky@mssm.edu    United States, Tennessee Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Matthew Fister    615-875-9979    matthew.c.fister@vumc.org    Principal Investigator: David Chism, MD Less <<
NCT00560573 Carcinoma, Non-Small-Cell Lung Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Charleroi, Belgium, 6000 Ireland Pfizer Investigational Site Dublin, Ireland, 8 Spain Pfizer Investigational Site Madrid, Spain, 28041 Pfizer Investigational Site Sevilla, Spain, 41013 Less <<
NCT02221999 Tubular Breast Cancer ... More >> Mucinous Breast Cancer Invasive Ductal Breast Cancer Inflammatory Breast Cancer Less << Phase 2 Phase 3 Recruiting October 2022 China, Hebei ... More >> HanDan Central Hospital Recruiting Handan, Hebei, China, 056001 Contact: Yinzhou Zhang, MD          China, Hunan The First Affiliated Hospital of University of South China Recruiting Hengyang, Hunan, China, 421001 Contact: Hongguang Liu, MD          China, Jiangsu The second people's hospital of Kunshan city Recruiting Kunshan, Jiangsu, China, 215300 Contact: Bei Gu, MD          China, Shanghai Zhongshan Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Hongwei Zhang, MD          Shanghai Jiaotong University School of Medicine, Renji Hospital Recruiting Shanghai, Shanghai, China, 200127 Contact: Jinsong Lu, MD       lujjss@163.com    Principal Investigator: Jinsong Lu, MD          Yueyang hospital of integrated traditional Chinese and Western medine Recruiting Shanghai, Shanghai, China, 200437 Contact: Xiaohong Xue, MD          Armed Police Corps Hospital of Shanghai Recruiting Shanghai, Shanghai, China, 201103 Contact: Yumei Ye, MD          China, Zhejiang Zhoushan hospital Recruiting Zhoushan, Zhejiang, China, 316021 Contact: Jing Xu, MD Less <<
NCT00560573 - Completed - -
NCT00387127 Neoplasms, Head and Neck Phase 2 Completed - -
NCT00122460 Head and Neck Cancer Phase 3 Completed - -
NCT00122460 - Completed - -
NCT01074970 Breast Cancer Phase 2 Active, not recruiting December 2018 -
NCT01622660 - Terminated(Safety reasons) - -
NCT00803062 - Completed - -
NCT01622660 Bladder Cancer Phase 2 Terminated(Safety reasons) - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT02325986 Esophageal Squamous Cell Carci... More >>noma Less << Phase 2 Unknown December 2017 China, Guangdong ... More >> SYSU Cancer Center Recruiting Guangzhou, Guangdong, China, 510000 Contact: Yujia Zhu, Phd.    18520121368    sysucc@sysucc.org.cn Less <<
NCT01441349 Small Cell Lung Carcinoma Phase 2 Recruiting December 2020 Korea, Republic of ... More >> National Cancer Center , Korea Recruiting Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Contact: JONGHEE HAN, RN    82-31-920-0409    hanjonghee@ncc.re.kr    Sub-Investigator: Jin Soo Lee, MD          Sub-Investigator: Heung Tae Kim, MD          Sub-Investigator: Tak Yun, MD          Sub-Investigator: Young Joo Lee, MD          Sub-Investigator: Geon Kook Lee, MD          Sub-Investigator: Soo Hyun Lee, MD Less <<
NCT01158248 Cervical Cancer Phase 2 Unknown - Austria ... More >> Innsbruck Universitaetsklinik Recruiting Innsbruck, Austria, A-6020 Contact: Contact Person    43-512-504-24155    Alain.zeimet@i-med.ac.at Less <<
NCT02256982 - Terminated(Slow accrual.) - -
NCT02533765 Neoplasms, Germ Cell and Embry... More >>onal Less << Phase 2 Recruiting December 2018 Italy ... More >> U.O Oncologia Medica, IRST IRCCS Recruiting Meldola, FC, Italy, 47014 Contact: Ugo De Giorgio, MD       ugo.degiorgi@irst.emr.it    Istituto Nazionale Tumori IRCCS "Fondazione G.Pascale" Recruiting Napoli, Italy, 80131 Contact: Sandro Pignata, MD       sandro.pignata@fondazionepascale.it Less <<
NCT02256982 Unresectable Intrahepatic Chol... More >>angiocarcinoma Resectable Intrahepatic Cholangiocarcinoma Less << Not Applicable Terminated(Slow accrual.) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00387127 - Completed - -
NCT01373463 Nonsquamous Nonsmall Cell Neop... More >>lasm of Lung Nonsmall Cell Lung Cancer Stage III Less << Phase 1 Terminated(Investigator left s... More >>ite) Less << - United States, South Carolina ... More >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT03601871 Chemotherapy-induced Nausea an... More >>d Vomiting Less << Not Applicable Recruiting December 30, 2020 China, Heilongjiang ... More >> cancer hospital of Haerbin Medical University Not yet recruiting Haerbin, Heilongjiang, China Contact: Jin Wu, M.D.          China, Jilin Siping City Cancer Hospital Not yet recruiting Siping, Jilin, China Contact: Zhuohui Qu          Sub-Investigator: Zhuohui Qu          China, Liaoning Anshan Hospital of First Hospital of China Medical University Not yet recruiting Anshan, Liaoning, China Contact: Mingran Sun, PhD.M.D.          Sub-Investigator: Mingran Sun          Anshan Tumor Hospital Not yet recruiting Anshan, Liaoning, China Contact: Xiuna Zhang, M.D.          Sub-Investigator: Xiuna Zhang          Sub-Investigator: Jinfang Lv          Sub-Investigator: Fugang When          Sub-Investigator: Li Man          Central hospital of Dalian Not yet recruiting Dalian, Liaoning, China Contact: Wei Huo          Sub-Investigator: Wei huo          Sub-Investigator: Min Zhong          Sub-Investigator: Liangwei Yin          Second Affiliated Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China Contact: Zhaoxia Dai, M.D.          Sub-Investigator: Zhaoxia Dai          Sub-Investigator: Jun Chen          The Fifth Hospital of Dalian City Not yet recruiting Dalian, Liaoning, China Contact: Jilai Bian          Sub-Investigator: Jilai Bian          The First Affiliated Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China Contact: Jiwei Liu, PhD;M.D.          Sub-Investigator: Jiwei Liu          Zhuanghe Central Hospital Not yet recruiting Dalian, Liaoning, China Contact: Huali Tang          Sub-Investigator: Huali Tang          Fushun Central Hospital Recruiting Fushun, Liaoning, China Contact: Li Ning          Sub-Investigator: Li Ning          General Hospital of Mining Bureau Not yet recruiting Fushun, Liaoning, China Contact: Yuyang Zhang          Sub-Investigator: Yuyang Zhang          Jinzhou Central Hospital Not yet recruiting Jinzhou, Liaoning, China Contact: Wei Wang          Principal Investigator: Wei Wang          The First Hospital of Liaoning Medical University Not yet recruiting Jinzhou, Liaoning, China Contact: Zhitu Zhu          Sub-Investigator: Zhitu Zhu          Chinese Medicine Hospital of Liaoyang county Not yet recruiting Liaoyang, Liaoning, China Contact: Haifeng Liu, M.D.          Sub-Investigator: Haifeng Liu          Liaoyang Central Hospital Not yet recruiting Liaoyang, Liaoning, China Contact: Jian Zhang, M.D.          Sub-Investigator: Jian Zhang          Petrochemical General Hospital of Liaoyang city Not yet recruiting Liaoyang, Liaoning, China Contact: Hao Chen          Sub-Investigator: Hao Chen          Panjin central Hospital Not yet recruiting Panjin, Liaoning, China Contact: Junwei Zhang          Sub-Investigator: Junwei Zhang          Sub-Investigator: Zhichang Sun          Sub-Investigator: Yu Jiang          Sub-Investigator: Qinghua Gao          Chest Hospital of Shenyang City Not yet recruiting Shengyang, Liaoning, China Contact: Yinyin Li          Sub-Investigator: Yinyin Li          Shengjing Hospital of China Medical University Not yet recruiting Shenyang, Liaoning, China, 110004 Contact: Huawei Zou, M.D.          Sub-Investigator: Huawei Zou          Sub-Investigator: Rong Wu          General Hospital of Shenyang Military Region Not yet recruiting Shenyang, Liaoning, China Sub-Investigator: Zhendong Zheng          Liaoning Tumor Hospital & Institute Not yet recruiting Shenyang, Liaoning, China Contact: Yu Tang, M.D.          Sub-Investigator: Yu Tang          The First Hospital of China Medical University Recruiting Shenyang, Liaoning, China Contact: Yunpeng Liu, M.D.;Ph.D.          Principal Investigator: Yunpeng Liu          Sub-Investigator: Xiujuan Qu          Sub-Investigator: Lingyun Zhang          the People'S Hospital Not yet recruiting Shenyang, Liaoning, China Contact: Lijie He, M.D.          Sub-Investigator: Lijie He          Tieling city Central Hospital Not yet recruiting Tieling, Liaoning, China Contact: Huijun Zhang          Sub-Investigator: Huijun Zhang          China Central Hospital of Anshan City Not yet recruiting Anshan, China Contact: Chuanchun Leng          Sub-Investigator: Chuanchun Leng          Benxi Central Hospital Not yet recruiting Benxi, China Contact: Tiejun Chen          Sub-Investigator: Tiejun Chen          Chaoyang Central Hospital Not yet recruiting Chaoyang, China Contact: Xiujie Cui          Sub-Investigator: Xiujie Cui          Zhongshan Hospital Not yet recruiting Dalian, China Contact: Xuening Ji, M.D.          Sub-Investigator: Xuening Ji          Sub-Investigator: Gang Wang          Sub-Investigator: Tong Zhao          Liaohe Oilfield General Hospital Not yet recruiting Panjin, China Contact: Qiang Chen          Sub-Investigator: Qiang Chen Less <<
NCT00066391 Penile Cancer Phase 2 Completed - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Institut Gustave Roussy Villejuif, France, F-94805 Hungary National Institute of Oncology Budapest, Hungary, 1122 Netherlands Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Poland Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Warsaw, Poland, 02-781 United Kingdom Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Less <<
NCT03723941 Adrenocortical Carcinoma Phase 3 Recruiting June 30, 2021 Italy ... More >> ASST Spedali Civili di Brescia Recruiting Brescia, BS, Italy, 25123 Contact: Alfredo Berruti, MD    0039 030 399 5410    alfredo.berruti@gmail.com Less <<
NCT00094081 Head and Neck Neoplasms Phase 3 Completed - United States, Arizona ... More >> Foundation for Cancer Research and Education Phoenix, Arizona, United States, 85013 United States, California Stanford University Medical Center Palo Alto, California, United States, 94305 United States, Florida H-Lee Moffitt Cancer Center and Research Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21231 United States, Michigan Harper Hospital Detroit, Michigan, United States, 48201 United States, New Jersey VA New Jersey Health Care Medical Center East Orange, New Jersey, United States, 07018 United States, New York University of Rochester Medical Center Rochester, New York, United States, 14620 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Virginia Eastern Virginia Medical School Norfolk, Virginia, United States, 23507 Less <<
NCT00126633 Pancreatic Cancer Phase 2 Completed - United States, California ... More >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00415194 - Completed - -
NCT00191126 Non-Small Cell Lung Cancer Phase 3 Completed - -
NCT00933816 Hepatocellular Carcinoma Phase 1 Phase 2 Completed - Japan ... More >> Kurume University Medical Center Kurume, Fukuoka, Japan, 839-0863 Ogaki Municipal Hospital Oogaki, Gifu, Japan, 503-8502 Kinki University School of Medicine Osaka-Sayama, Osaka, Japan, 589-8511 Less <<
NCT00415194 Head and Neck Neoplasms Phase 3 Completed - -
NCT01999933 Cervical Cancer ... More >> Toxicity Due to Radiotherapy Less << Phase 2 Phase 3 Unknown November 2018 China, Shaanxi ... More >> Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University Recruiting Xi'an, Shaanxi, China, 710032 Contact: Mei Shi, MD    +86-029-84775425    mshifmmu@yahoo.com    Principal Investigator: Mei Shi, MD          Sub-Investigator: Li-Chun Wei, M.D.,Ph.D Less <<
NCT03559803 Cervical Cancer UNKNOWN 2025-12-19 Guizhou Province People's Hosp... More >>ital, Guizhou, Guizhou, China|West China Hospital, Sichuan University, Chendu, Sichuan, 610041, China Less <<
NCT00003896 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 2 Completed - -
NCT00003896 - Completed - -
NCT00771563 Non-Small Cell Lung Cancer Phase 3 Completed - Belgium ... More >> University Hospital Antwerp Edegem, Antwerp, Belgium, 2650 Centre Hospitalier Universitaire Sart Tilman Liège, Belgium, 4000 Less <<
NCT01809379 Recurrent Ovarian Cancer Phase 2 Completed - Germany ... More >> Ruhr University Bochum Bochum, NRW, Germany, 44623 Less <<
NCT00380588 Biliary Tract Cancer Phase 2 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 466-8560 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277-8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 811-1395 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 060-8648 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 241-0815 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shizuoka, Japan, 411-8777 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tokyo, Japan, 104-0045 Less <<
NCT02526316 HPV-induced Cancers Phase 1 Completed - Germany ... More >> Krankenhaus Nordwest Frankfurt, Germany, 60488 Less <<
NCT02006667 - Completed - -
NCT00314678 Epithelial Ovarian Cancer ... More >> Primary Peritoneal Cancer Less << Phase 2 Completed - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT00220129 Oesophageal Carcinoma Phase 2 Completed - United Kingdom ... More >> Royal Marsden Hospital Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00380588 - Completed - -
NCT03020329 Nasopharyngeal Carcinoma ... More >> Children Less << Phase 2 Recruiting December 2021 China, Guangdong ... More >> Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: HaiQiang Mai, PhD    8620-38606186    maihq@sysucc.org.cn Less <<
NCT00942838 Recurrent Ovarian Carcinoma Phase 1 Withdrawn(PI decision due to u... More >>nder accrual.) Less << - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00002717 Ovarian Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 3 Completed - -
NCT02006667 Urinary Tract Cancer Phase 2 Completed - Germany ... More >> Aschersleben, Germany, 06449 Dessau, Germany, 06846 Fulda, Germany, 36043 Leipzig, Germany, 04103 Leipzig, Germany, 04277 Marburg, Germany, 35043 Weiden, Germany, 92637 Less <<
NCT00004547 Abdominal Neoplasm ... More >> Colonic Neoplasm Mesothelioma Peritoneal Neoplasm Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03380468 Lung Neoplasms Phase 2 Phase 3 Recruiting December 31, 2025 China, Shanghai ... More >> Fudan University Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Chen Haiquan, MD    +86-21 64175590 ext 1707    hqchen1@yahoo.com Less <<
NCT02797977 Advanced Solid Tumors Phase 1 Phase 2 Recruiting June 2020 Spain ... More >> Hospital Universitario Vall d'Hebron Recruiting Barcelona, Spain, 08035 Contact: Elena Garralda       egarralda@vhio.net    Principal Investigator: Elena Garralda          Hospital Clinic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Javier Garcia Corbacho          Principal Investigator: Javier Garcia Corbacho          START Madrid Recruiting Madrid, Spain, 28040 Contact: Victor Moreno       victor.moreno@start.stoh.com    Principal Investigator: Victor Moreno          Hospital Universitario 12 de Octobre Recruiting Madrid, Spain, 28041 Contact: Daniel Castellano          Principal Investigator: Daniel Castellano          Hospital Universitario Virgen de la Victoria Recruiting Málaga, Spain, 29010 Contact: Begona Jimenez Rodrigues          Principal Investigator: Begona Jimenez Rodrigues          Biomedical Research Institute INCLIVA Recruiting Valencia, Spain, 46010 Contact: Desamparados Roda Perez          Principal Investigator: Desamparados Roda Perez          United Kingdom Royal Marsden Hospital Recruiting Sutton, London, United Kingdom, SM2 5PT Contact: Udai Banerji, MD       Udai.Banerji@icr.ac.uk    Principal Investigator: Udai Banerji, MD          Belfast City Hospital Recruiting Belfast, Northern Ireland, United Kingdom, BT9 7AB Contact: Melanie Morris    02890638468    melanie.morris@belfasttrust.hscni.net    Principal Investigator: Vicky Coyle          Oxford University Hospitals Recruiting Headington, Oxford, United Kingdom, OX3 7LE Contact: Sarah Blagden          Principal Investigator: Sarah Blagden          Velindre Cancer Centre Recruiting Cardiff, Whitchurch, United Kingdom, CF14 2TL Contact: Rob Jones, MD       Robert.Hugh.Jones@wales.nhs.uk    Principal Investigator: Rob Jones, MD          The Clatterbridge Cancer Centre Recruiting Bebington, Wirral, United Kingdom, CH63 4JY Contact: Daniel Palmer          Principal Investigator: Daniel Palmer          The Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom, G12 0YN Contact: Patricia Roxburgh, MD       p.roxburgh@beatson.gla.ac.uk    Principal Investigator: Patricia Roxburgh, MD          Leeds Teaching Hospital of St James University Hospital Recruiting Leeds, United Kingdom, LS9 7TF Contact: David A Anthoney          Principal Investigator: David A Anthoney          University Hospital of Leceister NHS TRUST Recruiting Leicester, United Kingdom, LE1 5WW Contact: Harriet Walter       hw191@le.ac.uk    Principal Investigator: Harriet Walter          Guy's and St Thomas' Recruiting London, United Kingdom, SE1 9RT Contact: Debashis Sarker       debashis.sarker@kcl.ac.uk    Principal Investigator: Debashis Sarker          Sarah Cannon Research Institute Recruiting London, United Kingdom, W1G 6AD Contact: Hendrik-Tobias Arkenau          Principal Investigator: Hendrik-Tobias Arkenau          University College London Recruiting London, United Kingdom, WC1E 6BT Contact: Rebecca Kristeleit       r.kristeleit@ucl.ac.uk    Principal Investigator: Rebecca Kristeleit          The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Contact: Louise Carter       louise.carter@christie.nhs.uk    Principal Investigator: Louise Carter          Freeman Hospital Recruiting Newcastle upon Tyne, United Kingdom, NE7 7DN Contact: Elizabeth R Plummer       Ruth.Plummer@newcastle.ac.uk    Principal Investigator: Elizabeth R Plummer, MD          Sheffield Teaching Hospitals Recruiting Sheffield, United Kingdom, S10 2SJ Contact: Sarah Danson          Principal Investigator: Sarah Danson Less <<
NCT02871518 Nasopharyngeal Carcinoma Phase 2 Recruiting July 2021 China, Guangdong ... More >> Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Haiqiang Mai, MD,Ph.D    86-20-8734-3643    maihq@mail.sysu.edu.cn Less <<
NCT01124253 Non-small Cell Lung Cancer Phase 3 Completed - China ... More >> The Lung Cancer Center of shanghai chest Hospital Shanghai, China, 2000043 Less <<
NCT00004547 - Completed - -
NCT00683514 NSCLC Phase 3 Completed - Germany ... More >> Pierre Fabre Pharma GmbH Freiburg, Jechtinger Str. 13, Germany, D-79111 Less <<
NCT00085631 - Terminated(Study was closed be... More >>cause of slow accrual) Less << - -
NCT00085631 Cervical Cancer Phase 3 Terminated(Study was closed be... More >>cause of slow accrual) Less << - United States, North Carolina ... More >> Duke Cancer Institute Durham, North Carolina, United States, 27710 Less <<
NCT00673179 Osteosarcoma Not Applicable Terminated(Low accrual.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00268372 Head and Neck Cancer Phase 3 Terminated(SWOG eliminated its... More >> head and neck committee) Less << - -
NCT01655628 Stage IV Nasopharyngeal Carcin... More >>oma Less << Phase 2 Unknown December 2014 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou city, Guangdong, China, 510080 Contact: Jian-jun Li, M.D. Ph.D    86-2087343381    lijj@sysucc.org.cn    Principal Investigator: Jian-jun Li, M.D. Ph.D. Less <<
NCT01588431 Carcinoma, Squamous Cell of He... More >>ad and Neck Less << Phase 2 Active, not recruiting March 2022 United States, Texas ... More >> Cancer Therapy and Research Center at UTHSCSA San Antonio, Texas, United States, 78229 Less <<
NCT00673179 - Terminated(Low accrual.) - -
NCT00220103 Adenocarcinoma of Oesophagus Phase 2 Completed - United Kingdom ... More >> Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom Less <<
NCT00447421 Small Cell Lung Cancer ... More >> Carcinoma, Small Cell SCLC Less << Phase 1 Phase 2 Terminated(Interim results of ... More >>another trial showed inferior activity of treatment) Less << - Belgium ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium, 3000 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Amsterdam, Netherlands, 1081 HV For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Den Bosch, Netherlands, 5211 NL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rotterdam, Netherlands, 3075 EA Less <<
NCT00064077 - Completed - -
NCT01915134 Effects of Chemotherapy ... More >> Stage IVC Nasopharyngeal Carcinoma Less << Phase 3 Unknown December 2016 China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Bin Li    86-571-88122091    libindoctor@163.com    Contact: Xinglai Feng    86-571-88122092    fengxinglai@hotmail.com    Principal Investigator: Bin Li Less <<
NCT00093665 Head and Neck Cancer Phase 2 Unknown - Japan ... More >> National Hospital Organization - Medical Center of Kure Hiroshima, Japan, 737-0023 Kanazawa University Kanazawa, Japan, 920-8641 Kyoto Prefectural University of Medicine Kyoto, Japan, 602 Aichi Cancer Center Nagoya, Japan, 464-8681 Nara Medical University Cancer Center Nara, Japan, 634-8522 Graduate School of Medical Science at the University of Ryukyu Okinawa, Japan, 903-0215 Mie University School of Medicine Tsu, Japan, 514-8507 Less <<
NCT02432378 Cancer of Ovary ... More >> Cancer of the Ovary Neoplasms, Ovarian Ovarian Cancer Ovary Cancer Ovary Neoplasms Less << Phase 1 Phase 2 Recruiting December 2020 United States, Pennsylvania ... More >> UPMC CancerCenter at Magee-Womens Hospital of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15213 Hillman Cancer Center Not yet recruiting Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00109954 Liver Cancer Phase 3 Completed - United States, Pennsylvania ... More >> Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00064077 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma Recurrent Cervical Carcinoma Stage IVB Cervical Cancer Less << Phase 3 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT01733823 HNSCC,Larynx, Pharynx and Oral... More >> Cavity Less << Phase 1 Phase 2 Completed - Denmark ... More >> Aarhus Aarhus, Aarhus C, Denmark, 8000 Odense Odense, Odense C, Denmark, 5000 Aalborg Aalborg, Denmark, 9100 Herlev Herlev, Denmark, 2730 Less <<
NCT02281708 Stage Ib Lung Carcinoma Phase 3 Recruiting September 2020 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Contact: Sanghoon Jheon, Ph.D.    82317877140    jheon@snubh.org Less <<
NCT00447421 - Terminated(Interim results of ... More >>another trial showed inferior activity of treatment) Less << - -
NCT01931163 Breast Cancer ... More >> Triple Negative Breast Cancer Less << Phase 2 Active, not recruiting August 2019 United States, Texas ... More >> The Methodist Hospital Houston, Texas, United States, 77030 Houston Methodist Hospital Willowbrook Houston, Texas, United States, 77070 Houston Methodist Hospital Sugar Land Sugar Land, Texas, United States, 77479 Less <<
NCT02461043 Esophageal Cancer Phase 3 Recruiting December 2023 China ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, China, 100021 Contact: Xi Wang, M.D          Principal Investigator: Jie He, M.D. Less <<
NCT00290966 Stomach Neoplasm Phase 2 Phase 3 Completed - -
NCT01640860 - Completed - Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun, Jeolanamdo, Korea, Republic of, 519-809 Less <<
NCT01787006 Esophageal Cancer Phase 2 Unknown - Germany ... More >> Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Strahlentherapie Recruiting Lübeck, Germany, 23538 Contact: Dirk Rades, Prof. Dr.    0049 451 500-6660    dirk.rades@uksh.de    Principal Investigator: Dirk Rades, Prof. Dr. Less <<
NCT03468010 Cervical Cancer ... More >> Adjuvant Chemotherapy Radiation Lymph Node Metastases Less << Phase 3 Recruiting March 1, 2025 China, Guangdong ... More >> Sun Yat-sen University Affiliated Foshan Hospital Not yet recruiting Foshan, Guangdong, China Contact: Rong Huang, M.D    86-13927736853    nnjbhg@163.com    Hospital of of Guangdong Armed Police Corps Not yet recruiting Guangzhou, Guangdong, China Contact: Zhen-lun Li, M.D    86-13580516205    sfqiu@126.com    Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China Contact: Wei-jun Ye, M.D    86-13538799871    yewj@sysucc.org.cn    Contact: Junyun Li, M.D    86-18824712702    LIJUNY@sysucc.org.cn    The First affiliated Hospital of Guangdong Pharmaceutical University Not yet recruiting Guangzhou, Guangdong, China Contact: Xi-cheng Wang, M.D    86-13902400598    13902400598@126.com    Guangzhou First People's Hospital Not yet recruiting Guanzhou, Guangdong, China Contact: Guo-long Liu, M.D    86-13802527172    liugl@fimmu.com    China, Guangxi The People's Hospital of Guangxi Zhuang Autonomous Region Not yet recruiting Nanning, Guangxi, China Contact: Jia-xin Chen    86-13978609888    cjx166@163.com    China, Hainan Hainan General Hospital Not yet recruiting Haikou, Hainan, China Contact: Guang Huang, M.D    86-18089777161    2842749787@qq.com    China, Xinjiang Xinjiang Medical University Affiliated Tumor Hospital Not yet recruiting Ürümqi, Xinjiang, China Contact: Xiao-wen Li, M.D    86-13899856295    lixiaowen1026@sohu.com Less <<
NCT00102505 Non-Small-Cell Lung Carcinoma ... More >> Carcinoma, Bronchogenic Less << Phase 1 Completed - United States, Texas ... More >> The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00006464 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90033-0804 City of Hope Medical Group Pasadena, California, United States, 91105 University of California Davis Cancer Center Sacramento, California, United States, 95817 United States, New Hampshire Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756-0002 Less <<
NCT00293085 Non-Small Cell Lung Cancer Phase 2 Completed - -
NCT01590017 Cervical Cancer ... More >> Acquired Immunodeficiency Syndrome Less << Phase 2 Completed - South Africa ... More >> Clinical HIV Research Unit, a Division of the Wits Health Consortium (Pty) Ltd Johannesburg, South Africa, 2092 Zimbabwe University of Zimbabwe Clinical Research Centre / Parirenyatwa Hospital Harare, Zimbabwe Less <<
NCT01372111 Head and Neck Cancer Phase 2 Unknown - United States, North Carolina ... More >> Coleman Radiation Oncology Center Morehead City, North Carolina, United States, 28557 CarolinaEast Cancer Care New Bern, North Carolina, United States, 28561 South Atlantic Radiation Oncology Supply, North Carolina, United States, 28462 Coastal Carolina Radiation Oncology Wilmington, North Carolina, United States, 28401 Zimmer Cancer Center Wilmington, North Carolina, United States, 28401 Less <<
NCT00887159 Extensive Stage Small Cell Lun... More >>g Carcinoma Recurrent Small Cell Lung Carcinoma Less << Phase 2 Completed - -
NCT01928160 Recurrent Non-small Cell Lung ... More >>Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Withdrawn(study not accruing) - -
NCT01540045 - Completed - -
NCT00820248 - Completed - -
NCT00820248 Head and Neck Cancer Phase 3 Completed - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Atlantic Health Sciences Corporation Saint John, New Brunswick, Canada, E2L 4L2 Canada, Newfoundland and Labrador Dr. H. Bliss Murphy Cancer Centre St. John's, Newfoundland and Labrador, Canada, AIB 3V6 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Ottawa Health Research Institute - General Division Ottawa, Ontario, Canada, K1H 8L6 Northeast Cancer Center Health Sciences Sudbury, Ontario, Canada, P3E 5J1 Thunder Bay Regional Health Science Centre Thunder Bay, Ontario, Canada, P7B 6V4 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Hopital Maisonneuve-Rosemont Montreal, Quebec, Canada, H1T 2M4 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 CHUQ-Pavillon Hotel-Dieu de Quebec Quebec City, Quebec, Canada, G1R 2J6 Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT01540045 - Completed - Mexico ... More >> National Cancer Institute of Mexico Mexico city, Distrito Federal, Mexico, 14080 Less <<
NCT01682031 Chemotherapeutic Agent Toxicit... More >>y Mucositis Radiation Toxicity Stage III Squamous Cell Carcinoma of the Hypopharynx Stage III Squamous Cell Carcinoma of the Larynx Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Stage III Squamous Cell Carcinoma of the Nasopharynx Stage III Squamous Cell Carcinoma of the Oropharynx Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Larynx Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IV Squamous Cell Carcinoma of the Oropharynx Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Xerostomia Less << Phase 2 Terminated(Due to a lack of fu... More >>nding) Less << - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 New Zealand Waikato Hospital Hamilton, New Zealand, 3204 Less <<
NCT01682031 - Terminated(Due to a lack of fu... More >>nding) Less << - -
NCT00887159 - Completed - -
NCT00576914 Non-small Cell Lung Cancer Phase 3 Unknown June 2012 China, Beijing ... More >> The Lung Cancer Center of Cancer Hospital Recruiting Beijing, Beijing, China, 100021 Contact: Xinling Liu, Bachelor    86-10-87788495    liuxinling1985@126.com    Contact: Fang Li, M.D.    86-13910145882    nc_lifang@yahoo.com.cn    Sub-Investigator: Xiangru Zhang, M.D. Less <<
NCT01669226 Bulky Stage IIIC and IV Epithe... More >>lial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma Less << Phase 2 Completed - China, Jiangsu ... More >> Zhongda Hospital Southeast University Nanjing, Jiangsu, China, 210009 Suzhou Municipal Hospital Suzhou, Jiangsu, China Wuxi Cancer Hospital Wuxi, Jiangsu, China China, Shanghai Shanghai Zhongshan Hospital Shanghai, Shanghai, China, 200030 Ren Ji Hospital Affiliated to Shanghai JiaoTong University School of Medicine Shanghai, Shanghai, China Shanghai Frist Maternity and Infant Hospital Affiliated to Tongji University Shanghai, Shanghai, China China Fudan University Cancer Hospital Shanghai, China, 200032 Less <<
NCT00010023 Cancer Phase 1 Completed - United States, New York ... More >> NYU Cancer Institute at New York University Medical Center New York, New York, United States, 10016 Less <<
NCT01679405 Metastatic Disease Phase 1 Terminated(2016/04/26) December 2016 Germany ... More >> I. Medizinische Klinik und Poliklinik der Universitätsmedizin Mainz, Germany, 55131 Less <<
NCT00548548 - Completed - -
NCT00003809 Head and Neck Cancer Phase 3 Completed - -
NCT00590967 Cervical Cancer Phase 2 Terminated(Due to low accrual) - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00601692 Esophageal Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00590967 - Terminated(Due to low accrual) - -
NCT01461759 Advanced or Recurrent Endometr... More >>ial Cancer Less << Phase 2 Recruiting December 2017 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Joo-Hyun Nam, M.D., Ph.D    +82-2-3010-3633    jhnam@amc.seoul.kr Less <<
NCT01861496 Phase 1: Advanced or Refractor... More >>y Solid Tumours Phase 2 Part: Metastatic Breast Cancer and Skin Cancer Less << Phase 1 Phase 2 Recruiting May 2019 Denmark ... More >> Aalborg Universitetshospital Withdrawn Aalborg, Denmark, 9100 The Phase One Unit, The Finsen Centre, Rigshospitalet Active, not recruiting Copenhagen, Denmark, DK-2100 Herlev & Gentofte Hospital Recruiting Herlev, Denmark, 2730 Contact: Dorte Nielsen, Professor MD    +45 38682344    Dorte.Nielsen01@rehionh.dk    Contact: Peter G. Sørensen, MD PhD    +4538689044    PeteGrundtvig.Sørensen@regionh.dk    Nordsjællands Hospital Hillerød Recruiting Hillerod, Denmark, 3400 Contact: Hella Danoe, MD    +45 48297309    Hella.danoe.01@regionh.dk    Vejle Sygehus Recruiting Vejle, Denmark, 7100 Contact: Erik Hugger Jakobsen, MD    +45 79406015    Erik.hugger.jakobsen@rsyd.dk Less <<
NCT00006028 Ovarian Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - -
NCT03324282 Bladder Carcinoma Phase 2 Recruiting December 31, 2022 France ... More >> CHU de Besançon Recruiting Besançon, France Contact: Antoine THIERY VUILLEMIN    +33 (0)3 81 66 87 05    a.thieryvuillemin@mac.com    CHU de Bordeaux Recruiting Bordeaux, France Contact: Alain RAVAUD          Contact    +33 (0)5 56 79 58 08    alain.ravaud@chu-bordeaux.fr    Institut Bergonié Recruiting Bordeaux, France Contact: Guilhem ROUBAUD    +33 (0)5 24 07 19 12    G.Roubaud@bordeaux.unicancer.fr    Centre François Baclesse Recruiting Caen, France Contact: Elodie COQUAN    +33 (0)2 31 45 50 02    coque@baclesse.unicancer.fr    Centre Léon Bérard Recruiting Lyon, France Contact: Aude FLECHON    +33 (0)4 78 78 26 43    aude.flechon@lyon.unicancer.fr    Institut Paoli Calmettes Not yet recruiting Marseille, France Contact: Gwenaëlle GRAVIS    +33 (0)4 91 22 37 40    gravisg@ipc.unicancer.fr    Institut de cancérologie de l'Ouest - René Gauducheau Recruiting Nantes, France Contact: Frédéric ROLLAND    +33 (0)2 40 67 99 76    frederic.rolland@ico.unicancer.fr    Hôpital Européen Georges-Pompidou, AP-HP Recruiting Paris, France Contact: Stéphane OUDARD    +33 (0)1 56 09 34 47    stephane.oudard@aphp.fr    Hôpital Saint-Louis, AP-HP Recruiting Paris, France Contact: Stéphane CULINE    +33 (0)1 42 49 42 47    stephane.culine@aphp.fr    CHU de Strasbourg Recruiting Strasbourg, France Contact: Philippe BARTHELEMY    +33 (0)3 88 11 67 28    Philippe.barthelemy@chru-strasbourg.fr    Institut Universitaire du Cancer de Toulouse - Oncopole Recruiting Toulouse, France Contact: Christine CHEVREAU    +33 (0)5 31 15 51 52    Chevreau.Christine@iuct-oncopole.fr    Institut Gustave Roussy Not yet recruiting Villejuif, France Contact: Yohann LORIOT    +33 (0)1 42 11 52 76    yohann.loriot@gustaveroussy.fr Less <<
NCT01232452 - Completed - -
NCT00548548 Adenocarcinoma Phase 3 Completed - United States, California ... More >> Tower Cancer Research Fnd Beverly Hills, California, United States, 90211-1850 Moores UCSD Cancer Center La Jolla, California, United States, 92093 Kenmar Research Institute LLC Los Angeles, California, United States, 90057 USC/Norris Cancer Center Los Angeles, California, United States, 90089 United States, District of Columbia Georgetown University Washington, D.C., District of Columbia, United States, 20007 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33916 H. Lee Moffitt Cancer Tampa, Florida, United States, 33612 United States, Kansas Cancer Center of Kansas Wichita, Kansas, United States, 67214-3728 United States, Nebraska Methodist Cancer Center Onc Omaha, Nebraska, United States, 68114 United States, New York Memorial Sloan Kettering New York, New York, United States, 10021 United States, North Carolina Duke Univ Medical Center Durham, North Carolina, United States, 27710 United States, South Carolina South Carolina Oncology Assoc Columbia, South Carolina, United States, 10595 United States, Tennessee The Sarah Cannon Research Inst Nashville, Tennessee, United States, 37203 Less <<
NCT03541252 Carcinoma, Basal Cell Phase 1 Phase 2 Recruiting May 2019 Denmark ... More >> Department of Dermatology, Bispebjerg Hospital Recruiting Copenhagen, Hovedstaden, Denmark, 2400 Contact: Emily C Wenande, MD    +4540505590    emilycathrinew@hotmail.com Less <<
NCT00063999 - Unknown - -
NCT01232452 Non-Small-Cell Lung Carcinoma Phase 2 Completed - -
NCT00248495 - Completed - -
NCT00248495 Lung Cancer Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00736944 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Active, not recruiting August 31, 2020 United States, Missouri ... More >> Washington University Saint Louis, Missouri, United States, 63110 Less <<
NCT00005965 Cervical Cancer Phase 2 Completed - United States, New York ... More >> Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 Saint Vincent Catholic Medical Center of New York New York, New York, United States, 10011 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 New York Presbyterian Hospital - Cornell Campus New York, New York, United States, 10021 Mount Sinai Medical Center, NY New York, New York, United States, 10029 New York Medical College Valhalla, New York, United States, 10595 Less <<
NCT00063999 Recurrent Uterine Corpus Carci... More >>noma Stage IIIA Uterine Corpus Cancer Stage IIIB Uterine Corpus Cancer Stage IIIC Uterine Corpus Cancer Stage IVA Uterine Corpus Cancer Stage IVB Uterine Corpus Cancer Less << Phase 3 Unknown - -
NCT00020696 Ovarian Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - -
NCT01069081 Breast Cancer ... More >> Metastasis, Neoplasm Less << Phase 2 Completed - China, Shanghai ... More >> Fudan University Cancer Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT03189719 Esophageal Neoplasms Phase 3 Recruiting August 22, 2021 -
NCT00003345 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01379976 Non Small Cell Lung Cancer Phase 3 Terminated(Recruitment was pre... More >>maturely stopped due to difficulty of recruitment encountered by the experimental centers) Less << - Italy ... More >> Istituto Oncologico del Mediterraneo Viagrande, CT, Italy, 95029 Azienda Ospedaliera Ospedale S. Anna Como, Italy, 22020 Azienda Ospedaliera Istituti Ospitalieri Cremona, Italy, 26100 Azienda Ospedaliera di Desio e Vimercate - Presidio Ospedaliero di Desio Desio, Italy, 20832 Ospedale Civile Guastalla, Italy, 42016 Ospedale Alessandro Manzoni Lecco, Italy, 23900 Azienda Ospedaliera Ospedale Civile di Legnano Legnano, Italy, 20025 Azienda Ospedaliera Fatebenefratelli e Oftalmico Milano, Italy, 20121 Istituto Europeo Di Oncologia Milano, Italy, 20141 Azienda Ospedaliera San Paolo Milano, Italy, 20142 Azienda Ospedaliera Ospedale San Carlo Borromeo Milano, Italy, 20153 Azienda Ospedaliero Universitaria di Parma Parma, Italy, 43126 Fondazione Salvatore Maugeri Pavia, Italy, 0381 33329 Azienda Ospedaliera Perugia Perugia, Italy, 06075 Arcispedale S. Maria Nuova Reggio Emilia, Italy, 42100 IRCCS di Reggio Emilia Reggio Emilia, Italy, 42123 Azienda Ospedaliera Busto Arsizio - Presidio Ospedaliero di Saronno Saronno, Italy, 21047 Ospedale SS Annunziata - ASL1 Sassari, Italy, 07100 Azienda Ospedaliera Valtellina e Valchiavenna , Presidio Ospedaliero di Sondrio Sondrio, Italy, 23100 Azienda Ospedaliera di Pavia, Ospedale Civile di Vigevano Vigevano, Italy, 27029 Azienda Ospedaliera di Desio e Vimercate - Presidio Ospedaliero di Vimercate Vimercate, Italy, 20059 Less <<
NCT01763788 Squamous Non-small Cell Lung C... More >>ancer Less << Phase 1 Phase 2 Active, not recruiting May 2018 Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan, 464-8681 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan, 277 8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ehime, Japan, 791-0280 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan, 830-0011 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan, 070-8644 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyogo, Japan, 650-0047 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ishikawa, Japan, 920-8641 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan, 240-0062 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Koto-ku, Japan, 135-8550 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miyagi, Japan, 980-8574 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nagasaki, Japan, 852-8501 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Niigata, Japan, 951-8566 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oita, Japan, 8795593 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Okayama, Japan, 700-8558 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Osaka, Japan, 573-1191 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saitama, Japan, 362-0806 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sendai, Japan, 980-0873 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shizuoka, Japan, 411-8777 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wakayama, Japan, 641-8510 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yamaguchi, Japan, 755-0241 Less <<
NCT00736944 - Active, not recruiting - -
NCT00003029 Pancreatic Cancer Phase 3 Completed - Belgium ... More >> Hopital de Jolimont Haine Saint Paul, Belgium, 7100 Les Cliniques Saint-Joseph ASBL Liege, Belgium, B 4000 France Centre Hospitalier de la Cote Basque Bayonne, France, 64109 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre de Lutte Contre le Cancer, Georges-Francois Leclerc Dijon, France, 21079 Hopital Perpetuel Secours Levallois-Perret, France, 92300 Centre Hospital Regional Universitaire de Limoges Limoges, France, 87042 Hopital Notre-Dame de Bon Secours Metz, France, 55038 Centre Hospitalier de Montlucon Montlucon, France, 03109 Clinique Hartmann Neuilly sur Seine, France, 92200 Hopital Saint-Louis Paris, France, 75475 Hopital Cochin Paris, France, 75674 Centre Rene Huguenin Saint Cloud, France, 92211 Hopital Bellevue Saint Etienne, France, 42055 Clinique de l'Orangerie Strasbourg, France, 67010 Hopital Paul Brousse Villejuif, France, 94804 Israel Wolfson Medical Center Holon, Israel, 58100 Italy Universita G.D'Annunzio Di Chieti Chieti, Italy, 66100 Portugal Hospital Fernando Fonseca Amadora, Portugal, P-2700 Less <<
NCT00997906 Head and Neck Cancer Phase 2 Phase 3 Active, not recruiting July 2023 Singapore ... More >> National Cancer Centre - Singapore Singapore, Singapore, 169610 Less <<
NCT02254278 Stage III Oropharyngeal Squamo... More >>us Cell Carcinoma Stage IVA Oropharyngeal Squamous Cell Carcinoma Stage IVB Oropharyngeal Squamous Cell Carcinoma Stage IVC Oropharyngeal Squamous Cell Carcinoma Tongue Carcinoma Less << Phase 2 Active, not recruiting May 31, 2024 -
NCT00068406 - Completed - -
NCT00068406 Stage III Vulvar Cancer ... More >> Stage IVB Vulvar Cancer Vulvar Squamous Cell Carcinoma Less << Phase 2 Completed - -
NCT00001450 Carcinoma, Non-Small-Cell Lung... More >> Lung Neoplasms Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT02967497 Epithelial Growth Factor Recep... More >>tor Negative Non-small Cell Lung Cancer Less << Phase 2 Unknown September 2018 -
NCT01830270 Stomach Neoplasms ... More >> Oesophageal Junction Cancer Lower Oesophagus Cancer Less << Phase 2 Terminated - France ... More >> University hospital of Besançon Besançon, France, 25000 FNLCC center Georges François Leclerc Dijon, France, 21000 Hospital of Belfort-Montbeliard Montbeliard, France, 25200 Less <<
NCT01303926 Non-squamous Nonsmall Cell Neo... More >>plasm of Lung Less << Phase 3 Unknown June 2012 Italy ... More >> "Giovanni Paolo II" Oncology Institute Bari, BA, Italy, 70124 "San Paolo Hospital" Oncology Service Bari, BA, Italy Division of Medical Oncology, "Fatebenefratelli" Hospital Benevento, BN, Italy Division of Medical Oncology, "Sen. Perrino" Hospital, Brindisi, Italy Brindisi, BR, Italy, 72100 7 Division of Medical Oncology, "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, FG, Italy Medical Oncology Division "Vito Fazzi" Hospital Lecce, Le, Italy Division of Medical Oncology, "Buccheri-La Ferla" Hospital Palermo, PA, Italy Division of Medical Oncology, "La Maddalena" Hospital Palermo, PA, Italy Division of Medical Oncology, Castellaneta Hospital Castellaneta, TA, Italy Division of Medical Oncology "San Giuseppe Moscati Hospital" Taranto, TA, Italy Clinical Trials Office, Department of Medical Sciences, Azienda ULSS 13 Mirano, VE, Italy National Cancer Institute "G. Pascale" Thoracic Dept. Napoli, Italy Less <<
NCT03340896 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 3 Recruiting June 30, 2021 France ... More >> Hôpital Bretonneau, Service CORad Pôle Henry S Kaplan Recruiting Tours, France, 37044 Contact: Gilles CALAIS, Pr    + 33 247478265    gilles.calais@univ-tours.fr    Contact: Marie-Hélène GIRARD CALAIS    +33 247479121    rc.corad@chu-tours.fr Less <<
NCT02709512 Mesothelioma Phase 2 Phase 3 Recruiting June 2021 -
NCT02036359 Non-small Cell Lung Cancer(NSC... More >>LC) Less << Phase 2 Unknown - Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Recruiting Taipei,, Taiwan Contact: Chong Jen YU, M.D., Ph.D.       jefferycjyu@ntu.edu.tw Less <<
NCT00005868 Lung Cancer Phase 2 Completed - Germany ... More >> Thoraxklinik Rohrbach Heidelberg, Germany, D-69126 Italy Istituto Nazionale per la Ricerca sul Cancro Genoa (Genova), Italy, 16132 Oncologia Medica - Perugia Perugia, Italy, 06122 Netherlands Leyenburg Ziekenhuis 's-Gravenhage (Den Haag, The Hague), Netherlands, 2545 CH Groot Ziekengasthuis 's-Hertogenbosch 's-Hertogenbosch, Netherlands, 5211 NL Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1001HV Antoni van Leeuwenhoekhuis Amsterdam, Netherlands, 1066 CX Slotervaart Ziekenhuis Amsterdam, Netherlands, 1066 EC Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Longarts Dr. J.M. Smit Rynstate Hospital Arnhem, Netherlands, 6800 TA Ziekenhuis St Jansdal Harderwijk, Netherlands, 3840 AC Leiden University Medical Center Leiden, Netherlands, 2300 CA Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Canisius-Wilhelmina Ziekenhuis Nijmegen, Netherlands, 6532 SZ University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB University Hospital - Rotterdam Dijkzigt Rotterdam, Netherlands, 3000 CA Twee Steden Ziekenhuis Vestiging Tilburg Tilburg, Netherlands, 5042 AD Academisch Ziekenhuis Utrecht Utrecht, Netherlands, 3584 CX Zaas Medisch Centrum Zaandam, Netherlands, 1502 DV Sophia Ziekehuis Zwolle, Netherlands, 8000 GK Poland Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Warsaw, Poland, 02-781 United Kingdom Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Royal Marsden Hospital Sutton, England, United Kingdom, SM2 5PT Less <<
NCT03058094 NSCLC Phase 3 Not yet recruiting January 2020 China, Beijing ... More >> Beijing Cancer Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Jian Fang          Chinese General PLA Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Yi Hu          Peking Union Medical College Hospital Not yet recruiting Beijing, Beijing, China, 100000 Contact: Mengzhao Wang          China, Chongqing Xinqiao Hospital Army Medical University Not yet recruiting Chongqing, Chongqing, China, 400000 Contact: Dong Wang          China, Fujian Fujian Cancer Hospital Not yet recruiting Fuzhou, Fujian, China, 350000 Contact: Cheng Huang          Fuzhou General Hospital of Nanjing Military Command Not yet recruiting Fuzhou, Fujian, China, 350000 Contact: Xuenong Ouyang          China, Hebei Tumor Hospital of Hebei Province Not yet recruiting Shijiazhuang, Hebei, China, 050000 Contact: Cuimin Ding          China, Heilongjiang Harbin Medical University Cancer Hospital Not yet recruiting Harbin, Heilongjiang, China, 150000 Contact: Gongyan Chen          China, Henan Henan Cancer Hospital Not yet recruiting Zhengzhou, Henan, China, 450000 Contact: Zhiyong Ma          China, Jiangsu Jiangsu Province Hospital Not yet recruiting Nanjing, Jiangsu, China, 210000 Contact: Yongqian Shu          Nanjing General Hospital Not yet recruiting Nanjing, Jiangsu, China, 210000 Contact: Yong Song          China, Liaoning The First Affiliated Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China, 116000 Contact: Jiwei Liu          The second Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China, 116000 Contact: Yang Zhang          The First Affiliated Hospital of China Medical University Not yet recruiting Shenyang, Liaoning, China, 110000 Contact: Yunpeng Liu          China, Shanghai Fudan University Shanghai Cancer Center Not yet recruiting Shanghai, Shanghai, China, 200000 Contact: Jianhua Chang          China, Sichuan Sichuan Cancer Hospital & Institute Not yet recruiting Chengdu, Sichuan, China, 610000 Contact: Ping Yu          West China Hospital,Sichuan University Not yet recruiting Chengdu, Sichuan, China, 610000 Contact: You Lu          China, Tianjin Tianjin Medical University Cancer Institute & Hospital Not yet recruiting Tianjin, Tianjin, China, 300000 Contact: Kai Li          China, Zhejiang The First Affiliated Hospital,Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China, 310000 Contact: Qiong Zhao          Zhejiang Cancer Hospital Not yet recruiting Hangzhou, Zhejiang, China, 310000 Contact: Yiping Zhang          China Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting Beijing, China, 100021 Principal Investigator: Yuankai Shi, Professor Less <<
NCT01342965 Non-Small Cell Lung Cancer Phase 3 Completed - China ... More >> Beijing, China, 100071 Beijing, China, 101149 Changchun, China, 130012 Chongqing, China, 400038 ChongQing, China, 400042 Fuzhou, China, 350014 Guangzhou, China, 510080 Hangzhou, China, 310016 Nanjing, China, 210002 Shanghai, China, 200030 Shanghai, China, 200032 Shanghai, China, 200433 Shantou, China, 515041 Wuhan, China, 430023 Xi'an, China, 710061 Malaysia Kelantan, Malaysia, 16150 Kuala Lumpur, Malaysia, 50603 Kuala Lumpur, Malaysia, 59100 Nilai, Malaysia, 71800 Pahang, Malaysia, 25100 Petaling Jaya, Selangor, Malaysia, 46050 Petaling Jaya, Malaysia, 46150 Pulau Pinang, Malaysia, 11600 Philippines Davao, Philippines, 8000 Desmarinas City, Philippines, 4114 Manila, Philippines, 1000 Quezon City, Philippines, 1104 San Juan, Philippines, 1500 Less <<
NCT00003132 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Less <<
NCT01342965 - Completed - -
NCT00681967 Head and Neck Cancer Phase 1 Completed - Switzerland ... More >> Research Site Basel, Switzerland Research Site Bern, Switzerland Less <<
NCT00974584 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 1 Completed - United States, New York ... More >> Buffalo, New York, United States, 14263 France Villejuif, France, 94805 Netherlands Groningen, Netherlands, 9700 RB Less <<
NCT00068549 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Small Cell Carcinoma Cervical Squamous Cell Carcinoma Stage IB Cervical Cancer Stage IIA Cervical Cancer Stage IIB Cervical Cancer Stage III Cervical Cancer Stage IVA Cervical Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00003264 Head and Neck Cancer Phase 2 Completed - United States, New Jersey ... More >> Hunterdon Regional Cancer Center Flemington, New Jersey, United States, 08822 Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly, New Jersey, United States, 08060 Riverview Medical Center - Booker Cancer Center Red Bank, New Jersey, United States, 07701 St. Francis Medical Center Trenton, New Jersey, United States, 08629 United States, Pennsylvania St. Luke's Network - Bethlehem Bethlehem, Pennsylvania, United States, 18015 Delaware County Memorial Hospital Drexel Hill, Pennsylvania, United States, 19026 Harrisburg Polyclinic Medical Center Harrisburg, Pennsylvania, United States, 17101 Saint Mary Regional Center Langhorne, Pennsylvania, United States, 19047 North Penn Hospital Lansdale, Pennsylvania, United States, 19446-1200 Paoli Memorial Hospital Paoli, Pennsylvania, United States, 19301-1792 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 Less <<
NCT00127049 Germ Cell Tumor Phase 2 Unknown - France ... More >> Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Karim FIZAZI, Dr    33 1 42114559    fizazi@igr.fr Less <<
NCT03228537 Biphasic Mesothelioma ... More >> Epithelioid Mesothelioma Stage I Pleural Malignant Mesothelioma AJCC v7 Stage IA Pleural Malignant Mesothelioma AJCC v7 Stage IB Pleural Malignant Mesothelioma AJCC v7 Stage II Pleural Malignant Mesothelioma AJCC v7 Stage III Pleural Malignant Mesothelioma AJCC v7 Less << Phase 1 Recruiting June 1, 2020 -
NCT00477711 Gastric Cancer Phase 2 Completed - China ... More >> Peking University,School of Oncology, Gastrointestinal Department Beijing, China, 100036 Less <<
NCT00431236 Nausea and Vomiting, Chemother... More >>apy-Induced Less << Phase 3 Completed - -
NCT00191100 Cancer of Cervix Phase 3 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buenos Aires, Argentina Bosnia and Herzegovina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sarajevo, Bosnia and Herzegovina India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mumbai, India Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico Pakistan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Karachi, Pakistan Peru For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lima, Peru Thailand For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bangkok, Thailand Less <<
NCT00651456 Mesothelioma Phase 2 Phase 3 Completed - -
NCT01217177 Locally Advanced Cervical Canc... More >>er Less << Phase 1 Completed - Brazil ... More >> Novartis Investigative Site Rio de Janeiro, RJ, Brazil, 20230-130 Novartis Investigative Site Rio de Janeiro, Brazil Less <<
NCT01025349 Metastatic Breast Cancer Phase 2 Completed - Taiwan ... More >> Taipei Medical University Hospital Taipei, Taiwan, 110 Less <<
NCT00191100 - Completed - -
NCT00003182 Head and Neck Cancer Phase 1 Phase 2 Unknown - United States, Kansas ... More >> Bethany Medical Center Kansas City, Kansas, United States, 66102 Heartland Cancer Research Network Kansas City, Kansas, United States, 66102 Less <<
NCT01138137 Ovarian Carcinoma, Stage 3 or ... More >>4 Epithelial Ovarian Carcinoma Primary Peritoneal Carcinoma Less << Phase 1 Withdrawn(No funding was avail... More >>able for the cost of the IV N-acetylcysteine (NAC).) Less << - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT00343239 Stomach Neoplasms Phase 2 Completed - Turkey ... More >> Sanofi-Aventis Administrative Office Istanbul, Turkey Less <<
NCT01042522 Ovarian Granulosa Cell Tumor ... More >> Ovarian Gynandroblastoma Ovarian Sertoli-Leydig Cell Tumor Ovarian Sex Cord Tumor With Annular Tubules Ovarian Sex Cord-Stromal Tumor Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types Ovarian Steroid Cell Tumor Less << Phase 2 Recruiting - -
NCT02029690 Pleural Mesothelioma Malignant... More >> Advanced Peritoneal Mesothelioma Malignant Advanced Non-squamous Non-small Cell Lung Carcinoma Stage IIIB/IV (NSCLC) Metastatic Uveal Melanoma Hepatocellular Carcinoma (HCC) Glioma Sarcomatoid Cancers Less << Phase 1 Active, not recruiting February 2019 United States, Minnesota ... More >> Mayo Clinic Rochester Rochester, Minnesota, United States, 55902 United Kingdom Centre for Experimental Cancer Medicine (CECM) London, England, United Kingdom, EC1M 6BQ Cambridge Hospital Cambridge, United Kingdom, CB2 0QQ Guys Hospital London, United Kingdom, SE1 7EH Less <<
NCT00004090 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Less <<
NCT02702700 Pleural Effusion, Malignant Phase 1 Recruiting June 2019 Switzerland ... More >> Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV) Recruiting Lausanne, Vaud (VD), Switzerland, 1011 Contact: Solange Peters, MD-PhD    +41 21 314 44 62    solange.peters@chuv.ch Less <<
NCT01192633 Sarcoma Chemo... More >>therapy Less << Phase 2 Unknown January 2011 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Zhiguo Luo, PhD          Sub-Investigator: Zhiyu Chen, PhD Less <<
NCT00003108 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, District of Col... More >>umbia Lombardi Cancer Center Washington, District of Columbia, United States, 20007 Less <<
NCT00763646 Gastric Junction Adenocarcinom... More >>a Gastroesophageal Junction Adenocarcinoma Less << Phase 2 Unknown - Canada, Quebec ... More >> McGill University Recruiting Montreal, Quebec, Canada, H2W 1S6 Contact: Penny Chipman    514398-1444    penny.chipman@mcgill.ca    Contact: Crystal Lameira    514-398-2229    crystal.lameira@mcgill.ca    Principal Investigator: Lorenzo Ferri Less <<
NCT01947062 Lung Cancer S... More >>quamous Cell Carcinoma of the Lung Locally Advanced and Metastatic Squamous Cell Carcinoma of the Lung Less << Phase 3 Unknown October 2014 India ... More >> Swami Rama Cancer Hospital & Research Institute Not yet recruiting Haldwani, Nainital, Uttarakhand, India, 263139 Contact: Swaroop Revannasiddaiah, MD    91 ext 8971862565    swarooptheone@gmail.com    Principal Investigator: Swaroop Revannasiddaiah, MD          Sub-Investigator: Kailash C Pandey, MD          Sub-Investigator: Sridhar P Susheela, MD Less <<
NCT00891761 Cancer Chemot... More >>herapy-Induced Nausea and Vomiting Nausea and Vomiting Solid Tumor Cancer Less << Phase 3 Withdrawn(This study has been ... More >>cancelled prior to enrollment.) Less << July 2010 United States, Florida ... More >> GSK Investigational Site Tampa, Florida, United States, 33614 United States, Minnesota GSK Investigational Site Robbinsdale, Minnesota, United States, 55422 Canada, Quebec GSK Investigational Site Sherbrooke, Quebec, Canada, J1H 5N4 Less <<
NCT00006106 Lip and Oral Cavity Cancer ... More >> Head and Neck Cancer Oropharyngeal Cancer Less << Phase 1 Withdrawn - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00716976 Brain Tumor C... More >>entral Nervous System Tumor Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor Liver Cancer Neuroblastoma Ototoxicity Ovarian Cancer Sarcoma Less << Phase 3 Completed - -
NCT00005087 Head and Neck Cancer Phase 2 Completed - -
NCT02899299 Mesothelioma Phase 3 Active, not recruiting September 28, 2021 -
NCT01608464 Carcinoma of Esophagus Phase 2 Terminated(poor accrual) - Saudi Arabia ... More >> King Faisal Specialist Hospital & Research Center Riyadh, Saudi Arabia, 11211 Less <<
NCT00003690 Breast Cancer ... More >> Melanoma (Skin) Prostate Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00252161 Gastric Neoplasm Phase 3 Completed - Japan ... More >> Aichi Cancer Center Hospital Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi, Japan, 464-8681 Fujita Health University Toyoake,Kutsukake-cho,Dengakugakubo,1-98, Aichi, Japan, 470-1192 National Cancer Center Hospital East Kashiwa,Kashiwanoha,6-5-1, Chiba, Japan, 277-8577 National Hospital Organization Shikoku Cancer Center Matsuyama,Horinouchi,13, Ehime, Japan, 790-0007 Gifu Municipal Hospital Gifu,Kashima-cho,7-1, Gifu, Japan, 500-8323 Hiroshima City Hospital Hiroshima,Naka-ku,Motomachi,7-33, Hiroshima, Japan, 730-8518 Itami City Hospital Itami,Koyaike,1-100, Hyogo, Japan, 664-8540 Iwate Medical University Morioka,Uchimaru,19-1, Iwate, Japan, 020-8505 Kagoshima University,Faculty of Medicine Kagoshima,Sakuragaoka,8-35-1, Kagoshima, Japan, 890-8520 Kanagawa Cancer Center Yokohama,Asahi-ku,Nakao,1-1-2, Kanagawa, Japan, 241-0815 Kyoto Second Red Cross Hospital Kamigyo-ku,Kamanza-Marutamachi,355-5, Kyoto, Japan, 602-8026 Miyagi Cancer Center Natori,Medeshima-Shiode,Nodayama,47-1, Miyagi, Japan, 981-1293 National Hospital Organization, Sendai Medical Center Sendai,Miyagino-ku,Miyagino,2-8-8, Miyagi, Japan, 983-8520 Nagaoka Chuo General Hospital Nagaoka,Kawasaki,2041, Niigata, Japan, 940-8653 Niigata Cancer Center Hospital Niigata,Kawagishi-cho,2-15-3, Niigata, Japan, 951-8566 Tsubame Rosai Hospital Tsubame,Sawatari,633, Niigata, Japan, 959-1228 Oita University Fuculty of Medicine Oita,Hasama-machi,Oogaoka,1-1, Oita, Japan, 879-5593 Osaka National Hospital Osaka,Chuo-ku,Hoenzaka,2-1-14, Osaka, Japan, 540-0006 Osaka Medical Center for Cancer and Cardiovascular Diseases Osaka,Higashinari-ku,Nakamichi,1-3-3, Osaka, Japan, 537-8511 Kinki University School of Medicine Osaka-Sayama,Ohno-higashi,377-2, Osaka, Japan, 589-8511 Sakai Municipal Hospital Sakai,Minamiyasuicho,1-1-1, Osaka, Japan, 590-0064 Osaka Medical College Takatsuki,Daigakucho,2-7, Osaka, Japan, 569-0801 Toyonaka Municipal Hospital Toyonaka,Shibaharacho,4-14-1, Osaka, Japan, 560-0055 Saitama Cancer Center Kita-adachi,Ina,Komuro,818, Saitama, Japan, 362-0806 National Defense Medical College Tokorozawa,Namiki,3-2, Saitama, Japan, 359-8513 Shizuoka General Hospital Shizuoka,Aoi-ku,Kitaando,4-27-1, Sizuoka, Japan, 420-8527 Tokyo Metropolitan Komagome Hospital Bunkyo-ku,Honkomagome,3-18-22, Tokyo, Japan, 113-8677 Tokyo Medical and Dental University Hospital Bunkyo-ku,Yushima,1-5-45, Tokyo, Japan, 113-8519 National Cancer Center Hospital Chuo-ku,Tsukiji,5-1-1, Tokyo, Japan, 104-0045 Cancer Institute Hospital Koto-ku,Ariake,3-10-6, Tokyo, Japan, 135-8550 International Medical Center of Japan Shinjuku-ku,Toyama,1-21-1, Tokyo, Japan, 162-8655 Tokyo Metropolitan Bokutoh Hospital Sumida-ku,Koutoubashi,4-23-15, Tokyo, Japan, 130-8575 Toyama Prefectural Central Hospital Toyama,nishinagae,2-2-78, Toyama, Japan, 930-8550 Wakayama Medical University, School of Medicine Wakayama,Kimiidera,811-1, Wakayama, Japan, 641-8510 Yamagata Prefectural Central Hospital Yamagata,Aoyagi,1800, Yamagata, Japan, 990-2292 Less <<
NCT03557164 - Recruiting July 1, 2018 United Kingdom ... More >> Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom, G12 0YN Contact: Alan Cameron, MBChB    04143302418    alan.cameron2@glasgow.ac.uk    Contact: Ninian Lang, MBChB PhD    0141 330 1985    ninian.lang@glasgow.ac.uk Less <<
NCT00295789 Uterine Cervical Neoplasms Phase 3 Completed - Japan ... More >> Aichi Cancer Center Hospital Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi, Japan, 464-8681 Nagoya Medical Center Nagoya,Naka-ku,Sannomaru,4-1-1, Aichi, Japan, 460-0001 National Hospital Organization Shikoku Cancer Center Matsuyama,Horinouchi,13, Ehime, Japan, 790-0007 Kyushu University Hospital Fukuoka,Higashi-ku,Maidashi,3-1-1, Fukuoka, Japan, 812-8582 National Kyushu Cancer Center Fukuoka,Minami-ku,Notame,3-1-1, Fukuoka, Japan, 811-1395 Kurume University School of Medicine Kurume, Asahi-machi, 67, Fukuoka, Japan, 830-0011 Gunma Prefectural Cancer Center Ota,Takabayashi-nishi-cho,617-1, Gunma, Japan, 373-8550 National Hospital Organization Kure Medical Center Chugoku Cancer Center Kure,Aoyama-cho,3-1, Hiroshima, Japan, 737-0023 Hokkaido University Hospital North-14 West-5 Kita-ku,Sapporo, Hokkaido, Japan, 060-8648 Sapporo Medical University S-1,W-16,Chuo-ku,Sapporo, Hokkaido, Japan, 060-8543 Hyogo Medical Center for Adults Akashi,Kitaouji-cho,13-70, Hyogo, Japan, 673-8558 Institute of Clinical Medicine,Tsukuba University Hospital Tsukuba,Tennodai,1-1-1, Ibaraki, Japan, 305-8575 Kagoshima City Hospital Kagoshima,Kajiya-cho,20-17, Kagoshima, Japan, 892-8580 Tohoku University Hospital Sendai,Aoba-ku,Seiryo-machi,1-1, Miyagi, Japan, 980-8574 Sinshu University Matsumoto,Asahi,3-1-1, Nagano, Japan, 390-8621 Nagaoka Red Cross Hospital Nagaoka,Terashima-cho,297-1, Niigata, Japan, 940-2085 Niigata Cancer Center Hospital Niigata,Kawagishi-cho,2-15-3, Niigata, Japan, 951-8566 Osaka Medical Center for Cancer and Cardiovascular Diseases Osaka,Higashinari-ku,Nakamichi,1-3-3, Osaka, Japan, 537-8511 Osaka City General Hospital Osaka,Miyakojima-ku,Miyakojimahondori,2-13-22, Osaka, Japan, 534-0021 Kinki University School of Medicine Osaka-Sayama,Ohno-higashi,377-2, Osaka, Japan, 589-8511 Faculty of Medicine, Saga University Saga,Nabeshima,5-1-1, Saga, Japan, 849-8501 Saitama Medical Center, Saitama Medical School Kawagoe,Komoda,1981, Saitama, Japan, 350-8550 Saitama Cancer Center Kita-adachi,Ina,Komuro,818, Saitama, Japan, 362-0806 National Defense Medical College Tokorozawa,Namiki,3-2, Saitama, Japan, 359-8513 Juntendo University School of Medicine Bunkyo-ku,Hongo,3-1-3, Tokyo, Japan, 113-0033 The University of Tokyo Hospital Bunkyo-ku,Hongo,7-3-1, Tokyo, Japan, 113-8655 National Cancer Center Hospital Chuo-ku,Tsukiji,5-1-1, Tokyo, Japan, 104-0045 Cancer Institute Hospital Koto-ku,Ariake,3-10-6, Tokyo, Japan, 135-8550 Jikei University Hospital Minato-ku,Nishishinbashi,3-25-8, Tokyo, Japan, 105-8461 Tottori University School of Medicine Yonago,Nishimachi,36-1, Tottori, Japan, 683-8504 Less <<
NCT00005996 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Unknown - -
NCT01494558 Non-Small Cell Lung Cancer Phase 2 Phase 3 Completed - -
NCT00733889 Esophageal Carcinoma Phase 2 Completed - Spain ... More >> Spanish Cooperative Group for Gastrointestinal Tumour Therapy Madrid, Spain, 28046 Less <<
NCT02923258 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Phase 3 Recruiting December 2022 China, Shanghai ... More >> Shanghai ninth people's hospital Recruiting Shanghai, Shanghai, China, 200011 Contact: Guopei Zhu, M.D. Less <<
NCT00062439 - Completed - -
NCT02604784 Peritoneal Carcinomatosis Phase 1 Phase 2 Recruiting October 2018 Italy ... More >> Department of Surgical Oncology - FPO-IRCCS Institute for Cancer Research and Treatment Recruiting Candiolo, Turin, Italy, 10060 Contact: Michele De Simone, MD    011993 ext 3673    michele.desimone@ircc.it    Contact: Marco Vaira, MD    011993 ext 3683    marco.vaira@ircc.it    Principal Investigator: Michele De Simone, MD          Sub-Investigator: Marco Vaira, MD          Sub-Investigator: Manuela Robella, MD Less <<
NCT00716976 - Completed - -
NCT00003580 Drug/Agent Toxicity by Tissue/... More >>Organ Head and Neck Cancer Oral Complications Radiation Toxicity Less << Phase 2 Completed - United States, Tennessee ... More >> William F. Bowld Hospital Memphis, Tennessee, United States, 38103 Less <<
NCT00490880 Bladder Cancer Phase 2 Completed - Poland ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland Less <<
NCT00620971 Non Small Cell Lung Cancer Phase 2 Completed - Greece ... More >> University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece "Metaxa's" Anticancer Hospital of Piraeus,1st Dep of Medical Oncology Athens, Greece 401 Military Hospital, Medical Oncology Unit Athens, Greece Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece Sismanogleio General Hospital, 1st, 2nd Dep of Pulmonary Diseases Athens, Greece Sotiria" General Hospital, 1st, 3rd, 8th Dep of Pulmonary Diseases Athens, Greece "Theagenion" Anticancer Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT00062439 Lung Cancer Phase 2 Completed - -
NCT00492505 Melanoma (Skin) Phase 2 Unknown - United States, California ... More >> San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas Recruiting Encinitas, California, United States, 92024 Contact: Edward F. McClay, MD    760-452-3340    emcclay@pacificoncology.com Less <<
NCT00006000 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Ohio ... More >> Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210-1240 Less <<
NCT00054444 Cervical Adenocarcinoma ... More >> Cervical Squamous Cell Carcinoma Stage IB Cervical Cancer Stage IIA Cervical Cancer Stage IIB Cervical Cancer Stage III Cervical Cancer Stage IVA Cervical Cancer Less << Phase 1 Completed - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Missouri University of Missouri - Ellis Fischel Columbia, Missouri, United States, 65212 United States, New Jersey Cooper Hospital University Medical Center Camden, New Jersey, United States, 08103 United States, Ohio MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Riverside Methodist Hospital Columbus, Ohio, United States, 43214 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 Cancer Care Associates-Midtown Tulsa, Oklahoma, United States, 74104 Tulsa Cancer Institute Tulsa, Oklahoma, United States, 74146 Less <<
NCT00004264 Drug/Agent Toxicity by Tissue/... More >>Organ Lung Cancer Less << Phase 1 Phase 2 Unknown - United States, Wisconsin ... More >> University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT02976909 Esophageal Squamous Cell Carci... More >>noma Less << Phase 2 Recruiting December 2018 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Yu-hong Li, MD, Ph D       liyh@sysucc.org.cn    Principal Investigator: Yu-hong Li, MD, Ph D Less <<
NCT02633202 Nasopharyngeal Carcinoma Phase 3 Recruiting December 2021 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Lei Chen, M.D.    +86-20-87343096    chenlei@sysucc.org.cn Less <<
NCT01100801 Recurrent Gastric Cancer Phase 2 Unknown December 2018 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore Contact: Wei Peng Yong, MRCP, MB ChB    65 6772 4670    Wei_Peng_Yong@nuhs.edu.sg Less <<
NCT00057928 Cervical Cancer Phase 3 Withdrawn(lack of accrual) - -
NCT00458887 - Completed - -
NCT00054626 Bladder Cancer Phase 3 Unknown - -
NCT03532451 Bladder Cancer Phase 1 Recruiting September 2022 United States, Texas ... More >> University of TX Southwestern Recruiting Dallas, Texas, United States, 75390 Contact: Allison Beaver Beaver    214-645-8788    allison.beaver@utsouthwestern.edu    Contact: Darren Fleming    214-648-8310    darren.fleming@utsouthwestern.edu    Principal Investigator: Kevin Courtney, MD          United States, Virginia University of Virginia Recruiting Charlottesville, Virginia, United States, 22903 Contact: Jennifer Drake, RN    434-297-7782    jd4cx@virginia.edu    Contact: Stacey Williams    434-243-8588    scw6n@virginia.edu    Principal Investigator: Robert Dreicer, MD Less <<
NCT00098995 Cervical Cancer Phase 1 Completed - Australia, Victoria ... More >> Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 8006 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00726986 Lung Cancer Phase 2 Terminated(Extreme toxicity) - United States, New York ... More >> Columbia Presbyterian New York, New York, United States, 10032 United States, Ohio Lake/University Ireland Cancer Center Cleveland, Ohio, United States, 44060 Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 MetroHealth Medical Center Cleveland, Ohio, United States, 44109 CCF-Fairview Hospital Cleveland, Ohio, United States, 44111 UHHS Chagrin Highlands Medical Center Cleveland, Ohio, United States, 44122 Southwest General Health Center Cleveland, Ohio, United States, 44130 UHHS Westlake Medical Center Cleveland, Ohio, United States, 44145 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 UH-Monarch Mayfield Heights, Ohio, United States, 44124 UH-Firelands Sandusky, Ohio, United States, 44870 Less <<
NCT00004189 Lymphoma Smal... More >>l Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Texas ... More >> University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78229-3900 Cancer Therapy and Research Center San Antonio, Texas, United States, 78229 St. Luke's Lutheran Hospital San Antonio, Texas, United States, 78229 Less <<
NCT01461746 Endometrial Cancer Phase 2 Recruiting December 2017 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Joo-Hyun Nam, M.D., Ph.D.    +82-2-3010-3633    jhnam@amc.seoul.kr    Contact: Jeong-Yeol Park, M.D., Ph.D.    +82-2-3010-3646    obgyjypark@amc.seoul.kr Less <<
NCT00726986 - Terminated(Extreme toxicity) - -
NCT00131586 - Terminated - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT00229723 Neoplasms, Squamous Cell Phase 2 Completed - United States, Colorado ... More >> Research Site Aurora, Colorado, United States United States, Texas Research Site Dallas, Texas, United States Belgium Research Site Brussels, Belgium Research Site Gent, Belgium Research Site Leuven, Belgium Czech Republic Research Site Hradec Kralove, Czech Republic Research Site Pardubice, Czech Republic Research Site Plzen, Czech Republic Germany Research Site Berlin, Germany Research Site Essen, Germany Research Site Muenster, Germany Research Site Saarbrucken, Germany India Research Site Bangalore, India Research Site Mumbai, India Research Site New Delhi, India Research Site Thiruvananthapuram, India Poland Research Site Gliwice, Poland Research Site Kraków, Poland Research Site Lodz, Poland Research Site Lublin, Poland Research Site Warszawa, Poland Serbia Research Site Belgrade, Serbia Research Site Sremska Kamenica, Serbia Taiwan Research Site Taipei, Taiwan Research Site Taoynan, Taiwan Less <<
NCT01503385 Lung Cancer Phase 2 Unknown December 2016 China, Beijing ... More >> Cancer Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Liang Jun, Doctor    +861087788503    lj139117@yahoo.com.cn    Contact: Wang luhua, Doctor    +861087788799    wlhwq@yahoo.com    Sub-Investigator: Chen Bo, Doctor          Jun Liang Recruiting Beijing, Beijing, China, 100021 Contact: Jun Liang, Doctor    8610-87788503    lj139117@yahoo.com.cn Less <<
NCT00017459 Lung Cancer Phase 3 Completed - -
NCT00005814 Head and Neck Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00090909 Lymphoma Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1678 Less <<
NCT00489944 Intraocular Melanoma Phase 2 Unknown - United States, California ... More >> San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas Recruiting Encinitas, California, United States, 92024 Contact: Edward F. McClay, MD    760-452-3340    emcclay@pacificoncology.com Less <<
NCT01077427 Resected Pancreatic Adenocarci... More >>noma Less << Phase 3 Recruiting March 2021 Germany ... More >> Klinikum Grosshadern, Medical Center, University of Munich Recruiting Munich, Bavaria, Germany, 81377 Contact: Rolf D. Issels, MD, PhD    +49-89-4400-77776    heat@med.uni-muenchen.de    Principal Investigator: Rolf D. Issels, MD, PhD Less <<
NCT01735409 Nasopharyngeal Neoplasms Phase 1 Phase 2 Unknown June 2014 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT00246974 Bladder Cancer Phase 2 Completed - Germany ... More >> Research Site Aachen, Germany Research Site Augsburg, Germany Research Site Berlin, Germany Research Site Dresden, Germany Research Site Freiburg, Germany Research Site Halle/ Saale, Germany Research Site Hamburg, Germany Research Site Hannover, Germany Research Site Kassel, Germany Research Site Mainz, Germany Research Site Mannheim, Germany Research Site Münster, Germany Research Site Tübingen, Germany Research Site Ulm, Germany Less <<
NCT00229723 - Completed - -
NCT01889303 Gastric Cancer Phase 2 Recruiting December 2019 China, Hubei ... More >> Zhongnan Hospital of Wuhan University Recruiting Wuhan, Hubei, China, 430071 Contact: F X Zhou, PHD    86-27-67813155    happyzhoufx@sina.com    Contact: Y F Zhou, PHD    86-27-67823096    yfzhouwhu@163.com Less <<
NCT00077311 Anemia Drug/A... More >>gent Toxicity by Tissue/Organ Lung Cancer Neutropenia Less << Phase 2 Completed - -
NCT01620242 Recurrent Head and Neck Cancer... More >> Metastatic Head and Neck Cancer Less << Phase 2 Completed - France ... More >> Centre Oscar Lambret Lille, France, 59020 Centre Léon Berard Lyon, France, 69008 Centre Antoine Lacassagne Nice, France, 06189 Institut Curie Paris, France, 75231 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT03413579 Cervical Cancer Phase 3 Recruiting December 2019 Algeria ... More >> Centre Pierre et Marie Curie (CPMC) Recruiting Algiers, Algeria Contact: Esma KERBOUA          Principal Investigator: Esma KERBOUA, Prof.          CAC Annaba Recruiting Annaba, Algeria Contact: Ibtissem BOULOUH          Principal Investigator: Ibtissem BOULOUH          CAC Batna Recruiting Batna, Algeria Contact: Wassila BENBRAHIM, Prof.          Principal Investigator: Wassila BENBRAHIM          CHU Frantz Fanon Recruiting Blida, Algeria Contact: Adda BOUNEDJAR, Prof.          Principal Investigator: Adda BOUNEDJAR, Prof          CHU Sidi Belloua Active, not recruiting Tizi Ouzou, Algeria Less <<
NCT03127774 Adrenocortical Carcinoma ... More >> Peritoneal Carcinomatosis Less << Phase 2 Recruiting May 2023 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032-3729 Contact: Michael Kluger, MD    212-305-6514    mk2462@cumc.columbia.edu    Contact: Vilma Rosario    212-305-6033    vr2222@cumc.columbia.edu    Principal Investigator: Michael Kluger, MD          Sub-Investigator: Antonio T Fojo, MD Less <<
NCT01445392 Mesothelioma Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00651833 Advanced Non-Small Cell Lung C... More >>ancer Less << Phase 2 Completed - -
NCT01025089 Thymoma Thymi... More >>c Carcinoma Clinical Masaoka Stage II to IVA Less << Phase 2 Active, not recruiting December 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 United States, New Jersey Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 United States, Texas Md Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00583674 Gastrointestinal Cancer Phase 2 Completed - -
NCT03298893 Cervical Cancer ... More >> Locally Advanced Cervical Cancer Less << Phase 1 Phase 2 Recruiting April 2020 France ... More >> Institut Curie Recruiting Paris, France, 75005 Contact: Manuel Rodrigues, MD       manuel.rodrigues@curie.fr    Hopital Européen Georges Pompidou Active, not recruiting Paris, France, 75015 Institut Curie Hopital René Huguenin Recruiting Saint Cloud, France, 9220 Contact: Coraline Dubot, MD       coraline.dubot@curie.fr Less <<
NCT03067792 Inoperable Gastric Cancer Phase 3 Completed - -
NCT02657460 Malignant Pleural Effusion Phase 2 Recruiting December 2018 China, Hubei ... More >> Union Hospital, Tongji Medical College, Huazhong University of Science & Technology Recruiting Wuhan, Hubei, China, 430022 Contact: Yang Jin, doctor    +86 13554361146    whuhjy@sina.com Less <<
NCT00276796 Cervical Cancer Phase 2 Completed - -
NCT01057277 Head and Neck Cancer Phase 1 Terminated(Pharmaceutical co- ... More >>re aligned their specialties- no longer will fund H&N ca) Less << - United States, Rhode Island ... More >> Rhode Island Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT01057277 - Terminated(Pharmaceutical co- ... More >>re aligned their specialties- no longer will fund H&N ca) Less << - -
NCT00242762 Head and Neck Cancer Phase 2 Completed - Spain ... More >> Research Facility Granada, Spain Research Facility Madrid, Spain Research Facility Murcia, Spain Research Site Sevilla, Spain Less <<
NCT00926640 Carcinoma Neuroendocrine ... More >> Small Cell Lung Carcinoma Malignant Epithelial Neoplasms Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01177956 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 3 Completed - China ... More >> Cancer Institute & Hospital, Chinese Academy of Medical Sciences Beijing, China Jilin Cancer Hospital Changchun, China The Xiangya 2nd Hospital of Central South University Changsha City, China Fuijan Provincial Tumor Hospital Fuijian, China Nanfang Hospital of Nanfang Medical University Guangzhou, China Sun Yat-Sen Univesity Cancer Center Guangzhou, China Zhejiang Provincial Tumor Hospital Hangzhou, China Jiangsu Cancer Hospital Jiangsu, Nanjing, China Tumor Hospital of Guangxi Zhuang Autonomous Region / The Tumor Affiliated Hospital of Guangxi Medical University Nanning City, China Eye & ENT Hospital of Fundan University Shanghai, China Fundan University Shanghai Cancer Center Shanghai, China Tongji Hospital of Tongji Medical College of Huazhong University of Science & Technology Wuhan City, China Xijing Hospital, the Fourth Military Medical University Xi'an, China Korea, Republic of Clinical Trial Center of Medical Research Institute, Pusan National University Hospital Busan, Korea, Republic of Less <<
NCT00004884 Pancreatic Cancer Phase 2 Completed - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 Hopital Universitaire Erasme Brussels, Belgium, 1070 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Egypt National Cancer Institute of Egypt Cairo, Egypt France CHU Ambroise Pare Boulogne Billancourt, France, F-92104 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Germany Klinikum St. Marien Amberg, Germany, D-92224 Universitaetsklinik und Strahlenklinik - Essen Essen, Germany, D-45122 Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 Marien Hospital Hagen, Germany, 58095 Hermann-Holthusen Institute for Radiotherapy Hamburg, Germany, D-20099 Medizinische Hochschule Hannover Hannover, Germany, D-30625 Praxis Innere Medizin Neustadt, Germany, D-01844 Klinikum der Universitaet Ulm Ulm, Germany, D-89081 Netherlands Saint Laurentius Ziekenhuis Roermond, Netherlands, 6043 CV Poland Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Warsaw, Poland, 02-781 Turkey Dokuz Eylul University School of Medicine Izmir, Turkey, 35340 United Kingdom Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT00582205 Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Carcinoma Uterine Cancer Less << Phase 2 Terminated(Study completed per... More >> investigator.) Less << - United States, Oklahoma ... More >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT00582205 - Terminated(Study completed per... More >> investigator.) Less << - -
NCT01687413 Oropharyngeal Neoplasms Phase 3 Active, not recruiting August 9, 2021 United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00304135 Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Liver Cancer Less << Phase 2 Phase 3 Completed - France ... More >> Centre Hospitalier General Belfort, France, 90000 Centre Hospitalier Pierre Oudot Bourgoin-Jallieu, France, 38300 Hopital Louis Pasteur Colmar, France, 68024 Centre Hospitalier de Dax Dax, France, 40100 Hopital Du Bocage Dijon, France, 21034 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Hospitalier Departemental La Roche Sur Yon, France, F-85025 C. H. Du Mans Le Mans, France, 72037 CHU de la Timone Marseille, France, 13385 Centre Hospitalier General de Mont de Marsan Mont-de-Marsan, France, 40000 CHR D'Orleans - Hopital de la Source Orleans, France, 45100 Hopital Bichat - Claude Bernard Paris, France, 75018 CHU Pitie-Salpetriere Paris, France, 75651 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Hopital Sebastopol, C.H.U. de Reims Reims, France, 51092 Centre Eugene Marquis Rennes, France, 35062 Hopital Charles Nicolle Rouen, France, 76031 Centre Hospitalier de Semur en Auxois Semur en Auxois, France, 21140 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Centre Hospitalier de Tarbes Tarbes, France, 65013 Less <<
NCT01927744 Head and Neck Cancer Phase 2 Active, not recruiting December 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00632853 Lung Cancer Phase 3 Recruiting - -
NCT00659113 Esophageal Cancer Phase 2 Unknown - Korea, Republic of ... More >> Yonsei Cancer Center at Yonsei University Medical Center Recruiting Seoul, Korea, Republic of, 120-752 Contact: Joo-Hang Kim, MD    82-2-2228-8131    kjhang@yuhs.ac Less <<
NCT01099358 Solid Tumor Phase 2 Completed - United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Kansas University of Kansas Medical Center Fairway, Kansas, United States, 66205 United States, Nevada VA Sierra Nevada Health Care System Reno, Nevada, United States, 89502 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Texas University of Texas Health Science Center - San Antonio San Antonio, Texas, United States, 78229 Canada For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. London, Canada, N6A 4L6 For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Toronto, Canada, M5G 2M9 Less <<
NCT01177956 - Completed - -
NCT00273546 Cancer Phase 3 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Argentina Sanofi-Aventis Administrative Office Buenos Aires, Argentina Canada Sanofi-Aventis Administrative Office Laval, Canada France Sanofi-Aventis Administrative Office Paris, France Portugal Sanofi-Aventis Administrative Office Porto Salvo, Portugal Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Less <<
NCT02263105 High-grade Gliomas Phase 2 Completed - China, Shanghai ... More >> Huashan Hospital Shanghai, Shanghai, China, 200040 Less <<
NCT00112710 Lung Cancer Phase 3 Unknown - United Kingdom ... More >> Institute of Clinical Research - Birmingham Recruiting Birmingham, England, United Kingdom, B15 2TT Contact: Hugh Jarrett    44-121-414-6425       Birmingham Heartlands Hospital Recruiting Birmingham, England, United Kingdom, B9 5SS Contact: Joyce Thompson    44-121-766-6611 Less <<
NCT00995293 Head and Neck Neoplasms Phase 3 Completed - China ... More >> Sanofi Administrative Office Shanghai, China Less <<
NCT00696007 Transitional Cell Carcinoma Phase 2 Withdrawn(Study was unable to ... More >>recruit subjects meeting the study requirements.) Less << - United States, Massachusetts ... More >> Lahey Clinic, Inc. Burlington, Massachusetts, United States, 01805 Less <<
NCT00268450 - Terminated - -
NCT02518802 Lung Neoplasms Phase 3 Recruiting January 2020 China, Shaanxi ... More >> Tangdu Hospital of the Fourth Millitary Medical University Recruiting Xi'an, Shaanxi, China, 710038 Contact: Li Xiaofei, MD    +8629,84777436    lxfchest@fmmu.edu.cn    Contact: Yan Xiaolong, MD    +862984717558    yanxiaolong@fmmu.edu.cn Less <<
NCT00268450 Bladder Cancer Phase 2 Terminated - United States, South Carolina ... More >> Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 McLeod Regional Medical Center Florence, South Carolina, United States, 29501 Lowcountry Hematology and Oncology, PA Mount Pleasant, South Carolina, United States, 29464-3233 Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 Less <<
NCT00003358 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00502177 - Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00491127 Non-Hodgkin's Lymphoma Phase 2 Completed - Spain ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain Less <<
NCT02804646 Adenocarcinoma of Lung Phase 4 Unknown December 2018 China, Anhui ... More >> Anhui provincial hospital Recruiting Hefei, Anhui, China, 230000 Contact: Lejie Cao, prefessor       sycaolejie@163.com    Contact: Nana Hu       493305821@qq.com Less <<
NCT03415854 Pancreatic Cancer ... More >> Pancreatic Ductal Adenocarcinoma Pancreatic Adenocarcinoma Pancreas Metastases Adenocarcinoma Less << Phase 2 Recruiting December 15, 2020 United States, Arizona ... More >> HonorHealth Research Institute Recruiting Scottsdale, Arizona, United States, 85258 Contact: Joyce Schaffer, MSN, AOCNS    480-323-1339 ext option #2    Joyce.Schaffer@HonorHealth.com    Principal Investigator: Erkut Borazanci, MD Less <<
NCT01099358 - Completed - -
NCT00087711 Non Small Cell Lung Carcinoma Phase 3 Completed - -
NCT00079079 Head and Neck Cancer Phase 2 Completed - Canada, Manitoba ... More >> CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Ontario London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada, N6A 4L6 Ottawa Hospital Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01711658 Non-HPV Locally Advanced Head ... More >>and Neck Cancer Less << Phase 2 Active, not recruiting March 31, 2023 United States, Alabama ... More >> University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, California University of California, San Diego La Jolla, California, United States, 92093 Sutter General Hospital Sacramento, California, United States, 95816 University of California San Francisco San Francisco, California, United States, 94143 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Georgia Emory University Atlanta, Georgia, United States, 30308 United States, Kentucky James Graham Brown Cancer Center at University of Louisville Louisville, Kentucky, United States, 40202 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73190 United States, Pennsylvania Fox Chase Cancer Center Buckingham Furlong, Pennsylvania, United States, 18925 United States, Texas University of Texas Southwestern Medical School Dallas, Texas, United States, 75390 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Quebec McGill Cancer Centre at McGill University Montreal, Quebec, Canada, H2W 1S6 Less <<
NCT00072527 Lung Cancer Phase 2 Completed - -
NCT01839032 Lung Cancer Phase 2 Completed - France ... More >> CHU CAEN Caen, France, 14033 Less <<
NCT00160030 Esophageal Neoplasms Phase 2 Completed - France ... More >> Sanofi-Aventis Paris, France Less <<
NCT01616849 Stage IV Nasopharyngeal Carcin... More >>oma Less << Phase 2 Completed - China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China Less <<
NCT00875615 Liver Cancer Phase 2 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00875615 - Completed - -
NCT00215501 Solid Tumor Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02940925 Nasopharyngeal Carcinoma Phase 3 Recruiting August 2024 China, Guangdong ... More >> SunYat-senU Recruiting Guangzhou, Guangdong, China, 510060 Contact: Yanqun Xiang, MD    +86-18666096623    xiangyq@sysucc.org.cn    Contact: Weixiong Xia, MD    +86-18520415699    xiawx@sysucc.org.cn Less <<
NCT03769935 Progression Free Survival Phase 2 Recruiting July 1, 2020 China, Shandong ... More >> Qingdao Central Hospital, Qingdao Cancer Hospital Recruiting Qingdao, Shandong, China, 266042 Contact: youxin ji, M.D.    8653268665078    mdji001@gmail.com    Principal Investigator: ketao lan, M.D.          Sub-Investigator: chunling zhang, M.D.          Sub-Investigator: youxin ji, M.D. Less <<
NCT01705184 Non-small Cell Lung Cancer Met... More >>astatic Nonsquamous Nonsmall Cell Neoplasm of Lung Less << Phase 2 Completed - France ... More >> Avignon - Institut Sainte-Catherine Avignon, France, 84918 Caen - Centre François Baclesse Caen, France, 14000 Caen - CHU Côte de Nacre Caen, France, 14000 Centre Hospitalier Chauny, France CH du Mans Le Mans, France Hôpital Nord - Oncologie Multidisciplinaire & Innovations Thérapeutiques Marseille, France Mulhouse - CH Mulhouse, France, 68000 Nantes - Centre René Gauducheau Nantes, France, 44805 Hopital Tenon - Pneumologie Paris, France, 75020 HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Rennes - CHU Rennes, France, 35033 Strasbourg - NHC Strasbourg, France, 63000 Less <<
NCT02107235 Head and Neck Neoplasms ... More >> Carcinoma, Squamous Cell Less << Phase 1 Completed - United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 United States, Delaware Christiana Care Health Services Newark, Delaware, United States, 19713 United States, New York Montefiore Medical Center The Bronx, New York, United States, 10467 United States, Ohio The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00191308 Non-Small Cell Lung Cancer ... More >> Carcinoma Less << Phase 2 Completed - Poland ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bystra Slaska, Poland, 43-360 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 60-569 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland, 02-781 Less <<
NCT00695032 Chemotherapeutic Agent Toxicit... More >>y Renal Toxicity Unspecified Adult Solid Tumor, Protocol Specific Less << Not Applicable Suspended - France ... More >> Institut Claudius Regaud Toulouse, France, 31052 Less <<
NCT00556621 Bladder Cancer Phase 1 Phase 2 Completed - France ... More >> Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Less <<
NCT01912053 Cholangiocarcinoma Phase 2 Completed - France ... More >> Hôpital Beaujon - Service de Chirurgie Clichy, France, 92118 Hôpital Henri Mondor Créteil, France, 94010 Hôpital saint-Eloi Montpellier, France, 34295 CHU Nancy - Hôpital Brabois Nancy, France, 54000 CHU- Hotel Dieu Nantes, France, 44093 CHU Poitiers Poitiers, France Centre Eugene Marquis Rennes, France, 35042 Less <<
NCT00648648 Solid Tumors Phase 1 Completed - -
NCT01108042 Oropharynx Cancer ... More >> Squamous Cell Carcinoma of the Oral Cavity Less << Phase 1 Phase 2 Completed - Germany ... More >> Städt. Kliniken Bielefeld gem. GmbH Bielefeld, Germany, 33604 Friedrich-Schiller-University Jena Jena, Germany, 07740 Universitätsklinikum Leipzig - Klinik und Poliklinik für HNO-Heilkunde Leipzig, Germany, 04103 Klinikum Ernst von Bergmann Potsdam, Germany, 14467 Less <<
NCT01296763 - Completed - -
NCT01296763 Pancreatic Cancer Phase 1 Completed - United States, Maryland ... More >> The Johns Hopkins University School of Medicine Baltimore, Maryland, United States, 21231 United States, New York Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00271323 Non-Small-Cell Lung Carcinoma Phase 2 Terminated - France ... More >> Sanofi-Aventis Paris, France Less <<
NCT00191308 - Completed - -
NCT00555672 Stomach Neoplasms Phase 1 Completed - Spain ... More >> Pfizer Investigational Site L'hospitalet de Llobregat, Barcelona, Spain, 08907 Pfizer Investigational Site Barcelona, Spain, 08003 Pfizer Investigational Site Madrid, Spain, 28041 Less <<
NCT00005088 Head and Neck Cancer Phase 2 Completed - -
NCT00625664 Urinary Bladder Neoplasms Phase 3 Completed - -
NCT01810913 Stage III Squamous Cell Carcin... More >>oma of the Hypopharynx Stage III Squamous Cell Carcinoma of the Larynx Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Stage III Squamous Cell Carcinoma of the Oropharynx Stage III Verrucous Carcinoma of the Larynx Stage III Verrucous Carcinoma of the Oral Cavity Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Verrucous Carcinoma of the Larynx Stage IVA Verrucous Carcinoma of the Oral Cavity Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Verrucous Carcinoma of the Larynx Stage IVB Verrucous Carcinoma of the Oral Cavity Tongue Cancer Less << Phase 2 Phase 3 Active, not recruiting May 2025 -
NCT03503136 Nasopharyngeal Carcinoma Phase 3 Not yet recruiting June 2026 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT03527264 Cervical Cancer Phase 2 Not yet recruiting December 2023 United States, Rhode Island ... More >> Rhode Island Hospital Not yet recruiting Providence, Rhode Island, United States, 02903 Contact: Kayla Rosati    401-863-3000    kayla_rosati@brown.edu    Principal Investigator: Don Dizon, MD          Women and Infants Hospital Not yet recruiting Providence, Rhode Island, United States, 02905 Contact: Kayla Rosati    401-863-3000    kayla_rosati@brown.edu Less <<
NCT00452881 Lung Cancer Phase 2 Unknown December 2014 Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of, 411-769 Less <<
NCT00614965 Non Small Cell Lung Cancer Phase 2 Completed - Greece ... More >> Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece Less <<
NCT00091377 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 1 Phase 2 Completed - United States, Connecticut ... More >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520-8028 Australia, Victoria Royal Women's Hospital Carlton, Victoria, Australia, 3053 Less <<
NCT00002659 Head and Neck Cancer Phase 3 Unknown - -
NCT00655876 Esophageal Cancer Phase 3 Active, not recruiting April 2020 -
NCT00555672 - Completed - -
NCT01461772 Cervical Cancer Phase 3 Terminated(Because of very slo... More >>w rate of enrollement) Less << - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT01910844 Metastatic Breast Cancer Phase 2 Terminated(Because of difficul... More >>ties in recruting) Less << - France ... More >> Centre Jean Perrin Clermont-Ferrand, France, 63011 Less <<
NCT00768755 Carcinoma, Non-Small Cell Lung Phase 1 Phase 2 Completed - -
NCT00939848 Biliary Tract Neoplasms Phase 2 Phase 3 Completed - United Kingdom ... More >> University College London Hospitals NHS Foundation Trust London, United Kingdom, NW1 2PQ The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Less <<
NCT00756444 Squamous Cell Carcinoma of Hea... More >>d and Neck Less << Phase 2 Completed - -
NCT01762150 Renal Cell Carcinoma Phase 2 Completed - China, Beijing ... More >> Beijing Cancer Hospital Beijing, Beijing, China, 100142 China, Guangdong Sun Yat-sen university cancer center Guangzhou, Guangdong, China, 510060 China, Liaoning Shenyang general hospital of Shenyang military command Shenyang, Liaoning, China, 110016 China, Shanxi Xijing Hospital Xi'an, Shanxi, China, 710032 China, Sichuan West China Hospital Chengdu, Sichuan, China, 610041 Less <<
NCT00360945 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Ireland Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Middlesex Hospital London, England, United Kingdom, W1T 3AA Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton University Hospital NHS Trust Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00068744 Anal Cancer Phase 2 Phase 3 Terminated(low accrual) - Belgium ... More >> Ziekenhuis Netwerk Antwerpen Middelheim Antwerpen, Belgium, B-2020 Institut Jules Bordet Brussels, Belgium, 1000 Centre Hospitalier Lyon Sud Brussels, Belgium, 1200 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Cazk Groeninghe - Campus Maria's Voorzienigheid Kortrijk, Belgium, B-8500 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Algemeen Ziekenhuis Sint-Augustinus Wilrijk, Belgium, 2610 Egypt National Cancer Institute of Egypt Cairo, Egypt France Institut Sainte Catherine Avignon, France, 84082 Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besancon, France, 25030 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Germany Urologische Klinik - Universitaetsklinikum Aachen Aachen, Germany, D-52074 Charite - Campus Charite Mitte Berlin, Germany, D-10117 Robert Roessle Comprehensive Cancer Center - Charite Campus Buch Berlin, Germany, D-13122 Universitaetsklinikum Essen Essen, Germany, D-45122 Universitaetsklinikum Halle Halle, Germany, D-06097 Onkologische Schwerpunktpraxis - Leer Leer, Germany, D-26789 Universitaetsklinikum Tuebingen Tuebingen, Germany, D-72076 Italy Ospedale Sant Anna Como, Italy, 22100 Ospedale Busonera - Divisione Oncologia Medica Padova, Italy, 35128 Netherlands Arnhems Radiotherapeutisch Instituut Arnhem, Netherlands, 6815 AD Dr. Bernard Verbeeten Instituut Tilburg, Netherlands, 5042 SB Serbia Institute of Oncology and Radiology of Serbia Belgrade, Serbia, 11000 Less <<
NCT00655876 - Active, not recruiting - -
NCT03534804 Metastatic Urothelial Carcinom... More >>a Bladder Cancer Less << Phase 2 Recruiting September 2023 United States, Utah ... More >> Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Jill Broghammer    801-213-6232    jill.broghammer@hci.utah.edu    Principal Investigator: Neeraj Agarwal, MD Less <<
NCT02555644 Head and Neck Neoplasms Phase 1 Recruiting February 28, 2019 United States, Alabama ... More >> University of Alabama at Birmingham Medical Center Recruiting Birmingham, Alabama, United States, 35249 Contact    205-934-2762       Principal Investigator: Eddy Yang          United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact    713-792-6363       Principal Investigator: Mehmet Altan          France Centre Leon Berard Recruiting Lyon, France, 69008 Contact    33478785103       Principal Investigator: Jérôme Fayette          Gustave Roussy Recruiting Villejuif Cedex, France, 94805 Contact    33142114931       Principal Investigator: Eric Deutsch Less <<
NCT00002876 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic Jacksonville Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00768755 - Completed - -
NCT02236936 Squamous Cell Carcinoma of the... More >> Hypopharynx Stage III Squamous Cell Carcinoma of the Hypopharynx Stage IV Laryngeal Squamous Cell Carcinoma Stage III Laryngeal Squamous Cell Carcinoma Stage IV Oropharyngeal Squamous Cell Carcinoma Stage III Oropharyngeal Squamous Cell Carcinoma Stage IV Squamous Cell Carcinoma of the Oral Cavity Stage III Squamous Cell Carcinoma of the Oral Cavity Stage IV Locally Advanced Malignant Neoplasm Less << Phase 3 Recruiting September 2021 Austria ... More >> Landeskrankenhaus Feldkirch Recruiting Feldkirch, Austria, A-6807 Contact: Alexander De Vries, Univ.Doz. MD    +43 5522303 ext 3300    alexander.devries@lkhf.at    Principal Investigator: Alexander De Vries, Univ.Doz. MD          Medizinische Universität Graz, HNO Universitätsklinik Recruiting Graz, Austria, A-8036 Contact: Dietmar Thurnher, Prof.,MD    +43 316 3851 ext 3448    dietmar.thurnher@medunigraz.at    Contact: Sabine Reinisch, MD, Senior    +43 316 3851 ext 3448    sabine.reinisch@medunigraz.at    Principal Investigator: Dietmar Thurnher, Prof.,MD          Klinikum Klagenfurt am Wörthersee, HNO-Abteilung Recruiting Klagenfurt am Wörthersee, Austria, A-9020 Contact: Thomas J. Primosch, MD    +43 463 538 ext 27107    thomasprimosch@gmx.at    Principal Investigator: Thomas J. Primosch, MD          Ordensklinikum Linz - Barmherzigen Schwestern, Abteilung f. HNO, Kopf- und Halschirurgie Recruiting Linz, Austria, 4010 Contact: Magdalena Sturm, DI    +43 7327677 ext 7521    magdalena.sturm@ordensklinikum.at    Contact: Martin Burian, Prof.Dr.    +43 7327677 ext 4828    martin.burian@ordenskliniku.at    Principal Investigator: Martin Burian, Prof.Dr.          Hanuschkrankenhaus Not yet recruiting Vienna, Austria, 1140 Contact: Barbara Dixer, MSc    +43 1 91021 ext 85435    barbara.dixer@wgkk.at    Contact: Kathrin Holzer, Mag.    +43 1 91021 ext 85435    kathrin.holzer@wgkk.at    Principal Investigator: Adelheid Seebacher, Dr.          Landesklinikum Wiener Neustadt Not yet recruiting Wiener Neustadt, Austria, 2700 Contact: Laurenz N. Kopf    +43 2622 9004 ext 73778    laurenznathanael.kopf@wienerneustadt.lknoe.at    Principal Investigator: Johannes Reiß-Kornfehl, Prof.Dr.          Krankenhaus Hietzing, Sonderabteilung f. Strahlentheapie Not yet recruiting Wien, Austria, 1130 Contact: Gerhard Kren, MD    +43 1 801 10 ext 2331    gerhard.kren@wienkav.at    Principal Investigator: Tomas-Hendrik Knocke-Abulesz, Prof.Dr. Less <<
NCT00933387 Oral Cancer Phase 2 Completed - Taiwan ... More >> National Health Research of Institutes, Taiwan Cooperative Oncology Group Tainan, Taiwan Less <<
NCT00756444 - Completed - -
NCT01234324 Stomach Neoplasms ... More >> Gastroesophageal Junction Neoplasms Less << Phase 2 Completed - Germany ... More >> AIO-Studien gGmbH Berlin, Germany, 10623 Less <<
NCT00259402 Esophageal Neoplasms Phase 2 Completed - Spain ... More >> Sanofi-Aventis Administrative Office Barcelona, Spain Less <<
NCT00635726 Bladder Cancer Phase 2 Terminated(Due to poor accrual... More >>) Less << - Greece ... More >> University General Hospital of Alexandroupolis, Dept. of Medical Oncology Alexandroupolis, Greece 401 Military Hospital, Medical Oncology Unit Athens, Greece Air Forces Military Hospital, Dept. of Medical Oncology Athens, Greece IASO General Hospital of Athens, 1st Dept. of Medical Oncology Athens, Greece Laikon General Hospital, Medical Oncology Unit, Propedeutic Dept. of Internal Medicine Athens, Greece Metaxa's Anticancer Hospital of Piraeus, 1st Dept. of Medical Oncology Piraeus, Greece Theagenion Anticancer Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT00005060 Gastric Cancer Phase 3 Completed - Italy ... More >> European Institute of Oncology Milan, Italy, 20141 Switzerland Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Zentrum fuer Tumordiagnostikund Praevention St. Gallen, Switzerland, CH-9006 Less <<
NCT00657423 Lung Neoplasms Phase 3 Unknown April 2009 China, Shaanxi ... More >> Dept. Resp. Diseases, Xijing Hospital Recruiting Xi'an, Shaanxi, China, 710032 Contact: Shengqing Li, MD. PHD.    086-029-84771132    shengqingli@gmail.com Less <<
NCT00401323 Head and Neck Neoplasms ... More >> Neoplasm Recurrence, Local Neoplasm Metastasis Less << Phase 2 Phase 3 Completed - -
NCT00072215 Extragonadal Germ Cell Tumor ... More >> Testicular Germ Cell Tumor Less << Phase 3 Terminated(poor accrual) - -
NCT00003263 Malignant Mesothelioma Phase 1 Completed - United States, Louisiana ... More >> Office of S. Terry Kraus Marrero, Louisiana, United States, 70072 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Virginia Virginia Oncology Associates Newport News, Virginia, United States, 23606 Less <<
NCT00453154 Extensive Stage Small Cell Lun... More >>g Carcinoma Recurrent Small Cell Lung Carcinoma Less << Phase 1 Phase 2 Active, not recruiting - -
NCT00103051 Lung Cancer Phase 2 Completed - Netherlands ... More >> Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands Less <<
NCT00003055 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00453154 - Active, not recruiting - -
NCT00144053 Lung Cancer Phase 3 Completed - -
NCT00370890 Nasopharyngeal Cancer Phase 3 Active, not recruiting December 2018 Hong Kong ... More >> Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital Hong Kong, Hong Kong Department of Clinical Oncology, Prince of Wales Hospital Hong Kong, Hong Kong Department of Clinical Oncology, Queen Elizabeth Hospital Hong Kong, Hong Kong Department of Clinical Oncology, Queen Mary Hospital Hong Kong, Hong Kong Department of Clinical Oncology, Tuen Mun Hospital Hong Kong, Hong Kong Department of Oncology, Princess Margaret Hospital Hong Kong, Hong Kong Less <<
NCT00255476 Squamous Cell Cancer ... More >> Cancer of Head and Neck Less << Phase 2 Completed - United Kingdom ... More >> Research Site London, United Kingdom Less <<
NCT01624051 Lung Cancer Phase 2 Unknown September 2015 Canada, Alberta ... More >> Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Principal Investigator: Michael B Sawyer, MD Less <<
NCT00738582 Malignant Pleural Mesothelioma Phase 2 Completed - -
NCT00154882 Breast Cancer Phase 2 Unknown July 2007 Taiwan ... More >> Department of Oncology , National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Yen-Shen Lu, M.D.    886-2-23123456 ext 7009    yslu@ha.mc.ntu.edu.tw    Sub-Investigator: Sung-Hsin Kuo, M.D.          Sub-Investigator: Chia-Chi Lin, M.D. Less <<
NCT03668639 Chemotherapy-induced Nausea an... More >>d Vomiting Adverse Event Cervical Cancer Less << Phase 2 Phase 3 Recruiting February 15, 2020 Denmark ... More >> Department of Oncology, Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Christina H. Ruhlmann, MD, PhD    22314446 ext +45    christina.ruhlmann@rsyd.dk    Contact: Annemieke Sibtsen, RN    29427758 ext +45    Annemieke.Sibtsen@rsyd.dk    Principal Investigator: Christina H. Ruhlmann, MD, PhD          Sub-Investigator: Anja Ør Knudsen, MD Less <<
NCT02776163 Salivary Gland Tumors ... More >> Head and Neck Cancer Less << Phase 2 Recruiting December 2020 China, Shanghai ... More >> Shanghai ninth people's hospital Recruiting Shanghai, Shanghai, China, 200011 Contact: Guopei Zhu, M.D. Less <<
NCT00004077 Testicular Germ Cell Tumor Phase 2 Completed - United Kingdom ... More >> Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Less <<
NCT01074697 Nausea Vomiti... More >>ng Genital Neoplasms, Female Less << Phase 3 Completed - Australia ... More >> RAH Cancer Centre, Royal Adelaide Hospital Adelaide SA, Australia, 5000 Denmark Department of Oncology Aarhus, Denmark, 8000 Rigshospitalet, Finsen Centret Copenhagen, Denmark, 2100 Herlev Hospital Herlev, Denmark, 2730 Department of Oncology, Odense University Hospital Odense, Denmark, 5000 Germany Vivantes Klinikum Neukolln Berlin, Germany Universitatsklinikum Schleswig Holstein Kiel, Germany, 24105 Norway The Norwegian Radium Hospital Oslo, Norway, 0310 Less <<
NCT02459457 Stage III Esophageal Squamous ... More >>Cell Carcinoma Less << Phase 3 Recruiting December 2021 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Kuaile Zhao, M.D    +86 18017312534    kuaile_z@sina.com Less <<
NCT03349710 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 3 Active, not recruiting November 10, 2022 -
NCT00003379 Cervical Cancer Phase 1 Phase 2 Completed - -
NCT01614132 Medulloblastoma Phase 1 Phase 2 Active, not recruiting March 2021 Germany ... More >> Vivantes Netzwerk für Gesundheit GmbH Berlin, Germany, 10249 Neurologische Universitätsklinik Bochum, Germany, 44892 Universitätsklinikum Bonn Bonn, Germany, 53105 Universitätsklinikum Freiburg Freiburg, Germany, 79106 Medizinische Hochschule Hannover Hannover, Germany, 30625 Universitätsklinikum Heidelberg Heidelberg, Germany, 69120 Universitätsklinikum Leipzig Leipzig, Germany, 04103 Universitätsklinikum Schleswig-Holstein Lübeck, Germany, 23538 Otto-von-Guericke Universität Magdeburg, Germany, 39120 Johannes Gutenberg-Universität Mainz Mainz, Germany, 55131 Universitätsklinikum Münster Münster, Germany, 48149 Universitätsklinikum Regensburg Regensburg, Germany, 93053 Katharinenhospital Stuttgart, Germany, 70174 Universitätsklinikum Tübingen Tübingen, Germany, 72076 Universitätsklinikum Ulm Ulm, Germany, 89081 Less <<
NCT00082862 Pancreatic Cancer Phase 2 Unknown - United States, Texas ... More >> University of Texas Health Science Center at Houston Recruiting Houston, Texas, United States, 77030 Contact: Clinical Trials Office - University of Texas Health Science Ce    713-500-9500 Less <<
NCT00389688 Lung Cancer Phase 2 Terminated(low accrual) - Belgium ... More >> Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Less <<
NCT00077051 Head and Neck Cancer Phase 1 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Less <<
NCT00955240 Anal Cancer Phase 2 Unknown - France ... More >> Institut Bergonie Bordeaux, France, 33076 CHU Hopital A. Morvan Brest, France, 29609 Centre Regional Francois Baclesse Caen, France, 14076 Centre Hospitalier Departemental La Roche Sur Yon, France, F-85025 Centre Oscar Lambret Lille, France, 59020 Centre Hospital Regional Universitaire de Limoges Limoges, France, 87042 Centre Leon Berard Lyon, France, 69373 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Institut Curie Hopital Paris, France, 75248 Hopital Saint-Louis Paris, France, 75475 Hopital Tenon Paris, France, 75970 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Hopital Charles Nicolle Rouen, France, 76031 Centre Hospitalier Prive Saint-Gregoire Saint-Gregoire, France, 35768 Clinique Du Parc Toulouse, France, 31078 Groupe Oncorad Garonne Toulouse, France, 31300 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00551122 Brain and Central Nervous Syst... More >>em Tumors Extragonadal Germ Cell Tumor Ovarian Cancer Testicular Germ Cell Tumor Less << Phase 1 Phase 2 Unknown - United Kingdom ... More >> Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Recruiting Birmingham, England, United Kingdom, B15 2TH Contact: Michael H. Cullen, MD    0121-627-2444       Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: G. Mead, MD    44-23-8079-8639       Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Robert A. Huddart, MD    44-20-8661-3457    robert.huddart@icr.ac.uk Less <<
NCT03469531 Neoplasms Cer... More >>vical Adenosquamous Cell Carcinoma Cervical Squamous Cell Carcinoma in Situ Stage IB Cervical Cancer Stage IIA Cervical Cancer Stage IIB Cervical Cancer Stage III Cervical Cancer Stage IVA Cervical Cancer Less << Phase 2 Recruiting December 30, 2021 China, Guangdong ... More >> Zhujiang Hospital Recruiting Guangzhou, Guangdong, China, 510282 Contact: junguo bu, MD    13729810406    ljq821028@126.com    Contact: jiqiang li, MD    13631317203    13631317203@163.com Less <<
NCT03392571 Resectable Pancreatic Cancer Phase 2 Not yet recruiting December 30, 2020 -
NCT00112697 Pancreatic Cancer Phase 2 Unknown - France ... More >> Centre Paul Papin Angers, France, 49036 Centre Oscar Lambret Lille, France, 59020 Polyclinique des Quatre Pavillons Lormont, France, 33310 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Centre Rene Huguenin Saint Cloud, France, 92210 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT01216644 Gastric Cancer Phase 2 Phase 3 Active, not recruiting September 2018 Germany ... More >> Krankenhaus Nordwest Frankfurt, Germany, 60488 Less <<
NCT00310011 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Less << Phase 2 Completed - United States, North Carolina ... More >> Carolinas Hematology-Oncology Associates Charlotte, North Carolina, United States, 28203-4239 Regional Cancer Center Greensboro, North Carolina, United States, 27403-1199 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT01126216 Head and Neck Cancer Phase 3 Active, not recruiting June 2019 Germany ... More >> Klinikum Coburg, Strahlentherapie, DiaCura Coburg, Germany, 96450 Universitätsklinikum Düsseldorf, Klinik und Poliklinik für Strahlentherapie und Radiologische Onkologie Düsseldorf, Germany, 40225 Universitätsklinikum Erlangen, Strahlenklinik Erlangen, Germany, 91054 Universitätsklinikum Frankfurt, Klinik für Strahlentherapie und Radioonkologie Frankfurt/M., Germany, 60590 Klinikum am Eichert, Praxis für Strahlentherapie und Klinik für Radioonkologie Göppingen, Germany, 73035 Universitätsklinikum des Saarlandes, Klinik für Strahlentherapie und Radioonkologie, Homburg/Saar, Germany, 66421 Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik und Poliklinik für Hals-Nasen- und Ohrenkranke Lübeck, Germany, 23538 Kliniken Maria Hilf GmbH Mönchengladbach, Klinik für Strahlentherapie Mönchengladbach, Germany, 41063 Klinikum München Pasing und Perlach, Klinik für HNO München, Germany, 81241 Brüderkrankenhaus st. Josef Paderborn, Klinik für Strahlentherapie Paderborn, Germany, 33098 Universitätsklinikum Regensburg, Klinik und Poliklinik für Strahlentherapie Regensburg, Germany, 93053 Klinikum St. Elisabeth Straubing, Klinik für Hals-Nasen-Ohren-Heilkunde Straubing, Germany, 94315 MVZ am Klinikum Mutterhaus der Borrmäerinnen, Strahlentherapie Trier, Germany, 54290 Less <<
NCT00045162 - Completed - -
NCT02567253 Ovarian Cancer ... More >> Primary Peritoneal Cancer Less << Phase 2 Recruiting November 2018 Belgium ... More >> UZ Ghent Recruiting Ghent, East-Flanders, Belgium, 9000 Contact: Wim P Ceelen, MD, PhD, FACS    09 332 62 51    wim.ceelen@ugent.be    Contact: Wouter Willaert, MD, PhD    09 332 8950    wouter.willaert@ugent.be Less <<
NCT00259285 Non-Small-Cell Lung Cancer Phase 2 Terminated(Trial was stopped e... More >>arly due to low enrollment.) Less << - Spain ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barakaldo, Spain, 48903 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. La Coruña, Spain, 15006 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46014 Less <<
NCT01019278 Cervical Cancer ... More >> Stage IB Cervical Cancer Stage IIA Cervical Cancer Stage IIB Cervical Cancer Stage III Cervical Cancer Stage IVA Cervical Cancer Less << Phase 2 Withdrawn - -
NCT00084318 - Completed - -
NCT00045162 Lung Cancer Phase 3 Completed - -
NCT00561054 Carcinoma, Non-Small-Cell Lung Phase 2 Unknown - Portugal ... More >> fERNANDO bARATA Recruiting cOIMBRA, Portugal, 3040 Contact: Fernando Barata, MD    00351 239 800 195    fjssbarata@sapo.pt    Contact: Agostinho Costa, MD    00351 21 7548032    COSTA.AGOSTINHO@CLIX.PT Less <<
NCT00084318 Head and Neck Cancer Phase 2 Completed - -
NCT00408694 Stage II Nasopharyngeal Kerati... More >>nizing Squamous Cell Carcinoma AJCC v7 Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7 Less << Phase 2 Completed - -
NCT00408694 - Completed - -
NCT00155259 Breast Cancer Phase 2 Completed - Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei, Taiwan Less <<
NCT00398385 Lung Cancer Phase 2 Unknown - Korea, Republic of ... More >> National Cancer Center - Korea Recruiting Goyang, Korea, Republic of, 410-769 Contact: Heungtae T. Kim, MD, PhD    82-31-920-1622    htkim@ncc.re.kr Less <<
NCT00178763 Pancreatic Neoplasms Phase 2 Unknown June 2013 United States, Texas ... More >> Memorial Hermann Hospital Recruiting Houston, Texas, United States, 77030 Contact: Joan M Bull, M.D.    713-500-6815    Joan.M.Bull@uth.tmc.edu    Contact: Esperanza N. Fernandez, N/D    713-500-6774    Esperanza.N.Fernandez@uth.tmc.edu    Principal Investigator: Joan M. Bull, M.D. Less <<
NCT00055965 Lung Cancer Phase 3 Unknown - United Kingdom ... More >> Christie Hospital NHS Trust Manchester, England, United Kingdom, M20 4BX Less <<
NCT02083211 Cervical Cancer Recurrent or P... More >>ersistent Palliative Treatment Monoclonal Antibody in Cervical Cancer Treatment Less << Phase 3 Completed - Mexico ... More >> National Institute of Cancerología México, Tlalpan, Mexico, 14080 Less <<
NCT00251888 Cervix Cancer Phase 1 Completed - France ... More >> CRLC Val d'Aurelle Montpellier, France, 34298 Centre Claudius Régaud Toulouse, France, 31052 Less <<
NCT00387699 Lung Cancer Phase 2 Completed - -
NCT00259285 - Terminated(Trial was stopped e... More >>arly due to low enrollment.) Less << - -
NCT00001569 Carcinoma Per... More >>itoneal Neoplasm Less << Phase 1 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00022191 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 3 Completed - -
NCT00959387 Head and Neck Cancer Phase 2 Completed - Brazil ... More >> Barretos Cancer Hospital Barretos, São Paulo, Brazil, 14784-400 Less <<
NCT01414608 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Chemotherapeutic Agent Toxicity Cognitive Side Effects of Cancer Therapy Psychological Impact of Cancer Radiation Toxicity Sexual Dysfunction and Infertility Stage IB Cervical Cancer Stage IIA Cervical Cancer Stage IIB Cervical Cancer Stage IIIB Cervical Cancer Stage IVA Cervical Cancer Less << Phase 3 Active, not recruiting - -
NCT01977209 Non-small Cell Lung Cancer Phase 3 Unknown September 2016 China, Chongqing ... More >> Daping Hospital, Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Dong Wang, PH.D.    86-23-68757151    dongwang64@hotmail.com    Principal Investigator: Dong Wang, PH.D.          Chongqing Zhongshan Hospital Recruiting Chongqing, Chongqing, China Contact: Zhixiang Yang, M.D.    13032372491       Principal Investigator: Zhixiang Yang          Fuling Central Hospital Recruiting Chongqing, Chongqing, China Contact: Qi Zhou, M.D.    86-23-7222676       Principal Investigator: Qi Zhou, M.D.          Jiangjin Central Hospital Recruiting Chongqing, Chongqing, China Contact: Debing Xiang, M.D.    86-13320336639       Principal Investigator: Debing Xiang, M.D.          The Second Affiliated Hospital of Medical University Of Chongqing Recruiting Chongqing, Chongqing, China Contact: Xianquan Zhang, M.D.    86-23-63693000       Principal Investigator: Xianquan Zhang, M.D.          Three Gorges Central Hospital Recruiting Chongqing, Chongqing, China Contact: Biyong Ren    13896327099       Principal Investigator: Biyong Ren, M.D. Less <<
NCT00006118 Bladder Cancer Phase 2 Unknown - France ... More >> Hopital Drevon Dijon, France, 21000 CHR de Grenoble - La Tronche Grenoble, France, 38043 Hopital Perpetuel Secours Levallois-Perret, France, 92300 CHU de la Timone Marseille, France, 13385 Hopital Notre-Dame de Bon Secours Metz, France, 57038 Hopital Laennec Paris, France, 75007 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Polyclinique De Courlancy Reims, France, F-51100 C.H. Senlis Senlis, France, 60309 Centre Hospitalier Regional Metz Thionville Thionville, France, 57126 Monaco Centre Hospitalier Princesse Grace Monte Carlo, Monaco, 98000 Less <<
NCT00052312 Endometrial Cancer Phase 2 Completed - -
NCT00213642 - Terminated - -
NCT01048645 Non-Small-Cell Lung Carcinoma Phase 2 Completed - Mexico ... More >> National Institute of Cancerología Mexico City, Mexico, 14080 Less <<
NCT01187238 Nasopharyngeal Carcinoma Phase 2 Completed - China, Guangdong ... More >> Cancer hospital, Sun Yat-sen University Guangzhou, Guangdong, China, 510060 China, Zhejiang Zhejiang province cancer hospital Hangzhou, Zhejiang, China, 310022 China Cancer hospital, Chinese Academy of Medical Sciences Beijing, China, 100021 Less <<
NCT00003078 Cervical Cancer Phase 3 Completed - -
NCT03623646 Oropharyngeal Squamous Cell Ca... More >>rcinoma Less << Phase 2 Not yet recruiting November 2022 -
NCT03748134 Esophageal Squamous Cell Carci... More >>noma Less << Phase 3 Not yet recruiting September 30, 2022 -
NCT03580395 Breast Cancer Phase 2 Phase 3 Enrolling by invitation May 2020 China, Hebei ... More >> Fourth Hospital of Hebei Medical University, Tumor Hospital of Hebei Province Shijiazhuang, Hebei, China, 050011 Less <<
NCT00062374 Gastric Adenocarcinoma ... More >> Stage II Gastric Cancer Stage III Gastric Cancer Stage IV Gastric Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00062374 - Completed - -
NCT00773188 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 1 Completed - Canada, Alberta ... More >> Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario Oshawa, Ontario, Canada, L1G 2B9 Ottawa, Ontario, Canada, K1H 8L6 Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT03066778 Small Cell Lung Cancer ... More >> SCLC Less << Phase 3 Active, not recruiting October 5, 2021 -
NCT00458315 Unknown Primary Tumors Phase 2 Withdrawn(never been started) May 2012 Denmark ... More >> Rigshospitalet, Dept of Oncology Copenhagen, Denmark, 2100 Less <<
NCT00216008 Esophageal Adenocarcinomas ... More >> Adenocarcinomas of the Gastroesophageal Junction Less << Phase 2 Terminated(IRB Closure) - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00001499 Carcinoma, Non-Small-Cell Lung... More >> Lung Neoplasms Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00003569 - Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT01504815 Head and Neck Cancer Phase 3 Recruiting September 2021 France ... More >> Gustave Roussy Cancer Institute Recruiting Villejuif, France, 94800 Contact: Yungan Tao, MD    +33 1 42116532    yungan.tao@gustaveroussy.fr    Principal Investigator: Yungan Tao, MD          Netherlands Netherlands Cancer Institute Recruiting Amsterdam, Netherlands, 1066CX Contact: Olga Hamming-Vrieze, MD    +31205122135    o.vrieze@nki.nl    Principal Investigator: Olga Hamming-Vrieze, MD          Universitair Medisch Centrum Groningen Recruiting Groningen, Netherlands, 9713 GZ Contact: Roel Steenbakkers, MD, PhD       r.steenbakkers@umcg.nl    Principal Investigator: Roel Steenbakkers, MD, PhD          Maastro Clinic Recruiting Maastricht, Netherlands, NL-6229 ET Contact: Frank Hoebers, MD    +31 88 4455521    frank.hoebers@maastro.nl    Principal Investigator: Frank Hoebers, MD          Erasmus Medical Centre Recruiting Rotterdam, Netherlands, 3075 EA Contact: Lisa Tans, MD, PhD       l.tans@erasmusmc.nl    Principal Investigator: Lisa Tans, MD, PhD          University Medical Centre Utrecht Recruiting Utrecht, Netherlands, NL-3508GA Contact: Chris Terhaard, MD PhD    +31 88 7553137    c.h.j.terhaard@umcutrecht.nl    Principal Investigator: Chris Terhaard, MD PhD          Spain University Hospital Vall d'Hebron Recruiting Barcelona, Spain, 08035 Contact: Jordi Giralt, MD       jgiralt@vhebron.net    Contact: Berta Garrido    +34 93 2746000 ext 4695    bgarrido@vhebron.net    Principal Investigator: Jordi Giralt, MD          Sweden Karolinska Institute Recruiting Stockholm, Sweden, 17177 Contact: Teresa Herlestam, MD    +46 8 51770000    maria.herlestam-calero-moreno@karolinska.se    Principal Investigator: Teresa Herlestam, MD          United Kingdom Christie Hospital NHS Trust Recruiting Manchester, United Kingdom, M20 5BX Contact: Nick Slevin, MD    +44 161 9187939    nick.slevin@christie.nhs.uk    Principal Investigator: Nick Slevin, MD Less <<
NCT00417248 Non-Small Cell Lung Cancer Phase 1 Phase 2 Terminated(Negative sorafenib ... More >>results from ESCAPE trial and safety concerns of regimen) Less << - United States, Illinois ... More >> Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Center for Cancer Care at Goshen Health System Goshen, Indiana, United States, 46527 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Ohio Oncology Partners Network Cincinnati, Ohio, United States, 45247 Less <<
NCT00887315 Non-small Cell Lung Cancer Phase 2 Terminated(Slow accrual and lo... More >>ss of sponsor) Less << - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01302834 Head and Neck Cancer ... More >> Precancerous Condition Less << Phase 3 Active, not recruiting June 2024 -
NCT00887315 - Terminated(Slow accrual and lo... More >>ss of sponsor) Less << - -
NCT00613626 Small Cell Lung Cancer Phase 2 Completed - United States, Delaware ... More >> Helen F. Graham Cancer Center Newark, Delaware, United States, 19713 United States, Illinois Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 IN Onc/Hem Associates Indianapolis, Indiana, United States, 46202 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 St. Vincent Hospital & Health Centers Indianapolis, Indiana, United States, 46206 IU Health Arnett Cancer Center Lafayette, Indiana, United States, 47904 Horizon Oncology Researcg Lafayette, Indiana, United States, 47905 IU Health at Ball Memorial Hospital Muncie, Indiana, United States, 47303 Monroe Medical Associates Munster, Indiana, United States, 46321 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, New Jersey Hematology Oncology Associates S.J., P.A. Mt. Holly, New Jersey, United States, 08060 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Pennsylvania Pennsylvania Oncology-Hematology Associates Philadelphia, Pennsylvania, United States, 19106 Less <<
NCT00701857 Esophageal Cancer Phase 1 Completed - United States, Arizona ... More >> University of Arizona Cancer Center Tucson, Arizona, United States, 85724 Less <<
NCT00584155 Hearing Loss Phase 1 Withdrawn(PI left the universi... More >>ty.) Less << - United States, Oklahoma ... More >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT01090466 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 1 Phase 2 Completed - United Kingdom ... More >> Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Less <<
NCT00417248 - Terminated(Negative sorafenib ... More >>results from ESCAPE trial and safety concerns of regimen) Less << - -
NCT00538681 Lung Cancer Phase 2 Completed - Belgium ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven, Belgium, 3000 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gauting, Germany, 82131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. GroBhansdorf, Germany, D-22927 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, D 21075 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, 69126 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy, 24128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Catania, Italy, 95100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trento, Italy, 38100 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Otwock, Poland, 05-400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland, 60-569 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucharest, Romania, 022328 Less <<
NCT00046917 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00625937 Head and Neck Cancer Phase 2 Unknown - Korea, Republic of ... More >> Yonsei Cancer Center at Yonsei University Medical Center Recruiting Seoul, Korea, Republic of, 120-752 Contact: Joo-Hang Kim, MD    82-2-2228-8131    kjhang@yuhs.ac Less <<
NCT00016874 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 New York Presbyterian Hospital - Cornell Campus New York, New York, United States, 10021 Less <<
NCT00004201 Lung Cancer Phase 2 Completed - -
NCT00226239 Cancer Phase 2 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01108601 Hearing Loss Phase 1 Phase 2 Unknown - Canada, Quebec ... More >> Montreal General Hospital Recruiting Montreal, Quebec, Canada, H3G 1A1 Contact: Victoria Akinpelu Less <<
NCT00613626 - Completed - -
NCT00226239 - Completed - -
NCT02446574 Esophageal Neoplasms Phase 1 Phase 2 Completed - China, Beijing ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Science Beijing, Beijing, China, 100021 Less <<
NCT00326378 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT01077713 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 2 Completed - Italy ... More >> Rionero in Vulture, Basilicata, Italy, 85028 Catanzaro, Calabria, Italy, 88100 Avellino, Campania, Italy, 83100 Napoli, Campania, Italy, 80131 Bologna, Emilia-Romagna, Italy, 40139 Aviano, Friuli-Venezia Giulia, Italy, 33081 Udine, Friuli-Venezia Giulia, Italy, 33100 Roma, Lazio, Italy, 00128 Roma, Lazio, Italy, 00152 Roma, Lazio, Italy, 00189 Viterbo, Lazio, Italy, 01100 Genova, Liguria, Italy, 16149 Bergamo, Lombardia, Italy, 24128 Milano, Lombardia, Italy, 20142 Monza, Lombardia, Italy, 20052 Rho, Lombardia, Italy, 20017 Sondalo, Lombardia, Italy, 23039 Sondrio, Lombardia, Italy, 23100 Ancona, Marche, Italy, 60121 Pesaro, Marche, Italy, 61122 Novara, Piemonte, Italy, 28100 Catania, Sicilia, Italy, 95100 Lido Di Camaiore, Toscana, Italy, 55043 Perugia, Umbria, Italy, 06156 Mirano, Veneto, Italy, 30035 Padova, Veneto, Italy, 35128 Less <<
NCT00789373 Non-Small Cell Lung Cancer Phase 3 Completed - -
NCT01077713 - Completed - -
NCT01192243 Toxicity Non-... More >>small Cell Lung Cancer Less << Phase 2 Unknown - China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jianhua Chang, MD,PhD    13916619284    changjianhua@hotmail.com Less <<
NCT02667743 Non-Small Cell Lung Cancer(NSC... More >>LC) Less << Phase 3 Active, not recruiting December 2019 China, Guangdong ... More >> Guangdong General Hospital Guangzhou, Guangdong, China, 510080 China, Shanghai Shanghai Chest Hospital Shanghai, Shanghai, China, 200030 China, Zhejiang Jiangsu Cancer Hospital Nanjing, Zhejiang, China, 210009 Less <<
NCT00789373 - Completed - -
NCT02879227 Esophagus Cancer Phase 2 Completed - -
NCT00603915 - Completed - -
NCT00603915 Nasopharyngeal Cancer Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00568971 Gastric Cancer Phase 2 Terminated(The study has finis... More >>hed.) Less << - China, Shanghai ... More >> Fudan University Cancer Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT02217956 Ovarian Adenocarcinoma ... More >> Fallopian Tube Adenocarcinoma Primary Peritoneal Carcinoma Less << Phase 1 Completed - France ... More >> Gustave Roussy Villejuif, Val de Marne, France, 94805 Less <<
NCT00002932 Head and Neck Cancer Phase 2 Completed - United States, California ... More >> University of California San Diego Cancer Center La Jolla, California, United States, 92093-0658 UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States, 94115-0128 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Louisiana MBCCOP - LSU Medical Center New Orleans, Louisiana, United States, 70112 United States, Maryland Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 United States, Tennessee CCOP - Baptist Cancer Institute Memphis, Tennessee, United States, 38117 University of Tennessee, Memphis Cancer Center Memphis, Tennessee, United States, 38163 Vanderbilt Cancer Center Nashville, Tennessee, United States, 37232-6838 United States, Vermont Fletcher-Allen Health Care Burlington, Vermont, United States, 05401 Green Mountain Oncology Group Rutland, Vermont, United States, 05701 United States, Virginia Naval Medical Center, Portsmouth Portsmouth, Virginia, United States, 23708-2197 United States, Washington University Cancer Center Seattle, Washington, United States, 98195 University of Washington Neutron Facility and Cancer Center Seattle, Washington, United States, 98195 Less <<
NCT00101192 - Completed - -
NCT00005636 Malignant Mesothelioma Phase 3 Completed - United States, New Jersey ... More >> Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00316862 Esophageal Cancer Phase 2 Completed - United States, Indiana ... More >> Elkhart General Hospital Elkhart, Indiana, United States, 46515 Howard Community Hospital Kokomo, Indiana, United States, 46904 Center for Cancer Therapy at LaPorte Hospital and Health Services La Porte, Indiana, United States, 46350 Saint Joseph Regional Medical Center Mishawaka, Indiana, United States, 46545-1470 CCOP - Northern Indiana CR Consortium South Bend, Indiana, United States, 46601 Memorial Hospital of South Bend South Bend, Indiana, United States, 46601 Michiana Hematology-Oncology, PC - South Bend South Bend, Indiana, United States, 46601 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1002 United States, Maine CancerCare of Maine at Eastern Maine Medical Center Bangor, Maine, United States, 04401 Maine Center for Cancer Medicine and Blood Disorders - Scarborough Scarborough, Maine, United States, 04074 United States, Michigan Lakeland Regional Cancer Care Center - St. Joseph Saint Joseph, Michigan, United States, 49085 United States, Nebraska Methodist Estabrook Cancer Center Omaha, Nebraska, United States, 68114 United States, New Hampshire New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care Concord, New Hampshire, United States, 03301 New Hampshire Oncology - Hematology, PA - Hooksett Hooksett, New Hampshire, United States, 03106 Lakes Region General Hospital Laconia, New Hampshire, United States, 03246 Elliot Regional Cancer Center at Elliot Hospital Manchester, New Hampshire, United States, 03103 United States, New York Veterans Affairs Medical Center - Buffalo Buffalo, New York, United States, 14215 Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 SUNY Upstate Medical University Hospital Syracuse, New York, United States, 13210 United States, North Carolina Wayne Memorial Hospital, Incorporated Goldsboro, North Carolina, United States, 27534 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 United States, Vermont Mountainview Medical Berlin, Vermont, United States, 05602 Fletcher Allen Health Care - University Health Center Campus Burlington, Vermont, United States, 05401 Less <<
NCT00004920 Malignant Mesothelioma Phase 3 Completed - -
NCT03114280 Head and Neck Squamous Cell Ca... More >>rcinoma (HNSCC) Less << Phase 1 Phase 2 Not yet recruiting November 2020 France ... More >> PEYRADE Frédéric Not yet recruiting Nice, France, 06000 Contact: Frédéric PEYRADE    +33 4 92031022    frederic.peyrade@nice.unicancer.fr Less <<
NCT00316862 - Completed - -
NCT00154804 Esophageal Cancer Phase 2 Completed - Taiwan ... More >> Department of Oncology, Nationa Taiwan University Hospital Taipei, Taiwan Less <<
NCT00544362 Esophageal Cancer Phase 1 Phase 2 Completed - France ... More >> Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besancon, France, 25030 Hopital Saint Andre Bordeaux, France, 33075 C.H.U. de Brest Brest, France, 29200 CHR Clermont Ferrand, Hotel Dieu Clermont-Ferrand, France, 63058 Hopital Du Bocage Dijon, France, 21034 Federation Francophone de Cancerologie Digestive Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 Centre Hospital Universitaire Hop Huriez Lille, France, 59037 CHU de la Timone Marseille, France, 13385 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Centre Hospitalier Regional de Purpan Toulouse, France, 31059 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Less <<
NCT00489996 Non-Small Cell Lung Cancer Phase 2 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China Less <<
NCT00003723 Malignant Mesothelioma Phase 2 Completed - -
NCT00101192 Cervical Cancer Phase 2 Completed - United States, California ... More >> Providence Saint Joseph Medical Center - Burbank Burbank, California, United States, 91505 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 United States, Georgia Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah, Georgia, United States, 31403-3089 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Kansas Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City, Kansas, United States, 66160-7357 United States, Louisiana Ochsner Cancer Institute at Ochsner Clinic Foundation New Orleans, Louisiana, United States, 70121 Christus Schumpert Cancer Treatment Center Shreveport, Louisiana, United States, 71101 United States, Mississippi University of Mississippi Cancer Clinic Jackson, Mississippi, United States, 39216 United States, New Jersey Fox Chase Virtua Health Cancer Program at Virtua West Jersey Voorhees, New Jersey, United States, 08043 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio MetroHealth Cancer Care Center at MetroHealth Medical Center Cleveland, Ohio, United States, 44109 Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Oklahoma Oklahoma University Cancer Institute Oklahoma City, Oklahoma, United States, 73104 Cancer Care Associates - Midtown Tulsa Tulsa, Oklahoma, United States, 74104 United States, Pennsylvania Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States, 19111-2497 McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555-0361 M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT00445861 Esophageal Cancer Phase 1 Phase 2 Completed - Switzerland ... More >> Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Klinik Stephanshorn St. Gallen, Switzerland, Ch-9016 Less <<
NCT02200042 Stage III Intrahepatic Cholang... More >>iocarcinoma Stage IVA Intrahepatic Cholangiocarcinoma Less << Phase 3 Terminated - -
NCT01243632 Malignant Pleural Mesothelioma Phase 2 Completed - Slovenia ... More >> Institute of Oncology Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT01165021 - Completed - -
NCT01154920 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Active, not recruiting July 2020 United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 20115 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00466466 Small-Cell Lung Cancer Phase 1 Completed - United States, Arkansas ... More >> Highlands Oncology Group Fayetteville, Arkansas, United States, 72703 United States, Colorado University of Colorado Health Sciences Center Aurora, Colorado, United States, 80045 United States, Massachusetts Dana Faber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Cancer Therapy and Research Center at UTHSCSA San Antonio, Texas, United States, 78229 France Novartis Investigative Site Paris, France Less <<
NCT01165021 Non Small Cell Lung Cancer Phase 2 Completed - Italy ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20133 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Novara, Italy, 28100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orbassano, Italy, 10043 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pisa, Italy, 56100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00144 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sondalo, Italy, 23039 Less <<
NCT03133390 Urothelial Carcinoma Phase 2 Recruiting January 2019 United States, New York ... More >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Swati Chitkara       swati.chitkara@nyumc.org    Principal Investigator: Arjun Balar, MD Less <<
NCT01736410 HER 2 Positive Advanced Gastri... More >>c Cancer Less << Phase 2 Completed - Singapore ... More >> National Cancer Centre Singapore Singapore, Singapore, 169610 Less <<
NCT00898495 - Completed - -
NCT01848457 Osteosarcoma ... More >>Nephrotoxicity Ototoxicity Less << Phase 2 Active, not recruiting January 2019 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00083252 Melanoma Skin... More >> Cancer Less << Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas Medical Sciences Little Rock, Arkansas, United States, 72205 United States, California Cancer Institute Medical Group, Inc. Santa Monica, California, United States, 90404 United States, Colorado University of Colorado Health Sciences Center Aurora, Colorado, United States, 80045 United States, Florida Cancer Center of Florida Ocoee, Florida, United States, 34761 United States, Indiana Indiana Hematology Oncology Consultants Indianapolis, Indiana, United States, 46202 United States, New Mexico New Mexico Cancer Center Alliance Albuquerque, New Mexico, United States, 87106 United States, New York NYU School of Medicine New York, New York, United States, 10016 Fifth Avenue Medical Healthcare New York, New York, United States, 10128 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28203 United States, South Carolina Cancer Center of the Carolinas Greenville, South Carolina, United States, 29615 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75246 Tyler Cancer Center Tyler, Texas, United States, 75702 United States, Washington Cancer Care Northwest Research Spokane, Washington, United States, 99218 Less <<
NCT00033449 Stage III Squamous Cell Carcin... More >>oma of the Hypopharynx Stage III Squamous Cell Carcinoma of the Larynx Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Stage III Squamous Cell Carcinoma of the Oropharynx Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Larynx Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IV Squamous Cell Carcinoma of the Oropharynx Less << Phase 1 Terminated(Administratively co... More >>mplete.) Less << - United States, Colorado ... More >> University of Colorado Denver, Colorado, United States, 80217-3364 Less <<
NCT02887248 Urothelial Carcinoma ... More >> Bladder Cancer Transitional Cell Carcinoma Less << Phase 2 Active, not recruiting December 30, 2019 United States, Florida ... More >> Florida Cancer Specialists - South Fort Myers, Florida, United States, 33916 Florida Cancer Specialists-North Saint Petersburg, Florida, United States, 33705 Florida Cancer Specialists-East West Palm Beach, Florida, United States, 33401 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas Center for Cancer and Blood Disorders Fort Worth, Texas, United States, 76104 Less <<
NCT00509366 Non Small Cell Lung Cancer Phase 2 Terminated(Study terminated du... More >>e to reproducibility issues with genomics prediction model.) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Maria Parham Hospital Henderson, North Carolina, United States, 27536 Scotland HealthCare System (Scotland Memorial Hospital) Laurinburg, North Carolina, United States, 28352 Southeastern Regional Medical Center, Gibson Cancer Center Lumberton, North Carolina, United States, 28358 Duke Raleigh Hospital Raleigh, North Carolina, United States, 27609 United States, South Carolina Beaufort Memorial Hospital Beaufort, South Carolina, United States, 29902 Coastal Cancer Center Myrtle Beach, South Carolina, United States, 29572 United States, Virginia Community Memorial Health Center South Hill, Virginia, United States, 23970 Less <<
NCT03737123 Urothelial Carcinoma Phase 2 Not yet recruiting January 2022 -
NCT03383094 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Not yet recruiting June 2024 United States, California ... More >> UC San Diego Moores Cancer Center La Jolla, California, United States, 92093 Less <<
NCT03071822 Peripheral T Cell Lymphoma Phase 4 Recruiting February 28, 2022 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: King Hei Lu, MMedSc    852-22554361 ext 1654    khlu@hku.hk    Contact: Zoe Chan, BNs    852-22551654    zoechan1@hku.hk    Principal Investigator: Yok Lam Kwong, MD(HK)          Sub-Investigator: Thomas Chan, MBBS(HK) Less <<
NCT00509366 - Terminated(Study terminated du... More >>e to reproducibility issues with genomics prediction model.) Less << - -
NCT00095875 - Completed - -
NCT03029832 Urothelial Carcinoma Phase 2 Completed - -
NCT03381066 Completely Resected NSCLC With... More >> Common EGFR Mutations Less << Phase 3 Not yet recruiting December 2023 Korea, Republic of ... More >> Department of Oncology, Yonsei University College of Medicine Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Byoung Chul Cho, MD    82 2 2228 0880    cbc1971@yuhs.ac Less <<
NCT00401492 Non Small Cell Lung Cancer Phase 2 Completed - -
NCT01000415 Cervical Cancer Phase 3 Unknown June 2018 Thailand ... More >> Gynecologic Oncology Unit, Department of Obstertrics and Gynecology, Faculty of medicine, Prince of Songkla University Recruiting Hat-Yai, Songkhla, Thailand, 90110 Contact: Rakchai - Buhachat, MD.    66 74 451201    brakchai@medicine.psu.ac.th    Contact: Chutaporn - Dampan, BSc.    66 74 451201    djutapor@medicine.psu.ac.th    Principal Investigator: Rakchai - Buhachat, MD. Less <<
NCT00095875 Head and Neck Cancer Phase 3 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 United States, Colorado CCOP - Colorado Cancer Research Program Denver, Colorado, United States, 80224 United States, Florida Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus Boca Raton, Florida, United States, 33486 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Illinois Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Maine Maine Center for Cancer Medicine and Blood Disorders - Scarborough Scarborough, Maine, United States, 04074 United States, Maryland Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New Hampshire Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756-0002 United States, New Jersey UMDNJ University Hospital Newark, New Jersey, United States, 07103 United States, New York Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx, New York, United States, 10461 United States, North Carolina Blumenthal Cancer Center at Carolinas Medical Center Charlotte, North Carolina, United States, 28232-2861 United States, Pennsylvania UPMC Cancer Centers Pittsburgh, Pennsylvania, United States, 15232 Germany Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 Less <<
NCT01038661 Lung Neoplasms Phase 3 Completed - China ... More >> Sanofi-Aventis Administrative Office Shanghai, China Less <<
NCT00705874 - Completed - -
NCT01360086 Adenocarcinoma of the Gastroes... More >>ophageal Junction Gastric Cancer Less << Phase 2 Completed - France ... More >> Centre Hospitalier Regional et Universitaire de Lille Lille, France, 59037 CHU - Robert Debre Reims, France, 51092 Less <<
NCT01211275 Malignant Pleural Mesothelioma Phase 1 Phase 2 Completed - Netherlands ... More >> Antoni van Leeuwenhoekziekenhuis (NKI-AVL) Amsterdam, Noord-Holland, Netherlands, 1066 CX Less <<
NCT00051480 Esophageal Cancer Phase 2 Completed - United States, California ... More >> UCSD Cancer Center La Jolla, California, United States, 92093-0064 University of California, Irvine Orange, California, United States, 92868 Palo Alto VA Health Care Systems Palo Alto, California, United States, 94304 United States, Illinois The University of Chicago Medical Center Chicago, Illinois, United States, 60637-1470 United States, Maryland Johns Hopkins School of Medicine Baltimore, Maryland, United States, 21231-2410 United States, Missouri St. Louis University St. Louis, Missouri, United States, 63110 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 United States, Texas US Oncology, Mary Crowley Center Dallas, Texas, United States, 75246 University of Texas/MD Anderson Houston, Texas, United States, 77030-4009 Scott & White Center for Cancer Prevention and Care Temple, Texas, United States, 76508 Tyler Cancer Center Tyler, Texas, United States, 75702 United States, Virginia Medical College of Virginia Richmond, Virginia, United States, 23298-0058 Less <<
NCT00705874 Cancer Phase 1 Completed - United States, Colorado ... More >> Rocky Mountain Cancer Centre Denver, Colorado, United States United States, Florida Cancer Centres of Florida Ocoee, Florida, United States, 34761 United States, Indiana Central Indiana Cancer Centres Indianapolis, Indiana, United States, 46219 United States, Nevada Comprehensive Cancer Centres of Nevada Las Vegas, Nevada, United States, 89169 United States, New York New York Oncology Hematology PC Albany, New York, United States, 12206 United States, Ohio Dayton Oncology and Hematology, PA Kettering, Ohio, United States, 45409 United States, South Carolina Cancer Centres of the Carolinas Greenville, South Carolina, United States, 29605 United States, Texas Texas Oncology, PA Dallas, Texas, United States, 75246 Tyler Cancer Centre Tyler, Texas, United States, 75702 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 United States, Washington Northwest Cancer Specialists - Vancouver Cancer Centre Vancouver, Washington, United States, 98684 North Star Lodge Cancer Centre Yakima, Washington, United States, 98902 Less <<
NCT01301716 Solid Cancers Phase 1 Completed - United States, California ... More >> Los Angeles, California, United States, 90025 United States, Florida Tampa, Florida, United States, 33612 United States, Massachusetts Boston, Massachusetts, United States, 02114 Boston, Massachusetts, United States, 02215 Spain Madrid, Spain, 28050 Less <<
NCT00660270 Pancreatic Cancer Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63119 Less <<
NCT02906150 Non-Small Cell Lung Cancer Phase 2 Not yet recruiting July 2019 Italy ... More >> Azienda Sanitaria Locale Frosinone Not yet recruiting Frosinone, Italy Contact: Dott.ssa Teresa Gamucci          Principal Investigator: Dott.ssa Teresa Gamucci          Istituto Nazionale dei Tumori Not yet recruiting Milan, Italy Contact: Dott.ssa Marina Chiara Garassino          Principal Investigator: Dott.ssa Marina Chiara Garassino          Roma_Campus Bio-Medico Not yet recruiting Rome, Italy Contact: Prof. Daniele Santini          Principal Investigator: Prof. Daniele Santini          Roma_Gemelli Not yet recruiting Rome, Italy Contact: Prof. Carlo Antonio Mario Barone          Principal Investigator: Prof. Carlo Antonio Mario Barone          Roma_Regina Apostolorum Not yet recruiting Rome, Italy Contact: Dott. Francesco Angelini          Principal Investigator: Dott. Francesco Angelini          Roma_Tor Vergata Not yet recruiting Rome, Italy Contact: Prof. Mario Roselli          Principal Investigator: Prof. Mario Roselli          Sant'Andrea Hospital Not yet recruiting Rome, Italy Contact: Prof. Paolo Marchetti          Principal Investigator: Prof. Paolo Marchetti          Presidio Sanitario San Camillo Not yet recruiting Torino, Italy Contact: Dott.ssa Maria Rita Migliorino          Principal Investigator: Dott.ssa Maria Rita Migliorino Less <<
NCT02171325 Small Cell Lung Cancer Phase 2 Recruiting June 2018 China, Jilin ... More >> Jilin cancer hospital Recruiting Changchun, Jilin, China, 130000 Contact: ying cheng, doctor    86-43185871902    jl.cheng@163.com Less <<
NCT01121393 Carcinoma, Non-Small-Cell Lung... More >> Adenocarcinoma Less << Phase 3 Completed - China ... More >> Beijing Chao-Yang Hospital Beijing, China, 100020 307 Hospital of PLA Beijing, China, 100071 Peking Union Medical College Hospital Beijing, China, 100730 Beijing Chest Hospital Beijing, China, 101149 First Hospital of Jilin University Changchun, China, 130021 Xiangya Hospital, Central South University Changsha, China, 410008 Hunan Province Tumor Hospital Changsha, China West China Hospital Chengdu, China, 610041 Fujian Provincial Tumor Hospital Fuzhou, China, 350014 Guangdong General Hospital Guangzhou, China, 510080 Guangzhou Institute of Respiratory Disease Guangzhou, China, 510120 NanFang Hosptial Guangzhou, China, 510515 The Third Affiliated Hospital of Harbin Medical University Haerbin, China, 150081 Zhejiang Cancer Hospital Hangzhou, China, 310022 Hubei Cancer Hospital HongShan, China Yunnan Provincial Tumor Hospital Kunming, China, 650118 Lin Yi Tumor Hospital Linyi, China, 276001 The Affiliated Cancer Hospital, Guangxi Medical University Nan Ning, China the 81th Hospital of PLA Nanjing, China, 210002 Jiangsu Cancer Hospital Nanjing, China, 210009 The affiliated hospital of medicalcollege qingdao university Qingdao, China, 266101 Shanghai Changzheng Hospital Shanghai, China, 200003 Shanghai Chest Hospital Shanghai, China, 200030 Zhongshan Hospital Fudan University Shanghai, China, 200032 Shanghai Pulmonary Hospital Shanghai, China, 200433 Changhai Hospital Shanghai, China, 200443 The First Hospital of Chinese Medical University Shenyang, China, 110001 Hebei Provincial Tumor Hospital Shijiazhuang, China Tangdu Hospital Xi'An, China, 710038 Northern Jiangsu People's Hospital Yangzhou, China, 225001 Korea, Republic of Kosin University Gospel Hospital Busan, Korea, Republic of, 602-702 Chungbuk National University Hospital Cheongju, Korea, Republic of, 361711 Yeungnam University Medical Center Daegu, Korea, Republic of, 705-717 Konkuk University Medical Center Seoul, Korea, Republic of, 143-729 Korea University Guro Hospital Seoul, Korea, Republic of, 152-703 Thailand Songklanagarind Hospital Songkla, Thailand, 90110 Less <<
NCT03256916 Carcinoma Cervix, Stage III Phase 3 Not yet recruiting September 30, 2025 India ... More >> Tata Memorial Centre Not yet recruiting Mumbai, Maharashtra, India, 400012 Contact: Supriya J Sastri, MD    9930958309    supriyasastri@gmail.com    Contact: Jayant Goda, MD    24177000 ext 7027    godajayantsastri@gmail.com    Principal Investigator: Supriya J Sastri, MD          Principal Investigator: Jayant Goda, MD Less <<
NCT02494583 Gastric Adenocarcinoma Phase 3 Active, not recruiting June 6, 2020 -
NCT01121393 - Completed - -
NCT00319514 Advanced Non-Small Cell Lung C... More >>ancer Less << Phase 2 Completed - Korea, Republic of ... More >> Gachon University Gil Medical Center Incheon, Korea, Republic of, 405 760 Less <<
NCT02096380 - Unknown December 2018 -
NCT00165490 Adenocarcinoma of Esophagus ... More >> Squamous Cell Carcinoma of Esophagus Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02436733 Malignant Pleural Mesothelioma Phase 2 Recruiting April 2020 Belgium ... More >> UZ Antwerpen Recruiting Antwerpen, Belgium Contact: Jan Van Meerbeeck, Prof          UZ Gent Recruiting Gent, Belgium Contact: Veerle Surmont, Prof          France Assistance Publique - Hopitaux de Marseille - Hopital Nord Recruiting Marseille, France Contact: Pascal-Alexandre Thomas, Prof          Netherlands The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis Recruiting Amsterdam, Netherlands Contact: Paul Baas, Prof          Erasmus MC Hospital Recruiting Rotterdam, Netherlands Contact: Joachim Aerts, Prof Less <<
NCT00213486 Esophageal Neoplasms Phase 2 Completed - France ... More >> CHU de Rouen Rouen, France, 76031 Less <<
NCT02532192 Lymphoma Phase 1 Withdrawn(Withdrawal of study ... More >>support.) Less << - -
NCT02718742 Recurrent Bladder Urothelial C... More >>arcinoma Stage IV Bladder Urothelial Carcinoma Less << Phase 2 Withdrawn - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 Less <<
NCT00077103 Head and Neck Cancer Phase 1 Phase 2 Terminated(slow accrual) - United States, Michigan ... More >> Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, Ohio Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00848783 - Terminated(Due to slow accrual... More >>) Less << - -
NCT00290719 Esophageal Cancer Phase 1 Terminated(low enrollment) - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00430313 Liver Cancer ... More >>Liver Metastasis Less << Not Applicable Active, not recruiting January 2021 China ... More >> Fudan University Cancer Hospital Shanghai, China Less <<
NCT01221753 - Terminated(Due to slow accrual... More >>) Less << - -
NCT00721513 Head and Neck Cancer Phase 2 Unknown - United States, North Carolina ... More >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT00848783 Gastric Cancer ... More >> Gastric Adenocarcinoma Esophageal Cancer Less << Phase 2 Terminated(Due to slow accrual... More >>) Less << - United States, California ... More >> Norris Cancer Center Los Angeles, California, United States, 90033 United States, New York Bellevue Hospital New York, New York, United States, 10016 NYU Cancer Center New York, New York, United States, 10016 Less <<
NCT01578668 Lung Adenocarcinoma ... More >> Brain Metastases Less << Phase 2 Completed - China, Guangdong ... More >> The first affiliated hospital of Guangzhou MC Guangzhou, Guangdong, China, 510120 Less <<
NCT03734692 Ovarian Cancer Recurrent Phase 1 Phase 2 Not yet recruiting November 20, 2023 United States, Pennsylvania ... More >> Magee-Womens Hospital of UPMC Not yet recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Robert Edwards, MD    412-641-4212    edwarp@upmc.edu    Contact: Brenda Steele, RN    412-641-3418    steeleb@upmc.edu Less <<
NCT01221753 Squamous Cell Carcinoma of the... More >> Head and Neck Human Papilloma Virus Less << Phase 2 Terminated(Due to slow accrual... More >>) Less << - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT03668730 Nasopharyngeal Carcinoma Phase 2 Recruiting December 30, 2023 China, Guangdong ... More >> Hai Qiang Mai Recruiting Guangzhou, Guangdong, China, 510060 Contact: Hai Qiang Mai, MD.PHD    020-87343380    maihq@sysucc.org.cn Less <<
NCT01200797 - Terminated(Slow accrual was th... More >>e reason for study termination.) Less << - -
NCT00017004 Anemia Cervic... More >>al Adenocarcinoma Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma Drug Toxicity Radiation Toxicity Stage IIB Cervical Cancer Stage III Cervical Cancer Stage IVA Cervical Cancer Less << Phase 3 Completed - United States, Arizona ... More >> Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States, 85012 Less <<
NCT00066742 Limited Stage Small Cell Lung ... More >>Cancer Less << Phase 2 Completed - United States, Texas ... More >> Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States, 78245 Less <<
NCT00066742 - Completed - -
NCT02998385 HNSCC Phase 3 Recruiting November 2026 France ... More >> Hôpital Bégin Recruiting Saint-Mandé, France, 94 Contact: François Régis FERRAND, MD       francoisregisferrand@gmail.com Less <<
NCT00470366 Brain and Central Nervous Syst... More >>em Tumors Extragonadal Germ Cell Tumor Ovarian Cancer Teratoma Testicular Germ Cell Tumor Less << Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00470366 - Completed - -
NCT00842660 Cervical Cancer Phase 3 Unknown January 2013 Taiwan ... More >> Chong Jong Wang, Kaohsiung, Taiwan, M.D Chien-Sheng Tsai Keelung, Taiwan Less <<
NCT00434668 Non-small Cell Lung Cancer Phase 2 Completed - Belgium ... More >> ZNA Middelheim Antwerpen, Antwerp, Belgium, 2020 University Hospital Antwerp Edegem, Antwerp, Belgium, 2650 St Augustinus ziekenhuis Wilrijk, Antwerp, Belgium, 2610 Less <<
NCT01200797 Recurrent Fallopian Tube Cance... More >>r Recurrent Ovarian Epithelial Cancer Recurrent Primary Peritoneal Cavity Cancer Less << Phase 2 Terminated(Slow accrual was th... More >>e reason for study termination.) Less << - United States, Connecticut ... More >> Hartford Hospital Hartford, Connecticut, United States, 06102 Oncology Associates PC Hartford, Connecticut, United States, 06106 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT02885974 Bladder Cancer Phase 1 Recruiting June 2020 United States, Texas ... More >> Baylor Clinic Recruiting Houston, Texas, United States, 77030 Contact: Edward Yen, MD    713-798-3750       Harris Health System - Smith Clinic Recruiting Houston, Texas, United States, 77054 Contact: Aihua Edward Yen, MD    713-798-3750    ay044661@bcm.edu Less <<
NCT03193931 Cancer of Head and Neck Phase 2 Recruiting September 1, 2023 Germany ... More >> Medizinsche Hochschule Hannover Recruiting Hannover, Germany, 30625 Less <<
NCT00541073 Malignant Mesothelioma Phase 2 Completed - France ... More >> Centre Oscar Lambret Lille, France, 59020 Less <<
NCT03585998 Small Cell Lung Cancer Phase 2 Recruiting December 19, 2021 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, MA, Korea, Republic of, 06351 Contact: Jong-Mu Sun, Associate Professor    82234101795    jongmu.sun@samsung.com Less <<
NCT00916669 Small Cell Lung Cancer Phase 2 Withdrawn(sponsor withdrew fun... More >>ding prior to patient enrollment) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 North Shore Medical Center Peabody, Massachusetts, United States, 01970 Less <<
NCT01716546 Gastric Cancer Phase 1 Phase 2 Terminated(Not reached the pri... More >>mary endpoint target according to the statistical design) Less << - Greece ... More >> "IASO" General Hospital of Athens Athens, Greece 401 Military Hospital of Athens Athens, Greece Air Forces Military Hospital of Athens Athens, Greece "Ag.Georgios" General Hospital of Chania Chania, Greece University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece Heraklion, Greece State General Hospital of Larissa Larissa, Greece "Metaxa's" Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology Piraeus, Greece "Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology Thessaloniki, Greece Diabalkaniko General Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT01679340 Gastric Cancer Phase 2 Unknown June 2018 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Shen Lin, Professor    010-88196561    xiaotong10241@sina.com    Principal Investigator: Shen Lin, professor Less <<
NCT03255252 Cervical Cancer Phase 2 Not yet recruiting January 2020 France ... More >> ICM Val d'Aurelle Not yet recruiting Montpellier, France, 34298 Contact: BLEUSE Jean-pierre    00467613102    jean-pierre.bleuse@icm.unicancer.fr    Principal Investigator: Olivier RIOU Less <<
NCT03319537 Mesothelioma Phase 1 Phase 2 Recruiting October 2020 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Majorie Zauderer, MD    646-888-4656       Memoral Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Marjorie Zauderer, MD    646-888-4656       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Marjorie Zauderer, MD    646-888-4656       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Marjorie Zauderer, MD    646-888-4656       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Majorie Zauderer, MD    646-888-4656       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Marjorie Zauderer, MD    646-888-4656       Contact: Andrea Cercek, MD    646-888-4189       Principal Investigator: Marjorie Zauderer, MD          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Marjorie Zauderer, MD    646-888-4656 Less <<
NCT00075738 Esophageal Cancer Phase 2 Unknown - France ... More >> Clinique La Casamance Abugne, France, 13400 Hopital Saint Andre Bordeaux, France, 33075 Hopital Drevon Dijon, France, 21000 Centre Jean Bernard Le Mans, France, 72000 Centre Hospital Universitaire Hop Huriez Lille, France, 59037 Clinique Saint Jean Lyon, France, 69008 Hopital Notre-Dame de Bon Secours Metz, France, 57038 Hopital Bichat - Claude Bernard Paris, France, 75018 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Hopital Haut Leveque Pessac, France, 33604 Clinique Ste - Marie Pontoise, France, 95300 Clinique Armoricaine De Radiologie Saint Brieuc, France, F-22015 Clinique Francois Saint-Dizier, France, 52100 Centre Medico-Chirurgical Foch Suresnes, France, 92151 Less <<
NCT01336049 Esophageal Squamous Cell Cance... More >>r Less << Phase 2 Unknown - China, Beijing ... More >> Xiaodong Zhang Recruiting Beijing, Beijing, China, 100142 Contact: xiaodong zhang, MD    86-10-88196175    zxd0829@yahoo.com.cn    Principal Investigator: xiaodong zhang, MD Less <<
NCT01495676 Infiltrating Bladder Urothelia... More >>l Carcinoma Less << Phase 2 Recruiting September 2020 France ... More >> CRLC Val d'Aurelle-Paul Lamarque Recruiting Montpellier, France, 34000 Contact: Jean-Pierre Bleuse, MD    +33 4 67 61 23 44    Jean-Pierre.Bleuse@montpellier.unicancer.fr    Principal Investigator: David Azria, MD, Ph D Less <<
NCT01454102 Non-small Cell Lung Cancer Phase 1 Active, not recruiting December 29, 2018 United States, California ... More >> Ucla Santa Monica, California, United States, 90404 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas Ut Southwestern Medical Center At Dallas Dallas, Texas, United States, 75390-8852 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 Canada, Ontario Local Institution Hamilton, Ontario, Canada, L8V 5C2 Local Institution Ottawa, Ontario, Canada, K1H 8L6 Local Institution Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT03117257 Locally Advanced Head and Neck... More >> Squamous Cell Carcinoma Less << Phase 2 Recruiting August 20, 2021 China, Guizhou ... More >> Cancer Hospital of Guizhou Medical University Recruiting Guiyang, Guizhou, China, 550000 Contact: Feng Jin, Bachelor    0851-86512802    jinf8865@yahoo.com.cn    Sub-Investigator: Weili Wu, master          Sub-Investigator: Jinhua Long, master          Sub-Investigator: Yuanyuan Li, master          Sub-Investigator: Xiuyun Gong, Bachelor          Sub-Investigator: Xiaoxiao Chen, Bachelor          Sub-Investigator: Mang Zhang, Bachelor Less <<
NCT00511992 - Completed - -
NCT01665183 Cutaneous Melanoma, Uveal Mela... More >>noma, Ovarian Carcinoma or Other Advanced Solid Tumors Less << Phase 1 Completed - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States Taiwan NCKUH Tainan, Taiwan, 704 Less <<
NCT02396498 Stage Ⅲ Gastric Cancer Phase 3 Unknown December 2016 China, Shaanxi ... More >> IEC of Insititution for National Drug Clinical Trials,Tangdu Hospital,Fourth Military Medical University Recruiting Xi'an, Shaanxi, China, 029 Contact: Lina Liu    029-84777631    tangduec@126.com Less <<
NCT00174772 Lung Neoplasms Phase 2 Completed - Belgium ... More >> Sanofi-Aventis Administrative Office Diegem, Belgium Finland Sanofi-Aventis Administrative Office Helsinki, Finland France Sanofi-Aventis Administrative Office Paris, France Italy Sanofi-Aventis Administrative Office Milan, Italy Netherlands Sanofi-Aventis Administrative Office Gouda, Netherlands Spain Sanofi-Aventis Administrative Office Barcelona, Spain Turkey Sanofi-Aventis Administrative Office Istanbul, Turkey United Kingdom Sanofi-Aventis Administrative Office Guilford, United Kingdom Less <<
NCT02818725 Infiltrating Urothelial Carcin... More >>oma KRAS Gene Mutation Less << Phase 3 Unknown September 2017 France ... More >> Hopital Saint Andre Bordeaux, France, 33075 Institut Bergonie Bordeaux, France, 33076 Centre Francois Baclesse Caen, France, 14076 Hopital Henri Mondor Creteil, France, 94010 Centre Leon Berard Lyon, France, 69008 Institut Paoli Calmettes Marseille, France, 13273 Centre Alexis Vautrin Nancy, France, 54511 Centre Rene Gauducheau Nantes, France, 44800 Chu de Nimes Nimes, France, 30029 Institut Curie Paris, France, 75005 Diaconesses - Croix St Simon Paris, France, 75012 Pitie Salpetriere Paris, France, 75013 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Institut Cancerologie de La Loire St Priest En Jarez, France, 42270 Hopitaux Universitaires Strasbourg, France, 67091 Institut Claudius Regaud Toulouse, France, 31052 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT00511992 Advanced Ovarian Carcinoma ... More >> Primary Peritoneal Carcinoma Ovarian Carcinosarcoma Less << Phase 2 Completed - United States, Oklahoma ... More >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT02994251 Unresectable Intrahepatic Chol... More >>angiocarcinoma Less << Phase 2 Recruiting June 2020 United States, Connecticut ... More >> Smilow Cancer Center Recruiting New Haven, Connecticut, United States, 06510 Contact: Todd Schlachter, MD    203-785-4747    todd.schlachter@yale.edu    Sub-Investigator: Hyun Kim, MD          Sub-Investigator: Stacey Stein, MD          Sub-Investigator: Howard S Hochster, MD          Sub-Investigator: Jill Lacy, MD          Sub-Investigator: Jeffrey Pollak, MD Less <<
NCT00021333 Head and Neck Cancer ... More >> Lung Cancer Less << Phase 2 Completed - United States, New Jersey ... More >> Hunterdon Regional Cancer Center Flemington, New Jersey, United States, 08822 Kimball Medical Center Lakewood, New Jersey, United States, 08701 South Jersey Regional Cancer Center Millville, New Jersey, United States, 08332 Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly, New Jersey, United States, 08060 Riverview Medical Center - Booker Cancer Center Red Bank, New Jersey, United States, 07701 Community Medical Center Toms River, New Jersey, United States, 08755 St. Francis Medical Center Trenton, New Jersey, United States, 08629 United States, Pennsylvania Bon Secours-Holy Family Health System Altoona, Pennsylvania, United States, 16602 Delaware County Memorial Hospital Drexel Hill, Pennsylvania, United States, 19026 Pinnacle Health Hospitals Harrisburg, Pennsylvania, United States, 17105-8700 Conemaugh Memorial Hospital Johnstown, Pennsylvania, United States, 15905 Saint Mary Regional Center Langhorne, Pennsylvania, United States, 19047 Central Montgomery Medical Center Lansdale, Pennsylvania, United States, 19446-1200 Paoli Memorial Hospital Paoli, Pennsylvania, United States, 19301-1792 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Pottstown Memorial Regional Cancer Center Pottstown, Pennsylvania, United States, 19464 Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 Southern Chester County Medical Center West Grove, Pennsylvania, United States, 19390 Less <<
NCT00004063 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Phase 2 Unknown - United States, Texas ... More >> University of Texas Health Science Center at Houston Recruiting Houston, Texas, United States, 77225 Contact: Joan M.C. Bull, MD    713-500-6820    joan.m.bull@uth.tmc.edu Less <<
NCT00106626 Advanced Cancer Phase 1 Completed - -
NCT00602082 Gastrointestinal Carcinoid Tum... More >>or Islet Cell Tumor Less << Phase 2 Completed - United Kingdom ... More >> Basildon University Hospital Basildon, England, United Kingdom, SS16 5NL Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Cookridge Hospital Leeds, England, United Kingdom, LS16 6QB Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Aintree University Hospital Liverpool, England, United Kingdom, L9 7AL UCL Cancer Institute London, England, United Kingdom, NW3 2QG St. Thomas' Hospital London, England, United Kingdom, SE1 7EH Mid Kent Oncology Centre at Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Christie Hospital Manchester, England, United Kingdom, M20 4BX Clatterbridge Centre for Oncology Merseyside, England, United Kingdom, CH63 4JY Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle-Upon-Tyne, England, United Kingdom, NE4 6BE Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Southend University Hospital NHS Foundation Trust Westcliff-On-Sea, England, United Kingdom, SS0 0RY Edinburgh Cancer Centre at Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G12 0YN Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Less <<
NCT00106626 - Completed - -
NCT00059761 Lung Cancer Phase 1 Completed - -
NCT01192165 Cancer Phase 1 Completed - United States, Arizona ... More >> GSK Investigational Site Scottsdale, Arizona, United States, 85259 United States, California GSK Investigational Site Duarte, California, United States, 91010 GSK Investigational Site Sacramento, California, United States, 95817 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80218 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89169 United States, New York GSK Investigational Site Albany, New York, United States, 12206 United States, South Carolina GSK Investigational Site Greenville, South Carolina, United States, 29605 United States, Tennessee GSK Investigational Site Nashville, Tennessee, United States, 37203 United States, Texas GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Houston, Texas, United States, 77030 GSK Investigational Site Tyler, Texas, United States, 75702 United States, Virginia GSK Investigational Site Norfolk, Virginia, United States, 23502 United States, Washington GSK Investigational Site Vancouver, Washington, United States, 98684 Canada, Ontario GSK Investigational Site Toronto, Ontario, Canada, M5G 2M9 France GSK Investigational Site Caen Cedex 9, France, 14033 GSK Investigational Site Marseille cedex 5, France, 13385 GSK Investigational Site Saint-Herblain cedex, France, 44805 GSK Investigational Site Toulouse cedex, France, 31052 Korea, Republic of GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Seoul, Korea, Republic of, 135-710 Less <<
NCT01949870 Inoperable Locally Advanced or... More >> Metastatic Biliary Tract Cancer Less << Phase 1 Terminated(change in the devel... More >>opment strategy) Less << - Japan ... More >> AZD6244 PhI Japanese Gem/ Kashiwa Shi, Chiba, Japan AZD6244 PhI Japanese Gem/ Chuo Ku, Tokyo, Japan Less <<
NCT01949870 - Terminated(change in the devel... More >>opment strategy) Less << - -
NCT00169247 Larynx Cancer ... More >> Hypopharynx Cancer Less << Phase 2 Completed - France ... More >> Centre Oscar Lambret Lille, France, 59020 Centre René Gauducheau Nantes, France, 44805 CHU de Tours Tours, France, 37044 Less <<
NCT00716560 - Terminated(Administratively te... More >>rminated.) Less << - United States, Pennsylvania ... More >> Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT03480971 Mucositis Nep... More >>hrotoxicity Ototoxicity Less << Phase 2 Not yet recruiting October 2019 United States, Maryland ... More >> University Maryland School of Medicine Not yet recruiting Baltimore, Maryland, United States, 21201 Contact: Robert Malyapa, MD    410-328-6080       Principal Investigator: Robert Malyapa, MD Less <<
NCT00191789 Breast Cancer Phase 2 Completed - India ... More >> For additional information regarding investigative sites for this clinical trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT -5 hours, EST), or speak with your personal physician. Pune, Maharashtra, India, 411001 For additional information regarding investigative sites for this clinical trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT -5 hours, EST), or speak with your personal physician. Vellore, Tamil Nadu, India, 632004 For additional information regarding investigative sites for this clinical trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT -5 hours, EST), or speak with your personal physician. Delhi, India, 110029 Less <<
NCT00555620 Stomach Neoplasms Phase 1 Completed - Korea, Republic of ... More >> Pfizer Investigational Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Pfizer Investigational Site Goyang, Gyeonggi, Korea, Republic of, 410-769 Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Less <<
NCT02609503 Head and Neck Cancer Phase 2 Active, not recruiting March 19, 2020 United States, Maryland ... More >> John Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT03361865 UC (Urothelial Cancer) Phase 3 Active, not recruiting September 2020 -
NCT00191789 - Completed - -
NCT00002559 Ovarian Cancer ... More >> Testicular Germ Cell Tumor Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00055835 Bladder Cancer ... More >> Urethral Cancer Less << Phase 2 Completed - -
NCT00555620 - Completed - -
NCT01222676 Bladder Cancer Phase 2 Unknown - Italy ... More >> Fondazione Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Contact: Contact Person    39-2-2390-2359    roberto.salvioni@istitutotumori.mi.it Less <<
NCT01245959 Nasopharyngeal Carcinoma Phase 3 Unknown April 2018 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT00952497 Gastric Cancer Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Georgia Central Georgia Cancer Care, P.C. Macon, Georgia, United States, 31201 United States, Pennsylvania University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Spain Hospital Vall d' Hebron Barcelona, Spain, 08035 Hospital Universitari Germans Trias i Pujol Barcelona, Spain, 08916 Hospital Universitario Ramon y Cajal Madrid, Spain, 28034 Hospital Clinico San Carlos Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario Marques de Valdecilla Santander, Spain, 39008 Less <<
NCT01594099 Cervical Cancer Phase 2 Unknown March 2014 -
NCT01041404 Gastric Cancer Phase 3 Completed - -
NCT00633568 Non-small Cell Lung Carcinoma Phase 3 Terminated(Slow recruitment) - Belgium ... More >> Department of Pneumology RHMS Hôpital de la Madeleine Ath, Belgium, 7800 Department of Pneumology Clinique Saint-Luc Bouge, Belgium, 5004 Department of Pneumology CHR St Joseph-Warquignies Boussu, Belgium, 7360 Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet Brussels, Belgium, 1000 Department of Pneumology Hospital Ixelles-Molière Brussels, Belgium Department of Pneumology CHU Charleroi Charleroi, Belgium Department of Pneumology Hôpital Saint-Joseph Gilly, Belgium, 6060 Hôpital Ambroise Paré Mons, Belgium, 7000 Hôpital Vésale - Montigny-le-Tilleul Montigny-le-Tilleul, Belgium, 6110 Department of Pneumology Centre Hospitalier de Mouscron Mouscron, Belgium, 7700 CH Peltzer-La Tourelle Verviers, Belgium, 4800 France Service de Pneumologie Centre Hospitalier de Douai Douai, France, 59507 Service de Pneumologie Hôpital de Hayange Hayange, France, 57700 Pneumology department of CHU Lille Lille, France Service de Pneumologie Centre Hospitalier Intercommunal le Raincy-Montfermeil Montfermeil, France, 93370 Service de Pneumologie CHG Tourcoing Tourcoing, France, 59208 Cabinet médical Saint-Michel Valenciennes, France, 59300 Greece Medical Oncology St Savas Hospital Athens, Greece, 11522 Spain Medical Oncology Hospital de Sagunto Valencia, Spain Less <<
NCT01258634 Osteosarcoma ... More >>Lung Metastases Less << Phase 1 Terminated(PI no longer affili... More >>ated with institution; only 2 subjects enrolled) Less << - United States, Illinois ... More >> University of Chicago Department of Pediatrics Hematology/Oncology Chicago, Illinois, United States, 60637 Less <<
NCT01882621 Non-small Cell Lung Cancer Phase 3 Unknown August 2016 China, Guangdong ... More >> Sun Yat-Sen University Cancer Center Recruiting GuangZhou, Guangdong, China, 510030 Contact: Ting Zhou    8602087343786    zhouting@sysucc.org.cn    Sub-Investigator: Yan Huang, Doctor Less <<
NCT00952341 - Completed - -
NCT01466244 - Completed - -
NCT00022217 Head and Neck Cancer Phase 2 Unknown - United States, Arizona ... More >> Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States, 85012 Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States, 85723 United States, Illinois Division of Head and Neck Surgery Evanston, Illinois, United States, 60201 United States, Louisiana Louisiana State University Health Sciences Center - Shreveport Shreveport, Louisiana, United States, 71130-3932 Less <<
NCT00952341 Chemotherapy-induced Nausea an... More >>d Vomiting (CINV) Less << Phase 3 Completed - -
NCT01041404 - Completed - -
NCT00320294 Stomach Neoplasm Phase 2 Unknown - Korea, Republic of ... More >> Gachon University Gil Medical Center Incheon, Korea, Republic of, 405 760 Less <<
NCT00130780 - Completed - -
NCT00130780 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01131429 Neoplasms, Lung ... More >> Carcinoma, Non-Small Cell Lung Drug Therapy Genes, EGFR Less << Phase 2 Unknown June 2015 China, Beijing ... More >> Chinese PLA General Hospital Not yet recruiting Beijing, Beijing, China, 100853 Contact: Liang-An Chen, MD, phD    86-10-66939361    chenla301@263.net    Principal Investigator: Liang-An Chen, MD, phD Less <<
NCT00316888 Anal Cancer Phase 2 Active, not recruiting May 2022 -
NCT02402842 Anal Canal Carcinoma Phase 2 Active, not recruiting September 2021 France ... More >> University hospital of Besançon Besançon, France, 25000 FNLCC center Georges François Leclerc Dijon, France, 21000 Oscar Lambret center Lille, France, 59000 Jean Mermoz Private Hospital Lyon, France, 69 008 Hospital of Belfort-Montbeliard Montbeliard, France, 25200 Regional Institute of Cancer Montpellier, France, 34 298 Institute of Cancerology of Lorraine Nancy, France, 54 519 Antoine Lacassagne Center Nice, France, 06 189 Paris Saint-Joseph Hospital Group Paris, France, 75 014 Curie Institute Paris, France, 75 248 Pitié Salpétrière Hospital Paris, France, 75 651 Mutualist Montsouris Institute Paris, France, 75 674 European Georges Pompidou Hospital Paris, France, 75 908 Saint-Antoine Hospital Paris, France, 75571 University Robert Debré Hospital Reims, France, 51 092 Paul Strauss Center Strasbourg, France, 67 065 Less <<
NCT00538525 Breast Cancer Not Applicable Completed - -
NCT00977561 Small Cell Lung Carcinoma Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT03121716 Nasopharyngeal Carcinoma Phase 1 Recruiting April 2018 China ... More >> Jiangsu Hengrui Recruiting Shanghai, China Contact: Qing Yang    +8615705155017    yangqing@hrs.com.cn Less <<
NCT01714908 Non-small Cell Lung Cancer Phase 2 Active, not recruiting October 20, 2018 China, Beijing ... More >> Cancer Institute & Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100021 Beijing Cancer Hospital Beijing, Beijing, China, 100142 Chinese PLA General Hospital Beijing, Beijing, China, 100853 The General Hospital of the People's Liberation Army Beijing, Beijing, China, 100853 China, Fujian Fujian Province Cancer Hospital Fuzhou, Fujian, China, 350008 The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China, 361003 China, Guizhou Guizhou Cancer Hospital Guiyang, Guizhou, China, 550004 China, Hebei Hebei Medical University Fourth Hospital Shijiazhuang, Hebei, China, 050011 China, Henan Henan Cancer Hospital Zhengzhou, Henan, China, 450008 China, Hubei Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China, 430022 Zhongnan Hospital of Wuhan University Wuhan, Hubei, China, 430030 Renmin Hospital of Wuhan University Wuhan, Hubei, China, 430060 China, Liaoning The First Hospital of China Medical University Shenyang, Liaoning, China, 110001 China, Shandong Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 China, Shanghai Fudan University Shanghai Cancer Center Shanghai, Shanghai, China, 200032 China, Sichuan West China Hospital, West China School of Medicine, Sichuan University Chengdu, Sichuan, China, 610041 China, Tianjin Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin, China, 300060 China, Zhejiang The First People's Hospital of Hangzhou Hangzhou, Zhejiang, China, 310006 Zhejiang Cancer Hospital Hangzhou, Zhejiang, China, 310022 Less <<
NCT00964626 Ovarian Cancer Phase 2 Unknown - Russian Federation ... More >> Russian Academy of Medical Sciences Cancer Research Center Recruiting Moscow, Russian Federation, 115478 Contact: Sergei A. Tjulandin, MD, PhD    7-495-324-9874 Less <<
NCT00977561 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00269152 Non-Small Cell Lung Cancer Phase 2 Completed - France ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bordeaux, France, 33076 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Paris, France, 75571 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rennes, France, 35033 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St Priest En Jarez, France, 42270 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Toulouse, France, 31059 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bad Berka, Germany, 99437 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bielefeld, Germany, D-33604 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Großhansdorf, Germany, D-22927 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halle, Germany, D-06120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, D-30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kassel, Germany, 34125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Köln, Germany, D-51109 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Loewenstein, Germany, 74245 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, D-55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santiago De Compostela, Spain, 15706 Less <<
NCT00400179 Gastric Cancer Phase 3 Completed - -
NCT00316888 - Active, not recruiting - -
NCT00191841 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - Russian Federation ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Barnaul, Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Moscow, Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician St Petersburg, Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Ufa, Russian Federation Less <<
NCT02324543 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 1 Phase 2 Active, not recruiting January 2020 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT00072787 Gastric Cancer Phase 1 Phase 2 Completed - United States, California ... More >> Rosen, Lee Los Angeles, California, United States, 90025 University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States, 90089 United States, Hawaii Chong, Clayton Honolulu, Hawaii, United States, 96817 Straub Clinic and Hospital Honolulu, Hawaii, United States, 96817 United States, Illinois Northwestern University Robert H Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 University of Chicago Chicago, Illinois, United States, 60637 United States, New Mexico Lovelace Sandia Health System Albuquerque, New Mexico, United States, 87108 New Mexico VA Health Care System Albuquerque, New Mexico, United States, 87108 University of New Mexico - Albuquerque Albuquerque, New Mexico, United States, 87131 United States, Pennsylvania Abramson Cancer Center at the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00269152 - Completed - -
NCT00536640 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - Germany ... More >> Klinikum Bayreuth GmbH Bayreuth, Germany, D-95445 Charite´ Mitte Berlin, Germany, D-10117 Gemeinschaftskrankenhaus Havelhöhe Berlin, Germany, D-14089 Helios Klinikum Emil v. Behring Berlin, Germany, D-14165 Augusta-Krankenanstalten Bochum, Germany, D-44791 Johanniter-Krankenhaus Bonn Bonn, Germany, D-53113 Forschungszentrum Borstel Borstel, Germany, D-23845 St. Johannes Hospital Duisburg, Germany, D-47166 Krankenhaus Nordwest Frankfurt am Main, Germany, D-60488 Klinikum Frankfurt (Oder)GmbH Frankfurt Oder, Germany, D-15232 Städtisches Krankenhaus Frankfurt-Höchst Frankfurt, Germany, D-65929 Medizinisches Versorgungszentrum Osthessen Fulda, Germany, D-36043 Universitätsklinikum Greifswald Greifswald, Germany, D-17487 Krankenhaus Großhansdorf Großhansdorf, Germany, D-22927 Georg-August-Universität Göttingen Göttingen, Germany, D-37075 Diakoniekrankenhaus Halle/S. Halle, Germany, D-06114 Asklepios Klinik Harburg Hamburg, Germany, D-21075 Thoraxklinik Universitätsklinikum Heidelberg Heidelberg, Germany, D-69126 Lungenklinik Hemer Hemer, Germany, 58675 Fachklinik für Lungenerkrankungen Immenhausen Immenhausen, Germany, D-34376 St. Vincentius-Kliniken Karlsruhe Karlsruhe, Germany, D-76137 Klinikum Kassel GmbH Kassel, Germany, 34125 Katholisches Klinikum Haus Marienhof Koblenz, Germany, 56073 Malteser Krankenhaus St. Hildegardis Köln, Germany, D-50931 Onkologische Schwerpunktpraxis Dr. Lothar Müller Leer, Germany, D-26789 Klinikum Lippe-Lemgo Lemgo, Germany, D-32657 Klinikum Ludwigshafen Ludwigshafen, Germany, D-67063 Klinik Löwenstein Löwenstein, Germany, 74245 Universitätsklinikum Schleswig-Holstein Lübeck, Germany, D-23538 St. Hildegardis Krankenhaus Mainz, Germany, D-55131 Universitätsklinikum Marburg Marburg, Germany, D-35033 Johannes Wesling Klinikum Minden Minden, Germany, 32429 Krankenhaus Barmherzige Brüder Regensburg, Germany, D-93049 Hanse-Klinikum Stralsund Stralsund, Germany, D-18410 Onkologische Gemeinschaftspraxis Dr. Nusch Velbert, Germany, D-42551 Fachkliniken Wangen Wangen, Germany, D-88239 Helios Klinikum Wuppertal Wuppertal, Germany, D-42283 Less <<
NCT00126269 Carcinoma Phase 3 Unknown - France ... More >> Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Karim FIZAZI, Dr    33 1 42114559    fizazi@igr.fr Less <<
NCT01160731 Lung Cancer Phase 1 Withdrawn - -
NCT00400179 - Completed - -
NCT01150630 Pancreatic Cancer Phase 2 Completed - Italy ... More >> Istituto Scientifico H. San Raffaele Milan, Italy, 20132 Less <<
NCT00003044 Liver Cancer Phase 2 Unknown - United States, Maryland ... More >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21287 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Hong Kong Prince of Wales Hospital Shatin, New Territories, Hong Kong Less <<
NCT02889666 Recurrent Non-small Cell Lung ... More >>Cancer Less << Phase 1 Recruiting December 2020 China, Jilin ... More >> China-Japan Union Hospital, Jilin University Recruiting Changchun, Jilin, China, 130033 Contact: Xian-Ling Cong, M.D    86-0431-89876626    qingzhao_jilin@126.com    China Shanghai 10th People's Hospital Recruiting Shanghai, China, 200072 Contact: Da Fu, Ph.D    86-15921527578    fu800da900@126.com    Shanghai Pulmonary Hospital, Tongji University School of Medicine Recruiting Shanghai, China, 200433 Contact: Chun-Yan Wu, M.D    86-65115006-3030    51917533@qq.com Less <<
NCT00069966 Lymphoma Phase 2 Unknown - -
NCT00677118 Nasopharyngeal Carcinoma Phase 3 Unknown March 2015 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT00968799 Epithelial Ovarian Cancer ... More >> Fallopian Tube Carcinoma Less << Not Applicable Terminated(poor patient accrua... More >>l) Less << - Switzerland ... More >> Department of Surgery, Cantonal Hospital St. Gallen St. Gallen, Switzerland, 9007 Less <<
NCT02795988 Gastrointestinal Neoplasms ... More >> Adenocarcinoma Less << Phase 1 Phase 2 Recruiting December 2020 Georgia ... More >> ARENSIA Exploratory Medicine LLC Recruiting Tbilisi, Georgia, 0112 Contact: Lili Ioseliani, MD          Principal Investigator: Marina Maglakelidze, MD          Hong Kong Department of Medicine, Queen Mary Hospital Recruiting Hong Kong, Hong Kong Contact: Thomas Yau, MD          Moldova, Republic of ARENSIA Exploratory Medicine IMSP Institutul Oncologic Recruiting Chisinau, Moldova, Republic of, 2025 Contact: Natalia Pirtac, MD          Principal Investigator: Lurie Bulat, MD          Taiwan Chang Gung Memorial Hospital Recruiting Taipei, Songshan District, Taiwan, 105 Contact: Wen-Chi Chou, MD          Principal Investigator: Wen-Chi Chou, MD          China Medical University Hospital Recruiting Taichung, Taichung City, Taiwan, 40402 Contact: Li-Yuan Bai, MD          Principal Investigator: Li-Yuan Bai, MD          National Cheng-Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Chia-Jui Yen, MD          Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 11217 Contact: Yee Chao, MD          Thailand Immunology Unit, Research Division, National Cancer Institute Recruiting Bangkok, Bankgkok, Thailand, 10400 Contact: Wirote Lausoontornsiri, MD          Principal Investigator: Wirote Lausoontornsiri, MD          Division of Medical Oncology, Department of Medicine, Prince of Songkla University, Songklanagarind Hospital Recruiting Hat Yai, Songkhla Province, Thailand, 90110 Contact: Arunee Dechaphunkul, MD          Principal Investigator: Arunee Dechaphunkul, MD          Chulabhorn Hospital Recruiting Bangkok, Thailand, 10210 Contact: Teerapat Ungtrakul, MD          Principal Investigator: Teerapat Ungtrakul, MD          Division of Medical Oncology, Department of Medicine, Chulalongkorn University Recruiting Bangkok, Thailand, 10330 Contact: Suebpong Tansanvimon, MD          Principal Investigator: Suebpong Tansanvimon, MD          Oncology Unit, Department of Medicine, Rajavithi Hospital Recruiting Bangkok, Thailand, 10400 Contact: Jedzada Maneechavakajorn, MD          Principal Investigator: Jedzada Maneechavakajorn, MD          Division of Oncology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University Recruiting Chiang Mai, Thailand, 50200 Contact: Chaiyut Charoentum, MD          Principal Investigator: Chaiyut Charoentum, MD          Srinagarind Hospital Recruiting Khon Kaen, Thailand, 40002 Contact: Aumkhae Sookprasert, MD          Principal Investigator: Aumkhae Sookprasert, MD Less <<
NCT00968799 - Terminated(poor patient accrua... More >>l) Less << - -
NCT00588835 Tumor Phase 4 Terminated - Netherlands ... More >> University Medical Center Groningen Groningen, Netherlands Radboud University Nijmegen Medical Centre Nijmegen, Netherlands Less <<
NCT00418535 Lymphoma, T-Cell Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT03317496 Non-small Cell Lung Cancer ... More >> Urothelial Cancer Less << Phase 2 Recruiting October 2, 2021 -
NCT03102320 Neoplasms Phase 1 Recruiting July 28, 2021 -
NCT00041015 Lung Cancer Phase 3 Completed - United States, Ohio ... More >> Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00082472 NSCLC Phase 1 Phase 2 Unknown - United States, Connecticut ... More >> Yale University Cancer Center New Haven, Connecticut, United States, 06520 United States, Nevada Southern Nevada Cancer Research Foundation Las Vegas, Nevada, United States, 89106 Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, New York Montefiore Medical Center Bronx, New York, United States, 10461 United States, Ohio Arthur G James Cancer Hospital and Richard Solove Research Institute at Ohio State University Columbus, Ohio, United States, 43210 United States, Wisconsin University of Wisconsin Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00001426 Ovarian Neoplasm Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02290145 Mouth Neoplasms ... More >> Carcinoma, Squamous Cell Less << Phase 2 Recruiting December 2019 China, Shanghai ... More >> Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200011 Contact: Lai-ping Zhong, PhD, MD, DDS    +86-21-23271699 ext 5160    zhonglaiping@163.com Less <<
NCT00006043 Ovarian Cancer ... More >> Testicular Germ Cell Tumor Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01093690 Cancer Not Applicable Completed - Thailand ... More >> Division of medical oncology, department of medicine Siriraj Hospital Bangkok, Thailand, 10700 Less <<
NCT01604863 Cancer Phase 1 Suspended(Study suspended prio... More >>r to enrollment) Less << July 2014 United States, Arizona ... More >> Scottsdale, Arizona, United States, 85258 United States, Massachusetts Boston, Massachusetts, United States, 02114 Less <<
NCT01093690 - Completed - -
NCT00828386 Nasopharyngeal Cancers Phase 3 Terminated(Low accrual) - France ... More >> Hôpital de la Pitié-Salpétrière Paris, France, 75013 Institut Gustave Roussy Villejuif, France, 94805 Morocco University of Casablanca Casablanca, Morocco Romania University of Cluj Cluj, Romania Tunisia Hôpital Habib Bourguiba Sfax, Tunisia Less <<
NCT01833832 Adrenocortical Carcinoma ... More >> Peritoneal Carcinomatosis Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00005840 Endometrial Clear Cell Adenoca... More >>rcinoma Endometrial Serous Adenocarcinoma Stage III Uterine Corpus Cancer Stage IV Uterine Corpus Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT01424709 Non-small Cell Lung Cancer Phase 2 Unknown December 2014 China ... More >> Medical Department, Shanghai Pulmonary Hospital Shanghai, China, 200433 Less <<
NCT01936376 - Unknown June 2015 United States, Massachusetts ... More >> Harvard Medical School - Brigham and Women's Hospital Not yet recruiting Boston, Massachusetts, United States, 02115 Contact: Research Coordinator1          Contact: Research Coordinator2          Principal Investigator: Sushrut Waikar, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Research Coordinator1          Contact: Research Coordinator2          Principal Investigator: Robert Haddad, MD          United States, Texas University of Texas MD Anderson Recruiting Houston, Texas, United States, 77030 Contact: Research Coordinator1          Contact: Research Coordinator2          Principal Investigator: Bonnie Glisson, MD          Sub-Investigator: Ala Abudayyeh, MD Less <<
NCT00040625 - - - United States, New Jersey ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Basking Ridge, New Jersey, United States Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Porto Alegre, RS, Brazil For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Sao Paulo, Brazil Egypt "For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician." Cairo, Egypt For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Cairo, Egypt Saudi Arabia For additional information regarding investigative sites for this trial, contact the Clinical Trials support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician Jeddah, Saudi Arabia Less <<
NCT00811447 Stomach Neoplasms Phase 3 Completed - China ... More >> Sanofi-Aventis Administrative Office Shanghai, China Less <<
NCT01029678 Non Small Cell Lung Cancer Phase 2 Completed - France ... More >> CHU Brest Brest, France Centre Hospitalier GAP GAP, France Département de Pathologie Respiratoire du CHU de Limoges Limoges, France CH de Meaux Meaux, France CHU Reims Reims, France Less <<
NCT03258554 Head and Neck Squamous Cell Ca... More >>rcinoma Squamous Cell Carcinoma of Unknown Primary Origin Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 Less << Phase 2 Phase 3 Suspended(Scheduled Interim Mo... More >>nitoring) Less << December 31, 2025 -
NCT02812420 Hydronephrosis ... More >> Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant Renal Pelvis Urothelial Carcinoma Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 Stage II Renal Pelvis Cancer AJCC v7 Stage II Ureter Cancer AJCC v7 Stage II Urethral Cancer AJCC v7 Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 Stage III Renal Pelvis Cancer AJCC v7 Stage III Ureter Cancer AJCC v7 Stage III Urethral Cancer AJCC v7 Stage IV Renal Pelvis Cancer AJCC v7 Stage IV Ureter Cancer AJCC v7 Stage IV Urethral Cancer AJCC v7 Ureter Urothelial Carcinoma Urethral Urothelial Carcinoma Less << Phase 1 Recruiting March 31, 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Jianjun Gao    713-792-2830       Principal Investigator: Jianjun Gao Less <<
NCT00003157 Gastric Cancer ... More >> Pancreatic Cancer Less << Phase 1 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Less <<
NCT02445872 Chemotherapy-Induced Nausea an... More >>d Vomiting Lung Cancer Less << Phase 2 Unknown May 2016 China, Zhejiang ... More >> The first affiliated hospital, Zhejiang University Hangzhou, Zhejiang, China, 310003 Less <<
NCT00006096 Vulvar Cancer Phase 3 Terminated - -
NCT00109850 Esophageal Cancer Phase 2 Terminated(Closed due to poor ... More >>accrual) Less << - -
NCT02001896 Non-Small Cell Lung Cancer Phase 3 Unknown June 2015 China, Xinjiang ... More >> Xinjiang medical university Not yet recruiting Urumqi, Xinjiang, China, XJTHLC001 Contact: Li Shan, Master    13609989394    shanlinew319@163.com    Sub-Investigator: Qiang Wang, Master Less <<
NCT00026403 Pancreatic Cancer Phase 2 Completed - -
NCT00550901 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - -
NCT00686114 Esophageal Cancer Phase 3 Unknown December 2014 China, Zhejiang ... More >> 1st affliated hospital of Wen Zhou Medical college Recruiting Wen Zhou, Zhejiang, China, 325000 Contact: Shixiu Wu, M.D.    +86057788069372    wushixiu@medmail.com.cn    Contact: Xuebang Zhang, M.D.       baxuza@126.com    Principal Investigator: Shixiu Wu, MD Less <<
NCT00109850 - Terminated(Closed due to poor ... More >>accrual) Less << - -
NCT01215136 Transitional Cell Carcinoma ... More >> Bladder Carcinoma Urothelial Carcinoma Less << Phase 2 Active, not recruiting June 2018 United States, Alabama ... More >> University of Alabama Hematology Oncology Clinic at Medical West Birmingham, Alabama, United States, 35294 United States, Illinois Northwestern University, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 United States, Indiana Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 IU Health Central Indiana Cancer Centers Indianapolis, Indiana, United States, 46219 United States, Michigan Metro Health Cancer Care Wyoming, Michigan, United States, 49519 United States, Nebraska Nebraska Cancer Specialists Omaha, Nebraska, United States, 68114 United States, New York Icahn School of Medicine: Tisch Cancer Institute at Mount Sinai Medical Center New York, New York, United States, 10029 United States, South Carolina MUSC Hollings Cancer Center Charleston, South Carolina, United States, 29425 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 Less <<
NCT00857246 - Completed - -
NCT02335411 Gastric Adenocarcinoma ... More >> Gastroesophageal Junction Adenocarcinoma Less << Phase 2 Active, not recruiting May 27, 2019 -
NCT00191139 Non-small Cell Lung Cancer Phase 2 Completed - United States, Colorado ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Denver, Colorado, United States, 80218 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph South Bend, Indiana, United States, 46601 United States, Maryland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Baltimore, Maryland, United States, 21237 United States, Michigan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Kalamazoo, Michigan, United States, 49048 United States, Missouri For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Kansas City, Missouri, United States, 64128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph St Louis, Missouri, United States, 63141 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Cleveland, Ohio, United States, 44106 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Portland, Oregon, United States, 97213 United States, Pennsylvania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Memphis, Tennessee, United States, 38120 Argentina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Rosario, Argentina, 2000 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Beijing, China, 100021 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Chengdu, China, 610041 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Seoul, Korea, Republic of, 138-736 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Suwon-City, Korea, Republic of, 442-723 Less <<
NCT01755845 Cervical Cancer Phase 3 Unknown December 2016 China, Zhejiang ... More >> The First Affiliated Hospital of Wenzhou Medical College Recruiting Wenzhou, Zhejiang, China, 325000 Contact: congying xie    +86-577-88069316    wzxiecongying@163.com    Principal Investigator: congying xie, MD Less <<
NCT00857246 Gastric Cancer ... More >> Stomach Cancer Less << Phase 2 Completed - United States, New York ... More >> NYU Cancer Center New York, New York, United States, 10016 Less <<
NCT00599755 - Completed - -
NCT00599755 Carcinoma Non... More >>-small Cell Lung Cancer Less << Phase 1 Completed - -
NCT01501149 Nasal and Nasal-type NK/T-cell... More >> Lymphoma Less << Phase 4 Recruiting May 2019 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr       mingzhi_zhang@126.com    Principal Investigator: Mingzhi Zhang, Pro,Dr Less <<
NCT00867009 Non-Small-Cell Lung Cancer Phase 2 Completed - Austria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Graz, Austria, 8036 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salzburg, Austria, 5020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wels, Austria, 4600 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 13125 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halle, Germany, D-06120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg, Germany, 66421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tuebingen, Germany, 72076 Greece For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Athens, Greece, 11527 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Patras, Greece, 26500 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bari, Italy, 70126 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bergamo, Italy, 24128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Palermo, Italy, 90146 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Potenza, Italy, 85028 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Torino, Italy, 10100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Treviso, Italy, 31100 Netherlands For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Amsterdam, Netherlands, 1081 HV For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Groningen, Netherlands, 9713 GZ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maastricht, Netherlands, 6229 HX For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. S-Hertogenbosch, Netherlands, 5211 NL Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lleida, Spain, 25198 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28034 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Reus, Spain, 43201 Less <<
NCT00757549 Head and Neck Cancer Early Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00402051 Non-Small-Cell Lung Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Germany, D-01640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 65929 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Großhansdorf, Germany, D-22927 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Halle, Germany, D-06120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, D-21075 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hofheim, Germany, D-65719 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Homburg/Saar, Germany, 66421 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Immenhausen, Germany, D-34376 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leipzig, Germany, 04207 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Luebeck, Germany, 23538 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz, Germany, 55131 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Muenchen, Germany, 81664 Less <<
NCT00191139 - Completed - -
NCT00817895 Hepatocellular Carcinoma Not Applicable Completed - China, Shanghai ... More >> Eastern Hepatobiliary Surgery Hospital Shanghai, Shanghai, China, 200438 Less <<
NCT00402051 - Completed - -
NCT00985998 Non-small Cell Lung Cancer Phase 1 Withdrawn(no paticipants enrol... More >>led) Less << - China, Beijing ... More >> Cancer Institute & Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100000 Less <<
NCT00169182 Larynx Cancer ... More >> Hypopharynx Cancer Less << Phase 3 Completed - France ... More >> CHU Bretonneau Tours, France, 37044 Less <<
NCT00868491 Head and Neck Cancer Phase 2 Completed - Slovenia ... More >> Institute of Oncology Ljubljana Ljubljana, Slovenia, SI-1000 Less <<
NCT00867009 - Completed - -
NCT01194635 - Completed - -
NCT00290953 Lung Cancer P... More >>ulmonary Neoplasms Small Cell Lung Cancer Less << Phase 2 Phase 3 Completed - Argentina ... More >> Sanofi-Aventis Administrative Office Buenos Aires, Argentina Australia Sanofi-Aventis Administrative Office Macquarie Park, Australia Belgium Sanofi-Aventis Administrative Office Diegem, Belgium Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil France Sanofi-Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Berlin, Germany Hungary Sanofi-Aventis Administrative Office Budapest, Hungary Italy Sanofi-Aventis Administrative Office Milano, Italy Mexico Sanofi-Aventis Administrative Office Mexico, Mexico Netherlands Sanofi-aventis adminsitrative office Gouda, Netherlands Poland Sanofi-Aventis Administrative Office Warszawa, Poland Russian Federation Sanofi-Aventis Administrative Office Moscow, Russian Federation Spain Sanofi-Aventis Administrative Office Barcelona, Spain United Kingdom Sanofi-Aventis Administrative Office Guildford Surrey, United Kingdom Less <<
NCT03240016 Urothelial Carcinoma Phase 2 Recruiting October 1, 2021 United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Ajjai Alva, M.D.    734-936-0091    ajjai@umich.edu    Principal Investigator: Ajjai Alva, MD Less <<
NCT00940069 Non-small-cell Lung Cancer ... More >> Adenocarcinoma Less << Phase 2 Completed - China, Hunan ... More >> HuNan province tumor hospital ChangSha, Hunan, China, 410013 Less <<
NCT00616785 Lung Cancer Phase 2 Unknown - Korea, Republic of ... More >> Yonsei Cancer Center at Yonsei University Medical Center Recruiting Seoul, Korea, Republic of, 120-752 Contact: Joo-Hang Kim, MD    +82-10-4507-6063    kjhang@yuhs.ac Less <<
NCT00402545 Head and Neck Neoplasms Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00480597 Metastatic Breast Cancer Phase 2 Completed - -
NCT01639521 Anterior Urethral Cancer ... More >> Localized Transitional Cell Cancer of the Renal Pelvis and Ureter Posterior Urethral Cancer Recurrent Bladder Cancer Recurrent Urethral Cancer Regional Transitional Cell Cancer of the Renal Pelvis and Ureter Stage III Bladder Cancer Transitional Cell Carcinoma of the Bladder Ureter Cancer Urethral Cancer Associated With Invasive Bladder Cancer Less << Phase 2 Withdrawn(Lack of funding) - -
NCT00409006 Non-small Cell Lung Cancer Phase 2 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fujian, China, 350014 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Qingdao, China, 266003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 201900 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 137-701 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changhua, Taiwan, 500 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan, 100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tao-Yuan, Taiwan, 333 Less <<
NCT03613168 Cholangiocarcinoma ... More >> Biliary Tract Cancer HER-2 Protein Overexpression HER-2 Gene Amplification Less << Phase 2 Not yet recruiting December 1, 2020 -
NCT00052494 Lung Cancer Phase 1 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT03544814 Lung Adenocarcinoma ... More >> EGFR Activating Mutation Less << Phase 2 Completed - -
NCT00409006 - Completed - -
NCT00268671 Head and Neck Neoplasms Phase 1 Phase 2 Completed - -
NCT01859741 Stage IV Small Cell Lung Cance... More >>r Less << Phase 1 Phase 2 Completed - -
NCT02610010 Nasopharyngeal Carcinoma Phase 3 Recruiting November 2025 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Fang-Yun Xie, M.D.    +86-020-87342618    xiefy@sysucc.org.cn    Contact: Pu-Yun OuYang, M.D.    +86-020-87342618    ouyangpy@sysucc.org.cn Less <<
NCT00156286 Small Cell Lung Cancer Phase 2 Completed - United States, Michigan ... More >> Univeristy of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00003930 Bladder Cancer Phase 1 Phase 2 Completed - -
NCT03267940 Cholangiocarcinoma Non-resecta... More >>ble Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma, Extrahepatic Gallbladder Adenocarcinoma Less << Phase 1 Recruiting February 29, 2020 -
NCT02041819 Squamous Cell Carcinoma of Eso... More >>phagus Less << Phase 2 Withdrawn(No recruitment) January 2017 China, Zhejiang ... More >> The first affiliated hospital, Zhejiang University Zhejiang, Zhejiang, China, 310003 Less <<
NCT02120807 Stage IV Lung Adenocarcinoma Phase 1 Active, not recruiting April 2019 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT00999700 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 3 Active, not recruiting December 2021 Italy ... More >> Ospedale Civile Ss. Antonio E Biagio Alessandria, Italy Ausl Della Valle D' Aosta Aosta, Italy Policlinico S. Orsola-Malpighi Bologna, Italy Asl 8 - Ospedale Businco Cagliari, Italy A.S.O. S. Croce E Carle Cuneo, Italy, 12100 Irccs - Aou S. Martino - Oncology Genoa, Italy Irccs - Aou San Martino - Radiotherapy Genoa, Italy Asl 3 Genovese Genova, Italy E.O. Ospedali Galliera Genova, Italy Azienda Ospedaliera Villa Scassi - Asl3 Italy, Italy Istituto Nazionale Dei Tumori Milano, Italy Azienda Ospedaliero Universitaria Di Modena Modena, Italy Ospedale S. Giacomo Novi Ligure (al), Italy Azienda Ospedaliero-Universitaria Di Parma Parma, Italy Azienda Ospedaliera Ospedali Riuniti Di Fano Pesaro, Italy Arcispedale S. Maria Nuova Reggio Emilia, Italy Irccs Centro Di Riferimento Oncologico Di Basilicata (Crob) Rionero in Vulture (pz), Italy Ospedale S. Filippo Neri Roma, Italy Ospedale S. Paolo Savona, Italy A.O. Universitaria S. Giovanni Battista-Molinette Di Torino Torino (to) Turin, Italy A.O. Universitaria S. Giovanni Battista-Molinette Di Torino Turin, Italy Less <<
NCT01530997 Carcinoma, Squamous Cell ... More >> Head and Neck Neoplasms Oropharyngeal Neoplasms Less << Phase 2 Active, not recruiting January 2022 United States, Colorado ... More >> Penrose Cancer Center Colorado Springs, Colorado, United States, 80907 United States, Florida University of Florida, Department of Radiation Oncology Gainesville, Florida, United States, 32610-0385 United States, North Carolina University of North Carolina at Chapel Hill, Department of Radiation Oncology Chapel Hill, North Carolina, United States, 27599 Rex Healthcare Raleigh, North Carolina, United States, 27607 Rex Cancer Center of Wakefield Raleigh, North Carolina, United States, 27614 Less <<
NCT00269997 Anemia Neopla... More >>sms Less << Phase 2 Completed - -
NCT03100955 Progression Free Survival Phase 3 Recruiting August 1, 2019 China, Shandong ... More >> Affiliated Hospital of Qingdao University Recruiting Qingdao, Shandong, China, 266001 Contact: Zhuang Yu, MD    (86)18661805688    yuzhuang2002@163.com    Principal Investigator: Zhuang Yu, MD, Ph.D Less <<
NCT03502681 Metastatic Urothelial Cell Can... More >>cer Less << Phase 1 Recruiting July 2019 United States, Pennsylvania ... More >> Penn State Cancer Intsitute Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Heather Rutherford    717-531-0003       Principal Investigator: Monika Joshi Less <<
NCT01192750 - Completed - -
NCT00066222 Lung Cancer Phase 2 Completed - -
NCT01530997 - Active, not recruiting - -
NCT02821533 Hepatocellular Carcinoma Phase 2 Terminated(Poor case accrual) - Hong Kong ... More >> Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong, Hong Kong Less <<
NCT03480672 HNSCC Phase 2 Recruiting August 2022 Germany ... More >> Department of Head Medicine and Oral Health, University of Leipzig Recruiting Leipzig, Germany, 04103 Contact: Andreas Dietz, Prof. Dr. Less <<
NCT00774319 Head and Neck Cancer Phase 2 Unknown April 2012 Netherlands ... More >> Netherlands Cancer Institute Recruiting Amsterdam, Netherlands Contact: J.P. de Boer    31 20 512 9111    j.d.boer@nki.nl    Principal Investigator: J.P. de Boer          University Medical Center Nijmegen st Radboud Recruiting Nijmegen, Netherlands, 6525 GH Principal Investigator: C.M.L van Herpen, Md, Phd Less <<
NCT00296335 Stomach Cancer Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00296335 - Completed - -
NCT00427102 Squamous Cell Carcinoma ... More >> Head and Neck Cancer Resected Head and Neck Cancer Mucositis Less << Phase 1 Terminated(No subjects enrolle... More >>d and PI went to another facility) Less << - -
NCT00066222 - Completed - -
NCT00477867 Ovarian Cancer Not Applicable Withdrawn(Trial was never acti... More >>vated) Less << - -
NCT02705612 Cervical Cancer Phase 2 Unknown September 2018 China, Shaanxi ... More >> Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University Recruiting Xi'an, Shaanxi, China, 710032 Contact: Mei Shi, MD    +86-029-84775425    mshifmmu@yahoo.com    Principal Investigator: Mei Shi, MD          Sub-Investigator: Li-Chun Wei, M.D.,Ph.D Less <<
NCT01697072 Gastric Cancer Phase 3 Terminated(All Amgen sponsored... More >> AMG102 clinical studies were terminated following a pre-planned Data Monitoring Committee safety review of study 20070622.) Less << - -
NCT01611506 Gastric Cancer Phase 1 Phase 2 Terminated(Outcome of EXPAND s... More >>tudy (no benefit from adding cetuximab to the first-line chemotherapy in advanced gastric cancer in the overall patient population)) Less << - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland Less <<
NCT00034268 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - -
NCT00002654 Head and Neck Cancer Phase 3 Completed - Switzerland ... More >> Universitaetsspital Zurich, Switzerland, CH-8091 Less <<
NCT00005819 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT02558959 Biliary Tract Neoplasms Phase 2 Completed - China, Zhejiang ... More >> First affiliated hospital, Zhejiang University Hangzhou, Zhejiang, China, 310006 Less <<
NCT00354549 Lung Cancer Phase 2 Completed - Switzerland ... More >> Universitaetsspital-Basel Basel, Switzerland, CH-4031 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Less <<
NCT02579564 Malignant Hydrothorax ... More >> Non Small Cell Lung Cancer Less << Phase 3 Unknown December 2018 -
NCT00433498 Lung Cancer Phase 3 Completed - -
NCT00506155 - Completed - -
NCT02586207 Head and Neck Cancer ... More >> Squamous Cell Carcinoma Oral Cavity Cancer Oropharynx Cancer Hypopharynx Cancer Larynx Cancer Laryngeal Cancer Less << Phase 1 Active, not recruiting September 2021 United States, California ... More >> UCSD Moores Cancer Center La Jolla, California, United States, 92093-0698 United States, North Dakota Sanford-Bismarck Medical Center Bismarck, North Dakota, United States, 58501 Sanford-Roger Maris Cancer Center Fargo, North Dakota, United States, 58122 United States, South Dakota Sanford Health Cancer Center Sioux Falls, South Dakota, United States, 57104 Less <<
NCT02778308 Gallbladder Cancer Not Applicable Unknown December 2017 India ... More >> GIPMER Recruiting New Delhi, India, 110002 Contact: Sundeep S Saluja, MCh    (718599259    sundeepsaluja@yahoo.co.in Less <<
NCT02012062 Nasopharyngeal Carcinoma Phase 3 Unknown June 2018 China ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China, 200032 Contact: Lin Kong, MD    86 18017312533    konglinj@gmail.com    Principal Investigator: Jiade J Lu, MD          Principal Investigator: Jianji Pan, MD          Sub-Investigator: Shaojun Lin, MD          Principal Investigator: Qin Lin, MD          Sub-Investigator: Chaosu Hu, MD Less <<
NCT00540280 Carcinoma, Non-Small-Cell Lung Phase 3 Suspended(Follow up only) October 2013 -
NCT01297101 - - - -
NCT00506155 Bladder Cancer Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00190801 Gastrointestinal Neoplasms Phase 2 Completed - Korea, Republic of ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. In Cheon, Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of Less <<
NCT00404326 Cervical Cancer Phase 2 Completed - Mexico ... More >> National Institute of Cancerologia Mexico City, Tlalpan, Mexico, 14080 Less <<
NCT00716417 Neoplasms Phase 1 Completed - Belgium ... More >> 1200.37.3202 Boehringer Ingelheim Investigational Site Bruxelles, Belgium 1200.37.3201 Boehringer Ingelheim Investigational Site Edegem, Belgium 1200.37.3203 Boehringer Ingelheim Investigational Site Gent, Belgium Less <<
NCT00716417 - Completed - -
NCT00191815 Breast Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9AM to 5PM Eastern time (UTC/ GMT - 5hours, EST), or speak with your personal physician Munich, Germany, 81377 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9AM to 5PM Eastern time (UTC/ GMT - 5hours, EST), or speak with your personal physician Moscow, Russian Federation, 115478 Less <<
NCT00191815 - Completed - -
NCT00942357 Endometrial Clear Cell Adenoca... More >>rcinoma Endometrial Serous Adenocarcinoma Stage IA Uterine Corpus Cancer Stage IB Uterine Corpus Cancer Stage II Uterine Corpus Cancer Stage IIIA Uterine Corpus Cancer Stage IIIB Uterine Corpus Cancer Stage IIIC Uterine Corpus Cancer Stage IVA Uterine Corpus Cancer Less << Phase 3 Active, not recruiting - -
NCT01265147 Nasopharyngeal Carcinoma Phase 2 Unknown December 2017 China ... More >> Daping Hospital Not yet recruiting Chong Qing, China Contact: Zhenzhou Yang, Dr.          Principal Investigator: Zhenzhou Yang, Dr. Less <<
NCT03086993 Bile Duct Cancer ... More >> Intrahepatic Cholangiocarcinoma Less << Phase 2 Phase 3 Recruiting May 2023 United States, North Carolina ... More >> Duke Health Recruiting Durham, North Carolina, United States, 27710 Contact: Kim Turnage, MSN    919-684-3381       Principal Investigator: Sabino Zani, MD          United States, Ohio Ohio State University/Teaching Hospital Active, not recruiting Columbus, Ohio, United States, 43210 United States, Tennessee West Cancer Center Recruiting Memphis, Tennessee, United States, 38120 Contact: Catherine Morningstar, BS    901-683-0055    cmorningstar@WESTCLINIC.com    Principal Investigator: Evan Glazer, MD, PhD Less <<
NCT01874678 Non-small-cell Lung Cancer (NS... More >>CLC) Less << Not Applicable Completed - Taiwan ... More >> Dalin Tzu Chi General Hospital Chiayi, Taiwan E-Da Hospital Kaohsiung, Taiwan China Medical University Hospital Taichung, Taiwan Taichung Veterans General Hospital Taichung, Taiwan Taipei Veterans General Hospital Taipei, Taiwan Less <<
NCT00452634 Small Cell Lung Cancer Phase 2 Completed - Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyenggi, Korea, Republic of, 411-769 Less <<
NCT02944357 Infiltrating Bladder Urothelia... More >>l Carcinoma Stage II Bladder Urothelial Carcinoma Stage III Bladder Urothelial Carcinoma Stage IV Bladder Urothelial Carcinoma Less << Not Applicable Withdrawn - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02344095 Epithelial Ovarian Carcinoma ... More >> Fallopian Tube Carcinoma Primary Peritoneal Carcinoma Less << Phase 1 Unknown October 2015 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam-si, Gyeonggi-do, Korea, Republic of, 463707 Contact: Kidong Kim       kidong.kim.md@gmail.com    Sub-Investigator: Kidong Kim Less <<
NCT01854749 Esophageal Squamous Cell Carci... More >>noma Less << Phase 2 Completed - China, Shanghai ... More >> Cancer hospital Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT02326285 Non-squamous Non-small Cell Lu... More >>ng Cancer Stage II Non-squamous Non-small Cell Lung Cancer Stage IIIA Non-squamous Non-small Cell Lung Cancer Stage IIIB Activating EGFR Mutation NSCLC Less << Phase 2 Phase 3 Terminated(Due to low patient ... More >>enrollment was stopped. Only one patient could be enrolled. 37 patients were pre-screened, but not into the inclusion criteria (wt-EGFR)) Less << - Germany ... More >> Pius-Hospital Oldenburg, Germany, 26121 Less <<
NCT00041106 Metastatic Transitional Cell C... More >>ancer of the Renal Pelvis and Ureter Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter Less << Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT03772028 Ovarian Cancer Phase 3 Not yet recruiting February 1, 2025 -
NCT01154140 Non Squamous Lung Cancer Phase 3 Completed - -
NCT02996214 Lung Squamous Cell Carcinoma Phase 4 Not yet recruiting June 2020 -
NCT01154140 - Completed - -
NCT00304278 Head and Neck Cancer Phase 2 Completed - United States, Illinois ... More >> Simmons Cooper Cancer Institute/SIU School of Medicine Springfield, Illinois, United States, 62702 Less <<
NCT02276248 Stage I/II Extranodal NK/T-cel... More >>l Lymphoma Less << Phase 2 Completed - China, Beijing ... More >> Cancer Hospital and Institute, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Beijing, Beijing, China, 100021 Less <<
NCT00304278 - Completed - -
NCT00385606 Advanced Non-Small Cell Lung C... More >>ancer Less << Phase 2 Phase 3 Completed - Italy ... More >> Azienda Ospedaliera S. Giuseppe Moscati, U.O. di Oncologia Medica Monteforte Irpino, AV, Italy, 83024 Ospedale Regionale Miulli, Divisione Medicina Interna Sezione Oncologica Acquaviva delle Fonti, BA, Italy, 70021 IRCCS Oncologico Bari, Oncologia Medica Bari, BA, Italy, 70126 Istituto Oncologico di Bari, U.O. di Oncologia Medica e Sperimentale Bari, BA, Italy, 70126 Policlinico Universitario, Oncologia Medica II Cagliari, CA, Italy, 09042 Ospedale A. Cardarelli Campobasso, CB, Italy, 86100 Ospedale Mariano Santo, U.O. di Oncologia Medica Cosenza, CS, Italy, 87100 Ospedale Umberto di Frosinone Frosinone, FR, Italy, 03031 Ospedale Civile di Legnano Legnano, MI, Italy Ospedale S. Paolo Milano, MI, Italy, 20142 Policlinico Universitario P. Giaccone Palermo, PA, Italy, 90100 Casa di Cura La Maddalena S.p.A., Dipartimento Oncologico Palermo, PA, Italy, 90146 Istituto Oncologico Veneto Padova, PD, Italy Ospedale Civile Umberto I, Day Hospital Oncoematologico Nocera Inferiore, SA, Italy, 84014 Divisione di Oncologia Medica, U.S.L.L. 13 .Noale, VE, Italy, 30033 Ospedale S. Bortolo ULSS 6, U.O. di Oncologia Medica Vicenza, VI, Italy, 36100 Ospedale L. Sacco Milano, Italy Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B Napoli, Italy, 80131 Istituto Nazionale dei Tumori, Divisione di Oncologia Medica C Napoli, Italy, 80131 Second University of Naples Napoli, Italy Ospedale Santa Corona Pietre Ligure, Italy Istituto Regina Elena, Divisione di Oncologia Medica Roma, Italy, 00144 Ospedale S. Giovanni Calibita Gatebenefratelli Roma, Italy, 00186 Ospedale San Camillo - Forlanini Rome, Italy Azienda Ospedaliera Di Busto Arsizio Saronno, Italy Less <<
NCT01289522 Squamous Cell Head and Neck Ca... More >>rcinoma Recurrent or Metastatic Disease Less << Phase 2 Completed - Belgium ... More >> Cliniques Universitaires Bruxelles, Belgium Clinique Sainte Elisabeth Namur, Belgium Clinique universitaire de Mont Godinne UCL Yvoir, Belgium France Hôpital Saint André Bordeaux, France Centre Jean Perrin, Clermont-Ferrand, France Centre G-F Leclerc Dijon, France Centre Hospitalier de la Dracénie Draguignan, France Centre Hospitalier de Bretagne Sud Lorient, France Centre Léon Bérard Lyon, France Hôpital de la Timone Marseille, France Centre Henri Becquerel Rouen, France Hôpital Foch Suresnes, France CHU Bretonneau Tours, France Institut Gustave Roussy Villejuif, France Less <<
NCT02322593 Gastric Cancer Phase 3 Active, not recruiting May 2019 Japan ... More >> Taiho Pharmaceutical Co., Ltd selected site Ibaraki, Japan, 305-8576 Taiho Pharmaceutical Co., Ltd selected site Kumamoto, Japan, 860-8556 Taiho Pharmaceutical Co., Ltd selected site Tokyo, Japan, 104-0045 Korea, Republic of Taiho Pharmaceutical Co., Ltd selected site Seoul, Korea, Republic of, 110-744 Taiho Pharmaceutical Co., Ltd selected site Seoul, Korea, Republic of, 120-752 Taiho Pharmaceutical Co., Ltd selected site Seoul, Korea, Republic of, 138-736 Less <<
NCT02337712 Small Cell Lung Cancer Phase 2 Recruiting December 2020 China, Guangdong ... More >> Sun yat-sen university cancer center Recruiting Guangzhou, Guangdong, China, 510000 Contact: Bo Qiu, Attending    +86-020-87343031    qiubo@sysucc.org.cn Less <<
NCT00188266 Stomach Neoplasms Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01289522 - Completed - -
NCT00334815 Adenosquamous Lung Carcinoma ... More >> Large Cell Lung Carcinoma Lung Adenocarcinoma Minimally Invasive Lung Adenocarcinoma Squamous Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Less << Phase 2 Active, not recruiting - -
NCT00334815 - Active, not recruiting - -
NCT00526396 Small Cell Lung Cancer Phase 3 Unknown July 2016 Italy ... More >> Azienda Sanitaria S. Giuseppe Moscati Monteforte Irpino, AV, Italy Azienda Ospedaliera G. Rummo Benevento, BN, Italy Casa di Cura La Maddalena S.p.A., Dipartimento Oncologico Palermo, PA, Italy, 90146 Istituto Oncologico Veneto Padova, PD, Italy Ospedale E. Morelli Sondalo, SO, Italy, 23039 Ospedale San Lazzaro Alba, Italy Ospedale Mater Domini Catanzara, Italy Ospedale L. Sacco Polo Universitario Milano, Italy Istituto Nazionale dei Tumori Napoli, Italy Ospedale Cotugno Napoli, Italy Ospedale Guglielmo da Saliceto Piacenza, Italy Ospedale Maggiore Trieste, Italy Less <<
NCT01542931 Stage III Oral Cavity Squamous... More >> Cell Carcinoma Stage IVA Oral Cavity Squamous Cell Carcinoma Less << Phase 2 Phase 3 Completed - China, Shanghai ... More >> Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai, China, 200011 Less <<
NCT00720083 Head and Neck Cancer Phase 2 Terminated(Withdrawal of drug ... More >>supply.) Less << - -
NCT00423852 Brain and Central Nervous Syst... More >>em Tumors Extragonadal Germ Cell Tumor Ovarian Cancer Teratoma Testicular Germ Cell Tumor Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT03472274 Bladder Cancer Phase 2 Not yet recruiting December 2022 Spain ... More >> ICO Badalona Not yet recruiting Badalona, Spain Contact: Albert Font          Hospital Clinic Not yet recruiting Barcelona, Spain Contact: Begoña Mellado          Hospital de la Santa Creu i Sant Pau Not yet recruiting Barcelona, Spain Contact: Pablo Maroto          ICO L'Hospitalet Not yet recruiting L'Hospitalet De Llobregat, Spain Contact: Francisco J García del Muro          Hospital 12 de Octubre Not yet recruiting Madrid, Spain Contact: Daniel Castellano          Hospital Clinico San Carlos Not yet recruiting Madrid, Spain Contact: Javier Puente          Hospital Ramon y Cajal Not yet recruiting Madrid, Spain Contact: Teresa Alonso-Gordoa          MD Anderson Cancer Center Not yet recruiting Madrid, Spain Contact: Enrique Grande          Hospital Marqués de Valdecilla Not yet recruiting Santander, Spain Contact: Ignacio Durán          Instituto Valenciano de Oncología Not yet recruiting Valencia, Spain Contact: Miguel A Climent Less <<
NCT00030862 Esophageal Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00066482 Childhood Germ Cell Tumor ... More >> Extragonadal Germ Cell Tumor Less << Not Applicable Completed - -
NCT00578864 Neuroblastoma Phase 2 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00423852 - Completed - -
NCT00578864 - Completed - -
NCT02711553 Biliary Tract Cancer ... More >> Metastatic Cancer Advanced Cancer Less << Phase 2 Active, not recruiting May 31, 2020 -
NCT00505492 Uterine Neoplasms Phase 2 Terminated(Slow accrual.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington University of Washington School of Medicine Seattle, Washington, United States, 98104 Less <<
NCT00720083 - Terminated(Withdrawal of drug ... More >>supply.) Less << - -
NCT00122746 Cancer of the Cervix Phase 3 Unknown - India ... More >> Dept. of Atomic Energy, Tata Memorial Centre Recruiting Mumbai, India Contact: Reena Engineer, MD       reena_engineer@rediffmail.com    Principal Investigator: Reena Engineer, MD          South Africa Johannesburg Hospital Active, not recruiting Johannesburg, South Africa Tanzania Ocean Road Cancer Institute Recruiting Dar Es Salaam, Tanzania Contact: Twalib Ngoma, MD       ngoma@uccmail.co.tz    Principal Investigator: Twalib Ngoma, MD          Uganda Radiotherapy Centre Recruiting Kampala, Uganda Contact: Joseph Kigula, MD       jbkigula@yahoo.com    Principal Investigator: Joseph Kigula, MD          Zimbabwe Radiotherapy Centre Active, not recruiting Harare, Zimbabwe Less <<
NCT02901301 Gastric Cancer Phase 1 Phase 2 Recruiting March 2019 Korea, Republic of ... More >> Severance Hospital, Yonsei University Health System Recruiting Seoul, Korea, Republic of, 03722 Contact: Hyo Song Kim Less <<
NCT01907100 Mesothelioma Phase 3 Completed - -
NCT02161419 Small Cell Lung Carcinoma Phase 2 Terminated - -
NCT00191854 Breast Cancer Phase 2 Completed - Brazil ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santo André, Brazil, 09060-020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sao Paulo, Brazil, 05403-900 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100071 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China, 310016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nan Jing, China, 210009 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wu Han, China, 430030 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Delhi, India, 110085 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kolkata, India, 700053 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ludhiana, India, 141001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mumbai, India, 400016 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pune, India, 411001 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 138-736 Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cuernavaca, Mexico, 62200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mexico City, Mexico, 01120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Villahermosa, Mexico, 86090 Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Antalya, Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gaziantep, Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kayseri, Turkey, 38039 Less <<
NCT00253591 Lung Cancer Phase 2 Phase 3 Completed - United Kingdom ... More >> Wansbeck General Hospital Ashington, England, United Kingdom, NE63 9JJ Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Derbyshire Royal Infirmary Derby, England, United Kingdom, DE1 2QY University Hospital of North Durham Durham, England, United Kingdom, DH1 5TW Queen Elizabeth Hospital Gateshead, England, United Kingdom, NE9 6SX Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle-Upon-Tyne, England, United Kingdom, NE4 6BE Mount Vernon Cancer Centre at Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Kings Mill Hospital Nottinghamshire, England, United Kingdom, NG17 4JL Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Churchill Hospital Oxford, England, United Kingdom, OX3 7LJ Cancer Research Centre at Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Great Western Hospital Swindon, England, United Kingdom, SN3 6BB Worcester Royal Hospital Worcester, England, United Kingdom, WR5 1DD Yeovil District Hospital Yeovil, England, United Kingdom, BA21 4AT Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G12 0YN Crosshouse Hospital Kilmarnock, Scotland, United Kingdom, KA2 OBE Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Llandough Hospital Llandough, Wales, United Kingdom, CF64 2XX Royal Gwent Hospital Newport Gwent, Wales, United Kingdom, NP9 2UB Less <<
NCT00384878 Stomach Neoplasms Phase 2 Unknown - Taiwan ... More >> Kun Huei Yeh, Ph.D Recruiting Taipei, Ban-Ciao, Taiwan, 220 Contact: Kun Huei Yeh, Ph.D.    886-2-89667000 ext 1611    khyeh@mail.femh.org.tw Less <<
NCT01884259 Squamous Cell Carcinoma of the... More >> Hypopharynx Stage III Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Larynx Stage III Squamous Cell Carcinoma of the Larynx Stage IV Squamous Cell Carcinoma of the Oropharynx Stage III Squamous Cell Carcinoma of the Oropharynx Stage IV Squamous Cell Carcinoma of the Oral Cavity Stage III Squamous Cell Carcinoma of the Oral Cavity Stage IV Less << Phase 2 Active, not recruiting June 2019 Austria ... More >> Landeskrankenhaus Feldkirch Feldkirch, Austria, A-6807 Landesklinikum Krems Krems, Austria, A-3500 Krankenhaus d. Barmherzigen Schwestern Linz Linz, Austria, A-4010 Kepler Universitätsklinikum, Med Campus III. Klinik für Interne 3 - Schwerpunkt Hämatologie u. Onkologie Linz, Austria, A-4021 PMU Salzburg Salzburg, Austria, 5020 Hanusch Krankenhaus Wien Vienna, Austria, 1140 Universität f. Strahlentherape, AKH Wien Vienna, Austria, A-1090 Klinikum Kreuzschwestern Wels GmbH Wels, Austria, A-4600 Less <<
NCT00006116 Lung Cancer Phase 2 Unknown - France ... More >> Clinique Sainte Catherine Avignon, France, 84082 C.H.G. Beauvais Beauvais, France, 60021 Centre Hospitalier Departmental Felix Guyon Bellepierre, France, 97400 Centre Hospitalier General Brive, France Centre Hospitalier Emile Roux Eaubonne, France, 95602 Centre Jean Bernard Le Mans, France, 72000 C.H. Mans Le Mans, France, 72037 Hopital Perpetuel Secours Levallois-Perret, France, 92300 Clinique St. Faron Mareuil Les Meaux, France, 77100 Clinique de Docteur Terrioux Meaux, France, 77100 Clinique Hartmann Neuilly sur Seine, France, 92200 American Hospital of Paris Neuilly Sur Seine, France, F-92202 Clinique Du Mont Louis Paris, France, 75011 Hopital Saint Antoine Paris, France, 75571 Hopital Tenon Paris, France, 75970 Hopital Claude Gallien Quincy Sous Senart, France, 91480 Groupe Medical Saint Remy Reims, France, 51096 Clinique les Bleuets Reims, France, 51100 Polyclinique De Courlancy Reims, France, F-51100 Centre Rene Huguenin Saint Cloud, France, 92210 Centre du Rouget Sarcelles, France, 95250 Less <<
NCT02999893 Oesophageal Carcinoma Phase 1 Phase 2 Recruiting April 30, 2023 Australia, Victoria ... More >> Monash Medical Centre Recruiting Clayton, Victoria, Australia, 3000 Contact: Benjamin Markman          Principal Investigator: Benjamin Markman, MBBS, FRACP          Austin Health Not yet recruiting Heidelberg, Victoria, Australia, 3000 Contact: Niall Tebbutt          Principal Investigator: Niall Tebbutt, MBBS, FRACP          Peter MacCallum Cancer Centre Recruiting Melbourne, Victoria, Australia, 3002 Contact: Lara Lipton, MSc       lara.lipton@petermac.org    Principal Investigator: Lara Lipton, MBBS, FRACP          Sub-Investigator: Michael Michael, MBBS, FRACP          Alfred Hospital Not yet recruiting Prahran, Victoria, Australia, 3000 Contact: Andrew Haydon          Principal Investigator: Andrew Haydon, MBBS, FRACP          Sunshine Hospital Western Health Not yet recruiting Sunshine, Victoria, Australia, 3000 Contact: Lara Lipton       lara.lipton@petermac.org    Principal Investigator: Lara Lipton, MBBS, FRACP Less <<
NCT02309658 Cancer of Cervix Phase 2 Completed - Brazil ... More >> Instituto de Medicina Integral Fernando Figueira Recife, Pernambuco, Brazil, 50070550 Less <<
NCT00191854 - Completed - -
NCT00002813 Cervical Cancer Phase 2 Completed - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 United States, Hawaii MBCCOP - Hawaii Honolulu, Hawaii, United States, 96813 United States, Maryland Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21231 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, New York Cancer Center of Albany Medical Center Albany, New York, United States, 12208 United States, North Carolina Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157-1082 United States, South Carolina CCOP - Upstate Carolina Spartanburg, South Carolina, United States, 29303 United States, Tennessee Brookview Research, Inc. Nashville, Tennessee, United States, 37203 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01646853 Esophageal Neoplasms Not Applicable Unknown - China, Jiangsu ... More >> Jiangsu Province Hospital Nanjing, Jiangsu, China, 210029 Less <<
NCT00057837 Extensive Stage Small Cell Lun... More >>g Cancer Less << Phase 2 Completed - -
NCT00057837 - Completed - -
NCT01016561 Cervical Cancer Not Applicable Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the Unviersity of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01047007 Solid Tumors Phase 1 Terminated(The study has been ... More >>terminated due to business reasons.) Less << - -
NCT00334594 Malignant Mesothelioma Phase 2 Completed - Germany ... More >> Universitaetsklinikum Freiburg Freiburg, Germany, D-79106 Switzerland Kantonsspital Aarau Aarau, Switzerland, CH-5001 Kantonsspital Baden Baden, Switzerland, CH-5404 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Spital Tiefenau Bern 4, Switzerland, 3004 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Olten Olten, Switzerland, CH-4600 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 SpitalSTS AG Simmental-Thun-Saanenland Thun, Switzerland, 3600 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT00209690 Esophageal Cancer Phase 1 Phase 2 Completed - Japan ... More >> ・ Hokkaido University Hospital (Hokkaido University Graduate School of Medicine / School of Medicine) Sapporo, Hokkaido, Japan, 060-8638 Less <<
NCT01372202 Esophageal Cancer Phase 2 Active, not recruiting June 2019 United States, Maryland ... More >> Ronan Kelly, M.D. Baltimore, Maryland, United States, 21287 Less <<
NCT03617913 Bladder Carcinoma Infiltrating... More >> the Muscle of the Bladder Wall Stage II Bladder Cancer AJCC v8 Stage II Renal Pelvis Cancer AJCC v8 Stage II Ureter Cancer AJCC v8 Stage II Urethral Cancer AJCC v8 Stage III Bladder Cancer AJCC v8 Stage III Renal Pelvis Cancer AJCC v8 Stage III Ureter Cancer AJCC v8 Stage III Urethral Cancer AJCC v8 Stage IIIA Bladder Cancer AJCC v8 Stage IIIB Bladder Cancer AJCC v8 Urethral Urothelial Carcinoma Less << Phase 2 Recruiting July 31, 2025 United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85054 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Parminder Singh, M.D          United States, Florida Mayo Clinic in Florida Recruiting Jacksonville, Florida, United States, 32224 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Winston W. Tan, M.D.          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Brian A. Costello, M.D. Less <<
NCT01087970 Head and Neck Neoplasms Phase 2 Completed - -
NCT03330028 Diseases of Oesophagus Stomach... More >> and Duodenum Less << Phase 1 Recruiting April 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       bbadgwell@mdanderson.org Less <<
NCT01047007 - Terminated(The study has been ... More >>terminated due to business reasons.) Less << - -
NCT02474368 Recurrent Head and Neck Carcin... More >>oma Head and Neck Cancer Metastatic Head or Neck Cancer Less << Phase 1 Recruiting June 2021 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Jonathan Schoenfeld, MD, MPH    617-632-5734    Jdschoenfeld@partners.org    Principal Investigator: Jonathan Schoenfeld, MD, MPH Less <<
NCT01087970 - Completed - -
NCT01372202 - Active, not recruiting - -
NCT02025036 Stage III Esophageal Squamous ... More >>Cell Carcinoma Stage II Esophageal Squamous Cell Carcinoma Less << Phase 3 Recruiting December 2020 China, Henan ... More >> The First Affiliated Hospital of Henan University of Science and Technology Recruiting Luoyang, Henan, China, 471003 Contact: Shegan Gao, M.D Ph.D    +86(379)64811906    gsg112258@163.com    Contact: Tanyou Shan, master    +86(379)64815350    shantanyou@163.com    Sub-Investigator: Dan Zhou, M.D.M.S Less <<
NCT00042510 Stomach Neoplasms ... More >> Esophageal Neoplasms Less << Phase 2 Completed - -
NCT01160744 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - -
NCT01920061 Neoplasm Phase 1 Recruiting January 2019 -
NCT01675765 Malignant Pleural Mesothelioma Phase 1 Active, not recruiting December 2018 United States, California ... More >> University of California at San Francisco San Francisco, California, United States, 94115 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00072124 Melanoma (Skin) Phase 3 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00623558 Head and Neck Neoplasm Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT00209716 Esophageal Cancer Phase 1 Phase 2 Completed - Japan ... More >> ・ Hokkaido University Hospital (Hokkaido University Graduate School of Medicine) Sapporo, Hokkaido, Japan, 060-8638 Less <<
NCT00949650 Carcinoma, Non-Small-Cell Lung... More >> Adenocarcinoma Less << Phase 3 Completed - -
NCT00275951 Gastric Cancer Phase 2 Completed - Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT01160744 - Completed - -
NCT00949650 - Completed - -
NCT01639001 NSCLC (Non-small Cell Lung Can... More >>cer) Less << Phase 3 Active, not recruiting January 2019 -
NCT00985855 Non-Small-Cell Lung Carcinoma Phase 2 Completed - France ... More >> Institut de Cancerologie de la Loire St Priest en Jarez, France, 42271 Less <<
NCT01557959 - Completed - -
NCT01639001 - Active, not recruiting - -
NCT01557959 Adenocarcinoma of the Lung ... More >> Adenosquamous Cell Lung Cancer Bronchoalveolar Cell Lung Cancer Large Cell Lung Cancer Non-small Cell Lung Cancer Recurrent Non-small Cell Lung Cancer Squamous Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Completed - United States, North Carolina ... More >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT03047265 Nasopharyngeal Carcinoma Phase 2 Active, not recruiting June 1, 2027 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT00313690 Lung Cancer Phase 1 Phase 2 Withdrawn(Recruitment difficul... More >>ties) Less << - -
NCT00154700 Esophageal Cancer Phase 2 Completed - Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00024323 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Arizona ... More >> Arizona Clinical Research Center Tucson, Arizona, United States, 85712 United States, Connecticut Yale Comprehensive Cancer Center New Haven, Connecticut, United States, 06520-8028 Less <<
NCT03288350 Gastric Adenocarcinoma ... More >> Esophageal Adenocarcinoma Less << Phase 2 Recruiting December 2023 Canada, Quebec ... More >> McGill University Health Centre Recruiting Montréal, Quebec, Canada, H4A 3J1 Contact: Penny Chipman    514-934-1934 ext 64802    penny.chipman@muhc.mcgill.ca    Principal Investigator: Thierry Alcindor, MD, MSc Less <<
NCT00547157 Cancer Head a... More >>nd Neck Cancer Oncology Squamous Cell Carcinoma Less << Phase 2 Completed - -
NCT01824004 Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun-Eup, Jeollanam-do, Korea, Republic of, 519-809 Less <<
NCT02786641 Nasopharyngeal Carcinoma Phase 3 Not yet recruiting August 2021 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT02177695 Bladder Cancer Phase 2 Recruiting October 2022 -
NCT02289807 Nasopharyngeal Carcinoma Not Applicable Not yet recruiting March 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT00536614 Pancreatic Cancer Phase 2 Completed - Italy ... More >> A.O. Treviglio-Caravaggio, P.le Ospedale n1 Treviglio, Bergamo, Italy, 24047 Ospedale S.Gerardo, Via Donizetti, 106 Monza, Milano, Italy, 20052 A.O. Ospedale Umberto I - Università - Località Torretta Ancona, Italy, 60020 Ospedali Riuniti, Largo Barozzi, 1 Bergamo, Italy, 24128 Casa di Cura di Poliambulanza, Via Bissolati 57 Brescia, Italy, 25100 A.O. Careggi-Università, Viale Pieraccini, 17 Firenze, Italy, 50139 Azienda USL 6 - Viale Alfieri, 36 Livorno, Italy, 57121 A.O. Carlo Poma - Via Albertoni, 1 Mantova, Italy, 46100 A.O. Cà Granda, Piazza Ospedale Maggiore, 3 Milano, Italy, 20162 Università Campus Biomedico, Via Emilio Longoni, 83 Roma, Italy, 00155 Less <<
NCT01633203 - Active, not recruiting September 2018 Chile ... More >> Instituto Nacional del Cáncer Santiago, RM, Chile, 8380455 Less <<
NCT00662311 Stage IIIA Non-small Cell Lung... More >> Cancer Stage IIIB Non-small Cell Lung Cancer Less << Phase 1 Phase 2 Terminated - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT02099786 Cisplatin Ototoxicity ... More >> Hearing Loss Less << Not Applicable Completed - United States, Oregon ... More >> VA Portland Health Care System, Portland, OR Portland, Oregon, United States, 97239 Less <<
NCT00547157 - Completed - -
NCT02980991 Lung Adenocarcinoma Phase 2 Unknown April 2018 China ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China, 200032 Contact: Haiquan Chen, MD    +86-21 64175590 ext 1707    hqchen1@yahoo.com    Contact: Xinghua Cheng, MD,PhD    +8618017317567    chengxinghua_001@163.com    Principal Investigator: Haiquan Chen, MD Less <<
NCT00033657 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - -
NCT01488838 Malignant Salivary Gland Tumor... More >>s Less << Phase 2 Completed - Saudi Arabia ... More >> King Faisal Specialist Hospital& Research Center Riyadh, Saudi Arabia, 11211 Less <<
NCT00033657 - Completed - -
NCT03071848 - Completed - Argentina ... More >> Hospital General de Agudos J. A. Penna ; Breast Pathology Buenos Aires, Argentina, 1437 Instituto Ángel H. Roffo - Universidad de Buenos Aires Buenos Aires, Argentina, B1650 Hospital Julio C. Perrando Chaco, Argentina Hospital General de Agudos Juan Antonio Fernandez Ciudad Autonoma de Buenos Aires, Argentina, 1425 Hospital Pablo Soria Jujuy, Argentina Centro Oncologico Riojano Integral (CORI) La Rioja, Argentina, F5300COE Hospital Interzonal General De Agudos "Luisa C. de Gandulfo" Lomas de Zamora, Argentina Hospital Privado de Comunidad; Oncology Mar Del Plata, Argentina, 7600 Hosp Provincial D. Centenarios; Oncology Dept Rosario, Argentina, S2002KDS CENICLAR Rosario, Argentina Policlínico regional de San Luis San Luis, Argentina Centro Medico San Roque San Miguel de Tucuman, Argentina, T4000IAK Less <<
NCT00191334 Ovarian Cancer Phase 2 Completed - Russian Federation ... More >> For additional information regarding investigative sites for thsi trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Irkutsk, Russian Federation For additional information regarding investigative sites for thsi trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ivanovo, Russian Federation For additional information regarding investigative sites for thsi trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation For additional information regarding investigative sites for thsi trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. St. Petersburg, Russian Federation For additional information regarding investigative sites for thsi trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Stavropol, Russian Federation Less <<
NCT03567642 Lung Cancer Phase 1 Recruiting June 2020 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Helena Yu, MD    646-888-4274       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Helena Yu, MD    646-888-4274       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Helena Yu, MD    646-888-4274       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Helena Yu, MD    646-888-4274       Principal Investigator: Helena Yu, MD          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Helena Yu, MD    646-888-4274       Contact: Mark Kris, MD    646-888-4205       Principal Investigator: Helena Yu, MD          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Helena Yu, MD    646-888-4274 Less <<
NCT00662311 - Terminated - -
NCT00191334 - Completed - -
NCT00705016 Squamous Cell Cancer Phase 1 Phase 2 Completed - -
NCT00001427 Ovarian Neoplasms Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00001272 Ovarian Neoplasms Phase 1 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00994097 Non-small Cell Lung Cancer Phase 2 Completed - Italy ... More >> Istituto Nazionale per la ricerca sul cancro Genoa, Italy, 16132 Fondazione San Raffaele del Monte Tabor Milan, Italy, 20132 Istituto Nazionale dei Tumori Milan, Italy, 20133 Istituto Europeo Oncologico Milan, Italy Less <<
NCT00705016 - Completed - -
NCT00002774 Squamous Neck Carcinoma of the... More >> Head and Neck Cancer (SCCHN) Less << Phase 2 Completed - United States, California ... More >> Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States, 94304 Stanford University Medical Center Stanford, California, United States, 94305-5408 Less <<
NCT01573338 Small Cell Lung Carcinoma Phase 1 Phase 2 Terminated - United States, Missouri ... More >> Saint Louis, Missouri, United States, 63110 United States, New York Buffalo, New York, United States, 14263-0001 United States, Ohio Cleveland, Ohio, United States, 44195 France Caen Cedex, France, 14033 Lyon Cedex, France, 69008 Marseille, France, 13005 Villejuif Cedex, France, 94805 Korea, Republic of Seoul, Korea, Republic of, 03080 Seoul, Korea, Republic of, 120-752 Less <<
NCT00190476 Non-small-cell Lung Cancer Phase 3 Terminated - Japan ... More >> Aichi Cancer Center Hospital Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi, Japan, 464-8681 Aichi Cancer Center,Aichi Hospital Okazaki,Kake-machi,Kuriyado,18, Aichi, Japan, 444-0011 National Cancer Center Hospital East Kashiwa,Kashiwanoha,6-5-1, Chiba, Japan, 277-8577 National Hospital Organization Shikoku Cancer Center Matsuyama,Horinouchi,13, Ehime, Japan, 790-0007 Kyushu University Hospital Higashi-ku,Maidashi,3-1-1, Fukuoka, Japan, 812-8582 Gifu Municipal Hospital Gifu,Kashima-cho,7-1, Gifu, Japan, 500-8323 Gunma Prefectural Cancer Center Ota,Takabayashi-nishi-cho,617-1, Gunma, Japan, 373-8550 National Nishigunma Hospital Shibukawa,Kanai,2854, Gunma, Japan, 377-8511 National Hospital Organization, Dohoku National Hospital Asahikawa,Hanasaki,7-4048, Hokkaido, Japan, 070-8644 National Hospital Organization Hokkaido Cancer Center Sapporo,Shiroishi-ku,Kikusui,4-2-3-54, Hokkaido, Japan, 003-0804 Hyogo Medical Center for Adults Akashi,Kitaouji-cho,13-70, Hyogo, Japan, 673-8558 Hyogo College of Medicine Nishinomiya,Mukogawa-cho,1-1, Hyogo, Japan, 663-8501 Ibaraki Kenritsu Chuo Hospital & Cancer Center Nishi-ibarakigun,Tomobemachi,Koibuchi,6528, Ibaraki, Japan, 309-1793 Kanagawa Cancer Center Yokohama,Asahi-ku,Nakao,1-1-2, Kanagawa, Japan, 241-0815 Yokohama Mucipical Citizen's Hospital Yokohama,Hodogaya-ku,Okazawa-cho,56, Kanagawa, Japan, 240-8555 Kumamoto Regional Medical Center Hospital Kumamoto,Honjo,5-16-10, Kumamoto, Japan, 860-0811 Niigata Cancer Center Hospital Niigata,Kawagishi-cho, 2-15-3, Niigata, Japan, 951-8566 Osaka Prefectural Medical Center for Respiratory and Allergic Disease Habikino,Habikino,3-7-1, Osaka, Japan, 583-8588 Osaka Medical Center for Cancer and Cardiovascular Diseases Osaka,Higashinari-ku,Nakamichi,1-3-3, Osaka, Japan, 537-8511 Osaka City General Hospital Osaka,Miyakojima-ku,Miyakojimahondori,2-13-22, Osaka, Japan, 534-0021 Kinki University School of Medicine Osaka-Sayama,Ohno-higashi,377-2, Osaka, Japan, 589-8511 National Hospital Organization Kinki-Chuo Chest Medical Center Sakai,Nagasone,1180, Osaka, Japan, 591-8555 National Hospital Organization Toneyama National Hospital Toyonaka,Toneyama,5-1-1, Osaka, Japan, 560-8552 Saitama Cancer Center Kita-adachi,Ina,Komuro,818, Saitama, Japan, 362-0806 Sizuoka Cancer Center Sunto-gun,Nagaizumi-cho,Shimonagakubo,1007, Shizuoka, Japan, 411-8777 Tochigi Cancer Center Utsunomiya,Yohnan,4-9-13, Tochigi, Japan, 320-0834 National Cancer Center Hospital Chuo-ku,Tsukiji,5-1-1, Tokyo, Japan, 104-0045 International Medical Center of Japan Shinjuku-ku,Toyama,1-21-1, Tokyo, Japan, 162-8655 Yamagata Prefectural Central Hospital Yamagata,Aoyagi,1800, Yamagata, Japan, 990-2292 Less <<
NCT01262859 Head and Neck Neoplasms Phase 2 Withdrawn(PI relocated to anot... More >>her institution. No subjects went on treatment.) Less << - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00389155 Bladder Cancer ... More >> Transitional Cell Carcinoma Metastasis Less << Phase 2 Phase 3 Completed - -
NCT03061630 Urinary Bladder Phase 2 Active, not recruiting February 2020 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 06351 Less <<
NCT03234153 Muscle-invasive Bladder Cancer Phase 2 Recruiting March 2025 Switzerland ... More >> Departement of Medical Oncology, University Hospital Berne Recruiting Berne, Switzerland, 3010 Contact: Julian Schardt, MD    +41 31 632 8195    Julian.Schardt@insel.ch Less <<
NCT03326947 Neoplasm Neck Phase 2 Not yet recruiting January 1, 2023 China, Shanghai ... More >> Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai, China, 200011 Less <<
NCT00490659 Non-Small Cell Lung Cancer Phase 2 Completed - Poland ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lublin, Poland Less <<
NCT02162537 Non-small Cell Lung Cancer Met... More >>astatic Non-small Cell Lung Cancer Adenocarcinoma of Lung Metastatic to Brain Cerebral Metastases Less << Phase 3 Recruiting January 2019 France ... More >> Centre Hospitalier du Pays d'Aix Recruiting Aix En Provence, France, 13613 Contact: Jacques LE TREUT       jletreut@ch-aix.fr    Principal Investigator: Jacques LE TREUT          Centre Hospitalier Victor Dupouy Recruiting Argenteuil, France, 95100 Contact: Christine RAYNAUD       christine.raynaud@ch-argenteuil.fr    Principal Investigator: Christine RAYNAUD          Centre d'Oncologie et de Radiothérapie du Pays Basque Recruiting Bayonne, France, 64100 Contact: Aurélien BLOUET       aurelien.blouet@oncologie-pays-basque.org    Principal Investigator: Aurélien BLOUET          Centre Hospitalier Recruiting Beauvais, France, 60021 Contact: Jacky CREQUIT       Jacky.crequit@orange.fr    Principal Investigator: Jacky CREQUIT          Hôpital Avicenne Not yet recruiting Bobigny, France, 93000 Contact: Antoine CARPENTIER       antoine.carpentier@avc.aphp.fr    Principal Investigator: Antoine CARPENTIER          HIA de Clermont-Tonnerre Not yet recruiting Brest, France, 22240 Contact: Nicolas PALEIRON       nicolas.paleiron@free.fr    Principal Investigator: Nicolas PALEIRON          CHU Recruiting Brest, France, 29200 Contact: Gilles ROBINET       gilles.robinet@chu-brest.fr    Principal Investigator: Gilles ROBINET          Centre François Baclesse Recruiting Caen, France, 14000 Contact: Radj GERVAIS       r.gervais@baclesse.fr    Principal Investigator: Radj GERVAIS          Centre Hospitalier Recruiting Charleville Meziere, France, 08000 Contact: Stéphane CHOUABE       Schouabe@ch-charleville-mezieres.fr    Principal Investigator: Stéphane CHOUABE          Centre Hospitalier Laennec Recruiting Creil, France, 60109 Contact: Sandrine LOUTSKI-VETTESE       sandrine.loutski@ch-creil.fr.fr    Principal Investigator: Sandrine LOUTSKI-VETTESE          Centre Hospitalier Intercommunal Recruiting Creteil, France, 94010 Contact: Isabelle MONNET       isabelle.monnet@chicreteil.fr    Principal Investigator: Isabelle MONNET          Centre Hospitalier Recruiting Draguignan, France, 83300 Contact: Hervé LE CAER       herve.lecaer@ch-draguignan.fr    Principal Investigator: Hervé LE CAER          Centre Hospitalier Recruiting GAP, France, 05000 Contact: Pascal THOMAS       pascal.thomas@chicas-gap.fr    Principal Investigator: Pascal THOMAS          Centre Hospitalier Robert Boulin Recruiting Libourne, France, 33500 Contact: Samir ABDICHE       samir.abdiche@ch-libourne.fr    Principal Investigator: Samir ABDICHE          Hôpital Le Cluzeau Recruiting Limoges, France, 87042 Contact: Alain VERGNENEGRE       avergne@unilim.fr    Principal Investigator: Alain VERGNENEGRE          Centre Hospitalier Régional Recruiting Longjumeau, France, 91161 Contact: Gérard OLIVIERO       gerard.oliviero@ch-longjumeau.fr    Principal Investigator: Gérard OLIVIERO          Centre Hospitalier de Bretagne Sud Recruiting Lorient, France, 56322 Contact: Régine LAMY       r.lamy@ch-bretagne-sud.fr    Principal Investigator: Régine LAMY          Centre Léon Bérard Recruiting Lyon, France, 69373 Contact: Maurice PEROL       maurice.perol@lyon.unicancer.fr    Principal Investigator: Maurice PEROL          Centre Hospitalier Les Chanaux Recruiting Macon, France, 71000 Contact: Dominique ARPIN       doarpin@ch-macon.fr    Principal Investigator: Dominique ARPIN          Centre Hospitalier F. QUESNAY Recruiting Mantes La Jolie, France, 78200 Contact: Jean-Bernard AULIAC       j-b.auliac@ch-mantes-la-jolie.rss.fr    Principal Investigator: Jean-Bernard AULIAC          Institut Paoli Calmette Recruiting Marseille, France, 13000 Contact: Anne MADROSZYC       madroszyca@marseille.fnclcc.fr    Principal Investigator: Anne MADROSZYC          Hôpital Nord APHM Recruiting Marseille, France, 13915 Contact: Laurent GREILLIER       laurent.greillier@mail.ap-hm.fr    Principal Investigator: Laurent GREILLIER          Centre Hospitalier Recruiting Meaux, France, 77108 Contact: Chrystèle LOCHER       ch-locher@ch-meaux.fr    Principal Investigator: Chrystèle LOCHER          Centre Hospitalier Intercommunal Recruiting Meulan, France, 78250 Contact: Etienne LEROY-TERQUEM       etiennelt@hotmail.fr    Principal Investigator: Etienne LEROY-TERQUEM          Clinique du Pont de Chaume Recruiting Montauban, France, 82000 Contact: Franck THOUVENY       fthouveny@clinique-pontdechaume.fr    Principal Investigator: Franck THOUVENY          Centre Hospitalier Recruiting Perigueux, France, 24019 Contact: Jean-Yves DELHOUME       jy.delhoume@ch-perigeux.fr    Principal Investigator: Jean-Yves DELHOUME          Centre Catalan d'Oncologie Recruiting Perpignan, France, 66000 Contact: Sabine VIEILLOT       sabinevieillot@gmail.com    Principal Investigator: Sabine VIEILLOT          Centre Hospitalier René Dubos Recruiting Pontoise, France, 95303 Contact: Gislaine FRABOULET       gislaine.fraboulet@ch-pontoise.fr    Principal Investigator: Gislaine FRABOULET          Centre Hospitalier de la Région d'Annecy (CHRA) Recruiting Pringy, France, 74374 Contact: Chantal DECROISETTE       cdecroisette@ch-annecy.fr    Principal Investigator: Chantal DECROISETTE          Centre Hospitalier Intercommunal de Cornouaille Recruiting Quimper, France, 29107 Contact: Anne-Marie CHIAPPA       am.chiappa@ch-cornouaille.fr    Principal Investigator: CHIAPPA Anne-Marie          Hôpital Pontchailloux Recruiting Rennes, France, 35033 Contact: Hervé LENA       herve.lena@chu-rennes.fr    Principal Investigator: Hervé LENA          Hôpital Charles Nicolle Recruiting Rouen, France, 79031 Contact: Suzanna BOTA       Suzanna.bota@chu-rouen.fr    Principal Investigator: Suzanna BOTA          Clinique Mutualiste de l'Estuaire Recruiting Saint Nazaire, France, 44600 Contact: Philippe DEGUIRAL       philippe.deguiral@mla.fr    Principal Investigator: Philippe DEGUIRAL          Institut de Cancérologie de la Loire (I.C.L) Recruiting Saint Priest En Jarez, France, 42271 Contact: Pierre FOURNEL       pierre.fournel@icloire.fr    Principal Investigator: Pierre FOURNEL          Centre Hospitalier de Salon de Provence Recruiting Salon de Provence, France, 13658 Contact: Jacques LE TREUT       jletreut@ch-aix.fr    Principal Investigator: Jacques LE TREUT          Centre Hospitalier Recruiting Sens, France, 89108 Contact: GONZALEZ Gilles       ggonzalez@ch-sens.fr    Principal Investigator: GONZALEZ Gilles          Centre Paul Strauss Recruiting Strasbourg, France, 67000 Contact: Roland SCHOTT       rschott@strasbourg.unicancer.fr    Principal Investigator: Roland SCHOTT          Hopital d'Instruction des Armées Sainte Anne Recruiting Toulon, France, 83800 Contact: Henri BERARD       hberard@libertysurf.fr    Principal Investigator: Henri BERARD          Hôpital Larrey Recruiting Toulouse, France, 31059 Contact: Laurence BIGAY-GAME       bigaygame.l@chu-toulouse.fr    Principal Investigator: Laurence BIGAY-GAME          Clinique Pasteur Recruiting Toulouse, France, 31076 Contact: Olivier GALLOCHER       o.gallocher@clinique-pasteur.com    Principal Investigator: Olivier GALLOCHER          Centre Hospitalier Recruiting Villefranche Sur Saone, France, 69655 Contact: Lionel FALCHERO       lfalchero@ch-villefranche.fr    Principal Investigator: Lionel FALCHERO Less <<
NCT01405079 Non-small Cell Lung Cancer Phase 3 Active, not recruiting December 2020 China ... More >> Guangdong General Hospital Guangzhou, China Less <<
NCT01425736 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Completed - China, Guangdong ... More >> First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510000 China, Jiangsu Institute of Stomatology of Nanjing Medical University Nanjing, Jiangsu, China, 210000 Wuxi People's Hospital; Nanjing Medical University Wuxi, Jiangsu, China, 214000 Xuzhou Central Hospital of Xuzhou city,Dongnan University Xuzhou, Jiangsu, China, 221009 China, Shanghai 9th People's Hospital, School of Stomatology,Shanghai Jiaotong University Shanghai, Shanghai, China, 200011 Less <<
NCT00861094 Esophageal Cancer Phase 2 Phase 3 Completed - France ... More >> CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 Hopital Saint Andre Bordeaux, France, 33075 Institut Bergonie Bordeaux, France, 33076 Hopital Ambroise Pare Boulogne-Billancourt, France, F-92104 Polyclinique Du Parc Caen, France, 14052 Centre Regional Francois Baclesse Caen, France, 14076 Hopital Du Bocage Dijon, France, 21034 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 Centre Hospital Regional Universitaire de Limoges Limoges, France, 87042 Centre Leon Berard Lyon, France, 69373 CHU de la Timone Marseille, France, 13385 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Antoine Lacassagne Nice, France, 06189 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Saint-Louis Paris, France, 75475 Hopital Tenon Paris, France, 75970 CHU Poitiers Poitiers, France, 86021 Institut Jean Godinot Reims, France, 51056 CHU - Robert Debre Reims, France, 51092 Centre Eugene Marquis Rennes, France, 35042 Hopital Charles Nicolle Rouen, France, 76031 Clinique Armoricaine De Radiologie Saint Brieuc, France, F-22015 Centre Paul Strauss Strasbourg, France, 67065 Institut Claudius Regaud Toulouse, France, 31052 Clinique Du Parc Toulouse, France, 31078 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00068575 Pancreatic Cancer Phase 2 Completed - United States, Texas ... More >> M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT00068575 - Completed - -
NCT02383966 Carcinoma, Squamous Cell of He... More >>ad and Neck Less << Phase 3 Active, not recruiting November 30, 2018 Germany ... More >> Please contact the Merck KGaA Communication Center Darmstadt, Germany Less <<
NCT00295672 Lung Neoplasm Phase 2 Completed - France ... More >> CHU of Brest Brest, France, 29250 CH GAP GAP, France, 05000 CHU de LIMOGES Limoges, France, 87042 Hopital de la Croix Rousse Lyon, France, 69317 Hôpital Sainte Margueritte Marseilles, France, 13274 CHU Hôpital Nord Saint Etienne, France, 42055 Less <<
NCT00262769 Extrahepatic Bile Duct Cancer ... More >> Gallbladder Cancer Less << Phase 3 Completed - United Kingdom ... More >> Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom, RG24 9NA Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom, B15 2TH Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Cumberland Infirmary Carlisle, England, United Kingdom, CA2 7HY Gloucestershire Oncology Centre at Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Derbyshire Royal Infirmary Derby, England, United Kingdom, DE1 2QY Princess Alexandra Hospital Essex, England, United Kingdom, CM20 1QX Gloucestershire Royal Hospital Gloucester, England, United Kingdom, GL1 3NN Princess Royal Hospital at Hull and East Yorkshire NHS Trust Hull, England, United Kingdom, HU8 9HE Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Helen Rollason Cancer Care Centre at North Middlesex Hospital London, England, United Kingdom, N18 1QX Royal Marsden - London London, England, United Kingdom, SW3 6JJ Hammersmith Hospital London, England, United Kingdom, W12 OHS UCL Cancer Institute London, England, United Kingdom, WC1E 6DD University College of London Hospitals London, England, United Kingdom, WIT 3AA Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Clatterbridge Centre for Oncology Merseyside, England, United Kingdom, CH63 4JY Mount Vernon Cancer Centre at Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Nottingham City Hospital Nottingham, England, United Kingdom, NG5 1PB Portsmouth Oncology Centre at Saint Mary's Hospital Portsmouth Hants, England, United Kingdom, PO3 6AD Cancer Research Centre at Weston Park Hospital Sheffield, England, United Kingdom, S10 2SJ Belfast City Hospital Trust Incorporating Belvoir Park Hospital Belfast, Northern Ireland, United Kingdom, BT9 7AB Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Glan Clwyd Hospital Rhyl, Denbighshire, Wales, United Kingdom, LL 18 5UJ Less <<
NCT00183885 Hepatocellular Carcinoma ... More >> Liver Cancer Less << Phase 2 Active, not recruiting May 28, 2019 United States, California ... More >> U.S.C. / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01222312 Non Small Cell Lung Cancer Phase 2 Completed - Germany ... More >> Krankenhaus Nordwest Frankfurt/Main, Germany, 60488 Less <<
NCT00261703 Head and Neck Neoplasms Phase 2 Phase 3 Completed - Portugal ... More >> Sanofi-Aventis Porto Salvo, Portugal Spain Sanofi-Aventis Barcelona, Spain Less <<
NCT00886028 Malignant Pleural Mesothelioma Phase 2 Unknown June 2009 Mexico ... More >> National Institute of Cancerología Mexico city, Distrito Federal, Mexico, 14080 Less <<
NCT03028766 Hypopharynx Squamous Cell Carc... More >>inoma Oral Cavity Squamous Cell Carcinoma Larynx Cancer Less << Phase 1 Recruiting December 2019 United Kingdom ... More >> University Hospital Birmingham Nhs Foundation Trust Recruiting Birmingham, West Midlands, United Kingdom, B15 2TH Principal Investigator: James Good          Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom, G12 0YN Principal Investigator: Stefano Schipani          University College London Hospitals Recruiting London, United Kingdom, W1T 7HA Principal Investigator: Martin Forster          Clatterbridge Cancer Centre Not yet recruiting Wirral, United Kingdom, CH63 4JY Principal Investigator: Joseph Sacco Less <<
NCT00016367 Lung Cancer Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00191620 Non-Small-Cell Lung Carcinoma Phase 2 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/ GMT - 5 hours, EST), or speak with your personal physician Buenos Aires, Argentina Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/ GMT - 5 hours, EST), or speak with your personal physician Sao Paulo, Brazil Chile For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/ GMT - 5 hours, EST), or speak with your personal physician Santiago, Chile Mexico For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/ GMT - 5 hours, EST), or speak with your personal physician Mexico City, Mexico Less <<
NCT01139281 Ototoxicity H... More >>earing Loss Less << Phase 2 Completed - Brazil ... More >> Hospital de Base do Distrito Federal (HBDF) Brasília, DF, Brazil, 70000-000 Less <<
NCT01585805 BRCA1 Gene Mutation ... More >> BRCA2 Gene Mutation Metastatic Pancreatic Adenocarcinoma PALB2 Gene Mutation Pancreatic Adenocarcinoma Recurrent Pancreatic Carcinoma Stage III Pancreatic Cancer AJCC v6 and v7 Stage IV Pancreatic Cancer AJCC v6 and v7 Less << Phase 2 Recruiting - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Recruiting Chicago, Illinois, United States, 60637 Contact: Hedy L. Kindler    773-702-0360    hkindler@medicine.bsd.uchicago.edu    Principal Investigator: Hedy L. Kindler          Ingalls Memorial Hospital Recruiting Harvey, Illinois, United States, 60426 Contact: Mark F. Kozloff    708-339-4800    mkozloff@bsd.uchicago.edu    Principal Investigator: Mark F. Kozloff          United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Mark M. Zalupski    734-615-3969    zalupski@umich.edu    Principal Investigator: Mark M. Zalupski          United States, Missouri Mercy Hospital Saint Louis Completed Saint Louis, Missouri, United States, 63141 United States, New Jersey Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Han Xiao    212-639-7202       Sub-Investigator: Han Xiao          Sub-Investigator: Sree B. Chalasani          Sub-Investigator: Afsheen Iqbal          United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Jahan Aghalar    212-639-7202       Sub-Investigator: Jahan Aghalar          Sub-Investigator: Avni M. Desai          Sub-Investigator: Juliana W. Eng          Sub-Investigator: John J. Fiore          Sub-Investigator: Stuart M. Lichtman          Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Parisa Momtaz       kashanie@mskcc.org    Sub-Investigator: Parisa Momtaz          Sub-Investigator: Philip C. Caron          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Eileen M. O'Reilly    646-888-4182    oreillye@mskcc.org    Principal Investigator: Eileen M. O'Reilly          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Arlyn J. Apollo    212-639-7202       Sub-Investigator: Arlyn J. Apollo          Sub-Investigator: Pamela R. Drullinsky          Sub-Investigator: Zoe Goldberg          Sub-Investigator: Kenneth K. Ng          Sub-Investigator: Tiffany Troso-Sandoval          Canada, Ontario University Health Network-Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Neesha Dhani    416-946-4501    neesha.dhani@uhn.ca    Principal Investigator: Neesha Dhani          Israel Shaare Zedek Medical Center Recruiting Jerusalem, Israel, 91031 Contact: Amiel Segal    972-2-666-6331    segal@szmc.org.il    Principal Investigator: Amiel Segal          Chaim Sheba Medical Center Recruiting Tel Hashomer, Israel, 52621 Contact: Talia Golan    972-3-530-3030    tailia.golan@sheba.health.gov.il    Principal Investigator: Talia Golan Less <<
NCT00754858 Lung Cancer Phase 2 Completed - Korea, Republic of ... More >> Yonsei Cancer Center at Yonsei University Medical Center Seoul, Korea, Republic of, 120-752 Less <<
NCT00320359 Lung Cancer, Small Cell Phase 3 Completed - -
NCT00005830 Endometrial Adenocarcinoma ... More >> Endometrial Clear Cell Adenocarcinoma Endometrial Serous Adenocarcinoma Stage III Uterine Corpus Cancer Stage IV Uterine Corpus Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00717951 Advanced Breast Cancer Phase 2 Unknown May 2010 -
NCT02133612 Esophageal Cancer Phase 2 Completed - China, Beijing ... More >> Xiao Lv Beijing, Beijing, China, 100021 Less <<
NCT01671449 Gastric Cancer Phase 3 Completed - Korea, Republic of ... More >> Chungbuk National University Hospital Cheongju-si, Chungcheongbuk-do, Korea, Republic of, 361-711 Seoul National University Bundang Hospital Bundang-gu, Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 National Cancer Center Ilsan, Gyeonggi-do, Korea, Republic of Chonnam National University Hwasun Hospital Hwasun-eup, Hwasun-gun, Jeollanam-do, Korea, Republic of, 519-763 Dongnam Institute of Radiological and Medical Sciences Busan, Korea, Republic of, 619-953 Yeungnam University Medical Center Daegu, Korea, Republic of, 705-717 Gangneung Asan Hospital Gangneung-si, Korea, Republic of, 210-711 Seoul St. Mary's hospital of the Catholic University of Korea Seoul, Korea, Republic of, 137-701 Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT02278250 Solid Tumor A... More >>dvanced Solid Tumor Less << Phase 1 Recruiting September 23, 2019 United States, Massachusetts ... More >> Research site Recruiting Boston, Massachusetts, United States, 02114 United States, Tennessee Research site 1 Recruiting Nashville, Tennessee, United States, 37203 Research site 2 Recruiting Nashville, Tennessee, United States, 37232 Netherlands Research site Recruiting Rotterdam, Netherlands, 3075 EA United Kingdom Research site Recruiting London, United Kingdom, W1G 6AD Research site Recruiting Sutton, United Kingdom Less <<
NCT01100944 Thymoma Thymi... More >>c Carcinoma Less << Phase 1 Phase 2 Terminated(Principal investiga... More >>tor left the National Institutes of Health (NIH).) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00976768 Advanced Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Asan medical center Seoul, Korea, Republic of, 138-736 Less <<
NCT00003627 Head and Neck Cancer Phase 3 Unknown - France ... More >> Centre Oscar Lambret Lille, France, 59020 Institut J. Paoli and I. Calmettes Marseille, France, 13273 CHU de la Timone Marseille, France, 13385 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Institut Jean Godinot Reims, France, 51056 Centre Henri Becquerel Rouen, France, 76038 Centre Rene Huguenin Saint Cloud, France, 92211 Centre Hospitalier Universitaire Bretonneau de Tours Tours, France, 37044 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Less <<
NCT02595905 Breast Carcinoma Metastatic in... More >> the Brain Deleterious BRCA1 Gene Mutation Deleterious BRCA2 Gene Mutation Estrogen Receptor Negative HER2/Neu Negative Progesterone Receptor Negative Recurrent Breast Carcinoma Stage IV Breast Cancer AJCC v6 and v7 Triple-Negative Breast Carcinoma Less << Phase 2 Recruiting - -
NCT00088816 Gastric Cancer Phase 2 Unknown - Japan ... More >> Shimane Prefectural Central Hospital Izumo-shi, Shimane, Japan, 693-0068 Kyoto University Hospital Kyoto, Japan, 606-8507 National Hospital Organization - Kyoto Medical Center Kyoto, Japan, 612-0861 Kyoto-Katsura Hospital Kyoto, Japan, 615-8256 Kitano Hospital Osaka, Japan, 530-8480 Kansai Denryoku Hospital Osaka, Japan, 553-0003 Yamato Municipal Hospital Yamato City Kanagawa, Japan, 242-8602 Less <<
NCT01501136 Nasal and Nasal-type NK/T-cell... More >> Lymphoma Less << Phase 4 Recruiting May 2019 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com    Principal Investigator: Mingzhi Zhang, Pro,Dr Less <<
NCT01627379 Esophageal Squamous Cell Cance... More >>r Less << Phase 3 Terminated(Sponsor decision du... More >>e to recommendation of the IDMC.) Less << - Germany ... More >> Johannes-Gutenberg-Universität Mainz, I. Medizinische Klinik und Poliklinik Mainz, Rheinland-Pfalz, Germany, 55101 Less <<
NCT00003587 Lung Cancer Phase 2 Completed - -
NCT00047008 - Active, not recruiting - -
NCT02513355 Non-small Cell Lung Cancer Phase 4 Unknown - China, Jiangsu ... More >> Jiangsu Taizhou People's Hospital Recruiting Nanjing City, Jiangsu, China, 225499 Contact: Qingfeng Yin, Clinical Manager    0086013912903257    y_qingfeng@163.com    Contact: Xiaolei Zhou, Manager    0086013776639377    zhouxiaolei@simcere.com Less <<
NCT00324298 Drug/Agent Toxicity by Tissue/... More >>Organ Testicular Germ Cell Tumor Less << Phase 3 Completed - United Kingdom ... More >> Basildon University Hospital Basildon, England, United Kingdom, SS16 5NL Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Essex County Hospital Colchester, England, United Kingdom, C03 3NB Ipswich Hospital Ipswich, England, United Kingdom, IP4 5PD Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE University College of London Hospitals London, England, United Kingdom, WIT 3AA Norfolk and Norwich University Hospital Norwich, England, United Kingdom, NR4 7UY Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Southend University Hospital NHS Foundation Trust Westcliff-On-Sea, England, United Kingdom, SS0 0RY Less <<
NCT01100944 - Terminated(Principal investiga... More >>tor left the National Institutes of Health (NIH).) Less << - -
NCT00047008 Head and Neck Cancer Phase 3 Active, not recruiting - -
NCT00512096 - Completed - -
NCT00512096 Penile Cancer Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02952586 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 3 Recruiting May 18, 2022 -
NCT00182611 Gastric Cancer Phase 3 Completed - Japan ... More >> Yamato Municipal Hospital Yamatotakada, Nara, Japan, 635-8501 Shimane Prefectural Central Hospital Izumo-shi, Shimane, Japan, 693-0068 Fukui Red Cross Hospital Fukui, Japan, 918-8501 Kyoto University Hospital Kyoto, Japan, 606-8507 National Hospital Organization - Kyoto Medical Center Kyoto, Japan, 612-0861 Kitano Hospital Osaka, Japan, 530-8480 Less <<
NCT03533582 Childhood Hepatocellular Carci... More >>noma Childhood Malignant Liver Neoplasm Elevated Alpha-Fetoprotein Hepatoblastoma SMARCB1 Gene Mutation Less << Phase 2 Phase 3 Recruiting March 31, 2025 -
NCT03267498 Nasopharyngeal Carcinoma Phase 2 Recruiting October 15, 2020 United States, California ... More >> Helen Diller Family Comprehensive Center, UCSF Recruiting San Francisco, California, United States, 94115 Contact: Clinical Trials Office    877-827-3222    cancertrials@ucsf.edu    Principal Investigator: Sue Yom, M.D. Less <<
NCT02879513 Invasive Ductal Breast Cancer ... More >> Tubular Breast Cancer Mucinous Breast Cancer Inflammatory Breast Cancer Less << Phase 3 Recruiting December 2022 China, Shanghai ... More >> Shanghai Jiaotong University School of Medicine, Renji Hospital Recruiting Shanghai, Shanghai, China, 200127 Contact: Jinsong Lu, MD       lujjss@163.com Less <<
NCT02104986 Extra Cranial Non Seminomateou... More >>s Malignant Germ Cell Tumour Less << Phase 2 Recruiting May 2024 France ... More >> CHU Not yet recruiting Amiens, France, 80054 Principal Investigator: Catherine DEVOLDERE          CHU Recruiting Angers, France, 49033 Principal Investigator: Isabelle PELLIER          CHRU Not yet recruiting Besançon, France, 25030 Principal Investigator: Véronique LAITHIER          CHU Recruiting Bordeaux, France, 33076 Principal Investigator: Cécile VERITE          Chu Morvan Not yet recruiting Brest, France, 26609 Principal Investigator: Philippe LEMOINE          CHU Not yet recruiting Caen, France, 14033 Principal Investigator: Odile MINCKES          Chu Estaing Not yet recruiting Clermont-ferrand, France, 63003 Principal Investigator: Eric DORE          CHU Not yet recruiting Dijon, France, 21079 Principal Investigator: GERARD COUILLAULT          Centre Oscar Lambret Recruiting Lille, France, 59000 Principal Investigator: HELENE SUDOUR          CHU Not yet recruiting Limoges, France, 87042 Principal Investigator: CHRISTOPHE PIGUET          Hopital de La Timone Recruiting Marseille, France, 13385 Principal Investigator: ANGELIQUE ROME          CHU Not yet recruiting Montpellier, France, 34295 Principal Investigator: NICOLAS KALFA          CHU Recruiting Nancy, France, 54511 Principal Investigator: PASCAL CHASTAGNER          CHU Recruiting Nantes, France, 44093 Principal Investigator: ESTELLE THEBAUD          CHU Recruiting Nice, France, 06202 Principal Investigator: MARILYNE POIREE          Institut Curie Not yet recruiting Paris, France, 75005 Principal Investigator: DANIEL ORBACH          Hopital Trousseau Not yet recruiting Paris, France, 75012 Principal Investigator: SYLVIE FASOLA          CHU Not yet recruiting Poitiers, France, 86021 Principal Investigator: FREDERIC MILLOT          CHU Not yet recruiting Reims, France, 51092 Principal Investigator: MARTINE MUNZER          CHU Not yet recruiting Rennes, France, 35203 Principal Investigator: VIRGINIE GANDEMER          CHU Recruiting Rouen, France, 76031 Principal Investigator: CECILE DUMESNIL DE MARICOURT          Hopital Felix Guyon Not yet recruiting Saint Denis, France, 97405 Principal Investigator: MATHILDE JEHANNE          CHRU Recruiting Saint Etienne, France, 42055 Principal Investigator: CLAIRE BERGER          CHRU Not yet recruiting Strasbourg, France, 67098 Principal Investigator: PATRICK LUTZ          CHU Not yet recruiting Toulouse, France, 31059 Principal Investigator: MARIE PIERRE CASTEIX          CHRU Not yet recruiting Tours, France, 37044 Principal Investigator: ODILE LEJARS          Institut Gustave Roussy Not yet recruiting Villejuif, France, 94805 Principal Investigator: VERONIQUE MINARD Less <<
NCT00003996 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinical and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Less <<
NCT00045617 Lung Cancer Phase 2 Terminated(Closed due to lack ... More >>of drug availability.) Less << - -
NCT01167192 Breast Neoplasms Phase 2 Terminated - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01167192 - Terminated - -
NCT02513342 Advanced Lung Squamous Carcino... More >>ma Less << Phase 4 Unknown April 2018 China, Jiangsu ... More >> Jinling Hospital Recruiting Nanjing, Jiangsu, China, 210002 Contact: Yin Qingfeng, Manager    0086013912903257    y_qingfeng@163.com    Contact: Zhou Xiaolei, Manager    0086013776639377    zhouxiaolei@simcere.com    Principal Investigator: Song Yong, director          The first affiliated hospital of soochow university Recruiting Soochow, Jiangsu, China, 215006 Contact: Yin Qingfeng, mananger    08613912903257    y_qingfeng@163.com    Contact: Zhou Xiaolei, mananger    08613776639377    zhouxiaolei@simcere.com    Principal Investigator: Huang Jianan, director Less <<
NCT00963807 - Completed - -
NCT00963807 Recurrent Non-Small Cell Lung ... More >>Carcinoma Stage IB Non-Small Cell Lung Carcinoma Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT02157116 Non-small Cell Lung Cancer Phase 2 Terminated(Insufficient accrua... More >>l to meet analysis goals) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02157116 - Terminated(Insufficient accrua... More >>l to meet analysis goals) Less << - -
NCT02936388 Uveal Melanoma Phase 2 Unknown December 2018 Germany ... More >> Charité - University Medicine Berlin, Dept. of Haematology, Medical Oncology and Tumor Immunology, Campus Benjamin Franklin Recruiting Berlin, Germany, 12200 Contact: Caroline Anna Peuker    +49 30 450 513470    caroline-anna.peuker@charite.de    Contact: Sebastian Ochsenreither       sebastian.ochsenreither@charite.de Less <<
NCT00003242 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00292955 Cancer of the Cervix Phase 2 Unknown - United States, Missouri ... More >> Washinton University School of Medicine Suspended St. Louis, Missouri, United States, 63110 United States, Virginia University of Virginia Cancer Center Recruiting Charlottesville, Virginia, United States, 22908 Less <<
NCT02512315 Nasopharyngeal Carcinoma Phase 3 Recruiting December 2024 China, Guangdong ... More >> Cancer Center of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510030 Contact: Tong-chong Zhou, M.D    +86-13808841276    noveaie@163.com    Contact: Hai-hua Peng, M.D    +86-15011978349    phhnihao@126.com    Principal Investigator: Tong-chong Zhou, M.D          Sub-Investigator: Hai-hua Peng, M.D          First Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Bi-Xiu Wen, M.D    +86-18903056780    wenbix@mail.sysu.edu.cn    Contact: Cheng-tao Wang, M.D    +86-13711132767    ct_wang@163.com    Principal Investigator: Bi-Xiu Wen, M.D          Sub-Investigator: Cheng-tao Wang, M.D          Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Yuan-hong Gao, M.D    +86-13560182168    gaoyh@sysucc.org.cn    Contact: Hui Chang, M.D    +86-13480295989    changhui@sysucc.org    Principal Investigator: Yuan-hong Gao, M.D          Sub-Investigator: Li-xia Lu, M.D          Sub-Investigator: Qing Liu, Ph.D          Sub-Investigator: Hui Chang, M.D          Sub-Investigator: Xin-hua Jiang, M.D          Sub-Investigator: Wei-wei Xiao, M.D          Sub-Investigator: Qi-wen Li, M.D          Sub-Investigator: Lu-ning Zhang, M.D          Sub-Investigator: Xin Yu, M.D          Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China, 518020 Contact: Ya-jie Liu, M.D    +86-13823394075    liuyj-dr@sohu.com    Contact: Shi-hai Wu, M.D    +86-13632935732    jiangxiwu84@126.com    Principal Investigator: Ya-jie Liu, M.D          Sub-Investigator: Shi-hai Wu, M.D Less <<
NCT01860040 Non-squamous Cell Non-Metastat... More >>ic Non-Small Cell Lung Cancer Squamous Cell Non-Metastatic Non-Small Cell Lung Cancer Less << Phase 2 Terminated(Poor accrual, no da... More >>ta to analyze) Less << - United States, Arizona ... More >> Western Regional Medical Center Goodyear, Arizona, United States, 85338 Less <<
NCT00014196 Lung Cancer Phase 2 Terminated(This study was clos... More >>ed early due to poor accrual.) Less << - -
NCT01004250 - Completed - -
NCT00324415 Anal Cancer Phase 2 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States, 90095-1793 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New York Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx, New York, United States, 10461 United States, Pennsylvania Joan Karnell Cancer Center at Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19106 United States, Washington Benaroya Research Institute at Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT01064921 Stage III Squamous Cell Carcin... More >>oma of the Oropharynx Stage IV Squamous Cell Carcinoma of the Oropharynx Less << Phase 1 Completed - United States, Ohio ... More >> The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00329472 Carcinoma, Non-Small-Cell Lung Phase 3 Withdrawn(poor enrollment) July 2010 -
NCT01004250 Non-Small Cell Lung Cancer Phase 2 Completed - Denmark ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Copenhagen, Denmark, 2200 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Herlev, Denmark, 2730 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Germany, 01640 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany, 60431 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 22087 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamm, Germany, 59071 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Magdeburg, Germany, D-39120 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mannheim, Germany, 68167 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lecce, Italy, 73100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Padova, Italy, 35128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00144 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rozzano, Italy, 20089 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Trento, Italy, 38100 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaen, Spain, 23007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28046 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pozuelo De Alarcon, Spain, 28223 Sweden For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Malmo, Sweden, 205 02 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Solna, Sweden, 17176 Less <<
NCT00746655 Hepatocellular Carcinoma Not Applicable Withdrawn(Unable to recruit) - United States, Pennsylvania ... More >> UPMC Presbyterian/Montifore Pittsburgh, Pennsylvania, United States, 15213 Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 UPMC Cancer Pavilion Pittsburgh, Pennsylvania, United States, 15232 UPMC Shadyside Radiation Oncology Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00324415 - Completed - -
NCT01057589 - Completed - -
NCT01566435 Head and Neck Neoplasms Phase 2 Active, not recruiting October 31, 2023 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01860040 - Terminated(Poor accrual, no da... More >>ta to analyze) Less << - -
NCT02328716 Peritoneal Carcinomatosis From... More >> Ovarian Cancer Fallopian Tube Carcinoma Primary Peritoneal Carcinoma Less << Phase 3 Recruiting December 2018 Spain ... More >> Hospital Clínico Universitario Virgen de la Arrixaca Recruiting El Palmar., Murcia, Spain, 30120 Contact: Pedro Cascales Campos    968369500       Principal Investigator: Pedro Cascales Campos, M.D Less <<
NCT02486718 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting September 25, 2026 -
NCT01057589 Head and Neck Neoplasms Phase 2 Completed - Belgium ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Edegem, Belgium, 2650 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Herblain, France, 44805 Germany For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dresden, Germany, 01307 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Essen, Germany, 45122 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hannover, Germany, 30625 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leipzig, Germany, 04103 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Milano, Italy, 20133 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Barcelona, Spain, 08041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Madrid, Spain, 28041 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Pamplona, Spain, 31008 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46014 United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cardiff, South Glamorgan, United Kingdom, CF14 2TL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. London, United Kingdom, SW3 6JJ Less <<
NCT01664975 Peripheral T-cell Lymphoma Phase 4 Completed - China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China, 450052 Less <<
NCT02707666 Pleural Mesothelioma Phase 1 Recruiting September 2018 United States, Illinois ... More >> University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Mehwish Ahmad    773-834-1472    mahmad3@medicine.bsd.uchicago.edu    Contact: Buerkley Rose, RN    773 834 4002    brose@medicine.bsd.uchicago.edu    Principal Investigator: Hedy Kindler, M.D. Less <<
NCT02716961 Bladder Cancer ... More >> Gemcitabine and Cisplatin Chemotherapy Epirubicin Instillation Recurrence Prognosis Less << Not Applicable Recruiting December 2020 China, Jiangsu ... More >> The first affiliated hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210000 Contact: Qiang Lu, PhD    13505196501    dxhlvqiang@163.com    Contact: Pengchao Li, PhD    13584025756    superkulian@aliyun.com Less <<
NCT01918124 Prosthesis Survival Phase 2 Completed - China, Shanghai ... More >> Shanghai Cancer Center Shanghai, Shanghai, China, 200000 Less <<
NCT01566435 - Active, not recruiting - -
NCT00599131 Cancer of Larynx Phase 2 Terminated(The study was disco... More >>ntinued prematurely due to early stopping rules.) Less << - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0848 Less <<
NCT01664975 - Completed - -
NCT00147147 Gastric Neoplasm Phase 3 Completed - Japan ... More >> Gastric Surgery Division, National Cancer Center Hospital Chuo-ku, Tokyo, Japan, 104-0045 Less <<
NCT00008112 Cervical Cancer Phase 2 Unknown - Netherlands ... More >> Academisch Medisch Centrum Amsterdam, Netherlands, 1105 AZ University Hospital - Rotterdam Dijkzigt Rotterdam, Netherlands, 3000 CA Rotterdam Cancer Institute Rotterdam, Netherlands, 3075 EA Academisch Ziekenhuis Utrecht Utrecht, Netherlands, 3584 CX Less <<
NCT01312350 Hypopharyngeal Cancer Phase 2 Unknown December 2016 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT03641547 Oesophageal Adenocarcinoma ... More >> Squamous Cell Carcinoma Solid Tumor Less << Phase 1 Not yet recruiting May 2023 United Kingdom ... More >> The Churchill Hospital, Oxford University Hospitals Trust Not yet recruiting Oxford, United Kingdom, OX3 7LE Contact: Maria A Hawkins, MD FRCR MRCP Less <<
NCT01210131 Small Cell Lung Cancer (SCLC) Not Applicable Withdrawn August 2014 -
NCT01569919 Malignant Ple... More >>ural Mesothelioma Less << Phase 2 Unknown December 2014 United Kingdom ... More >> Velindre Cancer Centre Recruiting Cardiff, South Wales, United Kingdom, CF14 2TL Sub-Investigator: Mick Button Less <<
NCT00599131 - Terminated(The study was disco... More >>ntinued prematurely due to early stopping rules.) Less << - -
NCT00509561 Esophageal Cancer Phase 2 Phase 3 Unknown - -
NCT01487226 Cervical Cancer Phase 2 Unknown January 2015 Korea, Republic of ... More >> KGOG Recruiting Seoul, Korea, Republic of Contact: Eunkyung Park    8225125420    koreagynonco@gmail.com Less <<
NCT02575547 - Active, not recruiting December 2020 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China Less <<
NCT00537875 Nausea Vomiti... More >>ng Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> National Research Institute of Tuberculosis and Lung Disease (NRITLD) Tehran, Iran, Islamic Republic of, P.O: 19575/154 Less <<
NCT01659554 Recurrent Ovarian Cancer ... More >> Fallopian Tube Cancer Less << Phase 2 Terminated(Principal Investiga... More >>tor left institution) Less << - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01880359 Locally Advanced Head and Neck... More >> HPV Negative Squamous Cell Cancers Less << Phase 3 Active, not recruiting December 2020 Australia ... More >> Royal Brisbane And Women's Hospital Brisbane, Australia, QLD 4029 Princess Alexandra Hospital - University Of Queensland Brisbane, Australia, QLD 4102 Royal North Shore Hospital St Leonards, Australia, NSW 2065 Belgium Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium, 1000 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 U.Z. Leuven - Campus Gasthuisberg Leuven, Belgium, 3000 France Centre Georges-Francois-Leclerc Dijon, France, 21079 CHU de Tours - Hopital Bretonneau Tours, France, 37044 Institut Gustave Roussy Villejuif, France, 94805 Germany Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum Berlin, Germany Ludwig-Maximilians-Universitaet Muenchen - Klinikum der Universitaet Muenchen - Campus Grosshadern Muenchen, Germany, 81377 Netherlands Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 7007MB Radboud University Medical Center Nijmegen Nijmegen, Netherlands, 6500 H Poland Medical University Of Gdansk Gdansk, Poland, 80 211 The Great Poland Cancer Centre Poznan, Poland Maria Sklodowska-Curie Memorial Cancer Centre Warsaw, Poland Lower Silesian Oncology Centre Wrocław, Poland Switzerland Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie Geneva, Switzerland, 1211 UniversitaetsSpital Zurich Zurich, Switzerland, 8091 Less <<
NCT03298763 Adenocarcinoma of Lung Phase 1 Phase 2 Not yet recruiting March 1, 2024 United Kingdom ... More >> University College London Hospital Not yet recruiting London, United Kingdom Less <<
NCT00004033 Malignant Mesothelioma Phase 2 Completed - United States, New York ... More >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT01659554 - Terminated(Principal Investiga... More >>tor left institution) Less << - -
NCT00520091 Esophageal Cancer Phase 2 Completed - -
NCT00109928 - Completed - -
NCT00352105 Head and Neck Cancer Phase 1 Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00352105 - Completed - -
NCT03701451 Nasopharyngeal Carcinoma Phase 1 Phase 2 Recruiting December 1, 2020 China, Guangxi ... More >> Guilin Hospital of Traditional Chinese Medicine Recruiting Guilin, Guangxi, China, 541002 Contact: Ruihua Xiong, Ph.D.          Guilin Medical University Recruiting Guilin, Guangxi, China Contact: Rongjun Zhang, Mster    +8618977330177    41974954@qq.com    Contact: Wei Jiang, Ph.D    +8613788561863 Less <<
NCT01005680 Non Small Cell Lung Cancer Phase 3 Completed - China ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China, 100730 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changchun, China, 130012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dalian, China, 116023 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Guang Zhou, China, 510080 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanjing, China, 210002 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nanning, China, 530000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Shanghai, China, 200433 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sichuan, China, 610041 Less <<
NCT00379665 Carcinoma, Non-Small-Cell Lung PHASE2 COMPLETED 2025-09-12 Cancer Treatment Centers of Am... More >>erica ? Southwestern Regional Medical Center, Tulsa, Oklahoma, 74133, United States Less <<
NCT00109928 Lymphoma Phase 2 Completed - -
NCT03123445 Non Small Cell Lung Cancer Phase 2 Not yet recruiting September 2019 -
NCT01005680 - Completed - -
NCT01216111 - - - -
NCT02986503 - Completed - Germany ... More >> Cooperative Osteosarcoma Study Group Stuttgart, Germany, D-70176 Italy Istituti Ortopedici Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Bologna, Italy, 40136 Sweden Scandinavian Sarcoma Group Lund, Sweden, SE-221 85 Less <<
NCT00191490 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - Italy ... More >> For additional information regarding investigative sites for this trial, please call 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Monday-Friday, 9:00 am to 5:00 pm Eastern time (UTC/GMT - 5 hours, EST) or speak with your physician Sesto Fiorentino, Florence, Italy, 50019 Less <<
NCT02429687 Ovarian Germ Cell Cancer ... More >> Ovarian Neoplasms Ovarian Cancer Less << Phase 3 Recruiting May 2024 China, Shandong ... More >> Qilu Hospital of Shandong University Recruiting Jinan, Shandong, China, 250012 Contact: Beihua Kong, MD. PhD.    +8618560081888    kongbeihua@sdu.edu.cn Less <<
NCT00051506 Lung Neoplasms Phase 2 Completed - United States, Arkansas ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Springdale, Arkansas, United States United States, California For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Los Angeles, California, United States United States, Florida For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Fort Myers, Florida, United States For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Miami, Florida, United States United States, New York For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Latham, New York, United States United States, North Carolina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Burlington, North Carolina, United States For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Chapel Hill, North Carolina, United States United States, South Carolina For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Charleston, South Carolina, United States Less <<
NCT00454519 Stomach Neoplasms ... More >> Colorectal Neoplasms Neoplasm Metastasis Mesothelioma Less << Phase 2 Unknown - China, Hubei ... More >> Cancer Center of Wuhan University & Department of Oncology, Zhongnan Hospital of Wuhan University Recruiting Wuhan, Hubei, China, 430071 Contact: Yan Li, M.D., Ph.D    +86-27-67813152 ext 3152    liyansd2@163.com    Contact: Yonemura Yutaka, M.D., Ph.D    +81-072-433-2131    y.yonemura@coda.ocn.ne.jp    Sub-Investigator: Guo-Liang Yang, M.D          Sub-Investigator: Fu-Lin Cheng, M.D.          Principal Investigator: Yan Li, M.D., Ph.D          Sub-Investigator: Mao-Hui Feng, M.D., Ph.D          Sub-Investigator: Shibo Masaya, M.D. Less <<
NCT02429700 Ovarian Sex Cord Stromal Tumor... More >> Ovarian Neoplasms Ovarian Cancer Less << Phase 3 Recruiting May 2024 China, Shandong ... More >> Qilu Hospital of Shandong University Recruiting Jinan, Shandong, China Contact: Beihua Kong, MD. PhD. Less <<
NCT01903018 Radiation Induced Mucositis in... More >> Head and Neck Cancer Less << Phase 2 Completed - India ... More >> Bharat Cancer Hospital & Research Institute Surat, Gujarat, India, 395010 Sri Venkateshwara Hospitals Bangalore, Karnataka, India, 560068 Mazumdar Shaw Cancer Center Bangalore, Karnataka, India, 560099 Tata Memorial Hospital Mumbai, Maharashtra, India, 400012 Curie Manavta Cancer Centre Nashik, Maharashtra, India, 422004 Ruby Hall Clinic Pune, Maharashtra, India, 411001 Meenakshi Mission Hosp. & Res. Centre Madurai, Tamil Nadu, India, 625107 Less <<
NCT01088581 Hepatocellular Carcinoma Phase 3 Completed - Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT03304756 Triple Negative Breast Cancer ... More >>Patients Less << Phase 2 Completed - -
NCT00101842 Carcinoma, Transitional Cell Phase 1 Phase 2 Completed - United States, Texas ... More >> For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-285-4559) or speak with your personal physician. Dallas, Texas, United States Less <<
NCT02949700 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 1 Phase 2 Recruiting December 2021 United States, Texas ... More >> Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Vlad Sandulache, MD, PhD    713-798-7218    vlad.sandulache@bcm.edu    Michael E. DeBakey Veterans Affairs Medical Center Recruiting Houston, Texas, United States, 77030 Contact: Vlad Sandulache, MD, PhD    713-798-7218    vlad.sandulache@bcm.edu    Harris Health System - Smith Clinic Recruiting Houston, Texas, United States, 77054 Contact: Vlad Sandulache, MD, PhD    713-798-7218    vlad.sandulache@bcm.edu Less <<
NCT00003621 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Less <<
NCT00777491 Bladder Cancer Phase 2 Active, not recruiting January 2023 United States, Georgia ... More >> Georgia Cancer Center for Excellence at Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Idaho Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center Boise, Idaho, United States, 83706 United States, Illinois Cancer Institute at St. John's Hospital Springfield, Illinois, United States, 62702 United States, Indiana Parkview Regional Cancer Center at Parkview Health Fort Wayne, Indiana, United States, 46805 United States, Maryland St. Agnes Hospital Cancer Center Baltimore, Maryland, United States, 21229 United States, Massachusetts Hudner Oncology Center at Saint Anne's Hospital - Fall River Fall River, Massachusetts, United States, 02721 United States, Michigan Saint Joseph Mercy Cancer Center Ann Arbor, Michigan, United States, 48106-0995 University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0942 West Michigan Cancer Center Kalamazoo, Michigan, United States, 49007-3731 Canada, Quebec McGill Cancer Centre at McGill University Montreal, Quebec, Canada, H2W 1S6 Less <<
NCT00425191 Non-small Cell Lung Cancer Phase 2 Completed - Italy ... More >> Sanofi-Aventis Milan, Italy Less <<
NCT01525771 Stage IV Gastric Cancer With M... More >>etastasis Less << Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of Less <<
NCT00239304 Head and Neck Neoplasms Phase 1 Phase 2 Completed - Finland ... More >> Research Centre Helsinki, Finland Less <<
NCT03217747 Malignant Neoplasm of Breast ... More >> Malignant Neoplasms of Bone and Articular Cartilage Malignant Neoplasms of Digestive Organs Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System Malignant Neoplasms of Female Genital Organs Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites Malignant Neoplasms of Independent (Primary) Multiple Sites Malignant Neoplasms of Lip Oral Cavity and Pharynx Malignant Neoplasms of Male Genital Organs Malignant Neoplasms of Mesothelial and Soft Tissue Malignant Neoplasms of Respiratory and Intrathoracic Organs Malignant Neoplasms of Thyroid and Other Endocrine Glands Malignant Neoplasms of Urinary Tract Neoplasms of Uncertain or Unknown Behavior Less << Phase 1 Phase 2 Recruiting August 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       anaing@mdanderson.org Less <<
NCT00006487 Lung Cancer Phase 1 Completed - -
NCT01326468 Head and Neck Cancer Not Applicable Withdrawn(funding) - -
NCT02845323 Urothelial Carcinoma ... More >> Bladder Cancer Less << Phase 2 Recruiting January 2020 United States, Maryland ... More >> Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21205 Contact: Noah Hahn, MD    443-287-2886    nhahn4@jhmi.edu    Contact: Rana Sullivan, RN    410-614-6337    tomalra@jhmi.edu Less <<
NCT01023347 Non Small Cell Lung Cancer Phase 2 Completed - Korea, Republic of ... More >> Chungnam National University Hospital Daejeon, Jung-gu, Korea, Republic of, 301-721 Less <<
NCT01857726 Hepatocellular Carcinoma Not Applicable Withdrawn(No participants were... More >> enrolled) Less << December 2016 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT03015727 Locally Advanced Nasopharyngea... More >>l Carcinoma Less << Phase 3 Recruiting December 2024 China, Zhejiang ... More >> Xiaozhong Chen Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Xiaozhong Chen, MD    +86-571-88128202    cxzfyun@sina.com Less <<
NCT00699517 Sarcoma Phase 3 Completed - -
NCT00505635 - Terminated(Slow accrual) - -
NCT03272217 Urothelial Carcinoma Phase 2 Active, not recruiting April 2021 United States, Minnesota ... More >> HealthPartners Institute Minneapolis, Minnesota, United States, 55440 United States, New York New York University Clinical Cancer Center New York, New York, United States, 10016 United States, Tennessee West Cancer Center University of Tennessee Memphis, Tennessee, United States, 38120 Less <<
NCT01902875 - Unknown - China, Jiangsu ... More >> Nanjing General Hospital of Nanjing Military Command(Jinling Hospital) Recruiting Nanjing, Jiangsu, China, 210002 Contact: Longbang Chen, M.D.       dr.chenlb@nju.edu.cn    Principal Investigator: Longbang Chen, M.D. Less <<
NCT00217698 Lung Cancer Phase 2 Completed - Switzerland ... More >> Saint Claraspital AG Basel, Switzerland, CH-4016 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Spitaeler Chur AG Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Liestal, Switzerland, CH-4410 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 Kantonsspital Winterthur Winterthur, Switzerland, CH-8400 City Hospital Triemli Zurich, Switzerland, 8063 Klinik Hirslanden Zurich, Switzerland, CH-8008 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT02764593 Head and Neck Squamous Cell Ca... More >>rcinoma (HNSCC) Less << Phase 1 Active, not recruiting March 2021 United States, California ... More >> Stanford Cancer Institute Palo Alto, California, United States, 94304 United States, Florida University of Florida Cancer Center at Orlando Health Orlando, Florida, United States, 32806 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Kentucky University of Louisville Louisville, Kentucky, United States, 40202 United States, Ohio University Hospitals Cleveland Medical Center Cleveland, Ohio, United States, 44106 Ohio State University Columbus, Ohio, United States, 43210 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Pennsylvania UPMC - Shadyside Hospital Pittsburgh, Pennsylvania, United States, 15232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia Inova Fairfax Hospital Falls Church, Virginia, United States, 22042 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT01003964 Non Small Cell Lung Cancer Phase 2 Unknown December 2014 Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of Less <<
NCT01081041 Head and Neck Cancer Phase 2 Completed - -
NCT00331760 Cervical Cancer ... More >> Endometrial Cancer Less << Phase 2 Completed - -
NCT02969083 Upper Tract Urothelial Carcino... More >>ma Less << Phase 2 Recruiting October 2023 Netherlands ... More >> Leiden University Medical Centre Recruiting Leiden, South Holland, Netherlands Less <<
NCT00309972 Lung Cancer Phase 3 Completed - United Kingdom ... More >> Clatterbridge Centre for Oncology Merseyside, England, United Kingdom, CH63 4JY Less <<
NCT00843934 Carcinoma, Hepatocellular Phase 2 Phase 3 Unknown February 2015 Japan ... More >> Department of Digestive Surgery, Nihon University School of Medicine Recruiting Itabashi, Tokyo, Japan, 173-8610 Contact: Masashi Fujii, MD    +81332931711 ext 207    masashi.fujii@gioncology.jp    Contact: Tadatoshi Takayama, MD    +81339728111 ext 2471    Takayama.Tadatoshi@nihon-u.ac.jp Less <<
NCT00331760 - Completed - -
NCT00215644 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - Germany ... More >> Research Site Essen, Germany Research Site Hamburg, Germany Research Site Oldenburg, Germany Research Site Recklinghausen, Germany Spain Research Site A Coruna, Spain Research Site Barcelona, Spain Research Site Cadiz, Spain Research Site Valencia, Spain Switzerland Research Site Bern, Switzerland Research Site Geneva, Switzerland Research Site Lausanne, Switzerland Research Site St. Gallen, Switzerland United Kingdom Research Site Northwood, Middlesex, United Kingdom Research Site Bournemouth, United Kingdom Research Site Cambridge, United Kingdom Research Site Chelmsford, United Kingdom Research Site Guildford, United Kingdom Research Site Leicester, United Kingdom Research Site London, United Kingdom Research Site Newcastle, United Kingdom Research Site Northwood, United Kingdom Research Site Portsmouth, United Kingdom Less <<
NCT00215644 - Completed - -
NCT01327235 Malignant Pleural Effusion ... More >> Malignant Ascites Less << Phase 2 Completed - China ... More >> The 81st Hospital of Chinese PLA Nanjing, China The Affiliated Hospital of Medical College, QingDao University Qingdao, China Fudan University Shanghai Cancer Center Shanghai, China Less <<
NCT00249977 Solid Tumors ... More >>Cancer Less << Phase 1 Completed - United States, New Mexico ... More >> University of New Mexico Albuquerque, New Mexico, United States, 87131 Less <<
NCT03773302 Advanced Cholangiocarcinoma Phase 3 Not yet recruiting October 31, 2022 -
NCT01081041 - Completed - -
NCT02298595 Carcinoma, Squamous ... More >> Squamous Cell Carcinoma Oropharyngeal Neoplasms Oropharyngeal Cancer Less << Phase 1 Phase 2 Withdrawn August 2024 -
NCT00588237 - Completed - -
NCT00505635 Melanoma Phase 2 Terminated(Slow accrual) - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01204307 Advanced Non-Squamous Non-Smal... More >>l Cell Lung Cancer Less << Phase 2 Completed - Taiwan ... More >> Chang Gung Memorial Hospital, Kaohsiung Branch Kaohsiung, Taiwan Chang Gung Memorial Hospital Taipei, Taiwan, 10507 McKay Memorial Hospital Taipei, Taiwan Shin Kong Wu Ho-Su Memorial Hospital Taipei, Taiwan Less <<
NCT01453660 - Active, not recruiting October 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00588237 Ovarian Cancer ... More >> Primary PERITONEUM Fallopian Tube Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02973386 Local Advanced High Risk Nasop... More >>haryngeal Carcinoma Less << Phase 2 Phase 3 Recruiting December 2024 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China Contact: Zhao chong, M.D    +86-13902206160    zhaochong@sysucc.org.cn Less <<
NCT02725918 Non-small Cell Lung Cancer Phase 2 Recruiting June 2020 China, Guangdong ... More >> Guangdong Lung cancer institute Recruiting Guangzhou, Guangdong, China, 510080 Contact: Qing Zhou, MD    86 13544561166    gzzhouqing@126.com Less <<
NCT01187615 Small Cell Lung Carcinoma Phase 1 Terminated - United States, Connecticut ... More >> New Haven, Connecticut, United States, 06519 United States, Nevada Las Vegas, Nevada, United States, 89135-3011 United States, New York New York, New York, United States, 10065 United States, North Carolina Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00064259 Adenocarcinoma of the Esophagu... More >>s Adenocarcinoma of the Gastroesophageal Junction Diffuse Adenocarcinoma of the Stomach Intestinal Adenocarcinoma of the Stomach Mixed Adenocarcinoma of the Stomach Recurrent Esophageal Cancer Recurrent Gastric Cancer Squamous Cell Carcinoma of the Esophagus Stage III Esophageal Cancer Stage IIIA Gastric Cancer Stage IIIB Gastric Cancer Stage IIIC Gastric Cancer Stage IV Esophageal Cancer Stage IV Gastric Cancer Less << Phase 1 Phase 2 Terminated(Discontinued develo... More >>pment of G3139 (oblimersen)) Less << - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467-2490 Less <<
NCT00716391 Head and Neck Cancer Phase 3 Unknown December 2013 Spain ... More >> Hospital Puerta del Mar Recruiting Almeria, Almería, Spain Principal Investigator: Esperanza Arriola, MD          Hospital Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Principal Investigator: Beatriz Cirauqui, MD          Hospital Durán i Reynals Recruiting Hospitalet de Ll., Barcelona, Spain Principal Investigator: Ricard Mesía, MD          Hospital de Manresa Recruiting Manresa, Barcelona, Spain Principal Investigator: Esther Casado          Hospital Mútua de Terrassa Recruiting Terrassa, Barcelona, Spain Principal Investigator: Romà Bastús, MD          Hospital Son Dureta Recruiting Palma de Mallorca, Mallorca, Spain, 07014 Principal Investigator: José Fuster, MD          Hospital de Sagunto Recruiting Sagunto, Valencia, Spain Principal Investigator: José M Vicent, MD          Hospital general Universitario Recruiting Alicante, Spain Principal Investigator: Juan L. Martí Ciriquián, MD          Hospital Clínic i Provincial de Barcelona Recruiting Barcelona, Spain, 08036 Principal Investigator: Juan J Grau, MD          Hospital de Basurto Recruiting Bilbao, Spain Principal Investigator: Elena Galve, MD          Hospital General Yagüe Recruiting Burgos, Spain Principal Investigator: Carlos García Girón, MD          Hospital San Pedro de Alcántara Terminated Cáceres, Spain Hospital Dr. Trueta (ICO Girona) Recruiting Girona, Spain, 17007 Principal Investigator: José Rubio, MD          Oncogranada Terminated Granada, Spain, 18014 H. Virgen de las Nieves Recruiting Granada, Spain Principal Investigator: Antonio L Irigoyen          Hospital General de Jaén Not yet recruiting Jaén, Spain Principal Investigator: Miguel A Moreno, MD          Hospital Xeral Calde Recruiting Lugo, Spain Principal Investigator: J. Ramón Mel, MD          Hospital Universitari Arnau de Vilanova Recruiting Lérida, Spain, 25198 Principal Investigator: Santiaago Miguel Sanz, MD          Hospital Clínico San Carlos Recruiting Madrid, Spain, 28040 Principal Investigator: José A García, MD          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Principal Investigator: Ricardo Hitt, MD          Clínica Quirón Recruiting Madrid, Spain Principal Investigator: Ramón Pérez Carrión, MD          Fundación Jiménez Díaz Recruiting Madrid, Spain Principal Investigator: Victoria Casado, MD          Hospital Gregorio Marañon Recruiting Madrid, Spain Principal Investigator: Yolanda Escobar, MD          Hospital La Paz Recruiting Madrid, Spain Principal Investigator: Beatriz Castelo, MD          Hospital Son Llàtzer Recruiting Mallorca, Spain Principal Investigator: Belén González, MD          Hospital Universitario Central de Asturias Recruiting Oviedo, Spain, 33006 Principal Investigator: Enrique estrada, MD          Hospital Universitario de Salamanca Recruiting Salamanca, Spain, 37007 Sub-Investigator: Juan J Cruz, MD          Principal Investigator: Elvira del Barco Morillo, MD          Sub-Investigator: Juan Carlos Adansa Klain, MD          Hospital Universitario Marques de Valdecilla Recruiting Santander, Spain, 39008 Principal Investigator: Almudena García Castaño, MD          Hospital Clínico de Santiago Not yet recruiting Santiago de Compostela, Spain Principal Investigator: Jorge J García, MD          Hospital General de Segovia Recruiting Segovia, Spain Principal Investigator: Beatriz Esteban, MD          Hospital Arnau de Vilanova Recruiting Valencia, Spain, 46015 Principal Investigator: Oscar Juan Vidal          Hospital General Universitario Recruiting Valencia, Spain Principal Investigator: Alfonso Berrocal, MD          Hospital La Fe Recruiting Valencia, Spain Contact: Miguel Pastor Borgoñon, MD          Principal Investigator: Miguel Pastor Borgoñon, MD          Hospital Xeral Cies Recruiting Vigo, Spain, 36024 Principal Investigator: Javier Castellanos, MD          Hospital de Meixoeiro Recruiting Vigo, Spain, 36200 Principal Investigator: Carlos Grande, MD          Hospital Provincial de Zamora Recruiting Zamora, Spain, 49021 Principal Investigator: Yolanda López, MD          Hospital Clínico Lozano Blesa Recruiting Zaragoza, Spain Principal Investigator: Julio Lambea, MD          Hospital Miguel Servet Recruiting Zaragoza, Spain Principal Investigator: Javier Martínez Trufero, MD          Hospital Nuestra Señora de Sonsoles Recruiting Ávila, Spain Contact: Elena Filipovich, MD          Principal Investigator: Elena Filipovich, MD Less <<
NCT03002064 Esophagus Cancer ... More >> Chemotherapy Effects Less << Phase 3 Recruiting December 2020 China, Guangdong ... More >> Cancer center of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Rui-Hua Xu, MD, PhD    86-020-87343333    xurh@sysucc.org.cn    Contact: Miao-Zhen Qiu, MD, PhD    86-020-87342490    qiumzh@sysucc.org.cn    Sub-Investigator: Miao-zhen Qiu, MD          Principal Investigator: Rui-hua Xu, MD, PhD Less <<
NCT01088906 Carcinoma, Non Small Cell Lung Phase 2 Terminated(No safety reasons. ... More >>Low recruitment.) Less << - Spain ... More >> H. Clínica Benidorm Benidorm, Alicante, Spain, 03501 H. General de Elche Elche, Alicante, Spain, 03202 H. Germans Trias i Pujol Badalona, Barcelona, Spain, 088916 H. Insular de Gran Canarias Las Palmas de Gran Canarias, Gran Canarias, Spain, 35016 H. Universitario de Canarias La Laguna, Tenerife, Spain, 38320 MD Anderson Madrid, Spain, 28033 Hospital 12 de Octubre Madrid, Spain, 28041 H. Morales Messeguer Murcia, Spain, 30008 Less <<
NCT00064259 - Terminated(Discontinued develo... More >>pment of G3139 (oblimersen)) Less << - -
NCT00337532 Head and Neck Cancer Phase 2 Phase 3 Completed - Korea, Republic of ... More >> Local Insitution Seoul, Korea, Republic of Local Institution Seoul, Korea, Republic of Less <<
NCT01641172 Testicular Cancer Phase 4 Completed - Netherlands ... More >> University Medical Center Groningen Groningen, Netherlands, 9713 GZ Less <<
NCT00003596 Anal Cancer Phase 3 Completed - -
NCT03366415 Nasopharyngeal Carcinoma Phase 3 Recruiting December 2023 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Chaosu Hu, MD,PhD    +86 18017312302 Less <<
NCT00046969 Anemia Cervic... More >>al Cancer Less << Phase 4 Completed - Germany ... More >> Martin Luther Universitaet Halle, Germany, D-06097 Less <<
NCT03535207 Esophageal Cancer Not Applicable Recruiting April 1, 2021 China, Shanghai ... More >> Shanghai Genernal Hospital Recruiting Shanghai, Shanghai, China, 210000 Contact: Ningning Chen, MD    37798364 ext 8119    ningcnn@163.com    Contact: yong Liu, MD    37798364    drliuyrt@163.com Less <<
NCT01123473 Adenocarcinoma of the Gastroes... More >>ophageal Junction Gastric Cancer Less << Phase 2 Terminated(company withdrew in... More >>terest) Less << - Belgium ... More >> Institut Jules Bordet Brussels, Belgium U.Z. Gasthuisberg Leuven, Belgium Germany Johannes Gutenberg Universitaetskliniken Mainz, Germany Portugal I.P.O. Francisco Gentil - Centro De Lisboa Lisboa, Portugal Less <<
NCT01784549 Non Small Cell Lung Cancer Phase 2 Unknown December 2015 Italy ... More >> IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro Recruiting Genoa, Italy, 16132 Contact: Francesco Grossi, MD    +393355255484    fg1965@libero.it Less <<
NCT00817258 Nasopharyngeal Carcinoma Phase 2 Unknown December 2009 China ... More >> Department of Radiation Oncology, Cancer Hospital, Fudan University Recruiting Shanghai, China, 200032 Contact: Jing Yuan    8621-64175590 ext 6511    skelly_sh@hotmail.com Less <<
NCT03699956 Carcinoma, Small Cell ... More >> Carcinoma, Small Cell Lung Less << Phase 3 Not yet recruiting May 1, 2021 -
NCT00887549 - Completed - -
NCT00887549 Non-Small Cell Lung Cancer Phase 2 Completed - Ireland ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dublin, Ireland United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Derby, Derbyshire, United Kingdom, DE22 3NE For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Exeter, Devon, United Kingdom, EX2 5DW For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Maidstone, Kent, United Kingdom, ME16 9QQ For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Preston, Lancashire, United Kingdom, PR2 9HT For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Liverpool, Merseyside, United Kingdom, L14 3PE For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Northwood, Middlesex, United Kingdom, HA6 2RN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Scunthorpe, North Lincolnshire, United Kingdom, DN15 7BH For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Belfast, Northern Ireland, United Kingdom, BT9 7BL For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nottingham, Nottinghamshire, United Kingdom, NG5 1PD For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aberdeen, Scotland, United Kingdom, AB25 2ZN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wolverhampton, West Midlands, United Kingdom, WV10 0QP For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Grimsby, United Kingdom For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Manchester, United Kingdom, M23 9LT Less <<
NCT03389438 Urinary Bladder Neoplasm Phase 2 Recruiting January 2021 China ... More >> Huanxing ward, Cancer Hospital Chinese Academy of Medical Sciences Recruiting Beijing, China Contact: Dong Wang, Master    +86-13701017215    wangdong1199@126.com Less <<
NCT00003332 Pancreatic Cancer Phase 1 Phase 2 Completed - United States, New York ... More >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Less <<
NCT02281955 Carcinoma, Squamous Cell ... More >> Head and Neck Neoplasms Oropharyngeal Neoplasms Less << Phase 2 Active, not recruiting November 2024 United States, Florida ... More >> University of Florida Gainesville, Florida, United States, 32610 United States, North Carolina University of North Carolina at Chapel Hill, Department of Radiation Oncology Chapel Hill, North Carolina, United States, 27599 Pardee Memorial Hospital Hendersonville, North Carolina, United States, 28791 High Point Regional Health High Point, North Carolina, United States, 27262 Rex Healthcare Raleigh, North Carolina, United States, 27607 Less <<
NCT00227539 Lung Cancer Phase 2 Completed - United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 University of Washington School of Medicine Seattle, Washington, United States, 98195 Less <<
NCT00002472 Brain and Central Nervous Syst... More >>em Tumors Pediatric Germ Cell Tumor Extragonadal Germ Cell Tumor Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT02268695 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Active, not recruiting December 2018 France ... More >> Institut Sainte Catherine Avignon, France, 84082 Centre Hospitalier de la Dracénie Draguignan, France Centre Médical de Forcilles Férolles-Attilly, France, 77150 Clinique des Ormeaux Le Havre, France, 76600 Centre Hospitalier de Bretagne Sud (CHBS) Lorient, France, 56322 Centre Léon Bérard Lyon, France, 69008 Hôpital de la Timone Marseille, France, 13385 ICM Val d'Aurelle, Montpellier Montpellier, France, 34298 Centre Antoine-Lacassagne Nice, France, 06189 Val de Grace Paris, France, 75005 Centre Eugene Marquis Rennes, France, 35042 Centre Henri Becquerel Rouen, France, 76038 Institut de Cancérologie de l'Ouest (ICO) René Gauducheau Saint Herblain, France, 44805 L'Institut de Cancérologie de Lorraine (ICL) Alexis Vautrin Vandoeuvre les Nancy, France, 54511 Gustave Roussy Villejuif, France, 94805 Germany Charité Campus Benjamin Franklin Berlin, Germany, 12203 Spain Instituto Catalá de Oncologia (ICO) Barcelona, Spain, 08907 Less <<
NCT00592501 Nasopharyngeal Carcinoma Phase 2 Active, not recruiting December 2019 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00062322 Lung Cancer Phase 1 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT02092298 Gastrointestinal Cancer Phase 2 Active, not recruiting May 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03534713 Cervical Cancer TNM Staging Re... More >>gional Lymph Nodes (N) Less << Phase 3 Not yet recruiting December 2024 -
NCT02285413 Melanoma Phase 2 Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT00379717 Non-Small-Cell Lung Carcinoma Phase 1 Phase 2 Unknown - Belgium ... More >> UZ Brussel Recruiting Jette, Belgium, 1090 Contact: Samuel Bral, MD    0032 2 477 64 15    samuel.bral@uzbrussel.be    Contact: Nicolas Fontaine, Mr    0032 2 477 54 61    nicolas.fontaine@uzbrussel.be Less <<
NCT02983097 Diffuse Large B-cell Lymphoma ... More >>(DLBCL) Follicular Lymphoma Grade III (FL III°) Mantle Cell Lymphoma (MCL), Blastoid Variant Burkitt Lymphoma (BL) Aggressive Marginal Zone Lymphoma (MZL) Less << Phase 1 Phase 2 Terminated(Phase II no scienti... More >>fic interests are given anymore) Less << - Germany ... More >> Diakonie Krankenhaus Bremen Bremen, Germany, 28239 Klinikum Chemnitz Chemnitz, Germany, 09113 Universitätsklinikum Essen Essen, Germany, 45122 Klinikum Frankfurt/Oder Frankfurt/Oder, Germany, 15236 Universitätsklinikum Göttingen Göttingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, 20099 Asklepios Klinik Altona Hamburg, Germany, 22763 Universitätsklinikum Heidelberg Heidelberg, Germany, 69120 Universitätsklinikum des Saarlandes Homburg, Germany, 66421 Westpfalz Klinikum Kaiserslautern, Germany, 67665 Städtisches Klinikum Karlsruhe Karlsruhe, Germany, 76133 LMU Klinikum München-Großhadern München, Germany, 81377 Less <<
NCT01084083 Head and Neck Cancer ... More >> Precancerous Condition Less << Phase 2 Completed - -
NCT01084083 - Completed - -
NCT00190554 Esophageal Neoplasms ... More >> Carcinoma, Squamous Cell Less << Phase 3 Terminated - Japan ... More >> Aichi Cancer Center Hospital Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi, Japan, 464-8681 Chiba University, Graduate School of Medicine Chiba,Chuo-ku,Inohana,1-8-1, Chiba, Japan, 260-8670 Tokyo Dental College Ichikawa General Hospital Ichikawashi,Sugano,5-11-13, Chiba, Japan, 2728513 National Cancer Center Hospital East Kashiwa,Kashiwanoha,6-5-1, Chiba, Japan, 277-8577 National Hospital Organization Shikoku Cancer Center Matsuyama,Horinouchi,13, Ehime, Japan, 790-0007 Kurume University School of Medicine Kurume,Asahi-machi,67, Fukuoka, Japan, 830-0011 Hiroshima City Asa Hospital Hiroshima,Asakitaku,KabeminamiHiroshima,2-1-1, Hiroshima, Japan, 731-0293 Iwate Medical University Morioka,Uchimaru,19-1, Iwate, Japan, 020-8505 Tokai University School of Medicine Isehara,Shimokasuya,143, Kanagawa, Japan, 259-1193 Kanagawa Cancer Center Yokohama,Asahi-ku,Nakao,1-1-2, Kanagawa, Japan, 241-0815 Kyoto University Hospital Kyoto,Sakyo-ku,Syogoinkawara,54, Kyoto, Japan, 606-8507 Niigata University Medical and Dental Hospital Niigata,Asahimachi-dori,1-754, Niigata, Japan, 951-8520 Niigata Cancer Center Hospital Niigata,Kawagishi-cho,2-15-3, Niigata, Japan, 951-8566 Osaka National Hospital Osaka,Chuo-ku,Hoenzaka,2-1-14, Osaka, Japan, 540-0006 Osaka Medical Center for Cancer and Cardiovascular Diseases Osaka,Higashinari-ku,Nakamichi,1-3-3, Osaka, Japan, 537-8511 Sizuoka Cancer Center Sunto-gun,Nagaizumi-cho,Shimonagakubo,1007, Shizuoka, Japan, 411-8777 Tochigi Cancer Center Utsunomiya,Yohnan,4-9-13, Tochigi, Japan, 320-0834 Juntendo University School of Medicine Bunkyo-ku,Hongo,3-1-3, Tokyo, Japan, 113-0033 Tokyo Medical and Dental University Hospital Bunkyo-ku,Yushima,1-5-45, Tokyo, Japan, 113-8519 National Cancer Center Hospital Chuo-ku,Tsukiji,5-1-1, Tokyo, Japan, 104-0045 National Hospital Organization Tokyo Medical Center Meguro-ku,Higashigaoka,2-5-1, Tokyo, Japan, 152-8902 Toranomon Hospital Minato-ku,Toranomon,2-2-2, Tokyo, Japan, 105-8470 Tokyo Women's Medical University Shinjuku-ku,Kawada-cho,8-1, Tokyo, Japan, 162-8666 Keio University Hospital Shinjuku-ku,Shinanomachi,35, Tokyo, Japan, 160-8582 Less <<
NCT02795884 NSCLC Phase 3 Withdrawn(Because of reconside... More >>ration of using erlotinib(EGFR Tyrosine kinase inhibitor) as adjuvant aim) Less << November 2020 -
NCT03177174 Drug-Related Side Effects and ... More >>Adverse Reactions Less << Not Applicable Recruiting June 1, 2020 China ... More >> Chinese PLA general hospital Recruiting Beijing, China Contact: LUO yanrong, doctor    +8601066936933    lyr961lyr@163.com Less <<
NCT00227539 - Completed - -
NCT02985658 - - - United States, Washington ... More >> Seattle Cancer Care Allliance Seattle, Washington, United States, 98109 Contact: Jennifer Specht, MD    206-606-6329 Less <<
NCT00173862 Transitional Cell Carcinoma Phase 2 Completed - Taiwan ... More >> Department of Oncology , National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00166881 Gastric Cancer Phase 2 Completed - Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00002684 Bladder Cancer ... More >> Urethral Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02088515 Squamous Cell Carcinoma Phase 4 Completed - China, Hunan ... More >> Hunan Xiangya Hospital Changsha, Hunan, China China, Jiangsu Nanjing Military General Hospital Nanjing, Jiangsu, China China, Shanghai Shanghai Chest hospital Shanghai, Shanghai, China, 200000 China, Shanxi Xijing Hospital Xian, Shanxi, China Less <<
NCT00208936 Esophageal Diseases Phase 2 Terminated - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00227630 Malignant Mesothelioma Phase 2 Completed - Belgium ... More >> Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Italy Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Azienda Ospedaliera Di Parma Parma, Italy, 43100 Universita Degli Studi di Udine Udine, Italy, 33100 Netherlands Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE United Kingdom Princess Royal Hospital at Hull and East Yorkshire NHS Trust Hull, England, United Kingdom, HU8 9HE Edinburgh Cancer Centre at Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Less <<
NCT00801736 Lung Cancer Phase 3 Terminated(The antibody used d... More >>id not appear prognostic/predictive based on interim results.) Less << - United Kingdom ... More >> University College London Hospitals London, United Kingdom Less <<
NCT01479504 Nasopharyngeal Carcinoma Phase 3 Unknown December 2017 China, Guangxi ... More >> Department of Radiotherapy，the First Affiliated Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 530021 Contact: Wang R Sheng, M.D.    8613807806008    wrsgx@yahoo.com.cn    Contact: Wu Fang, M.D.    8613978880156    96160f@163.com    Principal Investigator: Wang R Sheng, M.D.          Principal Investigator: Wu Fang, M.D. Less <<
NCT00335543 Pancreatic Cancer Phase 2 Completed - Austria ... More >> Innsbruck Universitaetsklinik Innsbruck, Austria, A-6020 Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria, A-1090 Germany Robert Roessle Comprehensive Cancer Center - Charite Campus Buch Berlin, Germany, D-13125 Knappschaft Krankenhaus Bochum, Germany, D-44892 DIAKO Ev. Diakonie Krankenhaus gGmbH Bremen, Germany, D-28239 Krankenhaus Dresden - Friedrichstadt Dresden, Germany, D-01008 Universitaet Erlangen Erlangen, Germany, D-91054 Arbeitsgruppe Lebermetastasen und Tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie Frankfurt, Germany, 60590 Klinik am Eichert Goeppingen, Germany, D-73035 Chirurgische Universitaetsklinik Heidelberg, Germany, D-69120 Universitaet Leipzig Leipzig, Germany, D-04103 Staedtisches Klinikum Magdeburg Magdeburg, Germany, D-39130 Klinikum der Universitaet Muenchen - Grosshadern Campus Munich, Germany, D-81377 Klinikum Nuernberg - Klinikum Nord Nuremberg, Germany, D-90419 Klinikum der Universitaet Regensburg Regensburg, Germany, D-93053 Universitaetsklinikum Tuebingen Tuebingen, Germany, D-72076 Switzerland Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Less <<
NCT03663205 Non-Small Cell Lung Cancer Phase 3 Recruiting September 23, 2020 China ... More >> Shanghai Chest Hospital Recruiting Shanghai, China Less <<
NCT00993655 Fallopian Tube Cancer ... More >> Metastatic Cancer Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 2 Completed - -
NCT01648023 Unresectable Intrahepatic Chol... More >>angiocarcinoma Less << Phase 2 Recruiting July 2020 United States, Kentucky ... More >> University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Mary Healey, CCRC    502-629-3327    mary.healey@louisville.edu    Contact: Robert Martin, MD, PhD    502-629-3355    robert.martin@louisville.edu    Principal Investigator: Robert Martin, MD, PhD Less <<
NCT00002993 Sarcoma Phase 2 Terminated - -
NCT00004865 Head and Neck Cancer Phase 2 Completed - United States, New Jersey ... More >> Cooper Cancer Institute Camden, New Jersey, United States, 08103 Kimball Medical Center Lakewood, New Jersey, United States, 08701 Monmouth Medical Center Long Branch, New Jersey, United States, 07740 Less <<
NCT02227940 Advanced Malignant Solid Neopl... More >>asm ALK Positive Metastatic Pancreatic Adenocarcinoma Stage III Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 1 Recruiting January 11, 2019 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park    877-275-7724    ASKRPCI@RoswellPark.org    Principal Investigator: Renuka V. Iyer Less <<
NCT03684811 Cohort 1a and 1b: Glioma ... More >> Cohort 1a and 1b: Glioblastoma Multiforme Cohort 2a and 2b: Hepatobiliary Tumors (Hepatocellular Carcinoma, Bile Duct Carcinoma, Intrahepatic Cholangiocarcinoma, Other Hepatobiliary Carcinomas) Cohort 3a and 3b: Chondrosarcoma Cohort 4a and 4b: Intrahepatic Cholangiocarcinoma Cohort 5a: Other Solid Tumors With IDH1 Mutations Less << Phase 1 Phase 2 Recruiting April 1, 2022 United States, Florida ... More >> University of Miami, Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Tamara Leon    305-243-0865    txl351@med.miami.edu Less <<
NCT00002488 Lymphoma Phase 2 Unknown - Canada, Ontario ... More >> Ottawa Regional Cancer Center - General Division Ottawa, Ontario, Canada, K1H 8L6 Ottawa Regional Cancer Centre - Civic Campus Ottawa, Ontario, Canada, K1Y 4K7 Less <<
NCT00113386 Lung Cancer Phase 3 Terminated(This study terminat... More >>ed early due to low accrual.) Less << - -
NCT00993655 - Completed - -
NCT00792701 Lung Cancer Phase 2 Completed - -
NCT00113386 - Terminated(This study terminat... More >>ed early due to low accrual.) Less << - -
NCT00792701 - Completed - -
NCT00003624 Cervical Cancer ... More >> Endometrial Cancer Fallopian Tube Cancer Neurotoxicity Ovarian Cancer Primary Peritoneal Cavity Cancer Sarcoma Less << Phase 2 Terminated - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 United States, District of Columbia Vincent T. Lombardi Cancer Research Center, Georgetown University Washington, District of Columbia, United States, 20007 United States, Georgia Emory University Hospital - Atlanta Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5265 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, North Carolina Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States, 27599-7295 United States, Ohio Cleveland Clinic Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00996567 Cancer Phase 2 Completed - Belgium ... More >> UZ Antwerpen Antwerpen, Belgium University Hospital Ghent Ghent, Belgium, 9000 AZ St. Maarten Mechelen, Belgium, 2800 Netherlands AMC Heerlen Heerlen, Netherlands Less <<
NCT02177838 Stage III Squamous Cell Carcin... More >>oma of the Hypopharynx Stage III Squamous Cell Carcinoma of the Larynx Stage III Squamous Cell Carcinoma of the Oropharynx Stage III Verrucous Carcinoma of the Larynx Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IVA Squamous Cell Carcinoma of the Larynx Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVA Verrucous Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Larynx Stage IVB Squamous Cell Carcinoma of the Oropharynx Stage IVB Verrucous Carcinoma of the Larynx Tongue Cancer Less << Not Applicable Suspended(MedOnc turnover at t... More >>he institution) Less << June 2020 United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 New Jersey Medical School Newark, New Jersey, United States, 07103 Less <<
NCT01820754 Non Small Cell Lung Cancer Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT01820754 - Completed - -
NCT01797900 Nasopharyngeal Neoplasms Phase 2 Completed - China, Beijing ... More >> Department of Radiation Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing, China, 100021 Less <<
NCT00776698 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 1 Completed - Netherlands ... More >> Amsterdam, Netherlands, 1007 MB Groningen, Netherlands, 9713 GZ Maastricht, Netherlands, 6229 HX United Kingdom Aberdeen, United Kingdom, AB9 2ZB Manchester, United Kingdom, M2O 4BX Less <<
NCT00522886 Non-small Cell Lung Cancer Phase 1 Completed - Netherlands ... More >> Maastricht Radiation Oncology, MAASTRO clinic Maastricht, Limburg, Netherlands Less <<
NCT00816816 Nasopharyngeal Carcinoma Phase 2 Unknown June 2010 China ... More >> Department of Radiation Oncology, Cancer Hospital, Fudan University Recruiting Shanghai, China, 200032 Contact: Jing Yuan    8621-64175590 ext 6511    skelly_sh@hotmail.com Less <<
NCT00002888 Head and Neck Cancer Phase 3 Completed - -
NCT02878889 Nasopharyngeal Carcinoma Phase 2 Recruiting - China, Zhejiang ... More >> Xiaozhong Chen Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Xiaozhong Chen, MD    +86-571-88122098    cxzfyun@sina.com    Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Xiaozhong Chen, MD    86-571-88122098    cxzfyun@sina.com    Principal Investigator: Xiaozhong Chen, MD Less <<
NCT00011960 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - -
NCT00470340 Liver Neoplasms ... More >> Liver Cirrhosis Carcinoma, Hepatocellular Recurrence Neoplasm Recurrence, Local Less << Phase 3 Terminated(during the study) - France ... More >> Urc La Pitie Salpetriere, Poissy, France, 75013 Less <<
NCT01276730 Cervical Cancer Phase 2 Completed - India ... More >> Chittaranjan National Cancer Institute Kolkata, India, 700026 Less <<
NCT00816855 Nasopharyngeal Carcinoma Phase 2 Unknown June 2010 China ... More >> Department of Radiation Oncology, Cancer Hospital, Fudan University Recruiting Shanghai, China, 200032 Contact: Jing Yuan    8621-64175590 ext 6511    skelly_sh@hotmail.com Less <<
NCT02651441 Lung Cancer N... More >>on-small Cell Lung Cancer Less << Phase 1 Phase 2 Recruiting August 2019 China, Guangdong ... More >> Affiliated Tumor Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510010 Contact: Yuan Z Wang, Professor    020-66673666    WangZY@QQ.com Less <<
NCT00330499 Transitional Cell Carcinoma of... More >> Urinary Bladder Less << Phase 3 Completed - Australia, New South Wales ... More >> Liverpool Hospital Liverpool, New South Wales, Australia, 1871 Calvary Mater Newcastle Newcastle, New South Wales, Australia, 2298 Nepean Cancer Care Centre Penrith, New South Wales, Australia, 2751 Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Westmead Hospital Wentworthville, New South Wales, Australia, 2145 Australia, Queensland Mater Centre - South Brisbane Brisbane, Queensland, Australia, 4120 Townsville Hospital Douglas, Queensland, Australia, 4814 Royal Brisbane Hospital Herston, Queensland, Australia, 4029 East Coast Cancer Centre Tugun, Queensland, Australia, 4224 Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Tasmania Launceston General Hospital Launceston, Tasmania, Australia, 7250 Australia, Victoria Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 Andrew Love Cancer Care Centre, Geelong Hospital Geelong, Victoria, Australia, 3220 Alfred Hospital Prahran, Victoria, Australia, 3181 Australia, Western Australia Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia, 6009 Royal Perth Hospital Perth, Western Australia, Australia, 6000 New Zealand Auckland Hospital Auckland, New Zealand, 1001 Christchurch Hospital Christchurch, New Zealand, 4710 Dunedin Hospital Dunedin, New Zealand Palmerston North Hospital Palmerston North, New Zealand Wellington Hospital Wellington, New Zealand, 7902 Less <<
NCT00215514 Stomach Cancer ... More >> Gastric Cancer Gastro-esophageal Junction Cancer Less << Early Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00980954 Cervical Cancer Phase 3 Recruiting August 2026 -
NCT03765918 Head and Neck Neoplasms Phase 3 Not yet recruiting January 24, 2026 -
NCT03067610 Head and Neck Cancer ... More >> Carcinoma, Squamous Cell Neoplasms, Oral Neoplasms, Pharyngeal Less << Phase 2 Recruiting December 31, 2026 United States, Texas ... More >> University of Texas Southwestern Medical Center - Dallas Recruiting Dallas, Texas, United States, 75390 Less <<
NCT00971932 - Completed - -
NCT00971932 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Completed - Japan ... More >> Research Site Aichi, Japan National Cancer Center East Hospital Chiba, Japan Research Site Ehime, Japan Research Site Hokkaido, Japan Research Site Kanagawa, Japan Tokai University Kanagawa, Japan Research Site Osaka, Japan Research Site Shizuoka, Japan Research Site Tochigi, Japan Research Site Tokyo, Japan Less <<
NCT00634595 Head and Neck Squamous Carcino... More >>ma Nasopharyngeal Carcinoma Less << Phase 2 Unknown December 2010 China, Guangdong ... More >> Cancer center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Xubin Lin, MD, PhD       linxubin@mail.sysu.edu.cn Less <<
NCT00686959 Non Small Cell Lung Cancer Phase 3 Completed - -
NCT00686959 - Completed - -
NCT00941135 Laryngeal Neoplasms Phase 2 Terminated May 2013 Spain ... More >> Hospital Carlos Haya Malaga, Andalucía, Spain, 29010 Clinica Universitaria de Navarra Pamplona, Navarra, Spain, 31008 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Fundación Jiménez Díaz Madrid, Spain, 28040 Less <<
NCT00002568 Ovarian Cancer Phase 3 Completed - -
NCT00004199 Lung Cancer Phase 3 Completed - United States, California ... More >> Agouron Pharmaceuticals, Inc. La Jolla, California, United States, 92037 Less <<
NCT00178698 Neuroendocrine Cancer ... More >> Small Cell Lung Cancer Non-Small Cell Lung Cancer Gastric Cancer Less << Phase 2 Unknown June 2014 United States, Texas ... More >> Memorial Hermann Hospital Recruiting Houston, Texas, United States, 77030 Contact: Joan M Bull, M.D.    713-600-6820    Joan.M.Bull@uth.tmc.edu    Contact: Esperanza N Fernandez    713-500-6774    Esperanza.N.Fernandez@uth.tmc.edu    Principal Investigator: Joan M Bull, M.D. Less <<
NCT01214343 Advanced Hepatocellular Carcin... More >>oma Carcinoma Carcinoma, Hepatocellular Liver Neoplasms Neoplasms Less << Phase 3 Unknown September 2013 Japan ... More >> National Cancer Center Hospital East Recruiting Kashiwa, Chiba, Japan, 277-8577 Contact: Masafumi Ikeda, Dr.          Principal Investigator: Masafumi Ikeda, Dr.          Kurume University Medical Center Recruiting Kurume, Fukuoka, Japan, 839-0863 Contact: Masatoshi Tanaka, Professor          Principal Investigator: Masatoshi Tanaka, Professor          Ogaki Municipal Hospital Recruiting Ogaki, Gifu, Japan, 503-8502 Contact: Takashi Kumada, Dr          Principal Investigator: Takashi Kumada, Dr.          Sapporo Medical University Recruiting Sapporo, Hokkaido, Japan, 060-8556 Contact: Junji Kato, Dr.          Principal Investigator: Junji Kato, Dr.          Sapporo-Kosei General Hospital Recruiting Sapporo, Hokkaido, Japan, 060-8556 Contact: Takumi Ohmura, Dr.          Principal Investigator: Takumi Ohmura, Dr.          Japanese Red Cross Takamatsu Hospital Recruiting Takamatsu, Kagawa, Japan, 760-0017 Contact: Chikara Ogawa, Dr.          Principal Investigator: Chikara Ogawa, Dr.          Mie University Hospital Recruiting Tsu, Mie, Japan, 514-8507 Contact: Katsuya Shiraki, Dr.          Principal Investigator: Katsuya Shiraki, Dr.          National Hospital Organization Nagasaki Medical Center Recruiting Ohmura, Nagasaki, Japan, 856-8562 Contact: Hiromi Ishibashi, Dr.          Principal Investigator: Hiromi Ishibashi, Dr.          Kawasaki Medical School Hospital Recruiting Kurashiki, Okayama, Japan, 701-0192 Contact: Keisuke Hino, Dr.          Principal Investigator: Keisuke Hino, Dr.          Ikeda Municipal Hospital Recruiting Ikeda, Osaka, Japan, 563-8510 Contact: Yasuharu Imai, Dr.          Principal Investigator: Yasuharu Imai, Dr.          Kinki University Hospital Recruiting Osaka-Sayama, Osaka, Japan, 589-8511 Contact: Masatoshi Kudo, Professor    +81-72-366-0221 ext 3149    m-kudo@med.kindai.ac.jp    Contact: Kazuomi Ueshima, Dr.    +81-72-366-0221 ext 3525    kaz-ues@med.kindai.ac.jp    Principal Investigator: Masatoshi Kudo, Professor          Sub-Investigator: Kazuomi Ueshima, Dr.          Principal Investigator: Kazuto Nishio, Professor          Osaka University Hospital Recruiting Suita, Osaka, Japan, 565-0871 Contact: Hiroaki Nagano, Professor          Principal Investigator: Hiroaki Nagano, Professor          Kyorin University Hospital Recruiting Mitaka, Tokyo, Japan, 181-8611 Contact: Junji Furuse, Professor          Principal Investigator: Junji Furuse, Professor          Musashino Red Cross Hospital Recruiting Musashino, Tokyo, Japan, 180-8610 Contact: Namiki Izumi, Dr.          Principal Investigator: Namiki Izumi, Dr.          Juntendo University Nerima Hospital Recruiting Nerima, Tokyo, Japan, 177-0033 Contact: Shigehiro Kokubu, Dr.          Principal Investigator: Shigehiro Kokubu, Dr.          Yamaguchi University Hospital Recruiting Ube, Yamaguchi, Japan, 755-8505 Contact: Isao Sakaida, Prof          Principal Investigator: Isao Sakaida, Professor          Chiba University Hospital Recruiting Chiba, Japan, 260-8677 Contact: Fumihiko Kanai, Dr.          Principal Investigator: Fumihiko Kanai, Dr.          Gifu Municipal Hospital Recruiting Gifu, Japan, 500-8513 Contact: Eiichi Tomita, Dr.          Principal Investigator: Eiichi Tomita, Dr.          Hiroshima City Hospital Recruiting Hiroshima, Japan, 730-8518 Contact: Yoshiyuki Kobayashi, Dr.          Principal Investigator: Yoshiyuki Kobayashi, Dr.          Hiroshima University Hospital Recruiting Hiroshima, Japan, 734-8551 Contact: Hiroshi Aikata, Dr.          Principal Investigator: Hiroshi Aikata, Dr.          Kumamoto University Hospital Recruiting Kumamoto, Japan, 860-8556 Contact: Yutaka Sasaki, Professor          Principal Investigator: Yutaka Sasaki, Professor          Kyoto University Hospital Recruiting Kyoto, Japan, 606-8507 Contact: Etsuro Hatano, Professor          Principal Investigator: Etsuro Hatano, Professor          Center for Gastroenterological and Hepatological Diseases Recruiting Miyazaki, Japan, 880-0003 Contact: Hidemori Sakamoto, Dr.          Principal Investigator: Hidemori Sakamoto, Dr.          Saiseikai Niigata Dai-ni Hospital Recruiting Niigata, Japan, 950-1104 Contact: Toru Ishikawa, Dr.          Principal Investigator: Toru Ishikawa, Dr.          Niigata University Medical and Dental Hospital Recruiting Niigata, Japan, 951-8520 Contact: Kouhei Akazawa          Principal Investigator: Kouhei Akazawa          Okayama University Hospital Recruiting Okayama, Japan, 700-8558 Contact: Kazuhide Yamamoto, Professor          Principal Investigator: Kazuhide Yamamoto, Professor          Osaka Red Cross Hospital Recruiting Osaka, Japan, 543-8555 Contact: Ikuo Osaki, Dr.          Principal Investigator: Ikuo Osaki, Dr.          The University of Tokushima Faculty of Medicine Recruiting Tokushima, Japan, 770-8503 Contact: Tetsuji Takayama, Dr.          Principal Investigator: Tetsuji Takayama, Dr.          Kyoundo Hospital Recruiting Tokyo, Japan, 101-0062 Contact: Shuntaro Obi, Dr.          Principal Investigator: Shuntaro Obi, Dr.          National Cancer Center Hospital Recruiting Tokyo, Japan, 104-0045 Contact: Takushi Okusaka, Dr.          Principal Investigator: Takushi Okusaka, Dr. Less <<
NCT00055601 Bladder Cancer Phase 2 Completed - United States, Utah ... More >> LDS Hospital Salt Lake City, Utah, United States, 84103 Utah Cancer Specialists at UCS Cancer Center Salt Lake City, Utah, United States, 84106 Less <<
NCT01683864 Gastric Cancer ... More >> Peritoneal Carcinomatosis Less << Phase 2 Phase 3 Terminated(Recruitment problem... More >>s) Less << - Germany ... More >> University of Tuebingen Tuebingen, BW, Germany, 72076 Less <<
NCT00055601 - Completed - -
NCT00003037 Lung Cancer Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00794547 Non Small Cell Lung Cancer Phase 1 Phase 2 Terminated - United States, Michigan ... More >> VA Ann Arbor Healthcare System Ann Arbor, Michigan, United States, 48105 St. Joseph Mercy Hospital Ann Arbor, Michigan, United States, 48106 University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT00794547 - Terminated - -
NCT00992199 Advanced Gastric Cancer Phase 2 Unknown December 2011 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Jin Li, MD    86(021)64175590 ext 5108    fudanlijin@163.com    Contact: Xiaodong Zhu, MD    86(021)64175590 ext 5008    xddr001@163.com    Principal Investigator: Jin Li, MD          Sub-Investigator: Haiyi Guo, MD          Sub-Investigator: xiaodnog Zhu, MD Less <<
NCT01933568 Inoperable Locally Advanced No... More >>n Small Cell Lung Cancer Less << Phase 1 Completed - Netherlands ... More >> The Netherlands Cancer Institute Amsterdam, Netherlands, 1066 CX Less <<
NCT01345279 - Completed - -
NCT01683864 - Terminated(Recruitment problem... More >>s) Less << - -
NCT03515538 Oral Mucositis Phase 2 Recruiting June 2020 United States, California ... More >> John Wayne Cancer Institute @ Providence St. John's Health Center Recruiting Santa Monica, California, United States, 90401 Contact: Mini Gill, RN BSN    310-582-7437    Jaya.Gill@providence.org    Principal Investigator: Santosh Kesari, MD, PhD          United States, Colorado Centura Health Research Center Recruiting Denver, Colorado, United States, 80210 Contact: Sheryl Giambartolomei, RN    303-765-3536    sherylgiambartolomei@centura.org    Principal Investigator: Seth Reiner, MD          United States, District of Columbia George Washington University Recruiting Washington, District of Columbia, United States, 20037 Contact: Richard Lush, PhD    202-994-3647    rmlush3@email.gwu.edu    Principal Investigator: Sharad Goyal, MD          United States, New York Montefiore Medical Center Recruiting Bronx, New York, United States, 10467 Contact: Alyssa Asaro    718-920-5636    aasaro@montefiore.org    Principal Investigator: Rafi Kabarriti, MD          United States, North Carolina East Carolina University Recruiting Greenville, North Carolina, United States, 27834 Contact: Debra Peaden, CCRP       peadend@ecu.edu    Principal Investigator: Brian C Muzyka, DMD, MD, MBA          United States, Ohio University of Cincinnati Medical Center Recruiting Cincinnati, Ohio, United States, 45267 Contact: Vinita Takiar, MD    513-584-7661    Vinita.Takiar@UCHealth.com    Principal Investigator: Vinita Takiar, MD          Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Nancy Curtis    614-685-8029    Nancy.Curtis@osumc.edu    Principal Investigator: Marcelo Bonomi, MD          United States, Pennsylvania Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dawn Poller    215-955-1964    Dawn.Poller@jefferson.edu    Principal Investigator: Voichita Bar-Ad, MD          United States, Tennessee Ballad Health Recruiting Johnson City, Tennessee, United States, 37604 Contact: Anna Yakubenko    423-431-5647    Anna.Yakubenko@balladhealth.org    Principal Investigator: Kyle T. Colvett, MD Kyle T Colvett, MD Less <<
NCT00003237 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - -
NCT00045604 Lung Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00003298 - Completed - -
NCT00009932 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Unknown - United States, Ohio ... More >> Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210-1240 Less <<
NCT03389477 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Recruiting June 30, 2026 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Douglas R Adkins, M.D.    314-362-4471    dadkins@wustl.edu    Principal Investigator: Douglas R Adkins, M.D.          Sub-Investigator: Olivia Aranha, M.D.          Sub-Investigator: Mackenzie Daly, M.D.          Sub-Investigator: Hiram Gay, M.D.          Sub-Investigator: Ryan Jackson, M.D.          Sub-Investigator: Peter Oppelt, M.D.          Sub-Investigator: Randal Paniello, M.D.          Sub-Investigator: Patrik Pipkorn, M.D.          Sub-Investigator: Jason Rich, M.D.          Sub-Investigator: Wade Thorstad, M.D.          Sub-Investigator: Jose Zevallos, M.D., MPH Less <<
NCT01064479 Metastatic Squamous Cell Carci... More >>noma of the Hypopharynx Metastatic Squamous Cell Carcinoma of the Larynx Metastatic Squamous Cell Carcinoma of the Oral Cavity Metastatic Squamous Cell Carcinoma of the Oropharynx Recurrent Hypopharyngeal Squamous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Oral Cavity Squamous Cell Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IV Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVC Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7 Less << Phase 2 Active, not recruiting February 28, 2019 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 MD Anderson Regional Care Center-Katy Houston, Texas, United States, 77094 MD Anderson Regional Care Center-Bay Area Nassau Bay, Texas, United States, 77058 MD Anderson Regional Care Center-Sugar Land Sugar Land, Texas, United States, 77478 MD Anderson Regional Care Center-The Woodlands The Woodlands, Texas, United States, 77384 Less <<
NCT03040999 Head and Neck Neoplasms Phase 3 Recruiting June 29, 2023 -
NCT01711515 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Positive Para-Aortic Lymph Node Positive Pelvic Lymph Node Stage IB2 Cervical Cancer AJCC v6 and v7 Stage II Cervical Cancer AJCC v7 Stage IIA Cervical Cancer AJCC v7 Stage IIB Cervical Cancer AJCC v6 and v7 Stage IIIB Cervical Cancer AJCC v6 and v7 Stage IVA Cervical Cancer AJCC v6 and v7 Less << Phase 1 Active, not recruiting - United States, California ... More >> Los Angeles County-USC Medical Center Los Angeles, California, United States, 90033 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Connecticut Hartford Hospital Hartford, Connecticut, United States, 06102 The Hospital of Central Connecticut New Britain, Connecticut, United States, 06050 United States, Georgia Augusta University Medical Center Augusta, Georgia, United States, 30912 United States, New Mexico University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87102 United States, New York Montefiore Medical Center-Einstein Campus Bronx, New York, United States, 10461 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Rhode Island Women and Infants Hospital Providence, Rhode Island, United States, 02905 United States, Virginia Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT00304070 Stage I Adrenocortical Carcino... More >>ma Stage II Adrenocortical Carcinoma Stage III Adrenocortical Carcinoma Stage IV Adrenocortical Carcinoma Less << Phase 3 Completed - -
NCT00003298 Gastric Cancer Phase 2 Completed - -
NCT03138720 Resectable Pancreatic Cancer ... More >> Unresectable Pancreatic Cancer Pancreatic Adenocarcinoma Less << Phase 2 Recruiting March 1, 2020 United States, Arizona ... More >> HonorHealth Research Institute Recruiting Scottsdale, Arizona, United States, 85258 Contact: Joyce Schaffer, MSN, AOCNS    480-323-1339 ext option #2    Joyce.Schaffer@HonorHealth.com    Principal Investigator: Erkut Borazanci, MD Less <<
NCT02074189 Bladder Cancer Phase 3 Enrolling by invitation April 2019 China, Chongqing ... More >> Southwest hospital,China Chongqing, Chongqing, China, 400030 Less <<
NCT00006011 Endometrial Adenocarcinoma ... More >> Endometrial Adenosquamous Carcinoma Endometrial Clear Cell Adenocarcinoma Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation Endometrial Serous Adenocarcinoma Stage III Uterine Corpus Cancer Less << Phase 3 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00006011 - Completed - -
NCT00304070 - Completed - -
NCT00020787 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 3 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT00961415 - Completed - -
NCT02435186 Ovarian Epithelial Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Cancer Less << Phase 2 Unknown August 2018 China, Liaoning ... More >> xijing hospital in China Medical University Not yet recruiting Shenyang, Liaoning, China, 110022 Contact: xiuqing Li, MD    +86 18940251286    2403621353@qq.com Less <<
NCT01185847 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 2 Completed - Belgium ... More >> Charleroi, Belgium, B6000 Leuven, Belgium, 3000 Liège, Belgium, 4000 France Caen, France, 14033 Marseille, France, 13915 Saint Herblain, France, 44805 Toulouse, France, 31400 Germany Bad Berka, Germany, 99437 Gauting, Germany, 82131 Grosshansdorf, Germany, 22927 Heidelberg, Germany, 69126 Köln, Germany, 51109 Mainz, Germany, 55131 Mannheim, Germany, 68167 Italy Milano, Lombardia, Italy, 20162 Milan, Lombardia, Italy, 20132 Ancona, Marche, Italy Lido Di Camaiore, Toscana, Italy, 55043 Livorno, Toscana, Italy, 57100 Perugia, Umbria, Italy, 06156 Poland Lodz, Poland, 93-509 Otwock, Poland, 05-400 Warszawa, Poland, 02-781 Spain Barcelona, Spain, 08003 Barcelona, Spain, 08035 Madrid, Spain, 28040 Madrid, Spain, 28041 Madrid, Spain, 28046 Madrid, Spain, 28050 Malaga, Spain, 29010 Sevilla, Spain, 41013 United Kingdom London, United Kingdom, SE1 9RT Less <<
NCT00961415 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 3 Completed - -
NCT00450138 Head and Neck Cancer Phase 1 Completed - United States, Colorado ... More >> Research Site Denver, Colorado, United States United States, Illinois Research Site Chicago, Illinois, United States United States, Texas Research Site Dallas, Texas, United States Research Site Houston, Texas, United States Less <<
NCT03700476 Nasopharyngeal Neoplasms Phase 3 Not yet recruiting January 2025 China, Guangdong ... More >> Panyu central hospital Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Guo-Rong Zhou, MD          SUN YAT-SEN UNIVERSITY cANCER CENTER Guangzhou, Guangdong, China, 510060 China, Guangxi Cancer Hospital of Guangxi Medical University Not yet recruiting Nanning, Guangxi, China Contact: Xiao-Dong Zhu, MD          China, Guizhou Cancer Hospital of Guizhou Medical University Not yet recruiting Guiyang, Guizhou, China Contact: Feng Jin, MD          China, Hubei Union Hospital Affiliated with Tongji Medical College of Huazhong University of Science and Technology Not yet recruiting Wuhan, Hubei, China Contact: Kun-Yu Yang, MD          China, Hunan Xiangya Hospital Central South University Not yet recruiting Changsha, Hunan, China Contact: Liang-Fang Shen, MD          China, Shanxi Xijing Hospital, Fourth Military Medical University Not yet recruiting Xi'an, Shanxi, China Contact: Mei SHI, MD Less <<
NCT01670890 Malignant Gliomas Phase 2 Unknown - China, Beijing ... More >> Beijing Tiantan Hospital Affiliated to Capital Medial University Recruiting Beijing, Beijing, China, 100050 Contact: Jiang tao, MD    86-010-67021832    jiangtao369@sohu.com    Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: wang ren zhi, MD    86-010-69156071    wangrz@126.com    Principal Investigator: Ma wen bin, MD          Sub-Investigator: wang yu, MD          China, Tianjin Tianjin medical university general university Recruiting Tianjin, Tianjin, China, 300052 Contact: Yang xue jun, MD       ydenny@yahoo.com Less <<
NCT02954536 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Recruiting November 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States Contact: Yelena Janjigian, MD    646-888-4186       Principal Investigator: Yelena Janjigian, MD          Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Yelena Janjigian, MD    646-888-4186       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Yelena Janjigian, MD    646-888-4186       Principal Investigator: Yelena Janjigian, MD          Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Yelena Janjigian, MD    646-888-4186       Memorial Sloan Kettering Cancer Center 1275 York Avenue Recruiting New York, New York, United States, 10065 Contact: Yelena Janjigian, MD    646-888-4186       Contact: David Ilson, MD, PhD    646-888-4183       Principal Investigator: Yelena Janjigian, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Yelena Janjigian, MD    646-888-4186       Principal Investigator: Yelena Janjigian, MD          United States, Texas Md Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Mariela Blum Murphy, MD    713-792-2828       Principal Investigator: Mariela Blum Murphy, MD Less <<
NCT03413358 Non-small-Cell Lung Cancer Not Applicable Recruiting October 31, 2019 China, Beijing ... More >> CHINA ACADENY OF CHINESE MEDICAL SCIENCES Guang'anmen Hospital Recruiting Beijing, Beijing, China, 100053 Contact: Hongsheng Lin, Professor    010-88001192    drlinhongsheng@163.com    Contact: , Professor Less <<
NCT03600831 Esophageal Squamous Cell Carci... More >>noma Less << Phase 2 Phase 3 Recruiting December 31, 2023 China, Jiangsu ... More >> Chinese Peiple's Liberation Army No.82 Hospital Recruiting Huai'an, Jiangsu, China, 223300 Contact: Qian-wen Li, MD          Huai'an second peiple's Hospital Recruiting Huai'an, Jiangsu, China, 223300 Contact: Li-qing Zhou, Phd          Lianshui County Peoples Hospital Recruiting Huai'an, Jiangsu, China, 223300 Contact: juan pu, MD          xuyi peiple's Hospital Recruiting Xu Yi, Jiangsu, China, 211700 Contact: Lian Wang, MD Less <<
NCT00682383 Unresectable Locally Advanced ... More >>NSCLC Less << Phase 2 Completed - United States, Florida ... More >> Mount Sinai Medical Center Miami Beach, Florida, United States, 33140 Less <<
NCT00313872 Gastric Cancer ... More >> Metastases Less << Phase 3 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT02022098 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Not Applicable Active, not recruiting April 2019 France ... More >> Centre Hospitalier de Bretagne Sud - HÔPITAL DU SCORFF Lorient, Bp 2233, France, 56322 C.H.U. Sud Amiens Amiens, France, 80054 ICO Paul Papin Angers Cedex 02, France, CS 10059 Institut Sainte-Catherine Avignon Cedex 9, France, 84918 CHU Côte de Nacre CAEN Cedex 09, France, CS30001 Centre Jean Perrin Clermont-Ferrand Cedex 01, France, BP 392 Centre Georges François Leclerc Dijon, France, 21079 CHU Grenoble Grenoble, France, BP 217 CHD Vendée La Roche Sur Yon cedex 9, France, F- 85925 Centre Guillaume le Conquérant Le Havre, France, 76600 Centre Jean Bernard Le Mans, France Centre Léon Berard Lyon, France Hôpital Nord Franche-Comté Montbéliard, France, 25200 ICM - Val D'Aurelle Montpellier, France, 34298 Institut Curie Paris, France, 75248 Centre Henri Becquerel Rouen, France, 76038 Institut de Cancérologie de l'Ouest (ICO) René Gauducheau Saint-Herblain, France, BP 217 Institut de Cancérologie Lucien Neuwirth (ICLN) Saint-Priest en Jarez, France, BP 60008 Institut Claudius Regaud Toulouse, France, 31052 L'Institut de Cancérologie de Lorraine (ICL) Alexis Vautrin Vandoeuvre-lès-Nancy, France, CS 30519 Institut Gustave Roussy Villejuif, France, 94000 Switzerland Inselspital Bern, Universitätsklinik für Radio-Onkologie, Freiburgstrasse 4 Bern, Switzerland, 3010 Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland, 1011 Less <<
NCT01454089 Urologic Neoplasms ... More >> Metastatic Bladder Cancer Urinary Tract Neoplasms Less << Phase 2 Completed - -
NCT02901483 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 1 Phase 2 Recruiting December 2020 Taiwan ... More >> Keelung Chang Gung Memorial Hospital (Lovers Lake Branch) Recruiting Keelung, Taiwan Less <<
NCT02000531 Carcinoma, Non-Small-Cell Lung Phase 4 Completed - China ... More >> Beijing, China, 101149 Changchun, China, 130012 Chongqing, China, 400038 ChongQing, China, 400042 Fuzhou, China, 350014 Guangzhou, China Nanjing, China Shanghai, China, 200030 Shanghai, China, 200433 Shantou, China, 515041 Wuhan, China, 430023 Less <<
NCT00028743 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 3 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 Lions Gate Hospital North Vancouver, British Columbia, Canada, V7L 2L7 BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick The Moncton Hospital Moncton, New Brunswick, Canada, E1C 6Z8 Atlantic Health Sciences Corporation Saint John, New Brunswick, Canada, E2L 4L2 Canada, Newfoundland and Labrador Dr. H. Bliss Murphy Cancer Centre St. John's, Newfoundland and Labrador, Canada, AIB 3V6 Canada, Nova Scotia QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 Grand River Regional Cancer Centre Kitchener, Ontario, Canada, N2G 1G3 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Ottawa Health Research Institute - General Division Ottawa, Ontario, Canada, K1H 8L6 Niagara Health System St. Catharines, Ontario, Canada, L2R 7C6 Northeast Cancer Center Health Sciences Sudbury, Ontario, Canada, P3E 5J1 Thunder Bay Regional Health Science Centre Thunder Bay, Ontario, Canada, P7B 6V4 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Prince Edward Island PEI Cancer Treatment Centre,Queen Elizabeth Hospital Charlottetown, Prince Edward Island, Canada, C1A 8T5 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 Hopital du Sacre-Coeur de Montreal Montreal, Quebec, Canada, H4J 1C5 CHUQ-Pavillon Hotel-Dieu de Quebec Quebec City, Quebec, Canada, G1R 2J6 Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT02000531 - Completed - -
NCT00122772 Cervix Cancer Phase 3 Completed - Austria ... More >> University of Vienna; Department of Radiotherapy and Radiobiology Vienna, Austria Brazil rmandade de Santa Casa de Misericordia de Porto Alegre; Hospital Santa Rita Porto Alegre, Brazil Canada, Ontario Peel Regional Cancer Centre Mississauga, Ontario, Canada India Department of Atomic Energy (DAE); Tata Memorial Centre (TMC); Tata Mumbai, India Korea, Republic of National Cancer Center Seoul, Korea, Republic of Macedonia, The Former Yugoslav Republic of Radiotherapy and Oncology University Clinic Skopje, Macedonia, The Former Yugoslav Republic of Morocco Institut National d'Oncologie Rabat, Morocco Pakistan Bahawalpur Institute of Nuclear Medicine and Oncology (BINO) Bahawalpur, Pakistan Peru Instituto Nacional de Enfermedades Neoplásicas Lima, Peru South Africa Department of Radiation Oncology, Groote Schuur Hospital Cape Town, South Africa United Kingdom Christie Hospital; NHS Trust Manchester, United Kingdom Less <<
NCT01487499 Small Cell Lung Cancer PHASE3 TERMINATED 2025-03-15 University of Florida, Gainesv... More >>ille, Florida, 32610, United States Less <<
NCT03449693 Febrile Neutropenia Phase 2 Recruiting December 2019 Mexico ... More >> Hospital Infantil de Mexico Dr. Federico Gomez Recruiting Cuauhtémoc, Ciudad De México, Mexico, 06720 Contact: Victoria E Barrios, QFB    +52 1 2291290208    victoria.barrios@cinvestav.mx    Contact: Miguel A Palomo, MD Less <<
NCT00123318 Gastric Cancer Phase 3 Completed - Australia, New South Wales ... More >> Liverpool Hospital Liverpool, New South Wales, Australia, 1871 Calvary Mater Newcastle Newcastle, New South Wales, Australia, 2298 Nepean Cancer Care Centre Penrith, New South Wales, Australia, 2751 Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Royal Prince Alfred Hospital Sydney, New South Wales, Australia, 2050 Royal North Shore Hospital Sydney, New South Wales, Australia, 2069 Westmead Hospital Sydney, New South Wales, Australia, 2145 Australia, Queensland Mater QRI Brisbane, Queensland, Australia Royal Brisbane Hospital Herston, Queensland, Australia, 4029 East Coast Cancer Centre Tugun, Queensland, Australia, 4224 Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Australia, Tasmania Launceston General Hospital Launceston, Tasmania, Australia, 7250 Australia, Victoria Box Hill Hospital Box Hill, Victoria, Australia Andrew Love Cancer Care Centre, Geelong Hospital Geelong, Victoria, Australia, 3220 Austin Health Melbourne, Victoria, Australia, 3081 Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 8006 Alfred Hospital Prahran, Victoria, Australia, 3181 Australia, Western Australia Sir Charles Gairdner Hospital Perth, Western Australia, Australia, 6009 New Zealand Christchurch Hospital Christchurch, New Zealand, 4710 Less <<
NCT00916097 Head and Neck Neoplasms Phase 2 Completed - Algeria ... More >> Sanofi-Aventis Administrative Office Alger, Algeria Morocco Sanofi-Aventis Administrative Office Casablanca, Morocco Tunisia Sanofi-Aventis Administrative Office Megrine, Tunisia Less <<
NCT00006248 Head and Neck Cancer Phase 2 Completed - -
NCT03201146 Lung Cancer N... More >>on Small Cell Lung Cancer Combination Chemotherapy Apatinib Less << Phase 1 Phase 2 Recruiting August 1, 2020 China, Sichuan ... More >> West China Hospital, Sichuan University Recruiting Chengdu, Sichuan, China, 610041 Contact: You Lu, MD    86-028-85422114    radyoulu@hotmail.com    Contact: Meijuan Huang, MD    86-028-85422114    hmj107@163.com Less <<
NCT01076231 Stage IIIA Non-small Cell Lung... More >> Cancer Less << Phase 1 Phase 2 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00539669 Ovarian Neoplasms Phase 2 Completed - Korea, Republic of ... More >> Sanofi-Aventis Seoul, Korea, Republic of Less <<
NCT01487499 Small Cell Lung Cancer PHASE3 TERMINATED 2025-03-15 University of Florida, Gainesv... More >>ille, Florida, 32610, United States Less <<
NCT01783951 Gastric Cancer Phase 1 Phase 2 Completed - China, Beijing ... More >> Capital Medical University Cancer Center Beijing, Beijing, China, 100038 Less <<
NCT03147404 Neuroendocrine Carcinoma, Grad... More >>e 3 Less << Phase 2 Recruiting February 2020 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 Contact: seungtae kim, MD,PhD Less <<
NCT03387774 Oral Mucositis (Ulcerative) Du... More >>e to Radiation Less << Phase 3 Recruiting November 30, 2018 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China Contact: zhao chong, M.D    +86-13902206160    zhaochong@sysucc.org.cn Less <<
NCT02595879 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Stage IB Vulvar Cancer AJCC v7 Stage IB2 Cervical Cancer AJCC v6 and v7 Stage II Vulvar Cancer AJCC v7 Stage IIA1 Cervical Cancer AJCC v7 Stage IIA2 Cervical Cancer AJCC v7 Stage IIB Cervical Cancer AJCC v6 and v7 Stage IIIA Cervical Cancer AJCC v6 and v7 Stage IIIA Vulvar Cancer AJCC v7 Stage IIIB Cervical Cancer AJCC v6 and v7 Stage IIIB Vulvar Cancer AJCC v7 Stage IIIC Vulvar Cancer AJCC v7 Stage IVA Cervical Cancer AJCC v6 and v7 Stage IVA Vulvar Cancer AJCC v7 Vulvar Adenocarcinoma Vulvar Squamous Cell Carcinoma Less << Phase 1 Suspended(Drug Supply Issues) - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Virginia University of Virginia Cancer Center Charlottesville, Virginia, United States, 22908 Less <<
NCT02243436 CLASSICAL HODGKIN LYMPHOMA Phase 1 Phase 2 Active, not recruiting January 2019 Spain ... More >> Hospital Universitario Central de Asturias Oviedo, Asturias, Spain, 33006 Institut Català d'Oncologia, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Institut Català d'Oncologia, Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Hospital Son Espases Palma, Islas Baleares, Spain Hospital del Mar Barcelona, Spain, 08003 Hospital Clinic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital General Universitario Gregorio Marañon Madrid, Spain, 28007 Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario de Canarias Santa Cruz de Tenerife, Spain, 38320 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Hospital Clínico de Valencia Valencia, Spain, 46010 Less <<
NCT03306901 Esophageal Cancer Not Applicable Recruiting December 31, 2025 Korea, Republic of ... More >> National Cancer Center Not yet recruiting Goyang-si, Korea, Republic of Contact: Jong Mog Lee    +82-10-7236-1078    jongmog@ncc.re.kr    Pusan National University Hospital Not yet recruiting Pusan, Korea, Republic of, 06351 Contact: Jihyung Kang    +82-2-2008-4259    sammy_jkang@naver.com    Seoul National University Bundang Hospital Not yet recruiting Seongnam, Korea, Republic of Contact: Jihyung Kang    +82-2-2008-4259    sammy_jkang@naver.com    Asan Medical Center Not yet recruiting Seoul, Korea, Republic of Contact: Jihyung Kang    +82-2-2008-4259    sammy_jkang@naver.com    Gangnam Severance Hospital Not yet recruiting Seoul, Korea, Republic of Contact: Jihyung Kang    +82-2-2008-4259    sammy_jkang@naver.com    Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Jihyung Kang    +82-2-2008-4259    sammy_jkang@naver.com    Seoul St. Mary's Hospital Not yet recruiting Seoul, Korea, Republic of Contact: Jihyung Kang    +82-2-2008-4259    sammy_jkang@naver.com Less <<
NCT01443078 - Completed - -
NCT00027703 Advanced Malignant Mesotheliom... More >>a Epithelial Mesothelioma Localized Malignant Mesothelioma Recurrent Malignant Mesothelioma Sarcomatous Mesothelioma Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01046461 Solid Tumour ... More >>Postoperative Nausea and Vomiting Less << Phase 2 Unknown June 2012 Korea, Republic of ... More >> Hallym University Sacred Heart Hospital Anyang-si, Gyeonggi-do, Korea, Republic of, 431-070 Less <<
NCT01982955 Non-small Cell Lung Cancer Phase 1 Phase 2 Active, not recruiting October 16, 2018 Germany ... More >> Please contact the Merck KGaA Communication Center located in Darmstadt, Germany Less <<
NCT02031250 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Recruiting December 2020 United States, Michigan ... More >> Veterans Affairs (VA) Ann Arbor Healthcare System Recruiting Ann Arbor, Michigan, United States, 48105 Contact: Nicky Chalpe    734-845-3713    Niharika.Chalpe@va.gov    University of Michigan Hospital Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Michelle Mierzwa, M.D.       mmierzwa@med.umich.edu    Principal Investigator: Michelle Mierzwa, M.D. Less <<
NCT01443078 Lung Cancer Phase 2 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT00423449 Non-Small Cell Lung Cancer Phase 1 Completed - -
NCT02902432 Nasopharyngeal Neoplasms Phase 2 Active, not recruiting December 2018 China, Hunan ... More >> the Second Xiangya Hospital Changsha, Hunan, China, 410011 Less <<
NCT00717938 Small Cell Lung Cancer Phase 3 Completed - Sweden ... More >> Gävle hospital Gävle, Sweden, 801 87 Sahlgrenska University Hospital Göteborg, Sweden, 413 45 Helsingborg Hospital Helsingborg, Sweden Ryhov Hospital, Jönköping Jönköping, Sweden Blekinge Hospital Karlskrona, Sweden, 371 85 Central Hospital Karlstad, Sweden, 651 85 Central Hospital Kristianstad, Sweden, 291 85 University Hospital Linköping Linköping, Sweden, 581 85 University Hospital Department of Respiratory Medicine Lund, Sweden, 221 85 University Hospital MAS Malmö, Sweden, 205 02 Karolinska University Hospital Stockholm, Sweden, 171 76 Norrlands University Hospital Umeå, Sweden Akademiska hospital Uppsala Uppsala, Sweden, 751 85 Central Hospital Växjö, Sweden, 351 85 Ystad hospital Ystad, Sweden, 271 82 University Hospital, Örebro Örebro, Sweden Less <<
NCT02187315 Nasopharyngeal Carcinoma Phase 2 Recruiting December 2019 China, Guizhou ... More >> The Affiliated Hospital of Guiyang Medical College/The Affiliated Cancer Hospital of Guiyang Medical College/Guizhou Cancer Hospital Recruiting Guiyang, Guizhou, China, 550001 Contact: Feng Jin, Professor    +86 13985124806    jinf8865@gmail.com Less <<
NCT02060656 Diffuse Large B-Cell Lymphoma Phase 2 Unknown - United Kingdom ... More >> Royal Marsden NHS Foundation Trust - London and Surrey Recruiting London, United Kingdom, SM2 5PT Contact: Bijal Patel, Msc    +44 (0)208 661 3808    bijal.patel@rmh.nhs.uk    Principal Investigator: David Cunningham, MD FRCP Less <<
NCT01512407 Hepatocellular Carcinoma Phase 3 Unknown January 2018 China ... More >> Prince of Wales Hospital Recruiting Hong Kong, China Contact: Yue Sun Cheung, MBChB    (852) 26321411    yuesun@surgery.cuhk.edu.hk    Principal Investigator: Yue Sun Cheung, MBChB Less <<
NCT00006027 Endometrial Cancer Phase 3 Completed - -
NCT00719550 Esophagogastric Junction Adeno... More >>carcinoma Gastric Cancer Esophageal Cancer Less << Phase 1 Phase 2 Completed - -
NCT00907543 Esophageal Neoplasms Phase 2 Phase 3 Recruiting November 2018 Canada, Ontario ... More >> London Health Sciences Centre Recruiting London, Ontario, Canada, N6A 5W9 Contact: Richard Malthaner, MD    519-667-6835    richard.malthaner@lhsc.on.ca    Contact: Deb Lewis, BSc    519-685-8500 ext 75685    deb.lewis@lhsc.on.ca    Principal Investigator: Richard Malthaner, MD Less <<
NCT00423449 - Completed - -
NCT00003742 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01544179 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting December 31, 2018 -
NCT01088802 Squamous Cell Carcinoma of Oro... More >>pharynx Less << Phase 2 Active, not recruiting January 2022 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT01755897 Uterine Cervical Neoplasms ... More >> Cervical Cancer Uterine Cervical Cancer Less << Phase 3 Active, not recruiting December 2018 China, Hubei ... More >> Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China, 430030 China, Shandong Qilu Hospital, Shandong University Jinan, Shandong, China, 250012 China, Zhejiang Women's Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China, 310006 Less <<
NCT00002521 Lymphoma Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase - Temple Cancer Center Philadelphia, Pennsylvania, United States, 19111-2442 Less <<
NCT01544179 - Active, not recruiting - -
NCT01268878 - Completed - France ... More >> Institut Sainte Catherine Avignon, France, 84082 Centre Hospitalier Universitaire Besancon, France, 25000 Polyclinique de Bordeaux Nord Bordeaux, France, 33077 Centre Hospitalier Universitaire Caen, France, 14033 Centre Jean Perrin Clermont Ferrand, France, 63011 Centre Hospitalier Draguignan, France, 83300 Centre Hospitalier de Vendée La Roche sur Yon, France, 85925 Centre Guillaume le Conquerant Le Havre, France, 76600 Centre Oscar Lambret Lille, France, 59020 Centre Hospitalier Lorient, France, 56000 Centre Leon Berard Lyon, France, 69008 Centre Antoine Lacassagne Nice, France, 06189 Groupe Hospitalier Pitié Salpétrière Paris, France, 75651 Institut Jean Godinot Reims, France, 51056 Centre Eugene Marquis Rennes, France, 35042 Clinique Armoricaine Saint Brieuc, France, 22015 Centre René Gauducheau Saint Herblain, France, 44885 Centre Hospitalier Bretonneau Tours, France, 37044 Less <<
NCT00002722 Gastric Cancer Phase 2 Completed - -
NCT03556839 Carcinoma of the Cervix, Stage... More >> IVB Less << Phase 3 Recruiting December 2023 Spain ... More >> Intitut Català d' Oncolgia L' Hospitalet Not yet recruiting Hospitalet de LLobregat, Barcelona, Spain, 08907 Contact: Beatriz Pardo, MD          Principal Investigator: Beatriz Pardo, MD          Parc Taulí Not yet recruiting Sabadell, Barcelona, Spain, 08208 Contact: Yolanda García, MD          Principal Investigator: Yolanda García, MD          Hospital Universitario Donostia- Donostia Unibertsitate Ospitalea Not yet recruiting Donostia, Gipuzkoa, Spain, 20014 Contact: Nerea Anzizar, MD          Principal Investigator: Nerea Anzizar, MD          Hospital Universitario Son Espases Not yet recruiting Palma De Mallorca, Islas Baleares, Spain, 07120 Contact: Jesús Alarcón, MD          Principal Investigator: Jesús Alarcón, MD          Hospital de la Vall d'Hebron Recruiting Barcelona, Spain, 08035 Contact: Ana Oaknin, MD PhD    +34 932746085    aoaknin@vhio.net    Principal Investigator: Ana Oaknin, MD PhD          H. Clínic Barcelona Not yet recruiting Barcelona, Spain, 08036 Contact: Lydia Gaba, MD          Principal Investigator: Lydia Gaba, MD          Hospital Reina Sofía Cordoba Not yet recruiting Cordoba, Spain, 14004 Contact: Maria Jesus Rubio, MD          Principal Investigator: Maria Jesus Rubio, MD          ICO Girona Not yet recruiting Girona, Spain, 17007 Contact: Pilar Barretina, MD          Principal Investigator: Pilar Barretina, MD          Hospital Ramon y Cajal Not yet recruiting Madrid, Spain, 28034 Contact: Eva Guerra, MD          Principal Investigator: Eva Guerra, MD          Hospital Universitario 12 de Octubre Not yet recruiting Madrid, Spain, 28041 Contact: Luis Manso Sánchez, MD          Principal Investigator: Luis Manso Sánchez, MD          Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Contact: Andrés Redondo, MD          Principal Investigator: Andrés Redondo, MD          Hospital Clinico Universitario Virgen Arrixaca Not yet recruiting Murcia, Spain, 30120 Contact: Jerónimo Martínez, MD          Principal Investigator: Jerónimo Martínez, MD          Complejo Hospitalario Regional de Málaga Not yet recruiting Málaga, Spain, 29010 Contact: Enrique Sáez, MD          Principal Investigator: Enrique Sáez, MD          Hosptial Clinico Universitario de Santiago de Compostela Not yet recruiting Santiago de Compostela, Spain, 15706 Contact: Juan Cueva, MD          Principal Investigator: Juan Cueva, MD          Hospital Virgen de la Salud Not yet recruiting Toledo, Spain Contact: Carmen Esteban, MD          Principal Investigator: Carmen Esteban, MD          Instituto Valenciano de Oncología Not yet recruiting Valencia, Spain, 46009 Contact: Ignacio Romero, MD          Principal Investigator: Ignacio Romero, MD          Hospital Clínico Universitario de Valencia Not yet recruiting Valencia, Spain, 46010 Contact: José A Pérez Fidalgo, MD          Principal Investigator: José A Pérez Fidalgo, MD          Hospital Miguel Servet Not yet recruiting Zaragoza, Spain, 50009 Contact: Ana Herrero, MD          Principal Investigator: Ana Herrero, MD Less <<
NCT00006048 Lung Cancer Phase 3 Unknown - United States, Delaware ... More >> AstraZeneca Pharmaceuticals LP Wilmington, Delaware, United States, 19850-5437 Less <<
NCT00193882 Esophagus Cancer Phase 3 Completed - -
NCT00191230 Carcinoma, Non Small Cell Lung Phase 2 Completed - United States, North Carolina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chapel Hill, North Carolina, United States Less <<
NCT03750539 Cervix Cancer Not Applicable Active, not recruiting November 10, 2021 Mexico ... More >> David Cantu de Leon Mexico City, Tlalpan, Mexico, 14080 Less <<
NCT03071289 Cervical Cancer ... More >> Lymphocyst Radiation Therapy Less << Phase 3 Recruiting March 31, 2025 China, Guangdong ... More >> Sun Yat-sen University Affiliated Foshan Hospital Not yet recruiting Foshan, Guangdong, China, 528000 Contact: Rong Huang, M.D    86-13927736853    nnjbhg@163.com    Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Wei-jun Ye, M.D    86-13538799871    yewj@sysucc.org.cn    Contact: Hui Chang, M.D    86-13480295989    changhui@sysucc.org.cn    The First affiliated Hospital of Guangdong Pharmaceutical University Not yet recruiting Guangzhou, Guangdong, China, 510080 Contact: Xi-cheng Wang, M.D    86-13902400598    13902400598@126.com    Guangzhou First People's Hospital Not yet recruiting Guangzhou, Guangdong, China, 510180 Contact: Guo-long Liu, M.D    86-13802527172    liugl@fimmu.com    Hospital of of Guangdong Armed Police Corps Not yet recruiting Guangzhou, Guangdong, China, 510507 Contact: Zhen-lun Li, M.D    86-13580516205    sfqiu@126.com    China, Guangxi The People's Hospital of Guangxi Zhuang Autonomous Region Not yet recruiting Nanning, Guangxi, China, 530021 Contact: Jia-xin Chen, M.D    86-13978609888    cjx166@163.com    China, Hainan Hainan General Hospital Not yet recruiting Haikou, Hainan, China, 570311 Contact: Guang Huang, M.D    86-18089777161    2842749787@qq.com    China, Xinjiang Xinjiang Medical University Affiliated Tumor Hospital Not yet recruiting Wulumuqi, Xinjiang, China, 830000 Contact: Xiao-wen Li, M.D    86-13899856295    lixiaowen1026@sohu.com Less <<
NCT00770393 Squamous Cell Carcinoma Phase 2 Phase 3 Completed - France ... More >> CALLOC'H Aix Les Bains, France LITAS Le Puy, France PIGNAT Lyon, France, 69000 MAYAUD Montbrison, France Crampette Montpellier, France Lallemant Nîmes, France LACHEB Roanne, France Less <<
NCT00005049 Colorectal Cancer ... More >> Gastric Cancer Gastrointestinal Carcinoid Tumor Gastrointestinal Stromal Tumor Ovarian Cancer Peritoneal Cavity Cancer Small Intestine Cancer Less << Phase 2 Completed - United States, New York ... More >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Less <<
NCT00005086 Bladder Cancer Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Louis A. Weiss Memorial Hospital Chicago, Illinois, United States, 60640 Oncology/Hematology Associates of Central Illinois, P.C. Peoria, Illinois, United States, 61602 United States, Indiana Fort Wayne Medical Oncology and Hematology, Inc. Fort Wayne, Indiana, United States, 46885-5099 Less <<
NCT00003322 Ovarian Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 3 Completed - -
NCT00002493 Endometrial Cancer ... More >> Psychosocial Effects of Cancer and Its Treatment Less << Phase 3 Completed - -
NCT03682068 Unresectable Locally Advanced ... More >>Urothelial Cancer Metastatic Urothelial Cancer Less << Phase 3 Recruiting April 27, 2022 -
NCT01181401 Squamous Cell Carcinoma of the... More >> Head Squamous Cell Carcinoma of the Neck Less << Phase 2 Unknown December 2012 Germany ... More >> Charité Universitaetsmedizin Berlin, CVK, CBF Recruiting Berlin, Germany, 13353 Contact: Carmen Stromberger, MD    0049 (0) 30 450 ext 657105    carmen.stromberger@charite.de    Sub-Investigator: Carmen Stromberger, MD          Sub-Investigator: Jan-Dirk Raguse, MD          Sub-Investigator: Eva-Tessina Becker, MD          Sub-Investigator: Ulrich Keilholz, MD, PhD          Sub-Investigator: Lutz Moser, MD          Sub-Investigator: Heidi Olze, MD, PD          University Medical Center Hamburg - Eppendorf Not yet recruiting Hamburg, Germany, 20246 Contact: Rainald Knecht, MD, PhD    0049 (0) 40 / 74105 ext 2360    r.knecht@uke.de    Sub-Investigator: Philippe Schafhausen, MD          Sub-Investigator: Cordula Petersen, MD, PD          Medizinische Hochschule Hannover Not yet recruiting Hannover, Germany, 30625 Contact: Viktor Grünwald Grünwald, MD, PD    0049 (0) 511 5324077 / 9196    Gruenwald.Viktor@mh-hannover.de    Sub-Investigator: Viktor Grünwald, MD, PD          Universitätsklinikum Gießen und Marburg Not yet recruiting Marburg, Germany, 35043 Contact: Rita Engenhart-Cabillic, MD, PD    0049 (0) 6421 58-66434    engenhar@med.uni-marburg.de    Sub-Investigator: Rita Engenhart-Cabillic, MD, PD          Universitätsklinikum Regensburg Not yet recruiting Regensburg, Germany, 93053 Contact: Oliver Koelbel, MD, PD    0049 (0941) 944 9410    oliver.koelbl@klinik.uni-regensburg.de    Sub-Investigator: Oliver Koelbl, MD, PD          Sub-Investigator: Hermann Hilber, MD Less <<
NCT03612219 Nasopharyngeal Carcinoma Phase 2 Recruiting July 28, 2021 China, Guangxi ... More >> People's Hospital of Baise Enrolling by invitation Baise, Guangxi, China Guangxi Naxishan Hospital Enrolling by invitation Guilin, Guangxi, China Guilin Medical University Recruiting Guilin, Guangxi, China Contact: Wei Jiang, Ph.D    +8613788561863    weijiang@glmc.edu.cn    People's Hospital of Laibin Enrolling by invitation Laibin, Guangxi, China People's Hospital of Lingshan Enrolling by invitation Linshan, Guangxi, China Wuzhou Red Cross Hospital Enrolling by invitation Wuzhou, Guangxi, China Less <<
NCT00539630 Carcinoma, Squamous Cell Phase 3 Completed - Korea, Republic of ... More >> Sanofi-Aventis Seoul, Korea, Republic of Less <<
NCT02908477 Oropharynx Cancer Phase 3 Recruiting September 15, 2024 United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Clinical Trials Referral Office    855-776-0015       United States, Minnesota Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015 Less <<
NCT03260712 Biliary Tract Cancer ... More >> Metastatic Cancer Advanced Cancer Gallbladder Cancer Less << Phase 2 Not yet recruiting June 1, 2021 -
NCT02353260 Head and Neck Cancer Phase 2 Unknown September 2017 China, Jiangsu ... More >> Xuzhou Central Hospital Recruiting Xuzhou, Jiangsu, China, 221000 Contact: Jian Meng, MD          Principal Investigator: Jian Meng, MD Less <<
NCT00140556 Head and Neck Cancer ... More >> Pharynx Cancer Less << Early Phase 1 Completed - United States, North Carolina ... More >> Department of Radiation Oncology; Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00140556 - Completed - -
NCT00005791 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT03577704 Advanced Solid Tumors Phase 1 Phase 2 Recruiting October 30, 2021 China, Shanghai ... More >> Shanghai East Hospital Recruiting Shanghai, Shanghai, China, 200123 Contact: Jin E Li, Phd    （021）38804518 ext 22228    lijin@csco.org.cn    Contact: Jin E Li       lijin@csco.org.cn    Principal Investigator: Jin Li, PhD          Sub-Investigator: Ye Guo, PhD Less <<
NCT00003144 Drug/Agent Toxicity by Tissue/... More >>Organ Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Less <<
NCT00004100 Lung Cancer Phase 3 Unknown - Italy ... More >> Ospedale San Lazzaro Alba, Italy, 12051 Ospedale Civile Avellino Avellino, Italy Ospedale G. Di Maria - Avola (SR) Avola (SR), Italy Azienda Ospedaliena G. Rummo Benevento, Italy, 82100 Ospedale Cardarelli - Campobasso Campobasso, Italy Ospedale Civile Cosenza Cosenza, Italy, 87100 Ospedale San Martino/Cliniche Universitarie Convenzionate Genoa, Italy, 16132 Ospedale Gen. Provinciale Santa Maria Goretti Latina, Italy, 04100 Ospedale di Legnano Legnano, Italy, 20025 Ospedale Maggiore Lodi Lodi, Italy, I-20075 Istituto Di Science Biomediche San Paolo Milano, Italy, 20142 Ospedale Di Gabargnate Milanese Milan, Italy, 20024 Ospedale San Carlo Borromeo Milan, Italy, 20153 Federico II University Medical School Naples, Italy, 80131 Istituto Nazionale per lo Studio e la Cura dei Tumori Naples, Italy, 80131 Ospedale S. Gennora USL 42 Naples, Italy, 80136 Ospedale Vincenzo Monaldi Napoli, Italy, 80131 ASL 2 - Napoli Napoli, Italy Universita di Palermo Palermo, Italy, 90141 Ospedale La Maddalena - Palermo Palermo, Italy Ospedale S. Francesco - Paola Paola (CS), Italy Ospedale Agnelli Pinerolo, Italy, 10064 Ospedale San Carlo Potenza, Italy, 85100 Ospedali Riuniti Reggio Calabria, Italy, 89100 U.S.S.L. 33 Rho, Italy Ospedale Oncologieo G. Fortunato Rionero, Italy Istituti Fisioterapici Ospitalieri - Roma Rome, Italy, 00161 Ospedale Civile - Rovereto Rovereto, Italy Ospedale San Bortolo Vicenza, Italy, 36100 Less <<
NCT00198367 Non-small Cell Lung Cancer Phase 2 Completed - France ... More >> Centre Hospitalier Lyon-Sud - Radiotherapie/Oncologie Pierre-Benite, France Less <<
NCT01285037 Cancer Phase 1 Completed - United States, Arizona ... More >> Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, District of Columbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, New York Mount Sinai Medical Center New York, New York, United States, 10029 United States, Pennsylvania University of Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19104 Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT03175939 Nasopharyngeal Cancer Phase 2 Completed - -
NCT03738228 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Positive Lymph Node Stage IB2 Cervical Cancer AJCC v8 Stage II Cervical Cancer AJCC v8 Stage IIA Cervical Cancer AJCC v8 Stage IIA1 Cervical Cancer AJCC v8 Stage IIA2 Cervical Cancer AJCC v8 Stage IIB Cervical Cancer AJCC v8 Stage IIIB Cervical Cancer AJCC v8 Stage IVA Cervical Cancer AJCC v8 Less << Phase 1 Recruiting October 31, 2019 United States, Pennsylvania ... More >> NRG Oncology Recruiting Philadelphia, Pennsylvania, United States, 19103 Contact: Jyoti S. Mayadev    858-822-6040    jmayadev@ucsd.edu    Principal Investigator: Jyoti S. Mayadev Less <<
NCT00004003 Pancreatic Cancer Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT03351842 Chemotherapy, Adjuvant ... More >> Lung Adenocarcinoma, Stage I Treatment Histological Type of Neoplasm Less << Phase 2 Recruiting September 1, 2024 China ... More >> Thoracic Surgery Department of Shanghai Pulmonary Hospital Recruiting Shanghai, China, 200000 Contact: Yingran Shen    86-18117166317    elaineshen91@gmail.com Less <<
NCT01967875 Stomach Neoplasms Phase 2 Unknown May 2016 China, Liaoning ... More >> The Fourth Hospital of Anshan Not yet recruiting Anshan, Liaoning, China The First Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China The Second Hospital of Dalian Medical University Not yet recruiting Dalian, Liaoning, China The First Hospital of Liaoning Medical University Not yet recruiting Jinzhou, Liaoning, China The First Hospital of China Medical University Recruiting Shenyang, Liaoning, China, 110001 Contact: Yunpeng Liu, MD., PhD.    86-24-83282312    cmuliuyunpeng@hotmail.com    Liaoning Tumor Hospital Not yet recruiting Shenyang, Liaoning, China Shengjing Hospital of China Medical University Not yet recruiting Shenyang, Liaoning, China Less <<
NCT02350712 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 1 Completed - United Kingdom ... More >> The Royal Marsden Hospital Sutton, Surrey, United Kingdom, SM2 5PT University College London Hospital London, United Kingdom, NW1 2BU The Royal Marsden Hospital London, United Kingdom, SW3 6JJ Less <<
NCT00003202 Lung Cancer Phase 1 Phase 2 Completed - United States, North Carolina ... More >> Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157-1082 Less <<
NCT03373019 Chidamide Lym... More >>phoma, B-Cell Lymphoma, Large B-Cell, Diffuse Neoplasm by Histology Neoplasms Lymphoproliferative Disorders Lymphatic Diseases Immunoproliferative Disorders Immune System Diseases Lymphoma, Non-Hodgkin Cyclophosphamide Rituximab Gemcitabine Cisplatin Dexamethasone HDAC Inhibitor Less << Phase 2 Recruiting March 1, 2021 China, Shanghai ... More >> Kai Xue Recruiting Shanghai, Shanghai, China, 200032 Contact: Kai Xue, MD    13818659448    xuekaishanghai@126.com    China Kai Xue Recruiting Shanghai, China Contact: Kai Xue, MD    13818659448    xuekaishanghai@126.com    Contact: Junning Cao, MD    13818659448 Less <<
NCT01409174 Melanoma Phase 1 Terminated(Slow accrual, close... More >>d in Phase I.) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00601705 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Unknown - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT01147809 Thrombocytopaenia Phase 2 Completed - -
NCT00080795 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 2 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT00006374 Lung Cancer Phase 2 Withdrawn(Slow accrual) - -
NCT01147809 - Completed - -
NCT00815308 - Completed - -
NCT00815308 Esophageal Cancer Phase 2 Completed - China, Shandong ... More >> Department of Radiation Oncology, Shandong Cancer Hospital and Institute Jinan, Shandong, China, 250117 Less <<
NCT00005850 Anxiety Disorder ... More >> Depression Fatigue Lung Cancer Less << Phase 2 Completed - -
NCT00980759 Cervical Cancer Phase 2 Active, not recruiting November 2019 Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of, 410-769 Less <<
NCT02324296 - Completed - -
NCT00989651 Fallopian Tube Carcinosarcoma ... More >> Fallopian Tube Clear Cell Adenocarcinoma Fallopian Tube Endometrioid Adenocarcinoma Fallopian Tube Mucinous Adenocarcinoma Fallopian Tube Serous Neoplasm Fallopian Tube Transitional Cell Carcinoma Fallopian Tube Undifferentiated Carcinoma Ovarian Brenner Tumor Ovarian Carcinosarcoma Ovarian Clear Cell Adenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Adenocarcinoma Ovarian Seromucinous Tumor Ovarian Serous Adenocarcinoma Ovarian Transitional Cell Carcinoma Ovarian Undifferentiated Carcinoma Primary Peritoneal Serous Adenocarcinoma Stage IIA Fallopian Tube Cancer AJCC v6 and v7 Stage IIA Ovarian Cancer AJCC V6 and v7 Stage IIB Fallopian Tube Cancer AJCC v6 and v7 Stage IIB Ovarian Cancer AJCC v6 and v7 Stage IIC Fallopian Tube Cancer AJCC v6 and v7 Stage IIC Ovarian Cancer AJCC v6 and v7 Stage IIIA Fallopian Tube Cancer AJCC v7 Stage IIIA Ovarian Cancer AJCC v6 and v7 Stage IIIA Primary Peritoneal Cancer AJCC v7 Stage IIIB Fallopian Tube Cancer AJCC v7 Stage IIIB Ovarian Cancer AJCC v6 and v7 Stage IIIB Primary Peritoneal Cancer AJCC v7 Stage IIIC Fallopian Tube Cancer AJCC v7 Stage IIIC Ovarian Cancer AJCC v6 and v7 Stage IIIC Primary Peritoneal Cancer AJCC v7 Stage IV Fallopian Tube Cancer AJCC v6 and v7 Stage IV Ovarian Cancer AJCC v6 and v7 Stage IV Primary Peritoneal Cancer AJCC v7 Less << Phase 1 Active, not recruiting - -
NCT01472653 Head and Neck Cancer Phase 2 Unknown December 2016 Slovenia ... More >> Institute of Oncology Ljubljana Recruiting Ljubljana, Slovenia, SI-1000 Contact: Primož Strojan, Prof.       pstrojan@onko-i.si    Sub-Investigator: Marta Dremelj, MD, MSc          Sub-Investigator: Igor Fajdiga, MD, PhD          Sub-Investigator: Cvetka Kuhar Grašič, MD, PhD          Sub-Investigator: Jančar Boris, MD, MSc          Sub-Investigator: Simona Jereb, MD          Sub-Investigator: Katarina Karner, MD, MSc          Sub-Investigator: Barbara Žumer, MD Less <<
NCT00005638 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 1 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90033-0804 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02934503 Small Cell Lung Cancer (SCLC) Phase 2 Recruiting October 2020 United States, New York ... More >> Laura and Isaac Perlmutter Cancer Center at NYU Langone Recruiting New York, New York, United States, 10016 Contact: Leena Gandhi, MD, Ph.D.    212-731-6363    Leena.Gandhi@nyumc.org    Principal Investigator: Leena Gandhi, MD, Ph.D. Less <<
NCT02445391 Estrogen Receptor Negative ... More >> HER2/Neu Negative Invasive Breast Carcinoma Progesterone Receptor Negative Stage II Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage III Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Triple-Negative Breast Carcinoma Less << Phase 3 Recruiting May 31, 2024 -
NCT00003111 Lung Cancer Phase 2 Completed - United States, Connecticut ... More >> Yale Comprehensive Cancer Center New Haven, Connecticut, United States, 06520-8028 Less <<
NCT00003803 Lung Cancer Phase 3 Terminated(low accrual) - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Hopital de Jolimont Haine Saint Paul, Belgium, 7100 France CHR de Grenoble - La Tronche Grenoble, France, 38043 Germany Mutterhaus der Borromaerinnen Trier, Germany, D-54219 Netherlands Medisch Centrum Haaglanden 's-Gravenhage (Den Haag, The Hague), Netherlands, 2501 CK Antoni van Leeuwenhoekhuis Amsterdam, Netherlands, 1066 CX Academisch Medisch Centrum Amsterdam, Netherlands, 1105 AZ Gelre Ziekenhuizen - Lokatie Lukas Apeldoorn, Netherlands, 7334 DZ Amphia Ziekenhuis Breda, Netherlands, 4810 EV Amphia Ziekenhuis - locatie Molengracht Breda, Netherlands, 4818 CK Reinier de Graaf Group Delft, Netherlands, NL 2600 GA Radiotherapeutisch Instituut-(Riso) Deventer, Netherlands, 7400 AC Catharina Ziekenhuis Eindhoven, Netherlands, 5602 ZA Twee Steden Ziekenhuis Vestiging Tilburg Tilburg, Netherlands, 5042 AD Dr. Bernard Verbeeten Instituut Tilburg, Netherlands, 5042 SB Sophia Ziekehuis Zwolle, Netherlands, 8000 GK United Kingdom Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Less <<
NCT00622349 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - Belgium ... More >> Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet Brussels, Belgium, 1000 France Pneumology department of CHU Lille Lille, France Greece Hellenic Cancer Institute - St Savas Oncology Hospital Athens, Greece Spain Medical Oncology Hospital de Sagunto Valencia, Spain Less <<
NCT02047201 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Completed - Lithuania ... More >> Lithuanian University of Health Sciences Kaunas, Lithuania, LT-44307 Less <<
NCT03579758 Stage I Gallbladder Cancer AJC... More >>C v8 Stage II Gallbladder Cancer AJCC v8 Stage IIA Gallbladder Cancer AJCC v8 Stage IIB Gallbladder Cancer AJCC v8 Stage III Gallbladder Cancer AJCC v8 Stage IIIA Gallbladder Cancer AJCC v8 Stage IIIB Gallbladder Cancer AJCC v8 Less << Phase 3 Not yet recruiting January 31, 2026 United States, Georgia ... More >> Emory University Hospital Midtown Not yet recruiting Atlanta, Georgia, United States, 30308 Contact: Shabnam Montazeri    404-686-0242    shabnam.montazeri@emory.edu    Principal Investigator: Shishir Maithel, MD          Emory University Hospital/Winship Cancer Institute Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Sheena Abraham    404-778-2670    sheena.abraham@emory.edu    Principal Investigator: Shishir Maithel, MD          Emory Saint Joseph's Hospital Not yet recruiting Atlanta, Georgia, United States, 30342 Contact: Alicia Escobar    678-843-7029    alicia.m.escobar@emory.edu    Principal Investigator: Shishir Maithel, MD Less <<
NCT03623087 Non-Hodgkin's Lymphoma, Relaps... More >>ed Non-Hodgkin T-cell Lymphoma Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type Less << Phase 3 Recruiting June 30, 2020 Hong Kong ... More >> The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: King Hei Lu, MMedSc    852-22554361 ext 1654    khlu@hku.hk    Contact: Zoe Chan, BNs    852-22551654    zoechan1@hku.hk    Principal Investigator: Yok Lam Kwong, MD(HK)          Sub-Investigator: Thomas Chan, MBBS(HK) Less <<
NCT03664024 Non-Small Cell Lung Cancer Phase 2 Recruiting March 4, 2022 United States, Maryland ... More >> Harry & Jeanette Weinberg Cancer Institute ( Site 0901) Recruiting Baltimore, Maryland, United States, 21237 Contact: Study Coordinator    443-777-7364       Canada, Quebec CISSS de la Monteregie-Centre ( Site 0801) Recruiting Greenfield Park, Quebec, Canada, J4V 2H1 Contact: Study Coordinator    45046650003226       Hungary Orszagos Koranyi TBC es Pulmonologiai Intezet ( Site 0400) Recruiting Budapest, Hungary, 1121 Contact: Study Coordinator    +36302005233       Petz Aladar Megyei Oktato Korhaz ( Site 0402) Recruiting Gyor, Hungary, 9024 Contact: Study Coordinator    +3696418244       Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 0401) Recruiting Szolnok, Hungary, 5900 Contact: Study Coordinator    +36209323256       Israel Meir Medical Center ( Site 0501) Recruiting Kfar-Saba, Israel, 4428132 Contact: Study Coordinator    +97297472414       Chaim Sheba Medical Center ( Site 0500) Recruiting Ramat Gan, Israel, 5262000 Contact: Study Coordinator    +97235307096       Spain Hospital Universitario Insular de Gran Canaria ( Site 0700) Recruiting Las Palmas de Gran Canaria, Gran Canaria, Spain, 35001 Contact: Study Coordinator    +34928441738       H.U. Vall de Hebron ( Site 0701) Recruiting Barcelona, Spain, 08035 Contact: Study Coordinator    +34932746085       Hospital General Universitario 12 de Octubre ( Site 0703) Recruiting Madrid, Spain, 28041 Contact: Study Coordinator    +34914692313       Hospital Universitario Central de Asturias ( Site 0704) Recruiting Oviedo, Spain, 33011 Contact: Study Coordinator    +34609804227 Less <<
NCT01220583 Head and Neck Cancer Phase 2 Recruiting October 2028 -
NCT01059188 Lung Cancer Phase 2 Active, not recruiting June 2021 Switzerland ... More >> Saint Claraspital AG Basel, Switzerland, CH-4016 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland, CH-6500 Inselspital Bern Bern, Switzerland, CH-3010 Spitalzentrum Biel Biel, Switzerland, CH-2501 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Hopital Fribourgeois Fribourg, Switzerland, 1708 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Liestal Liestal, Switzerland, CH-4410 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 Kantonsspital Winterthur Winterthur, Switzerland, CH-8400 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT00022308 Lung Cancer Phase 1 Completed - United States, New Jersey ... More >> South Jersey Regional Cancer Center Millville, New Jersey, United States, 08332 Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County Mount Holly, New Jersey, United States, 08060 Riverview Medical Center - Booker Cancer Center Red Bank, New Jersey, United States, 07701 Community Medical Center Toms River, New Jersey, United States, 08755 St. Francis Medical Center Trenton, New Jersey, United States, 08629 United States, Pennsylvania Delaware County Memorial Hospital Drexel Hill, Pennsylvania, United States, 19026 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 Less <<
NCT02116231 Effects of Chemotherapy Phase 2 Unknown May 2018 China, Guangxi ... More >> Cancer Hospital of Guangxi Medical University Not yet recruiting Nanning, Guangxi, China, 530021 Contact: Xiaodong Zhu, Doctor       zhuxiaodong83@163.com    Principal Investigator: Song Qu, Doctor          Principal Investigator: Ling Li, Master Less <<
NCT00004103 Gastric Cancer Phase 2 Completed - United States, New York ... More >> NYU Cancer Institute at New York University Medical Center New York, New York, United States, 10016 Less <<
NCT00137358 Cervical Cancer Phase 1 Withdrawn(unable to obtain fun... More >>ding to conduct study) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT00002984 Esophageal Cancer Phase 1 Phase 2 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT01756170 Cervical Cancer Phase 3 Unknown December 2016 China, Zhejiang ... More >> The First Affiliated Hospital of Wenzhou Medical College Recruiting Wenzhou, Zhejiang, China, 325000 Contact: congying xie, MD    +86-577-88069316    wzxiecongying@163.com    Principal Investigator: congying xie, MD Less <<
NCT03709147 Advanced LKB1-inactive Lung Ad... More >>enocarcinoma Less << Phase 2 Not yet recruiting September 10, 2023 Italy ... More >> Marina Chiara Garassino Not yet recruiting Milan, Italy, 20133 Contact: MARINA CHIARA GARASSINO, MD    0223903813 ext +39    marina.garassino@istitutotumori.mi.it Less <<
NCT00150670 Gastric Cancer Phase 3 Completed - Japan ... More >> East Hospital, Kitasato University 2-1-1, Asamizodai, Sagamihara, Kanagawa, Japan Less <<
NCT01356368 Non-Small Cell Lung Cancer Phase 2 Terminated(slow accrual rate) - Saudi Arabia ... More >> King Abdul Aziz Medical City for National Guard Health Affairs Riyadh, Saudi Arabia Less <<
NCT00003811 Childhood Germ Cell Tumor ... More >> Drug/Agent Toxicity by Tissue/Organ Extragonadal Germ Cell Tumor Ovarian Cancer Less << Phase 2 Completed - -
NCT00172380 NSCLC Phase 2 Completed - Taiwan ... More >> Department of Internal Medicine, National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT02667925 Ovarian Cancer Not Applicable Withdrawn(Because of the obsol... More >>escence of the study) Less << - France ... More >> Centre Jean Perrin Clermont-Ferrand, France, 63000 Less <<
NCT03619824 Nasopharyngeal Neoplasms Phase 2 Not yet recruiting March 2024 China, Guangdong ... More >> SUN YAT-SEN UNIVERSITY cANCER CENTER Guangzhou, Guangdong, China, 510060 Less <<
NCT02429037 Advanced Head and Neck Cancer Phase 2 Unknown December 2018 China, Jiangsu ... More >> Jiangsu cancer hospital Not yet recruiting Nanjing, Jiangsu, China, 210000 Contact: Xia He, MD, PhD    86-13601458518    13601458515@qq.com    Contact: Jianfeng Wu, MD, PhD    86-13923753040    595864485@qq.com Less <<
NCT02891083 Esophageal Neoplasms Phase 3 Recruiting January 2021 China ... More >> Shanghai Chest Hospital Recruiting Shanghai, China, 200030 Contact: Wentao Fang, MD    +86-21-62821990 ext 2901    vwtfang12@shchest.org    Contact: Xufeng Guo, MD    +86-21-62821900 ext 2608    shandagxf@126.com Less <<
NCT00367497 Lymphoma, Non-Hodgkin Phase 2 Terminated(The stopping rule w... More >>as applied because of low response rates.) Less << - Japan ... More >> Keio University School of Medicine Tokyo, Japan, 160-8582 Less <<
NCT00407186 Gastric Cancer Phase 3 Active, not recruiting December 2025 Netherlands ... More >> Nederlands Kanker Instituut/Antoni van Leeuwenhoek Ziekenhuis Amsterdam, Netherlands, 1066 CX Less <<
NCT01502202 Non Small Cell Lung Cancer ... More >> Adenocarcinoma Less << Phase 2 Unknown February 2015 Korea, Republic of ... More >> National Cancer Center Recruiting Goyang-si, Gyenggido, Korea, Republic of, 410-769 Contact: Sung Jin Yoon, RN    +82-31-920-0405    jinijiniya@ncc.re.kr    Contact: Jin Soo Lee, MD. Ph.D.    +82-31-920-1501    jslee@ncc.re.kr Less <<
NCT00006260 Breast Cancer Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5055 Less <<
NCT00667342 Osteosarcoma ... More >>Malignant Fibrous Histiocytoma (MFH) of Bone Less << Phase 2 Active, not recruiting May 2019 United States, California ... More >> Rady Children's Hospital and Health Center San Diego, California, United States, 92123 United States, Maryland Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 NCI/NIH - Pediatric Oncology Branch Bethesda, Maryland, United States, 20892 United States, Tennessee St Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT01670409 Esophageal Neoplasms Phase 2 Completed - China, Guangdong ... More >> Cancer Hospital, Shantou University Medical College Shantou, Guangdong, China, 515031 Less <<
NCT00823719 Lymphoma, Large-Cell, Diffuse Phase 2 Completed - -
NCT00719524 Neoplasms Phase 1 Completed - France ... More >> Investigational Site Number 250001 Villejuif, France, 94805 Italy Investigational Site Number 380001 Milano, Italy, 20133 Switzerland Investigational Site Number 756001 Bellinzona, Switzerland, 6500 Less <<
NCT02825940 Neoplasms Phase 1 Recruiting January 10, 2020 China ... More >> Beijing Cancer Hospital Active, not recruiting Beijing, China, 100142 Jilin Cancer Hospital Recruiting Changchun, China, 130012 Cancer Center, Sun Yat-sen University of Medical Sciences; Department of Medical Oncology Recruiting Guangzhou, China, 510060 Sir Run Run Shaw Hospital Recruiting Hangzhou, China, 310016 Harbin Medical University Cancer Hospital Recruiting Harbin, China, 150081 Harbin Medical University Cancer Hospital Not yet recruiting Harbin, China, 150081 Fudan University Shanghai Cancer Center Recruiting Shanghai, China, 200032 Zhongshan Hospital Fudan University Recruiting Shanghai, China, 200032 Less <<
NCT00823719 - Completed - -
NCT00667342 - Active, not recruiting - -
NCT02047487 - Unknown August 2018 China ... More >> PLAGH Recruiting Beijing, China, 100853 PLA307 Recruiting Beijing, China Less <<
NCT00498979 Stage IV Melanoma Phase 1 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00490360 Cancer of the Pancreatic Head Phase 2 Completed - Switzerland ... More >> University Hospital of Zurich, Department of Surgery Zurich, Switzerland Less <<
NCT00369954 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 2 Withdrawn(Trial was never acti... More >>vated) Less << - -
NCT02741856 Oesophageal Cancer Phase 2 Phase 3 Recruiting April 2023 United Kingdom ... More >> Aberdeen Royal Infirmary Recruiting Aberdeen, United Kingdom Contact: Lucy Wells          Bristol Haematology & Oncology Recruiting Bristol, United Kingdom Contact: Stephen Falk          Addenbrooke's Hospital Recruiting Cambridge, United Kingdom Contact: Susan Harden          Kent and Canterbury Not yet recruiting Canterbury, United Kingdom Contact: Mathilda Cominos          Velindre Cancer Care Centre Recruiting Cardiff, United Kingdom, CF14 2TL Contact: Carys Morgan    02920 615 888    carys.morgan6@wales.nhs.uk    Cheltenham General Hospital Recruiting Cheltenham, United Kingdom Contact: Charles Candish          University Hospital Coventry Recruiting Coventry, United Kingdom Contact: Sharmila Sothi          Derby Teaching Hospitals NHS Trust Recruiting Derby, United Kingdom Contact: Prantik Das          Glan Clwyd Hospital Recruiting Glan Clwyd, United Kingdom Contact: Angel Garcia          Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom Contact: David McIntosh          Gloucestershire Royal Hospital Recruiting Gloucester, United Kingdom Contact: Charles Candish          Castle Hill Hospital Recruiting Hull, United Kingdom Contact: Raj Roy          The Clatterbridge Cancer Centre nhs Foundation Trust Recruiting Liverpool, United Kingdom Contact: Raj Sripadam          Guy's and St Thomas' Recruiting London, United Kingdom Contact: Asad Qureshi          Imperial College Healthcare NHS Trust Recruiting London, United Kingdom Contact: Danielle Power          North Middlesex Hospital Recruiting London, United Kingdom Contact: Lucinda Melcher          The Royal Marsden Hospitals (Fulham) Recruiting London, United Kingdom Contact: Katharine Aitken          The James Cook University Hospital Recruiting Middlesbrough, United Kingdom Contact: David Wilson          Churchill Hospital Recruiting Oxford, United Kingdom Contact: Somnath Mukherjee          Peterborough and Stamford Hospitals NHS Foundation Trust Recruiting Peterborough, United Kingdom Contact: Catherine Jephcott          Sheffield Teaching Hospitals - Weston Park Hospital Recruiting Sheffield, United Kingdom Contact: Jon Wadsley          University Hospital Southampton NHS Foundation Trust Recruiting Southampton, United Kingdom Contact: Andrew Bateman          The Royal Marsden Hospitals (Sutton, Surrey) Recruiting Sutton, United Kingdom Contact: Katharine Aitken          Singleton Hospital Recruiting Swansea, United Kingdom Contact: Sarah Gwynne          Worcestershire Royal Hospital Recruiting Worcester, United Kingdom Contact: Cheng Boon          Wrexham Maelor Recruiting Wrexham, United Kingdom Contact: Simon Gollins Less <<
NCT00017173 Head and Neck Cancer Phase 2 Terminated(Terminated for poor... More >> accrual.) Less << - United States, Kansas ... More >> Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City, Kansas, United States, 66160-7357 United States, Kentucky Markey Cancer Center at University of Kentucky Chandler Medical Center Lexington, Kentucky, United States, 40536-0293 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00054054 Head and Neck Cancer Phase 2 Completed - -
NCT00004913 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT02627807 Nasopharyngeal Neoplasms Not Applicable Active, not recruiting December 2022 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT00003888 Head and Neck Cancer Phase 3 Completed - -
NCT00002546 Sarcoma Phase 3 Completed - -
NCT02422563 Cervical Cancer Phase 3 Not yet recruiting October 2025 -
NCT02573584 - Recruiting May 2021 Netherlands ... More >> Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis (NKI-AVL) Recruiting Amsterdam, Netherlands Contact: J. Kerst, MD PhD          University Medical Center Groningen (UMCG) Recruiting Groningen, Netherlands Contact: J.A. Gietema, MD PhD       j.a.gietema@umcg.nl    Contact: S. Lubberts, MD       s.lubberts@umcg.nl    Maastricht University Medical Center (MUMC) Recruiting Maastricht, Netherlands Contact: M. Aarts, MD PhD          Portugal Instituto Portuges de Oncologia Francisco Gentil (IPOLFG) Recruiting Lisbon, Portugal Contact: M. Brito, MD PhD          Switzerland UniversitatsSpital Zurich Recruiting Zurich, Switzerland Contact: J. Beyer, MD PhD          Contact: C. Fankhauser, MD PhD Less <<
NCT00436644 Ovarian Cancer ... More >> Peritoneal Cavity Cancer Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Arizona Scottsdale, Arizona, United States, 85254 United States, Florida Mayo Clinic in Jacksonville Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT02404571 Lymphoma, T-Cell, Peripheral Phase 2 Unknown December 2016 China, Beijing ... More >> Cancer Hospital and Institute, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Recruiting Beijing, Beijing, China, 100021 Contact: Mei Dong    (86)13811929322    dongmei030224@163.com Less <<
NCT03027284 Advanced Cancer ... More >> Metastatic Cancer Biliary Tract Carcinoma Cholangiocarcinoma Gall Bladder Carcinoma Solid Tumor Non-Hodgkin's Lymphoma Less << Phase 1 Active, not recruiting February 2, 2019 Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chiba, Japan, 277 8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tokyo, Japan, 104-0045 Less <<
NCT00436644 - Completed - -
NCT01225523 Squamous Carcinoma of Esophagu... More >>s Esophagus Disorders Less << Phase 1 Completed - China, Shaanxi ... More >> First Affiliated Hospital of College of Medicine of Xi'an Jiao Tong University Xi'an, Shaanxi, China, 710061 Less <<
NCT00508664 Squamous Cell Carcinoma of the... More >> Hypopharynx Larynx Carcinoma Less << Phase 2 Completed - Austria ... More >> Universitätsklinik für HNO Graz, Austria, 8036 Landeskrankenhaus Klagenfurt Klagenfurt, Austria, A-9020 Allgemeines Krankenhaus der Stadt Wien Vienna, Austria, 1090 Germany Helios Klinikum Erfurt GmbH Klinik für HNO-Heilkunde, Plastische Operationen Erfurt, Thüringen, Germany, 99089 Universitätsklinik Aachen Aachen, Germany, 52074 Charité, Campus Benjamin Franklin Berlin, Germany, 12200 Klinikum Neukölln, Vivantes GmbH Berlin, Germany, 12351 Klinikum Bielefeld-Mitte Bielefeld, Germany, 33604 Malteser Krankenhaus St. Anna gGmbH, HNO-Klinik Duisburg, Germany, 47259 Klinikum Fulda gAG, Klinik für Hals-Nasen-Ohrenkrankheiten Fulda, Germany, 36043 Medizinische Hochschule Hannover Hannover, Germany, 30625 Klinikum Hannover Nordstadt Hannover, Germany Universitätsklinikum Heidelberg Heidelberg, Germany, 69120 Universitätsklinikum Jena Jena, Germany, 07743 St. Vincentius Kliniken Karlsruhe, Germany Klinikum Kassel GmbH Kassel, Germany, 34125 Katholisches Klinikum Koblenz Marienhof Koblenz, Germany, 56073 Universitätsklinik Köln Köln, Germany, 50924 Universitätsklinikum Leipzig Leipzig, Germany, 04103 Universtitätsklinikum Schleswig-Holstein Lübeck, Germany, 23538 Klinikum Großhadern München, Germany, 81377 Medizinische Fakultät der Westfälischen Wilhelms-Universität Münster Münster, Germany, 48149 Südharz-Krankenhaus Nordhausen gGmbH Nordhausen, Germany Klinikum Ernst von Bergmann gGmbH Potsdam, Germany, 14467 Universtitätsklinikum Regensburg Regensburg, Germany Klinikum Stuttgart Katharinenhospital, Klinik für HNO-Krankheiten Stuttgart, Germany, 70174 Bayerischen Julius Maximillians-Universtät Würzburg Würzburg, Germany, 97080 Less <<
NCT01230476 Nasopharyngeal Carcinoma Phase 2 Terminated - Malaysia ... More >> University Malaya Medical Centre Kuala Lumpur, Wilayah Persekutuan, Malaysia, 59100 Less <<
NCT03747419 Bladder Cancer ... More >> Muscle Invasive Bladder Cancer Less << Phase 2 Not yet recruiting January 31, 2031 United States, Massachusetts ... More >> Brigham and Women's Hospital Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Kent Mouw, MD, PhD    617-525-7382    kent_mouw@dfci.harvard.edu    Principal Investigator: Kent Mouw, MD, PhD Less <<
NCT01551589 Esophageal Squamous Cell Carci... More >>noma Less << Not Applicable Completed - China, Guangxi ... More >> Guangxi Tumor Hospital Nanning, Guangxi, China, 530021 China, Guizhou GuiZhou Cancer Hospital Guiyang, Guizhou, China, 550000 China, Sichuan The Second People's Hospital of Sichuan Chengdu, Sichuan, China, 610000 China, Yunnan Yunnan Tumor Hospital, The Third Affiliated Hospital of KUNMING Medical University Kunming, Yunnan, China, 652100 Less <<
NCT03675737 Stomach Neoplasms Phase 3 Recruiting February 2, 2024 United States, Maryland ... More >> Greater Baltimore Medical Center ( Site 0102) Recruiting Baltimore, Maryland, United States, 21204 Contact: Study Coordinator    443-849-3122       United States, Minnesota Minnesota Oncology Hematology, PA ( Site 8000) Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Study Coordinator    281-863-4643       United States, Virginia Oncology & Hematology Assoc. SW Virginia, Inc., DBA Blue Ridge Cancer Care ( Site 8001) Recruiting Roanoke, Virginia, United States, 24014 Contact: Study Coordinator    281-863-4643       United States, Washington Wenatchee Valley Clinic [Wenatchee, WA] ( Site 0116) Recruiting Wenatchee, Washington, United States, 98801 Contact: Study Coordinator    509-665-5800       Australia, New South Wales Southern Medical Day Care Centre ( Site 2303) Recruiting Wollongong, New South Wales, Australia, 4020 Contact: Study Coordinator          Canada, Quebec McGill University Health Centre ( Site 0208) Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Study Coordinator    5149341934       France C.H.R.U. de Brest - Hopital Morvan ( Site 1007) Recruiting Brest, France, 29200 Contact: Study Coordinator    +33298223428       Israel Rabin Medical Center ( Site 1302) Recruiting Petah Tikva, Israel, 4941492 Contact: Study Coordinator    +97239378077       Chaim Sheba Medical Center ( Site 1304) Recruiting Ramat Gan, Israel, 5262000 Contact: Study Coordinator    +97235307776       Sourasky Medical Center ( Site 1306) Recruiting Tel Aviv, Israel, 6423906 Contact: Study Coordinator    +97236973082       Korea, Republic of Seoul National University Hospital ( Site 2803) Recruiting Seoul, Korea, Republic of, 03080 Contact: Study Coordinator    +82220720701       Severance Hospital Yonsei University Health System ( Site 2800) Recruiting Seoul, Korea, Republic of, 03722 Contact: Study Coordinator    +82222288132       Asan Medical Center ( Site 2802) Recruiting Seoul, Korea, Republic of, 05505 Contact: Study Coordinator    +82230103230       Samsung Medical Center ( Site 2801) Recruiting Seoul, Korea, Republic of, 06351 Contact: Study Coordinator    +82234101779       Switzerland Luzern Kantonsspital ( Site 1904) Recruiting Luzern, Switzerland, 6000 Contact: Study Coordinator    +41412055875       Taiwan National Cheng Kung University Hospital ( Site 2901) Recruiting Tainan, Taiwan, 704 Contact: Study Coordinator    +886623535354559 Less <<
NCT00003087 Esophageal Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01926236 Biliary Tract Cancer ... More >> Gallbladder Cancer Cholangiocarcinoma Ampullary Cancer Less << Phase 3 Active, not recruiting February 2019 United Kingdom ... More >> Queen Elizabeth Hospital Birmingham, United Kingdom Bristol Haematology & Oncology Centre Bristol, United Kingdom North Cumbria University Hospitals Carlisle, United Kingdom Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN Castle Hill Hospital Hull, United Kingdom St James' Hospital Leeds, United Kingdom Clatterbridge Cancer Centre Liverpool, United Kingdom Guy's and St Thomas' Hospital London, United Kingdom Hammersmith Hospital London, United Kingdom Royal Free Hospital London, United Kingdom University College London London, United Kingdom Maidstone Hospital Maidstone, United Kingdom The Christie NHS Foundation Trust Manchester, United Kingdom Nottingham City Hospital Nottingham, United Kingdom Churchill Hospital Oxford, United Kingdom Weston Park Hospital Sheffield, United Kingdom Southampton General Hospital Southampton, United Kingdom Less <<
NCT02412670 Localized Urothelial Carcinoma... More >> of the Renal Pelvis and Ureter Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter Regional Urothelial Carcinoma of the Renal Pelvis and Ureter Less << Phase 2 Active, not recruiting - -
NCT02951767 - Active, not recruiting - -
NCT02951767 Bladder Cancer Phase 2 Active, not recruiting May 18, 2019 -
NCT03690921 Anal Canal Squamous Cell Carci... More >>noma Less << Phase 2 Recruiting May 23, 2022 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Emma B. Holliday    713-563-2300       Principal Investigator: Emma B. Holliday Less <<
NCT03472560 Non-Small Cell Lung Cancer ... More >> Urothelial Cancer Less << Phase 2 Recruiting September 18, 2020 United States, Arizona ... More >> Arizona Oncology Associates- Saguaro Cancer Center Recruiting Glendale, Arizona, United States, 85308 Arizona Oncology Associates- Biltmore Cancer Center Recruiting Phoenix, Arizona, United States, 85016 Arizona Oncology Associates- Deer Valley Cancer Center Recruiting Phoenix, Arizona, United States, 85027 Arizona Oncology Associates- East Valley Cancer Center Recruiting Tempe, Arizona, United States, 85284 United States, Michigan Karmanos Cancer Institute Not yet recruiting Detroit, Michigan, United States, 48201 Karmanos Cancer Institute Not yet recruiting Farmington Hills, Michigan, United States, 48334 United States, Missouri Oncology Hematology Associates Recruiting Springfield, Missouri, United States, 65807 United States, Nebraska Oncology Hematology West, PC dba Nebraska Cancer Specialists Recruiting Omaha, Nebraska, United States, 68114 Oncology Hematology West, PC dba Nebraska Cancer Specialists Recruiting Omaha, Nebraska, United States, 68130 United States, Ohio Toledo Clinic Cancer Center- Toledo Not yet recruiting Toledo, Ohio, United States, 43623 United States, South Carolina Saint Francis Hospital Recruiting Greenville, South Carolina, United States, 29601 Saint Francis Hospital Cancer Center Recruiting Greenville, South Carolina, United States, 29607 Hungary Orszagos Onkologiai Intezet Not yet recruiting Budapest, Hungary, H-1122 Pecsi Tudomanyegyetem Klinikai Kozpont Not yet recruiting Pecs, Hungary, H-7624 Tudogyogyintezet Torokbalint Recruiting Torokbalint, Hungary, H-2045 Korea, Republic of National Cancer Center Recruiting Goyang-si, Gyeonggi-do, Korea, Republic of, 10408 Samsung Medical Center Recruiting Gangnam-gu, Seoul, Korea, Republic of, 06351 Asan Medical Center Not yet recruiting Songpa-gu, Seoul, Korea, Republic of, 05505 Severance Hospital, Yonsei University Health System Recruiting Seoul, Korea, Republic of, 03722 Taiwan Chi Mei Hospital, Liouying Recruiting Tainan City, Liouying District, Taiwan, 73657 National Cheng Kung University Hospital Not yet recruiting Tainan, Taiwan, 704 Less <<
NCT03105596 B-cell Non-Hodgkin's Lymphoma Phase 2 Not yet recruiting September 30, 2019 -
NCT00090207 Nausea Vomiti... More >>ng Less << Phase 4 Completed - -
NCT01914900 Locally Advanced Resectable Or... More >>al Cavity Squamous Cell Cancer Less << Phase 2 Unknown March 2015 Italy ... More >> Istituto Nazionale Tumori Recruiting Milano, Italy, 20133 Contact: Paolo Bossi, MD    +390223902765    paolo.bossi@istitutotumori.mi.it    Principal Investigator: Lisa Licitra, MD Less <<
NCT00700440 Nasopharyngeal Carcinoma Phase 2 Completed - China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT02279576 Penile Squamous Cell Carcinoma... More >> Stage IV Less << Phase 2 Terminated(The low recruitment... More >> of patients will not allow to complete the study with the required number of patients within reasonable time.) Less << - Spain ... More >> Institut Català D'Oncologia L'Hospitalet Hospitalet de Llobregat, Barcelona, Spain, 08908 Complejo Hospitalario de Navarra Pamplona, Navarra, Spain, 31008 Hospital de La Santa Creu I Sant Pau Barcelona, Spain, 08025 Complejo Hospitalario Regional Reina Sofía Córdoba, Spain, 14004 Hospital Universitario Lucus Augusti Lugo, Spain, 27003 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital General Universitario J.M. Morales Meseguer Murcia, Spain, 30008 Instituto Valenciano de Oncología Valencia, Spain, 46009 Less <<
NCT01714037 Non-small Cell Lung Cancer Phase 1 Terminated - France ... More >> Centre GF Leclerc Dijon, France Centre Léon Bérard Lyon, France Institut de Cancérologie de l'Ouest- Institut René Gauduchau Nantes, France Institut Claudius Regaud Toulouse, France Spain Hospital Universitari Vall d'Hebron Barcelona, Spain Hospital Puerta de Hierro Majadahonda Madrid, Spain Hospital Universitario Virgen del Rocío Seville, Spain United Kingdom Freeman Hospital Newcastle, United Kingdom Less <<
NCT03036098 Urothelial Cancer Phase 3 Recruiting December 23, 2022 -
NCT00700440 - Completed - -
NCT02516813 Advanced Solid Tumors Phase 1 Recruiting January 8, 2021 United States, California ... More >> Research site Recruiting Fresno, California, United States, 93720 United States, Florida Research site Recruiting Fort Lauderdale, Florida, United States, 33308 Research site Recruiting Miami, Florida, United States, 33136-1002 United States, Montana Research site Recruiting Billings, Montana, United States, 59101 United States, New York Research site Recruiting Bronx, New York, United States, 10461 United States, Pennsylvania Research site Recruiting Philadelphia, Pennsylvania, United States, 19107 United States, Texas Research site Not yet recruiting Houston, Texas, United States, 77030 United States, Washington Research site Completed Tacoma, Washington, United States, 98405 Belgium Research site Active, not recruiting Leuven, Belgium Denmark Research site Recruiting Copenhagen, Denmark, 2100 Research site Recruiting Herlev, Denmark Germany Research site Active, not recruiting Freiburg, Baden Wuerttemberg, Germany, 79106 Research site Recruiting Heidelberg, Baden Wuerttemberg, Germany Research site Recruiting Mannheim, Baden Wuerttemberg, Germany Research site Recruiting Tuebingen, Baden Wuerttemberg, Germany, 72076 Research site Recruiting Mainz, Rhineland-Palatinate, Germany, 55131 Research site Recruiting Dresden, Sachsen, Germany, 1307 Research site Recruiting Kiel, Schleswig-Holstein, Germany, 24105 Research site Recruiting Berlin, Germany, 12200 Netherlands Research site Recruiting Amsterdam, Netherlands, 1066 CX Research site 1 Active, not recruiting Amsterdam, Netherlands Norway Research site Active, not recruiting Oslo, Norway Sweden Research site Recruiting Solna, Sweden, 17176 Less <<
NCT00993616 - Completed - -
NCT02607631 Thymic Epithelial Tumors Phase 2 Unknown August 2018 -
NCT03390595 Metastatic Urothelial Cancer Phase 2 Recruiting April 2020 Spain ... More >> Hospital General Universitario de Elche Recruiting Elche, Alicante, Spain, 03203 Contact: Federico José Vázquez, MD, PhD    +34 966 616 250    fvazquezmd@gmail.com    Principal Investigator: Federico José Vázquez, MD, PhD          Instituto Catalán de Oncología (ICO L'Hospitalet) - H. Durán i Reynals Recruiting L'Hospitalet De Llobregat, Barcelona, Spain, 08907 Contact: Xavier García del Muro, MD, PhD    +34 932 607 332    garciadelmuro@iconcologia.net    Principal Investigator: Xavier García del Muro, MD, PhD          Fundación Althaia - Xarxa Assistencial Univ. de Manresa Recruiting Manresa, Barcelona, Spain, 08243 Contact: Montserrat Domènech, MD, PhD    +34 938 75 93 00    mdomenech@althaia.cat    Principal Investigator: Montserrat Domènech, MD, PhD          Hospital Universitario Parc Tauli Recruiting Sabadell, Barcelona, Spain, 08208 Contact: Teresa Bonfill, MD, PhD    +34 935 537 134    tbonfill@tauli.cat    Principal Investigator: Teresa Bonfill, MD, PhD          Sub-Investigator: Enrique Gallardo, MD, PhD          Clínica Universidad de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: José Luís Pérez, MD, PhD    +34 948 25 54 00    jlgracia@unav.es    Principal Investigator: José Luís Pérez, MD, PhD          Hospital del Mar Recruiting Barcelona, Spain, 08003 Contact: Alejo Rodríguez-Vida, MD, PhD    +34 932 483 139    arodriguezvida@hospitaldelmar.cat    Principal Investigator: Alejo Rodríguez-Vida, MD, PhD          Hospital de la Santa Creu i Sant Pau Recruiting Barcelona, Spain, 08025 Contact: José Pablo Maroto, MD, PhD    +34 935 537 134    JMaroto@santpau.cat    Principal Investigator: José Pablo Maroto, MD, PhD          Hospital Universitario Vall d'Hebron Recruiting Barcelona, Spain, 08035 Contact: Rafael Morales, MD, PhD    +34 934 89 30 00    rmorales@vhio.net    Sub-Investigator: Joan Carles Galceran, MD, PhD          Hospital Clìnic de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Begoña Mellado, MD, PhD    +34 93 227 54 02    BMELLADO@clinic.cat    Principal Investigator: Begoña Mellado, MD, PhD          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28026 Contact: Daniel Castellano, MD,PhD    +34 913 90 80 00    cdanicas@hotmail.com    Principal Investigator: Daniel Castellano, MD, PhD          Hospital Clínico San Carlos Recruiting Madrid, Spain, 28040 Contact: Javier Puente, MD, PhD    +34 913 30 30 01    jpuente.hcsc@salud.madrid.org    Principal Investigator: Javier Puente, MD, PhD          Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Contact: Álvaro Pinto, MD, PhD    +34 91 727 75 16    alvaropintomarin@gmail.com    Principal Investigator: Álvaro Pinto, MD, PhD          Hospital General Universitario Morales Meseguer Recruiting Murcia, Spain, 30008 Contact: Enrique González, MD, PhD    +34 968 360 900 ext 3807    enrique.gonzalezbilla@gmail.com    Principal Investigator: Enrique González, MD, PhD          Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain, 41013 Contact: Begoña Pérez, MD, PhD    +34 955 01 30 68    bperezv@gmail.com    Principal Investigator: Begoña Pérez, MD, PhD          Fundación Instituto Valenciano de Oncología Recruiting Valencia, Spain, 46009 Contact: Miguel Ángel Climent, MD, PhD    +34 961 11 40 00    macliment@fivo.org    Principal Investigator: Miguel Ángel Climent, MD, PhD Less <<
NCT01584284 Cancer of Head and Neck Phase 1 Completed - United States, California ... More >> Moores UC San Diego Cancer Center La Jolla, California, United States, 92037 Less <<
NCT00040534 Neoplasms Phase 1 Terminated - -
NCT00993616 Brenner Tumor ... More >> Fallopian Tube Cancer Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mixed Epithelial Carcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma Ovarian Undifferentiated Adenocarcinoma Primary Peritoneal Cavity Cancer Recurrent Ovarian Epithelial Cancer Less << Phase 2 Completed - -
NCT00606021 Non Small Cell Lung Cancer Phase 2 Completed - Egypt ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Assiut, Egypt, 0000 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt, 11372 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mounofia, Egypt, 32514 Lebanon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beirut, Lebanon Saudi Arabia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Riyadh, Saudi Arabia, 11211 Less <<
NCT03322267 Esophageal Squamous Cell Carci... More >>noma Less << Phase 2 Recruiting January 2025 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei City, Taiwan, 10002 Contact: Chih-Hung Hsu, MD, PhD    +886-2-23123456 ext 67680    chihhunghsu@ntu.edu.tw Less <<
NCT02215265 Human Papillomavirus (HPV)-Pos... More >>itive Oropharyngeal Cancer Less << Phase 2 Phase 3 Recruiting February 2024 United Kingdom ... More >> Poole Hospital NHS Foundation Trust Recruiting Poole, Dorset, United Kingdom, BH15 2JB Contact: Emma King, Dr       emmabarker@doctors.org.uk    Royal United Hospitals Bath NHS Foundation Trust Recruiting Bath, United Kingdom, BA1 3NH Contact: Emma De Winton, Dr       emma.dewinton@nhs.net    Queen Elizabeth Hospital Not yet recruiting Birmingham, United Kingdom, B15 2TH Contact: Andrew Hartley, Dr          University Hospitals Bristol NHS Foundation Trust Recruiting Bristol, United Kingdom, BS2 8ED Contact: Matthew Beasley, Dr       Matthew.Beasley@UHBristol.nhs.uk    Cambridge University Hospitals NHS Foundation Trust Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Irune Ekpemi, Dr       ekpemi.irune@addenbrookes.nhs.uk    Velindre Cancer Centre Not yet recruiting Cardiff, United Kingdom, CF14 2TL Contact: Waheeda Owadally, Dr       Waheeda.Owadally@wales.nhs.uk    HPV Research Group Section of Pathology Cardiff University ,School of Medicine Not yet recruiting Cardiff, United Kingdom, CF14 4XN Contact: Ned Powell, Dr       PowellNG@cardiff.ac.uk    Cardiff and Vale University Local Health Board Recruiting Cardiff, United Kingdom, CF14 4XW Contact: David Owens, Dr       david.owens2@wales.nhs.uk    Wales Cancer Trials Unit Not yet recruiting Cardiff, United Kingdom, CF14 4YS Contact: Chris Hurt    02920687471    HurtCN@cf.ac.uk    Velindre NHS Trust Not yet recruiting Cardiff, United Kingdom, CF142TL Contact: Nachi Palaniappan, Dr       Nachi.Palaniappan@wales.nhs.uk    Castle Hill Hospital Recruiting Cottingham, United Kingdom, HU16 5JQ Contact: Lorcan O'Toole, Dr       lorcan.otoole@hey.nhs.uk    Derby Teaching Hospitals NHS Foundation Trust Recruiting Derby, United Kingdom, DE22 3DT Contact: Sean Mortimore, Dr       sean.mortimore@nhs.net    Aintree University Hospitals NHS Foundation Trust Recruiting Liverpool, United Kingdom, L3 9TA Contact: Terry Jones, Professor       T.M.Jones@liverpool.ac.uk    Cwm Taf University Health Board Recruiting Llantrisant, United Kingdom, CF72 8XR Contact: Sandeep Berry, Dr       sandeep.berry2@wales.nhs.uk    Barts Health NHS Trust Not yet recruiting London, United Kingdom, E1 1RD Contact: Paul Stimpson, Dr       paul.stimpson2@bartshealth.nhs.uk    Central Manchester University Hospital NHS Foundation Trust Not yet recruiting Manchester, United Kingdom, M13 9WL Contact: Jarrod Homer, Professor       jarrod.j.homer@manchester.ac.uk    The Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom, M20 4BX Contact: David Thomson, Dr       david.thomson@christie.nhs.uk    The James Cook University Hospital Recruiting Middlesbrough, United Kingdom, TS4 3BW Contact: Shane Lester, Mr       shanelester@nhs.net    Newcastle upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle upon Tyne, United Kingdom, NE7 7DN Contact: Rebecca Goranova, Dr       Rebecca.goronova@nuth.nhs.uk    Institute of Health and Society Not yet recruiting Newcastle, United Kingdom, NE2 4AX Contact: Jo Patterson, Dr       joanne.patterson@newcastle.ac.uk    Centre for Oral Health Research Newcastle University Not yet recruiting Newcastle, United Kingdom, NE24BW Contact: Conrad Robinson, Dr       max.robinson@newcastle.ac.uk    Oxford University Hospitals NHS Foundation Trust Recruiting Oxford, United Kingdom, OX3 7LD Contact: Stuart Winter, Dr       stuart.winter@ouh.nhs.uk    Queen Alexandra Hospital Recruiting Portsmouth, United Kingdom, PO6 3LY Contact: Costa Repanos, Mr       costa.repanos@porthosp.nhs.uk    Royal Berkshire Hospital Not yet recruiting Reading, United Kingdom, RG1 5AN Contact: Alice Freebairn, Dr       alice.freebairn@royalberkshire.nhs.uk    Sunderland Royal Hospital Recruiting Sunderland, United Kingdom, SR4 7TP Contact: Helen Cocks, Dr       helen.cocks@chsft.nhs.uk    Abertawe Bro Morgannwg University Health Board Recruiting Swansea, United Kingdom, SA2 8QA Contact: Conor Marnane, Dr       conor.marnane@wales.nhs.uk Less <<
NCT00070096 Brain and Central Nervous Syst... More >>em Tumors Extragonadal Germ Cell Tumor Ovarian Cancer Testicular Germ Cell Tumor Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00859495 Pleural Mesothelioma Phase 2 Unknown December 2014 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Less <<
NCT02773485 Cholangiocarcinoma Phase 3 Recruiting June 2022 India ... More >> Advanced Centre of Treatment Research and Education In Cancer,Tata Memorial Centre Recruiting Navi Mumbai, Maharashtra, India, 410210 Contact: Dr Supriya Chopra, MD    91-22-27405000 ext 5491    schopra@actrec.gov.in    Principal Investigator: Supriya Chopra, MD Less <<
NCT03692780 Chemotherapy-Induced Myelosupp... More >>ression Less << Phase 1 Phase 2 Not yet recruiting June 2021 -
NCT00630240 - Completed - Taiwan ... More >> Division of Hepatobiliary Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, No. 100 Tzyou 1st Road Kaohsiung, Taiwan, 807 Less <<
NCT01565109 Gastric Adenocarcinoma Phase 2 Unknown March 2018 France ... More >> Institut Sainte Catherine Recruiting Avignon, France, 84000 Contact: LAURENT MINEUR, DOCTOR    04.90.27.62.68    l.mineur@isc84.org Less <<
NCT03737968 Stage II-IVB Operable HNSCC Or... More >>al Cavity Hypopharynx Oropharynx Larynx Less << Phase 2 Not yet recruiting December 2022 -
NCT00606021 - Completed - -
NCT01899989 Non-small Cell Lung Cancer Phase 1 Recruiting July 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Andreas Rimner, MD    212-639-6025       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Andreas Rimner, MD    212-639-6025       Contact: Jamie Chaft, MD    646-888-4545       Principal Investigator: Andreas Rimner, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Andreas Rimner, MD    212-639-6025       Contact: Jamie Chaft, MD    646-888-4545       Principal Investigator: Andreas Rimner, MD Less <<
NCT01203735 Locally Advanced Inoperable No... More >>n-small-lung Cancer Less << Phase 1 Phase 2 Unknown February 2015 Israel ... More >> Soroka University Medical Center Recruiting Beer Sheva, Israel, 84101 Contact: Konstantin Lavrenkov, MD, PhD    +97286400537    constant@bgu.ac.il    Contact: Julia Dudnik, MD    +97286400537    juliad@clalit.org.il    Sub-Investigator: Vladimir Gavrilov, MD, PhD          Sub-Investigator: Julia Dudnik, MD          Sub-Investigator: Kerenr Rouvinov, MD Less <<
NCT02890030 - Active, not recruiting December 2018 United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT02662504 Malignant Pleural Mesothelioma Phase 2 Completed - France ... More >> CHRU de Lille Hôpital Calmette Lille, France Less <<
NCT00004873 Gastric Cancer Phase 2 Completed - Switzerland ... More >> Hopital Cantonal Universitaire de Geneva Geneva, Switzerland, CH-1211 Less <<
NCT02739204 Oral Squamous Cell Carcinoma Phase 2 Unknown December 2017 Taiwan ... More >> Department of Otolaryngology Recruiting Taichung, Taiwan, 40447 Contact: Ming-Hsul Tsai, M.D. Ph.D.    886-4-22052121 ext 4436    minghsui@mail.cmuh.org.tw    Principal Investigator: Chun-Hung Hua, M.D. Less <<
NCT02344979 - Unknown June 2015 China, Shanghai ... More >> Shanghai Chest Hospital Shanghai, Shanghai, China, 200030 Less <<
NCT00002882 Melanoma Skin... More >> Cancer Less << Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT03734809 NPC Phase 2 Not yet recruiting December 31, 2023 Hong Kong ... More >> Department of Clinical Oncology, Prince of Wales Hospital Not yet recruiting Hong Kong, Hong Kong Contact: Anthony TC Chan, MD    3505 2119    anthonytcchan@cuhk.edu.hk    Contact: Candy Yuen, RN    3505 1040    sf_yuen@clo.cuhk.edu.hk    Singapore National Cancer Centre of Singapore Not yet recruiting Singapore, Singapore Contact: Darren WT Lim, MD       darren.lim.w.t@singhealth.com.sg    Contact: Yoke Lim YL Soong, MD       Soong.yoke.lim@Singhealth.com.sg Less <<
NCT02124148 Neoplasm Metastasis ... More >> Colorectal Neoplasms Breast Cancer Less << Phase 1 Recruiting February 27, 2020 United States, Florida ... More >> Florida Cancer Specialists Recruiting Sarasota, Florida, United States, 34232 Contact    9413779993       Principal Investigator: Manish Rajni Patel          United States, Oklahoma University of Oklahoma Health Sciences Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact    405-271-4022       Principal Investigator: Kathleen Moore          United States, Tennessee Sarah Cannon Research Institute SCRI Recruiting Nashville, Tennessee, United States, 37203 Contact    615-329-7615       Principal Investigator: SMO Sarah Cannon Research Inst.          Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact    6153297274       Principal Investigator: Johanna Chock Bendell          United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact    713-563-5844       Principal Investigator: David S Hong Less <<
NCT03524508 Metastatic Biliary Tract Cance... More >>r Less << Phase 2 Recruiting March 2021 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 05505 Contact: Changhoon Yoo, MD          Principal Investigator: Changhoon Yoo, MD Less <<
NCT01303978 Chemotherapy-induced Nausea an... More >>d Vomiting Less << Phase 2 Completed - Denmark ... More >> Herlev Hospital Copenhagen, Denmark Rigshospitalet Copenhagen, Denmark Odense University Hospital Odense, Denmark United Kingdom University Hospital of South Manchester NHS Trust Manchester, United Kingdom Less <<
NCT02633800 Head and Neck Neoplasms Phase 2 Completed - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 Univeristair Ziekenhuis Antwerpen Edegem, Belgium, 2650 UZ Leuven Leuven, Belgium, 3000 France Institut Curie Paris, Cedex, France, 75248 Institut de Cancerologie de l'Ouest Angers cedex 02, France, 49055 Centre Hospitalier de Bordeaux - Hôpital Saint André Bordeaux, France, 33075 Hopital Croix-Rousse Lyon, France, 69004 Centre Leon Berard Lyon, France, 69373 CHU Hopital de la Timone Marseille, France, 13005 Hopital Saint Joseph Marseille, France, 13008 Centre de Cancerologie du Grand Montpellier Montpellier, France, 34070 Institut de Cancerologie de l'Ouest Saint-Herblain Cedex, France, 44805 Gustave Roussy Villejuif, France, 94805 Germany Charite Universitatsmedizin Berlin Berlin, Germany, 12200/12203 Medizinische Hochschule Hannover Hannover, Germany, 30625 Klinikum der Universitat Munchen München, Germany, 81377 Hungary Orszagos Onkologiai Intezet Budapest, Hungary, 1122 Debreceni Egyetem Orvos-es Egeszsegtudomanyi Centrum Debrecen, Hungary, 4032 Bacs-Kiskun Megyei Korhaz Kecskemet, Hungary, 6000 Borsod Abauj Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz Miskolc, Hungary, 3526 Josa Andras Oktatokorhaz Nyíregyháza, Hungary, 4400 Poland Centrum Onkologii im. Prof. Franciszka Lukaszczyka w Bydgoszczy Bydgoszcz, Poland, 85-796 Przychodnia Lekarska "KOMED" Konin, Poland, 62-500 Regionalny Osrodek Onkologiczny Szpital im. M. Kopernika w Lodzi Lodz, Poland, 93-513 Romania Medisprof SRL Cluj-Napoca, Romania, 400058 Centrul de Oncologie Sfantul Nectarie Craiova, Romania, 200347 Institutul Regional de Oncologie Iasi Iasi, Romania, 700483 United Kingdom University College London Hospitals NHS Foundation Trust - University College Hospital London, United Kingdom, NW1 2PG Guy's and St Thomas' NHS Foundation Trust - St Thomas' Hospital London, United Kingdom, SE1 7EH The Royal Marsden NHS Foundation Trust London, United Kingdom, SW3 6JJ Weston Park Hospital Sheffield, United Kingdom, S10 2SJ The Shrewsbury and Telford Hospital NHS Trust Shrewsbury, United Kingdom, SY3 8XQ Southampton General Hospital Southampton, United Kingdom, SO16 6YD The Royal Marsden NHS Foundation Trust Sutton, United Kingdom, SM2 5PT Less <<
NCT02933099 Chemotherapy-induced Nausea an... More >>d Vomiting Less << Phase 3 Unknown December 2018 -
NCT00052962 Gastrointestinal Neoplasm Phase 3 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00052962 - Completed - -
NCT02728492 Non-small Cell Lung Cancer ... More >> Epithelial Ovarian Cancer Less << Phase 1 Completed - Russian Federation ... More >> Russian Oncological Research Center n.a. N. N. Blokhin RAMS Moscow, Russian Federation, 115478 State Budgetary Healthcare Institution of Stavropol Territory "Pyatigorsk oncology dispensary" Pyatigorsk, Russian Federation, 357502 Saint-Peterburg State Budgetary healthcare Institution "City Clinical Oncology Dispensary" Saint-Petersburg, Russian Federation, 197022 BioEq LLC Saint-Petersburg, Russian Federation, 197342 State Budget Institution of healthcare "Saint-Petersburg clinical research and practical centre of specialized medical aid (oncology)" Saint-Petersburg, Russian Federation, 197758 State Healthcare Institution of Yaroslavl region "Regional Clinical oncology hospital" Yaroslavl, Russian Federation, 150054 Less <<
NCT00020709 Adenocarcinoma of the Lung ... More >> Bronchoalveolar Cell Lung Cancer Large Cell Lung Cancer Squamous Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Less << Phase 3 Completed - United States, Texas ... More >> Southwest Oncology Group (SWOG) Research Base San Antonio, Texas, United States, 78245 Less <<
NCT03321188 Ovarian Cancer ... More >> Epithelial Ovarian Cancer Fallopian Tube Cancer Less << Phase 2 Recruiting December 15, 2020 United States, Kansas ... More >> The University of Kansas Cancer Center Recruiting Kansas City, Kansas, United States, 66160-7357 Contact: Kerry Hepler    913-945-7552    ctnursenav@kumc.edu Less <<
NCT00002536 Cervical Cancer Phase 3 Completed - -
NCT00945451 Lung Cancer Not Applicable Recruiting December 2021 France ... More >> Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Pierre-Yves Bondiau, MD, PhD    33-4-9203-1261 Less <<
NCT00301301 - Completed - United Kingdom ... More >> Royal Marsden NHS trust Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT00411138 Endometrial Cancer Phase 3 Active, not recruiting December 2020 Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2300 RC Less <<
NCT00113581 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 1 Completed - United Kingdom ... More >> The Royal Marsden Hospital London, United Kingdom Less <<
NCT03464968 Biliary Cancer Metastatic Phase 2 Recruiting December 25, 2020 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam, Gyeonggi, Korea, Republic of, 13620 Contact: Jin Won Kim, MD, PhD    82-31-787-8209    jwkim@snubh.org Less <<
NCT03062800 Advanced Nsclc Phase 2 Recruiting October 2018 China, Shandong ... More >> Qilu hospital of Shandong University Recruiting Jinan Shi, Shandong, China, 250012 Contact: Shuguang Li, MD.    +86 18560082862    lishuguang96@163.com    Principal Investigator: Xiuwen Wang, MD. Less <<
NCT01558947 Gastric Cancer Phase 2 Unknown June 2013 China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: xiangdong Cheng, MD    +86 571 88122516    abdsurg@hotmail.com    Principal Investigator: xiangdong Cheng, MD Less <<
NCT00002601 Sarcoma Phase 2 Completed - United States, California ... More >> Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States, 91010-3000 Less <<
NCT00006111 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 2 Unknown - France ... More >> Institut Sainte Catherine Avignon, France, 84082 Centre Oscar Lambret Lille, France, 59020 Centre Leon Berard Lyon, France, 69373 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Antoine Lacassagne Nice, France, 06189 C.H.U. - Hopital Gaston Doumergue Nimes, France, 30006 Centre Eugene Marquis Rennes, France, 35064 Centre Rene Huguenin Saint Cloud, France, 92211 Centre Hospitalier General de Saint Nazaire Saint Nazaire, France, 44600 Institut Claudius Regaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Less <<
NCT00002601 - Completed - -
NCT01160185 - Completed - -
NCT00014209 Lymphoma Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, New Brunswick Moncton Hospital Moncton, New Brunswick, Canada, E1C 6ZB Canada, Newfoundland and Labrador Newfoundland Cancer Treatment and Research Foundation St. Johns, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Ontario Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Kingston Regional Cancer Centre Kingston, Ontario, Canada, K7L 5P9 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Credit Valley Hospital Mississauga, Ontario, Canada, L5M 2N1 Northwestern Ontario Regional Cancer Centre, Thunder Bay Thunder Bay, Ontario, Canada, P7A 7T1 Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Humber River Regional Hospital Weston, Ontario, Canada, M9N 1N8 Cancer Care Ontario - Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Less <<
NCT01688700 Esophageal Squamous Cell Carci... More >>noma Resectable Less << Phase 2 Unknown September 2017 China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Yun Fan, doctor    0086-571-88122192    fanyun@csco.org.cn    Principal Investigator: Weimin Mao, doctor Less <<
NCT01730222 Pancreatic Cancer Phase 1 Phase 2 Completed - Italy ... More >> IRCCS S Raffaele Milan, Italy, 20132 Less <<
NCT00003118 Esophageal Cancer Phase 3 Completed - -
NCT01379339 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 1 Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT02158988 Malignant Neoplasm of Stomach ... More >> Secondary Malignant Neoplasm of Peritoneum Secondary Malignant Neoplasm of Other and Unspecified Sites Less << Phase 3 Recruiting September 2020 Germany ... More >> Klinik für Allgemein-, Visceral-, Gefäß- und ThoraxchirurgieCharité Campus Mitte Recruiting Berlin, Germany, 10117 Contact: Beate Rau    +49 (0)30 450 622 ext 214    beate.rau@charite.de Less <<
NCT00524498 Hepatocellular Carcinoma Phase 2 Completed - Japan ... More >> Chubu region, Japan Chugoku region, Japan Hokkaido region, Japan Kanto region, Japan Kinki region, Japan Kyushu region, Japan Tohoku region, Japan Less <<
NCT01125020 Liver Transplantation ... More >> Hepatocellular Carcinoma Tumor Recurrence and Metastasis Survival Adjuvant Chemotherapy Less << Not Applicable Unknown December 2010 China, Shanghai ... More >> Shanghai First People's Hospital Recruiting Shanghai, Shanghai, China, 200080 Contact: Zhi-Hai Peng, MD    0086-021-63240090 ext 3132    pengpzh@hotmail.com    Principal Investigator: Jun-Wei Fan, MD Less <<
NCT01631357 Lung Cancer Phase 2 Phase 3 Unknown December 2016 China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Active, not recruiting Tianjin, Tianjin, China, 300060 Less <<
NCT00525200 Esophageal Cancer Phase 3 Completed - Austria ... More >> Landesklinikum St. Pölten St. Polten, Lower Austria, Austria, 3100 Landesklinikum Wiener Neustadt Wiener Neustadt, Lower Austria, Austria, 2700 Medical University Innsbruck Innsbruck, Tirol, Austria Landesklinikum Feldkirch Feldkirch, Vorarlberg, Austria Landeskrankenhaus Leoben Leoben, Austria, 8790 Krankenhaus der Elisabethinen Linz, Austria, 4020 Krankenhaus der Barmherzigen Brüder Stankt Veit, Austria, 9300 Rudolfstiftung Vienna, Austria, 1030 Medical University of Vienna Vienna, Austria, 1090 Kaiser Franz Josef Spital Vienna, Austria, 1100 Hanusch Krankenhaus Vienna, Austria, 1140 SMZ OST Vienna, Austria Wilhelminenspital Vienna, Austria Less <<
NCT02957266 Cervical Cancer Phase 3 Recruiting December 2020 Azerbaijan ... More >> National Center of Oncology Recruiting Baku, Azerbaijan, AZ1011 Contact: Aziz Aliyev, Professor    +994504807021    internationalnoc@gmail.com Less <<
NCT00474669 Ovarian Carcinoma Phase 1 Completed - United States, Kentucky ... More >> James Graham Brown Cancer Center Louisville, Kentucky, United States, 40202 Less <<
NCT01450761 - Completed - -
NCT02250404 - Withdrawn(PI left institution) August 22, 2019 United States, California ... More >> Los Angeles County-USC Medical Center Los Angeles, California, United States, 90033 USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01450761 Small Cell Lung Carcinoma Phase 3 Completed - -
NCT00310128 AIDS-related Lymphoma ... More >> Adult Non-Hodgkin's Lymphoma Anaplastic Large Cell Lymphoma Less << Phase 2 Withdrawn(Drug supply unavaila... More >>ble) Less << - -
NCT00193921 Non Small Cell Lung Carcinoma Phase 2 Completed - Australia, New South Wales ... More >> Calvary Mater Newcastle Newcastle, New South Wales, Australia, 2298 Australia, Queensland Mater Misericordiae Hospital Brisbane, Queensland, Australia, 4101 Princess Alexandra Hospital Brisbane, Queensland, Australia, 4102 North Queensland Oncology Service Townsville, Queensland, Australia, 4810 The John Flynn Hospital Tugun, Queensland, Australia, 4224 Australia, Victoria Frankston Hospital Frankston, Victoria, Australia Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 8006 Border Medical Oncology Wondonga, Victoria, Australia Less <<
NCT00550784 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 1 Completed - -
NCT00301028 - Completed - -
NCT00778908 Nasopharyngeal Carcinoma Phase 2 Phase 3 Completed - China, Guangxi ... More >> People's Hospital of Guangxi Zhuang Autonomous Region Nanning, Guangxi, China, 530021 Less <<
NCT02603003 Non-small Cell Lung Cancer(NSC... More >>LC) Less << Phase 1 Active, not recruiting December 2019 -
NCT02760667 Head and Neck Cancer Phase 2 Active, not recruiting June 2020 United States, District of Col... More >>umbia George Washington University-Medical Faculty Associates Washington, District of Columbia, United States, 20037 Less <<
NCT00817583 Nasopharyngeal Carcinoma Phase 2 Unknown July 2011 China, Shanghai ... More >> Department of Radiation Oncology, Cancer Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Xiaoshen Wang, M.D.    86-21-64175590 ext 6516    wangxiaoshen@gmail.com    Contact: TingTing Xu, M.D.    86-21-64175590 ext 6511    littlepuppyxtt@gmail.com Less <<
NCT00301028 Head and Neck Cancer Phase 2 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT00930891 Small Cell Lung Cancer Phase 2 Phase 3 Completed - -
NCT02784171 Mesothelioma Phase 2 Recruiting December 2019 Canada, Alberta ... More >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Desiree Hao    403 521-3706       Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Quincy Chu    780 432-8248       Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Recruiting Kelowna, British Columbia, Canada, V1Y 5L3 Contact: Delia Sauciuc    250 712-3900 ext 683930       BCCA - Fraser Valley Cancer Centre Recruiting Surrey, British Columbia, Canada, V3V 1Z2 Contact: Christopher Lee    604 930-4017       Canada, Manitoba CancerCare Manitoba Recruiting Winnipeg, Manitoba, Canada, R3E 0V9 Contact: David Dawe    204 787-8644       Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: John Goffin    905 387-9495       London Regional Cancer Program Recruiting London, Ontario, Canada, N6A 5W9 Contact: Mark D. Vincent    519 685-8640       Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Paul Wheatley-Price    613 737-7700 ext 79859       University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Penelope A. Bradbury    416 946-4501 ext 3544       Canada, Quebec CHUM-Centre Hospitalier de l'Universite de Montreal Recruiting Montreal, Quebec, Canada, H2X 3E4 Contact: Marie Florescu    514 890-8444       The Research Institute of the McGill University Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Scott Owen    514 398-8307       University Institute of Cardiology and Recruiting Quebec City, Quebec, Canada, G1V 4G5 Contact: Catherine Labbe    418 656-8711 ext 5504       Canada, Saskatchewan Allan Blair Cancer Centre Recruiting Regina, Saskatchewan, Canada, S4T 7T1 Contact: Mussawar Iqbal    306 766-2691       Italy Oncologia SS Antonio e Biagio Alessandria Recruiting Alessandria, AL, Italy, 15121 Contact: Federica Grosso          Azienda Ospedaliera San Giuseppe Moscati Recruiting Avellino, AV, Italy, 83100 Contact: Gridelli Cesare          Oncologia Medica Humanitas Gavazzeni Bergamo Not yet recruiting Bergamo, BG, Italy, 24125 Contact: Giovanni Luca Ceresoli          Azienda Ospedaliera Garibaldi Nesima Recruiting Catania, CT, Italy, 95123 Contact: Roberto Bordonaro          Oncologia Medica IRCCS Arcispedale Maria Recruiting Reggio Emilia, RE, Italy, 42123 Contact: Maria Pagano          Istituti Fisioterapici Ospitalieri IFO Istituto Recruiting Rome, RM, Italy, 00144 Contact: Fabiana Letizia Cecere          PO A Perrino ASL Brindisi - UOC Oncologia Medica Recruiting Brindisi, Italy, 72100 Contact: Saverio Cinieri          AOU Policlinico Vittorio Emanuele UOC di Oncologia Recruiting Catania, Italy, 95125 Contact: Hector Jose Soto Parra    2 8224-4459       U.O. di Oncologia Ospedale Villa Scassi Recruiting Genova, Italy, 16149 Contact: Manlio Mencoboni    010 410-2639       Intstituto Scientifico Romangnolo Recruiting Meldola, Italy, 47014 Contact: Marco Angelo Burgio    054 373-9100       Instituto Nazionale Tumori Recruiting Milan, Italy Contact: Maria Chiara Garassino          U.O.C. di Oncologia U.L.S.S. 13 Recruiting Mirano, Italy, 30035 Contact: Francesco Rosetti    3904 1579-4002       Azienda Ospedaliera di Rilievo Nazionale Not yet recruiting Napoli, Italy, 80131 Contact: Giacomo Carteni          Dott. Fortunato Ciardiello,Cattedra Oncologia Medica Recruiting Napoli, Italy, 80131 Contact: Fortunato Ciardiello    081 566-6745       Unita Sperimentazioni Cliniche Istituto per lo Recruiting Napoli, Italy, 80131 Contact: Alessandro Morabito    081 590-3571       Azienda USL di Piacenza, Ospedale Gugliemimo Salieto Recruiting Piacenza, Italy, 29100 Contact: Luigi Cavanna    052 330-2697 Less <<
NCT00274911 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health at Royal Victoria Infirmary Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00003691 Endometrial Cancer Phase 3 Completed - -
NCT02726399 Gastric Cancer ... More >> Gastroesophageal Junction Cancer Less << Phase 2 Active, not recruiting March 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center 1275 York Avenue New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Less <<
NCT00421096 Uterine Cervical Cancer Phase 2 Terminated(Problems of recruit... More >>ment) Less << - France ... More >> Centre Leonard de Vinci Dechy, France, 59187 Centre Oscar Lambret Lille, France, 59020 Less <<
NCT00276666 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Cookridge Hospital Leeds, England, United Kingdom, LS16 6QB Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health at Royal Victoria Infirmary Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT02409186 Prosthesis Survival Phase 3 Recruiting December 2021 China, Beijing ... More >> Cancer Hospital Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100021 Contact: Lvhua Wang    13601283715    wlhwq@yahoo.com    Contact: Zongmei Zhou    13801389769    zhouzongmei2013@163.com    Principal Investigator: Lvhua Wang          Sub-Investigator: Zongmei Zhou          Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Guangying Zhu    13717999977    zgypu@yahoo.com.cn    Contact: Anhui Shi    13901136511    anhuidoctor@163.com    Principal Investigator: Guangying Zhu          Sub-Investigator: Anhui Shi          China, Guangdong Cancer Hospital of Shantou University Medical College Not yet recruiting Shantou, Guangdong, China, 515041 Contact: Zhixiong Lin    13829638278    zxlin5@qq.com    Contact: Zhining Yang    13750443575    36407342@qq.com    Principal Investigator: Zhixiong Lin          Sub-Investigator: Zhining Yang          China, Guangxi The Guangxi Zhuang Autonomous Region Cancer Hospita Not yet recruiting Nanning, Guangxi, China, 530021 Contact: Xiaodong Zhu    13978873616    zhuxiaodong83@163.com    Contact: Long Chen    13977129168    clong6@126.com    Principal Investigator: Xiaodong Zhu          Sub-Investigator: Long Chen          China, Guizhou Affiliated Hospital of Zunyi Medical College Not yet recruiting Zunyi, Guizhou, China, 563099 Contact: Hu Ma    18385034657    mahuab@163.com    Contact: Xiaoli Gou    15121201843    526392247@qq.com    Principal Investigator: Hu Ma          Sub-Investigator: Xiaoli Gou          China, Hebei Fourth Hospital of Hebei Medical University Tumor Recruiting Shijiazhuang, Hebei, China, 50011 Contact: Chun Han    13831105846    hanchun@yahoo.com.cn    Contact: Jun Wang    13931182128    wangjunzr@163.com    Principal Investigator: Chun Han          Sub-Investigator: Jun Wang          China, Henan Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450008 Contact: Jianhua Wang    13938278827    huajianye@sina.cn    Contact: Yongshun Chen    15286831671    yongshun2007@163.com    Principal Investigator: Jianhua Wang          Sub-Investigator: Yongshun Chen          China, Jiangsu Jiangsu Cancer Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Jun Zhu    15380882705    zhujdr@126.com    Contact: Hong Ji    18625155033    dr_jihong@163.com    Principal Investigator: Jun Zhu          Sub-Investigator: Hong Ji          Affiliated Hospital of Jiangsu University Recruiting Zhenjiang, Jiangsu, China, 212013 Contact: Dai Chunhua, PhD    13952850012       Principal Investigator: Dai Chunhua, PhD          China, Liaoning The First Hospital of China Medical University Recruiting Shenyang, Liaoning, China, 310022 Contact: Guang Li    13804058616    13804058616@163.com    Contact: Jun Dang    13898150850    dangjunsy@163.com    Principal Investigator: Guang Li          Sub-Investigator: Jun Dang          China, Shandong Shandong Cancer Hospital and Institute Recruiting Jinan, Shandong, China, 250117 Contact: Xue Meng, Ph.D, M.D    86-531-67626142    mengxue5409@126.com    Sub-Investigator: Xue Meng, Ph.D, M.D          China, Shanghai Renji Hospital Shanghai Jiao Tong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200127 Contact: Ming Ye    13901814744    renjiyeming@gmail.com    Contact: Xin Xu    13917978366    157198711@qq.com    Principal Investigator: Ming Ye          Sub-Investigator: Xin Xu          China, Zhejiang The First Hospital of Zhejiang Province Not yet recruiting Hangzhou, Zhejiang, China, 310003 Contact: Senxiang Yan    13957162839    yansenxiang@zju.edu.cn    Contact: Haogang Yu    13516721749    jusn3@163.com    Principal Investigator: Senxiang Yan          Sub-Investigator: Haogang Yu          Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Ming Chen    18758875572    chenming@sysucc.org.cn    Contact: Yujin Xu    13858037993    xuyj@zjcc.org.cn    Principal Investigator: Ming Chen          Sub-Investigator: Yujin Xu Less <<
NCT03406299 Biliary Tract Neoplasms Phase 2 Recruiting December 31, 2020 Taiwan ... More >> Taiwan Cooperative Oncology Group, National Health Research Institutes Recruiting Taipei, Taiwan Contact: Tsang-Wu Liu, MD    +886-2-26534401 ext 25150    walter@nhri.org.tw    Principal Investigator: Li-Tzong Chen, MD PHD          Principal Investigator: Nai-Jung Chiang, MD Less <<
NCT03332069 Cervical Cancer Phase 3 Recruiting July 31, 2020 South Africa ... More >> Charlotte Maxeke Johannesburg Academic Hospital Recruiting Johannesburg, Gauteng, South Africa, 2163 Contact: Jeffrey A Kotzen, MBBCH    +27825747385       Contact: Carrie A Minnaar, Masters    +27721234292 Less <<
NCT00083915 Multiple Myeloma Phase 3 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00083915 - Completed - -
NCT03389295 Nasopharyngeal Carcinoma Phase 2 Recruiting October 2020 China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Xiayun He, MD    +86-18017312167    hexiayun1962@163.com    Contact: Fen Xue, MD    +86-18505123563    xuefen1992@126.com Less <<
NCT00352118 Head and Neck Cancer Phase 2 Terminated(Low dose radiation ... More >>treatment was not appropriate for these patients.) Less << - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00352118 - Terminated(Low dose radiation ... More >>treatment was not appropriate for these patients.) Less << - -
NCT03519295 Anal Cancer Phase 2 Recruiting June 2022 France ... More >> CHRU Jean Minjoz Recruiting Besançon, France, 25000 Contact: Stefano KIM, MD          CHU Bordeaux - Hôpital Haut Lévêque Recruiting Bordeaux, France Contact: Denis SMITH          Centre François Baclesse Recruiting Caen, France Contact: Aurélie PARZY, MD          Centre Georges François Leclerc Recruiting Dijon, France Contact: françois GHIRINGHELLI, MD          Centre Oscar Lambert Recruiting Lille, France Contact: Farid EL HAJBI, MD          Centre Léon Bérard Recruiting Lyon, France Contact: Christelle de la Fouchardière, MD          Hôpital Jean Mermoz Recruiting Lyon, France Contact: Jérôme DESRAME, MD          Hopital Montbéliard Recruiting Montbéliard, France Contact: Christophe BORG, MD          ICM Val d'Aurelle Recruiting Montpellier, France Contact: Emmanuelle SAMALIN, MD          Centre Antoine Lacassagne Recruiting Nice, France Contact: Eric FRANCOIS, MD          Hôpital Saint Antoine Recruiting Paris, France, 7514 Contact: Daniel LOPEZ TRABADA ATAZ          Groupe Hospitalier Saint Joseph Recruiting Paris, France Contact: Nabil BABA HAMED, MD          Hôpital Européen Georges Pompidou Recruiting Paris, France Contact: Simon PERNOT          Hôpital Henri Mondor Not yet recruiting Paris, France Contact: Isabelle BAUMGAERTNER, MD          Hôpital saint Louis Recruiting Paris, France Contact: Nelson LOURENCO, MD          Insitut Curie Recruiting Paris, France Contact: Bruno BUECHER          CHU Robert Debré Reims Recruiting Reims, France Contact: Olivier BOUCHE, MD          Centre Paul Strauss Recruiting Strasbourg, France Contact: Meher BENABDELGHANI, MD Less <<
NCT00400114 Esophageal Cancer Phase 2 Completed - Canada, Ontario ... More >> The Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 University Health Network (Princess Margaret & Toronto General Hospitals) Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT00842712 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - -
NCT00002711 Esophageal Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02759575 Head and Neck Cancer Phase 1 Phase 2 Recruiting January 2020 United States, Ohio ... More >> University of Cincinnati Medical Center Recruiting Cincinnati, Ohio, United States, 45219 Contact: UC Cancer Institute Clinical Trials Office    513-584-7698    cancer@uchealth.com    Principal Investigator: Vinita Takiar, MD Less <<
NCT00842712 - Completed - -
NCT02403531 Neoplasms Phase 2 Active, not recruiting December 2018 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT00578760 Hearing Loss ... More >>Ototoxicity Less << Not Applicable Unknown February 2010 Canada, Ontario ... More >> Princess Margaret Hospital Not yet recruiting Toronto, Ontario, Canada Sub-Investigator: Emma Barker, FRCS, PhD Less <<
NCT01167738 Pancreatic Cancer Phase 2 Terminated(concern of detrimen... More >>tal effect) Less << - Italy ... More >> Istituto Scientifico H. San Raffaele Milan, Italy, 20132 Less <<
NCT00005601 Lymphoma Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Health Plaza Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, North Dakota Medcenter One Health System Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 United States, Ohio CCOP - Toledo Community Hospital Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57104 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT03025477 Ovarian Cancer, Epithelial Phase 2 Recruiting October 2029 France ... More >> Centre Georges François Leclerc Recruiting Dijon, France Contact: Leïla BENGRINE, MD          Principal Investigator: Leïla BENGRINE, MD          Institut Hospitalier Franco-Britannique Recruiting Levallois-Perret, France Contact: Aimery De GRAMONT, MD          Principal Investigator: Aimery De GRAMONT, MD          Groupe Hospitalier Diaconesses Croix Saint Simon Recruiting Paris, France Contact: Richard VILLET, MD          Principal Investigator: Richard VILLET, MD          Hôpital Saint Antoine Recruiting Paris, France Contact: Honorine GERVAIS, MD          Principal Investigator: Honorine GERVAIS, MD          Sub-Investigator: Delphine COCHEREAU, MD          Hôpital Poissy Saint Germain Recruiting Poissy, France Contact: Cyrille HUCHON, MD          Principal Investigator: Cyrille HUCHON, MD          CHU Poitiers Recruiting Poitiers, France Contact: Nadia RABAN          Principal Investigator: Nadia RABAN, MD          Centre Hospitalier Senlis Recruiting Senlis, France Contact: Elisabeth CAROLA, MD          Principal Investigator: Elisabeth CAROLA, MD Less <<
NCT01627288 Cancer of the Cervix ... More >> Cervical Neoplasms Less << Not Applicable Active, not recruiting June 2020 United States, North Carolina ... More >> Radiation Oncology, DUMC Durham, North Carolina, United States, 27710 Less <<
NCT00705627 Nasopharyngeal Carcinoma Phase 3 Unknown June 2017 China, Guangdong ... More >> Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Sumei Cao, Ph. D    86-20-8734-5685    caosumei@mail.sysu.edu.cn    Principal Investigator: Minghuang Hong, MD Less <<
NCT00002783 Gastric Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02630264 Head and Neck Neoplasms Phase 3 Unknown December 2016 China, Guangdong ... More >> Guangzhou DB Recruiting Gaungzhou, Guangdong, China, 510663 Contact: Chao Zhang       georgezhang2015@sina.com Less <<
NCT03612791 Locally Advanced Cervical Canc... More >>er Less << Phase 2 Recruiting July 2022 France ... More >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: Cyrus CHARGARI, MD, PhD    0142114211 ext +33    cyrus.chargari@gustaveroussy.fr Less <<
NCT02425397 - Unknown March 2016 France ... More >> Institut Curie Paris, France, 75005 Less <<
NCT00146276 Bladder Cancer ... More >> Carcinoma, Transitional Cell Less << Phase 3 Unknown - Germany ... More >> Saarland University Recruiting Homburg/Saar, Saarland, Germany, 66421 Contact: Jan Lehmann, MD    +49-(0)6841-1624700    jan.lehmann@uniklinikum-saarland.de    Contact: Michael Stöckle, MD    +49-(0)6841-1624702    michael.stoeckle@uniklinikum-saarland.de    Principal Investigator: Michael Stöckle, MD          Sub-Investigator: Jan Lehmann, MD Less <<
NCT03515837 Non-small Cell Lung Cancer Phase 3 Recruiting June 15, 2023 -
NCT02381847 Malignant Neoplasm of Stomach Phase 3 Recruiting March 2020 China, Jiangsu ... More >> Meng Wang Recruiting Nanjing, Jiangsu, China, 210000 Contact: Meng Wang    86-13815890469    wangmeng001@263.net    Contact: Wenxian Guan    86-25-83106666    guan_wx@163.com    Principal Investigator: Wenxian Guan, MD          Sub-Investigator: Baorui Liu, MD          Sub-Investigator: Meng Wang, MD Less <<
NCT01791374 Part 1- Advanced Solid Tumors ... More >> Part 2- Advanced or Metastatic Gastric Cancer Part 2- Advanced or Metastatic GEJ Less << Phase 1 Completed - Japan ... More >> Research Site Nagoya-shi, Aichi, Japan, 464-8681 Research Site Kashiwa-shi, Chiba, Japan, 277-8577 Research Site Matsuyama-shi, Ehime, Japan, 791-0280 Research Site Sapporo-shi, Hokkaido, Japan, 060-8648 Research Site Kawasaki-shi, Kanagawa, Japan, 216-8511 Research Site Kitaadachi-gun, Saitama, Japan, 362-0806 Research Site Suntou-gun, Shizuoka, Japan, 411-8777 Less <<
NCT00039910 Non-Hodgkin Lymphoma ... More >> Hodgkin Disease Thrombocytopenia Less << Phase 3 Completed - -
NCT03635567 Cervical Cancer Phase 3 Recruiting November 23, 2022 -
NCT01406249 Gastric Cancer Phase 2 Active, not recruiting December 2017 Japan ... More >> Epidemiological and Clinical Research Information Network Kyoto, Japan, 606-8392 Less <<
NCT02262325 Recurrent Non-small Cell Lung ... More >>Cancer Stage IIA Non-small Cell Lung Cancer Stage IIB Non-small Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Less << Phase 2 Recruiting December 31, 2018 United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Terence M. Williams    614-293-5557    terence.williams@osumc.edu    Principal Investigator: Terence M. Williams Less <<
NCT02578680 Non-Small-Cell Lung Carcinoma Phase 3 Active, not recruiting April 15, 2019 -
NCT03246750 Extranodal NK/T-cell Lymphoma Phase 1 Phase 2 Not yet recruiting February 2022 -
NCT00544414 Head and Neck Cancer Phase 2 Active, not recruiting January 2019 -
NCT00984997 Lung Cancer Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02578680 - Active, not recruiting - -
NCT00981656 Bladder Cancer Phase 2 Active, not recruiting October 2023 United States, Georgia ... More >> Emory Crawford Long Hospital Atlanta, Georgia, United States, 30308 Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland St. Agnes Hospital Cancer Center Baltimore, Maryland, United States, 21229 United States, Massachusetts Hudner Oncology Center at Saint Anne's Hospital - Fall River Fall River, Massachusetts, United States, 02721 United States, New Hampshire Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756-0002 United States, New York Beth Israel Medical Center - Petrie Division New York, New York, United States, 10003-3803 United States, Ohio Summa Center for Cancer Care at Akron City Hospital Akron, Ohio, United States, 44309-2090 Barberton Citizens Hospital Barberton, Ohio, United States, 44203 Cancer Care Center, Incorporated Salem, Ohio, United States, 44460 Cancer Treatment Center Wooster, Ohio, United States, 44691 United States, Pennsylvania Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States, 19111-2497 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555-0361 United States, Vermont Norris Cotton Cancer Center - North Saint Johnsbury, Vermont, United States, 05819 Less <<
NCT00003376 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 3 Completed - -
NCT02662062 Bladder Cancer Phase 2 Recruiting January 2024 Australia, New South Wales ... More >> Chris O'Brien Lifehouse Recruiting Camperdown, New South Wales, Australia, 2050 Principal Investigator: Peter Grimison, MBBS, FRACP          Prince of Wales Hospital Recruiting Randwick, New South Wales, Australia, 2013 Contact: Christie Norris, RN, MPH    +61 2 9382 2588    Christie.Norris@health.nsw.gov.au    Principal Investigator: Elizabeth Hovey, MBBS, FRACP          Royal North Shore Hospital Not yet recruiting St Leonards, New South Wales, Australia, 2065 Contact: Clare Banks       Clare.Banks@health.nsw.gov.au    Contact: George Hruby       george.hruby@health.nsw.gov.au    Principal Investigator: George Hruby          Australia, Victoria Austin Health Recruiting Heidelberg, Victoria, Australia, 3084 Contact: Andrew Weickhardt, MBBS, FRACP    +61 39496 5763    andrew.weickhardt@onjcri.org.au    Contact: Jenni Flynn, BNur    +61 3 9496 3352    jenni.flynn@austin.org.au    Principal Investigator: Andrew Weickhardt, MBBS, FRACP          Peter MacCallum Cancer Centre Terminated Melbourne, Victoria, Australia, 3002 Australia, Western Australia Sir Charles Gairdner Hospital Recruiting Nedlands, Perth, Western Australia, Australia, 6009 Contact: Judy Innes-Rowe    +61 0408 818 656    judy.innes-rowe@health.wa.gov.au    Contact: Jennifer McConnell, BNur    +61 8 6383 3187    jennifer.mcconnell@health.wa.gov.au    Principal Investigator: Siobhan Ng, MBBS, FRACP Less <<
NCT03775265 Bladder Carcinoma Infiltrating... More >> the Muscle of the Bladder Wall Bladder Urothelial Carcinoma Stage II Bladder Cancer AJCC v8 Stage III Bladder Cancer AJCC v8 Stage IIIA Bladder Cancer AJCC v8 Less << Phase 3 Not yet recruiting June 1, 2025 -
NCT01230996 Locally Advanced Cervical Canc... More >>er Less << Phase 1 Phase 2 Active, not recruiting April 2018 United Kingdom ... More >> Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Hammersmith Hospital London, England, United Kingdom Royal Marsden - London London, England, United Kingdom Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, United Kingdom Less <<
NCT01461057 Gastric Cancer Phase 2 Completed - Belgium ... More >> Cliniques Universitaires St-Luc Bruxelles, Belgium, 1200 UZ Leuven Gasthuisberg Leuven, Belgium, 3000 Czechia Masaryk Memorial Cancer Institute; Oncological Clinic Brno, Czechia, 656 53 Fakultni Nemocnice Hradec Kralove; Dept of Radiotherapy & Oncology Hradec Kralove, Czechia, 500 05 Fakultni nemocnice Olomouc; Onkologicka klinika Olomouc, Czechia, 779 00 Fakultní Nemocnice V Motole; Radioterapeuticko-Onkologicke Oddeleni Praha 5, Czechia, 150 06 University Hospital Na Bulovce; Institut of Radiation Oncology Praha 8, Czechia, 180 81 France Hopital Morvan Brest, France, 29200 CRLCC Val dAurelle Paul Lam Montpellier cedex 5, France, 34298 Hopital Robert Debre; DERMATOLOGIE Reims, France, 51092 Germany Charité-Universitätsm. Berlin; Med. Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunolo. Berlin, Germany, 10117 Klinikum Braunschweig; Medizinische Klinik III; Klinik für Hämatologie und Onkologie Braunschweig, Germany, 38114 Krankenhaus Nordwest; Klinik f. Onkologie und Hämatologie Frankfurt, Germany, 60488 Klinikum Mannheim III. Medizinische Klinik Mannheim, Germany, 68167 Italy Campus Universitario S.Venuta; Centro Oncologico T.Campanella Catanzaro, Calabria, Italy, 88100 Irccs Istituto Nazionale Dei Tumori (Int);S.C. Medicina Oncologica 2 Milano, Lombardia, Italy, 20133 A.O. Universitaria Pisana; Oncologia Pisa, Toscana, Italy, 56100 Korea, Republic of Seoul National Uni Hospital; Dept. of Internal Medicine/Hematology/Oncology Seoul, Korea, Republic of, 03080 Yonsei Medical Center; Dept. of Medicine , Division of Hemato-Oncology Seoul, Korea, Republic of, 03722 Asan Medical Center; Medical Oncology Seoul, Korea, Republic of, 05505 Netherlands Academish Ziekenhuis Maastricht (Azm); Inwendige Geneeskunde Maastricht, Netherlands, 6229 HX Spain Hospital del Mar; Servicio de Oncologia Barcelona, Spain, 08003 Hospital Universitario La Paz; Servicio de Oncologia Madrid, Spain, 28046 Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia Valencia, Spain, 46010 Less <<
NCT00960284 Pancreatic Cancer Phase 2 Phase 3 Completed - Italy ... More >> Istituto Scientifico H. San Raffaele Milan, Italy, 20132 Less <<
NCT01336543 Stage III Non-small Cell Lung ... More >>Cancer Less << Phase 2 Withdrawn(Low accrual, small p... More >>atient population at center.) Less << - United States, Louisiana ... More >> LSU Health Sciences Center, 1501 Kings Highway Shreveport, Louisiana, United States, 71103 Less <<
NCT02977169 Non-small Cell Lung Cancer Sta... More >>ge IIIA Radiotherapy Less << Phase 2 Recruiting December 2019 China, Shanghai ... More >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD    +862122200000 ext 3602    xlfu1964@126.com Less <<
NCT00883779 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 3 Completed - China ... More >> Beijing, China, 100021 Beijing, China, 100142 Beijing, China, 101149 Guangzhou, China, 510060 Guangzhou, China Hangzhou, China Nanjing, China, 210029 Shanghai, China, 200030 Shanghai, China, 200433 Hong Kong Hong Kong, Hong Kong, 852 Hong Kong, Hong Kong Shatin, Hong Kong Indonesia Jakarta, Indonesia, 13230 Jogjakarta, Indonesia, 55284 Surabaya, Indonesia, 60286 Korea, Republic of Gyeonggi-do, Korea, Republic of, 410-769 Philippines Manila, Philippines, 1000 Pasig City, Philippines, 1605 Quezon City, Philippines, 1104 Taiwan Taichung, Taiwan, 407 Taipei, Taiwan, 100 Taipei, Taiwan, 116 Taipei, Taiwan Thailand Bangkok, Thailand, 10400 Bangkok, Thailand, 10700 Chiang Mai, Thailand, 50200 Less <<
NCT00957086 Carcinoma, Squamous Cell of He... More >>ad and Neck Less << Phase 3 Recruiting June 2021 -
NCT00003027 Melanoma (Skin) Phase 3 Completed - -
NCT00039338 Cervical Cancer Phase 3 Active, not recruiting - Austria ... More >> Karl-Franzens-University Graz Graz, Austria Kaiser Franz Josef Hospital Vienna, Austria Belgium Universitair Ziekenhuis Antwerpen Edegem, Belgium U.Z. Gasthuisberg Leuven, Belgium Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 France Centre Regional Francois Baclesse Caen, France Italy Istituto Europeo Di Oncologia Milano, Italy Ospedale San Gerardo Monza, Italy Istituto Nazionale Per Lo Studio E La Cura Dei Tumori Naples, Italy Ospedale Mauriziano Umberto I Torino, Italy, 10128 Clinica Universitaria Turin, Italy, 10126 Ospedale di Circolo e Fondazione Macchi Varese, Italy Netherlands Academisch Medisch Centrum at University of Amsterdam Amsterdam, Netherlands, 1105 AZ Vrije Universiteit Medisch Centrum Amsterdam, Netherlands Medisch Spectrum Twente Enschede, Netherlands Leiden University Medical Center Leiden, Netherlands Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands Erasmus MC - Daniel den Hoed Cancer Center Rotterdam, Netherlands, 3008 AE Universitair Medisch Centrum - Academisch Ziekenhuis Utrecht, Netherlands Portugal Hospitais da Universidade de Coimbra (HUC) Coimbra, Portugal Spain Hospital Universitario San Carlos Madrid, Spain United Kingdom Queen Elizabeth The Queen Mother Hospital Margate, England, United Kingdom NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom Mid Kent Oncology Centre Maidstone, Kent, United Kingdom Less <<
NCT00460265 Recurrent and/or Metastatic He... More >>ad and Neck Cancer Less << Phase 3 Completed - -
NCT01102231 Stage III Non-small Cell Lung ... More >>Cancer Less << Phase 2 Completed - France ... More >> Clinique de l'Europe Amiens, France Centre Hospitalier Annemasse, France CHU Besancon - Pneumologie Besancon, France, 25000 Bordeaux - Polyclinique Nord Bordeaux, France, 33300 Caen - Centre François Baclesse Caen, France, 14000 Caen - CHU Côte de Nacre Caen, France, 14000 CH Chartres, France CH Cholet, France CHU Clermont-Ferrand, France CH Colmar, France Clinique des Cèdres Cornebarrieu, France Dijon - CAC Dijon, France, 21000 CHU Grenoble Grenoble, France, 38000 Institut d'Oncologie Hartmann Levallois, France CHU (Hôpital Calmette) - Pneumologie Lille, France, 59000 CH Longjumeau, France Clinique des 4 Pavillons Lormont, France Hôpital Louis Pradel Lyon, France Hôpital Nord Marseille, France Centre Hospitalier Montélimar, France CHU Nancy, France CH Nevers, France Centre Hospitalier Niort, France APHP - Hopital Tenon - Pneumologie Paris, France, 75020 Hôpital du Val de Grâce Paris, France Hôpital Saint-Joseph Paris, France Perpignan - Centre Catalan d'Oncologie Perpignan, France, 66000 HCL - Lyon Sud Pierre Bénite, France, 69495 CHU Poitiers, France Centre Hospitalier Rambouillet, France Reims - CHU Reims, France, 51092 Institut Jean Godinot Reims, France Centre Frederic Joliot Rouen, France Centre Etienne Dolet Saint-Nazaire, France Hôpitaux Universitaires - Nouvel Hôpital Civil Strasbourg, France, 63000 Suresnes - Hopital Foch Suresnes, France, 92151 Tours - CHU Tours, France, 37000 Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT00883779 - Completed - -
NCT00003582 Carcinoma of Unknown Primary ... More >> Head and Neck Cancer Less << Phase 1 Phase 2 Completed - United States, Florida ... More >> Sylvester Cancer Center, University of Miami Miami, Florida, United States, 33136 Less <<
NCT00460265 - Completed - -
NCT00433563 Lung Cancer Not Applicable Active, not recruiting February 2019 United Kingdom ... More >> The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Less <<
NCT00394966 Nausea Vomiti... More >>ng Less << Phase 2 Completed - -
NCT00360971 Head and Neck Cancer ... More >> Mucositis Pain Radiation Toxicity Less << Phase 3 Terminated(Due to positive pre... More >>liminary results from other palifermin studies.) Less << - -
NCT01063478 Non-Small Cell Lung Cancer Phase 1 Terminated(Poor accrual) - United States, Illinois ... More >> University of Chicago Medical Center Chicago, Illinois, United States, 60637 Less <<
NCT01720563 Cancer-related Fatigue Phase 2 Terminated(Change study drug d... More >>osage form) Less << - Taiwan ... More >> Chang Gung Memorial Hospital Taoyuan, Taiwan, 333 Less <<
NCT01424839 Intracranial Germ Cell Tumors Phase 4 Unknown October 2018 Germany ... More >> University Hospital Muenster Recruiting Muenster, Germany, 48129 Contact: Gabriele Calaminus, MD    +492518358060    gabriele.calaminus@ukmuenster.de    Contact: Carmen Teske    +492518358055    carmen.teske@ukmuenster.de    Principal Investigator: Gabriele Calaminus, MD Less <<
NCT00310739 - Unknown - Japan ... More >> Hamamatsu University School of Medicine Recruiting Hamamatsu, Shizuoka, Japan, 431-3192 Contact: Takayuki Tsuji, MD    +81-53-435-2261    tsu@hama-med.ac.jp Less <<
NCT01734798 Locally Advanced Bladder Cance... More >>r Less << Phase 3 Completed - Egypt ... More >> National cancer Institute-Cairo University Cairo, Egypt Less <<
NCT01040312 - Unknown March 2014 Japan ... More >> Department of Obstetrics and Gynecology, National Defense Medical College Hospital Tokorozawa, Saitama, Japan, 359-8513 Less <<
NCT02672865 Locally Advanced Malignant Neo... More >>plasm Gastric Cancer Less << Phase 1 Recruiting December 2018 United States, California ... More >> Loma Linda University Cancer Center Recruiting Loma Linda, California, United States, 92354 Contact: Maheswari Senthil, MD    909-558-4000 ext 15460    msenthil@llu.edu Less <<
NCT01809210 Locally Advanced or Metastatic... More >> NSCL Cancer Stage IIIB IV Less << Phase 1 Completed - United Kingdom ... More >> Research Site Glasgow, United Kingdom, G12 0YN Research Site London, United Kingdom, W1G 6AD Research Site Manchester, United Kingdom, M20 4BX Research Site Newcastle upon Tyne, United Kingdom, NE7 7DN Less <<
NCT00003004 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT03579004 Esophageal Neoplasms ... More >> Squamous Cell Carcinoma Concurrent Chemoradiotherapy Less << Phase 2 Recruiting July 10, 2020 Russian Federation ... More >> Alexey Tryakin Recruiting Moscow, Russian Federation, 115478 Contact: Alexey Tryakin, MD, PhD    4993249259 ext +7    atryakin@mail.ru    Russian Cancer Research Center named after N.N.Blokhin RAMS Recruiting Moscow, Russian Federation, 115478 Contact: Alexey Tryakin, PhD    +74993249259    atryakin@mail.ru    Contact: Ilya Pokataev    +74993241219    pokia@mail.ru    Principal Investigator: Alexey Tryakin, PhD Less <<
NCT01809210 - Completed - -
NCT01993979 Transitional Cell Carcinoma of... More >> Ureter Less << Phase 3 Active, not recruiting May 2022 -
NCT00003642 Bladder Cancer Phase 2 Terminated(low accrual) - France ... More >> Institut Bergonie Bordeaux, France, 33076 CHR de Grenoble - La Tronche Grenoble, France, 38043 Netherlands Dr. Bernard Verbeeten Instituut Tilburg, Netherlands, 5042 SB Less <<
NCT00003053 Lung Cancer Phase 3 Unknown - -
NCT02115464 Lung Cancer Phase 2 Recruiting December 2020 Canada, Alberta ... More >> Cross Cancer Institute Recruiting Edmonton, Alberta, Canada Principal Investigator: Wilson Roa          Canada, Manitoba CancerCare Manitoba Recruiting Winnipeg, Manitoba, Canada, R3E 0V9 Principal Investigator: Naseer Ahmed          Canada, Ontario Juravinski Cancer Centre Recruiting Hamilton, Ontario, Canada Principal Investigator: Theos Tsakiridis          Cancer Centre of Southeastern Ontario at Kingston General Hospital Recruiting Kingston, Ontario, Canada Principal Investigator: Andrew Robinson          Grand River Regional Cancer Centre Active, not recruiting Kitchener, Ontario, Canada Walker Family Cancer Centre - Niagara Health System Recruiting St. Catharines, Ontario, Canada Principal Investigator: Theos Tsakiridis          Canada, Quebec Montreal General Hospital - McGill Recruiting Montreal, Quebec, Canada Principal Investigator: Bassam Abdulkarim Less <<
NCT02444949 Nasopharyngeal Neoplasms Phase 3 Unknown June 2017 -
NCT01133678 Head and Neck Cancer Phase 2 Active, not recruiting October 2018 United States, Illinois ... More >> The University of Chicago Medical Center Chicago, Illinois, United States, 60637 NorthShore University Health System Evanston, Illinois, United States, 60201 Less <<
NCT01004978 Hepatocellular Carcinoma ... More >> Unresectable Hepatocellular Carcinoma Less << Phase 3 Active, not recruiting - -
NCT03423849 Breast Cancer ... More >> Chemotherapy Effect Disease-free Survival Less << Phase 2 Phase 3 Not yet recruiting February 8, 2020 -
NCT02749526 Esophageal Phase 2 Unknown December 2016 China, Jiangsu ... More >> The First Affiliated Hospital with Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210000 Contact: Yin Qingfeng, Manager    13912903257    363994906@qq.com Less <<
NCT00450203 Oesophagogastric Cancer Phase 2 Phase 3 Unknown December 2017 United Kingdom ... More >> Royal Bournemouth Hospital Recruiting Bournemouth, England, United Kingdom, BH7 7DW Contact: Tom Geldart    44-1202-726-088       Bradford Royal Infirmary Active, not recruiting Bradford, England, United Kingdom, BD9 6RJ Bristol Haematology and Oncology Centre Recruiting Bristol, England, United Kingdom, BS2 8ED Contact: Stephen J. Falk, MD    44-117-928-3074    stephen.falk@ubht.nhs.uk    Addenbrooke's Hospital Active, not recruiting Cambridge, England, United Kingdom, CB2 2QQ Cumberland Infirmary Active, not recruiting Carlisle, England, United Kingdom, CA2 7HY Doncaster Royal Infirmary Recruiting Doncaster, England, United Kingdom, DN2 5LT Contact: Jonathan Wadsley    44-1302-366-666       St. Luke's Cancer Centre at Royal Surrey County Hospital Recruiting Guildford, England, United Kingdom, GU2 7XX Contact: Gary W. Middleton    44-1483-570-122    gmiddleton@royalsurrey.nhs.uk    Huddersfield Royal Infirmary Recruiting Huddersfield, West Yorks, England, United Kingdom, HD3 3EA Contact: Jo Dent    44-1484-342-000       Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Matthew T. Seymour, MA, MD, FRCP    44-113-206-6400       Lincoln County Hospital Active, not recruiting Lincoln, England, United Kingdom, LN2 5QY Aintree University Hospital Recruiting Liverpool, England, United Kingdom, L9 7AL Contact: David Smith, MD    44-151-525-5980       Saint Bartholomew's Hospital Recruiting London, England, United Kingdom, EC1A 7BE Contact: Sarah Slater, MD    44-20-7601-8391       St. George's Hospital Active, not recruiting London, England, United Kingdom, SW17 0QT St. Mary's Hospital Active, not recruiting London, England, United Kingdom, W2 1NY Mid Kent Oncology Centre at Maidstone Hospital Recruiting Maidstone, England, United Kingdom, ME16 9QQ Contact: Justin Waters, MD    44-1622-729-000       Christie Hospital Recruiting Manchester, England, United Kingdom, M20 4BX Contact: Was Mansoor, MD    44-845-226-3000       Clatterbridge Centre for Oncology Recruiting Merseyside, England, United Kingdom, CH63 4JY Contact: David Smith, MD    44-151-334-1155    david.smith@ccotrust.nhs.uk    Northern Centre for Cancer Treatment at Newcastle General Hospital Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE4 6BE Contact: Fareeda Coxon, MD    44-191-256-3551    fareeda.coxon@nuth.nhs.uk    Derriford Hospital Active, not recruiting Plymouth, England, United Kingdom, PL6 8DH Dorset Cancer Centre Active, not recruiting Poole Dorset, England, United Kingdom, BH15 2JB Berkshire Cancer Centre at Royal Berkshire Hospital Recruiting Reading, England, United Kingdom, RG1 5AN Contact: Joss Adams, MD    44-118-322-7878       Rochdale Infirmary Active, not recruiting Rochdale, England, United Kingdom, 0L12 0NB Salisbury District Hospital Recruiting Salisbury, England, United Kingdom, SP2 8BJ Contact: Tim J. Iveson, MD    44-1722-336-262 ext. 4688       Wexham Park Hospital Recruiting Slough, Berkshire, England, United Kingdom, SL2 4HL Contact: Marcia Hall, MD    44-1753-634-364    marcia.hall@nhs.net.uk    Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Tim J. Iveson, MD    44-23-8079-6802    t.iveson@soton.ac.uk    Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: David Cunningham, MD    44-20-8661-3279    david.cunningham@rmh.nhs.uk    Aberdeen Royal Infirmary Recruiting Aberdeen, Scotland, United Kingdom, AB25 2ZN Contact: Russell Petty, MD    44-84-5456-6000       Velindre Cancer Center at Velindre Hospital Recruiting Cardiff, Wales, United Kingdom, CF14 2TL Contact: Tom Crosby, MD    44-29-2031-6292       Basingstoke and North Hampshire Hospital Recruiting Basingstoke, United Kingdom Principal Investigator: Charlotte Rees          Birmingham Heartlands Hospital Recruiting Birmingham, United Kingdom Principal Investigator: Jo Dent          Castle Hill Hospital Recruiting Cottingham, United Kingdom Principal Investigator: Mohan Hingorani          University Hospitals Coventry and Warwickshire Recruiting Coventry, United Kingdom Principal Investigator: Sharmila Sothi          Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom Principal Investigator: Janet Graham          St James Hospital Recruiting Leeds, United Kingdom Principal Investigator: Matt Seymour          Leicester Royal Infirmary Recruiting Leicester, United Kingdom Principal Investigator: Anne Thomas          Norfolk and Norwich University Hospital Recruiting Norwich, United Kingdom Principal Investigator: Tom Roques          Churchill Hospital Recruiting Oxford, United Kingdom Principal Investigator: Kinnari Patel          Queens Hospital Recruiting Romford, United Kingdom Principal Investigator: Sherif Raouf          Weston Park Recruiting Sheffield, United Kingdom Principal Investigator: Suzanne Darby          Great Western Hospital Recruiting Swindon, United Kingdom Principal Investigator: Claire Blesing          Musgrove Park Hospital Recruiting Taunton, United Kingdom Principal Investigator: Emma Cattell Less <<
NCT01055301 Multiple Myeloma ... More >> Plasma Cell Myeloma Less << Phase 2 Withdrawn(lack of accrual) - United States, Louisiana ... More >> Tulane Cancer Center Office of Clinical Research Alexandria, Louisiana, United States, 71315-3198 Hematology-Oncology Clinic Baton Rouge, Louisiana, United States, 70809 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 United States, Mississippi University of Mississippi Cancer Clinic Jackson, Mississippi, United States, 39216 United States, Washington Island Hospital Cancer Care Center at Island Hospital Anacortes, Washington, United States, 98221 St. Joseph Cancer Center Bellingham, Washington, United States, 98225 Olympic Hematology and Oncology Bremerton, Washington, United States, 98310 Highline Medical Center Cancer Center Burien, Washington, United States, 98166 Columbia Basin Hematology Kennewick, Washington, United States, 99336 Skagit Valley Hospital Cancer Care Center Mount Vernon, Washington, United States, 98274 Harrison Poulsbo Hematology and Onocology Poulsbo, Washington, United States, 98370 Harborview Medical Center Seattle, Washington, United States, 98104 Minor and James Medical, PLLC Seattle, Washington, United States, 98104 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Group Health Central Hospital Seattle, Washington, United States, 98112 Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle, Washington, United States, 98122-4307 University Cancer Center at University of Washington Medical Center Seattle, Washington, United States, 98195 North Puget Oncology at United General Hospital Sedro-Woolley, Washington, United States, 98284 Cancer Care Northwest - Spokane South Spokane, Washington, United States, 99202 Evergreen Hematology and Oncology, PS Spokane, Washington, United States, 99218 Wenatchee Valley Medical Center Wenatchee, Washington, United States, 98801-2028 Less <<
NCT00496652 Cancer of the Head and Neck Phase 3 Completed - Denmark ... More >> Department of Experimental Clinical Oncology, Aarhus University Hospital Aarhus, Denmark, 8000 N Less <<
NCT00030810 Lung Cancer Phase 2 Completed - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT00559351 Esophageal Neoplasms ... More >> Squamous Cell Cancer Less << Phase 3 Terminated(difficulty in recru... More >>itment) Less << - Poland ... More >> 2nd Department of General, Gastrointestinal Surgery & Surgical Oncology of the Digestive Tract, Medical University of Lublin, Poland Lublin, Lubelskie, Poland, 20-081 Less <<
NCT00875849 Head and Neck Cancer Phase 2 Completed - France ... More >> Centre Antoine Lacassagne Nice, France, 06189 Less <<
NCT01034332 Esophageal Cancer Phase 2 Unknown December 2009 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Chin-Hung Hsu, MD    02-23123456 ext 7680    chihhunghsu@ntu.edu.tw Less <<
NCT03042429 Neuroblastoma Phase 3 Completed - Germany ... More >> University of Cologne Koln, Germany, 50924 Less <<
NCT02949895 Small Cell Lung Cancer Phase 1 Completed - Japan ... More >> Local Institution Takatsuki-shi, Osaka, Japan, 5698686 Local Institution Chuo-ku, Tokyo, Japan, 1040045 Less <<
NCT03287375 Peritoneum; Carcinomatosis ... More >> Peritoneal Neoplasms Peritoneal Metastases Chemotherapy Effect Chemotherapeutic Toxicity Quality of Life Histologic Progression Less << Phase 2 Recruiting December 1, 2020 Denmark ... More >> Department of Surgery, Odense University Hospital Recruiting Odense, Denmark, 5000 Principal Investigator: Michael B Mortensen, MD, Ph.D. Less <<
NCT02283489 Head and Neck Neoplasms Phase 2 Unknown October 2016 China, Sichuan ... More >> West China Hospital, Sichuan University Recruiting Chengdu, Sichuan, China, 610041 Contact: Liqun Zou, M.D.          Principal Investigator: Liqun Zou, M.D.          Sichuan Provincial People's Hospital Recruiting Chengdu, Sichuan, China, 610072 Contact: Ke Xie, M.D.          Principal Investigator: Ke Xie, M.D.          China Chongqing Cancer Hospital Recruiting Chongqing, China, 400030 Contact: Xiaohong Zhou, M.D.          Principal Investigator: Xiaohong Zhou, M.D.          Shanghai Ninth People's Hospital Affiliated Shanghai JiaoTong University School of Medicine Recruiting Shanghai, China, 200011 Contact: Wei Guo, M.D.          Principal Investigator: Wei Guo, M.D. Less <<
NCT01103544 - Completed - Germany ... More >> Pierre Fabre Pharma GmbH Freiburg, Germany Less <<
NCT01828099 - Active, not recruiting - -
NCT00052429 - Completed - -
NCT00052429 Head and Neck Cancer Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan - Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02120118 Solid Tumors Phase 2 Withdrawn(Taiwan FDA asked for... More >> seperating this protocol into one disease site per protocol.) Less << February 2017 Taiwan ... More >> Shin Kong Wu Ho-Su Memorial Hospital Taipei, Taiwan, 11101 Less <<
NCT02072148 Human Papilloma Virus ... More >> Oropharyngeal Squamous Cell Carcinoma Less << Not Applicable Recruiting March 2019 United States, New York ... More >> Mount Sinai Beth Israel Recruiting New York, New York, United States, 10003 Principal Investigator: Raymond Chai, MD          Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Principal Investigator: Brett A Miles, DDS, MD Less <<
NCT02320448 Peritoneal Carcinomatosis Phase 2 Completed - Denmark ... More >> Odense University Hospital Odense, Denmark, 5000 Less <<
NCT00588770 Recurrent Hypopharyngeal Squam... More >>ous Cell Carcinoma Recurrent Laryngeal Squamous Cell Carcinoma Recurrent Laryngeal Verrucous Carcinoma Recurrent Lip and Oral Cavity Squamous Cell Carcinoma Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma Recurrent Oral Cavity Verrucous Carcinoma Recurrent Oropharyngeal Squamous Cell Carcinoma Recurrent Salivary Gland Carcinoma Salivary Gland Squamous Cell Carcinoma Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Stage IV Major Salivary Gland Cancer AJCC v7 Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Laryngeal Verrucous Carcinoma AJCC v7 Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA Major Salivary Gland Cancer AJCC v7 Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IVA Oral Cavity Cancer AJCC v6 and v7 Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Laryngeal Verrucous Carcinoma AJCC v7 Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVB Major Salivary Gland Cancer AJCC v7 Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IVB Oral Cavity Cancer AJCC v6 and v7 Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVC Laryngeal Squamous Cell Carcinoma AJCC v7 Stage IVC Laryngeal Verrucous Carcinoma AJCC v7 Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVC Major Salivary Gland Cancer AJCC v7 Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Stage IVC Oral Cavity Cancer AJCC v6 and v7 Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7 Tongue Carcinoma Untreated Metastatic Squamous Cell Carcinoma to Neck With Occult Primary Less << Phase 3 Active, not recruiting - -
NCT02194556 EGFR Positive Non-small Cell L... More >>ung Cancer Adenocarcinoma Less << Phase 4 Unknown July 2017 China, Guangxi ... More >> First Affiliated Hospital of Guangxi Medical University NanNing, Guangxi, China, 530021 Less <<
NCT01743482 Germ Cell Tumors ... More >> Measurable Disease Relapse or Progression After 2 or 3 Chemotherapy Regimens. Relapse or Progression After High-dose Chemotherapy. Less << Phase 2 Unknown April 2015 Italy ... More >> Fondazione IRCCS Istituto Nazionale dei Tumori Not yet recruiting Milano, Mi, Italy, 20133 Contact: Andrea Necchi, MD    +39 02 2390 2402    andrea.necchi@istitutotumori.mi.it    Sub-Investigator: Patrizia Giannatempo, MD          Principal Investigator: Andrea Necchi, MD Less <<
NCT02987699 HepatoCellular Carcinoma Phase 2 Unknown May 2017 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Ming Shi, MD.       shiming@sysu.edu.cn    Principal Investigator: shi Ming, MD. Less <<
NCT01828099 Non-Small Cell Lung Cancer Phase 3 Active, not recruiting April 11, 2022 -
NCT01249352 Esophageal Cancer ... More >> Adenocarcinoma Less << Phase 2 Phase 3 Completed - Brazil ... More >> Hospital Universitário de Brasília Brasília, DF, Brazil Hospital Evangélico do Cachoeiro do Itapemirim Cachoeiro do Itapemirim, ES, Brazil Santa Casa de Misericórdia de BH Belo Horizonte, MG, Brazil Hospital Erasto Gaetner Curitiba, PR, Brazil Hospital Geral de Bonsucesso Rio de Janeiro, RJ, Brazil Instituto Nacional do Câncer (INCA) Rio de Janeiro, RJ, Brazil Hospital da cidade de Passo Fundo Passo Fundo, RS, Brazil Hospital de Clínicas de Porto Alegre Porto Alegre, RS, Brazil Hospital Nossa Senhora da Conceição Porto Alegre, RS, Brazil Centro de Novos Tratamentos de Itajaí Itajaí, SC, Brazil Hospital Municipal São José Joinville, SC, Brazil Hospital Amaral Carvalho Jau, SP, Brazil Centro Oncológico Mogi das Cruzes Mogi das Cruzes, SP, Brazil Faculdade de Medicina do ABC / CEPHO Santo André, SP, Brazil Centro de Estudos de Investigações Clíncas (CEIC) São Caetano do Sul, SP, Brazil Hospital de Base São José do Rio Preto, SP, Brazil Hospital Santa Marcelina São Paulo, SP, Brazil Hospital São Paulo (UNIFESP) São Paulo, SP, Brazil Instituto do Câncer do Estado de São Paulo São Paulo, SP, Brazil Less <<
NCT03706287 Lung Cancer Metastatic Phase 1 Phase 2 Not yet recruiting March 10, 2021 China, Sichuan ... More >> Sichuan Cancer Hospital Not yet recruiting Chengdu, Sichuan, China, 610041 Contact: juan li, doctor    +8613880276636    dr.lijuan@gmail.com    Contact: rui shi, doctor    +8613880898008    shirui729@hotmail.com    Principal Investigator: ping yu, doctor          Principal Investigator: juan li, doctor          China Chengdu fifth people's hospital Not yet recruiting Chengdu, China Contact: mei mei          Principal Investigator: mei mei          People's hospital of deyang city Deyang, China The affiliated hospital of southwest medical university Not yet recruiting Luzhou, China Contact: Sheng Lin          Principal Investigator: Sheng Lin          Nanchong central hospital Not yet recruiting Nanchong, China Contact: xin hu          Principal Investigator: xin hu          Suining central hospital Not yet recruiting Suining, China Contact: qiang zhou          Principal Investigator: qiang zhou Less <<
NCT01516996 Oropharyngeal Cancer ... More >> Hypopharyngeal Cancer Less << Phase 2 Unknown March 2018 China, Gansu ... More >> Gansu Province Medical Science Institute Active, not recruiting Lanzhou, Gansu, China, 730050 China, Guangxi Guangxi Tumor Hospital Active, not recruiting Nanning, Guangxi, China, 530021 China, Guizhou GuiZhou Cancer Hospital Active, not recruiting Guiyang, Guizhou, China, 550004 China, Neimenggu Neimenggu Tumor Hospital Active, not recruiting Baotou, Neimenggu, China, 014030 China, Ningxia The Tumor Affiliated Hospital of Ningxia Medical University General Hospita Active, not recruiting Yinchuan, Ningxia, China, 750004 China, Qinghai Qinghai Five Hospital Active, not recruiting Xining, Qinghai, China China, Shanxi Xijing Hospital Active, not recruiting Xi-an, Shanxi, China, 710032 ShanXi Cancer Hospital Active, not recruiting Xian, Shanxi, China, 710061 China, Sichuan The Second People's Hospital of Sichuan Recruiting Chengdu, Sichuan, China, 610041 Contact: Peng Xu, M.D.    15828312322    xupeng4618@163.com    West China Hospital, Sichuan University Active, not recruiting Chengdu, Sichuan, China, 610041 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Active, not recruiting Chongqing, Sichuan, China, 400042 China, Xinjiang Xinjiang tumor hospital, The Third Affiliated Hospital of Xinjiang Medical University Active, not recruiting Wulumuqi, Xinjiang, China, 830000 China, Yunnan Yunnan Tumor Hospital, The Third Affiliated Hospital of KUNMING Medical University Active, not recruiting Kunming, Yunnan, China, 652100 Less <<
NCT01840579 Solid Tumor N... More >>on-small Cell Lung Cancer Small Cell Lung Cancer Less << Phase 1 Active, not recruiting April 17, 2020 -
NCT02178241 Metastatic Ureter Carcinoma ... More >> Metastatic Urethral Carcinoma Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 Stage III Ureter Cancer AJCC v7 Stage III Urethral Cancer AJCC v7 Stage IV Bladder Urothelial Carcinoma AJCC v7 Stage IV Ureter Cancer AJCC v7 Stage IV Urethral Cancer AJCC v7 Ureter Urothelial Carcinoma Urethral Urothelial Carcinoma Less << Phase 2 Active, not recruiting December 31, 2018 United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Los Angeles County-USC Medical Center Los Angeles, California, United States, 90033 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Keck Medical Center of USC Pasadena Pasadena, California, United States, 91105 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Colorado University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, District of Columbia MedStar Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, Florida Moffitt Cancer Center P2C Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 UC Comprehensive Cancer Center at Silver Cross New Lenox, Illinois, United States, 60451 United States, Minnesota Mayo Clinic Cancer Center P2C Rochester, Minnesota, United States, 55905 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Texas University of Texas M D Anderson Cancer Center P2C Houston, Texas, United States, 77030 Canada, Ontario University Health Network Princess Margaret Cancer Center P2C Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02501278 Uterine Cervical Neoplasms Phase 2 Withdrawn(company (Inovio) is ... More >>no longer able to support the study) Less << May 2021 Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland Less <<
NCT01459484 Osteosarcoma Phase 2 Phase 3 Recruiting February 2020 Italy ... More >> I.R.C.C. - Unit of Medical Oncology Not yet recruiting Candiolo, Torino, Italy, 10060 Contact: Giovanni Grignani, MD    +39.011.9933 ext 278    giovanni.grignani@ircc.it    Contact: Luisa Gioeni, Pharmacist    +39.011.9933 ext 278    luisa.gioeni@ircc.it    Sub-Investigator: Giovanni Grignani, MD          Principal Investigator: Massimo Aglietta, MD          Presidio Sanitario Gradenigo Not yet recruiting Torino, TO, Italy, 10153 Contact: Alessandro Comandone, MD    +390118151 ext 211    alessandro.comandone@gradenigo.it    Principal Investigator: Alessandro Comandone, MD          Istituto Ortopedico Rizzoli Recruiting Bologna, Italy, 40136 Contact: Stefano Ferrari, MD    +390516366 ext 411    stefano.ferrari@ior.it    Contact: Emanuela Marchesi, PhD    +390516366 ext 400    emanuela.marchesi@ior.it    Principal Investigator: Stefano Ferrari, MD          A.O. Universitaria Meyer Recruiting Firenze, Italy, 50139 Contact: Angela Tamburini, MD    +3905556 ext 621    a.tamburini@meyer.it    Principal Investigator: Angela Tamburini, MD          Istituto Giannina Gaslini Not yet recruiting Genova, Italy Contact: Carla Manzitti, MD          Principal Investigator: Carla Manzitti, MD          FONDAZIONE IRCCS Istituto Nazionale dei Tumori Recruiting Milano, Italy Contact: Rossella Bertulli, MD          Principal Investigator: Rossella Bertulli, MD          FONDAZIONE IRCCS Istituto Nazionale dei Tumori Recruiting Milano, Italy Contact: Roberto Luksch, MD          Principal Investigator: Roberto Luksch, MD          Istituto Nazionale Tumori "Fondazione G. Pascale" Not yet recruiting Napoli, Italy, 80131 Contact: Gaetano Apice, MD          Principal Investigator: Gaetano Apice, MD          Azienda Ospedaliera di Padova Recruiting Padova, Italy Contact: Gianni Bisogno, MD          Principal Investigator: Gianni Bisogno, MD          Istituti Fisioterapici Ospitalieri di Roma Recruiting Roma, Italy Contact: Virginia Ferraresi, MD          Principal Investigator: Virginia Ferraresi, MD          Ospedale Pediatrico Bambin Gesu' Recruiting Roma, Italy Contact: Raffaele Cozza, MD          Principal Investigator: Raffaele Cozza, MD          Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Recruiting Torino, Italy, 10126 Contact: Franca Fagioli, MD    +39.011.3135 ext 230    franca.fagioli@unito.it    Principal Investigator: Franca Fagioli, MD Less <<
NCT00002461 Lymphoma Phase 2 Completed - United States, New York ... More >> Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 Less <<
NCT02083679 Carcinoma, Non-Small-Cell Lung Phase 1 Terminated(Sponsor the return ... More >>rights of the compound to the collaboration partner for further clinical development) Less << - United States, Massachusetts ... More >> Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States Germany Please contact the Merck KGaA Communication Center located in Darmstadt, Germany Less <<
NCT02788461 Non-Small Cell Lung Cancer Not Applicable Recruiting April 2025 Canada, Ontario ... More >> London Regional Cancer Program Recruiting London, Ontario, Canada, N6A 4L6 Contact: David Palma, MD    519-685-8500    david.palma@lhsc.on.ca    Stronach Regional Cancer Centre at Southlake Regional Health Centre Recruiting Newmarket,, Ontario, Canada, L3Y 2P9 Contact: Mojgan Taremi, MD, FRCPC    905-895-4521 ext 6595    mtaremi@southlakeregional.org    Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Alex Sun, MD, FRCPC    (416) 946-2000    alex.sun@rmp.uhn.on.ca    Canada, Ont Kingston General Hospital Recruiting Kingston, Ont, Canada, K7L 2V7 Contact: Allison Ashworth, MD, FRCPC    613-544-2631 ext 8106    allison.ashworth@krcc.on.ca    Canada, Quebec McGill University Health Centre, Glen site Cedars Cancer Center Recruiting Montreal,, Quebec, Canada, H4A 3J1 Contact: Sergio L. Faria, MD, PhD    (514) 934-1934 ext 36157       Contact: Marianna Perna    (514) 934-1934 ext 43191    marianna.perna@muhc.mcgill.ca    Canada CHU de Quebec - L'Hôtel-Dieu de Québec Recruiting Quebec, Canada, G2L 2Z3 Contact: Anne Dagnault, MD PhD    1 418-525-4444, ext 15264    anne.dagnault@mail.chuq.qc.ca    Contact: Josee Allard;    (418) 525-4444 ext 16730    Josee.Allard@chudequebec.ca Less <<
NCT01031420 Muscle Invasive Bladder Cancer... More >> High Risk Urothelial Carcinoma of the Upper Urinary Tracts Less << Phase 2 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT02083679 - Terminated(Sponsor the return ... More >>rights of the compound to the collaboration partner for further clinical development) Less << - -
NCT03425643 Non-small Cell Lung Cancer Phase 3 Recruiting June 29, 2026 -
NCT01687439 Non-small Cell Lung Cancer Phase 2 Completed - China ... More >> Fudan University Shanghai Cancer Center Shanghai, China Less <<
NCT02365805 Breast Cancer Phase 2 Completed - Spain ... More >> Hospital Universitario Puerta del Mar Cádiz, Spain, 11009 Hospital Universitario Reina Sofía Córdoba, Spain, 14004 Hospital Universitario Juan Ramón Jimenez Huelva, Spain, 21005 Complejo Hospitalario de Jaén Jaén, Spain, 23007 Hospital Universitario Virgen Macarena Seville, Spain, 41007 Hospital Universitario Virgen del Rocío Seville, Spain, 41013 Hospital Universitario Nuestra Señora de Valme Seville, Spain, 41014 Less <<
NCT00201383 Oral Cavity S... More >>quamous Cell Carcinoma Less << Phase 3 Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00626639 Mucositis Hea... More >>d and Neck Cancer Less << Phase 1 Phase 2 Completed - -
NCT00532818 Metastatic Cervical Cancer Phase 3 Unknown December 2010 Mexico ... More >> Instituto Nacional de Cancerologia Recruiting Mexico City, Distrito Federal, Mexico, 14080 Principal Investigator: Lucely Cetina, MD Less <<
NCT00863512 Lung Cancer Phase 3 Terminated - -
NCT02867865 Gall Bladder Cancers Phase 2 Phase 3 Recruiting August 2022 India ... More >> Tata Memorial Centre Recruiting Mumbai, Maharashtra, India, 400012 Contact: Reena Engineer, MD    +912224177165    reena_engineer@rediffmail.com    Contact: ShyamKishore Shrivastava, MD    +912224177163    shrivastavask@tmc.gov.in    Principal Investigator: Reena Engineer, MD Less <<
NCT00626639 - Completed - -
NCT00416507 Pancreatic Cancer Phase 3 Completed - -
NCT00003401 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT00003211 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Texas Children's Cancer Center Houston, Texas, United States, 77030-2399 Australia, New South Wales Children's Hospital at Westmead Westmead, New South Wales, Australia, 2145 Australia, Victoria Royal Children's Hospital Parkville, Victoria, Australia, 3052 Less <<
NCT00863512 - Terminated - -
NCT01107639 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Cancer Less << Phase 3 Completed - -
NCT00504751 Non-Hodgkin's Lymphoma Phase 2 Completed - United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10021 Less <<
NCT00002481 Lymphoma Phase 2 Unknown - United States, Wisconsin ... More >> St. Luke's Medical Center Milwaukee, Wisconsin, United States, 53215 Less <<
NCT00002854 Cancer Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00003402 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT03215719 Oropharyngeal Carcinoma ... More >> HPV Positive Oropharyngeal Squamous Cell Carcinoma Less << Phase 2 Recruiting July 2021 United States, New York ... More >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Sunita Latchman    646-754-4590    Sunita.Latchman@nyumc.org    Principal Investigator: Kenneth Hu, MD Less <<
NCT02899728 Extensive Stage Lung Small Cel... More >>l Carcinoma Less << Phase 2 Suspended(Other - Pending prot... More >>ocol amendment) Less << April 7, 2020 United States, California ... More >> Los Angeles County-USC Medical Center Los Angeles, California, United States, 90033 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Keck Medical Center of USC Pasadena Pasadena, California, United States, 91105 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Kentucky University of Kentucky/Markey Cancer Center Lexington, Kentucky, United States, 40536 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Siteman Cancer Center at West County Hospital Creve Coeur, Missouri, United States, 63141 Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Siteman Cancer Center at Christian Hospital Saint Louis, Missouri, United States, 63136 Siteman Cancer Center at Saint Peters Hospital Saint Peters, Missouri, United States, 63376 United States, New York Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York, United States, 10016 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Pennsylvania Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States, 19107 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Virginia University of Virginia Cancer Center Charlottesville, Virginia, United States, 22908 Virginia Commonwealth University/Massey Cancer Center Richmond, Virginia, United States, 23298 Less <<
NCT00002642 Lung Cancer Phase 2 Completed - United States, Tennessee ... More >> Vanderbilt Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT02285543 Mouth Neoplasms ... More >> Carcinoma, Squamous Cell Less << Phase 2 Active, not recruiting December 2021 China, Shanghai ... More >> Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai, China, 200011 Less <<
NCT00049348 Pancreatic Cancer Phase 2 Completed - -
NCT00003399 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT00504751 - Completed - -
NCT02715531 Solid Tumor Phase 1 Recruiting January 28, 2021 -
NCT01993810 Stage II Non-Small Cell Lung C... More >>ancer AJCC v7 Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 Stage III Non-Small Cell Lung Cancer AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Less << Phase 3 Recruiting December 31, 2025 United States, Florida ... More >> University of Florida Health Science Center - Jacksonville Recruiting Jacksonville, Florida, United States, 32209 Contact: Site Public Contact    412-339-5294    Roster@nrgoncology.org    Principal Investigator: Bradford S. Hoppe          United States, Illinois Northwestern Medicine Cancer Center Warrenville Suspended Warrenville, Illinois, United States, 60555 United States, Maryland Maryland Proton Treatment Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact    410-369-5226    info@mdproton.com    Principal Investigator: Charles B. Simone          University of Maryland/Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Site Public Contact    800-888-8823       Principal Investigator: Charles B. Simone          Upper Chesapeake Medical Center Recruiting Bel Air, Maryland, United States, 21014 Contact: Site Public Contact    443-643-3010       Principal Investigator: Jack J. Hong          Central Maryland Radiation Oncology in Howard County Recruiting Columbia, Maryland, United States, 21044 Contact: Site Public Contact    443-546-1300       Principal Investigator: Charles B. Simone          Tate Cancer Center Recruiting Glen Burnie, Maryland, United States, 21061 Contact: Site Public Contact    410-553-8100       Principal Investigator: Charles B. Simone          United States, Massachusetts Massachusetts General Hospital Cancer Center Suspended Boston, Massachusetts, United States, 02114 Mass General/North Shore Cancer Center Suspended Danvers, Massachusetts, United States, 01923 United States, Missouri Siteman Cancer Center at West County Hospital Recruiting Creve Coeur, Missouri, United States, 63141 Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu    Principal Investigator: Jeffrey D. Bradley          Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Site Public Contact    800-600-3606    info@siteman.wustl.edu    Principal Investigator: Jeffrey D. Bradley          United States, New Jersey Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          ProCure Proton Therapy Center-Somerset Suspended Somerset, New Jersey, United States, 08873 United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Site Public Contact    212-639-7592       Principal Investigator: Abraham J. Wu          Memorial Sloan Kettering Sleepy Hollow Suspended Sleepy Hollow, New York, United States, 10591 United States, Pennsylvania University of Pennsylvania/Abramson Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Site Public Contact    800-474-9892       Principal Investigator: Samuel Swisher-McClure          Thomas Jefferson University Hospital Active, not recruiting Philadelphia, Pennsylvania, United States, 19107 United States, Tennessee Tennessee Cancer Specialists-Dowell Springs Recruiting Knoxville, Tennessee, United States, 37909 Contact: Site Public Contact    865-244-3209       Principal Investigator: J. B. Wilkinson          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact    877-312-3961       Principal Investigator: Quynh-Nhu Nguyen          MD Anderson Regional Care Center-Katy Suspended Houston, Texas, United States, 77094 MD Anderson Regional Care Center-Bay Area Suspended Nassau Bay, Texas, United States, 77058 MD Anderson Regional Care Center-Sugar Land Suspended Sugar Land, Texas, United States, 77478 MD Anderson Regional Care Center-The Woodlands Suspended The Woodlands, Texas, United States, 77384 United States, Washington ProCure Proton Therapy Center-Seattle Recruiting Seattle, Washington, United States, 98133 Contact: Site Public Contact    412-339-5294    Roster@nrgoncology.org    Principal Investigator: Ramesh Rengan          University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Contact: Site Public Contact    800-804-8824       Principal Investigator: Ramesh Rengan Less <<
NCT02359058 Stomach Neoplasms Phase 1 Completed - Japan ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Aichi, Japan, 464-8681 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Chiba, Japan, 277-8577 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician. Ehime, Japan, 791-0280 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT-5 hours, EST), or speak with your personal physician Osaka, Japan, 565-0871 Less <<
NCT02359058 - Completed - -
NCT02886195 EGFR Gene Mutation Phase 3 Enrolling by invitation July 2019 -
NCT03251313 Triple Negative Breast Cancer Phase 1 Not yet recruiting December 2020 -
NCT00715611 Mesothelioma Phase 2 Recruiting July 2019 United States, Florida ... More >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Bradford Perez, MD    888-663-3488       Principal Investigator: Bradford Perez, MD          United States, Massachusetts Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Raymond Mak, MD    617-632-3591       United States, Minnesota Mayo Clinic Cancer Center Recruiting Rochester, Minnesota, United States, 55905 Contact: Nina Garces, MD    507-538-3270       United States, New Jersey Memorial Sloan Kettering at Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Andreas Rimner, MD    212-639-6025       United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering West Harrison Recruiting Harrison, New York, United States, 10604 Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Andreas Rimner, MD    212-639-6025       Contact: Valerie Rusch, MD    212-639-5873       Principal Investigator: Andreas Rimner, MD          Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Andreas Rimner, MD    212-639-6025       Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Recruiting Sleepy Hollow, New York, United States, 10591 Contact: Andreas Rimner, MD    212-639-6025       United States, Texas Md Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Daniel Gomez, MD          Principal Investigator: Daniel Gomez, MD Less <<
NCT00003105 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00201396 Nasopharyngeal Carcinoma Phase 3 Completed - Taiwan ... More >> Kaohsiung Medical University Hospital Kaohsiung, Taiwan, 80708 China Medical University Hospital Taichung, Taiwan, 40447 National Taiwan University Hospital Taipei, Taiwan, 115 Chang-Gung Memorial Hospital(Lin-Kou), Taoyuan, Taiwan, 333 Less <<
NCT02542111 Diffuse Large B-cell Lymphoma Phase 2 Recruiting May 2018 China, Shanghai ... More >> Ruijin Hospital Recruiting Shanghai, Shanghai, China Contact: Pengpeng XU, MD    64370045 ext 610707 Less <<
NCT00003240 Lung Cancer Phase 3 Unknown - United Kingdom ... More >> Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, WIT 3AA Less <<
NCT02959385 Stage II Esophageal Cancer ... More >> Stage III Esophageal Cancer Less << Phase 2 Recruiting September 2021 China, Tianjin ... More >> Department of Radiation Oncology, Tianjin Medical University Cancer Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: QING SONG PANG, M.D    +86-22-23340123-1314    pangqingsong@yahoo.com.cn Less <<
NCT00014573 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT02567383 Recurrent Head and Neck Cancer Phase 2 Recruiting March 2020 Taiwan ... More >> Shin Kong Wu Ho-Su Memorial Hospital Recruiting Taipei, Taiwan Contact: Kwan-Hwa Chi, M.D.    886-2-28332211 ext 2274    M006565@ms.skh.org.tw    Contact: Kai-Lin Yang, M.D.    886-2-28332211 ext 2275    M011360@ms.skh.org.tw Less <<
NCT00022178 Carcinoma of Unknown Primary Phase 3 Unknown - United Kingdom ... More >> Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Less <<
NCT01218048 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Completed - United States, Pennsylvania ... More >> UPCI - Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01218048 - Completed - -
NCT00004887 Lung Cancer Phase 3 Unknown - United Kingdom ... More >> Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Less <<
NCT00069953 Esophageal Cancer Phase 2 Completed - -
NCT00069953 - Completed - -
NCT03473756 Urothelial Carcinoma Phase 1 Phase 2 Recruiting July 25, 2022 -
NCT02520219 Peripheral T-cell Lymphomas Phase 2 Unknown December 2015 China, Jiangsu ... More >> Jiangsu province tumor hospital Recruiting Nanjing City, Jiangsu, China, 210002 Contact: Qingfeng Yin, Clinical Manager    0086013912903257    y_qingfeng@163.com    Contact: Xiaolei Zhou, Manager    0086013776639377    zhouxiaolei@simcere.com Less <<
NCT00016341 Endometrial Cancer Phase 3 Terminated - -
NCT02641847 Triple Negative Breast Cancer ... More >> Breast Cancer Less << Phase 2 Phase 3 Recruiting - China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Zhi-Min Shao, MD.PhD.    86-18017312288    zhimingshao@yahoo.com Less <<
NCT01793701 Locally Advanced Cervical Canc... More >>er Less << Phase 1 Phase 2 Active, not recruiting April 2018 United Kingdom ... More >> Barts Health NHS Trust London, United Kingdom Hammersmith Hospital London, United Kingdom Royal Marsden London, United Kingdom Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, United Kingdom Less <<
NCT03331575 Unresectable Stage III Non-sma... More >>ll-cell Lung Cancer Less << Phase 3 Recruiting November 2020 China, Shanghai ... More >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD    +862122200000 ext 3602    xlfu1964@126.com    Contact: Qin Zhang, PhD    +8618017321606 ext 3602    zhangq0616@163.com Less <<
NCT03540017 Ovarian Cancer|Fallopian Tube ... More >>Cancer|Primary Peritoneal Carcinoma Less << PHASE1 RECRUITING 2025-07-05 Long Island Jewish Medical Cen... More >>ter, New Hyde Park, New York, 11040, United States Less <<
NCT00128037 Pulmonary Neoplasm Phase 2 Completed - Japan ... More >> National Cancer Center Chuo-ku, Tokyo, Japan, 104-0045 Less <<
NCT03023436 Stomach Neoplasm Phase 3 Recruiting June 2022 China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100-142 Contact: Xiangqian Su, M.D., Ph.D.    +86-138-0126-2916       Principal Investigator: Xiangqian Su, M.D., Ph.D          China, Fujian Fujian Provincial Hospital Recruiting Fuzhou, Fujian, China, 350-014 Contact: Liangxiang Huang, M.D., Ph.D.    0086-138-5902-0211       Principal Investigator: Liangxiang Huang, M.D., Ph.D.          China, Guangdong Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510-060 Contact: Zhiwei Zhou, M.D., Ph.D.    +86-139-0222-2859    zhouzhw@sysucc.org.cn    Principal Investigator: Zhiwei Zhou, M.D., Ph.D.          Guangdong General Hospital Recruiting Guangzhou, Guangdong, China, 510-080 Contact: Yong Li, M.D., Ph.D.    +86-138-2217-7479    yuan821007@126.com    Principal Investigator: Yong Li, M.D., Ph.D.          Cancer Center of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510-095 Contact: Shuzhong Cui, M.D., Ph.D.    +86-138-0251-3800    cuishuzhong@126.com    Principal Investigator: cuishuzhong@126.com Cui, M.D., Ph.D.          Zhujiang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China, 510-280 Contact: Jinlong Yu, M.D., Ph.D.    +86-131-8909-7861    yujinlong640506@163.com    Principal Investigator: Jinlong Yu, M.D., Ph.D.          Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510-515 Contact: Guoxin Li, M.D., Ph.D.    +86-138-0277-1450    gzliguoxin@163.com    Contact: Hao Liu, M.D., Ph.D.    +86-138-2215-8578    liuhaofbi@163.com    Principal Investigator: Guoxin Li, M.D., Ph.D.          The Third Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510-630 Contact: Hong-Bo Wei, M.D., Ph.D.    0086-18922102969    drweihb@126.com    Contact: Bo Wei, M.D.    0086-13527794069    sanpi2013@163.com    Principal Investigator: Hong-Bo Wei, M.D., Ph.D.          The Sixth Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510-655 Contact: Junsheng Peng, M.D., Ph.D.    +86-138-0296-3578    pengsir1010@126.com    Principal Investigator: Junsheng Peng, M.D., Ph.D.          Meizhou People's Hospital Recruiting Meizhou, Guangdong, China, 514-031 Contact: Zuguang Wu, M.D.    +86-135-0252-3063    wuzg1913@163.com    Principal Investigator: Zuguang Wu, M.D.          Zhongshan City People Hospital Recruiting Zhongshan, Guangdong, China, 528-403 Contact: Hong Chen, M.D., Ph.D.    +86-135-9084-3781    cenhong228@sohu.com    Principal Investigator: Hong Chen, M.D., Ph.D.          China, Shanghai Zhongshan Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200-032 Contact: Yihong Sun, M.D., Ph.D.    +86-137-0173-5406    yihongsun@medmail.com.cn    Principal Investigator: Yihong Sun, M.D., Ph.D.          China, Sichuan West China Hospital, Sichuan University Recruiting Chengdu, Sichuan, China, 610-041 Contact: Jiankun Hu, M.D., Ph.D.    +86-189-8060-1504    hujkwch@126.com    Principal Investigator: Jiankun Hu, M.D.,Ph.D. Less <<
NCT02741570 Head and Neck Cancer Phase 3 Recruiting August 15, 2025 -
NCT00360971 - Terminated(Due to positive pre... More >>liminary results from other palifermin studies.) Less << - -
NCT01633541 Laryngeal Cancer Phase 2 Active, not recruiting December 2018 United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00808899 Neuroblastoma Phase 2 Terminated(Voluntarily closed ... More >>and terminated by the PI due to lack of feasibility) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03708042 Stage II Esophageal Cancer ... More >> Stage III Esophageal Cancer Less << Phase 3 Not yet recruiting December 1, 2023 -
NCT00199758 Non Small Cell Lung Carcinoma Phase 2 Completed - France ... More >> Service de Pneumologie Beauvais, France Service de Pneumologie Bordeaux, France Service de Pneumologie Charleville Mezière, France Service de Pneumologie Créteil, France Service de Pneumologie Draguignan, France Service de Pneumologie Elbeuf, France Service de Pneumologie Gap, France Service de Pathologie Respiratoire Limoges, France Service de Pneumologie, Hôpital de la Croix Rousse Lyon, France Service de Pneumologie Mantes La Jolie, France Département des Maladies Respiratoires Marseille, France Service de Pneumologie-Allergologie Martigues, France Service de Pneumologie Meaux, France Service de Pneumologie Mulhouse, France Service de Pneumologie - Hôpital St Antoine Paris, France Service de Pneumologie, Hôpital Pontchailloux Rennes, France Hôpital Charles Nicolle, Service de Pneumologie Rouen, France Service de Pneumologie, Hôpital Bois Guillaume Rouen, France Service de Pneumologie, Hôpital Nord saint Etienne, France Service de Pathologie Respiratoire Toulon naval, France Service de Pneumologie Villefranche, France Less <<
NCT00002522 Lymphoma Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase - Temple Cancer Center Philadelphia, Pennsylvania, United States, 19111-2442 Less <<
NCT02876861 High-Grade Upper Tract Urothel... More >>ial Carcinoma Less << Phase 2 Recruiting August 2020 China, Hunan ... More >> Xiangya Hospital of Central South Univeristy Recruiting Changsha, Hunan, China, 410008 Contact: Long Wang, M.D. Ph.D.    008613873151645    doctorwanglong@163.com Less <<
NCT00113399 - Terminated(Terminated early du... More >>e to low accrual.) Less << - -
NCT00006038 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00113399 Head and Neck Cancer Phase 3 Terminated(Terminated early du... More >>e to low accrual.) Less << - -
NCT00468169 Head and Neck Cancer Phase 2 Unknown November 2012 United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT03306121 Nasopharyngeal Carcinoma Phase 3 Recruiting November 9, 2023 China, Guangdong ... More >> Sun Yat-sen Universitty Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Hai-Qiang Mai, MD,PhD    +862087343643    maihq@sysucc.org.cn    Principal Investigator: Hai-Qiang Mai, MD,PhD Less <<
NCT02987998 Stage IIIA Non-Small Cell Lung... More >> Cancer Less << Phase 1 Recruiting January 2020 United States, Ohio ... More >> University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Withdrawn Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Nathan Pennell, MD, PhD    216-445-9282    penneln@ccf.org Less <<
NCT00808899 - Terminated(Voluntarily closed ... More >>and terminated by the PI due to lack of feasibility) Less << - -
NCT02595554 Cervical Carcinoma Stage IIB Phase 3 Recruiting December 2020 China, Guangdong ... More >> Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Jihong Liu, Ph.D.    86-20-87343102    Liujih@mail.sysu.edu.cn    Contact: He Huang, Ph.D.    86-20-87343104    huangh@sysucc.org.cn Less <<
NCT03249519 Cervical Cancer Not Applicable Recruiting December 31, 2099 Germany ... More >> Universitätsklinikum Erlangen, Strahlenklinik Recruiting Erlangen, Germany, 91054 Contact: Oliver Ott, MD    ++49 9131 85 ext 33968    st-studiensekretariat@uk-erlangen.de Less <<
NCT02076477 Oligo-metastatic Stage IV Non-... More >>small Cell Lung Cancer Less << Phase 3 Unknown - China, Sichuan ... More >> Sichuan Cancer Hospital & Institute Recruiting Chengdu, Sichuan, China, 610041 Contact: TAO LI, MD, PhD    86-18908178818    litaoxmf@163.com    Principal Investigator: TAO LI, MD, PhD          Sub-Investigator: XIAOHU WANG, MD, PhD          Sub-Investigator: XIAOBO DU, MD, PhD          Sub-Investigator: BING LU, MD, PhD Less <<
NCT02082522 Hilar Cholangiocarcinoma Phase 3 Terminated(Accrual rate remain... More >>ing too low) Less << - -
NCT00138658 Non-small Cell Lung Cancer Phase 1 Phase 2 Completed - United States, California ... More >> LAC-USC Medical Center Los Angeles, California, United States, 90033 University of Southern California Norris Los Angeles, California, United States, 90033 United States, New York New York Oncology Hematology Albany, New York, United States, 12208 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29605 United States, Texas Mary Crowley Medical Research Center Dallas, Texas, United States, 75246 Canada, Alberta Tom Baker Cancer Centre Calgary, Alberta, Canada Canada, British Columbia BC Cancer Agency, Fraser Valley Centre Surrey, British Columbia, Canada BC Cancer Agency, Vancouver Center Vancouver, British Columbia, Canada Canada, Newfoundland and Labrador Dr. H. Bliss Murphy Cancer Center St. Johns, Newfoundland and Labrador, Canada Canada, Ontario Royal Victoria Hospital of Barrie Barrie, Ontario, Canada London Regional Cancer Centre London, Ontario, Canada Ottawa Hospital Ottawa, Ontario, Canada Toronto Sunnybrook Regional Cancer Center Toronto, Ontario, Canada Canada, Quebec Hopital Laval Ste-Foy, Quebec, Canada Less <<
NCT01631136 Advanced Non Small Cell Lung C... More >>ancer Less << Phase 3 Completed - -
NCT01534949 Diffuse Large B-Cell Lymphoma Phase 1 Terminated - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01802021 Carcinoma, Non-Small-Cell Lung Phase 2 Phase 3 Unknown February 2014 Taiwan ... More >> Center for traditional chinese medicine, Chang Gung Memorial Hospital Recruiting Gueishan Township, Taoyuan County, Taiwan, 33378 Contact: Tse-Hung Huang, M.D.    +886-3196200 ext 2613    tsehunghuang_1089@yahoo.com.tw    Principal Investigator: Tse-Hung Huang, M.D. Less <<
NCT01134861 Lung Cancer Phase 3 Completed - -
NCT01536392 Cancer of the Cervix Phase 3 Active, not recruiting March 2020 United States, Texas ... More >> Lyndon B. Johnson General Hospital Houston, Texas, United States, 77026 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00627432 Bladder Cancer Phase 2 Suspended - France ... More >> Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Less <<
NCT03274414 Paranasal Sinus Cancer ... More >> Nasal Cavity Tumor Nasal Cavity Adenocarcinoma Less << Phase 2 Recruiting September 1, 2020 United States, New Jersey ... More >> Memoral Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Marc Cohen, MD    212-639-3769       Memoral Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Marc Cohen, MD    212-639-3769       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Marc Cohen, MD    212-639-3769       United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10021 Contact: Marc Cohen, MD    212-639-3769 Less <<
NCT03212651 Bladder Cancer Phase 2 Recruiting May 2019 France ... More >> Gustave Roussy Recruiting Villejuif, Val de Marne, France, 94805 Contact: Yohann LORIOT, MD    0142115276 ext +33    yohann.loriot@gustaveroussy.fr    Principal Investigator: Yohann LORIOT, MD Less <<
NCT01222572 Non-small Cell Lung Cancer ... More >> Lung Cancer NSCLC Less << Phase 1 Phase 2 Terminated(Slow accrual due to... More >> restrictive eligibility criteria) Less << - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00138658 - Completed - -
NCT01222572 - Terminated(Slow accrual due to... More >> restrictive eligibility criteria) Less << - -
NCT00921635 Cervical Cancer ... More >> Anemia Less << Phase 3 Suspended - -
NCT00675597 Lung Cancer Not Applicable Completed - United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT00675597 - Completed - -
NCT00003852 Childhood Germ Cell Tumor ... More >> Extragonadal Germ Cell Tumor Ovarian Cancer Testicular Germ Cell Tumor Less << Phase 2 Terminated(lack of patient inc... More >>lusion) Less << - France ... More >> Centre Paul Papin Angers, France, 49036 CHR de Besancon - Hopital Jean Minjoz Besancon, France, 25030 Institut Bergonie Bordeaux, France, 33076 Centre Regional Francois Baclesse Caen, France, 14076 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre de Lute Contre le Cancer,Georges-Francois Leclerc Dijon, France, 21079 CHR de Grenoble - La Tronche Grenoble, France, 38043 Clinique Saint Michel La Rochelle, France, 17000 Centre Leon Berard Lyon, France, 69373 Institut J. Paoli and I. Calmettes Marseille, France, 13273 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Antoine Lacassagne Nice, France, 06189 Hopital d'Instruction des Armees du Val de Grace Paris, France Institut Jean Godinot Reims, France, 51056 Centre Henri Becquerel Rouen, France, 76038 Centre Rene Huguenin Saint Cloud, France, 92211 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00616109 Extensive-Stage Small Cell Lun... More >>g Cancer Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT02212574 Medulloblastoma Not Applicable Recruiting May 2022 United States, Arizona ... More >> Phoenix Childrens Hospital Hematology/Oncology Recruiting Phoenix, Arizona, United States, 85016-7710 Contact: Michael Etzl, Dr    602-546-0920    metzl@phoenixchildrens.com    United States, Colorado Children's Hospital Colorado Center for Cancer & Blood Disorders Recruiting Aurora, Colorado, United States, 80045 Contact: Kathleen Dorris, M.D., M.S.    720-777-6772    kathleen.dorris@childrenscolorado.org    United States, Florida M D Anderson Cancer Center-Orlando Pediatric Hematology/Oncology Not yet recruiting Orlando, Florida, United States, 32806 Contact: Amy Smith, Dr    321-841-8588    amy.smith@orlandohealth.com    All Children's Hospital Pediatric Hematology/Oncology Recruiting Saint Petersburg, Florida, United States, 33701 Contact: Stacie Stapleton, Dr    727-767-4176    Stacie.Stapleton@allkids.org    United States, Georgia Children's Healthcare of Atlanta- Egleston Pediatric Neuro-Oncology Recruiting Atlanta, Georgia, United States, 30322 Contact: Tobey MacDonald, Dr    404-727-1447    tobey.macdonald@emory.edu    United States, Illinois Ann and Robert H Lurie Children's Hospital of Chicago Hematology/Oncology Recruiting Chicago, Illinois, United States, 60611 Contact: Stewart Goldman, Dr    312-227-4844    sgoldman@northwestern.edu    United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21287 Contact: Kenneth Cohen, MD, MBA    410-614-5055    kcohen@jhmi.edu    Contact: Tammy Scott, RN    4140-614-5990    scottta@jhmi.edu    United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Pratiti Bandopadhayay, MBBS, PhD          United States, Missouri Washington University School of Medicine Pediatric Hematology/Oncology Recruiting Saint Louis, Missouri, United States, 63110 Contact: Joshua Rubin, Dr    314-454-6018    rubin_j@kids.wustl.edu    United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Derek Hanson, MD    551-996-5437    dhanson@hackensackumc.org    United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Kevin De Braganca, MD    212-639-3449    debragak@mskcc.org    United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27705 Contact: David Ashley, MD, PhD       david.ashley@duke.edu    Principal Investigator: David Ashley, MD, PhD          United States, Ohio Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Mohamed S AbdelBaki, MBBCh    614-722-3250    mohamed.abdelbaki@nationwidechildrens.org    United States, Oregon Oregon Health and Science University Pediatric Hematology/Oncology Not yet recruiting Portland, Oregon, United States, 97239-3098 Contact: Kellie Nazemi, Dr    503-494-0714    nazemik@ohsu.edu    United States, Washington Seattle Children's Hospital Hematology/Oncology Recruiting Seattle, Washington, United States, 98105 Contact: Sarah Leary, Dr    206-987-2106    sarah.leary@seattlechildrens.org    United States, Wisconsin Childrens Hospital of Wisconsin (Medical College of Wisconsin) Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Jeffrey Knipstein, MD    414-955-4108    jknipstein@jhmi.edu Less <<
NCT00616109 - Completed - -
NCT00429754 Nausea Vomiti... More >>ng Less << Phase 4 Withdrawn(change of study popu... More >>lation and chemotherapeutic regimen) Less << - -
NCT02750670 Lymphoma, Non-Hodgkin's Phase 2 Active, not recruiting May 2020 Canada, Ontario ... More >> Princess Margaret Cancer Centre Toronto, Ontario, Canada Less <<
NCT03432598 Locally Advanced or Metastatic... More >> Lung Cancer Less << Phase 2 Recruiting July 2019 China, Beijing ... More >> Chinese Academy of Medical Sciences Tumor Hospital Recruiting Beijing, Beijing, China, 100021 Contact: Lijuan Zhao    861087788495    cancergcp@163.com    Principal Investigator: Jie Wang, MD          Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Jun Huang    861088196023    hj19840804@163.com    Principal Investigator: Jun Zhao, MD          Beijing Chest Hospital Recruiting Beijing, Beijing, China, 133500 Contact: Jing Liu    861089509157    liujingworkbj@126.com    Principal Investigator: Zhe Liu, MD          China, Henan Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450008 Contact: Hongxia Li    8637165588007    51lihongxia@sina.com    Principal Investigator: Zhiyong Ma, MD          China, Jiangsu Jaingsu People's Hospital Recruiting Nanjing, Jiangsu, China, 210029 Contact: Mingmin Sun    862568136221    jsphkj@163.com    Principal Investigator: Yongqian Shu, MD          China, Jilin Jilin University First Hospital Recruiting Changchun, Jilin, China, 130021 Contact: Fei Wang    8643188786014    wangfei5780@126.com    Principal Investigator: Ying Cheng, MD          Jilin Cancer Hospital Recruiting Changchun, Jilin, China, 132000 Contact: Yan Xi    8643185879120    417064629@qq.com    Principal Investigator: Ying Cheng, MD Less <<
NCT02397486 Head and Neck Neoplasms Phase 2 Completed - Egypt ... More >> Ain Shams University Hospitals Cairo, Egypt Less <<
NCT00965172 Sarcoma Oral ... More >>Mucositis Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03243825 Cervical Cancer Not Applicable Completed - China ... More >> Cancer Hospital, Chinese Acadamy of Medical Sceinces Beijing, China, 100021 Less <<
NCT00502463 Head and Neck Cancer Not Applicable Unknown December 2013 Austria ... More >> LKH Feldkirch, Dept. of Radiooncology Feldkirch, Austria, 6807 Medical University of Graz, Dept. of Radiooncology Graz, Austria, 8036 LKH Leoben Dept. of Hemato-Oncology Leoben, Austria, 8700 Medical University of Vienna, Dept. of Medicine I Vienna, Austria, 1090 Less <<
NCT02591030 Bile Duct Cancer Phase 2 Phase 3 Recruiting September 2023 France ... More >> Chu Picardie Recruiting Amiens, France Principal Investigator: Vincent Heutefeuille          Ico Paul Papin Recruiting Angers, France Principal Investigator: Olivier Capitain          CH Victor Dupouy Recruiting Argenteuil, France Principal Investigator: Arnaud BOUTAN-LAROZE          CH de la Côte Basque Recruiting Bayonne, France, 64109 Principal Investigator: Franck AUDEMAR          CHRU Besançon Recruiting Besançon, France Principal Investigator: Marine Jarry          Hôpital Avicenne Not yet recruiting Bobigny, France Principal Investigator: Thomas Aparicio          Hôpital Saint-André Recruiting Bordeaux, France, 33000 Principal Investigator: Jean-Frédéric Blanc          Polyclinique Nord Recruiting Bordeaux, France, 33000 Principal Investigator: Cedric Lecaille          Hôpital Duchenne Recruiting Boulogne sur Mer, France Principal Investigator: Vincent Bourgeois          Centre François Baclesse Recruiting Caen, France Principal Investigator: Aurélie PARZY          Chu D'Estaing Recruiting Clermont-Ferrand, France Principal Investigator: Caroline Petorin          Hôpitaux Civils Recruiting Colmar, France Principal Investigator: Laurianne Plastaras          Ch Sud Francilien Recruiting Corbeil-Essonnes, France, 91100 Principal Investigator: Samy LOUAFI          Centre de radiothérapie et oncologie du Parc Recruiting Dijon, France, 21000 Principal Investigator: Ariane DARUT-JOUVE          Centre Georges François Leclerc Recruiting Dijon, France Principal Investigator: François GHIRINGHELLI          Hôpital Michallon Recruiting Grenoble, France Principal Investigator: Thomas DECAENS          CHD Vendée Recruiting La Roche sur Yon, France Principal Investigator: Roger Faroux          Clinique du cap d'Or Recruiting La Seyne sur Mer, France Principal Investigator: Mounira EL DEMERY          CH Le Kremlin Bicetre Recruiting Le Kremlin-Bicêtre, France Principal Investigator: Anne THIROT-BIDAULT          CHRU Lille Recruiting Lille, France Principal Investigator: Stéphane CATTAN          Centre Hospitalier de Longjumeau Recruiting Longjumeau, France, 91160 Principal Investigator: Samy LOUAFI          Clinique de la Sauvegarde Not yet recruiting Lyon, France, 69000 Principal Investigator: Isabelle Moullet          Centre Léon Bérard Recruiting Lyon, France Principal Investigator: Françoise DESSEIGNE          Hôpital de la Croix Rousse Recruiting Lyon, France Principal Investigator: Marielle Guillet          Hôpital Lyon Sud Recruiting Lyon, France Principal Investigator: Marion Chauvenet          Hôpital Saint-Joseph Recruiting Marseille, France Principal Investigator: Hervé Perrier          Centre Catherine de Sienne Recruiting Nantes, France Principal Investigator: Hélène Castanie          CHR Orléans Recruiting Orléans, France Principal Investigator: Jérome Meunier          HEGP Recruiting Paris, France Principal Investigator: Julien TAIEB          Hôpital Cochin Recruiting Paris, France Principal Investigator: Romain Coriat          Hôpital Saint-Jean Recruiting Perpignan, France Principal Investigator: Faiza KHEMISSA-AKOUZ          CHU La Miletrie Recruiting Poitiers, France Principal Investigator: David Tougeron          CHU Reims Recruiting Reims, France Principal Investigator: Alexandra Heurgue          Centre Eugène Marquis Recruiting Rennes, France Principal Investigator: Julien Edeline          Hôpital Drôme Nord Recruiting Romans sur Isère, France Principal Investigator: Marie-Claude Goutttebel          Chu Rouen Recruiting Rouen, France Principal Investigator: Pierre Michel          CHU Saint-Etienne Recruiting Saint-Etienne, France, 42055 Principal Investigator: Jean-Marc Phelip, PhD          CH Saint-Jean de Luz Recruiting Saint-Jean de Luz, France, 64500 Principal Investigator: Etienne Mauriac          CH Saint-Quentin Recruiting Saint-Quentin, France Principal Investigator: Innocenti DADAMESSI          Ch Robert Morlevat Recruiting Semur en Auxois, France Principal Investigator: Arnaud Patenotte          CAC Paul Strauss Recruiting Strasbourg, France, 67065 Principal Investigator: Meher BEN ABDELGHANI          CHU Tours Recruiting Tours, France Principal Investigator: Thierry Lecomte Less <<
NCT00439426 Nasopharyngeal Cancer Phase 2 Completed - Morocco ... More >> Agadir, Morocco, 80000 Casablanca, Morocco, 20502 Marrakech, Morocco, 40000 Rabat, Morocco, 10000 Rabat, Morocco, 6213 Less <<
NCT00312819 Non-small Cell Lung Cancer Phase 2 Phase 3 Completed - Israel ... More >> Oncology Institute Meir Medical Center Kfar Saba, Israel Less <<
NCT01857232 CINV Phase 2 Completed - Denmark ... More >> Odense University Hospital Odense, Denmark Less <<
NCT00452985 - Completed - Bangladesh ... More >> Sanofi-Aventis Dhaka, Bangladesh Less <<
NCT01665417 EGFR Positive Non-small Cell L... More >>ung Cancer Adenocarcinoma Less << Phase 4 Recruiting December 2017 China, Beijing ... More >> Chinese People's Liberation Army (PLA) General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Jiao Shunchang, MD    0086-13801380677       Principal Investigator: Jiao Shunchang, MD Less <<
NCT00162721 Uterine Sarcoma Phase 3 Unknown - France ... More >> Institut Gustave Roussy Recruiting Villejuif, France, 94800 Contact: Patricia Pautier, Dr    33 1 42 11 4340    pautier@igr.fr Less <<
NCT02665039 Urothelial Carcinoma ... More >> Bladder Cancer Renal Pelvis Cancer Ureter Cancer Urethra Cancer Less << Phase 2 Active, not recruiting January 2019 Denmark ... More >> Department of Oncology, Rigshospitalet Copenhagen, Denmark, DK-2100 Sweden Department of Oncology, Karolinska University Hospital Stockholm, Sweden Less <<
NCT00139230 Squamous Cell Carcinoma ... More >> Carcinoma of Head/Neck Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00198432 NSCLC Stage IIIB ... More >> Concomitant Radiochemotherapy Less << Phase 2 Completed - France ... More >> CHU Saint-Etienne Pneumologie Saint-Etienne, France, 42000 Less <<
NCT01104714 - Completed - France ... More >> CH d'Alès Alès, France, 30103 CHU de Bordeaux - Groupe Hospitalier Saint-André Bordeaux, France, 33075 CHU de Bordeaux - Groupe Hospitalier Pellegrin Bordeaux, France, 33076 CHU de Grenoble Grenoble cedex 09, France, 38043 Centre de Lutte Contre le Cancer - Centre Oscar Lambret Lille Cedex, France, 59020 CHU de Montpellier - Hôpital Gui de Chauliac Montpellier cedex 5, France, 34295 Centre Regional de Lutte Contre le Cancer - Val d'Aurelle - Paul Lamarque Montpellier cedex 5, France, 34298 Centre Antoine Lacassagne Nice cedex 2, France, 06189 CHU de Nîmes - Hôpital Universitaire Carémeau Nîmes, France, 30029 CHRU de Toulouse - Hôpital Purpan Toulouse Cedex 9, France, 31059 Centre de Lutte Contre le Cancer - Institut Claudius Regaud Toulouse Cedex, France, 31052 Pharmacologie Clinique, expérim. des anticancéreux, CLCC Claudius Regaud Toulouse, France, 31052 CHRU de Toulouse - Hôpital de Rangueil Toulouse, France, 31059 CHRU de Toulouse - Hôpital Larrey Toulouse, France, 31059 Less <<
NCT02074241 - Enrolling by invitation April 2019 China, Chongqing ... More >> Southwest hospital,Chian Chongqing, Chongqing, China, 400030 Less <<
NCT02240238 Solid Tumors Phase 1 Phase 2 Recruiting November 30, 2019 United States, California ... More >> California Cancer Associates for Research and Excellence Recruiting Encinitas, California, United States, 92024 UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92037 Pacific Hematology Oncology Associates Recruiting San Francisco, California, United States, 94115 United States, Illinois Northwestern University Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 United States, Massachusetts Tufts Medical Center Recruiting Boston, Massachusetts, United States, 02111 United States, North Carolina University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 United States, Ohio University Hospitals Case Medical Center Recruiting Cleveland, Ohio, United States, 44121 United States, Oklahoma University of Oklahoma Health Sciences Center Recruiting Oklahoma City, Oklahoma, United States, 73104 United States, Texas University of Texas Southwestern Medical Center Recruiting Dallas, Texas, United States, 75390 MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Bulgaria Multiprofile Hospital for Active Treatment Serdika EOOD Recruiting Sofia, Sofia-Grad, Bulgaria, 1632 Complex Oncology Center - Shumen EOOD Recruiting Shumen, Bulgaria, 9700 Italy Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori IRST Recruiting Meldola, Italy, 47014 ASST Grande Ospedale Metropolitano Niguarda - Presidio Ospedaliero Ospedale Niguarda Ca' Granda Recruiting Milano, Italy, 20162 Poland Wojewodzki Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie Recruiting Krakow, Poland, 31826 Med-Polonia Sp. z o.o. Recruiting Poznan, Poland, 60693 Romania Fundeni Clinical Institute Recruiting Bucharest, Romania, 22328 Coltea Clinical Hospital Recruiting Bucharest, Romania, 30171 Prof Dr I Chiricuta Institute of Oncology Recruiting Cluj-Napoca, Romania, 400015 Oncology Center Sfantul Nectarie Recruiting Craiova, Romania, 200347 Euroclinic Oncology Center SRL Recruiting Iasi, Romania, 700106 Institutul Regional de Oncologie Iasi Recruiting Iasi, Romania, 700483 Less <<
NCT01118039 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 2 Unknown - Spain ... More >> Hospital Del Mar Recruiting Barcelona, Spain, 08003 Contact: Contact Person    34-39-3248-3861    XVillanueva@imas.imim.es    Hospital de la Santa Cruz i Sant Pau Recruiting Barcelona, Spain, 08025 Contact: Contact Person    34-93-553-7118    jmaroto@santpau.cat    Hospital Universitario San Carlos Recruiting Madrid, Spain, 28040 Contact: Contact Person    34-91-330-3000, Ext. 7935    jgonzalezl.hcsc@salud.madrid.org    Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Contact Person    34-91-469-2313    cdanicas@hotmail.com Less <<
NCT00883480 Non-Small Cell Lung Cancer Not Applicable Completed - Spain ... More >> Ico-Hospital Universitarios Germans Trias I Pujol Badalona, Barcelona, Spain, 08916 Hospital Carlos Haya Málaga, Spain Less <<
NCT03404791 Bladder Cancer TNM Staging Pri... More >>mary Tumor (T) T2A Bladder Cancer TNM Staging Primary Tumor (T) T2B Bladder Cancer TNM Staging Primary Tumor (T) T3A Bladder Cancer TNM Staging Primary Tumor (T) T3B Less << Phase 1 Recruiting May 2019 United States, Arizona ... More >> Mayo Clinic Recruiting Phoenix, Arizona, United States, 85054 Contact: Clinical Trails Office - All Mayo Clinic Locations    855-776-0015       United States, Georgia North Georgia Urology Recruiting Dalton, Georgia, United States, 30720 Contact: Tennille Emery    423-315-7240    tennille.emery@elligodirect.com    United States, Maryland Chesapeake Urology Enrolling by invitation Hanover, Maryland, United States, 21076 United States, Michigan Michigan Institute of Urology Recruiting Troy, Michigan, United States, 48084 Contact: Danielle Osterhout, MLS(ASCP)CM    248-786-0467    OsterhoutD@michiganurology.com    United States, New York University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Contact: Mare Perevich, BSN,CCRC    585-275-0989    mare_perevich@urmc.rochester.edu    United States, Tennessee Urology Associates of Nashville Recruiting Nashville, Tennessee, United States, 37209 Contact: Rick Trotter, CRC    615-250-9268    crtrotter@ua-pc.com    Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Pam Steele, RN,BSN,CCRC    615-434-2120    pamela.steele@vanderbilt.edu    United States, Texas North Austin Urology Recruiting Austin, Texas, United States, 78750 Contact: Atilano Mendoza    737-931-0927    atilano.mendoza@elligodirect.com    United States, Virginia Urology of Virginia Recruiting Virginia Beach, Virginia, United States, 23462 Contact: Laurie Jackson    757-452-3461    LaurieJackson@urologyofva.net Less <<
NCT02167711 Cholangio Carcinoma Phase 2 Recruiting October 2018 Hong Kong ... More >> Department of Clinical Oncology, Prince of Wales Hospital Recruiting Hong Kong, Hong Kong Contact: Stephen L Chan, FRCP    35052166    l_chan@clo.cuhk.edu.hk    Contact: Jane Koh, RN    35051142    jane@clo.cuhk.edu.hk Less <<
NCT02508389 Radiation Induced Oral Mucosit... More >>is Less << Phase 2 Active, not recruiting August 2019 -
NCT02016209 Non Small Cell Lung Cancer Phase 2 Unknown March 2016 China, Zhejiang ... More >> The first affiliated hospital, Zhejiang University Not yet recruiting Hangzhou, Zhejiang, China, 310003 Contact: Qiong Zhao, PhD    0571-87236802    doczq.2008@gmail.com    Principal Investigator: Qiong Zhao, PhD Less <<
NCT03629925 Squamous NSCLC Phase 3 Not yet recruiting August 2020 -
NCT00637624 Carcinoma, Non-Small-Cell Lung... More >> Carcinoma, Small Cell Lung Mesothelioma Less << Not Applicable Unknown February 2012 Netherlands ... More >> Rijnstate Hospital Recruiting Arnhem, Gelderland, Netherlands, 6800TA Contact: Idris Bahce, MD    +31263788888 ext 3652    I.Bahce@VUmc.nl    Principal Investigator: Idris Bahce, MD Less <<
NCT02985255 Tongue Neoplasms ... More >> Squamous Cell Carcinoma Anterior Tongue Squamous Cell Carcinoma Less << Phase 2 Unknown June 2017 India ... More >> HealthCare Global Enterprises Ltd Recruiting Bangalore, Karnataka, India, 560027 Contact: Vishal US Rao, MS    00919739774949    drvishalrao@yahoo.com    Contact: Sataksi Chatterjee, MS    00918971966903    sataksis2007@gmail.com    Sub-Investigator: Shekhar Patil, DM          Sub-Investigator: Radheshyam Naik, DM          Sub-Investigator: Vijay Agarwal, Phd          Sub-Investigator: Ajai BS Kumar, MS          Sub-Investigator: Kumara Swamy, MD          Sub-Investigator: Vikram Maiya, MD          Sub-Investigator: Ravi Nayar, MS          Sub-Investigator: Sataksi Chaterjee, MS          Sub-Investigator: Raghavendra M Rao, PhD          Sub-Investigator: Amritanshu Ram, PhD Less <<
NCT03390946 Osteosarcoma ... More >>Feasibility Treatment Response Biomarker Less << Phase 2 Not yet recruiting December 31, 2020 Korea, Republic of ... More >> National Cancer Center Not yet recruiting Goyang-si, Gyeonggi, Korea, Republic of, 10408 Contact: Byung-Kiu Park, M.D., Ph.D.    82-31-920-1240    bkpark@ncc.re.kr    Contact: Mi Mi Kwon, RN    82-31-920-1240    rnjsalal@ncc.re.kr Less <<
NCT03662841 Carcinoma, Hepatocellular Not Applicable Recruiting March 2021 Hong Kong ... More >> Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Carmen Wong    (852)3505 3210    carmenwongsp@cuhk.edu.hk    Contact: Pui Man Chong    (852)3505 3211    siuman@cuhk.edu.hk Less <<
NCT00226473 Metastatic Melanoma Phase 4 Unknown - Germany ... More >> Skin Cancer Unit, German Cancer Ressearch Center and Dept. of Dermatology, University Hospital of Mannheim Recruiting Mannheim, Baden-Württemberg, Germany, D-68167 Contact: Dirk Schadendorf, MD    +49-621-3832127    d.schadendorf@dkfz.de    Principal Investigator: Dirk Schadendorf, MD          Dept. of Dermatology, University Hospital Tuebingen Recruiting Tuebingen, Baden-Württemberg, Germany, D-72076 Contact: Claus Garbe, MD    +49-7071-2980872    studienzentrum-derm-onko@med.uni-tuebingen.de    Principal Investigator: Claus Garbe, MD          Dept. of Dermatology, University of Frankfurt Recruiting Frankfurt, Hessen, Germany, D-60590 Contact: Konstanze Spieth, MD    +49-69-6301-5311    konstanze.spieth@kgu.de    Principal Investigator: Konstanze Spieth, MD          Dept. of Dermatology, Medical Center Buxtehude Recruiting Buxtehude, Niedersachsen, Germany, D-21641 Contact: Peter Mohr, MD    +49-4161-7036297    mohrpe@cs.com    Principal Investigator: Peter Mohr, MD          Dept. of Dermatology, Hildesheim Recruiting Hildesheim, Niedersachsen, Germany, D-31134 Contact: Michael Tronnier, MD    +49-05121-894821       Principal Investigator: Michael Tronnier, MD          Dept. of. Dermatology, University of Saarland, Homburg Recruiting Homburg, Saaland, Germany, D-66421 Contact: Wolfgang Tilgen, MD    +49-6841-3800    hawtil@med-rz-sb.de    Sub-Investigator: Dorothea Tadler, MD          Dept. of Dermatology, University Otto von Guericke Recruiting Magdeburg, Saxony-Anhalt, Germany, D-39120 Contact: Jens Ulrich, MD    +49-391-6715428    jens.ulrich@medizin.uni-magdeburg.de    Contact: Vassiliki Bekou, MD    +49-391-6715264    vassiliki.bekou@medizin.uni-magdeburg.de    Sub-Investigator: Vassiliki Bekou, MD          Dept. of Dermatology, University of Schleswig-Holstein Recruiting Kiel, Schleswig-Holstein, Germany, D-24105 Contact: Axel Hauschild, MD    +49-431-596-1613    ahauschild@dermatology.uni.kiel.de    Principal Investigator: Axel Hauschild, MD          Dept. of Dermatology, University of Schleswig-Holstein, Campus Lübeck Recruiting Lübeck, Schleswig-Holstein, Germany, D-23538 Contact: Sven Krengel, MD    +49-451-5002517    svenkrengel@gm.net    Principal Investigator: Sven Krengel, MD          Dept. of Dermatology, Helios Clinic Erfurt Recruiting Erfurt, Thuringia, Germany, 99012 Contact: Ruthild Linse, MD    +49-361-7814300       Principal Investigator: Ruthild Linse, MD          Sub-Investigator: Yvonne Kellner, MD          Dept. of Dermatology, University of Jena Recruiting Jena, Thuringia, Germany, D-07740 Contact: Martin Kaatz, MD    +49-3641-937302    kaatz@derma.uni-jena.de    Principal Investigator: Martin Kaatz, MD          Dept. of Dermatology, Charité Berlin Recruiting Berlin, Germany, D-10098 Contact: Uwe Trefzer, MD    +49-30-450518063    uwe.trefzer@charite.de    Contact: Maja Hofmann, MD    +49-30-450518063    maja.hofmann@charite.de    Principal Investigator: Uwe Trefzer, MD          Dept. of Dermatology, Vivantes Clinics Recruiting Berlin, Germany, D-12351 Contact: Peter Kohl, MD    +49-30-60043601    p.kohl@vivantes.de    Principal Investigator: Peter Kohl, MD Less <<
NCT02258659 Human Papilloma Virus Infectio... More >>n Stage III Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Oropharynx Less << Phase 2 Active, not recruiting December 2021 United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT03520491 Bladder Cancer Phase 2 Recruiting January 2021 United States, New Jersey ... More >> Memoral Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Min Yuen Teo, MB BCh    914-367-7393       United States, New York Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Min Yuen Teo, MB BCh    914-367-7393       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Min Yuen Teo, MB BCh    914-367-7393       Contact: Jonathan Rosenberg, MD    646-888-4741 Less <<
NCT00112996 Neurotoxicity ... More >> Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 3 Completed - United States, Arkansas ... More >> Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States, 72913 United States, Indiana Horizon Oncology Center Lafayette, Indiana, United States, 47905 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana Cabrini Center for Cancer Care at Christus St. Frances Cabrini Hospital Alexandria, Louisiana, United States, 71301 United States, Michigan CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Minnesota CCOP - Metro-Minnesota St. Louis Park, Minnesota, United States, 55416 United States, Missouri Cancer Research for the Ozarks Springfield, Missouri, United States, 65804 United States, Oregon CCOP - Columbia River Oncology Program Portland, Oregon, United States, 97225 United States, Pennsylvania CCOP - Main Line Health Wynnewood, Pennsylvania, United States, 19096 United States, South Carolina CCOP - Greenville Greenville, South Carolina, United States, 29615 United States, Texas University of Texas M.D. Anderson CCOP Research Base Houston, Texas, United States, 77030-4009 CCOP - Scott and White Hospital Temple, Texas, United States, 76508 United States, Wisconsin Marshfield Clinic - Marshfield Center Marshfield, Wisconsin, United States, 54449 Less <<
NCT01191892 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Ureter Cancer Urethral Cancer Less << Phase 2 Unknown December 2014 United Kingdom ... More >> Beatson West of Scotland Cancer Centre Recruiting Glasgow, Scotland, United Kingdom, G12 0YN Contact: Contact Person    44-141-301-7095    Rob.Jones@ggc.scot.nhs.uk    Wales Cancer Trials Unit Recruiting Cardiff, Wales, United Kingdom, CF11 9LJ Contact: Contact Person    44-29-2019-6800       Ayr Hospital Recruiting Ayr, United Kingdom, KA66DX Contact: Margaret McKernan    01563 825749    margaret.mckernan@aaaht.scot.nhs.uk    Principal Investigator: Jawaher Ansari          Royal Bournemouth General Hospital Recruiting Bournemouth, United Kingdom, BH7 7DW Contact: Susannah Brock       susannah.brock@poole.nhs.uk    Principal Investigator: Susannah Brock          Queens Hospital Recruiting Burton upon Trent, United Kingdom, DE13 0RB Contact: Pugazhenthi Pattu    01332 340131    pugazhenthi.pattu@nhs.net    Principal Investigator: Pugazhenthi Pattu          Velindre Hospital Recruiting City and County of Cardiff, United Kingdom, CF142TL Contact: Dr Lester, Jason    44-2920 196159    jason.lester2@wales.nhs.uk    Principal Investigator: Jason Lester          Western General Hospital Recruiting Edinburgh, United Kingdom, EH4 2XU Contact: Duncan McLaren       duncan.mclaren@luht.scot.nhs.uk    Principal Investigator: Duncan McLaren          Calderdale Royal Infirmary Recruiting Halifax, United Kingdom, HX30PW Contact: Lisa Gledhill    01484 342925    lisa.gledhill@cht.nhs.uk    Principal Investigator: Ursula Hofmann          Huddersfield Royal Infirmary Recruiting Huddersfield, United Kingdom, HD3 3EA Contact: Uschi Hofmann    0484 847299    uschi.hofmann@cht.nhs.uk    Principal Investigator: Uschi Hofmann          The Royal Lancaster Infirmary Recruiting Lancaster, United Kingdom, LA1 4RP Contact: Alison Birtle    01524 583219    alison.birtle@lhtr.nhs.uk    Principal Investigator: Alison Birtle          St. James's University Hospital Recruiting Leeds, United Kingdom, LS9 7TF Contact: Satinder Jagdev    0113 2067645    satinder.jagdev@leedsth.nhs.uk    Principal Investigator: Satinder Jagdev          The Royal Free Hospital Not yet recruiting London, United Kingdom, NW3 2QG Principal Investigator: Maria Vilarino-Varela          St Marys Hospital Not yet recruiting London, United Kingdom, W21NY Contact: Gillian Hornzee       Gillian.Hornzee@imperial.nhs.uk    Principal Investigator: Simon Stewart          Charing Cross Hospital Not yet recruiting London, United Kingdom, W68RF Contact: Simon Stewart       simon.stewart@imperial.nhs.uk    Principal Investigator: Simon Stewart          Christie Hospital Recruiting Manchester, United Kingdom, M20 4BX Contact: Tony Eliott    01619187214    tony.eliott@christie.nhs.uk    Principal Investigator: Tony Eliott          Mount Vernon Hospital Recruiting Northwood Middlesex, United Kingdom, HA6 2RN Contact: Peter Hoskin    01923 844533    peter.hoskin@nhs.net    Principal Investigator: Peter Hoskin          Churchill Hospital Recruiting Oxford, United Kingdom, OX37LJ Contact: Georgina Rogers       patpandrewprotheroe@oncology.ox.ac.uk    Principal Investigator: Andrew Protheroe          Weston Park Hospital Recruiting Sheffield, United Kingdom, S102SJ Contact: Linda Evans    0114 226500    linda.evans@sth.nhs.uk    Principal Investigator: Linda Evans          Southampton General Hospital Recruiting Southampton, United Kingdom, S016 6YD Contact: Simon Crabb       s.j.crabb@southampton.ac.uk    Principal Investigator: Simon Crabb          Royal Surrey County Hospital Recruiting Surrey, United Kingdom, GU27XX Contact: Katie Wood    01483 571122    katiewood@nhs.net    Principal Investigator: Katie Wood          The Royal Marsden Hospital Recruiting Surrey, United Kingdom, KT2 7QB Contact: Robert Huddart    020 8661 3457    robert.huddart@icr.ac.uk    Principal Investigator: Robert Huddart Less <<
NCT03171493 Urothelial Carcinoma Phase 1 Recruiting December 2019 United States, Minnesota ... More >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Tessa Kroeninger    507-538-6107    kroeninger.tessa@mayo.edu    Contact: Tanner Miest, MD, PhD       miest.tanner@mayo.edu    Principal Investigator: Bradley Leibovich, MD          Sub-Investigator: Tanner Miest, MD, PhD Less <<
NCT01192230 Carcinoma, Non-Small-Cell Lung Phase 2 Unknown - China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Jianhua Chang, MD,PhD    13916619284    changjianhua@hotmail.com Less <<
NCT01969578 Salivary Gland Cancer Phase 2 Recruiting June 2021 Austria ... More >> Medical University Vienna - General Hospital AKH Recruiting Vienna, Austria, 1090 Principal Investigator: Thorsten Fuereder          Belgium ZNA Middelheim Recruiting Antwerp, Belgium, 2020 Principal Investigator: Dirk Schrijvers          Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet Recruiting Brussels, Belgium, 1000 Principal Investigator: Yassine Lalami          Cliniques Universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Principal Investigator: Jean-Pascal Machiels          Universitair Ziekenhuis Antwerpen Recruiting Edegem, Belgium, 2650 Principal Investigator: Pol Specenier          U.Z. Leuven - Campus Gasthuisberg Recruiting Leuven, Belgium Principal Investigator: Paul Clement          France CHU de Bordeaux - Groupe Hospitalier Saint-André - Hopital Saint-Andre Recruiting Bordeaux, France, 33075 Principal Investigator: Laurence Digue          Institut régional du Cancer Montpellier Recruiting Montpellier, France Principal Investigator: Didier Cupissol          Institut de Cancerologie de l'Ouest (ICO) - Centre Rene Gauducheau Recruiting Nantes, France, 44805 Principal Investigator: Frederic Rolland          CHU de Nantes - Hotel Dieu Recruiting Nantes, France Principal Investigator: Olivier Malard          Centre Antoine Lacassagne Recruiting Nice, France, 06189 Principal Investigator: Joel Guigay          Assistance Publique - Hopitaux de Paris - Hopital Tenon Recruiting Paris, France, 75020 Principal Investigator: Bertrand Baujat          Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole - Institut Claudius Regaud Recruiting Toulouse, France, 31059 Principal Investigator: Jean Pierre Delord          Institut de Cancérologie de Lorraine Recruiting Vandoeuvre-Les-Nancy, France, 54519 Principal Investigator: Marie-Christine Kaminsky-Forrett          Gustave Roussy Recruiting Villejuif, France Principal Investigator: Caroline Even          Germany Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Recruiting Berlin, Germany, 12200 Principal Investigator: Sebastian Ochsenreither          Universitaetsklinikum Jena-Radiation Therapy and Radiooncology Clinic Recruiting Jena, Germany, 07747 Principal Investigator: Orlando Guntinas-Lichius          Universitaetsklinikum Leipzig-Ambulanzen/Sprechstunden Recruiting Leipzig, Germany Principal Investigator: Andreas Dietz          Greece Athens University - Attikon University General Hospital Recruiting Athens, Greece, 12462 Principal Investigator: Amanda Psyrri          Hungary National Institute Of Oncology Recruiting Budapest, Hungary, 1122 Principal Investigator: Erika Hitre          Italy Azienda Ospedaliera Papa Giovanni XXIII Recruiting Bergamo, Italy, 24127 Principal Investigator: Cecilia Moro          Fondazione IRCCS Istituto Nazionale dei Tumori Recruiting Milan, Italy Principal Investigator: Laura Locati          Azienda Provinciale per i Servizi Sanitari - Ospedale Santa Chiara Recruiting Trento, Italy, 38100 Principal Investigator: Alessia Caldara          Netherlands Spaarne Gasthuis - Vrije Universiteit Medisch Centrum Recruiting Amsterdam, Netherlands, 1007MB Principal Investigator: Jan Buter          University Medical Center Groningen (UMCG) Recruiting Groningen, Netherlands, 9713 GZ Principal Investigator: Sjoukje Oosting-Lenstra          Radboud University Medical Center Nijmegen Recruiting Nijmegen, Netherlands Principal Investigator: Carla van Herpen Less <<
NCT03467360 Small Cell Lung Cancer Phase 1 Not yet recruiting December 30, 2022 -
NCT03159143 Metastatic Transitional Cell C... More >>ancer of the Urothelial Tract Less << Phase 2 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00392327 Anaplastic Medulloblastoma ... More >> Medulloblastoma Untreated Childhood Medulloblastoma Less << Phase 3 Suspended(Temporarily stopped ... More >>for assessment. Contact ctsucontact@westat.com for specifics) Less << - -
NCT00828841 Non-Small Cell Lung Cancer Phase 2 Completed - -
NCT03159143 - Completed - -
NCT02580994 Small Cell Lung Cancer (SCLC) Phase 2 Recruiting August 2020 Egypt ... More >> Ain Shams University Faculty of Medicine - Ain Shams University Hospital Not yet recruiting Cairo, Egypt, 11331 Contact: Omar Abdel-Rahman          Principal Investigator: Omar Abdel-Rahman, MD          National Cancer Institute Not yet recruiting Cairo, Egypt, 11796 Contact: Rabab Gaafar          Principal Investigator: Rabab Gaafar, MD, PhD          France Centre Hospitalier d'Avignon - Hopital Duffaut Recruiting Avignon, France, 84902 Contact: Nicolas Cloarec       cloarec.nicolas@ch-avignon.fr    Principal Investigator: Nicolas Cloarec, MD          CHU de Brest Recruiting Brest, France, 29200 Contact: Gilles Robinet       gilles.robinet@chu-brest.fr    Principal Investigator: Gilles Robinet, MD          Centre Regional Francois Baclesse Recruiting Caen, France, 14076 Contact: Radji Gervais       r.gervais@baclesse.unicancer.fr    Principal Investigator: Radji Gervais, MD          Centre Hopitalier Intercommunal De Creteil Recruiting Créteil, France, 94010 Contact: Isabelle Monnet, MD       Isabelle.Monnet@chicreteil.fr    Principal Investigator: Isabelle Monnet, MD          Centre Leon Berard Recruiting Lyon, France, 69008 Contact: Jerome Fayette       jerome.fayette@lyon.unicancer.fr    Principal Investigator: Jerome Fayette, MD          Assistance Publique - Hopitaux de Marseille - Hopital Nord Recruiting Marseille, France, 13015 Contact: Laurent Greillier       laurent.greiller@ap-hm.fr    Principal Investigator: Laurent Greillier, MD, PhD          Centre Hospitalier D'Annecy Recruiting Metz-Tessy, France, 74370 Contact: Chantal Decroisette       cdecroisette@ch-annecygenevois.fr    Principal Investigator: Chantal Decroisette, MD          Assistance Publique - Hopitaux de Paris - Hopital Avicenne Recruiting Paris, France, 93009 Contact: Boris Duchemann       boris.duchemann@aphp.fr    Principal Investigator: Boris Duchemann, MD          Centre Paul Strauss Recruiting Strasbourg, France, 67065 Contact: Roland Schott       rschott@strasbourg.unicancer.fr    Principal Investigator: Roland Schott, MD          Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Benjamin Besse       Benjamin.besse@gustaveroussy.fr    Principal Investigator: Benjamin Besse, MD, PhD          Italy Ospedale Cannizzaro Recruiting Catania, Italy, 95126 Contact: Giuseppe Banna          Principal Investigator: Giuseppe Banna, MD          Santa Croce e Carle General Hospital Not yet recruiting Cuneo, Italy, 12100 Contact: Ida Colantonio       colantonio.i@ospedale.cuneo.it    Principal Investigator: Ida Colantonio, MD          Azienda Ospedaliero-Universitaria Careggi Not yet recruiting Firenze, Italy, 50134 Contact: Lorenzo Livi          Principal Investigator: Lorenzo Livi, MD, PhD          Istituto Europeo di Oncologia Recruiting Milano, Italy, 20141 Contact: Filippo De Marinis       filippo.demarinis@ieo.it    Principal Investigator: Filippo De Marinis, MD, PhD          Ospedale San Paolo Recruiting Milano, Italy, 20142 Contact: Andrea Luciani       andrea.luciani@asst-santipaolocarlo.it    Principal Investigator: Andrea Luciani, MD          Ospedale S. Luigi Gonzaga - Universita Di Torino Recruiting Orbassano, Italy, 10043 Contact: Silvia Novello       silvia.novello@unito.it    Principal Investigator: Silvia Novello, MD, PhD          Azienda Ospedaliero-Universitaria "Santa Maria della Misericordia" di Udine Not yet recruiting Udine, Italy, 33100 Contact: Alessandro Follador       alessandro.follador@asuiud.sanita.fvg.it    Principal Investigator: Alessandro Follador, MD          Azienda Ospedaliera Universitaria Integrata Verona - Ospedale Borgo Roma Not yet recruiting Verona, Italy, 37134 Contact: Emilio Bria       emilio.bria@univr.it    Principal Investigator: Emilio Bria, MD, PhD          United Kingdom NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital Not yet recruiting Glasgow, United Kingdom, G12 0YN Contact: Nicola Steele       Nicola.Steele@ggc.scot.nhs.uk    Principal Investigator: Nicola Steele, MD          The Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom, M20 4BX Contact: Raffaele Califano       raffaele.califano@christie.nhs.uk    Principal Investigator: Raffaele Califano, MD          Newcastle Hospitals NHS Trust - Freeman Hospital, Northern Centre For Cancer Care Not yet recruiting Newcastle Upon Tyne, United Kingdom, NE7 7DN Contact: Alastair Greystoke       alastair.greystoke@newcastle.ac.uk    Principal Investigator: Alastair Greystoke, MD          Sheffield Teaching Hospitals NHS Foundation Trust - Weston Park Hospital Not yet recruiting Sheffield, United Kingdom, S10 2SJ Contact: Robin Young       r.j.young@sheffield.ac.uk    Principal Investigator: Robin Young, MD          University Hospital Southampton NHS Foundation Trust - Southampton General Hospital Not yet recruiting Southampton, United Kingdom, SO16 6YD Contact: Judith Cave       Judith.Cave@uhs.nhs.uk    Principal Investigator: Judith Cave, MD          Royal Marsden Hospital - Sutton, Surrey Not yet recruiting Sutton, United Kingdom, SM2 5PT Contact: Jaishree Bhosle       Jaishree.Bhosle@rmh.nhs.uk    Principal Investigator: Jaishree Bhosle, MD Less <<
NCT03082586 Esophageal Cancer Not Applicable Completed - China, Shanghai ... More >> the Ethic Committee of Shanghai General Hospital Shanghai, Shanghai, China, 210000 Less <<
NCT00454636 Gastric Cancer Phase 2 Completed - -
NCT00828841 - Completed - -
NCT02579616 Biliary Tract Cancer Phase 2 Active, not recruiting February 1, 2019 Japan ... More >> Nagoya, Aichi, Japan Kashiwa, Chiba, Japan Yokohama, Kanagawa, Japan Ina-machi, Saitama, Japan Chuo-ku, Tokyo, Japan Koto-ku, Tokyo, Japan Mitaka, Tokyo, Japan Less <<
NCT00454636 - Completed - -
NCT00405405 Head and Neck Cancer ... More >> Parotid Gland Cancer Thyroid Gland Cancer Melanoma Stage IV Head and Neck Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT02467426 - Completed - -
NCT02812641 Stage III Esophageal Squamous ... More >>Cell Carcinoma Less << Phase 2 Recruiting December 2021 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Jason Chia-Hsien Cheng    +886-2-23123456 ext 66696    jasoncheng@ntu.edu.tw Less <<
NCT00042835 Adenocarcinoma of the Lung ... More >> Bronchoalveolar Cell Lung Cancer Large Cell Lung Cancer Squamous Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Less << Phase 1 Terminated(Administratively co... More >>mplete.) Less << - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT00201344 Nasopharyngeal Carcinoma Phase 3 Terminated - Taiwan ... More >> Veterans General Hospital-Taipei Taipei, Taiwan, 112 Less <<
NCT01579630 NSCLC Phase 2 Phase 3 Unknown June 2014 Taiwan ... More >> Veterans General Hospital -Taipei Taipei, Taiwan, 112 Less <<
NCT02572843 NSCLC Non-small Cell Lung Canc... More >>er Less << Phase 2 Recruiting December 2021 Germany ... More >> Uniklinik Köln Recruiting Köln, Germany, 50937 Contact: Jürgen Wolf, Prof    +49 221 478-89050    juergen.wolf@uk-koeln.de    Principal Investigator: Jürgen Wolf, Prof          Universitätsklinikum Gießen und Marburg Recruiting Marburg, Germany, 35043 Contact: Jorge Riera Knorrenschild, MD    +49 (06421) 58-62784    rierakno@med.uni-marburg.de    Principal Investigator: Jorge Riera Knorrenschild, MD          Switzerland Stadtspital Triemli Recruiting Zürich, Zurich, Switzerland, 8063 Contact: Donat Dürr, MD    +41 44 416 34 80    donat.duerr@triemli.zuerich.ch    Principal Investigator: Donat Dürr, MD          Kantonsspital Aarau Recruiting Aarau, Switzerland, CH-5001 Contact: Wolf-Dieter Janthur, MD    +41 62 838 55 80    wolf-dieter.janthur@ksa.ch    Principal Investigator: Wolf-Dieter Janthur, MD          Kantonsspital Baden Recruiting Baden, Switzerland, 5404 Contact: Christine Waibel, MD    +41 (0)56 486 27 62    christine.waibel@ksb.ch    Principal Investigator: Christine Waibel, MD          St. Claraspital Basel Recruiting Basel, Switzerland, 4016 Contact: Martin Buess, MD    +41 (0)61 685 83 68    martin.buess@claraspital.ch    Principal Investigator: Martin Buess, MD          Universitaetsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Sacha Rothschild, MD    +41 61 265 25 25    sacha.rothschild@usb.ch    Principal Investigator: Sacha Rothschild, MD          IOSI Ospedale Regionale di Bellinzona e Valli Recruiting Bellinzona, Switzerland, 6500 Contact: Patrizia Froesch, MD    +41 (0)91 811 48 40    patrizia.froesch@eoc.ch    Principal Investigator: Patrizia Froesch, MD          Inselspital Bern Recruiting Bern, Switzerland, CH-3010 Contact: Adrian Ochsenbein, Prof    +41 31 632 81 69    adrian.ochsenbein@sec.insel.ch    Principal Investigator: Adrian Ochsenbein, Prof          Hôpital du Valais Not yet recruiting Brig, Switzerland, 3900 Contact: Reinhard Zenhäusern, MD    +41 (0)27 604 36 60    reinhard.zenhaeusern@hopitalvs.ch    Principal Investigator: Reinhard Zenhäusern, MD          Kantonsspital Bruderholz Not yet recruiting Bruderholz, Switzerland, CH-4101 Contact: Lorenz M. Jost, MD    41-61-436-3636    lorenz.jost@ksbh.ch    Principal Investigator: Lorenz M. Jost, MD          Kantonsspital Graubuenden Recruiting Chur, Switzerland, CH-7000 Contact: Michael Mark, MD    +41 81 256 61 11    michael.mark@ksgr.ch    Principal Investigator: Michael Mark, MD          Spital Thurgau AG Terminated Frauenfeld, Switzerland, CH-8500 Hopital Fribourgeois HFR Recruiting Fribourg, Switzerland, 1708 Contact: Daniel Betticher, Prof    +41(0)26 426 72 40    daniel.betticher@h-fr.ch    Principal Investigator: Daniel Betticher, Prof          Hopital Cantonal Universitaire de Geneve Recruiting Geneva, Switzerland, CH-1211 Contact: Nicolas Mach    +41 (0)22 372 98 81    nicolas.mach@hcuge.ch    Principal Investigator: Nicolas Mach, MD          CCAC Lausanne Recruiting Lausanne, Switzerland, 1004 Contact: Pierre Bohanes, MD    +41 (21) 646 79 94    pbohanes@bluewin.ch    Principal Investigator: Pierre Bohanes, MD          Centre hospitalier universitaire vaudois CHUV Recruiting Lausanne, Switzerland, CH-1011 Contact: Solange Peters, Prof    +41 79 556 01 92    solange.peters@chuv.ch    Principal Investigator: Solange Peters, Prof          Luzerner Kantonsspital Recruiting Luzern, Switzerland, CH-6000 Contact: Oliver Gautschi, PD MD    +41 41 205 58 60    oliver.gautschi@luks.ch    Principal Investigator: Oliver Gautschi, MD          Kantonsspital St. Gallen Recruiting St. Gallen, Switzerland, 9007 Contact: Martin Früh, MD    +41 (0)71 494 63 25    martin.frueh@kssg.ch    Principal Investigator: Martin Früh, MD          Regionalspital Recruiting Thun, Switzerland, 3600 Contact: Daniel Rauch, MD    +41 33 226 26 45    daniel.rauch@spitalstsag.ch    Principal Investigator: Daniel Rauch, MD          Kantonsspital Winterthur Recruiting Winterthur, Switzerland, CH-8401 Contact: Miklos Pless, Prof    41-52-266-2552    miklos.pless@ksw.ch    Principal Investigator: Miklos Pless, Prof          Klinik Hirslanden Onkozentrum Zürich Recruiting Zurich, Switzerland, CH-8032 Contact: Thomas von Briel, MD    +41 (0)44 387 21 11    vonbriel@onkozentrum.ch    Principal Investigator: Thomas von Briel, MD          UniversitaetsSpital Zuerich Recruiting Zurich, Switzerland, CH-8091 Contact: Christian Britschgi, MD    +41 (44) 255 22 14    christian.britschgi@usz.ch    Principal Investigator: Christian Britschgi, MD Less <<
NCT00785421 Pancreatic Cancer Phase 2 Phase 3 Completed - Germany ... More >> Universitätsmedizin - Berlin - Charite Berlin, Germany, 13353 Less <<
NCT03572829 Vomiting Naus... More >>ea Post Chemotherapy Head Neck Cancer Less << Phase 2 Recruiting December 20, 2019 China ... More >> National Cancer Center/ Cancer Hospital, Chinese Academy of Medcal science and Peking Union Medical College Recruiting Beijing, China Contact: Ye Zhang, M.D.    8610-87787625    drzye1983@163.com Less <<
NCT00911092 Esophageal Cancer Phase 4 Completed - France ... More >> Centre Paul Papin Angers, France, 49933 Centre Hospitalier Universitaire Brest, France, 29200 Centre François BACLESSE Caen, France, 14046 Centre Oscar Lambret Lille, France, 59020 Centre Eugène Marquis Rennes, France, 35042 CHU - Hopital Charles Nicolle Rouen, France, 76031 Less <<
NCT01693718 Head and Neck Phase 2 Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60653 Less <<
NCT03568097 Small Cell Lung Carcinoma Phase 2 Recruiting August 2021 Greece ... More >> Agii Anargiri Cancer Hospital Not yet recruiting Néa Kifisiá, Athens, Greece, 14564 Contact: Gerasimos Aravantinos, MD    0030 210 3501283    garavantinos@yahoo.gr    Agii Anargiri Cancer Hospital Recruiting Néa Kifisiá, Athens, Greece, 14564 Contact: Eleni Res, MD    0030 210 3501273    nellieres@yahoo.gr    Metropolitan Hospital Recruiting Néo Fáliro, Athens, Greece, 18547 Contact: Helena Linardou, MD    0030 210 4809852    elinardou@otenet.gr Less <<
NCT01612351 Head and Neck Cancer ... More >> Squamous Cell Carcinoma of the Head and Neck Less << Phase 2 Active, not recruiting November 2031 United States, North Carolina ... More >> The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00398307 Renal Impairment Phase 1 Completed - United States, Arizona ... More >> Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85260 United States, California LAC/USC Medical Center Los Angeles, California, United States, 90033 Premiere Oncology Santa Monica, California, United States, 90404 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06520 United States, Kentucky University of Kentucky/Division of Hematology/Oncology and Blood Marrow Transplantation Lexington, Kentucky, United States, 40536 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Missouri Washington University School of Medicine St Louis, Missouri, United States, 63110 United States, New Mexico Cancer Research & Treatment Center/University of New Mexico Albuquerque, New Mexico, United States, 87131 United States, Texas The Institute for Drug Development San Antonio, Texas, United States, 78245 Less <<
NCT03664115 Lung Cancer Phase 2 Recruiting December 2, 2020 Egypt ... More >> oncology department Ain shams university Recruiting Cairo, Egypt, 11591 Contact: Amr sh Tawfik, MD          Contact: Asmaa WH Mohamed, Master    01003538597    drasmaa_wahid@hotmail.com Less <<
NCT00398424 Impaired Hepatic Function Phase 1 Completed - United States, Arizona ... More >> Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85260 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06520 United States, Kentucky University of Kentucky/Division of Hematology/Oncology and Blood Marrow Transplantation Lexington, Kentucky, United States, 40536 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Missouri Washington University School of Medicine St Louis, Missouri, United States, 63110 United States, Texas The Institute for Drug Development San Antonio, Texas, United States, 78245 Less <<
NCT02861872 - Unknown December 2017 Netherlands ... More >> Radboudumc Recruiting Nijmegen, Netherlands, 6500HB Contact: Mark Rietveld, M.D. MSc.    +31243610353    mark.rietveld@radboudumc.nl    Contact: Peter van Essen, MSc.    +31243610353    peter.vanessen@radboudumc.nl    Principal Investigator: Nelleke Ottevanger, M.D. PhD. Less <<
NCT03639090 - Recruiting May 1, 2019 United States, Oklahoma ... More >> University of Oklahoma HSC, Department of Urology Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Jonathan Heinlen, M.D.    405-271-6900    jonathan-heinlen@ouhsc.edu    Contact: Felicia Kiplinger, B.A.    405-271-6900    felicia-kiplinger@ouhsc.edu Less <<
NCT03367871 Cervical Cancer Phase 2 Recruiting October 2025 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Marilyn Huang, MD    305-243-2233    m.huang@med.miami.edu Less <<
NCT00697905 Nasopharyngeal Carcinoma Phase 2 Completed - Malaysia ... More >> Ipoh Specialist Centre Ipoh, Malaysia Johor Specialist Centre Johor Bahru, Malaysia Sabah Medical Centre Kota Kinabalu, Malaysia Tung Shin Hospital Kuala Lumpur, Malaysia University Malaya Medical Centre Kuala Lumpur, Malaysia Hospital Universiti Sains Malaysia Kubang Kerian, Malaysia Normah Medical Specialist Centre Kuching, Malaysia Likas Hospital Likas, Malaysia NCI Cancer Hospital Nilai, Malaysia Loh Guan Lye Specialist Centre Penang, Malaysia Penang General Hospital Penang, Malaysia Less <<
NCT01612351 - Active, not recruiting - -
NCT02337530 Non-Small Cell Lung Cancer Phase 2 Active, not recruiting December 31, 2018 Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Abbotsford Centre Abbotsford, British Columbia, Canada, V2S 0C2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, New Brunswick Regional Health Authority B, Zone 2 Saint John, New Brunswick, Canada, E2L 4L2 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 Lakeridge Health Oshawa Oshawa, Ontario, Canada, L1G 2B9 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 University Health Network Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 Less <<
NCT01427478 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 3 Active, not recruiting September 2021 France ... More >> Centre Paul Papin Angers, France, 49933 Institut Sainte-Catherine Avignon, France, 84000 CHU Bordeaux - Hôpital Saint-André Bordeaux, France, 33075 Polyclinique de Bordeaux Nord Bordeaux, France, 33300 CHRU Brest - Hôpital Morvan Brest, France, 29609 Centre François Baclesse Caen, France, 14076 CHIC Créteil Créteil, France, 94010 Centre Guillaume le Conquérant Le Havre, France, 76600 Centre Hospitalier Bretagne Sud Lorient, France, 56100 Centre Léon Bérard Lyon, France, 69373 AP-HM La Timone Adultes Marseille, France, 13386 Cedex Centre Antoine Lacassagne Nice, France, 06189 CHU Poitiers Poitiers, France, 86021 Centre Eugène Marquis Rennes, France, 44229 Centre Henri Becquerel Rouen, France, 76038 Institut de Cancérologie de la Loire Saint Priest en Jarez, France, 42270 Institut de Cancérologie de l'Ouest Saint-Herblain, France, 44805 Pôle Hospitalier Mutualiste- Centre Etienne Dolet Saint-Nazaire, France, 44600 Strasbourg Oncologie Libérale Strasbourg, France, 67000 Hopitaux du Léman Thonon-les-bains, France, 74203 Clinique Pasteur Bâtiment l'Atrium Toulouse, France, 31076 Institut Claudius Regaud Toulouse, France, 71000 CHU TOURS (Hôpital Bretonneau) Tours, France, 37044 Centre de Radiothérapie Marie Curie Valence, France, 26000 Institut de Cancérologie de lorraine (ICL) Vandoeuvre-les-Nancy, France, 54519 cedex Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT00448240 Head and Neck Cancer ... More >> Carcinoma, Squamous Cell Less << Phase 2 Phase 3 Terminated(Low Accrual, Fundin... More >>g) Less << January 2015 -
NCT02504229 Gastric Cancer Phase 2 Unknown - China, Beijing ... More >> Chinese Academy of Medical Sciences Tumor Hospital Recruiting Beijing, Beijing, China Contact: jinwan Wang       lyang69@sina.com    Contact: lin Yang       lyang69@sina.com    Principal Investigator: jinwan Wang          Principal Investigator: lin Yang Less <<
NCT00169572 Nausea and Vomiting ... More >> Chemotherapy-Induced Less << Phase 2 Completed - -
NCT01096368 Cellular Ependymoma ... More >> Childhood Anaplastic Ependymoma Childhood Infratentorial Ependymoma Childhood Supratentorial Ependymoma Clear Cell Ependymoma Ependymoma Newly Diagnosed Childhood Ependymoma Papillary Ependymoma Less << Phase 3 Recruiting - -
NCT01059552 Locally Advanced Non-small Cel... More >>l Lung Cancer Less << Phase 1 Active, not recruiting December 1, 2018 United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT02937519 Esophageal Neoplasms Phase 2 Recruiting June 2018 China, Guizhou ... More >> Cancer Hospital of Guizhou Medical University Recruiting Guiyang, Guizhou, China, 550000 Contact: Feng Jin, Bachelor    0851-86512802    jinf8865@yahoo.com.cn    Principal Investigator: Feng Jin, Bachelor          Sub-Investigator: Ling Guo, Doctor          Sub-Investigator: Ling Wu, Bachelor          Sub-Investigator: Weili Wu, master          Sub-Investigator: Jinhua Long, master          Sub-Investigator: Yuanyuan Li, master          Sub-Investigator: Xiuyun Gong, Bachelor          Sub-Investigator: Xiaoxiao Chen, Bachelor          Sub-Investigator: Zhuoling Li, master          Sub-Investigator: Hang Jiang, Bachelor Less <<
NCT02195453 Non-Small Cell Lung Cancer Phase 4 Unknown December 2016 -
NCT00775385 Carcinoma, Non-Small-Cell Lung Phase 2 Phase 3 Completed - France ... More >> Centre Hospitalier Aix en Provence, France Clinique de L'Europe Amiens, France Angers - CHU Angers, France, 49000 Centre Hospitalier Béziers, France Centre F. Baclesse Caen, France, 14000 CHU - Pneumologie Caen, France, 14000 Centre Hospitalier Chauny, France Chevilly Larue - CH Chevilly Larue, France Hôpital Percy-Armées - Pneumologie Clamart, France, 92140 Clermont Ferrand - CHU Clermont Ferrand, France, 63000 Colmar - CH Colmar, France, 68000 Dax - CH Dax, France, 40107 Ermont - Clinique Claude Bernard Ermont, France CHU Grenoble - pneumologie Grenoble, France, 38000 Le Mans - CHG Le Mans, France Centre Léon Bérard Lyon, France, 69000 Lyon - Hôpital Louis Pradel (Pneumologie) Lyon, France Mantes La Jolie - CH Mantes La Jolie, France, 78200 APHM - Hôpital Sainte Marguerite Marseille, France, 13000 Institut Paoli Calmette Marseille, France Metz - Belle Isle Metz, France Mont de Marsan - CH Mont de Marsan, France, 40000 Montpellier - Clinique Clémentville Montpellier, France, 34070 Mulhouse - CH Mulhouse, France, 68000 Nancy - Polyclinique Gentilly Nancy, France Nevers - CH Nevers, France, 58033 Paris - Saint Louis Paris, France, 75000 APHP - Hopital Tenon - Pneumologie Paris, France, 75020 Pau - CH Pau, France, 64046 HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Reims - CHU Reims, France, 51092 Rennes - CHU Rennes, France Centre Hospitalier Saint-Quentin, France Nouvel Hopital Civil Strasbourg, France, 63000 Hôpital Foch Suresnes, France Centre Hospitalier Intercommunal Toulon, France CHU Toulouse - Pneumologie Toulouse, France Clinique Pasteur Toulouse, France Tours - CHU Tours, France, 37000 Nancy - CHU Vandoeuvre lès Nancy, France, 54500 Institut Gustave Roussy Villejuif, France, 94805 Centre Hospitalier Intercommunal Villeneuve-Saint-Georges, France Less <<
NCT00568607 Lymphoma Phase 2 Unknown December 2010 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Biyun Wang, MD    8613701748410    wangbiyun@msn.com    Sub-Investigator: Biyun Wang, M.D. Less <<
NCT03598517 Non-small Cell Lung Cancer Not Applicable Recruiting July 1, 2020 China, Shanghai ... More >> Shanghai Genernal Hospital Recruiting Shanghai, Shanghai, China, 210000 Contact: Ningning Cheng    37798364 ext 8119    ningcnn@163.com    Contact: yong Liu    37798364 ext 8110    drliuyrt@163.com Less <<
NCT03652142 - Recruiting May 1, 2020 Greece ... More >> Attikon Hospital Recruiting Athens, Chaidari, Greece Contact: AMANDA PSYRRI, MD    +2105831664    psyrri237@yahool.com Less <<
NCT03406650 Urothelial Cancer Phase 2 Recruiting April 2026 Switzerland ... More >> Kantonspital Aarau Recruiting Aarau, Switzerland, CH-5001 Contact: Tobias Wehrhahn, MD    +41 62 838 59 27    tobias.wehrhahn@ksa.ch    Principal Investigator: Tobias Wehrhahn, MD          Kantonsspital Baden Recruiting Baden, Switzerland, CH-5404 Contact: Andreas Erdmann, MD    +41 56 486 27 62    andreas.erdmann@ksb.ch    Principal Investigator: Andreas Erdmann, MD          Universitaetsspital Basel Recruiting Basel, Switzerland, 4031 Contact: Sacha Rothschild, MD    +41 61 265 25 25    sacha.rothschild@usb.ch    Principal Investigator: Sacha Rothschild, MD          Inselspital Recruiting Bern, Switzerland, 3010 Contact: Roland Seiler, MD    +41 31 632 20 45    roland.seiler@insel.ch    Principal Investigator: Roland Seiler, MD          Kantonsspital Graubünden Recruiting Chur, Switzerland, 7000 Contact: Richard Cathomas, MD    +41 81 256 61 11    Richard.Cathomas@ksgr.ch    Principal Investigator: Richard Cathomas, MD          Spital Thurgau AG Not yet recruiting Frauenfeld, Switzerland, CH-8500 Contact: Regina Woelkly, MD    +41 52 723 76 91    regina.woelkly@stgag.ch    Principal Investigator: Regina Woelkly, MD          Centre Hospitalier Universitaire Vaudois CHUV Recruiting Lausanne, Switzerland, CH-1011 Contact: Dominik Berthold, MD    +41 21 314 80 83    Dominik.Berthold@chuv.ch    Principal Investigator: Dominik Berthold, MD          Luzerner Kantonsspital Recruiting Luzern, Switzerland, 6000 Contact: Christian Riklin, MD    +41 41 205 58 73    christian.riklin@luks.ch    Principal Investigator: Christian Riklin, MD          Kantonsspital St. Gallen Recruiting St. Gallen, Switzerland, CH-9007 Contact: Sabine Schmid, MD    +41 71 494 11 11    sabine.schmid@kssg.ch    Principal Investigator: Sabine Schmid, MD          Kantonsspital Winterthur Not yet recruiting Winterthur, Switzerland, 8401 Contact: Miklos Pless, Prof    +41 52 266 36 40    miklos.pless@ksw.ch    Principal Investigator: Miklos Pless, Prof          City Hospital Triemli Not yet recruiting Zurich, Switzerland, 8063 Contact: Mathias Schmid, MD    +41 44 466 11 11    mathias.schmid@triemli.zuerich.ch    Principal Investigator: Mathias Schmid, MD          UniversitaetsSpital Zuerich Not yet recruiting Zurich, Switzerland, 8091 Contact: Axel Mischo, MD    +41 44 255 22 14    axel.mischo@usz.ch    Principal Investigator: Axel Mischo, MD          Klinik Hirslanden - Onkozentrum Hirslanden Recruiting Zürich, Switzerland, 8032 Contact: Anita Hirschi, MD    +41 44 387 37 80    ahirschi@onkozentrum.ch    Principal Investigator: Anita Hirschi, MD          OnkoZentrum Zürich Recruiting Zürich, Switzerland, 8038 Contact: Ulf Petrausch, MD    +41 43 344 33 33    ulf.petrausch@ozh.ch    Principal Investigator: Ulf Petrausch, MD Less <<
NCT00611962 Neoplasms, Germ Cell and Embry... More >>onal Less << Phase 2 Completed - France ... More >> Sanofi-Aventis Lyon, France Less <<
NCT00478699 Non-small-cell Lung Cancer Phase 3 Completed - Spain ... More >> Hospital de Elche Elche, Alicante, Spain, 03202 Hospital Central de Asturias Oviedo, Asturias, Spain Ico - H. Germans Trias I Pujol Badalona, Barcelona, Spain, 08916 Hospital D'Althaia Manresa, Barcelona, Spain, 08243 Hospital de Mataró Mataró, Barcelona, Spain, 08034 Hospital Insular de Gran Canaria Las Palmas de Gran Canaria, Gran Canaria, Spain Hospital Clin. Univ. Santiago de Compostela Santiago de Compostela, La Coruna, Spain, 15076 Hospital San Pedro Logrono, La Rioja, Spain, 26004 F.H.Alcorcon Alcorcon, Madrid, Spain, 28922 Hospital Severo Ochoa Leganés, Madrid, Spain, 28911 Hospital de La Ribera Alzira, Valencia, Spain, 46600 Hospital de Cruces Baracaldo, Vizcaya, Spain, 48903 Hospital de Basurto Bilbao, Vizcaya, Spain H.G.U. Alicante Alicante, Spain, 03010 Hospital de La Santa Creu I Sant Pau Barcelona, Spain, 08025 Hospital Clínic de Barcelona Barcelona, Spain, 08036 Hospital Univ. Sagrat Cor Barcelona, Spain, 08036 Instituto Universitario Dexeus Barcelona, Spain, 28036 Hospital Provincial de Castellón Castellón, Spain Hospital Reina Sofía Córdoba, Spain, 14004 Ico-Girona (Hospital Josep Trueta) Girona, Spain, 17007 Hospital Virgen de Las Nieves Granada, Spain, 18015 Hospital de Jaén Jaén, Spain, 23007 Hospital de León Leon, Spain Hospital Arnau de Vilanova Lleida, Spain, 46015 Hospital 12 de Octubre Madrid, Spain, 28006 Hospital Clínico San Carlos Madrid, Spain, 28006 Hospital de La Princesa Madrid, Spain, 28006 Md Anderson Internacional Madrid, Spain, 28033 Fundación Jiménez Díaz Madrid, Spain, 28040 Hospital La Paz Madrid, Spain, 28046 Hospital Puerta de Hierro Madrid, Spain, 28222 Hospital Carlos Haya Malaga, Spain, 29010 Hospital Morales Messeguer Murcia, Spain, 30008 Clínica Rotger Palma de Mallorca, Spain, 07012 Hospital Son Dureta Palma de Mallorca, Spain, 07014 Hospital Son Llátzer Palma de Mallorca, Spain, 07198 Hospital Clinico de Salamanca Salamanca, Spain, 37007 Hospital de Donostia San Sebastián, Spain, 20014 Instituto Oncológico de San Sebastián San Sebastián, Spain Hospital Universitario de Canarias Santa Cruz de Tenerife, Spain H. Arnau de Vilanova Valencia, Spain, 46015 Hospital General de Valencia Valencia, Spain Instituto Valenciano de Oncología Valencia, Spain Hospital Provincial de Zamora Zamora, Spain, 49012 Hospital Lozano Blesa Zaragoza, Spain Hospital Miguel Servet Zaragoza, Spain Less <<
NCT01828736 Recurrent Bladder Cancer ... More >> Stage IV Bladder Cancer Transitional Cell Carcinoma of the Bladder Less << Phase 2 Completed - Belgium ... More >> Cliniques saint Luc - Université Catholique de Louvain Bruxelles, Belgium, 1200 France CHU de Besançon Besançon, France, 25000 CHU Hôpital Saint André Bordeaux, France, 33000 Hôpital Jean Perrin Clermont Ferrand, France, 63000 Centre Hospitalier Départemental de la Vendée La Roche-sur-yon, France, 85000 Clinique Victor Hugo Le Mans, France, 72000 CHU Hôpital La Timone Marseille, France, 13005 Institut Paoli Calmettes Marseille, France, 13009 Clinique Hartmann Neuilly-Sur-Seine, France, 92200 Curie Institute Paris, France, 75005 Hôpital Saint Louis Paris, France, 75010 Groupe Hospitalier Saint Joseph Paris Paris, France, 75014 Hôpital Cochin Paris, France, 75014 Hôpital Européen Georges Pompidou Paris, France, 75015 Hôpital Foch Suresnes, France, 92151 Less <<
NCT01936974 Ovarian Carcinoma ... More >> Fallopian Tube Carcinoma Peritoneal Carcinoma Less << Phase 2 Terminated(PI Decision) - United States, Arizona ... More >> Western Regional Medical Center Goodyear, Arizona, United States, 85338 Less <<
NCT00933673 Lymphoma Phase 2 Unknown June 2012 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Ye Guo, MD    862164175590    pattrick_guo@msn.com    Principal Investigator: Ye Guo, MD Less <<
NCT02875314 Medulloblastoma ... More >> Central Nervous System Embryonal Tumors Less << Phase 4 Recruiting September 2020 -
NCT03621696 HPV Related Oropharyngeal Squa... More >>mous Cell Carcinoma Less << Phase 2 Recruiting July 31, 2024 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Douglas Adkins, M.D.    314-747-8475    dadkins@wustl.edu    Principal Investigator: Douglas Adkins, M.D.          Sub-Investigator: Wade Thorstad, M.D.          Sub-Investigator: Jose Zevallos, M.D.          Sub-Investigator: Mackenzie Daly, M.D.          Sub-Investigator: Ryan Jackson, M.D.          Sub-Investigator: Jason Rich, M.D.          Sub-Investigator: Peter Oppelt, M.D.          Sub-Investigator: Randall Paniello, M.D.          Sub-Investigator: Patrick Pipkorn, M.D.          Sub-Investigator: Hiram Gay, M.D.          Sub-Investigator: Esther Lu, Ph.D.          Sub-Investigator: Rebecca Chernock, M.D.          Sub-Investigator: Samir El-Mofty, DMD, M.S., Ph.D. Less <<
NCT00101582 Mucositis Sol... More >>id Tumors Stomatitis Head and Neck Cancer Squamous Cell Carcinoma Less << Phase 3 Completed - -
NCT01566240 Cervical Cancer Phase 3 Recruiting September 2021 Mexico ... More >> Instituto Nacional de Cancerologia (INCAN) Recruiting Mexico City, Mexico Principal Investigator: Dolores Dr Gallardo          United Kingdom North Devon District Hospital Recruiting Barnstaple, Devon, United Kingdom, EX31 4JB Principal Investigator: Jennifer Forrest          University College London Hospital Recruiting London, Greater London, United Kingdom, NW1 2BU Principal Investigator: Mary McCormack          Weston Park Hospital Recruiting Sheffield, South Yorkshire, United Kingdom, S10 2SJ Principal Investigator: Simon Pledge          Belfast City Hospital Recruiting Belfast, United Kingdom Principal Investigator: Ursula Dr McGiven          Pilgrim Hospital Recruiting Boston, United Kingdom Principal Investigator: Miguel Dr Panades          Royal Sussex County Hospital Recruiting Brighton, United Kingdom Principal Investigator: Kate Dr Lankester          Velindre Cancer Centre Recruiting Cardiff, United Kingdom Principal Investigator: Louise Dr Hanna          Cheltenham General Hospital Recruiting Cheltenham, United Kingdom Principal Investigator: Audrey Dr Cook          Royal Derby Hospital Recruiting Derby, United Kingdom Principal Investigator: Mojca Dr Persic          Royal Devon and Exeter NHS Foundation Trust Recruiting Exeter, United Kingdom, EX2 5DY Principal Investigator: Jennifer Forrest          Beatson WOSCC Recruiting Glasgow, United Kingdom Principal Investigator: Nick Dr Reed          Gloucester Royal Hospital Recruiting Gloucester, United Kingdom Principal Investigator: Audrey Dr Cook          Grantham and District Hospital Recruiting Grantham, United Kingdom Principal Investigator: Miguel Dr Panades          Castle Hill Hospital Recruiting Hull, United Kingdom Principal Investigator: Faheem Dr Bashir          Leicester Royal Infirmary Recruiting Leicester, United Kingdom Principal Investigator: David Dr Peel          Lincoln County Hospital Recruiting Lincoln, United Kingdom Principal Investigator: Miguel Dr Panades          Guy's and St Thomas' NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Vinod Dr Mullassery          Imperial College Healthcare NHS Trust Recruiting London, United Kingdom Contact: Sophie Kathirgamanathan          Principal Investigator: Gemma EMinowicz          St Bart's Hospital Recruiting London, United Kingdom Principal Investigator: Melanie Dr Powell          The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Principal Investigator: Susan Davidson          James Cook University Hospital Recruiting Middlesbrough, United Kingdom Principal Investigator: Madhavi Dr Adusumalli          Norfolk and Norwich University Hospital Recruiting Norfolk, United Kingdom Principal Investigator: Robert Dr Wade          Northampton General Hospital Recruiting Northampton, United Kingdom Principal Investigator: Anupama Dr Gore          Nottingham University Hospitals NHS Trust Recruiting Nottingham, United Kingdom, NG5 1PB Principal Investigator: Anjana Anand          Derriford Hospital Recruiting Plymouth, United Kingdom Contact: Irene Harvey          Principal Investigator: Sidharth Dubey          Southampton General Hospital Recruiting Southampton, United Kingdom Principal Investigator: Victoria Dr Lankaster          Royal Stoke University Hospital Recruiting Stoke-On-Trent, United Kingdom Principal Investigator: Rajanee Dr Bhana          The Clatterbridge Cancer Centre Recruiting Wirral, United Kingdom Principal Investigator: Karen Dr Whitmarsh          New Cross Hospital Recruiting Wolverhampton, United Kingdom Principal Investigator: Rozenne Dr Allerton Less <<
NCT02582697 Germ Cell Tumor Phase 3 Recruiting July 2023 Australia, New South Wales ... More >> Calvary Mater Newcastle Recruiting Newcastle, New South Wales, Australia, 2298 Contact: Louise Plowman       Louise.Plowman@calvarymater.org.au    Contact: Girish Mallesara       girish.mallesara@calvarymater.org.au    Principal Investigator: Girish Mallesara          Royal North Shore Hospital Recruiting St Leonards, New South Wales, Australia, 2065 Contact: Susan Kirby-Lewis       Susan.KirbyLewis@health.nsw.gov.au    Contact: Alexander Guminski       aguminski@nsccahs.health.nsw.gov.au    Principal Investigator: Alexander Guminski          Prince of Wales Hospital Recruiting Sydney, New South Wales, Australia, 2031 Contact: Daisy Buchanan       Daisy.buchanan@sesiahs.health.nsw.gov.au    Contact: Julie Howard       Julie.howard@sesiahs.health.nsw.gov.au    Principal Investigator: Elizabeth Hovey          Chris O'Brien Lifehouse Recruiting Sydney, New South Wales, Australia, 2050 Contact: Melissa Quaggiott       melissa.mcmahon@lh.org.au    Contact: Peter Grimison       peter.grimison@lh.org.au    Principal Investigator: Peter Grimison          Macquarie Cancer Clinical Trials Recruiting Sydney, New South Wales, Australia, 2109 Contact: Louise Francisco       louise.francisco@mq.edu.au    Contact: Radhika Butala       radhika.butala@mq.edu.au    Principal Investigator: Howard Gurney          Concord Repatriation General Hospital Recruiting Sydney, New South Wales, Australia, 2139 Contact: Kathy Hall       Kathy.Hall@sswahs.nsw.gov.au    Contact: Martin Stockler       martin.stockler@sydney.edu.au    Principal Investigator: Martin Stockler          Westmead Hospital Recruiting Sydney, New South Wales, Australia, 2145 Contact: Vicky Wegener       vicky.wegener@sydney.edu.au    Contact: Howard Gurney       howard_gurney@wmi.usyd.edu.au    Principal Investigator: Howard Gurney          Nepean Hospital Recruiting Sydney, New South Wales, Australia, 2751 Contact: Jeremy Jones       jeremy.jones@swahs.health.nsw.gov.au    Contact: Amanda Stevanovic       amanda.stevanovic@swahs.health.nsw.gov.au    Principal Investigator: Amanda Stevanovic          Tweed Hospital Recruiting Tweed Heads, New South Wales, Australia, 2485 Contact: Charmayne Chorlton       Charmayne.Chorlton@ncahs.health.nsw.gov.au    Contact: Ehtesham Abdi       eaabdi@mac.com    Principal Investigator: Ehtesham Abdi          SAN Clinical Trials Unit Recruiting Wahroonga, New South Wales, Australia, 2076 Contact: James McQuilan       James.McQuillan@sah.org.au    Contact: Gavin Marx       gmarx@nhog.com.au    Principal Investigator: Gavin Marx          Australia, Queensland Royal Brisbane & Women's Hospital Recruiting Brisbane, Queensland, Australia, 4029 Contact: Natasha Roberts       natasha.roberts@health.qld.gov.au    Contact: David Wyld       david.wyld@health.qld.gov.au    Principal Investigator: David Wyld          Princess Alexandra Recruiting Woolloongabba, Queensland, Australia, 4102 Contact: Paul Baxter       Paul.Baxter@health.qld.gov.au    Contact: Euan Walpole       Euan.Walpole@health.qld.gov.au    Principal Investigator: Euan Walpole          Australia, South Australia Royal Adelaide Hospital Recruiting Adelaide, South Australia, Australia, 5000 Contact: Hazel Bourke       hazel.bourke@health.sa.gov.au    Contact: Thean Hsiang Tan       hsiang.tan@health.sa.gov.au    Principal Investigator: Thean Tan          Flinders Medical Centre Recruiting Bedford Park, South Australia, Australia, 5042 Contact: Alex Scott-Hoy       Alex.Scott-Hoy@health.sa.gov.au    Contact: Ganessan Kichenadasse       Ganessan.Kichenadasse@health.sa.gov.au    Principal Investigator: Ganessan Kichenadasse          Australia, Tasmania Royal Hobart Hospital Recruiting Hobart, Tasmania, Australia, 7000 Contact: Lesley Oliver       lesley.oliver@dhhs.tas.gov.au    Contact: David Boadle       david.boadle@dhhs.tas.gov.au    Principal Investigator: David Boadle          Australia, Victoria Box Hill Hospital Recruiting Box Hill, Victoria, Australia, 3128 Contact: Lauren Mitchell       lauren.mitchell@monash.edu    Contact: Philip Parente       Phillip.parente@monash.edu    Principal Investigator: Philip Parente          Peter MacCallum Cancer Centre Recruiting East Melbourne, Victoria, Australia, 3002 Contact: Jennifer Petersen       jennifer.petersen@petermac.org    Contact: Guy Toner       guy.toner@petermac.org    Principal Investigator: Guy Toner          Austin Health Recruiting Heidelberg, Victoria, Australia, 3084 Contact: Jaren Caine       Jaren.Caine@austin.org.au    Contact: Andrew Weickhardt       Andrew.Weickhardt@ludwig.edu.au    Principal Investigator: Andrew Weickhardt          Sunshine Hospital Recruiting St Albans, Victoria, Australia, 3021 Contact: Jessica Tanner       Jessica.Tanner@wh.org.au    Contact: Shirley Wong       shirleys.wong@mh.org.au    Principal Investigator: Shirley Wong          Border Medical Oncology Recruiting Wodonga, Victoria, Australia, 3690 Contact: Lauren Callow       lcallow@bordermedonc.com.au    Contact: Craig Underhill       cunderhill@bordermedonc.com.au    Principal Investigator: Craig Underhill          Australia, Western Australia Fiona Stanley Hospital Recruiting Murdoch, Western Australia, Australia, 6847 Contact: Jaye Harding       jaye.harding@health.wa.gov.au    Contact: Simon Troon       simon.troon@health.wa.gov.au    Principal Investigator: Simon Troon          New Zealand Auckland Hospital Recruiting Grafton, Auckland, New Zealand, 1142 Contact: Andrew Conley       andrewcon@adhb.govt.nz    Contact: Fritha Hanning       FrithaH@adhb.govt.nz    Principal Investigator: Fritha Hanning          Palmerston North Hospital Recruiting Roslyn, Palmerston North, New Zealand, 4442 Contact: Sarah Holwell       Sarah.Holwell@midcentraldhb.govt.nz    Contact: Gary Forgeson       Garry.Forgeson@midcentraldhb.govt.nz    Principal Investigator: Gary Forgeson          Christchurch Hospital Recruiting Christchurch, New Zealand, 8011 Contact: Elizabeth Thompson       liz.thompson@cdhb.health.nz    Contact: Mark Jeffrey       Mark.jeffery@cdhb.health.nz    Principal Investigator: Mark Jeffrey          Dunedin Hospital Recruiting Dunedin, New Zealand, 9054 Contact: Rachel McLay-Barnes       ONCRESEARCH@southerndhb.govt.nz    Contact: David Perez       david.perez@southerndhb.govt.nz    Principal Investigator: David Perez Less <<
NCT01936974 - Terminated(PI Decision) - -
NCT00267046 - Completed - -
NCT00262951 Pancreatic Cancer Phase 2 Terminated(Closed at a planned... More >> interim analysis by meeting a predefined toxicity endpoint) Less << - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00267046 Sarcoma Oral ... More >>Mucositis Less << Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00021320 Esophageal Cancer Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT00101582 - Completed - -
NCT00620269 Lung Cancer N... More >>SCLC Less << Phase 2 Unknown March 2015 Korea, Republic of ... More >> National Cancer Center, Korea Recruiting Goyang-si, Gyenggi-do, Korea, Republic of, 411-769 Contact: Jin Soo Lee, M.D.    +82-31-920-1601       Principal Investigator: Jin Soo Lee, M.D.          Sub-Investigator: Heung Tae Kim, M.D.          Sub-Investigator: Ji-Youn Han, M.D.          Sub-Investigator: Geon Kook Lee, M.D.          Sub-Investigator: Tak Yun, M.D.          Sub-Investigator: Kwan Ho Cho, M.D.          Sub-Investigator: Hong Ryull Pyo, M.D.          Sub-Investigator: Bin Hwangbo, M.D.          Sub-Investigator: Hee Seok Lee, M.D.          Sub-Investigator: Kun young Lim, M.D.          Sub-Investigator: Kyong-Ah Yoon, PH.D.          Sub-Investigator: Byung-Ho Nam, Ph.D.          Sub-Investigator: Young Ho Yun, M.D.          Sub-Investigator: Jae-ill Zo, M.D. Less <<
NCT01970722 Recurrent Uterine Corpus Cance... More >>r Recurrent Fallopian Tube Cancer Recurrent Ovarian Cancer Recurrent Primary Peritoneal Cancer Stage IIIA Uterine Corpus Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Cancer Stage IIIA Primary Peritoneal Cavity Cancer Stage IIIB Uterine Corpus Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Cancer Stage IIIB Primary Peritoneal Cavity Cancer Stage IIIC Uterine Corpus Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Cancer Stage IIIC Primary Peritoneal Cavity Cancer Stage IV Fallopian Tube Cancer Stage IV Ovarian Cancer Stage IV Primary Peritoneal Cavity Cancer Stage IVA Uterine Corpus Cancer Stage IVB Uterine Corpus Cancer Less << Phase 1 Recruiting May 2020 United States, California ... More >> City of Hope Corona Recruiting Corona, California, United States, 92879 Contact: Cheryl Corpus    626-256-4673 ext 81529       Contact: Misagh Karimi, MD    626-256-4673       Principal Investigator: Misagh Karimi, MD          City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Thanh Dellinger    800-826-4673       Principal Investigator: Thanh Dellinger          City of Hope Rancho Cucamonga Recruiting Rancho Cucamonga, California, United States, 91730 Contact: Valerie Estala    626-256-4673 ext 81699       Principal Investigator: Behnam Ebrahimi, MD Less <<
NCT01760811 Squamous Cell Carcinoma Phase 1 Phase 2 Unknown December 2017 Israel ... More >> Rabin Medical Center Not yet recruiting Petah Tiqva, Israel, 49100 Contact: Aron Popovtzer, MD    9729378044    aronp@clalit.org.il    Sub-Investigator: Dror Limon, MD          Sub-Investigator: Salomon Stemmer, MD          Sub-Investigator: Rafael Feinmesser, MD          Sub-Investigator: Thomas Spitzer, MD          Sub-Investigator: Gideon Bachar, MD          Principal Investigator: Aron Popovtzer, MD Less <<
NCT00262951 - Terminated(Closed at a planned... More >> interim analysis by meeting a predefined toxicity endpoint) Less << - -
NCT03314935 Biliary Tract Cancer (BTC) ... More >> Colorectal Cancer (CRC) Endometrial Cancer Gastroesophageal Cancer (GC) Ovarian Cancer Solid Tumors Less << Phase 1 Phase 2 Recruiting May 27, 2020 United States, Alabama ... More >> University of Alabama Not yet recruiting Birmingham, Alabama, United States, 35294-3300 USA Mitchell Cancer Center Recruiting Mobile, Alabama, United States, 36604 United States, California UC Davis - Comprehensive Cancer Centre Not yet recruiting Sacramento, California, United States, 95817 United States, Georgia Northwest Georgia Oncology Centers Recruiting Marietta, Georgia, United States, 30060 United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 START San Antonio Recruiting San Antonio, Texas, United States, 78229 Belgium Grand Hopital de Charleroi - Department of Medical Oncology Not yet recruiting Brussels, Belgium, 6000 Institut Jules Bordet - Clinical Trials Conduct Unit Recruiting Brussels, Belgium, B-1000 United Kingdom University of Liverpool Not yet recruiting Liverpool, United Kingdom, L69 3BX UCL Cancer Institute Recruiting London, United Kingdom, WC1E 6BT The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Less <<
NCT00003907 - Completed - -
NCT03456063 Non-Small-Cell Lung Phase 3 Recruiting November 20, 2024 -
NCT00577057 Nasopharyngeal Neoplasms Not Applicable Unknown August 2013 China ... More >> Pamela Youde Nethersole Eastern Hospital Not yet recruiting Hong Kong, China Prince of Wales Hospital Not yet recruiting Hong Kong, China Princess Margaret Hospital Not yet recruiting Hong Kong, China Sub-Investigator: Ashley Cheng, Dr          Queen Elizabeth Hospital Not yet recruiting Hong Kong, China Sub-Investigator: Roger Ngan, Dr          Queen Mary Hospital Not yet recruiting Hong Kong, China Sub-Investigator: Dora Kwong, Dr          Tuen Mun Hospital Not yet recruiting Hong Kong, China Sub-Investigator: Stewart Y Tung, Dr Less <<
NCT00085735 - Completed - -
NCT03386838 Head and Neck Cancer Phase 3 Terminated(Business objectives... More >> have changed.) Less << - United States, Pennsylvania ... More >> Allegheny General Hospital Pittsburgh, Pennsylvania, United States, 15212-0000 Less <<
NCT01711541 Head and Neck Squamous Cell Ca... More >>rcinoma Stage IVA Oropharyngeal Carcinoma AJCC v7 Stage IVB Oropharyngeal Carcinoma AJCC v7 Less << Phase 1 Phase 2 Active, not recruiting - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States, 60201 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00301782 Extragonadal Germ Cell Tumor ... More >> Teratoma Testicular Germ Cell Tumor Less << Phase 2 Completed - United Kingdom ... More >> Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom, B15 2TH Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Gloucestershire Oncology Centre at Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Walsgrave Hospital Coventry, England, United Kingdom, CV2 2DX Royal Devon and Exeter Hospital Exeter, England, United Kingdom, EX2 5DW Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE University College of London Hospitals London, England, United Kingdom, WIT 3AA Christie Hospital Manchester, England, United Kingdom, M20 4BX Clatterbridge Centre for Oncology Merseyside, England, United Kingdom, CH63 4JY Nottingham City Hospital Nottingham, England, United Kingdom, NG5 1PB Rosemere Cancer Centre at Royal Preston Hospital Preston, England, United Kingdom, PR2 9HT Berkshire Cancer Centre at Royal Berkshire Hospital Reading, England, United Kingdom, RG1 5AN Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G11 6NT Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Less <<
NCT00871013 Myeloma Phase 2 Recruiting December 2020 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Nathan Petty    501-526-6990 ext 2435    pettynathanm@uams.edu    Sub-Investigator: Frits van Rhee, M.D.,Ph.D.          Sub-Investigator: Maurizio Zangari, MD          Sub-Investigator: Atul Kothari, MD          Sub-Investigator: Carolina Schinke, MD          Sub-Investigator: Faith Davies, MD          Sub-Investigator: Gareth Morgan, MD          Sub-Investigator: Juan Crescencio, MD          Sub-Investigator: Mary Burgess, MD          Sub-Investigator: Meera Mohan, MD          Sub-Investigator: Muthukumar Radhakrishnan, MD          Sub-Investigator: Pankaj Mathur, MD          Sub-Investigator: Sharmilan Thanendrajan, MD Less <<
NCT02114229 Malignant Rhabdoid Tumor ... More >> Atypical Teratoid Rhabdoid Tumor Less << Phase 2 Recruiting May 2027 United States, California ... More >> Children's Hospital of Los Angeles Withdrawn Los Angeles, California, United States, 90027 Lucille Packard Children's Hospital at Stanford University Medical Center Recruiting Palo Alto, California, United States, 94304 Contact: Sonia Partap, MD    650-723-0993    spartap@stanford.edu    Principal Investigator: Sonia Partap, MD          Rady Children's Hospital Recruiting San Diego, California, United States, 92123 Contact: John Crawford, MD, MS    858-576-1700    jcrawford@rchsd.org    Principal Investigator: John Crawford, MD, MS          United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Kathleen Dorris, MD    720-777-6672    kathleen.dorris@childrenscolorado.org    Principal Investigator: Kathleen Dorris, MD          United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Lindsay B. Kilburn, MD    202-476-2800    lkilburn@childrensnational.org    Principal Investigator: Lindsay B. Kilburn, MD          United States, Florida UF Cancer Center at Orlando Health Recruiting Orlando, Florida, United States, 32806 Contact: Amy A. Smith, MD    321-841-7246    amy.smith@orlandohealth.com    Principal Investigator: Amy A. Smith, MD          United States, Georgia Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Sindy Moon    404-785-1441    cindy.moon@choa.org    Contact: Jaclyn Smith    404-785-0692    jaclyn.smith@choa.org    Principal Investigator: Dolly Aguilera, MD          United States, Minnesota Children's Hospital and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55102 Contact: Anne Bendel, MD    651-220-6732    anne.bendel@childrensmn.org    Principal Investigator: Anne Bendel, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tabatha E. Doyle, RN    901-595-2544    tabatha.doyle@stjude.org    Principal Investigator: Santhosh Upadhyaya, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Patricia Baxter, MD    832-824-1000    pabaxter@txch.org    Principal Investigator: Patricia Baxter, MD          United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Sarah Leary, MD    866-987-2000    sarah.leary@seattlechildrens.org    Principal Investigator: Sarah Leary, MD Less <<
NCT02157792 Advanced Solid Tumor Phase 1 Recruiting September 18, 2019 -
NCT01496742 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 2 Completed - -
NCT00580983 Head and Neck Cancer Not Applicable Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109-5010 Less <<
NCT02607423 Stage IIIA Non-Small Cell Lung... More >> Cancer Less << Phase 2 Withdrawn(The study failed to ... More >>meet its accrual targets.) Less << - United States, Pennsylvania ... More >> ECOG-ACRIN Cancer Research Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00580983 - Completed - -
NCT00869232 Multiple Myeloma Phase 2 Active, not recruiting October 2019 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT03588494 Quality of Life Phase 2 Phase 3 Not yet recruiting September 1, 2021 China, Sichuan ... More >> Affiliated Hospital of North Sichuan Medical College Not yet recruiting Nanchong, Sichuan, China, 600000 Contact: Daiyuan Ma, M.D    868172246171    angenpn@gmail.com    Principal Investigator: xin hu, M.D          Principal Investigator: xiangdong fang, M.D Less <<
NCT02576574 First Line Non-Small Cell Lung... More >> Cancer Less << Phase 3 Active, not recruiting September 5, 2024 -
NCT00003907 Liver Cancer ... More >>Metastatic Cancer Less << Phase 2 Completed - -
NCT02280993 Hodgkin Lymphoma ... More >> Refractory Relapse Less << Phase 1 Active, not recruiting May 2020 Denmark ... More >> Rigshospitalet Copenhagen, Denmark France Centre Hospitalier Universitaire Lille, France Hospices Civils de Lyon Lyon, France Centre Hospitalier et Universitaire Nantes, France Hôpital Saint Louis Paris, France Institut Gustave Roussy Paris, France Netherlands Academic Medical Center Amsterdam, Netherlands, 1105 AZ Free University Medical Center Amsterdam, Netherlands University Medical Center Groningen Groningen, Netherlands Erasmus Medical Center Rotterdam, Netherlands United Kingdom Cambridge University Hospitals NHS Foundation Trust | Addenbrooke's Hospital Cambridge, United Kingdom King's College Hospital NHS Foundation Trust London, United Kingdom Christie Hospital, Manchester Manchester, United Kingdom Less <<
NCT01108666 Non Small Cell Lung Cancer Phase 1 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02995850 Gastric Cancer With Peritoneal... More >> Metastasis (PCI<12) Less << Phase 1 Phase 2 Recruiting May 2023 Korea, Republic of ... More >> Department of Surgery, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 03722 Contact: Woo Jin Hyung, MD    82-2-2228-2129    WJHYUNG@yuhs.ac Less <<
NCT01843049 Esophageal Cancer Phase 1 Phase 2 Unknown - China ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China Less <<
NCT01278602 Diffuse Large B-cell Lymphoma Phase 2 Unknown February 2014 China ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, China, 200032 Contact: Ye Guo, MD       pattrick_guo@msn.com    Principal Investigator: Ye Guo, MD Less <<
NCT02116530 - Completed - -
NCT02205047 Malignant Neoplasm of Stomach ... More >> Malignant Neoplasm of Cardio-esophageal Junction of Stomach Epidermal Growth Factor Receptor (EGFR) Protein Overexpression Less << Phase 2 Recruiting September 2024 -
NCT00670631 Multiple Myeloma Phase 2 Completed - -
NCT00083681 Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT02784795 Solid Tumor B... More >>reast Cancer Colon Cancer Cholangiocarcinoma Soft Tissue Sarcoma Less << Phase 1 Active, not recruiting January 31, 2019 United States, Florida ... More >> Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Denmark Rigshospitalet Copenhagen, København Ø, Denmark, 2100 France Institut Bergonie Bordeaux, France, 33076 Centre Leon Berard Lyon Cedex 08, France, 69373 Gustave Roussy Villejuif Cedex, France, 94805 Spain Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Fundacion Jimenez Diaz Madrid, Spain, 28040 Hospital Madrid Norte Sanchinarro Madrid, Spain, 28050 Less <<
NCT02116530 Hematopoietic/Lymphoid Cancer ... More >> Nausea and Vomiting Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 3 Completed - -
NCT03288545 Carcinoma, Transitional Cell ... More >> Urinary Bladder Neoplasms Urologic Neoplasms Renal Pelvis Neoplasms Urothelial Cancer Ureteral Neoplasms Urethral Neoplasms Less << Phase 1 Recruiting September 2024 United States, California ... More >> University of California at San Francisco Recruiting San Francisco, California, United States, 94134 Stanford Cancer Center / Blood & Marrow Transplant Program Recruiting Stanford, California, United States, 94305 United States, Colorado University of Colorado Hospital / University of Colorado Recruiting Aurora, Colorado, United States, 80045-0510 United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States, 06520 United States, Florida University of Miami Recruiting Miami, Florida, United States, 33136 United States, Georgia Winship Cancer Institute / Emory University School of Medicine Recruiting Atlanta, Georgia, United States, 30322 United States, Illinois Cardinal Bernardin Cancer Center / Loyola University Medical Center Recruiting Maywood, Illinois, United States, 60153 United States, Kansas University of Kansas Cancer Center Recruiting Westwood, Kansas, United States, 66205 United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Weill Cornell Medical College Recruiting New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10087-9049 United States, North Carolina UNC Lineberger Comprehensive Cancer Center / University of North Carolina Recruiting Chapel Hill, North Carolina, United States, 27599 Levine Cancer Institute Recruiting Charlotte, North Carolina, United States, 28204 United States, Ohio Case Western Reserve University / University Hospitals Case Medical Center Recruiting Cleveland, Ohio, United States, 44106 United States, South Carolina Medical University of South Carolina/Hollings Cancer Center Recruiting Charleston, South Carolina, United States, 29425 Less <<
NCT00670631 - Completed - -
NCT01151761 Cholangiocarcinoma ... More >> Hepatobiliary Neoplasm Liver Cancer Bile Duct Cancer Cancer of Gallbladder Less << Phase 2 Terminated(Poor accrual) - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01151761 - Terminated(Poor accrual) - -
NCT00003941 Mediastinal Cancer ... More >> Metastatic Cancer Testicular Germ Cell Tumor Less << Phase 3 Completed - -
NCT01440270 Locally Advanced Malignant Neo... More >>plasm Oral Cancer Oropharyngeal Carcinoma Less << Phase 2 Active, not recruiting October 2019 China, Shanghai ... More >> Eye & Ear Hospital of Fudan University Shanghai, Shanghai, China Fudan University Shanghai Cancer Center Shanghai, Shanghai, China Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai, China Shanghai Changzheng Hospital Shanghai, Shanghai, China Shanghai First People's Hospital Shanghai, Shanghai, China Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai, China Tongji University Dongfang Hospital Shanghai, Shanghai, China Less <<
NCT02358863 Esophageal Cancer ... More >> Gastric Cancer Less << Not Applicable Terminated(Issues with recruit... More >>ment.) Less << - United States, District of Col... More >>umbia Georgetown University Washington, District of Columbia, United States, 20057 Less <<
NCT01033578 Hepatocellular Carcinoma Not Applicable Unknown December 2010 China ... More >> Liver Cancer Insitute, Zhongshan Hospital Recruiting Shanghai, China, 200032 Contact: Jia Fan, Doctor    86-21-64041990 ext 2375    jiafan99@yahoo.com    Contact: Xiaoying Wang, Doctor    86-21-64041990 ext 2918    xiaoyingwang@fudan.edu.cn    Principal Investigator: Jia Fan, Doctor Less <<
NCT02738723 Small Cell Lung Cancer Phase 2 Recruiting January 2020 China, Chongqing ... More >> Daping Hospital, Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: Xueqin Yang, PH.D.    86-23-68757151    yangxueqin@hotmail.com    Principal Investigator: Xueqin Yang, PH.D. Less <<
NCT02830139 Malignant Neoplasm of Colorect... More >>um Less << Phase 2 Not yet recruiting July 2021 -
NCT01545687 Head and Neck Cancer ... More >> Oral Complications of Radiation Therapy Pain Weight Changes Less << Phase 3 Withdrawn - -
NCT00085735 Untreated Childhood Medullobla... More >>stoma Less << Phase 3 Completed - -
NCT02720614 Non-small Cell Lung Cancer Phase 2 Completed - -
NCT03727061 Recurrent Head and Neck Carcin... More >>oma Locally Advanced Head and Neck Carcinoma Less << Phase 2 Not yet recruiting November 1, 2022 -
NCT00642824 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 2 Terminated(Terminated due to l... More >>ow enrollment. No statistical analyses were performed.) Less << - Spain ... More >> Alcorcon, Spain, 28922 Alcoy, Spain, 03804 Alicante, Spain, 03010 Badalona, Spain, 08915 Barakaldo, Spain, 48903 Burgos, Spain, 09005 Elche, Spain, 03203 Girona, Spain, 17007 Huesca, Spain, 22004 La Laguna, Spain, 38320 Las Palmas de Gran Canaria, Spain, 35016 Lugo, Spain, 27004 Madrid, Spain, 28006 Madrid, Spain, 28040 Madrid, Spain, 28046 Murcia, Spain, 30008 Palma de Mallorca, Spain, 07014 Pamplona, Spain, 31008 Salamanca, Spain, 37007 Valencia, Spain, 41014 Valencia, Spain, 46009 Zaragoza, Spain, 50009 Less <<
NCT01689558 1、Enough Cases ... More >> 2、Elekta Precise 1343 Digital Control Electron Linear Accelerator Can Undertake Nasopharyngeal Carcinoma Specimens in the Materia， Image Department of Nose Pharynx Ministry MRI Dynamic Testing, Less << Phase 2 Phase 3 Unknown January 2017 China, Guizhou ... More >> Cancer Hospital of Guizhou province Recruiting Guiyang, Guizhou, China, 550002 Contact: Feng Jin, Professor    +86 13985124806    jinf8865@gmail.com    Principal Investigator: Feng Jin, Professor Less <<
NCT02358863 - Terminated(Issues with recruit... More >>ment.) Less << - -
NCT02095119 Uterine Cervical Cancer Phase 1 Phase 2 Completed - Mexico ... More >> Instituto Nacional de Cancerología Mexico City, Federal District, Mexico, 14080 Less <<
NCT03502785 Urothelial Carcinoma Phase 1 Phase 2 Recruiting September 2020 United States, Alaska ... More >> Alaska Clinical Research Center, LLC Recruiting Anchorage, Alaska, United States, 99503 Contact: Study Coordinator Talia Wyckoff    907-276-1455    TWyckoff@akmed.com    United States, Florida H. Lee Moffitt Cancer Center & Research Institute, Inc. Recruiting Tampa, Florida, United States, 33612 Contact: Study Coordinator Yazmin Rodriguez    813-745-3353    Yazmin.Rodriguez@moffitt.org    United States, Indiana Indiana University Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Clinical Research Nurse Christin Snow, RN, BSN    317-274-5830    chsnow@iu.edu    United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Study Coordinator Veena Ramakrishna    313-576-9703    ramakriv@karmanos.org    United States, Missouri Washington University School of Medicine in St. Louis Recruiting Saint Louis, Missouri, United States, 63110 Contact: Study Coordinator Andrew Atkocius    314-747-1343    a.atkocius@wustl.edu    United States, New York Columbia University, Herbert Irving Comprehensive Cancer Center Recruiting New York, New York, United States, 10032 Contact: Study Coordinator Bridget James    212-304-5543    bb2771@cumc.columbia.edu    United States, Pennsylvania University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Study Coordinator Daniel Mocan, RN    412-235-1319    mocand@upmc.edu    United States, South Carolina Greenville Memorial Hospital Recruiting Greenville, South Carolina, United States, 29615 Contact: Study Coordinator Gina Norris    864-241-6251    gnorris@ghs.org    Spain Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Principal Investigator Daniel Castellano       dcastellano.ec@gmail.com Less <<
NCT00738452 Lung Cancer Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00257829 Cervical Cancer Phase 2 Withdrawn(This study was close... More >>d due to lack of funding.) Less << - -
NCT01917695 Carcinoma Cervix Phase 3 Unknown August 2018 India ... More >> Government Royapettah Hospital Recruiting Chennai, Tamil Nadu, India, 600014IndiaNaduI6 Contact: Rajaraman Ramamurthy, MS MCh    +919444046168    rajaanu1@rediffmail.com    Contact: Subbiah Shanmugam, MS MCh    +919360206030    subbiah_doctor@yahoo.co.uk    Principal Investigator: Rajaraman Ramamurthy, MS MCh          Sub-Investigator: Subbiah Shanmugam, MS MCh Less <<
NCT02801487 Nasopharyngeal Carcinoma Phase 1 Phase 2 Recruiting March 2021 China, Shanghai ... More >> Shanghai Proton and Heavy Ion Center Recruiting Shanghai, Shanghai, China, 201315 Contact: Lin Kong, MD       lin.kong@sphic.org.cn    Contact: Jiyi Hu, MD       jiyi.hu@sphic.org.cn    Principal Investigator: Jiade J Lu, MD Less <<
NCT02296684 Cancer of Head and Neck ... More >> Head and Neck Cancer Neoplasms, Head and Neck Carcinoma, Squamous Cell of Head and Neck Squamous Cell Carcinoma of the Head and Neck Squamous Cell Carcinoma, Head and Neck Less << Phase 2 Recruiting March 31, 2023 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Ravindra Uppaluri, M.D., Ph.D.    617-632-3091       Principal Investigator: Ravindra Uppaluri, M.D., Ph.D.          Sub-Investigator: Robert Haddad, M.D.          Sub-Investigator: Nicole Chau, M.D.          Sub-Investigator: Jochen Lorch, M.D.          Sub-Investigator: Guilherme Rabinowitz, M.D.          Sub-Investigator: Glenn Hanna, M.D.          Sub-Investigator: Jason Glass, NP          Sub-Investigator: Patricia McHugh, RN          Sub-Investigator: Michelle Flynn, RN          Sub-Investigator: Jennifer McColgan, PA          Sub-Investigator: Jonathan Schoenfeld, M.D., MPH          Sub-Investigator: Danielle Margalit, M.D., MPH          Sub-Investigator: Roy Tishler, M.D., Ph.D.          Sub-Investigator: Donald Annino, M.D.          Sub-Investigator: Laura Goguen, M.D.          Sub-Investigator: Sonia Patel, NP, MPH          Sub-Investigator: Elizabeth Castronovo, NP          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Douglas R Adkins, M.D.    314-362-4471    dadkins@wustl.edu    Sub-Investigator: Max Artyomov, Ph.D.          Sub-Investigator: Rebecca Chernock, M.D.          Sub-Investigator: Hiram Gay, M.D.          Sub-Investigator: Nsangou Ghogomu, M.D.          Sub-Investigator: Dorina Kallogjeri, M.D., M.P.H.          Sub-Investigator: Brian Nussenbaum, M.D.          Sub-Investigator: Randall Paniello, M.D.          Sub-Investigator: Jay Piccirillo, M.D.          Sub-Investigator: Jason Rich, M.D.          Sub-Investigator: Robert Schreiber, Ph.D.          Sub-Investigator: Wade Thorstad, M.D.          Sub-Investigator: Tanya Wildes, M.D.          Sub-Investigator: Gavin P Dunn, M.D., Ph.D.          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Luc Morris, M.D.    212-639-3049       Principal Investigator: Luc Morris, M.D.          Sub-Investigator: Lara Dunn, M.D.          Sub-Investigator: Sean McBride, M.D.          Sub-Investigator: Jatin Shah, M.D.          Sub-Investigator: Bhuvanesh Singh, M.D., Ph.D.          Sub-Investigator: Snehal Patel, M.D.          Sub-Investigator: Jennifer Cracchiolo, M.D.          Sub-Investigator: Benjamin Roman, M.D.          Sub-Investigator: Marc Cohen, M.D.          Sub-Investigator: Vaios Hatzoglou, M.D.          Sub-Investigator: Nora Katabi, M.D.          Sub-Investigator: Nancy Lee, M.D.          Sub-Investigator: Daniel Higginson, M.D. Less <<
NCT00030771 Lung Cancer Phase 3 Active, not recruiting December 2037 Germany ... More >> Klinik Loewenstein gGmbH Löwenstein, Germany, 74245 Klinikum der Stadt Mannheim Mannheim, Germany, D-68135 Serbia Institut za plucne bolesti Sremska Kamenica, Serbia, 21204 Institute of Oncology Sremska Kamenica, Serbia, 21204 Switzerland Kantonsspital Aarau Aarau, Switzerland, CH-5001 Kantonsspital Baden Baden, Switzerland, CH-5404 Kantonsspital Baden, Switzerland, CH-5404 Saint Claraspital AG Basel, Switzerland, CH-4016 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland, 6500 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Kantonsspital Freiburg Freiburg, Switzerland, 1708 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Pluridisciplinaire d' Oncologie Lausanne, Switzerland, 1011 Kantonsspital Liestal Liestal, Switzerland, CH-4410 Kantonsspital Olten Olten, Switzerland, CH-4600 FMH Onkologie/Haematologie Rheinfelden, Switzerland, 4310 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 Kantonsspital Winterthur Winterthur, Switzerland, CH-8400 Onkozentrum Zurich, Switzerland, 8038 City Hospital Triemli Zurich, Switzerland, CH-8063 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT01732640 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 1 Phase 2 Terminated(Slow accrual and hi... More >>gh levels of toxicity lead to early termination.) Less << - United States, Maryland ... More >> Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 United States, Tennessee Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT01732640 - Terminated(Slow accrual and hi... More >>gh levels of toxicity lead to early termination.) Less << - -
NCT03092518 Gastric Adenocarcinoma ... More >> Esophagogastric Junction Gastric Cancer Less << Phase 2 Recruiting October 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Less <<
NCT03523234 Small-cell Lung Cancer Not Applicable Recruiting July 2023 China, Shanghai ... More >> Shanghai Pulmonary Hospital Recruiting Shanghai, Shanghai, China, 200000 Contact: Peng Zhang, doctor Less <<
NCT00379262 Nasopharyngeal Carcinoma Phase 3 Active, not recruiting December 2018 China ... More >> Cancer Center, Sun Yat Sen University Guangzhou, China Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital Hong Kong, China Department of Clinical Oncology, Prince of Wales Hospital Hong Kong, China Department of Clinical Oncology, Princess Margaret Hospital Hong Kong, China Department of Clinical Oncology, Queen Elizabeth Hospital Hong Kong, China Department of Clinical Oncology, Queen Mary Hospital Hong Kong, China Department of Clinical Oncology, Tuen Mun Hospital Hong Kong, China Less <<
NCT01709487 Ovarian Carcinoma ... More >> Fallopian Tube Carcinoma Primary Peritoneal Carcinoma Less << Phase 1 Phase 2 Completed - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 Hopital de la Citadelle Liège, Belgium, 4000 Less <<
NCT00002839 Head and Neck Cancer Phase 3 Completed - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 France CHR de Besancon - Hopital Jean Minjoz Besancon, France, 25030 Centre Regional Francois Baclesse Caen, France, 14076 Centre Hospitalier Universitaire de Dijon Dijon, France, 21033 Centre de Lutte Contre le Cancer, Georges-Francois Leclerc Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 Centre Hospitalier Regional et Universitaire de Lille Lille, France, 59037 CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Hopital Charles Nicolle Rouen, France, 76031 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Israel Rambam Medical Center Haifa, Israel, 31096 Italy Istituto Nazionale per lo Studio e la Cura dei Tumori Milano (Milan), Italy, 20133 Ospedale Civile Monselice Monselice, Padova, Italy, 35043 Azienda Ospedaliera "Santa Maria Degli Angeli" Pordenone, Italy, 33170 Netherlands Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1007 MB Leiden University Medical Center Leiden, Netherlands, 2300 CA Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT02976051 Locally Advanced Head and Neck... More >> Cancer Radiotherapy Less << Phase 2 Recruiting December 2021 Denmark ... More >> Department of Experimental Clinical Oncology, Aarhus University Hospital Recruiting Aarhus, Denmark, 8000 C Contact: Jens Overgaard, Prof., MD    +45 7846 2629    jens@oncology.au.dk    Contact: Mette Saxø, MD    +89492619    mette.saksoe@oncology.au.dk Less <<
NCT00258323 Esophageal Cancer Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT03718741 Bladder Cancer Phase 2 Recruiting November 1, 2023 Italy ... More >> Istituto Clinico Humanitas Recruiting Rozzano, Milano, Italy, 20089 Contact: Giuseppe D'Agostino, MD Less <<
NCT00401609 Small Cell Lung Cancer Phase 1 Phase 2 Completed - Italy ... More >> Azienda Ospedaliera S. Giuseppe Moscati, U.O. di Oncologia Medica Monteforte Irpino, AV, Italy, 83024 IRCCS Oncologico Bari, Oncologia Medica Bari, BA, Italy, 70126 Ospedale A. Cardarelli Campobasso, CB, Italy, 86100 Ospedale Mariano Santo, U.O. di Oncologia Medica Cosenza, CS, Italy, 87100 Ospedale Umberto di Frosinone Frosinone, FR, Italy, 03031 Umberto I SS. Trinita' Ospedale Frosinone, FR, Italy Ospedale San Martino Genova, GE, Italy Ospedale Serbelloni Gorgonzola, MI, Italy Policlinico Universitario P. Giaccone Palermo, PA, Italy, 90100 Ospedale La ferla Palermo, PA, Italy Policlinico Giaccone Palermo, PA, Italy Istituto Oncologico Veneto Padova, PD, Italy Ospedale Civile Polla, SA, Italy Divisione di Oncologia Medica, U.S.L.L. 13 Noale, VE, Italy, 30033 Ospedale L. Sacco Milano, Italy Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B Napoli, Italy, 80131 Ospedale Monaldi Napoli, Italy Azienda Sanitaria Locale 2 Pozzuoli, Italy Istituto Regina Elena, Divisione di Oncologia Medica Roma, Italy, 00144 Ospedale S. Giovanni Calibita Fatebenefratelli Roma, Italy, 00186 Ospedale San Camillo - Forlanini Rome, Italy Less <<
NCT02820857 Neuroendocrine Carcinomas Phase 2 Recruiting March 4, 2022 France ... More >> Service d'Hépato-Gastroenterologie et Oncologie Digestive, Hôpital Sud, CHU d'Amiens Recruiting Amiens, France, 80054 Contact: Vincent HAUTEFEUILLE, MD          Principal Investigator: Vincent HAUTEFEUILLE, MD          Service d'Hépatogastroentérologie, CHU d'Angers Recruiting Angers, France, 49933 Contact: Guillaume ROQUIN, MD          Principal Investigator: Guillaume ROQUIN, MD          Service de Gastroentérologie et Pancréatologie, Hôpital Beaujon, APHP Recruiting Clichy, France, 92118 Contact: Olivia HENTIC, MD          Principal Investigator: Olivia HENTIC, MD          Service d'Hépato-Gastroentérologie et Oncologie Digestive, CHU de Dijon Recruiting Dijon, France, 21000 Contact: Côme LEPAGE, MD          Principal Investigator: Côme LEPAGE, MD          Service d'Hépatogastroentéologie, Hôpital Michallon, CHU de Grenoble Recruiting Grenoble, France, 38043 Contact: Victoire GRANGER, MD          Principal Investigator: Victoire GRANGER, MD          Département de Cancérologie Urologique et Digestive, Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Farid EL HAJBI, MD          Principal Investigator: Farid EL HAJBI, MD          Service d'Oncologie Médicale - Hôpital Edouard Herriot - Hospices Civils de Lyon Recruiting Lyon, France, 69437 Contact: Thomas WALTER, MD    4 72 11 73 98 ext +33    thomas.walter@chu-lyon.fr    Principal Investigator: Thomas WALTER, MD          Service d'Hépato-Gastroentérologie et d'Oncologie Digestive, Hôpital de la Timone, APHM Recruiting Marseille, France, 13365 Contact: Laetitia DAHAN, MD          Principal Investigator: Laetitia DAHAN, MD          Service d'Oncologie Médicale, Hôpital Saint Eloi, CHU de Montpellier Recruiting Montpellier, France, 34298 Contact: Eric ASSENAT, MD          Principal Investigator: Eric ASSENAT, MD          Service d'Hépato-Gastroentérologie et d'Oncologie Digestive, Hôpital de la Salpêtrière, APHP Recruiting Paris, France, 75013 Contact: Olivier DUBREUIL, MD          Principal Investigator: Olivier DUBREUIL, MD          Service de Gastroentérologie, Hôpital Cochin, APHP Recruiting Paris, France, 75014 Contact: Romain CORIAT, MD          Principal Investigator: Romain CORIAT, MD          Service d'Hépato-Gastroenterologie et Oncologie Digestive, Hôpital Européen Georges Pompidou, APHP Recruiting Paris, France, 75015 Contact: Céline LEPERE, MD          Principal Investigator: Céline LEPERE, MD          Service d'Hépato-Gastroentérologie et d'Oncologie Digestive, Hôpital Haut Lévêque, CHU Bordeaux Recruiting Pessac, France, 33604 Contact: Denis SMITH, MD          Principal Investigator: Denis SMITH, MD          Pôle Régional de Cancérologie, CHU de Poitiers Recruiting Poitiers, France, 86021 Contact: Aurélie FERRU, MD          Principal Investigator: Aurélie FERRU, MD          Service d'Hépato-Gastroentérologie et Cancérologie, Hôpital Robert Debré, CHU de Reims Recruiting Reims, France, 51100 Contact: Guillaume CADIOT, MD          Principal Investigator: Guillaume CADIOT, MD          Service d'Hépatogastroentérologie, Hôpital Pontchaillou, CHU de Rennes Recruiting Rennes, France, 35000 Contact: Astrid LIEVRE, MD          Principal Investigator: Astrid LIEVRE, MD          Service de Gastroentérologie, CHU de Rouen Recruiting Rouen, France, 76031 Contact: Alice GANGLOFF, MD          Principal Investigator: Alice GANGLOFF, MD          Service de Gastro-Entérologie, Hôpital Nord, CHU de ST-Etienne Recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Nadia BOUARIOUA, MD          Principal Investigator: Nadia BOUARIOUA, MD          Service d'Oncologie Médicale, Hôpital Civil, CHU de Strasbourg Recruiting Strasbourg, France, 67200 Contact: Jean-Emmanuel KURTZ, MD          Principal Investigator: Jean-Emmanuel KURTZ, MD          Service d'Oncologie Endocrinienne, Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Eric BAUDIN, MD          Principal Investigator: Eric BAUDIN, MD Less <<
NCT00002875 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 3 Completed - -
NCT01416961 Lung Cancer Phase 1 Withdrawn(Neutron therapy has ... More >>become unavailable) Less << - -
NCT03514849 Small-cell Lung Cancer Not Applicable Recruiting March 2026 China, Shanghai ... More >> Shanghai Pulmonary Hospital Recruiting Shanghai, Shanghai, China, 200000 Contact: Peng Zhang, doctor Less <<
NCT03632798 Recurrent Ovarian Cancer Phase 3 Recruiting January 31, 2022 United States, Mississippi ... More >> Univeristy of Mississippi Medical Center Recruiting Jackson, Mississippi, United States, 39216 Contact: Kelly J Wilkinson, MD    888-815-2005    kjeanes@umc.edu    United States, West Virginia Charleston Area Medical Center Recruiting Charleston, West Virginia, United States, 25326 Contact: Stephen Bush, MD    304-925-4200       Contact: Tina Garten, RN    304-388-9995    Tina.Garten@camc.org    Edwards Comprehensive Cancer Center - Cabell Huntington Hospital Recruiting Huntington, West Virginia, United States, 25705 Contact: Nadim Bou Zgheib, MD    304-399-6600    zgheib@marshall.edu    Contact: Barbara Payne, RN    304-399-6617    Barbara.Payne@chhi.org Less <<
NCT02687958 Neuroendocrine Carcinoma Phase 2 Recruiting May 2017 Italy ... More >> S.C. Oncologia - Policlinico Active, not recruiting Modena, Emilia - Romagna, Italy, 41124 U.O. Oncologia Medica 1 - AOU Pisana Recruiting Pisa, Tuscany, Italy, 56126 Contact: Cinzia Orlandini, SC          Principal Investigator: Sergio Ricci, MD          Azienda Ospedaliera "Spedali Civili di Brescia" Active, not recruiting Brescia, Italy, 25123 Azienda Ospedaliera Universitaria Careggi Recruiting Florence, Italy, 50134 Contact: Luisa Di Cerbo, SC    +390557947298    luisa.dicerbo@libero.it    Contact: Alessandro Di Costanzo, SC    +390557947298    adicostanzo.oncmed@hotmail.com    Principal Investigator: Francesco Di Costanzo, MD          Principal Investigator: Lorenzo Antonuzzo, MD          Istituto Europeo di Oncologia Active, not recruiting Milano, Italy, 20141 Less <<
NCT00413283 Lung Cancer C... More >>hemotherapy-Induced Thrombocytopenia Non-Small Cell Lung Cancer Cancer Lung Neoplasms Oncology Solid Tumors Thrombocytopenia Less << Phase 2 Completed - -
NCT00413283 - Completed - -
NCT00193804 - Active, not recruiting May 2017 India ... More >> Tata Memorial Hospital Mumbai, Maharastra, India, 400 012 Less <<
NCT02264990 Non-squamous Non-small Cell Lu... More >>ng Cancer Less << Phase 3 Active, not recruiting July 26, 2019 -
NCT01719926 Colorectal Neoplasms ... More >> Esophageal Neoplasms Ovarian Neoplasms Less << Phase 1 Completed - Netherlands ... More >> Meander Medisch Centrum Amersfoort, Utrecht, Netherlands, 3813TZ the Netherlands Cancer Institute Amsterdam, Netherlands, 1066 CX UMC Utrecht Utrecht, Netherlands, 3584CX Switzerland Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Less <<
NCT01362127 Carcinoma, Squamous Cell ... More >> Adenocarcinoma of the Esophagus and Gastric Cardia Less << Phase 2 Active, not recruiting June 2018 Sweden ... More >> Gastrocentrum. Department of surgery, Karolinska University Hospital Stockholm, Sweden, 14186 Less <<
NCT03519971 Non-Small Cell Lung Cancer Phase 3 Recruiting August 1, 2022 -
NCT00193739 Cancer of Cervix Phase 3 Active, not recruiting July 31, 2019 India ... More >> Tata Memorial Hospital Mumbai, Maharashtra, India, 400012 Less <<
NCT00381706 Esophageal Cancer Phase 2 Completed - -
NCT02052960 Carcinoma, Squamous Cell of He... More >>ad and Neck Less << Phase 2 Active, not recruiting December 15, 2017 Belgium ... More >> Investigator Antwerp, Belgium, 2650 Investigator Brussels, Belgium, 1000 Investigator Brussels, Belgium, 1200 Investigator Gent, Belgium, 9000 France Investigator Avignon, France, 84918 Investigator Lille, France, 59020 Investigator Lyon, France, 69008 Investigator Nice, France, 06189 Investigator St Herblain, France, 44805 Germany Investigator Aachen, Germany, 52074 Investigator Berlin, Germany, 12203 Investigator Dresden, Germany, 01307 Investigator Essen, Germany, 45122 Investigator Hamburg, Germany, 20246 Investigator Hannover, Germany, 30625 Investigator Leipzig, Germany, 04103 Italy Investigator Milan, Italy, 20142 Investigator Pavia, Italy, 27100 Poland Investigator Bydgoszcz, Poland, 85-796 Investigator Krakow, Poland Investigator Lodz, Poland, 93-513 Investigator Lublin, Poland, 20-090 Investigator Warsaw, Poland, 2781 Romania Investigator Brasov, Romania, 500091 Investigator Clui-Napoca, Romania, 400015 Investigator Cluj-Napoca, Romania, 400015 Investigator Craiova, Romania, 200385 Investigator Oradea, Romania, 410469 Investigator Ploiesti, Romania, 100011 Investigator Timisoara, Romania, 300167 Investigator Timisoara, Romania, 300239 Spain Investigator Barcelona, Spain, 08036 Investigator Madrid, Spain, 28050 Investigator Madrid, Spain, 28911 Investigator Valencia, Spain, 46009 Less <<
NCT03077243 Carcinoma, Squamous Cell ... More >> Head and Neck Neoplasms Oropharyngeal Neoplasms Less << Phase 2 Recruiting February 2025 United States, Florida ... More >> University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Robert Amdur, MD    352-265-0287    amdurr@shands.ufl.edu    University of Florida Proton Therapy Institute Recruiting Jacksonville, Florida, United States, 32206 Contact: Roi Dagan, MD    904-588-1445    rdagan@floridaproton.org    United States, North Carolina University of North Carolina at Chapel Hill, Department of Radiation Oncology Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Bhishamjit Chera, MD    984-974-0400    bchera@med.unc.edu    Contact: Rebecca Green, MSW    (984) 974-8440    rlgreen@med.unc.edu    Rex Healthcare Recruiting Raleigh, North Carolina, United States, 27607 Contact: Nathan Sheets, MD    919-784-1251    nathan.sheets@unchealth.unc.edu Less <<
NCT01294280 - Recruiting - United States, New York ... More >> SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Stephen Graziano, MD    315-464-4353 Less <<
NCT02055144 - Recruiting March 2018 Italy ... More >> IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro Recruiting Genoa, Italy, 16132 Contact: Francesco Grossi, MD    +393355255484    fg1965@libero.it Less <<
NCT02858804 Mantle Cell Lymphoma Phase 4 Recruiting June 2020 China ... More >> Shuhua Yi Recruiting Tianjin, China, 300020 Contact: Shuhua Yi, Doc    86-22-23909106    yishuhua@ihcams.ac.cn    Contact: Lugui Qiu, Doc    86-22-23909172    qiulg@ihcams.ac.cn Less <<
NCT00381706 - Completed - -
NCT00455572 Lung Cancer, Non-Small Cell Phase 1 Terminated(Study early termina... More >>tion was due to slow recruitment and difficulties at achieving the required enrolment for the study.) Less << - Belgium ... More >> GSK Investigational Site Genk, Belgium, 3600 GSK Investigational Site Leuven, Belgium, 3000 GSK Investigational Site Liège, Belgium, 4000 Canada, Alberta GSK Investigational Site Edmonton, Alberta, Canada, T6G 1Z2 Canada, Quebec GSK Investigational Site Greenfield Park, Quebec, Canada, J4V 2H1 GSK Investigational Site Montreal, Quebec, Canada, H4J 1C5 France GSK Investigational Site Montpellier, France, 34295 GSK Investigational Site Pierre Benite, France, 69495 GSK Investigational Site Saint Herblain, France, 44805 GSK Investigational Site Strasbourg, France, 67091 Germany GSK Investigational Site Hemer, Nordrhein-Westfalen, Germany, 58675 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Halle, Sachsen-Anhalt, Germany, 06120 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Bad Berka, Thueringen, Germany, 99437 GSK Investigational Site Hamburg, Germany, 20246 Italy GSK Investigational Site Udine, Friuli-Venezia-Giulia, Italy, 33100 GSK Investigational Site Roma, Lazio, Italy, 00152 GSK Investigational Site Genova, Liguria, Italy, 16132 GSK Investigational Site Milano, Lombardia, Italy, 20132 GSK Investigational Site Milano, Lombardia, Italy, 20141 United Kingdom GSK Investigational Site Wythenshawe, Greater Manchester, United Kingdom, M23 9LT GSK Investigational Site Bebington, Wirral, United Kingdom, CH63 4JY GSK Investigational Site London, United Kingdom, SE1 9RT GSK Investigational Site Nottingham, United Kingdom, NG5 1PB GSK Investigational Site Southampton, United Kingdom, SO16 6YD Less <<
NCT00180791 Medulloblastoma ... More >> Brain Tumors Neuroectodermal Tumors, Primitive Less << Phase 2 Unknown - France ... More >> Institut Gustave Roussy Recruiting Villejuif, France, 94800 Contact: Chantal Kalifa, MD    33 1 42 11 4166    kalifa@igr.fr Less <<
NCT02974426 Non-small Cell Lung Cancer Sta... More >>ge IIIA Radiotherapy Less << Phase 3 Recruiting December 2020 China, Shanghai ... More >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD    +862122200000 ext 3602    xlfu1964@126.com Less <<
NCT00003912 Liver Cancer Phase 3 Completed - Italy ... More >> Azienda Ospedaliera di Padova Padova, Italy, 35128 Less <<
NCT00002555 Head and Neck Cancer Phase 3 Completed - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 France Centre de Lute Contre le Cancer,Georges-Francois Leclerc Dijon, France, 21079 CHR de Grenoble - La Tronche Grenoble, France, 38043 Centre Oscar Lambret Lille, France, 59020 CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Hopital Jean Bernard Poitiers, France, 86021 Institut Gustave Roussy Villejuif, France, F-94805 Italy Istituto Nazionale per lo Studio e la Cura dei Tumori Milan, Italy, 20133 Istituti Fisioterapici Ospitalieri - Roma Rome, Italy, 00161 Netherlands University Medical Center Nijmegen Nijmegen, Netherlands, NL-6252 HB Poland Medical University of Gdansk Gdansk, Poland, 80-211 Slovenia Institute of Oncology, Ljubljana Ljubljana, Slovenia, Sl-1000 Spain Ciudad Sanitaria Vall D'Hebron Barcelona, Spain, 08035 Switzerland Ospedale San Giovanni Bellinzona, Switzerland, CH-6500 Inselspital, Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Universitaetsspital Zurich, Switzerland, CH-8091 Turkey Dokuz Eylul University School of Medicine Izmir, Turkey, 35340 United Kingdom Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Less <<
NCT00002550 Lung Cancer Phase 3 Completed - United States, Illinois ... More >> CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 Veterans Affairs Medical Center - Indianapolis (Roudebush) Indianapolis, Indiana, United States, 46202 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, New York University of Rochester Cancer Center Rochester, New York, United States, 14642 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania Hahnemann University Hospital Philadelphia, Pennsylvania, United States, 19102-1192 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213-3489 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 United States, Wisconsin CCOP - Green Bay Green Bay, Wisconsin, United States, 54301 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Veterans Affairs Medical Center - Milwaukee (Zablocki) Milwaukee, Wisconsin, United States, 53295 South Africa Pretoria Academic Hospitals Pretoria, South Africa, 0001 Less <<
NCT01667302 Extranodal NK/T-cell Lymphoma,... More >> Nasal Type Less << Phase 2 Unknown December 2016 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting SHanghai, Shanghai, China, 200032 Contact: Ye Guo, MD    862164175590    pattrick_guo@msn.com Less <<
NCT02853305 Urothelial Carcinoma Associate... More >>d 1 RNA, Human Less << Phase 3 Active, not recruiting May 31, 2020 -
NCT02621333 Lung Adenocarcinoma Phase 2 Unknown September 2018 China, Henan ... More >> Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university Recruiting ZhengZhou, Henan, China, 450008 Contact: Quanli Gao, M.D.    +8615038171966    guaoquanli2015@126.com    Contact: Lingdi Zhao, M.D.    +8637165587483    lingdi1010@sohu.com    Principal Investigator: Quanli Gao, M.D. Less <<
NCT00210171 Carcinoma, Non-Small-Cell Lung Phase 2 Terminated - France ... More >> Centre de radiothérapie d'Agen Agen, France, 47000 Clinique Tivoli Bordeaux, France, 33000 Polyclinique Bordeaux Nord Bordeaux, France, 33000 Centre Hospitalier Universitaire de Bordeaux Bordeaux, France, 33076 Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest Bordeaux, France, 33076 Hôpital Robert Boulin Libourne, France, 33500 Clinique Francheville Perigueux, France, 24000 Less <<
NCT00174629 Lung Neoplasms Phase 3 Completed - Germany ... More >> Sanofi-Aventis Berlin, Germany Spain Sanofi-Aventis Barcelona, Spain Switzerland Sanofi-Aventis Genève, Switzerland Less <<
NCT00186680 Breast Cancer Phase 1 Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT03360760 Osteosarcoma of Pelvis Not Applicable Recruiting February 2025 China, Beijing ... More >> Peking University People's Hospital Recruiting Beijing, Beijing, China, 100034 Contact: Jie Xu, M.D.    86 15901040835    xujie_pkuph@sina.com Less <<
NCT00002558 - Completed - -
NCT00050973 Non-small Cell Lung Cancer Phase 3 Completed - -
NCT00453232 Extragonadal Germ Cell Tumor ... More >> Teratoma Testicular Germ Cell Tumor Less << Phase 2 Completed - United Kingdom ... More >> Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle-Upon-Tyne, England, United Kingdom, NE4 6BE Churchill Hospital Oxford, England, United Kingdom, OX3 7LJ Edinburgh Cancer Centre at Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT00003994 Childhood Hepatoblastoma ... More >> Recurrent Childhood Liver Cancer Stage I Childhood Liver Cancer Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01212354 Locally Advanced Head and Neck... More >> Cancer Less << Phase 3 Recruiting September 2025 Germany ... More >> Klinik für RadioOnkologie Strahlentherapie Recruiting Munich, Bavaria, Germany, 81675 Contact: Steffi U. Pigorsch, Dr. med.    +49 (0)89-4140 ext -5611    steffi.pigorsch@lrz.tum.de    Contact: Sabine Barta, Dr.    +49 (0)89-4140 ext 7787    sabine.barta@mri.tum.de    Principal Investigator: Steffi U. Pigorsch, Dr. med.          Sub-Investigator: Stephanie Combs, Prof. Dr. Less <<
NCT00002558 Extragonadal Germ Cell Tumor ... More >> Ovarian Cancer Testicular Germ Cell Tumor Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00003231 Lung Cancer Phase 2 Completed - Switzerland ... More >> Kantonspital Aarau Aarau, Switzerland, 5001 Office of Walter Weber-Stadelman Basel, Switzerland, CH 4051 University Hospital Basel, Switzerland, CH-4031 Inselspital, Bern Bern, Switzerland, CH-3010 Hopital Cantonal Universitaire de Geneva Geneva, Switzerland, CH-1211 Istituto Oncologico della Svizzera Italiana Lugano, Switzerland, CH-6900 Burgerspital, Solothurn Solothurn, Switzerland, 4500 City Hospital Triemli Zurich, Switzerland, 8063 Klinik Hirslanden Zurich, Switzerland, CH-8008 Less <<
NCT00578526 Urothelial Cancer ... More >> Bladder Cancer Adult Less << Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia British Columbia Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 London Health Sciences Centre London, Ontario, Canada, T6A 4L6 Less <<
NCT02937116 Cancer, Solid Tumor Phase 1 Unknown December 2018 -
NCT00303758 Pancreatic Cancer Phase 3 Completed - France ... More >> Centre Hospitalier d'Abbeville Abbeville, France, 80101 Hopital Duffaut Avignon, France, 84902 Centre Hospitalier de Blois Blois, France, 41016 Centre Hospitalier Docteur Duchenne Boulogne Sur Mer, France, 62200 Centre Hospitalier Universitaire Ambroise Pare - Boulogne Boulogne, France, F-92104 C.H. Bourg En Bresse Bourg En Bresse, France, 01012 Centre Hospitalier Pierre Oudot Bourgoin-Jallieu, France, 38300 Centre Hospitalier Universitaire d'Amiens Caen, France, 14076 Centre Hospitalier de Chalons-en-Champagne Chalons-en-Champagne, France, 51000 CHR Clermont Ferrand, Hotel dieu Clermont-Ferrand, France, 63003 Hopital Beaujon Clichy, France, 92118 Hopital Louis Pasteur Colmar, France, 68024 Hopital Du Bocage Dijon, France, 21034 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Hospitalier Draguignan Draguignan, France, 83300 Centre Hospitalier De Dunkerque - CHD Dunkerque, France, 59240 Centre Hospitalier Intercommunal St. Aubin les Elbeuf Elbeuf, France, 76503 CHU de Grenoble - Hopital de la Tronche Grenoble, France, 38043 Clinique Pasteur Guilherand Granges, France, 07500 Hopital Robert Boulin Libourne, France, 33500 Centre Hospital Universitaire Hop Huriez Lille, France, 59037 Centre Hospitalier Regional et Universitaire de Lille Lille, France, 59037 Hopital Edouard Herriot Lyon, France, 69437 Hopital Saint Joseph Marseille, France, 13008 CHU de la Timone Marseille, France, 13385 CHU Nord Marseille, France, 13915 Centre Hospitalier de Martigues Martigues, France, 13698 Centre Hospitalier General de Mont de Marsan Mont-de-Marsan, France, 40000 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 CHR Hotel Dieu Nantes, France, 44093 CHR D'Orleans - Hopital de la Source Orleans, France, 45100 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Bichat - Claude Bernard Paris, France, 75018 Hopital Haut Leveque Pessac, France, 33604 Clinique Ste - Marie Pontoise, France, 95301 CHU - Robert Debre Reims, France, 51092 Centre Eugene Marquis Rennes, France, 35064 Hopital Charles Nicolle Rouen, France, 76031 Clinique Armoricaine De Radiologie Saint Brieuc, France, F-22015 Centre Joliot Curie Des Docteurs Jean-Christophe Chardon Jacques Hernandez Et Laurent Gasnault Saint Martin Boulogne, France, 62280 Centre Hospitalier de Saint-Quentin Saint-Quentin, France, 02321 Centre Hospitalier de Semur en Auxois Semur en Auxois, France, 21140 Centre Hospitalier de Soissons Soissons cedex, France, 02209 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Centre Hospitalier de Tarbes Tarbes, France, 65013 Nouvelle Clinique Generale Valence, France, 26000 Less <<
NCT00014274 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 2 Phase 3 Completed - -
NCT00463515 Non-Small-Cell-Lung Cancer Phase 2 Completed - Belgium ... More >> ZNA Middelheim Antwerpen, Antwerp, Belgium University Hospital Antwerp Edegem, Antwerp, Belgium Sint Augustinus Ziekenhuis Wilrijk, Antwerp, Belgium Less <<
NCT00070629 Carcinoma, Non-Small Cell Lung Phase 2 Completed - -
NCT03321539 Nasopharyngeal Carcinoma Phase 3 Recruiting December 31, 2025 China, Guangdong ... More >> Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Dong-Ping Chen, MD    +862066673626    chen_dpgz@163.com    The First Affiliated Hospital of Guangdong Pharmaceutical University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Xi-Cheng Wang, MD    +862061321397    13902400598@126.com    Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Hai-Qiang Mai, MD,PhD    +862087343643    maihq@sysucc.org.cn Less <<
NCT00062270 Lung Cancer Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3300 Less <<
NCT02549261 Non-small Cell Lung Cancer Not Applicable Unknown December 2015 China, Beijing ... More >> Cancer Institute & Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China Less <<
NCT02283476 Lung Cancer Phase 3 Unknown November 2017 China ... More >> Tianjin Cancer Hospital Not yet recruiting TianJin, China, 300060 Contact: Jinhuai Xue, Master    8613502065304    xuejh1210@sina.com    Principal Investigator: Kai Li, Doctor Less <<
NCT01599013 Bladder Transitional Cell Carc... More >>inoma Stage IV Less << Phase 2 Completed - France ... More >> Pierre Fabre Research Institute Boulogne, France Less <<
NCT02621970 Nasopharyngeal Carcinoma Phase 3 Not yet recruiting January 2024 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT03604965 Locally Advanced Nasopharyngea... More >>l Carcinoma Less << Phase 3 Recruiting July 21, 2020 China, 贵州省 ... More >> Cancer Hospital of Guizhou Medical University Recruiting Guiyang, 贵州省, China, 550000 Contact: Yuanyuan Li, master    085186512802    lilyuanyuan@qq.com    Sub-Investigator: Feng Jin, Bachelor          Sub-Investigator: Weili Wu, Master          Sub-Investigator: Jinhua Long, Master          Sub-Investigator: Xiuling Luo, Bachelor          Sub-Investigator: Xiuyun Gong, Bachelor          Sub-Investigator: Yanfang Cen, Bachelor Less <<
NCT00002735 Head and Neck Cancer Phase 2 Terminated(Terminated due to p... More >>oor accrual.) Less << - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, California USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033-0800 United States, Colorado University of Colorado Cancer Center Denver, Colorado, United States, 80262 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160-7357 United States, Louisiana MBCCOP - LSU Medical Center New Orleans, Louisiana, United States, 70112 United States, Michigan Veterans Affairs Medical Center - Ann Arbor Ann Arbor, Michigan, United States, 48105 University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 Veterans Affairs Medical Center - Detroit Detroit, Michigan, United States, 48201-1932 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, Missouri Veterans Affairs Medical Center - Kansas City Kansas City, Missouri, United States, 64128 United States, New York Veterans Affairs Medical Center - Brooklyn Brooklyn, New York, United States, 11209 United States, Ohio Cleveland Clinic Cancer Center Cleveland, Ohio, United States, 44195 United States, Oklahoma Oklahoma Medical Research Foundation Oklahoma City, Oklahoma, United States, 73104 Veterans Affairs Medical Center - Oklahoma City Oklahoma City, Oklahoma, United States, 73104 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555-1329 Veterans Affairs Medical Center - Temple Temple, Texas, United States, 76504 CCOP - Scott and White Hospital Temple, Texas, United States, 76508 Less <<
NCT00003133 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01867086 Stage III Ovarian Cancer ... More >> Stage IV Ovarian Cancer Less << Phase 2 Completed - United States, Texas ... More >> Mary Crowley Cancer Research Centers Dallas, Texas, United States, 75230 Less <<
NCT01548573 Multiple Myeloma Phase 2 Terminated(Met study stopping ... More >>rules) Less << - United States, Iowa ... More >> University of Iowa Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 Less <<
NCT02724579 Medulloblastoma ... More >> Untreated Childhood Medulloblastoma Less << Phase 2 Recruiting May 31, 2025 -
NCT02940990 NSCLC SBRT ... More >> GM-CSF Less << Phase 2 Not yet recruiting - China, Shanghai ... More >> Shanghai Chest Hospital Not yet recruiting Shanghai, Shanghai, China Contact: Xiaolong Fu, PhD    +862122200000 ext 3602    xlfu1964@126.com Less <<
NCT00276705 Liver Cancer Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health at Royal Victoria Infirmary Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT01867086 - Completed - -
NCT02098954 Carcinoma, Non-Small Cell Lung... More >> EGFR Gene Mutation Less << Phase 2 Unknown December 2016 China, Hunan ... More >> Hunan Province Tumor Hospital Recruiting Changsha, Hunan, China Contact: Nong Yang, MD    +86 731 89762323    yangnong0217@163.com    Contact: Ming Zhou, MD    +86 731 89762321    zhouming243@gmail.com    Principal Investigator: Nong Yang, MD Less <<
NCT00498953 Head and Neck Cancer Phase 1 Phase 2 Completed - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 Less <<
NCT01878617 Medulloblastoma Phase 2 Recruiting December 2026 -
NCT01175356 - Completed - -
NCT01175356 Disseminated Neuroblastoma ... More >> Ganglioneuroblastoma Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Regional Neuroblastoma Stage 4S Neuroblastoma Less << Not Applicable Completed - -
NCT01142414 Head and Neck Cancer Phase 3 Withdrawn - -
NCT00003141 Brain Tumors ... More >>Central Nervous System Tumors Neuroblastoma Sarcoma Less << Phase 1 Completed - -
NCT00416676 Neuroblastoma Phase 3 Unknown - -
NCT00031590 Brain Tumors ... More >>Central Nervous System Tumors Medulloblastoma Primitive Neuroectodermal Tumor Less << Phase 2 Terminated(The study was termi... More >>nated prematurely due to slow accrual.) Less << - United States, California ... More >> Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 Less <<
NCT01783197 Non Small Cell Lung Cancer Phase 1 Active, not recruiting December 2018 Canada, British Columbia ... More >> BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT02240771 Hepatocellular Carcinoma Phase 2 Phase 3 Unknown March 2015 India ... More >> AII India Institute of Medical Sciences Recruiting New Delhi, Delhi, India, 110029 Contact: Subrat K Acharya, DM    +91-11-26594934    subratacharya2004@yahoo.com    Contact: Shalimar . ., DM    +91-9968405815    drshalimar@yahoo.com    Principal Investigator: Subrat K Acharya, DM          Sub-Investigator: Shashi B. Paul, Ph.D          Sub-Investigator: Shivanand R Gamanagatti, M.D          Sub-Investigator: Sreenivas Vishnubhatla, Ph.D Less <<
NCT00238160 Localized Resectable Adult Pri... More >>mary Liver Cancer Stage III Childhood Liver Cancer Less << Phase 3 Withdrawn - Japan ... More >> Kyoto Prefectural University of Medicine Kyoto, Japan, 602-8566 Kyoto City Hospital Kyoto, Japan, 604-8845 Kyoto University Hospital Kyoto, Japan, 606-8501 Kyoto-Katsura Hospital Kyoto, Japan, 615-8256 Less <<
NCT00186849 Neuroblastoma Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01909856 Cancer Phase 2 Completed - China, Hubei ... More >> Tongji Hospital,Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China, 430030 Less <<
NCT00530179 Diffuse Large B Cell Lymphoma Not Applicable Unknown - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T4C 2H5 Canada, Ontario Ottawa General Hospital Ottawa, Ontario, Canada, K1H 8L6 Canada, Saskatchewan Saskatchewan Cancer Agency Regina, Saskatchewan, Canada, S7N 4H4 Less <<
NCT00554463 Lung Cancer Phase 2 Completed - United States, Florida ... More >> University of Florida Shands Cancer Center Gainesville, Florida, United States, 32610-0232 CCOP - Mount Sinai Medical Center Miami Beach, Florida, United States, 33140 United States, Kentucky Lucille P. Markey Cancer Center at University of Kentucky Lexington, Kentucky, United States, 40536-0093 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Montana Northern Rockies Radiation Oncology Center Billings, Montana, United States, 59101 United States, Nebraska Methodist Estabrook Cancer Center Omaha, Nebraska, United States, 68114 United States, Ohio McDowell Cancer Center at Akron General Medical Center Akron, Ohio, United States, 44307 Summa Center for Cancer Care at Akron City Hospital Akron, Ohio, United States, 44309-2090 Charles M. Barrett Cancer Center at University Hospital Cincinnati, Ohio, United States, 45267 Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford Salem, Ohio, United States, 44460 Cancer Treatment Center Wooster, Ohio, United States, 44691 United States, Pennsylvania McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 United States, Wisconsin Veterans Affairs Medical Center - Milwaukee Milwaukee, Wisconsin, United States, 53295 Less <<
NCT00554463 - Completed - -
NCT00006461 Untreated Childhood Medullobla... More >>stoma Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT03169764 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT00732498 Lymphoma Phase 2 Active, not recruiting December 31, 2019 United States, Arizona ... More >> The University of Arizona Cancer Center Tucson, Arizona, United States, 85724 Less <<
NCT00293358 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT01032967 Esophageal Cancers Phase 3 Completed - -
NCT02445209 HER2 Negative Gastric Cancer Phase 3 Completed - -
NCT00645632 Sarcoma Not Applicable Completed - -
NCT02099188 Unresectable Sinonasal Tumors Phase 2 Active, not recruiting January 2024 Italy ... More >> Presidio Ospedaliero Spedali Civili di Brescia Brescia, BS, Italy, 25125 Fondazione IRCCS Istituto Nazionale Tumori Milano, MI, Italy, 20133 IRCCS Policlinico San Matteo Pavia, PV, Italy, 27100 A.O. Ospedale di Circolo e Fondazione Macchi Varese, VA, Italy, 21100 Azienda Ospedaliera "Maggiore della Carità" Novara, Italy, 28100 Less <<
NCT00911222 - Completed - Germany ... More >> iOMEDICO AG Freiburg, Baden-Württemberg, Germany, 79108 Less <<
NCT02099175 Sinonasal Tumors Phase 2 Active, not recruiting January 2024 Italy ... More >> Presidio Ospedaliero Spedali Civili di Brescia Brescia, BS, Italy, 25125 Fondazione IRCCS Istituto Nazionale Tumori Milano, MI, Italy, 20133 IRCCS Policlinico San Matteo Pavia, PV, Italy, 27100 A.O. Ospedale di Circolo e Fondazione Macchi Varese, VA, Italy, 21100 Azienda Ospedaliera "Maggiore della Carità" Novara, Italy, 28100 Less <<
NCT00004188 Neuroblastoma Phase 3 Completed - -
NCT00278278 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Unknown - United States, Texas ... More >> M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT03169738 Non-small Cell Lung Cancer Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT01111942 Head and Neck Cancer Early Phase 1 Terminated(lack of enrollment) - United States, Illinois ... More >> Southern Illinois University School of Medicine Springfield, Illinois, United States, 62701 Less <<
NCT00931645 Chronic Lymphocytic Leukemia Phase 3 Completed - France ... More >> DBIM Hopital Saint Louis Paris, France, 75000 Less <<
NCT03197571 Urothelial Carcinoma Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT02710734 Urothelial Carcinoma of the Bl... More >>adder Less << Phase 2 Recruiting April 2023 United States, Pennsylvania ... More >> Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Daniel Geynisman, MD    215-728-4300    daniel.geynisman@fccc.edu    Principal Investigator: Daniel Geynisman, MD Less <<
NCT00003937 Cardiac Toxicity ... More >> Sarcoma Less << Phase 3 Completed - -
NCT01719536 NSCLC Phase 3 Unknown December 2016 -
NCT01548573 - Terminated(Met study stopping ... More >>rules) Less << - -
NCT00085098 - Completed - -
NCT03175666 Triple Negative Breast Cancer Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT02777788 Cancer Phase 2 Phase 3 Active, not recruiting December 2019 -
NCT03342352 Head and Neck Cancer Phase 3 Withdrawn(Study was cancelled ... More >>prior to enrolling any patients.) Less << - -
NCT00085098 Brain Tumor C... More >>entral Nervous System Tumor Less << Phase 3 Completed - -
NCT02142738 Non-Small Cell Lung Carcinoma Phase 3 Active, not recruiting May 31, 2019 -
NCT01849783 Extramedullary Plasmacytoma ... More >> Isolated Plasmacytoma of Bone Light Chain Deposition Disease Primary Systemic Amyloidosis Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Active, not recruiting December 2020 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 Less <<
NCT01211002 Non-small Cell Lung Cancer Phase 4 Unknown December 2012 China ... More >> Daping Hospital Not yet recruiting Chongqin, China Contact: zhenzhou yang, M.D.       yangzhenzhou@sohu.com    Principal Investigator: zhenzhou yang, M.D. Less <<
NCT00514293 Lung Cancer Phase 2 Unknown - United States, California ... More >> R. Nandan M.D. Incorporated Recruiting Lakewood, California, United States, 90712 Contact: Raghu Nandan, MD    562-272-7630    traghu9@hotmail.com Less <<
NCT00705549 Non-Small-Cell Lung Cancer Phase 2 Terminated(Due to poor accrual... More >>) Less << - Greece ... More >> University General Hospital of Alexandroupolis, Dept. of Medical Oncology Alexandroupolis, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece 401 Military Hospital, Medical Oncology Unit Athens, Greece Air Forces Military Hospital, Dep of Medical Oncology Athens, Greece IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece Sismanogleio General Hospital, 1st, 2nd Dep of Pulmonary Diseases Athens, Greece Sotiria" General Hospital, 1st, 3rd, 8th Dep of Pulmonary Diseases Athens, Greece "Metaxa's" Anticancer Hospital of Piraeus,1st Dep of Medical Oncology Piraeus, Greece "Theagenion" Anticancer Hospital of Thessaloniki Thessaloniki, Greece Less <<
NCT02142738 - Active, not recruiting - -
NCT03086681 Cervical Carcinoma Phase 3 Not yet recruiting February 2020 China, Guangxi ... More >> First Affiliated Hospital of Guangxi Medical University Not yet recruiting Nanning, Guangxi, China, 530021 Contact: Yong Zhang, M.D.    0086-13607884001    zhangyonggx@163.com    Contact: Fang Wu, M.D.          Sub-Investigator: Jian Li, M.D.          Sub-Investigator: Hemin Lu, M.D.          Sub-Investigator: Haixin Huang, Master          Sub-Investigator: Zhanxiong Luo, Master          Sub-Investigator: Meilian Liu, Master          Sub-Investigator: Gaojuan Lin, Master          Sub-Investigator: Sihui Liao, bachelor          Sub-Investigator: Hongqian Wang, bachelor Less <<
NCT00416858 Esophageal Cancer Phase 3 Completed - -
NCT03532737 Locally Advanced Head and Neck... More >> Cancer Less << Phase 2 Recruiting October 31, 2022 Kuwait ... More >> Kuwait Cancer Control Center Recruiting Kuwait, Kuwait Contact: Mustafa El-Sherify Less <<
NCT03498521 Cancer of Unknown Primary Site Phase 2 Recruiting April 16, 2022 -
NCT03174275 Carcinoma, Squamous Cell ... More >> Oral Cancer Oropharynx Cancer Larynx Cancer Lip Cancer Esophageal Cancer Less << Phase 2 Recruiting September 1, 2026 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Jared Weiss, MD    919-843-7718    jared_weiss@med.unc.edu    Principal Investigator: Jared Weiss, MD Less <<
NCT02124421 Stage III Ovarian Cancer ... More >> Stage IV Ovarian Cancer Epithelial Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Carcinoma Ovarian Carcinoma Fallopian Tube Carcinoma Less << Phase 2 Recruiting April 2020 United States, Maryland ... More >> Mercy Medical Center Recruiting Baltimore, Maryland, United States, 21202 Sub-Investigator: Teresa Diaz-Montes, M.D., M.P.H          Principal Investigator: Armando Sardi, M.D. Less <<
NCT01553942 Lung Cancer Phase 2 Recruiting December 2020 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Geoffrey Oxnard, MD    617-632-6049    goxnard@partners.org    Principal Investigator: Geoffrey Oxnard, MD          Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Lecia V Sequist, MD MPH    617-724-4000    lvsequist@partners.org    Principal Investigator: Lecia V Sequist, MD MPH Less <<
NCT03192644 Hepatocellular Carcinoma Phase 3 Recruiting December 31, 2024 China ... More >> Cancer Center of Sun Yat-Sen University Recruiting Guangzhou, China Contact: Shaohua Li, MD       lishaoh@sysucc.org.cn Less <<
NCT03656965 Drug Use for Unapproved Schedu... More >>le Less << Phase 3 Active, not recruiting May 2021 Kuwait ... More >> Kuwait Cancer Control Center Kuwait, Kuwait Less <<
NCT01066234 Non-small Cell Lung Cancer Phase 2 Unknown March 2017 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT00002492 Sarcoma Phase 2 Completed - United States, Florida ... More >> Sylvester Cancer Center, University of Miami Miami, Florida, United States, 33136 Less <<
NCT03323463 HPV-Associated Oropharyngeal S... More >>quamous Cell Carcinoma Squamous Cell Carcinoma of the Neck Less << Phase 2 Recruiting October 2020 United States, New Jersey ... More >> Memoral Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Nancy Lee, MD    212-639-3341       Memoral Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Nancy Lee, MD    212-639-3341       Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Nancy Lee, MD    212-639-3341       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Nancy Lee, MD    212-639-3341       Memoral Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Nancy Lee, MD    212-639-3341       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10021 Contact: Nancy Lee, MD    212-639-3341       Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Nancy Lee, MD    212-639-3341 Less <<
NCT00969306 Small Cell Lung Cancer Phase 1 Completed - Netherlands ... More >> NKI/AvL Amsterdam, Netherlands VU Medical Center Amsterdam, Netherlands Maastricht Radiation Oncology Maastricht, Netherlands Maastricht University Medical Center Maastricht, Netherlands Less <<
NCT01042041 Hepatocellular Carcinoma ... More >> Liver Cancer Localized Unresectable Liver Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02580253 Hepatocellular Carcinoma Phase 2 Not yet recruiting December 2018 China, Zhejiang ... More >> First affiliated hospital, Zhejiang University Hangzhou, Zhejiang, China, 310006 Less <<
NCT01733589 Stage III Non-small-Cell Lung ... More >>Cancer Less << Phase 1 Phase 2 Completed - China, Zhejiang ... More >> Zhejiang Cancer Hospital Hangzhou, Zhejiang, China, 310022 Less <<
NCT03150628 Gastric Cancer ... More >> Peritoneal Carcinomatosis HIPEC Less << Phase 2 Suspended(Conflicting recruitm... More >>ent with PERISCOPE II study (NCT03348150)) Less << June 1, 2025 Netherlands ... More >> University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Less <<
NCT03107182 HPV-Related Squamous Cell Carc... More >>inoma HNSCC Less << Phase 2 Recruiting June 2020 United States, Illinois ... More >> University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Sara Kochanny    773-702-2336    skochanny@medicine.bsd.uchicago.edu    Principal Investigator: Tanguy Seiwert, MD Less <<
NCT00576056 Carcinoma, Hepatocellular Phase 2 Terminated(Bayer Healthcare is... More >> no supplying the study drug) Less << - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01549730 Cervix Cancer Not Applicable Active, not recruiting May 2019 Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT03004287 Multiple Myeloma Phase 2 Recruiting January 2021 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Nathan Petty    501-526-6990 ext 2435    pettynathanm@uams.edu Less <<
NCT03070366 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Recruiting October 2021 France ... More >> Hôpital Nord Franche Comté Recruiting Montbéliard, France, 25209 Contact: Xu Shan SUN, MD    (0)3 81 98 88 68 ext +33    xssun@chbm.fr Less <<
NCT01434394 Locally Advanced Malignant Neo... More >>plasm Oral Cancer Oropharyngeal Carcinoma Effects of Chemotherapy Less << Phase 2 Phase 3 Completed - China, Shanghai ... More >> Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, Shanghai, China, 200011 Less <<
NCT03700905 Head and Neck Cancer Phase 3 Recruiting May 2024 Germany ... More >> Universitätsklinikum Ulm Recruiting Ulm, Baden-Württemberg, Germany, 89075 Contact: Dr. med. Simon Laban    +49(0)731 500-59501    simon.laban@uniklinik-ulm.de    Contact: PD Dr. med. Jens Greve    +49(0)731 500-59501    jens.greve@uniklinik-ulm.de    Technische Universität München, Klinikum rechts der Isar Not yet recruiting München, Bayern, Germany, 81675 Contact: Dr. med. Folker Scheller    +49(0) 089-4140-5647    folker.schneller@tum.de    Contact: PD Dr. med. Andreas Knopf    +49(0) 089-41405383    Andreas.Knopf@mri.tum.de    Universitätsklinikum Gießen Not yet recruiting Gießen, Hessen, Germany, 35392 Contact: Prof. Dr. med. Claus Wittekind    +49 (0) 641-985-43725    claus.wittekindt@hno.med.uni-giessen.de    Contact: Dr. med. Christine Langer    +49 (0) 641/985-43732    christine.langer@hno.med.uni-giessen.de    Klinikum Bielefeld Not yet recruiting Bielefeld, Nordrhein-Westfalen, Germany, 330604 Contact: PD Dr. med. Martin Görner    +49 (0) 521-581-3601    Martin.goerner@klinikumbielefeld.de    Contact: Dr. med. Kai Wegehenkel    +49 (0) 521-581-3613    Kai.wegehenkel@klinikumbielefeld.de    HELIOS Klinikum Erfurt GmbH Not yet recruiting Erfurt, Thüringen, Germany, 99089 Contact: Dr. med. Kristin Möller    +49(0) 361 781-72536    kristin.moeller@helios-kliniken.de    Contact: Dr. med. Stefanie Pratsch    +49(0) 361 781-72538    Stefanie.Pratsch@helios-kliniken.de    Universitätsklinikum Hamburg Eppendorf Recruiting Hamburg, Germany, 20246 Contact: PD Dr. med. Chia- Jung Busch    +49(0)40 7410 50038    cjbusch@uke.de    Contact: Dr. med. Philippe Schafhausen    +49(0)40 7410 57122    schafhausen@uke.de    Katholisches Marienkrankenhaus Hamburg Recruiting Hamburg, Germany, 22087 Contact: Dr.med. Peter Ebeling    +49(0)40 25 46-25 02    ebeling.innere@marienkrankenhaus.org    Contact: Dr. med. Gunnar Hapke    +49(0)40 25 46 - 25 31    hapke.innere@marienkrankenhaus.org Less <<
NCT00052910 - Completed - -
NCT00576056 - Terminated(Bayer Healthcare is... More >> no supplying the study drug) Less << - -
NCT02672254 - Completed - -
NCT00104676 Extragonadal Germ Cell Tumor ... More >> Teratoma Testicular Germ Cell Tumor Less << Phase 3 Unknown - United States, Texas ... More >> M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U    713-792-3245       France Centre Paul Papin Recruiting Angers, France, 49100 Contact: Remy Delva    33-49-800-918-507       Institut Bergonie Recruiting Bordeaux, France, 33076 Contact: Nguyen Binh Bui, MD    33-5-5633-3813       C.H.U. de Brest Recruiting Brest, France, 29609 Contact: Jean-Pierre Malhaire, MD    33-298-223-333 ext. 233-95       Centre Regional Francois Baclesse Recruiting Caen, France, 14076 Contact: Emmanuel Sevin, MD    33-2-3145-5000    e.sevin@baclesse.fr    CHU de Grenoble - Hopital de la Tronche Recruiting Grenoble, France, 38043 Contact: Francois Ringeisen    33-4-7676-5537       Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Armelle Caty, MD    33-32-029-5959    acaty@o-lambret.fr    Centre Leon Berard Recruiting Lyon, France, 69008 Contact: Aude Flechon    33-4-78-78-26-45       Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Gwenaelle Gravis, MD    33-4-9122-3740    gravisg@marseille.fnclcc.fr    Hopital Notre-Dame de Bon Secours Recruiting Metz, France, 57038 Contact: Christian Platini, MD    33-3-8755-3554    cplatini@chr-metz-thionville.fr    Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Stephane Culine, MD    33-4-6761-3755    stculine@valdorel.fnclcc.fr    CRLCC Nantes - Atlantique Recruiting Nantes-Saint Herblain, France, 44805 Contact: Frederic Rolland, MD    33-2-40-67-99-76    F-rolland@nantes.fnclcc.fr    Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Antoine Thyss, MD    33-04-9203-1538    antoine.thyss@cal.nice.fnclcc.fr    Hopital Europeen Georges Pompidou Recruiting Paris, France, 75015 Contact: Stephane Oudard, MD, PhD    33-1-56-093-476    stephane.oudard@hop.egp.ap-hop-paris.fr    Hopital Tenon Recruiting Paris, France, 75970 Contact: Jean-Pierre Lotz, MD    33-1-5601-6058    jean-pierre.lotz@tnn.ap-hop-paris.fr    Institut Jean Godinot Recruiting Reims, France, 51056 Contact: Jean-Christophe Eymard, MD    33-03-2650-4444    jc.eymard@reims.fnclcc.fr    Centre Eugene Marquis Recruiting Rennes, France, 35042 Contact: Pierre Kerbrat, MD, PhD    33-299-253-280    kerbrat@rennes.fnclcc.fr    Centre Hospitalier de Rodez Recruiting Rodez, France, 12027 Contact: Laurent Mosser    33-05-6575-1212       Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Paule Chinet-Charrot    33-2-3208-2222       Institut Claudius Regaud Recruiting Toulouse, France, 31052 Contact: Christine Chevreau-Dalbianco, MD    33-56-142-4114    chevreau.christine@claudiusregaud.fr    Centre Hospitalier Universitaire Bretonneau de Tours Recruiting Tours, France, 37044 Contact: Claude Linassier, MD, PhD    33-2-4747-3827    linassier@med.univ-tours.fr    Centre Alexis Vautrin Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Lionnel Geoffrois, MD    33-3-8359-8400       Institut Gustave Roussy Recruiting Villejuif, France, F-94805 Contact: Karim Fizazi, MD, PhD    33-1-4211-4559    fizazi@igr.fr    Slovakia National Cancer Institute - Bratislava Recruiting Bratislava, Slovakia, 833 10 Contact: Maria Reckova, MD    421-2-5937-8366    maria.reckova@nou.sk Less <<
NCT00052910 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 3 Completed - -
NCT03745222 Carcinoma, Non-Small-Cell Lung Phase 3 Recruiting October 26, 2023 United States, Maryland ... More >> Center For Cancer and Blood Disorders Not yet recruiting Bethesda, Maryland, United States, 20817 United States, Washington Medical Oncology Associates, P.S. Recruiting Spokane, Washington, United States, 99208 Less <<
NCT02568033 Non Small Cell Lung Cancer Early Phase 1 Unknown October 2017 United States, New Jersey ... More >> MD Anderson Cancer Center at Cooper Recruiting Camden, New Jersey, United States, 08103 Contact: Kim Krieger    856-735-6237 Less <<
NCT01672229 Graft Versus Host Disease Phase 1 Active, not recruiting December 2019 United States, California ... More >> University of California Comprehensive Cancer Center Sacramento, California, United States, 95817 Less <<
NCT01857934 Neuroblastoma Phase 2 Recruiting July 2021 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Wayne L. Furman, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Wayne L. Furman, MD Less <<
NCT03387111 Squamous Cell Carcinoma Phase 1 Phase 2 Recruiting December 2019 United States, California ... More >> Chan Soon-Shiong Institute for Medicine Recruiting El Segundo, California, United States, 90245 Contact: NantKWest Clinical Review Team    800-988-6083    clinical.trials@NantKwest.com Less <<
NCT00003573 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 2 Completed - -
NCT03387085 Triple Negative Breast Cancer Phase 1 Phase 2 Recruiting January 2020 United States, California ... More >> Chan Soon-Shiong Institute for Medicine Recruiting El Segundo, California, United States, 90245 Less <<
NCT02041533 - Active, not recruiting - -
NCT00867178 Medulloblastoma ... More >> Pineoblastoma Supratentorial Embryonal Tumor, Not Otherwise Specified Untreated Childhood Medulloblastoma Untreated Childhood Pineoblastoma Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Less << Not Applicable Active, not recruiting - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois Lurie Children's Hospital-Chicago Chicago, Illinois, United States, 60611 United States, Maryland National Cancer Institute Pediatric Oncology Branch Bethesda, Maryland, United States, 20892 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT03275194 HPEC Ovarian ... More >>Cancer Women's Health: Neoplasm of Ovary Chemotherapy Effect Less << Phase 2 Recruiting December 1, 2025 Mexico ... More >> National Cancer Institute of Mexico Recruiting Mexico City, Mexico, 14080 Contact: Rosa A Salcedo-Hernández, M.Sc    525534265921    rosasalher@gmail.com    Contact: Leonardo S Lino-Silva    525534265921    saul.lino.sil@gmail.com Less <<
NCT02054819 Non-small Cell Lung Cancer Phase 2 Terminated(Didn't meet accrual... More >> goal, change in standard of care.) Less << - United States, North Carolina ... More >> Leo W. Jenkins Cancer Center Greenville, North Carolina, United States, 27834 Less <<
NCT01858922 Hodgkin Disease Phase 2 Active, not recruiting March 2021 United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT02393248 Lung Cancer S... More >>olid Tumor Gastric Cancer UC (Urothelial Cancer) Endometrial Cancer Multiple Myeloma MPN (Myeloproliferative Neoplasms) Breast Cancer Cholangiocarcinoma Less << Phase 1 Phase 2 Recruiting January 2020 United States, Alabama ... More >> University of Alabama Recruiting Tuscaloosa, Alabama, United States, 35205 United States, California Cedars Sinai Terminated Los Angeles, California, United States, 90048 United States, Connecticut Yale Cancer Center Terminated New Haven, Connecticut, United States, 06520 United States, District of Columbia Georgetown University - Lombardi Comprehensive Cancer Center Terminated Washington, District of Columbia, United States, 20007 United States, Florida Hematology - Oncology Associates of Treasure Coast Recruiting Port Saint Lucie, Florida, United States, 34952 United States, Michigan University of Michigan Health System Recruiting Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 United States, North Carolina Duke Cancer Institute Recruiting Durham, North Carolina, United States, 27710 United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Signal Point Clinical Research Center Terminated Middletown, Ohio, United States, 45042 United States, South Carolina Greenville Health System Recruiting Greenville, South Carolina, United States, 29605 United States, Texas Mary Crowley Cancer Research Center Recruiting Dallas, Texas, United States, 75230 MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 South Texas Accelerated Research Therapeutics, LLC Recruiting San Antonio, Texas, United States, 78229 Denmark Onkologisk Klinik Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Less <<
NCT02041533 Stage IV or Recurrent Non-Smal... More >>l Cell Lung Cancer Less << Phase 3 Active, not recruiting October 1, 2018 -
NCT02448797 Non-small Cell Lung Cancer Phase 3 Recruiting December 2022 China, Beijing ... More >> 307 Hospital of PLA Recruiting Beijing, Beijing, China, 100071 Principal Investigator: Xiao-qing Liu, M.D.          China, Fujian Fujian Provincal Cancer Hospital Recruiting Fuzhou, Fujian, China, 350014 Contact: Huang Cheng, M.D.    0086-13905010397       Principal Investigator: Huang Cheng, M.D.          China, Guangdong The First Affiliated Hospital Of Guangzhou Medical Collage Recruiting Guangzhou, Guangdong, China, 510120 Contact: He Jianxing    0086-13802777270       Principal Investigator: He Jianxing, M.D.          Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China, 518020 Contact: Zheng Wang, MD    13502886638       Principal Investigator: Zheng Wang, MD          China, Liaoning The First Hospital of China Medical University Recruiting Shenyang, Liaoning, China, 110001 Contact: Liu Yunpeng, M.D.    0086-13898865122       Principal Investigator: Liu Yunpeng, M.D.          First Affiliated Hospital of China Medical University Active, not recruiting Shenyang, Liaoning, China, 150081 China, Shanghai Shanghai Pulmonary Hospital Recruiting Shanghai, Shanghai, China, 200433 Principal Investigator: Cai-Cun Zhou          China, Zhejiang The First Affiliated Hospital of Medical School of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Zhou Jianying, M.D.    0086-13750881678    drzjy@163.com    Principal Investigator: Zhou Jianying, M.D. Less <<
NCT00003203 Brain Tumors ... More >>Central Nervous System Tumors Neuroblastoma Less << Phase 2 Completed - -
NCT00025298 Drug/Agent Toxicity by Tissue/... More >>Organ Head and Neck Cancer Oral Complications Radiation Toxicity Less << Phase 2 Terminated(low accrual) - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 U.Z. Gasthuisberg Leuven, Belgium, B-3000 France CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Italy Ospedale Santa Croce Cuneo, Italy, 12100 Istituto Nazionale per la Ricerca sul Cancro Genoa (Genova), Italy, 16132 Istituto Nazionale per lo Studio e la Cura dei Tumori Milano (Milan), Italy, 20133 Istituto Nazionale per lo Studio e la Cura dei Tumori Naples, Italy, 80131 Spain Hospital General de Jerez Jerez, Spain, 11407 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Turkey Istanbul University-Institute of Oncology Istanbul, Turkey, 34390 United Kingdom Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT02279134 Esophageal Neoplasms ... More >> Esophageal Cancer Less << Phase 2 Phase 3 Recruiting October 2022 China, Beijing ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Science Recruiting Beijing, Beijing, China, 100021 Contact: Zefen Xiao, MD    8610-87787463    xiaozefen@sina.com    Contact: Shufei Yu, MD    86-15911070901    sophie314@yeah.net Less <<
NCT00209222 Lymphoma, Mantle-Cell Phase 3 Unknown December 2014 France ... More >> Groupe D´Etudes des Lymphomes De l´Adulte (GELA) Recruiting Paris, France, F-75743 Contact: Guylène Chartier    +33-1-42499811    Guylene.chartier@chu-stlouis.fr    Contact: Olivier Hermine, PhD    +33-1-44 49 52 83    hermine@necker.fr    Principal Investigator: Olivier Hermine, PhD          Germany German Low Grade Study Group (Glsg) Recruiting Munich, Germany, D-81377 Contact: Michael Unterhalt, Dr.    +49-89-7095 ext 4915    Michael.Unterhalt@med.uni-muenchen.de    Contact: Martin Dreyling, PhD    +49-89-7095 ext 2202    Martin.Dreyling@med.uni-muenchen.de    Principal Investigator: Wolfgang Hiddemann, PhD          Poland The Maria Sklodowska Memorial, Cancer Center - Inst. of Oncology Recruiting Warszawa, Poland, PL-02-781 Contact: Jan Walewski, MD    +48-22-546-2223    walewski@coi.waw.pl    Contact: Marek P Nowacki, MD    +48-22-546-2223       Principal Investigator: Jan Walewski, MD Less <<
NCT00354393 Malignant Mesothelioma Phase 2 Unknown - United States, Ohio ... More >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00053352 Childhood Embryonal Tumor ... More >> Childhood Extracranial Germ Cell Tumor Childhood Extragonadal Germ Cell Tumor Childhood Malignant Ovarian Germ Cell Tumor Childhood Malignant Testicular Germ Cell Tumor Childhood Teratoma Ovarian Embryonal Carcinoma Ovarian Yolk Sac Tumor Stage II Malignant Testicular Germ Cell Tumor Stage IIA Ovarian Germ Cell Tumor Stage IIB Ovarian Germ Cell Tumor Stage IIC Ovarian Germ Cell Tumor Stage III Malignant Testicular Germ Cell Tumor Stage IIIA Ovarian Germ Cell Tumor Stage IIIB Ovarian Germ Cell Tumor Stage IIIC Ovarian Germ Cell Tumor Testicular Choriocarcinoma and Yolk Sac Tumor Testicular Embryonal Carcinoma Less << Phase 3 Completed - -
NCT00053352 - Completed - -
NCT01261299 Carcinoma, Non-Small-Cell Lung... More >> Urinary Bladder Neoplasms Less << Early Phase 1 Terminated(Contract ended) - United States, California ... More >> University of California Los Angeles Los Angeles, California, United States, 90095 University of California, Davis Sacramento, California, United States, 95817 Less <<
NCT01822496 Stage III Non-Small Cell Lung ... More >>Cancer AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Less << Phase 2 Terminated - -
NCT03088540 Carcinoma，Non-Small-Cell Lung ... More >> Lung Carcinomas, Non-Small-Cell Non-small-cell Lung Carcinoma Nonsmall Cell Lung Cancer Less << Phase 3 Recruiting September 20, 2022 -
NCT00663741 Gastric Cancer Phase 1 Completed - Japan ... More >> Kashiwa, Chiba, Japan, 277-8577 Kobe, Hyogo, Japan, 650-0017 Chuo-ku, Tokyo, Japan, 104-0045 Less <<
NCT03043872 Small Cell Lung Carcinoma Exte... More >>nsive Disease Less << Phase 3 Recruiting September 30, 2020 -
NCT00057785 Head and Neck Cancer ... More >> Oral Complications of Radiation Therapy Radiation Toxicity Less << Phase 2 Completed - United States, Alabama ... More >> Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California University of California Davis Cancer Center Davis, California, United States, 95616 Radiological Associates of Sacramento Medical Group, Incorporated Sacramento, California, United States, 95815 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital St Louis, Missouri, United States, 63110 United States, New Jersey Monmouth Medical Center Long Branch, New Jersey, United States, 07740 United States, New Mexico Albuquerque Regional Medical Center at Lovelace Sandia Health System Albuquerque, New Mexico, United States, 87102 United States, Ohio Akron City Hospital Akron, Ohio, United States, 44304 United States, Pennsylvania Kimmel Cancer Center at Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States, 19107 Fox Chase-Temple Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 CCOP - MainLine Health Wynnewood, Pennsylvania, United States, 19096 United States, Texas M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030 Wilford Hall Medical Center Lackland AFB, Texas, United States, 78236 United States, Utah McKay-Dee Hospital Center Ogden, Utah, United States, 84403 United States, Wisconsin Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03622827 Uterine Cervical Neoplasms Phase 2 Recruiting July 30, 2025 China, Jiangsu ... More >> The Affiliated Suzhou Hospital of Nanjing Medical University Recruiting Suzhou, Jiangsu, China, 215001 Contact: Ke Gu, M.D., Ph.D    86-13405070898    dr.guke@hotmail.com    Contact: Zhiliang Ding, M.D.    86-18913535515 Less <<
NCT00193791 Cancer of Cervix Phase 3 Active, not recruiting May 2018 India ... More >> Tata Memorial Hospital Mumbai, Maharastra, India, 400 012 Less <<
NCT00057785 - Completed - -
NCT00152828 Cervix Neoplasms Phase 1 Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00094497 Carcinoma, Adrenal Cortical Phase 3 Completed - United States, Maryland ... More >> National Cancer Institute - Center for Cancer Research Bethesda, Maryland, United States United States, Michigan University of Michigan, Department of Internal Medicine Ann Arbor, Michigan, United States, 48109 Australia Royal Adelaide Hospital Adelaide, Australia, SA 5000 Austria University of Graz Graz, Austria, 8036 France Clinique Marc Linquette Lille, France Centre Leon Berard Lyon, France Hospital de Marseille la timone Marseille, France, 13385 Cochin Hospital Paris, France, 75679 Hospital Bordeaux haut leveque Pessac, France, 33600 Institut Gustave Roussy Villejuif, France, 94805 Germany Charité-University, Dept. of Endocrinology; Campus Benjamin Franklin Berlin, Germany Charité-Universitätsmedizin Berlin - Campus Mitte Berlin, Germany Dept. of Medicine III Dresden, Germany University of Duesseldorf, Dept. of Endocrrinology Duesseldorf, Germany, 40001 Zentrum für Innere Medizin - Endokrinologie des Universitätsklinikum Essen Essen, Germany Endokrinologie Medizinische Hochschule Hannover Hannover, Germany Otto-von-Guericke University; Dept. of Endocrinology Magdeburg, Germany, 39120 Dept of Medicine I Mainz, Germany University of Munich, Dept. of Internal Medicine (Innenstadt) Munich, Germany, 80336 University of Wuerzburg - Dept. of Medicine Wuerzburg, Germany, 97080 Italy University of Turin, Dept of Internal Medicine Orbassano, Italy, 10043 Clinica Endocrinologica, Università di Padova, Azienda Ospedaliera di Padova Padova, Italy Netherlands Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1007 Academisch Medisch Centrum; Dept. of Endocrinology Amsterdam, Netherlands, 1105 AZ Maxima Medisch Centrum; Dept. of Internal Medicine Eindhoven, Netherlands, 5631 BM University Hospital Groningen; Dept. of Internal Medine Groningen, Netherlands, 9700 Leiden University Medical Center Leiden, Netherlands Sweden Department of Oncology, Sahlgrenska University Hospital Gothenburg, Sweden Department of Oncology, Linköping University Hospital Linköping, Sweden Department of Medicine, The Jubileum Institute, Lund University Lund, Sweden Dept of Surgery, Karolinska Hospital, Stockholm Stockholm, Sweden Uppsala University Hospital - Dept of Medical Sciences Uppsala, Sweden, 751 85 Less <<
NCT01052844 Vomiting Cisp... More >>latin Adverse Reaction Less << Phase 3 Completed - Brazil ... More >> Faculdade de Medicina do ABC Santo André, São Paulo, Brazil, 09060-650 Less <<
NCT00094497 - Completed - -
NCT03723343 - Not yet recruiting June 30, 2021 China, Guizhou ... More >> Cancer Hospital of Guizhou Medical University Recruiting Guiyang, Guizhou, China, 550000 Contact: Jinhua Long, Master    085186512802    longjinhua100@sina.cn    Principal Investigator: Feng Jin          Principal Investigator: Weili Wu          Principal Investigator: Yuanyuan Li          Principal Investigator: hong Tang          Principal Investigator: Xiuling Luo          Principal Investigator: Xiuyun Gong          Principal Investigator: Xiaoxiao Chen Less <<
NCT01052844 - Completed - -
NCT00951496 Malignant Ovarian Mixed Epithe... More >>lial Tumor Ovarian Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma Stage IIA Fallopian Tube Cancer Stage IIA Ovarian Cancer Stage IIB Fallopian Tube Cancer Stage IIB Ovarian Cancer Stage IIC Fallopian Tube Cancer Stage IIC Ovarian Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Cancer Stage IIIA Primary Peritoneal Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Cancer Stage IIIB Primary Peritoneal Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Cancer Stage IIIC Primary Peritoneal Cancer Undifferentiated Ovarian Carcinoma Less << Phase 3 Active, not recruiting March 15, 2022 -
NCT00084838 Central Nervous System Tumor, ... More >>Pediatric Less << Phase 2 Completed - United States, California ... More >> Stanford Cancer Center Stanford, California, United States, 94305-5826 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06520-8028 United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus Atlanta, Georgia, United States, 30342 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota, United States, 55404 United States, Nevada Sunrise Hospital and Medical Center Las Vegas, Nevada, United States, 89109 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Less <<
NCT00167401 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - United States, New York ... More >> University of Rochester, Dept. Radiation Oncology Rochester, New York, United States, 14642 Less <<
NCT03206684 Cervical Cancer Phase 4 Not yet recruiting September 2018 China, Shaanxi ... More >> Department of Radiation Oncology, Xijing Hospital, Fourth Military Medical University Not yet recruiting Xi'an, Shaanxi, China, 710032 Contact: Mei Shi, MD    +86-029-84775425    Shimei82@gmail.com Less <<
NCT03628716 Bladder Cancer Phase 2 Recruiting November 2023 United States, Massachusetts ... More >> Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Michelle Wright       MWright10@mgh.harvard.edu    Sub-Investigator: Richard Lee, MD          Principal Investigator: Guru Sonpavde, MD          Dana Farber Cancer Institute (DFCI) Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Alyssa Klein       Alyssa_Klein@DFCI.Harvard.edu    Principal Investigator: Guru Sonpavde, MD          United States, Utah University of Utah - Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Sally Fairbairn       sally.fairbairn@hci.utah.edu    Principal Investigator: Benjamin Maughan, MD Less <<
NCT00951496 - Active, not recruiting - -
NCT00401401 Head and Neck Cancer ... More >> Squamous Cell Cancer Less << Phase 1 Phase 2 Terminated(MTD was established... More >> and patients completed 16 months safety f-up and response assessments. It is considered of limited value to follow patients for 3 years.) Less << - United States, Oregon ... More >> Oregon Health Sciences Center Portland, Oregon, United States, 97239 Belgium St-Luc University Hospital Brussels, Belgium University Hospital Gasthuisberg Leuven, Belgium France Centre Georges-Francois Leclerc Hospital Dijon, France Hopital Bretonneau Clinique d'Oncologie et Radiothérapie Tours, France Netherlands Nijmegen University Hospital Nijmegen, Netherlands Sweden Lund University Hospital Lund, Sweden Less <<
NCT00401401 - Terminated(MTD was established... More >> and patients completed 16 months safety f-up and response assessments. It is considered of limited value to follow patients for 3 years.) Less << - -
NCT02972216 - Completed - -
NCT01752517 - Unknown December 2015 China, Beijing ... More >> Department of Respiratory Medicine, Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Mengzhao Wang, MD    010-69155039 ext +86    mengzhaowang@sina.com    Contact: Jing Zhao, MD    010-69158206 ext +86    pumchzj@sina.com    Sub-Investigator: Wei Zhong, MD          Sub-Investigator: Jinmei Luo, MD Less <<
NCT00003637 Head and Neck Cancer Phase 3 Unknown - Singapore ... More >> National Cancer Centre - Singapore Singapore, Singapore, 169610 Less <<
NCT00004141 Melanoma (Skin) Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT01798004 Disseminated Neuroblastoma ... More >> Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Regional Neuroblastoma Stage 4S Neuroblastoma Less << Not Applicable Suspended(CRM 31684 - CTEP PIO... More >> requested) Less << October 2018 -
NCT00030745 Malignant Mesothelioma Phase 2 Completed - Switzerland ... More >> UniversitaetsSpital Zurich, Switzerland, CH-8091 Less <<
NCT01798004 - Suspended(CRM 31684 - CTEP PIO... More >> requested) Less << - -
NCT00005022 Lung Cancer Phase 1 Completed - -
NCT02662634 Non-small Cell Lung Cancer (NS... More >>CLC) Less << Phase 2 Unknown March 2018 United States, Nebraska ... More >> Cancer Research Network of Nebraska / Oncology Associates Recruiting Omaha, Nebraska, United States, 68118 Contact: Tony Romero, MS, CCRC    402-697-2229    tromero@gucancer.com    Principal Investigator: Stephen Lemon, MD Less <<
NCT00006051 Head and Neck Cancer Phase 2 Unknown - France ... More >> Centre Jean Perrin Clermont-Ferrand, France, 63011 Hopital Jean Monnet Epinal, France, 88021 CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Centre Hospitalier Universitaire Bretonneau de Tours Tours, France, 37044 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT03358004 Triple Negative Breast Cancer Phase 2 Terminated(Low accrual rate) - Italy ... More >> AOU Ospedali riuniti di Ancona Torrette, Ancona, Italy, 60126 ASST Monza Monza, MB, Italy, 20052 Azienda Ospedaliero-Universitaria Pisana Pisa, PI, Italy, 56126 Azienda Ospedaliero Universitaria di Parma Parma, PR, Italy, 43126 Ospedale Civile di Guastalla Reggio Emilia, RE, Italy, 42016 Ospedale Martini ASL Torino 1 Torino, TO, Italy, 10141 Istituto Tumori Giovanni Paolo II Bari, Italy, 70124 ASST Papa Giovanni XXIII Bergamo, Italy, 24127 A. Ospedaliero universitaria di Bologna Bologna, Italy, 40138 Azienda Sanitaria Locale Brindisi Brindisi, Italy, 72100 ASST - Cremona Cremona, Italy, 26100 A.O. San Croce e Carle Cuneo, Italy, 12100 Ospedale Vito Fazzi Lecce, Italy, 73100 Istituto Europeo di Oncologia Milano, Italy, 20141 Policlinico di Modena Modena, Italy, 41124 Policlinico Paolo Giaccone Palermo, Italy, 90127 Casa di Cura La Maddalena Palermo, Italy, 90146 Ospedale Felice Lotti Pontedera, Italy, 56025 Istituto Nazionale Regina Elena Roma, Italy, 0144 Azienda Ospedaliero Universitaria di Sassari Sassari, Italy, 07100 Portugal Instituto Portugues Oncologia de Coimbra Coimbra, Portugal, 3000-075 CHLN Hospital Santa Maria Lisboa, Portugal, 1349-035 Hospital de S. Francisco Xavier Lisboa, Portugal, 1449-005 Hospital Beatriz Angelo Loures, Portugal, 2674-514 Centro Hospitalar Do Porto Porto, Portugal, 4099-001 Centro Hospitalar De Sao Joao EPE Porto, Portugal, 4200 Instituto Portugues Oncologia de Porto Porto, Portugal, 4200 Spain Hospital Vall d'Hebron Barcelona, Spain, 08035 Hospital Virgen de la Salud Toledo, Spain, 45071 Hospital Clinico Universitario Lozano Blesa Zaragoza, Spain, 50009 Less <<
NCT00324805 Stage IB Non-Small Cell Lung C... More >>arcinoma Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-small Cell Lung Cancer Less << Phase 3 Active, not recruiting October 16, 2023 -
NCT02204306 Metastatic Gastric Cancer Phase 2 Unknown December 2016 China, Hunan ... More >> Institute of Clinical Pharmacology Recruiting Changsha, Hunan, China, 410005 Contact: Yijing He, MD, PhD    +86-15874812612    yijinghe@gmail.com    Principal Investigator: Zihua Chen, MD          Principal Investigator: Meizuo Zhong, MD          Principal Investigator: Jing Huang, MD, PhD          Principal Investigator: Xianli Ying, MD          Principal Investigator: Fang Xiang, MD, PhD          Principal Investigator: Keli Yan, MD          Principal Investigator: Weisheng Ye, MD          Principal Investigator: Xianrang Song, MD Less <<
NCT00003589 Lung Cancer Phase 3 Completed - -
NCT03188497 Acute Toxic Effects ... More >> Tumor Responses Less << Phase 1 Completed - China, Guangdong ... More >> the Fifth Hospital Affiliated to Sun Yat-Sen University Zhuhai, Guangdong, China, 519000 Less <<
NCT00563927 Nasopharyngeal Neoplasms ... More >> Carcinoma, Squamous Cell Less << Not Applicable Unknown October 2009 China ... More >> Pamela Youde Nethersole Eastern Hospital Hong Kong, China Queen Elizabeth Hospital Hong Kong, China Queen Mary Hospital Hong Kong, China Tuen Mun Hospital Hong Kong, China Less <<
NCT00324805 - Active, not recruiting - -
NCT00002897 Esophageal Cancer Phase 3 Completed - Italy ... More >> University of Padua Padua, Italy, 35128 Less <<
NCT01887340 Seminoma Phase 2 Recruiting June 2026 France ... More >> Gustave Roussy Recruiting Villejuif, Val de Marne, France, 94805 Contact: Yohann LORIOT, MD    0142115276 ext +33    yohann.loriot@gustaveroussy.fr Less <<
NCT00002999 Head and Neck Cancer Phase 2 Withdrawn - -
NCT00004209 Lung Cancer Phase 3 Unknown - United Kingdom ... More >> Royal Marsden NHS Trust London, England, United Kingdom, SW3 6JJ Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Less <<
NCT01782339 Germ Cell Tumour Phase 2 Recruiting January 2021 United Kingdom ... More >> St Bartholomew's Hospital Recruiting London, United Kingdom, EC1A 7BE Contact: GAMMA coordinator          Principal Investigator: Jonathan Shamash, MD FRCP Less <<
NCT00256295 Cancer of the Head and Neck Phase 2 Terminated(Low accrual) - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT01726452 Adenocarcinoma of the Oesophag... More >>us Adenocarcinoma of the Oesophago-gastric Junction Oesophageal Tumours Junctional Tumours Oesophageal Cancer Less << Phase 3 Recruiting - Denmark ... More >> Rigshospitalet Recruiting Blegdamsvej 9, Denmark, 2100 København Ø Contact: Contact Person    +45 35 45 35 45       Principal Investigator: Dr Lene Baeksgaard          France Centre Hospitalier Régional, Universitaire de Lille 2 Avenue Oscar Lambret, 59000 Not yet recruiting Lille, France Contact: Contact Person    +33 3 20 44 41 45       Principal Investigator: Prof Guillaume Piessen          Ireland Belfast Health and Social Care Trust, Northern Ireland Cancer Centre, Belfast CityHospital Recruiting Belfast, Ireland, BT9 7AB Contact: contact    + 44 028 9097 2756       Principal Investigator: Dr Richard Turkingon          Cork University Hospital Recruiting Cork, Ireland Contact: Contact Person    +353 21-4271971       Principal Investigator: Dr Derek Power          Beaumont Hospital Recruiting Dublin, Ireland Contact: Contact Person    +353 1 809 3000       Principal Investigator: Prof Liam Grogan          SLRON- St Luke's Radiation Oncology Network Recruiting Dublin, Ireland Contact: Contact Person    +353 1 4065000       Principal Investigator: Dr Moya Cunningham          St. James's Hospital Recruiting Dublin, Ireland Contact: Contact Person    +353 1 410 3000       Principal Investigator: Prof John Reynolds          University Hospital Galway Recruiting Galway, Ireland Contact: Contact Person    +353 91 524222       Principal Investigator: Dr Greg Leonard          United Kingdom The Royal Bournemouth Hospital Recruiting The Royal Bournemouth And Christchurch Hospitals NHS Foundation, Bournemouth, United Kingdom, BH7 7DW Contact: Contact Person    +44 1202 726127       Principal Investigator: Joanne Parkinson          Cambridge University Hospitals NHS Foundation Trust Recruiting Addenbrooke's Hospital, Box 279(s4), Cambridge Biomedical Camp, Cambridge, United Kingdom, CB2 0QQ Contact: Contact Person    +44 1223 256620       Principal Investigator: Dr Hugo Ford          Velindre Cancer Centre Recruiting Velindre NHS Trust, Velindre Road, Whitchurch, Cardiff, United Kingdom, CF14 2TL Contact: Contact Person    +44 29 20 615 888       Principal Investigator: Carys Morgan          University Hospitals Coventry & Warwickshire Recruiting Clifford Bridge Road, Walsgrave, Coventry, United Kingdom, CV2 2DX Contact: Contact Person    +44 2476 966 202       Principal Investigator: Sharmila Sothi          Hull and East Yorkshire Hospitals NHS Trust, Castle Hill Hospital, Recruiting Cottingham, East Riding Of Yorkshire, United Kingdom, HU16 5JQ Contact: Contact Person    +44 23 8120 8448       Principal Investigator: Dr Rajarshi Roy          Portsmouth Hospitals NHS Trust Recruiting Southwick Hill Road, Cosham, Hampshire, United Kingdom, PO6 3LY Contact: Contact Person    +44 2392 286000       Principal Investigator: Freddie Bartlett          Mount Vernon Cancer Centre Recruiting E & N Hertfordshire NHS Trust, Rickmansworth Road, Northwood, Middlesex, United Kingdom, HA6 2RN Contact: Contact Person    +44 203 826 2063       Principal Investigator: Mark Harrison          Nottingham City Hospital Recruiting Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham, United Kingdom, HG5 1PB Contact: Contact Person    +44 115 969 1169       Principal Investigator: Simon Parsons          Oxford University Hospital NHS Trust Churchill Hospital Recruiting Headington, Oxfordshire, United Kingdom, OX3 7LE Contact: Contact Person    +44 1865 741841       Principal Investigator: Somnath Mukherjee          University Hospital Southampton NHS Foundation Trust Recruiting Southampton General Hospital, Division A Cancer Care, Mp307, T, Southampton, United Kingdom, SO16 6YD Contact: Contact Person    +44 23 8120 8448       Principal Investigator: Dr Andrew Bateman          Royal Surrey County Hospital Recruiting Guildford, Surrey, United Kingdom, GU2 7XX Contact: Contact Person    +44 1483 571122       Principal Investigator: Shaun Preston          Worcestershire Royal Hospital Recruiting Worcestershire Oncology Centre, Charles Hastings Way, Worcester, United Kingdom, WR5 1DD Contact: Contact Person    +44 1905 733194       Principal Investigator: Mr Martin Wadley          University Hospitals Bristol NHS Foundation Trust Recruiting Bristol, United Kingdom, BS2 8ED Contact: Contact Person    +44 117 342 0231       Principal Investigator: Dr Stephen Falk          NHS Lothian, Edinburgh Cancer Centre, Recruiting Edinburgh, United Kingdom, EH4 2XU Contact: Contact Person    +44 131 242 3327       Principal Investigator: Dr Sorcha Campbell          Imperial College Healthcare NHS Trust St Mary's Hospital Recruiting London, United Kingdom, W2 1NY Contact: Contact Person    +44 20 3312 6666       Principal Investigator: Prof George Hanna          The Newcastle upon Tyne Hospital NHS Foundation TrustFreeman Hospital, Freeman Road, High Heaton Recruiting Newcastle upon Tyne, United Kingdom, NE7 7DN Contact: Contact Person    +44 191 233 6161       Principal Investigator: Prof Michael Griffin Less <<
NCT03721757 Squamous Cell Carcinoma of the... More >> Oral Cavity Less << Phase 2 Not yet recruiting November 2021 -
NCT02164942 - Terminated(Futility) - United States, North Carolina ... More >> Carolinas Healthcare System Charlotte, North Carolina, United States, 28203 Less <<
NCT00600210 Cervical Cancer Phase 2 Withdrawn(low patient accrual) - United States, North Carolina ... More >> East Carolina University School of Medicine Greenville, North Carolina, United States, 27834 Less <<
NCT03101995 Cervical Cancer Phase 2 Recruiting July 1, 2019 Mexico ... More >> National Institute of Cancer Recruiting Mexico City, DF, Mexico, 14080 Contact: Lucely Cetina, MD, MSc    +521555 4851237    micuentalucely@yahoo.com Less <<
NCT03006432 OESOPHAGO-GASTRIC CARCINOMA Phase 3 Recruiting August 2022 -
NCT00661011 Non Small Cell Lung Carcinoma Phase 2 Terminated(The study was termi... More >>nated due to too slow recruitment) Less << - Belgium ... More >> Department of Pneumology RHMS Hôpital de la Madeleine Ath, Belgium, 7800 Department of Pneumology CHR St Joseph-Warquignies Boussu, Belgium, 7360 Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet Brussels, Belgium, 1000 Department of Pneumology Hospital Ixelles-Molière Brussels, Belgium Department of Pneumology CHU Charleroi Charleroi, Belgium, 6000 Department of Pneumology Hôpital Saint-Joseph Gilly, Belgium, 6060 Hôpital Ambroise Paré Mons, Belgium, 7000 Hôpital Vésale - Montigny-le-Tilleul Montigny-le-Tilleul, Belgium, 6110 Department of Pneumology Centre Hospitalier de Mouscron Mouscron, Belgium, 7700 CH Peltzer-La Tourelle Verviers, Belgium, 4800 Greece Medical Oncology St Savas Hospital Athens, Greece, 11522 Spain Medical Oncology Hospital de Sagunto Valencia, Spain Less <<
NCT02842307 Chemotherapy-induced Nausea an... More >>d Vomiting Less << Not Applicable Completed - China, Beijing ... More >> Dongzhimen Hospital, Beijing University of Chinese medicine Beijing, Beijing, China, 100007 Guanganmen Hospital,China Academy of Chinese Medical Sciences Beijing, Beijing, China, 100053 China Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing, China, 100091 Less <<
NCT01534585 Nasopharyngeal Carcinoma Phase 1 Phase 2 Completed - China, Zhejiang ... More >> Taizhou Hospital, Wenzhou Medical College Taizhou, Zhejiang, China, 317000 Less <<
NCT01639625 Squamous Cell Carcinoma of the... More >> Cervix Adenocarcinoma of the Cervix Less << Phase 2 Completed - Argentina ... More >> Instituto de Oncologia Angel H. Roffo Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, C1417DTB Less <<
NCT00256295 - Terminated(Low accrual) - -
NCT00347256 Paranasal Sinus Neoplasms Not Applicable Withdrawn - -
NCT00186277 Bladder Cancer Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02880007 Cervical Adenocarcinoma ... More >> Stage IB Cervical Cancer Stage II Cervical Cancer Stage III Cervical Cancer Less << Phase 2 Recruiting February 2020 France ... More >> CHU de Besançon Recruiting Besancon, France, 25030 Contact: BARON Marie-Hélène, MD          Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: THOMAS Laurence, MD          Contact: PETIT Adeline, MD          Centre Georges-François Leclerc Recruiting Dijon, France, 21079 Contact: PEIGNAUX Karine, MD          Contact: MARTIN Etienne, MD          Centre Léon Bérard Recruiting Lyon, France, 69373 Contact: POMMIER Pascal, MD          Contact: CARRIE Christian, MD          Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: KERR Christine, MD          Centre Paul Strauss Recruiting Strasbourg, France, 67065 Contact: POP Marius, MD          Centre Claudius Regaud Recruiting Toulouse, France, 31052 Contact: DELANNES Martine, MD          Contact: DUCASSOU Anne, MD          CHRU Tours - Hôpital Bretonneau Recruiting Tours, France, 37044 Contact: BARILLOT Isabelle, MD          Institut de Cancérologie de Lorraine Recruiting Vandoeuvre-les-Nancy, France, 54519 Contact: PEIFFERT Didier, MD          Contact: BRUNAUD Claire, MD Less <<
NCT01326767 Carcinoma, Non-Small-Cell Lung Phase 3 Completed - Germany ... More >> CESAR Study Center Bochum, Germany CESAR study center Bonn, Germany CESAR Study Center Essen, Germany CESAR study center Gerlingen, Germany CESAR study center Großhansdorf, Germany CESAR Study Center Halle an der Saale, Germany CESAR Study Center Leer, Germany CESAR Study Center Löwenstein, Germany CESAR Study Center Munich, Germany CESAR Study Center Tübingen, Germany Switzerland Kantonsspital St. Gallen St. Gallen, Switzerland, 9007 Less <<
NCT02635360 Cervical Cancer Phase 2 Recruiting May 2021 United States, Alabama ... More >> University of South Alabama Mitchell Cancer Institute Recruiting Mobile, Alabama, United States, 36604 Contact: Joanie Broemmelsiek    251-445-9866    jbroemmelsiek@health.southalabama.edu    Contact: Tammy Mitchem-Welch    251-445-9649    twelch@health.southalabama.edu    Principal Investigator: Jennifer Scalici, MD          United States, Maryland Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Marquis Simms    410-955-8849    msimms10@jhmi.edu    United States, Missouri Washington University, School of Medicine Recruiting Saint Louis, Missouri, United States, 63108 Contact: Jehan Ganachaud, M.Sc.    314-747-9202    ganachaud.j@wustl.edu    United States, North Carolina Levine Cancer Institute Recruiting Charlotte, North Carolina, United States, 28204 Contact: Heather Neagle, RN, BSN    980-442-2303    Heather.Neagle@Carolinashealthcare.org    United States, Oklahoma University of Oklahoma Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Braden Curry    405-271-8777    braden-curry@ouhsc.edu    United States, Virginia University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Sheena Clift    434-924-2745    SHC2WN@hscmail.mcc.virginia.edu    Principal Investigator: Linda Duska, MD          INOVA Fairfax Hospital Recruiting Falls Church, Virginia, United States, 22042 Contact: Kelly Jeffords    703-208-6606    Kelly.Jeffords@inova.org    Virginia Commonwealth University Recruiting Richmond, Virginia, United States, 23298 Contact: Melanie R Hamilton       mrhamilton2@vcu.edu Less <<
NCT01462474 Locally Advanced Nasopharyngea... More >>l Carcinoma Less << Phase 1 Completed - China, Guangdong ... More >> Department of Medical Oncology, Cancer Center, Sun Yet-sen University Guangzhou, Guangdong, China Less <<
NCT00450762 Breast Cancer Phase 2 Completed - -
NCT03061058 Stomach Neoplasms ... More >> Chemotherapy Effect Chemotherapeutic Toxicity Less << Phase 3 Recruiting December 2019 China, Anhui ... More >> Ma'anshan People's Hospital Recruiting Ma'anshan, Anhui, China Contact: Fenglin Zhang, MD          Contact: Fangbo Cui, MD          China, Jiangsu Jiangyin People's Hospital Recruiting Jiangyin, Jiangsu, China Contact: Weisheng Shen, MD          Contact: Lei Xi, MD          Nanjing Gaochun People's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Rongfu Wei, MD          Contact: Yajun Xin, MD          Nanjing Lishui People's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Chunlan Nie, MD          Contact: Hui Xu, MD          The Comprehensive Cancer Center of Nanjing Drum Tower Hospital Recruiting Nanjing, Jiangsu, China, 210008 Contact: Yang Yang, MD,PhD,MSCR    0086-18602568379    wing_young7@hotmail.com    Contact: Baorui Liu, MD, PhD    0086-13770621908    baoruiliu07@163.com    Suqian People's Hospital Recruiting Suqian, Jiangsu, China Contact: Chuanwen You, MD          Contact: Qing Zhu, MD          Xuzhou Central Hospital Recruiting Xuzhou, Jiangsu, China Contact: Sanyuan Sun, MD          Contact: Yuan Yuan, MD          Affiliated Hospital of Jiangsu University Recruiting Zhenjiang, Jiangsu, China Contact: Xiaoqing Li, MD          Contact: Meilian Cheng, MD Less <<
NCT03418038 High Grade B-Cell Lymphoma Wit... More >>h MYC and BCL2 or BCL6 Rearrangements Recurrent Diffuse Large B-Cell Lymphoma Recurrent Hodgkin Lymphoma Recurrent Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Lymphoma Less << Phase 2 Recruiting March 15, 2024 United States, Arizona ... More >> Mayo Clinic in Arizona Not yet recruiting Scottsdale, Arizona, United States, 85259 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Craig B. Reeder          United States, Florida Mayo Clinic in Florida Not yet recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Taimur Sher          United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Not yet recruiting Iowa City, Iowa, United States, 52242 Contact: Umar Farooq       umar-farooq@uiowa.edu    Principal Investigator: Umar Farooq          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Thomas E. Witzig Less <<
NCT00453115 Lung Cancer Phase 2 Unknown May 2011 Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-dog, Korea, Republic of, 411-769 Less <<
NCT02188615 Squamous Cell Esophageal Carci... More >>noma Less << Phase 2 Recruiting July 2019 China, Zhejiang ... More >> Thaizhou Hospital Recruiting Linhai, Zhejiang, China, 317000 Contact: Cheng chu Zhu, professor    +86-576-85199876    zhucc669266@163.com    Principal Investigator: Bao fu Chen, professor Less <<
NCT03219762 Small Cell Lung Cancer Phase 2 Recruiting January 2019 Italy ... More >> UO di Oncologia Ematologia, Azienda Ospedaliero Universitaria di Ferrara Recruiting Cona, Ferrara, Italy, 44124 Principal Investigator: Antonio Frassoldati, MD          Sezione Pneumo-Oncologica - Medicina Interna I; IRCCS "Casa Sollievo della Sofferenza" Not yet recruiting San Giovanni Rotondo, Foggia, Italy, 71013 Principal Investigator: Vito D'Alessandro, MD          Oncologia Medica, IRST. Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori, IRCCS di Meldola Recruiting Meldola, Forlì-Cesena, Italy, 47014 Principal Investigator: Angelo Del Monte, MD          Oncologia Medica - Ospedale Versilia Not yet recruiting Lido di Camaiore, Lucca, Italy, 55043 Principal Investigator: Andrea Camerini, MD          SC di Oncologia Medica, A.O. San Gerardo di Monza Not yet recruiting Monza, MB, Italy, 20900 Principal Investigator: Diego Cortinovis, MD          UO Medicina Oncologica Ospedale di Carpi (MO) Recruiting Carpi, Modena, Italy, 41012 Principal Investigator: Lucia Longo, MD          UOC di Oncologia Medica - Ospedale di Saronno Not yet recruiting Saronno, Varese, Italy, 21047 Principal Investigator: Claudio Verusio, MD          UOC Oncologia Medica, Azienda ULSS21 di Legnago Not yet recruiting Legnago, Verona, Italy, 37045 Principal Investigator: Andrea Bonetti, MD          Oncologia Medica, Ospedale Sacro Cuore - Don Calabria - Negrar (VR) Not yet recruiting Negrar, Verona, Italy, 37024 Principal Investigator: Stefania Gori, MD          SC Oncologia - ASO "SS Antonio e Biagio e Cesare Arrigo,Alessandria Not yet recruiting Alessandria, Italy, 15121 Principal Investigator: Perluigi Piovano          Cliniche Humanitas Gavazzeni Not yet recruiting Bergamo, Italy, 24125 Principal Investigator: Giovanni Luca Ceresoli          Oncologia Medica, Ospedale Papa Giovanni XXIII Recruiting Bergamo, Italy, 24127 Principal Investigator: Anna Bettini, MD          UO di Oncologia Medica, Azienda Ospedaliero-Universitaria S. Orsola Malpighi di Bologna, Recruiting Bologna, Italy, 40138 Principal Investigator: Andrea Ardizzoni, MD          Divisione di Oncologia Medica - Ospedale di Bolzano, Recruiting Bolzano, Italy, 39100 Principal Investigator: Emanuela Vattemi, MD          UOC Oncologia Medica PO A.Perino ASL di Brindisi Recruiting Brindisi, Italy, 72100 Principal Investigator: Saverio Cinieri, MD          SC di Oncologia, Istituti Ospitalieri di Cremona Not yet recruiting Cremona, Italy, 26100 Principal Investigator: Matteo Brighenti, MD          Dipartimento di Oncologia Medica A.O. Santa Croce e Carle Ospedale Carle Recruiting Cuneo, Italy, 12100 Principal Investigator: Ida Colantonio, MD          Azienda Ospedaliera Careggi, UO di Oncologia Medica Not yet recruiting Firenze, Italy, 50139 Principal Investigator: Francesco Di Costanzo, MD          UOC Oncologia, Azienda USL di Imola, Ospedale Santa Maria della Scaletta Not yet recruiting Imola, Italy, 40028 Principal Investigator: Antonio Maestri, MD          Dipartimento Oncologico, Azienda USL 2 di Lucca, Ospedale San Luca Not yet recruiting Lucca, Italy, 55100 Principal Investigator: Carmelo Tibaldi, MD          Azienda Ospedaliero-Universitaria di Modena-Policlinico, U.O. di Oncologia Medica ed Ematologia Recruiting Modena, Italy, 41100 Principal Investigator: Fausto Barbieri, MD          S. C. di Oncologia Medica AORN "Antonio Cardarelli" Not yet recruiting Napoli, Italy, 80131 Principal Investigator: Ferdinando Riccardi, MD          UOC di Oncologia Medica di Parma, Azienda Ospedaliero Universitaria di Parma Not yet recruiting Parma, Italy, 43126 Principal Investigator: Marcello Tiseo, MD          Dipartimento di Oncologia e Ematologia, UO di Oncologia Medica Azienda USL di Piacenza Recruiting Piacenza, Italy, 29121 Principal Investigator: Luigi Cavanna, MD          Dipartimento di Oncologia Ematologia. UO di Oncologia Medica, AUSL della Romagna, Ospedale Santa Maria delle Croci di Ravenna Recruiting Ravenna, Italy, 48121 Principal Investigator: Claudio Dazzi, MD          Azienda Sanitaria Ospedaliera Molinette, U.O. di Oncologia Medica Not yet recruiting Torino, Italy, 10126 Principal Investigator: Libero Ciuffreda, MD Less <<
NCT01026467 - Completed - United States, New York ... More >> Syracuse VA Medical Center Syracuse, New York, United States, 13210 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT01898494 Human Papilloma Virus Infectio... More >>n Stage III Squamous Cell Carcinoma of the Oropharynx Stage IVA Squamous Cell Carcinoma of the Oropharynx Stage IVB Squamous Cell Carcinoma of the Oropharynx Less << Phase 2 Active, not recruiting February 2023 -
NCT00336024 Untreated Childhood Medullobla... More >>stoma Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Less << Phase 3 Completed - -
NCT02200354 Advanced Non-small Cell Lung C... More >>ancer Less << Phase 2 Recruiting March 2019 Japan ... More >> Kobe City Medical Center General Hospital Recruiting Kobe, Hyogo, Japan, 650-0046 Contact: Daichi Fujimoto, MD    +81-78-302-4321 ext 773    daichianzen@yahoo.co.jp Less <<
NCT02862535 Gastric Adenocarcinoma ... More >> Gastroesophageal Junction Adenocarcinoma Less << Phase 1 Active, not recruiting July 2019 Japan ... More >> Nagoya, Japan Osaka, Japan Tokyo, Japan Less <<
NCT01684904 Esophagus Cancer Not Applicable Recruiting August 2024 United States, California ... More >> Loma Linda University Medical Center Recruiting Loma Linda, California, United States, 92354 Contact: Gary Yang, MD    909-558-4280    gyang@llu.edu    Principal Investigator: Gary Yang, MD Less <<
NCT00336024 - Completed - -
NCT03221426 Gastric Cancer ... More >> Gastroesophageal Junction Cancer Less << Phase 3 Recruiting July 26, 2023 -
NCT02497053 Malignant Pleural Mesothelioma Phase 2 Unknown - Egypt ... More >> Ain Shams University Hospitals Recruiting Cairo, Egypt Contact: Omar Abdel-Rahman, MD    26858397    omar.abdelrhman@med.asu.edu.eg    Contact: Ahmed Nagi, MD       ahmedalynagy@yahoo.com    Principal Investigator: Omar Abdel-Rahman, MD          Sub-Investigator: Ahmed Nagi, MD Less <<
NCT03163979 Cervical Cancer Phase 2 Phase 3 Recruiting July 31, 2019 China, Jiangsu ... More >> Nanjing Medical University Affiliated Suzhou Hospital Recruiting Suzhou, Jiangsu, China, 215000 Contact: Ke Gu, doctor    +86-512-62364013    dr.guke@hotmail.com Less <<
NCT00142038 Stomach Neoplasm ... More >> Neoplasm Metastasis Less << Phase 2 Completed - Germany ... More >> Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum, Dept. of Hematology and Oncology Berlin, Germany, 13353 Less <<
NCT02633514 Thymoma and Thymic Carcinoma Phase 3 Unknown - China, Shanghai ... More >> Kailiang Wu Recruiting Shanghai, Shanghai, China, 20032 Contact: Kailiang Wu, M.D. Ph. D.    +86 64175590 ext 86722    wukailiang@aliyun.com Less <<
NCT03193788 Bladder Cancer ... More >> Ureter Cancer Transitional Cell Carcinoma Less << Phase 3 Recruiting June 2020 Korea, Republic of ... More >> Hallym University Medical Center, Hallym University College of Medicine Recruiting Anyang, Korea, Republic of Contact: Ho Young Kim       ksfam@daum.net    Keimyeong University Dongsan Medical Center Recruiting Daegu, Korea, Republic of, 700-712 Contact: Jin Young Kim, MD       takgu@dsmc.or.kr    Fatima Hospital Recruiting Daegu, Korea, Republic of Contact: Jung Lim Lee       junglim3@gmail.com    Chungnam University Hospital Recruiting Daejeon, Korea, Republic of, 301-721 Contact: Hyo Jin Lee, MD, PhD.       cymed@cnu.ac.kr    National Health Insurance Service Ilsan Hospital Recruiting Goyang, Korea, Republic of Contact: Soo Jung Hong       suzzy901@nhimc.or.kr    Hallym University Dongtan Sacred Heart Hospital Recruiting Hwaseong-si, Korea, Republic of Contact: Hyun Ae Jung       hyunaejung@hallym.or.kr    Gil Medical Center Recruiting Incheon, Korea, Republic of, 21565 Contact: Inkeun Park, MD       ingni79@hanmail.net    Dong-A University Medical Center Recruiting Pusan, Korea, Republic of Contact: Suee Lee          Inje University Haeundae Paik Hospital Recruiting Pusan, Korea, Republic of Contact: Il-Hwan Kim       onelement@daum.net    Pusan National University Hospital, Pusan National University School of Medicine Recruiting Pusan, Korea, Republic of Contact: Hyo Jung Kim       leonkim80@naver.com    Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Jae-Lyun Lee, MD, PhD    82 2 3010 5977    jaelyun@amc.seoul.kr    Chung Ang University Hospital Recruiting Seoul, Korea, Republic of, 156-755 Contact: Hee Joon Kim, MD       heejun.dino11@gmail.com    Inje University Sanggye Paik Hospital Recruiting Seoul, Korea, Republic of Contact: Byeong Seok Sohn       imbs@paik.ac.kr    Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine Recruiting Seoul, Korea, Republic of Contact: Yun-Gyoo Lee       gosciny@gmail.com    Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Contact: Yoon Ji Choi       yoonji23@hanmail.net    Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine Recruiting Seoul, Korea, Republic of Contact: Bhum Suk Keam          Contact       bhumsuk@snu.ac.kr    Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea Recruiting Seoul, Korea, Republic of Contact: In-Ho Kim       ihkmd@naver.com    Yonsei Cancer Center Recruiting Seoul, Korea, Republic of Contact: Sang Joon Shin       ssj338@yuhs.ac    St. Vincent's Hospital, The Catholic University of Korea Recruiting Suwon, Korea, Republic of Contact: Byoung Yong Shim       shimby@catholic.ac.kr    Uijeongbu St Mary's hospital, Catholic university of Korea Recruiting Uijeongbu, Korea, Republic of Contact: Yoon Ho Ko       koyoonho@catholic.ac.kr    Pusan National University Yangsan Hospital Recruiting Yangsan, Korea, Republic of Contact: Kwonoh Park       parkkoh@hanmail.net Less <<
NCT00084838 - Completed - -
NCT00960518 Hepatitis B Virus ... More >> Hepatocellular Carcinoma Less << Phase 2 Unknown August 2015 China, Heilongjiang ... More >> The Fourth Affiliated Hospital of Haerbin Medical University Recruiting Ha'er'bin, Heilongjiang, China, 150001 Contact: Baozhong Shen, MD    +86-451-82576888    drbaozhong.shen@gmail.com    Principal Investigator: Baozhong Shen, MD          China, Shanghai Shanghai 10th Hospital of Tongji University Recruiting Shanghai, Shanghai, China, 200025 Contact: Maoquan Li, MD, PhD    +86-21-6630058    drmaoquan.li@gmail.com    Principal Investigator: Maoquan Li, MD, PhD Less <<
NCT02489903 Small Cell Carcinoma ... More >> Carcinoma, Non-Small-Cell Lung Neuroendocrine Tumors Ovarian Epithelial Cancer Less << Phase 2 Recruiting July 2020 United States, California ... More >> Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Melanie San Pedro-Salcedo    650-724-1388    msanpedro@stanford.edu    Principal Investigator: Sukhmani Padda, MD          United States, Connecticut VA Connecticut Cancer Center Recruiting West Haven, Connecticut, United States, 06516 Contact: Jessica Jordan    203-932-5711 ext 3287    jessica.jordan@va.gov    Principal Investigator: Michal Rose, MD          United States, Indiana Memorial Hospital of South Bend Recruiting South Bend, Indiana, United States, 46601 Contact: Amie Lake    574-647-6784    ALake@beaconhealthsystem.org    Contact: Mary Jane Danner    574-647-7309    MDanner@beaconhealthsystem.org    Principal Investigator: Thomas J Reid, MD, PhD          United States, Kentucky Baptist Health Recruiting Lexington, Kentucky, United States, 40503 Contact: Stephanie Cason    859-260-3197    stephanie.cason@bhsi.com    Contact: Micheal F Stephens    859-260-6456    micheal.stephens@BHSI.com    Principal Investigator: Arvinda Padmanabhan, MD          United States, Maryland Walter Reed National Military Medical Center Recruiting Bethesda, Maryland, United States, 20889 Contact: Sonja Skeete    301-319-4599    sonja.t.skeete.ctr@mail.mil    Principal Investigator: Karen Zeman, MD          United States, Michigan Henry Ford Allegiance Health Recruiting Jackson, Michigan, United States, 49201 Contact: Kris Strzalkowski, RN    517-205-1522    KSTRZAL1@hfhs.org    Contact: Natalie Peterson, RN OCN    (517) 205-1549    npeters8@hfhs.org    Principal Investigator: Malcolm Trimble, MD          United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Dan Blume    314-362-0872    dan.blume@wustl.edu    Principal Investigator: Daniel Morgensztern, MD          United States, Ohio University of Cincinnati Cancer Institute Recruiting Cincinnati, Ohio, United States, 45267 Contact: Lauren Hendricks    513-584-5725    hendrilu@ucmail.uc.edu    Principal Investigator: John C Morris, MD          United States, Tennessee University of Tennessee Medical Center Withdrawn Knoxville, Tennessee, United States, 37920 United States, Virginia Virginia Cancer Specialists Recruiting Fairfax, Virginia, United States, 22031 Contact: Karin Choquette, MSN, RN    703-208-9268    Karin.Choquette@USONCOLOGY.COM    Principal Investigator: Alexander Spira, MD          United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506 Contact: Carla Ross, RN    304-581-1158    cjross@hsc.wvu.edu    Principal Investigator: Patrick Ma, MD Less <<
NCT00577993 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02896582 Mantle Cell Lymphoma Phase 2 Recruiting March 2025 France ... More >> CHU d'Amiens Recruiting Amiens, France, 80480 Principal Investigator: Jean-Pierre Marolleau, Dr          CHU d'Angers Recruiting Angers, France, 49000 Principal Investigator: Marie-Pierre Moles-Moreau, Dr          CH d'Avignon Recruiting Avignon, France, 84902 Principal Investigator: Hacene Zerazhi, Dr          CHU de Caen Recruiting Caen, France, 14033 Principal Investigator: Christophe Fruchart, Dr          CHU de Clermont Ferrand Recruiting Clermont Ferrand, France, 63000 Principal Investigator: Victoria Cacheux, Dr          Hopital Henri Mondor Recruiting Créteil, France, 94010 Principal Investigator: Corinne Haioun          CHU de Dijon - Hôpital le Bocage Recruiting Dijon, France, 21034 Principal Investigator: Olivier Casasnovas, Dr          CHU de Grenoble Recruiting Grenoble, France, 38700 Principal Investigator: Rémy Gressin, Dr          CHD Vendée Recruiting La Roche sur Yon, France, 85925 Principal Investigator: Nadine Morineau, Dr          Clinique Victor Hugo Recruiting Le Mans, France, 72000 Principal Investigator: Katell Le Du, Dr          CHRU Lille - Hôpital Claude Huriez Recruiting Lille, France, 59037 Principal Investigator: Franck MORSCHHAUSER, Pr          CHU Limoges Recruiting Limoges, France, 87042 Principal Investigator: Julie Abraham, Dr          CHU Montpellier Recruiting Montpellier, France, 34295 Principal Investigator: Guillaume Cartron, Dr          CHU Nantes Recruiting Nantes, France, 44093 Principal Investigator: Steven Le Gouill, Pr          Hôpital Saint Louis Recruiting Paris, France, 75475 Principal Investigator: Catherine THIEBLEMONT          APHP - Hopital Necker Recruiting Paris, France, 75743 Principal Investigator: Richard Delarue, Dr          CH Perpignan Recruiting Perpignan, France, 66046 Principal Investigator: Laurence Sanhes, Dr          CHU de Haut Leveque Recruiting Pessac, France, 33604 Principal Investigator: Kamal Bouabdallah, Dr          CHU Lyon Sud Recruiting Pierre Bénite, France, 69130 Principal Investigator: Gilles Salles          CHU de Poitiers Recruiting Poitiers, France, 86021 Principal Investigator: Vincent Delwail, Dr          Centre Hospitalier Annecy-Genevois Recruiting Pringy, France, 74374 Principal Investigator: Nicolas Daguindau, Dr          CHU Robert Debré Recruiting Reims, France, 51092 Principal Investigator: Alain Delmer, Pr          CHU Pontchaillou Recruiting Rennes, France, 35033 Principal Investigator: Thierry Lamy de la Chapelle, Pr          Centre Henri Becquerel Recruiting Rouen, France, 76038 Principal Investigator: Hervé Tilly, Dr          Institut de Cancérologie de Loire Recruiting Saint priest en Jarez, France, 42271 Principal Investigator: Jérome Cornillon, Dr          CHU de Strasbourg Recruiting Strasbourg, France, 67091 Principal Investigator: Luc-Matthieu Fornecker, Dr          I.U.C.T Oncopole Recruiting Toulouse, France, 31100 Principal Investigator: Lucie Oberic, Dr          CHRU Bretonneau Recruiting Tours, France, 37044 Principal Investigator: Caroline Dartigeas, Dr          CHU de Brabois Recruiting Vandoeuvre les Nancy, France Principal Investigator: Pierre Feugier, Dr          Gustave Roussy Cancer Campus Recruiting Villejuif, France, 94805 Principal Investigator: Vincent Ribrag, Dr Less <<
NCT01248299 Squamous Cell Carcinoma of Eso... More >>phagus Less << Phase 2 Unknown September 2016 France ... More >> CHU Brest Brest, France, 29200 Centre François BACLESSE Caen, France, 14076 Centre Georges François Leclerc Dijon, France, 21079 CHU Dijon Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 CHU Lille Lille, France, 59035 CHU La Timone Marseille, France, 13385 Centre Val d'Aurelle Montpellier, France, 34298 Centre René Gauducheau Nantes Saint-herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Centre Eugène Marquis Rennes, France, 35042 Clinique de la Theuillerie Ris Orangis, France, 91130 CHU Rouen Rouen, France, 76031 Clinique de l'Armoricaine St-Brieuc, France, 22000 Centre Paul Strauss Strasbourg, France, 67000 Centre Alexis Vautrin Vandoeuvre-les-nancy, France, 54511 Centre Hospitalier Intercommunal Villeneuve St Georges, France, 94190 Less <<
NCT03520231 Urothelial Carcinoma ... More >> Kidney Cancer Ureter Cancer Bladder Cancer Less << Phase 2 Recruiting June 1, 2020 Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Srikala Sridhar, M.D.    416-946-4501 ext 2662    srikala.sridhar@uhn.ca    Principal Investigator: Srikala Sridhar, M.D. Less <<
NCT02771743 Newly Diagnosed High Risk Neur... More >>oblastoma Less << Phase 2 Recruiting March 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT02340936 Diffuse Large B-cell Lymphoma Phase 1 Phase 2 Active, not recruiting September 2019 Spain ... More >> ICO- Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 ICO- Hospital Duran i Reynals L´Hospitalet de Llobregat, Barcelona, Spain, 08908 Hospital del Mar Barcelona, Spain, 08003 Hospital Clinic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Regional Universitario de Málaga Málaga, Spain, 29010 Alejandro Martín Salamanca, Spain, 37007 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Hospital Universitario La Fe Valencia, Spain, 46026 Less <<
NCT00554788 Extraocular Retinoblastoma Phase 3 Active, not recruiting - -
NCT03581786 Recurrent or Metastatic NPC Phase 3 Recruiting August 21, 2020 -
NCT02829008 Metastatic Breast Cancer Phase 2 Active, not recruiting April 2020 China, Beijing ... More >> Cancer Hospital, ChineseAMS Beijing, Beijing, China, 100021 Less <<
NCT02436707 Lymphoma Phase 2 Recruiting December 2019 Canada, Alberta ... More >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Douglas A. Stewart    403 521-3347       Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Neil Sun Chua    780 432-8340       Canada, British Columbia BCCA - Vancouver Cancer Centre Suspended Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Suspended Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick The Moncton Hospital Recruiting Moncton, New Brunswick, Canada, E1C 6Z8 Contact: Nizar Abdel-Samad    506 870-2404       The Vitalite Health Network - Dr. Leon Richard Suspended Moncton, New Brunswick, Canada, E1C 8X3 Canada, Nova Scotia QEII Health Sciences Centre Recruiting Halifax, Nova Scotia, Canada, B3H 1V7 Contact: Stephen Couban    902 473-8562       Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: Graeme Fraser    905 575-7820       Kingston Health Sciences Centre Recruiting Kingston, Ontario, Canada, K7L 2V7 Contact: Annette Hay    613 533-6430 ext 77094       Ottawa Hospital Research Institute Suspended Ottawa, Ontario, Canada, K1H 8L6 Odette Cancer Centre Suspended Toronto, Ontario, Canada, M4N 3M5 University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: John Kuruvilla    416 946-2827       Canada, Quebec CIUSSS de l'Est-de-I'lle-de-Montreal Suspended Montreal, Quebec, Canada, H1T 2M4 CHUM-Centre Hospitalier de l'Universite de Montreal Suspended Montreal, Quebec, Canada, H2X 3E4 CHU de Quebec-Hopital l'Enfant-Jesus (HEJ) Recruiting Quebec City, Quebec, Canada, G1J 1Z4 Contact: Jean-Francois Larouche    418 649-5726       Canada, Saskatchewan Allan Blair Cancer Centre Suspended Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT02031601 Non-Small-Cell Lung Cancer Phase 4 Unknown December 2017 China, Shandong ... More >> Yu Li Recruiting Jinan, Shandong, China, 250012 Contact: Yu Li Less <<
NCT00818350 Urinary Bladder Neoplasms Phase 1 Phase 2 Unknown January 2011 -
NCT01683175 Non-small Cell Lung Cancer Sta... More >>ge III Less << Phase 2 Active, not recruiting October 2020 China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin, China, 300060 China Beijing Cancer Hospital Beijing, China Chinese PLA General Hospital Beijing, China The second people's hospital of Sichuan Chengdu, China Fujian Medical University Union Hospital Fuzhou, China Sun Yat-Sen University Cancer Center Guangzhou, China Zhejiang Cancer Hospital Hangzhou, China The third affiliated hospital of Harbin Medical Univer Harbin, China The affiliated hospital of medical college Qingdao University Qingdao, China Fudan University Shanghai Cancer Center Shanghai, China Zhongshan Hospital Fudan University Shanghai, China Liaoning Cancer Hospital & Institute Shenyang, China Hebei Provincial Tumor Hospital Shijiazhuang, China The first affiliated hospital of Soochow University Suzhou, China The fourth military medical university，Tangdu Hospital Xi'an, China Less <<
NCT03219333 Carcinoma, Transitional Cell ... More >> Urinary Bladder Neoplasms Urologic Neoplasms Renal Pelvis Neoplasms Urothelial Cancer Ureteral Neoplasms Urethral Neoplasms Less << Phase 2 Recruiting May 2025 -
NCT01283204 Recurrent or Metastatic Gastri... More >>c Cancer Less << Phase 2 Unknown August 2016 Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT02784015 Unresectable Localized Soft Ti... More >>ssue Sarcoma Less << Phase 2 Recruiting May 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT00256269 Esophageal Cancer ... More >> Gastroesophageal Cancer Less << Phase 2 Terminated(Study was terminate... More >>d by funding entity) Less << - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT02862457 Neoplasms Car... More >>cinoma, Non-Small-Cell Lung Less << Phase 1 Recruiting November 30, 2020 Japan ... More >> MSD K.K. Recruiting Chiyoda-Ku, Tokyo, Japan, 102-8667 Contact: Japan Call Center    81-3-6272-1957 Less <<
NCT03631784 Non-small Cell Lung Cancer Phase 2 Recruiting January 12, 2022 United States, California ... More >> St Joseph Heritage Healthcare ( Site 1403) Recruiting Santa Rosa, California, United States, 95403 Contact: Study Coordinator    707-521-3830       United States, Indiana Parkview Cancer Institute ( Site 1415) Recruiting Fort Wayne, Indiana, United States, 46845 Contact: Study Coordinator    833-724-8356       United States, Massachusetts UMass Memorial Medical Center ( Site 1417) Recruiting Worcester, Massachusetts, United States, 01655 Contact: Study Coordinator    508-334-5539       United States, Michigan Henry Ford Hospital ( Site 1418) Recruiting Detroit, Michigan, United States, 48202 Contact: Study Coordinator    313-916-2635       United States, Nebraska St. Francis Cancer Treatment Center ( Site 1421) Recruiting Grand Island, Nebraska, United States, 68803 Contact: Study Coordinator    308-398-5450       United States, New Jersey Rutgers Cancer Institute of New Jersey ( Site 1422) Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Study Coordinator    732-235-6048       United States, Oklahoma CTCA Southwestern ( Site 1428) Recruiting Tulsa, Oklahoma, United States, 74133 Contact: Study Coordinator    918-286-5448       Australia, New South Wales Blacktown Hospital Western Sydney Local Health District ( Site 0204) Recruiting Blacktown, New South Wales, Australia, 2148 Contact: Study Coordinator    +61403170371       MNCCI Port Macquarie Base Hospital ( Site 0200) Recruiting Port Macquarie, New South Wales, Australia, 2444 Contact: Study Coordinator    +61265801818       Australia, Victoria Ballarat Health Services ( Site 0206) Recruiting Ballarat, Victoria, Australia, 3350 Contact: Study Coordinator    +61353204735       Korea, Republic of Chungbuk National University Hospital ( Site 1003) Recruiting Cheongju si, Chungcheongbuk Do, Korea, Republic of, 28644 Contact: Study Coordinator    +82432696015       Samsung Medical Center ( Site 1001) Recruiting Seoul, Korea, Republic of, 06351 Contact: Study Coordinator    +82234103459       Ulsan University Hospital ( Site 1000) Recruiting Ulsan, Korea, Republic of, 44033 Contact: Study Coordinator    +82522508832       Poland Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 0811) Recruiting Bydgoszcz, Poland, 85-796 Contact: Study Coordinator    +48523743029       Osrodek Badan Klinicznych przy Szpitalu Specjalistycznym ( Site 0802) Recruiting Krakow, Poland, 31-826 Contact: Study Coordinator    +48721295010       Centrum Onkologii Instytut im. Marii Sklodowskiej Curie ( Site 0800) Recruiting Warszawa, Poland, 02-781 Contact: Study Coordinator    +48225463066       Russian Federation Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 0910) Recruiting Kazan, Russian Federation, 420029 Contact: Study Coordinator    +79172662851       N.N. Blokhin National Medical Oncology Research Centre ( Site 0902) Recruiting Moscow, Russian Federation, 115478 Contact: Study Coordinator    +79031990755       National Medical Research Center of Oncology n.a. N. N. Petrov ( Site 0904) Recruiting St. Petersburg, Russian Federation, 197758 Contact: Study Coordinator    +79117500005       Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 0903) Recruiting Ufa, Russian Federation, 450054 Contact: Study Coordinator    +79050058625       Spain Hospital Universitari Vall d Hebron ( Site 1101) Recruiting Barcelona, Spain, 08035 Contact: Study Coordinator    +34934894158       Hospital Clinic de Barcelona ( Site 1100) Recruiting Barcelona, Spain, 08036 Contact: Study Coordinator    +34932275402       Clinica Universitaria de Navarra ( Site 1102) Recruiting Madrid, Spain, 28027 Contact: Study Coordinator    +349135319027502 Less <<
NCT03053856 Stage IIIA Non-small Cell Lung... More >> Cancer Less << Phase 2 Not yet recruiting August 13, 2021 Korea, Republic of ... More >> Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea, Republic of, 135-710 Less <<
NCT03469557 Esophageal, Gastric, or Gastro... More >>esophageal Junction Carcinoma Less << Phase 2 Recruiting March 23, 2019 China, Beijing ... More >> The 307th Hospital of Military Chinese People's Liberation Army Recruiting Beijing, Beijing, China, 100071 Contact: Jinchao Hu, BS    86-10-66947797    jgb947797@163.com    Principal Investigator: Jianming Xu, MD          China, Heilongjiang The Tumor Hospital Affiliated to Harbin Medical University Recruiting Ha'erbin, Heilongjiang, China, 150006 Contact: Weilu Liu, BS    86-451-86298104    sylcyj609@163.com    Principal Investigator: Yuxian Bai, MD          China, Hubei Tongji Medical College Huanzhong University of Science&Technology Recruiting Wuhan, Hubei, China, 430030 Contact: Chang Shu, BS    86-27-83663625    lsjhe12345@163.com    Principal Investigator: Xianglin Yuan, MD          China, Jiangsu Clinical Medical School, Yangzhou University Affliated Hospital to Yangzhou University Recruiting Yangzhou, Jiangsu, China, 225001 Contact: Hua Zhu, BS    86-1805106131    yzsbhgcp@163.com    Principal Investigator: Buhai Wang, MD          China, Shanxi The First Affiliated Hospital of Xi'an Jiaotong University Recruiting Xi'an, Shanxi, China, 710000 Contact: Mingying Lu, BS    86-29-85324094    Lumy3215@163.com    Principal Investigator: Xiaoen Li, MD          China, Zhejiang The First Affiliated Hospital, Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310003 Contact: Lihua Wu, BS    86-571-87236560    zyct79@163.com    Principal Investigator: Nong Xu, MD Less <<
NCT02066220 Brain Tumors Phase 2 Phase 3 Recruiting April 2024 -
NCT01732939 - Unknown May 2014 China, Beijing ... More >> Hospital affiliated academy military medical science Recruiting Beijing, Beijing, China, 100071 Contact: Tao Wang, MD    8610-66947430       Contact: Shaohua ZHANG, MD    8610-66947173       Principal Investigator: Zefei Jiang, MD Less <<
NCT03421353 Carcinoma, Non-small-cell Lung... More >> Neoplasms Carcinoma, Bronchogenic Bronchial Neoplasms Thoracic Neoplasms Lung Neoplasms Respiratory Tract Neoplasms Less << Phase 1 Phase 2 Recruiting April 1, 2020 United States, Florida ... More >> Research Site Withdrawn Tampa, Florida, United States, 33612 United States, Indiana Research Site Recruiting Lafayette, Indiana, United States, 47905 United States, Oklahoma Research Site Recruiting Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Research Site Recruiting Nashville, Tennessee, United States, 37203 United States, Texas Research Site Recruiting Dallas, Texas, United States, 75230 Research Site Recruiting Houston, Texas, United States, 77030 United States, Virginia Research Site Not yet recruiting Fairfax, Virginia, United States, 22031 United Kingdom Research Site Not yet recruiting London, United Kingdom, W1G 6AD Less <<
NCT00936364 Fasting in Malignant Solid Tum... More >>ors Less << Not Applicable Recruiting July 9, 2020 United States, California ... More >> USC/Norris Comprehenseive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: America Casillas-Lopez    323-865-0804    America.Casillas-Lopez@med.usc.edu    Principal Investigator: David Quinn, MD Less <<
NCT02741388 B-cell Lymphoma Phase 1 Recruiting June 2020 Belgium ... More >> Institut Jules Bordet Recruiting Bruxelles, Belgium Contact: Marie MAEREVOET, MD    +32 25 41 32 12       Principal Investigator: Marie MAEREVOET, MD          France CHU Dijon Recruiting Dijon, France Contact: Olivier CASASNOVAS, MD    +33380295041       Principal Investigator: Olivier CASASNOVAS, MD          CHRU de Lille - Hôpital Claude Huriez Recruiting Lille, France Contact: Franck MORSCHHAUSER, MD    +33320445713       Principal Investigator: Franck MORSCHHAUSER, MD          CHU Montpellier - Hôpital Saint Eloi Recruiting Montpellier, France Contact: Guillaume CARTRON, MD    +33467338079       Principal Investigator: Guillaume CARTRON, MD          CHU Nancy - Hôpital de Brabois Recruiting Nancy, France Contact: Pierre FEUGIER, MD    +33383153282       Principal Investigator: Pierre FEUGIER, MD          Hôpital Saint-Louis Recruiting Paris, France Contact: Catherine THIEBLEMONT, MD    +33142499236       Principal Investigator: Catherine THIEBLEMONT, MD          CHU Bordeaux - Centre François Magendie Recruiting Pessac, France Contact: Kamal BOUABDALLAH    +33557656511       Principal Investigator: Kamal BOUABDALLAH, MD          Centre Henri Becquerel Recruiting Rouen, France Contact: Hervé TILLY, MD    +33232082202       Principal Investigator: Hervé TILLY, MD Less <<
NCT00005838 Adenocarcinoma of the Lung ... More >> Adenosquamous Cell Lung Cancer Large Cell Lung Cancer Squamous Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Less << Phase 3 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02822404 Kidney Diseases Not Applicable Active, not recruiting September 2020 France ... More >> CHU Toulouse Toulouse, France, 31059 Less <<
NCT02103257 EGFR Positive Non-small Cell L... More >>ung Cancer Adenocarcinoma Less << Phase 4 Unknown September 2017 China, Gansu ... More >> First Hospital of Lanzhou University Active, not recruiting Lanzhou, Gansu, China, 730000 Lanzhou military region general hospital Active, not recruiting Lanzhou, Gansu, China, 730050 China, Guangdong General Hospital of Guangzhou Military Command Active, not recruiting Guangzhou, Guangdong, China, 510010 Cancer Hospital of Sun Yat-sen Active, not recruiting Guangzhou, Guangdong, China, 510060 First Affiliated Hospital of Guangzhou Medical College Active, not recruiting Guangzhou, Guangdong, China, 510120 Jiangmen central hospital Active, not recruiting Jiangmen, Guangdong, China, 529030 The university of Hong Kong-Shenzhen Hospital Active, not recruiting Shenzhen, Guangdong, China, 518000 Shenzhen People's Hospital Active, not recruiting Shenzhen, Guangdong, China, 518020 Medical Oncology,Shenzhen Second People's Hospital Active, not recruiting Shenzhen, Guangdong, China, 518035 Thoracic Surgery,Shenzhen Second People's Hospital Active, not recruiting Shenzhen, Guangdong, China, 518035 Peking University Shenzhen Hospital Active, not recruiting Shenzhen, Guangdong, China, 518036 Guangdong Agribusiness Center Hospital Active, not recruiting Zhanjiang, Guangdong, China, 524009 China, Guangxi First Affiliated Hospital of Guangxi Medical University Active, not recruiting Nanning, Guangxi, China, 530021 China, Hainan Hainan Provincal Nong Ken Hospital Active, not recruiting Haikou, Hainan, China, 570311 Hainan Provincial People's Hospital Active, not recruiting Haikou, Hainan, China, 570311 China, Henan First Affiliated Hospital of Zhengzhou University Active, not recruiting Zhengzhou, Henan, China, 450052 China, Ningxia Medical Oncology，General Hospital of Ningxia Medical University Active, not recruiting Yinchuan, Ningxia, China, 750004 Radiation Oncology，General Hospital of Ningxia Medical University Active, not recruiting Yinchuan, Ningxia, China, 750004 Respiratory medicine，General Hospital of Ningxia Medical University Active, not recruiting Yinchuan, Ningxia, China, 750004 China, Shanxi Baoji Central Hospital Active, not recruiting Baoji, Shanxi, China, 721008 3201 Hospital, Hanzhong, Shanxi Active, not recruiting Hanzhong, Shanxi, China, 723000 Shaanxi province people's hospital Active, not recruiting Xi'an, Shanxi, China, 710000 Second Affiliated Hospital of Xi'an Jiaotong University Active, not recruiting Xi'an, Shanxi, China, 710004 Xi'an Chang'an Hospital Active, not recruiting Xi'an, Shanxi, China, 710018 Tangdu Hospital，Fourth Military Medical University Recruiting Xi'an, Shanxi, China, 710038 Contact: Helong Zhang, MD    13709202616       Principal Investigator: Helong Zhang, MD          First Affiliated Hospital of Xi'an Jiaotong University Active, not recruiting Xi'an, Shanxi, China, 710061 Shanxi Cancer Hospital Active, not recruiting Xi'an, Shanxi, China, 710061 China, Xinjiang Urumqi General Hospital of Lanzhou Military Region General Hospital Active, not recruiting Urumqi, Xinjiang, China, 830000 Xinjiang medical university affiliated tumor hospital Active, not recruiting Urumqi, Xinjiang, China, 830000 First Affiliated Hospital of Xinjiang Medical University Active, not recruiting Urumqi, Xinjiang, China, 830054 Autonome Region Xinjiang Uygur Chinese medicine hospital Active, not recruiting Urumqi, Xinjiang, China, 830099 Less <<
NCT00718913 Gastric Cancer Phase 2 Completed - Greece ... More >> University Hospital of Crete Dept of Medical Oncology Heraklion, Crete, Greece University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece "IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece 401 Military Hospital of Athens Athens, Greece Air Forces Military Hospital of Athens Athens, Greece General Hospital of Larissa Dept of Medical Oncology Larissa, Greece "Metaxa's" Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology Piraeus, Greece Less <<
NCT02352792 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Not Applicable Recruiting December 2022 Germany ... More >> Tuebingen university, radiation oncology Recruiting Tuebingen, Baden-Württemberg, Germany, 72076 Contact: Stefan Welz, Dr. med.    +49 7071 29 86144    stefan.welz@med.uni-tuebigen.de Less <<
NCT03167177 Melanoma Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT02972372 Esophagus Cancer Not Applicable Recruiting June 2021 China, Henan ... More >> Anyang Tumor Hospital Recruiting Anyang, Henan, China Contact: Fuyou Zhou, MD,PhD    +86 13939998799    jiaruinuo@163.com    The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology Recruiting Luoyang, Henan, China, 471003 Contact: Shegan Gao, MD, PhD    +86 18638859977    gsg112258@163.com    Contact: Ruinuo Jia, MD    +86 18537950766    jiaruinuo@163.com    Principal Investigator: Ruinuo Jia, MD          Sub-Investigator: Xinshuai Wang, MD, PhD          Sub-Investigator: Guoqiang Kong, MD          Sub-Investigator: Baoping Chang, MD, PhD          Sub-Investigator: Jiachun Sun, MD, PhD          Sub-Investigator: Xiaozhi Yuan, MD          Sub-Investigator: Dan Zhou, MD          Sub-Investigator: Ruina Yang, MD          Sub-Investigator: Jing Ren, MD          Sub-Investigator: Shuoguo Li, MD          Sub-Investigator: Wei Wang, MD          Sub-Investigator: Shiyuan Song, MD          Sub-Investigator: Weijiao Yin, MD Less <<
NCT00117572 Cancer of the Pharynx ... More >> Cancer of the Larynx Cancer of the Nasal Cavity Paranasal Sinus Neoplasms Cancer of the Oral Cavity Less << Phase 3 Completed - -
NCT00117572 - Completed - -
NCT02339753 Pediatric Solid Tumor Phase 2 Unknown December 2016 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Principal Investigator: HeeYeong shin Less <<
NCT02815592 Small Cell Lung Cancer Phase 1 Phase 2 Active, not recruiting October 2, 2019 Canada, Alberta ... More >> Local Institution Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario Local Institution Ottawa, Ontario, Canada, K1H 8L6 Spain Local Institution Barcelona, Spain, 08035 Local Institution Madrid, Spain, 28041 Local Institution Majadahonda - Madrid, Spain, 28222 Local Institution Malaga, Spain, 29010 Less <<
NCT00791154 Lung Cancer S... More >>mall Cell Lung Cancer Solid Tumors Extensive-stage Small Cell Lung Cancer Less << Phase 1 Phase 2 Completed - -
NCT03167164 Merkel Cell Carcinoma Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT01053390 Gallbladder Neoplasms Phase 3 Completed - China ... More >> Xinhua hospital affiliated shanghai jiaotong Shanghai, China Less <<
NCT03574324 Locally Advanced Nasopharyngea... More >>l Carcinoma Less << Phase 3 Recruiting May 24, 2023 China, 贵州省 ... More >> Cancer Hospital of Guizhou Medical University Recruiting Guiyang, 贵州省, China, 550000 Contact: Yuanyuan Li, master    085186512802    lilyuanyuan@qq.com    Sub-Investigator: Feng Jin, Bachelor          Sub-Investigator: Weili Wu, Master          Sub-Investigator: Jinhua Long, Master          Sub-Investigator: Xiuling Luo, Bachelor          Sub-Investigator: Xiuyun Gong, Bachelor          Sub-Investigator: Hang Jiang, Master          Sub-Investigator: Yanfang Cen, Bachelor Less <<
NCT03673735 Squamous Cell Head and Neck Ca... More >>rcinoma Less << Phase 3 Not yet recruiting December 2027 -
NCT02629718 PFS OS ... More >> Quality of Life Less << Phase 3 Recruiting December 2022 China, Guangdong ... More >> Sun Yat-sen University Cancer Center, Department of Gynecologic Oncology Recruiting GuangZhou, Guangdong, China, 510060 Contact: Ting Wan, Ph.D Less <<
NCT00135135 Neuroblastoma Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03358472 Head and Neck Cancer Phase 3 Active, not recruiting June 2020 -
NCT00766480 Esophageal Cancer Not Applicable Unknown - Japan ... More >> Aichi Cancer Center Recruiting Nagoya, Aichi, Japan, 464-8681 Contact: Shunzo Hatooka    81-52-762-6111       National Cancer Center Hospital East Recruiting Kashiwa, Chiba, Japan, 277-8577 Contact: Keiko Minashi    81-4-7133-1111       Kurume University School of Medicine Recruiting Kurume, Fukuoka, Japan, 830-0011 Contact: Toshiaki Tanaka    81-942-35-3311       Gunma University Graduate School of Medicine Recruiting Maebashi-shi, Gunma, Japan, 371-8511 Contact: Hiroyuki Kuwano, MD, PhD    81-27-220-8224    hkuwano@med.gunma-u.ac.jp    Hyogo College of Medicine Recruiting Nishinomiya, Hyogo, Japan, 663-8501 Contact: Koushi Oh    81-798-45-6582       Iwate Medical University Hospital Recruiting Morioka, Iwate, Japan, 020-8505 Contact: Kenichiro Ikeda    81-19-651-5111       Kawasaki Medical School Recruiting Kurashiki, Okayama, Japan, 701-01 Contact: Toshihiro Hirai    81-86-462-1199       Graduate School of Medical Science at the University of Ryukyu Recruiting Nishiharacho, Okinawa, Japan, 903-0215 Contact: Tadashi Nishimaki    81-98-895-3331       Kinki University School of Medicine Recruiting Osakasayama, Osaka, Japan, 589-8511 Contact: Takushi Yasuda    81-72-366-0221       Osaka University Graduate School of Medicine Recruiting Suita, Osaka, Japan, 565-0871 Contact: Masaichi Ohira    81-6-6645-3837       National Kyushu Cancer Center Recruiting Fukuoka, Japan, 811-1395 Contact: Yasushi Toh, MD, PhD    81-92-541-3231       Hiroshima City Asa Hospital Recruiting Hiroshima, Japan, 731-0293 Contact: Hidenori Mukaida    81-82-815-5211       Kagoshima University Recruiting Kagoshima, Japan, 890-8520 Contact: Shoji Natsugoe    81-99-275-5361       Kyoto University Hospital Recruiting Kyoto, Japan, 606-8507 Contact: Michihide Mitsumori    81-75-751-3417       Niigata University Medical and Dental Hospital Recruiting Niigata, Japan, 951-8510 Contact: Tatsuo Kanda, MD    81-25-227-2228       Niigata Cancer Center Hospital Recruiting Niigata, Japan, 951-8566 Contact: Hiroshi Yabusaki    81-25-266-5111       Osaka Medical Center for Cancer and Cardiovascular Diseases Recruiting Osaka, Japan, 537-8511 Contact: Ryu Ishihara    81-6-6972-1181       Mita Hospital at the International University of Health and Welfare Recruiting Tokyo, Japan, 108-8329 Contact: Ken-ichi Mafune, MD    81-3-3451-8121    mafune@iuhw.ac.jp    Tokyo Women's Medical University Recruiting Tokyo, Japan, 162-8666 Contact: Tsutomu Nakamura    81-3-3353-8111       Toyama University Hospital Recruiting Toyama, Japan, 930-8555 Contact: Yutaka Shimada, MD, PhD    81-76-434-7331 Less <<
NCT00003269 Breast Cancer ... More >> Drug/Agent Toxicity by Tissue/Organ Lung Cancer Lymphoma Ovarian Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 2 Completed - United States, California ... More >> Scripps Clinic La Jolla, California, United States, 92037 Less <<
NCT00004164 Head and Neck Cancer Phase 2 Unknown - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00586846 - Completed - -
NCT02402920 Extensive Stage Small Cell Lun... More >>g Carcinoma Limited Stage Small Cell Lung Carcinoma Neuroendocrine Neoplasm Less << Phase 1 Recruiting July 31, 2023 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: James Welsh    713-563-2300       Principal Investigator: James Welsh Less <<
NCT00617656 LUNG CANCER Phase 3 Terminated(No safety reasons. ... More >>Interim analysis shows that the hypothesis superiority of the experimental arm over the control arm- would not be confirmed.) Less << - Spain ... More >> H. Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Less <<
NCT00586846 Osteosarcoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01437488 Urothelial Carcinoma Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01136031 Advanced Gastric Cancer Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01247246 Oral Mucositis Phase 2 Unknown June 2014 -
NCT03737994 ALK Gene Rearrangement ... More >> ALK Positive Non-Squamous Non-Small Cell Lung Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 Less << Phase 2 Not yet recruiting December 13, 2025 -
NCT01524575 Metastatic Pancreatic Cancer ... More >> ERCC1 Less << Phase 2 Unknown January 2014 United States, Hawaii ... More >> University of Hawaii Recruiting Honolulu, Hawaii, United States, 96813 Contact: Jared D Acoba, MD    808-531-8521    jacoba@hawaii.edu Less <<
NCT01437488 - Completed - -
NCT00365183 Non-Small Cell Lung Carcinoma Phase 2 Terminated - United States, California ... More >> Huntington Beach, California, United States Long Beach, California, United States United States, Illinois Chicago, Illinois, United States United States, Maryland Baltimore, Maryland, United States United States, Minnesota Minneapolis, Minnesota, United States United States, Missouri St. Louis, Missouri, United States United States, New Mexico Albuquerque, New Mexico, United States Santa Fe, New Mexico, United States United States, New York Armonk, New York, United States United States, Ohio Columbus, Ohio, United States United States, Washington Seattle, Washington, United States Less <<
NCT02819752 Squamous Cell Carcinoma of the... More >> Head and Neck Squamous Cell Carcinoma Less << Phase 1 Unknown December 2018 -
NCT00606502 - Completed - -
NCT03250520 Brain Tumor, Pediatric, Brains... More >>tem Glioma Brain Tumor, Pediatric, Recurrent Less << Early Phase 1 Active, not recruiting February 28, 2021 Mexico ... More >> Hospital Infantil de Mexico Federico Gomez DF, Mexico Less <<
NCT03200340 Stomatitis Phase 2 Recruiting June 20, 2019 United States, Arkansas ... More >> NEA Baptist Cancer Center Recruiting Jonesboro, Arkansas, United States, 72401 Contact: Emily Carvel          United States, Georgia Winship Cancer Institute of Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Swathi Chinarangari          United States, Illinois NorthShore University HealthSystem Recruiting Evanston, Illinois, United States, 60201 Contact: Michelle Britto          United States, Indiana Goshen Center for Cancer Care Recruiting Goshen, Indiana, United States, 46526 Contact: Jill Borsa          United States, Kansas Cancer Center of Kansas Recruiting Wichita, Kansas, United States, 67214 Contact: Pat Stone          United States, Kentucky University of Kentucky, Chandler Medical Center, CCTS Recruiting Lexington, Kentucky, United States, 40536 Contact: Linda Rice          United States, Maryland Greater Baltimore Medical Center Recruiting Baltimore, Maryland, United States, 21204 Contact: Melissa Loomis          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110-1010 Contact: Josh Smith          United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: John Minger          United States, Pennsylvania St. Luke's Cancer Center - Anderson Campus Recruiting Easton, Pennsylvania, United States, 18045 Contact: Jillian Timer          United States, Texas Hope Cancer Center of East Texas Recruiting Tyler, Texas, United States, 75701 Contact: Grace Loredo          Baylor Scott & White Medical Center - Hillcrest Recruiting Waco, Texas, United States, 76712 Contact: Dedra Preece Less <<
NCT03644342 Metastatic Carcinoma of the Ce... More >>rvix Less << Phase 1 Phase 2 Not yet recruiting March 2, 2026 United States, Texas ... More >> Baylor College of Medicine Not yet recruiting Houston, Texas, United States, 77030 Contact: Michelle S Ludwig, MD, MPH, PhD    713-566-3757    Michelle.Ludwig@bcm.edu    Harris Health System - Smith Clinic Houston, Texas, United States, 77054 Less <<
NCT00771810 Thrombocytopenia ... More >> Neutropenia Lymphopenia Anemia Less << Phase 2 Completed - United States, Alabama ... More >> University of Southern Alabama Mitchell Cancer Institute Mobile, Alabama, United States, 36604 United States, California USC - LAC Medical Center Los Angeles, California, United States, 90033 University of California - Irvine, Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Kansas Associates in Women's Health Wichita, Kansas, United States, 67208 United States, New York Schwartz Gynecologic Oncology, PLLC Brightwaters, New York, United States, 11718 Less <<
NCT00771810 - Completed - -
NCT00723658 Lymphoma Phase 2 Withdrawn(lack of accrual) - United States, Connecticut ... More >> Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States, 06105 United States, Indiana St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove, Indiana, United States, 46107 Reid Hospital & Health Care Services Richmond, Indiana, United States, 47374 United States, Kansas Lawrence Memorial Hospital Lawrence, Kansas, United States, 66044 Wesley Medical Center Wichita, Kansas, United States, 67214 United States, Michigan Saint Joseph Mercy Cancer Center Ann Arbor, Michigan, United States, 48106-0995 CCOP - Michigan Cancer Research Consortium Ann Arbor, Michigan, United States, 48106 Oakwood Cancer Center at Oakwood Hospital and Medical Center Dearborn, Michigan, United States, 48123-2500 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Genesys Hurley Cancer Institute Flint, Michigan, United States, 48503 Hurley Medical Center Flint, Michigan, United States, 48503 Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods, Michigan, United States, 48236 Foote Memorial Hospital Jackson, Michigan, United States, 49201 Sparrow Regional Cancer Center Lansing, Michigan, United States, 48912-1811 St. Mary Mercy Hospital Livonia, Michigan, United States, 48154 St. Joseph Mercy Oakland Pontiac, Michigan, United States, 48341-2985 Mercy Regional Cancer Center at Mercy Hospital Port Huron, Michigan, United States, 48060 Seton Cancer Institute at Saint Mary's - Saginaw Saginaw, Michigan, United States, 48601 St. John Macomb Hospital Warren, Michigan, United States, 48093 United States, Ohio Grandview Hospital Dayton, Ohio, United States, 45405 Good Samaritan Hospital Dayton, Ohio, United States, 45406 David L. Rike Cancer Center at Miami Valley Hospital Dayton, Ohio, United States, 45409 CCOP - Dayton Dayton, Ohio, United States, 45420 Blanchard Valley Medical Associates Findlay, Ohio, United States, 45840 Middletown Regional Hospital Franklin, Ohio, United States, 45005-1066 Charles F. Kettering Memorial Hospital Kettering, Ohio, United States, 45429 UVMC Cancer Care Center at Upper Valley Medical Center Troy, Ohio, United States, 45373-1300 Clinton Memorial Hospital Wilmington, Ohio, United States, 45177 Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia, Ohio, United States, 45385 Less <<
NCT03135977 Extensive-stage Small Cell Lun... More >>g Cancer Lung Cancer Less << Phase 2 Recruiting December 2018 China, Sichuan ... More >> Sicchuan cancer hospital Recruiting Chendu, Sichuan, China, 610000 Contact: xiaohong Cai, Doctor    8618036672884    xionghong_cai@hotmail.com Less <<
NCT01718327 Unresectable and Advanced Chol... More >>angiocarcinoma Less << Phase 2 Completed - France ... More >> Hôpital Beaujon Clichy, France, 92118 Hôpital privé Jean Mermoz Lyon, France, 69008 CHU La Timone Marseille, France, 13005 Hôpital Saint Antoine Paris, France, 75012 Institut Mutualiste Montsouris Paris, France, 75014 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT02305654 Squamous Cell Carcinoma of the... More >> Penis, Usual Type Less << Phase 3 Recruiting July 2022 United Kingdom ... More >> The Royal Marsden NHS Foundation Trust Recruiting London, United Kingdom, SM2 5PT Contact: Dr Alison Tree          St George's Hospital NHS Foundation Trust Recruiting London, United Kingdom, SW17 0QT Contact: Mr Nick Watkin Less <<
NCT03627728 Gastric Cancer Phase 2 Recruiting December 2021 Italy ... More >> Struttura Complessa di OncologiaIRCCS- Istituto in Tecnologie Avanzate e Modelli Assistenziali in Oncologia Arcispedale Santa Maria Nuova Recruiting Reggio Emilia, Italy, 42123 Contact: gnoni roberta, biologist    +390522295181    gnoni.roberta@ausl.re.it Less <<
NCT00200681 Multiple Myeloma Phase 3 Completed - France ... More >> CHU de Nantes, Service d'Hématologie Nantes, France, 44093 Less <<
NCT02289547 Stomach Neoplasms Phase 3 Recruiting January 2019 Korea, Republic of ... More >> St. Vincent's Hospital Recruiting Suwon, Gyeonggi-do, Korea, Republic of, 442-723 Contact: Byoungyong Shim, Ph.D., M.D    82-31-249-8457       Principal Investigator: Byoungyong Shim, M.D., Ph.D          Buchon St. Mary's Hospital Recruiting Buchon, Korea, Republic of Contact: Cuk Jin Lee          Daejeon St. Mary's Hospital Recruiting Daejeon, Korea, Republic of Contact: Ji Chan Park          Incheon St. Mary's Hospital Recruiting Incheon, Korea, Republic of Contact: Jeo Ho Byen          Seoul St. Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Young Seon Hong          St. Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: In Sook Woo          Bundang Seoul National hospital Recruiting Sungnam, Korea, Republic of Contact: Keun Wook Lee          Ujeongbu St. Mary's Hospital Recruiting Ujeongbu, Korea, Republic of Contact: Yoon Ho Ko Less <<
NCT01993966 - Unknown December 2016 Taiwan ... More >> Department of Urology, National Taiwan University Hospital Not yet recruiting Taipei, No. 7, Chung Shans. Rd.,, Taiwan, 100 Contact: Kuo-How Huang, M.D.,Ph.D.    886-2-23123456       Contact: Chin-Ling Huang    886-2-23123456 ext 65233    d95447004@ntu.edu.tw    Department of Urology, National Taiwan University Hospital Not yet recruiting Taipei, No. 7, Chung Shans. Rd., Taiwan, 100 Contact: Kuo-How Huang, M.D.,Ph.D.    886-2-23123456 ext 65952    khhuang123@ntu.edu.tw Less <<
NCT00042952 Ovarian Dysgerminoma ... More >> Recurrent Malignant Testicular Germ Cell Tumor Recurrent Ovarian Germ Cell Tumor Stage II Malignant Testicular Germ Cell Tumor Stage II Ovarian Germ Cell Tumor Stage III Malignant Testicular Germ Cell Tumor Stage III Ovarian Germ Cell Tumor Testicular Seminoma Less << Phase 2 Terminated(Administratively co... More >>mplete.) Less << - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT02945852 Small Cell Lung Cancer Phase 2 Unknown December 2018 China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Yun Fan, MD    0086-571-88122192    fanyun@csco.org.cn    Principal Investigator: Yun Fan, MD Less <<
NCT01201265 - Completed - -
NCT01201265 Breast Cancer Phase 2 Completed - India ... More >> Ahmedabad, India, 380009 Bangalore, India, 560029 Bangalore, India, 560054 Delhi, India, 110029 Gandhinagar, India, 382428 Mumbai, India, 400012 Mumbai, India, 400016 Mumbai, India, 400020 New Delhi, India, 110011 New Delhi, India, 110085 Pune, India, 411004 Vellore, India, 632004 Less <<
NCT03180177 Epithelial Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Carcinoma Less << Phase 3 Not yet recruiting July 1, 2022 China, Guangdong ... More >> Department of Abdominal Surgery (Section 2), Affiliated Tumor Hospital of Guangzhou Medical University Not yet recruiting Guangzhou, Guangdong, China, 510095 Contact: shuzhong cui, M.D    0086-138-0251-3800    cuishuzhong@126.com    Contact: Xianzi Yang, M.D    0086-188-9853-4167    7097359@qq.com    Principal Investigator: shuzhong cui, M.D Less <<
NCT02643056 Advanced Head and Neck Squamou... More >>s Cancer Less << Phase 2 Completed - -
NCT01543412 Pancreatic Adenocarcinoma Phase 2 Completed - Italy ... More >> A.O. Treviglio-Caravaggio, P.le Ospedale n1 Treviglio, Bergamo, Italy, 24047 Azienda Ospedaliera "Di Liegro" Gaeta, Latina, Italy, 04024 A.O. Ospedale S.Paolo Milano, MI, Italy, 20100 A.O. S.Salvatore Pesaro, PS, Italy, 61100 Ospedale Morelli Sondalo, SO, Italy, 23100 Ospedali Riuniti Umberto I - GM Lancisi-G Salesi Ancona, Italy, 60126 Ospedali Riuniti, Largo Barozzi, 1 Bergamo, Italy, 24128 Fondazione Poliambulanza, Via Bissolati 57 Brescia, Italy, 25100 A.O. Carlo Poma - Via Albertoni, 1 Mantova, Italy, 46100 Less <<
NCT01486992 Advanced Esophageal Carcinoma Phase 2 Unknown November 2012 China, Beijing ... More >> Zhang Xiaodong Recruiting Beijing, Beijing, China, 100142 Contact: XIAODONG ZHANG, MD    861088196175    zxd0829@yahoo.com.cn Less <<
NCT00002565 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Brazil Faculdade de Medicina do ABC Sao Paulo, Brazil, 01224--010 Chile Clinica Alemana Santiago, Chile, 5951 Less <<
NCT00930605 Peripheral T-cell Lymphoma Phase 2 Completed - Thailand ... More >> King Chulalongkorn Memorial Hospital Bangkok, Thailand Less <<
NCT00392886 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Unknown - -
NCT01743157 Metastatic Melanoma Phase 1 Phase 2 Completed - United States, California ... More >> San Francisco Oncology Associates San Francisco, California, United States, 94115 Less <<
NCT03719924 Squamous Cell Carcinoma Phase 2 Not yet recruiting April 15, 2022 -
NCT03663166 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Recruiting March 1, 2027 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Austin Lannon    813-745-2169    Austin.Lannon@moffitt.org    Principal Investigator: Bradford Perez, MD          Sub-Investigator: Scott Antonia, MD, PhD          Sub-Investigator: Alberto Chiappori, MD          Sub-Investigator: Benjamin Creelan, MD          Sub-Investigator: Thomas Dilling, MD          Sub-Investigator: Jhanelle Gray, MD          Sub-Investigator: Eric Haura, MD          Sub-Investigator: Stephen Rosenberg, MD, MS          Sub-Investigator: Michael Shafique, MD          Sub-Investigator: Tawee Tanvetyanon, MD, MPH Less <<
NCT03373058 Epithelial Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Carcinoma Less << Phase 3 Not yet recruiting July 1, 2021 China, Guangdong ... More >> Affiliated Tumor Hospital of Guangzhou Medical University Not yet recruiting Guangzhou, Guangdong, China, 510095 Contact: shuzhong cui, M.D    0086-138-0251-3800    cuishuzhong@126.com    Contact: Zhen Tang, M.M    0086-159-2081-9128    57932181@qq.com    Principal Investigator: shuzhong cui, M.D Less <<
NCT01044420 Advanced Esophageal Carcinoma Phase 2 Unknown June 2012 China, Beijing ... More >> Zhang Xiaodong Recruiting Beijing, Beijing, China, 100142 Contact: zhang xiaodong, MD    86-10-88196175    zxd0829@yahoo.com.cn Less <<
NCT00161174 - Completed - Netherlands ... More >> University Medical Centre Groningen Groningen, Netherlands, 9713 GZ Less <<
NCT00514540 Prostate Cancer Phase 2 Completed - United States, California ... More >> University of California-San Francisco San Francisco, California, United States, 94143 United States, Texas UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02195973 Recurrent Ovarian Cancer Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 Less <<
NCT02817113 Head and Neck Neoplasms Phase 1 Unknown December 2017 Taiwan ... More >> National Taiwan University Hospital Not yet recruiting Taipei, Taiwan, 100 Contact: Ruey-Long Hong, MD PhD          Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 112 Contact: Muh-Hwa Yang, MD PhD          Chang Gung Memorial Hospital, Linkou Branch Recruiting Taoyuan, Taiwan, 333 Contact: Hung-Ming Wang, MD PhD Less <<
NCT00319839 Head and Neck Cancer Phase 2 Terminated(slow accrual) - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT00319839 - Terminated(slow accrual) - -
NCT03498196 Bladder Cancer ... More >> Metastatic Bladder Cancer Invasive Bladder Cancer Less << Phase 1 Phase 2 Recruiting January 2025 United States, Texas ... More >> Baylor Clinic Not yet recruiting Houston, Texas, United States, 77030 Contact: Jennifer M. Taylor, MD    713-798-4001    jennifer.taylor@bcm.edu    Baylor College of Medicine Not yet recruiting Houston, Texas, United States, 77030 Contact: Jennifer M. Taylor, M.D.    713-798-4001    jennifer.taylor@bcm.edu    Sub-Investigator: Martha P. Mims, M.D., Ph.D.          Sub-Investigator: Anita L. Sabichi, M.D.          Sub-Investigator: Aihua E. Yen, M.D.          Sub-Investigator: Seth Lerner, M.D.          Sub-Investigator: Guilherme Godoy, M.D.          Ben Taub General Hospital Recruiting Houston, Texas, United States, 77030 Contact: Jennifer M. Taylor, MD    713-798-4001    jennifer.taylor@bcm.edu    Sub-Investigator: Martha Mims, MD, PhD          Sub-Investigator: Aihua E. Yen, MD          Sub-Investigator: Seth Lerner, MD          Sub-Investigator: Guilherme Godoy, MD          Sub-Investigator: Anita L. Sabichi, MD          Michael E. DeBakey Veteran Affairs Medical Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Jennifer M. Taylor, MD    713-791-1414 ext 26429    jennifer.taylor@bcm.edu    Sub-Investigator: Anita L. Sabichi, MD          Sub-Investigator: Aihua E. Yen, MD          Sub-Investigator: Guilherme Godoy, MD Less <<
NCT02603159 Stage III Esophageal Squamous ... More >>Cell Carcinoma Stage II Esophageal Squamous Cell Carcinoma Less << Phase 3 Recruiting December 2019 China, Henan ... More >> The First Affiliated Hospital of Henan University of Science and Technology Recruiting Luoyang, Henan, China, 471003 Contact: shegan gao, doctor    0379 64811906    gsg112258@163.com    Contact: tanyou shan, master    0379 64815350    shantanyou@163.com Less <<
NCT00638937 - Completed - -
NCT01963052 Metastatic Urothelial Cancer Phase 1 Active, not recruiting March 2019 United States, Alabama ... More >> Site US00006 Birmingham, Alabama, United States, 35294 United States, Connecticut Site US00002 New Haven, Connecticut, United States, 06510 United States, Michigan Site US00001 Detroit, Michigan, United States, 48201 United States, Missouri Site US00003 Saint Louis, Missouri, United States, 63110 United States, New York Site US00009 Buffalo, New York, United States, 14263 United States, Pennsylvania Site US00011 Pittsburgh, Pennsylvania, United States, 15232 United States, Tennessee Site US00010 Nashville, Tennessee, United States, 37212 United States, Washington Site US00008 Seattle, Washington, United States, 98109 Canada, British Columbia Site CA00004 Vancouver, British Columbia, Canada, V5Z 1H5 Canada, Ontario Site CA00007 Hamilton, Ontario, Canada, L8V 5C2 Site CA00005 Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT00256230 Stage IV Melanoma Phase 1 Phase 2 Completed - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT00134030 Localized Osteosarcoma ... More >> Metastatic Osteosarcoma Less << Phase 3 Active, not recruiting - -
NCT02335424 Urothelial Cancer Phase 2 Active, not recruiting September 28, 2020 -
NCT00638937 Recurrent Non-small Cell Lung ... More >>Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 2 Completed - Canada, Ontario ... More >> Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 The Ottawa Hospital Cancer Centre (Ottawa Health Research Institute) Civic Campus Ottawa, Ontario, Canada, K1Y 4E9 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec McGill University Department of Oncology Montreal, Quebec, Canada, H2W 1S6 Less <<
NCT00336583 - Completed - -
NCT03631199 Non-small Cell Lung Cancer Phase 3 Not yet recruiting October 21, 2022 -
NCT00704639 Head and Neck Cancer Phase 1 Phase 2 Completed - Australia, Victoria ... More >> Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 3002 Less <<
NCT01467921 Curatively-resected, Node-posi... More >>tive Esophageal Squamous Cell Carcinoma Less << Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Mi yeon kwon, RN    +82-2-3410-1248    miyeon.kwon@samsung.com Less <<
NCT00336583 Non-Hodgkin's Lymphoma Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT02229656 Laryngeal Cancer Stage II ... More >> Laryngeal Cancer Stage III Carcinoma, Squamous Cell Head and Neck Neoplasms Less << Phase 1 Recruiting August 2020 Netherlands ... More >> The Netherlands Cancer Institute Recruiting Amsterdam, Netherlands, 1066 CX Contact: Marcel Verheij, MD, PhD    +31 20 512 2153    m.verheij@nki.nl    Contact: Rosemarie de Haan, MD    +31 20 512 9085    ro.d.haan@nki.nl    Principal Investigator: Marcel Verheij, MD, PhD          Sub-Investigator: Margot Tesselaar, MD, PhD          Sub-Investigator: Abrahim Al-Mamgani, MD, PhD Less <<
NCT01836575 Non Small Cell Lung Carcinoma Phase 3 Completed - United States, Florida ... More >> The Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States, 33140 Brazil Instituto do Câncer do Ceará - ICC Fortaleza, Ceará, Brazil Hospital Lifecenter Belo Horizonte, Minas Gerais, Brazil Hospital Caridade de Ijuí - CACON Ijuí, RS, Brazil Hospital São Lucas Porto Alegre, RS, Brazil Centro de Pesquisas Oncológicas - CEPON Florianópolis, Santa Catarina, Brazil Hospital Amaral Carvalho Jaú, São Paulo, Brazil INCA Rio de Janeiro, Brazil Instituto do Câncer Arnaldo Vieira de Carvalho São Paulo, Brazil Less <<
NCT03399643 - Active, not recruiting December 20, 2021 Germany ... More >> Praxis Dr.med. Wolfgang Hölzer Berlin, Germany, 13055 Urologie Schlosscarree Braunschweig, Germany, 38100 Coub Centrum F. Operative Urologie Bremen; Prof. Dr. Gerald Mickisch & Dr. Med. Roland Mattes Bremen, Germany, 28277 Urologische Praxis Dr. Krieger Chemnitz, Germany, 09127 Zeisigwaldkliniken Bethanien Chemnitz, Germany, 09130 St. Joseph-Stift Dresden; Praxis für Urologie Dresden, Germany, 01307 St. Georg Klinikum Eisenach GmbH Eisenach, Germany, 99817 St. Franziskus-Hospital; Malteser Krankenhaus; Medizinische Klinik I Flensburg, Germany, 24939 Klinikum Frankfurt Höchst GmbH; Klinik Innere Medizin 3 - Hämatologie, Onkologie, Palliativmedizin Frankfurt am Main, Germany, 65929 Dres.Jochen Wilke und Harald Wagner Fürth, Germany, 90766 Krankenhaus Martha-Maria Halle-Dölau, Klinik für Urologie Halle (Saale), Germany, 06120 Urologische Praxis Michael Steinacker Halle, Germany, 06120 Asklepios Klinik Altona, Abteilung für Urologie Hamburg, Germany, 22763 Onkologische Praxis in Heidenheim Heidenheim, Germany, 89522 St. Bernward-Krankenhaus Hildesheim, Germany, 31134 Onkologische Praxis Landshut Landshut, Germany, 84036 Gemeinschaftspraxis; Onkologisches Zentrum Lebach; Caritas Krankenhaus Lebach Lebach, Germany, 66822 ÜBAG MVZ Mitte / MVZ Delitzsch GmbH, Standort Leipzig Leipzig, Germany, 04103 Sankt Elisabeth Krankenhaus; Urlogische Abt. Leipzig, Germany, 04277 Drk Krankenhaus Luckenwalde Luckenwalde, Germany, 14943 Universitätsklinikum Schleswig-Holstein / Campus Lübeck; Klinik für Urologie Lübeck, Germany, 23538 Urologikum Lübeck Lübeck, Germany, 23566 Urologischen Praxis in Lüneburg Lüneburg, Germany, 21335 Medizinische Fakultät Mannheim, Universitätsklinikum Mannheim, Klinik für Urologie Mannheim, Germany, 68167 Praxis Markkleeberg Markkleeberg, Germany, 04416 Mühlenkreiskliniken; Johannes Wesling Klinikum Minden; Klinik für Hämatologie, Onkologie und Pallia. Minden, Germany, 32429 Städt.Kliniken München GmbH Klinikum Bogenhausen München, Germany, 81925 Praxis Dr. Uhlig, Naunhof Naunhof, Germany, 04683 Brüderkrankenhaus St. Josef Paderborn, Klinik für Hämatologie/Onkologie Paderborn, Germany, 33098 Praxis für Hämatologie & Onkologie Saarbruecken, Germany, 66113 MVZ für Hämatologie, Onkologie, Strahlentherapie und Palliativmedizin -; Klinik Dr. Hancken Stade, Germany, 21680 Krankenhaus der Barmherzigen Brüder Trier; Innere Medizin I, Hämatologie / Internistische Onkologie Trier, Germany, 54292 Urologische Praxis Wedel, Germany, 22880 Gemeinschaftspraxis für Hämatologie und Onkologie Westerstede Aurich Rhauder Westerstede, Germany, 26655 Less <<
NCT01487720 Prostate Cancer Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT01379482 Peritoneal Carcinomatosis ... More >> Gastric Cancer Less << Phase 2 Completed - Sweden ... More >> Uppsala University Uppsala, Sweden Less <<
NCT00231842 Uterine Cancer Phase 2 Completed - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10461 Less <<
NCT00953420 Nasopharyngeal Carcinoma Phase 2 Completed - United States, Texas ... More >> Houston Methodist Hospital Houston, Texas, United States, 77030 MD Anderson Cancer Center Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT01383148 Non-Small-Cell Lung Carcinoma Phase 2 Phase 3 Terminated - -
NCT00130936 Gastric Cancer ... More >> Esophageal Cancer Tumors Less << Phase 1 Phase 2 Terminated - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT00533533 Gastric Cancer Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT01921426 Squamous Cell Carcinoma of the... More >> Oral Cavity Squamous Cell Carcinoma of the Oropharynx Less << Phase 1 Completed - United States, Florida ... More >> Lakeland Regional Cancer Center Lakeland, Florida, United States, 33805 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New York University of Rochester Medical Center Rochester, New York, United States, 14642 United States, North Carolina Wake Forest Baptist Health Winston-Salem, North Carolina, United States, 27157 United States, Ohio Summa Health System- Cooper Cancer Center Akron, Ohio, United States, 44304 United States, Pennsylvania St. Luke's Cancer Center Easton, Pennsylvania, United States, 18045 Allegheny General Hospital Pittsburgh, Pennsylvania, United States, 15212 United States, Washington Cancer Care Northwest Spokane, Washington, United States, 99216 Less <<
NCT02921854 Non Small Cell Lung Cancer Not Applicable Recruiting January 2019 Belgium ... More >> Unuversity Hospitals Leuven Not yet recruiting Leuven, Belgium, 3000 Contact: Maarten Lambrecht    +32 16 34 76 00    maarten.lambrecht@uzleuven.be    Principal Investigator: Maarten Lambrecht          Netherlands MAASTRO clinic Recruiting Maastricht, Netherlands, 6229 ET Contact: Chantal Overhof-Wedick    +31 88 44 55 686    chantal.overhof@maastro.nl    Principal Investigator: Dirk De Ruysscher, MD, PhD Less <<
NCT00176735 Pancreatic Cancer Not Applicable Terminated - -
NCT03762161 Bladder Cancer Phase 2 Not yet recruiting December 2023 United States, Kansas ... More >> University of Kansas Cancer Center - Clinical Research Center Not yet recruiting Fairway, Kansas, United States, 66208 Contact: kerry hepler    913-945-7552    ctnursenav@kumc.edu    Principal Investigator: Rahul Parikh, MD          University of Kansas Cancer Center, Westwood Campus Not yet recruiting Kansas City, Kansas, United States, 66205 Contact: Clinical Trials Nurse Navigator    913-945-7552    ctnursenav@kumc.edu    Principal Investigator: Rahul Parikh, MD Less <<
NCT01613677 Treatment for Metastatic or Lo... More >>cally Advanced Cervical Cancer Less << Phase 2 Withdrawn September 2017 Brazil ... More >> Novartis Investigative Site Rio de Janiero, RJ, Brazil, 20231-050 Less <<
NCT01966913 Germ Cell Tumor Phase 1 Phase 2 Recruiting September 2018 France ... More >> Hopital Tenon Recruiting Paris, France, 75012 Less <<
NCT00130520 - Completed - -
NCT03006614 Breast Cancer Model ... More >> Effects of Chemotherapy Breast Cancer Less << Phase 3 Recruiting March 2023 China, Guangdong ... More >> Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Yanxia Shi, doctor    13609058827    shiyx@sysucc.org.cn Less <<
NCT00606502 Non-small Cell Lung Cancer Phase 2 Completed - -
NCT02499367 Breast Cancer Phase 2 Recruiting August 2022 Netherlands ... More >> Antoni van Leeuwenhoek Recruiting Amsterdam, Netherlands, 1066 CX Contact: Marleen Kok, MD    +3120512 ext 7901    m.kok@nki.nl    Contact: Ingrid AM Mandjes, MSc    +3120512 ext 2667    i.mandjes@nki.nl    Principal Investigator: Marleen kok, MD Less <<
NCT00130520 Ovarian Neoplasms Phase 2 Completed - United States, Arizona ... More >> University of Arizona Cancer Center Tucson, Arizona, United States, 85724 Less <<
NCT01364493 Gastric Cancer Phase 2 Completed - China, Beijing ... More >> Lin Shen Beijing, Beijing, China, 100142 Less <<
NCT00080028 Head and Neck Cancer ... More >> Oropharynx Cancer Larynx Cancer Hypopharynx Cancer Less << Phase 1 Terminated - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States United States, Texas University of Texas, San Antonio Health Science Center San Antonio, Texas, United States Less <<
NCT01259479 Solid Tumors ... More >>Brain Tumors Brain Metastases Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01330186 - Unknown May 2012 Denmark ... More >> Department of Oncology Herlev Hospital Recruiting Herlev, Denmark, 2730 Contact: Eva Serup-Hansen, MD    +4538689084    evseha01@heh.regionh.dk    Contact: Hanne Havsteen, MD    +4538682287    hahav@heh.regionh.dk    Principal Investigator: Eva Serup-Hansen, MD Less <<
NCT01503372 Advanced Gastric Cancer Phase 2 Unknown May 2015 Germany ... More >> Charite University medicine Recruiting Berlin, Germany, 13353 Contact: Mario Lorenz    + 49 30-450 553 889    magenkarzinom@charite.de    Contact: Daniela Bohnen    + 49 30-450 553 889    magenkarzinom@charite.de    Principal Investigator: Peter Thuss-Patience, Dr.          Sub-Investigator: Kirstin Breithaupt, Dr. Less <<
NCT00787488 Ovarian Cancer Not Applicable Withdrawn(Study not funded) - -
NCT01998919 Non-Small Cell Lung Cancer Phase 2 Completed - Australia ... More >> Campbelltown, Australia, 2560 Camperdown, Australia, 2050 Liverpool, Australia, 2170 China Guangzhou, China, 510060 Guangzhou, China, 510080 Shanghai, China, 200030 Shanghai, China, 200433 Hong Kong Hong Kong, Hong Kong Indonesia Jakarta, Indonesia, 10410 Jakarta, Indonesia, 10430 Jogjakarta, Indonesia, 55284 Semarang, Indonesia, 50136 Korea, Republic of Kyunggi-do, Korea, Republic of, 411-769 Philippines Manila, Philippines, 1000 Metro Manila, Philippines, 1502 Taiwan Taipei, Taiwan, 100 Taipei, Taiwan Thailand Bangkok, Thailand, 10400 Bangkok, Thailand, 10700 Less <<
NCT00965250 Thymoma Thymi... More >>c Carcinoma Thymic Carcinoid Thymic Neuroendocrine Tumors Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00325351 Ovarian Neoplasms Phase 2 Completed - United States, Arizona ... More >> Tucson, Arizona, United States, 85724 United States, Arkansas Little Rock, Arkansas, United States, 72205 United States, California Bakersfield, California, United States, 93309 La Jolla, California, United States, 92093 San Diego, California, United States, 92121 United States, Georgia Savannah, Georgia, United States, 31404 United States, Indiana South Bend, Indiana, United States, 46617 United States, Maryland Baltimore, Maryland, United States, 21204 United States, New Mexico Albuquerque, New Mexico, United States, 87131 United States, North Carolina Winston-Salem, North Carolina, United States, 27157 United States, Ohio Cleveland, Ohio, United States, 44109 United States, Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Knoxville, Tennessee, United States, 37920 United States, Virginia Roanoke, Virginia, United States, 24014 Canada, Alberta Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT00759824 Small Cell Lung Carcinoma Phase 2 Completed - Belgium ... More >> Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet Brussels, Belgium, 1000 Department of Pneumology CHU Charleroi Charleroi, Belgium, 6000 Department of Pneumology Hôpital Saint-Joseph Gilly, Belgium, 6060 Hôpital Ambroise Paré Mons, Belgium, 7000 Department of Pneumology Centre Hospitalier de Mouscron Mouscron, Belgium, 7700 Less <<
NCT02128243 Unresectable, Locally Advanced... More >> or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction Gastric Neoplasm Gastroesophageal Junction Adenocarcinoma Esophageal Adenocarcinoma Gastric Adenocarcinoma Esophageal Neoplasms Less << Phase 2 Recruiting September 2018 Germany ... More >> NCT-Med. Onkologie Recruiting Heidelberg, Baden-Württemberg, Germany, 69120 Contact: Georg Martin Haag, Dr.    +49-6221 ext 5637630    GeorgMartin.Haag@med.uni-heidelberg.de Less <<
NCT03178552 Non-Small Cell Lung Cancer Phase 2 Phase 3 Recruiting January 2, 2022 -
NCT01998919 - Completed - -
NCT00995488 - Terminated(Terminated prematur... More >>ely due to low accrual.) Less << - -
NCT00589290 Thymoma Thymi... More >>c Carcinoma Less << Phase 2 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5262 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02855944 Ovarian Cancer ... More >> Epithelial Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer Less << Phase 3 Recruiting June 2024 -
NCT00589290 - Completed - -
NCT00995488 Urothelial Cancer ... More >> Bladder Cancer Less << Phase 2 Terminated(Terminated prematur... More >>ely due to low accrual.) Less << - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT03575013 Urothelial Carcinoma Phase 1 Recruiting May 1, 2020 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Recruiting Iowa City, Iowa, United States, 52242 Contact: Rohan Garje, MD    319-356-1770    rohan-garje@uiowa.edu Less <<
NCT00742924 Sarcoma Phase 1 Completed - -
NCT02285530 Mouth Neoplasms ... More >> Carcinoma, Squamous Cell Less << Phase 2 Recruiting December 2021 China, Shanghai ... More >> Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University Recruiting Shanghai, Shanghai, China, 200011 Contact: Lai-ping Zhong, MD, PhD    +86-21-23271699 ext 5160    zhonglaiping@163.com    Principal Investigator: Lai-ping Zhong, MD, PhD Less <<
NCT00965250 - Completed - -
NCT02986568 Cervical Cancer ... More >> Uterine Cancer Less << Not Applicable Recruiting - Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Seungmee Lee, MD    82-2-2072-2821    yumenoarika@naver.com    Contact: Hee Seung Kim, MD    82-2-2072-4863    bboddi0311@gmail.com    Principal Investigator: Hee Seung Kim, MD Less <<
NCT01326923 Head and Neck Squamous Cell Ca... More >>ncer Less << Phase 2 Terminated(Principle Investiga... More >>tor left the institution.) Less << - United States, Louisiana ... More >> LSU Health Sciences Center Shreveport, Louisiana, United States, 71103 Less <<
NCT00742924 - Completed - -
NCT02064491 Non-small Cell Lung Cancer Phase 2 Completed - Finland ... More >> Helsinki University Hospital Espoo, Finland Helsinki University Hospital Helsinki, Finland Oulu University Hospital Oulu, Finland Pori Central Hospital Pori, Finland Tampere University Hospital Tampere, Finland Turku University Hopital Turku, Finland Vaasa Central Hospital Vaasa, Finland Less <<
NCT00321334 Non-small Cell Lung Cancer Phase 3 Completed - China, Guangdong ... More >> Chinese Society of Lung Cancer Guangzhou, Guangdong, China, 510080 Less <<
NCT00004917 Anemia Head a... More >>nd Neck Cancer Less << Phase 3 Completed - -
NCT00006356 Ovarian Cancer Phase 3 Terminated(low accrual) - Italy ... More >> Spedali Civili Brescia, Italy, 25123 Less <<
NCT02128230 Multiple Myeloma Phase 2 Recruiting May 2025 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Nathan M Petty    501-526-6990 ext 2435    pettynathanm@uams.edu    Contact: Doug Steward    501-526-6990 ext 2452    dmsteward@uams.edu    Sub-Investigator: Michele Fox, MD          Sub-Investigator: Maurizio Zangari, MD          Sub-Investigator: Atul Kothari, MD          Sub-Investigator: Carolina Schinke, MD          Sub-Investigator: Faith Davies, MD          Sub-Investigator: Gareth Morgan, MD          Sub-Investigator: Juan Crescencio, MD          Sub-Investigator: Mary Burgess, MD          Sub-Investigator: Meera Mohan, MD          Sub-Investigator: Muthukumar Radhakrishnan, MD          Sub-Investigator: Pankaj Mathur, MD          Sub-Investigator: Sandra Susanibar-Adaniya, MD          Sub-Investigator: Shadiqul Hoque, MD          Sub-Investigator: Sharmilan Thanendrarajan, MD Less <<
NCT00002894 Ovarian Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 3 Completed - United Kingdom ... More >> Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, WIT 3AA Less <<
NCT01377298 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Unknown May 2014 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Ruey-Long Hong, MD    +886 2 23123456 ext 67510    rlhong@ntu.edu.tw    Sub-Investigator: Jo-Pai Chen, MD          Principal Investigator: Ruey-Long Hong, MD Less <<
NCT02309242 Sarcoma, Soft Tissue ... More >> Osteosarcoma Tumor Less << Not Applicable Unknown October 2018 Belgium ... More >> UZ Leuven , pediatric oncology Recruiting Leuven, Vl Brabant, Belgium, 3000 Contact: Anne Uyttebroeck, MD, PhD    +32 16 343972    anne.uyttebroeck@uzleuven.be    Contact: Charlotte Sleurs, Msc    +32 16 340650    charlotte.sleurs@uzleuven.be    Principal Investigator: Anne Uyttebroeck, MD, PhD Less <<
NCT02492503 Metastatic Carcinoma to the Ut... More >>erine Cervix Recurrent Carcinoma Cervix Cervix Carcinoma Recurrent Less << Phase 1 Phase 2 Unknown August 2015 India ... More >> AIIMS New Delhi, India, 110029 Less <<
NCT00568815 Lymphoma Phase 2 Completed - China, Shanghai ... More >> Fudan University Cancer Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT01118676 Locally Advanced Non Small Cel... More >>l Lung Cancer (NSCLC)* Less << Phase 1 Completed - France ... More >> CHU Toulouse Larrey Toulouse, France, 31000 Institut Claudius Regaud Toulouse, France, 31000 Less <<
NCT00155766 Cervical Cancer Phase 1 Unknown - Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan Contact: Chi-An Chen, MD    886-2-2312-3456 ext 5157    cachen@ha.mc.ntu.edu.tw Less <<
NCT03582475 Bladder Small Cell Neuroendocr... More >>ine Carcinoma Castration-Resistant Prostate Carcinoma Metastatic Bladder Urothelial Carcinoma Metastatic Urethral Urothelial Carcinoma Prostate Carcinoma Metastatic in the Bone Prostate Neuroendocrine Neoplasm Prostate Small Cell Carcinoma Stage III Bladder Cancer AJCC v8 Stage III Prostate Cancer AJCC v8 Stage III Urethral Cancer AJCC v8 Stage IV Bladder Cancer AJCC v8 Stage IV Prostate Cancer AJCC v8 Stage IV Urethral Cancer AJCC v8 Stage IVA Bladder Cancer AJCC v8 Stage IVB Bladder Cancer AJCC v8 Ureter Small Cell Carcinoma Urothelial Carcinoma Less << Phase 1 Not yet recruiting September 1, 2021 United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Not yet recruiting Los Angeles, California, United States, 90095 Contact: Arnold Chin    310-206-6453       Principal Investigator: Arnold Chin Less <<
NCT01304784 HER-2 Gene Amplification Phase 1 Completed - United States, Colorado ... More >> Rocky Mountain Cancer Centers Denver, Colorado, United States, 80218 United States, Georgia Georgia Cancer Specialists Atlanta, Georgia, United States, 30342 United States, Indiana Central Indiana Cancer Centers Indianapolis, Indiana, United States, 46151 Horizon Oncology Research, Inc Lafayette, Indiana, United States, 47908 United States, Nevada Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States, 89135 United States, New York New York Oncology/Hematology Albany, New York, United States, 12206 United States, Ohio Innovation Center - Kettering Medical Center Health Network Kettering, Ohio, United States, 45429 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, South Carolina GHS Institute of Transitional Oncology Research Greenville, South Carolina, United States, 29605 United States, Texas Texas Oncology Cancer Center Austin, Texas, United States, 78731 Texas Oncology PA North/Sammans Cancer Center Dallas, Texas, United States, 75246 Texas Oncology - Tyler Tyler, Texas, United States, 75702 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 United States, Washington Evergreen Hematology and Oncology Spokane, Washington, United States, 99218 Northwest Cancer Specialists-Vancouver Cancer Center Vancouver, Washington, United States, 98684 Less <<
NCT02938546 Non-small-cell Lung Cancer Phase 3 Not yet recruiting January 2023 -
NCT01715233 Metastatic Esophageal Cancer ... More >> Gastroesophageal Cancer Gastric Cancer Less << Phase 2 Recruiting November 2019 United States, Maryland ... More >> SKCCC at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Charles P Raines, CRNP, MSN    410-502-3696    craines1@jhmi.edu Less <<
NCT02394652 Uterine Cervical Neoplasms ... More >> Squamous Cell Carcinoma Adenocarcinoma Carcinoma, Adenosquamous Less << Phase 2 Recruiting December 2019 Canada, Alberta ... More >> Tom Baker Cancer Centre Not yet recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Corinne Doll, M.D.    403-521-3685       Cross Cancer Institute Not yet recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Ericka Wiebe, M.D.    480-432-8755       Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Kathy Han, M.D., M.Sc.    416-946-2919       Canada, Quebec Hôpital Maisonneuve-Rosemont Not yet recruiting Montréal, Quebec, Canada, H1T 2M4 Contact: Eve-Lyne Marchand, M.D., Ph.D.    514-252-3425       Centre Hospitalier De L'Université de Montréal Not yet recruiting Montréal, Quebec, Canada, H2L 4M1 Contact: Maroie Barkati, M.D.    514-890-8000 ext 28820 Less <<
NCT00005834 Multiple Myeloma Phase 3 Terminated(poor accrual) - -
NCT03144466 Cervix Cancer Phase 1 Suspended(Slow recruitment.) June 2019 United Kingdom ... More >> The Royal Marsden NHS Foundation Trust London, United Kingdom, SW3 6JJ Less <<
NCT00500760 Head and Neck Cancer ... More >> Squamous Cell Carcinoma Less << Phase 2 Completed - -
NCT02807636 Urothelial Carcinoma Phase 3 Active, not recruiting November 17, 2020 -
NCT03604653 - Recruiting May 2021 United States, New Jersey ... More >> Holy Name Medical Center Recruiting Teaneck, New Jersey, United States, 07666 Contact: Sung Kwon, MD    201-541-5989    steve-kwonmd@mail.holyname.org    Contact: Julie Schwegman, PAC    201-541-5989    schwegman@holyname.org    Principal Investigator: Sung Kwon, MD          Principal Investigator: Sharyn Lewin, MD          Principal Investigator: Maria Schiavone, MD Less <<
NCT01926483 Non-small Cell Lung Cancer Sta... More >>ge IIIA Less << Phase 2 Unknown June 2016 China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Xu Yaping    +0086-571-88122082    xuyaping1207@gmail.com Less <<
NCT00500760 - Completed - -
NCT00003606 Lung Cancer Phase 3 Unknown - France ... More >> Hopital Arnaud de Villeneuve Montpellier, France, 34295 Less <<
NCT01028729 Non-small Cell Lung Cancer (NS... More >>CLC) Less << Phase 4 Unknown August 2011 China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Yiping Zhang, Dr.    86-0571-88122188 Less <<
NCT03100409 Uterine Cervical Neoplasm ... More >> Dietary Modification Radiation Toxicity Gastrointestinal Complication Less << Not Applicable Recruiting August 2020 Mexico ... More >> National Cancer Institute of Mexico Recruiting Mexico City, Tlalpan, Mexico, 14080 Contact: LUCELY CETINA, MD,MSc    +5215531952791    lucelycetina.incan@gmail.com    Contact: Angel D Castro, RDN, PhD    +5215541940650    angeldenisse@gmail.com Less <<
NCT02358031 Recurrent Head and Neck Cancer... More >> Metastatic Head and Neck Cancer Less << Phase 3 Active, not recruiting January 17, 2020 -
NCT01612286 Nasopharyngeal Carcinoma Phase 2 Unknown May 2014 China, Zhejiang ... More >> Zhejiang cancer hospital Hangzhou, Zhejiang, China, 310022 Less <<
NCT01209520 Lung Cancer N... More >>on Small Cell Lung Carcinoma Hypermethylation Less << Not Applicable Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Less <<
NCT01209520 - Completed - -
NCT01091636 Epithelial Ovarian Cancer Phase 2 Phase 3 Unknown December 2017 Korea, Republic of ... More >> National Cancer Center Goyang, Gyeonggi, Korea, Republic of, 410-769 Less <<
NCT01171170 Non Small Cell Lung Cancer Phase 2 Unknown August 2014 Netherlands ... More >> VU medisch centrum Recruiting Amsterdam, Netherlands Contact: Smit       ef.smit@vumc.nl    Principal Investigator: Egbert F. Smit, MD PhD          Amphia Ziekenhuis Recruiting Breda, Netherlands Contact: Aerts       jaerts@amphia.nl    Principal Investigator: Joachim G. Aerts, MD PhD          Jeroen Bosch Ziekenhuis Recruiting Den Bosch, Netherlands Contact: Biesma       b.biesma@jbz.nl    Principal Investigator: Bonne Biesma, MD PhD          Catharina-Ziekenhuis Recruiting Eindhoven, Netherlands Contact: van den Borne       ben.vd.borne@cze.nl    Principal Investigator: Ben E. van den Borne, MD PhD          Martini Ziekenhuis Recruiting Groningen, Netherlands Contact: van Putten       jwg.van.putten@mzh.nl    Principal Investigator: John W. van Putten, MD PhD          Maastricht UMC Recruiting Maastricht, Netherlands, 6202 AZ Contact: Anne-Marie C. Dingemans, MD PhD       a.dingemans@mumc.nl    Principal Investigator: Anne-Marie C. Dingemans, MD PhD          HagaZiekenhuis Recruiting The Hague, Netherlands Contact: Codrington       h.codrington@hagaziekenhuis.nl    Principal Investigator: Henk E. Codrington, MD          Isala Klinieken Recruiting Zwolle, Netherlands Contact: Stigt       j.a.stigt@isala.nl    Principal Investigator: Jos A. Stigt, MD Less <<
NCT00691236 Osteosarcoma Phase 2 Phase 3 Unknown August 2013 India ... More >> Tata Memorial Hospital Recruiting Mumbai, Maharashtra, India, 400012 Principal Investigator: Manish G Agarwal, M.S(Orth) Less <<
NCT01209507 - Completed - United States, Colorado ... More >> University of Colorado Denver Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT00580372 Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00580372 - Completed - -
NCT01946867 Head and Neck Cancer Phase 1 Unknown August 2017 France ... More >> Centre Oscar Lambret Recruiting Lille, France, 59000 Contact: Xavier Mirabel, MD          Institut Curie Recruiting Paris, France, 75005 Contact: Christophe LE TOURNEAU, MD-PhD          Contact: José RODRIGUEZ, MD          Principal Investigator: Christophe LE TOURNEAU, MD-PhD          Sub-Investigator: José RODRIGUEZ, MD          Sub-Investigator: Valentin CALUGARU, MD-PhD          CHU Pontchaillou Recruiting Rennes, France, 35033 Contact: Franck JEGOUX, Pr, MD          Spain START MADRID, Hospital Fundacion Jimenez Diaz Recruiting Madrid, Spain Contact: Victor MORENO, MD-PhD          START MADRID, Hospital Universitario Madrid Norte Sanchinarro Recruiting Madrid, Spain Contact: Emiliano CALVO, MD-PhD Less <<
NCT03612232 Adrenocortical Carcinoma Phase 2 Not yet recruiting June 2022 Germany ... More >> University Hospital Würzburg Not yet recruiting Würzburg, Germany, 97080 Contact: Matthias Kroiss, MD, PhD    +4993120139740    Kroiss_M@ukw.de    Contact: Martin Fassnacht, MD    +4993120139200    Fassnacht_M@ukw.de Less <<
NCT01167530 Non-small Cell Lung Cancer ... More >> Locally Advanced Disease Less << Phase 1 Unknown July 2014 France ... More >> Institut Gustave Roussy Recruiting Villejuif, France, 94800 Contact: Eric DEUTSCH, MD    33 1 42114413    eric.deutsch@igr.fr    Contact: Jean-Pierr PIGNON, MD    33 1 42114565    jean-pierre.pignon@igr.fr Less <<
NCT01253057 - Unknown December 2011 Taiwan ... More >> Taipei Medical University WanFang Hospital Taipei, Taiwan Less <<
NCT00228488 Head and Neck Cancer Phase 2 Completed - Hong Kong ... More >> Hong Kong, Hong Kong Singapore Singapore, Singapore Less <<
NCT02468661 Non-Small Cell Lung Cancer Phase 1 Phase 2 Recruiting March 31, 2020 -
NCT00198393 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - France ... More >> CHU Avicenne - Oncologie Bobigny, France, 93000 CHU Grenoble - pneumologie Grenoble, France, 38000 Less <<
NCT03603184 Endometrial Cancer Phase 3 Recruiting July 2022 Italy ... More >> AO SS Antonio e Biagio e Cesare Arrigo Not yet recruiting Alessandria, Italy Contact: Vittorio Fusco          Policlinico S. Orsola Malpighi Not yet recruiting Bologna, Italy Contact: Claudio Zamagni          Azienda Sanitaria dell'Alto Adige Not yet recruiting Bolzano, Italy Contact: Maria R Lusso          ASST degli Spedali Civili di Brescia Not yet recruiting Brescia, Italy Contact: Germana Tognon          Fondazione Poliambulanza Not yet recruiting Brescia, Italy Contact: Chiara Abeni          AOU Cagliari, Policlinico Universitario Not yet recruiting Cagliari, Italy Contact: Elena Massa          Ente ospedaliero Ospedali Galliera Not yet recruiting Genova, Italy Contact: Andrea De Censi          ASST di Lecco Not yet recruiting Lecco, Italy Contact: Antonio Ardizzoia          Ospedale San Luca Not yet recruiting Lucca, Italy Contact: Editta Baldini          Istituto Europeo di Oncologia Recruiting Milan, Italy Contact: Nicoletta Colombo          Ospedale San Gerardo Not yet recruiting Monza, Italy Contact: Andrea A Lissoni          Istituto Oncologico Veneto (IOV) Not yet recruiting Padova, Italy Contact: Giulia Tasca          AOU di Parma Not yet recruiting Parma, Italy Contact: Antonino Musolino          AOU Pisana Not yet recruiting Pisa, Italy Contact: Angiolo Gadducci          AO Arcispedale Santa Maria Nuova Not yet recruiting Reggio Emilia, Italy Contact: Alessandra Bologna          Policlinico Umberto I, Università di Roma "La Sapienza" Not yet recruiting Roma, Italy Contact: Pierluigi Benedetti Panici          Ospedale SS Trinità Not yet recruiting Sora, Italy Contact: Filomena Narducci          AO Ordine Mauriziano Not yet recruiting Torino, Italy Contact: Annamaria Ferrero          AOU Città della Salute e della Scienza di Torino - Ospedale Sant'Anna Not yet recruiting Torino, Italy Contact: Paolo Zola          ASST Valtellina e Alto Lario Not yet recruiting Varese, Italy Contact: Nicoletta Donadello Less <<
NCT03063450 Mesothelioma Phase 3 Recruiting July 2021 United Kingdom ... More >> Aberdeen Royal Infirmary Recruiting Aberdeen, United Kingdom Contact: Gillian Price          Belfast City Hospital Not yet recruiting Belfast, United Kingdom Contact: Gerry Hanna          Royal Bournemouth Hospital Recruiting Bournemouth, United Kingdom Contact: Tom Geldart          Addenbrooke's Hospital Not yet recruiting Cambridge, United Kingdom Contact: David Gilligan          Velindre Cancer Centre Recruiting Cardiff, United Kingdom Contact: Jason Lester          Ninewells Hospital Not yet recruiting Dundee, United Kingdom Contact: Angela Scott          Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom Contact: Nicola Steele          Harrogate District Hospital Recruiting Harrogate, United Kingdom Contact: Samuel Chan          University Hospitals Morecambe Bay Recruiting Lancaster, United Kingdom Contact: Amy Ford          Leicester Royal Infirmary Recruiting Leicester, United Kingdom Contact: Dean Fennell          Barts Cancer Institute Not yet recruiting London, United Kingdom Contact: Peter Szlosarek          University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Contact: Dionysis Papadatos-Pastos          Wythenshawe Hospital Recruiting Manchester, United Kingdom Contact: Raffaele Califano          Mount Vernon Cancer Centre Recruiting Northwood, United Kingdom Contact: Andreas Polychronis          Churchill Hospital Not yet recruiting Oxford, United Kingdom Contact: Denis Talbot          Southampton General Hospital Recruiting Southampton, United Kingdom Contact: Christian Ottensmeier          Southend Hospital Recruiting Southend-on-Sea, United Kingdom Contact: Gairin Dancey          Lister Hospital Recruiting Stevenage, United Kingdom Contact: Andreas Polychronis          Musgrove Park Hospital Recruiting Taunton, United Kingdom Contact: Petra Jankowska Less <<
NCT02272816 Metastatic Seminoma Phase 2 Active, not recruiting December 2017 United Kingdom ... More >> St Bartholomew's Hospital London, United Kingdom, EC1A 7BE Mount Vernon Hosoital London, United Kingdom, HA6 2RN Less <<
NCT01271322 Adenocarcinomas of the Esophag... More >>ogastric Junction Less << Phase 2 Terminated - Germany ... More >> Nationales Centrum für Tumorerkrankungen Heidelberg, Germany, 69120 Less <<
NCT02533700 Peripheral T-Cell Lymphoma ... More >> Angioimmunoblastic T Cell Lymphoma ALK-negative Anaplastic Large Cell Lymphoma Enteropathy Associated T Cell Lymphoma Subcutaneous Panniculitis Like T Cell Lymphoma Acute Adult T-Cell Leukemia/Lymphoma Less << Phase 4 Unknown December 2017 China, Shandong ... More >> Shandong Provincial Hospital Recruiting Jinan, Shandong, China, 250021 Contact: Xin Wang, MD, PHD    86-531-13156012606    xinw@sdu.edu.cn    Contact: Yujie Jiang, MD    86-531-13370506886    yujiejiang05@126.com Less <<
NCT03134846 Head and Neck Squamous Cell Ca... More >>rcinoma Margin Assessment Less << Phase 1 Phase 2 Recruiting January 2021 Netherlands ... More >> University Medical Center Groningen Recruiting Groningen, Netherlands, 9713 GZ Contact: Max J.H. Witjes, MD, PhD       m.j.h.witjes@umcg.nl    Contact: Floris J. Voskuil, MD    +31-50-3610030    f.j.voskuil@umcg.nl Less <<
NCT01222936 Small Cell Lung Carcinoma Phase 2 Completed - Germany ... More >> Klinik für Onkologie und Haematologie Frankfurt am Main, Germany, 60488 Klinikum Kassel Innere Medizin Kassel, Germany, 34125 Italy Azienda Ospedaliera "S. G. Moscati" Avellino, AV, Italy, 83100 Istituto Nazionale Ricerca sul Cancro Genova, GE, Italy, 16132 U.O. di Oncologia Medica Palermo, PA, Italy, 90141 Ospedale Maggiore di Parma Parma, PR, Italy, 43100 Azienda Ospedaliera San Camillo Forlanini Rome, RM, Italy, 00151 Az. San. Ospedaliera Molinette S. Giovanni Battista di Torino Torino, TO, Italy, 10126 Less <<
NCT03089892 - Recruiting December 31, 2018 Taiwan ... More >> Tri-Service General Hospital Recruiting Taipei, Taiwan Contact: Cheng-Chang Chang, M.D., Ph.D.          Principal Investigator: Cheng-Chang Chang, M.D., Ph.D.          Sub-Investigator: Mu-Hsien Yu, M.D., Ph.D.          Sub-Investigator: Yu-Chi Wang, M.D., Ph.D.          Sub-Investigator: Salvatore Giovanni Vitale, M.D. Less <<
NCT00107614 Waldenstrom Macroglobulinemia Phase 2 Terminated(Terminated due to p... More >>oor accrual.) Less << - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT01709006 Head and Neck Cancer Not Applicable Active, not recruiting December 31, 2020 Canada, Quebec ... More >> Notre-Hame Hospital of the CHUM Montreal, Quebec, Canada, H2L 4M1 Less <<
NCT00864266 Non Small Cell Lung Carcinoma Not Applicable Active, not recruiting March 2021 Belgium ... More >> Department of Pneumology Clinique Saint-Luc Bouge, Belgium, 5004 Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet Brussels, Belgium, 1000 Service de Pneumologie Hôpital Erasme Brussels, Belgium, 1070 Department of Pneumology Hôpital Saint-Joseph Gilly, Belgium, 6060 Hôpital Ambroise Paré Mons, Belgium, 7000 Department of Pneumology Centre Hospitalier de Mouscron Mouscron, Belgium, 7700 Less <<
NCT00469898 - Completed - -
NCT00469898 Lung Cancer Phase 2 Completed - United States, Kentucky ... More >> Owensboro Medical Health System Owensboro, Kentucky, United States, 42303 United States, Tennessee Memorial Health Care System Chattanooga, Tennessee, United States, 37404 West Tennessee Cancer Center at Jackson-Madison County General Hospital Jackson, Tennessee, United States, 38301 Tennessee Cancer Specialists Knoxville, Tennessee, United States, 37901 St. Thomas Health Services Nashville, Tennessee, United States, 37205 MBCCOP - Meharry Medical College - Nashville Nashville, Tennessee, United States, 37208 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Canada British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, Canada, V52 4 Less <<
NCT00107614 - Terminated(Terminated due to p... More >>oor accrual.) Less << - -
NCT03049410 Bladder Cancer Not Applicable Recruiting February 15, 2020 United Kingdom ... More >> North Bristol NHS Trust Recruiting Bristol, United Kingdom Principal Investigator: Edward Rowe          University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom, NW1 2BU Contact: Pramit Khetrapal       p.khetrapal@ucl.ac.uk    Principal Investigator: Prof John Kelly          Guy's Hospital Recruiting London, United Kingdom Principal Investigator: Shamim Khan          Royal Berkshire Hospital Recruiting Reading, United Kingdom Principal Investigator: Philip Charlesworth          Sheffield Teaching Hospitals NHS Foundation Trust Recruiting Sheffield, United Kingdom, S10 2JF Contact: Louise Goodwin       louise.goodwin@sth.nhs.uk    Principal Investigator: Prof James Catto          Lister Hospital Recruiting Stevenage, United Kingdom Principal Investigator: Nikhil Vasdev Less <<
NCT02424045 T-cell Lymphoma Phase 2 Completed - -
NCT03344328 - Not yet recruiting September 30, 2018 France ... More >> CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermmontferrand.fr    Principal Investigator: David BALAYSSAC Less <<
NCT01609114 - Unknown - Taiwan ... More >> Far Eastern Memorial Hospital New Taipei city, Taiwan, 220 Less <<
NCT00905983 Carcinoma, Non-Small-Cell Lung Phase 2 Unknown September 2011 Spain ... More >> Hospital Virgen de los Lirios Alcoy, Alicante, Spain, 3804 Hospital Clínica de Benidorm Benidorm, Alicante, Spain, 03501 Hospital General de Elda Elda, Alicante, Spain, 03600 Hospital Althaia, Xarxa Asistencial de Manresa Manresa, Barcelona, Spain, 08243 Hospital Provincial de Castellón Castellón de la Plana, Castellón, Spain, 12002 Hospital de Sagunto Sagunto, Valencia, Spain, 46520 Hospital San Juan de Alicante Alicante, Spain, 03550 Hospital Universitario La Fe Valencia, Spain, 46009 Instituto Valenciano de Oncología Valencia, Spain, 46009 Hospital Arnau de Vilanova Valencia, Spain, 46015 Hospital Universitario Dr. Peset Valencia, Spain, 46017 Less <<
NCT03470350 Colorectal Cancer Metastatic Phase 1 Phase 2 Recruiting June 1, 2020 Netherlands ... More >> Antoni van Leeuwenhoek (NKI-AVL) Recruiting Amsterdam, Noord-Holland, Netherlands, 1066 CX Contact: S Huijberts, MD    +31 (0)20-5129111    s.huijberts@nki.nl    Contact: N Steeghs, MD    +31 (0)20-5129111    n.steeghs@nki.nl    Principal Investigator: N Steeghs, Dr.          Sub-Investigator: S Huijberts, MD Less <<
NCT01472419 - Completed - -
NCT03529422 Larynx Lip ... More >> Oral Cancer Digestive Organs--Diseases Less << Phase 1 Recruiting February 2026 United States, North Carolina ... More >> UNC Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Dan Goldin    919-445-6241    dan_goldin@med.unc.edu    Principal Investigator: Jared Weiss, MD Less <<
NCT00058071 Gestational Trophoblastic Tumo... More >>r Neurotoxicity Peripheral Neuropathy Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 3 Completed - -
NCT00664105 Lung Cancer Phase 2 Terminated(Treatment became st... More >>andard.) Less << - United States, Florida ... More >> M.D. Anderson Cancer Center, Orlando Orlando, Florida, United States, 32806 United States, Maryland Chesapeake Oncology Hematology Associates Baltimore, Maryland, United States, 21225 United States, Ohio University Hospital of Cleveland Cleveland, Ohio, United States, 44106 United States, Pennsylvania Lehigh Valley Hospital - John & Dorothy Morgan Cancer Center Allentown, Pennsylvania, United States, 18103 United States, Tennessee Erlanger Health System Chattanooga, Tennessee, United States, 37403 Clarksville Regional Hematology Oncology Group Clarksville, Tennessee, United States, 37043 Jackson Madison County Hospital Jackson, Tennessee, United States, 38301 Tennessee Cancer Specialists Knoxville, Tennessee, United States, 37920 University of Tennessee Medical Center Knoxville, Tennessee, United States, 37920 The West Clinic, PC Memphis, Tennessee, United States, 38120 St. Thomas Health Services Nashville, Tennessee, United States, 37205 Meharry Medical College Nashville, Tennessee, United States, 37208 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas UT Southwestern Medical Center Dallas, Texas, United States, 75390 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 Less <<
NCT00664105 - Terminated(Treatment became st... More >>andard.) Less << - -
NCT02690012 Hypomagnesemia Not Applicable Unknown December 2017 Canada, Ontario ... More >> The Ottawa Hospital Cancer Centre Recruiting Ottawa, Ontario, Canada, K1H8L6 Less <<
NCT02353936 Squamous Cell Carcinoma of Eso... More >>phagus Less << Phase 2 Recruiting January 2019 Korea, Republic of ... More >> Severance hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Hye Ryun Kim, MD    82-2-2228-8125    nobelg@yuhs.ac Less <<
NCT00770588 Non-small Cell Lung Cancer (NS... More >>CLC) Less << Phase 4 Completed - China, Beijing ... More >> Research Site Beijing, Beijing, China China, Fujian Research Site Fuzhou, Fujian, China China, Guangdong Research Site Guangzhou, Guangdong, China China, Guangxi Research Site Nanning, Guangxi, China China, Henan Research Site Zhengzhou, Henan, China China, Hubei Research Site Wuhan, Hubei, China China, Jiangsu Research Site Nanjing, Jiangsu, China China, Jilin Research Site Changchun, Jilin, China China, Liaoning Research Site Shengyang, Liaoning, China China, Shanghai Research Site Shanghai, Shanghai, China China, Shanxi Research Site Xi'an, Shanxi, China China, Sichuan Research Site Chengdu, Sichuan, China China, Tianjin Research Site Tianjin, Tianjin, China China, Zhejiang Research Site Hangzhou, Zhejiang, China Less <<
NCT00770588 - Completed - -
NCT00049322 Liver Cancer Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT00049322 - Completed - -
NCT02105350 Biliary Tract Carcinoma ... More >> Gallbladder Carcinoma Less << Phase 1 Withdrawn(Study was never init... More >>iated) Less << - -
NCT02127255 Chemotherapy-induced Nausea an... More >>d Vomiting Less << Not Applicable Completed - China ... More >> Xiyuan Hospital, China Academy of Chinese Medical Sciences Beijing, China, 100091 Less <<
NCT00462735 - Completed - -
NCT00068653 Lung Cancer Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT02016287 Esophageal Squamous Cell Cance... More >>r Elderly Patients Less << Phase 2 Unknown July 2016 China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Lin Shen, MD    86-10-88196561    lin100@medmail.com.cn    Contact: Zhihao Lu, MD    86-10-88196561    pppeirain@126.com    Principal Investigator: Lin Shen, MD Less <<
NCT01099085 Gastric Cancer Phase 3 Completed - Korea, Republic of ... More >> Samsung Cancer Center Seoul, Korea, Republic of Less <<
NCT00462735 Head and Neck Cancer ... More >> Cancer of the Pharynx Cancer of the Larynx Nose Neoplasms Paranasal Sinus Neoplasms Cancer of the Oral Cavity Less << Phase 2 Completed - United States, New York ... More >> Mount Sinai School of Medicine New York, New York, United States, 10029 Less <<
NCT01243775 - Completed - -
NCT02430298 Head and Neck Cancer Phase 2 Completed - Thailand ... More >> Ubon Ratchathani Cancer Hospital Ubon Ratchathani, Thailand, 34000 Less <<
NCT01243775 Non-Small Cell Lung Cancer Phase 2 Completed - Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun, Jeonnam, Korea, Republic of, 519-809 Less <<
NCT00479674 Breast Cancer Phase 2 Completed - United States, North Carolina ... More >> Presbyterian Health Care Charlotte, North Carolina, United States, 28204 Northeast Oncology Associates Concord, North Carolina, United States, 28205 Duke University Medical Center Durham, North Carolina, United States, 27710 Forsyth Regional Cancer Center Winston-Salem, North Carolina, United States, 27103-3019 Less <<
NCT00479674 - Completed - -
NCT03577132 Urothelial Carcinoma Not Applicable Not yet recruiting May 31, 2022 -
NCT02108652 - Active, not recruiting - -
NCT00080444 Vomiting Phase 3 Completed - -
NCT02108652 Bladder Cancer Phase 2 Active, not recruiting May 18, 2019 -
NCT00002487 Ovarian Cancer Phase 2 Unknown - Canada, Ontario ... More >> Ottawa Regional Cancer Center - General Division Ottawa, Ontario, Canada, K1H 8L6 Ottawa Regional Cancer Centre - Civic Campus Ottawa, Ontario, Canada, K1Y 4K7 Less <<
NCT02735057 Oesophagus Cancer ... More >> Elderly Patients Less << Phase 1 Phase 2 Recruiting April 2024 France ... More >> Centre Hospitalier Universitaire de Besançon Recruiting Besancon, France, 25000 Contact: Sophie DEPIERRE       sdepierre@chu-besancon.fr    Principal Investigator: Gilles CREHANGE, PU-PH Less <<
NCT02433639 Biliary Tract Cancer Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT03598218 Nasopharyngeal Carcinoma Not Applicable Recruiting July 13, 2021 China ... More >> Guangxi Naxishan Hospital Recruiting Guilin, China Contact: Yu-fei Pan, M.D.          Linshan people's hospital Recruiting Linshan, China Contact: Yi-xin Su          Wuzhou Red Cross Hospital Recruiting Wuzhou, China Contact: Bin Zhang, M.D. Less <<
NCT01152853 Advanced Gastric Cancer ... More >> HER2 Less << Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT00659269 - Completed - -
NCT00659269 Cancer Phase 3 Completed - United States, New Mexico ... More >> University of New Mexico Cancer Center @ Lovelace Medical Center Albuquerque, New Mexico, United States, 87102 Hematology Oncology Associates Albuquerque, New Mexico, United States, 87106 Cancer Center at Presbyterian Hospital Albuquerque, New Mexico, United States, 87110 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 New Mexico Cancer Care Associates Santa Fe, New Mexico, United States, 87505 Less <<
NCT02229916 - Recruiting September 2029 Switzerland ... More >> Kantonsspital St.Gallen; Onkologie/Haematologie Recruiting St.Gallen, Switzerland, 9007 Contact: Christian Rothermundt, Dr. med.    +41 71 494 11 11    christian.rothermundt@kssg.ch    Principal Investigator: Christian Rothermundt, Dr. med. Less <<
NCT03079440 Neuroendocrine Tumors ... More >> Neuroendocrine Carcinoma Temozolomide Capecitabine Less << Phase 2 Recruiting October 2020 Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 05505 Contact: Changhoon Yoo, MD    +82-2-3010-1727    yooc@amc.seoul.kr Less <<
NCT01922232 - Withdrawn - United States, New York ... More >> NYU Langone Medical Center New York, New York, United States, 10016 Less <<
NCT00068289 Lung Cancer Phase 2 Completed - -
NCT03158129 Non-Small Cell Lung Cancer Phase 2 Recruiting June 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       tcascone@mdanderson.org Less <<
NCT00041626 Carcinoma, Squamous Cell Phase 3 Unknown - United States, Arkansas ... More >> University of Arkansas Recruiting Little Rock, Arkansas, United States, 72205 Contact: Karen Duvall    501-526-7129    kaduvall@uams.edu    Principal Investigator: James Suen, MD          United States, Colorado Unversity of Colorado Cancer Center Recruiting Aurora, Colorado, United States, 80045 Contact: Brittney Hines    720-848-0678    Brittany.Hines@uchsc.edu    Principal Investigator: Madeleine Kane, MD          United States, Florida University of Miami Hospital and Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Andrea Gachupin-Garcia    305-243-3379    agachupin@med.miami.edu    Principal Investigator: Jarrad Goodwin, MD          United States, Kentucky Norton Healthcare Pavilion Recruiting Louisville, Kentucky, United States, 40202 Contact: Daniela Neamtu    502-629-4679    daniela.neamtu@nortonhealthcare.org    Principal Investigator: John Hamm, MD          United States, Maryland Center Center of GBMC Recruiting Baltimore, Maryland, United States, 21204 Contact: Lauren Titus    443-849-3285    ltitus@gbmc.org    Principal Investigator: Marshall Levine, MD          United States, South Carolina WJB Dorn VA Medical Center Recruiting Columbia, South Carolina, United States, 29209 Contact: Justin Reynolds    803-776-4000 ext 6074    Justin.Reynolds@va.gov    Principal Investigator: William Hrushesky, MD          United States, Texas Mary Crowley Medical Research Center Recruiting Dallas, Texas, United States, 75201 Contact: Arlen Waclawczyk    214-658-1985    awaclawczyk@mcmrc.com    Principal Investigator: John Nemunaitis, MD          University of Texas, MD Andersen Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Aida Berryman    713-745-1428    atberryman@mdanderson.org    Principal Investigator: Gary Clayman, MD Less <<
NCT00183820 Testicular Cancer ... More >> Germ Cell Neoplasm Less << Phase 2 Completed - United States, California ... More >> Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT03170570 Cervical Cancer ... More >> Radiation Toxicity Recurrent Cervical Carcinoma Less << Not Applicable Recruiting January 31, 2020 China, Guangdong ... More >> Sun Yat-Sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: xinping cao, MD    (86)13602736388    caoxp@sysucc.org.cn Less <<
NCT02002195 - Unknown May 2016 Italy ... More >> Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore Recruiting Pesaro, PU, Italy, 61122 Principal Investigator: Vincenzo Catalano, MD          Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio San Salvatore, Recruiting Pesaro, Italy, 61122 Contact: Vincenzo Catalano, MD    0039072136 ext 4001    catalano_v@yahoo.it    Principal Investigator: Vincenzo Catalano, MD Less <<
NCT02236195 Urothelial Carcinoma Phase 2 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33905 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 University of Rochester Rochester, New York, United States, 14627 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Ohio State University Columbus, Ohio, United States, 43210 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00604461 Mesothelioma Phase 1 Phase 2 Terminated(Slow Accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01937208 Esophageal Carcinoma Phase 3 Unknown July 2017 China, Zhejiang ... More >> Zhejiang Cancer Hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: xiao zheng, MD    0086-571-88122078    zhengxiao@medmail.com    Principal Investigator: ming chen, PHD Less <<
NCT00867347 Bladder Cancer Phase 3 Unknown - United Kingdom ... More >> Institute of Cancer Research - Sutton Sutton, England, United Kingdom, SM2 5PT Less <<
NCT03059667 Small Cell Lung Cancer ... More >> Small Cell Lung Cancer Limited Stage Small Cell Lung Cancer Extensive Stage Less << Phase 2 Active, not recruiting December 2018 France ... More >> Annemasse - CH Ambilly, France, 74100 Angers - CHU Angers, France, 49000 CH Colmar, France CHRU Grenoble Grenoble, France Centre Hospitalier - Pneumologie Le Mans, France, 72000 Lorient - CHBS Lorient, France Montpellier - CHRU Montpellier, France, 34295 Mulhouse - CH Mulhouse, France, 68000 Centre Antoine Lacassagne Nice, France AP-HP Hopital Tenon - Pneumologie Paris, France, 75020 APHP - Paris Bichat Paris, France, 75877 GH Paris Saint-Joseph Paris, France CHG de Pau Pau, France HCL - Lyon Sud (Pneumologie) Pierre Bénite, France, 69495 Rouen - CHU Rouen, France, 76000 Centre Hospitalier Saint-Quentin, France Toulouse - CHU Larrey Toulouse, France CHU Tours - Pneumologie Tours, France Less <<
NCT02456714 Cholangiocarcinoma Phase 2 Active, not recruiting December 1, 2018 Netherlands ... More >> Academic medical center Amsterdam Amsterdam, Netherlands, 1105AZ Less <<
NCT03377400 Esophageal Squamous Cell Carci... More >>noma Less << Phase 2 Recruiting December 30, 2019 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, MA, Korea, Republic of, 06351 Contact: Jong-Mu Sun, Associate Professor    82234101795    jongmu.sun@samsung.com Less <<
NCT01845779 Metastatic Anal Canal Cancer ... More >> Human Papillomavirus Less << Not Applicable Recruiting January 2020 France ... More >> Medical Oncology - University Hospital of Besançon Recruiting Besançon, France, 25000 Contact: Christophe BORG, Prof    +3381615615    christophe.borg@efs.sante.fr    Contact: Marion JACQUIN       m1jacquin@chu-besancon.fr    Principal Investigator: Christophe BORG, Prof          Sub-Investigator: Jean-François BOSSET, Prof          Sub-Investigator: Thierry Nguyen, Doctor Less <<
NCT01207102 Metastatic Breast Cancer Phase 2 Terminated(Low enrollment and ... More >>there is insufficient data to publish.) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 China Peking University School of Oncology/Beijing Cancer Hospital Beijing, China, 100142 Less <<
NCT01207102 - Terminated(Low enrollment and ... More >>there is insufficient data to publish.) Less << - -
NCT02423811 Cancer Stem Cell Phase 2 Unknown - Taiwan ... More >> National Cheng Kung University Hospital Recruiting Tainan, Taiwan, 704 Contact: Forn-Chia Lin, M.D., Ph.D.    886-6-2353535 ext 2463    fornchia@mail.ncku.edu.tw Less <<
NCT00794339 Cervical Cancer Phase 2 Active, not recruiting December 2017 United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 Less <<
NCT02131480 Uterus Leiomyosarcoma ... More >> Soft Tissue Leiomyosarcoma Less << Phase 2 Completed - France ... More >> Gustave Roussy Cancer Campus Grand Paris Villejuif, Val de Marne, France, 94805 Less <<
NCT02783885 - Recruiting September 2020 Saudi Arabia ... More >> King Abdul Aziz Medical City for National Guard Health Affairs Recruiting Riyadh, Saudi Arabia, 11426 Contact: Abdularahman Jazieh, MD,MPH    0096612520088 ext 14688    jazieha@ngha.med.sa    Contact: Oncology Research    0096612520088 ext 14601    oncologyresearch@ngha.med.sa    King Abdul Aziz Medical City for National Guard Recruiting Riyadh, Saudi Arabia Contact: Nagham RZ Sheblaq    009668011111 ext 53352    sheblaqn@ngha.med.sa    Contact    009668011111 ext 53352    sheblaqn@ngha.med.sa    Principal Investigator: Nagham RZ Sheblaq, BS.c Less <<
NCT00066768 Recurrent Non-small Cell Lung ... More >>Cancer Stage IIIB Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer Less << Phase 1 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT01453504 Hodgkin Lymphoma Phase 1 Phase 2 Recruiting December 2018 Germany ... More >> 1st Dept. of Medicine, Cologne University Hospital Recruiting Cologne, Germany Contact: Michael Fuchs       ghsg@uk-koeln.de Less <<
NCT00511446 Stomach Neoplasms Phase 2 Completed - Germany ... More >> Charite - Universitatsmedizin Berlin Berlin, Germany, 13353 Medizinische Universitätsklinik - Knappschaftskrankenhaus Bochum, Germany, 44892 Städtische Kliniken Esslingen Esslingen, Germany, 73730 MVZ Osthessen Fulda, Germany, 36043 Martin-Luther-University Halle-Wittenberg Halle (Saale), Germany, 06120 Städt. Klinikum St. Georg Leipzig, Germany, 04129 OSP Lörrach-Rheinfelden Lörrach, Germany, 79539 Universitätsklinikum Mainz Mainz, Germany, 55101 Universitätsklinikum Mannheim Mannheim, Germany, 68167 Universitätsklinik Ulm Ulm, Germany, 89081 Less <<
NCT00190840 Carcinoma, Non-Small Cell Lung Phase 2 Completed - Australia, New South Wales ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wollongong, New South Wales, Australia, 2500 Australia, Queensland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chermside, Queensland, Australia, 4032 Australia, South Australia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ashford, South Australia, Australia, 5035 Australia, Victoria For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fitzroy, Victoria, Australia, 3065 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hong Kong, China Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alexandria, Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt, 11796 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hyderabad, Andhra Pradesh, India, 500004 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ludhiana, Punjab, India, 141001 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chandigarh, India, 160012 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chennai, India, 600035 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Delhi, India, 110085 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Gyeonggi-Do, Korea, Republic of, 411764 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Oradea, Bihor, Romania, 3700 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Craiova, Dolj, Romania, 1100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bucuresti, Romania, 72435 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Iasi, Romania, 6600 Taiwan For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Eskisehir, Turkey Less <<
NCT01523574 Peripheral Neuropathy Phase 2 Completed - Brazil ... More >> Faculdade de Medicina do ABC Santo Andre, Sao Paulo, Brazil, 09060-870 Faculdade de Medicina do ABC Santo André, São Paulo, Brazil, 09060-870 Less <<
NCT02665702 Esophageal Squamous Cell Carci... More >>noma Less << Phase 2 Recruiting September 2019 China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Chang jian hua, PD    13916619284    changjianhua@163.com Less <<
NCT00604461 - Terminated(Slow Accrual) - -
NCT00980460 Alpha Fetoprotein Increased ... More >> PRETEXT Stage 1 Hepatoblastoma PRETEXT Stage 2 Hepatoblastoma PRETEXT Stage 3 Hepatoblastoma PRETEXT Stage 4 Hepatoblastoma Less << Phase 3 Active, not recruiting December 31, 2018 -
NCT02114359 Gastric Cancer Phase 3 Recruiting February 2020 Korea, Republic of ... More >> Hallym University Sacred Heart Hospital Recruiting Anyang, Korea, Republic of, 431-796 Contact: ZANG, M.D.       fhdzang@hallym.ac.kr    Principal Investigator: ZANG, M.D.          Inje University Haeundae Paik Hospital Recruiting Busan, Korea, Republic of Contact: LEE, M.D.          Principal Investigator: LEE, M.D.          Chungbuk National University Hospital Not yet recruiting Cheongju, Korea, Republic of, 361-711 Contact: HAN, M.D.          Principal Investigator: HAN, M.D.          Kyungpook National University Medical Center Recruiting Daegu, Korea, Republic of, 702-210 Contact: KIM, M.D.          Principal Investigator: KIM, M.D.          Yeongnam University Medical Center Recruiting Daegu, Korea, Republic of Contact: KOH, M.D.          Principal Investigator: KOH, M.D.          National Cancer Center Recruiting Goyang, Korea, Republic of, 410-769 Contact: PARK, M.D.       youngiee@dreamwiz.com    Principal Investigator: PARK, M.D.          Gachon University Gil Medical Center Not yet recruiting Incheon, Korea, Republic of, 400-713 Contact: SIM, M.D.          Principal Investigator: SIM, M.D.          Inje University Pusan Paik Hospital Recruiting Pusan, Korea, Republic of, 614-735 Contact: KIM, M.D.          Principal Investigator: KIM, M.D.          Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of, 463-707 Contact: LEE, M.D.       hmodoctor@hanmail.net    Principal Investigator: LEE, M.D.          Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: RYU, M.D.          Principal Investigator: RYU, M.D.          SMG-SNU Boramae Medical Center Recruiting Seoul, Korea, Republic of, 156-707 Contact: CHOI, M.D.          Principal Investigator: CHOI, M.D.          Inje University Sanggye Paik Hospital Recruiting Seoul, Korea, Republic of Contact: SOHN, M.D.          Principal Investigator: SOHN, M.D.          Kangbuk Samsung Hospital Recruiting Seoul, Korea, Republic of Contact: KOO, M.D.          Principal Investigator: KOO, M.D.          The Catholic University of Korea Uijeongbu St. Mary's Hospital Recruiting Uijeongbu, Korea, Republic of Contact: KO, M.D.          Principal Investigator: KO, M.D. Less <<
NCT01749072 Non-small Cell Lung Cancer ... More >> Effects of Chemotherapy Less << Phase 2 Unknown December 2017 China, Beijing ... More >> Department of Respiratory Medicine, Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Mengzhao Wang, MD    010-69155039 ext +86    mengzhaowang@sina.com    Contact: Jing Zhao, MD    010-69158206 ext +86    pumchzj@sina.com    Sub-Investigator: Wei Zhong, MD          Sub-Investigator: Jinmei Luo, MD Less <<
NCT01070290 Gastric Cancer Phase 2 Withdrawn - -
NCT01870609 Malignant Pleural Mesothelioma Phase 2 Terminated(Interim analysis-DS... More >>MB stated good safety profile but lack of efficacy) Less << - -
NCT03719989 Diffuse Large B Cell Lymphoma ... More >> Relapsed Non Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Less << Phase 2 Not yet recruiting November 30, 2023 Korea, Republic of ... More >> Seoul National University Hospital Not yet recruiting Seoul, Korea, Republic of, 03080 Contact: Junshik Hong, MD    82220723383    alertjun@hanmail.net Less <<
NCT00446290 Stomach Cancer Phase 1 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT01453205 Diffuse Large B-Cell Lymphoma Phase 2 Completed - -
NCT01453205 - Completed - -
NCT00446290 - Completed - -
NCT00686985 Small Cell Lung Cancer Phase 2 Unknown July 2010 Netherlands ... More >> B. Biesma Recruiting 's-Hertogenbosch, Brabant, Netherlands, 5211NL Contact: B. Biesma, Dr.    31-073-699-2615    b.biesma@jbz.nl    Contact: F. Schramel, Dr.    31-0609-9111    f.schramel@antonius.net    Sub-Investigator: H van der Heijden, Dr.          Sub-Investigator: J.N.H. Timmer - Bonte, Dr.          Sub-Investigator: H Smit, Dr.          Sub-Investigator: H.J.M. Groen, Prof. Dr. Less <<
NCT01655823 Pain Peripher... More >>al Neuropathy Neuropathic Pain Less << Phase 2 Terminated(Interim analysis co... More >>mpleted and decided to terminate and proceed to Phase 3 trial.) Less << - -
NCT02557529 Head and Neck Neoplasms ... More >> Weight Loss Less << Phase 2 Unknown May 2018 Denmark ... More >> Department of Oncology, Copenhagen University hospital, Herlev Recruiting Herlev, Denmark, 2730 Contact: Julie Gehl    004538683868    julie.gehl@regionh.dk    Contact: Camilla K Lonkvist    004538689571       Principal Investigator: Julie Gehl Less <<
NCT01655823 - Terminated(Interim analysis co... More >>mpleted and decided to terminate and proceed to Phase 3 trial.) Less << - -
NCT00039039 Lung Cancer Phase 3 Unknown - Italy ... More >> Ospedale Civile di Asti Asti, Italy, 14100 Centro di Riferimento Oncologico - Aviano Aviano, Italy, 33081 Ospedali Riuniti di Bergamo Bergamo, Italy, 24100 Spedali Civili di Brescia Brescia, Italy, 25133 Civic Hospital of Carrara Carrara, Italy, I-54033 Ospedale Regionale A. Pugliese Catanzaro, Italy, 88100 Ospedale Mariano Santo Cosenza, Italy, 87100 Azienda Istituti Ospitalieri Cremona, Italy, 26100 Ospedale Santa Croce Cuneo, Italy, 12100 Ospedale Galliera Oncologia Genoa, Italy, 16100 Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Ospedale San Martino Genoa, Italy, 16132 Ospedale Civile di Ivrea Ivrea, Italy, 10015 Ospedale Santa Maria Goretti Latina, Italy, 04100 Ospedale Umberto I Lugo DI Romagna, Italy, 48022 Istituto Policlinico San Donato Milan, Italy, 20097 Istituto Nazionale per lo Studio e la Cura dei Tumori Milan, Italy, 20133 University of Modena Hospital and Reggio Emilia School of Medicine Modena, Italy, 41100 Nuovo Ospedale San Gerardo at University of Milano-Bicocca Monza, Italy, 20052 Azienda Ospedale S. Luigi at University of Torino Orbassano, Italy, 10043 Azienda Ospedaliera di Padova Padova, Italy, 35128 Azienda Ospedaliera Di Parma Parma, Italy, 43100 Policlinico Monteluce Perugia, Italy, 06122 Ospedale Santa Chiara Pisa Pisa, Italy, 56100 Ospedale Sta. Maria Delle Croci Ravenna, Italy, 48100 Ospedale Carlo Forlanini Rome, Italy, 00149 Ospedale S. Camillo-Forlanini Rome, Italy, 00152 Azienda Policlinico Umberto Primo Rome, Italy, 00161 Istituti Fisioterapici Ospitalieri - Roma Rome, Italy, 00161 Istituto Regina Elena Rome, Italy, 00161 Ospedale Casa Sollievo della Sofferenza San Giovanni - Rotondo, Italy, 71013 Azienda Ospedaliera S. Maria Terni, Italy, 051100 Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino Turin, Italy, 10123 Ospedale Evangelico Valdese Turin, Italy, 10125 Ospedale Ostetrico Ginecologica Sant Anna Turin, Italy, 10125 Azienda Ospedaliera Santa Maria della Misericordia Udine, Italy, 33100 Ospedale San Bortolo Vicenza, Italy, 36100 Less <<
NCT00085202 - Active, not recruiting - -
NCT01404156 Esophageal Cancer ... More >> Adenocarcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Less << Phase 2 Phase 3 Recruiting April 2021 Canada, Manitoba ... More >> Health Sciences Centre / CancerCare Manitoba Recruiting Winnipeg, Manitoba, Canada, R3A 1R9 Less <<
NCT00274937 - Completed - -
NCT02434614 Nasopharyngeal Carcinoma Phase 3 Active, not recruiting December 2021 China, Guangxi ... More >> Affiliated Hospital of Youjiang Medical University for Nationalities Baise, Guangxi, China Guigang People's Hospital Guigang, Guangxi, China Guangxi Naxishan Hospital Guilin, Guangxi, China Liuzhou People's Hospital Liuzhou, Guangxi, China Nanning Monority Hospital Nanning, Guangxi, China Wuzhou Red Cross Hospital Wuzhou, Guangxi, China Less <<
NCT00274937 Stage I Lymphoepithelioma of t... More >>he Nasopharynx Stage I Squamous Cell Carcinoma of the Nasopharynx Stage II Lymphoepithelioma of the Nasopharynx Stage II Squamous Cell Carcinoma of the Nasopharynx Stage III Lymphoepithelioma of the Nasopharynx Stage III Squamous Cell Carcinoma of the Nasopharynx Stage IV Lymphoepithelioma of the Nasopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Less << Phase 3 Completed - -
NCT02349958 Ovarian Cancer ... More >> Peritoneal Cancer Fallopian Tube Cancer Uterine Cancer Mesotheliomas Gastrointestinal Cancers Cervical Cancer Less << Phase 2 Recruiting January 2018 United States, California ... More >> James Lilja Recruiting Los Gatos, California, United States, 95032 Contact: Heather McAvoy, LVN    408-827-4274    info@bayareago.com    Principal Investigator: James Lilja, MD          Sub-Investigator: Augusto Bastidas, MD Less <<
NCT03017326 Hepatoblastoma ... More >> Carcinoma, Hepatocellular Less << Phase 3 Recruiting December 2022 United Kingdom ... More >> Royal Aberdeen Children's Hospital Recruiting Aberdeen, United Kingdom, AB25 2ZG Contact: Hugh Bishop, MBChB          Addenbrooke's Hospital Recruiting Cambridge, United Kingdom, CB2 0QQ Contact: Amos Burke, MB ChB       amos.burke@addenbrookes.nhs.uk Less <<
NCT01283178 Salivary Gland Squamous Cell C... More >>arcinoma Stage II Salivary Gland Cancer Stage II Squamous Cell Carcinoma of the Hypopharynx Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity Stage II Squamous Cell Carcinoma of the Oropharynx Stage II Verrucous Carcinoma of the Oral Cavity Stage III Salivary Gland Cancer Stage III Squamous Cell Carcinoma of the Hypopharynx Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Stage III Squamous Cell Carcinoma of the Oropharynx Stage III Verrucous Carcinoma of the Oral Cavity Stage IV Salivary Gland Cancer Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IV Squamous Cell Carcinoma of the Oropharynx Stage IV Verrucous Carcinoma of the Oral Cavity Less << Phase 1 Terminated(The study was termi... More >>nated. The data analysis was futile with only 3 accruals. PI opted to terminate with IRB and withdraw FDA IND.) Less << - United States, Virginia ... More >> Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT01461057 - Completed - -
NCT00059826 Pancreatic Cancer Phase 2 Completed - United States, Florida ... More >> University of Florida Shands Cancer Center Gainesville, Florida, United States, 32610-0232 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Kentucky James Graham Brown Cancer Center at University of Louisville Louisville, Kentucky, United States, 40202 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Fairview University Medical Center - University Campus Minneapolis, Minnesota, United States, 55455 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas Presbyterian Hospital of Dallas Dallas, Texas, United States, 75231 Baylor University Medical Center - Houston Houston, Texas, United States, 77030 United States, Wisconsin Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00870870 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Alabama ... More >> ImClone Investigational Site Anniston, Alabama, United States, 36207 United States, California ImClone Investigational Site La Jolla, California, United States, 92093 ImClone Investigational Site Orange, California, United States, 92868 United States, Florida ImClone Investigational Site Orlando, Florida, United States, 32806 United States, Georgia ImClone Investigational Site Atlanta, Georgia, United States, 30341 United States, Illinois ImClone Investigational Site Chicago, Illinois, United States, 60612 ImClone Investigational Site Chicago, Illinois, United States, 60637 United States, New Mexico ImClone Investigational Site Albuquerque, New Mexico, United States, 87131 United States, New York ImClone Investigational Site New York, New York, United States, 10011 ImClone Investigational Site New York, New York, United States, 10021 ImClone Investigational Site New York, New York, United States, 10032 United States, Ohio ImClone Investigational Site Cincinnati, Ohio, United States, 45247 Less <<
NCT00870870 - Completed - -
NCT00779714 Melanoma Phase 3 Unknown April 2013 Germany ... More >> Dept of Dermatology, University of Aachen Recruiting Aachen, Germany, 52074 Principal Investigator: Hans F Merk, Prof. (MD)          Dept of Dermatology, University of Berlin Charite Recruiting Berlin, Germany, 10117 Principal Investigator: Uwe Trefzer, PD (MD)          Dept of Dermatology, University of Bochum Recruiting Bochum, Germany, 44791 Principal Investigator: Norbert Brockmeyer, Prof. (MD)          Medizinisches Zentrum Bonn Friedensplatz Recruiting Bonn, Germany, 53111 Principal Investigator: Uwe Reinhold, Prof. (MD)          Dept of Dermatology, University of Essen Recruiting Essen, Germany, 45147 Principal Investigator: Dirk Schadendorf, Prof. (MD)          Dept of Dermatology, University of Frankfurt Recruiting Frankfurt / Main, Germany, 60590 Principal Investigator: Roland Kaufmann, Prof. (MD)          Dermatology, Klinikum Frankfurt/Oder Recruiting Frankfurt/Oder, Germany, 15236 Principal Investigator: Anett Milling, Dr. (MD)          Dept of Dermatology, University of Hannover Recruiting Hannover, Germany, 30449 Principal Investigator: Ralf Gutzmer, PD (MD)          Dept of Dermatology, Saarland University Recruiting Homburg/Saar, Germany, 66421 Principal Investigator: Knuth Rass, Dr. (MD)          Dept of Dermatology, University of Jena Recruiting Jena, Germany, 07740 Principal Investigator: Martin Kaatz, Dr. (MD)          Dept of Dermatology, University of Schleswig-Holstein Campus Kiel Recruiting Kiel, Germany, 24105 Principal Investigator: Axel Hauschild, Prof. (MD)          Dermatology, Klinikum Ludwishafen Recruiting Ludwigshafen, Germany, 67063 Principal Investigator: Edgar Dippel, Prof. (MD)          Dept of Dermatology, University of Schleswig-Holstein Campus Luebeck Recruiting Luebeck, Germany, 23538 Principal Investigator: Patrick Terheyden, Dr. (MD)          Dept of Dermatology, Univeristy of Magdeburg Recruiting Magdeburg, Germany, 39120 Principal Investigator: Martin Leverkus, Prof. (MD)          Dept of Dermatology, University of Mainz Recruiting Mainz, Germany, 55131 Principal Investigator: Carmen Loquai, Dr. (MD)          Dept of Dermatology, University of Mannheim Recruiting Mannheim, Germany, 68167 Principal Investigator: Jessica Hassel, Dr. (MD)          Dept of Dermatology, University of Marburg Recruiting Marburg, Germany, 35033 Principal Investigator: Michael Hertl, Prof. (MD)          Dept of Dermatology, University of Muenchen Recruiting Muenchen, Germany, 80337 Principal Investigator: Carola Berking, Prof. (MD)          Dept of Dermatology, University of Muenster Recruiting Muenster, Germany, 48149 Principal Investigator: Cord Sunderkoetter, Prof. (MD)          Dept of Medical Oncology, Fachklinik Hornheide Recruiting Muenster, Germany, 48157 Principal Investigator: Michael Fluck, Dr. (MD)          Dermatology, Klinikum Dorothea Christiane Erxleben Recruiting Quedlinburg, Germany, 06484 Principal Investigator: Jens Ulrich, PD (MD)          Dept of Dermatology, University of Tuebingen Recruiting Tuebingen, Germany, 72086 Principal Investigator: Claus Garbe, Prof. (MD)          Dept of Dermatology, University of Wuerzburg Recruiting Wuerzburg, Germany, 97080 Principal Investigator: Selma Ugurel, Prof. (MD) Less <<
NCT00002836 Breast Cancer Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT01391572 Esophageal Squamous Cell Carci... More >>noma Less << Phase 2 Unknown - China, Shanghai ... More >> Fudan University Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Xu-Wei Cai, M.D., Ph.D.    8621-64175590 ext 1504    birdhome2000@hotmail.com    Principal Investigator: Xiao-Long Fu, M.D., Ph.D. Less <<
NCT00053105 Lymphoma Phase 1 Unknown - United States, Arizona ... More >> Arizona Clinical Research Center Tucson, Arizona, United States, 85712 United States, Arkansas Highlands Oncology Group Springdale, Arkansas, United States, 72764 United States, California USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90033-0800 United States, Maryland Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5055 United States, Tennessee Boston Baskin Cancer Group, University Tennessee Memphis, Tennessee, United States, 38104 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00002615 Gastric Cancer Phase 3 Completed - United Kingdom ... More >> Epsom General Hospital Epsom, Surrey, United Kingdom, KT18 7EG Less <<
NCT00003576 Head and Neck Cancer Phase 3 Completed - Singapore ... More >> National Cancer Centre - Singapore Singapore, Singapore, 169610 Less <<
NCT00005825 Lung Cancer Phase 2 Unknown - United States, California ... More >> Rajendra Prasad M.D., Inc. Lakewood, California, United States, 90712 Less <<
NCT00021112 Lung Cancer Phase 2 Terminated(low accrual) - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Germany Thoraxklinik Rohrbach Heidelberg, Germany, D-69126 Netherlands Gelre Ziekenhuizen - Lokatie Lukas Apeldoorn, Netherlands, 7334 DZ Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Rotterdam Cancer Institute Rotterdam, Netherlands, 3000 CA University Hospital - Rotterdam Dijkzigt Rotterdam, Netherlands, 3000 CA Academisch Ziekenhuis Utrecht Utrecht, Netherlands, 3584 CX Poland Medical University of Gdansk Gdansk, Poland, 80-211 National Institute of Tuberculosis and Lung Diseases Warsaw, Poland Less <<
NCT01836029 Carcinoma, Squamous Cell of He... More >>ad and Neck Less << Phase 2 Unknown September 2016 -
NCT00004099 Gastric Cancer Phase 3 Terminated(low accrual) - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 Egypt National Cancer Institute of Egypt Cairo, Egypt Germany Robert Roessle Klinik Berlin, Germany, D-13122 Medizinische Klinik I Dresden, Germany, D-01307 Universitaetsklinik Duesseldorf Duesseldorf, Germany, D-40225 Department of Medicine III Erlangen, Germany, D-91054 Kliniken Essen - Mitte Essen, Germany, D-45136 Evangelisches Bethesda Krankenhaus GmbH Essen, Germany, D-45355 Krankenhaus Nordwest Frankfurt, Germany, D-60488 Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 Universitatsklinik - Saarland Homburg, Germany, D-66421 Klinik & Poliklinik fur Strahlentherapie der Universitat zu Koln Koln, Germany, D-50924 Kreiskrankenhaus Meissen Meissen, Germany, D-01657 Westfaelische Wilhelms-Universitaet Muenster, Germany, DOH-48149 Klinikum Rechts Der Isar/Technische Universitaet Muenchen Munich, Germany, D-81675 Staedtisches Krankenhaus Solingen, Germany, D-42653 Netherlands Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ Portugal Instituto Portugues de Oncologia Centro do Porto, SA Porto, Portugal, 4200 Less <<
NCT00030459 Malignant Mesothelioma Phase 2 Unknown - United Kingdom ... More >> Princess Royal Hospital Hull, England, United Kingdom, HU8 9HE Leeds Teaching Hospital Trust Leeds, England, United Kingdom, LS1 3EX Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Royal Marsden Hospital Sutton, England, United Kingdom, SM2 5PT Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Stobhill General Hospital Glasgow, Scotland, United Kingdom, G21 3UW Dorothy House Foundation Bradford-Onavon, United Kingdom, BA15 2LE St. Peters Hospital Chertsey Surrey, United Kingdom, KT 16 OPZ Less <<
NCT00025090 Anal Cancer Phase 3 Completed - United Kingdom ... More >> Northwick Park Hospital Harrow, England, United Kingdom, HA1 3UJ Ipswich Hospital Ipswich, England, United Kingdom, IP4 5PD Cookridge Hospital Leeds, England, United Kingdom, LS16 6QB Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Cancer Research UK and University College London Cancer Trials Centre London, England, United Kingdom, NW1 2ND James Cook University Hospital Middlesbrough, England, United Kingdom, TS4 3BW Mount Vernon Cancer Centre at Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Nottingham City Hospital Nottingham, England, United Kingdom, NG5 1PB Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Southend University Hospital NHS Foundation Trust Westcliff-On-Sea, England, United Kingdom, SS0 0RY Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Cancer Research Centre at Weston Park Hospital Sheffield, United Kingdom, S1O 2SJ Less <<
NCT00006212 Lung Cancer Phase 1 Unknown - United States, New York ... More >> Center for Molecular Medicine Garden City, New York, United States, 11530 Less <<
NCT00003652 Anal Cancer Phase 3 Unknown - France ... More >> Centre Paul Papin Angers, France, 49036 Institut Sainte Catherine Avignon, France, 84082 Institut Bergonie Bordeaux, France, 33076 CHU Ambroise Pare Boulogne Billancourt, France, F-92104 C.H. Bourg En Bresse Bourg En Bresse, France, 01012 Centre Regional Francois Baclesse Caen, France, 14076 Centre Hospitalier Chalon Sur Saone, France, F-71321 Hopital Louis Pasteur Colmar, France, 68024 Centre Hospitalier Universitaire Henri Mondor Creteil, France, 94010 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Hospitalier Departemental La Roche Sur Yon, France, F-85025 Centre Oscar Lambret Lille, France, 59020 Centre Hospital Regional Universitaire de Limoges Limoges, France, 87042 Centre Leon Berard Lyon, France, 69373 Institut J. Paoli and I. Calmettes Marseille, France, 13273 CHU de la Timone Marseille, France, 13385 Hopital Clinique Claude Bernard Metz, France, 57072 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Hospitalier de Mulhouse Mulhouse, France, 68051 Centre D'Oncologie De Gentilly Nancy, France, 54100 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Centre Catherine de Sienne Nante, France, 02 Centre Antoine Lacassagne Nice, France, 06189 CHR D'Orleans - Hopital de la Source Orleans, France, 45067 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Bichat - Claude Bernard Paris, France, 75018 Hopital Robert Debre Paris, France, 75019 Institut Curie - Section Medicale Paris, France, 75248 Hopital Saint-Louis Paris, France, 75475 CHU Pitie-Salpetriere Paris, France, 75651 Hopital Tenon Paris, France, 75970 Hopital Jean Bernard Poitiers, France, 86021 Clinique Ste - Marie Pontoise, France, 95301 Institut Jean Godinot Reims, France, 51056 Centre Eugene Marquis Rennes, France, 35042 Hopital Charles Nicolle Rouen, France, 76031 Centre Henri Becquerel Rouen, France, 76038 Clinique Armoricaine De Radiologie Saint Brieuc, France, F-22015 Centre Rene Huguenin Saint Cloud, France, 92211 Centre Hospitalier General de Saint Nazaire Saint Nazaire, France, 44600 Clinique de l'Orangerie Strasbourg, France, 67010 Centre Paul Strauss Strasbourg, France, 67065 Centre Hospitalier Regional Metz Thionville Thionville, France, 57126 Institut Claudius Regaud Toulouse, France, 31052 Clinique Fleming Tours, France, 37000 Nouvelle Clinique Generale Valence, France, 26000 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT02753140 Carcinoma, Squamous Cell of He... More >>ad and Neck Less << Phase 2 Unknown September 2018 -
NCT03269162 NSCLC Phase 3 Active, not recruiting September 30, 2019 -
NCT00085202 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Active, not recruiting January 2023 United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital Houston, Texas, United States, 77030-2399 Australia, New South Wales Sydney Children's Hospital Randwick, New South Wales, Australia, 2031 Children's Hospital at Westmead Westmead, New South Wales, Australia, 2145 Australia, Queensland Lady Cilento Children's Hospital, Brisbane Brisbane, Queensland, Australia, 4029 Australia, Victoria Royal Children's Hospital Parkville, Victoria, Australia, 3052 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00113932 Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00559156 Head and Neck Cancer Phase 2 Completed - -
NCT01063946 Neoplasms, Malignant Phase 1 Completed - Belgium ... More >> Sanofi-Aventis Administrative Office Brussels, Belgium Less <<
NCT02636556 Thymoma and Thymic Carcinoma Phase 2 Recruiting December 2017 China, Shanghai ... More >> Kailiang Wu Recruiting Shanghai, Shanghai, China, 20032 Contact: Kailiang Wu, M.D. Ph. D.    +86 64175590 ext 86722    wukailiang@aliyun.com Less <<
NCT02976142 Gastric Cancer, Metastatic Phase 2 Not yet recruiting December 2020 -
NCT01263886 Non-small Cell Lung Cancer Phase 2 Completed - -
NCT00004160 Lung Cancer Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 Less <<
NCT01262183 Irresectable Squamous Cell or ... More >>Adenocarcinoma of the Oesophagus Less << Phase 2 Terminated(low recruitment num... More >>bers) Less << October 2012 Netherlands ... More >> University Medical Centre Nijmegen Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT03760575 Mesotheliomas Pleural Phase 1 Not yet recruiting November 2021 United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Evan W Alley    588-216-0098    penncancertrials@emergingmed.com Less <<
NCT02132143 Lung Adenocarcinoma Patients W... More >>ith Postoperative in pN2 Less << Not Applicable Unknown January 2017 China ... More >> The People's Hospital of Guangxi Zhuang Autonomous Region Recruiting Nanning Shi, China, 530021 Contact: Hui Lin    8613878133266    linhui33266@sina.com Less <<
NCT01704716 Neuroblastoma Phase 3 Recruiting September 2024 -
NCT01525927 Oropharyngeal Neoplasms Phase 2 Terminated(Principal Investiga... More >>tor left institution. IRB approval lapsed.) Less << - United States, New York ... More >> Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Less <<
NCT01525927 - Terminated(Principal Investiga... More >>tor left institution. IRB approval lapsed.) Less << - -
NCT00112346 Non-Small-Cell Lung Carcinoma Phase 2 Completed - -
NCT03345810 Carcinoma, Non-Small-Cell Lung... More >> Metastatic Lung Cancer Non Small Cell Lung Cancer Lung Adenocarcinoma Metastatic Large Cell Lung Carcinoma Metastatic Less << Phase 2 Recruiting December 2022 Germany ... More >> Gesundheitszentrum St. Marien GmbH Recruiting Amberg, Germany, 92224 Contact: Ludwig Fischer von Weikersthal, Dr.    +49 9621 381637    weikersthal.ludwig@klinikum-amberg.de    DRK-Kliniken Berlin Mitte Recruiting Berlin-Mitte, Germany, 13359 Contact: Vincent van Laak, Dr.    +49 30 30356303    v.laak@drk-kliniken-berlin.de    Ev. Lungenklinik Berlin Recruiting Berlin, Germany, 13125 Contact: Christian Grohé, Prof. Dr.    +49 30 94802112    christian.grohe@pgdiakonie.de    Klinikum Darmstadt Recruiting Darmstadt, Germany, 64283 Contact: Helga Bernhard, Prof. Dr.    +49 61511076651    helga.bernhard@mail.klinikum-darmstadt.de    Universitätsklinikum Carl-Gustav-Carus Recruiting Dresden, Germany, 01307 Contact: Martin Wermke, Dr.    +49 351 4587566    martin.wermke@uniklinikum-dresden.de    Klinikum Esslingen Recruiting Esslingen, Germany, 73730 Contact: Martin Faehling, Dr.    +49 711 31032402    m.faehling@klinikum-es.de    Universitätsklinikum Frankfurt Recruiting Frankfurt am Main, Germany, 60590 Contact: Wolfgang Gleiber, Dr.    +49 69 63016337    wolfgang.gleiber@kgu.de    Klinik Schillerhöhe Recruiting Gerlingen, Germany, 70839 Contact: Martin Kimmich, Dr.    +49 7156 2037719    martin.kimmich@klinik-schillerhoehe.de    Universitätsmedizin Greifswald Recruiting Greifswald, Germany, 17475 Contact: Michael Boesche, Dr.    +49 3834 8680683    boeschem@uni-greifswald.de    Onkodoc GmbH Recruiting Gütersloh, Germany, 33332 Contact: Philipp Schütt, PD Dr.    +49 5241 8328150    schuett@onkologie-guetersloh.de    Krankenhaus Martha-Maria Halle Dölau Recruiting Halle (Saale), Germany, 06120 Contact: Wolfgang Schütte, Prof. Dr.    +49 345 5591440    wolfgang.schuette@Martha-Maria.de    Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital Recruiting Heidelberg, Germany Contact: Jonas Kuon, Dr    +49 6221 396 8008    Jonas.Kuon@med.uni-heidelberg.de    Lungenklinik Hemer Recruiting Hemer, Germany, 58675 Contact: Monika Serke, Dr    +49 2372 9082201    monika.serke@lkhemer.de    "Vincentius-Diakonissen-Kliniken gAG Recruiting Karlsruhe, Germany, 76137 Contact: Christian Meyer zum Büschenfelde, Prof. Dr.    +49 721 81083014    christian.mzb@vincentius-ka.de    Kliniken der Stadt Köln gGmbH Recruiting Köln, Germany, 51109 Contact: Walburga Engel-Riedel, Dr.    +49 221 890713962    engelriedelw@kliniken-koeln.de    Ortenau-Klinikum Lahr Active, not recruiting Lahr, Germany, 77933 Ev. Diakonissenkrankenhaus Leipzig Recruiting Leipzig, Germany, 04177 Contact: Sylvia Gütz, Dr.    +49 341 4443621    Sylvia.Guetz@ediacon.de    Klinikum Ludwigsburg Recruiting Ludwigsburg, Germany, 71640 Contact: Matthias Ulmer, Dr.    +49 7141 9994467    matthias.ulmer@kliniken-lb.de    Klinik Löwenstein gGmbH Recruiting Löwenstein, Germany, 74245 Contact: J.R. Fischer, PD Dr.    +49 7130 154207    jr.fischer@klinik-loewenstein.de    Klinikum der Universität München Recruiting München, Germany, 81377 Contact: Dominik Modest, PD Dr.    +40 89 44000    dominik.modest@med.uni-muenchen.de    Pius Hospital Oldenburg Recruiting Oldenburg, Germany, 26121 Contact: Frank Griesinger, Prof. Dr.    +49 441 2291691    frank.griesinger@pius-hospital.de    Krankenhaus Barmherzige Brüder Recruiting Regensburg, Germany, 93049 Contact: Nicolas Moosmann, Dr.    +49 941 3692151    nicolas.moosmann@barmherzige-regensburg.de    "Klinikum Rheine Not yet recruiting Rheine, Germany, 48341 Contact: Nicolas Dickgreber, Dr.    +49 5971-422701    n.dickgreber@mathias-spital.de    Marienhospital Recruiting Stuttgart, Germany, 70199 Contact: Claudio Denzlinger, Prof. Dr.       claudio.denzlinger@vinzenz.de    Krankenhaus der Barmherzigen Brüder Recruiting Trier, Germany, 54292 Contact: Heinz Kirchen, Dr.    +49 651 2082662    h.kirchen@bk-trier.de    Universitätsklinikum Ulm Recruiting Ulm, Germany, 89081 Contact: Cornelia Kropf-Sanchen, Dr.       cornelia.kropf-sanchen@uniklinik-ulm.de    Schwarzwald-Baar Klinikum Not yet recruiting Villingen-Schwenningen, Germany, 78052 Contact: Anja Rückert, Dr.    +49 7721-934013    anja.rueckert@sbk-vs.de    SHG-Kliniken-Völklingen Not yet recruiting Völklingen, Germany, 66333 Contact: Harald Schäfer, Prof. Dr.    +49 6898 122351    h.schaefer@vk.shg-kliniken.de    Hämatologisch-Onkologische Praxis Würselen Not yet recruiting Würselen, Germany, 52146 Contact: Christoph Maintz, Dr.    +49 2405-48920    c.maintz@aachen-onkologie.de    Klinikum Würzburg Mitte gGmbH Not yet recruiting Würzburg, Germany, 97074 Contact: Jens Kern, Dr.    +49 931 7912814    jens.kern@missioklinik.de Less <<
NCT01769391 Squamous Non Small Cell Lung C... More >>ancer Less << Phase 2 Completed - -
NCT01769391 - Completed - -
NCT02145390 Bladder Cancer ... More >> Bladder Carcinoma Transition Cell Cancer Muscle Invasive Bladder Carcinoma Less << Not Applicable Terminated(Investigator Decisi... More >>on - Insufficient Accrual) Less << - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Less <<
NCT01125995 Small Cell Lung Cancer Phase 3 Completed - Korea, Republic of ... More >> Keunchil Park Seoul, Korea, Republic of, 135-710 Asan Medican Center Seoul, Korea, Republic of Less <<
NCT02996617 Lymphoma,Non-Hodgkin Phase 4 Unknown December 2018 China, Shandong ... More >> Department of Hematology, Provincial Hospital Affiliated to Shandong University Recruiting Jin'an, Shandong, China, 250012 Contact: Xin Wang, MD, PHD    86-531-68778331    xinw007@126.com    Contact: changqing zhen, MD    86-531-68778331    zcq1521@163.com Less <<
NCT00486460 Pancreatic Cancer Phase 3 Unknown - Israel ... More >> Sourasky Medical Center Recruiting Tel Aviv, Israel, 64239 Contact: Nadir Arber, M.D, MSc, MHA    03-6953179    nadir@tasmc.health.gov.il Less <<
NCT01717924 Signet Ring Cell Gastric Adeno... More >>carcinoma Less << Not Applicable Recruiting April 2024 France ... More >> General and digestive surgical department, Claude Huriez Hospital, University Hospital Recruiting Lille cedex, France, 59037 Contact: christophe mariette, MD,PhD    +33320444407    christophe.mariette@chru-lille.fr    Principal Investigator: christophe mariette Less <<
NCT02055924 B-cell Lymphoma Phase 1 Terminated(ANSM decision due t... More >>o veino occlusive disease (security alert)) Less << - Belgium ... More >> Universite Catholique de Louvain Saint Luc Bruxelles, Belgium CHU de Liège Liège, Belgium, 04000 CHU UCL Namur asbl Yvoir, Belgium, 5530 France Centre François Baclesse Caen, France, 14076 Hôpital Henri Mondor Créteil, France, 94010 CHU de Dijon - Hôpital le Bocage Dijon, France, 21034 CHRU de Lille - Hôpital Claude Huriez Lille, France, 59037 Centre Léon Bérard Lyon, France, 69373 CHU Montpellier Montpellier, France, 34295 CHU de Nantes Nantes, France, 44093 Hôpital Saint Louis Paris, France, 75475 Centre François Magendie - Hôpital du Haut Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Bénite, France, 69495 CHU Pontchaillou Rennes, France, 35003 Centre Henri Becquerel Rouen, France, 76038 Less <<
NCT02765919 Squamous Cell Carcinoma of Cer... More >>vix Less << Phase 3 Completed - Bangladesh ... More >> BSM Medical University Dhaka, Bangladesh, 1200 Less <<
NCT01170923 Non-small Cell Lung Cancer Phase 2 Unknown - -
NCT00666783 Chemotherapy-Induced Nausea an... More >>d Vomiting Less << Phase 2 Completed - China, Shaanxi ... More >> Xijng Hospital Xi,an, Shaanxi, China, 710032 Less <<
NCT02557035 Chemotherapy-Induced Nausea an... More >>d Vomiting Less << Phase 3 Completed - -
NCT02145390 - Terminated(Investigator Decisi... More >>on - Insufficient Accrual) Less << - -
NCT02557035 - Completed - -
NCT00970385 Peripheral T Cell Lymphoma Phase 3 Completed - France ... More >> Dr REMY GRESSIN Grenoble, France, 38043 Less <<
NCT01074021 Nasopharyngeal Cancer Phase 3 Unknown August 2016 China, Fujian ... More >> Fujian Medical University Union Hospital Fuzhou, Fujian, China, 350001 Fujian Provincial Cancer Hospital Fuzhou, Fujian, China Xiamen First Hospital Xiamen, Fujian, China, 361003 China, Guangdong The Affiliated Cancer Hospital of Guangzhou Medical Hospital Guangzhou, Guangdong, China, 510095 China, Guangxi The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China Affiliated Tumor Hospital of Guangxi Medical University Xining, Guangxi, China, 530021 China, Hebei The Fourth Hebei Province Hospital Shijiazhuang, Hebei, China, 050011 China, Heilongjiang The Affiliated Cancer Hospital of Haerbin Medical University Haerbin, Heilongjiang, China, 150081 China, Henan Henan Cancer Hospital Zhengzhou, Henan, China, 450008 China, Hubei Hubei Province Caner Hospital Wuhan, Hubei, China, 430079 Wuhan Union Hospital Wuhan, Hubei, China China, Liaoning Shengjing Hospital of China Medical University Shenyang, Liaoning, China, 110003 Liaoning Province Cancer Hospital Shenyang, Liaoning, China, 110042 China, Shandong Shandong Caner Hospital Jinan, Shandong, China, 250117 China, Sichuan Sichuan Province Cancer Hospital Chengdu, Sichuan, China West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH) Chengdu, Sichuan, China China, Zhejiang Zhejiang Cancer Hospital Hangzhou, Zhejiang, China, 310022 China Cancer Institute & Hospital.Chinese Academy of Medical Sciences Beijing, China, 100021 Peking Union Medical College Hospital Beijing, China, 100032 Beijing Cancer Hospital Beijing, China, 100142 The General Hospital of the People's Liberation Army Beijing, China, 100853 The Affiliated Renji Hosptial of ShanghaiJiao Tong University Shanghai, China, 200001 Fudan University Shanghai Cancer Center ShangHai, China Tianjin Cancer Hospital Tianjin, China, 300060 Less <<
NCT03579082 Diffuse Large B Cell Lymphoma Phase 4 Recruiting December 1, 2019 China, Henan ... More >> Oncology Department of The First Affilliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com    Contact: Mingzhi Zhang, Pro,Drc    13838565629    mingzhi_zhang@126.com Less <<
NCT00570531 Loco-regional Esophageal Cance... More >>r Less << Phase 2 Terminated(The study was unabl... More >>e the accrue the required number of patients within a reasonable time.) Less << - -
NCT02516241 Urothelial Cancer Phase 3 Recruiting September 23, 2019 -
NCT00570531 - Terminated(The study was unabl... More >>e the accrue the required number of patients within a reasonable time.) Less << - -
NCT01770418 Lung Neoplasms Phase 1 Phase 2 Recruiting - United States, Florida ... More >> University of Florida Proton Therapy Institute Recruiting Jacksonville, Florida, United States, 32206 Contact: Samantha Sago    904-588-1529    SSago@floridaproton.org    Principal Investigator: Brad Hoppe, MD          United States, Illinois Northwestern Medicine Chicago Proton Center Recruiting Warrenville, Illinois, United States, 60555 Contact: Megan Boroczk    630-315-1797    Megan.Boroczk@nm.org    Principal Investigator: John Chang, MD          United States, Maryland Maryland Proton Treatment Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Carl Brown    410-364-5353    CarlBrown@umm.edu    Principal Investigator: Pranshu Mohindra, MD          United States, New Jersey Princeton ProCure Management LLC Recruiting Somerset, New Jersey, United States, 08873 Contact: Heba Darwish    732-357-2676    heba.darwish@nj.procure.com    Principal Investigator: Brian Chon, MD          United States, Oklahoma ProCure Proton Therapy Center Recruiting Oklahoma City, Oklahoma, United States, 73142 Contact: Kayla Tarrant    405-773-6775    research@okc.procure.com    Principal Investigator: Gary Larson, MD          United States, Virginia Hampton University Proton Therapy Institute Recruiting Hampton, Virginia, United States, 23666 Contact: Donna Sternberg, RN, BSN, OCN    757-251-6839    Donna.Sternberg@hamptonproton.org    Principal Investigator: Christopher Sinesi, MD Less <<
NCT02471027 - Not yet recruiting June 2019 China, Beijing ... More >> Beijing Obstetrics and Gynecology Hospital, Capital Medical University Beijing, Beijing, China, 100000 Less <<
NCT01945879 Pancreatic Cancer Phase 1 Phase 2 Completed - Germany ... More >> Charité - Universitätsmedizin Berlin Berlin, Germany, 13353 Less <<
NCT03274284 Bladder Cancer Phase 4 Not yet recruiting December 2019 -
NCT00954512 - Terminated(This study was term... More >>inated for business reasons.) Less << - -
NCT01187290 Non-small Cell Lung Cancer Phase 2 Unknown June 2013 -
NCT01553071 Solid Tumor Phase 1 Recruiting - United States, Texas ... More >> University of Texas Southwestern Not yet recruiting Dallas, Texas, United States, 75390 Contact: Dong Ying    214-648-5107    ying.dong@utsouthwestern.edu    Contact: Marcella Aguilar    214-648-1479    marcella.aguilar@utsouthwestern.edu    Principal Investigator: David Gerber, MD          Joe Arrington Cancer Center/Covenant Children's Hospital Recruiting Lubbock, Texas, United States, 79410 Contact: Christy Ratheal    806-725-8131    cratheal@covhs.org    Principal Investigator: Isaac Tafur, MD          University Medical Center Recruiting Lubbock, Texas, United States, 79415 Contact: Melanie Bisbee    806-775-8590    melanie.bisbee@umchealthsystem.com    Principal Investigator: Sanjay Awasthi, MD Less <<
NCT00128817 Larynx Neoplasms Phase 3 Terminated(Slow Accrual) May 2015 India ... More >> Tata Memorial Hospital Mumbai, Maharashtra, India, 400012 Less <<
NCT00954512 Neoplasms Phase 1 Phase 2 Terminated(This study was term... More >>inated for business reasons.) Less << - -
NCT02350361 Lung Cancer Phase 2 Phase 3 Unknown March 2016 China ... More >> Peking University Third Hospital Recruiting Beijing, China Contact: Li Liang, MD    13241870816 Less <<
NCT02014831 Squamous Cell Carcinoma of the... More >> Penis Less << Phase 2 Withdrawn(Industry decline to ... More >>supply study drug) Less << - France ... More >> CHRU Strasbourg Strasbourg, Bas Rhin, France, 67098 Institut Paoli Calmettes Marseille, Bouches du Rhône, France, 13273 Institut Bergonié Bordeaux, Gironde, France, 33076 Institut Claudius Regaud Toulouse, Haute Garonne, France, 31052 Institut Curie Paris, Ile de France, France, 75005 APHP Hôpital Saint Louis Paris, Ile de France, France, 75475 Centre Léon Bérard Lyon, Rhône, France, 69373 Less <<
NCT01950689 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 3 Recruiting June 2021 United Kingdom ... More >> Cheltenham General Hospital Recruiting Cheltenham, Gloucestershire, United Kingdom, GL53 7AN Principal Investigator: Warren Grant          Clatterbridge Centre for Oncology Recruiting Bebington, Merseyside, United Kingdom, CH63 4JY Principal Investigator: David Husband          St James' Hospital Recruiting Leeds, West Yorkshire, United Kingdom, LS9 7TF Principal Investigator: Mehmet Sen          Belfast City Hospital Recruiting Belfast, United Kingdom, BT9 7AB Contact: Fiona McCloskey          Queen Elizabeth Hospital Suspended Birmingham, United Kingdom, B15 2TH Bradford Teaching Hospitals NHS Foundation Trust Recruiting Bradford, United Kingdom, BD9 6RJ Principal Investigator: Michael Ho          Bristol Haematology and Oncology centre Recruiting Bristol, United Kingdom, BS2 8ED Principal Investigator: Hoda Booz          Addenbrookes Hospital Recruiting Cambridge, United Kingdom, CB2 0QQ Principal Investigator: Gill Barnett          Velindre Cancer Centre Recruiting Cardiff, United Kingdom, CF14 2TL Principal Investigator: Mererid Evans          University Hospitals Coventry and Warwickshire Recruiting Coventry, United Kingdom, CV2 2DX Principal Investigator: Andrew Chan          The Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom, G12 0YN Principal Investigator: Stefano Schipani          The Royal Surrey County Hospital Recruiting Guildford, United Kingdom, GU2 7XX Principal Investigator: Katie Wood          Leicester Royal Infirmary Recruiting Leicester, United Kingdom, LE1 5WW Principal Investigator: Thiagarajan Sridhar          University College London Hospital Recruiting London, United Kingdom, NW1 2PG Principal Investigator: Ruheena Mendes          The Royal Marsden Recruiting London, United Kingdom, SW3 6JJ Principal Investigator: Chris Nutting          The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Principal Investigator: Nick Slevin          The James Cook University Hospital Suspended Middlesborough, United Kingdom, TS4 3BW Mount Vernon Recruiting Middlesex, United Kingdom, HA6 2RN Principal Investigator: Catherine Lemon          Freeman Hospital Withdrawn Newcastle, United Kingdom, NE7 7DN Nottingham University Hospitals Recruiting Nottingham, United Kingdom, NG5 1PB Principal Investigator: Judith Christian          Weston Park Hospital Recruiting Sheffield, United Kingdom, S10 2SJ Principal Investigator: Bernadette Foran          Singleton Hospital Recruiting Swansea, United Kingdom, SA2 8QA Principal Investigator: Russell Banner          York Hospital Recruiting York, United Kingdom, Y031 8HE Principal Investigator: Robin Prestwich Less <<
NCT01692496 Advanced and / or Metastatic L... More >>iposarcoma Less << Phase 2 Completed - Germany ... More >> HELIOS Klinikum Berlin-Buch (Sarkomzentrum Berlin-Brandenburg) Berlin, Germany, D-10707 Universitätsklinikum EssenInnere Klinik (Tumorforschung) Essen, Germany, D-45147 Medizinische Hochschule Hannover (Zentrum Innere Medizin) Hannover, Germany, D-30625 Universitätsmedizin Mannheim (Sarkomzentrum) Manheim, Germany, D-68169 Klinikum Großhadern der LMU Universität München (Med. Klinik und Poliklinik II) Munich, Germany, D-80336 Spain Hospital Central de Asturias Oviedo, Asturias, Spain, 33011 Hospital Universitario de Canarias La Laguna, Islas Canarias, Spain, 38320 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Complejo Hospitalario Universitario de Vigo Vigo, Pontevedra, Spain, 36204 Hospital Vall d'Hebrón Barcelona, Spain, 08035 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital Universitari Son Espases Palma de Mallorca, Spain, 07010 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Instituto Valenciano de Oncología Valencia, Spain, 46009 Hospital Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT00450502 Neoplasms Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02509806 Gastric Cancer Phase 2 Phase 3 Recruiting December 2017 China, Hebei ... More >> Fourth Affiliated Hospital of Hebei Medical University Recruiting Shijiazhuang, Hebei, China, 050011 Principal Investigator: Zhao Qun, MD Less <<
NCT00003143 Lymphoma Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT03679338 Nonresectable Bile Duct Cancer Phase 2 Recruiting November 2021 France ... More >> Institut Paoli-Calmettes Recruiting Marseille, France, 13009 Contact: GENRE Dominique, MD    + 33 4 91 22 37 78    drci.up@ipc.unicancer.fr    Contact: COURNIER Sandra    + 33 4 91 22 37 78    drci.up@ipc.unicancer.fr    Principal Investigator: BORIES Erwan, MD Less <<
NCT00539877 Stomach Neoplasms Phase 1 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00127920 Ovarian Neoplasms Phase 2 Completed - United States, California ... More >> Gynecologic Oncology Associates Newport Beach, California, United States, 92663 United States, Florida Florida Hospital College of Health Sciences Orlando, Florida, United States, 32803 Less <<
NCT02679963 Non Small Cell Lung Cancer Phase 2 Recruiting January 2021 France ... More >> Gustave Roussy Cancer Campus Recruiting Villejuif, Val de Marne, France, 94805 Contact: Valérie Mairot    0142113730 ext +33    Valerie.mairot@gustaveroussy.fr Less <<
NCT01163552 Pleural Metastases ... More >> Breast Cancer Colon Cancer Ovarian Cancer Uterine Cancer Renal Cell Cancer Thymic Cancer Less << Phase 2 Completed - United States, New York ... More >> St. Luke's-Roosevelt Hospital Center New York, New York, United States, 10019 Less <<
NCT00815945 Mesenchymal Tumor ... More >> Carcinosarcoma Leiomyosarcoma Less << Phase 2 Completed - Germany ... More >> Charité, Campus Virchow Klinikum, Frauenklinik Berlin, Germany, 13353 Malteser Krankenhaus, Gynäkologie und Geburtshilfe Bonn, Germany, 53123 Klinikum Bremen-Mitte gGmbH, Frauenklinik Bremen, Germany, 28177 Universitätsklinikum Carl Gustav Carus, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe Dresden, Germany, 01307 Evangelisches Krankenhaus Düsseldorf, Frauenklinik Duesseldorf, Germany, 40217 Universitätsklinikum Essen, Frauenklinik Essen, Germany, 45122 Klinikum der J. W. Goethe-Universität, Klinik für Gynäkologie und Geburtshilfe Frankfurt, Germany, 60590 University Hospital Hamburg-Eppendorf Hamburg, Germany, 20251 Gynäkologisch-onkologische Praxis Hannover, Germany, 30177 St. Vincentius Kliniken AG, Frauenklinik Karlsruhe, Germany, 76135 Universitätsklinikum Giessen und Marburg GmbH, Klinik für Gynäkologie, Gynäkologische Endokrinologie und Onkologie Marburg, Germany, 35043 Klinikum Großhadern, Frauenklinik München, Germany, 81377 Universitätsklinikum Tübingen, Frauenklinik Tübingen, Germany, 72076 Universitätsklinikum Ulm, Universitätsfrauenklinik Ulm, Germany, 89075 Dr. Horst Schmidt Kliniken GmbH, Klinik für Gynäkologie und gynäkologische Onkologie Wiesbaden, Germany, 65199 Less <<
NCT03509012 Carcinoma, Squamous Cell of He... More >>ad and Neck Carcinoma, Non-Small-Cell Lung Small Cell Lung Carcinoma Less << Phase 1 Recruiting April 4, 2022 United States, Arizona ... More >> Research Site Recruiting Tucson, Arizona, United States, 85719 United States, Colorado Research Site Recruiting Aurora, Colorado, United States, 80045 United States, Missouri Research Site Not yet recruiting Saint Louis, Missouri, United States, 63110 United States, New Jersey Research Site Withdrawn Middletown, New Jersey, United States, 07748 Japan Research Site Recruiting Koto-ku, Japan, 135-8550 Research Site Recruiting Sunto-gun, Japan, 411-8777 Korea, Republic of Research Site Recruiting Seoul, Korea, Republic of, 03080 Research Site Recruiting Seoul, Korea, Republic of, 03722 Research Site Recruiting Seoul, Korea, Republic of, 05505 Research Site Recruiting Seoul, Korea, Republic of, 135-710 Taiwan Research Site Not yet recruiting Kaohsiung, Taiwan, 807 Research Site Not yet recruiting Taipei, Taiwan, 10002 Less <<
NCT00937612 Head and Neck Neoplasms ... More >> Carcinoma, Squamous Cell Less << Not Applicable Terminated(Study group showed ... More >>better results. Poor Accrual.) Less << - Taiwan ... More >> Chang Gung Memorial Hospital, Keelung branch Keelung, Taiwan, 222 Chang Gung Memorial Hospital, Linkou Branch Taoyuan, Taiwan, 333 Department of Radiation Therapy, Chang Gung Memorial Hospital, Linkou branch Taoyuan, Taiwan, 333 Less <<
NCT02118415 NSCLC Stage IIIA/B Phase 2 Unknown February 2018 Germany ... More >> Klinikum rechts der Isar, Strahlentherapie und Radiologische Onkologie Recruiting Munich, Germany, 81675 Contact: Hanno Specht, Dr.    +49 (0)89 4140 ext 5910    Hanno.Specht@mri.tum.de Less <<
NCT02284308 NSCLC Not Applicable Recruiting July 2023 Belgium ... More >> University Hospital Gent Not yet recruiting Gent, Belgium, 9000 Contact: Veerle Surmont          Netherlands Radiotherepiegroep Recruiting Arnhem, Gelderland, Netherlands, 6815 AD Principal Investigator: Marcel Stam          Caniusius-Wilhelmina Hospital Recruiting Nijmegen, Gelderland, Netherlands, 6532 SZ Principal Investigator: Yvonne Berk          Ziekenhuisgroep Twente Recruiting Almelo, Overijssel, Netherlands, 7609 PP Principal Investigator: Jeske Staal          Deventer Hospital Recruiting Deventer, Overijssel, Netherlands, 7416 SE Principal Investigator: Suzy Samii          Radiotherapiegroep Recruiting Deventer, Overijssel, Netherlands, 7416 SE Principal Investigator: Ernest Vonk          Gelre ziekenhuis Recruiting Apeldoorn, Netherlands Contact: N Pronk, Dr.          Principal Investigator: N Pronk          Rijnstate Ziekenhuis Recruiting Arnhem, Netherlands, 6815 AD Contact: Niels Claessens          Amphia Ziekenhuis Not yet recruiting Breda, Netherlands, 4818 CK Contact: Joachim Aerts          Medical Centre Haaglanden Recruiting Den Haag, Netherlands, 2512 VA Contact: Klaar Maas          Catharina Hospital Eindhoven Recruiting Eindhoven, Netherlands, 5623 EJ Contact: Ben van den Borne          Zuyderland Recruiting Heerlen, Netherlands, 6419 PC Principal Investigator: Gerben Bootsma          Leiden University Medical Centre Not yet recruiting Leiden, Netherlands, 2333 ZC Contact: Rajen Ramai          MAASTRO clinic Recruiting Maastricht, Netherlands, 6229 ET Contact: Judith van Loon, MD, PhD    +31 88 44 55 666    judith.vanloon@maastro.nl    Contact: Nadja Drummen    +31 88 44 55 817    nadja.drummen@maastro.nl    Principal Investigator: Judith van Loon          Maastricht University Medical Center Recruiting Maastricht, Netherlands, 6229 HX Contact: Anne-Marie Dingemans, MD, PhD    +31 43 387 65 43    a.dingemans@maastro.nl    Principal Investigator: Anne-Marie Dingemans          University Medical Centre Nijmegen Recruiting Nijmegen, Netherlands, 6525 GA Principal Investigator: Olga Schuurbiers          Laurentius Hospital Recruiting Roermond, Netherlands, 6043 VC Contact: Cordula Pitz          VieCuri Medical Centre Recruiting Venlo, Netherlands, 5912 BL Contact: Marcel Westenend Less <<
NCT03223740 Locally Advanced Gastric Carci... More >>noma Less << Phase 3 Recruiting October 2021 China, Shanxi ... More >> Xijing Hospital, GI institute Active, not recruiting Xi'an, Shanxi, China, 710032 China, Sichuan friendship Hospital Recruiting Chengdu, Sichuan, China, 610000 Contact: lili deng, MD    +8613880926676       ziyang People's Hospital Recruiting Siyang, Sichuan, China Contact: min wei, MD    +8613980386078 Less <<
NCT00159471 Pancreatic Cancer Not Applicable Terminated(Insufficient Accrua... More >>l) Less << - United States, California ... More >> U.S.C / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01653067 Diffuse Large B-Cell Lymphoma Phase 2 Unknown July 2018 Germany ... More >> University Hospital Freiburg Freiburg, Baden-Württemberg, Germany, 79106 University of Heidelberg Hospital Heidelberg, Baden-Württemberg, Germany, 69120 University Hospital Ulm Ulm, Baden-Württemberg, Germany, 89081 University Hospital Erlangen Erlangen, Bayern, Germany, 91054 Ludwig-Maximilians-University of Munich Munich, Bayern, Germany, 81377 Technische Universität München Munich, Bayern, Germany, 81675 Johann Wolfgang Goethe University Hospitals, Frankfurt Frankfurt, Hessen, Germany, 60590 Johannes Guttenberg University Mainz Mainz, Rheinland-Pfalz, Germany, 55101 Charité University Berlin Berlin, Germany, 12200 Less <<
NCT02644252 Lung Cancer Phase 3 Recruiting December 2019 Denmark ... More >> Department of Oncology, Vejle Hospital Recruiting Vejle, Denmark Contact: Christa H Nyhus, MD       christa.haugaard.nyhus@rsyd.dk    Principal Investigator: Lisbeth Bertelsen, MD Less <<
NCT03547973 Urothelial Carcinoma Phase 2 Recruiting May 2020 United States, Connecticut ... More >> Smilow Cancer Hospital at Yale-New Haven Recruiting New Haven, Connecticut, United States, 06510 Contact: Ebony Williams    203-785-5720    ebony.williams@yale.edu    Contact: Shelby DeCarlo    203-737-6299    shelby.decarlo@yale.edu    Principal Investigator: Daniel Petrylak, MD          United States, Nebraska Urology Cancer Center Recruiting Omaha, Nebraska, United States, 68130 Contact: Stacy Moore    402-697-2229    smoore@gucancer.com    Principal Investigator: Luke Nordquist, MD          United States, New York Weill Cornell Medicine Recruiting New York, New York, United States, 10021 Contact: Pryianka Patel       prp2013@med.cornell.edu    Contact: Monique Tarrant       mot2013@med.cornell.edu    Principal Investigator: Scott T. Tagawa, MD, MS Less <<
NCT00301548 Breast Neoplasms ... More >> Carcinoma Less << Phase 2 Completed - -
NCT02937272 Solid Tumor Phase 1 Recruiting May 3, 2021 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94115 Contact    415-514-6568       Principal Investigator: Pamela Munster          United States, Kentucky University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact    502-562-4158       Principal Investigator: Rebecca Redman          United States, New York NYU Clinical Cancer Center Not yet recruiting New York, New York, United States, 10016 Contact    212-263-2441       Principal Investigator: Dimitris Placantonakis          Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact    646-962-6137       Principal Investigator: Howard Fine          United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact    713-563-5844       Principal Investigator: Timothy Yap          Australia, New South Wales Calvary Mater Newcastle Recruiting Newcastle, New South Wales, Australia, 2298 Contact    61243401581       Principal Investigator: Andre van der Westhuizen          St Vincent's Hospital Recruiting Sydney, New South Wales, Australia, 2010 Contact    6193555655       Principal Investigator: Anthony Joshua          Australia, Queensland Greenslopes Private Hospital Recruiting Greenslopes, Queensland, Australia, 4120 Contact    61733947111       Principal Investigator: Victoria Atkinson          Canada, Ontario Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact    4169462277       Principal Investigator: Warren P Mason          France Hopital Saint-Louis Recruiting Paris, Cedex 10, France, 75475 Contact    33171207466       Principal Investigator: Antoine Carpentier          CHRU de Lille- Hôpital Roger Salengro Recruiting Lille, France, 59037 Contact    33662688717       Principal Investigator: Emilie Le Rhun          Hôpital Saint Joseph Recruiting Paris, France, 75014 Contact    330144127456       Principal Investigator: ERIC RAYMOND          Gustave Roussy Recruiting Villejuif Cedex, France, 94805 Contact    33142114338       Principal Investigator: Christophe Massard          Germany Universitätsklinikum Würzburg Recruiting Würzburg, Bayern, Germany, 97080 Contact    4993120140160       Principal Investigator: Mario Löhr          Universitätsklinikum Essen Recruiting Essen, Nordrhein-Westfalen, Germany, 45122 Contact    492017232024       Principal Investigator: Jörg Hense          Charité Universitätsmedizin Berlin Recruiting Berlin, Germany, 12203 Contact    493084452648       Principal Investigator: Sebastian Ochsenreither          Italy Istituto Clinico Humanitas Recruiting Rozzano, Milano, Italy, 20089 Contact    390282244080       Principal Investigator: Armando Santoro          Ospedale Policlinico Giambattista Rossi, Borgo Roma Recruiting Verona, Italy, 37134 Contact    390458128148       Principal Investigator: Davide Melisi          Japan National Cancer Center Hospital Not yet recruiting Chuo-Ku, Tokyo, Japan, 104-0045 Contact    81120360605       Principal Investigator: Shunsuke Kondo          Spain Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain, 08035 Contact    34934894374       Principal Investigator: Elena Garralda Cabanas          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact    34913908000       Principal Investigator: Juan Manuel Sepúlveda Sánchez          Hospital Clínico Universitario de Valencia Recruiting Valencia, Spain, 46010 Contact    34961973528       Principal Investigator: Andres Cervantes Ruiperez          Switzerland Ospedale Regionale di Bellinzona e Valli - Bellinzona Recruiting Bellinzona, Ticino, Switzerland, 6500 Contact    41918118931       Principal Investigator: Anastasios Stathis          Universitätsspital Zürich Recruiting Zürich, Switzerland, 8091 Contact    41442552214       Principal Investigator: Christian Britschgi Less <<
NCT02178397 NSCLC Patients With EGFR Activ... More >>ating Mutation Less << Phase 3 Terminated(lack of recruitment... More >>) Less << - France ... More >> CH Aix En Provence, France CH Amiens, France CHRU Angers, France, 49933 CH Annecy, France, 74374 CHU Brest, France, 29609 Centre François BACLESSE Caen, France, 14000 CHIC Creteil, France, 94000 CH Draguignan, France, 83007 CH Elbeuf, France CHIC GAP, France, 05007 Ch La Roche/Yon La Roche/yon, France Centre Hospitalier Le MANS, France, 72037 Centre Oscar Lambret Lille, France, 59020 CHU Limoges, France, 87042 CH Longjumeau, France, 91160 CH Lorient, France, 35632 CH Macon, France, 71018 CH Mantes La Jolie, France, 78201 Institut Paoli Calmettes Marseille, France, 13273 AP-HM - Hôpital Nord Marseille, France CH Meaux, France, 77104 Centre Hospitalier Intercommunal Meulan, France, 78250 CH PAU, France Centre Catalan Perpignan, France CHU Rennes, France, 35033 CH Roanne, France CHU Rouen, France CH Salon de Provence, France CH Sens, France, 89100 CH St BRIEUC, France Institut de Cancérologie de la Loire St ETIENNE, France, 42271 Centre Paul Strauss Strasbourg, France, 67065 CH Tarbes, France Hôpital d'instruction des Armées Sainte-Anne Toulon, France, 83041 CH Villefranche, France, 69655 Less <<
NCT02817958 Penile Cancer ... More >> Squamous Carcinoma Less << Phase 2 Recruiting September 2022 France ... More >> ICO-Paul Papin Recruiting Angers, France, 49055 Contact: Emmanuelle BOMPAS, Doctor    +33(0)2 41 35 27 00    emmanuelle.bompas@ico.unicancer.fr    Chr Besancon Recruiting Besançon, France, 25000 Contact: Tristant MAURINA, Doctor    +33(0)3 81 66 93 67    t1maurina@chu-besancon.fr    Hôpital SAINT ANDRE Recruiting Bordeaux, France, 33075 Contact: Amaury DASTE, Doctor       amaury.daste@chu-bordeaux.fr    Centre FRANCOIS BACLESSE Recruiting Caen, France, 14076 Contact: Florence JOLY, Prof    +33 2 31 45 50 02    f.joly@baclesse.unicancer.fr    Chru Gabriel Montpied Recruiting Clermont Ferrand, France, 63000 Contact: Laurent GUY, Professor    +33(0)4 73 75 14 97    lguy@chu-clermontferrand.fr    Ch de Limoges Recruiting Limoges, France, 87042 Contact: Aurélien DESCAZEAUD, Professor    +33(0)5 55 05 80 15    aurelien.descazeaud@chu-limoges.fr    Centre Leon Berard Recruiting Lyon, France, 69008 Contact: Aude FLECHON, Doctor    +33(0)4 78 78 26 43    aude.flechon@lyon.unicancer.fr    Chu Lyon Sud Recruiting Lyon, France, 69310 Contact: Jean-Etienne TERRIER, Dr    +33 4 72 67 88 01    jean-etienne.terrier01@chu-lyon.fr    Institut Paoli-Calmettes Recruiting Marseille, France, 13273 Contact: Gwenaelle GRAVIS, Doctor    +33(0)4 91 22 37 40    gravisg@ipc.unicancer.fr    Institut de Cancerologie de Lorraine Recruiting Nancy, France, 54519 Contact: Vincent MASSARD, Dr    +33 3 23 59 84 61    v.massard@nancy.unicancer.fr    Clinique Urologique- Chu Hotel Dieu Recruiting Nantes, France, 44093 Contact: Jérôme RIGAUD, Professor    +33(0)2 40 08 39 10    jrigaud@chu-nantes.fr    Institut de Cancerologie Du Gard - Centre Oncogard Recruiting Nîmes, France, 300029 Contact: Angélique CHAPELLE, Doctor    +33(0)4 30 06 10 14    a.chapelle@oncogard.com    Hopital Saint Louis Recruiting Paris, France, 75010 Contact: Stéphane CULINE, Professor    +33(0)1 42 49 42 47    stephane.culine@aphp.fr    Chu de Rouen Recruiting Rouen, France, 76031 Contact: Christian PFISTER, Professor    +33(0)2 32 88 81 63    christian.pfister@chu-rouen.fr    ICO-René Gauducheau Recruiting saint Herblain, France, 44805 Contact: Emmanuelle BOMPAS, Doctor    +33(0)2 40 67 97 00    emmanuelle.bompas@ico.unicancer.fr    Hopitaux Universitaires de Strasbourg Recruiting Strasbourg, France, 67091 Contact: Philippe BARTHELEMY, Doctor       philippe.barthelemy@chru-strasbourg.fr    Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Loic MOUREY, Doctor    +33(0)5 31 15 51 67    mourey.loic@iuct-oncopole.fr Less <<
NCT02215447 Gastrointestinal Neuroendocrin... More >>e Carcinomas Less << Phase 2 Active, not recruiting October 2020 Australia, New South Wales ... More >> Royal North Shore Hospital St Leonards, New South Wales, Australia, 2065 Australia, Victoria Barwon Health Geelong, Victoria, Australia, 3220 Royal Melbourne Hospital Parkville, Victoria, Australia, 3050 Less <<
NCT01048970 Lung Cancer Phase 2 Phase 3 Unknown December 2010 Mexico ... More >> National Institute of Cancerologia Recruiting Mexico City, Mexico, 14080 Contact: Oscar Arrieta, MD    (+52) (55) 5628-0400 ext 832    ogar@servidor.unam.mx    Contact: Karla Sanchez, MsC    (+52) (55) 5414-7200 ext 4216    ksanchez@medicasur.org.mx    National Institute of Cancerología Recruiting Mexico City, Mexico, 14080 Contact: Oscar Arrieta Less <<
NCT00920920 - Active, not recruiting December 2020 Austria ... More >> MUV Vienna, Austria, 1090 Less <<
NCT01376752 Ovarian Epithelial Cancer Recu... More >>rrent Less << Phase 3 Recruiting December 2020 Belgium ... More >> Institut Jules Bordet Recruiting Brussels, Belgium Principal Investigator: Gabriel LIBERALE          France CHU d'AMIENS Recruiting Amiens, France Principal Investigator: Sophie SANGUIN          Centre Paul Papin Recruiting Angers Cedex 9, France, 49933 Contact: Gérard LORIMIER, Doctor       g.lorimier@angers.fnclcc.fr    Principal Investigator: Romuald WERNERT          Centre Hospitaleir Universitaire Jean Minjoz Not yet recruiting Besancon, France, 25000 Contact: Elsa KALBACHER, Dr       ekalbacher@gmail.com    Principal Investigator: Elsa KALBACHER          Institut Bergonie Recruiting Bordeaux Cedex, France, 33076 Contact: Frédéric GUYON, Doctor       guyon@bergonie.org    Principal Investigator: Frédéric GUYON          Centre Francois Baclesse Not yet recruiting Caen Cedex 3, France, 14076 Contact: Jean-Marc GUILLOIT, Doctor       jm.guilloit@baclesse.fr    Principal Investigator: Jean-Marc GUILLOIT          Centre Jean Perrin Recruiting Clermont-ferrand Cedex 1, France, 63011 Contact: Christian POMEL, Pr       Christophe.POMEL@cjp.fr    Principal Investigator: Christian POMEL          Centre hospitalier de Dijon Recruiting Dijon, France Principal Investigator: Jean-Marc ROUSSELET          CHU Grenoble Not yet recruiting Grenoble, France, 38043 Contact: Fabien PETITPERRIN       FPetitperrin@chu-grenoble.fr    Principal Investigator: Fabien PETITPERRIN          CHU de Grenoble Recruiting Grenoble, France Principal Investigator: Cristina COSTAN          Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Eric LEBLANC, Dr       e-leblanc@o-lambret.fr    Principal Investigator: Eric LEBLANC          Centre Hospitalier Universitaire Dupuytren Recruiting Limoges, France, 87042 Contact: Sylvaine DURAND-FONTANIER, Doctor       sylvainedurand-fontanier@voila.fr    Principal Investigator: Sylvaine DURAND-FONTANIER          Centre Leon Berard Recruiting Lyon Cedex 08, France, 69373 Contact: Pierre MEEUS, Doctor       MEEUS@lyon.fnclcc.fr    Principal Investigator: Pierre MEEUS          Institut Paoli Calmettes Recruiting Marseille Cedex 9, France, 13273 Contact: Gilles HOUVENAEGHEL, Pr       houvenaeghelg@marseille.fnclcc.fr    Principal Investigator: Gilles HOUVENAEGHEL          AP-HM - Hôpital de la Timone Recruiting Marseille, France Principal Investigator: Aubert AGOSTINI          CRLC Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: François QUENET       francois.quenet@montpellier.unicancer.fr    Principal Investigator: François QUENET          Centre Hospitalier Universitaire Nice - Hopital L'Archet 2 Not yet recruiting Nice Cedex 3, France, 06202 Contact: Jean-Marc BEREDER, Dr       ber224@chu-nice.fr    Principal Investigator: Jean-Marc BEREDER          Hopital Lariboisiere Not yet recruiting Paris, France, 75010 Contact: Marc POCARD       marc.pocard@lrb.aphp.fr    Principal Investigator: Marc POCARD          Hopital Tenon Not yet recruiting Paris, France, 75020 Contact: Valeria LOI, Dr       valeria.loi@tnn.aphp.fr    Principal Investigator: Valeria LOI          Hôpital Européen Georges Pompidou Recruiting Paris, France Principal Investigator: Fabrice LECURU          Institut Curie Recruiting Paris, France Principal Investigator: Pascale MARIANI          Institute Curie Recruiting Paris, France Contact: Bernard BARANGER       bernard.baranger@curie.net    Principal Investigator: Bernard BARANGER          Centre Hopsitalier Lyon Sud Recruiting Pierre-benite Cedex, France, 69495 Contact: Olivier GLEHEN, Professor       olivier.glehen@chu-lyon.fr    Principal Investigator: Olivier GLEHEN          CHU - Hôpital de la Milétrie Recruiting Poitiers, France Principal Investigator: Cédric NADEAU          Centre Jean Godinot Not yet recruiting Reims Cedex, France, 51056 Contact: David KERE, Dr       david.kere@reims.fnclcc.fr    Principal Investigator: David KERE          Centre Hospitalier Universitaire Saint Etienne- Hopital Nord Not yet recruiting Saint-etienne, France, 42055 Contact: Karine ABBOUD, Dr       abboud_go@yahoo.fr    Principal Investigator: Karine ABBOUD          Ico-Centre Rene Gauducheau Recruiting Saint-herblain Cedex, France, 44805 Contact: Jean-Marc CLASSE, Professor       jm-classe@nantes.fnclcc.fr    Principal Investigator: Jean-Marc CLASSE          CHU Hautepierre Not yet recruiting Strasbourg, France, 67098 Contact: Cécile BRIGAND       cecile.brigand@chru-strasbourg.fr    Principal Investigator: Cécile BRIGAND          Institut Claudius Regaud Recruiting Toulouse Cedex, France, 31052 Contact: Gwenaël FERRON, Doctor       ferron.gwenael@claudiusregaud.fr    Principal Investigator: Gwenaël FERRON          Centre Alexis Vautrin Recruiting Vandoeuvre-les-nancy Cedex, France, 54511 Contact: Frédéric MARCHAL, Pr       f.marchal@nancy.fnclcc.fr    Principal Investigator: Frédéric MARCHAL          Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Sébastien GOUY, Doctor       sebastien.gouy@igr.fr    Principal Investigator: Sébastien GOUY          Spain Hospital Universitari Germans Trias I Pujol Recruiting Badalona, Spain Principal Investigator: Juan José TORRENT Less <<
NCT00540735 Cholangiocarcinoma Phase 3 Terminated(Big difficulties to... More >> enroll patients) Less << - France ... More >> UH Amiens Amiens, France, 80 000 UH Angers Angers, France, 49933 H Beaujon Clichy, France, 92 118 UH Henri Mondor Créteil, France, 94 010 UH Kremlin Bicêtre Le Kremlin Bicêtre, France, 94 275 UH Claude Huriez Lille, France, 59 037 Clinique Sainte Anne Lyon, France, 69 003 UH La Timone Marseille, France, 13 385 UH Marseille Nord Marseille, France, 13 915 H Metz-Thionville Metz, France, 57 038 UH Nantes Nantes, France, 44 000 Clinique du Trocadéro Paris, France, 75 116 UH Cochin Paris, France, 75 679 UH La Milétrie Poitiers, France, 86 021 UH Charles Nicolle Rouen, France, 76 031 UH Hôpital Civil Strasbourg, France, 67 091 UH Purpan Toulouse, France, 31 059 UH Rangueil Toulouse, France, 31 059 Less <<
NCT00772694 Testicular Cancer Phase 2 Unknown December 2011 Poland ... More >> Chemotherapy Unit, Dept of Urology, Instituite of Oncology Recruiting Warsaw, Poland, 02781 Principal Investigator: Iwona A Skoneczna, MD          Sub-Investigator: Agnieszka Chaladaj-Kujawska, MD Less <<
NCT02721576 Esophageal Neoplasms Phase 2 Recruiting December 2018 China, Shandong ... More >> Qianfoshan Hospital of Shandong Recruiting Jinan, Shandong, China, 250117 Contact: Jiandong Zhang    13583123486       Shandong Cancer Hospital and Institute Recruiting Jinan, Shandong, China, 250117 Contact: Jinming Yu    8653167626891       Jining NO.1 People's Hospital Recruiting Jining, Shandong, China, 250117 Contact: Peipei Wu    15853770581       Liaocheng People Hospital Recruiting Liaocheng, Shandong, China Contact: mingjun Li          Qingdao Center Medical Group Recruiting Qingdao, Shandong, China, 250117 Contact: Xuezhen Ma    18660221959       Rizhao City People 's Hospital Recruiting Rizhao, Shandong, China Contact: Yufeng Li          Fei Cheng People's Hospital Recruiting Tai'an, Shandong, China, 250117 Contact    13518688689       An Qiu People's Hospital Recruiting Weifang, Shandong, China, 250117 Contact: Chuandong Wang    15605368369       The Fourth People's Hospitalof Zibo Recruiting Zibo, Shandong, China, 250117 Contact: Qiang Zhang    13345221111 Less <<
NCT00264056 Advanced Metastastic Malignant... More >> Melanoma Refractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases Less << Not Applicable Unknown - Germany ... More >> Fachklinik Hornheide at the University of Münster, Germany Recruiting Münster, Germany, D-48157 Contact: Jens Atzpodien, MD PhD    49-251-3287-431    jens.atzpodien@fachklinik-hornheide.de    Sub-Investigator: Martina Reitz, Dr Less <<
NCT02721550 Esophageal Neoplasms Phase 2 Recruiting December 2018 China, Shandong ... More >> Qianfoshan Hospital of Shandong Recruiting Jinan, Shandong, China, 250117 Contact: Jiandong Zhang    13583123486       Shandong Cancer Hospital and Institute Recruiting Jinan, Shandong, China, 250117 Contact: Jinming Yu          Jining NO.1 People's Hospital Recruiting Jining, Shandong, China, 250117 Contact: Peipei Wu    15853770581       Liaocheng People Hospital Recruiting Liaocheng, Shandong, China Contact: Mingjun Li          Qingdao Center Medical Group Recruiting Qingdao, Shandong, China, 250117 Contact: Xuezhen Ma          Rizhao City People 's Hospital Recruiting Rizhao, Shandong, China Contact: Yufeng Li          Fei Cheng People's Hospital Recruiting Tai'an, Shandong, China, 250117 Contact: Wenyuan Zhao    13518688689       An Qiu People's Hospital Recruiting Weifang, Shandong, China, 250117 Contact: Chuandong Wang    15605368369       The Fourth People's Hospitalof Zibo Recruiting Zibo, Shandong, China, 250117 Contact: Qiang Zhang    13345221111 Less <<
NCT00760591 - Unknown - Korea, Republic of ... More >> Soon Chun Hyang University Hospital Recruiting Seoul, Korea, Republic of, 140-743 Contact: Soon Hyo Kwon, MD    +8-02-709-9491    ksoonhyo@hosp.sch.ac.kr    Principal Investigator: Dong Cheol Han, MD Less <<
NCT03325738 - Recruiting June 30, 2018 France ... More >> PEYRADE Frédéric Recruiting Nice, France, 06189 Contact: Frédéric PEYRADE    +33492031022    frederic.peyrade@nice.unicancer.fr Less <<
NCT03582800 Systemic Sclerosis ... More >> Dermatomyositis iPPSD2 Less << Phase 2 Not yet recruiting January 2022 France ... More >> CHU de BORDEAUX Not yet recruiting Bordeaux, France, 33000 Contact: Marie-Elise TRUCHETET, MD       marie-elise.truchetet@chu-bordeaux.fr    Principal Investigator: Marie-Elise TRUCHETET, MD          ApHp - Hôpital Bicêtre Not yet recruiting Le Kremlin-Bicêtre, France, 94270 Contact: Agnès LINGLART, MD       agnes.linglart@aphp.fr    Principal Investigator: Agnès LINGLART, MD          CHU de Limoges Not yet recruiting Limoges, France, 87042 Contact: Vincent GUIGONIS, MD       vincent.guigonis@unilim.fr    Contact: Claire BAHANS       claire.bahans@chu-limoges.fr    Principal Investigator: Vincent GUIGONIS, MD          Sub-Investigator: Anne-Laure FAUCHAIS, MD          Sub-Investigator: Pascalle VERGNE-SALLE, MD          Sub-Investigator: Didier MORIAU, MD          CHU de MONTPELLIER Not yet recruiting Montpellier, France, 34000 Contact: Alain LE QUELLEC, MD       a-lequellec@chu-montpellier.fr    Principal Investigator: Alain LE QUELLEC, MD          ApHp - hôpital Lariboisière Not yet recruiting Paris, France, 75000 Contact: Korng EA, MD       korngea@yahoo.fr    Principal Investigator: Korng EA, MD Less <<
NCT03456076 Carcinoma, Non-Small-Cell Lung Phase 3 Recruiting September 30, 2026 -
NCT02727868 Patient With Breast Cancer Not Applicable Unknown March 2018 France ... More >> Assistance Publique Hôpitaux de Marseille Recruiting Marseille, France, 13354 Contact: Urielle DESALBRES, Director    0491382747    drci@ap-hm.fr Less <<
NCT03691441 Oropharyngeal Cancer Phase 4 Recruiting June 5, 2023 Germany ... More >> Universitätsklinikum Hamburg Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Chia- Jung Busch, PD Dr.    004940741050038    cjbusch@uke.de    Contact: Andreas Krüll, PD Dr.    004940741055425    kruell@uke.de Less <<
NCT01216124 - - - -
NCT02721563 Esophageal Neoplasms Phase 2 Recruiting December 2018 China, Shandong ... More >> Qianfoshan Hospital of Shandong Recruiting Jinan, Shandong, China, 250117 Contact: Jiandong Zhang    13583123486       Qilu Hospital of Shandong University Not yet recruiting Jinan, Shandong, China, 250117 Contact: Yufeng Cheng    13869199969       Shandong Cancer Hospital and Institute Recruiting Jinan, Shandong, China, 250117 Contact: Jinming Yu    8653167626891       Jining NO.1 People's Hospital Recruiting Jining, Shandong, China, 250117 Contact: Peipei Wu    15853770581       Liaocheng People 's Hospital Recruiting Liaocheng, Shandong, China Contact: Mingjun Li, MD          Qingdao Center Medical Group Recruiting Qingdao, Shandong, China, 250117 Contact: Xuezhen Ma    18660221959       Rizhao City People 's Hospital Recruiting Rizhao, Shandong, China Contact: yufeng li          Fei Cheng People's Hospital Recruiting Tai'an, Shandong, China, 250117 Contact: Wenyuan Zhao    13518688689       An Qiu People's Hospital Recruiting Weifang, Shandong, China, 250117 Contact: Chuandong Wang    15605368369       The Fourth People's Hospitalof Zibo Recruiting Zibo, Shandong, China, 250117 Contact: Qiang Zhang    13345221111 Less <<
NCT03500133 Pediatric Hodgkin's Disease Phase 4 Recruiting October 31, 2032 Argentina ... More >> Hospital JP Garrahan Recruiting Buenos Aires, CF, Argentina, C1245AAL Contact: Carolina Cernadas, MD    541141226335    coordinacioninvestigacion@garrahan.gov.ar    Contact: Guillermo L Chantada, MD, PhD    541141226000    gchantada@yahoo.com    Sub-Investigator: Elizabeth Alfaro, MD          Sub-Investigator: Myriam Guitter, MD          Sub-Investigator: Cristian Sanchez La Rosa, MD          Sub-Investigator: María Sara Felice, MD Less <<
NCT02455843 Non Small Cell Lung Cancer Phase 3 Recruiting May 2018 China, Shandong ... More >> Binzhou Medical University Hospital Recruiting Binzhou, Shandong, China, +86 256600 Contact: Shao shui Chen, M.D    +86 15169959936    byfychenss@126.com    Dezhou People's Hospital Recruiting Dezhou, Shandong, China, +86 253000 Contact: Yu ting Dong    +86 13969286066    dyt1963@163.com    The Second People's Hospital of Dezhou Recruiting Dezhou, Shandong, China, +86 253000 Contact: Chun tang Wang, M.D    +86 13181378288    dzeyxwct@sina.com    Jinan Military General Hospital Recruiting Jinan, Shandong, China, +83 250001 Contact: Jing wang Bi, M.D    +86 15963119538    jingwangbi@outlook.com    Affliated Hospital of Shandong Academy of Medical Sciences Recruiting Jinan, Shandong, China, +86 250001 Contact: Ya hong Sun, M.D    13606415915    sunyahong0915@163.com    Shandong Provincial Hospital Recruiting Jinan, Shandong, China, +86 250001 Contact: Xin Ye, M.D    +86 0531-68773171    yexintaian2014@163.com    Affliated Hospital of Jining Medical University Recruiting Jining, Shandong, China, +86 272000 Contact: Jun ye Wang, M.D    +86 13563771996    jiningwangjunye@163.com    Liaocheng Cancer Hospital Recruiting Liaocheng, Shandong, China, +86 252000 Contact: Qing liang Feng, M.D    +86 15339949567    fql-123@sohu.com    The People's Hospital of Pingyi Country Recruiting Linyi, Shandong, China, +86 276000 Contact: Xing lu Xu, M.D    +86 18265398816    xlk2082@126.com    Affliated Hospital of Taishan Medical University Recruiting Taian, Shandong, China, +86 271000 Contact: Ben hua Zhang, M.D    +86 15169887577    zhangbenhua1964@163.com    The People's Liberation Army 88 Hospital Recruiting Taian, Shandong, China, +86 271000 Contact: Li cheng Zhang, M.D    +86 13605383651    zhanglc88@aliyun.com    Weifang People's Hospital Recruiting Weifang, Shandong, China, +86 262000 Contact: Guo hua Yu, M.D    +86 13685368817    ghyry@126.com    Yantai Yuhuangding Hospital Recruiting Yantai, Shandong, China, +86 264000 Contact: Liang ming Zhang, M.D    +86 18660079893    zhanglmdr@163.com    Tengzhou center of people's hospital Recruiting Zaozhuang, Shandong, China, +86 277000 Contact: Kai xian Zhang, M.D    +86 18663069829    kaixianzhang@aliyun.com Less <<
NCT00856830 Small Cell Lung Cancer ... More >> Extensive Stage Lung Cancer Chemonaive Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 - 0104 United States, Georgia Georgia Cancer Specialists Marietta, Georgia, United States, 30060 Less <<
NCT03443921 Pancreatic Cancer ... More >> Locally Advanced Pancreatic Cancer Neoadjuvant Therapy Borderline Resectable Pancreatic Cancer Less << Not Applicable Not yet recruiting March 2021 China, Jiangsu ... More >> The First Affiliated Hospital of Nanjing Medical University Not yet recruiting Nanjing, Jiangsu, China, 210029 Contact: Yi Miao, MD, PhD    +86-25-68136508    miaoyi@njmu.edu.cn Less <<
NCT02185768 Liver Cancer Phase 2 Completed - France ... More >> CHU Amiens Amiens, France CHU d'ANGERS Angers, France, 49933 CHU - Hôpital François Mitterand Dijon, France, 21079 Hôpital La Croix Rousse Lyon, France, 69317 Hôpital Edouard Herriot Lyon, France, 69437 CHU St Eloi Montpellier, France, 34295 Hôpital de l'Archet II Nice, France, 06202 Less <<
NCT01590160 Lung Cancer - Malignant Pleura... More >>l Mesothelioma Less << Phase 1 Phase 2 Active, not recruiting November 2018 United Kingdom ... More >> UCL Cancer Trials Centre London, United Kingdom, W1T 4TJ Less <<
NCT02036164 Uterine Cervical Cancer Phase 3 Recruiting January 2019 Thailand ... More >> Ratchaburi Hospital Active, not recruiting Muang, Ratchaburi, Thailand, 70000 Bhumibol Adulyadej Hospital Recruiting Bangkok, Thailand, 10220 Contact: Piyawan Pariyawateekul, MD    6689-0353777    nootpiya@hotmail.com    Contact: Apiradee Kridakara, MD    66-86-3671487    akrid7@hotmail.com    Principal Investigator: Piyawan Pariyawateekul, MD          Principal Investigator: Apiradee Kridakara, MD          Department of Obstetrics and Gynecology, Department of Radiology, Epidemiology Unit, Navamindradhiraj University Recruiting Bangkok, Thailand, 10300 Contact: Siriwan Tangjitgamol, MD    66-86-3841431    siriwanonco@yahoo.com    Contact: Kanisa Rongsriyam, MD    66-8181-68789    kanisa_r@hotmail.com    Principal Investigator: Siriwan Tangjitgamol, MD          Principal Investigator: Kanisa Rongsriyam, MD          Sub-Investigator: Jakkapan Khunnarong, MD          Sub-Investigator: Sunamchok Srijaipracharoen, MD          Sub-Investigator: Busaba Supawattanabodee, MSc          Sub-Investigator: Suphakarn Techapongsatorn, MD          Sub-Investigator: Kanyarat Katanyoo, MD          Health Intervention and Technology Assessment Program Not yet recruiting Bangkok, Thailand, 11000 Contact: Yot Teerawattananon, MD    66-84-6760080    yot.t@hitap.net    Principal Investigator: Yot Teerawattananon, MD          Department of Radiology, Department of Obstetrics and Gynecology, Chiang Mai University Recruiting Chiang Mai, Thailand, 50200 Contact: Ekkasit Tharavijitkul, MD    966-89-4338709    paan_31@hotmail.com    Principal Investigator: Ekkasit Tharavijitkul, MD          Sub-Investigator: Vichan Lordvithaya, MD          Sub-Investigator: Jatupol Srisomboon, MD          Chonburi Cancer Hospital Recruiting Chonburi, Thailand, 20000 Contact: Chokaew Tovanabutra, MD    66-81-4726633    chokaewt@hotmail.com    Principal Investigator: Chokaew Tovanabutra, MD          Sub-Investigator: Kittisak Chomprasert, MD          Lampang Cancer Hospital Recruiting Lampang, Thailand, 52000 Contact: Tussawan Asakit, MD    66-81-6715013    tussawan_a1@hotmail.com    Principal Investigator: Tussawan Asakit, MD          Sub-Investigator: Kannika Paengchit, MD          Lopburi Cancer Hospital Recruiting Lopburi, Thailand, 15000 Contact: Jirasak Sukhaboon, MD    66-89-7970600    fodjiji@gmail.com    Principal Investigator: Jirasak Sukhaboon, MD          Sub-Investigator: Panit Chiewaratanapong, MD          Department of Obstetrics and Gynecology, Department of Radiology, Prince of Songkla University Recruiting Songkla, Thailand, 90110 Contact: Thiti Atjimakul, MD    6681-2773793    thitiatjimakul@yahoo.com    Contact: Jitti Hanprasertpong, MD    66-89-6540214    hjitti@medicine.psu.ac.th    Principal Investigator: Thiti Atjimakul, MD          Principal Investigator: Duangjai Sangthawan, MD          Sub-Investigator: Jitti hanprasertpong, MD          Ubonratchathani Cancer Hospital Recruiting Ubonratchathani, Thailand, 34000 Contact: Taywin Chottetanaprasith, MD    66-81-9359756    taywinc@hotmail.com    Principal Investigator: Taywin Chottetanaprasith, MD          Sub-Investigator: Metee Wongsena, MD          Udonthani Cancer Hopital Recruiting Udonthani, Thailand, 41330 Contact: Sirentra Wanglikitkoon, MD    6684-6570028    sirentra@hotmail.com    Principal Investigator: Sirentra Wanglikitkoon, MD          Sub-Investigator: Somkit Penpattanagul, MD Less <<
NCT02208583 Hormone Refractory Prostate Ca... More >>ncer Less << Not Applicable Unknown December 2016 China, Tianjin ... More >> Department of Interventional Oncology, Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Wang HaiTao, Ph.D    +86-18630955984    peterrock2000@126.com    Principal Investigator: Wang HaiTao, Ph.D Less <<
NCT00856830 - Completed - -
NCT00532025 Carcinoma, Non-Small-Cell Lung Phase 2 Terminated - Germany ... More >> SIRN investigational trial site Essen, Germany SIRN investigational trial site Halle (Saale), Germany SIRN investigational trial site Loewenstein, Germany SIRN investigational trial site Johannes Gutenberg Universität Mainz, Germany SIRN investigational trial site Katholisches Klinikum Mainz, Germany SIRN investigational trial site Rotenburg (Wuemme), Germany Less <<
NCT01726374 Stage I Testicular Non-Seminom... More >>atous Germ Cell Tumor Less << Phase 3 Active, not recruiting August 2019 United Kingdom ... More >> Guy's Hospital London, England, United Kingdom, SE1 9RT Northampton General Hospital NHS Trust Northampton, England, United Kingdom, NN6 8BJ Velindre Cancer Center at Velindre Hospital Cardiff, Wales, United Kingdom, CF14 2TL Aberdeen Royal Infirmary Aberdeen, United Kingdom Ysbyty Gwynedd Bangor, United Kingdom Queen Elizabeth Hospital Birmingham, United Kingdom Royal Sussex County Hospital Brighton, United Kingdom Bristol Haematology and Oncology Centre Bristol, United Kingdom Queen's Hospital Burton-on-Trent, United Kingdom Addenbrooke's Hospital Cambridge, United Kingdom Cheltenham General Hospital Cheltenham, United Kingdom Gloucestershire Royal Hospital Cheltenham, United Kingdom University Hospitals Coventry and Warwickshire NHS Trust Coventry, United Kingdom Royal Derby Hospital Derby, United Kingdom Western General Hospital Edinburgh, United Kingdom Royal Devon and Exeter Hospital Exeter, United Kingdom Beatson West of Scotland Cancer Centre Glasgow, United Kingdom Royal Surrey County Hospital Guildford, United Kingdom Castle Hill Hospital Hull, United Kingdom Ipswich Hospital Ipswich, United Kingdom St James's University Hospital Leeds, United Kingdom Leicester Royal Infirmary Leicester, United Kingdom Lincoln County Hospital Lincoln, United Kingdom Clatterbridge Centre for Oncology Liverpool, United Kingdom Royal Liverpool University Hospital Liverpool, United Kingdom St Bartholomew's Hospital London, United Kingdom University College Hospital London, United Kingdom Maidstone Hospital Maidstone, United Kingdom James Cook University Hospital Middlesbrough, United Kingdom Norfolk and Norwich University Hospital Norwich, United Kingdom Nottingham City Hospital Nottingham, United Kingdom Churchill Hospital Oxford, United Kingdom Weston Park Hospital Sheffield, United Kingdom Southampton General Hospital Southampton, United Kingdom Royal Marsden Hospital Sutton, United Kingdom Less <<
NCT01218516 Adenocarcinoma of the Lung Phase 2 Completed - -
NCT02272699 Esophageal Squamous Cell Carci... More >>noma Less << Phase 2 Phase 3 Suspended(Because there are qu... More >>estions about adjuvant radiotherapy in this study, the clinical trial is under re-design.) Less << December 2018 China, Beijing ... More >> Beijing Cancer Hospital & Peking University Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT03701373 Gastric Cancer Stage IV ... More >> Cancer of Stomach Less << Phase 2 Recruiting December 2018 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Rui-hua Xu    +86-20-87343295    xurh@sysucc.org.cn    Contact: Ming-ming He, MD    +86-13632350737    hemm@sysucc.org.cn Less <<
NCT01313663 Lung Cancer, Small Cell Phase 2 Terminated - -
NCT01233843 Squamous Cell Head and Neck Ca... More >>rcinoma Less << Phase 3 Active, not recruiting May 2019 France ... More >> GIRARD CALAIS Marie-Helene Tours, France, 37044 Less <<
NCT02577341 Non-small-cell Lung Cancer Phase 2 Recruiting July 2020 China, Guangdong ... More >> Sun yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510000 Contact: Bo Qiu, Attending    020-87343031    qiubo@sysucc.org.cn Less <<
NCT01924819 Gastric Cancer Phase 2 Phase 3 Recruiting December 2020 Australia, New South Wales ... More >> Calvary Mater Newcastle Recruiting Newcastle, New South Wales, Australia Liverpool Hospital Recruiting Sydney, New South Wales, Australia Nepean Hospital Recruiting Sydney, New South Wales, Australia Prince of Wales Hospital Recruiting Sydney, New South Wales, Australia Royal North Shore Hospital Recruiting Sydney, New South Wales, Australia Royal Prince Alfred Hospital Recruiting Sydney, New South Wales, Australia St George Hospital Recruiting Sydney, New South Wales, Australia Westmead Hospital Recruiting Sydney, New South Wales, Australia The Tweed Hospital Recruiting Tweed Heads, New South Wales, Australia Wollongong Hospital Recruiting Wollongong, New South Wales, Australia Australia, Queensland Princess Alexandra Hospital Recruiting Brisbane, Queensland, Australia Australia, South Australia Flinders Medical Centre Recruiting Adelaide, South Australia, Australia Australia, Tasmania Royal Hobart Hospital Recruiting Hobart, Tasmania, Australia Launceston General Hospital Recruiting Launceston, Tasmania, Australia Australia, Victoria Geelong Hospital Recruiting Geelong, Victoria, Australia Austin Hospital Recruiting Melbourne, Victoria, Australia Monash Medical Centre Recruiting Melbourne, Victoria, Australia Peter MacCallum Cancer Centre Recruiting Melbourne, Victoria, Australia St Vincent's Hospital Recruiting Melbourne, Victoria, Australia Australia, Western Australia Sir Charles Gairdner Hospital Recruiting Nedlands, Western Australia, Australia Royal Perth Hospital Recruiting Perth, Western Australia, Australia New Zealand Auckland Hospital Recruiting Auckland, New Zealand Christchurch Hospital Recruiting Christchurch, New Zealand Dunedin Hospital Recruiting Dunedin, New Zealand Waikato Hospital Recruiting Waikato, New Zealand Less <<
NCT00896181 Stage II Lymphoepithelioma of ... More >>the Nasopharynx Stage II Squamous Cell Carcinoma of the Nasopharynx Stage III Lymphoepithelioma of the Nasopharynx Stage III Squamous Cell Carcinoma of the Nasopharynx Stage IV Lymphoepithelioma of the Nasopharynx Stage IV Squamous Cell Carcinoma of the Nasopharynx Less << Phase 2 Active, not recruiting July 2020 United States, California ... More >> Stanford University Hospitals and Clinics Stanford, California, United States, 94305 Less <<
NCT01284335 Advanced Solid Tumors Phase 1 Terminated(Study was terminate... More >>d due to the termination of tasisulam development.) Less << - United States, Alabama ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States, 35233 United States, Arkansas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fayetteville, Arkansas, United States, 72703 United States, Colorado For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Denver, Colorado, United States, 80218 United States, Florida For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orlando, Florida, United States, 32806 United States, Illinois For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Park Ridge, Illinois, United States, 60068 United States, Indiana For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46219 United States, Nevada For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States, 89169 United States, New York For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Albany, New York, United States, 12206 United States, Ohio For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kettering, Ohio, United States, 45429 United States, Oregon For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States, 97213 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenville, South Carolina, United States, 29605 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Austin, Texas, United States, 78731 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dallas, Texas, United States, 75246 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States, 77380 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tyler, Texas, United States, 75702 United States, Virginia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norfolk, Virginia, United States, 23502 United States, Washington For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Spokane, Washington, United States, 99218 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vancouver, Washington, United States, 98684 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Yakima, Washington, United States, 98902 Less <<
NCT01313663 - Terminated - -
NCT01284335 - Terminated(Study was terminate... More >>d due to the termination of tasisulam development.) Less << - -
NCT00572169 Multiple Myeloma Phase 3 Active, not recruiting August 2019 United States, Arkansas ... More >> University of Arkansas for Medical Sciences/Myeloma Institute Little Rock, Arkansas, United States, 72205 Less <<
NCT03085914 Solid Tumors ... More >>Colorectal Cancer (CRC) Adenocarcinoma (PDAC) Lung Cancer UC (Urothelial Cancer) Head and Neck Cancer Less << Phase 1 Phase 2 Active, not recruiting January 2020 United States, Arizona ... More >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, California University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States, 92093 The Angeles Clinic and Research Institute Los Angeles, California, United States, 90025 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Carolina Bio-Oncology Institute, PLLC Huntersville, North Carolina, United States, 28078 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Health System Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15237 United States, Tennessee Tennessee Oncology - Nashville; The Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Vanderbilt University; Henry Joyce Cancer Clinic Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00002835 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT03348904 Lung Cancer Phase 3 Terminated(Study halted premat... More >>urely and will not resume; participants are no longer being examined or receiving intervention.) Less << - United States, California ... More >> Pacific Cancer Medical Center, Inc Anaheim, California, United States, 92801 United States, Kansas Cancer Center of Kansas Wichita, Kansas, United States, 67214 Less <<
NCT01838538 Ovarian Cancer With Malignant ... More >>Ascites Less << Phase 2 Unknown - China, Beijing ... More >> First Hospital Affiliated to the PLA General Hospital, Beijing,China Recruiting Beijing, Beijing, China, 100048 Contact: Nan Du, PhD    861068989123    dunan05@yahoo.com.cn    Principal Investigator: Hui Zhao, PhD Less <<
NCT01336192 Non Small Cell Lung Cancer Phase 4 Unknown April 2013 China, Shanghai ... More >> Shanghai Pulmonary Hospital Medical Oncology Department Recruiting Shanghai, Shanghai, China, 200433 Contact: Ying Xu, MD    86-21-65115006 ext 1053    xuying2186@hotmail.com    Principal Investigator: Di Zheng, MD Less <<
NCT00956930 Liver Cancer Phase 2 Completed - United States, Illinois ... More >> Northwestern University, Northwestern Memorial Hospital Chicago, Illinois, United States, 60611-3013 Less <<
NCT00025259 - Completed - -
NCT01093066 Urothelial Carcinoma Phase 2 Active, not recruiting December 2022 France ... More >> CH du Pays d'Aix-en-Provence Aix-en-Provence, France Clinique AXIUM - AIX EN PROVENCE Aix-en-Provence, France CHU Bordeaux Bordeaux, France, 33000 Clinique Saint-Augustin Bordeaux, France Institut Bergonie Bordeaux, France CHU Caen Caen, France, 14000 Crlcc Francois Baclesse Caen, France, 54500 CHU Créteil Créteil, France Polyclinique de Lisieux Lisieux, France APHM - Marseille - Hôpital de la Conception Marseille, France, 13 385 APHM - Marseille - Hôpital la Timone Marseille, France CRLC Marseille Marseille, France Hôpital Européen - Marseille Marseille, France Hôpitaux privés de Metz Metz, France Chu Nancy Nancy, France Crlc Nancy Nancy, France Chu Nantes Nantes, France APHP - Saint-Louis Paris, France APHP- Hôpital Tenon Paris, France CHU Poitiers Poitiers, France, 86000 Chu Reims Reims, France Institut Jean Godinot - Reims Reims, France Clinique Mutualiste Chirurgicale Saint-etienne, France, 42055 ICO - SITE Gauducheau - ICL Nantes Saint-Herblain, France, 44 805 ICLN Saint-priest En Jarez, France, 42270 CHU Saint-Etienne Saint-Étienne, France Hôpitaux du Léman - Thonon-les-Bains Thonon-les-Bains, France CHI Toulon Toulon, France CHU Toulouse Toulouse, France, 31059 INSTITUT CLAUDIUS REGAUD - CRLC Toulouse Toulouse, France, 31059 Polyclinique Du Cotentin Équeurdreville-Hainneville, France Less <<
NCT02575859 Colorectal Neoplasm ... More >> Metastasis Less << Phase 1 Phase 2 Completed - -
NCT02542293 Non Small Cell Lung Carcinoma ... More >>NSCLC Less << Phase 3 Active, not recruiting March 29, 2019 -
NCT00576199 Liver Cancer Phase 2 Completed - Hong Kong ... More >> Hong Kong, Hong Kong, 0 Hong Kong, Hong Kong, 852 Hong Kong, Hong Kong Less <<
NCT00202969 Gastric Cancer Phase 3 Completed - China, Beijing ... More >> Beijing Cancer Hospital No.52 Fu-Cheng Road, Hai-dian District, Beijing, China Less <<
NCT00054067 Cervical Cancer Phase 3 Terminated - -
NCT00003400 Prostate Cancer Phase 2 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT00025259 Childhood Lymphocyte-Depleted ... More >>Classical Hodgkin Lymphoma Childhood Mixed Cellularity Classical Hodgkin Lymphoma Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma Childhood Nodular Sclerosis Classical Hodgkin Lymphoma Stage I Childhood Hodgkin Lymphoma Stage II Childhood Hodgkin Lymphoma Stage III Childhood Hodgkin Lymphoma Stage IV Childhood Hodgkin Lymphoma Less << Phase 3 Completed - -
NCT00077389 Liver Cancer Phase 2 Unknown - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Ireland Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 Netherlands Emma Kinderziekenhuis Amsterdam, Netherlands, NL-1100 DE United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Children's Cancer and Leukaemia Group Leicester, England, United Kingdom, LE1 6TH Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Middlesex Hospital London, England, United Kingdom, W1T 3AA Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health at Royal Victoria Infirmary Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00003701 Bladder Cancer ... More >> Urethral Cancer Less << Phase 3 Completed - United States, Georgia ... More >> Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States, 30033 United States, Indiana Indiana University Hospitals Indianapolis, Indiana, United States, 46202 United States, New Jersey Hunterdon Regional Cancer Center Flemington, New Jersey, United States, 08822 Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 South Jersey Hospital - Millville Millville, New Jersey, United States, 08332 Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County Mount Holly, New Jersey, United States, 08060 Riverview Medical Center Red Bank, New Jersey, United States, 07701 Overlook Hospital Summit, New Jersey, United States, 07902-0220 United States, New York Veterans Affairs Medical Center - New York New York, New York, United States, 10010 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Hahnemann University Hospital Philadelphia, Pennsylvania, United States, 19102-1192 United States, Tennessee Vanderbilt Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00002919 Bladder Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00281905 Brain and Central Nervous Syst... More >>em Tumors Neuroblastoma Less << Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00576199 - Completed - -
NCT00003214 Ovarian Cancer Phase 3 Completed - Switzerland ... More >> Kantonspital Aarau Aarau, Switzerland, 5001 Frauenspital, Basel Basel, Switzerland, 4031 Office of Walter Weber-Stadelman Basel, Switzerland, CH 4051 University Hospital Basel, Switzerland, CH-4031 Inselspital, Bern Bern, Switzerland, CH-3010 Hopital Cantonal Universitaire de Geneva Geneva, Switzerland, CH-1211 Istituto Oncologico della Svizzera Italiana Lugano, Switzerland, CH-6900 Burgerspital, Solothurn Solothurn, Switzerland, 4500 City Hospital Triemli Zurich, Switzerland, 8063 Klinik Hirslanden Zurich, Switzerland, CH-8008 Less <<
NCT00343408 Colorectal Cancer ... More >> Lung Cancer Less << Phase 1 Completed - Canada, Ontario ... More >> Ottawa Hospital Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Jewish General Hospital - Montreal Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT00003364 Lung Cancer Phase 3 Completed - United Kingdom ... More >> Heatherwood Hospital Ascot, England, United Kingdom, SL5 8AA Royal Sussex County Hospital Brighton, England, United Kingdom, BN2 5BE Addenbrooke's NHS Trust Cambridge, England, United Kingdom, CB2 2QQ Broomfield Hospital Chelmsford, Essex, England, United Kingdom, CM1 5ET Essex County Hospital Colchester, England, United Kingdom Royal Free Hospital Hampstead, London, England, United Kingdom, NW3 2QG Cookridge Hospital Leeds, England, United Kingdom, LS16 6QB Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Guy's and St. Thomas' Hospitals Trust London, England, United Kingdom, SE1 9RT Charing Cross Hospital London, England, United Kingdom, W6 8RF Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, WIT 3AA Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Peterborough Hospitals Trust Peterborough, England, United Kingdom, PE3 6DA Southend NHS Trust Hospital Westcliff-On-Sea, England, United Kingdom Less <<
NCT00312728 - Completed - -
NCT00231582 Testicular Neoplasms Phase 2 Completed - France ... More >> Hôpital TENON, Service d'Oncologie Médicale Paris, France, 75020 Less <<
NCT00005583 Endometrial Cancer Phase 3 Completed - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Cazk Groeninghe - Campus Maria's Voorzienigheid Kortrijk, Belgium, B-8500 U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Centre Henri Becquerel Rouen, France, 76038 Ireland Coombe Women's Hospital Dublin, Ireland, 8 St. James's Hospital Dublin, Ireland, 8 Italy Istituto Nazionale per lo Studio e la Cura dei Tumori Naples, Italy, 80131 Azienda Ospedaliera Di Parma Parma, Italy, 43100 Fondazione I.R.C.C.S. Policlinico San Matteo Pavia, Italy, 27100 Ospedale di Circolo e Fondazione Macchi Varese, Italy, 21100 Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Medisch Spectrum Twente Enschede, Netherlands, 7500 KA Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Norway Norwegian Radium Hospital Oslo, Norway, N-0310 Poland Medical University of Gdansk Gdansk, Poland, 80-211 Portugal Hospitais da Universidade de Coimbra (HUC) Coimbra, Portugal, 3049 South Africa Groote Schuur Hospital Cape Town, South Africa, 7925 Spain Hospital Universitario San Carlos Madrid, Spain, 28040 Hospital Universitario Central de Asturias Oviedo, Spain, 33006 United Kingdom Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Centre for Cancer Research and Cell Biology at Belfast City Hospital Belfast, Northern Ireland, United Kingdom, BT9 7AB Western Infirmary Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT00312728 Non-Small Cell Lung Cancer ... More >> Brain Neoplasms Less << Phase 2 Completed - -
NCT01466257 - Completed - -
NCT00734877 Multiple Myeloma Phase 3 Recruiting September 2020 United States, Arkansas ... More >> University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy Recruiting Little Rock, Arkansas, United States, 72205 Contact: Nathan Petty    501-526-6990 ext 2435    pettynathanm@uams.edu    Sub-Investigator: Frits van Rhee, MD, PhD          Sub-Investigator: Michele Fox, MD          Sub-Investigator: Maurizio Zangari, MD          Sub-Investigator: Atul Kothari, MD          Sub-Investigator: Carolina Schinke, MD          Sub-Investigator: Faith Davies, MD          Sub-Investigator: Gareth Morgan, MD          Sub-Investigator: Juan Crescencio, MD          Sub-Investigator: Mary Burgess, MD          Sub-Investigator: Meera Mohan, MD          Sub-Investigator: Muthukumar Radhakrishnan, MD          Sub-Investigator: Pankaj Mathur, MD          Sub-Investigator: Sharmilan Thanendrajan, MD          Sub-Investigator: Shadiqul Hogue, MD          Sub-Investigator: Sandra Susanibar-Adaniya, MD Less <<
NCT01703910 Adenocarcinoma of Colon ... More >> Adenocarcinoma of Rectum Metastatic Disease Less << Phase 2 Completed - Spain ... More >> Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain, 28950 Hospital Madrid Norte Sanchinarro Madrid, Spain, 28050 Less <<
NCT00058370 Brain and Central Nervous Syst... More >>em Tumors Less << Not Applicable Active, not recruiting February 2019 United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02759250 Cancer Phase 1 Completed - Belgium ... More >> UZG - Universitair Ziekenhuis Gent Gent, Belgium Less <<
NCT00002823 Lung Cancer Phase 3 Completed - -
NCT00938145 Bladder Cancer Not Applicable Recruiting December 31, 2018 United States, Ohio ... More >> Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Michael Knopp, MD, PhD    614-293-9998    knopp.16@osu.edu Less <<
NCT00820755 - Completed - -
NCT03032614 Breast Cancer Stage IV ... More >> Ovarian Cancer BRCA1 Mutation BRCA2 Mutation Less << Phase 2 Withdrawn(Lack of funding) April 30, 2020 -
NCT00820755 Non-Small Cell Lung Cancer (NS... More >>CLC) Less << Phase 3 Completed - Germany ... More >> Central Contact Darmstadt, Germany Less <<
NCT01305772 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Terminated(This study was term... More >>inated for low accrual.) Less << - United States, North Carolina ... More >> University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27514 Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02644408 Stage III Esophageal Squamous ... More >>Cell Carcinoma Stage II Esophageal Squamous Cell Carcinoma Less << Phase 3 Recruiting December 2020 China, Henan ... More >> The First Affiliated Hospital of Henan University of Science and Technology Recruiting Luoyang, Henan, China, 471003 Contact: shegan gao, doctor    0379 64811906    gsg112258@163.com    Contact: tanyou shan, master    0379 64815350    shantanyou@163.com Less <<
NCT00002524 Lymphoma Phase 2 Completed - United States, Florida ... More >> MD Anderson Cancer Center Orlando Orlando, Florida, United States, 32806 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03549715 Infiltrating Bladder Urothelia... More >>l Carcinoma Less << Phase 1 Phase 2 Not yet recruiting February 2022 France ... More >> Hôpital Européen Georges Pompidou Not yet recruiting Paris, Ile De France, France, 75015 Contact: Constance THIBAULT, MD    00 33 1 56 09 59 92    constance.thibault@aphp.fr    Principal Investigator: Constance THIBAULT, MD          Hôpital Saint André, CHU de Bordeaux Not yet recruiting Bordeaux, France, 33075 Contact: Marine GROSS-GOUPIL, MD       marine.gross-goupil@chu-bordeaux.fr    Sasu Roc37 Not yet recruiting Chambray Les Tours, France, 37170 Contact: Pierre COMBE, MD          CHU Henri-Mondor Not yet recruiting Créteil, France, 94000 Contact       carolina.saldana@aphp.fr    Principal Investigator: Carolina SALDANA, MD          Centre Leon Berard Not yet recruiting Lyon, France, 69008 Contact: Aude FLECHON, MD          Institut Paoli Calmettes Not yet recruiting Marseille, France, 13009 Contact: Gwaenaelle Gravis, MD       GRAVISG@marseille.fnclcc.fr    Centre Antoine Lacassagne Not yet recruiting Nice, France, 06100 Contact: Delphine BORCHIELLINI, MD       Delphine.BORCHIELLINI@nice.unicancer.fr    Hôpital Cochin Not yet recruiting Paris, France, 75679 Contact: Olivier HUILLARD, MD       olivier.huillard@aphp.fr    Centre Eugene Marquis Not yet recruiting Rennes, France, 35042 Contact: Brigitte LAGUERRE, MD       b.laguerre@rennes.unicancer.fr    Hia Begin Not yet recruiting Saint-Mandé, France, 94160 Contact: Francois-Regis FERRAND, MD          Hôpitaux universitaires de Strasbourg Not yet recruiting Strasbourg, France, 67000 Contact: Philippe BARTHELEMY, MD       philippe.barthelemy@chru-strasbourg.fr    Institut Claudius Regaud Not yet recruiting Toulouse, France, 31059 Contact: Damien POUESSEL, MD          Institut Gustave Roussy Not yet recruiting Villejuif, France, 94805 Contact: Yohann LORIOT Less <<
NCT01975766 Head and Neck Neoplasms Not Applicable Terminated(Poor accrual) - United States, Iowa ... More >> Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 Less <<
NCT01305772 - Terminated(This study was term... More >>inated for low accrual.) Less << - -
NCT00721799 Mouth Neoplasms ... More >> Oropharyngeal Neoplasms Laryngeal Neoplasms Head and Neck Neoplasms Less << Phase 2 Active, not recruiting June 30, 2020 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 Less <<
NCT02805530 Carcinoma, Non-Small-Cell Lung... More >> Synchronous Neoplasms Less << Not Applicable Recruiting December 2017 Mexico ... More >> Instituto Nacional de Cancerologia Recruiting Mexico City, Mexico, 14080 Contact: Oscar Arrieta    015556280400    ogarrieta@gmail.com Less <<
NCT01755585 - Unknown - -
NCT03674424 Non-metastatic Muscle Invasive... More >> Bladder Cancer Less << Phase 2 Recruiting April 1, 2023 Belgium ... More >> Institut Jules Bordet Recruiting Brussels, Belgium, 1000 Contact: Thierry Gil, MD    0032 2 541 31 88    thierry.gil@bordet.be    CHU de Liège Sart Tilman Not yet recruiting Liège, Belgium, 4000 Contact: Brieuc Sautois, MD    0032 4 366 82 03    Brieuc.Sautois@ulg.ac.be Less <<
NCT02701231 Lung Neoplasms Not Applicable Recruiting December 2020 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Liang-An Chen, MD, phD    8610-55499027    chenla301@263.net    Principal Investigator: Liang-An Chen, MD, phD          China, Shandong Affiliated hospital of Shandong University of traditional Chinese medicine Not yet recruiting Jinan, Shandong, China, 250011 Shandong Provincial Hospital Not yet recruiting Jinan, Shandong, China, 250021 China, Shanxi Xijing Hospital affiliated to the Fourth Military Medical University Not yet recruiting Xi'an, Shanxi, China, 710032 Less <<
NCT03503864 Neuroblastoma Phase 2 Recruiting December 30, 2029 China, Guangdong ... More >> Sun Yat-sen Memorial Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Yang Li, Professor    +8602081332456    drliyang@126.com Less <<
NCT03529279 Nasopharyngeal Carcinoma Phase 3 Not yet recruiting June 12, 2026 -
NCT02431403 Lymphoma, Non-Hodgkin Phase 1 Phase 2 Recruiting - Korea, Republic of ... More >> Dong-A University Hospital Recruiting Busan, Korea, Republic of Contact: Ji Sook Park       dongahicrc5@naver.com    Inje University Busan Paik Hospital Recruiting Busan, Korea, Republic of Contact: Jin Hwa Kong    +82-51-890-6987    velika-jh@nate.com    Kosin University Gospel Hospital Recruiting Busan, Korea, Republic of Contact: Saet Byeol Park       siou7777@naver.com    Pusan National University Hospital Recruiting Busan, Korea, Republic of Contact: Younghee Kim    +82-51-240-7899    shinyspring@naver.com    Ulsan University Hospital Recruiting Ulsan, Korea, Republic of Contact: Mi Sun Jeon       uuh3103@naver.com Less <<
NCT00460551 - Terminated(Due to consideratio... More >>ns regarding the appropriate therapeutic regimen for these patients.) Less << - -
NCT00721799 - Active, not recruiting - -
NCT02469493 Lung Neoplasms Not Applicable Unknown - China, Shaanxi ... More >> Xijing Hospital Recruiting Xi'an, Shaanxi, China, 710032 Contact: Yang    86(029)-84775343 Less <<
NCT02063412 - Withdrawn(Slow recruitment pac... More >>e) Less << - -
NCT00432315 Carcinoma, Squamous Cell Phase 2 Completed - Austria ... More >> Sanofi-Aventis Administrative Office Vienna, Austria Less <<
NCT01989858 Gastric Adenocarcinoma Phase 3 Terminated(lack of clinical ca... More >>ses) Less << - Italy ... More >> Ospedali Riuniti di Bergamo Bergamo, BG, Italy, 24128 A. O. Ospedale Treviglio-Caravaggio Treviglio, BG, Italy, 24047 A.O. Sant'Orsola Malpighi Bologna, BO, Italy, 40138 Policlinico Sant'Orsola Malpighi Bologna, BO, Italy, 40138 A.O. Santa Croce e Carle Cuneo, CN, Italy, 12100 Azienda Ospedaliero-Universitaria "Policlinico-Vittorio Emanuele" Catania, CT, Italy, 95123 Policlinico Universitario Mater Domini Catanzaro, CZ, Italy, 88100 Azienda Ospedaliero- Universitaria Careggi - Firenze Firenze, FI, Italy, 50141 A.O. Ospedale San Gerardo Monza, MB, Italy, 20052 Azienda Ospedaliera di Desio e Vimercate Vimercate, MB, Italy, 20059 Fondazione IRCCS Ospedale Maggiore Policlinico Milano, MI, Italy, 20122 Istituto Nazionale per la Cura e lo Studio dei Tumori Milano, MI, Italy, 20133 Istituto Oncologico Europeo Milano, MI, Italy, 20141 Azienda Ospedaliera "San Paolo" Milano, MI, Italy, 20142 Istituto Clinico Humanitas Rozzano, MI, Italy, 20089 Casa di Cura MultiMedica Sesto San Giovanni, MI, Italy, 20099 A. O. "Carlo Poma" Mantova, MN, Italy, 46100 Ospedale "Ramazzini " di Carpi Carpi, MO, Italy, 41012 Ospedale "Guglielmo da Saliceto" Piacenza, PC, Italy, 29100 IRCCS Istituto Oncologico Veneto Padova, PD, Italy, 35128 Ospedale Misericordia e Dolce - USL 4 Prato, PO, Italy, 59100 Ospedale Santa Croce Fano Fano, PU, Italy, 61032 Azienda Ospedaliera 'San Carlo' Potenza, PZ, Italy, 85100 Arcispedale S. Maria Nuova Azienda Ospedaliera Reggio Emilia, RE, Italy, 42100 Università "Campus Bio-Medico" Roma, RM, Italy, 00128 Policlinico Universitario A. Gemelli Roma, RM, Italy, 00168 A.O. della Valtellina e della Valchiavenna - "Ospedale E. Morelli" Sondalo, SO, Italy, 23100 IRCC/FPO -Istituto per la Ricerca e la Cura del Cancro di Candiolo Candiolo, TO, Italy, 10060 A. O. "Ospedale di Circolo di Busto Arsizio" - Busto Arsizio (VA) Busto Arsizio, VA, Italy, 21052 A. O. Busto Arsizio - P.O. Saronno Saronno, VA, Italy, 21047 A.O. Ospedale di Circolo e Fondazione Macchi Varese, VA, Italy, 21100 Fondazione "G. Pascale" Istituto Tumori di Napoli Napoli, Italy, 80131 Less <<
NCT02951897 Lung Adenocarcinoma, Stage I ... More >> Diagnoses Diseases Circulating Tumor Cells Treatment Less << Not Applicable Recruiting December 2019 China ... More >> Daping hospital Recruiting Chongqing, China Contact: Bo Deng    +86-13637782166    deng.bo@dphospital.tmmu.edu.cn Less <<
NCT00567567 Localized Resectable Neuroblas... More >>toma Localized Unresectable Neuroblastoma Recurrent Neuroblastoma Regional Neuroblastoma Stage 4 Neuroblastoma Stage 4S Neuroblastoma Less << Phase 3 Completed - -
NCT00567567 - Completed - -
NCT01418859 - Unknown December 2015 China, Shanxi ... More >> Xi'an Jiaotong University College of Medicine Recruiting Xi'an, Shanxi, China, 710061 Contact: Zi Liu, M.D    086-18991232167    18991232167@189.cn    Contact: Tao Wang, M.D    086-18991232386    18991232386@189.cn    Sub-Investigator: Tao Wang, M.D Less <<
NCT03057106 Lung Cancer Metastatic Phase 2 Active, not recruiting December 2019 -
NCT03126916 Childhood Ganglioneuroblastoma... More >> Childhood Neuroblastoma INRG Stage L2 INRG Stage M INRG Stage MS NMYC Gene Amplification Recurrent Neuroblastoma Less << Phase 3 Recruiting June 30, 2026 -
NCT00696735 Follicular Lymphoma Phase 3 Completed - France ... More >> Emmanuel GYAN Tours, France, 37000 Philippe COLOMBAT Tours, France, 37000 Less <<
NCT02371161 Non Hodgkin Lymphoma Phase 2 Recruiting February 2023 Italy ... More >> A.O. SS.Antonio e Biagio e C. Arrigo Recruiting Alessandria, AL, Italy, 15121 Contact: Flavia Salvi, MD    0131-206066    fsalvi@ospedale.al.it    Principal Investigator: Flavia Salvi, MD          Ospedali Riuniti Recruiting Ancona, AN, Italy, 60126 Contact: Attilio Olivieri, MD    071-5964226    a.olivieri@univpm.it    Principal Investigator: Attilio Olivieri, MD          Ospedale Perrino Active, not recruiting Brindisi, BR, Italy, 72100 Spedali Civili Recruiting Brescia, BS, Italy, 25123 Contact: Alessandra Tucci, MD    030-3995438    alessandra.tucci@spedalicivili.brescia.it    Principal Investigator: Alessandra Tucci, MD          Policlinico Vittorio Emanuele Active, not recruiting Catania, CT, Italy, 95123 Casa Sollievo della Sofferenza Active, not recruiting San Giovanni Rotondo, FG, Italy, 71013 IRST Meldola Recruiting Meldola, Forlì-Cesena, Italy, 47014 Contact: Gerardo Musuraca    0543-739291    g.musuraca@irst.emr.it    Principal Investigator: Gerardo Musuraca, MD          IRCCS San Martino - IST Active, not recruiting Genova, GE, Italy, 16132 ASUR Marche, Area Vasta 3 Active, not recruiting Civitanova Marche, MC, Italy, 62012 AO Riuniti Papardo Piemonte Recruiting Messina, ME, Italy, 98158 Contact: Donato Mannina, MD    090-3992239    donamanni@gmail.com    Principal Investigator: Donato Mannina, MD          IRCCS Humanitas Recruiting Rozzano, Milano, Italy, 20089 Contact: Luca Castagna, MD    02-82244580    luca.castagna@humanitas.it    Principal Investigator: Luca Castagna, MD          AO Niguarda Ca' Granda Recruiting Milano, MI, Italy, 20162 Contact: Chiara Rusconi, MD    02-64442668    chiara.rusconi@ospedaleniguarda.it    Principal Investigator: Chiara Rusconi, MD          Ospedale Civile "Guglielmo da Saliceto" Recruiting Piacenza, PC, Italy, 29100 Contact: Daniele Vallisa, MD    0523-303719    d.vallisa@ausl.pc.it    Principal Investigator: Danilele Vallisa, MD          Centro di Riferimento Oncologico Recruiting Aviano, PN, Italy, 33081 Contact: Mariagrazia Michieli, MD    0434-659601    mmichieli@cro.it    Principal Investigator: Mariagrazia Michieli, MD          Azienda Ospaliero Universitaria di Parma Recruiting Parma, PR, Italy, 43126 Contact: Francesca Re, MD    0521-033306    fre@ao.pr.it    Principal Investigator: Francesca Re, Prof.          Ospedale San Carlo Active, not recruiting Potenza, PZ, Italy, 85100 AUSL di Ravenna Recruiting Ravenna, RA, Italy, 48100 Contact: Monica Tani, MD    0544-286223    monica.tani@ausl.ra.it    Principal Investigator: Monica Tani, MD          A.O. Bianchi - Melacrino - Morelli Active, not recruiting Reggio Calabria, RC, Italy, 89125 Asmn-Irccs Recruiting Reggio Emilia, RE, Italy, 43123 Contact: Francesco Merli, MD    0522-296618    merli.francesco@asmn.re.it    Principal Investigator: Francesco Merli, MD          Policlinico Sant'Andrea Recruiting Roma, RM, Italy, 00189 Contact: Maria Christina Cox, MD    338-2268017    chrisscox@gmail.com    Principal Investigator: Maria Christina Cox, MD          Ospedale Nocera- Pagani Active, not recruiting Nocera Inferiore, SA, Italy, 84014 AOU San Giovanni e Ruggi Active, not recruiting Salerno, SA, Italy, 84131 AOU Città della Salute e della Scienza Recruiting Torino, TO, Italy, 10126 Contact: Federica Cavallo, MD    011-6334301    f.cavallo@unito.it    Principal Investigator: Federica Cavallo, MD          Ospedale Mauriziano Active, not recruiting Torino, TO, Italy, 10128 AO Santa Maria Active, not recruiting Terni, TR, Italy, 05100 Ospedale S.Andrea Active, not recruiting Vercelli, VC, Italy, 13100 Ospedale degli Infermi Recruiting Rimini, Italy, 47923 Contact: Anna Lia Molinari    0541-705423    annalia.molinari@auslromagna.it    Principal Investigator: Anna Lia Molinari, MD Less <<
NCT02556762 Esophageal Cancer Phase 3 Recruiting August 2021 China, Guangdong ... More >> Cancer Hospital, Shantou University Medical College Recruiting Shantou, Guangdong, China, 515031 Contact: Chuangzhen Chen, MD    86-13923995569    stccz@139.com    Contact: Jianzhou Chen, MD    86-13417049908    cjzeoeo@gmail.com    Principal Investigator: Chuangzhen Chen, MD Less <<
NCT00460551 Non Small Cell Lung Cancer Phase 2 Terminated(Due to consideratio... More >>ns regarding the appropriate therapeutic regimen for these patients.) Less << - United States, Maryland ... More >> Towson, Maryland, United States, 21204 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213-2967 Belgium UZ Gent Gent, Belgium, 9000 CHR La Citadelle Liege, Belgium, 4000 CHU Sart-Tilman Domaine Universitaire du Sart-Tilman Liege, Belgium, 4000 France CHRU Reims, Hospital Maison Blanche Reims, Cedex, France, 51092 Netherlands VU Medisch Centrum (VUMC) Amsterdam, Netherlands, 1004MB United Kingdom The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT01275664 - Terminated(Study terminated du... More >>e to no patient population available) Less << - -
NCT00574080 Multiple Myeloma Phase 3 Terminated(low accrual) - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT02883543 Non-small Cell Lung Cancer Phase 3 Active, not recruiting June 2019 -
NCT01275664 Nausea and Vomiting ... More >> Ovarian Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Seromucinous Carcinoma Ovarian Serous Cystadenocarcinoma Stage II Ovarian Cancer Stage IIA Fallopian Tube Cancer Stage IIA Ovarian Cancer Stage IIB Fallopian Tube Cancer Stage IIB Ovarian Cancer Stage IIC Fallopian Tube Cancer Stage IIC Ovarian Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Cancer Stage IIIA Primary Peritoneal Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Cancer Stage IIIB Primary Peritoneal Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Cancer Stage IIIC Primary Peritoneal Cancer Stage IV Fallopian Tube Cancer Stage IV Ovarian Cancer Stage IV Primary Peritoneal Cancer Undifferentiated Ovarian Carcinoma Less << Not Applicable Terminated(Study terminated du... More >>e to no patient population available) Less << - United States, Illinois ... More >> Sudarshan K Sharma MD Limted-Gynecologic Oncology Hinsdale, Illinois, United States, 60521 United States, Rhode Island Women and Infants Hospital Providence, Rhode Island, United States, 02905 Less <<
NCT00574080 - Terminated(low accrual) - -
NCT00531960 Non-Small Cell Lung Cancer Phase 2 Completed - -
NCT01327521 Carcinoma, Hepatocellular Phase 3 Withdrawn(Accrual below target... More >> levels) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00003643 Extragonadal Germ Cell Tumor ... More >> Teratoma Testicular Germ Cell Tumor Less << Phase 2 Phase 3 Unknown - -
NCT03294122 - Recruiting December 31, 2019 Italy ... More >> Fondazione IRCCS Istituto Nazionale Tumori Recruiting Milan, Italy, 20133 Contact: Riccardo Valdagni, MD, PhD    +39 02-23903034    riccardo.valdagni@istitutotumori.mi.it    Contact: Tiziana Rancati, MS    +39 02-23903786    tiziana.rancati@istitutotumori.mi.it    Principal Investigator: Riccardo Valdagni, MD, PhD Less <<
NCT01691625 Esophageal Carcinoma Not Applicable Recruiting September 2019 China, Beijing ... More >> Capital Medical University Cancer Center Recruiting Beijing, Beijing, China, 100038 Contact: Jun Ren, MD, PhD    86-10-63926317    renjun9688@yahoo.com    Principal Investigator: Jun Ren, MD, PhD Less <<
NCT03775486 Non-small Cell Lung Cancer NSC... More >>LC Less << Phase 2 Not yet recruiting May 23, 2022 -
NCT00531960 - Completed - -
NCT00009880 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - -
NCT02716896 Muscle Invasive Bladder Cancer Not Applicable Active, not recruiting June 2019 United States, Texas ... More >> University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78829 Less <<
NCT00033644 Sarcoma Phase 2 Terminated - -
NCT00003777 Head and Neck Cancer Phase 2 Unknown - United States, Pennsylvania ... More >> University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT03353675 NSCLC Phase 2 Recruiting September 2020 United States, North Carolina ... More >> Charlotte Recruiting Charlotte, North Carolina, United States, 28204 United States, Tennessee Nashville Recruiting Nashville, Tennessee, United States, 37203 Belgium Libramont Recruiting Libramont, Belgium Denmark Herlev Recruiting Herlev, Denmark France Créteil Recruiting Créteil, France Mulhouse Recruiting Mulhouse, France Rennes Recruiting Rennes, France Strasbourg Recruiting Strasbourg, France Hungary Budapest Recruiting Budapest, Hungary Szekesfehervar Recruiting Szekesfehervar, Hungary Less <<
NCT01216527 Squamous Cell Esophageal Carci... More >>noma Less << Phase 3 Active, not recruiting December 2019 China, Guangdong ... More >> Sun Yat-sen Uniersity Cancer Center GuangZhou, Guangdong, China, 510060 Cancer Hospital of Shantou University Medical College Shantou, Guangdong, China, 515000 Less <<
NCT00002884 Esophageal Cancer Phase 3 Unknown - France ... More >> Hopital Jules Courmont - Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Less <<
NCT00002631 Esophageal Cancer Phase 3 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 10309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinical and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Canada, Saskatchewan Saskatchewan Cancer Agency Regina, Saskatchewan, Canada, S4S 6X3 Less <<
NCT01680523 Cervical Cancer Not Applicable Recruiting July 2020 Korea, Republic of ... More >> Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Joo-Hyun Nam, M.D., Ph.D.    82-2-3010-3633    jhnam@amc.seoul.kr Less <<
NCT03164616 Non Small Cell Lung Cancer NSC... More >>LC Less << Phase 3 Recruiting September 24, 2021 -
NCT00041262 Esophageal Cancer Phase 3 Unknown - United Kingdom ... More >> Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Recruiting Birmingham, England, United Kingdom, B15 2TH Contact: Derek Alderson, MD    44-121-627-2276    d.alderson@bham.ac.uk Less <<
NCT01539785 First Recurrence of Ovarian Ca... More >>ncer Less << Not Applicable Unknown - Italy ... More >> Catholic University of Sacred the Hearth Recruiting Rome, Italy, 00100 Contact: Catholic University of Sacred the Hearth    +39 063 015 627 9       Principal Investigator: Fagotti Anna, MD, PhD          Principal Investigator: Fanfani Francesco, MD          Principal Investigator: Costantini Barbara, MD          Principal Investigator: Perelli Federica, MD Less <<
NCT00047112 Esophageal Cancer Phase 3 Completed - -
NCT00673361 Melanoma Phase 2 Terminated - -
NCT00673361 - Terminated - -
NCT00053872 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Unknown - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Institut Curie Hopital Paris, France, 75248 Germany Universitaets - Kinderklinik Wuerzburg Wuerzburg, Germany, D-97080 Italy Ospedale Infantile Regina Margherita Turin, Italy, 10126 Netherlands Academisch Medisch Centrum at University of Amsterdam Amsterdam, Netherlands, 1105 AZ Spain Hospital de Cruces Vizcaya, Spain, 48 Sweden Ostra Sjukhuset Gothenburg, Sweden, 41685 United Kingdom Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Less <<
NCT00735345 Esophageal Cancer Phase 2 Terminated(because of safety c... More >>oncerns the study was terminated prematurely) Less << - Austria ... More >> Landeskrankenhaus Feldkirch Feldkirch, Austria, A-6806 Universitätsklinikum Graz Graz, Austria, A-8036 Universitätsklinik Innsbruck Innsbruck, Austria, A-6020 A.ö. Landeskrankenhaus Leoben Leoben, Austria, A-8700 Universitaetsklinik f. Innere Medizin III Salzburg, Austria, A-5020 Krankenhaus Barmherzige Brueder St. Veit a.d. Glan St. Veit/ Glan, Austria, A-9300 Klinikum Kreuzschwestern Wels GmbH Wels, Austria, A-4600 Less <<
NCT00002858 Lung Cancer Phase 3 Unknown - France ... More >> Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 Centre Paul Papin Angers, France, 49036 Institut Bergonie Bordeaux, France, 33076 Centre Regional Francois Baclesse Caen, France, 14076 Hopital Antoine Beclere Clamart, France, 92141 Centre Hospitalier Sud Francilien - Site Corbeil Corbeil, France, 91100 Hopital Intercommunal De Creteil Creteil, France, 94010 Hopital De La Trouhade Dijon, France, 21034 Centre de Lute Contre le Cancer,Georges-Francois Leclerc Dijon, France, 21079 C.H. General Andre Boulloche Montbeliard, France, 25209 CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Hopital Haut Leveque Pessac, France, 33604 C.H. De Saumur Saumur, France, 49403 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Institut Claudius Regaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 CHRU de Nancy - Hopitaux de Brabois Vandoeuvre-Les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00003032 Breast Cancer Phase 3 Completed - Canada, Alberta ... More >> Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Moncton Hospital Moncton, New Brunswick, Canada, E1C 6ZB Saint John Regional Hospital Saint John, New Brunswick, Canada, E2L 4L2 Canada, Newfoundland and Labrador Newfoundland Cancer Treatment and Research Foundation St. Johns, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario William Osler Health Centre Brampton, Ontario, Canada, L6W 2Z8 Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 1C4 Hotel Dieu Hospital - St. Catharines St. Catharines, Ontario, Canada, L2R 5K3 Northeastern Ontario Regional Cancer Centre, Sudbury Sudbury, Ontario, Canada, P3E 5J1 Northwestern Ontario Regional Cancer Centre, Thunder Bay Thunder Bay, Ontario, Canada, P7A 7T1 Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Humber River Regional Hospital Weston, Ontario, Canada, M9N 1N8 Cancer Care Ontario - Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Prince Edward Island Queen Elizabeth Hospital, PEI Charlottetown, Prince Edward Island, Canada, C1A 8T5 Canada, Quebec L'Hotel Dieu de Levis Levis, Quebec, Canada, G6V 3Z1 Centre Hospitalier de l'Universite de Montreal Montreal, Quebec, Canada, H2L-4M1 McGill University Department of Oncology Montreal, Quebec, Canada, H2W 1S6 Hotel Dieu de Montreal Montreal, Quebec, Canada, H2W 1T8 Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec Quebec City, Quebec, Canada, G1R 2J6 Less <<
NCT03661320 Bladder Cancer ... More >> Muscle-Invasive Bladder Cancer BMS-986205 Less << Phase 3 Recruiting December 30, 2026 -
NCT00002747 Head and Neck Cancer Phase 3 Unknown - Italy ... More >> Istituto Nazionale per lo Studio e la Cura dei Tumori Milan, Italy, 20133 Less <<
NCT02864251 Non-Small-Cell Lung Carcinoma Phase 3 Recruiting December 31, 2023 -
NCT02755311 Hepatocellular Carcinoma Phase 3 Unknown June 2016 China, Guangdong ... More >> The First Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Zhenwei Peng, MD       pengzhenwei2005@163.com Less <<
NCT03643133 Osteosarcoma Phase 2 Recruiting October 2028 France ... More >> Institut Curie Not yet recruiting Paris, France, 75000 Contact: Sophie MD PIPERNO-NEUMANN, PhD    33 (0)144324672    sophie.piperno-neumann@curie.fr    Gustave Roussy Recruiting Villejuif, France, 94800 Contact: Nathalie MD GASPAR, PhD    33 (0)142114166    nathalie.gaspar@gustaveroussy.fr Less <<
NCT01346267 Central Nervous System Tumor, ... More >>Pediatric Chemotherapy-induced Nausea and Vomiting Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 3 Completed - -
NCT03376958 Relapsed /Refractory Diffuse L... More >>arge B Cell Lymphoma Less << Phase 4 Recruiting February 1, 2019 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com Less <<
NCT01432314 Hepatocellular Carcinoma Phase 2 Withdrawn(Another phase 2 rand... More >>omized study has been started by other investigators.) Less << - -
NCT02453282 Non-Small-Cell Lung Carcinoma ... More >>NSCLC Less << Phase 3 Active, not recruiting December 31, 2019 -
NCT02089204 - Unknown December 2015 -
NCT00967499 Postoperative Nausea and Vomit... More >>ing Less << Phase 2 Completed - United States, Arizona ... More >> Precision Trials Phoenix, Arizona, United States, 85032 United States, California Accurate Clinical Trials, Inc Laguna Hills, California, United States, 92653 University of California San Francisco San Francisco, California, United States, 94115 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Texas Scott and White Hospital Temple, Texas, United States, 76508 Less <<
NCT01480817 Hepatocellular Carcinoma Phase 2 Terminated(Difficulty of parti... More >>cipant enrollment.) Less << - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01628380 Ovarian Neoplasms Phase 3 Unknown July 2018 Germany ... More >> Jena University Hospital Recruiting Jena, Germany, 07743 Contact: Ingo B. Runnebaum, MD, MBA       INGO.RUNNEBAUM@med.uni-jena.de    Principal Investigator: Ingo B. Runnebaum, MD, MBA          Italy A.O. Papa Giovanni XXIII (former Ospedali Riuniti) Recruiting Bergamo, Bg, Italy, 24128 Contact: Luca Ansaloni, MD    +390352673477    lansaloni@hpg23.it    Contact: Marco Lotti, MD    +390352673477    mlotti@hpg23.it    Principal Investigator: Luca Ansaloni, MD          A.O. Universitaria Policlinico S.Orsola-Malpighi Di Bologna - Bologna (Bo) Recruiting Bologna, Bo, Italy, 40138 Contact: Pierandrea Deiaco, MD    +390516364426    pierandrea.deiaco@aosp.bo.it    Principal Investigator: Pierandrea Deiaco, MD          A.O. Universitaria Di Parma - Parma (Pr) Oncologia Chirurgica Recruiting Parma, Pr, Italy, 43100 Contact: Fausto Catena, MD    +390521703940    faustocatena@gmail.com    Principal Investigator: Fausto Catena, MD          POLICLINICO UNIVERSITARIO GEMELLI DI ROMA - ROMA (RM) GINECOLOGIA E OSTETRICIA Dipartimento per la Tutela della Salute della Donna e della Vita Nascente Recruiting Roma, Italy, 00168 Contact: Giovanni Scambia, MD    +390630156279    clinicaltrials@rm.unicatt.it    Principal Investigator: Giovanni Scambia, MD Less <<
NCT03237780 Metastatic Urothelial Carcinom... More >>a Recurrent Bladder Urothelial Carcinoma Recurrent Urethral Urothelial Carcinoma Recurrent Urothelial Carcinoma of the Renal Pelvis and Ureter Renal Pelvis Urothelial Carcinoma Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 Stage III Renal Pelvis Cancer AJCC v7 Stage III Ureter Cancer AJCC v7 Stage III Urethral Cancer AJCC v7 Stage IV Bladder Urothelial Carcinoma AJCC v7 Stage IV Renal Pelvis Cancer AJCC v7 Stage IV Ureter Cancer AJCC v7 Stage IV Urethral Cancer AJCC v7 Ureter Urothelial Carcinoma Less << Phase 2 Recruiting January 31, 2020 United States, California ... More >> Los Angeles County-USC Medical Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact    323-865-0451       Principal Investigator: David I. Quinn          USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact    323-865-0451       Principal Investigator: David I. Quinn          Keck Medical Center of USC Pasadena Recruiting Pasadena, California, United States, 91105 Contact: Site Public Contact    323-865-0451       Principal Investigator: David I. Quinn          University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact    916-734-3089       Principal Investigator: Chong-Xian Pan          United States, Pennsylvania University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Site Public Contact    412-647-8073       Principal Investigator: Leonard J. Appleman Less <<
NCT03001596 Esophageal Squamous Cell Carci... More >>noma Stage cT3-4aN0-1M0 Less << Phase 3 Not yet recruiting December 2023 China, Shanghai ... More >> Shanghai Zhongshan Hospital Not yet recruiting Shanghai, Shanghai, China, 200032 Contact: Han Tang    +862164041990    htang1989@163.com    Contact: Lijie Tan, MD    +862164041990    tan.lijie@zs-hospital.sh.cn    Sub-Investigator: Han Tang          Principal Investigator: Lijie Tan Less <<
NCT01265849 Squamous Cell Carcinoma of the... More >> Oral Cavity Squamous Cell Carcinoma of the Soft Palate Less << Phase 3 Completed - -
NCT01349647 Lung Cancer Phase 1 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00355199 - Completed - -
NCT00825669 Hepatocellular Carcinoma Not Applicable Completed - China, Shanghai ... More >> Eastern Hepatobiliary Surgery Hospital Shanghai, Shanghai, China, 200438 Less <<
NCT03161548 Tongue Cancer ... More >> Chemotherapy Effect Surgery Less << Phase 2 Terminated(Diffiult patient re... More >>cruitment) Less << - -
NCT02129699 Lung Cancer Non-small Cell Sta... More >>ge IV Less << Phase 3 Active, not recruiting September 2020 -
NCT02938195 Esophageal Cancer ... More >> Chemoradiation Surgery Less << Phase 2 Unknown January 2018 China, Shanghai ... More >> Shanghai Chest Hospital Recruiting Shanghai, Shanghai, China, 200030 Contact: Jun Liu, Doctor    +862122200000 ext 3602    drjunliu@qq.com Less <<
NCT00355199 Diffuse Large B-Cell Lymphoma Phase 3 Completed - Italy ... More >> Clinica di Ematologia - Nuovo Ospedale Torrette Ancona, Italy U.O. Ematologia - Ospedali Riuniti di Bergamo Bergamo, Italy Divisione di Ematologia - Ospedale Centrale di Bolzano Bolzano, Italy CTMO - Ematologia - Ospedale "R. Binaghi" Cagliari, Italy Divisione di Ematologia - Ospedale Ferrarotto Catania, Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, Italy Divisione Ematologia - Istituto S. Raffaele Milano, Italy Oncologia Medica - Istituto Nazionale dei Tumori Milano, Italy U.O. Ematologia - Istituto Nazionale dei Tumori Milano, Italy Divisione di Ematologia - Azienda Ospedaliera Padova, Italy Ematologia - Azienda Ospedaliera V. Cervello Palermo, Italy Ematologia Clinica - Ospedale Civile di Pescara Pescara, Italy Ematologia e TMO - Ospedale S. Camillo Roma, Italy Divisione Universitaria di Ematologia - Azienda Ospedaliera S. Giovanni Battista (Molinette) Torino, Italy Dipartimento di Medicina Clinica e Sperimentale - Università di Verona Verona, Italy Divisione di Ematologia - Presidio Ospedaliero S. Bortolo Vicenza, Italy Less <<
NCT02265770 Childhood Ependymoma Phase 2 Phase 3 Recruiting August 2026 -
NCT01626664 Adult T-cell Leukemia-Lymphoma Phase 2 Completed - United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 United States, Florida University of Miami / Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Memorial Sloan Kettering New York, New York, United States, 10021 Columbia Presbyterian New York, New York, United States, 10032 Weill Cornell Medical College New York, New York, United States, 10065 Belgium Cliniques Universitaires Saint-Luc Bruxelles, Belgium, 1200 Brazil Hospital Universitario Professor Edgard Santos- UFBA Salvador, Bahia, Brazil, 40110-060 Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Sao Paulo- SP, Brazil, CEP 05403-000 France CHU de Fort de France Fort De France Cedex, France, BP 632 97261 Hospital Necker Paris, France, 75743 Peru Hospital Nacional Edgardo Rebagliati Martins Lima, Peru, Lima11 Instituto Oncologico Miraflores Lima, Peru, Lima18 United Kingdom Guy's Hospital London, United Kingdom, SE1 9RT Imperial College London, United Kingdom, W2 1PG Sandwell General Hospital West Midlands, United Kingdom, B71 4HJ Less <<
NCT00028665 Lymphoma Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland, Ohio, United States, 44106-7284 Less <<
NCT00411151 Gastric Adenocarcinoma ... More >> Barrett Esophagus Less << Phase 2 Completed - Germany ... More >> Universität Heidelberg, Nationales Zentrum für Tumorerkrankungen Heidelberg, Baden-Würtemberg, Germany, 69120 Universitätsklinikum Tübingen Tübingen, Baden-Würtemberg, Germany, 72076 TU München, Klinikum rechts der Isar, II. Med. Klinik und Poliklinik München, Bayern, Germany, 81675 Klinikum der Universität Würzburg Würzburg, Bayern, Germany, 97070 Universitätsklinikum der GHS Essen, Innere Klinik und Poliklinik, Tumorforschung Essen, Nordrhein-Westfalen, Germany, 45122 Universitätsklinik zu Köln, Klinik I für Innere Medizin Köln, Nordrhein-Westfalen, Germany, 50937 Klinikum der Johannes Gutenberg-Universität Mainz Mainz, Rheinland-Pfalz, Germany, 55131 Universitätsklinikum des Saarlandes Homburg/Saar, Saarland, Germany, 66421 Otto-von-Guericke-Universität Magdeburg Magdeburg, Sachsen-Anhalt, Germany, 39120 Universitätsklinikum Carl Gustav Carus, Med. Klinik I Dresden, Sachsen, Germany, 01307 Charité, Campus Benjamin Franklin Berlin, Germany, 12200 KH Nordwest, Abteilung für Hämatologie und Onkologie Frankfurt, Germany, 60488 Less <<
NCT00411151 - Completed - -
NCT02640898 Gastric Cancer Not Applicable Recruiting December 2019 China, Shanghai ... More >> the Ethic Committee of Shanghai General Hospital Recruiting Shanghai, Shanghai, China, 210000 Contact: zhixiao chen, MD    021-63240090 ext 6218    chenzhixiaochen@sohu.com Less <<
NCT00452803 Lung Cancer Phase 2 Unknown December 2012 Korea, Republic of ... More >> National Cancer Center, Korea Recruiting Goyang-si, Gyeonggi-do, Korea, Republic of, 411-769 Sub-Investigator: Jae-Ill Zoo, M.D.          Sub-Investigator: Jong Mog Lee, M.D.          Sub-Investigator: Moon Soo Kim, M.D.          Sub-Investigator: Hyun-Sung Lee, M.D.          Sub-Investigator: Jin Soo Lee, M.D.          Sub-Investigator: Ji-Youn Han, M.D.          Sub-Investigator: Kwan Ho Cho, M.D.          Sub-Investigator: Hong Ryull Pyo, M.D.          Sub-Investigator: Bin Hwangbo, M.D.          Sub-Investigator: Hee Seok Lee, M.D.          Sub-Investigator: Hyae Young Kim, M.D.          Sub-Investigator: Geon Kook Lee, M.D.          Sub-Investigator: Moon Woo Seong, M.D.          Sub-Investigator: Kyeong-Man Hong, M.D.          Sub-Investigator: Byung-Ho Nam, Ph.D.          Sub-Investigator: Tak Yun, M.D. Less <<
NCT01365156 Cervical Squamous Cell Carcino... More >>ma Adenosquamous Carcinoma Adenocarcinoma Locally Advanced Malignant Neoplasm Cervical Cancer Less << Phase 3 Active, not recruiting September 2019 United States, Texas ... More >> Lyndon B. Johnson General Hospital Houston, Texas, United States, 77026 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Belgium Vall d'Hebron Hospital Brussels, Belgium Less <<
NCT01560195 NSCLC Neutrop... More >>enia Febrile Neutropenia Less << Phase 3 Unknown - China, Shanghai ... More >> Shanghai Pulmonary Hospital Recruiting Shanghai, Shanghai, China, 200433 Contact: Caicun Zhou, M. D.       caicunzhou@yahoo.com.cn Less <<
NCT00176800 - Completed - -
NCT01626664 - Completed - -
NCT00176800 Esophageal Carcinoma Phase 2 Completed - United States, Michigan ... More >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT02367443 Non-small Cell Lung Cancer Phase 1 Phase 2 Unknown December 2016 Poland ... More >> Independent Public Health Care Facility and Warmian & Mazurian Oncology Centre Recruiting Olsztyn, Poland, 10-228 Contact: Lucyna Kepka, Prof    +48 506 118 893    lucynak@coi.pl Less <<
NCT02151981 - Active, not recruiting - -
NCT02151981 Anticancer Treatment Phase 3 Active, not recruiting December 30, 2020 -
NCT00765011 Head and Neck Cancer Phase 2 Unknown May 2014 Spain ... More >> Hospital Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain, 08916 Principal Investigator: Beatriz Cirauqui, MD          Hospital Duran i Reynals Recruiting L'Hospitalet de Llobregat, Barcelona, Spain Principal Investigator: Ricard Mesia, MD          Hospital de Manresa Recruiting Manresa, Barcelona, Spain Principal Investigator: Esther Casado, MD          Hospital Clínic i Provincial de Barcelona Recruiting Barcelona, Spain, 08036 Principal Investigator: Juan J Grau, MD          Hospital General de Yagüe Withdrawn Burgos, Spain Hospital San Pedro de Alcántara Recruiting Cáceres, Spain Principal Investigator: Mª Angeles Rodríguez, MD          Hospital Dr.Josep Trueta (ICO Girona) Recruiting Girona, Spain, 17007 Principal Investigator: José Rubio, MD          Hospital Universitario Virgen de las Nieves Recruiting Granada, Spain Principal Investigator: Antonio L Irigoyen, MD          Oncogranada Terminated Granada, Spain Hospital General Ciudad de Jaén Withdrawn Jaén, Spain Hospital de León Withdrawn Leon, Spain Hospital Xeral Calde Recruiting Lugo, Spain Principal Investigator: José R Mel, MD          Clínica Quirón Withdrawn Madrid, Spain Hospital Gregorio Marañon Recruiting Madrid, Spain Principal Investigator: Yolanda escobar, MD          Hospital Universitario 12 de Octubre Terminated Madrid, Spain Hospital Universitario San Carlos Recruiting Madrid, Spain Principal Investigator: José A García, MD          Hospital Son Llátzer Recruiting Mallorca, Spain Principal Investigator: Mª Belén González, MD          Hospital General Universitario Morales Meseguer Withdrawn Murcia, Spain Hospital Universitario de Salamanca Recruiting Salamanca, Spain Sub-Investigator: Juan J Cruz, MD          Principal Investigator: Elvira del Barco Morillo, MD          Sub-Investigator: Juan Carlos Adansa Klain, MD          Hospital Universitario Marqués de Valdecilla Withdrawn Santander, Spain Hospital Clínico de Santiago Withdrawn Santiago de Compostela, Spain Hospital Universitario la Fe de Valencia Recruiting Valencia, Spain Principal Investigator: Miguel Pastor, MD          Hospital Xeral Cies Withdrawn Vigo, Spain Hospital Clínico Universitario de Zaragoza Recruiting Zaragoza, Spain Principal Investigator: Julio Lambea, MD          Hospital Miguel Servet Recruiting Zaragoza, Spain Principal Investigator: Javier Martínez Trufero, MD Less <<
NCT02363400 Nasopharyngeal Carcinoma Phase 3 Enrolling by invitation December 2022 -
NCT00391586 Carcinoma, Non-Small-Cell Lung Phase 2 Terminated(PI left institution... More >>.) Less << - United States, New Mexico ... More >> Lovelace Medical Group Albuquerque, New Mexico, United States, 87102 Hematology Oncology Associates NM Albuquerque, New Mexico, United States, 87106 Presbyterian Medical Group Albuquerque, New Mexico, United States, 87110 University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87131 New Mexico Cancer Care Associates Santa Fe, New Mexico, United States, 87505 Less <<
NCT02082886 - Recruiting January 2034 United States, Illinois ... More >> Elmhurst Memorial Health Care Recruiting Elmhurst, Illinois, United States, 60126 Contact: Kathy Seymour, BSN    630-646-6072    Kathy.Seymour@EEHealth.org    Principal Investigator: George I Salti, MD          Edward Hospital Recruiting Naperville, Illinois, United States, 60540 Contact: Kathy Seymour, BSN    630-646-6072    Kathy.Seymour@EEHealth.org    Principal Investigator: George I Salti, MD Less <<
NCT01861509 Metastatic Breast Cancer ... More >> Stage IV Breast Cancer Less << Phase 1 Completed - Israel ... More >> Oncology Unit. Sheba Medical Centre Ramat-Gan, Israel, 52621 Thailand Lampang Cancer Center Lampang, Thailand, 52000 Less <<
NCT01543620 - Unknown June 2015 United States, California ... More >> University of Southern California Recruiting Los Angeles, California, United States, 90033 Contact: Research Coordinator1          Contact: Research Coordinator2          Principal Investigator: Paul Beringer, PharmD          United States, Minnesota University of Minnesota - Cystic Fibrosis Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Research Coordinator1          Contact: Research Coordinator2          Principal Investigator: Joanne Billings, MD          United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84132 Contact: Research Coordinator1          Contact: Research Coordinator2          Principal Investigator: Dave Young, PharmD Less <<
NCT03210298 - Recruiting May 2019 Argentina ... More >> Roffo Cancer Institute Recruiting Buenos Aires, Argentina Contact: Laura Lay, MD       lauralay@ymail.com    Australia Peter MacCallum Cancer Centre Recruiting Melbourne, Australia Contact: Craig Lynch, MD          Belgium University Hospital Gent (UZ Gent) Recruiting Gent, Belgium, 9000 Contact: Woulter Willaert, MD       wouter.willaert@ugent.be    Denmark University Hospital Odense Recruiting Odense, Denmark Contact: Martin Graversen, MD       martin.graversen@rsyd.dk    France Hospices civils de Lyon Recruiting Lyon, France Contact: Olivier Glehen, MD    +33 478862371       Hôpital Lariboisière Recruiting Paris, France, 75010 Contact: Clarisse Eveno, MD    +33 1 49 95 25 80       Germany University Hospital Tübingen Recruiting Tübingen, Germany, 72076 Contact: Verena Schlaich    +4970712986722    pipac@med.uni-tuebingen.de    India Fortis Hospital Recruiting Bengaluru, India Contact: Aditi Bhatt, MD          Italy IRCC Torino Candiolo Recruiting Turin, Italy Contact: Marco Vaira, MD       marco.vaira@ircc.it    Poland F. Łukaszczyk Oncology Centre Recruiting Bydgoszcz, Poland Contact: Maciej Nowacki, MD       maciej.s.nowacki@gmail.com    Russian Federation Gersten Institute for Cancer Research Recruiting Moscow, Russian Federation Contact: Vladimir Khomyakov, MD       vladimirkhom@mail.ru    Singapore National University Hospital Recruiting Singapore, Singapore Contact: Janelle Phua       niam_sin_phua@nuhs.edu.sg    Spain Hospital de Pilar Recruiting Barcelona, Spain Contact: Juan Torrent, MD       juanjotorrent@yahoo.es    Switzerland University Hospital Lausanne CHUV Recruiting Lausanne, Switzerland, 1011 Contact: Martin Huebner, MD       chv.carcinose@chuv.ch Less <<
NCT03627390 Metastatic Pancreatic Cancer ... More >> Unresectable Pancreatic Cancer Less << Phase 2 Completed - Egypt ... More >> National Liver Institute, Menoufia University Cairo, Egypt Less <<
NCT00004897 Esophageal Cancer Phase 2 Terminated(Institutional Revie... More >>w Board requested termination - all patients deceased and no new accrual.) Less << - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00042367 Brain Tumors Not Applicable Completed - United States, North Carolina ... More >> Brain Tumor Center at Duke University Durham, North Carolina, United States, 27710 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105-0318 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT03617133 Uterine Cervical Neoplasms Phase 2 Recruiting April 2031 Austria ... More >> Medical University of Vienna Recruiting Vienna, Austria, 1090 Contact: Richard Pötter, MD    0043140400 ext 26920    richard.poetter@akhwien.at Less <<
NCT03603197 Metastatic Breast Cancer ... More >> Stage IV Breast Cancer Less << Phase 2 Completed - Thailand ... More >> Udon Thani Cancer Hospital Udon Thani, Udon Thani Province, Thailand, 41000 Siriraj Hospital, Mahidol University Bangkok, Thailand Lampang Cancer Center Lampang, Thailand, 52000 Ubon Ratchanthani Cancer Hospital Ubon Ratchathani, Thailand Less <<
NCT01737502 Extensive Stage Small Cell Lun... More >>g Carcinoma Lung Adenocarcinoma Recurrent Non-Small Cell Lung Carcinoma Recurrent Small Cell Lung Carcinoma Squamous Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Non-Small Cell Lung Cancer Less << Phase 1 Phase 2 Recruiting November 2018 United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Helen J. Ross Less <<
NCT02762266 Child-Pugh Class A ... More >> Child-Pugh Class B Recurrent Hepatocellular Carcinoma Less << Phase 3 Recruiting February 27, 2021 United States, California ... More >> Stanford University, School of Medicine Recruiting Palo Alto, California, United States, 94304 Contact: Rachel Freiberg    650-725-0438    rachelf@stanford.edu    Principal Investigator: Daniel T. Chang          Japan Hokkaido University Hospital Not yet recruiting Sapporo, Hokkaido, Japan, 060-8648 Contact: Rei Kikuchi    81-11-706-7600    reik777@huhp.hokudai.ac.jp    Principal Investigator: Hiroki Shirato Less <<
NCT01493544 - Completed - Argentina ... More >> Research Site Escobar, Buenos Aires, Argentina Research Site Ezeiza, Buenos Aires, Argentina Research Site Los Polvorines, Buenos Aires, Argentina Research Site Martinez, Buenos Aires, Argentina Research Site Quilmes, Buenos Aires, Argentina Research Site Ramos Mejia, Buenos Aires, Argentina Research Site Capital Federal, Argentina Colombia Research Site Medellin, Antioquia, Colombia Research Site Barranquilla, Atlantico, Colombia Research Site Manizales, Caldas, Colombia Research Site Armenia, Quindio, Colombia Research Site Cali, Valle Del Cauca, Colombia Uruguay Research Site Montevideo, Uruguay Venezuela Research Site Barquisimeto, Venezuela Research Site Caracas, Venezuela Research Site Maracaibo, Venezuela Research Site Porlamar, Venezuela Research Site Valencia, Venezuela Less <<
NCT01362530 Chemotherapy Induced Nausea an... More >>d Vomiting Less << Phase 3 Completed - -
NCT02783794 Metastatic Breast Cancer ... More >> Stage IV Breast Cancer Less << Phase 2 Completed - Russian Federation ... More >> Russian Oncological Research Centre n.a. N.N. Blokhin, Russian Academy of Medical Science (RAMS) Moscow, Russian Federation State Budgetary Institution of Nizhniy Novgorod Region "Oncology Dispensary of Nizhniy Novgorod" (Branch nr.1) Nizhniy Novgorod, Russian Federation St. Petersburg State Budgetary Health Organization, City Clinical Oncology Dispensary St Petersburg, Russian Federation Leningrad Regional Oncological Centre St. Petersburg, Russian Federation Thailand Siriraj Hospital, Mahidol University Bangkok, Thailand Udon Thani Cancer Hospital Udon Thani, Thailand Less <<
NCT03072238 Metastatic Prostate Cancer Phase 3 Recruiting November 18, 2023 -
NCT01726582 Pancreatic Adenocarcinoma Phase 2 Active, not recruiting December 2021 United States, Ohio ... More >> University of Cincinnati Cancer Center Cincinnati, Ohio, United States, 45221 United States, Wisconsin Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01362530 - Completed - -
NCT02630004 Oral Mucositis Phase 1 Phase 2 Completed - Spain ... More >> Institut Català d'Oncologia ICO Badalona Badalona, Barcelona, Spain, 08916 Institut Català d'Oncologia L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital Clínico Universitario de Santiago Santiago de Compostela, La Coruña, Spain, 15706 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08026 Hospital Universitari de la Vall d'Hebron Barcelona, Spain, 08035 Institut Català d'Oncologia Girona Girona, Spain, 17007 Hospital San Carlos, Madrid Madrid, Spain, 28040 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario Virgen de la Victoria Málaga, Spain, 29010 Hospital Universitario Marqués de Valdecilla Santander, Spain, 39008 Hospital Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT03206450 - Recruiting September 5, 2021 -
NCT02863003 - Not yet recruiting December 2020 Brazil ... More >> CPO - Pucrs Not yet recruiting Porto Alegre, Rio Grande do Sul, Brazil Contact: Virginia Webber          Principal Investigator: André Fay, MD          Hospital Israelita Albert Einstein Not yet recruiting São Paulo, Brazil Contact: Fernanda Cardoso          Principal Investigator: Oren Smaletz, MD          Hospital São José Not yet recruiting São Paulo, Brazil Contact: Cristiane Ibrahim          Principal Investigator: Fábio Schutz, MD          ICESP Not yet recruiting São Paulo, Brazil Contact: Bárbara Penna          Principal Investigator: Diogo Bastos, MD          Principal Investigator: Carlos Dzik, MD Less <<
NCT00131638 Head and Neck Cancer Phase 3 Completed - -
NCT02723604 Mucositis Not Applicable Recruiting March 2018 United States, Michigan ... More >> Wayne State University/Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Harold E. Kim    313-576-9543    kimh@karmanos.org    Principal Investigator: Harold E. Kim, M.D.          Sub-Investigator: Mark A. Zaki, M.D.          Sub-Investigator: Pamela Laszewski, R.N. Less <<
NCT02577172 Testicular Neoplasms Not Applicable Terminated(Unexpected events) - Norway ... More >> Oslo University Hospital Oslo, Norway Less <<
NCT03170960 Urothelial Carcinoma ... More >> Renal Cell Carcinoma Non-Small Cell Lung Cancer Castration-resistant Prostate Cancer Triple Negative Breast Cancer Ovarian Cancer Endometrial Cancer Hepatocellular Carcinoma Gastric Cancer Gastroesophageal Junction Adenocarcinoma Colorectal Cancer Head and Neck Cancer Differentiated Thyroid Cancer Less << Phase 1 Phase 2 Recruiting December 2020 -
NCT03328234 IMRT With or Without Concurren... More >>t Chemotherapy for Esophageal Cancer Less << Phase 3 Recruiting December 31, 2022 China ... More >> Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Recruiting Beijing, China, 100021 Contact: Xin Wang, MD    +861013311583220    beryl_wx2000@163.com Less <<
NCT01951586 Non-Small Cell Lung Cancer Phase 2 Completed - -
NCT00558220 Diffuse Large B-Cell Lymphoma.... More >> Primary Mediastinal B-Cell Lymphoma Follicular Lymphoma Grade III Less << Phase 2 Completed - Czech Republic ... More >> University Hospital Brno-Bohunice Brno, Czech Republic, 625 00 Hospital Chomutov Chomutov, Czech Republic, 430 12 University Hospital Hradec Králové Hradec Králové, Czech Republic, 500 05 University Hospital Královské Vinohrady Prague, Czech Republic, 100 34 General University Hospital Prague, Czech Republic, 128 08 University Hospital Motol Prague, Czech Republic, 150 00 Hospital Ústí nad Labem Usti nad Labem, Czech Republic, 401 13 Hospital České Budějovice České Budějovice, Czech Republic Less <<
NCT02750657 - Recruiting December 2021 Canada, Ontario ... More >> Kingston Health Sciences Centre Recruiting Kingston, Ontario, Canada, K7L2V7 Contact: Jim Biagi, M.D.    613-549-6666 ext 8105       Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Jennifer J. Knox, M.D.    416-946-2399       Principal Investigator: Jennifer J. Knox, M.D.          Canada, Quebec McGill University Health Centre Recruiting Montréal, Quebec, Canada, H4A3J1 Contact: George Zogopoulos, M.D.    514-934-1934 ext 76333 Less <<
NCT00827424 Obesity Not Applicable Completed - Israel ... More >> Clinical Research Unit, Clalit Health Services, Haifa and Western Galilee District . Haifa,, Israel, 35024 Less <<
NCT00119613 Small Cell Lung Cancer Phase 3 Completed - -
NCT00089453 Multiple Myeloma Phase 1 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT03034850 - Completed - -
NCT01951586 - Completed - -
NCT00412425 - Completed - -
NCT00412425 Melanoma Phase 1 Phase 2 Completed - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00083876 Multiple Myeloma Phase 3 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT01451853 Lung Cancer H... More >>ead and Neck Cancer Hearing Loss Ototoxicity Tinnitus Neuropathy Less << Phase 2 Not yet recruiting September 23, 2019 United States, Washington ... More >> VA Puget Sound Health Care Not yet recruiting Seattle, Washington, United States, 98108 Contact: Tony S. Quang, M.D.    206-768-5356       Principal Investigator: Tony S Quang, M.D. Less <<
NCT01037790 Adult Solid Tumor ... More >> Adenocarcinoma of the Colon Adenocarcinoma of the Rectum Adult Central Nervous System Germ Cell Tumor Adult Teratoma Benign Teratoma Estrogen Receptor-negative Breast Cancer Estrogen Receptor-positive Breast Cancer Familial Testicular Germ Cell Tumor HER2-negative Breast Cancer HER2-positive Breast Cancer Male Breast Cancer Ovarian Immature Teratoma Ovarian Mature Teratoma Ovarian Monodermal and Highly Specialized Teratoma Progesterone Receptor-negative Breast Cancer Progesterone Receptor-positive Breast Cancer Recurrent Breast Cancer Recurrent Colon Cancer Recurrent Extragonadal Germ Cell Tumor Recurrent Extragonadal Non-seminomatous Germ Cell Tumor Recurrent Extragonadal Seminoma Recurrent Malignant Testicular Germ Cell Tumor Recurrent Melanoma Recurrent Ovarian Germ Cell Tumor Recurrent Rectal Cancer Stage III Extragonadal Non-seminomatous Germ Cell Tumor Stage III Extragonadal Seminoma Stage III Malignant Testicular Germ Cell Tumor Stage III Ovarian Germ Cell Tumor Stage IV Breast Cancer Stage IV Colon Cancer Stage IV Extragonadal Non-seminomatous Germ Cell Tumor Stage IV Extragonadal Seminoma Stage IV Melanoma Stage IV Ovarian Germ Cell Tumor Stage IV Rectal Cancer Testicular Immature Teratoma Testicular Mature Teratoma Less << Phase 2 Recruiting - United States, Pennsylvania ... More >> Abramson Cancer Center of The University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Peter ODwyer    855-216-0098    PennCancerTrials@emergingmed.com    Principal Investigator: Peter ODwyer Less <<
NCT01887314 Cancer Nausea... More >> Vomiting Less << Not Applicable Completed - Italy ... More >> Istituto Nazionale dei Tumori Milan, Italy, 20133 IEO -Istituto Europeo di Oncologia- Milan, Italy, 20141 Ospedale S. Gerardo Monza, Italy, 20052 Policlinico Umberto I Rome, Italy, 00186 Istituti Fisioterapici Ospitalieri - Istituto Nazionale Tumori "Regina Elena" Rome, Italy Ospedale S. Maria Terni, Italy, 05100 Less <<
NCT01016028 - Withdrawn(Study assessment too... More >>l development delayed.) Less << - -
NCT02381782 - Completed - Belgium ... More >> General Hospital Groeninge Kortrijk, Belgium Less <<
NCT01941680 - Active, not recruiting March 2021 Guadeloupe ... More >> CHU Pinteà Pitre/Abymes Pointe à Pitre, Guadeloupe Martinique CHU de Martinique Fort de France, Martinique Less <<
NCT02658214 Small Cell Lung Carcinoma ... More >> Carcinoma, Squamous Cell of Head and Neck Stomach Neoplasms Triple Negative Breast Neoplasms Ovarian Neoplasms Fallopian Tube Neoplasms Peritoneal Neoplasms Esophagogastric Junction Neoplasms Carcinoma, Pancreatic Ductal Esophageal Squamous Cell Carcinoma Less << Phase 1 Recruiting June 28, 2019 United States, Georgia ... More >> Research Site Withdrawn Augusta, Georgia, United States, 30912 United States, Pennsylvania Research Site Withdrawn Pittsburgh, Pennsylvania, United States, 15232 Japan Research Site Recruiting Chuo-ku, Japan, 104-0045 Research Site Recruiting Kashiwa, Japan, 277-8577 Korea, Republic of Research Site Recruiting Seoul, Korea, Republic of, 03080 Research Site Recruiting Seoul, Korea, Republic of, 03722 Research Site Recruiting Seoul, Korea, Republic of, 05505 Research Site Recruiting Seoul, Korea, Republic of, 135-710 Less <<
NCT00040872 Neuroblastoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00302003 Childhood Favorable Prognosis ... More >>Hodgkin Lymphoma Childhood Lymphocyte Depletion Hodgkin Lymphoma Childhood Mixed Cellularity Hodgkin Lymphoma Childhood Nodular Sclerosis Hodgkin Lymphoma Stage I Childhood Hodgkin Lymphoma Stage II Childhood Hodgkin Lymphoma Less << Phase 3 Unknown - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT03689712 Oral Mucositis Phase 3 Recruiting October 2024 United States, Washington ... More >> Cancer Care NW Recruiting Spokane, Washington, United States, 99216 Less <<
NCT00513383 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00003397 Lymphoma Phase 2 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT01336270 - Completed - France ... More >> Cochin Hospital Paris, Ile de France, France, 75014 Less <<
NCT00653068 - Active, not recruiting - -
NCT00165139 Neuroblastoma ... More >> Ewings Sarcoma Non-rhabdomyosarcoma Soft Tissue Sarcoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00017368 Neuroblastoma Phase 2 Completed - United States, Georgia ... More >> AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish RiteCampus Atlanta, Georgia, United States, 30342 United States, Massachusetts Floating Hospital for Children Boston, Massachusetts, United States, 02111 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Oregon CCOP - Columbia River Oncology Program Portland, Oregon, United States, 97225 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 CCOP - Scott and White Hospital Temple, Texas, United States, 76508 United States, Wisconsin CCOP - Marshfield Clinic Research Foundation Marshfield, Wisconsin, United States, 54449 Australia, Western Australia Princess Margaret Hospital for Children Perth, Western Australia, Australia, 6001 Less <<
NCT00002596 Childhood Germ Cell Tumor ... More >> Extragonadal Germ Cell Tumor Testicular Germ Cell Tumor Less << Phase 3 Completed - -
NCT00003086 Breast Cancer Phase 1 Phase 2 Unknown - United States, Louisiana ... More >> Louisiana State University School of Medicine Shreveport, Louisiana, United States, 71130-3932 Less <<
NCT00006123 Breast Cancer Phase 1 Phase 2 Withdrawn(Never started) - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT00003386 Ovarian Cancer Phase 2 Terminated - -
NCT00302003 - Unknown - -
NCT00004900 Breast Cancer Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00012051 Lymphoma Phase 3 Completed - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Netherlands HagaZiekenhuis - Locatie Leyenburg 's-Gravenhage, Netherlands, 2545 CH Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands, 5211 NL Meander Medisch Centrum Amersfoort, Netherlands, 3816 CP Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 BE Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1081HV Academisch Medisch Centrum at University of Amsterdam Amsterdam, Netherlands, 1105 AZ Medisch Spectrum Twente Enschede, Netherlands, 7500 KA University Medical Center Groningen Groningen, Netherlands, 9713 EZ Medisch Centrum Leeuwarden - Zuid Leeuwarden, Netherlands, 8934 AD Leiden University Medical Center Leiden, Netherlands, 2300 CA Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Isala Klinieken - locatie Sophia Zwolle, Netherlands, 8000 GK Less <<
NCT00238368 Lymphoma Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00007982 Brain and Central Nervous Syst... More >>em Tumors Head and Neck Cancer Lymphoma Less << Phase 2 Completed - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00002772 Breast Cancer Phase 3 Terminated(poor accrual) - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00004906 Breast Cancer Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00017225 Neuroblastoma Phase 2 Completed - -
NCT00024193 Neuroblastoma Phase 2 Unknown - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00653068 Childhood Atypical Teratoid/Rh... More >>abdoid Tumor Less << Phase 3 Active, not recruiting - -
NCT02613286 Uterine Cervical Neoplasms Phase 2 Unknown June 2018 -
NCT00004903 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Unknown - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 Less <<
NCT00003273 Brain and Central Nervous Syst... More >>em Tumors Neuroblastoma Retinoblastoma Sarcoma Less << Phase 2 Withdrawn - United States, Hawaii ... More >> Cancer Research Center of Hawaii Honolulu, Hawaii, United States, 96813 United States, Maine Maine Children's Cancer Program Scarborough, Maine, United States, 04074-9308 United States, Michigan Spectrum Health and DeVos Children's Hospital Grand Rapids, Michigan, United States, 49503 United States, Nebraska Children's Hospital of Omaha Omaha, Nebraska, United States, 68114 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Albert Einstein Clinical Cancer Center Bronx, New York, United States, 10461 Winthrop University Hospital Mineola, New York, United States, 11501 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Beth Israel Hospital North New York, New York, United States, 10128 State University of New York Health Sciences Center - Stony Brook Stony Brook, New York, United States, 11790-7775 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Ohio St. Vincent Mercy Medical Center Toledo, Ohio, United States, 43608 United States, Pennsylvania Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Argentina Children's Hospital Buenos Aires, Argentina, 1425 Canada, British Columbia British Columbia Children's Hospital Vancouver, British Columbia, Canada, V6H 3V4 Less <<
NCT00002675 Retinoblastoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00025636 Lymphoma Phase 3 Unknown - -
NCT00002634 Neuroblastoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00920153 Lymphoma Phase 3 Terminated(Other new drugs) - France ... More >> FILO French Innovative Leukemia Organization Tours Cedex, France, 37044 Less <<
NCT01172912 Brain and Central Nervous Syst... More >>em Tumors Extragonadal Germ Cell Tumor Testicular Germ Cell Tumor Less << Phase 2 Unknown - Italy ... More >> Fondazione Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Contact: Contact Person    39-02-2390-2532    alessandro.gianni@unimi.it Less <<
NCT00025064 Lymphoma Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Meyerstein Institute of Oncology at University College of London Hospitals London, England, United Kingdom, WIT 3AA Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE7 7DN Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT02551159 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 3 Active, not recruiting December 31, 2018 -
NCT00003159 Lung Cancer Phase 3 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Less <<
NCT00003413 Ovarian Cancer Phase 2 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT00003042 Breast Cancer Phase 2 Active, not recruiting March 2019 United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00019864 Cardiac Toxicity ... More >> Sarcoma Less << Phase 2 Terminated - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 United States, Oklahoma Oklahoma University Cancer Institute Oklahoma City, Oklahoma, United States, 73104 United States, Texas Cook Children's Medical Center - Fort Worth Fort Worth, Texas, United States, 76104 Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital Houston, Texas, United States, 77030-2399 Less <<
NCT00410631 Neuroblastoma Phase 3 Unknown - -
NCT00006258 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States, 17822-1320 Canada, Alberta Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Less <<
NCT00055887 Lung Cancer Phase 3 Withdrawn(Study never started.... More >> No patients were enrolled.) Less << - United States, Arizona ... More >> St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States, 85013 United States, Idaho North Idaho Cancer Center Coeur d'Alene, Idaho, United States, 83814 United States, Kentucky Cancer Center at Lexington Clinic Lexington, Kentucky, United States, 40504 United States, Louisiana Willis - Knighton Cancer Center Shreveport, Louisiana, United States, 71103-3951 United States, Maryland St. Agnes Cancer Center Baltimore, Maryland, United States, 21229 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Washington Providence Everett Medical Center - Pacific Campus Everett, Washington, United States, 98206 United States, West Virginia Schiffler Cancer Center Wheeling, West Virginia, United States, 26003 Belgium Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Canada, Alberta Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Regional Cancer Centre Ottawa, Ontario, Canada, K1H 1C4 Canada, Quebec CHUS-Hopital Fleurimont Fleurimont, Quebec, Canada, J1H 5N4 Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada, H1T 2M4 Hopital Notre- Dame du CHUM Montreal, Quebec, Canada, H2L 4M1 McGill University Montreal, Quebec, Canada, H2W 1S6 Centre Hospitalier Universitaire de Quebec Quebec City, Quebec, Canada, G1R 2J6 Israel Soroka University Medical Center Beer-Sheva, Israel, 84101 Rambam Medical Center Haifa, Israel, 31096 Sheba Medical Center Tel Hashomer, Israel, 52621 Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel, 64239 Less <<
NCT00274950 Childhood Germ Cell Tumor ... More >> Extragonadal Germ Cell Tumor Ovarian Cancer Less << Phase 3 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health at Royal Victoria Infirmary Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00024271 Malignant Mesothelioma Phase 2 Unknown - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 Less <<
NCT00023868 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 3 Completed - United States, Arizona ... More >> Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 United States, Illinois Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New York NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104-4283 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00003309 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 United States, Illinois Veterans Affairs Medical Center - Lakeside Chicago Chicago, Illinois, United States, 60611-4494 Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 West Michigan Cancer Center Kalamazoo, Michigan, United States, 49007 United States, Minnesota CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, New Hampshire Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756-0002 United States, Tennessee Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center Nashville, Tennessee, United States, 37232-6307 United States, Wisconsin CCOP - Marshfield Clinic Research Foundation Marshfield, Wisconsin, United States, 54449 Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226-3596 Less <<
NCT00002822 Lung Cancer Phase 3 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Less <<
NCT00652860 Metastatic Cancer ... More >> Sarcoma Less << Phase 2 Completed - -
NCT00023998 Metastatic Osteosarcoma Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00070200 Neuroblastoma Phase 1 Completed - United States, California ... More >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0106 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Mary Bridge Children's Hospital and Health Center - Tacoma Tacoma, Washington, United States, 98405 Australia, New South Wales Westmead Hospital Westmead, New South Wales, Australia, 2145 Less <<
NCT00526318 Neuroblastoma Not Applicable Unknown - -
NCT00577096 Multiple Myeloma Not Applicable Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00577096 - Completed - -
NCT00002802 Neuroblastoma Phase 3 Completed - Germany ... More >> University of Cologne Frechen, Germany, DOH-5-0226 Less <<
NCT00646659 Head and Neck Cancer Phase 2 Terminated(Recruitment was sus... More >>pended prematurely for safety concerns and closed after IDMC review) Less << - Belgium ... More >> Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Less <<
NCT00004086 Leukemia Lymp... More >>homa Less << Phase 1 Unknown - United States, New Jersey ... More >> Garden State Cancer Center Belleville, New Jersey, United States, 07103 Less <<
NCT00003640 Bladder Cancer Phase 2 Terminated(low accrual) - Italy ... More >> San Raffaele Hospital Rome, Italy, 00144 Less <<
NCT00002566 Extragonadal Germ Cell Tumor ... More >> Testicular Germ Cell Tumor Less << Phase 3 Unknown - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00083083 Lung Cancer Phase 2 Unknown - -
NCT00276731 Neuroblastoma Phase 3 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00003209 Cervical Cancer Phase 3 Completed - United Kingdom ... More >> Derbyshire Royal Infirmary Derby, England, United Kingdom, DE1 2QY Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT00003776 Sarcoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT03668418 - Recruiting May 31, 2022 Italy ... More >> Azienda Ospedaliero-Universitaria Pisana Recruiting Pisa, Italy, 56124 Contact: Luca Morelli, Prof       luca.morelli@unipi.it    Sub-Investigator: Vittoria Raffa, Prof          Sub-Investigator: Enrico Vasile, Dr          Sub-Investigator: Gregorio Di Franco, MD          Sub-Investigator: Alice Usai, MSc Less <<
NCT00303810 Brain and Central Nervous Syst... More >>em Tumors Less << Not Applicable Completed - Germany ... More >> University Medical Center Hamburg - Eppendorf Hamburg, Germany, D-20246 Less <<
NCT00287950 Neuroblastoma Not Applicable Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Meyerstein Institute of Oncology at University College of London Hospitals London, England, United Kingdom, WIT 3AA Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT03770299 Non-Small Cell Lung Cancer ... More >> Non-Small-Cell Lung Carcinoma Circulating Tumor DNA Less << Phase 2 Not yet recruiting March 14, 2024 United States, Florida ... More >> Local Institution Not yet recruiting Jacksonville, Florida, United States, 32224 Contact: Site 0015          United States, Kentucky Local Institution Not yet recruiting Lexington, Kentucky, United States, 40503-1489 Contact: Site 0014          United States, South Carolina Local Institution Not yet recruiting Charleston, South Carolina, United States, 29414 Contact: Site 0010          United States, Texas Local Institution Not yet recruiting Tyler, Texas, United States, 75701 Contact: Site 0013          Germany Local Institution Not yet recruiting Gauting, Germany, 82131 Contact: Site 0005          Local Institution Not yet recruiting Grosshansdorf, Germany, 22927 Contact: Site 0006          Local Institution Not yet recruiting Heidelberg, Germany, 69126 Contact: Site 0007          Switzerland Local Institution Not yet recruiting Lausanne, Switzerland, 1011 Contact: Site 0009          Local Institution Not yet recruiting Zuerich, Switzerland, 8091 Contact: Site 0008          United Kingdom Local Institution Not yet recruiting London, United Kingdom, NW1 2BU Contact: Site 0001 Less <<
NCT00003862 Gastric Cancer Phase 2 Completed - -
NCT00683319 - Active, not recruiting - United Kingdom ... More >> Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00002496 Head and Neck Cancer Phase 3 Completed - United States, Colorado ... More >> CCOP - Colorado Cancer Research Program, Inc. Denver, Colorado, United States, 80209-5031 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Georgia Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States, 30033 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5265 Veterans Affairs Medical Center - Indianapolis (Roudebush) Indianapolis, Indiana, United States, 46202 United States, Iowa CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 United States, Massachusetts New England Medical Center Hospital Boston, Massachusetts, United States, 02111 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Michigan CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Minnesota CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, New Jersey Veterans Affairs Medical Center - East Orange East Orange, New Jersey, United States, 07018-1095 CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania Hahnemann University Hospital Philadelphia, Pennsylvania, United States, 19102-1192 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213 South Africa Pretoria Academic Hospital Pretoria, South Africa, 0001 Less <<
NCT00470223 Sarcoma Phase 3 Terminated(IDMC decision upon ... More >>interim efficacy analysis) Less << April 2025 France ... More >> Centre Paul Papin Angers, France, 49036 Institut Gustave Roussy Angers, France, 49036 Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besancon, France, 25030 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 Institut Bergonie Bordeaux, France, 33076 CHU Hopital A. Morvan Brest, France, 29609 CHU de Caen Caen, France, 14033 Centre Regional Francois Baclesse Caen, France, 14076 CHR Clermont Ferrand, Hotel Dieu Clermont-Ferrand, France, 63003 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Centre Hospitalier Universitaire de Dijon Dijon, France, 21079 CHU de Grenoble - Hopital Michallon Grenoble, France, 38043 Centre Oscar Lambret Lille, France, 59020 Centre Leon Berard Lyon, France, 69373 Hopital Edouard Herriot - Lyon Lyon, France, 69437 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 CHU de la Timone Marseille, France, 13385 Hopital d'Enfants de la Timone Marseille, France, 13385 CHU Nord Marseille, France, 13915 Hopital Arnaud de Villeneuve Montpellier, France, 34295 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Hopital de l'Archet CHU de Nice Nice, France, F-06202 Institut Curie Hopital Paris, France, 75248 Hopital Jean Bernard Poitiers, France, 86021 Centre Eugene Marquis Rennes, France, 35042 Hopital Charles Nicolle Rouen, France, 76031 Centre Henri Becquerel Rouen, France, 76038 Institut de Cancerologie de la Loire Saint Priest en Jarez, France, 42270 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants Toulouse, France, 31059 C.H. Bastien de Clocheville Tours, France, 3700 CHRU de Tours - Hopital Trousseau Tours, France, 37044 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Less <<
NCT00002887 Lung Cancer Phase 1 Unknown - Canada, Ontario ... More >> Ottawa Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 1C4 Less <<
NCT00629863 Esophageal Cancer ... More >> Gastric Cancer Less << Not Applicable Completed - United Kingdom ... More >> Royal Blackburn Hospital Blackburn, England, United Kingdom, BB2 3 HH Gloucestershire Royal Hospital Gloucester, England, United Kingdom, GL1 3NN Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW North Tyneside Hospital North Shields, England, United Kingdom, NE29 8NH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital Dundee, Scotland, United Kingdom, DD1 9SY Royal Infirmary - Castle Glasgow, Scotland, United Kingdom, G4 0SF North Wales Organisation for Randomised Trials in Health Bangor, Wales, United Kingdom, LL57 2PZ Less <<
NCT02477826 Non-Small Cell Lung Cancer Phase 3 Recruiting December 31, 2020 -
NCT03308552 Esophageal Neoplasms Phase 3 Recruiting August 30, 2021 China, Beijing ... More >> Department of Radiation Oncology, Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC) Recruiting Beijing, Beijing, China, 100021 Contact: Zefen Xiao, MD Less <<
NCT00075699 Malignant Mesothelioma Phase 3 Completed - United Kingdom ... More >> Leeds General Infirmary at Leeds Teaching Hospital NHS Trust Leeds, England, United Kingdom, LS1 3EX Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Less <<
NCT00190528 Cervical Neoplasms Phase 3 Terminated - Japan ... More >> National Cancer Center Hospital Chuo-ku, Tokyo, Japan, 1040045 Less <<
NCT02998528 Non Small Cell Lung Cancer Phase 3 Recruiting November 8, 2028 -
NCT03734952 Radiation Oncology Not Applicable Not yet recruiting January 1, 2029 -
NCT00365755 Neuroblastoma Phase 3 Completed - -
NCT03064854 Non-small Cell Lung Cancer Phase 1 Recruiting February 15, 2022 -
NCT02772107 Extensive-stage Small Cell Lun... More >>g Cancer Less << Phase 2 Phase 3 Unknown January 2018 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: haitao tao, PhD    +861066937875    whatyouknow@126.com Less <<
NCT03615326 Gastric Neoplasms ... More >> Gastroesophageal Junction Adenocarcinoma Less << Phase 3 Recruiting March 20, 2024 -
NCT03574649 Non Small Cell Lung Cancer Phase 2 Not yet recruiting December 30, 2020 United States, California ... More >> Chan Soon-Shiong Institute for Medicine El Segundo, California, United States, 90245 Less <<
NCT02013050 Oral Mucositis Phase 2 Completed - United States, Kentucky ... More >> Markey Cancer Center-University of Kentucky Lexington, Kentucky, United States, 40536 Less <<
NCT03161522 Malignant Neoplasms of Digesti... More >>ve Organs Esophageal Cancer Gastric Cancer Less << Phase 2 Recruiting February 2025 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       CR_Study_Registration@mdanderson.org Less <<
NCT03403049 Pancreatic Cancer ... More >> Cancer Less << Phase 1 Recruiting December 2019 United States, New York ... More >> Albert Einstein College of Medicine Not yet recruiting Bronx, New York, United States, 10461 Contact: Ravindran S. Kathirithamby, MBA    718-430-3697    ravindran.kathirithamby@einstein.yu.edu    China, Shanghai Shanghai Proton and Heavy Ion Center Recruiting Shanghai, Shanghai, China Contact: Guo-Liang Jiang, M.D.    +86-021-38296666-53609    guoliang.jiang@sphic.org.cn Less <<
NCT00028756 Stage III Bladder Cancer ... More >> Stage IV Bladder Cancer Transitional Cell Carcinoma of the Bladder Less << Phase 3 Completed - -
NCT02013050 - Completed - -
NCT00436774 - Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Recruiting Dublin, Ireland, 12 Contact: Contact Person    353-1-409-6653       United Kingdom Institute of Child Health at University of Bristol Recruiting Bristol, England, United Kingdom, BS2 8AE Contact: Contact Person    44-117-342-8811       Addenbrooke's Hospital Recruiting Cambridge, England, United Kingdom, CB2 2QQ Contact: Contact Person    44-1223-256-298       Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Adam Glaser, MD    44-113-206-4984    adam.glaser@leedsth.nhs.uk    Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Gill Levitt, MD    44-20-7405-9200 ext. 0073       Sir James Spence Institute of Child Health at Royal Victoria Infirmary Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Contact: Juliet Hale, MD    44-191-282-4101    j.p.hale@ncl.ac.uk    Children's Hospital - Sheffield Recruiting Sheffield, England, United Kingdom, S10 2TH Contact: Mary P. Gerrard, MBChB, FRCP, FRCPCH    44-114-271-7366    mary.gerrard@sch.nhs.uk    Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Janice A. Kohler, MD, FRCP    44-23-8079-6942       Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Mary Taj, MD    44-20-8642-6011 ext. 1307       Royal Aberdeen Children's Hospital Recruiting Aberdeen, Scotland, United Kingdom, AB25 2ZG Contact: Veronica Neefjes    44-1224-550-217       Royal Hospital for Sick Children Recruiting Edinburgh, Scotland, United Kingdom, EH9 1LF Contact: W. Hamish Wallace, MD    44-131-536-0426       Royal Hospital for Sick Children Recruiting Glasgow, Scotland, United Kingdom, G3 8SJ Contact: Milind D. Ronghe, MD    44-141-201-9309       Childrens Hospital for Wales Recruiting Cardiff, Wales, United Kingdom, CF14 4XW Contact: Heidi Traunecker, MD, PhD    44-29-2074-2285    heidi.traunecker@cardiffandvale.wales.nhs.uk Less <<
NCT00004192 Lymphoma Neut... More >>ropenia Less << Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT03322566 Lung Cancer Phase 2 Active, not recruiting September 2021 -
NCT00148395 Non-Small-Cell Lung Carcinoma Phase 3 Completed - Germany ... More >> Klinikum Kassel GmbH Kassel, Germany, 34125 Less <<
NCT02734524 Non-small Cell Lung Cancer Phase 2 Recruiting March 2019 China, Chongqing ... More >> Southwest Hospital of Third Millitary Medical University Recruiting Chongqing, Chongqing, China, 400000 Contact: Cheng Qian, PhD    008615086883400    cqian3184@163.com    Contact: Zhi Yang, PhD    008613206140093       Principal Investigator: Cheng Qian, PhD Less <<
NCT00983541 - Terminated(Low enrollment) - -
NCT00856791 Ovarian Cancer Phase 2 Completed - United States, Indiana ... More >> St. Vincent Gynecologic Oncology Indianapolis, Indiana, United States, 46260 Less <<
NCT02560441 Extranodal Natural Killer/T-Ce... More >>ll Lymphoma, Nasal Type Less << Phase 2 Recruiting - China ... More >> Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Recruiting Beijing, China Contact: Yuankai Shi          People's Hospital of Guangxi Recruiting Nanning, China Contact: Jiaxin Chen          Fourth Hospital of Hebei Medical University Recruiting Shijiazhuang, China Contact: Yuhuan Gao          Shanxi Dayi Hospital Recruiting Taiyuan, China Contact: Qiaohua Zhang          Shanxi Province Cancer Hospital Recruiting Taiyuan, China Contact: Liping Su Less <<
NCT00391586 - Terminated(PI left institution... More >>.) Less << - -
NCT03179579 Gastric Cancer ... More >> Peritoneal Carcinomatosis Less << Phase 3 Not yet recruiting August 1, 2022 China, Guangdong ... More >> Department of Abdominal Surgery (Section 2), Affiliated Tumor Hospital of Guangzhou Medical University Not yet recruiting Guangzhou, Guangdong, China, 510095 Contact: Xianzi Yang, M.D    8602066673666    7097359@qq.com    Principal Investigator: shuzhong cui, M.D Less <<
NCT00983541 Cancer Phase 2 Terminated(Low enrollment) - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT01510990 Non-small Cell Lung Cancer Phase 2 Unknown November 2015 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Sang-We Kim, M.D.    82-2-3010-3215    swkim@amc.seoul.kr    Principal Investigator: Sang-We Kim, M.D. Less <<
NCT01091168 Breast Cancer ... More >> Metastases Less << Phase 3 Completed - -
NCT01538641 Refractory Aggressive Non-Hodg... More >>kin's Lymphoma Relapsing Aggressive Non-Hodgkin's Lymphoma Less << Phase 2 Completed - -
NCT00856791 - Completed - -
NCT03141359 Lung Phase 2 Recruiting June 2020 United States, Maryland ... More >> University of Maryland Medical Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Caroline Poff, RN, MSN    410-369-5264    caroline.poff@umm.edu    Principal Investigator: Charles Simone, MD          United States, North Carolina Levine Cancer Institute Recruiting Charlotte, North Carolina, United States, 28204 Contact: Jenna Gregory, RN, BSN, OCN    704-403-1520    jenna.gregory@carolinashealthcare.org    Principal Investigator: John H Heinzerling, MD Less <<
NCT00807300 Hepatocellular Carcinoma Phase 2 Completed - Germany ... More >> Clinic of Diagnostic Radiology and Nuclear Medicine, Medical Faculty, University Magdeburg Magdeburg, Saxony-anhalt, Germany, 39120 Less <<
NCT01117402 Postsurgery Recurrent Carcinom... More >>a Cervix Less << Phase 2 Unknown December 2014 India ... More >> Tata Memorial Centre Recruiting Mumbai, Maharashtra, India, 400012 Contact: Reena Engineer, MD    +912224177165    reena_engineer@rediffmail.com    Contact: ShyamKishore Shrivastava, MD    +912224177163    shrivastavask@tmc.gov.in    Principal Investigator: Reena Engineer, MD Less <<
NCT03671265 Esophageal Cancer Not Applicable Not yet recruiting September 1, 2021 China, Tianjin ... More >> Department of Radiation Oncology, Tianjin Medical University Cancer Hospital Tianjin, Tianjin, China, 300060 Less <<
NCT02374424 Diffuse, Large B-Cell, Lymphom... More >>a Less << Phase 2 Terminated(interim analysis pl... More >>anned as per protocol didn't provide positive outcome) Less << - Italy ... More >> Azienda Ospedaliera S. Gerardo Di Monza Monza, Monza Brianza, Italy, 20900 Onco-Ematologia I.R.C.C. Candiolo, TO, Italy Ospedale Mauriziano Torino, TO, Italy, 10128 Ospedale San Bortolo Vicenza, VI, Italy, 36100 Ospedale "C. e G. Mazzoni", UOC Ematologia Ascoli Piceno, Italy, 63100 Ospedale di Bolzano, Reparto di Ematologia & CTMO Bolzano, Italy, 39100 A.O. Universitaria Careggi Di Firenze Firenze, Italy, 50139 USL 6 Livorno Centro Aziendale Ematologia Livorno, Italy, 57124 SC Ematologia AO Riuniti Papardo Piemonte Messina, Italy Ospedale dell'Angelo, U.O. Ematologia Mestre, Italy, 30174 A.O. Universitaria Policlinico Di Modena Modena, Italy, 41124 AUO Padova-Ematologia e Immunologia Clinica Padova, Italy, 35121 A.O. Ospedali Riuniti Villa Sofia-Cervello, U.O. Ematologia I Palermo, Italy, 90146 Ematologia Policlinico San Matteo Pavia, Italy, 27100 AO di Perugia S. Maria della misericordia Perugia, Italy, 06132 A.O. Universitaria Pisana Pisa, Italy, 56126 Ematologia Ospedale S.Camillo Forlanini Roma, Italy, 00149 Ematologia e Trapianto Istituto Regina Elena IFO Roma, Italy Policlinico Universitario Campus biomedico Roma, Italy Less <<
NCT00593723 Esophagus Cancer Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01124812 Non Small Cell Lung Cancer Phase 1 Terminated - Italy ... More >> University Hospital Pisa Pisa, Tuscany, Italy, 56126 Irst - Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori - Meldola (Fc) Meldola, Italy Less <<
NCT00522405 Hepatocellular Carcinoma Phase 2 Phase 3 Unknown October 2014 India ... More >> All India Institute of Medical Sciences Recruiting New Delhi, Delhi, India, 110029 Sub-Investigator: Shashi B Paul, Ph.D          Sub-Investigator: Shivanand Gamanagatti, MD          Sub-Investigator: Kaushal Madan, DM          Sub-Investigator: Sreenivasa B Chalamalasetty, DM          Sub-Investigator: Sreenivas Vishnubhatla, Ph.D Less <<
NCT03058432 Nasopharyngeal Carcinoma Phase 2 Recruiting December 2019 China, Zhejiang ... More >> Xiaozhong Chen Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Xiaozhong Chen, MD    +86-571-88128202    cxzfyun@sina.com Less <<
NCT00602667 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Active, not recruiting April 30, 2023 United States, California ... More >> Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 Rady Children's Hospital San Diego, California, United States, 92123 United States, Minnesota Children's Hospitals and Clinics of Minnesota - St. Paul Saint Paul, Minnesota, United States, 55102 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 Australia, Queensland Lady Cilento Children's Hospital, Brisbane Brisbane, Queensland, Australia, 4029 Less <<
NCT03007212 Hepatocellular Carcinoma (HCC) Phase 4 Completed - -
NCT03220932 Ovarian Epithelial Cancer Phase 3 Not yet recruiting December 31, 2022 France ... More >> Centre Hospitalier Lyon Sud Not yet recruiting Pierre-Bénite, France Contact: Naoual BAKRIN Less <<
NCT03402737 Head and Neck Neoplasm Not Applicable Recruiting January 31, 2021 Belgium ... More >> Radiotherapy department, University Hospital Ghent Recruiting Ghent, Oost-Vlaanderen, Belgium, 9000 Contact: Wilfried De Neve, MD, PhD    +32 9 332 30 15    wilfried.deneve@uzgent.be    Contact: Fréderic Duprez, MD, PhD    +32 9 332 30 15    frederic.duprez@uzgent.be    Principal Investigator: Wilfried De Neve, MD, PhD          Sub-Investigator: Fréderic Duprez, MD, PhD          Sub-Investigator: Katrien Vandecasteele, MD, PhD          Sub-Investigator: Sylvie Rottey, MD, PhD          UZ Leuven Recruiting Leuven, Belgium Contact: Sandra Nuyts, MD, PhD          CHU Namur Recruiting Namur, Belgium Contact: Jean-François Daisne, MD Less <<
NCT00797719 Malignant Pleural Mesothelioma Phase 1 Phase 2 Recruiting July 2019 Canada, Ontario ... More >> University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: John Cho, MD    416 946 2124    john.cho@rmp.uhn.on.ca    Principal Investigator: John Cho, MD Less <<
NCT02299999 Metastatic Breast Cancer Phase 2 Recruiting December 2022 France ... More >> Institut de Cancérologie de l'Ouest/Paul Papin Recruiting Angers, France Contact: Mario CAMPONE, MD       mario.campone@ico.unicancer.fr    Principal Investigator: Mario CAMPONE, MD          Institut Sainte-Catherine Recruiting Avignon, France Contact: Alice Mege, MD       a.mege@isc84.org    Principal Investigator: Alice Mege, MD          Polyclinique Bordeaux Nord Aquitaine Recruiting Bordeaux, France, 33077 Contact: Nadine DOHOLLOU, MD       n.dohollou@bordeauxnord.com    Contact: Nadine DOHOLLOU, MD          Institut Bergonié Recruiting Bordeaux, France Contact: Hervé Bonnefoi, MD       h.bonnefoi@bordeaux.unicancer.fr    Principal Investigator: Hervé Bonnefoi, MD          Centre François Baclesse Recruiting Caen, France Contact: Christelle Lévy, MD       c.levy@baclesse.unicancer.fr    Principal Investigator: Christelle Lévy, MD          Centre Jean Perrin Recruiting Clermont-Ferrand, France Contact: Marie-Ange Mouret Reynier, MD       marie-ange.mouret-reynier@cjp.fr    Principal Investigator: Marie-Ange Mouret Reynier, MD          Ch Alpes Leman Not yet recruiting Contamine Sur Arve, France, 74130 Contact: Carol ALLIOT, MD       calliot@ch-alpes-leman.fr    Contact: Carol ALLIOT, MD          Centre Georges François Leclerc Recruiting Dijon, France, 21079 Contact: Nicolas Isambert, MD       nisambert@cgfl.fr    Principal Investigator: Nicolas Isambert, MD          Chd Vendee Recruiting La Roche-sur-Yon, France, 85925 Contact: Tifenn L'Haridon, MD       tifenn.lharidon@chd-vendee.fr    Contact: Tifenn L'Haridon, MD          Centre Oscar Lambret Recruiting Lille, France Contact: Nuria KOTECKI, MD          Principal Investigator: Nuria KOTECKI, MD          Chu Dupuytren Not yet recruiting Limoges, France, 87000 Contact: Laurence VENAT-BOUVET, MD       laurence.venat-bouvet@chu-limoges.fr    Contact: Laurence VENAT-BOUVET, MD          Hopital Privé Jean Mermoz Not yet recruiting Lyon, France, 69008 Contact: Olfa DERBEL, MD       o.derbelmermoz@gmail.com    Contact: Olfa DERBEL, MD          Centre Hospitalier Lyon Sud Recruiting Lyon, France Contact: Benoit You, MD          Principal Investigator: Benoit You, MD          Centre Léon Bérard Recruiting Lyon, France Contact: Thomas Bachelot, MD       thomas.bachelot@lyon.unicancer.fr    Principal Investigator: Thomas Bachelot, MD          Institut Paoli Calmettes Recruiting Marseille, France Contact: Anthony Gonçalves, MD       goncalvesa@ipc.unicancer.fr    Principal Investigator: Anthony Gonçalves, MD          Institut Régional du Cancer Montpellier Val d'Aurelle Recruiting Montpellier, France Contact: William Jacot, MD       william.jacot@icm.unicancer.fr    Principal Investigator: William Jacot, MD          Centre Alexis Vautrin Recruiting Nancy, France Contact: Elisabeth Luporsi, MD       e.luporsi@nancy.unicancer.fr    Principal Investigator: Elisabeth Luporsi, MD          Institut de Cancérologie de l'Ouest/ René Gauducheau Recruiting Nantes, France Contact: Mario Campone, MD       mario.campone@ico.unicancer.fr    Principal Investigator: Mario Campone, MD          Centre Antoine Lacassagne Recruiting Nice, France Contact: Jean-Marc Ferrero, MD       jean-marc.ferrero@nice.unicancer.fr    Principal Investigator: Jean-Marc Ferrero, MD          Institut Curie Recruiting Paris, France Contact: Marie-Paule Sablin, MD       mariepaule.sablin@curie.fr    Principal Investigator: Marie-Paule Sablin, MD          Centre Eugène Marquis Recruiting Rennes, France Contact: Claudia Lefeuvre-Plesse, MD       c.lefeuvre@rennes.unicancer.fr    Principal Investigator: Claudia Lefeuvre-Plesse, MD          Centre Henri Becquerel Recruiting Rouen, France Contact: Jean-Christophe Théry, MD          Principal Investigator: Jean-Christophe Théry, MD          Institut Curie Recruiting Saint-Cloud, France Contact: Florence COUSSY, MD       florence.coussy@curie.fr    Principal Investigator: Florence COUSSY, MD          Hopitaux Universitaire de Strasbourg - Hopital Civil Recruiting Strasbourg, France Contact: Philippe BARTHELEMY, MD       philippe.barthelemy@chru-strasbourg.fr    Principal Investigator: Philippe BARTHELEMY, MD          Hopitaux Du Leman Recruiting Thonon-les-Bains, France, 74200 Contact: Francesco DEL PIANO, MD       f-delpiano@ch-hopitauxduleman.fr    Contact: Francesco DEL PIANO, MD          Institut Claudius Regaud Recruiting Toulouse, France Contact: Florence Dalenc, MD       dalenc.florence@iuct-oncopole.fr    Principal Investigator: Florence Dalenc, MD          Gustave Roussy Recruiting Villejuif, France Contact: Monica Arnedos, MD       Monica.ARNEDOS@gustaveroussy.fr    Principal Investigator: Monica Arnedos, MD          Sub-Investigator: Fabrice André, MD Less <<
NCT02918955 Head and Neck Neoplasms Phase 3 Recruiting June 2022 Switzerland ... More >> Inselspital Bern Recruiting Bern, Switzerland, 3010 Contact: OLGUN ELICIN, MD    +41 31 632 26 32    olgun.elicin@insel.ch    Genève University Hospital Recruiting Geneva, Switzerland Contact: Francesca Caparrotti, MD    +41 79 553 56 12    francesca.caparrotti@hcuge.ch    Contact: Laurence Zulianello       Laurence.Zulianello@hcuge.ch Less <<
NCT00083538 Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT02873416 Precision Cell Immunotherapy ... More >> Chemotherapy Advanced Lung Cancer Less << Phase 1 Phase 2 Unknown August 2018 China, Zhejiang ... More >> Ningbo No.5 Hospital (Ningbo Cancer Hospital) Recruiting Ningbo, Zhejiang, China Contact: Bi Wan    86-13310088259    biwang0218@126.com    Contact: Jiangtao Wang    86-15888102792 Less <<
NCT00415818 Carcinoma, Non-Small-Cell Lung Phase 2 Phase 3 Completed - France ... More >> Centre Hospitalier Belfort-Montbeliard Belfort, France, 90016 CHU, Service de Pneumologie Besancon, France, 25000 Centre Hospitalier Général, Service de Pneumologie Briey, France, 54151 Centre François Baclesse Caen, France, 14076 Hôpital Pasteur - Service de médecine F- Pavillon 43 Colmar, France, 68000 Centre Oscar Lambret Lille, France, 59020 Institut Paoli-Calmettes, Service d'oncologie médicale Marseille, France, 13273 Centre Hospitalier Lyon Sud Pierre-Bénite, France, 69495 CHRU Hôpital de Pontchaillou Rennes, France, 35033 Hôpital Lyautey - Service de Pneumologie Strasbourg, France, 67100 Centre Hospitalier de la Haute Saône, Service de Pneumologie - Allergologie Vesoul, France, 70014 Germany Asklepios Fachkliniken, Zentrum für Pneumonologie Gauting, Germany, 82131 Thoraxklinik Heidelberg Heidelberg, Germany, 69126 Lungenklinik Krankenhaus Merheim Köln, Germany, 51109 Klinikum Mannheim der Ruprecht-Karls Mannheim, Germany, 68167 Klinikum Offenburg, Medizinische Klinik II Offenburg, Germany, 77654 Hungary Fejér Megyei Szent György Kórház Székesfehérvár, Hungary, 8000 Poland Oddział II Chorób Płuc i Gruźlicy Bialystok, Poland, 15-540 Kujawsko-Pomorskie Centrum Pulmonologii Bydgoszcz, Poland, 85-326 Oddział Chemioterapii Krakow, Poland, 31-826 Oddział III Chorób Płuc i Gruźlicy Otwock, Poland, 05-400 Oddział Onkologii Klinicznej Poznan, Poland, 60-569 Dolnośląskie Centrum Wrocław, Poland, 53-439 Less <<
NCT01655225 Advanced Cancer ... More >> Metastatic Cancer Non-Hodgkin's Lymphoma Metastatic Breast Cancer Malignant Mesothelioma Non-small Cell Lung Cancer Less << Phase 1 Recruiting March 1, 2021 United States, California ... More >> UCLA Medical Center Recruiting Los Angeles, California, United States, 90095 Contact    3103258252       Principal Investigator: Parvin Fatheddin Peddi          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact    646-888-4226       Principal Investigator: Anna M Varghese          United States, Oklahoma Peggy and Charles Stephenson Oklahoma Cancer Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact    405-271-8777       Principal Investigator: Raid Aljumaily          United States, Pennsylvania Penn Presbyterian Medical Center Completed Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Sarah Cannon Cancer Center Recruiting Nashville, Tennessee, United States, 37203 Contact    615-239-7615       Principal Investigator: SMO Sarah Cannon Research Inst.          Tennessee Oncology PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact    6153297274       Principal Investigator: Johanna Chock Bendell          Italy Azienda Ospedaliero - Universitaria S. Luigi Gonzaga Completed Orbassano, Torino, Italy, 10043 Puerto Rico Fundacion de Investigacion de Diego Recruiting San Juan, Puerto Rico, 00927 Contact    7877221248       Principal Investigator: Mirelis Acosta-Rivera Less <<
NCT02862561 Precision Cell Immunotherapy ... More >> Chemotherapy Advanced Malignancies Less << Phase 1 Phase 2 Unknown July 2018 China, Shanghai ... More >> Shanghai International Medical Center Recruiting Shanghai, Shanghai, China, 201318 Contact: Naiyan Han    +86 (0) 182 1766 2469    naiyan.han@simcgroup.com Less <<
NCT02862587 Precision Cells ... More >> Chemotherapy Advanced Lung Cancer Less << Phase 1 Phase 2 Unknown August 2018 China, Shanghai ... More >> Shanghai International Medical Center Recruiting Shanghai, Shanghai, China, 201318 Contact: Naiyan Han    +86 (0) 182 1766 2469    naiyan.han@simcgroup.com Less <<
NCT00464893 Gastric Cancer ... More >> Gastric Adenocarcinoma Less << Phase 2 Completed - Austria ... More >> Innsbruck, Austria Germany Hamburg, Berlin, Heidelberg, Köln, Halle, Germany Spain Terrassa, Spain United Kingdom Nottingham, United Kingdom Less <<
NCT03058289 Melanoma Head... More >> and Neck Cancer Lymphoma Breast Cancer Pancreatic Cancer Liver Cancer Colon Cancer Lung Cancer Glioblastoma Less << Phase 1 Phase 2 Recruiting August 2020 United States, California ... More >> USC Norris Recruiting Los Angeles, California, United States, 90033 Contact: Xiomara Menendez    323-409-4368    xiomara.menendez@med.usc.edu    Contact: Jubilee Acap    323-865-0451    jubilee.acap@med.usc.edu    USC HOAG Recruiting Newport Beach, California, United States, 92663 Contact: Alicia Bogardus    949-764-6755    Alicia.bogardus@hoag.org    Contact: Cristina de Leon    9497645543    cristina.deleon@hoag.org    United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21205 Contact: Denise Gallagher, RN    410-502-5140    phase1trials@exchange.johnshopkins.edu    Principal Investigator: Nilofer Azad, MD          United States, Massachusetts UMASS Memorial Medical Center Recruiting Worcester, Massachusetts, United States, 01655 Contact: Cancer Research Office    508-856-3216    cancer.research@umassmed.edu    United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Contact: Daniel Sabo       Daniel.Sabo@fccc.edu    Principal Investigator: Anthony J. Olszanski, MD, RPh          Canada, Ontario Princess Margaret Cancer Center - University Health Network Recruiting Toronto, Ontario, Canada, M5G 2C4 Contact: Oncology Referral    416-946-4575 Less <<
NCT01837381 Hepatocellular Carcinoma Phase 2 Completed - Hong Kong ... More >> Department of Clinicl Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong, Hong Kong Department of Imaging and Interventional Radiology, Prince of Wales Hospital, The Chinsese University of Hong Kong Hong Kong, Hong Kong Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong Hong Kong, Hong Kong Less <<
NCT03003962 Non Small Cell Lung Carcinoma ... More >>NSCLC Less << Phase 3 Recruiting December 31, 2020 -
NCT02873520 Precision Cell Immunotherapy ... More >> Chemotherapy Advanced Gastric Cancer Less << Phase 1 Phase 2 Unknown August 2018 China, Zhejiang ... More >> Ningbo No.5 Hospital (Ningbo Cancer Hospital) Recruiting Ningbo, Zhejiang, China Contact: Bi Wan    86-13310088259    biwang0218@126.com    Contact: Jiangtao Wang    86-15888102792 Less <<
NCT01997775 Non-small Cell Lung Cancer Phase 2 Terminated(Difficult enrollmen... More >>t) Less << - Taiwan ... More >> National Cheng-Kung Uni. Hosp. Tainan, Taiwan, 704 Less <<
NCT03393507 Ovarian Cancer ... More >> Chemotherapeutic Toxicity Less << Phase 2 Recruiting December 1, 2019 China, Sichuan ... More >> Zhang xuan Recruiting Leshan, Sichuan, China, 600000 Contact: Zhang Xuan, MD    861890631232    79916363@qq.com Less <<
NCT00424255 - Completed - -
NCT02649829 Malignant Pleural Mesothelioma Phase 1 Phase 2 Recruiting November 2021 Belgium ... More >> Antwerp University Hospital Recruiting Edegem, Antwerp, Belgium, 2650 Contact: Zwi N Berneman, MD, PhD       zwi.berneman@uza.be    Contact: Sébastien Anguille, MD, PhD       sebastien.anguille@uza.be    Sub-Investigator: Paul Germonpré, MD          Sub-Investigator: Koen Deschepper, MD          AZ Middelares Recruiting Ghent, Belgium, 9000 Contact: Local investigator: Paul Germonpré, MD, PhD          AZ Nikolaas Recruiting Sint-Niklaas, Belgium, 9100 Contact: Local investigator: Koen Deschepper, MD Less <<
NCT00424255 Neoplasms, Head and Neck Phase 3 Completed - -
NCT02879214 Squamous Cell Carcinoma of Cer... More >>vix Less << Phase 2 Recruiting February 2020 China, Sichuan ... More >> Sichuan PPH, Departmentn of Gynecology Oncology Recruiting Chengdu, Sichuan, China, 610072 Contact: Lan Xie, MD    086-87398097       Contact: Yi Liu, MD    086-87398097 Less <<
NCT00577512 Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT01806272 Nasopharyngeal Cancers Phase 2 Unknown August 2014 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Wei LUO, M.D.    +862087343483    luowei2@mail.sysu.edu.cn Less <<
NCT01731548 Carcinoma of Lung ... More >> Small Cell Limited Stage Less << Phase 2 Phase 3 Unknown December 2016 China, Guangdong ... More >> Sun Yat-Sen University, Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Hui Liu, MD. PHD    086-020-87343033    liuhui@sysucc.org.cn    Contact: Yong Bao, MD    086-020-87343504    baoyong@sysucc.org.cn Less <<
NCT00577512 - Completed - -
NCT02944708 Nasopharyngeal Carcinoma Phase 3 Unknown October 2018 China, Beijing ... More >> Peking University Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Yan Sun, MD          China, Fujian The First Affiliated Hospital of Fujian Medical University Recruiting Fuzhou, Fujian, China, 350005 Contact: Jinshen Hong, MD       hjs703@126.com    The First Affiliated Hospital of Xiamen University Recruiting Xiamen, Fujian, China, 361003 Contact: Qin Lin, MD       linqin05@163.com    China, Guangxi Cancer Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 530021 Contact: Xiaodong Zhu, MD          The People's Hospital of Guangxi Zhuang Autonomous Region Recruiting Nanning, Guangxi, China, 530021 Contact: Heming Lu, MD          China, Hubei Tongji Hospital, Tongji Medical College of HUST Recruiting Wuhan, Hubei, China, 430030 Contact: Guoqing Hu, MD          China, Jiangxi Jiangxi Province Tumor Hospital Recruiting Nanchang, Jiangxi, China, 330029 Contact: Xiaochang Gong, MD       gxcanddw@163.com    Jiangxi Provincial Cancer Hospital Recruiting Nanchang, Jiangxi, China, 330029 Contact: Xiaochang Gong, MD       gxcanddw@163.com    China, Shanghai Fudan University Shanghai Cancer center Recruiting Shanghai, Shanghai, China, 201315 Contact: Chaosu Hu, MD       hucsu62@yahoo.com    Shanghai Proton and Heavy Ion Center Recruiting Shanghai, Shanghai, China, 201315 Contact: Lin Kong, MD       lin.kong@sphic.org.cn    Contact: Jiyi Hu, MD       jiyi.hu@sphic.org.cn    Principal Investigator: Jiade J Lu, MD          Eye & ENT Hospital of Fudan University Recruiting Shanghai, Shanghai, China Contact: Shengzi Wang, MD       shengziwang@fudan.edu.cn    China, Sichuan West China Hospital Recruiting Chengdu, Sichuan, China, 610041 Contact: Ping Li, MD          Singapore National Cancer Centre, Singapore Recruiting Singapore, Singapore, 119082 Contact: Boon Cher Goh, MD          Taiwan Taichung Veterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Jin-Ching Lin, MD       jclin@vghtc.gov.tw Less <<
NCT01020864 Head and Neck Neoplasms Phase 2 Unknown January 2018 Denmark ... More >> Department of Oncology, Odense University Hospital Recruiting Odense, Denmark, 5000 Contact: Jorgen Johansen, MD, PhD    +45 6541 4568    jorgen.johansen@ouh.regionsyddanmark.dk    Principal Investigator: Jorgen Johansen, MD, PhD Less <<
NCT02145078 Recurrent Non-small Cell Lung ... More >>Cancer Stage IV Non-small Cell Lung Cancer Less << Not Applicable Terminated(Slow accrual.) - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00083551 Multiple Myeloma Phase 3 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT03455205 Digestive Tract Not Applicable Recruiting December 30, 2019 China, Guangdong ... More >> First affiliated hospital of guangzhou university of traditional Chinese medicine Recruiting Guangzhou, Guangdong, China Contact: lin lizhu, Dr.    13501505588    13501505588@163.com Less <<
NCT00083551 - Completed - -
NCT00959582 Ovarian Cancer ... More >> Primary Peritoneal Cancer Fallopian Tube Cancer Less << Phase 1 Completed - -
NCT03215706 Non-Small Cell Lung Cancer Phase 3 Recruiting May 20, 2020 -
NCT01540058 Neoplasms, Unknown Primary Phase 3 Unknown October 2017 Denmark ... More >> Rigshospitalet Active, not recruiting Copenhagen, Denmark, 2100 France Institut Gustave Roussy Recruiting Villejuif, Val de Marne, France, 94805 Contact: Karim FIZAZI, MD, PhD    +33 1 42 11 43 17    karim.fizazi@igr.fr    Principal Investigator: Karim FIZAZI, MD, PhD          Netherlands Viecuri Medical Centre Venlo Active, not recruiting Venlo, Netherlands, 5912 BL Less <<
NCT01014208 Lymphoma, Large-Cell, Diffuse Phase 3 Completed - -
NCT02369835 Head and Neck Carcinoma ... More >> Radiation-Induced Dermatitis Less << Phase 3 Active, not recruiting December 2019 United States, California ... More >> Stanford Cancer Center South Bay San Jose, California, United States, 95124 Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01805557 Diffuse Large B-cell Lymphoma ... More >>Refractory Diffuse Large B-cell Lymphoma Recurrent Less << Phase 2 Phase 3 Unknown February 2018 Italy ... More >> AOU Careggi Terminated Firenze, FI, Italy, 50134 A.O. Niguarda Recruiting Milano, MI, Italy, 20162 Contact: Chiara Rusconi, MD    +39 02 - 64442668    chiara.rusconi@ospedaleniguarda.it    Principal Investigator: Chiara Rusconi, MD          Osp. San Gerardo Not yet recruiting Monza, MI, Italy, 20052 Contact: Enrico Pogliani, MD    039-2339435    enrico.pogliani@unimib.it; marziaborsetto@yahoo.it    Principal Investigator: Enrico Pogliani, MD          Ospedale Civile Guglielmo da Saliceto Recruiting Piacenza, PC, Italy, 29121 Contact: Daniele Vallisa, MD    +39 0523-303701/719    d.vallisa@auslpc.it    Principal Investigator: Daniele Vallisa, MD          CRO Aviano Recruiting Aviano, Pordenone, Italy, 33081 Contact: Mariagrazia Michieli, M.D.       mmichieli@cro.it    Principal Investigator: Mariagrazia Michieli, M.D.          Osp. Umberto I Recruiting Nocera Inferiore, SA, Italy, 84014 Contact: Alfonso M. D'Arco, MD    +39 081-9213370    medint.nocera@libero.it    Principal Investigator: Alfonso M. D'Arco, MD          Medicina Interna 2 ad indirizzo Ematologico AOU San Luigi Gonzaga Not yet recruiting Orbassano, Torino, Italy, 10043 Contact: Giuseppe Saglio, Prof.    00390119026721    giuseppe.saglio@unito.it    Principal Investigator: Giuseppe Saglio, Prof.          AOU San Giovanni Battista-Ematologia 1 Recruiting Torino, TO, Italy, 10126 Contact: Marco Ladetto, MD    +39 011-6334264    marco.ladetto@unito.it;antonella.fiorillo@yahoo.it    Principal Investigator: Marco Ladetto, MD          Azienda Ospedaliero - Universitaria di Udine Recruiting Udine, UD, Italy, 33100 Contact: Francesco Zaja, MD    +39 0432-559662    zaja.francesco@aoud.sanita.fvg.it;d'odorico.cristina@aoud.sanita.fvg.it    Principal Investigator: Francesco Zaja, MD          Osp. S. Antonio Abate Gallarate Recruiting Gallarate, Varese, Italy Principal Investigator: Fabrizio Ciambelli, MD          Ospedale di Circolo e Fondazione Macchi - Ematologia Not yet recruiting Varese, VA, Italy, 21100 Contact: Francesco Passamonti    +39 0332-393648    francesco.passamonti@ospedale.varese.it    Principal Investigator: Francesco Passamonti, MD          A.O. SS. Antonio e Biagio e C. Arrigo Recruiting Alessandria, Italy, 15121 Contact: Flavia Salvi, MD    +39 0131206294    segreteria@filinf.it    Principal Investigator: Flavia Salvi, MD          Clinica di ematologia AOU Umberto I Ospedali Riuniti Recruiting Ancona, Italy, 60100 Contact: Guido Gini, M.D    00390713580384    g.gini@ospedaliriuniti.marche.it    Principal Investigator: Guido Gini, M.D.          Divisione di Ematologia Spedali Civili Recruiting Brescia, Italy Principal Investigator: Alessandra Tucci, MD          Presidio Ospedaliero A.Perrino - Divisione di Ematologia Terminated Brindisi, Italy Divisione di Ematologia Osp. Businco Recruiting Cagliari, Italy Principal Investigator: Giuseppina Cabras, MD          Ospedale Roberto Binaghi Not yet recruiting Cagliari, Italy Principal Investigator: Giorgio La Nasa, DM          Università Cattolica Campobasso Terminated Campobasso, Italy A.O. Universitaria Ospedali Riuniti di Foggia Not yet recruiting Foggia, Italy Principal Investigator: Silvana Capalbo, MD          Ematologia 1 Ospedale S. Martino Not yet recruiting Genova, Italy, 16132 Principal Investigator: Angelo Michele Carella, PROF          Azienda Universitaria San Martino Not yet recruiting Genova, Italy Principal Investigator: Marco Gobbi, MD          Ospedale Santa Maria Goretti Not yet recruiting Latina, Italy Principal Investigator: Angelo De Blasio, MD          Ospedale Vito Fazzi Not yet recruiting Lecce, Italy Principal Investigator: Nicola Di Renzo, MD          SC Ematologia ‐ Trapianto di midollo osseo Fond. IRCCS Istituto Nazionale Tumori Recruiting Milano, Italy, 20133 Contact: Paolo Corradini, Prof.    00390223902950    paolo.corradini@unimi.it    Principal Investigator: Paolo Corradini, Prof.          Ospedale Maggiore IRCCS-Dipartimento di Ematologia Not yet recruiting Milano, Italy Principal Investigator: Luca Baldini, MD          AORN Cardarelli U.O.Ematologia Not yet recruiting Napoli, Italy Principal Investigator: Vincenzo Mettivier, MD          SCDU Ematologia ‐ Università del Piemonte Orientale Recruiting Novara, Italy, 28100 Contact: Gianluca Gaidano, Prof.    00390321660663       Principal Investigator: Gianluca Gaidano, Prof.          Ematologia e Immunologia Clinica, Dipartimento di Medicina Università di Padova Recruiting Padova, Italy, 35100 Contact: Giampiero Semenzato, Prof.    00390498212298    g.semenzato@unipd.it    Principal Investigator: Giampiero Semenzato, Prof.          Ospedale S. Antonio Not yet recruiting Padova, Italy Principal Investigator: Dario Marino, MD          Oncoematologia Dipartimento oncologico La Maddalena Not yet recruiting Palermo, Italy, 90146 Contact: Maurizio Musso, M.D.    00390916806801    mamusso@libero.it    Principal Investigator: Maurizio Musso, M.D.          U.O. Complessa di Ematologia Ospedale di Parma Recruiting Parma, Italy, 43100 Contact: Franco Aversa, Prof.    00390521903263    franco.aversa@unipr.it    Principal Investigator: Franco Aversa, Prof.          Fond. Maugeri - Centro medico Not yet recruiting Pavia, Italy Principal Investigator: Vittorio Fregoni, MD          Osp. S. Maria delle Croci Recruiting Ravenna, Italy Principal Investigator: Alfonso Zaccaria, MD          AO Bianchi Melacrino Morelli UO Ematologia Recruiting Reggio Calabria, Italy Principal Investigator: Caterina Stelitano, MD          AO Arcispedale S.Maria Nuova Ematologia Recruiting Reggio Emilia, Italy Principal Investigator: Francesco Merli, MD          Osp. degli Infermi Divisione di Oncologia Not yet recruiting Rimini, Italy Principal Investigator: Annalisa Molinari, MD          Ospedale Oncologico regionale CROB Not yet recruiting Rionero in Vulture (PZ), Italy Principal Investigator: Pellegrino Musto, MD          Ematologia Ospedale S.Camillo Forlanini Not yet recruiting Roma, Italy, 00149 Contact: Roberta Battistini, M.D.       rbattistini@scamilloforlanini.rm.it    Principal Investigator: Roberta Battistini, M.D.          A.O. Universitaria S. Andrea Recruiting Roma, Italy Principal Investigator: Maria Cristina, Cox          Osp.Sant'Eugenio Divisione di Ematologia Not yet recruiting Roma, Italy Principal Investigator: Elisabetta Abruzzese, MD          Policlinico Universitario Tor Vergata Not yet recruiting Roma, Italy Principal Investigator: Maria Cantonetti, MD          Universita' La Sapienza Not yet recruiting Roma, Italy Principal Investigator: Maurizio Martelli, MD          Clinica Humanitas Recruiting Rozzano (MI), Italy Sub-Investigator: Balzarotti Monica, MD          Policlinico Le Scotte Clinica Ematologica Not yet recruiting Siena, Italy Principal Investigator: Alberto Fabbri, MD          SC Oncoematologia con autotrapianto AO Santa Maria Recruiting Terni, Italy, 05100 Contact: Anna Marina Liberati, Prof    0744/205971    marinal@unipg.it    Principal Investigator: Anna Marina Liberati, M.D.          Osp. San Giovanni Battista_Molinette Ematologia 2 Recruiting Torino, Italy Principal Investigator: Umberto Vitolo, MD          Divisione di Ematologia Ospedale S. Nicola Not yet recruiting Trani, Italy Principal Investigator: Gaetano De Santis, MD Less <<
NCT00113919 Multiple Myeloma Phase 1 Phase 2 Terminated(Due to poor accrual... More >>) Less << - United States, Arkansas ... More >> University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy Little Rock, Arkansas, United States, 72205 University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT01745445 Small Cell Lung Cancer Phase 2 Unknown December 2016 China, Tianjin ... More >> Department of Radiation Oncology, Tianjin Medical University Cancer Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: QING SONG PANG, M.D    +86-22-23340123-1314    pangqingsong@yahoo.com.cn Less <<
NCT01664663 Non Small Cell Lung Cancer ... More >> Locally Advanced Disease Less << Phase 2 Terminated(Safety analysis sho... More >>wed increased grade 5 toxicity in experimental arm.) Less << October 2015 Sweden ... More >> Department of Oncology, Norrlands Universitetssjukhus Umeå, Norrland, Sweden, 901 85 Department of Oncology, Karolinska University Hospital Stockholm, Stockholm county, Sweden, 171 76 Department of Oncology, Sahlgrenska University Hospital Gothenburg, Västra Götaland, Sweden, 413 45 Less <<
NCT00620139 - Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01014208 - Completed - -
NCT01627197 Bladder Cancer Phase 3 Recruiting December 2021 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Fang-Jian Zhou, M.D Ph.D       zhoufj@sysucc.org.cn    Contact: Zhuo-wei Liu       liuzhw@sysucc.org.cn    Principal Investigator: Fang-Jian Zhou, M.D Ph.D          Sub-Investigator: Zhuo-Wei Liu, M.D Ph.D Less <<
NCT03513042 - Not yet recruiting December 2022 -
NCT00718354 Gastric Cancer ... More >> Gastroesophageal Cancer Less << Phase 3 Completed - India ... More >> Mahatma Gandhi Cancer Hospital & Research Institute ,1/7 M.V.P. Colony, - ,, . Vishakhapattanam, Andhra Pradesh, India, 530017 Mahavir Cancer Sansthan,Phulwari Sharif Patna, Bihar, India, 801505 Gujarat Cancer Research Institute, Civil Hospital Campus,Asarwa, , Ahmedabad, Gujarat,, India, 380016 Department Of Radiotherapy,S.S.G. Hospital, - Baroda,Vadodara, Gujarat,, India, 390 001 Gokula Curie Cancer Centre,M.S.Ramaiah Memorial Hospital,MSR Nagar, MSRIT Post Bangalore, Karnataka, India, 560054 Madhavan J.P. Trivandrum, Kerala,, India, 695011 MGM Medical College & MY Hospital, Indore, M.P, India, 452005 Curie Manavta Cancer Centre, Opp.Hotel Sandeep Naka,Nashik Mumbai, Maharashtra,, India, 425004 Ruby Hall Clinic,Cancer Building,40 sassoon Road, , , Pune, Maharashtra, India, 411001 Cancer Hospital & Research Institute, Cancer Hill Gwalior, MP, India, 474009 Acharya Tulsi Regional Cancer Treatment & Research Institute Bikaner, UP, India B.P.Poddar Hospital & Medical Research Ltd,71/1, Humayun Kabir Sarani,, Block-G, New Alipore Kolkata, west Bangol, India, 700053 Biswajit Sanyal Calcutta, West Bengal, India Chittaranjan National Cancer Institute,37, S.P.Mukhurjee Road Kolkata, West Bengal, India, 700026 Dr. BRA IRCH,all India Institute of Medical Sciences,Ansari Nagar, New Delhi, India, 110029. Less <<
NCT00113919 - Terminated(Due to poor accrual... More >>) Less << - -
NCT01472250 - Completed - China, Beijing ... More >> Lin Shen Beijing, Beijing, China, 100142 Less <<
NCT00921739 Non Small Cell Lung Cancer ... More >> Small Cell Lung Cancer Thymoma Thymus Neoplasms Less << Phase 1 Active, not recruiting December 2018 United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00230451 Esophageal Cancer Phase 2 Completed - United States, Michigan ... More >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48197 Less <<
NCT02786719 Neuroblastoma Not Applicable Recruiting June 2019 United States, California ... More >> Rady Children's Hospital Recruiting San Diego, California, United States, 92123 Contact: Laura Conner    858-966-5983    LConner@rchsd.org    Principal Investigator: Peter Zage, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Sarah Whittle, MD, BA    832-822-4242    sbwhittl@txch.org Less <<
NCT00333294 Non-Small Cell Lung Cancer Phase 2 Completed - France ... More >> Research Site Clermont Ferrand, France Research Site Grenoble, France Research Site Nantes, France Research SIte Paris, France Less <<
NCT03562897 Carcinoma Ova... More >>rian Neoplasm Endocrine Gland Neoplasm Urogenital Neoplasms Ovarian Diseases Adnexal Diseases Genital Diseases, Female Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Endocrine System Diseases Gonadal Disorders Genital Neoplasm, Female Neoplasms, Glandular and Epithelial Less << Phase 2 Not yet recruiting March 1, 2020 Cuba ... More >> National Institute of Oncology and Radiobiology (INOR) Not yet recruiting Havana, Cuba, 10400 Contact: Karen Lopez Miguel, Dr.    +53-78388589    karenlopez@infomed.sld.cu    Principal Investigator: Karen López Miguel, Dr.          Sub-Investigator: Yaniurka Cruz Camejo, Dr.          Sub-Investigator: Laura Selis Pomar, Dr.          Sub-Investigator: Alejandro Linchenat Lambert, Dr.          Sub-Investigator: Juan M. Silveira Pablo, Dr.          Sub-Investigator: Roberto Esperón Noa, Dr.          Sub-Investigator: Karelia Silvera Candó, BSc          Sub-Investigator: Vivian Diéguez Rodríguez, BSc          Sub-Investigator: Zaida Lastres Sosa, BSc          Sub-Investigator: Idelmis Curbelo Heredia, MSc          Sub-Investigator: Mircea Betancourt Cabeza, MSc          Sub-Investigator: Juan J. Lence Anta, Dr. Less <<
NCT00002539 Sarcoma Phase 3 Completed - Belgium ... More >> Institut Jules Bordet Brussels (Bruxelles), Belgium, 1000 Cliniques Universitaires Saint-Luc Brussels (Bruxelles), Belgium, 1200 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Denmark Aarhus Kommunehospital Aarhus, Denmark, DK-8000 Rigshospitalet Copenhagen, Denmark, 2100 France Centre Eugene Marquis Rennes, France, 35064 Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Emma Kinderziekenhuis Amsterdam, Netherlands, NL-1100 DE Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Academisch Ziekenhuis Utrecht Utrecht, Netherlands, 3584 CX Portugal Instituto Portugues de Oncologia de Francisco Gentil-Centro de Lisboa Lisbon, Portugal, 1099-023 Codex Saudi Arabia King Faisal Specialist Hospital and Research Centre Riyadh, Saudi Arabia, 11211 Slovenia Institute of Oncology, Ljubljana Ljubljana, Slovenia, Sl-1000 United Kingdom St. James's Hospital Leeds, England, United Kingdom, LS9 7TF Less <<
NCT00002669 Melanoma (Skin) Phase 2 Completed - Austria ... More >> Landeskrankenanstalten - Salzburg Salzburg, Austria, A-5020 Belgium Institut Jules Bordet Brussels (Bruxelles), Belgium, 1000 Hopital Universitaire Erasme Brussels, Belgium, 1070 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 U.Z. Gasthuisberg Leuven, Belgium, B-3000 France CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 Centre Leon Berard Lyon, France, 69373 CHU Pitie-Salpetriere Paris, France, 75651 Germany Universitaetsklinikum Charite Berlin, Germany, D-10117 Universitaetsklinikum Benjamin Franklin Berlin, Germany, D-12200 Robert Roessle Klinik Berlin, Germany, D-13122 Haematologisch-Onkologische Praxis Altona Hamburg, Germany, D-22765 Johannes Gutenberg University Mainz, Germany, D-55101 III Medizinische Klinik Mannheim Mannheim, Germany, D-68135 Italy Istituto Europeo Di Oncologia Milano, Italy, 20141 Netherlands University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Rotterdam Cancer Institute Rotterdam, Netherlands, 3075 EA Portugal Instituto Portugues de Oncologia do Porto Porto, Portugal, 4200 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Universitaetsspital Zurich, Switzerland, CH-8091 United Kingdom St. James's Hospital Leeds, England, United Kingdom, LS9 7TF Royal Marsden NHS Trust London, England, United Kingdom, SW3 6JJ Southend NHS Trust Hospital Westcliff-On-Sea, England, United Kingdom Royal Bournemouth Hospital Bournemouth, United Kingdom, BH7 7DW Less <<
NCT00563862 Nasopharyngeal Neoplasms ... More >> Carcinoma, Squamous Cell Less << Not Applicable Terminated - China ... More >> Pamela Youde Nethersole Eastern Hospital Hong Kong, China Prince of Wales Hospital Hong Kong, China Queen Elizabeth Hospital Hong Kong, China Queen Mary Hospital Hong Kong, China Tuen Mun Hospital Hong Kong, China Less <<
NCT03656393 NSCLC EGFR Phase 3 Recruiting September 30, 2020 China, Guangdong ... More >> Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China, 518000 Contact: wang wei, Doctor    15914030296    limey@sina.com    Contact: wang suo, Doctor    13590437796    908611104@qq.com Less <<
NCT00003583 Drug/Agent Toxicity by Tissue/... More >>Organ Lung Cancer Radiation Toxicity Less << Phase 2 Unknown - United States, Florida ... More >> University of Florida - Gainesville Gainesville, Florida, United States, 32610-0277 Less <<
NCT00002477 Ovarian Cancer Phase 3 Unknown - United Kingdom ... More >> Cochrane Cancer Network Oxford, England, United Kingdom, OX3 7LF Less <<
NCT00003636 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 3 Completed - -
NCT03100708 - Recruiting April 2021 Germany ... More >> Universitätsklinikum Leipzig - AöR Recruiting Leipzig, Sachsen, Germany, 04103 Less <<
NCT00002623 Lung Cancer Phase 3 Completed - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 A.Z. St. Jan Brugge, Belgium, 8000 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Hopital de Jolimont Haine Saint Paul, Belgium, 7100 U.Z. Gasthuisberg Leuven, Belgium, B-3000 CHR - Clinique Saint Joseph - Hopital de Warqueguies Mons, Belgium, B-7000 Clinique Universitaire De Mont-Godinne Mont-Godinne Yvoir, Belgium, 5530 Stedelijk Ziekenhuis Roesclare, Belgium, 8800 France Academisch Ziekenhuis Utrecht Vandoeuvre-les-Nancy, France, 54511 Italy Istituto Nazionale per la Ricerca sul Cancro Genoa (Genova), Italy, 16132 Netherlands Groot Ziekengasthuis 's-Hertogenbosch 's-Hertogenbosch, Netherlands, 5211 NL Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1001HV Antoni van Leeuwenhoekhuis Amsterdam, Netherlands, 1066 CX Arnhems Radiotherapeutisch Instituut Arnhem, Netherlands, 6815 AD Ziekenhuis St Jansdal Harderwijk, Netherlands, 3840 AC Atrium Medical Centre Heerlen, Netherlands, 6419 PC Elkerliek Ziekenhuis Helmond, Netherlands, 5707-HA Leiden University Medical Center Leiden, Netherlands, 2300 CA Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Canisius-Wilhelmina Ziekenhuis Nijmegen, Netherlands, 6532 SZ University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Saint Franciscus Ziekenhuis Roosendaal, Netherlands, 4708 AE University Hospital - Rotterdam Dijkzigt Rotterdam, Netherlands, 3000 CA Erasmus Medical Center Rotterdam, Netherlands, 3075 EA Twee Steden Ziekenhuis Vestiging Tilburg Tilburg, Netherlands, 5042 AD Diakonessenhuis Utrecht Utrecht, Netherlands, 3508 TG Sophia Ziekehuis Zwolle, Netherlands, 8000 GK United Kingdom Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Marsden Hospital Sutton, England, United Kingdom, SM2 5PT Royal Victoria Hospital Belfast, Northern Ireland, United Kingdom, BT12 6BA Less <<
NCT00004176 Drug/Agent Toxicity by Tissue/... More >>Organ Lung Cancer Radiation Toxicity Less << Phase 2 Completed - United States, Colorado ... More >> Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, Missouri Washington University Barnard Cancer Center Saint Louis, Missouri, United States, 63110 United States, North Carolina Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States, 27599-7295 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00003592 Head and Neck Cancer Phase 3 Completed - United States, Georgia ... More >> Emory University Hospital - Atlanta Atlanta, Georgia, United States, 30322 Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States, 30033 United States, Illinois Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 Veterans Affairs Medical Center - Chicago (Lakeside) Chicago, Illinois, United States, 60611 CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Michigan CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Minnesota CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, New Jersey Veterans Affairs Medical Center - East Orange East Orange, New Jersey, United States, 07018-1095 United States, New York Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 University of Rochester Cancer Center Rochester, New York, United States, 14642 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Veterans Affairs Medical Center - Nashville Nashville, Tennessee, United States, 37212 Vanderbilt Cancer Center Nashville, Tennessee, United States, 37232-6838 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Veterans Affairs Medical Center - Milwaukee (Zablocki) Milwaukee, Wisconsin, United States, 53295 South Africa Pretoria Academic Hospital Pretoria, South Africa, 0001 Less <<
NCT00791141 Head and Neck Cancer Phase 2 Completed - Germany ... More >> Department of Radiotherapy and Radiological Oncology, University Hospital Munich Munich, Bavaria, Germany, 81377 Department of Radiotherapeutics of the University Hospital Freiburg Freiburg, BW, Germany, 79106 Department of Radiological Oncology University Hospital Heidelberg Heidelberg, BW, Germany, 69120 Department of Radiotherapy and Radiological Oncology University Hospital Tuebingen Tuebingen, BW, Germany, 72076 Department of Radiotherapy and Radiological Oncology University Hospital Ulm Ulm, BW, Germany, 89091 Department of Radiotherapy an Radiological Oncology University Hospital Essen Essen, NW, Germany, 45122 Department of Radiotherapy and Radiological Oncology University Hospital Mainz Mainz, Rheinland-Pfalz, Germany, 55131 Department of Radiotherapy, University Hospital Schleswig Holstein, Campus Lübeck Lübeck, Schleswig Hostein, Germany, 23538 Department of Radiotherapy and Radiological Oncology Universität Hospital Jena Jena, Thueringen, Germany, 07743 Charité University Medicine, Department of Radiotherapy and Radiological Oncology Berlin, Germany, 13353 Less <<
NCT02009449 Melanoma Pros... More >>tate Cancer Ovarian Cancer Renal Cell Carcinoma Colorectal Carcinoma Pancreatic Carcinoma Non-small Cell Lung Carcinoma Solid Tumors Breast Cancer Less << Phase 1 Active, not recruiting March 2020 United States, California ... More >> UCLA Medical Hematology & Oncology Los Angeles, California, United States, 90024 UCSF San Francisco, California, United States United States, Colorado Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists & Research Institute Sarasota, Florida, United States, 34232 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Oklahoma Stephenson Cancer Center at Oklahoma University TSET Phase 1 Program Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 South Texas Accelerated Research Therapeutics San Antonio, Texas, United States, 78229 Less <<
NCT02999087 HNSCC Phase 3 Recruiting January 2021 France ... More >> Centre Hospitalier Bretagne Sud Recruiting Lorient, France, 56322 Contact: Christian SIRE, MD    (0)2 97 06 96 84 ext +33    c.sire@ch-bretagne-sud.fr    Contact: Guillaume BERA, MD    (0)2 97 06 96 84 ext +33    g.bera@ch-bretagne-sud.fr Less <<
NCT01843647 Non-small-cell Lung Cancer Phase 2 Unknown February 2018 China, Zhejiang ... More >> Zhejiang cancer hospital Recruiting Hangzhou, Zhejiang, China, 310022 Contact: Weimin Mao, MD    86-571-88122182       Principal Investigator: Weimin Mao, MD Less <<
NCT00300586 Stage IV Non-small Cell Lung C... More >>ancer Less << Phase 3 Completed - France ... More >> Maurice PEROL Lyon, France, 69317 Less <<
NCT01260103 Optic Nerve Glioma Phase 3 Withdrawn(Withdrawn study halt... More >>ed prematurely, prior to enrollment of first participant) Less << December 2018 -
NCT00806117 Cervical Cancer Phase 3 Active, not recruiting December 2018 China, Guangdong ... More >> Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT00533299 Ovarian Cancer Phase 3 Unknown December 2009 Mexico ... More >> Instituto Nacional de Cancerologia Recruiting Mexico City, Tlalpan, Mexico, 14080 Principal Investigator: Dolores Gallardo, MD Less <<
NCT03717610 Ovarian Cancer Recurrent Phase 3 Recruiting December 31, 2020 Sweden ... More >> Uppsala University Hopsital Recruiting Uppsala, Sweden, 75185 Contact: Marta Lomnytska, PhD    018-611 00 00 ext +46    marta.lomnytska@akademiska.se    Contact: Ilvars Silins, PhD    018-611 00 00 ext +46    ilvars.silins@akademiska.se    Sub-Investigator: Wilhelm Graf, Professor Less <<
NCT02495896 Head and Neck Squamous Cell Ca... More >>rcinoma Metastatic Pancreatic Adenocarcinoma Non-Resectable Cholangiocarcinoma Pancreatic Adenocarcinoma Recurrent Gallbladder Carcinoma Recurrent Non-Small Cell Lung Carcinoma Stage III Pancreatic Cancer Stage IIIA Gallbladder Cancer Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Gallbladder Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Gallbladder Cancer Stage IV Non-Small Cell Lung Cancer Stage IV Pancreatic Cancer Unresectable Gallbladder Carcinoma Unresectable Pancreatic Cancer Less << Phase 1 Recruiting December 3, 2020 United States, California ... More >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Anthony El-Khoueiry    323-865-3967    elkhouei@usc.edu    Principal Investigator: Anthony El-Khoueiry, MD          Hoag Memorial Hospital Presbyterian Recruiting Newport Beach, California, United States, 92663 Contact: Alicia Bogardus, MA    949-764-6755    Alicia.bogardus@hoag.org    Contact: Cristina De Leon, RN    949-764-5543    Cristina.deleon@hoag.org    Sub-Investigator: Diana Hanna, MD Less <<
NCT00404703 Non-Small Cell Lung Cancer Phase 2 Terminated(Primary (safety) en... More >>dpoint reached) Less << - Australia ... More >> Tugun, Australia Wollongong, Australia Belgium Liege, Belgium Czech Republic Ostrava, Czech Republic Usti nad Labem, Czech Republic France Bobigny, France Marseille, France Nantes, France Hungary Szekesfehervar, Hungary Szombathely, Hungary Israel Kfar Saba, Israel Ramat Gan, Israel Poland Lublin, Poland Poznan, Poland Szczecin, Poland Warszawa, Poland Russian Federation Balashikha, Russian Federation Moscow, Russian Federation St. Petersburg, Russian Federation Spain Madrid, Spain Sevilla, Spain Taiwan Kueishan, Taiwan Taichung, Taiwan Taipei, Taiwan Taoyuan, Taiwan Less <<
NCT00005051 Ovarian Cancer Phase 2 Completed - United States, New York ... More >> Albert Einstein Clinical Cancer Center Bronx, New York, United States, 10461 New York Hospital Medical Center of Queens Fresh Meadows, New York, United States, 11365 Saint Vincent Catholic Medical Center of New York New York, New York, United States, 10011 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 St. Luke's-Roosevelt Hospital Center - Roosevelt Division New York, New York, United States, 10019 New York Weill Cornell Cancer Center at Cornell University New York, New York, United States, 10021 Mount Sinai Medical Center, NY New York, New York, United States, 10029 Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 New York Medical College Valhalla, New York, United States, 10595 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-3236 Less <<
NCT01674738 Carcinoma, Non-Small-Cell Lung Phase 2 Withdrawn(Decision of the Spon... More >>sor, as the funding of the study was no longer guaranteed.) Less << - -
NCT00806923 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 3 Completed - -
NCT01232374 Squamous Cell Carcinoma Phase 2 Unknown January 2016 China, Beijing ... More >> Chinese Academy of Medical Sciences Cancer Hospital Beijing, Beijing, China, 266000 China, Fujian Fujian Provincial Tumor Hospital Fuzhou, Fujian, China, 350000 China, Guangdong Cancer Center of Sun Yat-sen Guangzhou, Guangdong, China, 510000 China, Henan First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China, 450052 China, Hubei Huazhong University of Science and Technology, Union Hospital, Tongji Medical College Wuhan, Hubei, China, 430000 China, Jiangsu Cancer Hospital of Jiangsu Province Nanjing, Jiangsu, China, 210000 The First Affiliated Hospital of Soochow University,Suzhou First People's Hospital Suzhou, Jiangsu, China, 215006 Northern Jiangsu People's Hospital Yangzhou, Jiangsu, China, 225001 China, Jilin The first bethune hospital of Jilin university Changchun, Jilin, China China, Shandong Affiliated Hospital of Qingdao University Medical College Qingdao, Shandong, China, 266000 China, Shanghai Fudan University Shanghai Cancer Center Shanghai, Shanghai, China, 200000 Shanghai Chest Hospital Shanghai, Shanghai, China, 201100 Shanghai First People's Hospital Shanghai, Shanghai, China, 201100 China, Shanxi Fourth Military Medical University Xijing Hospital Xian, Shanxi, China, 710000 China, Tianjin Tianjin Cancer Hospital Tianjin, Tianjin, China, 300000 China, Zhejiang Zhejiang Cancer Hospital Hangzhou, Zhejiang, China, 310000 The First Affiliated Hospital of College of Medicine, Zhejiang University Hangzhou, Zhejiang, China, 310003 Less <<
NCT00176137 Non-Small Cell Lung Cancer Phase 3 Completed - -
NCT01014767 Brain Cancer ... More >>Choroid Plexus Tumors Less << Phase 3 Suspended(PI departure from co... More >>ordinating institution) Less << - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Texas Children's Cancer Hospital at UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Germany St. Hedwig Children's Hospital, University of Regensburg (International Study Center) Regensburg, Germany Hungary Semmelweis University Budapest, Hungary New Zealand Christchurch Hospital Christchurch, New Zealand Less <<
NCT00012220 Pancreatic Cancer Phase 2 Completed - -
NCT02368990 - Withdrawn(Since the conception... More >> of the study, the competitive environment has developed and as a result this study is no longer able to generate the necessary information.) Less << June 2018 -
NCT00573131 Esophageal Cancer ... More >> Adenocarcinoma of the Esophagus Squamous Cell Carcinoma Less << Phase 2 Terminated(OncoGel did not sho... More >>w any impact on overall tumor response) Less << - United States, California ... More >> University of California San Diego San Diego, California, United States, 92093 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Indiana Indiana University Medical Center Indianapolis, Indiana, United States, 46202 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 Digestive Health Specialists of Tyler, Texas Tyler, Texas, United States, 75701 Czech Republic University Hospital Brno Brno, Czech Republic, 62500 Hospital Jablonec nad Nisou Jablonec nad Nisou, Czech Republic, 466 60 University Hospital Olomouc Olomouc, Czech Republic, 775 20 University Hospital Motol Praha, Czech Republic, 150 06 Massaryk's Hospital in Usti nad Labem Usti nad Labem, Czech Republic, 401 13 India Kidwai Memorial Institute of Oncology Bangalore, Karnataka, India, 560029 Amrita Institute of Medical Sciences Kochi, Kerala, India, 682026 Bombay Hospital & Medical Research Centre Mumbai, Maharashtra, India, 400020 Deenanath Mangeshkar Hospital Erandwane, Pune, India, 411004 Meenakshi Mission Hospital and Research Centre Madurai, Tamil Nadu, India, 625107 Poland Samodzielny Publiczny Szpital Kliniczny Lublin, Poland, 20-081 Samodzielnego Publicznego Szpitala Klinicznego Szczecin, Poland, 70-111 Less <<
NCT02001168 Non-small Cell Lung Cancer Phase 3 Active, not recruiting October 2022 China, Xinjiang ... More >> Cancer Hospital of Xinjiang Medical University Urumqi, Xinjiang, China, 830011 Less <<
NCT00263016 Carcinoma, Non-Small-Cell Lung Phase 2 Terminated(Slow recruitment) - Hong Kong ... More >> Sanofi-aventis Hong Kong, Hong Kong Less <<
NCT02844114 Carcinoma, Non-Small-Cell Lung Phase 2 Recruiting January 2018 China, Liaoning ... More >> First Hospital of Dalian Medical University Recruiting Dalian, Liaoning, China, 116000 Contact: Yajie Gao, Professor    0411-83634153    gaoyajie@126.com    Contact: Yan Dong, Physician    0411-83634153    dongyan979828@hotmail.com    Principal Investigator: Yajie Gao, Professor          Sub-Investigator: Yan Dong, Physician          Sub-Investigator: Bin Zhang, Physician          Sub-Investigator: Hui Mi, Postgraduate Less <<
NCT02365935 Uterine Cervical Neoplasms Not Applicable Completed - Italy ... More >> campus bio-medico of Rome Rome, Italy, 00128 Less <<
NCT01868022 Neoplasms Phase 1 Completed - -
NCT00006004 Lung Cancer Phase 2 Completed - United States, Georgia ... More >> Emory University Hospital - Atlanta Atlanta, Georgia, United States, 30322 United States, Iowa Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Mercy Medical Center Des Moines, Iowa, United States, 50314 Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316-2301 United States, Nebraska Alegent Health-Midlands Community Hospital Papillion, Nebraska, United States, 68128-4157 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New Mexico MBCCOP - University of New Mexico HSC Albuquerque, New Mexico, United States, 87131 United States, New York James P. Wilmot Cancer Center Rochester, New York, United States, 14642 United States, Oklahoma CCOP - Oklahoma Tulsa, Oklahoma, United States, 74136 United States, Pennsylvania Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 United States, Texas CCOP - Scott and White Hospital Temple, Texas, United States, 76508 United States, Wisconsin CCOP - St. Vincent Hospital Cancer Center, Green Bay Green Bay, Wisconsin, United States, 54307-3453 Australia, New South Wales Westmead Hospital Westmead, New South Wales, Australia, 2145 Peru Instituto de Enfermedades Neoplasicas Lima, Peru, 34 Puerto Rico San Juan City Hospital San Juan, Puerto Rico, 00936-7344 Less <<
NCT02644863 Esophageal Neoplasms ... More >> Neoplasms Digestive System Neoplasms Esophageal Cancer Less << Phase 2 Recruiting May 2019 China, Guangdong ... More >> Affiliated Tumor Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510000 Contact: Zhiyuan Wang       wangzhiyuan@hornetcorn.com Less <<
NCT02899195 Mesothelioma ... More >>Pleural Mesothelioma Less << Phase 2 Active, not recruiting December 2020 -
NCT02161692 Testicular Neoplasms ... More >> Germ Cell Tumors Less << Phase 2 Completed - Italy ... More >> Istituto Nazionale dei Tumori Milano, Italy, 20133 Less <<
NCT00005047 Bladder Cancer Phase 3 Terminated(Accrual was halted ... More >>on the basis of the Data and Safety Monitoring Board review of a futility analysis.) Less << - -
NCT00005047 - Terminated(Accrual was halted ... More >>on the basis of the Data and Safety Monitoring Board review of a futility analysis.) Less << - -
NCT02624531 Cervical Cancer Not Applicable Recruiting November 2020 China, Guangdong ... More >> Clinical Trial Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Jihong Liu, Ph.D.    86-20-87343102    Liujih@mail.sysu.edu.cn    Contact: Yanling Feng, Ph.D.    86-20-87343104    fengyl@sysucc.org.cn    Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Jihong Liu, Ph.D.    86-20-87343102    Liujih@mail.sysu.edu.cn    Contact: Yanling Feng, Ph.D.    86-20-87343104    fengyl@sysucc.org.cn Less <<
NCT00573131 - Terminated(OncoGel did not sho... More >>w any impact on overall tumor response) Less << - -
NCT02766348 NSCLC Phase 2 Unknown December 2018 China, Hubei ... More >> Jingzhou Central hospital Immunotherapy center Not yet recruiting Jingzhou, Hubei, China, 434020 Contact: Fan Fu, Researcher    +86 15027082046    Fufan@hornetcorn.com    Contact: Fan Fu Less <<
NCT01363479 - Completed - -
NCT00572572 Germ Cell Tumors Phase 3 Completed - United States, Indiana ... More >> Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 United States, Missouri Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Wisconsin Froedtert/Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00572572 - Completed - -
NCT01363479 Chemotherapy-Induced Nausea an... More >>d Vomiting Less << Phase 3 Completed - -
NCT00577707 Non Small Cell Lung Cancer ... More >> Lung Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02915965 Stage II and III Esophageal Sq... More >>uamous Cell Carcinoma Less << Phase 2 Unknown - China, Guangdong ... More >> The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China, 510655 Less <<
NCT01055496 Lymphoma, B-Cell Phase 1 Completed - -
NCT02819999 Small Cell Lung Cancer Phase 1 Recruiting December 2020 United States, Colorado ... More >> University of Colorado Recruiting Aurora, Colorado, United States, 80010 Principal Investigator: David Camidge, MD          Rocky Mountain Cancer Centers Recruiting Denver, Colorado, United States, 80218 Principal Investigator: Robert Jotte, MD          United States, Florida Cancer Institute of Florida Recruiting Orlando, Florida, United States, 32804 Principal Investigator: Tarek Mekhail, MD          United States, Maryland Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Principal Investigator: Christine Hann, MD          United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Principal Investigator: Daniel Morganzstern, MD          United States, Ohio Oncology Hematology Care Recruiting Cincinnati, Ohio, United States, 45242 Principal Investigator: Patrick Ward, MD          University Hospital of Cleveland Recruiting Cleveland, Ohio, United States, 44106 Principal Investigator: Afshin Dowlati, MD          Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Principal Investigator: Nathan Pennell, MD, PhD          United States, Pennsylvania University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15232 Principal Investigator: Timothy Burns, MD          United States, Texas Texas Oncology Recruiting Fort Worth, Texas, United States, 76104 Principal Investigator: Stephen Richey, MD          Texas Oncology Recruiting San Antonio, Texas, United States, 78258 Contact    800-381-2637       Principal Investigator: Sridhar Beeram, MD Less <<
NCT02135042 Epstein-Barr Virus Infection ... More >> Stage II Nasopharyngeal Carcinoma Stage III Nasopharyngeal Carcinoma Stage IVA Nasopharyngeal Carcinoma Stage IVB Nasopharyngeal Carcinoma Less << Phase 2 Phase 3 Recruiting July 2026 -
NCT00446225 Non-Small Cell Lung Cancer Phase 3 Completed - -
NCT00002883 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 3 Unknown - France ... More >> Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Less <<
NCT01774786 Gastric Cancer Phase 3 Active, not recruiting October 6, 2021 -
NCT00403403 Small Cell Lung Cancer Phase 2 Completed - -
NCT01774786 - Active, not recruiting - -
NCT00632333 Esophageal Cancer Phase 1 Unknown March 2012 Japan ... More >> Teikyo University Recruiting 2-11-1 Kaga Itabashi-ku, Tokyo, Japan, 173-0003 Contact: Hisae Iinuma, PhD    +81-33-964-1211    iinuma@med.teikyo-u.ac.jp    Principal Investigator: Hisae Iinuma, PhD Less <<
NCT00577707 - Completed - -
NCT00001332 Peritoneal Neoplasms ... More >> Stomach Neoplasms Less << Phase 1 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT01215266 Bladder Cancer Phase 2 Terminated(Slow recruitment) - -
NCT00142350 Gastric Cancer Phase 3 Completed - Japan ... More >> Aichi Cancer Center Hospital Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi, Japan, 464-8681 Nagoya Medical Center Nagoya,Naka-ku,Sannomaru,4-1-1, Aichi, Japan, 460-0001 Aichi Cancer Center,Aichi Hospital Okazaki,Kake-machi,Kuriyado,18, Aichi, Japan, 444-0011 Aomori Prefectural Central Hospital Higashitsukurimiti,2-1-1,Aomori, Aomori, Japan, 030-0911 Chiba Cancer Center Hospital Chiba,Chuo-ku,Nitona-cho,666-2, Chiba, Japan, 260-8717 Asahi General Hospital I-1326,Asahi, Chiba, Japan, 289-2511 National Cancer Center Hospital East Kashiwa,Kashiwanoha,6-5-1, Chiba, Japan, 277-8577 National Hospital Organization Shikoku Cancer Center Matsuyama,Horinouchi,13, Ehime, Japan, 790-0007 Kyushu University Hospital Fukuoka,Higashi-ku,Maidashi,3-1-1, Fukuoka, Japan, 812-8582 National Kyushu Cancer Center Fukuoka,Minami-ku,Notame,3-1-1, Fukuoka, Japan, 811-1395 Federation of national public service personnel mutual aid associations Tonan Hospital kita 1 nishi 6,Chuo-ku,Sapporo, Hokkaido, Japan, 060-0001 Hokkaido University Hospital North-14 West-5 Kita-ku,Sapporo, Hokkaido, Japan, 060-8648 Hyogo Medical Center for Adults Akashi,Kitaouji-cho,13-70, Hyogo, Japan, 673-8558 Kobe University Graduate School of Medicine Kobe,Chuo-ku,Kusunoki-cho,7-5-2, Hyogo, Japan, 650-0017 Ibaraki Kenritsu Chuo Hospital & Cancer Center Nishi-ibarakigun,Tomobemachi,Koibuchi,6528, Ibaraki, Japan, 309-1793 Iwate Prefectural Central Hospital Morioka,Ueda,1-4-1, Iwate, Japan, 020-0066 Kitasato University East Hospital Sagamihara,Asamizodai,2-1-1, Kanagawa, Japan, 228-8520 Kanagawa Cancer Center Yokohama,Asahi-ku,Nakao,1-1-2, Kanagawa, Japan, 241-0815 Yokohama Mucipical Citizen's Hospital Yokohama,Hodogaya-ku,Okazawa-cho,56, Kanagawa, Japan, 240-8555 Yokohama City University Medical Center Yokohama,Minami-ku,Urafunecho,4-57, Kanagawa, Japan, 232-0024 Kochi Health Science Center Kochi,Ike,2125-1, Kochi, Japan, 781-8555 Kumamoto Regional Medical Center Hospital Kumamoto,Honjo,5-16-10, Kumamoto, Japan, 860-0811 Kyoto University Hospital Kyoto,Sakyo-ku,Syogoinkawara,54, Kyoto, Japan, 606-8507 Tohoku University Hospital Sendai,Aoba-ku,Seiryo-machi,1-1, Miyagi, Japan, 980-8574 Saku Central Hospital Saku,Usuda,197, Nagano, Japan, 384-0301 Osaka Medical College Takatsuki,Daigakucho,2-7, Osaka, Japan, 569-0801 Saitama Medical School Hospital Iruma-gun,Moroyama-machi,Morohongo,38, Saitama, Japan, 350-0495 Saitama Cancer Center Kita-adachi,Ina,Komuro,818, Saitama, Japan, 362-0806 Div. of Gastrointestinal Oncology, Shizuoka Cancer Center Sunto-gun, Nagaizumi-cho, Shimonagakubo,1007, Shizuoka, Japan, 411-8777 Tochigi Cancer Center Utsunomiya,Yohnan,4-9-13, Tochigi, Japan, 320-0834 National Cancer Center Hospital Chuo-ku,Tsukiji,5-1-1, Tokyo, Japan, 104-0045 Cancer Institute Hospital Koto-ku,Ariake,3-10-6, Tokyo, Japan, 135-8550 Showa University School of Medicine Shinagawa-ku,Hatanodai,1-5-8, Tokyo, Japan, 142-8666 Yamagata Prefectural Central Hospital Yamagata,Aoyagi,1800, Yamagata, Japan, 990-2292 Less <<
NCT01625702 Gastric Cancer Not Applicable Completed - China, Beijing ... More >> Department of GI Oncology, Peking University Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT01958372 Adenocarcinoma of the Lung ... More >> Adenosquamous Cell Lung Cancer Bronchoalveolar Cell Lung Cancer Large Cell Lung Cancer Recurrent Non-small Cell Lung Cancer Squamous Cell Lung Cancer Stage IIIA Non-small Cell Lung Cancer Stage IIIB Non-small Cell Lung Cancer Less << Phase 1 Active, not recruiting June 30, 2018 United States, Michigan ... More >> Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States, 48706 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Karmanos Cancer Institute at McLaren Lapeer Region Lapeer, Michigan, United States, 48446 Karmanos Cancer Institute at McLaren Central Michigan Mount Pleasant, Michigan, United States, 48858 Karmanos Cancer Institute at McLaren Northern Petoskey, Michigan, United States, 49770 Less <<
NCT00403403 - Completed - -
NCT02921984 Salivary Gland Tumors ... More >> Head and Neck Cancer Less << Phase 1 Completed - China, Shanghai ... More >> Shanghai ninth people's hospital Shanghai, Shanghai, China, 200011 Less <<
NCT02938273 Carcinoma, Squamous Cell of He... More >>ad and Neck Less << Phase 1 Recruiting October 2018 Netherlands ... More >> Antoni van Leeuwenhoek Recruiting Amsterdam, Netherlands, 1066CX Contact: Jan Paul de Boer, MD,PhD    +31 20 512 9111       Principal Investigator: Jan Paul de Boer, MD,PhD Less <<
NCT00808639 Bladder Cancer ... More >> Muscle-invasive Bladder Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Lahey Clinic Burlington, Massachusetts, United States, 01805 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01343264 - Unknown - Germany ... More >> Dr. Horst Schmidt Klinik, Department of Thoracic Surgery Recruiting Wiesbaden, Germany Contact: Joachim Schirren, MD, PhD    +49 611 433132    joachim.schirren@hsk-wiesbaden.de    Principal Investigator: Joachim Schirren, MD, PhD          Sub-Investigator: Servet Bölükbas, MD, PhD Less <<
NCT01719835 Peripheral T-cell Lymphoma NOS... More >> Anaplastic Large Cell Lymphoma, ALK-Negative Angioimmunoblastic T-cell Lymphoma Hepatosplenic Gamma/ Delta T-cell Lymphoma Enteropathy-Associated T-Cell Lymphoma Less << Phase 2 Active, not recruiting August 2022 United Kingdom ... More >> Royal Marsden NHS Foundation Trust - London and Surrey London, United Kingdom, SM2 5PT Less <<
NCT00006012 Drug/Agent Toxicity by Tissue/... More >>Organ Lung Cancer Radiation Toxicity Less << Phase 1 Phase 2 Completed - -
NCT00612495 Endometrial Cancer Phase 2 Completed - France ... More >> Sanofi-Aventis Paris, France Less <<
NCT00808639 - Completed - -
NCT00454779 Metastatic or Recurrent Squamo... More >>us Cell Carcinoma of Head and Neck Less << Phase 2 Completed - -
NCT00454779 - Completed - -
NCT01086826 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 3 Completed - -
NCT02215356 Non-small Cell Lung Cancer Phase 2 Active, not recruiting February 2019 -
NCT01640782 Adenocarcinoma of the Stomach ... More >> Adenocarcinoma of the Gastroesophageal Junction Less << Phase 3 Completed - -
NCT03308604 Gynecologic Cancer Phase 1 Recruiting May 2021 France ... More >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: CHARGARI Cyrus, MD    0142113365 ext +33    cyrus.chargari@gustaveroussy.fr    Contact: PAOLETTI Xavier, MD    0142116564 ext +33    xavier.paoletti@gustaveroussy.fr    Principal Investigator: CHARGARI Cyrus, MD Less <<
NCT01817023 Nasopharyngeal Carcinoma Phase 3 Unknown April 2018 China, Guangdong ... More >> Department of nasopharyngeal carcinoma, Cancer hospital, Sun Yat-Sen University Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Xiang Guo, MD    8613902251681    guoxiang@sysucc.org.cn    Department of Radiation oncology, Cancer hospital, Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Chong Zhao, MD    8613902206160    zhaochong@sysucc.org.cn    China, Hubei Zhongnan Hospital of Wuhan University Not yet recruiting Wuhan, Hubei, China, 430030 Contact: Conghua Xie, MD    8613638607566    chxie_65@hotmail.com    Tongji hospital, Huazhong University of Science & Technology Recruiting Wuhan, Hubei, China, 430032 Contact: Guoqing Hu, MD    8613707189803    gqhu@tjh.tjmu.edu.cn    China, Jiangxi Jiangxi province cancer hospital Not yet recruiting Nanchang, Jiangxi, China, 330029 Contact: Jingao Li, MD    8613970866296    lijingao@hotmail.com    China Cancer hospital, Chinese Academy of Medical Sciences Recruiting Beijing, China, 100021 Contact: Junlin YI, MD    861087788504    junlinyi@sohu.com Less <<
NCT00454649 Neoplasms Phase 1 Completed - United States, Georgia ... More >> Pfizer Investigational Site Augusta, Georgia, United States, 30909 Pfizer Investigational Site Augusta, Georgia, United States, 30912 United States, Illinois Pfizer Investigational Site Harvey, Illinois, United States, 60426-4265 Pfizer Investigational Site Harvey, Illinois, United States, 60426 Pfizer Investigational Site Tinley Park, Illinois, United States, 60477 United States, Indiana Pfizer Investigational Site Hobart, Indiana, United States, 46342 Pfizer Investigational Site Munster, Indiana, United States, 46321 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030-4009 United States, Washington Pfizer Investigational Site Kennewick, Washington, United States, 99336 Poland Pfizer Investigational Site Warszawa, Poland, 02-781 Spain Pfizer Investigational Site Barcelona, Spain, 08003 Pfizer Investigational Site Madrid, Spain, 28046 Less <<
NCT01519804 Non-Squamous Non-Small Cell Lu... More >>ng Cancer Less << Phase 2 Completed - -
NCT02624999 Squamous Cell Carcinoma Head a... More >>nd Neck Less << Phase 2 Not yet recruiting May 2019 Thailand ... More >> National Cancer Institute of Thailand Not yet recruiting Bangkok, Thailand, 10400 Contact: Chindavijak Somjin, MD    +66 89 6937679    jksomjin@hotmail.com    Contact: Nitiya Ritthidechratn    +66261913356    nitiya@immunovative.com    Principal Investigator: Chindavijak Somjin, MD Less <<
NCT00014313 Sarcoma Phase 2 Terminated(low accrual) - United Kingdom ... More >> Institute of Cancer Research - UK Sutton, England, United Kingdom, SM2 5NG Less <<
NCT00871403 Lung Cancer, Non-Small Cell Phase 2 Completed - Denmark ... More >> GSK Investigational Site Herlev, Denmark, 2730 United Kingdom GSK Investigational Site Sutton, Surrey, United Kingdom, SM2 5PT Less <<
NCT01467115 Head and Neck Cancer Phase 2 Completed - United States, Pennsylvania ... More >> Hahnemann University Hospital Philadelphia, Pennsylvania, United States, 19102 Less <<
NCT03199300 - Recruiting January 2021 Netherlands ... More >> University Medical Center Groningen Recruiting Groningen, Netherlands, 9713 GZ Contact: J.A. Gietema, MD, PhD    +31 50 3612821    j.a.gietema@umcg.nl    Contact: L.C. Steggink, MD    +31 50 3612821    l.c.steggink@umcg.nl    Principal Investigator: J.A. Gietema, MD, PhD Less <<
NCT00014534 Bladder Cancer Phase 3 Completed - -
NCT00454649 - Completed - -
NCT00737438 - Completed - -
NCT00011999 Head and Neck Cancer Phase 2 Completed - -
NCT01101451 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Carcinoma Cervical Squamous Cell Carcinoma, Not Otherwise Specified Stage IA Cervical Cancer Stage IB Cervical Cancer Stage IIA Cervical Cancer Less << Phase 3 Recruiting - -
NCT00737438 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan Kettering Cancer Center Commack, New York, United States Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Cancer Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center@Phelps Sleepy Hollow, New York, United States Less <<
NCT01736917 - Completed - -
NCT00292695 Lymphoma Phase 2 Completed - Taiwan ... More >> National Health Research Institutes, Lymphoma Disease Committee Taipei, Taiwan Less <<
NCT00516750 Bladder Cancer Phase 2 Terminated(Withdrawn due to la... More >>ck of enrollment.) Less << - Japan ... More >> Nagoya University Hospital Nagoya, Aichi, Japan, 466-8560 Shiga Medical Center for Adults Moriyama, Shiga, Japan, 524-8524 Kyoto University Hospital Kyoto, Japan, 606-8507 National Hospital Organization - Kyoto Medical Center Kyoto, Japan, 612-0861 Osaka Red Cross Hospital Osaka, Japan, 543-8555 Less <<
NCT00871403 - Completed - -
NCT01672671 Early Triple Negative Breast C... More >>ancer Less << Phase 2 Completed - Russian Federation ... More >> Russian Cancer Research Center named after N.N.Blokhin RAMS Moscow, Russian Federation, 115478 Less <<
NCT00006237 Melanoma (Skin) Phase 3 Completed - -
NCT01736917 Chemotherapy-Induced Nausea an... More >>d Vomiting Less << Phase 2 Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Missouri Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, Nebraska Nebraska Cancer Specialists Omaha, Nebraska, United States, 68114 United States, South Carolina MUSC Hollings Cancer Center Charleston, South Carolina, United States, 29425 Less <<
NCT00006237 - Completed - -
NCT02375204 Germ Cell Tumor ... More >> Teratoma Choriocarcinoma Germinoma Mixed Germ Cell Tumor Yolk Sac Tumor Childhood Teratoma Malignant Germ Cell Neoplasm Extragonadal Seminoma Non-seminomatous Germ Cell Tumor Seminoma Less << Phase 3 Recruiting - -
NCT00589056 Lung Cancer Phase 1 Phase 2 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT02500940 Nasopharyngeal Carcinoma Phase 3 Recruiting May 2021 Taiwan ... More >> Taichung Vaterans General Hospital Recruiting Taichung, Taiwan, 40705 Contact: Jin Ching Lin, Professor    +886 4 23592525 ext 5613    jclin@vghtc.gov.tw Less <<
NCT00003251 Drug/Agent Toxicity by Tissue/... More >>Organ Head and Neck Cancer Radiation Toxicity Less << Phase 1 Phase 2 Unknown - United States, Illinois ... More >> University of Illinois at Chicago Health Sciences Center Chicago, Illinois, United States, 60612 Less <<
NCT01345084 Carcinoma Hea... More >>d and Neck Cancer Less << Phase 3 Withdrawn(change company strat... More >>egy) Less << November 2017 Brazil ... More >> Hospital Erasto Gaetner Curitiba, Paraná, Brazil, 81520-060 Hospital de Clínicas de Porto Alegre porto Alegre, Rio Grande do Sul, Brazil, 90035-903 Fundação Pio XII - Hospital de Câncer de Barretos Barretos, São Paulo, Brazil, 14784-400 Hospital Amaral Carvalho Jau, São Paulo, Brazil, 17210-120 Centro Oncológico de Mogi das Cruzes Mogi das Cruzes, São Paulo, Brazil, 08730-500 Hospital de Base São José do Rio Preto São José do Rio Preto, São Paulo, Brazil, 15090-000 Hospital Federal de Bonsucesso Rio de Janeiro, Brazil, 210041-030 Instituto do Câncer de São Paulo São Paulo, Brazil, 01246-000 Less <<
NCT01529411 Carcinoma, Transitional Cell Phase 2 Completed - Spain ... More >> Hospital General de Elda Virgen de la Salud Elda, Alicante, Spain, 03600 ICO-Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 ICO-Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Hospital Fundació Althaia Manresa, Barcelona, Spain, 08243 Corporació Sanitaria Parc Taulí Sabadell, Barcelona, Spain, 08208 Complejo Hosp. Univ. de Santiago de Compostela Santiago de Compostela, Galicia, Spain, 15706 Hospital Universitario Fundación Alcorcón Alcorcon, Madrid, Spain, 28922 H. del Mar (Fundació Institut Mar d´Investigacions Mèdiques - FIMIM) Barcelona, Spain, 08003 H. Universitari Vall d'Hebrón Barcelona, Spain, 08035 Hospital Clínic i Provincial de Barcelona Barcelona, Spain, 08036 H. General Universitario de Ciudad Real Ciudad Real, Spain, 13005 Hospital General Universitario Gregorio Marañon Madrid, Spain, 28007 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitari Son Espases Palma de Mallorca, Spain, 07010 Clínica Universitaria de Navarra (CUN) Pamplona, Spain, 31002 Complejo Hospitalario de Navarra Pamplona, Spain, 31008 H. Universitario Virgen de la Macarena Sevilla, Spain, 41009 H. Universitario Virgen del Rocío Sevilla, Spain, 41013 IVO Valencia, Spain, 46009 Less <<
NCT00665392 Head and Neck Cancer Phase 2 Completed - France ... More >> Hôpital Simone Veil Montmorency, France, 95160 Hôpital Privé St Joseph Paris, France, 75014 Hopital Europeen Georges Pompidou Paris, France, 75015 Hopital Bichat - Claude Bernard Paris, France, 75018 Hopital Tenon Paris, France, 75970 centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Centre René Huguenin Saint Cloud, France, 92100 Hopital Foch Suresnes, France, 92151 Less <<
NCT01812369 Bladder Cancer Phase 3 Recruiting August 2021 France ... More >> UHRouen Recruiting Rouen, France, 76031 Contact: Christian PFISTER, MD    00332888163    christian.fister@chu-rouen.fr    Principal Investigator: Christian PFISTER, MD Less <<
NCT01015339 Advanced Gastric Cancer Phase 3 Unknown August 2015 China, Beijing ... More >> Department of GI Oncology, Peking University, School of Oncology Recruiting Beijing, Beijing, China, 100142 Contact: Zhihao Lu, MD    86-10-88196561    pppeirain@126.com    Principal Investigator: Shen Lin, MD Less <<
NCT00023660 Cervical Cancer Phase 1 Phase 2 Completed - -
NCT02754726 Untreated Metastatic Pancreati... More >>c Ductal Adenocarcinoma Less << Phase 2 Recruiting July 2020 United States, Arizona ... More >> HonorHealth Research Institute Recruiting Scottsdale, Arizona, United States, 85258 Contact: Joyce Schaffer, MSN, AOCNS    480-323-1339 ext option #2    Joyce.Schaffer@HonorHealth.com    Principal Investigator: Erkut Borazanci, MD Less <<
NCT00910117 Head and Neck Cancer Phase 2 Completed - China, Shanghai ... More >> Fudan University Cancer Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT00455936 Lung Cancer Phase 3 Completed - Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyenggi-do, Korea, Republic of, 411-769 Samsung Medical Center Seoul, Korea, Republic of, 135-710 Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT02947113 Non-Small Cell Lung Cancer Phase 2 Withdrawn(New studies availabl... More >>e with immunotherapy so recruitment is no longer acceptable.) Less << November 2017 -
NCT00154687 Transitional Cell Carcinoma Phase 2 Completed - Taiwan ... More >> Department of Oncology, National Taiwan University Hospital Taipei, Taiwan, 100 Less <<
NCT00349219 Advanced Non-Small Cell Lung C... More >>ancer Less << Phase 3 Completed - -
NCT01019798 Non Small Cell Lung Cancer Phase 2 Unknown December 2011 Taiwan ... More >> Section of Hematology, Department of Medicine,Taipei Medical University Hospital Recruiting Taipei, Taiwan, 110 Contact: Cheng-Jeng Tai, M.D.    886-2-27372181 ext 3903    cjtai@tmu.edu.tw    Principal Investigator: Cheng-Jeng Tai, M.D. Less <<
NCT00002670 Head and Neck Cancer Phase 3 Completed - -
NCT00758381 Locally Advanced Pancreatic Ca... More >>ncer Less << Phase 2 Unknown August 2009 Italy ... More >> A.O. Treviglio-Caravaggio, P.le Ospedale n1 Recruiting Treviglio, Bergamo, Italy, 24047 Sub-Investigator: sandro Barni, MD          Ospedale S.Orsola Fatebenefratelli Active, not recruiting Brescia, BS, Italy, 15100 A.O. Ospedale S.Martino Recruiting Genova, GE, Italy, 16132 Sub-Investigator: Alberto Sobrero, MD          A.O. san Paolo Recruiting Milano, MI, Italy, 20100 Sub-Investigator: Paolo Foa, MD          Casa di Cura Igea Not yet recruiting Milano, MI, Italy, 20100 Sub-Investigator: Gianfranco Pancera, MD          Ospedale S.Carlo Borromeo Not yet recruiting Milano, MI, Italy, 20123 Sub-Investigator: Donata Tabiadon, MD          A.O. S.Gerardo Recruiting Monza, MI, Italy, 20052 Sub-Investigator: Paolo Bidoli, MD          A.O. Universitaria Ospedali Riuniti Umberto I Recruiting Ancona, Italy, 60020 Principal Investigator: Stefano Cascinu, M.Pr          Ospedali Riuniti, Largo Barozzi, 1 Recruiting Bergamo, Italy, 24128 Principal Investigator: Roberto Labianca, MD          A.O.Policlinico S.Orsola Malpighi Active, not recruiting Bologna, Italy, 40138 A.O. Careggi-Università, Viale Pieraccini, 17 Recruiting Firenze, Italy, 50139 Sub-Investigator: Francesco Di Costanzo, MD          Ospedale Galliera Active, not recruiting Genova, Italy, 16132 A.O. Carlo Poma - Via Albertoni, 1 Recruiting Mantova, Italy, 46100 Sub-Investigator: Enrico Aitini, MD          A.O. Cà Granda, Piazza Ospedale Maggiore, 3 Recruiting Milano, Italy, 20162 Sub-Investigator: Salvatore Siena, MPr          Policlinico di modena Active, not recruiting Modena, Italy, 41100 Università Campus Biomedico, Via Emilio Longoni, 83 Active, not recruiting Roma, Italy, 00155 A.O. S.Giovanni Calabita Fatebenefratelli Active, not recruiting Roma, Italy, 00186 Less <<
NCT02497118 Non Small Cell Lung Cancer Phase 4 Completed - China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin, China, 300060 Less <<
NCT03342378 - Recruiting October 2022 United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53792 Contact: Cancer Connect    800-622-8922    cancerconnect@uwcarbone.wisc.edu    Principal Investigator: Matthew E Witek, MD Less <<
NCT00002608 Adrenocortical Carcinoma ... More >> Brain and Central Nervous System Tumors Head and Neck Cancer Liver Cancer Malignant Mesothelioma Pheochromocytoma Sarcoma Less << Phase 2 Completed - Canada, Ontario ... More >> Ottawa Regional Cancer Centre at Ottawa Hospital - General Campus Ottawa, Ontario, Canada, K1H 1C4 Less <<
NCT03214003 Small Cell Lung Cancer Limited... More >> Stage Radiotherapy Less << Not Applicable Enrolling by invitation August 2025 China ... More >> Beijing Cancer Hospital Beijing, China Less <<
NCT00566540 Head and Neck Cancer Phase 2 Unknown - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00387868 Thymoma Phase 2 Completed - United States, New Jersey ... More >> Valley Health System - The Valley Hospital Ridgewood, New Jersey, United States, 07450 Canada, Ontario University of Toronto Toronto, Ontario, Canada, M5G2C4 Less <<
NCT00462397 Cervical Cancer Phase 2 Unknown - United Kingdom ... More >> Leicester Royal Infirmary Recruiting Leicester, England, United Kingdom, LE1 5WW Contact: R. Paul Symonds, MD, FRCP, FRCR    44-116-258-6296       Royal Marsden - London Recruiting London, England, United Kingdom, SW3 6JJ Contact: Peter R. Blake, MD    44-20-7808-2581    peter.blake@rmh.nthames.nhs.uk    University College of London Hospitals Recruiting London, England, United Kingdom, WIT 3AA Contact: Mary McCormack, MD    44-20-7380-9302 Less <<
NCT03240835 - Active, not recruiting September 2018 China, Guangdong ... More >> Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China, 510060 Less <<
NCT00003945 Cervical Cancer Phase 3 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Iowa John Stoddard Cancer Center at Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Mercy Cancer Center at Mercy Medical Center-Des Moines Des Moines, Iowa, United States, 50314 Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316-2301 United States, Nebraska Midlands Cancer Center at Midlands Community Hospital Papillion, Nebraska, United States, 68128-4157 United States, New Mexico MBCCOP - University of New Mexico HSC Albuquerque, New Mexico, United States, 87131 United States, Pennsylvania Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 United States, Wisconsin CCOP - St. Vincent Hospital Cancer Center, Green Bay Green Bay, Wisconsin, United States, 54307-3453 Australia, New South Wales Westmead Hospital Westmead, New South Wales, Australia, 2145 Peru Instituto de Enfermedades Neoplasicas Lima, Peru, 34 Puerto Rico San Juan City Hospital San Juan, Puerto Rico, 00936-7344 Less <<
NCT00078949 Lymphoma Phase 3 Active, not recruiting December 2018 -
NCT00043927 Small Cell Lung Cancer Phase 3 Completed - -
NCT03196869 Locally Advanced Head and Neck... More >> Squamous Cell Carcinoma Less << Phase 2 Recruiting August 12, 2022 China, Guizhou ... More >> Cancer Hospital of Guizhou Medical University Recruiting Guiyang, Guizhou, China, 550000 Contact: Feng Jin, Bachelor    0851-86512802    jinf8865@yahoo.com.cn    Sub-Investigator: Weili Wu, master          Sub-Investigator: Jinhua Long, master          Sub-Investigator: Yuanyuan Li, master          Sub-Investigator: Xiuyun Gong, Bachelor          Sub-Investigator: Xiaoxiao Chen, Bachelor          Sub-Investigator: Juan Li, Bachelor Less <<
NCT01291095 HEAD AND NECK CANCER Phase 2 Unknown December 2012 India ... More >> Dr B.R.A.I.R.C.H, ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI Recruiting New Delhi, Other state, India, 110029 Contact: Dr SUDEEP DAS, MBBS    919350114969    sudeepdas1981@gmail.com    Contact: Dr BIDHU K MOHANTI, MD    00911126173045    drbkmohanti@rediffmail.com Less <<
NCT03493425 Stage III Nasal Cavity and Par... More >>anasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 Less << Phase 2 Recruiting February 28, 2028 United States, Pennsylvania ... More >> ECOG-ACRIN Cancer Research Group Recruiting Philadelphia, Pennsylvania, United States, 19103 Contact: Nabil F. Saba    404-778-1868       Principal Investigator: Nabil F. Saba Less <<
NCT00078949 - Active, not recruiting - -
NCT03909776 Event-free Survival|Overall Su... More >>rvival|Local-recurrence Free Survival|Pathological Response Less << COMPLETED 2019-04-08 Peking University People's Hos... More >>pital, Beijing, Beijing, China Less <<
NCT05827523 Ovarian Cancer PHASE3 RECRUITING 2030-12-31 National Cancer Center, Goyang... More >>, Gyeonggi, Korea, Republic of Less <<
NCT06445114 Oropharyngeal Cancer|Carcinoma PHASE2 NOT_YET_RECRUITING 1932-03-01 Cedars-Sinai Cancer at Beverly... More >> Hills (THO), Beverly Hills, California, 90211, United States|Cedars Sinai Medical Center, Los Angeles, California, 90048, United States|CS Cancer at Valley Oncology Medical Group, Tarzana, California, 91356, United States|CS Cancer at the Hunt Cancer Center, Torrance, California, 90505, United States Less <<
NCT04595981 SCCHN|Squamous Cell Carcinoma PHASE2 NOT_YET_RECRUITING 2025-01-29 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35233, United States Less <<
NCT00846508 Cervical Cancer PHASE3 UNKNOWN 2025-01-13 Chang Gung Memory Hpspital, Ka... More >>ohsiung, Taiwan|Chang Gung Memory Hpspital, Keelung, Taiwan Less <<
NCT06095141 Pancreatic Adenocarcinoma|Homo... More >>logous Recombination Deficiency Less << PHASE2|PHASE3 RECRUITING 2026-10-31 Shanghai Cancer Center, Shangh... More >>ai, China Less <<
NCT06358599 Bladder Cancer|Bladder Cancer ... More >>Stage I|Bladder Cancer Stage II Less << COMPLETED 2024-01-15 Ankara Etlik City Hospital, An... More >>kara, 06170, Turkey Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.33mL

0.67mL

0.33mL

16.66mL

3.33mL

1.67mL

33.33mL

6.67mL

3.33mL
Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

[1]Wang X, et al. Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem. 2000 Dec 15;275(50):39435-43.

[2]Cummings BS, et al. Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther. 2002 Jul;302(1):8-17.

[3]Park HR, et al. Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice. BMC Cancer. 2009 Mar 17;9:85.

[4]Shimeda Y, et al. Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull. 2005 Sep;28(9):1635-8.

[5]Williams RM, Shah J, Mercer E, Tian HS, Thompson V, Cheung JM, Dorso M, Kubala JM, Gudas LJ, de Stanchina E, Jaimes EA, Heller DA. Kidney-Targeted Redox Scavenger Therapy Prevents Cisplatin-Induced Acute Kidney Injury. Front Pharmacol. 2022 Jan 3;12:790913.

 

Historical Records

Categories

Inhibitors/Agonists
Apoptosis
Apoptosis Inducer
Inhibitors/Agonists
DNA Damage
DNA Alkylator/Crosslinker
Inhibitors/Agonists
Other Inhibitors/Agonists
Anti-tumor

Tags: Cisplatin | cis-Platinum | CDDP | DNA Alkylator | DNA adduct | cross linking | DNA | damage | chemotherapy |apotosis | ferroptosis | autophagy | DNA Alkylator | 15663-27-1